Citrus Sinensis ID: 014595

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420--
Protein Sequence
MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccHHHHHHHccccccccccccccccccccccccccccEEEEEEEcccccccccEEEEEEEEEEEccccEEEEEEEEcccccEEEEEcccccccHHHHHHHHHHHcccccEEEEcEEEEcccccccEEEEEEEEcccccHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEccccccccccccccEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccccccHHHHHHccHHHHHHHcHHHHccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccHHHHccccccccccccccccccccEccccccccEEEEEEEccccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHcEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHcccHHHHHHHHcHHHHHHHcccccccc
Coil and Loop (DISEMBL)
masaslgnggvgssrsvngfksssSSVDWLGREMLEMRLRdqvdndedrdsepdiidgvgaetGHVIRttiggrngnskqKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLdhpnivalkhcffsttDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCigichrdikpqnllvnphthqlklcdfgsakvlvkgepnvsyicsryyrapelifgateyttaIDIWSTGCVMAELllgqplfpgesgVDQLVEIIKVLGtptreeikcmnpnytefkfpqikphpwhkvfqkrlppeaVDLVCRffqyspnlrctaleacvhpffdelrdpntrlpngrplpplfnfkppelsgippetinrlipEHARKQNLFMALHS
Flexible Loop (DISEMBL)
masaslgnggvgssrsvngfksssSSVDWLGREMLEMRLRdqvdndedrdsepdiidgvgaetghvirttiggrngnskQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVaikkvlqdkrYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNysrihqrmpLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Low Complexity Region (SEG)
MASAslgnggvgssrsvngfksssssVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKeelylnlvleyvpeTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Disordered region (IsUnstruct)
*******************************************************IDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR**************************************************
Disordered Region (DISOPRED)
*****************************************************************VIRTTIGG**GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLF*****
Disordered Region (DISEMBL)
**************RSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Disordered Region (DISPRO)
********************************************************DG**AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLF*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	422	2.2.26 [Sep-21-2011]
Q39019	421	Shaggy-related protein ki	yes	no	0.997	1.0	0.879	0.0
Q9FVS6	420	Shaggy-related protein ki	no	no	0.990	0.995	0.866	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.954	0.980	0.753	0.0
Q8VZD5	410	Shaggy-related protein ki	no	no	0.962	0.990	0.75	0.0
P51139	411	Glycogen synthase kinase-	N/A	no	0.954	0.980	0.758	0.0
P43288	405	Shaggy-related protein ki	no	no	0.928	0.967	0.773	0.0
P43289	409	Shaggy-related protein ki	no	no	0.969	1.0	0.737	0.0
P51137	411	Glycogen synthase kinase-	N/A	no	0.971	0.997	0.750	0.0
Q40518	409	Shaggy-related protein ki	N/A	no	0.928	0.958	0.773	0.0
Q96287	472	Shaggy-related protein ki	no	no	0.912	0.815	0.748	1e-180

>sp|Q39019|KSG10_ARATH Shaggy-related protein kinase kappa OS=Arabidopsis thaliana GN=ASK10 PE=2 SV=2

 Score =  791 bits (2042), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/422 (87%), Positives = 397/422 (94%), Gaps = 1/422 (0%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MAS+ LGNG VG+SRS  G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1   MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60  AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
           EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+PEHARKQNLFMAL
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

Query: 421 HS 422
           HS
Sbjct: 420 HS 421

May mediate extracellular signals to regulate transcription in differentiating cells.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FVS6|KSG4_ARATH Shaggy-related protein kinase delta OS=Arabidopsis thaliana GN=ASK4 PE=2 SV=1

 Score =  776 bits (2003), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/419 (86%), Positives = 394/419 (94%), Gaps = 1/419 (0%)

Query: 4   ASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAET 63
           + LGNG VGSSRS    K++SSSVDWL R+MLEM++RD+ + DE+RDSEPDIIDGVGAE 
Sbjct: 3   SHLGNG-VGSSRSAKNTKNTSSSVDWLSRDMLEMKIRDKTEADEERDSEPDIIDGVGAEP 61

Query: 64  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
           GHVI TT+ GRNG S+Q VSYIAEHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKRYKN
Sbjct: 62  GHVITTTLPGRNGQSRQTVSYIAEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKN 121

Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI 183
           RELQIMQMLDHPN+V LKH F+S T+ EE+YLNLVLE+VPETVNR AR+YSR++Q MPLI
Sbjct: 122 RELQIMQMLDHPNVVCLKHSFYSRTENEEVYLNLVLEFVPETVNRTARSYSRMNQLMPLI 181

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
           YVKLYTYQICR LAY+HNC G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+S
Sbjct: 182 YVKLYTYQICRGLAYLHNCCGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNIS 241

Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
           YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT
Sbjct: 242 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 301

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
           PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTA+EAC
Sbjct: 302 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAVEAC 361

Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS 422
           +HPFFDELRDPN RLPNGRPLPPLFNFKP ELSGIPPET++RL+PEHARKQN FMALHS
Sbjct: 362 IHPFFDELRDPNARLPNGRPLPPLFNFKPQELSGIPPETVDRLVPEHARKQNHFMALHS 420

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  660 bits (1704), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 309/410 (75%), Positives = 351/410 (85%), Gaps = 7/410 (1%)

Query: 6   LGNGGVGSSRSVNGFKSSSS-SVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETG 64
           +   GV  +  +    +SS+ +VD L  E+L MR++D      D++ E  ++DG   E G
Sbjct: 1   MATAGVAPASGIVDVNASSAIAVDKLPDEILGMRIKD------DKEMEAHVVDGNSTEAG 54

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
           HVI TTIGG+NG  KQ +SY+AE  VG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNR
Sbjct: 55  HVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 114

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
           ELQ M++LDHPN+V LKHCFFSTT+K+ELYLNLVLE+VPETV+R+ R+YS+++QRMPLIY
Sbjct: 115 ELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIY 174

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           VKLY+YQICR+LAYIHNC+G+ HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN+SY
Sbjct: 175 VKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 234

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           ICSRYYRAPELIFGATEYT+AIDIWS GCV+ ELLLGQPLFPG SGVDQLVEIIKVLGTP
Sbjct: 235 ICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVLGTP 294

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           TREEIKCMNPNYTEFKFPQIK HPWHK+F+KR+PPEAVDLV R  QYSPNLR TALEA V
Sbjct: 295 TREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSPNLRSTALEALV 354

Query: 365 HPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 414
           HPFFDELRDPNTRLPNGR LPPLFNFK  EL G+P E + +L+P HARKQ
Sbjct: 355 HPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPSHARKQ 404

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  660 bits (1702), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 309/412 (75%), Positives = 352/412 (85%), Gaps = 6/412 (1%)

Query: 9   GGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIR 68
           G + +S       ++S   + L   + EM+++D      D++ E  ++DG G ETGH+I 
Sbjct: 5   GTLPASSMATKQSNASICAEKLPEGINEMKIKD------DKEMEAAVVDGNGTETGHIIV 58

Query: 69  TTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI 128
           TTIGG+NG  KQ +SY+AE +VG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ 
Sbjct: 59  TTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT 118

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
           M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV R++++YSR +QRMP+IYVKLY
Sbjct: 119 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLY 178

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
           TYQICRALAYIH  +G+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSR
Sbjct: 179 TYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 238

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           YYRAPELIFGATEYTT IDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 239 YYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 298

Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           IKCMNPNYTEFKFPQIK HPWHK+F KR PPEAVDLV R  QYSPNLR TA+EA VHPFF
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFF 358

Query: 369 DELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
           DELRDPNTRLPNGR LPPLFNFKP EL G   E +++LIP+HARKQ  F+AL
Sbjct: 359 DELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  660 bits (1702), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/410 (75%), Positives = 354/410 (86%), Gaps = 7/410 (1%)

Query: 6   LGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEP-DIIDGVGAETG 64
           + +GGV  +       +SS  V+ L  EM +M++RD      D++ E   I+DG G ETG
Sbjct: 1   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRD------DKEMEAATIVDGNGTETG 54

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
           H+I TTIGG+NG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNR
Sbjct: 55  HIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 114

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
           ELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ R+Y++++QRMP+IY
Sbjct: 115 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIY 174

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           VKLY+YQICRALAYIHN IG+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+SY
Sbjct: 175 VKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISY 234

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           ICSRYYRAPELIFGATEYTTAIDIWS GCV+ ELLLGQPLFPGESGVDQLVEIIKVLGTP
Sbjct: 235 ICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTP 294

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           TREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPNLR TALEA V
Sbjct: 295 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALV 354

Query: 365 HPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 414
           HPF+D++RDPNTRLPNGR LPPLFNFK  EL G+P E + +L+P HARKQ
Sbjct: 355 HPFYDDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQ 404

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  657 bits (1696), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 308/398 (77%), Positives = 349/398 (87%), Gaps = 6/398 (1%)

Query: 23  SSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKV 82
            S+ VD L  EM +M++RD      D++ E  ++DG G ETGH+I TTIGGRNG  KQ +
Sbjct: 14  DSTGVDKLPEEMNDMKIRD------DKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTI 67

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKH
Sbjct: 68  SYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKH 127

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           CFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y++++QRMPLIYVKLYTYQI RAL+YIH C
Sbjct: 128 CFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRC 187

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
           IG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEY
Sbjct: 188 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 247

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
           TTAID+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP
Sbjct: 248 TTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 307

Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR 382
           QIK HPWHK+F KR+PPEAVDLV R  QYSPNLR  AL+  VHPFFDELRDPN RLPNGR
Sbjct: 308 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGR 367

Query: 383 PLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
            LPPLFNFKP EL G+P E + +L+PEHARKQ  ++ L
Sbjct: 368 FLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  657 bits (1694), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 306/415 (73%), Positives = 357/415 (86%), Gaps = 6/415 (1%)

Query: 6   LGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGH 65
           + + G+  S +V     + +  D L  EM +M+++D      D++ E  I++G   ETGH
Sbjct: 1   MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQD------DKEMEATIVNGNVTETGH 54

Query: 66  VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE 125
           +I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRE
Sbjct: 55  IIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRE 114

Query: 126 LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV 185
           LQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y++++QRMPL+YV
Sbjct: 115 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYV 174

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           KLYTYQI R+L+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYI
Sbjct: 175 KLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
           CSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPT
Sbjct: 235 CSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 294

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
           REEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPNLRC AL++ VH
Sbjct: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVH 354

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
           PFFDELRDPN RLPNGR LPPLFNFKP EL G+P E + +L+PEHARKQ  +++L
Sbjct: 355 PFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQCPWLSL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  657 bits (1694), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/417 (75%), Positives = 351/417 (84%), Gaps = 7/417 (1%)

Query: 4   ASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAET 63
           AS+G       R V G        D L  EM +M++RD      DR+ E  ++DG G ET
Sbjct: 2   ASVGVAPTSGFREVLG-DGEIGVDDILPEEMSDMKIRD------DREMEATVVDGNGTET 54

Query: 64  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
           GH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQDKRYKN
Sbjct: 55  GHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKN 114

Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI 183
           RELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++YS+++QRMP+I
Sbjct: 115 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMI 174

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
           YVKLYTYQI RAL+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+S
Sbjct: 175 YVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 234

Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
           YICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGE GVDQLVEIIKVLGT
Sbjct: 235 YICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVLGT 294

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
           PTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+P EAVDLV R  QYSPNLRC AL+  
Sbjct: 295 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQALDCL 354

Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
            HPFFDELRDPN RLP GR LPPLFNFKP EL G+P ET+ +L+PEHARKQ  F+ L
Sbjct: 355 THPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHARKQCPFLGL 411

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  654 bits (1686), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 310/401 (77%), Positives = 348/401 (86%), Gaps = 9/401 (2%)

Query: 17  VNGFKSSSS---SVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGG 73
           V+G + SSS    VD L  EM +MR+RD      D++ E  I+DG G ETGH+I TTIGG
Sbjct: 9   VSGLRESSSHSVGVDRLPEEMNDMRIRD------DKEIEAAIVDGNGTETGHIIVTTIGG 62

Query: 74  RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLD 133
           R+G  KQ +SY+AE +VG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LD
Sbjct: 63  RHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 122

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPN+V LKHCFFSTT+K+E+YLNLVLEYVPETV+R+ ++Y++++QRMPLI VKLYTYQI 
Sbjct: 123 HPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQIF 182

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
           RAL+YIH+ IG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAP
Sbjct: 183 RALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           ELIFGATEYTTAIDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN
Sbjct: 243 ELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 302

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           PNY EFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPNLRCTALEA  H FFDELRD
Sbjct: 303 PNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFFDELRD 362

Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 414
           PNTRLPNGR LPPLFNFK  EL G+  E + +L+PEHARKQ
Sbjct: 363 PNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVPEHARKQ 403

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  630 bits (1624), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 289/386 (74%), Positives = 333/386 (86%), Gaps = 1/386 (0%)

Query: 28  DWLGREMLEMRLRDQVD-NDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
           D L   M+EM++RD+ + N ED+D E  +++G G ETG VI TT+GGR+G  KQ +SY+A
Sbjct: 81  DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
           + VVGTGSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQIM++ DHPN+V L+H FFS
Sbjct: 141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
           TTDK+ELYLNLVLEYVPETV R +++Y++++Q MP+I+V+LYTYQICRAL Y+H  +G+C
Sbjct: 201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVC 260

Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
           HRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPN+SYICSRYYRAPELIFGATEYT AI
Sbjct: 261 HRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAI 320

Query: 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
           D+WS GCVMAELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIK 
Sbjct: 321 DMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKA 380

Query: 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
           HPWHK+F KR+PPEAVDLV R  QYSPNLRCTALEAC HPFFD+LRDPN  LPNGR LPP
Sbjct: 381 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPP 440

Query: 387 LFNFKPPELSGIPPETINRLIPEHAR 412
           LFNF   EL+G   E   RLIP H +
Sbjct: 441 LFNFTAQELAGASTELRQRLIPAHCQ 466

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	422
449460309	428	PREDICTED: shaggy-related protein kinase	1.0	0.985	0.954	0.0
224119932	422	predicted protein [Populus trichocarpa]	1.0	1.0	0.945	0.0
224129720	422	predicted protein [Populus trichocarpa]	1.0	1.0	0.945	0.0
225465185	422	PREDICTED: shaggy-related protein kinase	1.0	1.0	0.947	0.0
359806970	420	uncharacterized protein LOC100799387 [Gl	0.950	0.954	0.948	0.0
359806021	420	uncharacterized protein LOC100820098 [Gl	0.950	0.954	0.935	0.0
116787454	424	unknown [Picea sitchensis]	1.0	0.995	0.882	0.0
297849298	421	hypothetical protein ARALYDRAFT_471093 [	0.997	1.0	0.876	0.0
15218288	421	Shaggy-related protein kinase kappa [Ara	0.997	1.0	0.879	0.0
357445263	428	Glycogen synthase kinase-3-like protein	1.0	0.985	0.908	0.0

>gi|449460309|ref|XP_004147888.1| PREDICTED: shaggy-related protein kinase kappa-like [Cucumis sativus]

 Score =  853 bits (2203), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 403/422 (95%), Positives = 414/422 (98%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MASASLGNGGVGSSRS+NGFK SSSSVDWLGREMLEMRLRD+ D DEDRDSEPDIIDGVG
Sbjct: 7   MASASLGNGGVGSSRSINGFKGSSSSVDWLGREMLEMRLRDKTDTDEDRDSEPDIIDGVG 66

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTTIGGRNG SKQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 67  AEAGHVIRTTIGGRNGQSKQNISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 126

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIV+LKHCFFSTTDKEE+YLNLVLE+VPETVNRIARNYSRI QRM
Sbjct: 127 YKNRELQIMQMLDHPNIVSLKHCFFSTTDKEEVYLNLVLEFVPETVNRIARNYSRISQRM 186

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP
Sbjct: 187 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 246

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG+PLFPGESGVDQLVEIIKV
Sbjct: 247 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGKPLFPGESGVDQLVEIIKV 306

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 307 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 366

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
           EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP EL+GIPP+T+NRLIPEHARKQNLFMAL
Sbjct: 367 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPQELAGIPPDTVNRLIPEHARKQNLFMAL 426

Query: 421 HS 422
           H+
Sbjct: 427 HT 428

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119932|ref|XP_002331098.1| predicted protein [Populus trichocarpa] gi|222872826|gb|EEF09957.1| predicted protein [Populus trichocarpa]

 Score =  837 bits (2163), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 399/422 (94%), Positives = 411/422 (97%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           M+SASLGNGGVGSSRSVNGFKSSSSS+DWLGREMLEMRLRD+VD+DEDRDSEPDIIDGVG
Sbjct: 1   MSSASLGNGGVGSSRSVNGFKSSSSSMDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTTIGGRNG S+Q VSYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTIGGRNGQSRQTVSYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR + RM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRNNPRM 180

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP THQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCDFGSAKVLVKGEP 240

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
           EAC+HPFFDELRDP TRLPNGRPLPPLFNFKP ELSGIP + +NRLIP++ARKQNLFMAL
Sbjct: 361 EACIHPFFDELRDPATRLPNGRPLPPLFNFKPQELSGIPTDIVNRLIPDYARKQNLFMAL 420

Query: 421 HS 422
           H+
Sbjct: 421 HT 422

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224129720|ref|XP_002328786.1| predicted protein [Populus trichocarpa] gi|222839084|gb|EEE77435.1| predicted protein [Populus trichocarpa]

 Score =  837 bits (2162), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 399/422 (94%), Positives = 409/422 (96%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           M+SASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRD+VD+DEDRDSEPDIIDGVG
Sbjct: 1   MSSASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTTIGGRNG S+Q +SYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTIGGRNGQSRQTISYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIVALKH FFSTTDKEELYLNLVLEYVP+TVNRIARNYSR  QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHSFFSTTDKEELYLNLVLEYVPDTVNRIARNYSRNSQRM 180

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP THQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCDFGSAKVLVKGEP 240

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
           EACVHPFFDELRDP TRLPNGRPLPPLFNFK  ELSGIP + +NRLIPE+ARKQNLFMAL
Sbjct: 361 EACVHPFFDELRDPTTRLPNGRPLPPLFNFKSQELSGIPTDIVNRLIPEYARKQNLFMAL 420

Query: 421 HS 422
           H+
Sbjct: 421 HT 422

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225465185|ref|XP_002263398.1| PREDICTED: shaggy-related protein kinase kappa [Vitis vinifera] gi|297739515|emb|CBI29697.3| unnamed protein product [Vitis vinifera]

 Score =  814 bits (2102), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 400/422 (94%), Positives = 410/422 (97%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MASASLG+GGVGSSR+ NGFK SSSSVDWLGREMLEMRLRD+VD D+DRDSEPDIIDGVG
Sbjct: 1   MASASLGHGGVGSSRTANGFKGSSSSVDWLGREMLEMRLRDRVDQDDDRDSEPDIIDGVG 60

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT GGRNG SKQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTFGGRNGQSKQTVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE+VPETVNRIARNYSRI+QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEFVPETVNRIARNYSRINQRM 180

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
           EAC+HPFFDELRDP+TRLPNGRPLPPLFNFKP ELSGIP +   RLIPEHARKQNLFMAL
Sbjct: 361 EACIHPFFDELRDPSTRLPNGRPLPPLFNFKPQELSGIPSDIRTRLIPEHARKQNLFMAL 420

Query: 421 HS 422
           H+
Sbjct: 421 HT 422

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806970|ref|NP_001241073.1| uncharacterized protein LOC100799387 [Glycine max] gi|255641011|gb|ACU20785.1| unknown [Glycine max]

 Score =  803 bits (2075), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 383/404 (94%), Positives = 393/404 (97%), Gaps = 3/404 (0%)

Query: 19  GFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNS 78
           GF+ SSSSVDWLGREMLEMRLRD  D   DRDSEPDIIDGVGAETGHVIRT+IGGRNG S
Sbjct: 20  GFRGSSSSVDWLGREMLEMRLRDHED---DRDSEPDIIDGVGAETGHVIRTSIGGRNGQS 76

Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 138
           KQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV
Sbjct: 77  KQNVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 136

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL+HCFFSTTDKEE+YLNLVLEYVPETVNRIAR+YSRI+QRMPLIYVKLYTYQICRALAY
Sbjct: 137 ALRHCFFSTTDKEEVYLNLVLEYVPETVNRIARSYSRINQRMPLIYVKLYTYQICRALAY 196

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG
Sbjct: 197 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 256

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
           ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE
Sbjct: 257 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 316

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
           FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC+HPFFDELRDPNTRL
Sbjct: 317 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACIHPFFDELRDPNTRL 376

Query: 379 PNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS 422
           PN RPLPPLFNFKP ELSG+PP+ INRLIPEHARKQNLFMALH+
Sbjct: 377 PNARPLPPLFNFKPQELSGVPPDVINRLIPEHARKQNLFMALHT 420

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806021|ref|NP_001240918.1| uncharacterized protein LOC100820098 [Glycine max] gi|255639602|gb|ACU20095.1| unknown [Glycine max]

 Score =  796 bits (2055), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 378/404 (93%), Positives = 392/404 (97%), Gaps = 3/404 (0%)

Query: 19  GFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNS 78
           GF+ SSSSVDWLGREMLEM LRD  D    RDSEPDIIDG+GAETGHVIRT++GGRNG S
Sbjct: 20  GFRGSSSSVDWLGREMLEMSLRDHEDV---RDSEPDIIDGLGAETGHVIRTSVGGRNGQS 76

Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 138
           KQ VSYI+EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV
Sbjct: 77  KQNVSYISEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 136

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL+HCF+STTDKEE+YLNLVLEYVPETVNRIAR+YSRI+QRMPLIYVKLYTYQICRALAY
Sbjct: 137 ALRHCFYSTTDKEEVYLNLVLEYVPETVNRIARSYSRINQRMPLIYVKLYTYQICRALAY 196

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG
Sbjct: 197 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 256

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
           ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE
Sbjct: 257 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 316

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
           FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC+HPFFDELRDPNTRL
Sbjct: 317 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACIHPFFDELRDPNTRL 376

Query: 379 PNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS 422
           PNGRPLPPLFNFKP ELSG+PP+ INRLIPEHARKQNLFMALH+
Sbjct: 377 PNGRPLPPLFNFKPQELSGVPPDVINRLIPEHARKQNLFMALHT 420

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116787454|gb|ABK24513.1| unknown [Picea sitchensis]

 Score =  792 bits (2046), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/424 (88%), Positives = 403/424 (95%), Gaps = 2/424 (0%)

Query: 1   MASASLG-NGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRD-QVDNDEDRDSEPDIIDG 58
           MASASLG +GGVGSSR++N  K   +SVDWLGREMLEMR+RD ++D D+++D EP I+DG
Sbjct: 1   MASASLGHSGGVGSSRTINRLKGPVNSVDWLGREMLEMRIRDNKLDVDDEKDIEPAIVDG 60

Query: 59  VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 118
           +GAE+GH+I TTIGGRNG  KQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD
Sbjct: 61  MGAESGHIIATTIGGRNGQPKQTISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 120

Query: 119 KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ 178
           KRYKNRELQIM MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR+Y+R++Q
Sbjct: 121 KRYKNRELQIMHMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARHYNRMNQ 180

Query: 179 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
           RMPLIYVKLY+YQICR+LAYIHNC+GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG
Sbjct: 181 RMPLIYVKLYSYQICRSLAYIHNCVGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 240

Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           EPN+SYICSRYYRAPELIFGATEYTTAID+WSTGCVMAELLLGQPLFPGESGVDQLVEII
Sbjct: 241 EPNISYICSRYYRAPELIFGATEYTTAIDMWSTGCVMAELLLGQPLFPGESGVDQLVEII 300

Query: 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358
           KVLGTPTREEIKCMNPNYTEFKFPQIK HPWHKVFQKRLPPEAVDLV R  QYSPNLRCT
Sbjct: 301 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKVFQKRLPPEAVDLVSRLLQYSPNLRCT 360

Query: 359 ALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFM 418
           ALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP EL+GIPP+T+ RLIPEHARKQNLFM
Sbjct: 361 ALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELAGIPPDTLERLIPEHARKQNLFM 420

Query: 419 ALHS 422
           ALH+
Sbjct: 421 ALHT 424

Source: Picea sitchensis

Species: Picea sitchensis

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297849298|ref|XP_002892530.1| hypothetical protein ARALYDRAFT_471093 [Arabidopsis lyrata subsp. lyrata] gi|297338372|gb|EFH68789.1| hypothetical protein ARALYDRAFT_471093 [Arabidopsis lyrata subsp. lyrata]

 Score =  791 bits (2042), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/422 (87%), Positives = 398/422 (94%), Gaps = 1/422 (0%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MAS+ LGNG VG+SRS  G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1   MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60  AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPN+VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNVVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGA+EY+TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYSTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
           EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+PEHARKQNLFMAL
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

Query: 421 HS 422
           HS
Sbjct: 420 HS 421

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15218288|ref|NP_172455.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|30681397|ref|NP_849627.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|42571421|ref|NP_973801.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|79317477|ref|NP_001031013.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|145323818|ref|NP_001077498.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|145323820|ref|NP_001077499.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|38503402|sp|Q39019.2|KSG10_ARATH RecName: Full=Shaggy-related protein kinase kappa; AltName: Full=ASK-kappa; Short=AtK-1 gi|20260176|gb|AAM12986.1| shaggy-like protien kinase, kappa [Arabidopsis thaliana] gi|23197848|gb|AAN15451.1| shaggy-like protien kinase, kappa [Arabidopsis thaliana] gi|332190380|gb|AEE28501.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190381|gb|AEE28502.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190382|gb|AEE28503.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190383|gb|AEE28504.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190384|gb|AEE28505.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190385|gb|AEE28506.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana]

 Score =  791 bits (2042), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/422 (87%), Positives = 397/422 (94%), Gaps = 1/422 (0%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MAS+ LGNG VG+SRS  G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1   MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60  AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
           EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+PEHARKQNLFMAL
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

Query: 421 HS 422
           HS
Sbjct: 420 HS 421

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357445263|ref|XP_003592909.1| Glycogen synthase kinase-3-like protein [Medicago truncatula] gi|92893880|gb|ABE91930.1| Protein kinase [Medicago truncatula] gi|355481957|gb|AES63160.1| Glycogen synthase kinase-3-like protein [Medicago truncatula]

 Score =  789 bits (2037), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 389/428 (90%), Positives = 400/428 (93%), Gaps = 6/428 (1%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSS-VDWLGREMLEMRLR-----DQVDNDEDRDSEPD 54
           MASASLGNGG+GSS        ++SS VDWLGREML M L      D  D D+ R+SEPD
Sbjct: 1   MASASLGNGGIGSSSRSAAALRAASSSVDWLGREMLHMNLNRDHDHDDDDEDDARESEPD 60

Query: 55  IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 114
           IIDGVGAETGHVIRT+I  RNG SKQ VSYIAEHVVGTGSFG VFQAKCRETGEIVAIKK
Sbjct: 61  IIDGVGAETGHVIRTSIAARNGQSKQNVSYIAEHVVGTGSFGTVFQAKCRETGEIVAIKK 120

Query: 115 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 174
           VLQDKRYKNRELQIMQMLDHPNIVAL+HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS
Sbjct: 121 VLQDKRYKNRELQIMQMLDHPNIVALRHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 180

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
           RI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV
Sbjct: 181 RINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 240

Query: 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
           LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL
Sbjct: 241 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 300

Query: 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354
           VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN
Sbjct: 301 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 360

Query: 355 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 414
           LRCTALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP ELSGIPP+ INRLIPEHARKQ
Sbjct: 361 LRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPDVINRLIPEHARKQ 420

Query: 415 NLFMALHS 422
           NLFMALH+
Sbjct: 421 NLFMALHT 428

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	422
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.938	0.940	0.858	4.1e-191
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.919	0.958	0.746	1.9e-163
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.898	0.924	0.758	8.1e-163
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.917	0.946	0.737	2.7e-162
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.912	0.815	0.715	7.2e-155
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.888	0.910	0.720	9.5e-153
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.888	0.921	0.715	1.1e-151
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.869	0.965	0.701	1e-148
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.900	0.867	0.658	5.6e-139
UNIPROTKB|E2R4Y4	420	GSK3B "Uncharacterized protein	0.836	0.840	0.65	2.5e-120

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1852 (657.0 bits), Expect = 4.1e-191, P = 4.1e-191
 Identities = 340/396 (85%), Positives = 362/396 (91%)

Query:    27 VDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
             VDWL R++ E R+RD+V+ D++RDSEPDIIDG GAE GHVIRTT+ GRNG S+Q VSYI+
Sbjct:    26 VDWLTRDLAETRIRDKVETDDERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYIS 85

Query:    87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
             EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKRYKNRELQIMQMLDHPN VALKH FFS
Sbjct:    86 EHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFS 145

Query:   147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
              TD               TVNR+AR+YSR +Q MPLIYVKLYTYQICRALAYIHN  G+C
Sbjct:   146 RTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLC 205

Query:   207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
             HRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA+EYTTAI
Sbjct:   206 HRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAI 265

Query:   267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
             DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP
Sbjct:   266 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 325

Query:   327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
             HPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTALEAC+HP FDELRDPNTRLPNGRPLPP
Sbjct:   326 HPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPP 385

Query:   387 LFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS 422
             LFNFKP ELSGIPPE +NRL+PEHARKQNLFMALHS
Sbjct:   386 LFNFKPQELSGIPPEIVNRLVPEHARKQNLFMALHS 421

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1591 (565.1 bits), Expect = 1.9e-163, P = 1.9e-163
 Identities = 294/394 (74%), Positives = 333/394 (84%)

Query:    27 VDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
             VD L  EM +M++RD      D++ E  ++DG G ETGH+I TTIGGRNG  KQ +SY+A
Sbjct:    18 VDKLPEEMNDMKIRD------DKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMA 71

Query:    87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
             E VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHCFFS
Sbjct:    72 ERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFS 131

Query:   147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
             TT+K              TV+R+ ++Y++++QRMPLIYVKLYTYQI RAL+YIH CIG+C
Sbjct:   132 TTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVC 191

Query:   207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
             HRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAI
Sbjct:   192 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI 251

Query:   267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
             D+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 
Sbjct:   252 DVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 311

Query:   327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
             HPWHK+F KR+PPEAVDLV R  QYSPNLR  AL+  VHPFFDELRDPN RLPNGR LPP
Sbjct:   312 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPP 371

Query:   387 LFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
             LFNFKP EL G+P E + +L+PEHARKQ  ++ L
Sbjct:   372 LFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1585 (563.0 bits), Expect = 8.1e-163, P = 8.1e-163
 Identities = 292/385 (75%), Positives = 328/385 (85%)

Query:    36 EMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSF 95
             EM+++D      D++ E  ++DG G ETGH+I TTIGG+NG  KQ +SY+AE +VG GSF
Sbjct:    32 EMKIKD------DKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSF 85

Query:    96 GVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXX 155
             G+VFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LDHPN+V+LKHCFFSTT+K     
Sbjct:    86 GIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL 145

Query:   156 XXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL 215
                      TV R++++YSR +QRMP+IYVKLYTYQICRALAYIH  +G+CHRDIKPQNL
Sbjct:   146 NLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNL 205

Query:   216 LVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVM 275
             LVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTT IDIWS GCV+
Sbjct:   206 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVL 265

Query:   276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 335
             AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F K
Sbjct:   266 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 325

Query:   336 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPEL 395
             R PPEAVDLV R  QYSPNLR TA+EA VHPFFDELRDPNTRLPNGR LPPLFNFKP EL
Sbjct:   326 RTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQEL 385

Query:   396 SGIPPETINRLIPEHARKQNLFMAL 420
              G   E +++LIP+HARKQ  F+AL
Sbjct:   386 KGASLELLSKLIPDHARKQCSFLAL 410

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1580 (561.2 bits), Expect = 2.7e-162, P = 2.7e-162
 Identities = 290/393 (73%), Positives = 334/393 (84%)

Query:    28 DWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAE 87
             D L  EM +M+++D      D++ E  I++G   ETGH+I TTIGGRNG  KQ +SY+AE
Sbjct:    23 DRLPEEMKDMKIQD------DKEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAE 76

Query:    88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
              VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHCFFST
Sbjct:    77 RVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFST 136

Query:   148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
             T+K              TV+R+ ++Y++++QRMPL+YVKLYTYQI R+L+YIH CIG+CH
Sbjct:   137 TEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCH 196

Query:   208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAID 267
             RDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAID
Sbjct:   197 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID 256

Query:   268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
             +WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK H
Sbjct:   257 VWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 316

Query:   328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL 387
             PWHK+F KR+PPEAVDLV R  QYSPNLRC AL++ VHPFFDELRDPN RLPNGR LPPL
Sbjct:   317 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPL 376

Query:   388 FNFKPPELSGIPPETINRLIPEHARKQNLFMAL 420
             FNFKP EL G+P E + +L+PEHARKQ  +++L
Sbjct:   377 FNFKPHELKGVPVEMVAKLVPEHARKQCPWLSL 409

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1510 (536.6 bits), Expect = 7.2e-155, P = 7.2e-155
 Identities = 276/386 (71%), Positives = 319/386 (82%)

Query:    28 DWLGREMLEMRLRDQVD-NDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
             D L   M+EM++RD+ + N ED+D E  +++G G ETG VI TT+GGR+G  KQ +SY+A
Sbjct:    81 DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140

Query:    87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
             + VVGTGSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQIM++ DHPN+V L+H FFS
Sbjct:   141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200

Query:   147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
             TTDK              TV R +++Y++++Q MP+I+V+LYTYQICRAL Y+H  +G+C
Sbjct:   201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVC 260

Query:   207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
             HRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPN+SYICSRYYRAPELIFGATEYT AI
Sbjct:   261 HRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAI 320

Query:   267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
             D+WS GCVMAELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIK 
Sbjct:   321 DMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKA 380

Query:   327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
             HPWHK+F KR+PPEAVDLV R  QYSPNLRCTALEAC HPFFD+LRDPN  LPNGR LPP
Sbjct:   381 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPP 440

Query:   387 LFNFKPPELSGIPPETINRLIPEHAR 412
             LFNF   EL+G   E   RLIP H +
Sbjct:   441 LFNFTAQELAGASTELRQRLIPAHCQ 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1490 (529.6 bits), Expect = 9.5e-153, P = 9.5e-153
 Identities = 271/376 (72%), Positives = 314/376 (83%)

Query:    39 LRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVV 98
             L+ + D D D++    +I+G  A TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+V
Sbjct:    27 LKRRPDIDNDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIV 86

Query:    99 FQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXX 158
             FQAKC ETGE VAIKKVLQD+RYKNRELQ+M+++DHPN+V+LKHCFFSTT +        
Sbjct:    87 FQAKCLETGESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLV 146

Query:   159 XXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218
                   T+ R+ ++Y+  +QRMP+ YVKLYTYQI R LAYIH   G+CHRD+KPQNLLV+
Sbjct:   147 MEYVPETLYRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVD 206

Query:   219 PHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL 278
             P THQ KLCDFGSAKVLVKGE N+SYICSRYYRAPELIFGATEYT++IDIWS GCV+AEL
Sbjct:   207 PLTHQCKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAEL 266

Query:   279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP 338
             LLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+P
Sbjct:   267 LLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 326

Query:   339 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGI 398
             PEA+DL  R  QYSP+LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK  ELSG 
Sbjct:   327 PEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQ-ELSGA 385

Query:   399 PPETINRLIPEHARKQ 414
              PE INRLIPEH R+Q
Sbjct:   386 SPELINRLIPEHVRRQ 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1480 (526.0 bits), Expect = 1.1e-151, P = 1.1e-151
 Identities = 269/376 (71%), Positives = 312/376 (82%)

Query:    39 LRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVV 98
             L+ + + D D++    +I+G  A TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+V
Sbjct:    25 LKRRPELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIV 84

Query:    99 FQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXX 158
             FQAKC ETGE VAIKKVLQD+RYKNRELQ+M+ +DHPN+++LKHCFFSTT +        
Sbjct:    85 FQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLV 144

Query:   159 XXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218
                   T+ R+ R+Y+  +QRMP+ YVKLYTYQI R LAYIH   G+CHRD+KPQNLLV+
Sbjct:   145 MEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 204

Query:   219 PHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL 278
             P THQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYT +IDIWS GCV+AEL
Sbjct:   205 PLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAEL 264

Query:   279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP 338
             LLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+P
Sbjct:   265 LLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 324

Query:   339 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGI 398
             PEA+DL  R  QYSP+LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK  EL G 
Sbjct:   325 PEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQ-ELGGA 383

Query:   399 PPETINRLIPEHARKQ 414
               E INRLIPEH R+Q
Sbjct:   384 SMELINRLIPEHVRRQ 399

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1452 (516.2 bits), Expect = 1.0e-148, P = 1.0e-148
 Identities = 258/368 (70%), Positives = 307/368 (83%)

Query:    47 EDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRET 106
             +D++    ++DG    TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+VFQAKC ET
Sbjct:     3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62

Query:   107 GEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV 166
             GE VAIKKVLQD+RYKNRELQ+M+++DHPN+V LKHCFFSTT K              ++
Sbjct:    63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122

Query:   167 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 226
              R+ ++YS  +QRMPL+YVKLY YQI R LAYIHN  G+CHRD+KPQNLLV+P THQ+K+
Sbjct:   123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKI 182

Query:   227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP 286
             CDFGSAK LVKGE N+SYICSR+YRAPELIFGATEYTT+IDIWS GCV+AELLLGQPLFP
Sbjct:   183 CDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242

Query:   287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 346
             GE+ VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIK HPWHK+F KR+PPEA+D   
Sbjct:   243 GENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFAS 302

Query:   347 RFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRL 406
             R  QYSP+LRCTALEAC HPFFDELR+PN RLPNGRP PPLFNFK  E++G  PE +N+L
Sbjct:   303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQ-EVAGSSPELVNKL 361

Query:   407 IPEHARKQ 414
             IP+H ++Q
Sbjct:   362 IPDHIKRQ 369

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
 Identities = 254/386 (65%), Positives = 301/386 (77%)

Query:    28 DWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAE 87
             D L +E+ E+ L D      D+D +  II G G E+G +I T   G N    + +SY AE
Sbjct:    59 DHLPKEIREVGLGD------DKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAE 112

Query:    88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
             HV+GTGSFGVVFQAKC ET E VAIKKVLQDKRYKNRELQIM+MLDHPN+V LKH FFST
Sbjct:   113 HVIGTGSFGVVFQAKCLETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFST 172

Query:   148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
             T+K              T+ R +R+Y++++Q MPLIY++LYTYQICRA+ Y+H  +G+CH
Sbjct:   173 TEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCH 232

Query:   208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAID 267
             RDIKPQNLLVN  TH++K+CDFGSAK+L+ GEPN+SYICSRYYRAPELIFGATEYT+AID
Sbjct:   233 RDIKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAID 292

Query:   268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
             +WS GCVMAEL LG PLFPGE+ VDQLVEIIK+LGTP REEIK MNP Y +FKFPQIK  
Sbjct:   293 MWSVGCVMAELFLGHPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQ 352

Query:   328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL 387
             PWHK+F++++ PEA+DL  R  QYSPNLRCTALEAC HPFFD+LRDP   LPNGR LPPL
Sbjct:   353 PWHKIFRRQVSPEAMDLASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPL 412

Query:   388 FNFKPPELSGIPPETINRLIPEHARK 413
             F+F   EL+G   E  +RLIPEHARK
Sbjct:   413 FDFTAQELAGASVELRHRLIPEHARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|E2R4Y4 GSK3B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1184 (421.8 bits), Expect = 2.5e-120, P = 2.5e-120
 Identities = 234/360 (65%), Positives = 276/360 (76%)

Query:    57 DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
             D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct:    31 DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88

Query:   117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
             QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct:    89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query:   176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
               Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct:   149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

Query:   236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
             V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct:   208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query:   296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
             EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct:   268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327

Query:   356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
             R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct:   328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 385

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.7373	0.9691	1.0	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.7738	0.9289	0.9679	no	no
Q96287	KSG8_ARATH	2, ., 7, ., 1, 1, ., 1	0.7487	0.9123	0.8156	no	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6306	0.8080	0.8811	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.7446	0.8886	0.9213	no	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.75	0.8886	0.9101	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.7309	0.8696	0.9657	no	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.8791	0.9976	1.0	yes	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5872	0.6943	0.7918	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6687	0.7606	0.8867	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.8663	0.9905	0.9952	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.7730	0.9289	0.9584	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6805	0.8364	0.8404	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6556	0.7843	0.7087	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7505	0.9715	0.9975	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7536	0.9549	0.9805	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7585	0.9549	0.9805	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7192	0.9526	0.8589	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6805	0.8364	0.8404	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.75	0.9620	0.9902	no	no
Q91757	GSK3B_XENLA	2, ., 7, ., 1, 1, ., 2, 6	0.6713	0.8388	0.8428	N/A	no
Q5YJC2	GSK3B_SPECI	2, ., 7, ., 1, 1, ., 1	0.6777	0.8364	0.8404	N/A	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6805	0.8364	0.8404	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	422
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-136
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-91
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-87
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-86
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-84
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-82
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-81
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-79
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-78
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-76
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-73
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-72
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-68
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-66
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-65
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-65
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-65
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-63
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-63
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-63
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-62
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-62
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-60
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-59
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-58
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-58
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-58
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-57
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-57
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-57
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-56
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-54
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-54
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-53
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-53
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-52
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-51
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-50
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-50
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-50
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-50
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-49
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-49
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-49
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-49
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-49
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-48
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-48
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-48
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-48
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-47
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-45
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-43
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-41
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-39
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-39
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-39
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-38
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-37
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-36
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-35
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-35
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-35
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-34
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-34
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-34
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-33
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-32
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-30
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-28
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-28
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-27
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-27
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-27
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-27
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-25
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-24
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-24
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-23
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-21
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-20
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-20
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-20
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-20
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-19
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-19
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-19
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-18
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-18
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-18
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-17
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-17
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-17
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-17
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-16
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-16
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-16
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-16
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-15
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-15
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-14
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-13
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-13
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-08
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-07
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-06
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-04
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.001
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.002
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	0.002
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.003
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.003
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	0.004

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  396 bits (1019), Expect = e-136
 Identities = 176/337 (52%), Positives = 245/337 (72%), Gaps = 5/337 (1%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
           N     SY   +++G GSFGVV++A C +T E VAIKKVLQD +YKNREL IM+ L+H N
Sbjct: 61  NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHIN 120

Query: 137 IVALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           I+ LK  +++     +++ ++LN+V+E++P+TV++  ++Y+R +  +PL  VKLY+YQ+C
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
           RALAYIH+   ICHRD+KPQNLL++P+TH LKLCDFGSAK L+ G+ +VSYICSR+YRAP
Sbjct: 181 RALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP 239

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           EL+ GAT YTT ID+WS GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MN
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           PNY + KFP +KP    KVF K  P +A++ + +F +Y P  R   +EA   PFFD+LRD
Sbjct: 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359

Query: 374 PNTRLPNG-RPLPPLFNFKPPELSGIPPETINRLIPE 409
           P  +LP     LP LFNF   E+  +      ++IP+
Sbjct: 360 PCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  277 bits (712), Expect = 6e-91
 Identities = 118/330 (35%), Positives = 178/330 (53%), Gaps = 29/330 (8%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     +G+G++GVV  A  + TG  VAIKK+      L D +   RE+++++ L H NI
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 138 VALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQIC 193
           + L       S  D  ++Y+  V E +   ++++      I    PL   +++ + YQI 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKV------IKSPQPLTDDHIQYFLYQIL 113

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRY 249
           R L Y+H+   + HRD+KP N+LVN     LK+CDFG A+ +   E        Y+ +R+
Sbjct: 114 RGLKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           YRAPEL+  ++ YT AIDIWS GC+ AELL  +PLFPG   +DQL  I++VLGTP+ E++
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231

Query: 310 KCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           K + +     +    P+    P  K+F     PEA+DL+ +   + P  R TA EA  HP
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHP 290

Query: 367 FFDELRDPNTRLPNGRPLPPLFNFKPPELS 396
           +  +L DP    P  +P      F   EL+
Sbjct: 291 YLAQLHDPE-DEPVAKPPFDFDFFDDDELT 319

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  265 bits (681), Expect = 4e-87
 Identities = 117/302 (38%), Positives = 171/302 (56%), Gaps = 37/302 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
           Y     +G G++GVV++A+ ++TGEIVA+KK+  D   +         RE+ +++ L HP
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICR 194
           NIV L     +   + +LYL  V EY    +    + Y  +    +    +K   YQ+ R
Sbjct: 59  NIVKLLDVIHT---ERKLYL--VFEYCDMDL----KKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYR 251
            LAY H    I HRD+KPQN+L+N     LKL DFG A+    G P  +Y   + + +YR
Sbjct: 110 GLAYCH-SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYR 165

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++ G+  Y+TA+DIWS GC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E    
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW-- 223

Query: 312 MNPNYTEFK-----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
             P  T+       FP+  P    KV   RL PE +DL+ +  QY+P  R +A EA  HP
Sbjct: 224 --PGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280

Query: 367 FF 368
           +F
Sbjct: 281 YF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  264 bits (676), Expect = 2e-86
 Identities = 116/298 (38%), Positives = 171/298 (57%), Gaps = 25/298 (8%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKN---RELQIMQMLD 133
           QK+  I     G G++GVV++A+ + TGEIVAIKK+              RE+++++ L+
Sbjct: 2   QKLGKI-----GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN 56

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPNI+ L   F     K +LYL  V E++   + ++ ++  R    +P   +K Y YQ+ 
Sbjct: 57  HPNIIKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLL 108

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRA 252
           + LA+ H+  GI HRD+KP+NLL+N     LKL DFG A+       P   Y+ +R+YRA
Sbjct: 109 QGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PEL+ G   Y+T +DIWS GC+ AELL  +PLFPG+S +DQL +I + LGTP  E     
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226

Query: 313 NPN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                  +F FP+    P  K+F     P+A+DL+ +   Y P+ R TA +A  HP+F
Sbjct: 227 TSLARNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  258 bits (661), Expect = 5e-84
 Identities = 111/290 (38%), Positives = 167/290 (57%), Gaps = 23/290 (7%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+ G+VF+AK RETGE VA+KKV   +          RE++ +Q   HP +V L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F          L  V+EY+P  ++ + R+  R    +P   VK Y   + + +AY+H   
Sbjct: 68  F---PHGSGFVL--VMEYMPSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA-N 118

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSRYYRAPELIFGATE 261
           GI HRD+KP NLL++     LK+ DFG A++  + EP +    + +R+YRAPEL++GA +
Sbjct: 119 GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTE 318
           Y   +D+W+ GC+ AELL G PLFPGE+ ++QL  + + LGTP  E    +  + P+Y +
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDYNK 236

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
             FP+ KP P  ++F     PEA+DL+     Y P+ R +A EA  HP+F
Sbjct: 237 ITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  252 bits (646), Expect = 4e-82
 Identities = 105/292 (35%), Positives = 155/292 (53%), Gaps = 45/292 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 138
           Y     +G GSFG V+ A+ ++TG++VAIK +      +D+    RE++I++ L HPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            L   F    D+++LYL  V+EY    +  + + +       R+     + Y  QI  AL
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKK-----RGRLSEDEARFYLRQILSAL 110

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            Y+H+  GI HRD+KP+N+L++   H +KL DFG A+ L  GE   +++ +  Y APE++
Sbjct: 111 EYLHSK-GIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL 168

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
            G   Y  A+DIWS G ++ ELL G+P FPG+   DQL+E+ K +G P            
Sbjct: 169 LG-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK----------- 213

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                P   P  W       + PEA DL+ +     P  R TA EA  HPFF
Sbjct: 214 -----PPFPPPEW------DISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  252 bits (645), Expect = 2e-81
 Identities = 112/299 (37%), Positives = 162/299 (54%), Gaps = 29/299 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 134
           Y     +G G++ VV++A+ +ETG IVAIKK+   +R +          RE++++Q L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           PNI+ L   F          +NLV E++   + ++ ++ S +        +K Y     R
Sbjct: 62  PNIIGLLDVF--GHKS---NINLVFEFMETDLEKVIKDKSIVLT---PADIKSYMLMTLR 113

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC---SRYYR 251
            L Y+H+   I HRD+KP NLL+      LKL DFG A+    G PN        +R+YR
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APEL+FGA  Y   +D+WS GC+ AELLL  P  PG+S +DQL +I + LGTPT E    
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 312 MN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           +   P+Y EFK     P P  ++F      +A+DL+ R    +PN R TA +A  HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  244 bits (626), Expect = 9e-79
 Identities = 115/292 (39%), Positives = 164/292 (56%), Gaps = 21/292 (7%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALK 141
            VVG G++GVV + + + TGEIVAIKK  +   D+  K    RE+++++ L H NIV LK
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F     K  LYL  V EYV  T+  +          +P   V+ Y +Q+ +A+AY H+
Sbjct: 67  EAFRR---KGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHS 118

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNVSYICSRYYRAPELIFGA 259
              I HRDIKP+N+LV+     LKLCDFG A+ L      P   Y+ +R+YRAPEL+ G 
Sbjct: 119 -HNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYT 317
           T Y   +D+W+ GC+MAELL G+PLFPG+S +DQL  I K LG   P+ +E+   NP + 
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236

Query: 318 EFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              FP+   P    + +  ++   A+D +    +  P  R T  E   HP+F
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  243 bits (622), Expect = 2e-78
 Identities = 98/292 (33%), Positives = 147/292 (50%), Gaps = 39/292 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G+GSFG V++AK + TG+IVA+K + +            RE++I++ L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L   F    DK+ LYL  V+EY          +Y      +     K    QI R L 
Sbjct: 61  VRLIDAF---EDKDHLYL--VMEYCEGGDLF---DYLSRGGPLSEDEAKKIALQILRGLE 112

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELI 256
           Y+H+  GI HRD+KP+N+L++     +K+ DFG AK L+K      +++ + +Y APE++
Sbjct: 113 YLHSN-GIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL 170

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
            G   Y   +D+WS G ++ ELL G+P F GE+ +DQL  I ++LG P            
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL----------- 219

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              +F + K              EA DL+ +     P+ R TA E   HP+F
Sbjct: 220 ---EFDEPKWSS--------GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  238 bits (611), Expect = 2e-76
 Identities = 109/291 (37%), Positives = 172/291 (59%), Gaps = 26/291 (8%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQ-IMQMLDHPNIVALK 141
           +G G+FG V+ A+ +ETGE+VAIKK+ +  ++ +       RE++ + ++ +HPNIV LK
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    + +ELY   V EY+   + ++ +   R  +      ++   YQI + LA+IH 
Sbjct: 65  EVF---RENDELYF--VFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             G  HRD+KP+NLLV+     +K+ DFG A+ +    P   Y+ +R+YRAPE++  +T 
Sbjct: 118 H-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPNYT 317
           Y++ +DIW+ GC+MAEL   +PLFPG S +DQL +I  VLGTPT+++     K  +    
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK--L 233

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            F+FPQ  P   H++      PEA+DL+    ++ P  R TA +A  HP+F
Sbjct: 234 GFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  231 bits (592), Expect = 1e-73
 Identities = 97/292 (33%), Positives = 158/292 (54%), Gaps = 24/292 (8%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G++G V++A+ ++TGE+VA+KK+  +   K        RE++++Q L HPNIV LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S   K  +Y+  V EY+   +  +  +      +     +K Y  Q+   L Y+H+ 
Sbjct: 66  IVTSK-GKGSIYM--VFEYMDHDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
            GI HRDIK  N+L+N     LKL DFG A+   K   +  Y   + + +YR PEL+ GA
Sbjct: 120 -GILHRDIKGSNILINNDGV-LKLADFGLARPYTK-RNSADYTNRVITLWYRPPELLLGA 176

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 316
           T Y   +D+WS GC++AEL LG+P+F G + ++QL +I ++ G+PT E    +  + P +
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWF 235

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              K  +       + F+  + P A+DL+ +     P  R +A +A  H +F
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  230 bits (589), Expect = 2e-72
 Identities = 109/305 (35%), Positives = 176/305 (57%), Gaps = 35/305 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM---QMLDHPNIVAL 140
           +G G++G+V++A  R T E+VA+KK+        D +   RE  IM   ++ DHPNIV L
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDHPNIVKL 72

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQICRALAY 198
            +   +  DK+ +YL  V EY+   ++ + R      +H+R    Y+    YQ+ +AL Y
Sbjct: 73  LNVIKAENDKD-IYL--VFEYMETDLHAVIRANILEDVHKR----YI---MYQLLKALKY 122

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS------YICSRYYRA 252
           IH+   + HRD+KP N+L+N     +KL DFG A+ L + E N        Y+ +R+YRA
Sbjct: 123 IHSG-NVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++ G+T YT  +D+WS GC++ E+LLG+PLFPG S ++QL +II+V+G P+ E+I+ +
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240

Query: 313 NPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
              +        P     P  ++   +   +A+DL+ +   ++PN R TA EA  HP+  
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299

Query: 370 ELRDP 374
           +  +P
Sbjct: 300 QFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  218 bits (558), Expect = 5e-68
 Identities = 109/309 (35%), Positives = 166/309 (53%), Gaps = 28/309 (9%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPN 136
            Y     +G+G++GVV  A    +G+ VAIKK      V    +   REL+I++   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI--YVKLYTYQICR 194
           I+A++         +   + +V++ +   ++ I      IH   PL   +++ + YQ+ R
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHI------IHSDQPLTEEHIRYFLYQLLR 118

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICSRY 249
            L YIH+   + HRD+KP NLLVN     L++ DFG A+ L             Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           YRAPEL+    EYTTAID+WS GC+ AE+L  + LFPG++ V QL  I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236

Query: 310 KCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
             +       Y +   P+ +P PW K+F K   PEA+DL+ +  Q+ P  R T  +A  H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294

Query: 366 PFFDELRDP 374
           PF  +  DP
Sbjct: 295 PFLAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  212 bits (541), Expect = 4e-66
 Identities = 104/293 (35%), Positives = 164/293 (55%), Gaps = 30/293 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGEIVA+KK+  +   +       RE+ +++ L+HPNIV L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNY--SRIHQRMPLIYVKLYTYQICRALAYIHN 201
             S     +LYL  V E++    +   + Y  S     +    +K Y YQ+ + +AY H+
Sbjct: 67  VHSEN---KLYL--VFEFL----DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 258
              + HRD+KPQNLL++     LKL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 118 H-RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 173

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPN 315
           + +Y+T +DIWS GC+ AE++  +PLFPG+S +DQL  I + LGTP  +    +  + P+
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PD 232

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           Y    FP+       KV    L  + +DL+ +   Y P  R +A  A  HP+F
Sbjct: 233 YKP-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  210 bits (537), Expect = 2e-65
 Identities = 115/306 (37%), Positives = 170/306 (55%), Gaps = 37/306 (12%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 133
           +K++ I E     G++GVV++A+ ++TGEIVA+KK+  +K  +       RE+ I+  L 
Sbjct: 8   EKLNRIEE-----GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ 62

Query: 134 HPNIVALKHCFF-STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           HPNIV +K     S  DK  +Y+  V+EYV   +  +      + Q      VK    Q+
Sbjct: 63  HPNIVTVKEVVVGSNLDK--IYM--VMEYVEHDLKSL---METMKQPFLQSEVKCLMLQL 115

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 249
              +A++H+   I HRD+K  NLL+N +   LK+CDFG A+    G P   Y   + + +
Sbjct: 116 LSGVAHLHD-NWILHRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLW 171

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           YRAPEL+ GA EY+TAID+WS GC+ AELL  +PLFPG+S +DQL +I K+LGTPT +  
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 310 KCMNPNYTEFKFPQIKPHPWHKVFQ--KRLPP-----EAVDLVCRFFQYSPNLRCTALEA 362
               P ++E    + K    +   Q  K+ P         DL+ R   Y P  R +A +A
Sbjct: 232 ----PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287

Query: 363 CVHPFF 368
             HP+F
Sbjct: 288 LKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  211 bits (540), Expect = 3e-65
 Identities = 108/305 (35%), Positives = 164/305 (53%), Gaps = 26/305 (8%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y     VG+G++G V  A   +TG  VAIKK+ +        KR Y  REL++++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 136 NIVALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           N++ L   F   +  E+   + LV   +   +N I +      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            L YIH+  GI HRD+KP N+ VN    +LK+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++     Y   +DIWS GC+MAELL G+ LFPG   +DQL  I+ ++GTP  E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 315 ----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
               NY +   PQ+    + +VF     P A+DL+ +     P+ R TA EA  HP+  E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Query: 371 LRDPN 375
             DP 
Sbjct: 304 YHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  211 bits (539), Expect = 4e-65
 Identities = 106/325 (32%), Positives = 175/325 (53%), Gaps = 28/325 (8%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     +G G++G+V  A  + TG  VAIKK+         +R   RE++I++   H NI
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-TLREIKILRRFKHENI 65

Query: 138 VALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           + +       + +   ++Y+  V E +   + ++ +      Q +   +++ + YQI R 
Sbjct: 66  IGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRG 118

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----VSYICSRYYR 251
           L YIH+   + HRD+KP NLL+N     LK+CDFG A++      +      Y+ +R+YR
Sbjct: 119 LKYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++  +  YT AIDIWS GC++AE+L  +PLFPG+  + QL  I+ VLGTP++E++ C
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236

Query: 312 M-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           + +    NY +   P     PW+K+F     P+A+DL+ +   ++P+ R T  EA  HP+
Sbjct: 237 IISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Query: 368 FDELRDPNTRLPNGRPLPPLFNFKP 392
            ++  DP+       P P  F    
Sbjct: 295 LEQYHDPSDEPVAEEPFPFDFELFD 319

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  205 bits (524), Expect = 1e-63
 Identities = 109/292 (37%), Positives = 164/292 (56%), Gaps = 27/292 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
           +G GS+GVVF+ + RETG+IVAIKK ++       K+   RE+++++ L HPN+V L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 144 FFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 200
           F     + +  L+LV EY   TV N + +N     + +P   +K   +Q  +A+ + H  
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGA 259
           NCI   HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+ G 
Sbjct: 120 NCI---HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYT 317
           T+Y   +D+W+ GCV AELL GQPL+PG+S VDQL  I K LG   P  ++I   N  + 
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235

Query: 318 EFKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
               P+ +   P    F   +   A+  +    Q  P  R +  E   HP+F
Sbjct: 236 GLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  206 bits (527), Expect = 3e-63
 Identities = 115/330 (34%), Positives = 181/330 (54%), Gaps = 26/330 (7%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G++G+V  AK  ET E VAIKK+        D +   RE+++++ LDH N++A+K  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 144 FFSTTDK--EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 +   ++Y+  V E +   +++I R+     Q +   + + + YQ+ R L YIH+
Sbjct: 73  MPPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS 126

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGAT 260
              + HRD+KP NLL+N +   LK+CDFG A+    KG+    Y+ +R+YRAPEL+   +
Sbjct: 127 A-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS 184

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF 319
           EYTTAID+WS GC+ AELL  +PLFPG+  V QL  I ++LG+P+ E++  + N     +
Sbjct: 185 EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244

Query: 320 --KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377
               P      + ++F     P A+DL+ +   + P+ R T  EA  HP+   L DP+  
Sbjct: 245 IRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303

Query: 378 LPNGRPLPPLFNFKPPELSGIPPETINRLI 407
                P    F+F+   L+    E I  LI
Sbjct: 304 PVCQTPFS--FDFEEDALT---EEDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  204 bits (520), Expect = 6e-63
 Identities = 116/291 (39%), Positives = 173/291 (59%), Gaps = 23/291 (7%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALKH 142
           +VG GS+G+V + K +ETG+IVAIKK L+   DK  K    RE+++++ L H N+V L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 143 CFFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F     K+ LYL  V E+V  TV + + +  + + +      V+ Y +QI R + + H+
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELIFGAT 260
              I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE    Y+ +R+YRAPEL+ G T
Sbjct: 119 H-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTE 318
           +Y  A+DIW+ GC++ E+L G+PLFPG+S +DQL  IIK LG   P  +EI   NP +  
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236

Query: 319 FKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            + P++K   P  K F K L    +DL  +  +  P+ R ++ +   H FF
Sbjct: 237 MRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  202 bits (516), Expect = 3e-62
 Identities = 103/295 (34%), Positives = 160/295 (54%), Gaps = 23/295 (7%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDH-PNIVALKH 142
           +G G++G V++A+ + TG++VA+KK   +   +       RE+ ++QML     IV L  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                    +  L LV EY+   + + +  N     + +P   +K + YQ+ + +A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 258
             G+ HRD+KPQNLLV+     LK+ D G  +      P  SY   I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
           +T Y+T +DIWS GC+ AE+   QPLFPG+S + QL+ I K+LGTPT +      P  ++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSK 241

Query: 319 FK----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
            +    FPQ KP    +     L PE +DL+ +  +Y P  R +A  A  HP+FD
Sbjct: 242 LRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  200 bits (512), Expect = 8e-62
 Identities = 102/287 (35%), Positives = 152/287 (52%), Gaps = 21/287 (7%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQML-DHPNIVALKH 142
           G G+F  V +A+ R+TG+  AIK +   K +K+       RE+Q ++ L  HPNI+ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             F   D++   L LV E +   +  + +      + +P   VK Y YQ+ ++L ++H  
Sbjct: 66  VLF---DRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRDIKP+N+L+      LKL DFGS + +    P   YI +R+YRAPE +     Y
Sbjct: 120 -GIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTEFKF 321
              +DIW+ GCV  E+L   PLFPG + +DQ+ +I  VLGTP  E +K      +  + F
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           P  K     K+       E +DL+ +   Y P+ R TA +A  HP+F
Sbjct: 237 PSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  195 bits (498), Expect = 8e-60
 Identities = 107/292 (36%), Positives = 168/292 (57%), Gaps = 28/292 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G++  V++ + R TGEIVA+K++  D          RE+ +M+ L H NIV L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHN 201
             T +K    L LV EY+ + + +    Y   H     +    VK +TYQ+ + +A+ H 
Sbjct: 67  IHTENK----LMLVFEYMDKDLKK----YMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 258
              + HRD+KPQNLL+N    +LKL DFG A+    G P  ++   + + +YRAP+++ G
Sbjct: 119 N-RVLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 316
           +  Y+T+IDIWS GC+MAE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            +  FP+  P    ++F     P  +DL+ R  Q +P LR +A +A  HP+F
Sbjct: 235 -KPTFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  194 bits (496), Expect = 2e-59
 Identities = 103/298 (34%), Positives = 162/298 (54%), Gaps = 24/298 (8%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 137
           +Y     +G GS+  V++ + + TG++VA+K++ L+ +        RE  +++ L H NI
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L H    T       L LV EY+   + +   +       + +  V+L+ +Q+ R LA
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLA 117

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           Y H    + HRD+KPQNLL++    +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YCHQ-RRVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPD 173

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--C 311
           ++ G+TEY+T++D+W  GC+  E+  G+PLFPG + V DQL +I +VLGTPT E      
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            NP +  + FP   P P      +    P   +L  +F QY P  R +A EA  HP+F
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  193 bits (493), Expect = 2e-58
 Identities = 104/295 (35%), Positives = 171/295 (57%), Gaps = 25/295 (8%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
           VG G+FG+V  A+ + TG+ VAIKK+++        +   REL++++ L H NI++L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F S    E++Y   V E +   ++R+  +     + +   +++ + YQI R L Y+H+  
Sbjct: 78  FISP--LEDIYF--VTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA- 127

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEY 262
           G+ HRD+KP N+L+N +   LK+CDFG A++    +P ++ Y+ +RYYRAPE++    +Y
Sbjct: 128 GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 319
              +DIWS GC+ AE+L G+PLFPG+  V+Q   I  +LGTP  + I  + + N   F  
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
             P+ +P P+ + F+    P A+DL+ +   + P  R +A EA  HP+     DP
Sbjct: 244 SLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  192 bits (491), Expect = 2e-58
 Identities = 110/326 (33%), Positives = 157/326 (48%), Gaps = 52/326 (15%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 141
           + +G G++G+V++A+   +GEIVA+KKV  D           RE+ ++  L HPNIV LK
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 200
                   K    + LV+EY  + +  +  N            VK    Q+ R L Y+H 
Sbjct: 73  EV---VVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE 126

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 257
           N I   HRD+K  NLL+      LK+ DFG A+    G P       + + +YRAPEL+ 
Sbjct: 127 NFI--IHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLL 181

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PN 315
           G T YTTAID+W+ GC++AELL  +PL PG+S ++QL  II++LGTP        +  P 
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 316 YTEFKFPQ-----IKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
             +F  P+     +K   PW       L    + L+     Y P  R TA EA    +F 
Sbjct: 242 VGKFTLPKQPYNNLKHKFPW-------LSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Query: 370 ELRDPNTRLPNGRPLPPLFNFKPPEL 395
           E           +PLP       PE+
Sbjct: 295 E-----------KPLP-----CEPEM 304

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  191 bits (487), Expect = 4e-58
 Identities = 110/306 (35%), Positives = 166/306 (54%), Gaps = 41/306 (13%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 133
           QKV  I E     G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+
Sbjct: 3   QKVEKIGE-----GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPNIV L     +   + +LYL  V E++ + + +           +PLI  K Y +Q+ 
Sbjct: 58  HPNIVKLLDVIHT---ENKLYL--VFEFLHQDLKKFMDASPLSGIPLPLI--KSYLFQLL 110

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYY 250
           + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +Y
Sbjct: 111 QGLAFCHSH-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWY 166

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
           RAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP      
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV--- 223

Query: 311 CMNPNYTEFK-----FPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + P  T        FP+         F K +PP   +  DL+ +   Y PN R +A  A
Sbjct: 224 -VWPGVTSLPDYKPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278

Query: 363 CVHPFF 368
             HPFF
Sbjct: 279 LAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  191 bits (486), Expect = 3e-57
 Identities = 119/333 (35%), Positives = 180/333 (54%), Gaps = 33/333 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y  + V+G GS+GVV  A    TGE VAIKK+      + D     RE++++++L HP+I
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR---NYSRIHQRMPLIYVKLYTYQICR 194
           V +KH     + +E   + +V E +   ++++ +   + +  H        + + YQ+ R
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH-------QFFLYQLLR 114

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----VSYICSRYY 250
           AL YIH    + HRD+KP+N+L N    +LK+CDFG A+V     P       Y+ +R+Y
Sbjct: 115 ALKYIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 251 RAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           RAPEL  G+  ++YT AIDIWS GC+ AE+L G+PLFPG++ V QL  I  +LGTP+ E 
Sbjct: 173 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231

Query: 309 I-KCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACV 364
           I +  N     +     K  P    F ++ P   P A+ L+ R   + P  R TA EA  
Sbjct: 232 ISRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289

Query: 365 HPFFDELRDPNTRLPNGRPLPPL-FNFKPPELS 396
            P+F  L     R P+ +P+  L F F+   L+
Sbjct: 290 DPYFKGLAKVE-REPSAQPITKLEFEFERRRLT 321

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  188 bits (479), Expect = 4e-57
 Identities = 97/291 (33%), Positives = 142/291 (48%), Gaps = 46/291 (15%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 141
            ++G GSFG V+ A  ++TGE++A+K V L     +      RE++I+  L HPNIV   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             + S  D+E+  LN+ LEYV   +++ + + + ++ + +    ++ YT QI   LAY+H
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 257
           +  GI HRDIK  N+LV+     +KL DFG AK L     GE   S   + Y+ APE+I 
Sbjct: 119 SN-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G  EY  A DIWS GC + E+  G+P +         +  I   G P             
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
               P+I  H         L  EA D + +  +  P  R TA E   HPF 
Sbjct: 223 ----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  188 bits (479), Expect = 9e-57
 Identities = 105/298 (35%), Positives = 171/298 (57%), Gaps = 29/298 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ R T E +A+KK+  ++  +       RE+ +++ + H NIV L+  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 144 FFSTTDKEELYLNLVLEYVPETVNR---IARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             S     E  L LV EY+   + +    + ++++ + R+    +K Y YQI R +AY H
Sbjct: 70  VHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILRGIAYCH 119

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 257
           +   + HRD+KPQNLL++  T+ LKL DFG A+    G P  ++   + + +YRAPE++ 
Sbjct: 120 SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILL 176

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PN 315
           G+  Y+T +DIWS GC+ AE++  +PLFPG+S +D+L +I ++LGTP  E    +   P+
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           Y    FP+  P     V    L P  VDL+ +  +  P+ R TA  A  H +F +L D
Sbjct: 237 YKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  187 bits (477), Expect = 1e-56
 Identities = 110/296 (37%), Positives = 160/296 (54%), Gaps = 36/296 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  DK+   L LV EY  + + +    +   +  +    VK + +Q+ + LA+ H+  
Sbjct: 68  LHS--DKK---LTLVFEYCDQDLKKY---FDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N +  +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E      P  +  
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW----PGVS-- 229

Query: 320 KFPQIKPHP-------WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           K P  KP+P          V   +L     DL+      +P  R +A EA  HP+F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  183 bits (467), Expect = 1e-54
 Identities = 107/313 (34%), Positives = 159/313 (50%), Gaps = 45/313 (14%)

Query: 90  VGTGSFGVVFQAKCRET--GEIVAIKKV-------LQDKRYKNRELQIMQML-DHPNIVA 139
           +G G++G+V  A+  ET   E VAIKK+       +  KR   REL++++    H NI  
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-ALRELKLLRHFRGHKNITC 66

Query: 140 LKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           L            ELYL    E +   +++I R+     Q +   + + + YQI   L Y
Sbjct: 67  LYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKY 120

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNVS-YICSRYYRAP 253
           IH+   + HRD+KP NLLVN    +LK+CDFG A+       +    ++ Y+ +R+YRAP
Sbjct: 121 IHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------ 307
           E++     YT AID+WS GC++AELL  +P+F G+  VDQL +I++VLGTP  E      
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238

Query: 308 EIKCMN-----PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
             K  N     PN  +  F  I P+           P A+DL+ +   + P  R +  EA
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNA---------NPLALDLLEKLLAFDPTKRISVEEA 289

Query: 363 CVHPFFDELRDPN 375
             HP+     DP+
Sbjct: 290 LEHPYLAIWHDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  183 bits (466), Expect = 1e-54
 Identities = 99/304 (32%), Positives = 146/304 (48%), Gaps = 35/304 (11%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 143
           G G+FG V++A+  +TG +VA+KK+L     K+       RE++I++ L HPN+V L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 144 FFSTTDKE-----ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                DK       +Y+  V  Y+   ++ +  N   +      I  K Y  Q+   + Y
Sbjct: 76  AVERPDKSKRKRGSVYM--VTPYMDHDLSGLLEN-PSVKLTESQI--KCYMLQLLEGINY 130

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY------------IC 246
           +H    I HRDIK  N+L++ +   LK+ DFG A+      PN               + 
Sbjct: 131 LH-ENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188

Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           +R+YR PEL+ G   YTTA+DIW  GCV AE+   +P+  G+S +DQL  I K+ GTPT 
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248

Query: 307 EEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           E        P           P    + F K   PE +DL+ +     P  R TA +A  
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLG-PEGLDLLSKLLSLDPYKRLTASDALE 307

Query: 365 HPFF 368
           HP+F
Sbjct: 308 HPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  182 bits (462), Expect = 1e-53
 Identities = 108/301 (35%), Positives = 165/301 (54%), Gaps = 30/301 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A  R TG  VAIKK+       L  KR   REL++++ + H N++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMKHENVIGLLD 81

Query: 143 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F      +  +   LV+ ++   + ++ +     H+++    ++   YQ+ + L YIH 
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA 136

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I     
Sbjct: 137 A-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMH 192

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           YT  +DIWS GC+MAE+L G+PLF G   +DQL+EI+KV GTP++E ++ +      NY 
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252

Query: 318 EFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           + K P+ +     K F+  LP   P AV+++ +        R TA EA  HP+F+E  DP
Sbjct: 253 K-KLPRFR----KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Query: 375 N 375
            
Sbjct: 308 E 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  179 bits (457), Expect = 1e-53
 Identities = 99/294 (33%), Positives = 162/294 (55%), Gaps = 31/294 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLDHPNIVA 139
           +G G++GVV++ + ++TG+IVA+KK+    R ++          RE+ +++ L HPNIV 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L+         +E  L L+ E++   + +   +     Q M    VK Y YQI + + + 
Sbjct: 64  LQDVLM-----QESRLYLIFEFLSMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 256
           H+   + HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAPE++
Sbjct: 118 HS-RRVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 314
            G+  Y+T +DIWS G + AE+   +PLF G+S +DQL  I ++LGTPT +    +   P
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           +Y    FP+ K     +   K L  + +DL+ +   Y P  R +A +A  HP+F
Sbjct: 234 DYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (451), Expect = 1e-53
 Identities = 69/247 (27%), Positives = 121/247 (48%), Gaps = 40/247 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G FG V+ A+ ++TG+ VAIK + ++          RE++I++ L+HPNIV L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                ++E +L LV+EY    ++  + +       ++    +     QI   L Y+H+  
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN- 111

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEY 262
           GI HRD+KP+N+L++    ++KL DFG +K+L   +  +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 321
           +   DIWS G ++ EL              +L ++I+          K +  +  +    
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 322 PQIKPHP 328
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  176 bits (449), Expect = 2e-52
 Identities = 97/295 (32%), Positives = 150/295 (50%), Gaps = 30/295 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD---HPN 136
           +G G++G V++A+   TG  VA+KKV    R             RE+ +++ L+   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L           EL L LV E+V + +        +    +P   +K    Q+ R +
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK--PGLPPETIKDLMRQLLRGV 120

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++H    I HRD+KPQN+LV     Q+K+ DFG A++        S + + +YRAPE++
Sbjct: 121 DFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
             ++ Y T +D+WS GC+ AEL   +PLF G S  DQL +I  V+G P+ EE    N + 
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP-RNVSL 236

Query: 317 TEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
               FP   P      F+  +P    E +DL+ +   ++P+ R +A EA  HP+F
Sbjct: 237 PRSSFPSYTPRS----FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  176 bits (447), Expect = 1e-51
 Identities = 105/302 (34%), Positives = 158/302 (52%), Gaps = 21/302 (6%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNI 137
           Y +   VG+G++G V  A  + TGE VAIKK+    Q + +  R   EL +++ + H N+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 138 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           + L   F S    +E     LV+ Y+   + +I      +   +    V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI------MGHPLSEDKVQYLVYQMLCGL 130

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            YIH+  GI HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH--ADAEMTGYVVTRWYRAPEVI 186

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P  E ++ +    
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246

Query: 317 TEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            +  + +  P    K F    P   P+AVDL+ +  +   + R TA EA  HP+FD  RD
Sbjct: 247 AK-SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305

Query: 374 PN 375
            +
Sbjct: 306 AD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  175 bits (443), Expect = 1e-50
 Identities = 90/334 (26%), Positives = 136/334 (40%), Gaps = 48/334 (14%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHP 135
           SY     +G GSFG V+ A+ R+   +VA+K + +    K+       RE+QI+  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 136 -NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
            NIV L   F     ++E  L LV+EYV                 +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-------SYICS 247
           AL Y+H+  GI HRDIKP+N+L++     +KL DFG AK+L              + + +
Sbjct: 113 ALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 248 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG 302
             Y APE++ G +    +++ DIWS G  + ELL G P F GE       Q ++II  L 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
           TP                       P      + +   A DL+ +     P  R ++   
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Query: 363 CVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 396
             H     L+   + L +          +     
Sbjct: 273 LSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPP 306

Length = 384

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  171 bits (435), Expect = 2e-50
 Identities = 114/295 (38%), Positives = 160/295 (54%), Gaps = 30/295 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 142
           VVG G++GVV + + +ET EIVAIKK          K    REL++++ L   NIV LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL----IYVKLYTYQICRALAY 198
            F     + +LYL  V EYV        +N   + + MP       V+ Y YQ+ +A+ +
Sbjct: 68  AF---RRRGKLYL--VFEYV-------EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYICSRYYRAPELI 256
            H    I HRDIKP+NLL++ H   LKLCDFG A+ L +G       Y+ +R+YR+PEL+
Sbjct: 116 CHKN-DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NP 314
            GA  Y  A+D+WS GC++ EL  GQPLFPGES +DQL  I KVLG    E++K    NP
Sbjct: 174 LGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232

Query: 315 NYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            +   +FP +  P    + +   L    +DL+    + +P  R    +   HP F
Sbjct: 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  172 bits (437), Expect = 2e-50
 Identities = 106/299 (35%), Positives = 164/299 (54%), Gaps = 23/299 (7%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +YI    +G G++  VF+ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L       TDK    L LV EY+ + + +   +   I   M +  VK++ YQI R LA
Sbjct: 67  VTLHDIVH--TDKS---LTLVFEYLDKDLKQYMDDCGNI---MSMHNVKIFLYQILRGLA 118

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G++EY+T ID+W  GC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ 
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234

Query: 315 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           N  +  + FP+ KP P       RL  E ++L+ +F QY    R +A EA  H +F  L
Sbjct: 235 NDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  173 bits (440), Expect = 3e-50
 Identities = 109/307 (35%), Positives = 158/307 (51%), Gaps = 43/307 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK---VLQD----KRYKNRELQIMQMLDHPNIV---- 138
           +G G+FGVV+       G+ VA+KK   V Q+    KR   REL+++    H N++    
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66

Query: 139 ----ALKHCFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQIC 193
                    F      EE+Y+  V E +   +++ I        Q +   +VK++ YQI 
Sbjct: 67  ILQPPHIDPF------EEIYV--VTELMQSDLHKIIVSP-----QPLSSDHVKVFLYQIL 113

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-----ICSR 248
           R L Y+H+  GI HRDIKP NLLVN +   LK+CDFG A+V    EP+ S      + ++
Sbjct: 114 RGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVVTQ 168

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           YYRAPE++ G+  YT+A+DIWS GC+ AELL  + LF  +S + QL  I  +LGTP+ E 
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228

Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 365
           ++                 P   V          EAV L+CR   + P+ R +A +A  H
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288

Query: 366 PFFDELR 372
           P+ DE R
Sbjct: 289 PYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  170 bits (433), Expect = 1e-49
 Identities = 102/329 (31%), Positives = 154/329 (46%), Gaps = 54/329 (16%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------- 123
           +  ++      H+ G G++G V +A    TG+IVAIKKV +     N             
Sbjct: 5   SISERYIQKGAHL-GEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCG 62

Query: 124 ------RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 177
                 REL+IM  + H NI+ L   +      E  ++NLV++ +   + ++     +I 
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYV-----EGDFINLVMDIMASDLKKVVD--RKI- 114

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK---- 233
            R+    VK    QI   L  +H      HRD+ P N+ +N      K+ DFG A+    
Sbjct: 115 -RLTESQVKCILLQILNGLNVLHKWY-FMHRDLSPANIFINSKG-ICKIADFGLARRYGY 171

Query: 234 -VLVKGEPNVSYICSR----------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 282
                       +  R          +YRAPEL+ GA +Y  A+D+WS GC+ AELL G+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Query: 283 PLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP 339
           PLFPGE+ +DQL  I ++LGTP  +   + K + P YTEF     KP     +F      
Sbjct: 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKL-PLYTEFTP--RKPKDLKTIFPNA-SD 287

Query: 340 EAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           +A+DL+    + +P  R +A EA  H +F
Sbjct: 288 DAIDLLQSLLKLNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  169 bits (431), Expect = 2e-49
 Identities = 106/322 (32%), Positives = 151/322 (46%), Gaps = 56/322 (17%)

Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 140
           +G G++G V++AK +    G+  AIKK   DK           RE+ +++ L H N+V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRA 195
              F    DK    + L+ +Y    + +I + + +     I   M    VK   +QI   
Sbjct: 68  VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM----VKSLLWQILNG 120

Query: 196 LAYIH-NCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA-------KVLVKGEPNVSY 244
           + Y+H N +   HRD+KP N+LV    P    +K+ D G A       K L   +P V  
Sbjct: 121 VHYLHSNWV--LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLV 295
           I   +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F G             DQL 
Sbjct: 179 I---WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235

Query: 296 EIIKVLGTPTREE---IKCMNPNYTEFKFPQIKPHPW----HKVFQKRLP--PEAVDLVC 346
            I +VLGTPT ++   IK M P Y                  K  +K      +  DL+ 
Sbjct: 236 RIFEVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294

Query: 347 RFFQYSPNLRCTALEACVHPFF 368
           +  +Y P  R TA EA  HP+F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  169 bits (429), Expect = 6e-49
 Identities = 101/304 (33%), Positives = 158/304 (51%), Gaps = 21/304 (6%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ + H N++ L   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F   T  E    + LV   +   +N I +      Q++   +V+   YQ+ R L YIH+ 
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N+ VN    +L++ DFG A+     +    Y+ +R+YRAPE++     Y
Sbjct: 138 -GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPEIMLNWMHY 193

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +K ++  +      
Sbjct: 194 NQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253

Query: 323 QIKPHPWH---KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
            +   P     K+F +   P A+DL+ +      + R +A EA  HP+F +  DP    P
Sbjct: 254 SLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE-P 311

Query: 380 NGRP 383
              P
Sbjct: 312 EAEP 315

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  167 bits (425), Expect = 7e-49
 Identities = 98/308 (31%), Positives = 164/308 (53%), Gaps = 23/308 (7%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +YI    +G G++  V++ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L H    T    E  L LV EY+ + + +   +       + +  VKL+ +Q+ R L 
Sbjct: 67  VTL-HDIIHT----EKSLTLVFEYLDKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLN 118

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 312
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           N  +  + +P+ +    H     RL  +  +L+ +  Q+    R +A EA  HP+F  L 
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293

Query: 373 DPNTRLPN 380
           +   +LP+
Sbjct: 294 ERIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  167 bits (424), Expect = 8e-49
 Identities = 110/301 (36%), Positives = 166/301 (55%), Gaps = 30/301 (9%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
           SY+    +G GS+  V++   R  G++VA+K V+  K  +       RE  +++ L H N
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           IV L H    T +     L  V EY+  +    + ++   +H       V+L+ +Q+ R 
Sbjct: 65  IVLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRG 115

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRA 252
           LAYIH    I HRD+KPQNLL++ +  +LKL DFG A+   K  P+ +Y   + + +YR 
Sbjct: 116 LAYIHG-QHILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRP 171

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKC 311
           P+++ GAT+Y++A+DIW  GC+  E+L GQP FPG S V +QL +I  VLG PT +    
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231

Query: 312 MN--PNYTEFKFPQIKPHPWHKVFQKRL--PPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           ++  PNY    F   KP     V+ KRL  PP+A DL  +     P  R +A +A +HP+
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVW-KRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Query: 368 F 368
           F
Sbjct: 291 F 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  168 bits (427), Expect = 1e-48
 Identities = 92/307 (29%), Positives = 158/307 (51%), Gaps = 44/307 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-VLQDKR---YKNRELQIMQMLDHPNIVALKHCFF 145
           +G GS G+VF A   +  + VA+KK VL D +   +  RE++I++ LDH NIV +     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 146 S-----TTDKEELY----LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                 T D   L     + +V EY+   +  +          +   + +L+ YQ+ R L
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGL 127

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-------ICSRY 249
            YIH+   + HRD+KP N+ +N     LK+ DFG A+++   +P+ S+       + +++
Sbjct: 128 KYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGLVTKW 183

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTR 306
           YR+P L+     YT AID+W+ GC+ AE+L G+PLF G   ++Q+   +E + V+    R
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 307 EEIKCMNPNYTEFKFPQIKPHPW--HKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALE 361
            E+  + P++       ++       +  +  LP   PEA+D + +   ++P  R TA E
Sbjct: 244 NELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296

Query: 362 ACVHPFF 368
           A +HP+ 
Sbjct: 297 ALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  167 bits (424), Expect = 3e-48
 Identities = 104/298 (34%), Positives = 158/298 (53%), Gaps = 24/298 (8%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 143 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F      EE   + LV   +   +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 138

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 255 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  164 bits (418), Expect = 3e-48
 Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 42/285 (14%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHC 143
             +G G FG V++A+ + TG+ VAIK + L+ K  K     E+QI++   HPNIV     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           +     K+EL+  +V+E+    ++  + ++    +Q +    +     ++ + L Y+H+ 
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRDIK  N+L+     ++KL DFG +  L   +   + + + Y+ APE+I G   Y
Sbjct: 117 NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPY 174

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
               DIWS G    EL  G+P +  E    + +  I   G P                  
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPP---------------GLR 218

Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
              P  W          E  D + +  Q +P  R TA +   HPF
Sbjct: 219 --NPEKW--------SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  163 bits (416), Expect = 6e-48
 Identities = 91/292 (31%), Positives = 137/292 (46%), Gaps = 55/292 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALKH 142
           +G GSFG V   + ++TG++ A+K     K+++ K   +   E  I+  ++HP IV L H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             F T +K    L LVLEY P  E  + +++       R      + Y  +I  AL Y+H
Sbjct: 60  YAFQTEEK----LYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLH 110

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 259
           +  GI +RD+KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G 
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y  A+D WS G ++ E+L G+P F  E    ++ E I                     
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CV--HPFF 368
           +FP            + L PEA DL+    Q  P  R  +  A  +  HPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  164 bits (415), Expect = 1e-47
 Identities = 97/296 (32%), Positives = 156/296 (52%), Gaps = 23/296 (7%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +Y+    +G G++  VF+ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L H    T    E  L LV EY+   + +   N   +   M +  VK++ +Q+ R L+
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLS 117

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           Y H    I HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 118 YCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 173

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CM 312
           ++ G+TEY+T ID+W  GC++ E+  G+P+FPG +  ++L  I ++LGTPT E       
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           N  +  + FPQ +  P       RL  + +DL+     Y    R +A  A  H +F
Sbjct: 234 NEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  158 bits (402), Expect = 3e-45
 Identities = 97/310 (31%), Positives = 150/310 (48%), Gaps = 53/310 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 142
            +G G++G V++A+ ++TGE+VA+KKV  D   +       RE++I++ L+H NIV LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 143 CFFSTTD-----KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY------- 190
                 D     K++    LV EY+              H  M L+   L  +       
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMD-------------HDLMGLLESGLVHFSEDHIKS 120

Query: 191 ---QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYI 245
              Q+   L Y H      HRDIK  N+L+N +  Q+KL DFG A++    E  P  + +
Sbjct: 121 FMKQLLEGLNYCHK-KNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
            + +YR PEL+ G   Y  AID+WS GC++ EL   +P+F     + QL  I ++ G+P 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238

Query: 306 REEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRL-------PPEAVDLVCRFFQYSPNLRC 357
                 + P+  +   F  +KP    K +++RL       P  A+DL+       P+ RC
Sbjct: 239 ----PAVWPDVIKLPYFNTMKP---KKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291

Query: 358 TALEACVHPF 367
           TA EA   P+
Sbjct: 292 TAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  154 bits (391), Expect = 4e-43
 Identities = 103/319 (32%), Positives = 161/319 (50%), Gaps = 44/319 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKR-YKNRELQIMQMLDHP 135
           Y     +G+G+ G+V  A    TG+ VAIKK       V   KR Y  REL +M++++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 136 NIVALKHCFFSTTDK-----EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
           NI+ L + F  T  K     +++YL  V+E +   + ++       H+RM  +      Y
Sbjct: 76  NIIGLLNVF--TPQKSLEEFQDVYL--VMELMDANLCQVI-QMDLDHERMSYL-----LY 125

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
           Q+   + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYY
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
           RAPE+I G   Y   +DIWS GC+M E++ G  LFPG   +DQ  +II+ LGTP+ E + 
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 311 CMNP---NYTEFKFPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNL 355
            + P   NY E + P+   + + ++F             K    +A DL+ +     P  
Sbjct: 243 RLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301

Query: 356 RCTALEACVHPFFDELRDP 374
           R +  +A  HP+ +   DP
Sbjct: 302 RISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  147 bits (374), Expect = 3e-41
 Identities = 93/302 (30%), Positives = 141/302 (46%), Gaps = 34/302 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH- 142
           +G G+FG VF+A+ ++T +IVA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 143 CFFSTT----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           C    T     K   YL  V E+     + +A   S  + +  L  +K     +   L Y
Sbjct: 80  CRTKATPYNRYKGSFYL--VFEFCE---HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAP 253
           IH    I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 135 IHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCM 312
           EL+ G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E      
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252

Query: 313 N-PNYTEFKFPQ-----IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
               + + + PQ     +K      V      P A+DL+ +     P  R  A  A  H 
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYVKD----PHALDLIDKLLVLDPAKRIDADTALNHD 308

Query: 367 FF 368
           FF
Sbjct: 309 FF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  142 bits (360), Expect = 2e-39
 Identities = 94/296 (31%), Positives = 147/296 (49%), Gaps = 32/296 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R +  E             L+ ++  DHPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 137 IVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQR-MPLIYVKLYTYQIC 193
           IV L   C  S TD+E   + LV E+V + +    R Y  ++    +P   +K    Q  
Sbjct: 64  IVRLMDVCATSRTDRE-TKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 194 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           R L ++H NCI   HRD+KP+N+LV     Q+KL DFG A++          + + +YRA
Sbjct: 119 RGLDFLHANCI--VHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 176 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 233

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           +       F    P P   V  + +      L+     ++P+ R +A  A  HPFF
Sbjct: 234 DVTLPRGAFSPRGPRPVQSVVPE-IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  141 bits (358), Expect = 2e-39
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 22/217 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     +G GSFG V+  + +  G++  +K++       +++     E++I++ L+HPNI
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +     F     +E+  L +V+EY     +++  +   +  +  P   +  +  Q+C AL
Sbjct: 62  IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRA 252
            Y+H+   I HRDIKPQN+ +      +KL DFG +KVL      V    +     YY +
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLT-SNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLS 171

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           PEL      Y    DIWS GCV+ EL   +  F GE+
Sbjct: 172 PELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  141 bits (356), Expect = 3e-39
 Identities = 90/287 (31%), Positives = 134/287 (46%), Gaps = 46/287 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL---QDKRYK------NRELQIMQMLDHPNIVAL 140
           +G+GSFG V++    + G+  A+K+V      +  +       +E+ ++  L HPNIV  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               +  T++EE  L + LE VP     +A+   + +   P   ++LYT QI   L Y+H
Sbjct: 67  ----YLGTEREEDNLYIFLELVPG--GSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLH 119

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           +     HRDIK  N+LV+     +KL DFG AK +V+     S+  S Y+ APE+I    
Sbjct: 120 D-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y  A DIWS GC + E+  G+P +    GV  + +I +    P                
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---------------- 221

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                P P H      L  EA D + +  Q  P+LR TA E   HPF
Sbjct: 222 -----PIPDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  140 bits (354), Expect = 2e-38
 Identities = 101/302 (33%), Positives = 158/302 (52%), Gaps = 26/302 (8%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 137
           SY     +G GS+  V++ K +  G++VA+K + LQ++        RE  +++ L H NI
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           V L H    T +     L LV EYV  +    + ++   +H       VKL+ +Q+ R L
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 253
           +YIH    I HRD+KPQNLL++  T +LKL DFG A+   K  P+ +Y   + + +YR P
Sbjct: 117 SYIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPP 172

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM 312
           +++ G+TEY+T +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    +
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232

Query: 313 N--PNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
           +  P++   +F    P    + + K      A DL  +  Q  P  R +A  A  H +F 
Sbjct: 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292

Query: 370 EL 371
           +L
Sbjct: 293 DL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  135 bits (343), Expect = 4e-37
 Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 50/294 (17%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 141
           + +G G+FG V+ A   +TGE++A+K++ +QD   K       E++++++L HPN+V   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +     +E++Y+   +EY    T+  +   + RI   +    +++YT Q+   LAY+H
Sbjct: 64  -YYGVEVHREKVYI--FMEYCSGGTLEELLE-HGRI---LDEHVIRVYTLQLLEGLAYLH 116

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNVSYICSRYYRAPEL 255
           +  GI HRDIKP N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+
Sbjct: 117 SH-GIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 256 IFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           I G     +  A DIWS GCV+ E+  G+  +       Q++  +     P         
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP-------- 226

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                   P             +L PE  D + R  +  P  R TA E   HPF
Sbjct: 227 -------IPDS----------LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  136 bits (344), Expect = 4e-37
 Identities = 88/320 (27%), Positives = 138/320 (43%), Gaps = 77/320 (24%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLD-HP 135
           +    ++G GSF  V  AK +ET +  AIK     +++++K+  Y   E +++  L+ HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            I+ L + F    D+E LY   VLEY P   N     Y R +  +     + Y  +I  A
Sbjct: 63  GIIKLYYTF---QDEENLY--FVLEYAP---NGELLQYIRKYGSLDEKCTRFYAAEILLA 114

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRY-- 249
           L Y+H+  GI HRD+KP+N+L++   H +K+ DFG+AKVL                    
Sbjct: 115 LEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 250 ---------------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
                          Y +PEL+        + D+W+ GC++ ++L G+P F G +  + L
Sbjct: 173 EKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYL 229

Query: 295 V--EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
              +I+K                  E+ FP               PP+A DL+ +     
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260

Query: 353 PNLRCTALEACV----HPFF 368
           P  R    E       HPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  133 bits (338), Expect = 1e-36
 Identities = 87/288 (30%), Positives = 139/288 (48%), Gaps = 48/288 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALKH 142
           ++G G+FGVV++    ETG+ VAIK++ L+  + +      +E+ +++ L HPNIV    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                  +    L ++LEY    ++ +I + +    + +    V +Y YQ+ + LAY+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELIFGAT 260
             G+ HRDIK  N+L       +KL DFG A K+    + + S + + Y+ APE+I   +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
             +TA DIWS GC + ELL G P +                          +NP    F+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYD------------------------LNPMAALFR 210

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
             Q   HP      + + PE  D + + FQ  PNLR TA +   HP+ 
Sbjct: 211 IVQ-DDHP---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  131 bits (331), Expect = 2e-35
 Identities = 83/271 (30%), Positives = 135/271 (49%), Gaps = 45/271 (16%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALKHCFF 145
           G++G VF AK + TG+I AIK +   D   KN+      E  I+     P +V L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           S   K+ LYL  V+EY+P   +  +  N   + + +     ++Y  +I  AL Y+H+  G
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---------PNVSYICSRYYRAPEL 255
           I HRD+KP N+L++ + H LKL DFG +KV +             +   + +  Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII--KVLGTPTREEI---- 309
           I G   ++  +D WS GC++ E L+G P F GE+  +++ + I    +  P   E+    
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGKIEWPEDVEVSDEA 230

Query: 310 -----KCMNPNYTE---FK-FPQIKPHPWHK 331
                K + P+  +    K   +IK HP+ K
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  133 bits (335), Expect = 2e-35
 Identities = 98/305 (32%), Positives = 154/305 (50%), Gaps = 29/305 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F      EE   + LV+E +   + ++ +     H+RM  +      YQ+   + ++H+ 
Sbjct: 85  FTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 138

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 139 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 195

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 318
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255

Query: 319 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
                   FP++ P    P      K    +A DL+ +     P  R +  EA  HP+ +
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315

Query: 370 ELRDP 374
              DP
Sbjct: 316 VWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  133 bits (335), Expect = 3e-35
 Identities = 95/305 (31%), Positives = 154/305 (50%), Gaps = 29/305 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F      EE   + LV+E +   + ++  +    H+RM  +      YQ+   + ++H+ 
Sbjct: 89  FTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGIKHLHSA 142

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 143 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGY 199

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 319
              +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E 
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259

Query: 320 K-------FPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
           +       F ++ P    P      K    +A DL+ +     P+ R +  EA  HP+  
Sbjct: 260 RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319

Query: 370 ELRDP 374
              DP
Sbjct: 320 VWYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  129 bits (326), Expect = 1e-34
 Identities = 74/241 (30%), Positives = 127/241 (52%), Gaps = 21/241 (8%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYK-NRELQIMQMLDHPNIVALKH 142
            V+G GS GVV++ + + TG+I A+KK+     ++ R +  REL+ ++  + P +V    
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F+      E  +++VLEY+   ++  + +       ++P   +     QI + L Y+H 
Sbjct: 67  AFYK-----EGEISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFGAT 260
              I HRDIKP NLL+N    ++K+ DFG +KVL    +   +++ +  Y +PE I G +
Sbjct: 118 KRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 261 EYTTAIDIWSTGCVMAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
            Y+ A DIWS G  + E  LG+ P L PG+    +L++ I   G P     +  +P + +
Sbjct: 177 -YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEFSPEFRD 234

Query: 319 F 319
           F
Sbjct: 235 F 235

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  127 bits (322), Expect = 3e-34
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 47/290 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL--QDKRYKN---RELQIMQMLDHPNIVALKHC 143
            +G G+ GVV +   R TG+I+A+K +    ++  +    REL I+   + P IV     
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F++  D     +++ +EY+      + +    +  R+P   +      + + L Y+H   
Sbjct: 68  FYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
            I HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y+
Sbjct: 121 KIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDYS 177

Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              DIWS G  + EL  G+  +P E+       + L  I+               P    
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP---- 221

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              P++    +         P+  D V       P  R +  E   HPF 
Sbjct: 222 ---PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  130 bits (327), Expect = 4e-34
 Identities = 96/306 (31%), Positives = 155/306 (50%), Gaps = 31/306 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F      EE   + +V+E +   + ++ +     H+RM  +      YQ+   + ++H+ 
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 145

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 319
              +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262

Query: 320 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  126 bits (319), Expect = 2e-33
 Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 26/207 (12%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 141
            +GTGSFG V   + + +G+  A+K     K+++ K+ +    E +I+Q + HP +V L 
Sbjct: 8   TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F     +++  L LV+EYVP  E  + + ++      R P    + Y  Q+  AL Y+
Sbjct: 68  GSF-----QDDSNLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYL 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+   I +RD+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I  
Sbjct: 118 HSL-DIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIILS 172

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLF 285
              Y  A+D W+ G ++ E+L G P F
Sbjct: 173 -KGYGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  126 bits (317), Expect = 3e-33
 Identities = 93/304 (30%), Positives = 154/304 (50%), Gaps = 29/304 (9%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQML 132
           Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++ L
Sbjct: 1   QQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 133 D---HPNIVAL-KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
           +   HPN+V L   C  S TD+E   L LV E+V + +             +P   +K  
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDM 115

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
            +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + + 
Sbjct: 116 MFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTL 173

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+
Sbjct: 174 WYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232

Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE----AVDLVCRFFQYSPNLRCTALEACV 364
                P                 +  ++   +      DL+ +   ++P  R +A  A  
Sbjct: 233 W----PRDVALPRQAFHSKSAQPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286

Query: 365 HPFF 368
           HP+F
Sbjct: 287 HPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  121 bits (307), Expect = 4e-32
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 48/238 (20%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V++   +         VA+K + +D   +      RE +IM+ LDHPNI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 195
           V L       T++E L   +V+EY+P        +Y R ++   L    L  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 196 LAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+   N I   HRD+  +N LV      +K+ DFG ++ L   +         YY+  
Sbjct: 116 MEYLESKNFI---HRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVK 162

Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 299
                    APE +    ++T+  D+WS G ++ E+  LG+  +PG S   +++E +K
Sbjct: 163 GGKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  121 bits (305), Expect = 8e-32
 Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 47/237 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V++ K +         VA+K + +D   +      RE +IM+ LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L       T++E LY  +V+EY+         +Y R ++ ++ L  +  +  QI R +
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 197 AYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+   N I   HRD+  +N LV      +K+ DFG ++ L   +         YYR   
Sbjct: 116 EYLESKNFI---HRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRG 162

Query: 252 --------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 299
                   APE +    ++T+  D+WS G ++ E+  LG+  +PG S  ++++E +K
Sbjct: 163 GKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 1e-31
 Identities = 98/349 (28%), Positives = 146/349 (41%), Gaps = 87/349 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G G+FG V+  + ++TG++ A+K + +    K  ++        I+   D P IV L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             ++S  D+E LY  LV+EY+P  + +N + R         P    + Y  ++  AL  +
Sbjct: 67  --YYSFQDEEHLY--LVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSV 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------------------VLV 236
           H  +G  HRDIKP N+L++   H +KL DFG  K                       VLV
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 237 KGEPNVSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           +   +               Y APE++ G T Y    D WS G ++ E+L G P F  ++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Query: 290 GVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
               L E        T  +I     N+ E  +FP   P          + PEA+DL+CR 
Sbjct: 235 ----LQE--------TYNKII----NWKESLRFPPDPP----------VSPEAIDLICRL 268

Query: 349 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSG 397
                +   +  E   HPFF           N R   P F    PELS 
Sbjct: 269 LCDPEDRLGSFEEIKSHPFF-----KGIDWENLRETKPPF---VPELSS 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  118 bits (297), Expect = 1e-30
 Identities = 83/287 (28%), Positives = 128/287 (44%), Gaps = 47/287 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFS 146
            +G GS+G V++A  +ETG++VAIK V  ++  +   +E+ I++  D P IV     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 147 TTDKEELYLNLVLEY-VPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            TD     L +V+EY    +V+ I    N +   + +  I      YQ  + L Y+H+  
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI-----LYQTLKGLEYLHS-N 118

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIFGATE 261
              HRDIK  N+L+N    Q KL DFG +  L     + N + I + ++ APE+I     
Sbjct: 119 KKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRN-TVIGTPFWMAPEVIQE-IG 175

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y    DIWS G    E+  G+P                    P  +    ++P    F  
Sbjct: 176 YNNKADIWSLGITAIEMAEGKP--------------------PYSD----IHPMRAIFMI 211

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           P  KP P      ++  PE  D V +     P  R +A++   HPF 
Sbjct: 212 PN-KPPPTLSD-PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  117 bits (296), Expect = 2e-30
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 22/225 (9%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G GSFG V + + +  G+I+  K++       ++K+    E+ I++ L HPNIV    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 D+    L +V+EY     + ++ +   +  + +   ++     Q+  AL   HN
Sbjct: 67  RII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 202 CIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 254
                  + HRD+KP N+ ++   + +KL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
            +   + Y    DIWS GC++ EL    P F       QL   IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  116 bits (293), Expect = 4e-30
 Identities = 93/308 (30%), Positives = 141/308 (45%), Gaps = 67/308 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKN------RELQIMQ 130
           +I   ++G+GSFG V+      +GE++A+K+V           R ++      RE+ +++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT 189
            L H NIV               +LN+ LEYVP  +V  +  NY    + +    V+ + 
Sbjct: 62  ELQHENIVQYLGSSLDAD-----HLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV------- 242
            QI + L Y+HN  GI HRDIK  N+LV+ +   +K+ DFG +K   K E N        
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNG 167

Query: 243 ---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
              S   S ++ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFK 223

Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
           +                 E   P+I  +         +  EA+D + + F+   N R TA
Sbjct: 224 I----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258

Query: 360 LEACVHPF 367
            E   HPF
Sbjct: 259 AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  116 bits (292), Expect = 8e-30
 Identities = 91/305 (29%), Positives = 142/305 (46%), Gaps = 53/305 (17%)

Query: 82  VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYK------NRELQ 127
             ++   ++G G++G V+ A    TGE++A+K+V          D R K        E++
Sbjct: 1   FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60

Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVK 186
            ++ LDH NIV          +  E YL++ LEYVP  ++    R Y R  +++    V+
Sbjct: 61  TLKDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VR 111

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV---LVKGEPNVS 243
            +T Q+   LAY+H+  GI HRD+K  NLLV+      K+ DFG +K    +   + N+S
Sbjct: 112 FFTEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMS 169

Query: 244 YICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
              S ++ APE+I   ++ Y+  +DIWS GCV+ E+  G+  +  E              
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-------------- 215

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
               E I  M     +   P I P          L P A+D +   F  +P+ R TA E 
Sbjct: 216 ----EAIAAMFKLGNKRSAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTAREL 266

Query: 363 CVHPF 367
             HPF
Sbjct: 267 LQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  115 bits (291), Expect = 1e-29
 Identities = 85/294 (28%), Positives = 129/294 (43%), Gaps = 58/294 (19%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
             +G G+ G V++A  R TG+ VAIKK+ L+ +  +    E+ IM+   HPNIV     +
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 145 FSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                 +EL++  V+EY+         T N +  N  +I       YV     ++ + L 
Sbjct: 85  L---VGDELWV--VMEYMDGGSLTDIITQNFVRMNEPQI------AYVCR---EVLQGLE 130

Query: 198 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPE 254
           Y+H  N I   HRDIK  N+L++     +KL DFG A  L K +    S + + Y+ APE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +I    +Y   +DIWS G +  E+  G+P +  E  +  L  I    G P    +K    
Sbjct: 187 VIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK---- 237

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                      P  W   F+        D + +     P  R +A E   HPF 
Sbjct: 238 ----------NPEKWSPEFK--------DFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  113 bits (285), Expect = 6e-29
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 47/229 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
            +G G+FG V++   +  GE     VA+K + +    +       E  IM+ L HPNIV 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
           L       T  E LY  +V EY+P        ++ R H +++ L  +     QI + + Y
Sbjct: 66  LLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 199 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR----- 251
           +   N +   HRD+  +N LV      +K+ DFG ++ + + +         YYR     
Sbjct: 118 LESKNFV---HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGG 164

Query: 252 -------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                  APE +    ++T+  D+WS G ++ E+  LG+  +PG S  +
Sbjct: 165 KLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 1e-28
 Identities = 85/290 (29%), Positives = 128/290 (44%), Gaps = 56/290 (19%)

Query: 93  GSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQ---IMQMLDHPNIVALKHCF 144
           G+FG V+ AK R TG+  AIK      ++   +  N + +   +M   + P +  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAYIHN 201
           +S   K+  YL LV+EY+         + + + + +   P  + K Y  ++   +  +H 
Sbjct: 64  YSFQSKD--YLYLVMEYLN------GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRDIKP+NLL++   H LKL DFG ++    G  N  ++ +  Y APE I G  +
Sbjct: 116 -RGIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGD 170

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
                D WS GCV+ E L G P F  E+  D + + I          I            
Sbjct: 171 -DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRIN----------- 211

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF 368
                  W +  ++   PEAVDL+ R     P  R  A    E   HPFF
Sbjct: 212 -------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  112 bits (282), Expect = 1e-28
 Identities = 76/295 (25%), Positives = 126/295 (42%), Gaps = 48/295 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPN 136
           +    V+G G+FG V   + R+T ++ A+K     K ++    +N   E +I+Q L+HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           +V L   ++S  D+E +YL  V++ +     R    Y    + +     VK +  +I  A
Sbjct: 62  LVNL---WYSFQDEENMYL--VVDLLLGGDLR----YHLSQKVKFSEEQVKFWICEIVLA 112

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           L Y+H+  GI HRDIKP N+L++   H + + DF  A  +       S   +  Y APE+
Sbjct: 113 LEYLHS-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEV 170

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +     Y+ A+D WS G    E L G+  + G S                R++I      
Sbjct: 171 LCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQI------ 210

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEACVHPFF 368
               K            +      EA+D + +  +  P  R      +   HP+F
Sbjct: 211 --RAKQETADVL-----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  111 bits (280), Expect = 3e-28
 Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 56/296 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G FG V   K +      A+K V          + +   E +I++  +HP IV L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 143 CFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             F    K++ Y+ +++EY       T+ R    +     R        Y   +  A  Y
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-------FYIACVVLAFEY 108

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +HN  GI +RD+KP+NLL++     +KL DFG AK L  G+   ++  +  Y APE+I  
Sbjct: 109 LHN-RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              Y  ++D WS G ++ ELL G+P F GE   D +             +I   N     
Sbjct: 167 KG-YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL-- 213

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFD 369
            +FP              +   A DL+ +  + +P  R   L+  +     H +F+
Sbjct: 214 -EFPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 8e-28
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 48/228 (21%)

Query: 89  VVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
            +G G+FG V++ K +        VA+K + +D   + R     E ++M+ L HPN+V L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKL--YTYQICR 194
                  T++E LY  LVLEY+         R +R      ++  L    L  +  QI +
Sbjct: 62  LGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 195 ALAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
            + Y+     +   HRD+  +N LV      +K+ DFG ++ +   +         YYR 
Sbjct: 117 GMEYLASKKFV---HRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRK 163

Query: 252 -----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
                      APE +     +T+  D+WS G ++ E+  LG   +PG
Sbjct: 164 KTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  109 bits (275), Expect = 2e-27
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 17/214 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNR---ELQIMQMLDHPN 136
           +  E  +G G F VV++A C   G +VA+KKV    + D + +     E+ +++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           ++     F      E   LN+VLE      ++R+ +++ +  + +P   +  Y  Q+C A
Sbjct: 64  VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRAPE 254
           L ++H+   I HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
            I     Y    DIWS GC++ E+   Q  F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  110 bits (276), Expect = 3e-27
 Identities = 98/320 (30%), Positives = 155/320 (48%), Gaps = 52/320 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 144
           VG G++G V++AK R+ G+     A+K++          RE+ +++ L HPN+++L+  F
Sbjct: 9   VGRGTYGHVYKAK-RKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 145 FSTTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
            S  D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+
Sbjct: 68  LSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 200 HNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNVSYICSRY 249
           H    + HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKV 300
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240

Query: 301 LGTPTR---EEIKCMNPNYTEFK-FPQ--------IKPHPWHKVFQKRLPPEAVDLVCRF 348
           +G P     E+IK M  + T  K F +        IK    HKV   +   +A  L+ + 
Sbjct: 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKL 297

Query: 349 FQYSPNLRCTALEACVHPFF 368
               P  R T+ +A   P+F
Sbjct: 298 LTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  110 bits (275), Expect = 3e-27
 Identities = 95/318 (29%), Positives = 156/318 (49%), Gaps = 48/318 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 144
           VG G++G V++AK R+ G+     A+K++          RE+ +++ L HPN++AL+  F
Sbjct: 9   VGRGTYGHVYKAK-RKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 145 FSTTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
            S +D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+
Sbjct: 68  LSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 200 HNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNVSYICSRY 249
           H    + HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKV 300
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240

Query: 301 LGTPTR---EEIKCMNPNY----TEFKFPQIKPHPWHKVFQK-RLPPEA--VDLVCRFFQ 350
           +G P     E+I+ M P Y     +F+          K  +K ++ P++    L+ +   
Sbjct: 241 MGFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299

Query: 351 YSPNLRCTALEACVHPFF 368
             P  R T+ +A   P+F
Sbjct: 300 MDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  108 bits (272), Expect = 4e-27
 Identities = 79/296 (26%), Positives = 136/296 (45%), Gaps = 51/296 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYKN--RELQIMQMLDHPNIV 138
            +GTG+F   +QA+  +TG ++A+K+V         Q++  +   +E+++M  L+HP+I+
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                  +T   E+ + NL +E++   +V+ +   Y    +    + +  YT Q+ R L+
Sbjct: 67  ---RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGLS 117

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNVSYICSRYYRA 252
           Y+H    I HRD+K  NLL++    +L++ DFG+A  L       GE     + +  + A
Sbjct: 118 YLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++ G  +Y  + D+WS GCV+ E+   +P +  E   + L  I K         I   
Sbjct: 177 PEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IASA 226

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    P I  H         L P   D+  R  +  P  R  + E   HP F
Sbjct: 227 TTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 1e-26
 Identities = 86/298 (28%), Positives = 126/298 (42%), Gaps = 59/298 (19%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYKNRELQ---IMQMLDHPNIVALKH 142
           VG G +G VF AK ++TGEIVA+    K +L         L    I+       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHN 201
            F    D E LY  L +EYVP    R   N   +  +     + + Y  ++  A+  +H 
Sbjct: 69  AF---QDDEYLY--LAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            +G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE++ G   
Sbjct: 120 -LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG-KG 174

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y   +D WS GC++ E L G P F G                          PN T   +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGS------------------------TPNET---W 207

Query: 322 PQIKPHPWHKVFQK--------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
             +K   W +  Q+         L  EA DL+ +          +  +   HPFF E+
Sbjct: 208 ENLK--YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 1e-25
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 23/215 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDH---PNIVAL 140
           ++G G++G V++ K   TG +VA+K +  D    +     RE+ ++  L     PNI   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              +          L +++EY      R       I ++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGA 259
             +G+ HRDIK  N+LV  +T  +KLCDFG A +L +     S ++ + Y+ APE+I   
Sbjct: 119 K-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
             Y T  DIWS G  + E+  G P +   S VD  
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  102 bits (255), Expect = 2e-24
 Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 27/210 (12%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 140
             +G GSFG V+ A+   T E+VAIKK+    +  N       +E++ +Q L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
           K C+       E    LV+EY   +    A +   +H++ PL  V++    +   + LAY
Sbjct: 81  KGCYL-----REHTAWLVMEYCLGS----ASDILEVHKK-PLQEVEIAAICHGALQGLAY 130

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +H+   I HRDIK  N+L+      +KL DFGSA ++    P  S++ + Y+ APE+I  
Sbjct: 131 LHSHERI-HRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILA 185

Query: 259 ATE--YTTAIDIWSTGCVMAELLLGQ-PLF 285
             E  Y   +D+WS G    EL   + PLF
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  101 bits (253), Expect = 5e-24
 Identities = 102/346 (29%), Positives = 153/346 (44%), Gaps = 63/346 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKH 142
           +GTGSFG V  AK + TGE  AIK     ++L+ K+ +   +E  I+  L HP IV +  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    D+  +Y   +LE+V   V      + R   R P    K Y  ++  A  Y+H+ 
Sbjct: 86  SF---QDENRVY--FLLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-IC-SRYYRAPELIFGAT 260
             I +RD+KP+NLL++   H +K+ DFG AK +    P+ ++ +C +  Y APE+I  + 
Sbjct: 138 -DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVI-QSK 190

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            +  A+D W+ G ++ E + G P F  +              TP R   K +       K
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLK 233

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDELRDPN 375
           FP      W   F  R    A DLV    Q     R   L+  V     HP+F    + +
Sbjct: 234 FPN-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA-NWD 280

Query: 376 TRLPNGRPLP-PLFNFKPPELSGI---PPETINRLIPEHARKQNLF 417
                  P P P+    P + S     P   ++RL P  A +Q  F
Sbjct: 281 KLYARYYPAPIPVRVKSPGDTSNFEKYPDSPVDRLPPLTAAQQAEF 326

Length = 329

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 71/209 (33%), Positives = 102/209 (48%), Gaps = 26/209 (12%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIM-------QMLDHPNIVA 139
           V+G GSFG V  AK +  G+  A+ KVLQ K    K  +  IM       + + HP +V 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L H  F T DK    L  VL+YV   E    + R      +  P    + Y  +I  AL 
Sbjct: 61  L-HYSFQTADK----LYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALG 110

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL 168

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF 285
                Y   +D W  G V+ E+L G P F
Sbjct: 169 R-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 98.8 bits (246), Expect = 2e-23
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 42/287 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK---NRELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+ A+   T   +AIK++  +D RY    + E+ +   L H NIV      
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ----- 69

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           +  +D E  +  + +E VP  +++ + R+ +  +      I    YT QI   L Y+H+ 
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYLHD- 126

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELI-FGAT 260
             I HRDIK  N+LVN ++  +K+ DFG++K L    P   ++  +  Y APE+I  G  
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y    DIWS GC + E+  G+P F                       I+   P    FK
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAAMFK 223

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
               K HP      + L  EA + + R F+  P+ R +A +    PF
Sbjct: 224 VGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 80/293 (27%), Positives = 123/293 (41%), Gaps = 52/293 (17%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK---RYKNRELQIMQMLDHPNIVALKHC 143
             +G+G++G V++A+   TGE+VAIK + L+         +E+ +++   HPNIVA    
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI-YVKLYTYQICRALAYIHNC 202
           +          L +V+EY      +     +R       I YV   T +    LAY+H  
Sbjct: 69  YLRRD-----KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK---GLAYLHE- 119

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIFGAT 260
            G  HRDIK  N+L+      +KL DFG +  L     +   S+I + Y+ APE+   A 
Sbjct: 120 TGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEVA--AV 175

Query: 261 E----YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           E    Y    DIW+ G    EL   Q P+F         +  ++ L   ++         
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS-------- 219

Query: 316 YTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
              F  P++K    W  VF         D + +     P  R TA +   HPF
Sbjct: 220 --NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 98.9 bits (246), Expect = 3e-23
 Identities = 84/285 (29%), Positives = 135/285 (47%), Gaps = 37/285 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           ++  H +G GSFG V+ A    T E+VA+KK+    +  N       +E++ +Q L HPN
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICR 194
            +  K C+      +E    LV+EY   +    A +   +H++ PL  V++   T+   +
Sbjct: 83  TIEYKGCYL-----KEHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQ 132

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            LAY+H+   I HRDIK  N+L+     Q+KL DFGSA       P  S++ + Y+ APE
Sbjct: 133 GLAYLHSHNMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPE 187

Query: 255 LIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           +I    E  Y   +D+WS G    EL   +P     + +  L  I +   +PT +  +  
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSNEWT 246

Query: 313 NP-----NYTEFKFPQIKPHPW----HKVFQKRLPPEA-VDLVCR 347
           +      +Y   K PQ +P       H   ++  P    +DL+ R
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQR 291

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 98.7 bits (246), Expect = 3e-23
 Identities = 67/215 (31%), Positives = 112/215 (52%), Gaps = 36/215 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           VGTG+FG V   + R +    A+K +       L+ +++ + E ++++ + HP I+ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            F++  D+  LY+  ++EYVP  E  + + RN  R      L     Y  +I  AL Y+H
Sbjct: 67  -FWTEHDQRFLYM--LMEYVPGGELFSYL-RNSGRFSNSTGL----FYASEIVCALEYLH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAPE 254
           +   I +RD+KP+N+L++   H +KL DFG AK L        G P         Y APE
Sbjct: 119 S-KEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPE 168

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           +I  +  +  A+D W+ G ++ E+L+G P F  ++
Sbjct: 169 VI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 16/208 (7%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKH 142
           VVG G+FG+V   + +   ++V IK++  ++  K+       E Q++++L HPNI+    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F      E+  L +V+EY P  T+    +   R +  +    +  +  QI  AL ++H 
Sbjct: 67  NFL-----EDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHT 119

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            + I HRD+K QN+L++ H   +K+ DFG +K+L       + + +  Y +PEL  G   
Sbjct: 120 KL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-KP 177

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGES 289
           Y    DIW+ GCV+ EL   +  F   +
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 51/292 (17%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR------ELQIMQMLDHPNIVAL 140
           +G G+FG V+     +TG  +A+K+V         K        E+Q+++ L H  IV  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             C     D E L +   +EY+P       ++  + +  +     + YT QI   + Y+H
Sbjct: 70  YGCL---RDDETLSI--FMEYMP---GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPELI 256
           + + I HRDIK  N+L +     +KL DFG++K L      G    S   + Y+ +PE+I
Sbjct: 122 SNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
            G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT           
Sbjct: 180 SGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN---------- 225

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                PQ+  H         + P+A + + R F  +   R +A E   H F 
Sbjct: 226 -----PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 71/213 (33%), Positives = 100/213 (46%), Gaps = 36/213 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNI 137
           YI   V+G G+FG     +  E   +V  K+V L     K R     E+ I+ +L HPNI
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           +A  + F      ++  L + +EY       ++I R   +  Q      V  Y +QI  A
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR---QKGQLFEEEMVLWYLFQIVSA 113

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNVSYIC 246
           ++YIH   GI HRDIK  N+ +      +KL DFG +K+L         V G P      
Sbjct: 114 VSYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------ 165

Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
             YY +PEL  G  +Y    DIW+ GCV+ ELL
Sbjct: 166 --YYMSPELCQGV-KYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 29/214 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQML-DHPNIVALKH 142
           V+G G++G V++A+ ++TG++VAIK  + D           E  I++   +HPNI     
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 143 CFF---STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            F       + ++L+  LV+E     +V  + +   +  +R+   ++     +  R LAY
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 199 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPEL 255
           +H    I   HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+
Sbjct: 129 LHENKVI---HRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 256 IFGATE------YTTAIDIWSTGCVMAELLLGQP 283
           I  A +      Y    D+WS G    EL  G+P
Sbjct: 185 I--ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 94.8 bits (236), Expect = 6e-22
 Identities = 85/298 (28%), Positives = 137/298 (45%), Gaps = 49/298 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A  + TG  VA+KK+  D R + R      E+ IM+   HPNIV +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           + S    +EL++  V+E++    +  I       H RM    +      + +AL+++H  
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA- 133

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIFGATE 261
            G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     
Sbjct: 134 QGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLP 191

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y T +DIWS G ++ E++ G+P +  E  +  +            + I+   P       
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP------- 232

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
           P++K    HKV      P     + R     P  R TA E   HPF  +   P++ +P
Sbjct: 233 PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 94.6 bits (235), Expect = 9e-22
 Identities = 92/320 (28%), Positives = 139/320 (43%), Gaps = 56/320 (17%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALKH 142
           +G GSFG V Q + R+T  I A+K + +       E+        ++  ++ P IV LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             FS    E+LYL L      E  + + R       R  L   + YT ++  AL  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHK- 111

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATE 261
             + +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y APEL+ G   
Sbjct: 112 FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           YT A+D W+ G ++ E+L G P F  E+ V+++    K+L  P R               
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR--------------- 211

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDPNTRL 378
                      F      +A DL+       P  R     A E   HPFF +L     +L
Sbjct: 212 -----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS--WKKL 258

Query: 379 PNGRPLPPLFNFKPPELSGI 398
                 PP   FKP   S I
Sbjct: 259 LMKGIQPP---FKPAVSSAI 275

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 73/296 (24%), Positives = 117/296 (39%), Gaps = 57/296 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 138
           +     +G GSFG V++A  + T ++VAIK +       +     +E+Q +     P I 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                F   +      L +++EY          +  +   ++   Y+     ++   L Y
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCG---GGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYR 251
           +H   G  HRDIK  N+L++     +KL DFG     V G+   S +  R       ++ 
Sbjct: 114 LHE-EGKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFWM 165

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE+I   + Y    DIWS G    EL  G+P  P  S +  +    +VL        K 
Sbjct: 166 APEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPKN 213

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            NP       P ++ + + K F+        D V       P  R +A E   H F
Sbjct: 214 -NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 86/321 (26%), Positives = 134/321 (41%), Gaps = 61/321 (19%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G FG V   + + TG++ A KK L  KR K R        E +I++ +    IV+L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 142 HCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + F  T D   L + L+    L+Y    V       +R            Y  QI   L 
Sbjct: 60  YAF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR---------AIFYAAQIICGLE 109

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H    I +RD+KP+N+L++ H + +++ D G A  L  G+       +  Y APE++ 
Sbjct: 110 HLHQ-RRIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G   Y  ++D ++ GC + E++ G+  F       Q  E ++      +EE+K       
Sbjct: 168 GE-VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRRTLE-M 213

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 372
             ++P             +  PEA DL     Q  P  R      +A E   HP F +L 
Sbjct: 214 AVEYPD------------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261

Query: 373 DPNTRLPNGRPLPPLFNFKPP 393
               RL  G   PP   F P 
Sbjct: 262 WR--RLEAGMLEPP---FIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 58/299 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 140
           V+G GSFG V  A+ + T E+ A+K      +LQD   +    E +++ +   HP +  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAY 198
            H  F T D+    L  V+EYV    N     +  I +  R      + Y  +I   L +
Sbjct: 62  -HSCFQTKDR----LFFVMEYV----NGGDLMF-HIQRSGRFDEPRARFYAAEIVLGLQF 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           +H   GI +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y  A+D W+ G ++ E+L GQ  F G+   D+L + I             +     
Sbjct: 170 Y-QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSI-------------LEDEV- 213

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDEL 371
                          + + L  EA  ++  F   +P  R   L         HPFF E+
Sbjct: 214 --------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 92.1 bits (229), Expect = 5e-21
 Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 51/303 (16%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKHCF 144
           G G++GVV + +   TG I+A+K++   +  +  K    +L I M+ +D P  V      
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F   D     + + +E +  ++++  +        +P   +      I +AL Y+H+ + 
Sbjct: 70  FREGD-----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 261
           + HRD+KP N+L+N    Q+KLCDFG +  LV           + Y APE I        
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y    D+WS G  M EL  G+  FP +S             TP                F
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS-----------WKTP----------------F 214

Query: 322 PQIK-----PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
            Q+K     P P  ++  ++  PE  D V +  + +   R    E   HPFF+     NT
Sbjct: 215 QQLKQVVEEPSP--QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272

Query: 377 RLP 379
            + 
Sbjct: 273 DVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 22/203 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           C+       E    LV+EY   + + +   + +  Q + +  V   T+   + LAY+H+ 
Sbjct: 83  CYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLHSH 134

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 261
             + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    E 
Sbjct: 135 -NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEG 189

Query: 262 -YTTAIDIWSTGCVMAELLLGQP 283
            Y   +D+WS G    EL   +P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.5 bits (229), Expect = 7e-21
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 26/205 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+   T E+VAIKK+    +  N       +E++ +Q + HPN +  K 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 200
           C+       E    LV+EY   +    A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 93  CYL-----REHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQGLAYLH 142

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           +   I HRDIK  N+L+     Q+KL DFGSA +     P  S++ + Y+ APE+I    
Sbjct: 143 SHNMI-HRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197

Query: 261 E--YTTAIDIWSTGCVMAELLLGQP 283
           E  Y   +D+WS G    EL   +P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.0 bits (226), Expect = 7e-21
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           G GS+G V++ K     +  A+K+V L     K R     E++I+  ++HPNI++ K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIH 200
               D  +L +  V+EY P  +    I++   R  +R  +   +++    Q+ R L  +H
Sbjct: 69  L---DGNKLCI--VMEYAPFGDLSKAISK---RKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 201 NCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
               I HRD+K  N LLV      +K+ D G +KVL K     + I + +Y APE ++  
Sbjct: 121 E-QKILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKG 175

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
             Y+   DIWS GC++ E+    P F   S  D   ++ +
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 91.1 bits (226), Expect = 8e-21
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 31/213 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYK--NRELQIMQMLDHPNIV 138
           V+G G++G V+       G+++A+K+V  D        K Y+    E+ +++ L H NIV
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                 +  T  ++  +++ +E+VP     I+   +R       ++ K YT QI   +AY
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPG--GSISSILNRFGPLPEPVFCK-YTKQILDGVAY 117

Query: 199 IH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI-------CSRYY 250
           +H NC+   HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 118 LHNNCV--VHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
            APE+I   + Y    DIWS GC + E+  G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.9 bits (226), Expect = 9e-21
 Identities = 74/296 (25%), Positives = 122/296 (41%), Gaps = 52/296 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHC 143
           V+G G+  VV+ A C    E VAIK++  +K   +     +E+Q M   +HPN+V   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F     +EL+  LV+ Y+     ++ +  +Y R      +I   L   ++ + L Y+H+
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICSRYYRAPELI 256
             G  HRDIK  N+L+      +K+ DFG +  L  G          ++ +  + APE++
Sbjct: 121 N-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQP----LFPGESGVDQLVEIIKVLGTPTREEIKCM 312
                Y    DIWS G    EL  G        P +     L+  ++             
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQ------------- 221

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           N        P ++    +K + K        ++    Q  P+ R TA E   H FF
Sbjct: 222 ND------PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 91.8 bits (228), Expect = 9e-21
 Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 65/310 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALK 141
           ++  G++G V+  + +ET +  A+KK+  Q+   +N+      E  I+   ++P +V++ 
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            C F T    + +L +V+EYV       + +N       +P+   ++Y  +   AL Y+H
Sbjct: 67  FCSFET----KRHLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYLH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNV--------------SYI 245
           N  GI HRD+KP NLL+    H +KL DFG +K+ L+    N+                +
Sbjct: 119 N-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 246 C-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           C +  Y APE+I     Y   +D W+ G ++ E L+G   F G++  +   ++I      
Sbjct: 177 CGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----- 230

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALE 361
             ++I    P   E                  LP +A DL+ R  + +P  R     A E
Sbjct: 231 --DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAFE 269

Query: 362 ACVHPFFDEL 371
              H FF  L
Sbjct: 270 VKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 36/286 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G+ G V + K   TG ++A K V    +        RELQIM     P IV+    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            +  +     + + +E++   +++RI +    I    P+  +      +   L Y++N  
Sbjct: 73  LNENN-----ICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTYLYNVH 123

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
            I HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180

Query: 264 TAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              D+WS G  + EL LG+ P        D   + + +L                     
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223

Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           QI   P  ++     P +  D V       P  R T  + C  P F
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 84/301 (27%), Positives = 138/301 (45%), Gaps = 39/301 (12%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK-RYKN---RELQIMQMLDHPNIVALKHC 143
            +G G+ GVV +   R +G I+A K + L+ K   +N   REL+++   + P IV     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F+S  D E   +++ +E++   +++++ +   RI    P   +   +  + R L Y+   
Sbjct: 68  FYS--DGE---ISICMEHMDGGSLDQVLKKAGRI----PENILGKISIAVLRGLTYLREK 118

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
           T   DIWS G  + E+ +G+   P         E+  + G P   E +    +      P
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPV-SEGEAKESHRPVSGHP 230

Query: 323 QIKPHPWHKVFQ----------KRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPF 367
              P P   +F+           +LP      E  D V +  + +P  R    E   HPF
Sbjct: 231 PDSPRPM-AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289

Query: 368 F 368
            
Sbjct: 290 I 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 86/311 (27%), Positives = 136/311 (43%), Gaps = 67/311 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           V+G G+FG V   + + + ++ A+K + + +  K         E  IM   +   IV L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL- 108

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           H  F    +++ YL +V+EY+P  + VN ++ NY      +P  + + YT ++  AL  I
Sbjct: 109 HYAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----IPEKWARFYTAEVVLALDAI 158

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPE 254
           H+ +G  HRD+KP N+L++   H LKL DFG+    +K + N    C        Y +PE
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPE 213

Query: 255 LIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           ++    G   Y    D WS G  + E+L+G   F  +S V          GT +    K 
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------GTYS----KI 259

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFF- 368
           M+ +     FP              +  +A DL+C F         R    E   HPFF 
Sbjct: 260 MD-HKNSLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308

Query: 369 ------DELRD 373
                 D +R+
Sbjct: 309 NDQWTFDNIRE 319

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 17/211 (8%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 139
           E  +G G F  V++A C   G  VA+KKV    L D + +    +E+ +++ L+HPN++ 
Sbjct: 7   EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               F      E+  LN+VLE      ++R+ +++ +  + +P   V  Y  Q+C AL +
Sbjct: 67  YYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIF 257
           +H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE I 
Sbjct: 122 MHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
               Y    DIWS GC++ E+   Q  F G+
Sbjct: 180 -ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 38/210 (18%)

Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALA 197
            K   +S   +    L LV+EY+P    R  + ++  R+  R  L    LY  QIC+ + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNVSYICSR 248
           Y+     +   HRD+  +N+LV      +K+ DFG  KVL          EP  S I   
Sbjct: 123 YLGSKRYV---HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI--- 175

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAEL 278
           ++ APE +   ++++ A D+WS G V+ EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 33/209 (15%)

Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 138
           +G G FG V    CR       TGE VA+K        Q +    RE++I++ LDH NIV
Sbjct: 12  LGEGHFGKVE--LCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
             K             L L++EY+P    R    Y + H+ ++ L  + L++ QIC+ + 
Sbjct: 70  KYKGV---CEKPGGRSLRLIMEYLPSGSLRD---YLQRHRDQINLKRLLLFSSQICKGMD 123

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYY 250
           Y+ +     HRD+  +N+LV      +K+ DFG AKVL +        EP  S I   +Y
Sbjct: 124 YLGS-QRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY 179

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL 279
            APE +  +  +++A D+WS G  + EL 
Sbjct: 180 -APECLRTSK-FSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 85/310 (27%), Positives = 137/310 (44%), Gaps = 47/310 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF---- 144
           V+G GSFG V  A+ + T E  AIK + +D   ++ +++   +      +A +H F    
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F T   +E +L  V+EY+      +  +      R      + Y  +I   L ++H   G
Sbjct: 62  FCTFQTKE-HLFFVMEYL--NGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK-G 116

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYT 263
           I +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE++ G  +Y 
Sbjct: 117 IIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYN 174

Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
            ++D WS G ++ E+L+GQ  F GE   D+L + I         +               
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR-------------- 212

Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACVHPFFDELRDPNTRLPNGR 382
               P    F + +  EA D + + F+  P  R     +   HPFF   R  +      R
Sbjct: 213 ----PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWERLEKR 262

Query: 383 PLPPLFNFKP 392
            +PP   FKP
Sbjct: 263 EIPP--PFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 89.5 bits (222), Expect = 6e-20
 Identities = 86/285 (30%), Positives = 135/285 (47%), Gaps = 49/285 (17%)

Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPNIV 138
           V+G GSFG VF   +    + G++ A+K       KV    R K  E  I+  ++HP IV
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICRAL 196
            L H  F T  K    L L+L+++     R    ++R+ + +      VK Y  ++  AL
Sbjct: 62  KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPEL 255
            ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 112 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTPT--------- 305
           +     +T + D WS G +M E+L G   F G+   + +  I+K  LG P          
Sbjct: 170 V-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 228

Query: 306 -REEIKCMNPNYTEFKFPQ----IKPHP------WHKVFQKRLPP 339
            R   K  NP       P     IK HP      W+K++++ + P
Sbjct: 229 LRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.1 bits (218), Expect = 7e-20
 Identities = 69/217 (31%), Positives = 109/217 (50%), Gaps = 22/217 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G GSFG ++ AK +   E   IK++      +++K    +E+ ++  + HPNIV    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT--- 63

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            FF++  +E   L +V+EY    + + RI R    +     ++    +  QI   L +IH
Sbjct: 64  -FFASF-QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHIH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFG 258
           +   I HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE I  
Sbjct: 119 D-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-ICQ 175

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
              Y    DIWS GCV+ EL   +  F G + + QLV
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.6 bits (220), Expect = 7e-20
 Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 50/281 (17%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFF 145
           G G+ G V + + + TG I A+K +  D     ++   REL+I +    P IV     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68

Query: 146 STTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              D+    + + +EY     +     ++ +   RI ++  L  +      + + L+Y+H
Sbjct: 69  --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRAPELI 256
           +   I HRDIKP N+L+     Q+KLCDFG     V GE   S    +  + +Y APE I
Sbjct: 123 S-RKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIKVLGTPT------- 305
            G   Y+   D+WS G  + E+   +  FP E     G  +L+  I  +  P        
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 306 ----REEIK-----CMNPNYTEFKFP-QIKPHPWHKVFQKR 336
                EE K     C+  + T    P  +  HPW K   K+
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 78/304 (25%), Positives = 120/304 (39%), Gaps = 68/304 (22%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           G G+FG V++A+ +ETG   A K +       L+D      E+ I+    HPNIV L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 144 FFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIH 200
           +F         L +++E+     ++ I     R      L    ++    Q+  AL ++H
Sbjct: 71  YFYENK-----LWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLH 120

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI--- 256
           +   + HRD+K  N+L+      +KL DFG SAK     +   ++I + Y+ APE++   
Sbjct: 121 SHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 257 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
            F    Y    DIWS G  + EL   +P                    P  E    +NP 
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNPM 214

Query: 316 YTEFKFPQ------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
               K  +       +P  W   F         D +       P+ R TA E   HPF  
Sbjct: 215 RVLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVS 266

Query: 370 ELRD 373
           +  D
Sbjct: 267 DQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 57/295 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG+  A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F  T D     L  V+EY    E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTHD----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALGYL 111

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+C  + +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 168

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+        
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-------- 213

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                         F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 214 --------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 88.0 bits (218), Expect = 1e-19
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 50/300 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           +G G++G V++   R TG  +A+K++   L + ++     EL I+     P IV     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F      E  + + +EY+   +++++        + +P   ++  TY + + L ++    
Sbjct: 69  F-----IEGAVYMCMEYMDAGSLDKLYAGGVAT-EGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI-----FG 258
            I HRD+KP N+LVN +  Q+KLCDFG +  LV      +  C  Y  APE I       
Sbjct: 123 NIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQ 180

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPN 315
              YT   D+WS G  + E+ LG+  +P E+  +   QL  I+   G P       +   
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSG 233

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           Y+                      +A D V +     PN R T  +   HP+  + ++ +
Sbjct: 234 YS---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 87/282 (30%), Positives = 128/282 (45%), Gaps = 45/282 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 139
           V+G GSFG V  AK +  G+  A+ KVLQ K   NR+ Q         +++ + HP +V 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAV-KVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L H  F TT+K    L  VL++V   E    + R  S      P    + Y  +I  AL 
Sbjct: 61  L-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASALG 110

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
           Y+H+ I I +RD+KP+N+L++   H + L DFG  K  +      +  C +  Y APE+I
Sbjct: 111 YLHS-INIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII-KVL----GTPT------ 305
                Y   +D W  G V+ E+L G P F      +    I+ K L    G         
Sbjct: 169 -RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSIL 227

Query: 306 REEIKCMNPNYTEFK--FPQIKPHP------WHKVFQKRLPP 339
            E ++         K  F +I+ HP      W  + QK++PP
Sbjct: 228 EELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 85/303 (28%), Positives = 133/303 (43%), Gaps = 57/303 (18%)

Query: 89  VVGTGSFGVVFQAKCR---ETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 136
           V+GTG++G VF  +     + G++ A+K      ++Q  +         Q+L+     P 
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V L H  F T  K    L+L+L+YV   E    +   Y R  +      V++Y  +I  
Sbjct: 67  LVTL-HYAFQTDTK----LHLILDYVNGGELFTHL---YQR--EHFTESEVRVYIAEIVL 116

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 252
           AL ++H  +GI +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    Y A
Sbjct: 117 ALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 253 PELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           PE+I G +  +  A+D WS G +  ELL G   F  +   +   EI       +R  +K 
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRRILKS 227

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFF 368
             P                  F K +  EA D + +  +  P  R     A E   HPFF
Sbjct: 228 KPP------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Query: 369 DEL 371
             +
Sbjct: 270 QGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 87.2 bits (216), Expect = 4e-19
 Identities = 89/300 (29%), Positives = 130/300 (43%), Gaps = 63/300 (21%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIKKVLQ---------DKRYKNRELQIMQMLDHPN 136
           V+G G +G VFQ +     +TG+I A+K VL+         D  +   E  I++ + HP 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           IV L    F T  K  LYL  +LEY+   E    + R    +           Y  +I  
Sbjct: 62  IVDL-IYAFQTGGK--LYL--ILEYLSGGELFMHLEREGIFMEDT-----ACFYLSEISL 111

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAP 253
           AL ++H   GI +RD+KP+N+L++   H +KL DFG  K  +         C    Y AP
Sbjct: 112 ALEHLHQ-QGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E I   + +  A+D WS G +M ++L G P F  E+    + +I+K          K   
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNL 219

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
           P Y                    L PEA DL+ +  + +P+ R       A E   HPFF
Sbjct: 220 PPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.0 bits (213), Expect = 4e-19
 Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 24/227 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQ--DKRYKN---RELQIMQMLDHPNI 137
           +   + +G GSFGVVF+   +    + A+K++ L   ++R +     E +++  LD   I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +     F      ++  LN+V+EY     ++++ +      + +P   V  +  QI   L
Sbjct: 62  IRYYESFL-----DKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGL 114

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRA 252
           A++H+   I HRDIK  NL ++ +   +K+ D G AK+L     N ++    + + YY +
Sbjct: 115 AHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLS 169

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           PEL      Y    D+W+ G V+ E   G+  F   +    +++II+
Sbjct: 170 PELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 55/314 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           ++G GSFG VF A+ + T +  AIK + +D    + +++   +         +HP +  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +C F T  KE L+   V+EY+      +  +    H +  L     Y  +I   L ++H
Sbjct: 62  -YCTFQT--KENLFF--VMEYL--NGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH 113

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 259
           +  GI +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++ G 
Sbjct: 114 S-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG- 170

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            +Y T++D WS G ++ E+L+GQ  F G    +              + I+  NP Y  +
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCYPRW 218

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNTRL 378
                            L  EA D++ + F   P  R     +   HPFF E+    + L
Sbjct: 219 -----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID--WSAL 259

Query: 379 PNGRPLPPLFNFKP 392
                 PP   FKP
Sbjct: 260 EEREIEPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 80/308 (25%), Positives = 125/308 (40%), Gaps = 86/308 (27%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALK 141
           V+G G+FG V   + ++TG I A+KK+ + +   K +      E  I+   D+P +V L 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F     ++E YL L++EY+P  + +  + +      +     Y+     +   A+  I
Sbjct: 68  YSF-----QDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIA----ETILAIDSI 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPN--VSYI 245
           H  +G  HRDIKP NLL++   H +KL DFG              ++L    P+  + +I
Sbjct: 118 HK-LGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 246 CSRY-------------------------YRAPELIFGATEYTTAIDIWSTGCVMAELLL 280
                                        Y APE +F  T Y    D WS G +M E+L+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEMLV 234

Query: 281 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE 340
           G P F  +               P     K +N   T  +FP           +  L PE
Sbjct: 235 GYPPFCSD--------------NPQETYRKIINWKET-LQFPD----------EVPLSPE 269

Query: 341 AVDLVCRF 348
           A DL+ R 
Sbjct: 270 AKDLIKRL 277

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 30/233 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQ----IMQMLDHPNIVALKHC 143
           +G G+FG V +   + +G I+A+K++    D++ + R L     +M+  D P IV     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK---- 67

Query: 144 FFSTTDKE-------ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           F+    +E       EL +++ L+   + V      Y  +   +P   +        +AL
Sbjct: 68  FYGALFREGDCWICMEL-MDISLDKFYKYV------YEVLKSVIPEEILGKIAVATVKAL 120

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            Y+   + I HRD+KP N+L++ + + +KLCDFG +  LV           R Y APE I
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179

Query: 257 --FGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR 306
                  Y    D+WS G  + E+  G+  +P   S  DQL +++K  G P  
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 92/305 (30%), Positives = 140/305 (45%), Gaps = 60/305 (19%)

Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIKKVLQD----KRYKNRELQIM--QMLDH----P 135
           V+GTG++G VF   +    +TG++ A+K VLQ     ++ K  E       +L+H    P
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLIYVKLYTYQIC 193
            +V L H  F T  K    L+L+L+YV          ++ ++QR       V+ Y+ +I 
Sbjct: 66  FLVTL-HYAFQTEAK----LHLILDYVSG-----GEMFTHLYQRDNFSEDEVRFYSGEII 115

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YR 251
            AL ++H  +GI +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    Y 
Sbjct: 116 LALEHLHK-LGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE+I G   +  A+D WS G ++ ELL G   F  E   +   E+       +R  +KC
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRILKC 226

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHP 366
             P                  F   + PEA DL+ +  +  P  R       A E   HP
Sbjct: 227 DPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268

Query: 367 FFDEL 371
           FF  L
Sbjct: 269 FFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 90/301 (29%), Positives = 137/301 (45%), Gaps = 60/301 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQM-LDHPNIVAL 140
           V+G GSFG V  A+ + T E+ AIK      +LQD        E +I+ +   HP + AL
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            HC F T D+    L  V+EYV   + + +I R+      R      + Y  ++  AL +
Sbjct: 62  -HCCFQTKDR----LFFVMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMF 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 257
           +H   G+ +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y APE I 
Sbjct: 112 LHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-IL 168

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
              EY  ++D W+ G +M E++ GQP F  ++  D L E I                 + 
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL----------------HD 211

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC-----VHPFFDE 370
           +  +P      W       L  EAV ++  F   +PN R  C A +        HPFF E
Sbjct: 212 DVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259

Query: 371 L 371
           +
Sbjct: 260 I 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 84/316 (26%), Positives = 142/316 (44%), Gaps = 59/316 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GSFG V  A+ +  GE  A+K + +D    + +++   +         ++P +  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +C F T +    +L  V+E++   + +  I         R  L     Y  +I   L +
Sbjct: 62  -YCTFQTKE----HLFFVMEFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQF 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           +H+  GI +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ 
Sbjct: 112 LHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G  +YT ++D WS G ++ E+L+GQ  F G+   D+L E I+V                 
Sbjct: 170 G-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV----------------- 210

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNT 376
                   PH     + + +  E+ D++ + F+  P  R   +     HPFF  +   N 
Sbjct: 211 ------DTPH-----YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---NW 256

Query: 377 RLPNGRPLPPLFNFKP 392
                R L P   FKP
Sbjct: 257 TALEKRELDP--PFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 83.6 bits (206), Expect = 7e-18
 Identities = 67/224 (29%), Positives = 120/224 (53%), Gaps = 28/224 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+ GVV + + + +G I+A       IK  ++++    RELQ++   + P IV    
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F+S  D E   +++ +E++   +++++ +   RI + +    +   +  + R LAY+  
Sbjct: 71  AFYS--DGE---ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE 121

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 262 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 304
           Y+   DIWS G  + EL +G+ P+ P ++      E+  + G P
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 82.2 bits (203), Expect = 8e-18
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNI 137
           Y+    +G GSFG     K +E G+   IK++    +  K  +   +E+ ++  + HPNI
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQIC 193
           V  +  F     +E   L +V++Y           Y +I+ +  +++    +  +  QIC
Sbjct: 62  VQYQESF-----EENGNLYIVMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRA 252
            AL ++H+   I HRDIK QN+ +      +KL DFG A+VL    E   + I + YY +
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
           PE I     Y    DIW+ GCV+ E+ 
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.5 bits (206), Expect = 9e-18
 Identities = 67/229 (29%), Positives = 122/229 (53%), Gaps = 23/229 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+ GVVF+   + +G I+A       IK  ++++    RELQ++   + P IV    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F+S  D E   +++ +E++   +++++ +   RI +++    +   +  + + L Y+  
Sbjct: 71  AFYS--DGE---ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 262 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 309
           Y+   DIWS G  + E+ +G+ P+ P ++   +L+    V G P   E 
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 82.4 bits (203), Expect = 9e-18
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHP 135
           ++  E  +G G F  V++A C    + VA+KKV    + D + +    +E+ +++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           N++     F    +     LN+VLE      ++++ + + +  + +P   V  Y  Q+C 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAP 253
           A+ ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
           E I     Y    DIWS GC++ E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 61/297 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
           ++G G+FG V+     +TG  +A+K+V  D               E+Q+++ L H  IV 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C     D  E  L++ +E++P  ++    ++Y  + + +     + YT QI   ++Y
Sbjct: 69  YYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVSY 121

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPE 254
           +H+ + I HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +I G   Y    DIWS GC + E+L  +P +   +  + +  I K+   PT       NP
Sbjct: 180 VISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT-------NP 228

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                                 LPP   D  CR F     L+   +EA + P  DEL
Sbjct: 229 ---------------------VLPPHVSDH-CRDF-----LKRIFVEAKLRPSADEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 90/339 (26%), Positives = 142/339 (41%), Gaps = 81/339 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK----VLQDKR---YKNRELQIMQMLDHPNIVALK 141
           +VG G FG V   + + TG+I A+K     VL  +    +   E  I+ + + P I  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    DK+ LYL  V+EY P  + ++ + R   +  + M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSRYYRAPELI- 256
           H  +G  HRDIKP+N+L++   H +KL DFGSA  L   +   S   + +  Y APE++ 
Sbjct: 119 HQ-MGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 257 ----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
                G   Y    D WS G +  E++ G+  F   +       I+              
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222

Query: 313 NPNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA------CVH 365
             N+  F KFP+            ++  + +DL+        +L C   E       C H
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLI-------QSLLCGQKERLGYEGLCCH 263

Query: 366 PFFDELRDPNTRLPNGRPLPPLF----------NFKPPE 394
           PFF ++   N R      LPP            NF  PE
Sbjct: 264 PFFSKIDWNNIR----NSLPPFVPTLKSDDDTSNFDEPE 298

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 47/284 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE----------LQIMQMLDHPNIVA 139
           +G G+FG V+Q + ++T  I A+K + + +    +E          L    + + P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           LK  F + +D     L LV +Y+   E    + +       R      K Y  ++  AL 
Sbjct: 61  LKFSFQTDSD-----LYLVTDYMSGGELFWHLQKE-----GRFSEDRAKFYIAELVLALE 110

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELI 256
           ++H    I +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++
Sbjct: 111 HLHK-YDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII---------KVLGTPTRE 307
                YT  +D WS G ++ E+  G   F  E    Q+   I          VL    R+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFPKNVLSDEGRQ 227

Query: 308 EIKCM---NPNY---TEFKFPQIKPHP------WHKVFQKRLPP 339
            +K +   NP +         ++K HP      W  + +K++ P
Sbjct: 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITP 271

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 139
           V+G GSFG V  AK +  G   A+ KVLQ K    ++ Q         +++ L HP +V 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAV-KVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L + F +    E+LY   VL+YV   E    + R    +  R      + Y  ++  A+ 
Sbjct: 61  LHYSFQTA---EKLY--FVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAIG 110

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  V+ E   S  C +  Y APE +
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-V 167

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF 285
                Y   +D W  G V+ E+L G P F
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 139
           V+G GSFG V  A+ +   +  A+K VLQ K    K  E  IM       + + HP +V 
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L H  F T DK    L  VL+Y+   E    + R    +  R      + Y  +I  AL 
Sbjct: 61  L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++
Sbjct: 111 YLHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF 285
                Y   +D W  G V+ E+L G P F
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y    VVG GSFG     +   + +  A+K++   K         +E  ++  + HPNIV
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           A K  F     + + +L +V+EY    + + +I     ++    P   +  +  Q+C  +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPEL 255
            +IH    + HRDIK +N+ +     ++KL DFGSA++L   G    +Y+ + YY  PE 
Sbjct: 114 QHIHE-KRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170

Query: 256 IFGATEYTTAIDIWSTGCVMAEL 278
           I+    Y    DIWS GC++ EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.5 bits (198), Expect = 4e-17
 Identities = 65/235 (27%), Positives = 117/235 (49%), Gaps = 27/235 (11%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
           ++G G+FG V+     +TG  +A+K+V  D   +           E+Q+++ L H  IV 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C     D EE  L++ +EY+P  ++    + Y  + + +     + YT QI + ++Y
Sbjct: 69  YYGCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVSY 121

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNVSYICSRYYRAPE 254
           +H+ + I HRDIK  N+L +     +KL DFG++K    + + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           +I G   Y    D+WS  C + E+L  +P +   +  + +  I K+   PT+  +
Sbjct: 180 VISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.5 bits (199), Expect = 5e-17
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 20/208 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKN----RELQIMQM-LDHPNIVALKHC 143
           +G+G+ G V++ + ++TG ++A+K++ +   + +N     +L ++    D P IV     
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F + +D     + + +E +   ++++ +   RI   +P   +   T  I +AL Y+    
Sbjct: 83  FITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLKEKH 134

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGAT-- 260
           G+ HRD+KP N+L++  +  +KLCDFG +  LV  +    S  C+ Y  APE I      
Sbjct: 135 GVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPDPN 192

Query: 261 -EYTTAIDIWSTGCVMAELLLGQPLFPG 287
            +Y    D+WS G  + EL  GQ  +  
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 70/237 (29%), Positives = 116/237 (48%), Gaps = 43/237 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 136
           Y    V+G G+FG V   + + + ++ A+K + +       D  +   E  IM   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V L  C F    +++ YL +V+EY+P  + VN ++ NY      +P  + K YT ++  
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVL 153

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNVSY 244
           AL  IH+ +G+ HRD+KP N+L++ H H LKL DFG+   + +          G P+   
Sbjct: 154 ALDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD--- 208

Query: 245 ICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
                Y +PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 209 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 79.3 bits (195), Expect = 9e-17
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 52/293 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
           ++G G+FG V+     +TG  +A K+V  D               E+Q+++ L H  IV 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C     D+ E  L + +EY+P  +V    + Y  + + +     + YT QI   ++Y
Sbjct: 69  YYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQILEGMSY 121

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPE 254
           +H+ + I HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT       NP
Sbjct: 180 VISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT-------NP 228

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                        P H     R      D +   F  + + R +A E   HPF
Sbjct: 229 -----------QLPSHISEHAR------DFLGCIFVEARH-RPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 80.1 bits (197), Expect = 9e-17
 Identities = 82/302 (27%), Positives = 135/302 (44%), Gaps = 57/302 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A+ + +G  VA+K  + D R + R      E+ IM+   H N+V +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 144 FFSTTDKEELYLNLVLEYV-----PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           + S    EEL++  ++E++      + V++   N  +I               + +AL Y
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQI---------ATVCESVLQALCY 132

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIF 257
           +H+  G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I 
Sbjct: 133 LHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI- 189

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
             T Y T +DIWS G ++ E++ G+P +  +S V  +  +        R+          
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS--------- 232

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377
                   P P  K   K + P   D + R     P  R TA E   HPF  +   P   
Sbjct: 233 --------PPPKLKNAHK-ISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECL 283

Query: 378 LP 379
           +P
Sbjct: 284 VP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 80.0 bits (197), Expect = 9e-17
 Identities = 81/305 (26%), Positives = 138/305 (45%), Gaps = 59/305 (19%)

Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 136
           V+GTG++G VF   +    ++G++ A+K      ++Q  +         Q+L+H    P 
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICR 194
           +V L + F + T      L+L+L+Y+          ++ + QR       V++Y+ +I  
Sbjct: 67  LVTLHYAFQTDTK-----LHLILDYING-----GELFTHLSQRERFKEQEVQIYSGEIVL 116

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 252
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K   + E   +Y  C    Y A
Sbjct: 117 ALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174

Query: 253 PELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           P+++ G    +  A+D WS G +M ELL G   F  +   +   EI       +R  +K 
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKS 227

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHP 366
             P      +PQ             +   A D++ R     P  R       A E   HP
Sbjct: 228 EPP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP 269

Query: 367 FFDEL 371
           FF ++
Sbjct: 270 FFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 66/242 (27%), Positives = 102/242 (42%), Gaps = 47/242 (19%)

Query: 90  VGTGSFGVVFQAKCRETG--EI-VAIK-----KVLQDKRYKNRELQIMQMLDHPNIVALK 141
           +G G+FG V +         E+ VA+K      +   K+   RE  +M  LDHP IV L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                    E L   LV+E  P   + +    Y +  + +P+  +K   +Q+   +AY+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLLK----YLKKRREIPVSDLKELAHQVAMGMAYLE 112

Query: 201 NCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
           +     HRD+  +N LLVN   HQ K+ DFG ++ L  G        S YYR        
Sbjct: 113 SK-HFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 252 ----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVEIIKVLGTP 304
               APE I     +++  D+WS G  + E    G   +    G +   ++E  + L  P
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Query: 305 TR 306
             
Sbjct: 221 EE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 83/297 (27%), Positives = 135/297 (45%), Gaps = 47/297 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A  + +G++VA+KK+  D R + R      E+ IM+   H N+V + + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +      +EL+  +V+E++       A      H RM    +      + +AL+ +H   
Sbjct: 86  YLV---GDELW--VVMEFLEGG----ALTDIVTHTRMNEEQIAAVCLAVLKALSVLH-AQ 135

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEY 262
           G+ HRDIK  ++L+  H  ++KL DFG    + K  P   S + + Y+ APELI     Y
Sbjct: 136 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPY 193

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 234

Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
           ++K    HKV      P     + R     P  R TA E   HPF  +   P+  +P
Sbjct: 235 KLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 75/293 (25%), Positives = 137/293 (46%), Gaps = 55/293 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K + ++    + ++  +Q          +HP +V L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             CF     + E  L  V+E+V   + +  + R      +++P  + + Y+ +I  AL +
Sbjct: 62  HSCF-----QTESRLFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNF 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 257
           +H   GI +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII--KVLGTPTRE 307
           G  +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I  K +  P   
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 308 EIKC-------MNPNYTE-------FKFPQIKPHP------WHKVFQKR-LPP 339
            +K        +N +  E         F  IK HP      W  + QK+ LPP
Sbjct: 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 48/239 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR----ELQIMQMLDHPNIVALK 141
           ++G G  G VF  + + TG++ A+K   K    KR K +    E +I+  LDHP +  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             F + T     YL LV++Y P   + R+ +   +  + +     + Y  ++  AL Y+H
Sbjct: 68  ASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDF-------------------GSAKVLVKGEPN 241
             +GI +RD+KP+N+L++   H + L DF                   GS +  V   P+
Sbjct: 121 -LLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 242 VSYICS-----------RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
            ++                Y APE+I G   + +A+D W+ G ++ E+L G   F G +
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++AK +ETG  +A  KV++ K  +       E++I+   +HP IV L   F
Sbjct: 20  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +      +  L +++E+ P   V+ I     R     P I  ++   Q+  AL Y+H+ +
Sbjct: 79  Y-----WDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQI--QVICRQMLEALQYLHS-M 129

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGAT-- 260
            I HRD+K  N+L+      +KL DFG SAK +   +   S+I + Y+ APE++   T  
Sbjct: 130 KIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 261 --EYTTAIDIWSTGCVMAELLLGQP 283
              Y    DIWS G  + E+   +P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 37/211 (17%)

Query: 89  VVGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVA 139
           V+G G FG V    +      TGE+VA+K + ++   +N      E+ I++ L H NIV 
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
            K C    +++    L L++EYVP       R+Y   H ++ L  + L+  QIC  +AY+
Sbjct: 71  YKGC---CSEQGGKGLQLIMEYVPLGS---LRDYLPKH-KLNLAQLLLFAQQICEGMAYL 123

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE----- 254
           H+   I HRD+  +N+L++ +   +K+ DFG AK + +G          YYR  E     
Sbjct: 124 HSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDGDSP 173

Query: 255 LIFGATE------YTTAIDIWSTGCVMAELL 279
           + + A E      ++ A D+WS G  + ELL
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 21/219 (9%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 141
           V+G GSFG V  A+ + T E+ AIK      V+QD   +    E +++ + D P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 200
           H  F T D+    L  V+EYV      +  +  ++ + + P      Y  +I   L ++H
Sbjct: 67  HSCFQTVDR----LYFVMEYV--NGGDLMYHIQQVGKFKEP--QAVFYAAEISVGLFFLH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGA 259
              GI +RD+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I   
Sbjct: 119 R-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AY 175

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             Y  ++D W+ G ++ E+L GQP F GE   D+L + I
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 43/232 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P +V L 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F     +++ YL +V+EY+P  + VN ++ NY      +P  + + YT ++  AL  I
Sbjct: 110 YAF-----QDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLALDAI 158

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNVSYICSRY 249
           H+ +G  HRD+KP N+L++   H LKL DFG+   + K          G P+        
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD-------- 208

Query: 250 YRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           Y +PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 66/245 (26%), Positives = 112/245 (45%), Gaps = 37/245 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G FG V   + + TG++ A KK L  KR K +        E +I++ ++ P IV L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 142 HCFFSTTDKEELYLNLV--------LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + F S T     +L LV        L+Y    V        R+      I+   Y+ QI 
Sbjct: 60  YAFESKT-----HLCLVMSLMNGGDLKYHIYNVGERGLEMERV------IH---YSAQIT 105

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             + ++H+ + I +RD+KP+N+L++      +L D G A  L  G+       +  Y AP
Sbjct: 106 CGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAP 163

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E I     Y+  +D ++ GC + E++ G+  F       + V   ++      +E+K  +
Sbjct: 164 E-ILKEEPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEH 219

Query: 314 PNYTE 318
            N+TE
Sbjct: 220 QNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 91/315 (28%), Positives = 138/315 (43%), Gaps = 58/315 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 140
           V+G GSFG V  A+ +E+G + A+K      +LQD   +    E +I+ +  +HP +  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +C F T D+    L  V+E+V           SR   R      + Y  +I  AL ++H
Sbjct: 62  -YCCFQTPDR----LFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLH 113

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 259
           +  GI +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I   
Sbjct: 114 D-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQE 170

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y  ++D W+ G ++ E+L G   F  E+  D L E I        +E+          
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV---------- 213

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTAL--EACV--HPFFDELRD 373
                       V+   L  +AVD++  F   +P +R     L  E  +  HPFF EL  
Sbjct: 214 ------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL-- 259

Query: 374 PNTRLPNGRPLPPLF 388
            +    N R + P F
Sbjct: 260 -DWEKLNRRQIEPPF 273

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 41/293 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHC 143
           ++G G+ G V++A    T  I+A+K +  D     ++    EL+I+   D P I+     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           FF      E  +++  E++             +++++P   +      + + L Y+ + +
Sbjct: 68  FFV-----ENRISICTEFMDG-------GSLDVYRKIPEHVLGRIAVAVVKGLTYLWS-L 114

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
            I HRD+KP N+LVN    Q+KLCDFG +  LV      +Y+ +  Y APE I G  +Y 
Sbjct: 115 KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171

Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
              D+WS G    EL LG+  +P        +  +++L     E+             P 
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------PV 219

Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
           +    + + F        V  + +  +  P  R        HPF  +  D N 
Sbjct: 220 LPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 67/235 (28%), Positives = 119/235 (50%), Gaps = 32/235 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH--------PNIVAL 140
           V+G GS+  V   + ++  +I A+K V ++  + + ++  +Q   H        P +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             CF +T+      L LV+EYV   + +  + R      +++P  + + Y  +IC AL +
Sbjct: 62  HSCFQTTSR-----LFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNF 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 257
           +H   GI +RD+K  N+L++   H +KL D+G  K  L  G+   ++  +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 306
           G  EY  ++D W+ G +M E++ G+  F      P  +  D L ++I  L  P R
Sbjct: 170 GE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  A+ + T E+ AIK + +D   ++ +++       ++ +   P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+        L +V E VN     Y  I Q  +    +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR--------LYFVMEYVNGGDLMY-HIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+  GI +RD+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
              Y  ++D W+ G ++ E+L GQP F GE
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 78.2 bits (192), Expect = 6e-16
 Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 62/296 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKNRELQIM-QMLDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K V        +D  +   E  +  Q  +HP +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             CF     + E  L  V+EYV   + +  + R      +++P  + + Y+ +I  AL Y
Sbjct: 62  HSCF-----QTESRLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           +H   GI +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII----------- 298
           G  +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I           
Sbjct: 170 GE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 299 ---------KVLGTPTREEIKCMNPNYTEFKFPQIKPHP------WHKVFQKRLPP 339
                      L    +E + C      +  F  I+ HP      W  + QK++ P
Sbjct: 229 SVKAASVLKSFLNKDPKERLGCH----PQTGFADIQGHPFFRNVDWDLMEQKQVVP 280

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 84/326 (25%), Positives = 134/326 (41%), Gaps = 71/326 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A KK L+ KR K R        E QI++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 141 KHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQI 192
            + +  T D   L L L+    L++              I+      +       Y  +I
Sbjct: 66  AYAY-ETKDALCLVLTLMNGGDLKF-------------HIYNMGNPGFDEERAVFYAAEI 111

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
              L  +H    I +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y A
Sbjct: 112 TCGLEDLHR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMA 169

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++     YT + D W  GC++ E++ G+  F          E +K      REE++  
Sbjct: 170 PEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERR 216

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--C---TALEACVHPF 367
                E              + ++    A  +  +     P  R  C    A E   HPF
Sbjct: 217 VKEDQE-------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263

Query: 368 FDELRDPN-TRLPNGRPLPPLFNFKP 392
           F   R  N  RL  G   PP   F P
Sbjct: 264 F---RTANFKRLEAGMLEPP---FCP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 54/289 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 138 VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           V + + F  T DK    L+L+    L Y       ++++       M     + Y  +I 
Sbjct: 60  VCMSYAF-HTPDKLSFILDLMNGGDLHY------HLSQHGVFSEAEM-----RFYAAEII 107

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y AP
Sbjct: 108 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQ----------------------PLFPGESGV 291
           E++     Y ++ D +S GC++ +LL G                          P     
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 224

Query: 292 DQLVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 339
           +    +  +L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 94/335 (28%), Positives = 142/335 (42%), Gaps = 65/335 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKN----RELQIMQMLDHPNIVALK 141
           V+G G+FG V   K + TG++ A+K   K    KR +      E  ++   D   I  L 
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F     ++E  L LV++Y       +    S+   R+P    + Y  ++  A+  +H 
Sbjct: 68  YAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKG--EPNVS-----YICSRYYRAP 253
            +G  HRDIKP N+L++ + H ++L DFGS  ++L  G  + NV+     YI     +A 
Sbjct: 121 -LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E   G   Y    D WS G  M E+L G+  F  ES V+   +I+               
Sbjct: 179 E--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--------------- 221

Query: 314 PNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFD 369
            N+ E F+FP              +  EA DL+ R    SP  R       +   HPFF+
Sbjct: 222 -NHKEHFQFPPDVTD---------VSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHPFFE 270

Query: 370 ELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETIN 404
            +   N R        P      PE+S  P +T N
Sbjct: 271 GIDWDNIRNST----APYV----PEVSS-PTDTSN 296

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 15/203 (7%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 136
           +Y    VVG GS+G V   + R  G+   IKK+       ++++   +E Q++  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IVA +  +    + E+  L +V+ +  E  +   +   +  + +P   V  +  QI  AL
Sbjct: 61  IVAYRESW----EGEDGLLYIVMGFC-EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPEL 255
            Y+H    I HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PEL
Sbjct: 116 QYLHE-KHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 256 IFGATEYTTAIDIWSTGCVMAEL 278
            F    Y    D+W+ GC + E+
Sbjct: 174 -FSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 21/206 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A  + TG+ VA+KK+  D R + R      E+ IM+   H N+V + + 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +      +EL++  V+E++       A      H RM    +      + RAL+Y+HN  
Sbjct: 88  YLV---GDELWV--VMEFLEGG----ALTDIVTHTRMNEEQIATVCLSVLRALSYLHN-Q 137

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIFGATEY 262
           G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     Y
Sbjct: 138 GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRLPY 195

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGE 288
            T +DIWS G ++ E++ G+P +  E
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 91/348 (26%), Positives = 145/348 (41%), Gaps = 99/348 (28%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHP 135
           ++    +G G+FG V  A   +T  + A+K  L+ K   NR        E  I+   D+ 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNE 61

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
            +V L   ++S  DK+ LY   V++Y+P  + ++ + R      +  P +  + Y  ++ 
Sbjct: 62  WVVKL---YYSFQDKDNLYF--VMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELT 111

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG---------SAKVLVKG------ 238
            A+  +H  +G  HRDIKP N+L++   H +KL DFG         ++K   KG      
Sbjct: 112 LAIESVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169

Query: 239 --EPN-------------------------------VSYICSRYYRAPELIFGATEYTTA 265
             EP+                                S + +  Y APE++     YT  
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQL 228

Query: 266 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 325
            D WS G ++ E+L+GQP F              +  TPT  ++K +N   T    PQ+K
Sbjct: 229 CDWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK 274

Query: 326 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDEL 371
                      L PEAVDL+ +    +     R  A +   HPFF E+
Sbjct: 275 -----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 49/285 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNI 137
           V+G G FG V  A+ ++TGE+ AIK  L+               + R  +      HP +
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIK-ALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V L  CF     + E ++  V+EY    + +  I  +               Y   +   
Sbjct: 65  VNLFACF-----QTEDHVCFVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLG 113

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           L Y+H    I +RD+K  NLL++     +K+ DFG  K  +      S  C +  + APE
Sbjct: 114 LQYLHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG---ESGVDQLV-EIIKVLGTPTREEIK 310
           ++   T YT A+D W  G ++ E+L+G+  FPG   E   D +V + ++     +RE I 
Sbjct: 172 VLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAIS 230

Query: 311 CM------NPN----YTEFKFPQIKPHP------WHKVFQKRLPP 339
            M      NP       E     +K  P      W  +  +++ P
Sbjct: 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKP 275

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 63/245 (25%), Positives = 117/245 (47%), Gaps = 31/245 (12%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGE-IVAIKKVL-------QDKRYKNRELQ--------I 128
           + EH+ G+G+FG V++ + +  G+ ++A+K++        +DKR +++ +         I
Sbjct: 4   VLEHL-GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVL-EYVP--ETVNRIARNYSRI-HQRMPLIY 184
            + L HPNIV     F    + + LY+ + L E  P  E  N +     R   +R+  I+
Sbjct: 63  KEQLRHPNIVRYYKTF---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           V     Q+  AL Y+H    I HRD+ P N+++     ++ + DFG AK         S 
Sbjct: 120 V-----QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSV 173

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           + +  Y  PE++     Y    D+W+ GC++ ++   QP F   + +    +I++ +  P
Sbjct: 174 VGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232

Query: 305 TREEI 309
             E +
Sbjct: 233 LPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 23/205 (11%)

Query: 90  VGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALK 141
           +GTGSFG V  A  + E    VAIK+  + K  K +       E +I+  ++HP  V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F     K+E YL LVLE+V   +      + R ++R P      Y  QI     Y+ +
Sbjct: 98  GSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGAT 260
            + I +RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++    
Sbjct: 150 -LNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLNVG 204

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            +  A D W+ G  + E+L+G P F
Sbjct: 205 -HGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 70/258 (27%), Positives = 123/258 (47%), Gaps = 38/258 (14%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAIK++ LQ +  K     E+ +M+ 
Sbjct: 15  GDPKKK--YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
             HPNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 73  NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 172

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 302 GTPTREEIKCMNPNYTEF 319
           GTP  +  + ++  + +F
Sbjct: 231 GTPELQNPEKLSAIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 79/295 (26%), Positives = 128/295 (43%), Gaps = 56/295 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F  T D+    L  V+EY    E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALDYL 111

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+   + +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE +  
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLE 169

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+        
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-------- 214

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                         F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 215 --------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 86/339 (25%), Positives = 136/339 (40%), Gaps = 97/339 (28%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   + ++TG+I A+K +L+ + +K  +L        ++   D P +V+L 
Sbjct: 8   VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           + F     ++  YL L++E++P   +  +   Y    + +     + Y  +   A+  +H
Sbjct: 68  YSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAVH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNVSYICSR 248
             +G  HRDIKP N+L++   H +KL DFG              + L++G+ N + I +R
Sbjct: 119 K-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 249 Y------------------------------------YRAPELIFGATEYTTAIDIWSTG 272
                                                Y APE IF    Y    D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLG 235

Query: 273 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKPHPWHK 331
            +M E L+G P F  E+  +   +II                N+ E   FP         
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD-------- 271

Query: 332 VFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFF 368
                L  EA DL+ R    + N   R  A E   HPFF
Sbjct: 272 --DIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 86/317 (27%), Positives = 136/317 (42%), Gaps = 53/317 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A KK L+ KR K R        E QI++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            + + +   K+ L L L L    +    I   Y              Y  +IC  L  +H
Sbjct: 66  AYAYET---KDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++    
Sbjct: 120 Q-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KNE 176

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ +     E  
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE-- 222

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPN 375
                       + ++  P+A  L        P  R       A E   HP F ++    
Sbjct: 223 -----------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN--F 269

Query: 376 TRLPNGRPLPPLFNFKP 392
            RL  G   PP   FKP
Sbjct: 270 KRLEAGMLEPP---FKP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 22/206 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G+G++G V++A+   TGE+ AIK +     +D     +E+ +M+   H NIVA    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
           S   +++L++   +E+      +   + +       + YV   T Q    L Y+H+  G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 261
            HRDIK  N+L+  + H +KL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 262 -YTTAIDIWSTGCVMAELL-LGQPLF 285
            Y    DIW+ G    EL  L  P+F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 84/319 (26%), Positives = 138/319 (43%), Gaps = 62/319 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F  T D+    L  V+EY    E    ++R      +R      + Y  +I  AL Y+
Sbjct: 62  YAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEYL 111

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 168

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+        
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR-------- 213

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 373
                         F + L PEA  L+    +  P  R       A E   H FF  +  
Sbjct: 214 --------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259

Query: 374 PNTRLPNGRPLPPLFNFKP 392
            +  +   + LPP   FKP
Sbjct: 260 QD--VVQKKLLPP---FKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 28/208 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCF 144
           +G+G+ G V++   R TG + A+K +  +     +R   RE++I++ ++HPN+V   H  
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKC-HDM 140

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F    +    + ++LE++    +  +   + I     L  V     QI   +AY+H    
Sbjct: 141 FDHNGE----IQVLLEFM----DGGSLEGTHIADEQFLADV---ARQILSGIAYLHR-RH 188

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELI-----FG 258
           I HRDIKP NLL+N     +K+ DFG +++L +  +P  S + +  Y +PE I      G
Sbjct: 189 IVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFP 286
           A +   A DIWS G  + E  LG+  FP
Sbjct: 248 AYD-GYAGDIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 31/212 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 138 VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           V + + F  T DK    L+L+    L Y           +   H       ++ Y  +I 
Sbjct: 60  VCMTYAF-HTPDKLCFILDLMNGGDLHY-----------HLSQHGVFSEKEMRFYATEII 107

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y AP
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
           E++   T Y ++ D +S GC++ +LL G   F
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.7 bits (175), Expect = 5e-14
 Identities = 72/258 (27%), Positives = 124/258 (48%), Gaps = 38/258 (14%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQM 131
           G+ K+K  Y     +G G+ G VF A    TG+ VAIK++   K+ K      E+ +M+ 
Sbjct: 15  GDPKKK--YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
           L +PNIV     F      +EL++  V+EY+      + V     + ++I          
Sbjct: 73  LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAA-------- 119

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
                +CR    AL ++H    + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALEFLH-ANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKR 172

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 302 GTPTREEIKCMNPNYTEF 319
           GTP  +  + ++P + +F
Sbjct: 231 GTPELQNPEKLSPIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 35/208 (16%)

Query: 89  VVGTGSFGVVFQA--KCRETGEI-VAIKKVLQDKRYKNREL-----QIMQMLDHPNIVAL 140
            +G G FG V+Q      E  +I VA+K          RE       IM+  DHP+IV L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYI 199
                      E  + +V+E  P       R+Y ++++  + L  + LY+YQ+  ALAY+
Sbjct: 73  IGVI------TENPVWIVMELAPLGE---LRSYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 200 H--NCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYR 251
                +   HRDI  +N+LV +P    +KL DFG ++ L   E    Y  S+      + 
Sbjct: 124 ESKRFV---HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWM 175

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE I     +T+A D+W  G  M E+L
Sbjct: 176 APESI-NFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 27/243 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ETG ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIHN 201
           +   +     L +++E+     V+ +     R     PL    +++   Q   AL Y+H 
Sbjct: 72  YYENN-----LWILIEFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHE 121

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
              I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T
Sbjct: 122 N-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 261 E----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                Y    D+WS G  + E+   +P     + +  L++I K    PT  +    +  +
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSEF 238

Query: 317 TEF 319
            +F
Sbjct: 239 KDF 241

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 18/207 (8%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A K+ L+ KR K R        E QI++ ++   +V L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            + + +   K+ L L L +    +    I   Y+  +          Y  +I   L  +H
Sbjct: 66  AYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
                 +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++    
Sbjct: 120 R-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NNQ 176

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPG 287
            YT + D W  GC++ E++ GQ  F G
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           VG+G++G V++A+   TGE+ A+K +      D     +E+ +++   H NIVA    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
           S   +E+L+  + +EY      +   + +     + + YV   T Q    LAY+H+  G 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHS-KGK 127

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 261
            HRDIK  N+L+  +   +KL DFG +AK+        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184

Query: 262 -YTTAIDIWSTGCVMAELLLGQP 283
            Y    DIW+ G    EL   QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 30/295 (10%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
           GS G VF A  +       + K+ Q K     E  ++Q ++HP+++ +K    S      
Sbjct: 77  GSEGRVFVAT-KPGQPDPVVLKIGQ-KGTTLIEAMLLQNVNHPSVIRMKDTLVS----GA 130

Query: 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212
           +   ++  Y  +    + +    +     LI  K    QI   L Y+H    I HRD+K 
Sbjct: 131 ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK----QILEGLRYLHA-QRIIHRDVKT 185

Query: 213 QNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTG 272
           +N+ +N    Q+ + D G+A+  V     +    +    APE +    +Y +  DIWS G
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243

Query: 273 CVMAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----PTREEIKCMNPNYT 317
            V+ E+L             P    +S    L++II  L       P     + +   + 
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302

Query: 318 EFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           E+   + +P+  +  FQ+  LP +   LV +   +   +R +A E   +P F +L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 70.9 bits (173), Expect = 5e-13
 Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 41/244 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G G FG VF  K + T E    K +      +R K++   E+ +M+ L H NIV     
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI---YVKLYTYQICRALAYIH 200
           F +  +++   L +++E+       ++RN  + ++    I    +   T Q+  ALAY H
Sbjct: 81  FLNKANQK---LYILMEFC--DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135

Query: 201 NCIG------ICHRDIKPQNLLVNPHTHQL----------------KLCDFGSAKVLVKG 238
           N         + HRD+KPQN+ ++     +                K+ DFG +K +  G
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI--G 193

Query: 239 EPNVSYIC--SRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
             ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  G+  F   +   QL+
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI 253

Query: 296 EIIK 299
             +K
Sbjct: 254 SELK 257

Length = 1021

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 68.3 bits (168), Expect = 5e-13
 Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKE 151
           G FG V   K + T + + ++K+++ K +   E  + Q M D+PN + L +    TT K 
Sbjct: 27  GKFGKVSVLKHKPTQK-LFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSV--TTLKG 83

Query: 152 ELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            +   L+++Y+      + +        +   ++    VK    Q+  AL  +H    I 
Sbjct: 84  HV---LIMDYIKDGDLFDLL--------KKEGKLSEAEVKKIIRQLVEALNDLHK-HNII 131

Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
           H DIK +N+L +    ++ LCD+G  K  + G P+  Y  +  Y +PE I G   Y  + 
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSC-YDGTLDYFSPEKIKGHN-YDVSF 187

Query: 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
           D W+ G +  ELL G+   P +   D   E +         +++ +              
Sbjct: 188 DWWAVGVLTYELLTGK--HPFKEDED---EEL---------DLESLLKRQQ--------- 224

Query: 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFF 368
                 F K +   A D V    +Y+ N R T     + HPF 
Sbjct: 225 --KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 81/344 (23%), Positives = 122/344 (35%), Gaps = 113/344 (32%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G+FG V   +  +T  + A+K  L+      R        E  I+   D+  +V L 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVKL- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAY 198
             ++S  DK+ LY   V++Y+P        +   +  R+        + Y  ++  A+  
Sbjct: 67  --YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRLGIFEEDLARFYIAELTCAIES 116

Query: 199 IHNCIGICHRDIKPQNLLVNPH----------------THQLKL---------------- 226
           +H  +G  HRDIKP N+L++                  TH  K                 
Sbjct: 117 VHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 227 -------CDFGSAKVLVK------------GEPNVSYICSRYYRAPELIFGATEYTTAID 267
                  C     +   K            G PN        Y APE++   T YT   D
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQLCD 226

Query: 268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
            WS G ++ E+L+GQP F  +              TP   ++K +N   T    P     
Sbjct: 227 WWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWE-TTLHIP----- 266

Query: 328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFF 368
                 Q +L  EA DL+ R        R     A E   HPFF
Sbjct: 267 -----SQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 67.9 bits (166), Expect = 7e-13
 Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 54/264 (20%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++   +   E VA+K          KR   +E +I++  DHPNIV L    
Sbjct: 3   IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL---I 58

Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 200
                K+ +Y  +V+E VP    +  + +  +    R+ +  +   +      + Y+   
Sbjct: 59  GVCVQKQPIY--IVMELVPGGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESK 112

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------AP 253
           NCI   HRD+  +N LV    + LK+ DFG    + + E    Y  S   +       AP
Sbjct: 113 NCI---HRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAP 164

Query: 254 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           E L +G   YT+  D+WS G ++ E   LG   +PG S               TRE I+ 
Sbjct: 165 EALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------------TRERIE- 209

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQK 335
               Y     PQ+ P   +++  +
Sbjct: 210 --SGY-RMPAPQLCPEEIYRLMLQ 230

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 23/220 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 141
           V+G GSFG V  A+ + T E+ AIK      V+QD   +    E +++ +   P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+        L +V E VN     Y +I Q  R    +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR--------LYFVMEYVNGGDLMY-QIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFG 258
           H+  GI +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 86/327 (26%), Positives = 131/327 (40%), Gaps = 83/327 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA------LKH 142
           V+G G+FG V   + ++TG I A+K +L+      +E Q+  +    +I+       +  
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKE-QVAHIRAERDILVEADGAWVVK 65

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            F+S  DK  LYL  ++E++P  + +  + +  +   +       + Y  +   A+  IH
Sbjct: 66  MFYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------------------------ 230
             +G  HRDIKP NLL++   H +KL DFG                              
Sbjct: 119 Q-LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 231 ----SAKVLVKGEPNVSY--ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 284
                A+   K    ++Y  + +  Y APE +F  T Y    D WS G +M E+L+G P 
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL 344
           F  E              TP     K MN   T   FP   P          +  +A DL
Sbjct: 236 FCSE--------------TPQETYRKVMNWKET-LVFPPEVP----------ISEKAKDL 270

Query: 345 VCRFFQYSPNL--RCTALEACVHPFFD 369
           + RF   S N        E   HPFF+
Sbjct: 271 ILRFCTDSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 16/220 (7%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 148
           V+G G+FG V   K + T  I A+K + + +  K  E    +  +  N++    C + TT
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWITT 65

Query: 149 ----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
                ++E YL LV++Y       +    S+   R+P    + Y  ++  A+  IH  + 
Sbjct: 66  LHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-LH 122

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELIF----G 258
             HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     G
Sbjct: 123 YVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 65/206 (31%), Positives = 90/206 (43%), Gaps = 34/206 (16%)

Query: 105 ETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156
            TG  VAIK +  D         R++ RE  +   L HPNIVAL      + +     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 216
            V EYVP    R  R        +P         Q+  ALA  HN  GI HRD+KPQN++
Sbjct: 56  AVFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111

Query: 217 VN-----PHTHQLKLCDFGSAKVLVK-GEPNVS-------YICSRYYRAPELIFGATEYT 263
           V+     PH    K+ DFG   +L    + +V+        + +  Y APE + G    T
Sbjct: 112 VSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-T 167

Query: 264 TAIDIWSTGCVMAELLLGQPLFPGES 289
              D+++ G +  E L GQ +  G S
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 48/234 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
           V+G+G+FG V++      GE     VAIK + ++   K       E  +M  +DHP++V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 140 L-------KHCFFSTTDKEELYLNLVLEYVPETVNRIAR----NYSRIHQRMPLIYVKLY 188
           L       +    +    + + L  +L+YV    + I      N+               
Sbjct: 74  LLGICLSSQVQLIT----QLMPLGCLLDYVRNHKDNIGSQYLLNWCV------------- 116

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
             QI + ++Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +
Sbjct: 117 --QIAKGMSYLEE-KRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGK 172

Query: 249 Y---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
               + A E I     YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 173 VPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + +G+  A+K + ++      E+       ++++   HP + +LK
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F  T D+    L  V+EYV   E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTKDR----LCFVMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDYL 111

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+   I +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLE 168

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 39/229 (17%)

Query: 90  VGTGSFGVVFQAKCRE-TGEI--VAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALK 141
           +G GSFGVV + +     G++  VA+K +  DK         +E  IM  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR----MPLIYVKLYTYQICRALA 197
               +        L +V E  P     +     R+ +       +  +  Y  QI   + 
Sbjct: 63  GVVLTHP------LMMVTELAP-----LGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111

Query: 198 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
           Y+     I   HRD+  +N+L+     ++K+ DFG  + L + E +  Y+   + +    
Sbjct: 112 YLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFA 165

Query: 252 --APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
             APE +   T ++ A D+W  G  + E+   G+  + G SG   L +I
Sbjct: 166 WCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 59/251 (23%)

Query: 88  HVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
             +G G+FG V +A+            VA+K +  D   K+      E+++M+M+  H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNR-IARNYSRIHQRMPLIYVKLY 188
           I+ L       T +  LY  +V+EY             R      S    R P   +   
Sbjct: 78  IINLLGV---CTQEGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 189 -----TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
                 YQ+ R + ++    CI   HRD+  +N+LV    H +K+ DFG A+       +
Sbjct: 133 DLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVT-EDHVMKIADFGLAR-------D 181

Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
           + +I   YYR            APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 182 IHHI--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI 238

Query: 289 SGVDQLVEIIK 299
             V++L +++K
Sbjct: 239 P-VEELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.3 bits (159), Expect = 7e-12
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)

Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 140
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           K      T+     + L++E++P    +  + RN ++I+ +  L     Y  QIC+ + Y
Sbjct: 72  KGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL----KYAVQICKGMDY 124

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYR 251
           + +   + HRD+  +N+LV    HQ+K+ DFG  K +   E +  Y   +       ++ 
Sbjct: 125 LGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWY 179

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +  +  Y  A D+WS G  + ELL
Sbjct: 180 APECLIQSKFYI-ASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 64.5 bits (157), Expect = 9e-12
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 30/221 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G+G FGVV   K R   + VAIK + +    +     E ++M  L HP +V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQL---YGV 67

Query: 147 TTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            T ++ LY+  V E++     +N + +   ++ + M L   +     +C  + Y+     
Sbjct: 68  CTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGMEYLERN-S 120

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPELIFG 258
             HRD+  +N LV+  T  +K+ DFG  + ++  E    Y  S        +  PE +F 
Sbjct: 121 FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKWSPPE-VFN 174

Query: 259 ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII 298
            ++Y++  D+WS G +M E+   G+  F  +S   ++VE+I
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 85/343 (24%), Positives = 152/343 (44%), Gaps = 60/343 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQML------DHPNIVA 139
           ++G G+FG V +A  R+  E  A+K V    +Y      E+Q M+ +      D   ++ 
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 140 LKHCFFSTTDKEELYLNLVL-EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           ++  F      E  ++ +V+ +Y P  ++ I ++    H+ +  I      +Q   AL Y
Sbjct: 196 IQRYF----QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI-----IFQTGVALDY 246

Query: 199 IHNCIGICHRDIKPQNLL-------VNPHTHQ--------LKLCDFGSAKVLVKGEPNVS 243
            H  + + H D+KP+N+L       V+P T++        +++CD G      +     +
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTA 304

Query: 244 YICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
            + +R+YR+PE++ G    Y+T  D+WS GC++ EL  G+ L+     ++ L  + K LG
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362

Query: 303 T-PTREEIKCMNPNYTEF--KFPQIKP--HPWH--KVFQKRLPPEAV------DLVCRFF 349
             P+    +C             Q++P   P H  ++ + R   E +      DL+    
Sbjct: 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL 422

Query: 350 QYSPNLRCTALEACVHP----FFDELRD-PNTRLPNGRP-LPP 386
            Y    R  A +   HP    ++ E R  PN   P+ R  L P
Sbjct: 423 HYDRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRP 463

Length = 467

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 77/307 (25%), Positives = 122/307 (39%), Gaps = 49/307 (15%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
           G+ G  F     +T E V IK     +     E  I++ ++HP+I+ LK  F        
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF-------- 152

Query: 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212
            Y       +P     +   Y    + + +  +      + RA+ Y+H    I HRDIK 
Sbjct: 153 TYNKFTCLILPRYKTDL-YCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKA 210

Query: 213 QNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY--------RAPELIFGATEYTT 264
           +N+ +N H   + L DFG+A   V    N      +YY         APEL+     Y  
Sbjct: 211 ENIFIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGP 262

Query: 265 AIDIWSTGCVMAELLLGQPLFPGESGVD-------QLVEIIKVLGTPTRE---------- 307
           A+DIWS G V+ E+         + G+D       Q+  II+  GT   E          
Sbjct: 263 AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322

Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           EI       +  K P  +P  W  +++  LP +   L+C+   +  + R +A        
Sbjct: 323 EIYIGLAKKSSRK-PGSRP-LWTNLYE--LPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378

Query: 368 FDELRDP 374
           F ++ DP
Sbjct: 379 FQDIPDP 385

Length = 391

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 23/225 (10%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQA-KCRETGEIVAIKKV-LQDKR---YKNRELQIMQM 131
           N+ ++  Y+   +VG       F A +  +  E V  K V L D+R   Y   EL  +  
Sbjct: 62  NNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAA 121

Query: 132 LDHPNIVALKHCF-FSTTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPL--IYVKL 187
            DH  IV  KH   F + DK    L L++EY     +N+  +   R+ + +P     V L
Sbjct: 122 CDHFGIV--KHFDDFKSDDK----LLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGL 173

Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSY 244
             YQI  AL  +H+   + HRD+K  N+ + P T  +KL DFG +K     V  +   S+
Sbjct: 174 LFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
             + YY APEL +    Y+   D+WS G ++ ELL     F G S
Sbjct: 232 CGTPYYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A KK L+ KR K R        E +I++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAY 198
            + + +   K+ L L L +    +    I    N     QR        Y  ++C  L  
Sbjct: 66  AYAYET---KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR-----AIFYAAELCCGLED 117

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +     I +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y APE+I  
Sbjct: 118 LQR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-N 174

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLF 285
             +YT + D W  GC++ E++ GQ  F
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 22/202 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
              T      L +++EY+         +   + +  PL   ++ T   +I + L Y+H+ 
Sbjct: 72  LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATE 261
             I HRDIK  N+L++ H  ++KL DFG A  L   +   + ++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 89  VVGTGSFGVVFQAKC----RETGEI-VAIKKVLQDKRYKNR-----ELQIMQML-DHPNI 137
            +G G+FG V +A      +    + VA+K +        R     EL+IM  L +H NI
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 138 VALKHCFFSTTDKEELYLNLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V L     + T    + +  + EY    + +N + R          L+    ++YQ+ + 
Sbjct: 102 VNL---LGACTIGGPILV--ITEYCCYGDLLNFLRRKRESFLTLEDLLS---FSYQVAKG 153

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 250
           +A++   NCI   HRD+  +N+L+  H   +K+CDFG A+ ++     V    +R    +
Sbjct: 154 MAFLASKNCI---HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 22/202 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
              T      L +++EY+         +   + +  P    ++ T   +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLG------GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 261
             I HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177

Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 22/223 (9%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           V+G G+FG V   K +   ++ A+K + + +  K         E  ++   D+  I  L 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    D+  LYL  V++Y       +    S+   R+P    + Y  ++  A+  +H 
Sbjct: 68  YAF---QDENNLYL--VMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELIF-- 257
            +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++   
Sbjct: 121 -LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 258 --GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 58/242 (23%)

Query: 90  VGTGSFGVVFQAKCRE-----TGEI-VAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 138
           +G+G+FG V++    +     +G I VA+K        Q+K+   +E  +M   +HPNIV
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 139 A-LKHCFFSTTDKEELYLNL-------VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
             L  C       E  Y+ +       +L Y+ +   R+ R    +     L+ + L   
Sbjct: 63  KLLGVCL----LNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLDVA 116

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNVSYIC 246
           + C  L  +H      HRD+  +N LV+   +     +K+ DFG A+ + K         
Sbjct: 117 KGCVYLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK--------- 163

Query: 247 SRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
           S YYR            APE L+ G   +TT  D+WS G +M E+L LGQ  +P  +  +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221

Query: 293 QL 294
            L
Sbjct: 222 VL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.2 bits (153), Expect = 4e-11
 Identities = 80/307 (26%), Positives = 134/307 (43%), Gaps = 63/307 (20%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAIK++ LQ +  K     E+ +M+ 
Sbjct: 15  GDPKKK--YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
             +PNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 73  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 172

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
           GTP     +  NP                    +RL     D + R  +   + R +A E
Sbjct: 231 GTP-----ELQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKE 265

Query: 362 ACVHPFF 368
              HPF 
Sbjct: 266 LLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 62/322 (19%)

Query: 96  GVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHCFFSTTD 149
            +V  AK + T  +VA+KK+  D   K        E+   + L HPNI+     F     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70

Query: 150 KEELYL-----------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             ELY+           +L+  + PE               +P + +      +  AL Y
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEG--------------LPELAIAFILKDVLNALDY 116

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--------EPNVSYICSRYY 250
           IH+  G  HR +K  ++L++     + L     +  ++K         +   S + +  +
Sbjct: 117 IHS-KGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 251 RAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR--- 306
            +PE++    + Y    DI+S G    EL  G   F        L+E  KV GT      
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLD 232

Query: 307 -----EEIKCMNPNYTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358
                     M+ + +  + P  +    HP+ + F           V    Q  P  R +
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFS----EHFHQFVELCLQRDPESRPS 288

Query: 359 ALEACVHPFFDELRDPNTRLPN 380
           A +   H FF + +  NT L +
Sbjct: 289 ASQLLNHSFFKQCKRRNTSLLD 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 79/305 (25%), Positives = 121/305 (39%), Gaps = 83/305 (27%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   + ++TG + A+K      +L+ ++  +   E  I+   D   +V + 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F+S  DK  LYL  ++E++P  + +  + +  +   +       + Y  +   A+  I
Sbjct: 67  --FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSI 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--------------- 244
           H  +G  HRDIKP NLL++   H +KL DFG    L K      Y               
Sbjct: 118 HQ-LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 245 ---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
                                + +  Y APE +F  T Y    D WS G +M E+L+G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 284 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD 343
            F  E              TP     K MN   T   FP   P          +  +A D
Sbjct: 235 PFCSE--------------TPQETYKKVMNWKET-LIFPPEVP----------ISEKAKD 269

Query: 344 LVCRF 348
           L+ RF
Sbjct: 270 LILRF 274

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 26/207 (12%)

Query: 87  EHVVGTGSFGVVFQAKCRETG--EI-VAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G  EI VAIK +     +K+ ++   E  IM   DHPNI+
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L+     T  K  +   +V EY+    N     + R H  +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYME---NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRA 252
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 121 YLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 177

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
           PE I    ++T+A D+WS G VM E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 68/258 (26%), Positives = 123/258 (47%), Gaps = 38/258 (14%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
             +PNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 74  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 120

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 121 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 173

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 174 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATN 231

Query: 302 GTPTREEIKCMNPNYTEF 319
           GTP  +  + ++  + +F
Sbjct: 232 GTPELQNPEKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 144
           +G G++G V++   ++ G + A+ K+L      + E++    I+Q L +HPN+V     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAV-KILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +         L LVLE     +V  + +      QR+    +    Y     L ++HN  
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            I HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 263 TTA----IDIWSTGCVMAELLLGQP 283
             +     D+WS G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 26/199 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEI-VAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           +G+G FGVV   K R  G+I VAIK + +    ++    E ++M  L HPN+V L   + 
Sbjct: 12  LGSGQFGVVHLGKWR--GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YG 66

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIG 204
             T +  +++  V EY+    N    NY R  +        L     +C A+ Y+ +  G
Sbjct: 67  VCTKQRPIFI--VTEYM---ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-G 120

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-----APELIFGA 259
             HRD+  +N LV    + +K+ DFG A+ ++  +    Y  S+  +     AP  +F  
Sbjct: 121 FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDY 175

Query: 260 TEYTTAIDIWSTGCVMAEL 278
           + +++  D+WS G +M E+
Sbjct: 176 SRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 20/227 (8%)

Query: 84  YIAEHVVGTGSFGVVF---QAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDH 134
           YI +  +G GSFG V+     K      +  +K++        +    N+E Q++  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           P IV     F      E     ++ EY     ++          + +    V  +  Q+ 
Sbjct: 62  PAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRA 252
             + Y+H    I HRD+K +N+ +    + LK+ DFG +++L+   +   ++  + YY +
Sbjct: 117 LGVHYMHQ-RRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           PE +     Y +  DIWS GC++ E+      F G++ +  ++ I++
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 145
           VVG G++G V++ +  +TG++ AIK   V +D+  +   E+ +++   H   +A  +  F
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 146 --STTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +    +  L LV+E+    +V  + +N       +   ++     +I R LA++H  
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLH-A 139

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 257
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 140 HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 197

Query: 258 -GATEYTTAIDIWSTGCVMAELLLGQP 283
                Y    DIWS G    E+  G P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 31/209 (14%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V + + +  G+    VAIK +     DK+  +   E  IM   DHPNI+
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 196
            L+     +       + ++ EY+    N     + R +  +      V +    I   +
Sbjct: 69  RLEGVVTKSRP-----VMIITEYM---ENGSLDKFLRENDGKFTVGQLVGM-LRGIASGM 119

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY------ICSRYY 250
            Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R+ 
Sbjct: 120 KYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL 279
            APE I    ++T+A D+WS G VM E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 20/196 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIGI 205
            T +  +Y  +V EY+    N    NY R H +       L     +C  +AY+ +   I
Sbjct: 68  CTKQRPIY--IVTEYMS---NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEY 262
            HRD+  +N LV+     +K+ DFG ++ ++  E   S + S++   +  PE +   +++
Sbjct: 123 -HRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLYSKF 178

Query: 263 TTAIDIWSTGCVMAEL 278
           ++  D+W+ G +M E+
Sbjct: 179 SSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 144
           +G G++G VF+   ++ G   A+K +L      + E++    I++ L DHPN+V     +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +    K    L LVLE     +V  + + + +  +RM    +    ++    L ++H   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGA--- 259
            I HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I      
Sbjct: 145 TI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202

Query: 260 -TEYTTAIDIWSTGCVMAELLLGQP 283
            + Y    D+WS G    EL  G P
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
           +G GSFG V++     T E+VAIK + L++   +     +E+ ++   D P I      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHNC 202
              T      L +++EY+         +   + +  PL   Y+     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLG------GGSALDLLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 261
             I HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
           Y    DIWS G    EL  G+P
Sbjct: 178 YDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 28/209 (13%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFST 147
           G G FG V+      T + VA+K +           +E QIM+ L H  +V L   +   
Sbjct: 15  GAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL---YAVC 70

Query: 148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMP-LIYVKLYTYQICRALAYIH--NCI 203
           +++E +Y  +V EY+ + ++    ++      R+P L+ +     QI   +AY+   N I
Sbjct: 71  SEEEPIY--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQIAEGMAYLESRNYI 125

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI-FGA 259
              HRD+  +N+LV  +    K+ DFG A+++   E   +   +++   + APE   +G 
Sbjct: 126 ---HRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYG- 179

Query: 260 TEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
             +T   D+WS G ++ E++  G+  +PG
Sbjct: 180 -RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G FG V   + R TG++ A KK L  KR K R        E +I+  +    IV+L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           + F + TD     L LV+  +     R    N    +   P      YT QI   L ++H
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGA 259
               I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL+ G 
Sbjct: 115 Q-RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG- 171

Query: 260 TEYTTAIDIWSTGCVMAELL 279
            EY  ++D ++ G  + E++
Sbjct: 172 EEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.9 bits (145), Expect = 9e-10
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 26/228 (11%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLD 133
           Q   Y    V+G+G+ G V  AK    GE  A+K V        DK     E+  +   D
Sbjct: 30  QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD 89

Query: 134 HPNIVALKHCFFSTTDKEE---LYLNLVLEYV------PETVNRIARNYSRIHQRMPLIY 184
             +IV     F     +     L + LVL+Y        E  +R   N +       L++
Sbjct: 90  FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPN 241
           +     Q+  A+ ++H+   I HRDIK  N+L+  +   +KL DFG +K+    V  +  
Sbjct: 150 I-----QVLLAVHHVHSKHMI-HRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVG 202

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
            ++  + YY APE I+    Y+   D++S G ++ ELL  +  F GE+
Sbjct: 203 RTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 17/160 (10%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALK------HCFFS 146
           G+FG V+  + +   ++ A+K V++     N+ + + Q+    + +AL       H ++S
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNM-VHQVQAERDALALSKSPFIVHLYYS 72

Query: 147 TTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
                 +YL  V+EY +   V  +   Y    + M + Y+     ++  AL Y+H   GI
Sbjct: 73  LQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-GI 125

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
            HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 126 IHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 58.2 bits (140), Expect = 1e-09
 Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 145
           +VG G++G V++ +  +TG++ AIK   V  D+  +  +E+ +++   H   +A  +  F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 146 STTDKEEL--YLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +   +   L LV+E+    +V  + +N       +   ++     +I R L+++H  
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH 130

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 257
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 131 -KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 187

Query: 258 -GATEYTTAIDIWSTGCVMAELLLGQP 283
                Y    D+WS G    E+  G P
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 82  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 132
           VS +  E V+G G FG V + + +  G+    VAIK +      K R     E  IM   
Sbjct: 3   VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQ 191
           DHPNI+ L+     T  +  + +   +E      N    ++ R +  +  +I +      
Sbjct: 63  DHPNIIHLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRG 114

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 248
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S    
Sbjct: 115 IAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172

Query: 249 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               + APE I    ++T+A D+WS G VM E++
Sbjct: 173 IPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + V+G G FG VF+   +  G     VAIK +      K R     E  IM    H NI+
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 196
            L+               ++ EY+    N     Y R H  +      V +    I   +
Sbjct: 70  RLEGVVTKFKP-----AMIITEYME---NGALDKYLRDHDGEFSSYQLVGMLR-GIAAGM 120

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYR 251
            Y+ + +   HRD+  +N+LVN    + K+ DFG ++VL + +P  +Y  S       + 
Sbjct: 121 KYLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWT 177

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE I    ++T+A D+WS G VM E++
Sbjct: 178 APEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 60/236 (25%)

Query: 89  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNI 137
            +G G+FG VF  +C         E+VA+ K L++      ++   RE +++    H NI
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRM--------PLIYVKLY 188
           V         T+ +     +V EY+    +N+  R++      +         L   +L 
Sbjct: 71  VKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 189 --TYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
               QI   + Y+   H      HRD+  +N LV  +   +K+ DFG ++ +        
Sbjct: 126 QIAVQIASGMVYLASQH----FVHRDLATRNCLVG-YDLVVKIGDFGMSRDV-------- 172

Query: 244 YICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELLL--GQPLF 285
           Y    YYR             PE I     +TT  D+WS G V+ E+     QP +
Sbjct: 173 YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 29/216 (13%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL- 140
             +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L 
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 141 -----KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
                +  F+  T+    Y NL L+Y+ E  NR         Q +  + +     QI  A
Sbjct: 69  GVCTREPPFYIITEFMT-YGNL-LDYLREC-NR---------QEVNAVVLLYMATQISSA 116

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRA 252
           + Y+     I HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + A
Sbjct: 117 MEYLEKKNFI-HRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTA 173

Query: 253 PELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 287
           PE +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 174 PESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 18/149 (12%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 184 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 239

Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 301
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +  
Sbjct: 240 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEF 291

Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
               +E  +   P+YT  +  Q     WH
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 44/217 (20%)

Query: 89  VVGTGSFGVVFQAK----CRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIV 138
            +G G FG VF AK      E GE + + K LQ  + +N      REL + + L H N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYT--YQI 192
            L        + E  Y+  +LEY      +   R  ++     +  PL   +      QI
Sbjct: 72  RL---LGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
              + ++ N     HRD+  +N LV   + Q +       KV +       Y  S YY+ 
Sbjct: 127 ALGMDHLSN-ARFVHRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYYKL 175

Query: 252 ----------APELIFGATEYTTAIDIWSTGCVMAEL 278
                     APE +    +++T  D+WS G +M E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 38/225 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V++     T   VA+K +            E QIM+ L HP ++ L   +  
Sbjct: 14  LGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---YAV 69

Query: 147 TTDKEELYL-------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
            T +E +Y+         +LEY    +   A    ++ Q + +        Q+   +AY+
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEY----LQGGAGRALKLPQLIDM------AAQVASGMAYL 119

Query: 200 --HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE 254
              N I   HRD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + APE
Sbjct: 120 EAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPE 174

Query: 255 LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
                  ++   D+WS G ++ E++  G+  +PG +   V Q V+
Sbjct: 175 AAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 26/197 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V     R  G+ VA+K +  D         E  +M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
                 LY  +V EY+    + +    SR    + L     +   +C  + Y+       
Sbjct: 71  --QGNPLY--IVTEYM-AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFV 124

Query: 207 HRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATE 261
           HRD+  +N+LV   +  L  K+ DFG AK     E +      +    + APE +    +
Sbjct: 125 HRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175

Query: 262 YTTAIDIWSTGCVMAEL 278
           ++T  D+WS G ++ E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 11/106 (10%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-- 243
           +TYQ+ R + ++   NC+   HRD+  +N+L+      +K+CDFG A+ ++     VS  
Sbjct: 242 FTYQVARGMEFLASKNCV---HRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 244 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
                  + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 298 STFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 16/95 (16%)

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
           Q+  A+ YIH   GI HRDIK +N+LVN     + L DFG+A    +G    S+    +Y
Sbjct: 268 QLLSAIDYIH-GEGIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPFHY 320

Query: 251 --------RAPELIFGATEYTTAIDIWSTGCVMAE 277
                    APE++ G   YT ++DIWS G V+ E
Sbjct: 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           Y++Q+ R + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 179 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 234

Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 235 SARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 54/237 (22%), Positives = 104/237 (43%), Gaps = 49/237 (20%)

Query: 89  VVGTGSFGVV-----FQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIV 138
            +G G FG V     F+ K R     VA+K + ++      R    E  +++ ++HP+++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL----------- 187
            L   + + +    L L  ++EY         R++ R  +++   Y+             
Sbjct: 67  KL---YGACSQDGPLLL--IVEYAKYGS---LRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 188 -------------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
                        + +QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++ 
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAARNVLV-AEGRKMKISDFGLSRD 176

Query: 235 LVKGEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           + + +  V     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 19/110 (17%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKG 238
           ++ Q+ + + ++   NCI   HRD+  +N+L+       K+CDFG A+        +VKG
Sbjct: 217 FSSQVAQGMDFLASKNCI---HRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
              +       + APE IF    YT   D+WS G ++ E+  LG+  +PG
Sbjct: 273 NARLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 58/283 (20%)

Query: 90  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
           +G G FG V  A+         +    VA+K +  D   K+      E+++M+M+  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR--------IARNYSRIHQRMP---LIYV 185
           I+ L     + T    LY+  ++EY  +   R            YS    R+P   + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 186 KLY--TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
            L   TYQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG    L +   N
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVT-ENNVMKIADFG----LARDVNN 189

Query: 242 VSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
           + Y            + APE +F    YT   D+WS G +M E+  LG   +PG   V++
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEE 247

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
           L +++K  G    +   C N  Y   +        WH +   R
Sbjct: 248 LFKLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 67/311 (21%), Positives = 119/311 (38%), Gaps = 93/311 (29%)

Query: 90  VGTGSFGVVFQ--AKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVA 139
           +G GSFG+V++  AK    GE    VAIK V ++   + R     E  +M+  +  ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETV--NRIA----RNYSRIHQ--------RMPLIYV 185
           L              L +V    P  V    +A    ++Y R  +          P    
Sbjct: 74  L--------------LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 186 KLYTY--QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
           K      +I   +AY+       HRD+  +N +V      +K+ DFG  + + + +    
Sbjct: 120 KFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVA-EDLTVKIGDFGMTRDIYETD---- 173

Query: 244 YICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG 290
                YYR            APE +     +TT  D+WS G V+ E+  L +  + G S 
Sbjct: 174 -----YYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227

Query: 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350
            +++++ +         +   ++        P+  P    ++ +              +Q
Sbjct: 228 -EEVLKFVI--------DGGHLDL-------PENCPDKLLELMR------------MCWQ 259

Query: 351 YSPNLRCTALE 361
           Y+P +R T LE
Sbjct: 260 YNPKMRPTFLE 270

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 61/243 (25%), Positives = 94/243 (38%), Gaps = 68/243 (27%)

Query: 78  SKQKVSYIAEHVVGTGSFGVV-----FQAKCRETGEIVAIK--------KVLQDKRYKNR 124
               V ++ E  +G G+FG V          R +   VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIA 170
           E ++M  L HPNIV    C      KE+    L  EY+                 V   +
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCD 228
            + +         ++ +   QI   + Y+  H+     HRD+  +N LV      +K+ D
Sbjct: 113 GDETVKSSLDCSDFLHI-AIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG-LTVKISD 167

Query: 229 FGSAKVLVKGEPNVSYICSRYYR------------APELI-FGATEYTTAIDIWSTGCVM 275
           FG ++ +   +         YYR             PE I +G  ++TT  DIWS G V+
Sbjct: 168 FGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVL 216

Query: 276 AEL 278
            E+
Sbjct: 217 WEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 19/110 (17%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKG 238
           ++YQ+ + ++++   NCI   HRD+  +N+L+  H    K+CDFG A+        +VKG
Sbjct: 219 FSYQVAKGMSFLASKNCI---HRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKG 274

Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
              +       + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 275 NARLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 24/198 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G+G FG+V+     E  + VAIK +    + ++ +   E Q+M  L HP +V L     
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIHNCI 203
             +      + LV E++    +    +Y R  QR       L      +C  +AY+ +  
Sbjct: 70  ERSP-----ICLVFEFME---HGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGAT 260
            I HRD+  +N LV      +K+ DFG  + ++  +   S   +++   + +PE +F  +
Sbjct: 121 VI-HRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSFS 176

Query: 261 EYTTAIDIWSTGCVMAEL 278
           +Y++  D+WS G +M E+
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYK-NREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE     VAIK++ +    K N+E+     +M  +D+P++  
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 140 LKH-CFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           L   C  ST     + +    +L+YV E  + I              Y+  +  QI + +
Sbjct: 74  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ-----------YLLNWCVQIAKGM 122

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 123 NYLEE-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I     YT   D+WS G  + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 27/270 (10%)

Query: 112 IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR 171
           I K +   +   RE+ I++ + H  I+ L H +         + + V   +P+    +  
Sbjct: 123 IVKAVTGGKTPGREIDILKTISHRAIINLIHAY--------RWKSTVCMVMPKYKCDLF- 173

Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
            Y      +PL        ++  ALAY+H   GI HRD+K +N+ ++   + + L DFG+
Sbjct: 174 TYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAV-LGDFGA 231

Query: 232 AKVLVKGEPNVSYICSRY-----YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLF 285
           A  L       +  C  +       +PEL+     Y    DIWS G V+ E+ +    LF
Sbjct: 232 ACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288

Query: 286 PGE--SGVDQLVEIIKVLGTPTREEIKCMNPN----YTEFKFPQIKPHPWHKVFQKRLPP 339
             +  S   QL  II+ +     E  +  + N    + ++      P+    V +K    
Sbjct: 289 GKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMH 348

Query: 340 EAVD-LVCRFFQYSPNLRCTALEACVHPFF 368
             V+ L+ +   +    R +A +    P F
Sbjct: 349 MDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378

Length = 392

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           Y++Q+ R + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 178 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 233

Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 234 DARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 35/213 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V+        + VAIK + Q          E  +M+ L HP +V L    ++
Sbjct: 14  LGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL----YA 68

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIH--NC 202
              +E +Y+  + EY+    N    ++ +  + + L   KL     QI   +A+I   N 
Sbjct: 69  VVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPELI 256
           I   HRD++  N+LV+  T   K+ DFG A+++   E    Y           + APE I
Sbjct: 124 I---HRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAKFPIKWTAPEAI 175

Query: 257 -FGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +G   +T   D+WS G ++ E++  G+  +PG
Sbjct: 176 NYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 41/218 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNR---ELQIMQMLDHPNIVALKHC 143
           ++G G+FG VF+   ++    VA+K   +D  +  K +   E +I++  DHPNIV L   
Sbjct: 2   LLGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 144 FFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
               T ++ +Y  +V+E VP     +  R  ++  +  Q +       +       +AY+
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109

Query: 200 H--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 251
              NCI   HRD+  +N LV    + LK+ DFG    + + E +  Y  S        + 
Sbjct: 110 ESKNCI---HRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWT 161

Query: 252 APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           APE L +G   Y++  D+WS G ++ E   LG   +PG
Sbjct: 162 APEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 32/206 (15%)

Query: 90  VGTGSFGVVFQA--KCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 141
           +G+G+FG V +   K R+    VAIK VL+++  K+      RE +IM  LD+P IV + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                  + E L   LV+E        + +  S     + +  V    +Q+   + Y+  
Sbjct: 61  ---IGVCEAEALM--LVMEMASG--GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 202 CIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-------YRAP 253
                HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        + AP
Sbjct: 114 -KNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++++  D+WS G  M E  
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 23/151 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALKH 142
           +G G+FG V  A+  +T  + A+K + + D   +N+      E  I+   D+  +V L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL-- 66

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAYI 199
            ++S  DK+ LY   V++Y+P        +   +  RM   P    + Y  ++  A+  +
Sbjct: 67  -YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
           H  +G  HRDIKP N+L++   H +KL DFG
Sbjct: 118 HK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 50/236 (21%)

Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKV-----LQDKRYKNRELQI 128
           +  + Y+ +  +G G+FG VFQA+       E   +VA+K +        +    RE  +
Sbjct: 4   RNNIEYVRD--IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61

Query: 129 MQMLDHPNIVAL--------KHC----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRI 176
           M   DHPNIV L          C    + +  D  E   +          +  +      
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 177 HQRMPLIYVKLY--TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
              +PL   +      Q+   +AY+     + HRD+  +N LV  +   +K+ DFG ++ 
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSRN 179

Query: 235 LVKGEPNVSYICSRYYRA------------PELIFGATEYTTAIDIWSTGCVMAEL 278
           +   +         YY+A            PE IF    YTT  D+W+ G V+ E+
Sbjct: 180 IYSAD---------YYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 50.5 bits (120), Expect = 6e-07
 Identities = 79/317 (24%), Positives = 124/317 (39%), Gaps = 81/317 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 140 LKHCFFSTTDKEELYL---NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           L     S T +    L     +L+YV E  + I               +  +  QI + +
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQ-----------LLLNWCVQIAKGM 122

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A 
Sbjct: 123 MYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           E I    ++T   D+WS G  + EL+   G+P                  G PTRE    
Sbjct: 181 ECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTREI--- 220

Query: 312 MNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
             P+  E   + PQ              PP     +C    Y   ++C  ++A   P F 
Sbjct: 221 --PDLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFK 259

Query: 370 EL--------RDPNTRL 378
           EL        RDP   L
Sbjct: 260 ELAAEFSRMARDPQRYL 276

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 48/191 (25%), Positives = 75/191 (39%), Gaps = 44/191 (23%)

Query: 111 AIKKVLQDKRYKNRELQIMQMLDHPNIVAL-------KHCFFSTTDKEELYLNLVL-EYV 162
           A     +D     +E++I+  L  PNI  L                 E   LN  L ++V
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114

Query: 163 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPH 220
            ET        S+      L+Y+     QI   + Y+   N +   HRD+  +N LV   
Sbjct: 115 AETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV---HRDLATRNCLVGK- 165

Query: 221 THQLKLCDFGSAKVLVKGEPNVSYICSRYY----RAP--------ELIFGATEYTTAIDI 268
            + +K+ DFG ++ L        Y    YY    RAP        E +    ++TT  D+
Sbjct: 166 NYTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDV 215

Query: 269 WSTGCVMAELL 279
           W+ G  + E+L
Sbjct: 216 WAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 49/243 (20%)

Query: 90  VGTGSFGVVFQA--KCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALK 141
           +G+G+FG V +   K +++ + VA+K +  D      K    RE  +MQ LD+P IV + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM- 61

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYI- 199
                  + E   L + L  +      + +N +        L+      +Q+   + Y+ 
Sbjct: 62  ---IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELV------HQVSMGMKYLE 112

Query: 200 -HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------- 251
             N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+       
Sbjct: 113 ETNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALGADE--------NYYKAKTHGKW 160

Query: 252 -----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVEIIKVLGT 303
                APE +    ++++  D+WS G +M E    GQ  + G  G  V Q++E  + +  
Sbjct: 161 PVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC 219

Query: 304 PTR 306
           P R
Sbjct: 220 PQR 222

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 40/226 (17%)

Query: 89  VVGTGSFGVVFQAKCR-ETGEI--VAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 139
           ++G G FG V + +   + G    VA+K +  D    +       E   M+  DHPN++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 140 LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRA 195
           L    F  +  +++   +V L ++          YSR+    +++PL  +  +   I   
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYRAP 253
           + Y+ N   I HRD+  +N ++      + +C  DFG +K +  G+         YYR  
Sbjct: 126 MEYLSNRNFI-HRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 254 ELI-----FGATE------YTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +      + A E      YT+  D+W+ G  M E+   GQ  +PG
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 21/187 (11%)

Query: 160 EYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNL 215
           +Y+P    R  R+ + I++   L Y+ L  ++YQ+   + ++   NC+   HRD+  +N+
Sbjct: 215 QYLPSAPERTRRD-TLINESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNV 270

Query: 216 LVNPHTHQLKLCDFGSAKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTG 272
           L+      +K+CDFG A+ +++    +S         + APE IF    YTT  D+WS G
Sbjct: 271 LIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFG 328

Query: 273 CVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK 331
            ++ E+  LG   +P     +Q    IK          +   P +   +  +I    W +
Sbjct: 329 ILLWEIFTLGGTPYPELPMNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEE 381

Query: 332 VFQKRLP 338
            F+ R  
Sbjct: 382 KFEIRPD 388

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 26/69 (37%), Positives = 38/69 (55%), Gaps = 9/69 (13%)

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY- 249
           QI  AL  +H+  GI HRD+KPQN++ +  +   K+ D G+A  L  G   ++YI   + 
Sbjct: 263 QILFALDGLHS-TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318

Query: 250 ----YRAPE 254
               Y APE
Sbjct: 319 LDPRYAAPE 327

Length = 566

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 44/218 (20%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVALKHCFF 145
           +G+G FG V++   +     VAIK +  D   K +    E+Q ++ L H ++++L   F 
Sbjct: 14  LGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL---FA 69

Query: 146 STTDKEELYL--------NLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
             +  E +Y+        +L L ++  PE          ++     LI +     Q+   
Sbjct: 70  VCSVGEPVYIITELMEKGSL-LAFLRSPE---------GQVLPVASLIDM---ACQVAEG 116

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----Y 250
           +AY+       HRD+  +N+LV       K+ DFG A+++   E    Y+ S       +
Sbjct: 117 MAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARLI--KED--VYLSSDKKIPYKW 170

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG 287
            APE       ++T  D+WS G ++ E+   GQ  +PG
Sbjct: 171 TAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 59/243 (24%)

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQI 192
           PN+V L     S     E  + LVL++         + +S I +   +P   VK +  ++
Sbjct: 45  PNMVCLHKYIVS-----EDSVFLVLQHAEG-----GKLWSHISKFLNIPEECVKRWAAEM 94

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 251
             AL  +H   GI  RD+ P N+L++   H ++L  F       + E +         Y 
Sbjct: 95  VVALDALHR-EGIVCRDLNPNNILLDDRGH-IQLTYFSR---WSEVEDSCDGEAVENMYC 149

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK 310
           APE + G +E T A D WS G ++ ELL G+ L     SG++                  
Sbjct: 150 APE-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT----------------- 191

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----H 365
                +T    P+             +  EA  L+ +  Q++P  R  A  A V     H
Sbjct: 192 -----HTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234

Query: 366 PFF 368
           PFF
Sbjct: 235 PFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 50/223 (22%)

Query: 90  VGTGSFGVVFQAKC--------RETGEIVAIKKVLQDKRYK-NRELQIMQMLDHPNIVAL 140
           +G G+FG VF A+C        +    + A+K+  +  R    RE +++ +L H +IV  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNY---------SRIHQRMPLIYVKLY-- 188
              F+    +    L +V EY+    +NR  R++                 L   ++   
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
             QI   + Y+ + +   HRD+  +N LV      +K+ DFG ++ +   +         
Sbjct: 128 ASQIASGMVYLAS-LHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD--------- 176

Query: 249 YYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
           YYR             PE I    ++TT  DIWS G V+ E+ 
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 29/206 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA--------- 139
           V+G+G+FG V++      GE V I   ++  R         ++LD   ++A         
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 140 -LKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            L  C  ST     + +    +L+YV E  +RI               +  +  QI + +
Sbjct: 74  LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQ-----------DLLNWCVQIAKGM 122

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
           +Y+   + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A 
Sbjct: 123 SYLEE-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I     +T   D+WS G  + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 25/217 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEI--VAIK--KVLQDKRYKN----RELQIMQMLDHPNIVALK 141
           +G G FG V + +  +   I  VA+K  K+    R +      E   M+  DHPN++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 142 HCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRALA 197
                T + E     +V L ++          YSR+    Q +P   +  +   I   + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           Y+ +   I HRD+  +N ++N + + + + DFG +K +  G+    Y   R  + P + +
Sbjct: 127 YLSSKSFI-HRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP-VKW 180

Query: 258 GATE------YTTAIDIWSTGCVMAELLL-GQPLFPG 287
            A E      YTT  D+WS G  M E+   GQ  +PG
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 83/317 (26%), Positives = 131/317 (41%), Gaps = 75/317 (23%)

Query: 90  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
           +G G FG V  A+              VA+K +  D   K+      E+++M+M+  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR---IAR-----NYSRIHQRMP---LIYV 185
           I+ L     + T    LY+  ++EY  +   R    AR     +YS    ++P   L + 
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 186 KLYT--YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
            L +  YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG    L +   N
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVT-EDNVMKIADFG----LARDVHN 186

Query: 242 VSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
           + Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEE 244

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR----------------- 336
           L +++K       E  +   P     +   I    WH V  +R                 
Sbjct: 245 LFKLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297

Query: 337 LPPEAVDLVCRFFQYSP 353
              E +DL   F QYSP
Sbjct: 298 STDEYLDLSVPFEQYSP 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 56/231 (24%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNR---ELQIMQMLDHPNIVALKH 142
           +G G  G V+ A        VA+KK+ +D       K R   E +I   L HP IV +  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV-- 67

Query: 143 CFFSTTDKEELYLNLVLEYVP-ETVNRIARNY-------SRIHQRMPL-----IYVKLYT 189
            +   +D + +Y  +   Y+   T+  + ++          + ++  +     I+ K   
Sbjct: 68  -YSICSDGDPVYYTM--PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK--- 121

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV 242
             IC  + Y+H+  G+ HRD+KP N+L+      + L D+G+A         L+  + + 
Sbjct: 122 --ICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDE 177

Query: 243 SYICSRY------------YRAPELIFG--ATEYTTAIDIWSTGCVMAELL 279
             IC               Y APE + G  A+E T   DI++ G ++ ++L
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225

Length = 932

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 77/318 (24%), Positives = 134/318 (42%), Gaps = 76/318 (23%)

Query: 90  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQMLD-HPN 136
           +G G FG V +A+         +    VA+K +  +   K+      E+++M+++  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR------------IARNYSRIHQRMPLIY 184
           I+ L       T +  LY+  ++EY  +   R               + +++ +   L +
Sbjct: 80  IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-QLSF 133

Query: 185 VKLYT--YQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
             L +  YQ+ R + Y+ +  CI   HRD+  +N+LV    + +K+ DFG    L +G  
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVT-EDNVMKIADFG----LARGVH 185

Query: 241 NVSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
           ++ Y            + APE +F    YT   D+WS G +M E+  LG   +PG     
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP--- 241

Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR---------------- 336
            + E+ K+L    RE  +   P+    +   +    WH V  +R                
Sbjct: 242 -VEELFKLL----REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296

Query: 337 LPPEAVDLVCRFFQYSPN 354
           +  E +DL   F QYSP+
Sbjct: 297 VSEEYLDLSMPFEQYSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 53/226 (23%)

Query: 89  VVGTGSFGVVFQAKCRETG----EIVAIKKVLQDKRYKNRELQIMQML---------DHP 135
           ++  G+FG +F     +      E V +K V         E+Q+  +L          H 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS----EIQVTLLLQESCLLYGLSHQ 68

Query: 136 NIVALKH-CFFSTTDKEELY-------LNLVLE---YVPETVNRIARNYSRIHQRMPLIY 184
           NI+ + H C         LY       L L L+          +       +H  M +  
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH--MAI-- 124

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
                 QI   ++Y+H   G+ H+DI  +N +++    Q+K+ D   ++ L   +    Y
Sbjct: 125 ------QIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----Y 172

Query: 245 IC-----SRYYR--APELIFGATEYTTAIDIWSTGCVMAELL-LGQ 282
            C     +R  +  A E +    EY++A D+WS G ++ EL+ LGQ
Sbjct: 173 HCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 40/226 (17%)

Query: 89  VVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 139
           ++G G FG V +A+ +    + + VA+K +  D    +      RE   M+  DHPN++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 140 LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRA 195
           L      +  K  L + +V L ++           SRI +    +PL  +  +   I   
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+ +     HRD+  +N ++N     + +C  DFG +K +  G+         YYR  
Sbjct: 126 MEYLSS-KNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 252 -APELIFG--ATE------YTTAIDIWSTGCVMAELL-LGQPLFPG 287
            A +L     A E      YTT  D+W+ G  M E++  GQ  + G
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 37/218 (16%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQ-----DKRYKNRELQIMQML-DHPNIV 138
           + V+G G+FG V +A+ ++ G  +  AIK++ +     D R    EL+++  L  HPNI+
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 139 -ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK----------- 186
             L  C      +   YL L +EY P          SR+ +  P   +            
Sbjct: 72  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 187 --LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPN 241
              +   + R + Y+     I HRD+  +N+LV    +  K+ DFG ++   V VK    
Sbjct: 126 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KT 181

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 182 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 61/249 (24%), Positives = 107/249 (42%), Gaps = 39/249 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEI---VAIKKV-----LQDKRYKNRELQIMQMLDHPNIVAL 140
           V+G G FG V+     ++       A+K +     L++     +E  IM+   HPN+++L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICRAL 196
                     E   L +VL Y+    +   RN+ R     P    LI   L   Q+ + +
Sbjct: 62  LGICL---PSEGSPL-VVLPYM---KHGDLRNFIRSETHNPTVKDLIGFGL---QVAKGM 111

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL- 255
            Y+ +     HRD+  +N +++  +  +K+ DFG A+ +   E    Y     +   +L 
Sbjct: 112 EYLAS-KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLP 165

Query: 256 -IFGATE------YTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307
             + A E      +TT  D+WS G ++ EL+  G P +P     D  V +++  G    +
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQ 223

Query: 308 EIKCMNPNY 316
              C +P Y
Sbjct: 224 PEYCPDPLY 232

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 68/288 (23%)

Query: 90  VGTGSFGVVFQAKC-----RETGEI--VAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
           +G G FG V  A+       +   +  VA+K +  D   K+      E+++M+M+  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR----------IARNYSRIHQRMPLIYVK 186
           I+ L     + T    LY+  ++EY  +   R          +   Y+        +  K
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 187 LY---TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
                 YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG A+       +
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVT-EDNVMKIADFGLAR-------D 189

Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
           + +I   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 190 IHHI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV 246

Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
             V++L +++K  G    +   C N  Y   +        WH V  +R
Sbjct: 247 P-VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 34/204 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+FG VF  + R     VA+K         L+ K  +  E +I++   HPNIV L  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ--EARILKQYSHPNIVRL-- 58

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA---YI 199
                T K+ +Y  +V+E V     +     + +    P + VK     +  A A   Y+
Sbjct: 59  -IGVCTQKQPIY--IVMELV-----QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110

Query: 200 HN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE 254
            +  CI   HRD+  +N LV    + LK+ DFG ++    G    +    +    + APE
Sbjct: 111 ESKHCI---HRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166

Query: 255 -LIFGATEYTTAIDIWSTGCVMAE 277
            L +G   Y++  D+WS G ++ E
Sbjct: 167 ALNYG--RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 43.9 bits (103), Expect = 7e-05
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 23/207 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V+      T + VAIK +           +E QIM+ L H  +V L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              +E +Y+  V E++ + ++    +     + ++P + V +   QI   +AYI   +  
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIER-MNY 123

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL-IFGATE 261
            HRD++  N+LV  +    K+ DFG A+ L++     +   +++   + APE  ++G   
Sbjct: 124 IHRDLRAANILVGDNL-VCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG--R 179

Query: 262 YTTAIDIWSTGCVMAELLL-GQPLFPG 287
           +T   D+WS G ++ EL+  G+  +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 77/347 (22%), Positives = 131/347 (37%), Gaps = 85/347 (24%)

Query: 89  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +  F    D E   +   + Y     + I  ++      + + Y+      + +AL YIH
Sbjct: 65  RATFI--ADNELWVVTSFMAY-GSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIH 118

Query: 201 NCIGICHRDIKPQNLLVN-----------------PHTHQLKLC-DFG--SAKVLVKGEP 240
           + +G  HR +K  ++L++                  H  +L++  DF   S KVL    P
Sbjct: 119 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL----P 173

Query: 241 NVSYICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
            +S         PE++    + Y    DI+S G    EL  G   F        L+E  K
Sbjct: 174 WLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--K 222

Query: 300 VLGT------------------PTR--------EEIKCMNPNYTEFKFPQIKPHPWHKVF 333
           + GT                  P+R        E      P  +     +   HP+++ F
Sbjct: 223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNRTF 279

Query: 334 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL-RDPNTRLP 379
                P     V +  Q +P+ R +A     H FF ++ R  +  LP
Sbjct: 280 S----PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 27/189 (14%)

Query: 109 IVAIKKVLQD--KRYKN---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP 163
           +VA+K +  D  K  +N   +E++IM  L +PNI+ L      + D     L ++ EY+ 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL-GVCVSDDP----LCMITEYME 100

Query: 164 E------TVNRIARNYSRIHQRMPLIYVKLYTY---QICRALAYIHNCIGICHRDIKPQN 214
                     R   +       +P + +    Y   QI   + Y+ + +   HRD+  +N
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATRN 159

Query: 215 LLVNPHTHQLKLCDFGSAKVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWS 270
            LV  H + +K+ DFG ++ L  G+       + +  R+     ++ G  ++TTA D+W+
Sbjct: 160 CLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWA 216

Query: 271 TGCVMAELL 279
            G  + E+ 
Sbjct: 217 FGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 10/90 (11%)

Query: 175 RIHQRMP-----LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229
           +I   MP     +  +K    Q+   L  +H  IGI HRDIKP+NLLV     Q+K+ DF
Sbjct: 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDF 353

Query: 230 GSAKVLVKG---EPNVSYICSRYYRAPELI 256
           G+A  +  G    P    +  RY    EL+
Sbjct: 354 GAAVDMCTGINFNPLYGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 23/207 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V+        + VA+K +            E QIM+ L H  +V L    ++
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL----YA 68

Query: 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              +E +Y+  V EY+ + ++    ++      ++P + V +   Q+   +AYI   +  
Sbjct: 69  VVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMAYIER-MNY 123

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL-IFGATE 261
            HRD++  N+LV       K+ DFG A+ L++     +   +++   + APE  ++G   
Sbjct: 124 IHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG--R 179

Query: 262 YTTAIDIWSTGCVMAELLL-GQPLFPG 287
           +T   D+WS G ++ EL+  G+  +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 51/225 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKNR------ELQIMQML-DHPNIV 138
           E V+G G+FG V +A  ++ G ++ A  K+L++   +N       EL+++  L  HPNI+
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 139 AL-KHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIARNY---SRIHQRM 180
            L   C      +   YL + +EY P              ET    A+ +   S +  + 
Sbjct: 67  NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
            L     +   +   + Y+     I HRD+  +N+LV  +    K+ DFG    L +GE 
Sbjct: 121 LL----QFASDVATGMQYLSEKQFI-HRDLAARNVLVGENLAS-KIADFG----LSRGEE 170

Query: 241 NVSYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL 279
              Y+     R P + + A E      YTT  D+WS G ++ E++
Sbjct: 171 --VYVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 48/218 (22%), Positives = 82/218 (37%), Gaps = 48/218 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRE----TGEIVA----------------------IKKVLQ 117
           +  + ++G G FG V++ +C        + VA                      I K+  
Sbjct: 14  WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73

Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 177
            K   N        +DH  I     C      +   Y  ++LE + E    I   + RI 
Sbjct: 74  WKNIHN--------IDHLGIPKYYGCGSFKRCRM-YYRFILLEKLVENTKEI---FKRIK 121

Query: 178 QR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236
            +   LI  K     +   L YIH   GI H DIKP+N++V+ + ++  + D+G A   +
Sbjct: 122 CKNKKLI--KNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGN-NRGYIIDYGIASHFI 177

Query: 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCV 274
               ++      Y +  + +   T Y   +D  +  CV
Sbjct: 178 IHGKHI-----EYSKEQKDLHRGTLYYAGLDAHNGACV 210

Length = 294

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 24/102 (23%)

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
           QI   + Y+ + +   HRD+  +N LV  +   +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYLSS-LNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 251 R------------APELIFGATEYTTAIDIWSTGCVMAELLL 280
           R            A E I    ++TTA D+W+ G  + E+L+
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 49/232 (21%)

Query: 89  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
            +G G+FG V++   R          VA+K + +    ++      E  IM   +H NIV
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 139 ALKHCFFSTTDKEELYLNLVL-------EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
                   + ++   ++ L L        ++ E   R  R  S   +   L++      +
Sbjct: 73  ---RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD--LLFCARDVAK 127

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRY 249
            C+ L   H      HRDI  +N L+         K+ DFG A+ + +         + Y
Sbjct: 128 GCKYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------ASY 174

Query: 250 YR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 289
           YR            P   F    +T+  D+WS G ++ E+  LG   +PG +
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 8/116 (6%)

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSR 248
           Q+  A+ YIH+   + HRDIK +N+ +N    ++ L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVL 301
              +PE++ G   Y    DIWS G ++ ++L       G+ G     QL++II  L
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 51/223 (22%)

Query: 89  VVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKNR------ELQIM-QMLDHPNIV-A 139
           V+G G+FG V +A+ ++ G  + A  K +++   K+       EL+++ ++  HPNI+  
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIARNY---SRIHQRMPL 182
           L  C      +   YL L +EY P              ET    A      S +  +  L
Sbjct: 62  LGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
            +       + R + Y+     I HRD+  +N+LV  +    K+ DFG    L +G+   
Sbjct: 116 HFAA----DVARGMDYLSQKQFI-HRDLAARNILVGENYVA-KIADFG----LSRGQE-- 163

Query: 243 SYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL 279
            Y+     R P + + A E      YTT  D+WS G ++ E++
Sbjct: 164 VYVKKTMGRLP-VRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 52/201 (25%)

Query: 109 IVAIKKVLQD--KRYKN---RELQIMQMLDHPNIVAL--------KHC----FFSTTDKE 151
           +VA+K + +D  K  +N   +E++IM  L  PNI+ L          C    +    D  
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK 211
           +       +   E  + +  +YS       LI++     QI   + Y+ + +   HRD+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYST------LIFMAT---QIASGMKYLSS-LNFVHRDLA 157

Query: 212 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA-------------PELIFG 258
            +N LV    + +K+ DFG ++ L  G+         YYR                ++ G
Sbjct: 158 TRNCLVG-KNYTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMSWESILLG 207

Query: 259 ATEYTTAIDIWSTGCVMAELL 279
             ++TTA D+W+ G  + E+L
Sbjct: 208 --KFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 46/207 (22%), Positives = 90/207 (43%), Gaps = 31/207 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQI------MQMLDHPNIVA 139
           ++G+G FG V +      G+ + I    K +QD+  +    +I      M  LDH  IV 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 140 LKH-CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           L   C  ++       L LV +  P    ++ + ++   +  +  L +      QI + +
Sbjct: 74  LLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKGM 122

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRA 252
            Y+     + HR++  +N+L+   +  +++ DFG A +L   +    Y       ++   
Sbjct: 123 YYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
             ++FG   YT   D+WS G  + E++
Sbjct: 181 ESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 78/331 (23%), Positives = 138/331 (41%), Gaps = 85/331 (25%)

Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLI 183
           +M+     ++V L         K +  L +V+E +     ++  R  R  +  +   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 184 YVK---LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
            ++       +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173

Query: 241 NVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFP 286
                   YYR            APE +     +TT+ D+WS G V+ E+  L  QP + 
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223

Query: 287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 346
           G S  +Q+++ +             M+  Y +         P         P    DL+ 
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255

Query: 347 RFFQYSPNLRCTALEAC------VHPFFDEL 371
             +Q++P +R T LE        +HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 54/224 (24%)

Query: 90  VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 140
           +G G+FG VF A+C     E  +I+   K L+D     ++  +RE +++  L H +IV  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK- 71

Query: 141 KHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLIYVKL 187
               F     E   L +V EY+             P+ V     N      +  ++++  
Sbjct: 72  ----FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI-- 125

Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
              QI   + Y+ +     HRD+  +N LV  +   +K+ DFG ++ +   +        
Sbjct: 126 -AQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTD-------- 174

Query: 248 RYYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
            YYR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	422
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK10345	210	hypothetical protein; Provisional	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.81
smart00090	237	RIO RIO-like kinase.	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.55
KOG1243	690	consensus Protein kinase [General function predict	99.45
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.26
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.26
KOG3087	229	consensus Serine/threonine protein kinase [General	99.25
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.14
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.98
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.75
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.65
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.64
PRK09902	216	hypothetical protein; Provisional	98.63
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.58
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.53
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.52
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.44
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.31
PF01636	239	APH: Phosphotransferase enzyme family This family	98.29
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.14
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.13
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.01
PLN02876	822	acyl-CoA dehydrogenase	97.92
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.73
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.65
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.62
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.59
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.56
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.51
KOG2270	520	consensus Serine/threonine protein kinase involved	97.49
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.46
PRK10593	297	hypothetical protein; Provisional	97.36
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.34
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.28
PRK05231	319	homoserine kinase; Provisional	97.25
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.25
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.01
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.0
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.91
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.84
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.8
PLN02236	344	choline kinase	96.78
PRK12396	409	5-methylribose kinase; Reviewed	96.68
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.66
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.54
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.52
PLN02756	418	S-methyl-5-thioribose kinase	96.38
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.0
PRK11768	325	serine/threonine protein kinase; Provisional	95.07
PTZ00384	383	choline kinase; Provisional	94.84
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	94.72
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.63
PHA03111	444	Ser/Thr kinase; Provisional	94.0
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	93.53
PRK10271	188	thiK thiamine kinase; Provisional	93.43
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.32
COG2334	331	Putative homoserine kinase type II (protein kinase	92.4

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.2e-73  Score=515.20  Aligned_cols=354  Identities=73%  Similarity=1.192  Sum_probs=331.4

Q ss_pred             ceeEeccCCCCCCCcceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCccccccee
Q 014595           65 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF  144 (422)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  144 (422)
                      .+..+.+.+..........|...+++|.|+||.||+|....+++.||||++.++.+...+|+.+|+.++|||||+|..+|
T Consensus         7 ~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f   86 (364)
T KOG0658|consen    7 HVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFF   86 (364)
T ss_pred             eEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEE
Confidence            34455555665666677889999999999999999999999999999999999999999999999999999999999998


Q ss_pred             ecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcE
Q 014595          145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  224 (422)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~v  224 (422)
                      ....+.+..|+.+||||++.+|.+.++.+......++...++.|++||++||.|||+ .||+||||||.|+|+|.+.+.+
T Consensus        87 ~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~L  165 (364)
T KOG0658|consen   87 SSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVL  165 (364)
T ss_pred             EecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeE
Confidence            877766678899999999999999999988888999999999999999999999999 8999999999999999998899


Q ss_pred             EEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014595          225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       225 kl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      ||||||.|+.+..+++..++.+|++|+|||.+.|...|+.+.||||.||++.||+-|++.|+|.+..+++..|++.+|.|
T Consensus       166 KicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P  245 (364)
T KOG0658|consen  166 KICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP  245 (364)
T ss_pred             EeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCC
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPL  384 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~  384 (422)
                      +.+++.+|++++.++++|+++..+|..++....++++.+|+.++|+++|.+|.++.|+|.||||+.+++++..++++..+
T Consensus       246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~l  325 (364)
T KOG0658|consen  246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPL  325 (364)
T ss_pred             CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcC
Confidence            99999999999999999999999999988899999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCChhHHhhhCcHHHhhhhhhhhc
Q 014595          385 PPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL  420 (422)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (422)
                      |++++|+.. ...+.++.++.++|++.+.+.-.-..
T Consensus       326 p~lf~f~~~-e~~~~~~~~~~l~p~~~~~~~~~~~~  360 (364)
T KOG0658|consen  326 PPLFNFKRA-ELGISPELVNVLIPEHLREQEKDKIL  360 (364)
T ss_pred             CCccCchHH-HhccchHHHHhhccHhhhhhcccccc
Confidence            999999976 45667889999999999988755443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-61  Score=451.50  Aligned_cols=282  Identities=36%  Similarity=0.656  Sum_probs=254.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||.|.||.||+|+.+.+|+.||||++++.-     ....||+..|++|+ |||||++.+++.+..    ..+
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~L   85 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RIL   85 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ceE
Confidence            36999999999999999999999999999999886532     33358999999998 999999999984322    268


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++|||||..+|+++++..   ...+++..++.|++||+.||+|+|. +|+.|||+||||||+.... .|||+|||+|+..
T Consensus        86 ~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev  160 (538)
T KOG0661|consen   86 YFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGND-VIKIADFGLAREV  160 (538)
T ss_pred             eeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccc-eeEeccccccccc
Confidence            999999999999999875   5789999999999999999999999 8999999999999999665 6999999999999


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--C
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--N  313 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~  313 (422)
                      ....+.+.++.|++|+|||+++....|+.+.||||+|||++|+.+-++.|+|.+..+++.+|++++|.|....|...  .
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            88888899999999999999999999999999999999999999999999999999999999999999998877652  2


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      ...-.|.+|+..+.++..+++. .++++.+||.+||.+||.+||||.++|+||||+....
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence            2334578899999999888865 9999999999999999999999999999999986543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-60  Score=420.05  Aligned_cols=279  Identities=37%  Similarity=0.682  Sum_probs=244.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh------hHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .|....++|+|+||+||+|+++.||+.||||++..+..      ...||+++|++|+|+|+|.++++|     .....++
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----HhcceeE
Confidence            48888999999999999999999999999999865432      234899999999999999999999     5555588


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|+|||+.++.+.+..   ...+++...++.+++|++.|+.|+|+ +++|||||||+||||+.++ .+||||||+|+.+.
T Consensus        78 LVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNG-VVKLCDFGFARTLS  152 (396)
T ss_pred             EEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCC-cEEeccchhhHhhc
Confidence            9999999877555544   45789999999999999999999999 8999999999999999988 79999999999887


Q ss_pred             -cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--C
Q 014595          237 -KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--N  313 (422)
Q Consensus       237 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~  313 (422)
                       +++..+.++.|.+|+|||.+.|...|+..+||||+||++.||++|.+.|+|.++.+++..|.+.+|...+....-+  +
T Consensus       153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence             6666678899999999999999889999999999999999999999999999999999999999999888776644  5


Q ss_pred             cCCccCcCCCCCC-CCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          314 PNYTEFKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       314 ~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      +-|....+|.... .++..-+ +.++..+.||+++||..||++|++.+++|.||||.+..
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             CceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            6677777777543 3444444 56788999999999999999999999999999997653

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-59  Score=425.60  Aligned_cols=316  Identities=38%  Similarity=0.672  Sum_probs=268.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc------chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .|...+.||.|+||.|+.|.++.+|+.||||++..      ......||+.+|+.++|+||+.+.+++.........-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            47778999999999999999999999999999863      123345899999999999999999998664445555688


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|+|+|+.+|.++++.    ++.+++..++.+++||++||+|+|+ .+|+||||||.|+|++.+. .+||||||+|+...
T Consensus       103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADC-DLKICDFGLARYLD  176 (359)
T ss_pred             EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCC-CEEeccccceeecc
Confidence            9999999998888875    3449999999999999999999999 8999999999999999887 79999999999875


Q ss_pred             c---CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          237 K---GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       237 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      .   ....+.++.|.+|+|||++.....|+.+.||||+|||+.||++|++.|+|.+..+++..|...+|+|..+.+....
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            3   3444678899999999999888889999999999999999999999999999999999999999999999888765


Q ss_pred             cC-Cc--cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCC
Q 014595          314 PN-YT--EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  390 (422)
Q Consensus       314 ~~-~~--~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  390 (422)
                      .. ..  ..++|+.++.+|...|+ +.++.+.|||.+||.+||.+|+|++|+|.||||..+.++.+.....    +.+. 
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~----~~~~-  330 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ----PIFD-  330 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC----CCCc-
Confidence            22 11  22688889999999995 8999999999999999999999999999999999999987653221    1111 


Q ss_pred             CCCCCCCCChhHHhhhCcHHHh
Q 014595          391 KPPELSGIPPETINRLIPEHAR  412 (422)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~  412 (422)
                       +.... .+.+.++.+++++..
T Consensus       331 -~~~~~-~~~~~~r~~i~~e~~  350 (359)
T KOG0660|consen  331 -SFEHE-LTEEELRELIYKEIL  350 (359)
T ss_pred             -ccccc-ccHHHHHHHHHHHHH
Confidence             12222 667788887777643

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.8e-59  Score=403.54  Aligned_cols=278  Identities=38%  Similarity=0.700  Sum_probs=243.1

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|...+.||+|.||+||+|++..||+.||||+++...      ....||++.|+.++|+||+.++++|-.     ...+.
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-----~~~l~   77 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-----KSNLS   77 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-----CCceE
Confidence            5888999999999999999999999999999996542      234589999999999999999999943     33377


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|+||++.+|..+++..   ...++...++.|+.++++||+|||+ +.|+||||||.|+|++++| .+||+|||+|+.+.
T Consensus        78 lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   78 LVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDG-QLKIADFGLARFFG  152 (318)
T ss_pred             EEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCC-cEEeecccchhccC
Confidence            99999999998888763   3678999999999999999999999 8999999999999999998 79999999999876


Q ss_pred             cCCCcc-cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 014595          237 KGEPNV-SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  313 (422)
Q Consensus       237 ~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  313 (422)
                      ...... ..+.|.+|+|||.+.|...|+..+||||.|||+.||+.|.+.|+|.++.+++..|+..+|+|..+.|..+.  
T Consensus       153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            544333 34789999999999999999999999999999999999999999999999999999999999999998774  


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      ++|..++  +.+..+...+| ...+.++.||+.+||.+||.+|+|+.|+|+||||+....
T Consensus       233 pdY~~~~--~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  233 PDYVKIQ--QFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             ccHHHHh--cCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence            5665554  33344444455 567889999999999999999999999999999998543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-59  Score=428.42  Aligned_cols=257  Identities=35%  Similarity=0.497  Sum_probs=211.7

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----------hhHHHHHHHHHHcCCCCcccccceeecCC
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  148 (422)
                      ....|.+.+.||+|+||.|-+|..+.||+.||||++.+..           ....+|++||++|+|||||+++++|    
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----  245 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----  245 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence            4457999999999999999999999999999999986532           1225899999999999999999998    


Q ss_pred             CCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC--CCcEE
Q 014595          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLK  225 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~--~~~vk  225 (422)
                       ....+.||||||++| .|.+.+    -.++.+.+..-+.++.|++.|+.|||+ +||+||||||+|||+..+  ...+|
T Consensus       246 -~~~ds~YmVlE~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  246 -EVPDSSYMVLEYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             -ecCCceEEEEEEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEE
Confidence             334447899999986 332222    224678888889999999999999999 899999999999999765  23699


Q ss_pred             EeecCCccccccCCCcccccccccccchhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Q 014595          226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-QLVEIIKVLG  302 (422)
Q Consensus       226 l~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~~~-~~~~i~~~~~  302 (422)
                      |+|||+|+...++....+.||||.|.|||++.+.  ..+..++||||+||+||-+|+|.+||.+..... ..++|.+.  
T Consensus       320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G--  397 (475)
T KOG0615|consen  320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG--  397 (475)
T ss_pred             ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC--
Confidence            9999999998877777889999999999999643  335668999999999999999999998876554 44444431  


Q ss_pred             CCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                     .|.+        ....+..++.++++||.+||..||++|||++|+|+||||+..
T Consensus       398 ---------------~y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  398 ---------------RYAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             ---------------cccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence                           2211        112235689999999999999999999999999999999974

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.6e-57  Score=448.73  Aligned_cols=329  Identities=53%  Similarity=0.993  Sum_probs=282.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCC---CCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT---DKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~~~~~~~~lv  158 (422)
                      .+|.+.+.||+|+||+||+|.+..+++.||||++..+.....+|+.+++.++|||||+++++|+...   .....++++|
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv  145 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV  145 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence            3599999999999999999999999999999999877666778999999999999999988775432   2334568899


Q ss_pred             eecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      |||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|+.....
T Consensus       146 mE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  224 (440)
T PTZ00036        146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG  224 (440)
T ss_pred             EecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence            9999998877777666666789999999999999999999999 899999999999999977657999999999877665


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                      .......+|+.|+|||++.+...++.++|||||||++|||++|.+||.+.+..+.+.++++.++.|..+.+..+++.+..
T Consensus       225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~  304 (440)
T PTZ00036        225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD  304 (440)
T ss_pred             CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence            55566788999999999877667999999999999999999999999999999999999999999999999988888888


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCC-CCCCCCCCCCCCCCCCC
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN-GRPLPPLFNFKPPELSG  397 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  397 (422)
                      +.++......+...++...++++++||.+||++||.+|+|+.|+|+||||+++.++...++. ....|+++++.......
T Consensus       305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (440)
T PTZ00036        305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKE  384 (440)
T ss_pred             ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHhh
Confidence            88888877788888888899999999999999999999999999999999998876655444 24556667666555555


Q ss_pred             CChhHHhhhCcHHH
Q 014595          398 IPPETINRLIPEHA  411 (422)
Q Consensus       398 ~~~~~~~~~~~~~~  411 (422)
                      +..+..+.++|...
T Consensus       385 ~~~~~~~~~~~~~~  398 (440)
T PTZ00036        385 MSDACRRKIIPKCT  398 (440)
T ss_pred             CCHHHHHHHhhHHH
Confidence            66666666665543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-57  Score=406.32  Aligned_cols=288  Identities=34%  Similarity=0.560  Sum_probs=247.3

Q ss_pred             cceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh------hHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      +....|+.+..|++|+||.||+|+++.|++.||+|+++.+..      ...||+.+|.+++|||||.+.++.....   -
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~  149 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---M  149 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---c
Confidence            444579999999999999999999999999999999875442      1248999999999999999999875433   2


Q ss_pred             eEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ..+|||||||+.+|..++....   +++...+++.++.|++.||+|||. ..|+||||||+|+|++..| .+||+|||+|
T Consensus       150 d~iy~VMe~~EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G-~lKiaDFGLA  224 (419)
T KOG0663|consen  150 DKIYIVMEYVEHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKG-ILKIADFGLA  224 (419)
T ss_pred             ceeeeeHHHHHhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCC-cEEecccchh
Confidence            2378999999999988887643   789999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          233 KVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       233 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      +.+..... .+..+.|.+|+|||.+.+...|++++|+||+|||+.||+++++.|+|.+..+++.+|++.+|.|.+..|..
T Consensus       225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence            98865533 45567899999999999999999999999999999999999999999999999999999999999988765


Q ss_pred             cC--cCCccCcCCCCCCCCcccccccC-CChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          312 MN--PNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       312 ~~--~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      ..  +....+.++..+...+...|... ++....+|+..+|.+||.+|.||.|+|+|.||.+...+
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence            42  22233455555555565556443 78999999999999999999999999999999985443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-57  Score=434.19  Aligned_cols=250  Identities=31%  Similarity=0.518  Sum_probs=220.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|...++||+|||++||.+++..+|+.||+|++.+.       .....+|++|.+.|+|||||+++++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            5699999999999999999999999999999998652       23345899999999999999999999     55556


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +|||+|+|. +++..+++    ..+.++|.+++.+++||+.||.|||+ ++|+|||||..|+|++.+. +|||+|||+|+
T Consensus        93 VYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt  166 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENM-NVKIGDFGLAT  166 (592)
T ss_pred             eEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcC-cEEecccceee
Confidence            999999998 46655554    34789999999999999999999999 8999999999999999988 69999999999


Q ss_pred             ccccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          234 VLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       234 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .+... +...+.||||.|+|||++.+. ..+..+||||+||+||.||+|++||...+-.+.+.+|..             
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-------------  232 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-------------  232 (592)
T ss_pred             eecCcccccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------
Confidence            88744 778899999999999999754 589999999999999999999999998888888887765             


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                          .+|.+|            ..++.++++||.+||+.||.+|||++++|.|+||..-.
T Consensus       233 ----~~Y~~P------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  233 ----NEYSMP------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             ----cCcccc------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence                344444            46899999999999999999999999999999995543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-57  Score=410.07  Aligned_cols=254  Identities=33%  Similarity=0.520  Sum_probs=217.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.++++||+|+||+||+++.+.|++.||+|++++..       .....|..||..++||.||.++..|     +...
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence            346999999999999999999999999999999986543       3345799999999999999999888     4445


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+|+|+||+.| .|...+.    ..+.+++..++.|+.+|+.||.|||+ +|||||||||+|||+|.+|| ++|+|||+|
T Consensus        99 kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GH-i~LtDFgL~  172 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGH-IKLTDFGLC  172 (357)
T ss_pred             eEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCc-EEEeccccc
Confidence            58899999986 4433333    35789999999999999999999999 99999999999999999995 999999999


Q ss_pred             cccccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      +..... ....+.+||+.|||||++.+. .|+.++|+||||+++|||++|.+||.+.+......+|.+.-          
T Consensus       173 k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k----------  241 (357)
T KOG0598|consen  173 KEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK----------  241 (357)
T ss_pred             hhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc----------
Confidence            865444 445567999999999999876 49999999999999999999999999999888888887631          


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC----CHHHHhcCCcccccCCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELRDP  374 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~----t~~e~l~hp~f~~~~~~  374 (422)
                               .         ...+..++.++++||+++|+.||++|.    ++.++.+||||..+++.
T Consensus       242 ---------~---------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  242 ---------L---------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             ---------C---------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence                     0         011234899999999999999999996    68899999999998743

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-57  Score=423.04  Aligned_cols=282  Identities=36%  Similarity=0.600  Sum_probs=239.2

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ....|..++.||+|.||.||+|++..||+.||+|++.-+.      ....|||.||++|+||||++|.+...+.   ...
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~  191 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSG  191 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCc
Confidence            4456899999999999999999999999999999986543      3446999999999999999999988654   234


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .+|||+|||+.+|..++..   ..-.|++.+++.|+.||+.||+|||. +||+|||||.+|||||.+| .+||+|||+|+
T Consensus       192 siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr  266 (560)
T KOG0600|consen  192 SIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNG-VLKIADFGLAR  266 (560)
T ss_pred             eEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCC-CEEecccccee
Confidence            5889999999988777764   23579999999999999999999999 8999999999999999888 79999999999


Q ss_pred             ccccCC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          234 VLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       234 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      .+....  ..+..+.|.+|+|||.++|...|+.++|+||+||||.||++|++.|+|.+..+++.+|++..|.|....|..
T Consensus       267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~  346 (560)
T KOG0600|consen  267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV  346 (560)
T ss_pred             eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence            765443  456778899999999999999999999999999999999999999999999999999999999999988772


Q ss_pred             c-CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          312 M-NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       312 ~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      . .|.+..++-.+--...+...+ ..+++.+.+|+..||+.||.+|.||.++|+|+||..
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             ccCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            2 122233322221122233333 568999999999999999999999999999999944

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-55  Score=414.22  Aligned_cols=256  Identities=32%  Similarity=0.588  Sum_probs=223.2

Q ss_pred             cceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      +...+|..++.||+|+|++|++|+++.+++.||||++.+.       ..+..+|-++|.+| .||.|++|+..|     .
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence            3445799999999999999999999999999999987543       24456799999999 899999999888     4


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeec
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      +...+|+|+||++ |.|..++..+    +.+++..++.|+.||+.||+|||+ +|||||||||+|||+|.++ .+||+||
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dm-hikITDF  218 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDG-HIKITDF  218 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCC-cEEEeec
Confidence            4445889999998 5777777664    789999999999999999999999 8999999999999999999 5999999


Q ss_pred             CCccccccCCC--------------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014595          230 GSAKVLVKGEP--------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  295 (422)
Q Consensus       230 G~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~  295 (422)
                      |.|+.+.....              ..+++||..|.+||++.. ...+..+|||+||||||+|+.|.+||.+.+....++
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq  297 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ  297 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence            99987643211              145899999999999954 458999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      +|+.+                 .|.+|            +++++.++|||+++|..||++|+|+.+|.+||||.++.+.+
T Consensus       298 kI~~l-----------------~y~fp------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  298 KIQAL-----------------DYEFP------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HHHHh-----------------cccCC------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            99884                 34443            57899999999999999999999999999999999987654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-55  Score=401.06  Aligned_cols=256  Identities=30%  Similarity=0.558  Sum_probs=215.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +.+.++.||+|..|+||+|+|+.|++.+|+|++...     .+.+.+|+++++..+|||||.+|++|+....    .+++
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~isI  155 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EISI  155 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEEe
Confidence            467788999999999999999999999999999422     2344589999999999999999999965442    3789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||++ +|..++...    ++++|..+..++.+|++||.|||+.++||||||||+|||++..| .|||||||.++.+.
T Consensus       156 ~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lv  230 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILV  230 (364)
T ss_pred             ehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhh
Confidence            9999995 776665543    77999999999999999999999548999999999999999988 79999999999887


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCHHHHhh
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-----SGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      +. ...+++||..|||||.+.+. .|+.++||||||++++|+++|+.||...     +..+.+..|+..  .|+      
T Consensus       231 nS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~--ppP------  300 (364)
T KOG0581|consen  231 NS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE--PPP------  300 (364)
T ss_pred             hh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC--CCC------
Confidence            66 56789999999999999775 4999999999999999999999999874     334444444431  111      


Q ss_pred             cCcCCccCcCCCCCCCCccccccc-CCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  377 (422)
                              .            ++. .+|+++++||..||++||.+|+|+.|+++|||+++...++..
T Consensus       301 --------~------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd  347 (364)
T KOG0581|consen  301 --------R------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD  347 (364)
T ss_pred             --------C------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence                    0            122 379999999999999999999999999999999987665543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-55  Score=383.08  Aligned_cols=256  Identities=29%  Similarity=0.493  Sum_probs=220.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|...+.||.|+||.|.+++++.+|..+|+|++.+..       ....+|..+|+.+.||+++++.+.|     .+..+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~~  118 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNSN  118 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCCe
Confidence            35999999999999999999999999999999987643       2234799999999999999999887     55666


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +||||||++| .+-.++    +..+++++..++.|+.||+.||+|||+ ++|++|||||+|||+|.+|+ +||+|||+|+
T Consensus       119 lymvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G~-iKitDFGFAK  192 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNGH-IKITDFGFAK  192 (355)
T ss_pred             EEEEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCCc-EEEEeccceE
Confidence            9999999996 333333    345789999999999999999999999 89999999999999999995 9999999999


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ....  ...+.||||.|+|||++... .|+.++|+|||||++|||+.|.+||.+.+....+.+|+..             
T Consensus       193 ~v~~--rT~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-------------  256 (355)
T KOG0616|consen  193 RVSG--RTWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-------------  256 (355)
T ss_pred             EecC--cEEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-------------
Confidence            8743  36789999999999999654 5999999999999999999999999999999999998873             


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCCCCCCCCCCC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLPNGR  382 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~~~~~~~~  382 (422)
                          .+.+|            +.++++++|||+++|+.|-.+|.     ...++.+||||+++.+  .++.++.
T Consensus       257 ----~v~fP------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W--~~i~~r~  312 (355)
T KOG0616|consen  257 ----KVKFP------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW--EAILQRK  312 (355)
T ss_pred             ----cccCC------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH--HHHhhcc
Confidence                33443            56899999999999999999995     5689999999998764  4444433

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-54  Score=418.29  Aligned_cols=281  Identities=30%  Similarity=0.490  Sum_probs=237.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      -|.+++.||.|+.|.|.+|++..||+.+|||++.+.       ...+.+|+-||+.|.|||++++++++     .+..++
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~l   87 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHL   87 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceE
Confidence            399999999999999999999999999999999765       34567999999999999999999999     445568


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      |+|+||+++ .|.+    +....+++++.++..++.||+.|+.|+|. .+|+||||||+|+|+|..++ +||+|||+|..
T Consensus        88 ylvlEyv~gGELFd----ylv~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~n-IKIADFGMAsL  161 (786)
T KOG0588|consen   88 YLVLEYVPGGELFD----YLVRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKNN-IKIADFGMASL  161 (786)
T ss_pred             EEEEEecCCchhHH----HHHhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhcccC-Eeeeccceeec
Confidence            899999985 3322    33335899999999999999999999999 89999999999999999885 99999999998


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..++.-..+.||+|.|.|||++.|.++.+.++||||+|||||.||||+.||.+.+-...+.++.+               
T Consensus       162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~---------------  226 (786)
T KOG0588|consen  162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR---------------  226 (786)
T ss_pred             ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc---------------
Confidence            88888888999999999999999999899999999999999999999999998776666666655               


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPE  394 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (422)
                        +.|.+|            ..+|+++++||++||..||++|+|.+||++|||+.+..+.........+. .......|.
T Consensus       227 --G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~-~~~i~s~ps  291 (786)
T KOG0588|consen  227 --GVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPV-SVPILSIPS  291 (786)
T ss_pred             --CcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCc-ccceeecCC
Confidence              455555            46899999999999999999999999999999999876544321111110 011123456


Q ss_pred             CCCCChhHHh
Q 014595          395 LSGIPPETIN  404 (422)
Q Consensus       395 ~~~~~~~~~~  404 (422)
                      .+.|+|..++
T Consensus       292 ~~~IDp~Il~  301 (786)
T KOG0588|consen  292 IQEIDPLILQ  301 (786)
T ss_pred             cccCCHHHHh
Confidence            6788888886

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.5e-54  Score=390.93  Aligned_cols=289  Identities=35%  Similarity=0.700  Sum_probs=243.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh------hHHHHHHHHHHcCCCC-cccccceeecCCC-CCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPN-IVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~-~~~~~  154 (422)
                      .|..+++||+|+||+||+|+.+.+|+.||+|++.-+..      ...+|+.+++.|+|+| ||.+++++...+. .....
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            47778889999999999999999999999999864432      2368999999999999 9999999865442 23346


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++|+||+..++...+.........++...++.+++||+.||+|||+ +||+||||||+||||+..| .+||+|||+|+.
T Consensus        92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAra  169 (323)
T KOG0594|consen   92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSG-VLKLADFGLARA  169 (323)
T ss_pred             EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCC-cEeeeccchHHH
Confidence            88999999988887777654433578888999999999999999999 8999999999999999987 799999999987


Q ss_pred             cc-cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          235 LV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       235 ~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      .. +....+..++|.+|+|||++.+...|+..+||||+|||++||+++++.|+|.++.+++..|++.+|+|..+.|+...
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence            65 33445677889999999999999889999999999999999999999999999999999999999999998887542


Q ss_pred             --cCCccCcCCCCC-CCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          314 --PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       314 --~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                        ++|.. .++... +.++.... +..++++.+|+.+||+.||.+|.||+.+|.||||..+..+.
T Consensus       250 ~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  250 SLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             ccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence              33332 333333 44444444 44568999999999999999999999999999999975543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.3e-53  Score=403.45  Aligned_cols=259  Identities=33%  Similarity=0.546  Sum_probs=218.3

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-------hHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ...+|.+++.||+|+||.||+|+.+.||..||+|++++..-       ....|..+|...++|+||+|+..|     ++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            34579999999999999999999999999999999976542       234688899999999999999888     666


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      .++||||||++| ++..++..    .+.+++.+++.|+.+++.|++.||+ .|+|||||||+|+|||..|| +||+|||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GH-iKLSDFGL  287 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGH-IKLSDFGL  287 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCC-Eeeccccc
Confidence            679999999996 55444443    4789999999999999999999999 89999999999999999996 99999999


Q ss_pred             cccccc----------------------C-CC-------------------------cccccccccccchhhhcCCCCCC
Q 014595          232 AKVLVK----------------------G-EP-------------------------NVSYICSRYYRAPELIFGATEYT  263 (422)
Q Consensus       232 a~~~~~----------------------~-~~-------------------------~~~~~~t~~y~aPE~~~~~~~~~  263 (422)
                      ++.+..                      . ..                         ..+.+|||.|||||++.+.+ |+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence            843211                      0 00                         02367999999999998876 99


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHH
Q 014595          264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD  343 (422)
Q Consensus       264 ~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  343 (422)
                      ..+|+||||||+||||.|.+||.+.+..+...+|+..-               ..+.+|..          ..++++++|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr---------------~~l~fP~~----------~~~s~eA~D  421 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR---------------ETLKFPEE----------VDLSDEAKD  421 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---------------hhccCCCc----------CcccHHHHH
Confidence            99999999999999999999999999999999998742               11223321          356899999


Q ss_pred             HHHhhhhcCCCCcCC---HHHHhcCCcccccCCCCC
Q 014595          344 LVCRFFQYSPNLRCT---ALEACVHPFFDELRDPNT  376 (422)
Q Consensus       344 li~~~L~~dP~~R~t---~~e~l~hp~f~~~~~~~~  376 (422)
                      ||.+||+ ||++|+.   ++||.+||||+++.+...
T Consensus       422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l  456 (550)
T KOG0605|consen  422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHL  456 (550)
T ss_pred             HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchh
Confidence            9999999 9999995   899999999999986543

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.4e-53  Score=410.83  Aligned_cols=279  Identities=36%  Similarity=0.618  Sum_probs=231.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHH---HHHHHHHHcC-C-----CCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD-H-----PNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~---~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~~~  153 (422)
                      +|.+.+.||+|+||+|.+|.+..|++.||||+++....+..   .|+.+|..|+ |     -|||+++++|.     ...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~-----fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY-----FRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-----ccc
Confidence            79999999999999999999999999999999988776654   5889999986 3     48999999994     445


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC-CCcEEEeecCCc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~-~~~vkl~DfG~a  232 (422)
                      ++|||+|.++.+|+++++....  .++++..++.++.||+.||.+||+ .||||+|||||||||..- ...|||+|||.|
T Consensus       262 HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence            5999999999999999987543  669999999999999999999999 899999999999999533 347999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ...  .....+++.+++|+|||+++|.+ |+.+.||||||||++||++|.+.|+|.+..+++..|+..+|.|+...+...
T Consensus       339 c~~--~q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFE--SQRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             ccc--CCcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            765  33345889999999999999866 999999999999999999999999999999999999999999999887754


Q ss_pred             CcCCccCcC----C--------------------------CC----CCCCcccccccCCChHHHHHHHhhhhcCCCCcCC
Q 014595          313 NPNYTEFKF----P--------------------------QI----KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  358 (422)
Q Consensus       313 ~~~~~~~~~----~--------------------------~~----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t  358 (422)
                      ......|.-    +                          ..    ...++...+...-...+.|||++||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence            322111111    0                          00    0111222221122356799999999999999999


Q ss_pred             HHHHhcCCcccccC
Q 014595          359 ALEACVHPFFDELR  372 (422)
Q Consensus       359 ~~e~l~hp~f~~~~  372 (422)
                      +.++|+||||....
T Consensus       496 p~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  496 PAQALNHPFLTGTS  509 (586)
T ss_pred             HHHHhcCccccccc
Confidence            99999999999543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-53  Score=386.95  Aligned_cols=253  Identities=31%  Similarity=0.540  Sum_probs=216.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..+|.+.+.||.|+||+||+|+++.++..||||.+.+..      .....|+.+|+.++|||||.+++++     ....+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence            446999999999999999999999999999999986652      2335799999999999999999998     44446


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC-C----CcEEEee
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-T----HQLKLCD  228 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~-~----~~vkl~D  228 (422)
                      +|+|||||. |+|..+++.    .+.+++..++.++.||+.||++||+ ++||||||||+||||+.. .    -.+||+|
T Consensus        84 i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence            999999999 577766665    4689999999999999999999999 899999999999999864 1    2589999


Q ss_pred             cCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       229 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ||+|+.+.++....+.+|+|.|||||++.. ..|+.|+|+||+|+++|+|++|++||...+..+.+..+.+.-..     
T Consensus       159 FGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~-----  232 (429)
T KOG0595|consen  159 FGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI-----  232 (429)
T ss_pred             cchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc-----
Confidence            999999988888889999999999999964 56999999999999999999999999999888877654432100     


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                                  .         ..++..++....+|+..+|+.+|..|.+..+-+.|+++..
T Consensus       233 ------------~---------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  233 ------------V---------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             ------------c---------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                        0         1122346777889999999999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-52  Score=400.07  Aligned_cols=250  Identities=35%  Similarity=0.517  Sum_probs=216.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------hhhHHHHHHHHHHcC-CCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  150 (422)
                      ...|.+++.||+|+||+|++|.+..+|+.||+|++.+.         .....+|+.+++.++ ||||+++++++....  
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~--   93 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT--   93 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC--
Confidence            34599999999999999999999999999999976553         123358999999999 999999999984333  


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC-CCcEEEee
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCD  228 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~-~~~vkl~D  228 (422)
                         .+++|||||.+ .|.+.+..    .+++.+..++.++.|++.|++|||+ +||+||||||+|||++.+ + ++||+|
T Consensus        94 ---~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~-~~Kl~D  164 (370)
T KOG0583|consen   94 ---KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEG-NLKLSD  164 (370)
T ss_pred             ---eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCC-CEEEec
Confidence               38899999986 55444433    5889999999999999999999999 899999999999999998 6 699999


Q ss_pred             cCCcccc-ccCCCcccccccccccchhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          229 FGSAKVL-VKGEPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       229 fG~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      ||++... ..+....+.+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||.+.+...++.+|.+       
T Consensus       165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~-------  237 (370)
T KOG0583|consen  165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK-------  237 (370)
T ss_pred             cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-------
Confidence            9999887 4566677899999999999998776 557999999999999999999999999887777777655       


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCC-ChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL-PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                                ..+.+|            ..+ |+++++||++||..||.+|+|+.++++||||+.
T Consensus       238 ----------~~~~~p------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  238 ----------GEFKIP------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ----------CCccCC------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                      234444            345 999999999999999999999999999999997

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-54  Score=369.24  Aligned_cols=252  Identities=32%  Similarity=0.467  Sum_probs=216.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc------chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ..|.+.++||+|.|+.||++.+..||+.+|+|++..      +.+.+++|++|.+.|+|||||++++.+     .+..+.
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~~   85 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFH   85 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccccee
Confidence            459999999999999999999999999999997742      335567999999999999999999987     667788


Q ss_pred             EEEeecchh-HHH-HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC--CCcEEEeecCC
Q 014595          156 NLVLEYVPE-TVN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGS  231 (422)
Q Consensus       156 ~lv~e~~~~-~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~--~~~vkl~DfG~  231 (422)
                      |||+|++.| .+. ++...     ..+++..+-.+++||+.||.|+|. +||||||+||+|+|+-+.  +..+||+|||+
T Consensus        86 ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             EEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccce
Confidence            999999986 332 22222     457888899999999999999999 899999999999999543  33699999999


Q ss_pred             ccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      |..+..+......+|||.|||||++... .|+..+|||+.||+||-||.|.+||.+.+....++.|++.           
T Consensus       160 Ai~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-----------  227 (355)
T KOG0033|consen  160 AIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-----------  227 (355)
T ss_pred             EEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc-----------
Confidence            9988877777788999999999999655 4999999999999999999999999999999988888773           


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                            .+.++.   .     .++++++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus       228 ------~yd~~~---~-----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  228 ------AYDYPS---P-----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             ------ccCCCC---c-----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                  333332   1     23578999999999999999999999999999999976

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-52  Score=386.80  Aligned_cols=262  Identities=29%  Similarity=0.453  Sum_probs=218.2

Q ss_pred             CCCCCcceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------------------hhHHHHHHHHHHcCCC
Q 014595           74 RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------RYKNRELQIMQMLDHP  135 (422)
Q Consensus        74 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------------~~~~~E~~~l~~l~h~  135 (422)
                      .....++.++|++.+.||+|.||.|-+|++..+++.||||++.+..                  ....+|+.||+++.||
T Consensus        89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~  168 (576)
T KOG0585|consen   89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP  168 (576)
T ss_pred             CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence            3344566778999999999999999999999999999999985422                  1234799999999999


Q ss_pred             CcccccceeecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       136 nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                      |||+|+++.   ++.+...+|||+|||..+-.  ..  ....+. +.+.+++.|+++++.||+|||. +|||||||||+|
T Consensus       169 nVV~LiEvL---DDP~s~~~YlVley~s~G~v--~w--~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsN  240 (576)
T KOG0585|consen  169 NVVKLIEVL---DDPESDKLYLVLEYCSKGEV--KW--CPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSN  240 (576)
T ss_pred             CeeEEEEee---cCcccCceEEEEEeccCCcc--cc--CCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhh
Confidence            999999987   55667779999999984321  11  112234 8999999999999999999998 899999999999


Q ss_pred             eEEcCCCCcEEEeecCCccccccC------CCcccccccccccchhhhcC---CCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014595          215 LLVNPHTHQLKLCDFGSAKVLVKG------EPNVSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLF  285 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~~~~~~------~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~elltG~~pf  285 (422)
                      +||+.+| .|||+|||.+.....+      ......+|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+.||
T Consensus       241 LLl~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  241 LLLSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             eEEcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            9999997 7999999998765222      12234789999999999976   334678999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      -+....+.+.+|+.                 ....+|..          +.+.++++|||.+||++||++|+++.++..|
T Consensus       320 ~~~~~~~l~~KIvn-----------------~pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  320 FDDFELELFDKIVN-----------------DPLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             ccchHHHHHHHHhc-----------------CcccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            99999999988876                 23444432          2468999999999999999999999999999


Q ss_pred             Cccccc
Q 014595          366 PFFDEL  371 (422)
Q Consensus       366 p~f~~~  371 (422)
                      ||...-
T Consensus       373 pwvt~~  378 (576)
T KOG0585|consen  373 PWVTRD  378 (576)
T ss_pred             ceeccC
Confidence            999865

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-52  Score=403.18  Aligned_cols=263  Identities=29%  Similarity=0.505  Sum_probs=223.9

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcC-CCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|++.++||+|+||+|++|..+.+++.||||+++++.       .....|.+|+...+ ||.++.++.+|     +..
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT~  441 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QTK  441 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----ccC
Confidence            447999999999999999999999999999999987653       33346888888775 99999999999     555


Q ss_pred             eEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .++|+||||+.|+.  +..  ....+.+++..++.|+..|+.||+|||+ +||||||||.+|||+|.+|+ +||+|||++
T Consensus       442 ~~l~fvmey~~Ggd--m~~--~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh-~kiADFGlc  515 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGD--LMH--HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEGH-VKIADFGLC  515 (694)
T ss_pred             CeEEEEEEecCCCc--EEE--EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccCc-EEecccccc
Confidence            56899999998754  111  1224789999999999999999999999 89999999999999999995 999999999


Q ss_pred             cccc-cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          233 KVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       233 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      +... .+....+.+|||.|||||++.+. .|+.++|+|||||+|||||.|..||+|++..+.+..|+.            
T Consensus       516 Ke~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~------------  582 (694)
T KOG0694|consen  516 KEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN------------  582 (694)
T ss_pred             cccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc------------
Confidence            8765 55667789999999999999765 499999999999999999999999999999999988876            


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccCCCCCCCCCCCCCCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLPP  386 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~~~~~~~~~~~~~  386 (422)
                           .+..+            +..+|.++.++++++|..||++|+.     +++|..||||+.+.  |+.+.+.+.-||
T Consensus       583 -----d~~~y------------P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~--w~~L~~r~i~PP  643 (694)
T KOG0694|consen  583 -----DEVRY------------PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID--WDDLLNRRIKPP  643 (694)
T ss_pred             -----CCCCC------------CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC--HHHHhhccCCCC
Confidence                 22222            3468999999999999999999995     58999999999987  555555544443

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.9e-50  Score=380.38  Aligned_cols=276  Identities=33%  Similarity=0.639  Sum_probs=228.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|++.+.||.|+||+||+|++..+++.||+|++...     .....+|+.+++.++||||+++++++.     ...+.+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEE
Confidence            3599999999999999999999999999999988532     123458999999999999999999873     334578


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus        80 lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~  154 (288)
T cd07871          80 LVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARAKS  154 (288)
T ss_pred             EEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEECcCcceeecc
Confidence            9999999877665543   23457889999999999999999999 8999999999999999887 69999999987543


Q ss_pred             cCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  314 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  314 (422)
                      ... ......+++.|+|||++.+...++.++||||+||++|+|+||++||.+.+..+.+..+.+.++.++.+.+..... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            222 223456789999999987766689999999999999999999999999998999999999999999888765432 


Q ss_pred             -CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 -NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                       .+..+.++.....++... ...++.++++||++||++||.+|||++|+|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence             233333444433444332 24678999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-53  Score=367.81  Aligned_cols=255  Identities=27%  Similarity=0.492  Sum_probs=212.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc------chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ..|.+.++||.|+||.||++.+..+|+.||.|.+.-      .......|+.+|++|+|||||++++.-+.   ++...+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence            359999999999999999999999999999998852      23444579999999999999999874322   333447


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh--cC-CceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--CI-GICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~-givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ++|||||. |+|.++++.+....+.+++..++.++.|++.||..+|+  .+ -|+||||||.||+++.+| .|||+|||+
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL  174 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGL  174 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchh
Confidence            89999998 69999999999999999999999999999999999997  21 389999999999999888 799999999


Q ss_pred             ccccccCCCc-ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          232 AKVLVKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       232 a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ++.+...... .+++|||+||+||.+.+.+ |+.++||||+||++|||+.-.+||.|.+-.+.-.+|.++-         
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd---------  244 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD---------  244 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC---------
Confidence            9988655433 4689999999999997655 9999999999999999999999999997766666666531         


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                +|.+        -....|.++..||.-|+..||+.||+.     +|+++++..
T Consensus       245 ----------~~~~--------p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~  284 (375)
T KOG0591|consen  245 ----------YPPL--------PDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS  284 (375)
T ss_pred             ----------CCCC--------cHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence                      1110        013468999999999999999999985     566665543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.5e-52  Score=391.90  Aligned_cols=248  Identities=32%  Similarity=0.512  Sum_probs=214.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh------hHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||+|+||.||+|+.+.|.+.||||.+.+..+      ...+|++|++.|+|||||.+++.|     +....++
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~~   77 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHLW   77 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceEE
Confidence            58899999999999999999999999999999865432      346899999999999999999999     4445589


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|.|||.|+|..++..    .+.++|+.++.++.|++.||.|||+ .+|+|||+||.|||++..+ .+|+||||+|+.+.
T Consensus        78 vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   78 VVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGG-TLKLCDFGLARAMS  151 (808)
T ss_pred             EEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCC-ceeechhhhhhhcc
Confidence            9999999988776654    5789999999999999999999999 8999999999999999887 69999999999876


Q ss_pred             cCCCc-ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .+... ...-|||.|||||.+.+ ..|+..+|+|||||++|||++|++||...+-.+....|.+-               
T Consensus       152 ~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---------------  215 (808)
T KOG0597|consen  152 TNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---------------  215 (808)
T ss_pred             cCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---------------
Confidence            54432 45679999999999975 45999999999999999999999999887766666665541               


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                        +.        .|    +..++..++.||..+|.+||.+|+|..+++.|||.++-
T Consensus       216 --~v--------~~----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  216 --PV--------KP----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             --CC--------CC----cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence              11        11    23679999999999999999999999999999999864

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-50  Score=372.60  Aligned_cols=261  Identities=28%  Similarity=0.488  Sum_probs=220.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-------hHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..|++.+.||+|.-|+||+|+.+.++..+|+|++.+...       ..+.|.+||+.++||.++.||..|     +...|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDKY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccce
Confidence            358999999999999999999999999999999976432       223599999999999999999998     66678


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .|++||||+| +|..+.+.  ..++.+++..++.|+.+++.||+|||- .|||+|||||+||||.++|| |.|+||.++.
T Consensus       152 ~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGH-IMLsDFDLS~  227 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGH-IMLSDFDLSL  227 (459)
T ss_pred             eEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCc-EEeeeccccc
Confidence            9999999996 55555443  346889999999999999999999998 99999999999999999996 9999999873


Q ss_pred             cccc---------------------------------C-C-----------------------Ccccccccccccchhhh
Q 014595          234 VLVK---------------------------------G-E-----------------------PNVSYICSRYYRAPELI  256 (422)
Q Consensus       234 ~~~~---------------------------------~-~-----------------------~~~~~~~t~~y~aPE~~  256 (422)
                      ....                                 . .                       ...+++||-.|.|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            2210                                 0 0                       01246789999999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccC
Q 014595          257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR  336 (422)
Q Consensus       257 ~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (422)
                      .|.+ .+.++|+|+|||++||||.|..||.|.+..+++.+|+.                 .+..+|..          +.
T Consensus       308 ~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----------------~~l~Fp~~----------~~  359 (459)
T KOG0610|consen  308 RGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----------------QPLKFPEE----------PE  359 (459)
T ss_pred             ecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----------------CCCcCCCC----------Cc
Confidence            8876 79999999999999999999999999999999998875                 23344432          25


Q ss_pred             CChHHHHHHHhhhhcCCCCcCC----HHHHhcCCcccccCCCCCCCC
Q 014595          337 LPPEAVDLVCRFFQYSPNLRCT----ALEACVHPFFDELRDPNTRLP  379 (422)
Q Consensus       337 ~s~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~~~  379 (422)
                      ++..++|||+++|.+||++|+.    |.||.+||||++++++-.+..
T Consensus       360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~  406 (459)
T KOG0610|consen  360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCA  406 (459)
T ss_pred             chhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheecc
Confidence            7899999999999999999998    999999999999998754433

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-51  Score=376.08  Aligned_cols=256  Identities=34%  Similarity=0.573  Sum_probs=207.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..|...+.||+|+||.||++.+..+|+.+|||.+...    ...+.+|+.+|.+|+|||||++++......+   ..+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence            3488899999999999999999999999999998765    3446899999999999999999886422221   46789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC-CCCcEEEeecCCcccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKVL  235 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~-~~~~vkl~DfG~a~~~  235 (422)
                      +|||+++ ++.+++..+.   +.+++..++.+..||+.||.|||+ +|||||||||+|||++. ++ .+||+|||+++..
T Consensus        94 ~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNG-DVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCC-eEEeccCcccccc
Confidence            9999984 7777766532   269999999999999999999998 89999999999999998 45 7999999999876


Q ss_pred             cc----CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHh
Q 014595          236 VK----GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       236 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ..    ........||+.|||||++........++|||||||++.||+||.+||... ...+.+..+...   .      
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---~------  239 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---D------  239 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---C------
Confidence            53    222346789999999999974222345999999999999999999999763 323322222210   0      


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                               ..|         .++..+|+++++||.+||..||++||||+++|+|||.+...
T Consensus       240 ---------~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  240 ---------SLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ---------CCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence                     111         23457899999999999999999999999999999998744

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-49  Score=379.93  Aligned_cols=286  Identities=37%  Similarity=0.672  Sum_probs=226.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|++.+.||+|+||.||+|++..+|+.||||++...      .....+|+++++.++||||+++++++..........++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            499999999999999999999999999999987532      12345799999999999999999987654444445678


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            9999999877666543    3568999999999999999999999 8999999999999999887 69999999997543


Q ss_pred             cCCC----cccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          237 KGEP----NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       237 ~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ....    .....+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.++...+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2221    1245789999999998542 4589999999999999999999999999888888888888888887765543


Q ss_pred             cCcCC-ccC--cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          312 MNPNY-TEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       312 ~~~~~-~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      ..... ..+  .+....+.++...+ +.+++++.+||.+||+.||++|||+.|+|+||||+.+....
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~  300 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE  300 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence            32110 000  01111111222222 35688999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-50  Score=329.89  Aligned_cols=276  Identities=36%  Similarity=0.678  Sum_probs=233.5

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |.-.++||+|.||+||+|+++.+++.||+|.+.-+.      ....+|+.+++.|+|.|||+++++..+.     ..+.+
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kkltl   78 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLTL   78 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeEE
Confidence            666778999999999999999999999999986543      2346899999999999999999988433     33789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |+|||...+...   +....+.+..+.++.++.|+++||.|+|+ +++.||||||.|+||+.+| .+||+|||+++.+.-
T Consensus        79 vfe~cdqdlkky---fdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ng-elkladfglarafgi  153 (292)
T KOG0662|consen   79 VFEFCDQDLKKY---FDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGI  153 (292)
T ss_pred             eHHHhhHHHHHH---HHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCC-cEEecccchhhhcCC
Confidence            999999776444   44567889999999999999999999999 8999999999999999998 799999999987643


Q ss_pred             CC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 014595          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  313 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  313 (422)
                      .- -....+.|.+|++|.++.|..-|+...|+||.||++.|+.. |++.|+|.+..+++..|+..+|.|.++.|..+.  
T Consensus       154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence            32 22345679999999999999899999999999999999985 999999999999999999999999999887653  


Q ss_pred             cCCccCcCCCCCC-CCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          314 PNYTEFKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       314 ~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      ++|..  +|.++. ..|..+. ++++...+||++++|..+|.+|++|+++|+||||.+..
T Consensus       234 pdyk~--yp~ypattswsqiv-p~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  234 PDYKP--YPIYPATTSWSQIV-PKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCCcc--cCCccccchHHHHh-hhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            33333  233322 2455554 57788899999999999999999999999999998743

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.5e-49  Score=373.18  Aligned_cols=281  Identities=32%  Similarity=0.556  Sum_probs=217.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++....     ....+|+.+++.++||||+++++++.     ...+.+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~   79 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeEE
Confidence            46999999999999999999999999999999986422     23457999999999999999999883     334588


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  154 (303)
T cd07869          80 LVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTG-ELKLADFGLARAKS  154 (303)
T ss_pred             EEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECCCCcceecc
Confidence            9999999877665543   23568899999999999999999999 8999999999999999887 69999999987543


Q ss_pred             cC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      .. .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+..+ .+.+..+....+.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            22 2223456789999999987766689999999999999999999999987544 456666767667766554433211


Q ss_pred             --CCccCcCCCCCCCCcccccc-cCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          315 --NYTEFKFPQIKPHPWHKVFQ-KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       315 --~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                        .+..-.+....+..+...+. ...+.++.+||++||+.||++|||+.|+|+||||+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence              11100111111111111111 13567899999999999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.6e-49  Score=368.99  Aligned_cols=279  Identities=32%  Similarity=0.564  Sum_probs=220.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcC-CCeEEEEEEeccch------hhHHHHHHHHHHc---CCCCcccccceeecCCCCCc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vAiK~~~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~  152 (422)
                      +|++.+.||+|+||+||+|++.. +++.||||.+....      ....+|+.+++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            59999999999999999999854 47889999875321      2334677777766   69999999998754433445


Q ss_pred             eEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ..+++||||+++++...+....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence            5688999999988777665422  3458999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      +............+|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+.++....+.+..+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            866544444456789999999998654 5899999999999999999999999999999999999988887776554321


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      .. .....+......+..... +.+++.+++||.+||+.||++|||+.++|+||||
T Consensus       237 ~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VA-LPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hc-ccchhccCCCCCCHHHHc-cCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            10 011111111222222222 4578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-50  Score=380.98  Aligned_cols=249  Identities=30%  Similarity=0.490  Sum_probs=214.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .|.....||+|+.|.||.|+...+++.||||++...    +..+.+|+.+|+.++|+|||.+++.|....+     +++|
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWVV  348 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWVV  348 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEEE
Confidence            588888999999999999999999999999998643    3344589999999999999999998865433     8899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ +|.++...     ..++|..+..++++++.||+|||. +||+|||||.+|||++.++ .+||+|||+|..+..
T Consensus       349 MEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISE  421 (550)
T ss_pred             EeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCC-cEEEeeeeeeecccc
Confidence            999985 66666554     458999999999999999999999 8999999999999999998 699999999987765


Q ss_pred             CC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .. ...+.+|||+|||||++.. ..|+.++||||||++++||+-|.+||-..+....++.|... |.|.           
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~-----------  488 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPK-----------  488 (550)
T ss_pred             ccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCC-----------
Confidence            54 4567899999999999954 55999999999999999999999999988888877777653 2221           


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                        ++            .+..+|+.++|||.+||+.|+.+|++|.|+|+||||+.
T Consensus       489 --lk------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  489 --LK------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             --cC------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence              11            12578999999999999999999999999999999954

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.7e-48  Score=370.83  Aligned_cols=283  Identities=35%  Similarity=0.656  Sum_probs=230.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||+|.+....     ....+|+++++.++||||+++++++..     ....+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence            35999999999999999999999999999999886322     234579999999999999999998832     33478


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  155 (309)
T cd07872          81 LVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAKS  155 (309)
T ss_pred             EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence            9999999877665543   23458889999999999999999999 8999999999999999887 69999999987543


Q ss_pred             cCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|+||++||.+.+..+.+..+...++.+....+......
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            222 2234467899999999876666899999999999999999999999999988899999999999888777654321


Q ss_pred             --CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       316 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                        +..+.++.....++.... ..+++++++||.+||+.||.+|||+.|+|+||||+.+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  296 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHA-PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI  296 (309)
T ss_pred             hhhhhhhcCccCCCchhhhc-cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccccc
Confidence              223344444333433322 46799999999999999999999999999999999875443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-49  Score=362.73  Aligned_cols=268  Identities=26%  Similarity=0.446  Sum_probs=219.6

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ....|.+..+||.|..++||+|+...+++.||||++.-++     ..+.+|+..|..++||||++++..|.....     
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~-----   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE-----   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce-----
Confidence            3456999999999999999999999999999999986433     445689999999999999999998854443     


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||+||. |++.++++.+..  .++.|..+..+++++++||.|||. +|.||||||+.||||+.+| .|||+|||.+.
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG-~VkLadFgvsa  174 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDG-TVKLADFGVSA  174 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCC-cEEEcCceeee
Confidence            889999998 588888887654  669999999999999999999999 8999999999999999998 79999999876


Q ss_pred             ccccCCCc-----ccccccccccchhhh-cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          234 VLVKGEPN-----VSYICSRYYRAPELI-FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       234 ~~~~~~~~-----~~~~~t~~y~aPE~~-~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      .+......     .+.+||++|||||++ .....|+.|+||||||++..||.+|..||........+...++  +.|+..
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~  252 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTL  252 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCc
Confidence            65443321     345899999999995 4445699999999999999999999999998887766654333  344322


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      .....  ++.               ..+..+..++.+|..||+.||.+||||.++|+|+||+..+...
T Consensus       253 ~t~~~--~~d---------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  253 LTSGL--DKD---------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             ccccC--ChH---------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence            11000  000               1134677899999999999999999999999999999876543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.2e-50  Score=341.85  Aligned_cols=253  Identities=30%  Similarity=0.455  Sum_probs=218.4

Q ss_pred             cceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ....+|.+++.||+|-||.||+|+.+.++-.||+|++.+..       ....+|++|-..|+||||++++++|.+     
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-----   93 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-----   93 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-----
Confidence            34457999999999999999999999999999999986543       345689999999999999999999944     


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      ...+|+++||.+ |.+...+...  ....+.+...+.|+.|++.||.|+|. ++||||||||+|+|++.++ .+||+|||
T Consensus        94 ~~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~-~lkiAdfG  169 (281)
T KOG0580|consen   94 SKRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAG-ELKIADFG  169 (281)
T ss_pred             cceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCC-CeeccCCC
Confidence            344889999998 4665555532  24678899999999999999999999 8999999999999999988 79999999


Q ss_pred             CccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      .+.... .....+.+||..|.+||+..+.. ++..+|+|++|++.||++.|.+||...+..+.+++|.+.          
T Consensus       170 wsV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----------  237 (281)
T KOG0580|consen  170 WSVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----------  237 (281)
T ss_pred             ceeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc----------
Confidence            987654 45567889999999999996654 899999999999999999999999999888888888773          


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                             .+.+|            ..++.+++|||.+||..+|.+|++..|++.|||+...
T Consensus       238 -------~~~~p------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  238 -------DLKFP------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -------cccCC------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                   23333            4689999999999999999999999999999999764

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3e-48  Score=365.11  Aligned_cols=275  Identities=39%  Similarity=0.711  Sum_probs=218.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||+|+||+||+|+++.+++.||||++....      ....+|+.+++.++||||+++++++     ....+++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence            5999999999999999999999999999999886431      2345799999999999999999988     3334588


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  151 (287)
T cd07848          77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHND-VLKLCDFGFARNLS  151 (287)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence            9999999766544432   23578999999999999999999999 8999999999999999887 69999999998654


Q ss_pred             cCC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 014595          237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  313 (422)
Q Consensus       237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  313 (422)
                      ...  ......+|+.|+|||++.+.. ++.++|+|||||++|+|++|++||.+.+..+.+..+....+..+.+.+.... 
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            322  223456899999999996654 8999999999999999999999999988888887777777776665554321 


Q ss_pred             -cCCccCcCCCCC-CCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          314 -PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       314 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                       +.+.....+... ...+.......++.++.+||++||+.||++|||++++|+||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             112111222111 1112222234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.8e-48  Score=363.79  Aligned_cols=279  Identities=31%  Similarity=0.553  Sum_probs=221.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHc---CCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+....      ....+|+++++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4899999999999999999999999999999886421      2334677777765   799999999988655444556


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .++++|||+++++...+....  ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccCccc
Confidence            688999999987766655322  2458999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ............+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.++....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            76544444456789999999999654 48999999999999999999999999988888888888887777655443211


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      . .....+......++.... +.++.++.+||.+||+.||.+|||+.|++.||||
T Consensus       236 ~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 T-LPRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             c-ccccccCCCCCCchHHhC-cCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0 000111111222222222 4578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.6e-48  Score=375.70  Aligned_cols=285  Identities=31%  Similarity=0.542  Sum_probs=225.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|.+.+.||+|+||.||+|++..+++.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            4699999999999999999999999999999998642      1234579999999999999999988743321 23345


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +|+||||+++++...+.      ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus       104 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~  175 (364)
T cd07875         104 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  175 (364)
T ss_pred             EEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCC-cEEEEeCCCccc
Confidence            78999999987765543      347888899999999999999999 8999999999999999887 699999999986


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++...++.+..+.+..+.+
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         176 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             cCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            6444444456789999999999654 489999999999999999999999999999999999999888887765544332


Q ss_pred             C----------CccCcCCCCC---CCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          315 N----------YTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       315 ~----------~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      .          +..+.+....   ..++........+..+++||.+||+.||.+|||+.|+|+||||....++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  328 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS  328 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence            1          1111111100   01111111223467899999999999999999999999999998766554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.6e-48  Score=375.55  Aligned_cols=284  Identities=31%  Similarity=0.552  Sum_probs=222.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|++.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            4699999999999999999999999999999998542      2234579999999999999999998743322 12335


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +|+||||+++++...+.      ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus       101 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~  172 (359)
T cd07876         101 VYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  172 (359)
T ss_pred             eEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEecCCCccc
Confidence            78999999987655442      357888899999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  313 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  313 (422)
                      ...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+.... 
T Consensus       173 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         173 ACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             cccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            5444444556789999999999654 48999999999999999999999999998888888888888888765443221 


Q ss_pred             ---------cCCccCcCCCCCC---CCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          314 ---------PNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       314 ---------~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                               +.+....+....+   .+.........++++++||.+||+.||++|||+.|+|+||||+...++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  324 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP  324 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence                     1111111100000   000011122357889999999999999999999999999999876544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-49  Score=367.85  Aligned_cols=254  Identities=28%  Similarity=0.418  Sum_probs=225.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      -|.+.+.||+|.|++|-+|++.-||+.||||++.+.+      ..+.+|++.|+.+.|||||+||++.     ....-+|
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTKly   93 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTKLY   93 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccceEE
Confidence            4999999999999999999999999999999997643      3345899999999999999999987     3344488


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +|+|+-.+ ++.+++.+.   ..++.+..++.|++||+.|+.|+|+ ..+|||||||+||.+...-+-|||+|||++..+
T Consensus        94 LiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            99999875 776665543   4789999999999999999999999 899999999999887766558999999999999


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .++....+.||+..|.|||+++|..+..+++||||||||||.|++|++||+..++.+.+-.|+++               
T Consensus       170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC---------------  234 (864)
T KOG4717|consen  170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC---------------  234 (864)
T ss_pred             CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc---------------
Confidence            99999999999999999999999998889999999999999999999999999999999988874               


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                        .|..            +..++.+++|||..||+.||.+|.|.++|..|+|++.+..+
T Consensus       235 --KYtv------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  235 --KYTV------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             --cccC------------chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence              2332            35789999999999999999999999999999999987543

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.6e-50  Score=347.49  Aligned_cols=254  Identities=28%  Similarity=0.484  Sum_probs=216.8

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------h------hhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------K------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      |.-.+.||.|..++|.++.++.+|..+|+|++...      .      ....+|+.||+++ .||+|+++.++|     +
T Consensus        19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-----e   93 (411)
T KOG0599|consen   19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-----E   93 (411)
T ss_pred             cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----c
Confidence            77778899999999999999999999999987421      1      1224699999998 799999999998     5


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeec
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      ...++++|+|.|+ |.|.+.+.    ..-.+++...+.+++|++.|+.|||. ++||||||||+|||++++. ++||+||
T Consensus        94 s~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~-~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNM-NIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecccc-ceEEecc
Confidence            5666889999998 45544443    34679999999999999999999999 8999999999999999887 6999999


Q ss_pred             CCccccccCCCcccccccccccchhhhc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014595          230 GSAKVLVKGEPNVSYICSRYYRAPELIF-----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       230 G~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      |+|+.+..++.....||||.|.|||.+.     +.+.|+..+|+||+|||||.|+.|.+||....+.-++..|+..    
T Consensus       168 GFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG----  243 (411)
T KOG0599|consen  168 GFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG----  243 (411)
T ss_pred             ceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc----
Confidence            9999999999989999999999999973     4566999999999999999999999999988888778777763    


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                   .|.|..   ..|     .+++.+.+|||++||+.||.+|+|++|+|.||||..+..
T Consensus       244 -------------kyqF~s---peW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  244 -------------KYQFRS---PEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             -------------ccccCC---cch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence                         222221   122     467999999999999999999999999999999987643

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.9e-48  Score=375.68  Aligned_cols=282  Identities=35%  Similarity=0.587  Sum_probs=224.1

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |.+.+.||+|+||+||+|++..+|+.||||++...      .....+|+++++.++|+||+++++++.........++++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            78889999999999999999999999999987542      123457999999999999999999885433222336789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||+.+++...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++....
T Consensus        82 v~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~  155 (372)
T cd07853          82 VTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEP  155 (372)
T ss_pred             EeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCC-CEEeccccceeeccc
Confidence            999998876555432    4578999999999999999999999 8999999999999999887 799999999976433


Q ss_pred             CC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          238 GE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       238 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..  ......+|+.|+|||++.+...++.++|||||||++|||++|+.||.+.+..+++..+.+.+|.++.+.+......
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            22  1233467889999999977666899999999999999999999999999999999999999999888765432211


Q ss_pred             CccC--cCCCCCCCCccc--ccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          316 YTEF--KFPQIKPHPWHK--VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~--~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      ....  ..+...+ .+..  .+....++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       236 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         236 ARAHILRGPHKPP-SLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHhCCCCCC-chHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            1000  0000000 0000  12245688999999999999999999999999999998854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-48  Score=370.78  Aligned_cols=254  Identities=33%  Similarity=0.559  Sum_probs=216.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcC-CCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..|.+.+.||.|.||.||+|+.+.||+.+|+|.+.+..       ....+|+.+|+++. |||||.+++.|.+     ..
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-----~~  109 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-----PD  109 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-----CC
Confidence            35999999999999999999999999999999986543       25568999999998 9999999999943     33


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC---CcEEEeec
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDF  229 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~---~~vkl~Df  229 (422)
                      ++++|||+|.| .|.+.+...     .+++..+..++.|++.|+.|||+ .||+||||||+|+|+....   ..+|++||
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            58899999985 444433332     39999999999999999999999 8999999999999996542   26999999


Q ss_pred             CCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       230 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      |++.....+......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+......+|.+.         
T Consensus       184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~---------  253 (382)
T KOG0032|consen  184 GLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG---------  253 (382)
T ss_pred             CCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC---------
Confidence            99998877666778899999999999954 45999999999999999999999999999988887776652         


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                              .+.+   ...+|     +.++..+++||++||..||.+|+|+.++|+|||++...
T Consensus       254 --------~~~f---~~~~w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  254 --------DFDF---TSEPW-----DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             --------CCCC---CCCCc-----cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence                    1211   12233     56799999999999999999999999999999998764

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-47  Score=367.38  Aligned_cols=249  Identities=30%  Similarity=0.437  Sum_probs=206.7

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++.     ...
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence            456999999999999999999999999999999986432       23457999999999999999999883     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ++++||||+.+ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  165 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKG-HVKVTDFGFA  165 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence            58899999975 55554443    3578999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ......  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...            
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------------  230 (329)
T PTZ00263        166 KKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG------------  230 (329)
T ss_pred             eEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence            765332  3356789999999999654 4899999999999999999999999887766555544331            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~  372 (422)
                           ...+            +..++..+++||++||+.||.+|++     ++++++||||.+..
T Consensus       231 -----~~~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        231 -----RLKF------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             -----CcCC------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence                 1111            1346889999999999999999997     79999999998754

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.1e-47  Score=360.80  Aligned_cols=283  Identities=32%  Similarity=0.617  Sum_probs=227.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|.+.+.||.|+||.||+|++..+++.||+|.+....     ....+|+.+++.++||||+++++++.     ...+.+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeEE
Confidence            45999999999999999999999999999999885322     23457999999999999999999883     334578


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+..   ....+++..++.++.||+.||+|||+ .||+|+||||+|||++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~  155 (301)
T cd07873          81 LVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAKS  155 (301)
T ss_pred             EEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCC-cEEECcCcchhccC
Confidence            9999999877665543   23568899999999999999999999 8999999999999999887 69999999987543


Q ss_pred             cCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  314 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  314 (422)
                      ... ......+++.|+|||++.+...++.++|||||||++|+|+||++||.+.+..+.+..+...++.+....+..+.. 
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence            222 122345688999999987766688999999999999999999999999988888888888888887766554321 


Q ss_pred             -CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          315 -NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       315 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                       .+..+.++........ .....+++++++||.+||+.||.+|||+.|+|+||||+.+...-
T Consensus       236 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~  296 (301)
T cd07873         236 EEFKSYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI  296 (301)
T ss_pred             ccccccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence             1222233332221111 12346789999999999999999999999999999999887543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.5e-47  Score=369.93  Aligned_cols=284  Identities=32%  Similarity=0.557  Sum_probs=224.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            46999999999999999999999999999999886421      233479999999999999999998753322 22345


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++||||+++++...+.      ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus        97 ~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~-~~kl~Dfg~~~~  168 (355)
T cd07874          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  168 (355)
T ss_pred             eEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCC-CEEEeeCccccc
Confidence            78999999987655443      357888899999999999999999 8999999999999999887 699999999986


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..++..++.+..+.+..+.+
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             CCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            6444444556789999999999654 489999999999999999999999999988888888888888887765544332


Q ss_pred             C----------CccCcCCCCCC---CCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          315 N----------YTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       315 ~----------~~~~~~~~~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      .          +....++....   .+.........+.++++||.+||+.||++|||+.|+|+||||....++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            1          11111111100   011111223356789999999999999999999999999999876544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-47  Score=369.68  Aligned_cols=284  Identities=35%  Similarity=0.618  Sum_probs=227.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|.+.+.||.|+||+||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            35999999999999999999999999999999986432      223479999999999999999998743221 22334


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .+++++++++++..++.     ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus        95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~  167 (343)
T cd07878          95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ  167 (343)
T ss_pred             EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCC-CEEEcCCcccee
Confidence            67999999888766554     2569999999999999999999999 8999999999999999887 699999999986


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+.....
T Consensus       168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            533  234567899999999997756689999999999999999999999999888888888888888877765544322


Q ss_pred             CCccC---cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       315 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      .....   .++......+...+ ...++.+.+||.+||+.||.+|||+.|+|+||||....++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             hhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence            11100   11122222222222 35678899999999999999999999999999999876554

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-46  Score=377.03  Aligned_cols=283  Identities=22%  Similarity=0.382  Sum_probs=213.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCC------CcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHP------NIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~------nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+.||+|+||+||+|.+..+++.||||++....   .....|+.+++.+.|.      +++.++++|.    .+.
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~----~~~  204 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ----NET  204 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE----cCC
Confidence            56999999999999999999999999999999986422   2345688888887654      4777777763    223


Q ss_pred             eEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC----------
Q 014595          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH----------  222 (422)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~----------  222 (422)
                      .++|+||+++++.+.+.+..    ...+++..++.++.||+.||+|||+..|||||||||+|||++.++.          
T Consensus       205 ~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        205 GHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             ceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            45789999998877665543    3578999999999999999999996249999999999999986542          


Q ss_pred             -----cEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014595          223 -----QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI  297 (422)
Q Consensus       223 -----~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i  297 (422)
                           .+||+|||.+...  .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+
T Consensus       281 ~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             CCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                 4999999987543  2233456889999999999765 4899999999999999999999999999988888888


Q ss_pred             HHHhCCCCHHHHhhcCcC-----CccC-c-CCCCCCCCccccc------ccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          298 IKVLGTPTREEIKCMNPN-----YTEF-K-FPQIKPHPWHKVF------QKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~-----~~~~-~-~~~~~~~~~~~~~------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .+.++.++..........     +... . .+...+..+....      ....++.+.|||++||++||.+|||++|+|+
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            888887765433211000     0000 0 0000000000000      0012467889999999999999999999999


Q ss_pred             CCcccccCCCC
Q 014595          365 HPFFDELRDPN  375 (422)
Q Consensus       365 hp~f~~~~~~~  375 (422)
                      ||||.......
T Consensus       438 Hp~~~~~~~~~  448 (467)
T PTZ00284        438 HPYVLKYYPEC  448 (467)
T ss_pred             CccccccCCcc
Confidence            99999865443

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-47  Score=360.89  Aligned_cols=248  Identities=27%  Similarity=0.415  Sum_probs=206.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||+||+|++..+|+.||||++...       .....+|+++++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence            489999999999999999999999999999998542       12345799999999999999998877     334468


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ +|.+.+..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~  150 (291)
T cd05612          77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEG-HIKLTDFGFAKK  150 (291)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence            899999985 56555443    3578999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ....  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...              
T Consensus       151 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--------------  213 (291)
T cd05612         151 LRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--------------  213 (291)
T ss_pred             ccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence            5332  2345789999999998654 4899999999999999999999999888766665555431              


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  373 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  373 (422)
                         ...            ++..+++.+++||++||+.||.+|++     ++++++||||+.+..
T Consensus       214 ---~~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         214 ---KLE------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             ---CcC------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence               111            12356889999999999999999995     999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-47  Score=374.89  Aligned_cols=278  Identities=24%  Similarity=0.335  Sum_probs=212.5

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      ..+|.+.+.||+|+||.||+|++..+++.||||....  ....+|+++++.|+||||++++++|.     ...+.++|||
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEEEe
Confidence            3469999999999999999999999999999997543  34568999999999999999999883     2345789999


Q ss_pred             cchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC--
Q 014595          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--  238 (422)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~--  238 (422)
                      ++.+++...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|......  
T Consensus       164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINA  237 (391)
T ss_pred             cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCC-CEEEEeCCcccccccccc
Confidence            998877655443    3568899999999999999999999 8999999999999999887 6999999998653222  


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCCHHHHhh
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-------SGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.       +...++..++...+.++.+....
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            222346789999999999654 5899999999999999999999887543       23456677777766654321100


Q ss_pred             c----CcCC----ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          312 M----NPNY----TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       312 ~----~~~~----~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      .    ...+    ............|...  ..++.++.+||.+||++||.+|||+.|+|+||||+.+..+
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            0    0000    0000000001112221  1367889999999999999999999999999999886543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-47  Score=359.28  Aligned_cols=255  Identities=23%  Similarity=0.374  Sum_probs=205.0

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      |.+.+.||+|+||+||+|.+..+|+.||+|.+....       ....+|+.+++.++|+||+++++++.     ...+++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeEE
Confidence            888999999999999999999999999999875422       22357999999999999999988873     334588


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ ++...+...  ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        77 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~  152 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRG-HIRISDLGLAVQI  152 (285)
T ss_pred             EEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEc
Confidence            99999985 555444321  23468999999999999999999999 8999999999999999877 6999999999876


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...+....          
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  221 (285)
T cd05631         153 PEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ----------  221 (285)
T ss_pred             CCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc----------
Confidence            444444456789999999999654 589999999999999999999999987654333222222111000          


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccCC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  373 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  373 (422)
                                     ..++..+++++.+||++||+.||.+|++     ++++++||||+++..
T Consensus       222 ---------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         222 ---------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             ---------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence                           0122457899999999999999999997     899999999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.8e-47  Score=365.97  Aligned_cols=245  Identities=27%  Similarity=0.439  Sum_probs=200.4

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++.     ...++++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----cCCEEEEEEe
Confidence            46999999999999999999999999986432       22346899999999999999998873     3345889999


Q ss_pred             cchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc-C
Q 014595          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G  238 (422)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~-~  238 (422)
                      |+++ ++...+.    ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            9985 5544443    24678999999999999999999999 8999999999999999887 699999999875322 2


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                      ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  211 (323)
T ss_pred             CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence            233456789999999999654 5899999999999999999999999887665544443321                 1


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                      ..            ++..+++++.+||++||+.||++||     ++.++++||||+.+..
T Consensus       212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             CC------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            11            1245789999999999999999999     8999999999988643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.9e-47  Score=361.04  Aligned_cols=278  Identities=29%  Similarity=0.507  Sum_probs=209.0

Q ss_pred             eeeeeecCCeeEEEEEEc--CCCeEEEEEEeccch--hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           87 EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      +++||+|+||+||+|+++  .+++.||+|.+....  ....+|+.+++.++||||+++++++...   ....++++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence            457999999999999975  467899999886532  3356899999999999999999987432   234578999999


Q ss_pred             hhHHHHHHHHhhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC---CCCcEEEeecCCccc
Q 014595          163 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKV  234 (422)
Q Consensus       163 ~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~---~~~~vkl~DfG~a~~  234 (422)
                      ++++..++.....     ....+++..++.++.||+.||+|||+ .||+||||||+|||++.   ....+||+|||+++.
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            9887776653221     12358999999999999999999999 89999999999999942   223699999999976


Q ss_pred             cccCC----CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 014595          235 LVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKVL  301 (422)
Q Consensus       235 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---------~~~~~~i~~~~  301 (422)
                      .....    ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+...         .+++..+...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            53322    123457799999999997766789999999999999999999999975432         35677888888


Q ss_pred             CCCCHHHHhhcCcCCc------cC---cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          302 GTPTREEIKCMNPNYT------EF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       302 ~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      +.|....+.....-..      .+   .........+........+.++.+||++||++||.+|+|++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            8887766554321000      00   0000000000000112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-47  Score=350.08  Aligned_cols=250  Identities=25%  Similarity=0.437  Sum_probs=219.9

Q ss_pred             cceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ..+.+|.+.+.||+|.||+|-+|+....|+.||||.|.+++       ..+.+|++||..|+||||+.++++|     .+
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----EN  124 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----EN  124 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cC
Confidence            44568999999999999999999999999999999887643       2346899999999999999999999     33


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      ..-+.+||||.. |.|++++..    .+.+++.+++.+++||++|+.|+|. ++++|||||.+|||+|.++ ++||+|||
T Consensus       125 kdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~-NiKIADFG  198 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNN-NIKIADFG  198 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCC-Ceeeeccc
Confidence            344889999998 466666654    4789999999999999999999999 8999999999999999988 69999999


Q ss_pred             CccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ++..+..+....++||+|.|.+||++.|.++-++.+|.|||||+||.|+.|..||.|.+...++.+|...          
T Consensus       199 LSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G----------  268 (668)
T KOG0611|consen  199 LSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG----------  268 (668)
T ss_pred             hhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc----------
Confidence            9998887777889999999999999999888899999999999999999999999999988887777652          


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                             .|.             .+.-+.++.-||+.||-.||++|.|++++..|=|+.
T Consensus       269 -------aYr-------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  269 -------AYR-------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             -------ccc-------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                   221             134578899999999999999999999999998875

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8.8e-48  Score=340.79  Aligned_cols=284  Identities=34%  Similarity=0.585  Sum_probs=228.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCC----eEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ..|.+...||+|.||.||+|..+.++    +.+|||+++..+      ...-||+.+++.|+|||++.+..+|+..    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            35999999999999999999765553    378999987552      2335899999999999999999998643    


Q ss_pred             ceEEEEEeecchhHHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC----CCcEEE
Q 014595          152 ELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKL  226 (422)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~----~~~vkl  226 (422)
                      +..+++++||.+.+|..+++..... ...++...++.++.||+.|+.|||+ .=|+||||||.|||+..+    | .|||
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG-~VKI  177 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERG-RVKI  177 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccC-eeEe
Confidence            4558899999999999998865542 3568999999999999999999998 689999999999999877    5 7999


Q ss_pred             eecCCccccccCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------ChHHH
Q 014595          227 CDFGSAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE---------SGVDQ  293 (422)
Q Consensus       227 ~DfG~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~---------~~~~~  293 (422)
                      +|||+++.+.+.-..    ...+.|.+|+|||.++|...|+.+.|+||+|||+.||+|-.+.|.+.         -..++
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            999999987544322    24567999999999999999999999999999999999999999864         24578


Q ss_pred             HHHHHHHhCCCCHHHHhhcC--cCCc----cCcCCCCCCCCcccccc--cCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          294 LVEIIKVLGTPTREEIKCMN--PNYT----EFKFPQIKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      +..|+..+|.|+...|..+.  |.+.    .|.........+...+.  ..-++.+.+|+.+||+.||-+|.|++++|+|
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            99999999999999887653  2221    11111111111111121  2245669999999999999999999999999


Q ss_pred             Cccccc
Q 014595          366 PFFDEL  371 (422)
Q Consensus       366 p~f~~~  371 (422)
                      +||..-
T Consensus       338 ~yF~~d  343 (438)
T KOG0666|consen  338 PYFTED  343 (438)
T ss_pred             cccccC
Confidence            999874

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-46  Score=362.43  Aligned_cols=249  Identities=29%  Similarity=0.423  Sum_probs=205.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCC-eEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||.||+|.+..++ ..||+|++....       ....+|+.+++.++||||+++++++.     ...
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~  104 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----DES  104 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----eCC
Confidence            35999999999999999999876654 789999885422       23347999999999999999999883     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ++++||||+++ +|...+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~ikL~DFG~a  178 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDG-FIKMTDFGFA  178 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEecCCCC
Confidence            58899999974 66555543    3578999999999999999999999 8999999999999999877 6999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      +....  ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+.......+...            
T Consensus       179 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~------------  243 (340)
T PTZ00426        179 KVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG------------  243 (340)
T ss_pred             eecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC------------
Confidence            76532  23456789999999999654 4899999999999999999999999988766555555431            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                           ...            ++..+++.+.+||++||+.||.+|+     |++++++||||.++.+
T Consensus       244 -----~~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        244 -----IIY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             -----CCC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                 111            1235788999999999999999996     8999999999998653

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-46  Score=362.38  Aligned_cols=277  Identities=23%  Similarity=0.349  Sum_probs=206.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeec
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  161 (422)
                      .+|.+.+.||+|+||.||+|++..+++.||+|+....  ....|+.+++.++|+||+++++++..     ..+.++|||+
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEEc
Confidence            3599999999999999999999999999999975433  23579999999999999999998843     3347799999


Q ss_pred             chhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCc
Q 014595          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (422)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~  241 (422)
                      +.+++...+..   ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++........
T Consensus       139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence            99877666543   23578999999999999999999999 8999999999999999887 6999999999754444444


Q ss_pred             ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHHhCCCCHHHHhh
Q 014595          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESG---------VDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ....||+.|+|||++.+. .++.++|||||||++|||+++. ++|.....         ...+.+++..++..+......
T Consensus       214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            456789999999999654 4899999999999999999855 44443221         233444445444333221100


Q ss_pred             cCcCCc--cCcCCCCCCCCcc---cccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          312 MNPNYT--EFKFPQIKPHPWH---KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       312 ~~~~~~--~~~~~~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      ......  .+.+......++.   ......++.++.+||.+||++||.+|||+.|+|+||||+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            000000  0000000011111   11123568889999999999999999999999999999864

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-46  Score=356.96  Aligned_cols=286  Identities=35%  Similarity=0.670  Sum_probs=226.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...     .....+|+.+++.++|+||+++++++..........++
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            3599999999999999999999999999999988532     12234699999999999999999877544434445678


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +++||+++++...+..     ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        85 lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~  157 (336)
T cd07849          85 IVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD  157 (336)
T ss_pred             EEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence            9999999877655442     568999999999999999999999 8999999999999999887 69999999987653


Q ss_pred             cCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          237 KGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       237 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .....    ....+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+...++.+..+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            32211    23467889999998766556899999999999999999999999998888888888888888877665533


Q ss_pred             CcCCc-cC--cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          313 NPNYT-EF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       313 ~~~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      ..... .+  ..+.....++.... +..++++.+||.+||+.||++|||+.++++||||+.+.++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~  302 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS  302 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHh-cccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCC
Confidence            21110 00  01111122222221 35688999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.5e-46  Score=365.43  Aligned_cols=253  Identities=27%  Similarity=0.439  Sum_probs=203.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|++.+.||+|+||+||+|++..+++.||||++.+..       ....+|+.++..++|+||+++++.+     .+..++
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence            4899999999999999999999999999999986432       2345799999999999999999888     334458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ +|...+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~-~vkL~DFGla~~  150 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG  150 (363)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence            899999985 56555443    4678999999999999999999999 8999999999999999887 699999999875


Q ss_pred             cccCC------------------------------------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHH
Q 014595          235 LVKGE------------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  278 (422)
Q Consensus       235 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  278 (422)
                      .....                                    .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el  229 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence            42211                                    01235789999999999654 489999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCC---
Q 014595          279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL---  355 (422)
Q Consensus       279 ltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~---  355 (422)
                      ++|+.||.+.+..+.+.++.....               ...+|..          ..+++++++||.+|+. +|.+   
T Consensus       230 l~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~----------~~~s~~~~~li~~l~~-~~~~r~~  283 (363)
T cd05628         230 LIGYPPFCSETPQETYKKVMNWKE---------------TLIFPPE----------VPISEKAKDLILRFCC-EWEHRIG  283 (363)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCcC---------------cccCCCc----------CCCCHHHHHHHHHHcC-ChhhcCC
Confidence            999999998887766666554210               0111110          1368999999999876 4544   


Q ss_pred             cCCHHHHhcCCcccccCC
Q 014595          356 RCTALEACVHPFFDELRD  373 (422)
Q Consensus       356 R~t~~e~l~hp~f~~~~~  373 (422)
                      ||+++|+++||||+++..
T Consensus       284 r~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         284 APGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CCCHHHHhCCCCCCCCCH
Confidence            589999999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-46  Score=364.85  Aligned_cols=278  Identities=22%  Similarity=0.329  Sum_probs=211.2

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEc--CCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      ..+|.+.+.||.|+||.||+|...  .+++.||+|.+... ....+|+++++.++||||+++++++     .....++++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence            346999999999999999999764  35688999988654 3456899999999999999999887     333457899


Q ss_pred             eecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||++.+++...+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus       165 ~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence            9999887766552    24678999999999999999999999 8999999999999999887 6999999998765433


Q ss_pred             CC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHhhc
Q 014595          239 EP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       239 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ..   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..   ....+..+.+.++..+.+.....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            22   2345789999999999654 48999999999999999999999997753   34566667766655433211100


Q ss_pred             C----cCCccCcCCCCCCCCccccc-ccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          313 N----PNYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       313 ~----~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      .    ..+..+.........+...+ ...++.++.+||++||+.||.+|||+.|+|+||||++.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            0    00001111111111111111 12467889999999999999999999999999999773

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.4e-46  Score=348.61  Aligned_cols=275  Identities=35%  Similarity=0.569  Sum_probs=216.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||.|+||.||+|++..+|+.||+|.+....      ....+|+++++.++|+||+++++++.     +..+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence            3889999999999999999999999999999885421      23457999999999999999999883     334578


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +++||+++++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            9999999877655443   23568999999999999999999999 8999999999999999887 69999999987553


Q ss_pred             cCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ... ......+++.|+|||++.+...++.++|||||||++|+|+||..| |.+.+..+.+..+.+..+.+....+..+..
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            322 122345688999999987766689999999999999999998877 566666777888888877777665543321


Q ss_pred             CCccCcCCCCCCC-CcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 NYTEFKFPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 ~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      ......++..... .|.. ..+.+++++++||.+||+.||.+|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVN-VVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhh-hcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            1111111111111 1122 224678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=344.69  Aligned_cols=306  Identities=26%  Similarity=0.414  Sum_probs=241.5

Q ss_pred             CCCCcCceeEeccCCCCCCCcceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHH---HHHHHHHHcC--
Q 014595           59 VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD--  133 (422)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~---~E~~~l~~l~--  133 (422)
                      .....|.++...+|....    ..+|.+.++||.|.|++||+|.+..+.+.||+|+++....+.+   .||++|++++  
T Consensus        59 ~dY~kGGYHpV~IGD~F~----~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~  134 (590)
T KOG1290|consen   59 EDYRKGGYHPVRIGDVFN----GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG  134 (590)
T ss_pred             hhhhcCCCceeecccccc----CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence            346667788888887643    3569999999999999999999999999999999987766554   5999999883  


Q ss_pred             ------CCCcccccceeecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcee
Q 014595          134 ------HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH  207 (422)
Q Consensus       134 ------h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givH  207 (422)
                            ..+||+|++.|.. .+.++.++|||+|+++.+|..++....  .++++...++.|++||+.||.|||+..||||
T Consensus       135 Dp~~~~~~~VV~LlD~Fkh-sGpNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIH  211 (590)
T KOG1290|consen  135 DPNDPGKKCVVQLLDHFKH-SGPNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIH  211 (590)
T ss_pred             CCCCCCCceeeeeecccee-cCCCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence                  2469999998744 447889999999999999988887654  4789999999999999999999998789999


Q ss_pred             cCCCCCCeEEcCC-------------------------------------------------------------------
Q 014595          208 RDIKPQNLLVNPH-------------------------------------------------------------------  220 (422)
Q Consensus       208 rDlkp~Nill~~~-------------------------------------------------------------------  220 (422)
                      -||||+|||+...                                                                   
T Consensus       212 TDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~  291 (590)
T KOG1290|consen  212 TDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGL  291 (590)
T ss_pred             cCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccc
Confidence            9999999997300                                                                   


Q ss_pred             -------------------C------------------------------------------------------------
Q 014595          221 -------------------T------------------------------------------------------------  221 (422)
Q Consensus       221 -------------------~------------------------------------------------------------  221 (422)
                                         +                                                            
T Consensus       292 ~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~  371 (590)
T KOG1290|consen  292 EGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSP  371 (590)
T ss_pred             ccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCc
Confidence                               0                                                            


Q ss_pred             -------------------CcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCC
Q 014595          222 -------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ  282 (422)
Q Consensus       222 -------------------~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~  282 (422)
                                         -.|||+|||-|...  ....+.-+.|..|+|||++.|.. |+..+||||++|++|||+||.
T Consensus       372 ~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGD  448 (590)
T KOG1290|consen  372 GTIASNPLVNPDIPLPECDIRVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGD  448 (590)
T ss_pred             cccccccccCCCCCCCccceeEEEeeccchhhh--hhhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCc
Confidence                               02566666666543  22334556789999999999876 999999999999999999999


Q ss_pred             CCCCCC------ChHHHHHHHHHHhCCCCHHHHhhcC-------cCCccCcCCCCCCCCccccccc------CCChHHHH
Q 014595          283 PLFPGE------SGVDQLVEIIKVLGTPTREEIKCMN-------PNYTEFKFPQIKPHPWHKVFQK------RLPPEAVD  343 (422)
Q Consensus       283 ~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~------~~s~~~~~  343 (422)
                      ..|...      .++++++.|+..+|..++.......       ..-.--.+..+++.++..++..      .-..++.+
T Consensus       449 yLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsd  528 (590)
T KOG1290|consen  449 YLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSD  528 (590)
T ss_pred             eeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHH
Confidence            999642      4678999999999998887654322       1111123444455555444322      22356889


Q ss_pred             HHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          344 LVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       344 li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      ||.-||+++|++|+||.++|+|||+..+..+
T Consensus       529 FL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  529 FLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            9999999999999999999999999876543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-46  Score=358.85  Aligned_cols=256  Identities=30%  Similarity=0.482  Sum_probs=208.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||.||+|++..+++.||||++....       ....+|+++++.++||||+++++++     ....++
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence            4999999999999999999999999999999986432       2344799999999999999999887     334458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ +|..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~  150 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASG-HIKLTDFGLSKG  150 (333)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence            899999975 66665543    3568999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+......           
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------  216 (333)
T cd05600         151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-----------  216 (333)
T ss_pred             ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-----------
Confidence            533  33456789999999999765 5899999999999999999999999988776666555432100           


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                          +..+...      .....++.++.+||.+||..+|.+|+++.++++||||.++..
T Consensus       217 ----~~~~~~~------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         217 ----LQRPVYD------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             ----ccCCCCC------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence                0011000      000246899999999999999999999999999999998643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-46  Score=364.33  Aligned_cols=253  Identities=32%  Similarity=0.513  Sum_probs=204.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||+||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++.     ...++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-----DENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCeE
Confidence            4999999999999999999999999999999986432       23457999999999999999999883     34458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ +|.+.+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  150 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG  150 (364)
T ss_pred             EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence            899999975 56555443    3568999999999999999999999 8999999999999999887 699999999865


Q ss_pred             cccCCC---------------------------------------cccccccccccchhhhcCCCCCCCcchHHHHHHHH
Q 014595          235 LVKGEP---------------------------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVM  275 (422)
Q Consensus       235 ~~~~~~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  275 (422)
                      +.....                                       ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHH
Confidence            422110                                       112468999999999865 4589999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCC
Q 014595          276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL  355 (422)
Q Consensus       276 ~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~  355 (422)
                      |||++|.+||.+.+..+.+..+....               ..+.++.          ...+++++++||++||. +|.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~----------~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIINWK---------------ETLQFPD----------EVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHcCC---------------CccCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence            99999999999887766655554311               0011111          02468999999999997 9999


Q ss_pred             cCC---HHHHhcCCcccccCC
Q 014595          356 RCT---ALEACVHPFFDELRD  373 (422)
Q Consensus       356 R~t---~~e~l~hp~f~~~~~  373 (422)
                      |++   +.++++||||+....
T Consensus       284 R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         284 RLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             cCCCCCHHHHhcCCCcCCCCH
Confidence            998   999999999988643

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4e-46  Score=364.67  Aligned_cols=254  Identities=28%  Similarity=0.468  Sum_probs=201.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .|++++.||+|+||+||+|++..+++.||||++....       ....+|+.+++.++|+||+++++++.     +..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            3899999999999999999999999999999986432       23457999999999999999999883     33458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            899999975 66555443    3568999999999999999999999 8999999999999999887 699999999753


Q ss_pred             cccCC------------------------------------------------CcccccccccccchhhhcCCCCCCCcc
Q 014595          235 LVKGE------------------------------------------------PNVSYICSRYYRAPELIFGATEYTTAI  266 (422)
Q Consensus       235 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  266 (422)
                      .....                                                .....+||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence            21000                                                01235789999999999654 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHH
Q 014595          267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  346 (422)
Q Consensus       267 DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  346 (422)
                      |||||||++|||++|..||...+..+....+.....               ...++.          ...+++++++||.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------TLHIPP----------QVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------ccCCCC----------CCCCCHHHHHHHH
Confidence            999999999999999999988776555554433110               011111          1247899999999


Q ss_pred             hhhhcCC--CCcCCHHHHhcCCcccccCC
Q 014595          347 RFFQYSP--NLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       347 ~~L~~dP--~~R~t~~e~l~hp~f~~~~~  373 (422)
                      +||+.++  ..|+++.++++||||+++..
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            9776544  45999999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-46  Score=365.89  Aligned_cols=252  Identities=30%  Similarity=0.496  Sum_probs=201.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||+||+|++..+++.||||++.+..       ....+|+++++.++||||+++++++.     +..++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCee
Confidence            4999999999999999999999999999999885432       23457999999999999999999883     34468


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      |+||||+++ +|...+..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~-~~kl~DfGla~~  150 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGG-HIKLSDFGLSTG  150 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence            899999974 66555543    3578999999999999999999999 8999999999999999887 699999999863


Q ss_pred             cccCCC------------------------------------------------cccccccccccchhhhcCCCCCCCcc
Q 014595          235 LVKGEP------------------------------------------------NVSYICSRYYRAPELIFGATEYTTAI  266 (422)
Q Consensus       235 ~~~~~~------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~  266 (422)
                      ......                                                ....+||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~  229 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC  229 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence            211000                                                0124689999999999654 589999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHH
Q 014595          267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  346 (422)
Q Consensus       267 DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  346 (422)
                      |||||||++|||++|.+||.+.+..+.+..+....               ..+.+|.          ...++.++++||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dli~  284 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWR---------------ETLYFPD----------DIHLSVEAEDLIR  284 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC---------------CccCCCC----------CCCCCHHHHHHHH
Confidence            99999999999999999998887766665554311               0111111          0246899999999


Q ss_pred             hhhhcCCCCc---CCHHHHhcCCcccccC
Q 014595          347 RFFQYSPNLR---CTALEACVHPFFDELR  372 (422)
Q Consensus       347 ~~L~~dP~~R---~t~~e~l~hp~f~~~~  372 (422)
                      +||+ +|.+|   +|+.++++||||++..
T Consensus       285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         285 RLIT-NAENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             HHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            9998 77765   5999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-46  Score=354.93  Aligned_cols=242  Identities=31%  Similarity=0.535  Sum_probs=198.2

Q ss_pred             eeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      ||+|+||+||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++.     ...++++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence            699999999999999999999999986421       22346999999999999999988873     334578999999


Q ss_pred             hh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC-C
Q 014595          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-P  240 (422)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~-~  240 (422)
                      ++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...... .
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            85 55444432    4578999999999999999999999 8999999999999999887 69999999987543222 2


Q ss_pred             cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCc
Q 014595          241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  320 (422)
Q Consensus       241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  320 (422)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...                 ...
T Consensus       150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~~~  211 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------PLR  211 (312)
T ss_pred             cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------CCC
Confidence            3345789999999999654 5899999999999999999999999887766555544321                 111


Q ss_pred             CCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC---CHHHHhcCCcccccC
Q 014595          321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELR  372 (422)
Q Consensus       321 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~  372 (422)
                                  ++..+++++++||.+||..||.+|+   ++.++++||||.+..
T Consensus       212 ------------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         212 ------------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             ------------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                        2245789999999999999999997   589999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.5e-46  Score=357.03  Aligned_cols=244  Identities=26%  Similarity=0.422  Sum_probs=198.0

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +.||+|+||.||+|++..+|+.||||++.+..       ....+|+.+++.++||||+++++++.     ....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence            46999999999999999999999999986432       23346899999999999999988873     3345889999


Q ss_pred             cchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC-
Q 014595          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  238 (422)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~-  238 (422)
                      |+++ ++...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        76 y~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            9985 4433332    24578999999999999999999999 8999999999999999887 6999999998754222 


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+..                 ..
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-----------------~~  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------------ED  211 (328)
T ss_pred             cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-----------------CC
Confidence            222345789999999998654 589999999999999999999999987765544433321                 01


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccC
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~  372 (422)
                      ..            ++..+++++.+||++||+.||++|+     ++.++++||||....
T Consensus       212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         212 IK------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             cc------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            11            2245789999999999999999997     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.4e-45  Score=346.43  Aligned_cols=276  Identities=34%  Similarity=0.640  Sum_probs=216.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|++.+.||+|++|.||+|++..+++.||||++....      ....+|+.+++.++||||+++++++..     ..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence            3899999999999999999999999999999875321      234679999999999999999998842     34578


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+.... ....+++..++.++.||+.||+|||+ .||+|+||||+||+++.++ .+||+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            999999887766554322 23568999999999999999999999 8999999999999999887 69999999987543


Q ss_pred             cCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  314 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  314 (422)
                      ... ......+++.|+|||++.+...++.++|+|||||++|+|+||++||.+.+..+.+..+....+.+....+..... 
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            221 112345688899999987666688999999999999999999999999888887877777777665554432110 


Q ss_pred             -CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 -NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                       ++.. .++......... ....+++++++||++||+.||.+|||+.++++||||
T Consensus       233 ~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         233 PDYKN-TFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHh-hccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence             0000 011111111111 123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.9e-46  Score=365.03  Aligned_cols=253  Identities=28%  Similarity=0.479  Sum_probs=202.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .|++++.||+|+||+||+|++..+++.||||++.+..       ....+|+.+++.++|+||+++++++.     ...++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            4899999999999999999999999999999986532       23457999999999999999999883     33458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++|||||++ +|..++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence            899999985 56555433    3568999999999999999999999 8999999999999999887 699999999753


Q ss_pred             cccC------------------------------------------------CCcccccccccccchhhhcCCCCCCCcc
Q 014595          235 LVKG------------------------------------------------EPNVSYICSRYYRAPELIFGATEYTTAI  266 (422)
Q Consensus       235 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~  266 (422)
                      ....                                                ......+||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence            2100                                                001134689999999999654 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHH
Q 014595          267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  346 (422)
Q Consensus       267 DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  346 (422)
                      |||||||++|||++|++||.+.+..+...++.....               ...+|.          ...+++++.+||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT---------------SLHIPP----------QAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---------------CcCCCC----------cccCCHHHHHHHH
Confidence            999999999999999999998876665555443110               011111          1357899999999


Q ss_pred             hhhhcCCCCcCC---HHHHhcCCcccccCC
Q 014595          347 RFFQYSPNLRCT---ALEACVHPFFDELRD  373 (422)
Q Consensus       347 ~~L~~dP~~R~t---~~e~l~hp~f~~~~~  373 (422)
                      +|+ .||.+|++   ++++++||||+.+..
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            976 59999997   999999999988643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-47  Score=337.28  Aligned_cols=253  Identities=28%  Similarity=0.439  Sum_probs=212.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhH-------HHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-------~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|..+++||+|.||+|-+|+.+.+|+.||||+++++....       ..|-++|+..+||.+..+...|     +....
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~dr  242 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQDR  242 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCce
Confidence            46888899999999999999999999999999887654332       2477899999999999887777     33344


Q ss_pred             EEEEeecchhH-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +|+||||..|+ |...    ......+++...+.|...|+.||.|||+ ++||+||||.+|+|+|.+|+ +||+|||+++
T Consensus       243 lCFVMeyanGGeLf~H----Lsrer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDGH-IKitDFGLCK  316 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFH----LSRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDGH-IKITDFGLCK  316 (516)
T ss_pred             EEEEEEEccCceEeee----hhhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCCc-eEeeecccch
Confidence            89999999863 2211    2224679999999999999999999999 89999999999999999995 9999999997


Q ss_pred             ccc-cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          234 VLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       234 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .-. .+....++||||.|.|||++. ...|+.++|+|.+||++|||++|+.||...+....+..|...            
T Consensus       317 E~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------------  383 (516)
T KOG0690|consen  317 EEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------------  383 (516)
T ss_pred             hcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh------------
Confidence            643 344556789999999999995 456999999999999999999999999998888777776642            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCCCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPN  375 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  375 (422)
                           +++|            +..++++++.|+..+|..||.+|+     .|.|+.+|+||..+++..
T Consensus       384 -----d~kF------------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  384 -----DLKF------------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             -----hccC------------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                 3333            367999999999999999999998     478999999999988643

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.3e-46  Score=355.27  Aligned_cols=244  Identities=27%  Similarity=0.435  Sum_probs=199.2

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||++++++|.     ...++++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence            46999999999999999999999999986432       22346999999999999999998873     3345889999


Q ss_pred             cchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC-
Q 014595          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  238 (422)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~-  238 (422)
                      |+++ ++...+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...... 
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            9985 5543333    24578999999999999999999999 8999999999999999887 6999999998754222 


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E  211 (323)
T ss_pred             CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            222345789999999998654 5899999999999999999999999887766555444321                 1


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccC
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~  372 (422)
                      ..            ++..+++++.+||.+||..||.+|+     ++.++++||||.+..
T Consensus       212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CC------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            11            1245789999999999999999998     899999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-46  Score=360.92  Aligned_cols=253  Identities=32%  Similarity=0.549  Sum_probs=207.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||+||+|++..+|+.||||++....       ....+|++++..++|+||+++++++     ....++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence            4999999999999999999999999999999986432       2345799999999999999999887     334458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ +|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~  150 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADG-HIKLADFGLCKK  150 (350)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence            899999974 66555543    2678999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCC------------------------------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014595          235 LVKGE------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  284 (422)
Q Consensus       235 ~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~p  284 (422)
                      .....                              ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence            54332                              12345689999999999665 589999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-HHHHh
Q 014595          285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEAC  363 (422)
Q Consensus       285 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-~~e~l  363 (422)
                      |.+.+......++.....               .+.+|.          ...+++++.+||.+||. ||.+|++ +.+++
T Consensus       230 f~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll  283 (350)
T cd05573         230 FYSDTLQETYNKIINWKE---------------SLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK  283 (350)
T ss_pred             CCCCCHHHHHHHHhccCC---------------cccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence            998876665555543110               111111          02368999999999998 9999999 99999


Q ss_pred             cCCcccccCC
Q 014595          364 VHPFFDELRD  373 (422)
Q Consensus       364 ~hp~f~~~~~  373 (422)
                      +||||+++..
T Consensus       284 ~hp~~~~~~~  293 (350)
T cd05573         284 SHPFFKGIDW  293 (350)
T ss_pred             cCCCcCCCCH
Confidence            9999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.6e-46  Score=361.00  Aligned_cols=254  Identities=28%  Similarity=0.486  Sum_probs=207.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++     ....+
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~~~  117 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDDKY  117 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCE
Confidence            46999999999999999999999999999999985421       2345799999999999999999887     33446


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+++ +|..++..     ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~  190 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCC-CEEEEecccee
Confidence            8899999974 66665543     458899999999999999999999 8999999999999999887 69999999997


Q ss_pred             ccccCC--CcccccccccccchhhhcCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGE--PNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ......  ......||+.|+|||++.+.   ..++.++|||||||++|||++|++||.+.+....+.++.....      
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~------  264 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN------  264 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC------
Confidence            654322  12345789999999998643   2478999999999999999999999998877666666543110      


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCC--cCCHHHHhcCCcccccC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELR  372 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~  372 (422)
                               .+.++.          ...++.++++||++||+.+|.+  |+|++++++||||+...
T Consensus       265 ---------~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         265 ---------SLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             ---------cCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence                     111111          1247899999999999999998  99999999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=351.44  Aligned_cols=245  Identities=31%  Similarity=0.469  Sum_probs=199.6

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeE-EEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEI-VAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~-vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ..+.+.||.|+||+||+|.++  |+. ||||++....      ..+.+|+.+|.+++|||||++++++.....    .++
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~  116 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLC  116 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceE
Confidence            445556999999999999986  556 9999986532      356789999999999999999999844331    478


Q ss_pred             EEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-ceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g-ivHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +||||++ |+|..++...  ....++...+..++.||+.||+|||+ .+ ||||||||+|||++.+...+||+|||+++.
T Consensus       117 iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            9999998 4776766543  35789999999999999999999999 89 999999999999998853699999999987


Q ss_pred             cccC-CCcccccccccccchhhhcC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          235 LVKG-EPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       235 ~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .... .......||+.|||||++.+ ...|+.++||||||+++|||+||+.||.+.........+.....+|.       
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~-------  266 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP-------  266 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-------
Confidence            6544 33344789999999999974 35699999999999999999999999999887544444443221111       


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                          ++..+++.+..|+.+||..||.+||+..+++.
T Consensus       267 --------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  267 --------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             --------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                12347899999999999999999999988764

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.3e-45  Score=344.92  Aligned_cols=285  Identities=35%  Similarity=0.614  Sum_probs=221.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.+++.+. |+||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            4999999999999999999999999999999875432      23457999999995 6999999988855444344567


Q ss_pred             EEEeecchhHHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++|||+++++.+.+...... ...+++..++.++.||+.||.|||+ .||+||||||+||+++.+...+||+|||++..
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999998877766543322 3568999999999999999999999 89999999999999998344799999999875


Q ss_pred             cccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          235 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       235 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ..... ......+++.|+|||++.+...++.++|+|||||++|+|++|..||.+.+....+.++...++.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            43221 12233568889999998765668999999999999999999999999998888888888877777655443221


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                      .......++......... ..+.++.++.+||.+||..||.+|||+.|++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            111111122211111111 1245789999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.6e-45  Score=350.00  Aligned_cols=277  Identities=29%  Similarity=0.519  Sum_probs=206.3

Q ss_pred             eeeeeecCCeeEEEEEEcC--CCeEEEEEEeccch--hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           87 EHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~--~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      ...||+|+||+||+|++..  ++..||+|.+....  ....+|+++++.++||||+++++++...   ....++++|||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence            3679999999999999754  56899999886542  2456899999999999999999987542   234578999999


Q ss_pred             hhHHHHHHHHhhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEc----CCCCcEEEeecCCcc
Q 014595          163 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAK  233 (422)
Q Consensus       163 ~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~----~~~~~vkl~DfG~a~  233 (422)
                      ++++...+.....     ....+++..++.++.||+.||.|||+ .||+||||||+|||+.    .++ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence            9887766643221     12358889999999999999999999 8999999999999994    334 69999999997


Q ss_pred             ccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHH
Q 014595          234 VLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKV  300 (422)
Q Consensus       234 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---------~~~~~~i~~~  300 (422)
                      .......    .....+|+.|+|||++.+...++.++|||||||++|||+||++||.....         ..++..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            6543221    23456789999999997766689999999999999999999999975432         3456677777


Q ss_pred             hCCCCHHHHhhcCc--CCcc----CcCCCCCCCCc---ccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          301 LGTPTREEIKCMNP--NYTE----FKFPQIKPHPW---HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       301 ~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      ++.+....+.....  .+..    +..........   ........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            77776655543211  1100    00000000000   001112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.3e-45  Score=347.45  Aligned_cols=282  Identities=35%  Similarity=0.577  Sum_probs=223.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||.|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++|+||+++++++...   ....+
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~~   83 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDSI   83 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCeE
Confidence            45999999999999999999999999999999885321      1234799999999999999999987432   22346


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++||||+++++..++...   ...+++..+..++.||+.||.|||+ .|++||||||+||+++.++ .+||+|||++...
T Consensus        84 ~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~  158 (309)
T cd07845          84 FLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKG-CLKIADFGLARTY  158 (309)
T ss_pred             EEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccceeeec
Confidence            799999998776666542   2568999999999999999999999 8999999999999999877 6999999999766


Q ss_pred             ccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 014595          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  313 (422)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  313 (422)
                      .... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.+....+.... 
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            4332 22233457889999998776668999999999999999999999999999999999999888887765544321 


Q ss_pred             -cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          314 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       314 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                       +....+..+......+...+ ...++++.+||++||++||++|||+.++++||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             ccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence             11122222221111111111 23688999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-45  Score=359.66  Aligned_cols=257  Identities=28%  Similarity=0.486  Sum_probs=207.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++||||+++++++     ....+
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~~  117 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDDKY  117 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            4599999999999999999999999999999998542       22345799999999999999999988     33446


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+++ +|..++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~  190 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHG-HLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEEecccce
Confidence            8899999974 67665543     458899999999999999999999 8999999999999999887 69999999997


Q ss_pred             ccccCCC--cccccccccccchhhhcCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .......  ....+||+.|+|||++.+..   .++.++|+|||||++|+|++|+.||.+.+....+.++.....      
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~------  264 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN------  264 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc------
Confidence            6533221  23557899999999986432   378899999999999999999999998887666666554211      


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCC--cCCHHHHhcCCcccccCCCC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~~  375 (422)
                               .+.+|.          ...++..+++||.+||+.++.+  |+|+.|+++||||+.....+
T Consensus       265 ---------~~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~~  314 (370)
T cd05621         265 ---------SLNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNW  314 (370)
T ss_pred             ---------ccCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcCh
Confidence                     111111          0246899999999999866654  89999999999998754433

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.7e-45  Score=352.49  Aligned_cols=248  Identities=28%  Similarity=0.477  Sum_probs=200.5

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHH---HHcCCCCcccccceeecCCCCCce
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIM---QMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      |.+.+.||+|+||.||+|.+..+|+.||||++.+..       ....+|++++   +.++||||+++++++.     ...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence            678999999999999999999999999999986432       2233455554   4568999999999883     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ++|+||||+++ ++...+.     ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEG-FVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence            58899999986 4433322     3578999999999999999999999 8999999999999999887 6999999998


Q ss_pred             ccccc-CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          233 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       233 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      +.... ........|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...           
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----------  216 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-----------  216 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence            75322 2223456789999999998654 5899999999999999999999999988766665554431           


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                            ...            ++..+++++.+||.+||+.||.+||     ++.++++||||+++..
T Consensus       217 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         217 ------EVR------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             ------CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence                  001            1235789999999999999999999     7999999999988643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.2e-45  Score=353.36  Aligned_cols=284  Identities=32%  Similarity=0.573  Sum_probs=223.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|.+.+.||+|+||.||+|++..+|+.||||.+.+.      .....+|+.+++.++|+||++++++|..... .+..+
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            4599999999999999999999999999999988542      1233479999999999999999998753322 23345


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .++||||+.+++...+..      .+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus        96 ~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~  167 (353)
T cd07850          96 VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  167 (353)
T ss_pred             EEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCcccee
Confidence            789999999877665432      38888999999999999999999 8999999999999999887 699999999986


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+......++...++.|+.+.+..+..
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         168 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            6444333445678899999999664 489999999999999999999999999988888899988888887765444322


Q ss_pred             CCccC--cCCCCCCCCccccc------------ccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          315 NYTEF--KFPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       315 ~~~~~--~~~~~~~~~~~~~~------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      ....+  ..+.....++...+            ....+..+++||.+||+.||++|||+.|+|+||||+...++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~  320 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP  320 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence            11111  00111111111111            12346779999999999999999999999999999976554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.7e-45  Score=351.86  Aligned_cols=245  Identities=30%  Similarity=0.508  Sum_probs=199.0

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||+||+|+++.+++.||||++.+..       .....|..++..+ +||||+++++++.     ....+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEE
Confidence            36999999999999999999999999986432       2234677888776 7999999999883     334578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc-
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~-  237 (422)
                      ||+++ +|...+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence            99985 55444432    4578999999999999999999999 8999999999999999887 699999999875422 


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-----------------  211 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-----------------  211 (320)
T ss_pred             CCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            223345678999999999865 45899999999999999999999999988776665555431                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH------HHHhcCCcccccCC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  373 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~------~e~l~hp~f~~~~~  373 (422)
                      ...            ++..++.++.+||++||+.||.+|+++      +++++||||+.+..
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         212 EVV------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             CCC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            011            123478999999999999999999998      89999999988653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-45  Score=344.87  Aligned_cols=255  Identities=24%  Similarity=0.371  Sum_probs=205.2

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      |++.+.||+|+||+||+|.+..+++.||||++....       ....+|+.+++.++|+||+++++++.     ...+++
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   76 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeEE
Confidence            889999999999999999999999999999886422       22347999999999999999988873     334588


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+.+ ++...+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~  152 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYG-HIRISDLGLAVEI  152 (285)
T ss_pred             EEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCC-CEEEeeCCCceec
Confidence            99999975 555444321  23568999999999999999999999 8999999999999999877 6999999999876


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..........+++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+...+....          
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  221 (285)
T cd05605         153 PEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----------  221 (285)
T ss_pred             CCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----------
Confidence            444433455789999999999654 589999999999999999999999987665444333332211000          


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                                     ..++..++..+.+||.+||..||.+||     +++++++||||.....
T Consensus       222 ---------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05605         222 ---------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF  269 (285)
T ss_pred             ---------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence                           001235789999999999999999999     9999999999988543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.7e-45  Score=345.34  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=198.3

Q ss_pred             eeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      ||+|+||+||+|.+..+|+.||+|++....       .....|+++++.++|+||+++.+++.     ....+++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence            699999999999999999999999986432       22346999999999999999988873     334578999999


Q ss_pred             hh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCC-
Q 014595          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  240 (422)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~-  240 (422)
                      ++ +|...+.........+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            85 6655554433344678999999999999999999999 8999999999999999877 699999999876544322 


Q ss_pred             cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCc
Q 014595          241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  320 (422)
Q Consensus       241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  320 (422)
                      .....+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||...........+...+...             .. 
T Consensus       154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~-  218 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-------------SV-  218 (280)
T ss_pred             ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-------------CC-
Confidence            2345789999999999654 58999999999999999999999997654322222222111000             00 


Q ss_pred             CCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       321 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                                 .++..+++++.+|+.+||+.||++|+     |++++++||||++..+
T Consensus       219 -----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         219 -----------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             -----------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence                       12245789999999999999999999     8899999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.7e-46  Score=355.07  Aligned_cols=245  Identities=28%  Similarity=0.437  Sum_probs=198.0

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +.||+|+||+||+|++..+|+.||+|++....       ....+|+++++.++||||+++++++.     ...++++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-----~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----cCCEEEEEEe
Confidence            46999999999999999999999999986432       22346889999999999999988873     3345889999


Q ss_pred             cchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc-C
Q 014595          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G  238 (422)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~-~  238 (422)
                      |+++ ++...+.    ....+++..++.++.||+.||.|||+..||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG  150 (325)
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCC
Confidence            9985 4433332    2457899999999999999999999525999999999999999887 699999999875432 2


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...                 .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~  212 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  212 (325)
T ss_pred             cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            223345789999999999654 5899999999999999999999999887765544443221                 1


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccC
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~  372 (422)
                      ..            ++..+++++.+||.+||+.||++|+     ++.++++||||.++.
T Consensus       213 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         213 IR------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             CC------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            11            1245789999999999999999997     899999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.9e-46  Score=363.04  Aligned_cols=252  Identities=27%  Similarity=0.460  Sum_probs=201.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .|++.+.||+|+||+||+|++..+++.||||++.+.       .....+|+++++.++|+||+++++.+.     ...++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCEE
Confidence            499999999999999999999999999999998542       223457999999999999999998883     33458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ +|.+++..    .+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|..
T Consensus        77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence            899999974 66665543    3568899999999999999999999 8999999999999999887 699999999753


Q ss_pred             cccC--------------------------------------------CCcccccccccccchhhhcCCCCCCCcchHHH
Q 014595          235 LVKG--------------------------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWS  270 (422)
Q Consensus       235 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  270 (422)
                      +...                                            ......+||+.|+|||++.+. .++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence            2100                                            001134689999999999654 4899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhh
Q 014595          271 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ  350 (422)
Q Consensus       271 lG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  350 (422)
                      |||++|+|++|+.||.+.+..+....+....               ..+.++.          ...+++++.+||.+|+ 
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~----------~~~~s~~~~~li~~l~-  283 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVINWE---------------TTLHIPS----------QAKLSREASDLILRLC-  283 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHhccC---------------ccccCCC----------CCCCCHHHHHHHHHHh-
Confidence            9999999999999998887665554443210               0001110          1357899999999976 


Q ss_pred             cCCCCcC---CHHHHhcCCcccccC
Q 014595          351 YSPNLRC---TALEACVHPFFDELR  372 (422)
Q Consensus       351 ~dP~~R~---t~~e~l~hp~f~~~~  372 (422)
                      .+|.+|+   |+.++++||||+.+.
T Consensus       284 ~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         284 CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            5999999   999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.6e-46  Score=356.36  Aligned_cols=255  Identities=27%  Similarity=0.473  Sum_probs=207.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||+||+|++..+|+.||||++....       ....+|+.+++.++|+||+++++++.     ...++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeE
Confidence            4999999999999999999999999999999986532       23457899999999999999988873     33458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ +|.+++...   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~  151 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTG-HIKLADFGSAAR  151 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence            899999974 666655542   3578999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCCc--ccccccccccchhhhcC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          235 LVKGEPN--VSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       235 ~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      .......  ....+|+.|+|||++..     ...++.++|||||||++|+|++|..||.+.+....+.++....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------  225 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ------  225 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC------
Confidence            6433322  23468999999999853     3457899999999999999999999998887766666554321      


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                               ....++.          ...+++++.+||.+||+ ||.+|+|+.++++||||+.+..
T Consensus       226 ---------~~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~  271 (330)
T cd05601         226 ---------RFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW  271 (330)
T ss_pred             ---------CccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence                     0011111          12478999999999998 9999999999999999998654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.2e-45  Score=349.72  Aligned_cols=316  Identities=34%  Similarity=0.624  Sum_probs=238.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||.|+||+||+|++..+++.||||.+...      .....+|+.+++.++|+||+++++++.........+++
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            599999999999999999999999999999987542      12334799999999999999999987544433445578


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +++||+++++...+..    ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||++....
T Consensus        86 lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~  159 (337)
T cd07858          86 IVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANC-DLKICDFGLARTTS  159 (337)
T ss_pred             EEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECcCccccccC
Confidence            9999999877655543    3578999999999999999999999 8999999999999999887 69999999997654


Q ss_pred             cC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .. .......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+....+..+....+.+..+.+......
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            33 22234567889999999865455899999999999999999999999998888888888888888776655332211


Q ss_pred             -CccC--cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCC
Q 014595          316 -YTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP  392 (422)
Q Consensus       316 -~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  392 (422)
                       ...+  ..+.....++.. ..+.+++++.+||++||+.||++|||+.++++||||..++++......    +..+.++ 
T Consensus       240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~----~~~~~~~-  313 (337)
T cd07858         240 KARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVC----QTPFSFD-  313 (337)
T ss_pred             hhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccC----CCccchh-
Confidence             0000  011111111111 124678999999999999999999999999999999998776532221    1112222 


Q ss_pred             CCCCCCChhHHhhhCcHH
Q 014595          393 PELSGIPPETINRLIPEH  410 (422)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~  410 (422)
                      .+..++..+.+++++-.+
T Consensus       314 ~~~~~~~~~~~~~~~~~~  331 (337)
T cd07858         314 FEEDALTEEDIKELIYNE  331 (337)
T ss_pred             hhhhhcCHHHHHHHHHHH
Confidence            223335555666555444

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.8e-45  Score=341.38  Aligned_cols=276  Identities=40%  Similarity=0.756  Sum_probs=226.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..     ..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence            4899999999999999999999899999999886432      234579999999999999999998833     44578


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+...   ...+++..++.++.||+.||+|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            99999977887766542   2568999999999999999999999 8999999999999999877 69999999987664


Q ss_pred             cCCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 014595          237 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  313 (422)
Q Consensus       237 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  313 (422)
                      ....  .....++..|+|||++.+...++.++||||+||++|+|++|.+||.+.+....+..+...++.+....+.... 
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            4331  2345678899999998766667999999999999999999999999988888888888888888776655432 


Q ss_pred             -cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          314 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       314 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                       .++....++.....++...+ +..+.++.+||.+||..||++|||++++++||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             22333344444444444333 45679999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=352.84  Aligned_cols=250  Identities=26%  Similarity=0.443  Sum_probs=207.1

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .|+...+||+|+||.||+|.+..+++.||||++.-+.     ...++|+.+|..++++||.++++.|+....     +++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lwi   88 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LWI   88 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HHH
Confidence            4888899999999999999999999999999986432     344689999999999999999999865443     889


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||.+ ++.++++.    ...+.+..+..++++++.||.|||. .+.+|||||+.|||+..++ .+||+|||.+..+.
T Consensus        89 iMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESG-DVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccC-cEEEEecceeeeee
Confidence            9999985 55555443    3445888888999999999999999 8999999999999999886 79999999997765


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .... ..+++|||+|||||++.+ ..|+.++||||||++.+||++|.+|+.....+..+.                    
T Consensus       163 ~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--------------------  221 (467)
T KOG0201|consen  163 NTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--------------------  221 (467)
T ss_pred             chhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--------------------
Confidence            4433 367899999999999974 459999999999999999999999998766532222                    


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                          -+|.-.+..+    ...+++.+++||..||.+||+.||+|.++|+|+|++...
T Consensus       222 ----lIpk~~PP~L----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  222 ----LIPKSAPPRL----DGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             ----eccCCCCCcc----ccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence                2222222222    235789999999999999999999999999999998743

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=380.48  Aligned_cols=258  Identities=29%  Similarity=0.480  Sum_probs=221.1

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ...+|.++++||+|+||.|.+++++.|++.||+|++.+.       ...+..|..+|-.-+.+-|+.++..|     .+.
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~  147 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE  147 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence            345799999999999999999999999999999988652       34556799999999999999999988     677


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      .|+|+||||++| +|..++..+    ..+|+.+++.|+..|+.||.-||+ .|+|||||||+|||||..|| +||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GH-ikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGH-IKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCc-Eeeccchh
Confidence            789999999985 776666654    379999999999999999999999 99999999999999999996 99999999


Q ss_pred             ccccccCCC--cccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          232 AKVLVKGEP--NVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       232 a~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      |-.+..+..  ....+|||.|++||++..    ...|+..+|+||+||++|||+.|..||+..+-.+++-+|+..-    
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk----  297 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK----  297 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence            877654433  245789999999999842    2568999999999999999999999999999999999998741    


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC---HHHHhcCCcccccCCC
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDP  374 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~~~  374 (422)
                                 ..+.||+.          ..+|+++++||+++++ +|+.|+.   ++++.+||||.++.+.
T Consensus       298 -----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  298 -----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             -----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence                       23455531          2489999999999887 4888888   9999999999998763

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.2e-45  Score=349.82  Aligned_cols=250  Identities=27%  Similarity=0.442  Sum_probs=202.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCC-CcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~~~~  154 (422)
                      +|.+.+.||+|+||.||+|++..+++.||||++.+..       .....|++++..+.|+ +|+.+++++.     ...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence            3899999999999999999999999999999986432       2234688889999765 5777877773     2335


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+++ +|...+..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEG-HIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence            7899999975 55444432    3568899999999999999999999 8999999999999999887 69999999986


Q ss_pred             cccc-CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       234 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .... ........||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+...            
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------  216 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------  216 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence            4322 2233355789999999999654 4899999999999999999999999988776666555431            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH-----HHHhcCCcccccCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  373 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~  373 (422)
                           ...            ++..+++++.+||++||..||.+|+++     .++++||||+.+..
T Consensus       217 -----~~~------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         217 -----NVS------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             -----CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                 011            123578999999999999999999976     89999999988643

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-45  Score=352.13  Aligned_cols=245  Identities=27%  Similarity=0.453  Sum_probs=195.7

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-------hHHHHHH-HHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||+||+|++..+|+.||||++.....       ...+|.. +++.++||||+++++++.     ....+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence            469999999999999999999999999864321       1123333 567899999999998873     334578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ ++...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus        76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            99985 5544433    24678999999999999999999999 8999999999999999887 6999999998754222


Q ss_pred             -CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------------  211 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-----------------  211 (323)
T ss_pred             CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             223345789999999998654 4899999999999999999999999887766655554431                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH----HHHhcCCcccccCC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  373 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f~~~~~  373 (422)
                      ...            ++..+++.+.+||++||+.||.+||++    .++++||||..+..
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         212 PLR------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             CCC------------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            000            123578999999999999999999987    69999999987643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-46  Score=353.38  Aligned_cols=253  Identities=26%  Similarity=0.453  Sum_probs=221.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .|..++.+|+|+||.+++++++..++.|++|.+.-.      ++...+|+.+++++.|||||.+++.|.    .++.+++
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l~   80 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLLC   80 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceEE
Confidence            499999999999999999999999999999998532      234568999999999999999999884    4555699


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      |||+||+| ++.+.+....  +..+++..+..|+.|++.|+.|||+ .+|+|||||+.||+++.++ .|||+|||+|+.+
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDK-KVKLGDFGLAKIL  156 (426)
T ss_pred             EEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccC-ceeecchhhhhhc
Confidence            99999995 6666666544  5779999999999999999999998 8999999999999999988 5899999999998


Q ss_pred             ccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      .+.. ...+.+||+.||+||++.+. .|+.|+|||||||++|||++=+++|.+.+....+.+|.+....|          
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P----------  225 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP----------  225 (426)
T ss_pred             CCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC----------
Confidence            7776 66788999999999999654 59999999999999999999999999999888888888754322          


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                        .+...+.+++.||+.||..+|..||++.++|.+|.++...
T Consensus       226 ------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  226 ------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             ------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence                              1245789999999999999999999999999999998543

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.5e-45  Score=348.23  Aligned_cols=245  Identities=29%  Similarity=0.502  Sum_probs=196.8

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHH-cCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||+||+|++..+++.||||++....       .....|..++.. ++||||+++++++.     ...++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986532       223357777775 49999999998873     233588999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ +|...+..    ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence            99974 66555443    3568899999999999999999999 8999999999999999887 6999999998754222


Q ss_pred             -CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-----------------  211 (316)
T ss_pred             CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------
Confidence             223456789999999998654 4899999999999999999999999887765554443221                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHH-HHhcCCcccccCC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD  373 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-e~l~hp~f~~~~~  373 (422)
                      ...            ++..++.++++||.+||+.||.+|+++. ++++||||+.+..
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         212 NPC------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             CCC------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence            000            1234688999999999999999999996 8999999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.6e-45  Score=349.84  Aligned_cols=244  Identities=30%  Similarity=0.493  Sum_probs=198.9

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||.||+|++..+++.||||++....       .....|.+++..+ +||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence            36999999999999999999999999986532       1234688888766 8999999999883     334578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ +|...+.    ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus        76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence            99985 5544443    24578999999999999999999999 8999999999999999887 6999999998754322


Q ss_pred             -CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-----------------  211 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-----------------  211 (321)
T ss_pred             CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             223445789999999998654 5899999999999999999999999988877666665431                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-------CHHHHhcCCcccccC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-------TALEACVHPFFDELR  372 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-------t~~e~l~hp~f~~~~  372 (422)
                      ...            ++..++.++.+||.+||+.||++|+       ++.++++||||..+.
T Consensus       212 ~~~------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         212 DVL------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence            111            1234689999999999999999999       999999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.9e-45  Score=352.18  Aligned_cols=254  Identities=30%  Similarity=0.468  Sum_probs=199.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEc---CCCeEEEEEEeccch--------hhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      +|++.+.||+|+||+||+|++.   .+++.||+|++.+..        ....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            3899999999999999999874   478999999986421        2234689999999 599999998887     3


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeec
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      ...++++||||+++ ++...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEG-HVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCC-CEEEeeC
Confidence            33457899999985 55444432    3578999999999999999999999 8999999999999999887 6999999


Q ss_pred             CCccccccCC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          230 GSAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       230 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      |+++......  ......||+.|+|||++.+...++.++|||||||++|+|+||..||...........+...+.     
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----  224 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-----  224 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-----
Confidence            9997653332  223457899999999997665688999999999999999999999975432211111111100     


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~  372 (422)
                         ...                 ..++..+++.+.+||.+||+.||++||     +++++++||||++..
T Consensus       225 ---~~~-----------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         225 ---KCD-----------------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             ---cCC-----------------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence               000                 012245789999999999999999999     889999999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.4e-45  Score=356.65  Aligned_cols=253  Identities=28%  Similarity=0.461  Sum_probs=203.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||+||+|++..+++.||||++....       ....+|+.++..++|+||+++++.+     ....++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            4899999999999999999999999999999986421       2345699999999999999999887     334458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ +|...+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~-~vkL~DfG~~~~  150 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG  150 (360)
T ss_pred             EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence            899999985 56555443    3578999999999999999999999 8999999999999999887 699999999864


Q ss_pred             cccCC------------------------------------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHH
Q 014595          235 LVKGE------------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  278 (422)
Q Consensus       235 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  278 (422)
                      .....                                    .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel  229 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence            42110                                    01235789999999999654 489999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-
Q 014595          279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-  357 (422)
Q Consensus       279 ltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-  357 (422)
                      ++|++||.+.+....+.++....               ....+|.          ...+++++++||.+|+ .||.+|+ 
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~~  283 (360)
T cd05627         230 LIGYPPFCSETPQETYRKVMNWK---------------ETLVFPP----------EVPISEKAKDLILRFC-TDSENRIG  283 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCC---------------CceecCC----------CCCCCHHHHHHHHHhc-cChhhcCC
Confidence            99999999887766665554311               0011111          0136889999999987 4999998 


Q ss_pred             --CHHHHhcCCcccccCC
Q 014595          358 --TALEACVHPFFDELRD  373 (422)
Q Consensus       358 --t~~e~l~hp~f~~~~~  373 (422)
                        ++.++++||||+++.+
T Consensus       284 ~~~~~ei~~hp~f~~~~~  301 (360)
T cd05627         284 SNGVEEIKSHPFFEGVDW  301 (360)
T ss_pred             CCCHHHHhcCCCCCCCCH
Confidence              4899999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-44  Score=356.69  Aligned_cols=275  Identities=25%  Similarity=0.338  Sum_probs=205.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      ...|.+.+.||+|+||.||+|++..+++.||||....  ....+|++++++|+|+|||++++++..     ....++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence            3459999999999999999999999999999996432  335689999999999999999998732     334779999


Q ss_pred             cchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCC
Q 014595          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  240 (422)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~  240 (422)
                      ++.+++...+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.......
T Consensus       241 ~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        241 KYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWS  315 (461)
T ss_pred             ccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCC-CEEEcccCCceecccccc
Confidence            9988776655432   2468999999999999999999999 8999999999999999877 699999999976533221


Q ss_pred             ---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCHHH--
Q 014595          241 ---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREE--  308 (422)
Q Consensus       241 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~-------~~~~~~~i~~~~~~~~~~~--  308 (422)
                         .....||+.|+|||++.+. .++.++|||||||++|||++|..++....       ...++.++++..+....+.  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence               1235689999999999665 48999999999999999999876543221       1344555554433221110  


Q ss_pred             ------HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          309 ------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       309 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                            .............+......|....  .++.++.+||++||++||.+|||+.|+|+||||+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYY--KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhc--cccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                  0000000000111112222333322  46788999999999999999999999999999974

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-44  Score=340.75  Aligned_cols=282  Identities=37%  Similarity=0.648  Sum_probs=222.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh---------hHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      +|.+.+.||.|+||.||+|.+..+|+.||||.+.....         ....|+++++.++|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence            38889999999999999999998999999999864321         23469999999999999999998833     44


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +.++||||+.+++..++...   ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCC-CEEEccceeee
Confidence            58899999977776666532   1368999999999999999999999 8999999999999999887 69999999997


Q ss_pred             ccccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          234 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       234 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ....... .....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++....+.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            6644322 223456788999999866666899999999999999999999999988888888888887777766555432


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      ...............+.... ....+..+.+||.+||..||++|||+.|+++||||++...+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQI-FPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccccccccccCCcchhhh-cccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            11111111111111222222 245688999999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.6e-45  Score=348.30  Aligned_cols=244  Identities=31%  Similarity=0.494  Sum_probs=197.9

Q ss_pred             eeeeecCCeeEEEEEEc---CCCeEEEEEEeccch--------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           88 HVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +.||+|+||.||+|++.   .+++.||||++....        ....+|+.+++.++||||+++++++..     ...++
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeEE
Confidence            57999999999999864   468999999986421        223479999999999999999988832     33578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ +|...+..    ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus        77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (323)
T cd05584          77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQG-HVKLTDFGLCKES  150 (323)
T ss_pred             EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence            99999985 55444432    4568888999999999999999999 8999999999999999887 6999999998754


Q ss_pred             ccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+....+..+...              
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--------------  215 (323)
T cd05584         151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--------------  215 (323)
T ss_pred             ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence            322 223345789999999998654 4889999999999999999999999988766655554431              


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~  372 (422)
                         ...            ++..+++++.+||++||+.||++|+     ++.++++||||....
T Consensus       216 ---~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         216 ---KLN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             ---CCC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence               111            1235789999999999999999999     899999999998753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.3e-44  Score=347.49  Aligned_cols=276  Identities=25%  Similarity=0.427  Sum_probs=205.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|.+.+.||+|+||.||+|++..+|..||+|.+....     ..+.+|+++++.++||||+++++++..     ...++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   79 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS   79 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEEE
Confidence            46999999999999999999999999999999886431     335689999999999999999998843     23478


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ +|.+++..    ...+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  154 (331)
T cd06649          80 ICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  154 (331)
T ss_pred             EEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcccccc
Confidence            99999985 66665543    356899999999999999999999723699999999999999887 6999999998765


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh----
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC----  311 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----  311 (422)
                      ... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+. ..+   ++.+.......    
T Consensus       155 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~---~~~~~~~~~~~~~~~  228 (331)
T cd06649         155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAI---FGRPVVDGEEGEPHS  228 (331)
T ss_pred             ccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH---hcccccccccCCccc
Confidence            332 23345789999999999654 589999999999999999999999987665432 222   12111000000    


Q ss_pred             cCcCC----ccCcCCCCCCCC---------------cccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          312 MNPNY----TEFKFPQIKPHP---------------WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       312 ~~~~~----~~~~~~~~~~~~---------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      ..+..    ...........+               ....-...+++++++||.+||++||++|||+.++++||||+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence            00000    000000000000               00000124688999999999999999999999999999998754


Q ss_pred             C
Q 014595          373 D  373 (422)
Q Consensus       373 ~  373 (422)
                      .
T Consensus       309 ~  309 (331)
T cd06649         309 V  309 (331)
T ss_pred             c
Confidence            3

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.1e-45  Score=348.10  Aligned_cols=250  Identities=27%  Similarity=0.420  Sum_probs=202.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +|.+.+.||+|+||.||+|++..+++.||||++.+..       .....|..++..+ .|++|+.+++++.     ....
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence            3889999999999999999999999999999986532       1223577777777 5788888988873     3345


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+++ +|...+..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence            7899999974 55444432    3568999999999999999999999 8999999999999999887 69999999987


Q ss_pred             cccc-CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       234 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .... ........||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.+..+.+..+...            
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------  216 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------  216 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence            5432 2233356789999999999654 5899999999999999999999999988776666655441            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  373 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  373 (422)
                           ...            ++..++.++.+||.+||+.||.+|++     ..++++||||+.+.+
T Consensus       217 -----~~~------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         217 -----NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             -----CCC------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence                 111            12357899999999999999999998     489999999987653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-46  Score=328.28  Aligned_cols=259  Identities=30%  Similarity=0.474  Sum_probs=208.7

Q ss_pred             eeEEe-eeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEee
Q 014595           83 SYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        83 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +|.+. ++||-|-.|+|..|.++.||+.+|+|++.. ....++|+++.-.. .|||||.++++|.... .+..++.+|||
T Consensus        62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVmE  139 (400)
T KOG0604|consen   62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVME  139 (400)
T ss_pred             hheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeeee
Confidence            46653 579999999999999999999999997654 44456899886665 6999999999985444 45667889999


Q ss_pred             cchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEEEeecCCcccccc
Q 014595          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLVK  237 (422)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vkl~DfG~a~~~~~  237 (422)
                      .++| .|..-+.  .+....++|.++..++.||+.|+.|||+ .+|.||||||+|+|.....  ..+||+|||+|+....
T Consensus       140 ~meGGeLfsriq--~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  140 CMEGGELFSRIQ--DRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             cccchHHHHHHH--HcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            9986 3322222  2335679999999999999999999999 9999999999999996432  3699999999998766


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHhhcC
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      .....+.+.||+|.|||++ |...|+..+|+||+||++|-||+|.+||.......    +-.+|..              
T Consensus       217 ~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~--------------  281 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT--------------  281 (400)
T ss_pred             CccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc--------------
Confidence            6666788899999999998 77789999999999999999999999998765321    1122222              


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                         +.|.||.   ..|     ..+|++++|+|+++|..+|.+|+|+.+++.|||+....
T Consensus       282 ---gqy~FP~---pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  282 ---GQYEFPE---PEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             ---cCccCCC---hhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence               2334443   123     45799999999999999999999999999999998754

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.5e-45  Score=354.01  Aligned_cols=257  Identities=28%  Similarity=0.477  Sum_probs=206.1

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++||||+++++++     ....
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~  116 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR  116 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence            34699999999999999999999999999999998542       12345789999999999999999887     3345


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ++++||||+++ +|..++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~-~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCC-CEEEEeCCce
Confidence            68899999974 66665543     458899999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCC--cccccccccccchhhhcCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          233 KVLVKGEP--NVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ........  ....+||+.|+|||++.+.   ..++.++|||||||++|||++|..||.+.+....+.++.....     
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-----  264 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-----  264 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            76543221  2355789999999998643   2378999999999999999999999998877666666543210     


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCC--cCCHHHHhcCCcccccCCC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDP  374 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~  374 (422)
                                .+.++.          ...++..+++||.+||..++.+  |++++++++||||++....
T Consensus       265 ----------~~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~  313 (371)
T cd05622         265 ----------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  313 (371)
T ss_pred             ----------cccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence                      011111          1357899999999999844443  7899999999999885443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.7e-45  Score=346.36  Aligned_cols=244  Identities=27%  Similarity=0.470  Sum_probs=196.1

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||.||+|+++.+|+.||+|++....       .....|..++..+ +||||+++++++.     ...++++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986532       2234577777654 8999999999883     344688999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc-
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~-  237 (422)
                      ||+.+ +|...+..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence            99985 55444432    3578999999999999999999999 8999999999999999887 699999999875322 


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-----------------  211 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-----------------  211 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------
Confidence            2223456789999999999654 4899999999999999999999999887765554443221                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH-HHHhcCCcccccC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELR  372 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-~e~l~hp~f~~~~  372 (422)
                      ...            ++..++.++++||++||+.||++|+++ +++++||||+.+.
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         212 TPH------------YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             CCC------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence            000            123468999999999999999999997 5888999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.1e-45  Score=348.93  Aligned_cols=245  Identities=27%  Similarity=0.499  Sum_probs=194.0

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||.||+|++..+++.||||++.+..       ....+|..+++.+ +||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence            46999999999999999999999999986432       2245788899888 7999999999883     334578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc-c
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K  237 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~-~  237 (422)
                      ||+++ +|...+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++... .
T Consensus        76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence            99985 5544333    24679999999999999999999999 8999999999999999887 69999999987532 2


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  309 (422)
                      .......+||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.....        .+.+.+.+..         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            3333456789999999999654 589999999999999999999999963211        1111111110         


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC------HHHHhcCCcccccC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELR  372 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t------~~e~l~hp~f~~~~  372 (422)
                             ....            ++..++.++.+||++||+.||.+|+|      +.++++||||..+.
T Consensus       220 -------~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~  269 (329)
T cd05588         220 -------KQIR------------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID  269 (329)
T ss_pred             -------CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence                   0011            22457899999999999999999997      78999999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-46  Score=343.75  Aligned_cols=259  Identities=27%  Similarity=0.395  Sum_probs=212.0

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ...|..-++||+||||.||-++.+.||+.||+|++.+.+       .....|..||.+++.+.||.+-..|.+...    
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~----  259 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA----  259 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc----
Confidence            346888999999999999999999999999999875432       222368999999999999999777744333    


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                       +|+||..|.| +|...+.+  .....+++..++.|+.+|+.||++||+ .+||+|||||+|||+|+.|| |+|+|+|+|
T Consensus       260 -LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~Gh-vRISDLGLA  334 (591)
T KOG0986|consen  260 -LCLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHGH-VRISDLGLA  334 (591)
T ss_pred             -eEEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCCC-eEeeccceE
Confidence             8899999986 44332322  223589999999999999999999999 89999999999999999985 999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ..+..+.+....+||..|||||++.+.. |+...|+|||||+||||+.|+.||........-.++-+.+...+       
T Consensus       335 vei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~-------  406 (591)
T KOG0986|consen  335 VEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP-------  406 (591)
T ss_pred             EecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch-------
Confidence            9999999888889999999999996654 99999999999999999999999976543332222222211111       


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  374 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  374 (422)
                            .            .++..+|+++++|++.+|+.||.+|+     ++.++.+||||++++..
T Consensus       407 ------~------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  407 ------E------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             ------h------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence                  0            12357899999999999999999998     57899999999998754

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.1e-44  Score=335.81  Aligned_cols=275  Identities=37%  Similarity=0.663  Sum_probs=213.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|++.+.||+|+||.||+|++..+|+.||+|++....      ....+|+.+++.++|+||+++++++.     ...+.+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEEE
Confidence            4999999999999999999999999999999875322      23457999999999999999999883     334578


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+   ......+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .+||+|||++....
T Consensus        77 ~v~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07847          77 LVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQG-QIKLCDFGFARILT  151 (286)
T ss_pred             EEEeccCccHHHHH---HhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCC-cEEECccccceecC
Confidence            99999997543322   2234568999999999999999999999 8999999999999999887 69999999998664


Q ss_pred             cCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ... ......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+.+..+.............
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            433 2234457888999999876666889999999999999999999999988877777777665554433222211110


Q ss_pred             --CccCcCCCCCC-CCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          316 --YTEFKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       316 --~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                        +.....+.... .++... .+.++..+.+||.+||+.||++|||+.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         232 QFFKGLSIPEPETREPLESK-FPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccccCCCcccccCHHHH-hccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              11111121111 111111 23578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=347.39  Aligned_cols=257  Identities=28%  Similarity=0.429  Sum_probs=204.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||+||+|++..+++.||||++.+.       ...+.+|+.+++.++|+||+++++++.     ...++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCeE
Confidence            599999999999999999999999999999998642       123457899999999999999999883     34458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ +|..++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  151 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNG-HIRLADFGSCLR  151 (331)
T ss_pred             EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence            899999974 66665543   24578999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCCCc--ccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          235 LVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       235 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .......  ....||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+.+..+.+..+.....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~------  225 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------  225 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------
Confidence            5433222  23468999999999853    34578899999999999999999999988776666555543110      


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCC--cCCHHHHhcCCcccccCC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  373 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~  373 (422)
                               .+.++.         ....++.++++||++||+.++++  |+++.++++||||..+..
T Consensus       226 ---------~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         226 ---------HFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             ---------cccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence                     011111         01247899999999999865554  789999999999987643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.7e-45  Score=347.09  Aligned_cols=245  Identities=29%  Similarity=0.494  Sum_probs=198.8

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||+||+|++..+++.||||++.+..       ....+|.++++.+ +||||+++++++.     ...++++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999986532       2234688888888 7999999999873     333588999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc-
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~-  237 (422)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence            99975 55444332    3579999999999999999999999 8999999999999999887 699999999865322 


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      .......++|+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+.......+...                 
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------  211 (318)
T ss_pred             CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            2223345689999999999654 4899999999999999999999999887765555444321                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH-----HHHhcCCcccccCC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  373 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~  373 (422)
                      ...            ++..++.++.+||++||+.||.+|||+     .++++||||+.+..
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         212 EVR------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             CCC------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            011            123578999999999999999999999     99999999988643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-46  Score=337.09  Aligned_cols=281  Identities=28%  Similarity=0.501  Sum_probs=220.5

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhH---HHHHHHHHHcCC--C----CcccccceeecCCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDH--P----NIVALKHCFFSTTDKE  151 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~---~~E~~~l~~l~h--~----nIv~l~~~~~~~~~~~  151 (422)
                      ..+|.+++.+|+|.||.|..+.+..++..||||+++.-.++.   .-|+++|+++.+  |    -+|.+.++|     +-
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            446999999999999999999999999999999886543332   359999999943  2    267777777     55


Q ss_pred             ceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC-----------
Q 014595          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-----------  220 (422)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~-----------  220 (422)
                      ..++|+|+|.++-++.+.+....  ...++...++.+++|++.+++|||+ .+++|-||||+|||+-+.           
T Consensus       163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence            66799999999988877776532  3679999999999999999999999 899999999999997321           


Q ss_pred             --------CCcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 014595          221 --------THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  292 (422)
Q Consensus       221 --------~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~  292 (422)
                              ...|||+|||.|+..  .+.....+.|..|+|||++++-+ ++.++||||+||||+|+.||...|++.++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    125999999999754  44557788999999999999866 9999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhhcC---------cCCccCcCCC------CCCCCcccccc--cCCChHHHHHHHhhhhcCCCC
Q 014595          293 QLVEIIKVLGTPTREEIKCMN---------PNYTEFKFPQ------IKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNL  355 (422)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~---------~~~~~~~~~~------~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~  355 (422)
                      +++.+..++|..+...+....         -+|.+-....      ....|+.....  ...-.++.|||++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            998888888977766554431         1111111110      01122222111  112345889999999999999


Q ss_pred             cCCHHHHhcCCcccccC
Q 014595          356 RCTALEACVHPFFDELR  372 (422)
Q Consensus       356 R~t~~e~l~hp~f~~~~  372 (422)
                      |+|+.|+|.||||+.+.
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998764

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-47  Score=325.92  Aligned_cols=283  Identities=32%  Similarity=0.525  Sum_probs=231.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--h----hhHHHHHHHHHHcCCCCcccccceeecCCC---CCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--K----RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~~~  153 (422)
                      .|.-..+||+|.||.||+|+.+.+|+.||+|++.-+  +    ....+|+.+|..|+|+|++.+++.+-....   ....
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            377788999999999999999999999999976431  1    123489999999999999999888744332   3445


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .+|+||.+|+.+|..++.+.   ..+++..+++.++.+++.||.|+|+ ..|+|||+|++|+||+.++ .+||+|||+++
T Consensus        98 t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dg-ilklADFGlar  172 (376)
T KOG0669|consen   98 TFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDG-ILKLADFGLAR  172 (376)
T ss_pred             eeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCc-eEEeecccccc
Confidence            68899999999888877653   3679999999999999999999999 7999999999999999988 79999999997


Q ss_pred             ccccCC-----CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGE-----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .+....     ..+..+.|.+|++||.+.|...|+.+.|||..||++.||.||.+.|++.+...++..|....|..+.+.
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            654332     123456699999999999999999999999999999999999999999999999999999999999888


Q ss_pred             HhhcC--cCCccCcCCCCCCCCccccc----ccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          309 IKCMN--PNYTEFKFPQIKPHPWHKVF----QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       309 ~~~~~--~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      |+.+.  +-|..+..+.......+.+-    +-.-.+++.||+.+||..||.+|++++++|+|-||..
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            87654  22333333322222222211    0112568999999999999999999999999999976

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.9e-44  Score=345.51  Aligned_cols=287  Identities=36%  Similarity=0.673  Sum_probs=229.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||.|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.... ....++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            35999999999999999999999999999999886431      23347999999999999999998774333 344567


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++||||+.+++.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence            89999998876555432    3568999999999999999999999 8999999999999999887 6999999998765


Q ss_pred             ccCCC-----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          236 VKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       236 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      .....     .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....|.|+...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            33221     1234678899999998665568999999999999999999999999998888888888888988876654


Q ss_pred             hcCcCCcc---CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCC
Q 014595          311 CMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (422)
Q Consensus       311 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  376 (422)
                      ........   -.++.....+|.... +..++++.++|++||+.||++|||+.+++.||||.....+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIF-PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHc-ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence            33211100   012222233333322 457899999999999999999999999999999998776553

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-44  Score=337.33  Aligned_cols=276  Identities=35%  Similarity=0.666  Sum_probs=215.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|++.+.||+|++|.||+|.++.+++.||||.+....     ....+|+++++.++|+||+++++++.     ...+.+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeEE
Confidence            35999999999999999999999899999999885432     23457999999999999999999873     334588


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+...   ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||+++...
T Consensus        80 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~  154 (291)
T cd07844          80 LVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence            99999998776655432   3468899999999999999999999 8999999999999999887 69999999986542


Q ss_pred             cCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ... ......++..|+|||++.+...++.++||||+||++|+|++|+.||.+.. ..+.+..+.+..+.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            211 11223467889999998766668999999999999999999999998765 5566777777777777665543321


Q ss_pred             --CCccCcCCCCCCCCcccccccCCC--hHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 --NYTEFKFPQIKPHPWHKVFQKRLP--PEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 --~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                        .+.....+.....+....+ ..++  .++.++|.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence              1222222222222211111 2334  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-44  Score=344.33  Aligned_cols=288  Identities=37%  Similarity=0.672  Sum_probs=232.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||.|+||.||+|++..+++.||||++....      ....+|+.+++.++|+||+++++++..........++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4899999999999999999999899999999876422      3455799999999999999999988554433344678


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ++|||+++++.+.+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++....
T Consensus        81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            9999999876665543    3478999999999999999999999 8999999999999999887 79999999998765


Q ss_pred             cCC----CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          237 KGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       237 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ...    ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+.+..+....+.+....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            443    2334567889999999976646899999999999999999999999999999999999998888887665422


Q ss_pred             CcC-CccC--cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCC
Q 014595          313 NPN-YTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (422)
Q Consensus       313 ~~~-~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  377 (422)
                      ... ...+  ..+.....++...+ +.++.++.+||.+||++||.+|||+.++++||||++++.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhc-ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence            111 1111  11122222333332 4578999999999999999999999999999999998876544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-44  Score=345.16  Aligned_cols=244  Identities=30%  Similarity=0.513  Sum_probs=195.7

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHH-cCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||+||+|++..+++.||||++....       .....|..++.. .+||||+++++++.     ...++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999986532       122346666664 48999999998873     334588999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.....
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence            99975 55444432    3578999999999999999999999 8999999999999999887 6999999999754332


Q ss_pred             C-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      . .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------  211 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-----------------  211 (316)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            2 23345789999999999654 4899999999999999999999999988766555544321                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH-HHHhcCCcccccC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELR  372 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-~e~l~hp~f~~~~  372 (422)
                      .   +         .++..++.++.+||.+||..||.+|+++ .++++||||..+.
T Consensus       212 ~---~---------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         212 R---P---------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             C---C---------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence            0   0         0123578999999999999999999986 5888999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.3e-44  Score=362.08  Aligned_cols=260  Identities=24%  Similarity=0.340  Sum_probs=211.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCC---CCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD---KEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~~  152 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++...      .....+|+.++..++|+||+++++.+.....   ...
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            3699999999999999999999999999999998542      1234578999999999999998877643222   222


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      .++++||||++ ++|.+.+.........+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~-~vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNG-LVKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence            35789999998 47777776555555679999999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccC---CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          232 AKVLVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       232 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ++.....   .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+....       
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-------  261 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-------  261 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-------
Confidence            8765332   122345789999999999654 48999999999999999999999998877655555443210       


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                  .+         .++..+++++.+|+.+||+.||.+||++.++++|||++...
T Consensus       262 ------------~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        262 ------------YD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             ------------CC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                        00         02246789999999999999999999999999999998754

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.1e-44  Score=337.20  Aligned_cols=274  Identities=36%  Similarity=0.668  Sum_probs=216.1

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |.+.+.||.|++|.||+|++..+|+.||||.+..+.      ....+|++++++++||||+++++++.     +....++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   76 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLYL   76 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEEE
Confidence            889999999999999999999999999999885432      23557999999999999999999873     3345789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||+.+++...+...  ....+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++.....
T Consensus        77 v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~  152 (284)
T cd07860          77 VFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGV  152 (284)
T ss_pred             EeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEeeccchhhccc
Confidence            9999987766555432  23568999999999999999999999 8999999999999999887 699999999875533


Q ss_pred             CCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--
Q 014595          238 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  314 (422)
Q Consensus       238 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  314 (422)
                      ... .....+++.|+|||.+.+...++.++|+|||||++|+|+||+.||.+.+..+.+.++.+..+.+....+.....  
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence            221 22345678899999987666578999999999999999999999999888888888888877776543321110  


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      .+. ..++.......... .+.++++++++|.+||+.||.+|||+.++++||||
T Consensus       233 ~~~-~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         233 DYK-PSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHH-hhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            000 01222111112111 13578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.5e-44  Score=334.94  Aligned_cols=275  Identities=36%  Similarity=0.626  Sum_probs=218.0

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++++. |+||+++++++...   ...++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            678899999999999999999999999999876432     12236888888885 99999999988532   2235789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||+++++.+.+...   ...+++..+..++.|++.||.|||+ .|++||||||+||+++. + .+||+|||++.....
T Consensus        78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence            9999998776655432   2568999999999999999999999 89999999999999998 5 799999999987655


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC-C
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y  316 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~  316 (422)
                      ........+++.|+|||.+.+...++.++|+|||||++|||++|.+||.+.+..+.+..+...++.+........... .
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            444445667899999998765556789999999999999999999999999888888888888887776543322211 1


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      ..+.++......... ....++.++.+||.+||..||++|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            122222222111111 123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.1e-44  Score=337.55  Aligned_cols=280  Identities=36%  Similarity=0.648  Sum_probs=218.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||.|++|+||+|++..+|+.||||.+....      ....+|+++++.++|+||+++++++.     ...+.+
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   77 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRLY   77 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeEE
Confidence            5999999999999999999999999999999875421      23457999999999999999999883     334578


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+...  ....+++..++.++.||+.||+|||+ +||+|+||||+||+++.++..+||+|||++....
T Consensus        78 lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         78 LVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             EEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            99999987766555432  12346788889999999999999999 8999999999999998665579999999997543


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  313 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  313 (422)
                      .... .....+++.|+|||.+.+...++.++|+|||||++|+|+||.+||.+.+..+.+.++....+.+....+....  
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            3221 2334568899999998765668899999999999999999999999888888888888888877665543211  


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      +++. ..++....... ....+.+++++.++|.+||+.||++||++.++++||||.++.
T Consensus       235 ~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        235 PDYK-SAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhh-hhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence            1110 00111111111 111245789999999999999999999999999999999865

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.6e-44  Score=339.39  Aligned_cols=278  Identities=38%  Similarity=0.631  Sum_probs=222.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .|++.+.||.|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++++...   +..+.+
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~~   82 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKIY   82 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcEE
Confidence            5999999999999999999999999999999885422      1234799999999999999999887432   124588


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++..++...   ...+++..++.++.||+.||+|||+ .|++|+||||+||+++.++ .+||+|||++....
T Consensus        83 lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~  157 (293)
T cd07843          83 MVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRG-ILKICDFGLAREYG  157 (293)
T ss_pred             EEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-cEEEeecCceeecc
Confidence            99999998776665532   2368999999999999999999999 8999999999999999887 69999999987664


Q ss_pred             cC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 014595          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  314 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  314 (422)
                      .. .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++....+.+....+..... 
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            43 2223455788899999987666678999999999999999999999999988888888888888887766654321 


Q ss_pred             -CCccCcCCCCCCCCcccccccC-CChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 -NYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 -~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                       ..............+...++.. +++.+.+||++||+.||++|||+.|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence             1111111111222233334333 68899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.4e-44  Score=344.51  Aligned_cols=253  Identities=26%  Similarity=0.382  Sum_probs=195.9

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ..+|...+.||+|+||+||+|++..+++.||||++....     ..+.+|+++++.++|+||+++++++     .....+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~  147 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI  147 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence            346889999999999999999999999999999985432     3345899999999999999999987     333457


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++||||+.++..   ..    .....+..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       148 ~lv~e~~~~~~L---~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~  218 (353)
T PLN00034        148 QVLLEFMDGGSL---EG----THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAK-NVKIADFGVSRIL  218 (353)
T ss_pred             EEEEecCCCCcc---cc----cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEcccccceec
Confidence            899999986321   11    1345677888999999999999999 8999999999999999887 6999999999765


Q ss_pred             ccCC-CcccccccccccchhhhcCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          236 VKGE-PNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      .... ......||..|+|||++...    ...+.++|||||||++|||++|+.||......+....+......       
T Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-------  291 (353)
T PLN00034        219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-------  291 (353)
T ss_pred             ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-------
Confidence            4322 22345789999999987431    23456899999999999999999999743322211111111000       


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                .+        ......++.++++||.+||..||++|||+.|+++||||..-.
T Consensus       292 ----------~~--------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        292 ----------QP--------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             ----------CC--------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence                      00        001235789999999999999999999999999999998853

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.3e-45  Score=347.29  Aligned_cols=244  Identities=30%  Similarity=0.483  Sum_probs=198.9

Q ss_pred             eeeeecCCeeEEEEEE---cCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           88 HVVGTGSFGVVFQAKC---RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~---~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      +.||+|+||.||++++   ..+|+.||+|++....      ....+|++++++++||||+++++++.     ....+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence            5799999999999986   3578999999986432      22346999999999999999999883     33457899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  150 (318)
T cd05582          77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGLSKESID  150 (318)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence            999974 55444432    3568999999999999999999999 8999999999999999887 699999999876544


Q ss_pred             C-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          238 G-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       238 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      . .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...                
T Consensus       151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~----------------  213 (318)
T cd05582         151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA----------------  213 (318)
T ss_pred             CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC----------------
Confidence            3 223456789999999998654 4789999999999999999999999887766665554431                


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccC
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~  372 (422)
                       ...            ++..+++++.+||++||+.||.+|||     +.++++||||+.+.
T Consensus       214 -~~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         214 -KLG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             -CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence             111            12357899999999999999999999     77899999998764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-44  Score=340.39  Aligned_cols=281  Identities=34%  Similarity=0.594  Sum_probs=214.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcC--CCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      +|.+.+.||+|+||.||+|.+..  +++.||||.+....       ....+|+.+++.++||||+++++++...   +..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            38899999999999999999988  89999999987632       2345799999999999999999988432   234


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC----CCCcEEEee
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP----HTHQLKLCD  228 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~----~~~~vkl~D  228 (422)
                      .+++||||+++++..++....... ..+++..++.++.||+.||.|||+ .||+||||||+||+++.    ++ .+||+|
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            688999999987776665443332 378999999999999999999999 89999999999999998    66 699999


Q ss_pred             cCCccccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 014595          229 FGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---------DQLV  295 (422)
Q Consensus       229 fG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~---------~~~~  295 (422)
                      ||++........    .....+++.|+|||++.+...++.++|||||||++|+|++|++||.+....         ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876533222    123456888999999877666899999999999999999999999865432         3556


Q ss_pred             HHHHHhCCCCHHHHhhcC--cCCccC----cCCCCCCCCccccccc--CCChHHHHHHHhhhhcCCCCcCCHHHHhcCCc
Q 014595          296 EIIKVLGTPTREEIKCMN--PNYTEF----KFPQIKPHPWHKVFQK--RLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  367 (422)
                      .++..++.+....+..+.  +.+...    .............+..  ..+.++.++|.+||+.||.+|||+.|+++|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            667777766665443221  111110    0000000011111111  56789999999999999999999999999999


Q ss_pred             c
Q 014595          368 F  368 (422)
Q Consensus       368 f  368 (422)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9.3e-44  Score=343.07  Aligned_cols=285  Identities=29%  Similarity=0.519  Sum_probs=215.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCC-------
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-------  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-------  150 (422)
                      .+|.+.+.||.|+||.||+|.+..+|+.||+|++....    ....+|+++++.++||||+++++++......       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            45999999999999999999999999999999875432    3345799999999999999999876433211       


Q ss_pred             --CceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          151 --EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       151 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                        +..+.++||||+++++...+.     ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++..+||+|
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECC
Confidence              123578999999987655443     2568999999999999999999999 89999999999999986665799999


Q ss_pred             cCCccccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014595          229 FGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       229 fG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      ||++........    .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999875432211    1223568889999988665568899999999999999999999999888777777766655444


Q ss_pred             CHHHHhhcCcCCccC-c-CCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          305 TREEIKCMNPNYTEF-K-FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      ............... . .......+.... ...++.++++||.+||+.||.+|||+.++++||||+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDL-LPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHH-ccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence            432222111000000 0 000111122221 2457899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.1e-44  Score=343.45  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=205.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||+||++++..+++.||+|++.+..       ....+|+.++..++|+||+++++++.     ....+
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCEE
Confidence            4999999999999999999999999999999985421       22457888999999999999998873     33457


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||++ ++|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~  151 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSCLK  151 (332)
T ss_pred             EEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence            89999997 466666543   23568999999999999999999999 8999999999999999877 699999999876


Q ss_pred             cccCCCc--ccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          235 LVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       235 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .......  ....||+.|+|||++.+    ...++.++|||||||++|||++|+.||.+.+..+.+..+....       
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-------  224 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-------  224 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-------
Confidence            5333221  23568999999999852    3458899999999999999999999999887766666554311       


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCC--cCCHHHHhcCCcccccCC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  373 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~  373 (422)
                              ..+.++.         ....+++++++||++||+.++.+  |++++++++||||+++..
T Consensus       225 --------~~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         225 --------ERFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             --------ccccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence                    0111111         01357899999999999876555  689999999999998653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.7e-44  Score=370.70  Aligned_cols=261  Identities=27%  Similarity=0.425  Sum_probs=210.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||.|+||+||+|++..+++.||+|.+...      ...+..|+.+++.|+|||||+++++|...   ....+
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~~~l   89 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---ANQKL   89 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CCCEE
Confidence            4699999999999999999999999999999987532      23345799999999999999999987532   23457


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-------ceecCCCCCCeEEcCCC------
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-------ICHRDIKPQNLLVNPHT------  221 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g-------ivHrDlkp~Nill~~~~------  221 (422)
                      |+||||+++ +|..++.........+++..++.|+.||+.||.|||+ .+       ||||||||+||||+...      
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs-~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN-LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-cccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999984 7877776655555679999999999999999999997 44       99999999999996421      


Q ss_pred             ----------CcEEEeecCCccccccCCCcccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 014595          222 ----------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESG  290 (422)
Q Consensus       222 ----------~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~  290 (422)
                                ..+||+|||++.............+|+.|+|||++.+. ..++.++|||||||+||+|+||..||...+.
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                      24899999999866444444456789999999998643 3578999999999999999999999987665


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      ...+...+...  +               .++           ....+.++.+||.+||..+|.+||++.|+|.||||+.
T Consensus       249 ~~qli~~lk~~--p---------------~lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        249 FSQLISELKRG--P---------------DLP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             HHHHHHHHhcC--C---------------CCC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            55444333210  0               000           0245889999999999999999999999999999998


Q ss_pred             cCCC
Q 014595          371 LRDP  374 (422)
Q Consensus       371 ~~~~  374 (422)
                      +..+
T Consensus       301 i~~p  304 (1021)
T PTZ00266        301 VGPP  304 (1021)
T ss_pred             cCCC
Confidence            7654

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.8e-44  Score=344.69  Aligned_cols=245  Identities=28%  Similarity=0.515  Sum_probs=192.3

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||+||+|++..+++.||+|++.+..       ....+|+.++..+ +||||+++++++..     ...+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence            46999999999999999999999999986531       2234688888776 89999999998833     34578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc-
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~-  237 (422)
                      ||+++ +|...+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence            99985 4543332    24679999999999999999999999 8999999999999999887 699999999875322 


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCCHHHH
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--------GVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||....        ....+.+.+..         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  219 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence            2233456789999999999654 48999999999999999999999995311        11111111110         


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC------HHHHhcCCcccccC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELR  372 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t------~~e~l~hp~f~~~~  372 (422)
                             ....            ++..++..+.+||++||..||.+|+|      ..++++||||+.+.
T Consensus       220 -------~~~~------------~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         220 -------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             -------CCCC------------CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence                   0011            22457899999999999999999998      47999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.5e-44  Score=341.36  Aligned_cols=248  Identities=27%  Similarity=0.444  Sum_probs=200.4

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      |...+.||+|+||+||+|+++.+|+.||||++.+..       .....|..+++.+. |++|+++++++.     ....+
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~   76 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-----TVDRL   76 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-----cCCEE
Confidence            778899999999999999999999999999986432       12346888888886 466777888773     23358


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ +|...+.    ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~  150 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE  150 (323)
T ss_pred             EEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeccccccc
Confidence            899999985 5544443    23579999999999999999999999 8999999999999999887 699999999875


Q ss_pred             cccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          235 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       235 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...             
T Consensus       151 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------  216 (323)
T cd05615         151 HMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------  216 (323)
T ss_pred             cCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence            43222 23345689999999998654 5899999999999999999999999988776666555431             


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~  372 (422)
                          ...            ++..++.++.+|+.+||+.||.+|++     ..++++||||+.+.
T Consensus       217 ----~~~------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         217 ----NVS------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             ----CCC------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence                111            12357889999999999999999997     57999999999865

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.6e-44  Score=331.91  Aligned_cols=252  Identities=35%  Similarity=0.562  Sum_probs=203.0

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhh------HHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |++.+.||+|+||+||+|++..+++.||+|++......      ..+|+.+++.++||||+++++++..     ..+.++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            88999999999999999999999999999998654321      1348999999999999999998844     445779


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc-
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-  235 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~-  235 (422)
                      +|||+.+ ++..++.    ....+++..+..++.||+.||.+||+ .||+|+||||+||+++.++ .++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccccc
Confidence            9999997 7777666    34778999999999999999999999 8999999999999999777 7999999998753 


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..........++..|+|||++.....++.++|+||||+++|+|++|..||......+....+.+..........      
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  223 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS------  223 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc------
Confidence            22233345677999999999863456899999999999999999999999887444444443332211111000      


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                            .          .....+.++.++|++||+.||++|||+.++++||||
T Consensus       224 ------~----------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  224 ------Q----------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             ------T----------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             ------c----------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                  0          001124789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.9e-44  Score=336.43  Aligned_cols=250  Identities=25%  Similarity=0.380  Sum_probs=195.5

Q ss_pred             eeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      ||+|+||+||+++++.+|+.||+|.+....       .....|+++++.++||||+++++++.     ...++++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecC
Confidence            699999999999999999999999885421       22345999999999999999988873     344588999999


Q ss_pred             hh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCc
Q 014595          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (422)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~  241 (422)
                      ++ ++...+...  ....+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .++|+|||++.........
T Consensus        76 ~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence            75 555444322  23458888899999999999999999 8999999999999999877 6999999998776544443


Q ss_pred             ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcC
Q 014595          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  321 (422)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  321 (422)
                      ....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.........+......             ....+
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~  217 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------------DEVKF  217 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-------------ccccc
Confidence            4456889999999996654 899999999999999999999999765432221222111000             00000


Q ss_pred             CCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH----HHHhcCCcccccCC
Q 014595          322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  373 (422)
Q Consensus       322 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f~~~~~  373 (422)
                                 ....+++++++||++||+.||.+||++    +++++||||+.+..
T Consensus       218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~  262 (277)
T cd05607         218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF  262 (277)
T ss_pred             -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence                       013478999999999999999999999    67889999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1e-44  Score=347.24  Aligned_cols=244  Identities=28%  Similarity=0.461  Sum_probs=194.6

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHH-HHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||+||+|++..+|+.||||++.+..       ....+|.. +++.++||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence            46999999999999999999999999986432       11223433 567799999999998873     333578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc-
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~-  237 (422)
                      ||+++ ++...+.    ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            99985 4433332    34678999999999999999999999 8999999999999999887 699999999875322 


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------  211 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------  211 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            2233456789999999999654 4899999999999999999999999887766655554331                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH----HHHhcCCcccccC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELR  372 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f~~~~  372 (422)
                      ...            +.+..+..+.++|++||+.||.+||++    .++++||||....
T Consensus       212 ~~~------------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         212 PLV------------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             Ccc------------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            000            123578899999999999999999976    5999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.7e-44  Score=358.78  Aligned_cols=254  Identities=27%  Similarity=0.367  Sum_probs=208.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCC-CeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ..|.+.+.||+|+||.||+|.+..+ ++.||+|.+....    ....+|+.+++.++|||||++++++..     ...++
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEEE
Confidence            3499999999999999999998877 7889999764322    334579999999999999999998832     34588


Q ss_pred             EEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||++ ++|.+.+.........+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCC-cEEEEeCcCceec
Confidence            9999997 47777666544445678999999999999999999999 8999999999999999887 6999999999865


Q ss_pred             ccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          236 VKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       236 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .....   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....           
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-----------  287 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK-----------  287 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            43321   234568999999999865 458999999999999999999999998877666555544310           


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                            +  +         .++..++.++++||.+||..||++||++.+++.|||++.+
T Consensus       288 ------~--~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        288 ------Y--D---------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             ------C--C---------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                  0  0         0123578899999999999999999999999999999754

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.1e-44  Score=336.16  Aligned_cols=254  Identities=25%  Similarity=0.407  Sum_probs=201.4

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      |++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+.+++.+.     ...+++
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence            788899999999999999999999999999875421       22346999999999999999988873     234588


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ +|...+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~  152 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHG-HIRISDLGLAVHV  152 (285)
T ss_pred             EEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeccceeec
Confidence            99999974 665555332  23468999999999999999999999 8999999999999999877 6999999998765


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..........|+..|+|||++.+. .++.++|+||+||++|+|++|+.||.+................            
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------------  219 (285)
T cd05630         153 PEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------------  219 (285)
T ss_pred             CCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------------
Confidence            444333445789999999999654 5899999999999999999999999865432111111110000            


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~  372 (422)
                                   ....+...+++++.+||++||+.||.+|+|     ++|+++||||+.+.
T Consensus       220 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05630         220 -------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN  268 (285)
T ss_pred             -------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence                         000112457889999999999999999999     99999999998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-45  Score=348.32  Aligned_cols=244  Identities=28%  Similarity=0.474  Sum_probs=194.8

Q ss_pred             eeecCCeeEEEEEEcCCCeEEEEEEeccchh-------hHHHHHHHHHHc---CCCCcccccceeecCCCCCceEEEEEe
Q 014595           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      ||+|+||+||+|++..+|+.||||++.+...       ....|..++..+   +||||+.+++++.     ....+++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-----~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-----TDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-----cCCeEEEEE
Confidence            6999999999999999999999999864321       112456666655   7999999998883     334578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ ++...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus        76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATG-HIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence            99975 5544443    24678999999999999999999999 8999999999999999887 6999999998754322


Q ss_pred             -CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                       ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------  212 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----------------  212 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             22335678999999999976656899999999999999999999999887765555444321                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC----CHHHHhcCCcccccC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELR  372 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~----t~~e~l~hp~f~~~~  372 (422)
                      ...++.           ..+++++.+||++||..||.+||    ++.++++||||.+..
T Consensus       213 ~~~~~~-----------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         213 KVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCCCC-----------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            111111           24689999999999999999998    799999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.8e-44  Score=344.13  Aligned_cols=257  Identities=27%  Similarity=0.419  Sum_probs=204.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||+||+|++..+++.||+|++.+..       ....+|+.++..++|+||+.+++++     ....++
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            5999999999999999999999999999999986421       2245688999999999999999888     334468


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      |+||||+++ +|..++...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~  151 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNG-HIRLADFGSCLK  151 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCC-CEEEEeccceee
Confidence            899999974 666655432   3578999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCCc--ccccccccccchhhhcCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          235 LVKGEPN--VSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       235 ~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .......  ....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------  225 (331)
T cd05624         152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE------  225 (331)
T ss_pred             ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC------
Confidence            5433221  234689999999998542    3478899999999999999999999988776666555543110      


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCC--cCCHHHHhcCCcccccCC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  373 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~  373 (422)
                               .+.++.         ....++.++++||.+||+.++.+  |++++++++||||+.+..
T Consensus       226 ---------~~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         226 ---------RFQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             ---------cccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence                     011111         01346899999999999976655  569999999999987643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.5e-44  Score=343.64  Aligned_cols=244  Identities=25%  Similarity=0.437  Sum_probs=195.3

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-------hHHHH-HHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRE-LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~E-~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||+||+|++..+++.||+|++.+...       ...+| ..+++.++||||+++++++.     ....+++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence            369999999999999999999999999864321       11223 33567889999999998873     334578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc-
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~-  237 (422)
                      ||+++ ++...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            99986 55444432    4568889999999999999999999 8999999999999999887 699999999875432 


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------  211 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-----------------  211 (325)
T ss_pred             CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------------
Confidence            2223456789999999999654 5899999999999999999999999988776665555431                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHH----HHhcCCcccccC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL----EACVHPFFDELR  372 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~----e~l~hp~f~~~~  372 (422)
                      ...            +.+.++..+.+||.+||+.||.+|+++.    ++++|+||....
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         212 PLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             CcC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence            000            1245789999999999999999999875    899999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-43  Score=332.28  Aligned_cols=276  Identities=36%  Similarity=0.660  Sum_probs=220.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|.+.+.||.|++|.||+|++..+|+.||||++....     ....+|+.+++.++|+||+++++++...     ...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence            3899999999999999999999999999999886432     3345799999999999999999988432     34789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||+++++...+..... ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence            999999877666554221 2468999999999999999999998 8999999999999999877 699999999875533


Q ss_pred             CC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .. ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+.+.++......|....+..+. ..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence            22 12234568889999998776668899999999999999999999999998888888888888777776655432 11


Q ss_pred             cc--CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          317 TE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       317 ~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      ..  ..++......... +.+.++.+++++|.+||+.||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11  1122221112211 123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.6e-44  Score=342.20  Aligned_cols=245  Identities=27%  Similarity=0.428  Sum_probs=193.8

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-------hHHHHH-HHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      ++||+|+||+||+|++..+|+.||+|++.+...       ...+|. .+++.++||||+++++++.     ....+++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence            369999999999999999999999999864321       122333 4678899999999998873     334578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc-
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~-  237 (422)
                      ||+++ ++...+.    ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            99985 4433332    24678899999999999999999998 8999999999999999887 699999999875322 


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------  211 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-----------------  211 (321)
T ss_pred             CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            2223345789999999998654 4899999999999999999999999887765554444321                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH----HHHhcCCcccccCC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  373 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f~~~~~  373 (422)
                      ...            ++...+.++.++|.+||+.||.+|+++    .++++||||..+..
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         212 PLQ------------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             CCC------------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence            011            123568899999999999999999975    59999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.2e-43  Score=330.76  Aligned_cols=277  Identities=36%  Similarity=0.621  Sum_probs=210.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|++.+.||+|+||.||+|.+..+|+.||||.+....     ....+|+.+++.++|+||+++++++.     ...+.+
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeEE
Confidence            35999999999999999999999999999999885421     23457999999999999999999873     233578


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+.+++...+..   ....+++..++.++.|++.||.|||+ .||+|+||||+|||++.++ .+||+|||+++...
T Consensus        80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~  154 (291)
T cd07870          80 FVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence            9999998776554432   22457888899999999999999999 8999999999999999887 69999999987543


Q ss_pred             cCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcC-
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN-  313 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~-  313 (422)
                      ... ......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+. .+.+.++...++.|....+.... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            221 223345688999999987655688999999999999999999999976543 45666666667766655443221 


Q ss_pred             -cCCccCcCCCCCCCCcccccc-cCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          314 -PNYTEFKFPQIKPHPWHKVFQ-KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       314 -~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                       +.+.....+...+........ -..++++.+++.+||+.||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             111111111111111111110 1236789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=351.83  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=211.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .|.|+..||.|+||+||+|.++.++-..|.|+|....    ....-|++||..++||+||+|++.|+..+.     ++|+
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWIL  107 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEEE
Confidence            4888899999999999999999999888999875322    122359999999999999999999865554     8899


Q ss_pred             eecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc-cc
Q 014595          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VK  237 (422)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~-~~  237 (422)
                      .|||+|+..+.+-  ...+..+.+..+..+++|++.||.|||+ ++|||||||..|||++-+| .|+|+|||.+... ..
T Consensus       108 iEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKST  183 (1187)
T ss_pred             EeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecC-cEeeecccccccchhH
Confidence            9999986554433  2346789999999999999999999999 8999999999999999998 7999999987443 22


Q ss_pred             CCCcccccccccccchhhhc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          238 GEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      .....+++|||+|||||+..    ....|+.++||||||++|.||..+.+|-...+.+..+.+|.+.  .|+        
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePP--------  253 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP--------  253 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCC--------
Confidence            23446789999999999973    3556999999999999999999999999999888888777652  111        


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                      .-.-+.+.+..+.|||.+||..||..||++.++|+||||+++
T Consensus       254 ----------------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  254 ----------------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             ----------------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence                            011224567889999999999999999999999999999954

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-43  Score=339.21  Aligned_cols=312  Identities=34%  Similarity=0.618  Sum_probs=235.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|.+.+.||.|+||.||+|++..+++.||||++....      ....+|+.+++.++|+||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            35999999999999999999999999999999875421      223469999999999999999987743322 23345


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++|+||+++++.+++..     ..+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~  167 (343)
T cd07851          95 VYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDC-ELKILDFGLARH  167 (343)
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEcccccccc
Confidence            789999998887766653     568999999999999999999999 8999999999999999877 699999999976


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ....  .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.++...+..+..
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence            5332  33456788899999986655688999999999999999999999999888888888888877777655443321


Q ss_pred             CCc-cC--cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCC
Q 014595          315 NYT-EF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  391 (422)
Q Consensus       315 ~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  391 (422)
                      ... .+  ..+......+...+ ...++++.+||.+||..||.+|||+.++++||||++...+...     +.+++++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~-----~~~~~~~~~  319 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE-----PVAPPYDQS  319 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccc-----ccccccCcc
Confidence            110 00  01111111122212 3468999999999999999999999999999999987665432     112223221


Q ss_pred             CCCCCCCChhHHhhhCcH
Q 014595          392 PPELSGIPPETINRLIPE  409 (422)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~  409 (422)
                       ..-..++-+.++.++..
T Consensus       320 -~~~~~~~~~~~~~~~~~  336 (343)
T cd07851         320 -FESRDLTVDEWKELVYK  336 (343)
T ss_pred             -hhhhhcCHHHHHHHhHH
Confidence             22234556666665543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.2e-44  Score=341.25  Aligned_cols=246  Identities=27%  Similarity=0.483  Sum_probs=194.6

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||+||+|++..+++.||+|++.+..       ....+|+.++.++ +||||+.+++++.     ....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986532       2244788888888 6999999999883     334588999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc-c
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K  237 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~-~  237 (422)
                      ||+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++... .
T Consensus        76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence            99975 5544433    23579999999999999999999999 8999999999999999887 69999999987532 2


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhh
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||....      ..+.+..+...           
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  217 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-----------  217 (327)
T ss_pred             CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-----------
Confidence            2333456789999999999654 58999999999999999999999996422      11222222110           


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC------HHHHhcCCcccccCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRD  373 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t------~~e~l~hp~f~~~~~  373 (422)
                           ....            ++..++..+.++|++||..||.+|++      ..++++||||..+.+
T Consensus       218 -----~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         218 -----KPIR------------IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             -----CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence                 0011            22457899999999999999999998      579999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.1e-43  Score=333.51  Aligned_cols=282  Identities=30%  Similarity=0.505  Sum_probs=214.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC---CCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~~  152 (422)
                      .+|.+.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.+++.++||||+++++++.....   ...
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            35999999999999999999999999999999875321      123479999999999999999998754332   223


Q ss_pred             eEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ...++||||+++++...+..   ....+++..++.++.||+.||+|||+ .|++|+||||+||+++.++ .+||+|||++
T Consensus        92 ~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~  166 (310)
T cd07865          92 GSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDG-ILKLADFGLA  166 (310)
T ss_pred             ceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCC-cEEECcCCCc
Confidence            45689999999877665543   22468999999999999999999999 8999999999999999887 6999999998


Q ss_pred             cccccCCCc-----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          233 KVLVKGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       233 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      .........     ....++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.+.......+....+..+.+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            765332211     234567889999998766567899999999999999999999999888777777777766655544


Q ss_pred             HHhhcC--cCCccCcCCCCCCCCccc-ccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          308 EIKCMN--PNYTEFKFPQIKPHPWHK-VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       308 ~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      .+....  ..+..+.++......... ......+..+.+||.+||..||.+|||++++|+||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            332211  001111122111111111 0111246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3e-45  Score=311.94  Aligned_cols=283  Identities=31%  Similarity=0.585  Sum_probs=231.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-hhhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEEEEe
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .+|++.+++|+|.|+.||.|.+..+++.++||+++.- +..+.+|+.||+.|. ||||++++++..+   +......+++
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~SktpaLiF  114 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTPSLIF  114 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCchhHh
Confidence            4699999999999999999999999999999988653 355679999999996 9999999998843   4444566899


Q ss_pred             ecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC
Q 014595          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (422)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~  239 (422)
                      ||+...-      +......++.-.++.++.|++.||.|+|+ .||+|||+||.|++||.....++|+|+|+|.+.-.+.
T Consensus       115 E~v~n~D------fk~ly~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  115 EYVNNTD------FKQLYPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhhcccc------HHHHhhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            9998521      12223567888899999999999999999 9999999999999999887789999999999887776


Q ss_pred             CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHh-----hcC
Q 014595          240 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIK-----CMN  313 (422)
Q Consensus       240 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~  313 (422)
                      .....+.+.+|--||.+..-..|+..-|+|||||++..|+..+-| |.|.+..+++.+|.+.+|+.......     .++
T Consensus       188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld  267 (338)
T KOG0668|consen  188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD  267 (338)
T ss_pred             eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence            666778899999999998888899999999999999999987755 57889999999999999875433211     123


Q ss_pred             cCCccCcCCCCCCCCccccccc----CCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQK----RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      +.+..+ +......+|......    -+++++.|||.++|..|-.+|+||.|++.||||..+....
T Consensus       268 p~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~  332 (338)
T KOG0668|consen  268 PQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE  332 (338)
T ss_pred             hhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence            433332 112334566665533    2579999999999999999999999999999999876543

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.6e-43  Score=331.08  Aligned_cols=276  Identities=37%  Similarity=0.646  Sum_probs=212.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+++++.++||||+++++++     ....+.+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            4999999999999999999999899999999875422      2345799999999999999999988     3344578


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||++++.....   ......+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07846          77 LVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFARTLA  151 (286)
T ss_pred             EEEecCCccHHHHH---HhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence            99999997443222   2223468999999999999999999999 8999999999999999887 69999999987654


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  314 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  314 (422)
                      .... .....++..|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+....+.........+.. 
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            3322 23356788999999987666688999999999999999999999998887777777777665543322211110 


Q ss_pred             -CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 -NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                       .......+............+.++..+.+|+.+||..||++||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence             011111221111111111124678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.3e-43  Score=337.10  Aligned_cols=286  Identities=35%  Similarity=0.596  Sum_probs=224.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCC--CeEEEEEEeccc------hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRET--GEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vAiK~~~~~------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      +|.+.+.||+|+||.||+|++..+  +..||||++...      .....+|+++++++ +||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            388999999999999999999888  899999987642      12345799999999 5999999988653322 2234


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .++++++|++++|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~-~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADC-ELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence            4678999998877665542    4678999999999999999999999 8999999999999999887 69999999997


Q ss_pred             ccccCC-----CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGE-----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ......     ......+|+.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+..++..++.++.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            653221     122346789999999886655689999999999999999999999999988899999999999888765


Q ss_pred             HhhcCcCC-cc--CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCC
Q 014595          309 IKCMNPNY-TE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (422)
Q Consensus       309 ~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  376 (422)
                      +..+.... ..  .........++... ....+..+.+|+.+||+.||.+|||+.+++.||||+.++++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~  303 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD  303 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhh-CCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccc
Confidence            54432110 00  01111111122222 1346889999999999999999999999999999999877643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.7e-44  Score=341.56  Aligned_cols=278  Identities=25%  Similarity=0.416  Sum_probs=202.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|++.+.||.|+||.||+|.+..++..+|+|.+....     ....+|+++++.++|+||+++++++..     ..+++
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   79 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS   79 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEE
Confidence            45999999999999999999999999999999876431     235589999999999999999998843     33588


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ +|.+++..    ...+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~  154 (333)
T cd06650          80 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  154 (333)
T ss_pred             EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhh
Confidence            99999975 77666543    356889999999999999999999724799999999999999887 6999999998755


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--hCCCCHHHHhhc-
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV--LGTPTREEIKCM-  312 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~-  312 (422)
                      ... ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||......+. ..+...  .+.+........ 
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCccc
Confidence            332 22345688999999999654 489999999999999999999999976654322 221110  011100000000 


Q ss_pred             ------CcCCccCcCCCCC--------CCCccccc-ccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          313 ------NPNYTEFKFPQIK--------PHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       313 ------~~~~~~~~~~~~~--------~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                            ...+..-..+...        .......+ ...++.++++||.+||++||++|||+.|+++||||+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                  0000000000000        00000000 113578899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=313.98  Aligned_cols=259  Identities=25%  Similarity=0.425  Sum_probs=210.2

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-----hHHHHHHHHHHc-CCCCcccccceeecCCCCCceE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .++...+..||.|+.|+|++++.+.+|...|||.+.+...     .+...+.++..- ..|+||+.+++|....+     
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-----  165 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-----  165 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-----
Confidence            3456677889999999999999999999999999865332     112234443333 48999999999976665     


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++-||.|..-+..+++.   ..+.++|..+-.+...+++||.||.+.+||+|||+||+|||+|..| ++||||||++..
T Consensus       166 V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGr  241 (391)
T KOG0983|consen  166 VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGR  241 (391)
T ss_pred             HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccce
Confidence            778899988655555554   3478999999999999999999999878999999999999999888 699999999999


Q ss_pred             cccCCCcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhh
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      +.+...++...|.+.|||||.+.-  ...|+.++||||||++++||.||..||.+.+ +.+.+-++.+.  .|+      
T Consensus       242 lvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP------  313 (391)
T KOG0983|consen  242 LVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPP------  313 (391)
T ss_pred             eecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCC------
Confidence            988888888899999999999832  3468999999999999999999999999854 45666666552  111      


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                              .++.          ...+|+++++|+..||++|+.+||.-.++|+|||+......
T Consensus       314 --------~L~~----------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a  358 (391)
T KOG0983|consen  314 --------LLPG----------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA  358 (391)
T ss_pred             --------CCCc----------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence                    0110          13479999999999999999999999999999999876543

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.8e-43  Score=331.13  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=205.2

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      |+..+.||.|+||+||+|.+..+++.||+|.+....       ....+|+++++.++|+||+.+.+++.     ....++
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEEE
Confidence            788899999999999999999999999999885421       22457999999999999999988873     234588


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++|||+.+ ++...+..  .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        77 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~  152 (285)
T cd05632          77 LVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYG-HIRISDLGLAVKI  152 (285)
T ss_pred             EEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCC-CEEEecCCcceec
Confidence            99999985 45444432  123469999999999999999999999 8999999999999999887 6999999998765


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..........++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.........+........          
T Consensus       153 ~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----------  221 (285)
T cd05632         153 PEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----------  221 (285)
T ss_pred             CCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----------
Confidence            444333456789999999999654 489999999999999999999999987765544444332211100          


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccCC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  373 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  373 (422)
                                     ..+...+++++.+|+.+||+.||.+|||     +.++++||||+....
T Consensus       222 ---------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         222 ---------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             ---------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence                           0112457889999999999999999999     899999999998743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-43  Score=338.38  Aligned_cols=281  Identities=36%  Similarity=0.625  Sum_probs=221.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-CCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~  155 (422)
                      +|.+.+.||+|+||.||+|++..+|+.||||++....      ....+|+.+++.++|+||+++++++..... ......
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            5999999999999999999999899999999885421      234579999999999999999998754322 122346


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++|+||+..++....      ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||+++..
T Consensus        96 ~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~  167 (342)
T cd07879          96 YLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARHA  167 (342)
T ss_pred             EEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCCCCcCC
Confidence            799999986554322      2468999999999999999999999 8999999999999999887 6999999998754


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..  ......+++.|+|||.+.+...++.++|+|||||++|||++|+.||.+.+....+..+....+.+...........
T Consensus       168 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         168 DA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             CC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence            22  2234567889999999866556899999999999999999999999998888888888888887776655443221


Q ss_pred             C-cc--CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          316 Y-TE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       316 ~-~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      . ..  ...+......+...+ +..++++.+||.+||+.||.+||++.+++.||||..+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             chHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            1 00  011211222222222 3568899999999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.5e-43  Score=332.29  Aligned_cols=282  Identities=34%  Similarity=0.590  Sum_probs=218.5

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC---CC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  151 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~  151 (422)
                      ..+|.+.+.||.|+||.||+|.+..+++.||||++....      ....+|+++++.++|+||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            456999999999999999999999999999999875321      234679999999999999999988754332   23


Q ss_pred             ceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ..++++||||+.+++...+..   ....+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .+||+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQG-ILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECcCcc
Confidence            446789999998766554432   23579999999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccCCC------------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014595          232 AKVLVKGEP------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  299 (422)
Q Consensus       232 a~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~  299 (422)
                      +........            .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            875533221            12235678899999987666689999999999999999999999999988888888888


Q ss_pred             HhCCCCHHHHhhcC--cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          300 VLGTPTREEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       300 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      ..+.+....+....  +...........+..+...+ ..+++.+.+||.+||+.||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            77776655443321  11110000000011111111 2456889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.1e-43  Score=339.92  Aligned_cols=285  Identities=36%  Similarity=0.699  Sum_probs=224.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++++ +|+||+++++++..   .+...
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~~   83 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDKD   83 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCce
Confidence            3599999999999999999999989999999987432      12234799999999 99999999998733   23345


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .++||||+++++...+..     ..+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus        84 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~  156 (337)
T cd07852          84 IYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDC-RVKLADFGLARS  156 (337)
T ss_pred             EEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccchhc
Confidence            789999999877655443     367888888999999999999999 8999999999999999888 699999999876


Q ss_pred             cccCC------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          235 LVKGE------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       235 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .....      ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+....+....+....+.+..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            54332      122356788999999886666688999999999999999999999999888888888888888777665


Q ss_pred             HhhcCcCCccC---cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCC
Q 014595          309 IKCMNPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (422)
Q Consensus       309 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  377 (422)
                      +..+.......   ........+....+ +.++.++.+||.+||+.||++|||+.++++||||+....+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~  307 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDE  307 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCC
Confidence            54432211110   01111111122222 3478999999999999999999999999999999998766544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.9e-43  Score=337.35  Aligned_cols=284  Identities=35%  Similarity=0.589  Sum_probs=223.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++|+||+++++++..... .....
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            45999999999999999999999999999999886432      234479999999999999999988743221 22334


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .+++++++++++..++..     ..+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus        97 ~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~  169 (345)
T cd07877          97 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH  169 (345)
T ss_pred             EEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence            678999998777665542     468999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...  ......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+.......+..
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            432  233456788999999986655688999999999999999999999998888888888888777777665543322


Q ss_pred             CCccC---cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       315 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      .....   ..+......+...+ ...++++++||.+||+.||.+|+|+.++++||||++...+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhc-CCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence            11000   01111111111111 24688999999999999999999999999999999876654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-43  Score=329.30  Aligned_cols=274  Identities=35%  Similarity=0.655  Sum_probs=215.6

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |.+.+.||.|++|.||+|.+..+|+.||+|++....      ....+|+++++.++|+||+++++++.     ...+.++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            567889999999999999999999999999885432      23457999999999999999999873     3345789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      +|||+++++...+....  ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            99999877766554322  1368999999999999999999999 8999999999999999877 799999999875432


Q ss_pred             CC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--
Q 014595          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  314 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  314 (422)
                      .. ......+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+....+.++.+..+.+....+.....  
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            22 122335688899999886655578999999999999999999999999888888888888877777655432111  


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      ++. ..++......... ....++.++.++|.+||+.||.+|||+.|+++||||
T Consensus       232 ~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYK-PTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhh-hhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            100 0111111111111 124678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-45  Score=345.69  Aligned_cols=250  Identities=28%  Similarity=0.440  Sum_probs=215.0

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      |.-++.||.|+||.||.|++..+.+.||||++.-..       ..+.+|+.+|++++|||+|.+.+||+....     .+
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----aW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----AW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----HH
Confidence            777889999999999999999999999999985322       223479999999999999999999964443     77


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|||||-|+..+++....   +++.+.++..|+.+.+.||.|||+ .+.||||||..|||+...| .|||+|||.|... 
T Consensus       103 LVMEYClGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~-  176 (948)
T KOG0577|consen  103 LVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPG-LVKLADFGSASIM-  176 (948)
T ss_pred             HHHHHHhccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCC-eeeeccccchhhc-
Confidence            999999998888877654   689999999999999999999999 8999999999999999887 7999999999765 


Q ss_pred             cCCCcccccccccccchhhhc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          237 KGEPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                        .+..+++|||+|||||+++  ..+.|+-++||||||++..||.-.++|+...+.+..+..|.+.-             
T Consensus       177 --~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-------------  241 (948)
T KOG0577|consen  177 --APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------------  241 (948)
T ss_pred             --CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-------------
Confidence              3456789999999999984  34569999999999999999999999999999988888887621             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                            -|.+.        ....|..++.||..||+.-|.+|||++++|+|+|...-+.
T Consensus       242 ------sPtLq--------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  242 ------SPTLQ--------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             ------CCCCC--------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence                  11111        1345788999999999999999999999999999986544

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-44  Score=356.90  Aligned_cols=248  Identities=25%  Similarity=0.446  Sum_probs=199.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcC-CCCcccccc-eeecCCCCC-ceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKH-CFFSTTDKE-ELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~-h~nIv~l~~-~~~~~~~~~-~~~~  155 (422)
                      +++|.+.|.+|||+.||+|.+...|..||+|++...    .....+|+++|++|. |+|||.+++ ........+ ..-+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            599999999999999999999888899999987532    234468999999996 999999999 433333333 3556


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--ivHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .++||||. ++|.+++..+..  .+|++.+++.|++|+++|+.+||. +.  |||||||-|||||..++ .+||||||.|
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g-~~KLCDFGSa  193 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADG-NYKLCDFGSA  193 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCC-CEEeCccccc
Confidence            78999999 688888876554  569999999999999999999998 67  99999999999999888 6999999998


Q ss_pred             cccccCCCc----------ccccccccccchhhh--cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014595          233 KVLVKGEPN----------VSYICSRYYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  300 (422)
Q Consensus       233 ~~~~~~~~~----------~~~~~t~~y~aPE~~--~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~  300 (422)
                      +........          .....|+.|+|||++  .....+++|+|||||||+||.|+....||.+....    .|+. 
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIln-  268 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILN-  268 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEe-
Confidence            643222211          123458999999997  33445899999999999999999999999765321    1111 


Q ss_pred             hCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                      ..|.+|..          +..+..+++||+.||+.||.+||++.+++.+
T Consensus       269 ----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  269 ----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                            34455542          3578999999999999999999999888763

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=347.62  Aligned_cols=248  Identities=32%  Similarity=0.520  Sum_probs=204.3

Q ss_pred             eeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecchh
Q 014595           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE  164 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~  164 (422)
                      +||+|.||+||-|++..|...+|||.+...    .+-..+|+.+.++|+|.|||++++++     .+++++-+.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            699999999999999999999999988543    23345899999999999999999987     555678899999985


Q ss_pred             -HHHHHHHHhhhhcCCC--CHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCC-
Q 014595          165 -TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  240 (422)
Q Consensus       165 -~l~~~~~~~~~~~~~~--~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~-  240 (422)
                       +|..+++...   +++  .+..+..|..||+.||.|||+ ..|||||||-+||||+.-.+.+||+|||-++.+..-.+ 
T Consensus       657 GSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence             7777777533   455  788899999999999999999 89999999999999998877999999999988754443 


Q ss_pred             cccccccccccchhhhc-CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccC
Q 014595          241 NVSYICSRYYRAPELIF-GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  319 (422)
Q Consensus       241 ~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  319 (422)
                      ..++.||..|||||++. |...|+.++|||||||++.||.||++||.........  +++.                +.|
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV----------------Gmy  794 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV----------------GMY  794 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh----------------cce
Confidence            34678999999999993 4556999999999999999999999999765433221  1111                111


Q ss_pred             cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      +     .+|   -++..++.+++.||.+|+..||.+||+|.++|..||++.-
T Consensus       795 K-----vHP---~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  795 K-----VHP---PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             e-----cCC---CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            1     111   1335688999999999999999999999999999999875

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-45  Score=342.15  Aligned_cols=248  Identities=31%  Similarity=0.560  Sum_probs=209.7

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEecc------chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      .++||+|.||+||-|+++.+|+.||||+|.+      .....++|+.||+.+.||.||.+.-.|...+     .++.|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-----rvFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-----RVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-----eEEEEeh
Confidence            5789999999999999999999999999854      3455678999999999999999876663322     2778999


Q ss_pred             cchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEEEeecCCccccccC
Q 014595          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vkl~DfG~a~~~~~~  238 (422)
                      -+.|++..++....  .+++++...+.++.||+.||.|||- ++|+|+||||+|||+.+..  .++||||||+|+++.+.
T Consensus       644 Kl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  644 KLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            99987777665443  4889999999999999999999998 9999999999999997543  37999999999999887


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      .-..+.+|||.|.|||+++.. .|++.-|+||+|||+|--|.|..||....+ .+++++                    .
T Consensus       721 sFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN--------------------A  779 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN--------------------A  779 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhc--------------------c
Confidence            777889999999999999755 499999999999999999999999965432 233332                    2


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      .|.+|   +.||.     .+++++.|||..+|+..-++|.|.+..|.|||+++.
T Consensus       780 aFMyP---p~PW~-----eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  780 AFMYP---PNPWS-----EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ccccC---CCchh-----hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            23333   45674     579999999999999999999999999999999874

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-46  Score=328.53  Aligned_cols=253  Identities=30%  Similarity=0.458  Sum_probs=212.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc--chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      -|.++.+||+|+||.||+|.++.+|..+|||.+..  +.+.+.+|+.||++++.|++|++++.|+...+     +++|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence            38888999999999999999999999999999754  44566789999999999999999999977666     889999


Q ss_pred             cch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC-
Q 014595          161 YVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  238 (422)
Q Consensus       161 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~-  238 (422)
                      ||+ |+..++++..   .+.+++.++..++...+.||+|||. ..-||||||..|||++.+| ..||+|||.|..+.+. 
T Consensus       109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccc-hhhhhhccccchhhhhH
Confidence            998 6777877754   4789999999999999999999998 8999999999999999999 5999999999765432 


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                      ....+..|||.|||||++.. -.|+.++||||||++..||.-|++||.+-.....                        .
T Consensus       184 AKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------------------------I  238 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------------------------I  238 (502)
T ss_pred             HhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccce------------------------e
Confidence            22356789999999999964 4599999999999999999999999976543322                        1


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      |.+|..++..+.+  +...|.++.|||+.||...|++|-||.++++|||+++..
T Consensus       239 FMIPT~PPPTF~K--PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  239 FMIPTKPPPTFKK--PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             EeccCCCCCCCCC--hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            2233333333322  234688899999999999999999999999999998753

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.3e-43  Score=337.50  Aligned_cols=276  Identities=36%  Similarity=0.589  Sum_probs=217.2

Q ss_pred             eeE-EeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh------------------hHHHHHHHHHHcCCCCcccccce
Q 014595           83 SYI-AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------YKNRELQIMQMLDHPNIVALKHC  143 (422)
Q Consensus        83 ~y~-~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~~~  143 (422)
                      +|. +.+.||.|+||+||+|++..+++.||||++.....                  ...+|+++++.++|+||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            465 56789999999999999999999999998754211                  24579999999999999999998


Q ss_pred             eecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCc
Q 014595          144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  223 (422)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~  223 (422)
                      +.     ...+.+++|||+.+++...+..    ...+++..+..++.|++.||+|||+ .||+|+||||+||+++.++ .
T Consensus        89 ~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~-~  157 (335)
T PTZ00024         89 YV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKG-I  157 (335)
T ss_pred             Ee-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCC-C
Confidence            73     3345889999999877666543    3568999999999999999999999 8999999999999999887 6


Q ss_pred             EEEeecCCccccccC---------------CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014595          224 LKLCDFGSAKVLVKG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE  288 (422)
Q Consensus       224 vkl~DfG~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~  288 (422)
                      ++|+|||++......               .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999998765411               11122345788999999876666799999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcC--cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCC
Q 014595          289 SGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (422)
Q Consensus       289 ~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  366 (422)
                      +..+.+..+...++.+....+....  +.+..+  ....+...... ....+.++.+||.+||..||++|||++|+|.||
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             CHHHHHHHHHHHhCCCchhhCcchhhccccccc--CcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            9888888888888877665443221  111111  01111111111 135688999999999999999999999999999


Q ss_pred             cccccC
Q 014595          367 FFDELR  372 (422)
Q Consensus       367 ~f~~~~  372 (422)
                      ||+...
T Consensus       315 ~~~~~~  320 (335)
T PTZ00024        315 YFKSDP  320 (335)
T ss_pred             ccCCCC
Confidence            998743

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-43  Score=328.41  Aligned_cols=276  Identities=40%  Similarity=0.702  Sum_probs=219.1

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++...      .....+|+++++.++|+||+++++++..     ....+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            499999999999999999999999999999987532      1334689999999999999999998843     33478


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ++|||+++++...+.   .....+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++ .+||+|||++....
T Consensus        77 iv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~  151 (288)
T cd07833          77 LVFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESG-VLKLCDFGFARALR  151 (288)
T ss_pred             EEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence            999999976544332   223568999999999999999999999 8999999999999999877 69999999987665


Q ss_pred             cCC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 014595          237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  313 (422)
Q Consensus       237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  313 (422)
                      ...  ......++..|+|||++.+...++.++|+||||+++|+|++|++||.+.+..+.+..+...++.........+. 
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            443  23345678889999999776468999999999999999999999999888888787777776665554433222 


Q ss_pred             -cCCccCcCCCCC-CCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          314 -PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       314 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                       +.+....++... ...+...++..++.++++||++||..||++|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             122222222211 1122223334568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-43  Score=328.39  Aligned_cols=274  Identities=40%  Similarity=0.733  Sum_probs=221.2

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+....      ....+|+.+++.++|+||+++++++..     ...+++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence            567789999999999999999899999999876432      234579999999999999999998743     244789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ++||+++++...+...   ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            9999998776655442   2578999999999999999999999 8999999999999999877 699999999876644


Q ss_pred             CC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--
Q 014595          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  314 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  314 (422)
                      .. ......++..|+|||.+.+...++.++|+||||+++|+|+||+.||.+.+..+.+..+...++.+....+..+..  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            33 223345788899999987664689999999999999999999999999998888888888888877665554432  


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      ....+.++.......... .+.++.++++||.+||..||.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKL-FPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCHHHh-hhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            122233333222222222 24578999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-42  Score=335.32  Aligned_cols=285  Identities=35%  Similarity=0.638  Sum_probs=222.0

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCC-Cce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~~~  153 (422)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++|+||+++++++...... ...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            345999999999999999999999999999999885421      2345799999999999999999987433221 223


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .+++||||+++++..++.     ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus        94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence            467999999877765553     2568999999999999999999999 8999999999999999887 69999999987


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ....  ......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+....+.++++..+.++.+....+.
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            6532  22345678899999998664558899999999999999999999999888888888887776666554433222


Q ss_pred             cCCc-c--CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          314 PNYT-E--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       314 ~~~~-~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      .... .  ...+......+. .+.+.+++++.++|.+||+.||.+|||+.+++.||||+..+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~  308 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE  308 (343)
T ss_pred             chhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence            1100 0  011111111111 12246788999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.9e-42  Score=326.30  Aligned_cols=261  Identities=24%  Similarity=0.361  Sum_probs=206.7

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ..+|.+.+.||+|+||.||+|.+..+++.+|+|.+...   .....+|+.+++.+ +||||+++++++...........+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            34599999999999999999999999999999988643   23345789999998 899999999988654433344578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ ++.+++.........+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .+||+|||++...
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~  178 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence            99999975 7766665444445678999999999999999999999 8999999999999999877 6999999998765


Q ss_pred             ccCC-CcccccccccccchhhhcCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          236 VKGE-PNVSYICSRYYRAPELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      .... ......++..|+|||.+....    .++.++|||||||++|+|++|++||...+....+..+....  +      
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~------  250 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP--P------  250 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC--C------
Confidence            4322 122346788899999985432    26889999999999999999999998776554444332210  0      


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                              ..+          ..+...+..+.+||.+||+.||++||++.++++||||+
T Consensus       251 --------~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 --------PTL----------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             --------CCC----------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                    000          01134577899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=325.99  Aligned_cols=275  Identities=39%  Similarity=0.692  Sum_probs=220.0

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |.+.+.||.|+||+||+|+...+++.||||++....     ....+|+..++.++ |+||+++++++..     ....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            678899999999999999998899999999875432     22346899999999 9999999998843     334789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||+++++.+.+....  ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            99999888766655422  2468999999999999999999999 8999999999999999877 699999999987655


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC--
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--  315 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--  315 (422)
                      ........++..|+|||++.+...++.++|+||||+++|+|++|++||.+.+..+.+.++...++.+....+......  
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            444445677889999999866666899999999999999999999999999988899999888888876554322111  


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      .....++..........+ ...+.++.+||++||+.||++|||+.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            111122222211222222 2347899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-43  Score=323.40  Aligned_cols=247  Identities=28%  Similarity=0.454  Sum_probs=199.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .|.+.+.||+|++|.||+|.+..+++.||+|.+....         ....+|+++++.++||||+++++++.     ...
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DDE   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cCC
Confidence            3899999999999999999999999999999875321         23457999999999999999999883     233


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++++||+++ ++.+.+..    ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~-~~~l~dfg~~  151 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS  151 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence            68899999975 55555443    3568899999999999999999999 8999999999999999877 6999999998


Q ss_pred             cccccCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          233 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       233 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      +........    ....++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+....       
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------  223 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-------  223 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-------
Confidence            765332111    2345678899999997654 8999999999999999999999998765554443332210       


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                          ....++..++.++.+||++||..||.+|||+.++++||||
T Consensus       224 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 --------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             --------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                0001224578999999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=330.07  Aligned_cols=257  Identities=29%  Similarity=0.504  Sum_probs=207.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+....       ....+|+++++.++|+||+++++.+     ....+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            4999999999999999999999999999999886432       2345799999999999999999887     334468


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++|||+.+ +|.+++...  ....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~  152 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESG-HIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence            899999975 776655432  23578999999999999999999999 8999999999999999887 699999999865


Q ss_pred             cccCCC------------------------------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014595          235 LVKGEP------------------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  284 (422)
Q Consensus       235 ~~~~~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~p  284 (422)
                      ......                              .....||..|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence            432211                              1123578889999999654 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC----HH
Q 014595          285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT----AL  360 (422)
Q Consensus       285 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~  360 (422)
                      |.+.+....+.++...                 ...++.          ...++.+++++|.+||+.||++|||    ++
T Consensus       232 f~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         232 FKGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            9888766665554321                 011110          0136899999999999999999999    99


Q ss_pred             HHhcCCcccccCCCCC
Q 014595          361 EACVHPFFDELRDPNT  376 (422)
Q Consensus       361 e~l~hp~f~~~~~~~~  376 (422)
                      ++|+||||+....+..
T Consensus       285 ~ll~~~~~~~~~~~~~  300 (316)
T cd05574         285 EIKQHPFFRGVNWALI  300 (316)
T ss_pred             HHHcCchhhcCChhhc
Confidence            9999999998765443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-42  Score=326.44  Aligned_cols=256  Identities=27%  Similarity=0.416  Sum_probs=201.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHH-HHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||+|+||.||+|++..+|+.||||++....     .....|+.+ ++.++||||+++++++...     ..++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcEE
Confidence            4899999999999999999999999999999886432     122345554 6677999999999988432     3478


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++|||+++++..++.........+++..++.++.||+.||+|||+ + +++||||||+||+++.++ .+||+|||++...
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~  154 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL  154 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence            999999988877776544445679999999999999999999998 6 999999999999999887 6999999998765


Q ss_pred             ccCCCcccccccccccchhhhcCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhh
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ..........++..|+|||.+.+.   ..++.++|+|||||++|+|++|+.||... ...+.+..+....          
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  224 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP----------  224 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC----------
Confidence            443333335678889999988542   34688999999999999999999999643 2223333322210          


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                            ...++           ...+|.++.+||.+||..||.+|||+.++++||||....
T Consensus       225 ------~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         225 ------SPQLP-----------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ------CCCCC-----------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                  00010           124688999999999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-43  Score=335.59  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=197.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..|++++.||+||-+.||++.... .+.||+|++...      ...+..|+..|.+| .|.+||+|+++-     -.+.|
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~  434 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY  434 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence            369999999999999999999753 466777765321      23345899999999 589999999975     33678


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +||||||-+.+|..++..+.   ..++.-+++.|+.||+.|+.++|. .||||.||||.|+|+-. | .+||+|||+|..
T Consensus       435 lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlVk-G-~LKLIDFGIA~a  508 (677)
T KOG0596|consen  435 LYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLVK-G-RLKLIDFGIANA  508 (677)
T ss_pred             EEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEEe-e-eEEeeeechhcc
Confidence            99999999999999888754   234445899999999999999999 89999999999999884 4 699999999988


Q ss_pred             cccCCCc---ccccccccccchhhhcCCC----------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014595          235 LVKGEPN---VSYICSRYYRAPELIFGAT----------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  301 (422)
Q Consensus       235 ~~~~~~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~  301 (422)
                      +..+...   .+.+||+.||+||.+....          ..++++||||||||||+|+.|++||..-.  ..+ ..+..+
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~-aKl~aI  585 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQI-AKLHAI  585 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHH-HHHHhh
Confidence            7655433   4679999999999984321          25789999999999999999999995321  122 222333


Q ss_pred             CCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      ..|.           ..+.||.+.           -..++.++++.||++||.+|||+.++|+|||++-..
T Consensus       586 ~~P~-----------~~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  586 TDPN-----------HEIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             cCCC-----------ccccccCCC-----------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence            2221           223344321           123399999999999999999999999999998743

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.5e-42  Score=329.27  Aligned_cols=304  Identities=35%  Similarity=0.680  Sum_probs=232.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||.|+||.||+|.+..+++.||||++.+.      .....+|+++++.++||||++++++|...    ....
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~~~   85 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LEDI   85 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CCcE
Confidence            4599999999999999999999999999999987532      23345799999999999999999987432    2246


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++++||+++++..++.     ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus        86 ~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~  158 (328)
T cd07856          86 YFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENC-DLKICDFGLARIQ  158 (328)
T ss_pred             EEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCC-CEEeCcccccccc
Confidence            7999999887765554     2467888899999999999999999 8999999999999999877 6999999998754


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..  ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+.+.++.++.+........
T Consensus       159 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         159 DP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             CC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence            22  2234567888999998866456899999999999999999999999988887777778888888776654422111


Q ss_pred             -CccC--cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCC
Q 014595          316 -YTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP  392 (422)
Q Consensus       316 -~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  392 (422)
                       ...+  ..+.....+..... +.++..+.++|++||+.||++|||+.+++.||||.....+.....    ....++|.-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~----~~~~~~~~~  311 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV----AEEKFDWSF  311 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccC----chhhcCCch
Confidence             0000  11111122222222 357899999999999999999999999999999998876643311    122454542


Q ss_pred             CCCCCCChhHHh
Q 014595          393 PELSGIPPETIN  404 (422)
Q Consensus       393 ~~~~~~~~~~~~  404 (422)
                       .-.++|-++|+
T Consensus       312 -~~~~~~~~~~~  322 (328)
T cd07856         312 -NDADLPVDTWK  322 (328)
T ss_pred             -hcccCCHHHHH
Confidence             23456666664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.2e-43  Score=334.85  Aligned_cols=276  Identities=22%  Similarity=0.359  Sum_probs=198.5

Q ss_pred             Eeeeeeec--CCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           86 AEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        86 ~~~~lg~G--~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +.++||+|  +|++||+++++.+|+.||||++....      ....+|+++++.++||||+++++++..     ..+.++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence            45779999  78899999999999999999986431      345579999999999999999998843     234789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ ++.+++....  ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence            9999984 6666654322  2458999999999999999999998 8999999999999999887 69999998654332


Q ss_pred             cCCC--------cccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC----
Q 014595          237 KGEP--------NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT----  303 (422)
Q Consensus       237 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~----  303 (422)
                      ....        .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||..................    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence            1111        1123456779999998653 35899999999999999999999999876654443333221000    


Q ss_pred             ---CCHHHHhhcCcC-------CccC-c----CCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          304 ---PTREEIKCMNPN-------YTEF-K----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       304 ---~~~~~~~~~~~~-------~~~~-~----~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                         .+.+.+. +.+.       .... .    .+.... .........+++++.+||++||+.||++|||++++++||||
T Consensus       233 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f  310 (327)
T cd08227         233 TTTIPAEELT-MKPSRSGANSGLGESTTVSTPRPSNGE-SSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  310 (327)
T ss_pred             ccchhhhhcc-cCCcccCCcCCCCcccccCCcCccccC-CcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence               0001100 0000       0000 0    000000 00011223467899999999999999999999999999999


Q ss_pred             cccC
Q 014595          369 DELR  372 (422)
Q Consensus       369 ~~~~  372 (422)
                      +.+.
T Consensus       311 ~~~~  314 (327)
T cd08227         311 KQIK  314 (327)
T ss_pred             hhcc
Confidence            8864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=326.83  Aligned_cols=277  Identities=34%  Similarity=0.611  Sum_probs=216.4

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |.+.+.||.|+||.||+|++..+|+.||+|.+....      ....+|+++++.++|+|++++++++....   ..+.++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            678899999999999999999999999999986542      23457999999999999999999874321   245789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||+++++..++...   ...+++..++.++.||+.||+|||+ .|++|+||||+||+++.++ .+||+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDG-VLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence            9999998776555432   2478999999999999999999999 8999999999999999887 699999999976644


Q ss_pred             CCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          238 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       238 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ...  .....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+....+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            331  233456788999998876666899999999999999999999999998888888888887777765544322110


Q ss_pred             --CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       316 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                        ...+.............+...+++++.++|++||..||.+||++.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              00000000001111122222248999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.8e-42  Score=325.49  Aligned_cols=260  Identities=24%  Similarity=0.348  Sum_probs=205.7

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ..+|.+.+.||+|+||.||+|++..+++.+|+|++....   ....+|+.+++.+ +|+||+++++++.........+.+
T Consensus        17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   96 (286)
T cd06638          17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW   96 (286)
T ss_pred             ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence            346999999999999999999999999999999875422   3455799999999 799999999987654444556788


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ +|.+++.........+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||++...
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~  174 (286)
T cd06638          97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  174 (286)
T ss_pred             EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCC-CEEEccCCceeec
Confidence            99999974 6766665544445678999999999999999999999 8999999999999999887 6999999998765


Q ss_pred             ccCC-CcccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          236 VKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      .... ......+++.|+|||++..    ...++.++|+|||||++|+|++|..||...+....+.++...   .      
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~------  245 (286)
T cd06638         175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---P------  245 (286)
T ss_pred             ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---C------
Confidence            4322 2234468899999998743    234788999999999999999999999776543333221110   0      


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                .+       ....+...+.++.+||.+||+.||++|||+.|+++||||
T Consensus       246 ----------~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 ----------PP-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ----------CC-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                      00       000112357889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.9e-43  Score=352.28  Aligned_cols=278  Identities=22%  Similarity=0.306  Sum_probs=196.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCC-eEEEEE------------------Eeccc---hhhHHHHHHHHHHcCCCCccc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIK------------------KVLQD---KRYKNRELQIMQMLDHPNIVA  139 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vAiK------------------~~~~~---~~~~~~E~~~l~~l~h~nIv~  139 (422)
                      .+|.+.+.||+|+||+||+|..+... ..+++|                  .+...   ...+.+|+.+++.++|+|||+
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            46999999999999999999765332 222222                  11111   123457999999999999999


Q ss_pred             ccceeecCCCCCceEEEEEeecchhHHHHHHHHh-hhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEc
Q 014595          140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  218 (422)
Q Consensus       140 l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~  218 (422)
                      +++++..     ..+.+++++++.+++...+... ...........++.++.||+.||+|||+ +|||||||||+|||++
T Consensus       228 l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl~  301 (501)
T PHA03210        228 IEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFLN  301 (501)
T ss_pred             EeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC
Confidence            9998833     3347789999987665544321 1112334466778899999999999999 8999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC---CChHHH
Q 014595          219 PHTHQLKLCDFGSAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG---ESGVDQ  293 (422)
Q Consensus       219 ~~~~~vkl~DfG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~---~~~~~~  293 (422)
                      .++ .+||+|||+++.+.....  .....||+.|+|||++.+. .++.++|||||||++|||++|..++.+   .+...+
T Consensus       302 ~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        302 CDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            887 699999999986644322  2346789999999999664 489999999999999999998854432   234456


Q ss_pred             HHHHHHHhCCCCHHH-------HhhcCcCCccCcCCCCCCCCccccc-ccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          294 LVEIIKVLGTPTREE-------IKCMNPNYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       294 ~~~i~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      +.+++..++....+.       +....    ...+... .......+ ...++.++.++|.+||++||.+|||+.|+|.|
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~----~~~~~~~-~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYID----SAEIDHA-GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhh----hhhcccC-ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            666666554433221       00000    0000000 01111111 12467889999999999999999999999999


Q ss_pred             CcccccC
Q 014595          366 PFFDELR  372 (422)
Q Consensus       366 p~f~~~~  372 (422)
                      |||....
T Consensus       455 p~f~~~~  461 (501)
T PHA03210        455 PLFSAEE  461 (501)
T ss_pred             hhhhcCC
Confidence            9998754

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-42  Score=323.69  Aligned_cols=255  Identities=24%  Similarity=0.391  Sum_probs=201.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHc-CCCCcccccceeecCCCC-CceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK-EELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~-~~~~~~l  157 (422)
                      .|.+.+.||+|+||.||+|++..+++.||+|.+...   .....+|+.+++.+ +|+||+++++++...... ....+++
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   86 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL   86 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence            488999999999999999999999999999988543   23456799999998 799999999988654322 2346789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|||+++ ++..++...  ....+++..+..++.|++.||+|||+ .||+|+||||+||+++.++ .+||+|||++....
T Consensus        87 v~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~  162 (272)
T cd06637          87 VMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCC-CEEEccCCCceecc
Confidence            9999985 666655432  23568899999999999999999999 8999999999999999887 69999999987653


Q ss_pred             cC-CCcccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          237 KG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      .. .......+++.|+|||++.+    ...++.++|+|||||++|+|++|..||...........+...           
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~-----------  231 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-----------  231 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC-----------
Confidence            22 22234567889999999853    234788999999999999999999999765543332221110           


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                      +........++.++.+|+.+||..||.+|||+.++++||||
T Consensus       232 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         232 ----------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ----------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                            00001113468899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-42  Score=322.67  Aligned_cols=274  Identities=41%  Similarity=0.711  Sum_probs=222.5

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |++.+.||+|+||.||+|++..+++.||+|.+....      .....|+.+++.++|+||+++++++..     ..+.++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence            567788999999999999999999999999886532      233479999999999999999998843     245789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||+++++...+....   ..+++..+..++.|++.||+|||+ .||+||||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            99999988777665422   468999999999999999999999 8999999999999999877 699999999876543


Q ss_pred             CC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC-
Q 014595          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-  315 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  315 (422)
                      .. .......+..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++....+.+....+..+... 
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            32 2223455778999999876656899999999999999999999999999988889999998888888776544322 


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      +....++..........+ +.++..+.++|++||..||++||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            122233333333333333 3458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-43  Score=341.32  Aligned_cols=255  Identities=29%  Similarity=0.421  Sum_probs=215.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ...|.+.+.||+|.|++|.+|++..|+..||||.+.+..      ....+|+++|+.|+|||||+++.+.....     .
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~-----~  129 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA-----T  129 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-----e
Confidence            345999999999999999999999999999999987642      22458999999999999999999884433     3


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +|+||||+.++-   +..|...++++.+..++.++.|+++|++|||+ ++|||||||.+||||+.+. .+||+|||++..
T Consensus       130 lylV~eya~~ge---~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~  204 (596)
T KOG0586|consen  130 LYLVMEYASGGE---LFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENM-NIKIADFGFSTF  204 (596)
T ss_pred             eEEEEEeccCch---hHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccccc-ceeeecccccee
Confidence            889999998522   33444456788889999999999999999999 8999999999999999988 599999999999


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      +..+....+++|++.|.|||++.+..+.++.+|+||+|+++|.|+.|.+||.|.+-.+.-...+.               
T Consensus       205 ~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~---------------  269 (596)
T KOG0586|consen  205 FDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR---------------  269 (596)
T ss_pred             ecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee---------------
Confidence            88787788999999999999999988889999999999999999999999998763322211111               


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                        ..+.+|            -.++.++.+||+++|..+|.+|++.+++++|.|.......
T Consensus       270 --gk~rIp------------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 --GKYRIP------------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             --eeeccc------------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence              111221            3478999999999999999999999999999999876544

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-42  Score=322.71  Aligned_cols=278  Identities=34%  Similarity=0.595  Sum_probs=215.9

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHc---CCCCcccccceeecCCCCCceE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      |.+.+.||+|+||.||+|+++.+++.||+|.+....      ....+|+.+++++   +|+||+++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999998889999999986321      2234677777766   5999999999986655445556


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++++|||+++++...+....  ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDG-QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCC-CEEEeccCccee
Confidence            88999999887766554322  2368999999999999999999999 8999999999999999887 799999999977


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...........++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+..+.+.++.+..+.+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            6544444445678889999999664 489999999999999999999999999988888888887665554332211100


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                       .....++.....++... .+.+++.+.+||.+||+.||.+||++.++++||||
T Consensus       236 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 -LPRSSFPSYTPRSFKSF-VPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             -cchhhcccccccchhhh-hhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence             00001111111222221 13567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.4e-42  Score=324.52  Aligned_cols=248  Identities=30%  Similarity=0.503  Sum_probs=205.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+++++++.||||+++++++.     ....+
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCeE
Confidence            4999999999999999999999999999999885421       23457999999999999999999883     33457


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||++ +++.+.+..    ...+++..+..++.||+.||.|||+ .||+|+||+|.|||++.++ .+||+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~  150 (290)
T cd05580          77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDG-YIKITDFGFAKR  150 (290)
T ss_pred             EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence            89999995 566555543    3678999999999999999999999 8999999999999999887 699999999987


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ....  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+...              
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------  213 (290)
T cd05580         151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--------------  213 (290)
T ss_pred             cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------
Confidence            6443  3345678999999998654 5789999999999999999999999877754444443321              


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                         ...            ++..++..++++|.+||+.||.+|+     +++|+++||||..+..
T Consensus       214 ---~~~------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  262 (290)
T cd05580         214 ---KVR------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW  262 (290)
T ss_pred             ---Ccc------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence               011            1234689999999999999999999     9999999999988653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-42  Score=334.93  Aligned_cols=249  Identities=24%  Similarity=0.380  Sum_probs=190.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|++.+.||+|+||.||+|.+.     .+++.||||++....     ....+|+.+++.+ +||||+++++++...   
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---   83 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP---   83 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC---
Confidence            46999999999999999999752     345789999986422     2345799999999 899999999877422   


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhh------------------------------------------------------
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSR------------------------------------------------------  175 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------------------------------------------------  175 (422)
                       ...++++|||++ ++|.+++.....                                                      
T Consensus        84 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          84 -NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             -CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence             224678999998 467666553211                                                      


Q ss_pred             ----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCC---cccccccc
Q 014595          176 ----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSR  248 (422)
Q Consensus       176 ----~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~  248 (422)
                          ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.......   .....+++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCc
Confidence                12347788889999999999999999 8999999999999999877 699999999976533221   11234467


Q ss_pred             cccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCC
Q 014595          249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH  327 (422)
Q Consensus       249 ~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (422)
                      .|+|||++.+. .++.++|||||||++|||++ |..||.+....+.+...+...               ....       
T Consensus       241 ~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---------------~~~~-------  297 (338)
T cd05102         241 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG---------------TRMR-------  297 (338)
T ss_pred             cccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC---------------CCCC-------
Confidence            89999998654 48999999999999999997 999998765433333322210               0000       


Q ss_pred             CcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       328 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                           .+..+++++.+|+.+||..||.+|||+.++++
T Consensus       298 -----~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         298 -----APENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             -----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                 12356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.1e-42  Score=325.67  Aligned_cols=281  Identities=31%  Similarity=0.512  Sum_probs=217.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-----C
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-----K  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~  150 (422)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||.+....      ....+|+++++.++||||+++++++....+     .
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            45999999999999999999999999999999885422      234579999999999999999988754331     1


Q ss_pred             CceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      ...++++++||+++++...+..   ....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .+||+|||
T Consensus        87 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~kl~dfg  161 (302)
T cd07864          87 DKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKG-QIKLADFG  161 (302)
T ss_pred             cCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-cEEeCccc
Confidence            1236889999999876555443   13468999999999999999999999 8999999999999999887 69999999


Q ss_pred             CccccccCCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          231 SAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       231 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ++........  .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.+....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV  241 (302)
T ss_pred             ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            9876543331  12234577899999886655678999999999999999999999998888888888888777766554


Q ss_pred             HhhcCc--CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          309 IKCMNP--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       309 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      +.....  .+............+... ...++..+.+||.+||..||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            432211  000000000000011111 13468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=315.85  Aligned_cols=279  Identities=33%  Similarity=0.562  Sum_probs=228.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|.-++.+|.|.- .|..|.+.-+++.||+|++...      .+...+|..++..++|+||++++.+|.-... .+..-
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            36999999999999 8889999999999999987543      2334589999999999999999998843222 22334


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +|+|||+|..++.+.+.      ..+.-..+..+++|++.|++|||+ .||+||||||+||++..+. .+||.|||+|+.
T Consensus        96 ~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDC-TLKILDFGLART  167 (369)
T ss_pred             HHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchh-heeeccchhhcc
Confidence            78999999998877765      345667789999999999999999 8999999999999999887 799999999987


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ....-..+.++.|.+|+|||++.+.. |...+||||+||++.||++|+..|+|.+..++..++.+.+|.|.......+.+
T Consensus       168 e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  168 EDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             cCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            65554567789999999999998877 99999999999999999999999999999999999999999999998876654


Q ss_pred             CCccC--cCCCCCCCCcccccc-----------cCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          315 NYTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       315 ~~~~~--~~~~~~~~~~~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      ....|  ..|+.....+...|+           +.-+..+++|+.+||..||++|.+++++|+||||+-
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v  315 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV  315 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence            32211  122222122222221           122456899999999999999999999999999993

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.5e-42  Score=315.66  Aligned_cols=249  Identities=28%  Similarity=0.441  Sum_probs=200.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|++.+.||.|++|.||+|.+..+++.||+|.+....      ....+|+++++.++|+|++++++.+.    .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            3999999999999999999999999999999985321      23457999999999999999987662    2234578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++|||+++ ++.+.+...  ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            99999974 665555532  23568999999999999999999999 8999999999999999877 6999999998765


Q ss_pred             ccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..... .....+++.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+.......+....             
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-------------  218 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------
Confidence            43222 2334678899999998654 58899999999999999999999998776555444433210             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                            .+.         .+..+++++.+||.+||+.||++|||+.++++||||
T Consensus       219 ------~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 ------LPP---------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ------CCC---------CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  000         113578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-42  Score=324.78  Aligned_cols=252  Identities=27%  Similarity=0.451  Sum_probs=197.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|.+.++||+|+||.||+|++..+++.||+|.+..+.     ..+.+|++++++++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence            4788899999999999999999999999999885431     234579999999999999999998843     234679


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||+++......       ..+++..+..++.|++.||.|||+ .||+|+||||+|||++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence            9999986432211       357888899999999999999999 8999999999999999887 699999999976533


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ---LVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      . ......+|..|+|||++.+. .++.++|+|||||++|+|++|..||......+.   .......+...          
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------  215 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE----------  215 (279)
T ss_pred             c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc----------
Confidence            2 23345789999999998654 489999999999999999999999965322110   01111110000          


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      .     .+        .......++++++|+.+||+.||.+||++.++++||||+....
T Consensus       216 ~-----~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         216 D-----PP--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             C-----CC--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            0     00        0001246789999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=301.95  Aligned_cols=257  Identities=25%  Similarity=0.338  Sum_probs=203.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|++.+.||+|||+.||+++...++..||+|++.-.    .....+|++..++++|||+++++++............|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            4699999999999999999999999999999998543    234458999999999999999998876655556666889


Q ss_pred             Eeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--ivHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++|.. |++.+.+......+..+++..+..++.+|++||++||+ ..  ++||||||.|||+...+ .++|.|||.++.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSG-LPVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCC-ceEEEeccCccc
Confidence            999987 67888888877777789999999999999999999998 78  99999999999999876 799999999865


Q ss_pred             cccCC----------CcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 014595          235 LVKGE----------PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  302 (422)
Q Consensus       235 ~~~~~----------~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~  302 (422)
                      ..-..          ......+|..|+|||.+.-  ....++++|||||||+||+|+.|..||...         .+..|
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~Gg  249 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQGG  249 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcCC
Confidence            42111          1123456889999999832  234789999999999999999999999421         11000


Q ss_pred             CCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .-.   +..   ....+++|+.          ...|+.+.+||+.||+.||.+||++.+++.+
T Consensus       250 Sla---LAv---~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  250 SLA---LAV---QNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eEE---Eee---eccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            000   000   0012233321          3478999999999999999999999999864

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-43  Score=320.01  Aligned_cols=252  Identities=28%  Similarity=0.469  Sum_probs=210.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhH-------HHHHHHHHHc-CCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-------~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|..+.+||+|+||+|.+|..+.|.+.||||+++++....       ..|-++|... +-|.+++++.||....    
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD----  423 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD----  423 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh----
Confidence            346889999999999999999999999999999887653221       2477777766 5678889999884333    


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                       .+|+||||+.| +|-..+..    -+.+.+..+..|+..|+-||-|||+ +|||+||||.+|||++.+|+ +||+|||+
T Consensus       424 -RLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eGH-iKi~DFGm  496 (683)
T KOG0696|consen  424 -RLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGH-IKIADFGM  496 (683)
T ss_pred             -heeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCCc-eEeeeccc
Confidence             37899999986 44333333    3678899999999999999999999 99999999999999999995 99999999


Q ss_pred             ccccc-cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          232 AKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       232 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ++... .+....+.+|||.|+|||++. ...|+..+|+||+||+||||+.|.+||.|.+..+.++.|+..          
T Consensus       497 cKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh----------  565 (683)
T KOG0696|consen  497 CKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH----------  565 (683)
T ss_pred             ccccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----------
Confidence            97643 334456789999999999985 456999999999999999999999999999999999998873          


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH-----HHHhcCCcccccCC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  373 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~  373 (422)
                             ...            +++.+|.++.++++.+|...|.+|+..     .++-.||||+.+.+
T Consensus       566 -------nvs------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW  614 (683)
T KOG0696|consen  566 -------NVS------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW  614 (683)
T ss_pred             -------cCc------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence                   222            346789999999999999999999854     68999999998864

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.5e-42  Score=324.93  Aligned_cols=262  Identities=22%  Similarity=0.370  Sum_probs=201.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|...+.||+|+||.||++.+..+++.||||.+...     .....+|+.++.++. |+||+++++++...     ...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEE
Confidence            366778899999999999999999999999988642     223457889999996 99999999987432     2366


Q ss_pred             EEeecchhHHHHHHHHh-hhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++|||++.++..+.... ......+++..+..++.|++.||+|||+..||+||||||+||+++.++ .+||+|||++...
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence            89999987665544321 222467999999999999999999999734999999999999999877 6999999999766


Q ss_pred             ccCCCcccccccccccchhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ..........+++.|+|||++.+.  ..++.++|||||||++|+|++|+.||....  .....+.+.....         
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~---------  227 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGD---------  227 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCC---------
Confidence            544444455678899999998655  368999999999999999999999997654  1222222211000         


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                             .+...     ......++.++.+||.+||+.||++|||++++++||||+....
T Consensus       228 -------~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         228 -------PPILS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             -------CCcCC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence                   00000     0011347899999999999999999999999999999987553

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-42  Score=323.93  Aligned_cols=259  Identities=27%  Similarity=0.452  Sum_probs=202.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+....     ....+|+.++++++|+||+++++++..     ..++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEEE
Confidence            4889999999999999999999899999999875421     234579999999999999999998743     345789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ ++..++... .....+++..+..++.|++.||.|||+..||+|+||||+||+++.++ .+||+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  154 (286)
T cd06622          77 CMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLV  154 (286)
T ss_pred             EEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCccccc
Confidence            9999986 555544431 11347899999999999999999999625999999999999999876 69999999987653


Q ss_pred             cCCCcccccccccccchhhhcCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          237 KGEPNVSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ... .....+++.|+|||.+.+..     .++.++|+|||||++|+|++|+.||...........+......+.      
T Consensus       155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  227 (286)
T cd06622         155 ASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------  227 (286)
T ss_pred             CCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC------
Confidence            322 23345788899999985432     358899999999999999999999976554333332222111000      


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                                +         .++..++.++.+||.+||+.||.+||++.++++||||......
T Consensus       228 ----------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         228 ----------P---------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             ----------C---------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                      0         0123478999999999999999999999999999999886544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-42  Score=318.77  Aligned_cols=260  Identities=26%  Similarity=0.402  Sum_probs=206.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHc-CCCCcccccceeecCCC-CCceEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELYL  155 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-~~~~~~  155 (422)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++....   ..+.+|+.+++++ .|+||+++++++..... ....++
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            346999999999999999999999899999999886532   3456799999999 79999999998865443 345667


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ ++.+++.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++..
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~~  162 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNA-EVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCC-eEEECCCcccee
Confidence            899999985 6666665444335678999999999999999999999 8999999999999999887 699999999875


Q ss_pred             cccCC-CcccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          235 LVKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       235 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ..... ......++..|+|||++..    ...++.++|||||||++|+|++|..||........+..+....        
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------  234 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--------  234 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC--------
Confidence            53322 2234567889999998743    2347789999999999999999999997665544444332210        


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                 .+.     +  ......+.++++||.+||..||++|||+.++++|||+
T Consensus       235 -----------~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         235 -----------PPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -----------CCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                       000     0  0012367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-43  Score=310.10  Aligned_cols=256  Identities=25%  Similarity=0.435  Sum_probs=201.2

Q ss_pred             eEE-eeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIA-EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~-~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |.+ .+.||+|+|+.|--+....||..||||++.+..    ....+|++++.+. .|+||++|+++|     +++..+|+
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYL  153 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYL  153 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEE
Confidence            443 467999999999999999999999999997642    3345899999998 699999999998     44445889


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEEEeecCCccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  234 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vkl~DfG~a~~  234 (422)
                      |||-|.| .+...+..    ...+++.++..+..+|+.||+|||. +||.||||||+|||...-.  ..||||||.++..
T Consensus       154 VfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             EEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeeccccccc
Confidence            9999985 44333333    4679999999999999999999999 9999999999999986432  2599999988754


Q ss_pred             cccC--------CCcccccccccccchhhhc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-----------
Q 014595          235 LVKG--------EPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-----------  291 (422)
Q Consensus       235 ~~~~--------~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-----------  291 (422)
                      +...        ....+.+|+..|||||+..    ....|+.++|.||||||+|-||.|.+||.|.-..           
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            3211        1224567888899999862    2346999999999999999999999999875321           


Q ss_pred             ----HHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCc
Q 014595          292 ----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (422)
Q Consensus       292 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  367 (422)
                          ..+..|..                 +.|.||.   ..|     ..+|.+++|||+.+|..|+..|.++.++++|||
T Consensus       309 ~CQ~~LFesIQE-----------------GkYeFPd---kdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  309 VCQNKLFESIQE-----------------GKYEFPD---KDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             HHHHHHHHHHhc-----------------cCCcCCh---hhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence                12222221                 2344543   233     358999999999999999999999999999999


Q ss_pred             ccccCCC
Q 014595          368 FDELRDP  374 (422)
Q Consensus       368 f~~~~~~  374 (422)
                      ++.+...
T Consensus       364 ~~~~~~e  370 (463)
T KOG0607|consen  364 VQRCAPE  370 (463)
T ss_pred             ccccchh
Confidence            9987644

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=332.86  Aligned_cols=242  Identities=26%  Similarity=0.378  Sum_probs=199.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .+.+++.||+|.||.||+|.+.. ...||+|.++..   ...+.+|+.+|++|+|+|||++++++....     -+||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEE
Confidence            35677889999999999999963 347999988653   345568999999999999999999984322     378999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      |||+ |+|.+.++.  ..+..+.......++.|||.|++||++ +++|||||...||||+.+. .+||+|||+|+...++
T Consensus       281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDL-VVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCc-eEEEcccccccccCCC
Confidence            9998 678777776  335778999999999999999999999 8999999999999999887 7999999999954433


Q ss_pred             CCcccc--cccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          239 EPNVSY--ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       239 ~~~~~~--~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .-....  --...|.|||.+. ...++.+||||||||+||||+| |+.||.+.+..+.+..+.+...             
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~-~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR-------------  422 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALN-YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR-------------  422 (468)
T ss_pred             ceeecCCCCCCceecCHHHHh-hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc-------------
Confidence            322211  1245599999995 4569999999999999999998 9999999998888888766432             


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHh
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  363 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  363 (422)
                           +|.          +..+|+++.+++..||..+|++|||.+.+.
T Consensus       423 -----lp~----------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  423 -----LPR----------PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             -----CCC----------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                 222          257899999999999999999999998654

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.6e-42  Score=324.63  Aligned_cols=277  Identities=26%  Similarity=0.407  Sum_probs=201.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|.+.+.||+|+||.||+|.+..++..||+|.+....     ....+|+++++.++||||+++++++..     ..++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEEE
Confidence            4999999999999999999999999999999875431     234579999999999999999998843     335889


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|||+++ +|..++..    ...+++..+..++.|++.||.|||+..+++|+||||+|||++.++ .+||+|||++....
T Consensus        77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (308)
T cd06615          77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI  151 (308)
T ss_pred             EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence            9999985 66665543    366899999999999999999999624899999999999999887 69999999987553


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .. ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+... ...+...................
T Consensus       152 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         152 DS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             cc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence            32 22345778999999998654 48899999999999999999999997665322 22222111000000000000000


Q ss_pred             ccCcCCC----------CCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          317 TEFKFPQ----------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       317 ~~~~~~~----------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      .....+.          .........-...++.++++|+.+||..||++|||+.++++||||....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence            0000000          0000000000113678899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-42  Score=321.23  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=203.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|.+.+.||.|+||.||+|++..+++.||+|.+....     ....+|+.+++.++|+||+++++++..     ..++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEEE
Confidence            4889999999999999999999999999999885432     234579999999999999999998742     346889


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      |+||+++ ++.+.+..     ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||+++...
T Consensus        77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  149 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEG-DVKLADFGVSGQLT  149 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence            9999985 66555443     378999999999999999999999 8999999999999999887 69999999997765


Q ss_pred             cC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .. .......+++.|+|||.+.+.. ++.++|+|||||++|+|+||..||...+.......+....              
T Consensus       150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------------  214 (274)
T cd06609         150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--------------  214 (274)
T ss_pred             ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--------------
Confidence            43 2223456788899999996554 8999999999999999999999997766444333322210              


Q ss_pred             CccCcCCCCCCCCcccccccC-CChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                           .+.         .... +++++.++|.+||..||++|||+.++++||||++...
T Consensus       215 -----~~~---------~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         215 -----PPS---------LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             -----CCC---------CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence                 000         1112 6889999999999999999999999999999988543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.9e-42  Score=323.17  Aligned_cols=257  Identities=28%  Similarity=0.433  Sum_probs=202.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..|++.+.||.|+||.||+|++..+++.||+|.+....    ....+|+.+++.++|+||+++++++..     ....++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence            35999999999999999999999999999999986432    234569999999999999999998743     335789


Q ss_pred             EeecchhH-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||++++ +...+..   ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        87 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence            99999864 4333322   23568999999999999999999999 8999999999999999877 69999999986543


Q ss_pred             cCC-CcccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          237 KGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ... ......+++.|+|||++.+    ...++.++|+|||||++|+|++|.+||...+....+.++...  .++      
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~------  233 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP------  233 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc------
Confidence            221 2234567889999998842    334688999999999999999999999776654443333221  000      


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                            ..            ..+..++.++.+||.+||..||++||++.++++||||..+...
T Consensus       234 ------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         234 ------TL------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             ------cC------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                  00            0123567899999999999999999999999999999887543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.2e-41  Score=314.43  Aligned_cols=249  Identities=27%  Similarity=0.450  Sum_probs=204.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|++.+.||+|+||.||+|.+..+++.+|||.+...      .....+|+++++.++||||+++++.+.     .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            489999999999999999999999999999987543      223457999999999999999998773     334578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ ++.+.+....  ...+++..+..++.|++.||+|||+ +||+|+||||+||+++.++..+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999975 6666665422  3458899999999999999999999 899999999999999876657899999999876


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+.....             
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-------------  218 (256)
T ss_pred             CCCccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence            55544445677889999999865 4488999999999999999999999987766555444432100             


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                            .         .++..+++++.+++.+||..||++|||+.|+++||||
T Consensus       219 ------~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         219 ------A---------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ------C---------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                  0         0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.9e-42  Score=320.98  Aligned_cols=255  Identities=26%  Similarity=0.397  Sum_probs=200.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHc-CCCCcccccceeecCCC-CCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-~~~~~~~l  157 (422)
                      .|++.+.||.|+||.||+|++..+++.||+|.+....   .....|+.+++++ +|+||+++++++..... ....++++
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   96 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL   96 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence            5999999999999999999999999999999875432   2345788888888 79999999998754322 23456789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|||+++ ++..++....  ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        97 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~  172 (282)
T cd06636          97 VMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCcchhhhh
Confidence            9999985 6666665422  3458888899999999999999999 8999999999999999887 69999999987543


Q ss_pred             cC-CCcccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          237 KG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      .. .......+++.|+|||.+..    ...++.++|+|||||++|+|++|..||........+..+...   .       
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~-------  242 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P-------  242 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---C-------
Confidence            22 22334568889999998752    234788999999999999999999999766543333222110   0       


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                               .        .......++.++.+||.+||..||.+|||+.|+++||||
T Consensus       243 ---------~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 ---------P--------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ---------C--------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                     0        000113578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=335.60  Aligned_cols=239  Identities=23%  Similarity=0.389  Sum_probs=199.0

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecch-hH
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ET  165 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~  165 (422)
                      ++.||.|+.|.||+|+..  ++.||||++..-   .+.+|+-|++|+|+||+.+.++|     ....++|||||||. |-
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el---kETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL---KETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhhh---hhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence            456999999999999986  789999988542   34688999999999999999999     45566899999998 56


Q ss_pred             HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCccccc
Q 014595          166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI  245 (422)
Q Consensus       166 l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~  245 (422)
                      |+.+++.    ...+.......|..+|+.|+.|||. +.|||||||.-||||..+. .|||+|||-++...+....++++
T Consensus       199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhh
Confidence            6666654    5678888889999999999999999 8999999999999999887 79999999999888778888999


Q ss_pred             ccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCC
Q 014595          246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  325 (422)
Q Consensus       246 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (422)
                      ||..|||||++.+. ..+.|+|||||||+|||||||..||.+-+....+.    ..|.                      
T Consensus       273 GTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GVGs----------------------  325 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GVGS----------------------  325 (904)
T ss_pred             hhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEE----eccC----------------------
Confidence            99999999999654 59999999999999999999999997654332211    1111                      


Q ss_pred             CCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          326 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       326 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                       ..+.-..+..+|.-++=||+.||.-.|..||+..++|.|-=+.
T Consensus       326 -NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  326 -NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             -CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence             1111123467889999999999999999999999999986443

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.8e-42  Score=318.24  Aligned_cols=246  Identities=34%  Similarity=0.554  Sum_probs=197.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------------hhHHHHHHHHHHcCCCCcccccceeecCCC
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  149 (422)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+....             ....+|+.+++.++||||+++++++.    
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL----   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence            3788899999999999999998889999999875321             23457999999999999999999873    


Q ss_pred             CCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                       ...+.+++|||+++ ++...+..    ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++ .++|+|
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          77 -DADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             -eCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCC-CEEecc
Confidence             23457799999975 56555543    3568889999999999999999999 8999999999999999887 699999


Q ss_pred             cCCccccccCC-------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014595          229 FGSAKVLVKGE-------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  301 (422)
Q Consensus       229 fG~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~  301 (422)
                      ||+++......       ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+....+.++... 
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-  227 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-  227 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-
Confidence            99987654211       11223577889999998654 4789999999999999999999999876654443332220 


Q ss_pred             CCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                        ..+         .++..++..+.++|++||+.||.+||++.++++||||
T Consensus       228 ------------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 ------------------ASP---------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ------------------CCC---------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                              000         0123578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.2e-41  Score=321.74  Aligned_cols=251  Identities=25%  Similarity=0.409  Sum_probs=201.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|++.+.||.|+||.||+|++..+++.||+|.+....    ....+|+.+++.++|+||+++++.+..     ..+.++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence            35999999999999999999999999999999886432    344579999999999999999998743     335789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ ++..++..     ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        95 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~  167 (296)
T cd06654          95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (296)
T ss_pred             eecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEECccccchhcc
Confidence            9999975 66555432     457888999999999999999999 8999999999999999877 79999999987543


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+... +.+           
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~-----------  234 (296)
T cd06654         168 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP-----------  234 (296)
T ss_pred             ccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCC-----------
Confidence            3221 223467889999999865 44789999999999999999999999876654433322110 000           


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                             ..       ..+..++..+.+||.+||..||++|||+.++++||||...
T Consensus       235 -------~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         235 -------EL-------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             -------CC-------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence                   00       0123578899999999999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-41  Score=314.71  Aligned_cols=252  Identities=26%  Similarity=0.441  Sum_probs=204.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+...      ......|+.+++.++|+||+++++++..   ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            388999999999999999999999999999987532      1234468999999999999999887643   2334577


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH-----hcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-----NCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-----~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      ++|||+++ ++...+.........+++..++.++.||+.||.|||     + .+++|+||||+||+++.++ .+||+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~-~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANN-NVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCC-CEEEeccc
Confidence            99999974 777777655444577899999999999999999999     8 7999999999999999877 69999999


Q ss_pred             CccccccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          231 SAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       231 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ++........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+...         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------  225 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG---------  225 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC---------
Confidence            9987654433 3345688999999998654 4889999999999999999999999887644433332221         


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                ..+         .++...+..+.+|+.+||..||++|||+.++++|||+
T Consensus       226 ----------~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 ----------KFR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ----------CCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                      000         1224578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-41  Score=320.27  Aligned_cols=252  Identities=28%  Similarity=0.451  Sum_probs=203.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|++.+.||.|+||.||+|.+..+|+.||||.+....    ....+|+.+++.++|+||+++++.+..     ...+++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEEE
Confidence            35999999999999999999999999999999885422    334579999999999999999998842     335789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      |+||+++ ++...+.     ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||++....
T Consensus        94 v~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~  166 (296)
T cd06655          94 VMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQIT  166 (296)
T ss_pred             EEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccchhcc
Confidence            9999985 5544443     2468999999999999999999999 8999999999999999877 69999999987653


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+... ..+.          
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~----------  234 (296)
T cd06655         167 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE----------  234 (296)
T ss_pred             cccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc----------
Confidence            3322 223467889999999865 44889999999999999999999999887765544433221 0000          


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                         .            ..+..+++.+.+||++||..||.+|||+.+++.||||+...
T Consensus       235 ---~------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         235 ---L------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             ---c------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence               0            01135788999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.9e-42  Score=317.54  Aligned_cols=249  Identities=29%  Similarity=0.457  Sum_probs=196.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .|.+.+.||+|+||.||+|.+..+++.||+|++...         .....+|+.+++.++||||+++++++..   ....
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence            488999999999999999999999999999987532         1234579999999999999999987743   2234


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++++||+++ ++.+.+..    ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~-~~~l~dfg~~  153 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCCCc
Confidence            57799999975 66555543    3458889999999999999999998 8999999999999999877 6999999998


Q ss_pred             cccccC----CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          233 KVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       233 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ......    .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+....+.++...   +.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~---  226 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT---  226 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC---
Confidence            754321    11123457888999999865 44899999999999999999999999876544333322110   00   


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                                           ...++..+++.+++|| +||..||++||+++|+++||||+
T Consensus       227 ---------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ---------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ---------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                 0011234678899999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.5e-41  Score=312.19  Aligned_cols=247  Identities=25%  Similarity=0.406  Sum_probs=201.0

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |.+.+.||+|++|.||+|.+..+++.||+|.+...      .....+|+++++.++||||+++++++.     .....++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   76 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLNI   76 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEEE
Confidence            88899999999999999999999999999987532      233457999999999999999999873     2345789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ ++.+.+...  ....+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~  152 (256)
T cd08529          77 VMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCC-CEEEcccccceecc
Confidence            9999974 776666542  23578899999999999999999999 8999999999999999887 69999999987654


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .... .....+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+....              
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  217 (256)
T cd08529         153 DNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--------------  217 (256)
T ss_pred             CccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            3322 2234678899999998654 48899999999999999999999998777555444433210              


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                           ++.         +...++.++.++|.+||+.+|++||++.++++|||+
T Consensus       218 -----~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 -----FPP---------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             -----CCC---------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                 000         112468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.7e-42  Score=317.28  Aligned_cols=251  Identities=28%  Similarity=0.501  Sum_probs=198.9

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      |+..+.||+|+||.||+|.+..+++.||+|++....          ....+|+.+++.++|+||+++++++.     ...
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   76 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----EDS   76 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cCC
Confidence            788899999999999999999999999999885422          23457999999999999999999883     333


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ..++||||+.+ ++.+++..    ...+++..+..++.||+.||.|||+ +|++|+||||+||+++.++..+||+|||.+
T Consensus        77 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~~  151 (268)
T cd06630          77 HFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAA  151 (268)
T ss_pred             eEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence            47799999985 66665543    3568899999999999999999999 899999999999999877657999999998


Q ss_pred             cccccCCC-----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          233 KVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       233 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ........     .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+.+....    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----  226 (268)
T cd06630         152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA----  226 (268)
T ss_pred             cccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc----
Confidence            76543211     123457888999999865 45899999999999999999999999755433322222221000    


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                                 .         ....++..+++++.+++.+||..||.+|||+.++++||||+
T Consensus       227 -----------~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 -----------T---------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             -----------C---------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                       0         00012235789999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-41  Score=315.87  Aligned_cols=247  Identities=28%  Similarity=0.483  Sum_probs=196.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----------hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      +|++.+.||.|+||.||+|.+ .+|+.+|+|.+....          ....+|+++++.++|+||+++++++.     ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence            388899999999999999987 478999999875321          23457999999999999999999873     33


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      .+.++++||+++ ++.+.+..    ...+++..+..++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCC-eEEeccchh
Confidence            568899999975 66555543    3568899999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccC-------CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014595          232 AKVLVKG-------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       232 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      +......       .......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....+. 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  226 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-  226 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence            8754211       111234578899999998654 4889999999999999999999999776544433332221000 


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                      .+         .++..++.++.+||++||..||.+||++.++++||||
T Consensus       227 ----------------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 ----------------MP---------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ----------------CC---------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                            00         0124578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-41  Score=316.48  Aligned_cols=255  Identities=26%  Similarity=0.399  Sum_probs=202.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|++.+.||.|+||+||+|....++..+|+|++...     .....+|+.+++.++|+||+++++.+..     ....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEEE
Confidence            499999999999999999999889999999987543     2345689999999999999999887732     334779


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||++++ ++.+.+.... ....+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~  153 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDG-SVKIADFGVSASLA  153 (267)
T ss_pred             EEeccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccchHHHhc
Confidence            9999975 6655554321 12468999999999999999999999 8999999999999999877 69999999987664


Q ss_pred             cCCCc-----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          237 KGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       237 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      .....     ....++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.++...  .+       
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~-------  224 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DP-------  224 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CC-------
Confidence            43222     33467889999999866546899999999999999999999999877655444443321  00       


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                           ..+  +.       ......+++++.+|+.+||+.||++|||+.++++||||
T Consensus       225 -----~~~--~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         225 -----PSL--ET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -----CCc--CC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                 000  00       00013578999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-41  Score=319.25  Aligned_cols=252  Identities=26%  Similarity=0.411  Sum_probs=200.8

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      |++.+.||.|+||.||+|.+..++..+|+|.+....    ....+|+++++.++|+||+++++++..     ....++||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEEE
Confidence            788899999999999999999999999999885432    234579999999999999999998743     23577999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ ++...+..   ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++......
T Consensus        82 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~  156 (282)
T cd06643          82 EFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRT  156 (282)
T ss_pred             EecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCC-CEEEcccccccccccc
Confidence            99986 44333322   23568999999999999999999999 8999999999999999887 6999999998654322


Q ss_pred             C-Ccccccccccccchhhhc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          239 E-PNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       239 ~-~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      . ......+++.|+|||++.    ....++.++|+|||||++|+|++|.+||...+..+...++......          
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~----------  226 (282)
T cd06643         157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP----------  226 (282)
T ss_pred             ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC----------
Confidence            1 123446788999999874    2234778999999999999999999999887765555554331100          


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                          .  .          ..+..++.++.+||.+||..||.+|||+.++++||||...
T Consensus       227 ----~--~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         227 ----T--L----------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ----C--C----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                0  0          0123468899999999999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=9.4e-43  Score=327.15  Aligned_cols=280  Identities=32%  Similarity=0.540  Sum_probs=226.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhH---HHHHHHHHHcC------CCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLD------HPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~---~~E~~~l~~l~------h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+....|+|-|++|..|.+..-|..||||+|.......   .+|++||++|+      --|+++|+..|     ...
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hk  506 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHK  506 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhc
Confidence            36899999999999999999999999999999998765333   47999999995      34788888888     445


Q ss_pred             eEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .++|||+|-+.-+|..+++.|.. .-++....++.|+.|+..||..|.. +||+|.||||+|||++...+.+||||||.|
T Consensus       507 nHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  507 NHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             ceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCccc
Confidence            56999999999999999998765 4678999999999999999999999 799999999999999988889999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ...... ..+.+..+.+|+|||+++|-+ |+...|+||+||+||||.||+..|+|.+..+++...+.+-|..+...+...
T Consensus       585 ~~~~en-eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  585 SFASEN-EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             cccccc-cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            766444 345677789999999999866 999999999999999999999999999999999998888888877665432


Q ss_pred             C-------cCCccC--------------cCCCCCC-CCcccccc--cCCC-------hHHHHHHHhhhhcCCCCcCCHHH
Q 014595          313 N-------PNYTEF--------------KFPQIKP-HPWHKVFQ--KRLP-------PEAVDLVCRFFQYSPNLRCTALE  361 (422)
Q Consensus       313 ~-------~~~~~~--------------~~~~~~~-~~~~~~~~--~~~s-------~~~~~li~~~L~~dP~~R~t~~e  361 (422)
                      .       .++..+              .+...++ ..+...+.  ..++       ..+++||.+||..||++|.|..+
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence            1       111100              0011111 11111110  1122       35889999999999999999999


Q ss_pred             HhcCCcccc
Q 014595          362 ACVHPFFDE  370 (422)
Q Consensus       362 ~l~hp~f~~  370 (422)
                      +|+||||+.
T Consensus       743 AL~HpFi~~  751 (752)
T KOG0670|consen  743 ALKHPFITE  751 (752)
T ss_pred             HhcCCcccC
Confidence            999999975

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-41  Score=322.32  Aligned_cols=252  Identities=27%  Similarity=0.416  Sum_probs=201.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++|+||+++++++.     ...+.++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l   93 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV   93 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEEE
Confidence            46999999999999999999999999999999885422    33457999999999999999999883     3345789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ ++...+..     ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||++....
T Consensus        94 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~  166 (297)
T cd06656          94 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  166 (297)
T ss_pred             eecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEECcCccceEcc
Confidence            9999975 55554432     467888999999999999999999 8999999999999999877 69999999987653


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.. .+.+           
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~-----------  233 (297)
T cd06656         167 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-----------  233 (297)
T ss_pred             CCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC-----------
Confidence            3322 223467889999999865 4588999999999999999999999977654332221111 0000           


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                             .       ...+..++..+++||.+||..||++||++.++++||||+..+
T Consensus       234 -------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         234 -------E-------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             -------C-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence                   0       001235688899999999999999999999999999998864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-42  Score=320.07  Aligned_cols=255  Identities=26%  Similarity=0.413  Sum_probs=203.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|.+.+.||.|+||.||+|.+..+++.||+|.+....    ....+|+++++.++|+||+++++.+..     ....++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEEE
Confidence            35999999999999999999998899999999875432    234579999999999999999998842     335789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ ++..++..   ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~  154 (280)
T cd06611          80 LIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNK  154 (280)
T ss_pred             EeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCC-CEEEccCccchhhc
Confidence            9999986 56555443   23568999999999999999999999 8999999999999999887 69999999886543


Q ss_pred             cCC-CcccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          237 KGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ... ......+++.|+|||.+..    ...++.++|+|||||++|+|++|++||.+.+....+.++...  .+       
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-------  225 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP-------  225 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC-------
Confidence            322 2234567889999999742    234678999999999999999999999877655444333221  00       


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                +..       ..+..++.++.+||.+||+.||.+||++.++++||||....
T Consensus       226 ----------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         226 ----------PTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             ----------CCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                      000       01134688999999999999999999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-41  Score=312.14  Aligned_cols=248  Identities=34%  Similarity=0.549  Sum_probs=200.1

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      +|+..+.||+|+||+||+|.+..+++.||+|.+....         ..+.+|+.+++.++|+||+++++++.     ...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence            3778899999999999999998899999999875422         23457999999999999999998773     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++++||+++ ++.+++..    ...+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccc
Confidence            57899999985 66555543    3468899999999999999999999 8999999999999999887 6999999998


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .............++..|+|||.+.....++.++|+|||||++|+|++|+.||...........+....           
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----------  218 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-----------  218 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-----------
Confidence            766444433456678899999998544348899999999999999999999997765443333322210           


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                             ..+         .++..+++++.+|+.+||+.||.+|||+.+++.|||+
T Consensus       219 -------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 -------ELP---------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -------cCC---------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                   000         1124578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=308.93  Aligned_cols=285  Identities=33%  Similarity=0.554  Sum_probs=224.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc------chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +.+-.+.||.|+||.||.+.+..+|+.||+|++..      ......+|+++|..++|.|++..+++..-..-.-..-+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            34556789999999999999999999999998743      223345899999999999999988876322211111255


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      .+.|.+..+|..++-    ..+.++...++-+++||++||+|||+ .||.||||||.|+|++++. .+||||||+|+...
T Consensus       134 V~TELmQSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee  207 (449)
T KOG0664|consen  134 VLTELMQSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNC-ILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCc-eEEecccccccccc
Confidence            678888766655443    35778889999999999999999999 8999999999999999886 79999999998764


Q ss_pred             cCCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          237 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       237 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      .++.  .+..+.|-+|+|||++.|...|+.++||||+|||+.||+..+..|+..+..++++.|.+.+|+|..+.+..-+.
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            4332  23456688999999999999999999999999999999999999999999999999999999999998875544


Q ss_pred             CCccCcCCCCCCCC-ccccc----ccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          315 NYTEFKFPQIKPHP-WHKVF----QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       315 ~~~~~~~~~~~~~~-~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      ....--+......| +..++    +..-..+..+++.++|.+||++|.+.++++.|++..+.+-
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL  351 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence            32221111111111 11111    1133457889999999999999999999999999987654

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7e-42  Score=318.24  Aligned_cols=250  Identities=27%  Similarity=0.381  Sum_probs=196.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      +|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++||||+++++.+..     ....++|
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~iv   84 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWIC   84 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEEE
Confidence            599999999999999999999999999999988542    2334579999999999999999988743     2347799


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ +|.+.+..    ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~  158 (267)
T cd06646          85 MEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNG-DVKLADFGVAAKITA  158 (267)
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEECcCccceeecc
Confidence            999985 66555432    3568999999999999999999999 8999999999999999887 699999999976533


Q ss_pred             CC-CcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GE-PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      .. ......+++.|+|||.+.+  ...++.++|+|||||++|+|++|..||...+.......+..               
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~---------------  223 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK---------------  223 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec---------------
Confidence            22 2234567889999998742  33478899999999999999999999965543322211111               


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  367 (422)
                        ..+..+.     +.  ....++..+.+||++||+.||++|||++++++|+|
T Consensus       224 --~~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         224 --SNFQPPK-----LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             --CCCCCCC-----Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence              0011110     00  01246889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.9e-43  Score=335.53  Aligned_cols=250  Identities=27%  Similarity=0.431  Sum_probs=203.9

Q ss_pred             EEeeeeeecCCeeEEEEEEcCCCeEEEEEEec-----cc-h--hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QD-K--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~-----~~-~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +...+||+|+|-+||+|.|..+|..||.-.++     +. .  ..+..|+.+|+.|+|||||++++.+.+...   .++.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            34567999999999999999999999864332     22 2  445679999999999999999998865443   5678


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +|+|.+..+.   ++.|.+..+.+....++.|++||++||.|||+. -.|||||||.+||+|+.+.+.|||+|+|+|+..
T Consensus       120 ~iTEL~TSGt---Lr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  120 FITELFTSGT---LREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             eeeecccCCc---HHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            9999998432   445555567899999999999999999999982 359999999999999988889999999999876


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ... .....+|||.|||||++.  ..|+..+||||||++|.||+|+.+||.......++++.+-- |..+          
T Consensus       197 r~s-~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP----------  262 (632)
T KOG0584|consen  197 RKS-HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKP----------  262 (632)
T ss_pred             hcc-ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCH----------
Confidence            433 344589999999999994  56999999999999999999999999988777766665432 2221          


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                                 ..+.+    --.+++++||.+||.. .+.|+|+.|+|+||||+.
T Consensus       263 -----------~sl~k----V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  263 -----------AALSK----VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             -----------HHhhc----cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                       12222    2368999999999999 999999999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=334.26  Aligned_cols=244  Identities=30%  Similarity=0.440  Sum_probs=199.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      ..+|.+...+|.|+|+.|-.+.+..+++..++|++.+......+|+.++... +||||+++++.+     .+..++|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeeee
Confidence            4468888999999999999999999999999999988767777888777666 799999999988     5666689999


Q ss_pred             ecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE-cCCCCcEEEeecCCccccccC
Q 014595          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill-~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      |.+.+...  +.. ... .+.....+..|++||+.|+.|||+ +|||||||||+|||+ +..+ .++|+|||.++.....
T Consensus       396 e~l~g~el--l~r-i~~-~~~~~~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  396 ELLDGGEL--LRR-IRS-KPEFCSEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS  469 (612)
T ss_pred             hhccccHH--HHH-HHh-cchhHHHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCC-cEEEEEechhhhCchh
Confidence            99986331  111 111 222336777899999999999999 999999999999999 4666 6999999999876444


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                        ..+.+-|..|.|||++. ...|+.++||||||++||+||+|+.||......   .++...++.+..            
T Consensus       470 --~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~------------  531 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF------------  531 (612)
T ss_pred             --hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc------------
Confidence              33446688899999996 455999999999999999999999999876655   333333333221            


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                     ...+|.++++||++||++||.+|+++.+++.||||
T Consensus       532 ---------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  532 ---------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ---------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                           13589999999999999999999999999999999

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=329.82  Aligned_cols=253  Identities=27%  Similarity=0.414  Sum_probs=220.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ...++..||-||||.|-++........+|+|++++..       .....|..||...+.|.||++|..|     .+..|+
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~kyv  495 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKYV  495 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchhh
Confidence            3566778999999999999887655568999876532       2234689999999999999999998     777889


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ||+||-|- |.+..+++.    .+.+.+...+.|+..++.|++|||+ +|||+|||||+|.+++.+| -+||.|||+|+.
T Consensus       496 YmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~G-y~KLVDFGFAKk  569 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRG-YLKLVDFGFAKK  569 (732)
T ss_pred             hhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCC-ceEEeehhhHHH
Confidence            99999886 466666654    4778899999999999999999999 9999999999999999998 599999999999


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      +..+....+++|||.|.|||++++.+ .+.++|.||||+++|||++|.+||.+.++...+..|.+.+..           
T Consensus       570 i~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-----------  637 (732)
T KOG0614|consen  570 IGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-----------  637 (732)
T ss_pred             hccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----------
Confidence            99999999999999999999998765 799999999999999999999999999999999999886422           


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccCCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDP  374 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  374 (422)
                          +.            +++.++..+.+||+++...+|.+|+.     +.||.+|-||.+..+.
T Consensus       638 ----i~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  638 ----IE------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             ----hh------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence                22            33578999999999999999999996     8999999999988753

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.8e-41  Score=313.92  Aligned_cols=246  Identities=28%  Similarity=0.455  Sum_probs=200.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|++.+.||.|+||.||+|++..+++.||+|.+.+..       ....+|++++++++||||+++++++     .+..+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            3899999999999999999999999999999886432       3345799999999999999999887     334458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++|+||+.+ ++...+..    ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            899999975 55544433    2578999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ...........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.  ...+......            
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------
Confidence            6544334455678889999998654 489999999999999999999999987664  2222211110            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH--HHHhcCCcc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFF  368 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~--~e~l~hp~f  368 (422)
                                      ....++..++.++.++|.+||..||.+||++  .|+++||||
T Consensus       217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                            0001224568999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.9e-41  Score=312.94  Aligned_cols=249  Identities=29%  Similarity=0.457  Sum_probs=196.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .|.+.+.||+|+||.||+|++..+|+.||||.+...         .....+|+.+++.++||||+++++++..   ....
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence            499999999999999999999999999999987421         1234579999999999999999987632   2234


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .++++|||+++ ++.+.+..    ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~  153 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVG-NVKLGDFGAS  153 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCC-CEEECcCccc
Confidence            57799999975 66555443    3457888899999999999999999 8999999999999999877 6999999998


Q ss_pred             cccccC----CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          233 KVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       233 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ......    .......++..|+|||++.+. .++.++|+|||||++|+|++|+.||...+....+.++..   .+.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~---  226 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT---  226 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---
Confidence            754321    112234578899999998654 489999999999999999999999977654443332221   100   


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                                           ....+..++..+.++|++||. +|.+||+++++++|||+.
T Consensus       227 ---------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ---------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ---------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                 001223567889999999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1e-41  Score=317.22  Aligned_cols=250  Identities=26%  Similarity=0.384  Sum_probs=197.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      +|.+.+.||+|+||.||+|++..+++.||+|.+....    ....+|+.+++.++||||+++++.+..     ..+++++
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~lv   84 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWIC   84 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEEE
Confidence            5999999999999999999999999999999875432    234579999999999999999998732     3457899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ +|.+++..    .+.+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~  158 (267)
T cd06645          85 MEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNG-HVKLADFGVSAQITA  158 (267)
T ss_pred             EeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECcceeeeEccC
Confidence            999985 66655443    3578999999999999999999999 8999999999999999877 699999999875532


Q ss_pred             CC-Ccccccccccccchhhhc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GE-PNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      .. ......++..|+|||++.  ....++.++|+|||||++|+|++|..||........+..+...              
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--------------  224 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--------------  224 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--------------
Confidence            21 223456889999999874  2334788999999999999999999999765543332222110              


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  367 (422)
                         .+..+     .+..  ...++..+.+||.+||+.||++|||+.++++|||
T Consensus       225 ---~~~~~-----~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         225 ---NFQPP-----KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ---CCCCC-----cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence               00000     0000  0246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.5e-41  Score=316.82  Aligned_cols=247  Identities=25%  Similarity=0.380  Sum_probs=188.6

Q ss_pred             eeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHH---cCCCCcccccceeecCCCCCceEEEEE
Q 014595           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM---LDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~---l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .||+|+||.||+|.+..+++.||+|.+.+..       ....+|..+++.   .+|+||+.+++.+..     ....++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            4899999999999999999999999875432       112234443333   479999999888732     2347799


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ +|...+.    ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence            999985 5544433    24579999999999999999999999 8999999999999999877 799999999865533


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      .. .....+++.|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.....               
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~---------------  212 (279)
T cd05633         150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL---------------  212 (279)
T ss_pred             cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---------------
Confidence            22 233468999999999865455899999999999999999999999764322111 1111000               


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                        .        ....++..++.++.++|++||..||.+|+     |+.++++||||+++..
T Consensus       213 --~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~  263 (279)
T cd05633         213 --T--------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW  263 (279)
T ss_pred             --c--------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence              0        00012245789999999999999999999     6999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-41  Score=311.65  Aligned_cols=252  Identities=29%  Similarity=0.419  Sum_probs=200.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|.+.+.||.|+||.||+|.+..+++.+|+|.+...    .....+|+.+++.++||||+++++++..     ...+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence            3599999999999999999999989999999988643    2345689999999999999999988732     335789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|||+++ ++..++..   ....+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||++....
T Consensus        78 ~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDG-DVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCC-CEEECccccchhhh
Confidence            9999985 55544433   12578999999999999999999999 8999999999999999877 69999999987654


Q ss_pred             cCC-CcccccccccccchhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ... ......++..|+|||.+.+.  ..++.++|+|||||++|+|++|.+||.+.+.......+....            
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~------------  220 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN------------  220 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------
Confidence            322 22345678889999998543  257889999999999999999999998876555444332210            


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  367 (422)
                           +..+.       .......+.++.+||++||..||..|||+.++++|||
T Consensus       221 -----~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         221 -----FPPPK-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             -----CCCcc-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                 00000       0011245788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.6e-41  Score=311.15  Aligned_cols=249  Identities=29%  Similarity=0.458  Sum_probs=200.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch--hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +|.+.+.||.|+||.||+|++..+++.||+|.+....  ....+|+++++.++|+||+++++++..     ..+.++++|
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e   78 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVME   78 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEEe
Confidence            5999999999999999999999889999999986543  445689999999999999999998843     345789999


Q ss_pred             cchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC
Q 014595          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (422)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~  239 (422)
                      |+++ ++.+++..   ....+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++.......
T Consensus        79 ~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          79 YCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTM  153 (256)
T ss_pred             cCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCC-cEEEcccccchhcccCc
Confidence            9985 66555533   23568999999999999999999999 8999999999999999887 69999999987664433


Q ss_pred             -CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       240 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                       ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...                  
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------  214 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK------------------  214 (256)
T ss_pred             cccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC------------------
Confidence             22234578889999998654 5899999999999999999999999776543322221110                  


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                            ....+  ..+..++.++.++|.+||+.||.+|||+.|+|.||||
T Consensus       215 ------~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         215 ------PPPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ------CCCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                  00000  0113467899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.9e-41  Score=315.15  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=196.8

Q ss_pred             eeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      ||+|+||+||+|.+..+|+.||+|.+....       ....+|+++++.++||||+++++++.     .....|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence            689999999999999999999999875421       22346999999999999999988873     334578999999


Q ss_pred             hh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCc
Q 014595          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (422)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~  241 (422)
                      ++ +|...+....  ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence            84 6655554322  2468999999999999999999999 8999999999999999887 6999999998766444333


Q ss_pred             ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcC
Q 014595          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  321 (422)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  321 (422)
                      ....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+......             ...  
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~--  215 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-------------MAV--  215 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-------------ccc--
Confidence            4456788899999986654 899999999999999999999999776542222222111000             000  


Q ss_pred             CCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCCC
Q 014595          322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  374 (422)
Q Consensus       322 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  374 (422)
                                .++..+++.+.++|.+||+.||.+||     ++.++++||||..+..+
T Consensus       216 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         216 ----------EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             ----------cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence                      01235689999999999999999999     89999999999887643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.6e-41  Score=309.64  Aligned_cols=248  Identities=27%  Similarity=0.454  Sum_probs=200.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|++.+.||+|+||.||++++..+|+.||+|.+...      .....+|+.+++.++|+||+++++++     ....+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            489999999999999999999999999999987532      12345799999999999999999987     3334678


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+.+ ++...+...  ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            99999974 665554431  12457889999999999999999999 8999999999999999877 6999999998765


Q ss_pred             ccCCCc-ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...... ....+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+.+..+....             
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-------------  217 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-------------
Confidence            332221 234578889999998654 48899999999999999999999998776665555543310             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                            .+         ..+..++.++.++|.+||..+|.+||++.++++||||
T Consensus       218 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         218 ------YP---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ------CC---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                  00         0123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.3e-41  Score=315.26  Aligned_cols=240  Identities=17%  Similarity=0.219  Sum_probs=192.0

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      ..||+|++|.||+|.+  +|+.||||++....       ..+.+|+.+|++++||||+++++++.... ....++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5699999999999998  58999999986432       33458999999999999999999875422 22345789999


Q ss_pred             cchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC
Q 014595          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (422)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~  239 (422)
                      |+++ +|.+.+..    ...+++.....++.|++.||.|||+..+++||||||+|||++.++ .+||+|||+++....  
T Consensus       103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~--  175 (283)
T PHA02988        103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSS--  175 (283)
T ss_pred             eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcc--
Confidence            9995 56666543    356888899999999999999999734899999999999999887 799999999876532  


Q ss_pred             CcccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          240 PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       240 ~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                      ......+++.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+.+..+......               
T Consensus       176 ~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~---------------  240 (283)
T PHA02988        176 PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS---------------  240 (283)
T ss_pred             ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC---------------
Confidence            22345678899999998642 45899999999999999999999999887766555544331100               


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ..            ++...++++++|+.+||+.||++|||+.++++
T Consensus       241 ~~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        241 LK------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CC------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            01            11246889999999999999999999999985

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3e-41  Score=318.44  Aligned_cols=253  Identities=29%  Similarity=0.447  Sum_probs=201.7

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      |.....||.|+||.||++.+..+++.||||.+....    ....+|+.+++.++|+||+++++.+..     ..+.++||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~lv~   98 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELWVVM   98 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEEEEE
Confidence            555677999999999999999899999999875422    234579999999999999999998743     34578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ ++..++.     ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++......
T Consensus        99 e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~  171 (292)
T cd06658          99 EFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKE  171 (292)
T ss_pred             eCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccc
Confidence            99986 4544432     2468899999999999999999999 8999999999999999887 6999999998754332


Q ss_pred             CC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 EP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      .. .....++..|+|||.+.+ ..++.++|+|||||++|||++|..||.+.+....+..+.......             
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  237 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-------------  237 (292)
T ss_pred             cccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-------------
Confidence            22 234567889999999854 458999999999999999999999998776655444333211000             


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                         .+          .....+..+.++|.+||..||.+|||+.++++||||.....+.
T Consensus       238 ---~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         238 ---VK----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             ---cc----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence               00          0124688999999999999999999999999999999865443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.8e-41  Score=312.40  Aligned_cols=244  Identities=29%  Similarity=0.489  Sum_probs=197.3

Q ss_pred             eeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      ||.|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++.+.     ...++++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            689999999999999999999999885422       23457999999999999999999873     233478999998


Q ss_pred             h-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCc
Q 014595          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (422)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~  241 (422)
                      + ++|.+.+..    ...+++..+..++.||+.||.|||+ .|++|+||||+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence            7 466665543    2458999999999999999999999 8999999999999999887 6999999999876554333


Q ss_pred             ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhcCcCCccC
Q 014595          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF  319 (422)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  319 (422)
                      ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....  ..+...++....               ...
T Consensus       150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~  213 (262)
T cd05572         150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------GKL  213 (262)
T ss_pred             ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------------CCC
Confidence            445678899999998654 48999999999999999999999998765  333333332100               001


Q ss_pred             cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccC
Q 014595          320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (422)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~  372 (422)
                      .            ++...++++.++|.+||+.||++|++     +.|+++||||++..
T Consensus       214 ~------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         214 E------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             C------------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence            1            12345889999999999999999999     99999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.5e-41  Score=308.85  Aligned_cols=249  Identities=28%  Similarity=0.417  Sum_probs=200.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||.|+||.||+|.+..+|..||+|.+...      .....+|+.+++.++|+||+++++.+.     .....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence            388999999999999999999999999999988542      234458999999999999999999873     334578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +++||+++ ++.+.+...  ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++..+||+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999975 665555431  22357899999999999999999999 899999999999999987656799999998766


Q ss_pred             ccCCCc-ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...... ....+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence            433222 234578889999988554 48899999999999999999999998776555444332210             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                            .+         .....++.++.++|.+||..+|++|||+.++++||||
T Consensus       219 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ------FA---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------CC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                  00         0113568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-40  Score=313.39  Aligned_cols=264  Identities=25%  Similarity=0.430  Sum_probs=201.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|...+.||.|++|.||+|.+..+++.||+|.+....     ....+|+++++.++||||+++++++...   ....+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence            4899999999999999999999999999999886432     2345899999999999999999887432   2334779


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ +|.+++.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  156 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV  156 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence            9999974 6666555444445678999999999999999999999 8999999999999999877 69999999987553


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      .... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.....  .... +....+......       
T Consensus       157 ~~~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~-------  226 (287)
T cd06621         157 NSLA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSYIVNMPNP-------  226 (287)
T ss_pred             cccc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHHHHHhcCCch-------
Confidence            3222 23456788999999854 4589999999999999999999999976522  0001 111111000000       


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                           .++.   .+.   .....++.+.+||.+||..||++|||+.|+++||||+...
T Consensus       227 -----~~~~---~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         227 -----ELKD---EPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             -----hhcc---CCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                 0000   000   0012467899999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-40  Score=311.23  Aligned_cols=252  Identities=33%  Similarity=0.527  Sum_probs=197.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch--------------hhHHHHHHHHHHcCCCCcccccceeecCC
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  148 (422)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|.+....              ..+.+|+.+++.++|+||+++++++.   
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET---   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence            4899999999999999999998899999999874211              12456999999999999999998773   


Q ss_pred             CCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEe
Q 014595          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~  227 (422)
                        .....++||||+++ ++...+..    ...+++..++.++.||+.||.|||+ .|++|+||||+||+++.++ .++|+
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          79 --TEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             --cCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCC-eEEEe
Confidence              23347799999975 66555543    2568899999999999999999999 8999999999999999877 79999


Q ss_pred             ecCCccccccCC---CcccccccccccchhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014595          228 DFGSAKVLVKGE---PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  303 (422)
Q Consensus       228 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~  303 (422)
                      |||++.......   ......++..|+|||.+.... .++.++|+||||+++|+|++|..||...+....+.++....  
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--  228 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--  228 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--
Confidence            999987543221   122345788899999986543 47899999999999999999999997655443332221100  


Q ss_pred             CCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                   ...        .+.......++.++.+||.+||..||.+|||++++|+||||
T Consensus       229 -------------~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 -------------SAP--------PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -------------cCC--------cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                         000        00011123578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.5e-40  Score=307.27  Aligned_cols=248  Identities=31%  Similarity=0.474  Sum_probs=203.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|++.+.||.|+||.||.+++..+++.+++|.+....      ....+|++++++++|+||+++++++..     ...++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            3899999999999999999999999999999875321      234579999999999999999999843     34578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++|||+++ ++.+.+....  ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||++...
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            99999974 7766655322  3568899999999999999999998 8999999999999999887 6999999998765


Q ss_pred             ccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      .... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+....+...  ..          
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~----------  218 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NY----------  218 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CC----------
Confidence            3332 22345678999999998654 4789999999999999999999999887766655554331  00          


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                             +.         ....++.++.++|.+||..||.+||++.++++|||+
T Consensus       219 -------~~---------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         219 -------TP---------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -------CC---------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                   00         013568899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2e-40  Score=314.71  Aligned_cols=252  Identities=29%  Similarity=0.500  Sum_probs=200.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+++++.++||||+++++.+.     ...++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCEE
Confidence            4899999999999999999999999999999886432       23347899999999999999998873     33468


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++ ++..++..    ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||+++.
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~  150 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKI  150 (305)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence            899999985 66555543    3568999999999999999999999 8999999999999999877 799999998863


Q ss_pred             cccCC----------------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014595          235 LVKGE----------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  298 (422)
Q Consensus       235 ~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~  298 (422)
                      .....                ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            21000                00123467789999998654 48999999999999999999999998876655454443


Q ss_pred             HHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC---HHHHhcCCcccccC
Q 014595          299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELR  372 (422)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~  372 (422)
                      ...                 ...+.         ....++.++.++|.+||..||++||+   +.++|+||||....
T Consensus       230 ~~~-----------------~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         230 SDD-----------------IEWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             hcc-----------------cCCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence            310                 00110         01246889999999999999999997   79999999997754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=326.30  Aligned_cols=244  Identities=19%  Similarity=0.275  Sum_probs=192.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ...+...||+|.||+||+|++..   .||||++..+      .+.+++|+.++++-+|.||+-+.+++     .+..+ .
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p~~-A  463 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNPPL-A  463 (678)
T ss_pred             Hhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCCce-e
Confidence            46788899999999999999864   4999998643      34567899999999999999999988     33333 7


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +|..+|+| +|+..+....   ..|.....+.|+.||+.|+.|||. ++|||||||..||++..++ .|||+|||++..-
T Consensus       464 IiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk  538 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDL-KVKIGDFGLATVK  538 (678)
T ss_pred             eeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCC-cEEEecccceeee
Confidence            89999997 6766666533   578889999999999999999999 9999999999999999876 7999999998542


Q ss_pred             c---cCCCcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          236 V---KGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       236 ~---~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      .   .........|...|||||+++.  ...|+..+|||||||++|||+||..||...+....+..+-+....|....  
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~--  616 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK--  616 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh--
Confidence            1   1122233456788999999953  34589999999999999999999999985554433333322222222111  


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                            ...+.+.++++|+..||.+++++||...+||.
T Consensus       617 ----------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  617 ----------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ----------------------hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                                  11356789999999999999999999998876

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.5e-41  Score=312.29  Aligned_cols=255  Identities=30%  Similarity=0.520  Sum_probs=199.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|+..+.||.|+||.||+|.++.+++.||+|.+....     ....+|+++++.++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence            4788899999999999999999999999999876432     234579999999999999999988743     245789


Q ss_pred             Eeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ++||++ ++|.+++....   ..+++..+..++.|++.||.|||+..|++|+||||+||+++.++ .++|+|||.+....
T Consensus        77 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~  152 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhH
Confidence            999999 57766655422   67899999999999999999999735999999999999999877 69999999987653


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHH-hCCCCHHHHhhcCc
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKV-LGTPTREEIKCMNP  314 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~-~~~~~~~~~~~~~~  314 (422)
                      ..... ...++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+. ........+. ...+          
T Consensus       153 ~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  220 (265)
T cd06605         153 NSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP----------  220 (265)
T ss_pred             HHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC----------
Confidence            33222 26678889999998654 589999999999999999999999975421 1111111111 0000          


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                            .+.        .....++.+++++|.+||..||.+|||+.+++.||||+...
T Consensus       221 ------~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         221 ------PPR--------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             ------CCC--------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                  000        00012688999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.8e-41  Score=312.70  Aligned_cols=244  Identities=25%  Similarity=0.406  Sum_probs=189.3

Q ss_pred             eeeecCCeeEEEEEEcCCCeEEEEEEeccchh-------hHHHHH---HHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL---QIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~E~---~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      +||+|+||.||+|++..+++.||||.+.+...       ....|.   ..++...||||+.+++++.     ....+++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence            48999999999999999999999998754311       112333   3444568999999988873     33357899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+.+ +|...+.    ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||++.....
T Consensus        76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence            999985 5544433    24579999999999999999999999 8999999999999999877 699999999875533


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHhhcCcC
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ--LVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .. .....++..|+|||.+.+...++.++||||+||++|+|++|+.||.+......  .......               
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  213 (278)
T cd05606         150 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------  213 (278)
T ss_pred             cC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc---------------
Confidence            22 23457899999999986555589999999999999999999999976532211  1111110               


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~  372 (422)
                       ...            .++..++.++.++|.+||..||.+|+     ++.++++||||+...
T Consensus       214 -~~~------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         214 -MAV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             -cCC------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence             000            01234689999999999999999999     999999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.5e-41  Score=323.26  Aligned_cols=278  Identities=21%  Similarity=0.315  Sum_probs=196.4

Q ss_pred             eeeeec--CCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G--~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      ..||.|  +||+||+|++..+|+.||+|++....      ..+.+|+.+++.++||||++++++|..     ..+.++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence            346666  99999999999999999999876422      334578999999999999999998832     33478999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+.+ ++..++....  ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .++++||+.+......
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~  154 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence            99985 6666555432  2468999999999999999999999 8999999999999999877 6999999865333221


Q ss_pred             CCc--------ccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 014595          239 EPN--------VSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--  307 (422)
Q Consensus       239 ~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~--  307 (422)
                      ...        ....++..|+|||++.+. ..++.++|||||||++|+|++|++||.+......+..+.......+..  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            111        011235669999998653 347899999999999999999999998876655544443321110000  


Q ss_pred             -------HHhhcCcCCc----cCcCC-----CCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          308 -------EIKCMNPNYT----EFKFP-----QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       308 -------~~~~~~~~~~----~~~~~-----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                             .+......+.    .-...     ......+.......+++.+++||++||+.||++|||+.|+|+||||..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                   0000000000    00000     0000011111123467889999999999999999999999999999987


Q ss_pred             CCC
Q 014595          372 RDP  374 (422)
Q Consensus       372 ~~~  374 (422)
                      ...
T Consensus       315 ~~~  317 (328)
T cd08226         315 KEQ  317 (328)
T ss_pred             HHh
Confidence            653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-40  Score=315.69  Aligned_cols=253  Identities=20%  Similarity=0.286  Sum_probs=190.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC----------------CCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL  140 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l  140 (422)
                      .+|++.+.||+|+||.||+|.+..                ++..||+|.+....     ..+.+|++++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            469999999999999999998632                34579999886432     234579999999999999999


Q ss_pred             cceeecCCCCCceEEEEEeecchh-HHHHHHHHhhh---------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 014595          141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR---------------IHQRMPLIYVKLYTYQICRALAYIHNCIG  204 (422)
Q Consensus       141 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~g  204 (422)
                      ++++...     ...++||||+++ ++.+++.....               ....+++..+..++.||+.||.|||+ .|
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~  158 (304)
T cd05096          85 LGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LN  158 (304)
T ss_pred             EEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CC
Confidence            9988432     237899999974 67666543211               11246778889999999999999999 89


Q ss_pred             ceecCCCCCCeEEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-
Q 014595          205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-  280 (422)
Q Consensus       205 ivHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-  280 (422)
                      |+||||||+|||++.++ .+||+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|+|++ 
T Consensus       159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHc
Confidence            99999999999999887 699999999976533321   1123346789999998654 58999999999999999986 


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH
Q 014595          281 -GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA  359 (422)
Q Consensus       281 -G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~  359 (422)
                       |..||.+.+..+.+..+.........            ...         ...+..++..+.+|+.+||..||.+|||+
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQGR------------QVY---------LFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhccc------------ccc---------ccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence             56888877665555444332100000            000         00123568899999999999999999999


Q ss_pred             HHHh
Q 014595          360 LEAC  363 (422)
Q Consensus       360 ~e~l  363 (422)
                      .++.
T Consensus       296 ~~i~  299 (304)
T cd05096         296 SDIH  299 (304)
T ss_pred             HHHH
Confidence            9994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-40  Score=316.50  Aligned_cols=249  Identities=28%  Similarity=0.414  Sum_probs=200.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .|.+.+.||+|+||+||+|.+..+|+.||+|++....       ....+|+++++.++||||+++++++...     ...
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~~   90 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HTA   90 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----CeE
Confidence            4999999999999999999999899999999875321       2345799999999999999999988432     236


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++||||+.+++.+.+...   ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .+||+|||++...
T Consensus        91 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~  165 (307)
T cd06607          91 WLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPG-TVKLADFGSASLV  165 (307)
T ss_pred             EEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCC-CEEEeecCcceec
Confidence            799999998776655432   3568999999999999999999999 8999999999999999887 6999999998754


Q ss_pred             ccCCCcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ...   ....+++.|+|||++.+  ...++.++||||||+++|+|+||..||.+.+.......+...  .          
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~----------  230 (307)
T cd06607         166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--D----------  230 (307)
T ss_pred             CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--C----------
Confidence            322   34567888999998742  345888999999999999999999999877655444333210  0          


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                             .+..        .....+..++++|.+||..||.+||++.+++.||||..-
T Consensus       231 -------~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         231 -------SPTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             -------CCCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                   0000        012357889999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.9e-41  Score=315.97  Aligned_cols=249  Identities=26%  Similarity=0.399  Sum_probs=198.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .|...+.||.|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++|+||+++++++..     ....++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceEE
Confidence            3778889999999999999999899999999876322     234579999999999999999998842     334789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ ++...+.     ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06642          80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCC-CEEEcccccccccc
Confidence            9999985 5544443     2568899999999999999999998 8999999999999999877 69999999987654


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+...               
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------  216 (277)
T cd06642         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---------------  216 (277)
T ss_pred             CcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------
Confidence            3321 1234578889999998654 5889999999999999999999999765443322221110               


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                          ..+         .+....+.++.++|.+||..+|++|||+.++++||||....
T Consensus       217 ----~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         217 ----SPP---------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             ----CCC---------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                000         11234678899999999999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.4e-40  Score=308.17  Aligned_cols=246  Identities=29%  Similarity=0.475  Sum_probs=190.6

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecch
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP  163 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~  163 (422)
                      ..||+|+||.||+|++..++..||+|.+...    .....+|+.+++.++|+||+++++++.     ...+.++++||++
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~   88 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFMEQVP   88 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEEecCC
Confidence            5799999999999999999999999987543    234568999999999999999999873     3345789999997


Q ss_pred             h-HHHHHHHHhhhhcCCC--CHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCC
Q 014595          164 E-TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  240 (422)
Q Consensus       164 ~-~l~~~~~~~~~~~~~~--~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~  240 (422)
                      + +|...+....   ..+  ++..+..++.||+.||.|||+ .||+||||||+||+++.+...++|+|||++........
T Consensus        89 ~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          89 GGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             CCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            4 6766655321   234  778888999999999999999 89999999999999987444799999999876533222


Q ss_pred             -cccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          241 -NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       241 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                       .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||.................                
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  228 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK----------------  228 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc----------------
Confidence             2234578899999998543 3478999999999999999999999975432211110000000                


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                ....++..+++++++|+++||..+|.+|||+.+++.||||
T Consensus       229 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 ----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                      0001224578899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.2e-41  Score=325.98  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=190.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCC-----CeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  149 (422)
                      ..+|.+.+.||+|+||.||+|++..+     ++.||||++....     ....+|+++++.+ +|+|||++++++..   
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~---  113 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH---  113 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC---
Confidence            34699999999999999999986544     3579999986432     2345799999999 89999999998732   


Q ss_pred             CCceEEEEEeecchh-HHHHHHHHhhh-----------------------------------------------------
Q 014595          150 KEELYLNLVLEYVPE-TVNRIARNYSR-----------------------------------------------------  175 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  175 (422)
                        ...+++||||+++ +|.+.+.....                                                     
T Consensus       114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence              3347899999984 66665543210                                                     


Q ss_pred             -------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCc-
Q 014595          176 -------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-  241 (422)
Q Consensus       176 -------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~-  241 (422)
                                   ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++........ 
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence                         11347888899999999999999999 8999999999999999776 7999999999765433221 


Q ss_pred             --ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          242 --VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       242 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                        ....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||........+.++....                 
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~-----------------  331 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-----------------  331 (374)
T ss_pred             eccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc-----------------
Confidence              112245679999998654 58999999999999999997 999998765444333333210                 


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +..          ..+..+++++.+++.+||+.||.+|||+.++++
T Consensus       332 ~~~----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         332 YQM----------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             cCc----------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            000          011246899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.5e-40  Score=314.40  Aligned_cols=251  Identities=27%  Similarity=0.445  Sum_probs=199.6

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      |.....||.|+||.||+|.+..+++.||||.+...    .....+|+.+++.++||||+++++++..     ....+++|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence            44556799999999999999989999999987532    2334579999999999999999998743     33478999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ ++..++.     ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++......
T Consensus        98 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~  170 (297)
T cd06659          98 EFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKD  170 (297)
T ss_pred             ecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCC-cEEEeechhHhhcccc
Confidence            99985 5544432     2568899999999999999999999 8999999999999999887 6999999998755333


Q ss_pred             CC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 EP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      .. .....++..|+|||++.+. .++.++|+|||||++|+|++|+.||...+..+.+..+...   +.            
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~------------  234 (297)
T cd06659         171 VPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP------------  234 (297)
T ss_pred             cccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC------------
Confidence            22 2345678999999999654 4899999999999999999999999877655544332210   00            


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                               ..+.  ....++.++.++|.+||+.||.+||++.++++||||.+...
T Consensus       235 ---------~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         235 ---------PKLK--NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             ---------CCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence                     0000  11346889999999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1e-40  Score=312.28  Aligned_cols=249  Identities=25%  Similarity=0.391  Sum_probs=200.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .|...+.||.|+||.||+|.+..+++.||||.+....     ....+|+.+++.+.|+||+++++++.     ...+.++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            3888899999999999999999899999999876432     23457999999999999999999883     3345889


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ ++.+.+..     ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06640          80 IMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence            9999985 66555432     568889999999999999999999 8999999999999999877 69999999987654


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .... .....++..|+|||++.+. .++.++|+|||||++|+|+||..||.+.+.......+...               
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------  216 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN---------------  216 (277)
T ss_pred             CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC---------------
Confidence            3322 2234568889999998654 4899999999999999999999999876544333221110               


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                          ..+         .+...++..+.+++.+||..||.+||++.++++||||....
T Consensus       217 ----~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         217 ----NPP---------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             ----CCC---------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                000         11234678899999999999999999999999999997753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=307.15  Aligned_cols=246  Identities=33%  Similarity=0.528  Sum_probs=192.5

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-------hHHHHHHH-HHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||.|+||.||+|.+..+|+.||||.+.+...       ....|..+ ...++|+||+++++++.     ....+++++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            568999999999999999999999998864321       11234443 34458999999999883     333578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ +|..++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++..... 
T Consensus        77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence            99975 66655543    3568999999999999999999999 8999999999999999877 699999999875433 


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                        .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+....                 
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  209 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-----------------  209 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-----------------
Confidence              22345788899999987654 8999999999999999999999998776655444433210                 


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH---HHHhcCCcccccCC
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFFDELRD  373 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~---~e~l~hp~f~~~~~  373 (422)
                      ...+        ......+++++.++|.+||+.||++|||+   +|+++||||+++++
T Consensus       210 ~~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         210 INWP--------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             cCCC--------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            0000        01113578999999999999999999954   79999999988753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.3e-40  Score=304.88  Aligned_cols=245  Identities=26%  Similarity=0.426  Sum_probs=196.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|.+.+.||.|+||.||++.+..+++.||+|.+...     .....+|+.+++.++|+||+++++.+.     ...++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence            388999999999999999999999999999987532     233457999999999999999999873     3345889


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|||+++ ++...+...  ....+++..+..++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence            9999974 565544421  23568899999999999999999999 8999999999999999877 69999999987654


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .... .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+....              
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  216 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS--------------  216 (255)
T ss_pred             ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC--------------
Confidence            3222 2345678899999998554 48999999999999999999999998776554444433210              


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                           .+         .++..++..+.+||.+||..||.+|||+.+++.-
T Consensus       217 -----~~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -----YK---------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----CC---------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                 00         0123468889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.8e-40  Score=309.16  Aligned_cols=253  Identities=30%  Similarity=0.472  Sum_probs=201.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .|...+.||+|++|.||+|.+..+++.||+|++....    ....+|+.+++.++|+||+++++++..     ..+.+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            3666689999999999999998899999999875322    234579999999999999999998743     3347899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      +||+++ ++.+.+..     ..+++..+..++.|++.||+|||+ .||+||||+|+||+++.++ .++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCC-cEEEcccccchhhcc
Confidence            999975 66555443     468889999999999999999999 8999999999999999887 799999998865433


Q ss_pred             CCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          238 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       238 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      ... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+....+..+.... .             
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~-------------  232 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-P-------------  232 (285)
T ss_pred             CCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-C-------------
Confidence            222 2234678899999998654 48999999999999999999999998776555544433210 0             


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                           +..       .....++..+.+|+.+||..||++|||+.++++||||+..+++
T Consensus       233 -----~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         233 -----PKL-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             -----CCC-------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence                 000       0012367899999999999999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.6e-40  Score=303.56  Aligned_cols=250  Identities=30%  Similarity=0.499  Sum_probs=203.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||.|+||.||+|.+..+++.||+|++...      .....+|+++++.++|+|++++.+.+...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence            388999999999999999999989999999998643      23345799999999999999999887432     4578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +++||+++ ++...+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            99999985 7766666543334779999999999999999999999 8999999999999999877 6999999998765


Q ss_pred             ccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      .... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+.........             
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  219 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------------  219 (258)
T ss_pred             ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence            4432 22335678899999988654 48899999999999999999999997766444333332210             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                            .+.         ++..++.++.+++.+||..||++|||+.++|+||||
T Consensus       220 ------~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 ------YPP---------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ------CCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                  000         113568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.7e-40  Score=312.54  Aligned_cols=257  Identities=24%  Similarity=0.401  Sum_probs=198.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ..|.+.+.||+|+||.||+|.+..+++.||||.+....     ....+|+.++..+ .|+||+++++++..     ....
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~   89 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DSDV   89 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CCeE
Confidence            45999999999999999999999889999999986432     1223466666555 59999999998843     3358


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +++|||+++.+..+...   ....+++..+..++.|++.||.|||+..||+||||+|+||+++.++ .+||+|||++...
T Consensus        90 ~~v~e~~~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~~  165 (296)
T cd06618          90 FICMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGRL  165 (296)
T ss_pred             EEEeeccCcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchhc
Confidence            89999998766655543   2357899999999999999999999624999999999999999877 7999999998766


Q ss_pred             ccCCCcccccccccccchhhhcCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhh
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ..........++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||..... .+.+..+....          
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------  235 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE----------  235 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC----------
Confidence            444433444577889999998543   2478899999999999999999999976432 22222222110          


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                            ....+      .    ...++.++.+|+.+||..||.+||+++++++||||+....
T Consensus       236 ------~~~~~------~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         236 ------PPSLP------P----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             ------CCCCC------C----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence                  00000      0    0136789999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-40  Score=312.12  Aligned_cols=256  Identities=29%  Similarity=0.451  Sum_probs=198.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|++.+.||+|+||+||+|.+..+|+.||+|++....     ..+.+|+++++.++||||+++++++..     ...++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEEE
Confidence            45899999999999999999999999999999875432     234579999999999999999998843     24578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ ++...+..    .+.+++..+..++.|++.||.|||+..|++||||||+||+++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~  154 (284)
T cd06620          80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGEL  154 (284)
T ss_pred             EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccch
Confidence            99999985 55444432    356899999999999999999999635899999999999999877 7999999998654


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHHHhCCCCHHH
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-------LVEIIKVLGTPTREE  308 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~-------~~~i~~~~~~~~~~~  308 (422)
                      .... .....++..|+|||++.+. .++.++|+|||||++|+|+||..||........       +......+       
T Consensus       155 ~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  225 (284)
T cd06620         155 INSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI-------  225 (284)
T ss_pred             hhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH-------
Confidence            3222 2245678999999998654 589999999999999999999999986543211       11111100       


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      +..        ..+.        .....++.++.+|+.+||..||.+|||+.|+++||||.+-.
T Consensus       226 ~~~--------~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         226 VQE--------PPPR--------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             hhc--------cCCC--------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            000        0000        00013678899999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-40  Score=305.21  Aligned_cols=248  Identities=27%  Similarity=0.450  Sum_probs=197.1

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .|.+.+.||+|+||.||+|++..+++.||+|.+...         ...+.+|+++++.++|+||+++++++..   ....
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~~   79 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEEK   79 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCCC
Confidence            499999999999999999999999999999987421         1234579999999999999999988743   2233


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++++||+++ ++.+.+..    ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~  153 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECccccc
Confidence            46789999975 56554432    3458899999999999999999999 8999999999999999877 6999999998


Q ss_pred             cccccC----CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          233 KVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       233 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      +.....    .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+.++..   .+    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~----  225 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QP----  225 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CC----
Confidence            765321    112234678899999998654 488999999999999999999999987655444433221   11    


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                          ....++..+++.+.++|.+||. +|.+|||+.++++|||.
T Consensus       226 --------------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         226 --------------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             --------------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                0111335678999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-40  Score=309.87  Aligned_cols=250  Identities=28%  Similarity=0.485  Sum_probs=199.1

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcC---CCCcccccceeecCCCCCceEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      |.+.+.||.|+||.||+|.+..+++.||+|.+...     .....+|+.+++.+.   |||++++++++.     ...+.
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~~   77 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPRL   77 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCEE
Confidence            78889999999999999999999999999987532     223457999999996   999999999873     23457


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++|||+++ +|.+++..     ..+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++..
T Consensus        78 ~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~  150 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTG-NVKLCDFGVAAL  150 (277)
T ss_pred             EEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCC-CEEEccCCceee
Confidence            899999975 56554432     368899999999999999999999 8999999999999999877 799999999876


Q ss_pred             cccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          235 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       235 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ...... .....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+...             
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-------------  217 (277)
T cd06917         151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-------------  217 (277)
T ss_pred             cCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-------------
Confidence            644332 234467889999999866555789999999999999999999999776543222111000             


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                            ..+.     +   .....+.++.+++.+||..||.+||++.++++||||++..
T Consensus       218 ------~~~~-----~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         218 ------KPPR-----L---EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             ------CCCC-----C---CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                  0000     0   0123678999999999999999999999999999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5e-40  Score=304.96  Aligned_cols=250  Identities=30%  Similarity=0.519  Sum_probs=196.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|+||+++++.+.     ....++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence            4899999999999999999998899999999986432      23457999999999999999998763     233477


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +|+||+++ ++.+.+..    ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            99999984 66555443    3458889999999999999999999 8999999999999999877 6999999998766


Q ss_pred             ccCCCcc-----cccccccccchhhhcCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          236 VKGEPNV-----SYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       236 ~~~~~~~-----~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .......     ...++..|+|||++.+..  .++.++||||||+++|+|++|..||...+........... +.     
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~-----  223 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GH-----  223 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CC-----
Confidence            4332221     245678899999986432  3788999999999999999999999765432222211110 00     


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                               ...+|.          ...+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus       224 ---------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         224 ---------KPPIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ---------CCCCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                     000110          02358899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2e-40  Score=323.49  Aligned_cols=249  Identities=22%  Similarity=0.333  Sum_probs=190.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEE-----cCCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|.+.+.||+|+||+||+|.+     ..++..||||++....     ....+|+.+++.+ +||||+++++++..    
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~----  110 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV----  110 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc----
Confidence            3699999999999999999974     3457789999886432     2345799999999 89999999998732    


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhh------------------------------------------------------
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSR------------------------------------------------------  175 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  175 (422)
                       ....++|||||++ +|.+.+.....                                                      
T Consensus       111 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         111 -GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             -CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence             3347799999984 66555543110                                                      


Q ss_pred             -----------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          176 -----------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       176 -----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                                       ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~  267 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGR-ITKICDFGLARDIRND  267 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCC-cEEEecCccceeccCc
Confidence                             01247788899999999999999999 8999999999999999776 6999999999765433


Q ss_pred             CCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          239 EPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       239 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...   ....++..|+|||++.+. .++.++|||||||++|||++ |..||.+......+.+.+...             
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-------------  333 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG-------------  333 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC-------------
Confidence            211   122335679999999654 58999999999999999998 899998765444444333210             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                          +..          ..+...+.++.+||.+||..||++|||+.++++.
T Consensus       334 ----~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         334 ----YRM----------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ----ccC----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                000          0112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.5e-40  Score=312.42  Aligned_cols=248  Identities=29%  Similarity=0.451  Sum_probs=200.9

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      |...+.||+|+||+||+|++..+|+.||||++....       ....+|+++++.++|||++++++++..     ....+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence            777788999999999999999999999999885321       234579999999999999999998843     33478


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+.+++...+..   ....+++..+..++.||+.||.|||+ .||+|+||||+||+++.++ .+||+|||++....
T Consensus        98 lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~  172 (313)
T cd06633          98 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS  172 (313)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCC-CEEEeecCCCcccC
Confidence            9999999877665543   23568899999999999999999999 8999999999999999877 69999999986432


Q ss_pred             cCCCcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          237 KGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                         ......++..|+|||++.+  ...++.++|+|||||++|+|++|.+||.+.+....+..+....             
T Consensus       173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-------------  236 (313)
T cd06633         173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-------------  236 (313)
T ss_pred             ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-------------
Confidence               2234567889999999842  3457889999999999999999999998877655555443210             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                            .+.        .....++..+++|+.+||+.+|.+||++.++++||||+..
T Consensus       237 ------~~~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         237 ------SPT--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             ------CCC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                  000        0113457789999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4e-40  Score=306.49  Aligned_cols=243  Identities=21%  Similarity=0.272  Sum_probs=191.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEc---CCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +|.+.+.||+|+||.||+|.+.   ..+..||+|.+....     ..+.+|+.+++.++||||+++++++..     ...
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~   80 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----GNT   80 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----CCC
Confidence            5999999999999999999865   446789999886532     234579999999999999999998742     334


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .++||||+++ ++..++...   ...+++..+..++.||+.||+|||+ .|++||||||+|||++.++ .+|++|||.+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~-~~~l~dfg~~~  155 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDL-VCKISGFRRLQ  155 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCC-cEEECCCcccc
Confidence            7899999986 555555432   3568999999999999999999999 8999999999999999887 69999999875


Q ss_pred             ccccCCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          234 VLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       234 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ........  ....++..|+|||.+.+ ..++.++|||||||++||+++ |..||.+.+..+.+..+.+..         
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~---------  225 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF---------  225 (266)
T ss_pred             cccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC---------
Confidence            43222111  12234567999999865 458999999999999999775 999998877665554443210         


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                               ..+          .+..++..+.+++.+||+.||.+|||++++++
T Consensus       226 ---------~~~----------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         226 ---------RLP----------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ---------CCC----------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                     000          12357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.5e-40  Score=304.05  Aligned_cols=251  Identities=31%  Similarity=0.515  Sum_probs=203.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .|.+.+.||.|++|.||+|.+..+++.||||++....     ....+|+.++..++|+||+++++++..     ....++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEEE
Confidence            4889999999999999999999999999999886542     345679999999999999999998843     345789


Q ss_pred             Eeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|||++ ++|.+.+..    ...+++..+..++.|++.||+|||+..|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~  151 (264)
T cd06623          77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLE  151 (264)
T ss_pred             EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecc
Confidence            999999 566666553    267899999999999999999999625999999999999999887 69999999987664


Q ss_pred             cCCCcc-cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--h-HHHHHHHHHHhCCCCHHHHhhc
Q 014595          237 KGEPNV-SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--G-VDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       237 ~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~--~-~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ...... ...++..|+|||.+.+. .++.++|+||||+++|+|+||..||....  . .+....+...   .        
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~--------  219 (264)
T cd06623         152 NTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---P--------  219 (264)
T ss_pred             cCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---C--------
Confidence            433332 45678889999998554 58999999999999999999999997764  2 2222222110   0        


Q ss_pred             CcCCccCcCCCCCCCCcccccccC-CChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                              .+.         .... ++..+.++|.+||..+|++|||+.++++||||+..+
T Consensus       220 --------~~~---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         220 --------PPS---------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             --------CCC---------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                    000         1123 788999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.8e-40  Score=303.94  Aligned_cols=244  Identities=21%  Similarity=0.352  Sum_probs=194.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh---hHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+..+..   ...+|+++++.++|+||+++++++.     ....++++|
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~   81 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYIIT   81 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEEE
Confidence            49999999999999999999999999999998865432   3457999999999999999999873     233477999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||++ +++.+.+...  ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||++......
T Consensus        82 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~  157 (263)
T cd05052          82 EFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGD  157 (263)
T ss_pred             EeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-cEEeCCCccccccccc
Confidence            9997 4666655432  23468889999999999999999999 8999999999999999877 6999999998765433


Q ss_pred             CCcc--cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          239 EPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       239 ~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ....  ...++..|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+....+....              
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------------  222 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--------------  222 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------------
Confidence            2211  12235679999988654 48999999999999999998 999998876554444332210              


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                          ..          ..+..++.++.++|.+||..||++|||+.++++
T Consensus       223 ----~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 ----RM----------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ----CC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                00          112457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.9e-40  Score=304.75  Aligned_cols=244  Identities=33%  Similarity=0.580  Sum_probs=196.4

Q ss_pred             eeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      ||.|+||.||+|++..+|+.||+|.+....       ....+|+++++.++|+||+++++.+     ......++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999999899999999886432       2345789999999999999998877     3344578999999


Q ss_pred             hh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC--
Q 014595          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--  239 (422)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~--  239 (422)
                      ++ ++..++..    ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            75 66665543    2478999999999999999999999 8999999999999999887 69999999987553331  


Q ss_pred             -------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          240 -------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       240 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                             ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------  216 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG------------  216 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------
Confidence                   122345678899999986544 889999999999999999999999877755554443220            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH---HHHhcCCcccccC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFFDELR  372 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~---~e~l~hp~f~~~~  372 (422)
                           ....+.          ...++..+.+|+.+||+.+|.+|||+   .++|+||||+++.
T Consensus       217 -----~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         217 -----KIEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             -----CcCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence                 011111          01248899999999999999999999   9999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.3e-40  Score=314.49  Aligned_cols=280  Identities=20%  Similarity=0.294  Sum_probs=194.6

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |.+++.+|.  +|.||.++...+++.||||++...      .....+|+++++.++|+||+++++++..     ....++
T Consensus         4 ~~i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (314)
T cd08216           4 TLIGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYV   76 (314)
T ss_pred             hhhhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEE
Confidence            334444444  455666666678999999998543      1345689999999999999999998843     334789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|||+++ ++..++....  ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||.+....
T Consensus        77 ~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~  152 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMI  152 (314)
T ss_pred             EEeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCC-ceEEecCccceeec
Confidence            9999984 5666655432  3468899999999999999999999 8999999999999999877 69999999886543


Q ss_pred             cCCC--------cccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          237 KGEP--------NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       237 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ....        .....++..|+|||++.+. ..++.++|+|||||++|+|++|..||...+....+.+...........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (314)
T cd08216         153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD  232 (314)
T ss_pred             cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccc
Confidence            2211        1223457789999998553 348899999999999999999999998766544433322211000000


Q ss_pred             --HHhhcCcCCcc----CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          308 --EIKCMNPNYTE----FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       308 --~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                        ...........    ...+. ............++.++.+|+.+||+.||++|||+.++|+||||+.++.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~  305 (314)
T cd08216         233 KSTYPLYEDSMSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN  305 (314)
T ss_pred             cCchhhhcCCcCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccc
Confidence              00000000000    00000 001111112234567899999999999999999999999999999886443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.7e-40  Score=306.95  Aligned_cols=246  Identities=26%  Similarity=0.380  Sum_probs=189.9

Q ss_pred             eEEeeee--eecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEee
Q 014595           84 YIAEHVV--GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        84 y~~~~~l--g~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      |.+.+.+  |+|+||.||+++++.+++.+|+|.+..... ...|+.+...+ +|+||+++++++..     ....++|||
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv~e   89 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLIMD   89 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEEEE
Confidence            5555555  999999999999999999999998865321 12244444433 79999999998843     235889999


Q ss_pred             cch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC
Q 014595          161 YVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (422)
Q Consensus       161 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~  239 (422)
                      |++ ++|..++..    ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++..++|+|||++...... 
T Consensus        90 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-  163 (267)
T PHA03390         90 YIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-  163 (267)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence            997 477665543    2478999999999999999999999 899999999999999987746999999998765322 


Q ss_pred             CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          240 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       240 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                        ....++..|+|||++.+. .++.++|+|||||++|+|++|..||........ ...+......              .
T Consensus       164 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------~  226 (267)
T PHA03390        164 --SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK--------------K  226 (267)
T ss_pred             --ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--------------c
Confidence              234678899999999654 489999999999999999999999986543321 1111111000              0


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-HHHHhcCCcccc
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFDE  370 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-~~e~l~hp~f~~  370 (422)
                      .            ...+.+++.+.+||.+||+.||.+|++ .+++|+||||..
T Consensus       227 ~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        227 L------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             C------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            0            011357899999999999999999996 599999999963

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.6e-40  Score=311.22  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=199.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|.+.+.||+|+||.||+|.+..++..||+|.+....    ....+|+.+++.++||||+++++.+..     ....++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~l   93 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELWV   93 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEEE
Confidence            46999999999999999999998889999999875322    234579999999999999999998743     234779


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      |+||+++ ++.+++..     ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        94 v~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~  166 (293)
T cd06647          94 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  166 (293)
T ss_pred             EEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCC-CEEEccCcceeccc
Confidence            9999975 66555432     457888999999999999999999 8999999999999999877 69999999886543


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+....+..+.. .+.+           
T Consensus       167 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~-----------  233 (293)
T cd06647         167 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-----------  233 (293)
T ss_pred             ccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC-----------
Confidence            3222 223467888999999865 4588999999999999999999999987654433222111 0000           


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                  .+.  .+..++..++++|++||..||.+||++.+++.||||+..+
T Consensus       234 ------------~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         234 ------------ELQ--NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             ------------CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                        000  1134678899999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5e-40  Score=307.65  Aligned_cols=248  Identities=25%  Similarity=0.408  Sum_probs=198.9

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      |.+.+.||.|+||.||+|.+..+++.||||.+....     ....+|+.+++.++||||+++++++.     ...+.++|
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv   80 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWII   80 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEEE
Confidence            788899999999999999998899999999875322     23457999999999999999999883     33457899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ ++...+.     ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~  153 (277)
T cd06641          81 MEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTD  153 (277)
T ss_pred             EEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCC-CEEEeecccceeccc
Confidence            999985 5544443     2468899999999999999999999 8999999999999999887 699999999876533


Q ss_pred             CCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          238 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       238 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      ... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+... .              
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~--------------  217 (277)
T cd06641         154 TQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-N--------------  217 (277)
T ss_pred             chhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-C--------------
Confidence            221 123457888999999854 45789999999999999999999999766544333332110 0              


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                          .+         .+...++.++.++|.+||+.||.+||++.++++||||....
T Consensus       218 ----~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         218 ----PP---------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             ----CC---------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence                00         01235688999999999999999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.7e-40  Score=304.19  Aligned_cols=249  Identities=24%  Similarity=0.436  Sum_probs=197.1

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      +|.+.+.||+|+||.||+|++..++..+++|.++..         .....+|+.+++.++||||+++++++..     ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence            489999999999999999999877777777765421         1123468899999999999999998742     23


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ..+++|||+++ ++...+.........+++..++.++.|++.||.|||+ .|++|+||||+||+++. + .+||+|||++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~-~-~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN-N-LLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec-C-CEeecccCce
Confidence            37799999985 7766666555555779999999999999999999999 89999999999999985 3 5999999998


Q ss_pred             cccccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          233 KVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       233 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ........ .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+...  .        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~--------  221 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--P--------  221 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--C--------
Confidence            76543322 234457888999999854 44788999999999999999999999766544433333220  0        


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                               .+         .++..++.++.++|.+||..||++||++.++++||||
T Consensus       222 ---------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 ---------TP---------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ---------CC---------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                     00         0123568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.5e-40  Score=308.74  Aligned_cols=247  Identities=22%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCC-----eEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      +|.+.+.||+|+||.||+|.+...+     ..||+|.+....     ..+.+|+.+++.++||||+++++++..     .
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~   80 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-----E   80 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-----C
Confidence            5899999999999999999976554     789999886432     234679999999999999999998732     2


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~  219 (422)
                      ...+++|||+++ ++.+.+.....            ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEcC
Confidence            347799999974 66666654211            11457888999999999999999999 89999999999999998


Q ss_pred             CCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014595          220 HTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  295 (422)
Q Consensus       220 ~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~  295 (422)
                      ++ .+||+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+...
T Consensus       160 ~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05048         160 GL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            77 699999999875533221   1233457889999998654 48999999999999999998 999998877655544


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+....                   .+         ..+..++.++.+|+.+||+.||.+||++.+++++
T Consensus       238 ~i~~~~-------------------~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQ-------------------LL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCC-------------------cC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            433210                   00         0124578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=299.83  Aligned_cols=264  Identities=27%  Similarity=0.473  Sum_probs=207.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~  152 (422)
                      -.+|.++++||+|+|++|.+++++.|.+.||+|++++..       ...+.|..+..+. +||.+|-++.||     ..+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qte  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QTE  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----ccc
Confidence            346999999999999999999999999999999986532       2334577777666 799999999999     444


Q ss_pred             eEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ..+++|.||++|+-.  + ........+|++.++.|...|+.||.|||+ +|||+||||.+|||+|.+|+ +||+|+|++
T Consensus       324 srlffvieyv~ggdl--m-fhmqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaegh-ikltdygmc  398 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDL--M-FHMQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMC  398 (593)
T ss_pred             ceEEEEEEEecCcce--e-eehhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCCc-eeecccchh
Confidence            458899999986321  1 112224679999999999999999999999 89999999999999999995 999999999


Q ss_pred             ccc-ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHH-HHhCC
Q 014595          233 KVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG-------ESGVDQLVEII-KVLGT  303 (422)
Q Consensus       233 ~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~-------~~~~~~~~~i~-~~~~~  303 (422)
                      +.- .++....+++|||.|+|||++.+.. |+..+|+|+|||+++||+.|+.||.-       .+.++.+.+++ ..   
T Consensus       399 ke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek---  474 (593)
T KOG0695|consen  399 KEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK---  474 (593)
T ss_pred             hcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh---
Confidence            764 4455667889999999999997755 99999999999999999999999952       12222222222 11   


Q ss_pred             CCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC------HHHHhcCCcccccCCCCCC
Q 014595          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRDPNTR  377 (422)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t------~~e~l~hp~f~~~~~~~~~  377 (422)
                                    .+            .++..+|..+..+++..|.+||.+|..      ..++..||||+.+.  |+.
T Consensus       475 --------------qi------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id--wd~  526 (593)
T KOG0695|consen  475 --------------QI------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID--WDL  526 (593)
T ss_pred             --------------cc------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC--HHH
Confidence                          01            123567888999999999999999974      68999999999765  433


Q ss_pred             CCCCCCCCC
Q 014595          378 LPNGRPLPP  386 (422)
Q Consensus       378 ~~~~~~~~~  386 (422)
                      +...+.+||
T Consensus       527 leqk~v~pp  535 (593)
T KOG0695|consen  527 LEQKQVLPP  535 (593)
T ss_pred             HhhcccCCC
Confidence            444444443

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.8e-40  Score=339.54  Aligned_cols=249  Identities=22%  Similarity=0.360  Sum_probs=191.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.++||+|+||.||+|++..+|+.||||++..+       .....+|+++++.++||||+++++++.     .....
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~l   77 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDPV   77 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCEE
Confidence            599999999999999999999999999999998642       123457999999999999999998873     33457


Q ss_pred             EEEeecchh-HHHHHHHHhhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEe
Q 014595          156 NLVLEYVPE-TVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~  227 (422)
                      +++|||+++ +|.+++.....       ....++...+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg-~vKLi  155 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFG-EVVIL  155 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCC-CEEEE
Confidence            899999985 67666654211       12345667788899999999999999 8999999999999999887 69999


Q ss_pred             ecCCccccccCC-------------------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014595          228 DFGSAKVLVKGE-------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE  288 (422)
Q Consensus       228 DfG~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~  288 (422)
                      |||+++......                   .....+||+.|+|||++.+. .++.++|||||||++|||+||..||.+.
T Consensus       156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            999997651110                   01124689999999998654 4899999999999999999999999775


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      +.......  .....+.              .     ..+     ...+++.+.+++.+||..||++|++..+.+.+
T Consensus       235 ~~~ki~~~--~~i~~P~--------------~-----~~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        235 KGRKISYR--DVILSPI--------------E-----VAP-----YREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             chhhhhhh--hhccChh--------------h-----ccc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            43322211  0000000              0     000     13578999999999999999999987666543

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.2e-40  Score=313.53  Aligned_cols=244  Identities=23%  Similarity=0.369  Sum_probs=189.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeE----EEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|++.+.||+|+||+||+|++..+++.    ||||.+...     ...+.+|+.+++.++||||+++++++...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            3599999999999999999998766654    899987532     23345799999999999999999987431     


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                       ..+++++|++ +++.+.+...   ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~-~~kl~DfG~  155 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCC-cEEEccccc
Confidence             1457899887 4565555432   3468888899999999999999999 8999999999999999877 699999999


Q ss_pred             ccccccCCCcc---cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          232 AKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       232 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ++.........   ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+ +..+....      
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~------  227 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKG------  227 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCC------
Confidence            98764433221   1223567999999865 458999999999999999997 999998765443 23332210      


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                 ...+          .+...+.++.+++.+||..||++|||+.+++.+
T Consensus       228 -----------~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         228 -----------ERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             -----------CCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                       0000          013467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-42  Score=351.79  Aligned_cols=255  Identities=28%  Similarity=0.472  Sum_probs=205.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.-...||.|.||.||-|.+..+|+..|+|-+.-.      .....+|..++..|+|||+|+++++-...+.     +
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek-----v 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK-----V 1309 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----H
Confidence            4577788999999999999999999999999977422      2334589999999999999999887644333     6


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +|.||||.+ +|.+++..    ++..++...+.|..|++.|+.|||+ .|||||||||+||+++.+| .+|++|||.|..
T Consensus      1310 ~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNG-LIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCC-cEEeecccceeE
Confidence            789999985 66565543    4557788888999999999999999 8999999999999999888 799999999987


Q ss_pred             cccCCC-----cccccccccccchhhhcCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCH
Q 014595          235 LVKGEP-----NVSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTR  306 (422)
Q Consensus       235 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~  306 (422)
                      +.+...     .....||+.|||||++.+..  ....+.|||||||++.||+||+.||...+.. ..+.++-.       
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~------- 1456 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA------- 1456 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-------
Confidence            755431     23568999999999997643  3577999999999999999999999765433 22222211       


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                                  ...|+         ++.++|++.+|||.+||+.||.+|+++.|+|.|-|-+.-.+.+
T Consensus      1457 ------------gh~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1457 ------------GHKPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred             ------------cCCCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence                        11222         3356899999999999999999999999999999987655443

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.9e-39  Score=299.50  Aligned_cols=249  Identities=27%  Similarity=0.425  Sum_probs=201.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||.|+||.||++.+..+++.+|+|.+....      ....+|+.+++.++|+||+++++++...     ...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence            3889999999999999999999999999999875421      2334789999999999999999888432     4578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ ++...+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            99999974 6766665544445678999999999999999999999 8999999999999999876 6999999999776


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+...               
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------------  216 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---------------  216 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Confidence            544 23345678899999998654 4888999999999999999999999877654433332210               


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                          .++.         .....+.+++++|.+||..+|++|||+.++++||++
T Consensus       217 ----~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         217 ----KYPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ----CCCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                0111         112468899999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1e-39  Score=303.66  Aligned_cols=248  Identities=26%  Similarity=0.436  Sum_probs=195.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|++.+.||+|+||.||+|++..+++.||||.+...       .....+|+++++.++||||+++++++..     ....
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNEL   77 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCeE
Confidence            599999999999999999999999999999976431       1234579999999999999999998743     2347


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++++||+++ ++..++.........+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~  155 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGRF  155 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCC-CEEECcccccee
Confidence            799999985 7766665544444568999999999999999999999 8999999999999999877 699999999876


Q ss_pred             cccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhc
Q 014595          235 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       235 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ...... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||..... ...+...+...+.+        
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  226 (267)
T cd08228         156 FSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP--------  226 (267)
T ss_pred             ccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC--------
Confidence            543221 1234578889999998654 488999999999999999999999965432 11222222211111        


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                ..        .....+..+.+++.+||..||++|||+.++++
T Consensus       227 ----------~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         227 ----------PL--------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             ----------CC--------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                      00        11246788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.6e-39  Score=305.95  Aligned_cols=255  Identities=23%  Similarity=0.326  Sum_probs=195.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC-----CCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      .+|.+.+.||+|+||.||+|.++.     .+..||+|.+....     ....+|+.+++.++|+||+++++++..     
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----   80 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-----   80 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----
Confidence            469999999999999999997652     35589999875432     223468999999999999999998732     


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcE
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  224 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~v  224 (422)
                      ....++||||++ ++|.+.+......      ....+...+..++.|++.||.|||+ +||+||||||+|||++.++ .+
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~-~~  158 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDF-TV  158 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCC-cE
Confidence            234789999997 5777776543211      1234567788899999999999999 8999999999999999877 69


Q ss_pred             EEeecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014595          225 KLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  300 (422)
Q Consensus       225 kl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~  300 (422)
                      +|+|||+++........   ....++..|+|||.+.+. .++.++|+|||||++|||++ |..||.+.+..+....+...
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG  237 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999998754332211   122346679999998654 48999999999999999998 78999877655544333221


Q ss_pred             hCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc------CCcccccC
Q 014595          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDELR  372 (422)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~~~  372 (422)
                       +.               ..            .+...++.+.+++.+||+.||++|||+.++++      ||||.++.
T Consensus       238 -~~---------------~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         238 -GY---------------LD------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             -CC---------------CC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence             00               00            11346789999999999999999999999987      99998763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.4e-40  Score=308.20  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=194.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC-----CCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      .+|.+.+.||+|+||.||+|.+..     +++.||||.+...     ...+.+|+++++.++|+||+++++++...    
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG----   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC----
Confidence            358999999999999999998743     3678999988643     23456799999999999999999988432    


Q ss_pred             ceEEEEEeecchh-HHHHHHHHhh----------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC
Q 014595          152 ELYLNLVLEYVPE-TVNRIARNYS----------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  220 (422)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~  220 (422)
                       ...+++|||+++ +|...+....          .....+++..+..++.|++.||.|||+ +|++||||||+||+++.+
T Consensus        81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~  158 (280)
T cd05049          81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGYD  158 (280)
T ss_pred             -CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcCC
Confidence             347899999974 6666654321          122457888999999999999999999 899999999999999988


Q ss_pred             CCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014595          221 THQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE  296 (422)
Q Consensus       221 ~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~  296 (422)
                      + .+||+|||++........   .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus       159 ~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         159 L-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             C-eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            7 799999999875432221   1233456789999998654 48999999999999999998 9999988776655544


Q ss_pred             HHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       297 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +....                 .  +         ..+..++..+.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~-----------------~--~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         237 ITQGR-----------------L--L---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHcCC-----------------c--C---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            43210                 0  0         011357899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.5e-40  Score=316.47  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=191.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCCCC
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  151 (422)
                      +|++.+.||.|+||.||+|++.     .+++.||+|++....     ....+|+.+++++ +|+||+++++++...    
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~----   83 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP----   83 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC----
Confidence            6999999999999999999754     345789999875421     2334699999999 899999999877432    


Q ss_pred             ceEEEEEeecchh-HHHHHHHHhhh-------------------------------------------------------
Q 014595          152 ELYLNLVLEYVPE-TVNRIARNYSR-------------------------------------------------------  175 (422)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~-------------------------------------------------------  175 (422)
                      ...++++|||+++ ++...+.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            2347789999985 66655542110                                                       


Q ss_pred             --hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCC---cccccccccc
Q 014595          176 --IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYY  250 (422)
Q Consensus       176 --~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y  250 (422)
                        ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..+.....   .....++..|
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCccc
Confidence              12368889999999999999999999 8999999999999999877 699999999986533221   1223446679


Q ss_pred             cchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCc
Q 014595          251 RAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW  329 (422)
Q Consensus       251 ~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (422)
                      +|||++.+. .++.++|||||||++|||++ |..||.+....+.+...+...               ...          
T Consensus       242 ~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------------~~~----------  295 (337)
T cd05054         242 MAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG---------------TRM----------  295 (337)
T ss_pred             cCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc---------------CCC----------
Confidence            999998664 48999999999999999998 999998755444333332210               000          


Q ss_pred             ccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          330 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       330 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                        ..+...++++.+++.+||+.+|++||++.++++|
T Consensus       296 --~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         296 --RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             --CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              0123467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9.7e-40  Score=308.11  Aligned_cols=251  Identities=28%  Similarity=0.444  Sum_probs=199.6

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      |.....||+|+||.||+|.+..+++.||||++...    .....+|+.+++.++|+||+++++++..     ..+.+++|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEE
Confidence            44456799999999999999999999999987532    2234579999999999999999998843     34578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ ++..+..     ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++......
T Consensus        97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~  169 (292)
T cd06657          97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKE  169 (292)
T ss_pred             ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEcccccceecccc
Confidence            99986 4544332     2468899999999999999999999 8999999999999999887 6999999998655433


Q ss_pred             C-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      . ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+.+..+....  +             
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~-------------  233 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--P-------------  233 (292)
T ss_pred             cccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--C-------------
Confidence            2 1233567889999998854 457899999999999999999999998776655444332211  0             


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                           .    .+.  ....+++.+.+++.+||+.||.+||++.++++||||.....
T Consensus       234 -----~----~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         234 -----P----KLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             -----c----ccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence                 0    000  01346889999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.6e-40  Score=310.93  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=190.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeE--EEEEEeccc-----hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vAiK~~~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||.||+|.+..++..  +|+|.+...     ...+.+|++++.++ +|+||+++++++.     ...
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CCC
Confidence            3599999999999999999998877754  577766432     12345799999999 8999999999873     334


Q ss_pred             EEEEEeecch-hHHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC
Q 014595          154 YLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  220 (422)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~  220 (422)
                      +.++||||++ +++.+++.....            ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecCC
Confidence            5789999997 477666654321            12357899999999999999999999 899999999999999987


Q ss_pred             CCcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014595          221 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  299 (422)
Q Consensus       221 ~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~  299 (422)
                      + .+||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|+| |..||.+.+..+....+..
T Consensus       161 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         161 Y-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             C-cEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            7 699999999864321111112233567999998854 448999999999999999998 9999987665544333211


Q ss_pred             HhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .                  +..          ..+..+++++.+||.+||+.||++||++.+++.+
T Consensus       239 ~------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 G------------------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             C------------------CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                  000          0112467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.3e-39  Score=304.85  Aligned_cols=249  Identities=21%  Similarity=0.282  Sum_probs=191.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      ..+|++.+.||+|+||.||+|.+.     .++..||||++....     ..+.+|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----   79 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----
Confidence            346999999999999999999864     245789999875422     22457999999999999999998872     


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCc
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  223 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~  223 (422)
                      .....++||||+++ +|.+.+......      ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~-~  157 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T  157 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCC-C
Confidence            33347799999984 676666542211      1235677888999999999999999 8999999999999999887 6


Q ss_pred             EEEeecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014595          224 LKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  299 (422)
Q Consensus       224 vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~  299 (422)
                      ++|+|||+++........   ....+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999998755332211   12234678999999865 448999999999999999999 7899987765544443322


Q ss_pred             HhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      ..                   .+         ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~-------------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         237 GG-------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CC-------------------cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            10                   00         0123568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-39  Score=311.39  Aligned_cols=249  Identities=28%  Similarity=0.416  Sum_probs=201.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .|...+.||+|+||.||+|++..++..||+|.+....       ....+|+++++.++|+|++++++++..     ....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence            3888999999999999999999999999999885321       234579999999999999999998843     2347


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++||||+.+++.+.+..   ....+++..+..++.|++.||.|||+ .||+||||+|+||+++.++ .+||+|||++...
T Consensus       101 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~  175 (317)
T cd06635         101 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASIA  175 (317)
T ss_pred             EEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCC-CEEEecCCCcccc
Confidence            79999999877665543   23568899999999999999999999 8999999999999999877 6999999998654


Q ss_pred             ccCCCcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ..   .....+++.|+|||.+.+  ...++.++|+|||||++|+|++|..||.+.+....+..+......+         
T Consensus       176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  243 (317)
T cd06635         176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------  243 (317)
T ss_pred             CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence            32   234567888999999742  3457899999999999999999999998776555555544311000         


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                        ......++.+++||.+||+.+|.+||++.++++|||+...
T Consensus       244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                              0012467889999999999999999999999999999663

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.5e-39  Score=304.36  Aligned_cols=245  Identities=33%  Similarity=0.592  Sum_probs=200.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcC-CCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|++...       .....+|+++++++. |+||+++++++.     ....
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-----DEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-----CCce
Confidence            499999999999999999999999999999988642       133457899999998 999999999873     3345


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .+++|||+. +++.+.+..    ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence            789999994 577666554    3479999999999999999999999 8999999999999999877 69999999987


Q ss_pred             ccccCCC---------------------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 014595          234 VLVKGEP---------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  292 (422)
Q Consensus       234 ~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~  292 (422)
                      .......                     .....++..|+|||.+.+ ..++.++|+||||++++++++|+.||...+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            5533221                     122346788999998855 448899999999999999999999998877555


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH----HHHhcCCcc
Q 014595          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFF  368 (422)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f  368 (422)
                      .+..+...                 ...            ++..+++.+.+||.+||..||.+|||+    .++++||||
T Consensus       230 ~~~~~~~~-----------------~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         230 TFQKILKL-----------------EYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHhc-----------------CCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            54444321                 111            123568899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.8e-39  Score=297.06  Aligned_cols=247  Identities=29%  Similarity=0.485  Sum_probs=200.2

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      |.+.+.||+|++|.||+|.+..+++.|++|++....    ....+|+++++.++|+||+++++++...     ...++++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~~   76 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIVM   76 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEEE
Confidence            888999999999999999998899999999986543    3456899999999999999999987433     3477999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||++ +++.+.+...   ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~  151 (253)
T cd05122          77 EFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDT  151 (253)
T ss_pred             ecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCC-eEEEeecccccccccc
Confidence            9999 5666655432   1578999999999999999999999 8999999999999999877 6999999998776544


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                      .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+... .                
T Consensus       152 ~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~----------------  213 (253)
T cd05122         152 KARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-G----------------  213 (253)
T ss_pred             ccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-C----------------
Confidence            3334556788899999986544 889999999999999999999999876544444332220 0                


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCc
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  367 (422)
                        .+..   +    ....++..+.++|.+||+.||++|||+.++++|||
T Consensus       214 --~~~~---~----~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         214 --PPGL---R----NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             --CCCc---C----cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence              0000   0    00124789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.5e-39  Score=298.62  Aligned_cols=250  Identities=35%  Similarity=0.537  Sum_probs=200.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||+|++|.||+|.+..+++.|++|++....      ....+|+.++++++|+||+++++++....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            3888999999999999999999899999999886543      34567999999999999999998874321   24577


Q ss_pred             EEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +++||++ +++.+.+..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            9999995 566665554    2378999999999999999999999 8999999999999999877 6999999998876


Q ss_pred             ccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          236 VKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       236 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .....   .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+...  ..+......         
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~---------  219 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGSS---------  219 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhcccc---------
Confidence            55443   3445678899999998554 48999999999999999999999998765221  111111000         


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                            -..         ..++..++..+.+||.+||+.||++||++.++++||||
T Consensus       220 ------~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         220 ------GEP---------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ------CCC---------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                  000         01223568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-39  Score=308.71  Aligned_cols=247  Identities=22%  Similarity=0.302  Sum_probs=190.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCe--EEEEEEeccc-----hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~--~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +|++.+.||+|+||.||+|.+..++.  .+|+|.+...     .....+|+.++.++ +||||+++++++.     ....
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~~   77 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRGY   77 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCCc
Confidence            59999999999999999999877765  4688877532     12345799999999 7999999999873     2334


Q ss_pred             EEEEeecch-hHHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC
Q 014595          155 LNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  221 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~  221 (422)
                      .+++|||++ +++.+.+.....            ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCC
Confidence            789999997 477666654221            12358889999999999999999999 8999999999999999877


Q ss_pred             CcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014595          222 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  300 (422)
Q Consensus       222 ~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~  300 (422)
                       .+||+|||++..............+..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+...++...
T Consensus       157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~  234 (297)
T cd05089         157 -ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  234 (297)
T ss_pred             -eEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence             6999999998643221111122234569999998654 48999999999999999997 99999887765555443221


Q ss_pred             hCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      ..                  .          ..+..++..+.+|+.+||..||.+|||++++++.
T Consensus       235 ~~------------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         235 YR------------------M----------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CC------------------C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00                  0          0113578999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.2e-39  Score=309.81  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=200.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .|...+.||+|+||.||+|++..+++.||+|.+....       ....+|+++++.++|+|++++++++...     ...
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Cee
Confidence            4888899999999999999999999999999875321       1234799999999999999999988432     347


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++||||+.+++...+...   ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++...
T Consensus        91 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCC-cEEECCcccceee
Confidence            799999998776655432   3568899999999999999999999 8999999999999999877 6999999998765


Q ss_pred             ccCCCcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ..   .....+++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+..+....+....            
T Consensus       166 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------------  230 (308)
T cd06634         166 AP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------  230 (308)
T ss_pred             cC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC------------
Confidence            32   234467889999999752  2347889999999999999999999997765544444333210            


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                             .+.        ......+..+.+||++||..+|.+||++.++++|||+....
T Consensus       231 -------~~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         231 -------SPA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             -------CCC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence                   000        00134678899999999999999999999999999998853

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.8e-39  Score=305.60  Aligned_cols=252  Identities=24%  Similarity=0.358  Sum_probs=195.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..|.+.+.||+|+||+||++.+.     .++..+|+|.+....    ....+|+++++.++||||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            45999999999999999999852     345679999886432    23567999999999999999999873     23


Q ss_pred             eEEEEEeecch-hHHHHHHHHhh---------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYS---------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  222 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~  222 (422)
                      .+.+++|||++ +++.+++....         .....+++..+..++.|++.||+|||+ .|++||||||+|||++.++ 
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~-  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL-  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC-
Confidence            45789999997 46666665322         112358999999999999999999999 8999999999999999887 


Q ss_pred             cEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014595          223 QLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII  298 (422)
Q Consensus       223 ~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~  298 (422)
                      .+||+|||++........   .....++..|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+.+..+.+..+.
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            699999999876533221   112234678999999865 458999999999999999998 999998877655554443


Q ss_pred             HHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      ...                   .+         ..+...+.++.+|+.+||+.||.+|||+.+++.  .++++
T Consensus       237 ~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~  279 (288)
T cd05093         237 QGR-------------------VL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNL  279 (288)
T ss_pred             cCC-------------------cC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHH
Confidence            310                   00         011346889999999999999999999999954  35544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=302.75  Aligned_cols=251  Identities=21%  Similarity=0.298  Sum_probs=193.1

Q ss_pred             eEEeeeeeecCCeeEEEEEEcC---CCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-CCce
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  153 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~---~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~  153 (422)
                      |.+.+.||+|+||.||+|....   ++..||||.+..+.      ....+|+++++.++|+||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998764   34789999886432      234579999999999999999987754332 2334


Q ss_pred             EEEEEeecchh-HHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          154 YLNLVLEYVPE-TVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      +.+++|||+++ ++...+....  .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCC-eEEECCcc
Confidence            57799999984 6655554322  122468999999999999999999999 8999999999999999877 69999999


Q ss_pred             CccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          231 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       231 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      +++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-----  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            99765433211   11234567999999854 458999999999999999999 899998776655444332210     


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                 ...            .+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       233 -----------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 -----------RLK------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             -----------CCC------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                       000            113568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=295.93  Aligned_cols=262  Identities=24%  Similarity=0.358  Sum_probs=206.9

Q ss_pred             EEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHH-HHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      +-+..||.|+||+|++-.++.+|+..|||++....     ..+..|.+.. +.-+.||||++++..+...+     .++-
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cWiC  141 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CWIC  141 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----eeee
Confidence            34457999999999999999999999999986432     2333465543 44479999999999876555     7799


Q ss_pred             eecchhHHHHHHH-HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPETVNRIAR-NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||.|.-++..+-+ .|......++|..+..+....+.||+||.....|||||+||+|||++..| .|||||||++..+.+
T Consensus       142 MELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  142 MELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLVD  220 (361)
T ss_pred             HHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHHH
Confidence            9999977755433 34445678999999999999999999999878999999999999999988 699999999988877


Q ss_pred             CCCcccccccccccchhhhcCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          238 GEPNVSYICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .-..+...|...|||||.+..... |+-++|+||||++|||+.||..||.+.+. .+++..+..  |.|+.-..      
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~~------  292 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILLF------  292 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeecC------
Confidence            766677788889999999954433 89999999999999999999999987653 333333332  22221100      


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                                  +.   -.-+.+..+..+|..||.+|-+.||...+++++||++......
T Consensus       293 ------------~~---~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~  337 (361)
T KOG1006|consen  293 ------------DK---ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEG  337 (361)
T ss_pred             ------------cc---cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcC
Confidence                        00   0024688999999999999999999999999999998765544

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.7e-39  Score=306.02  Aligned_cols=254  Identities=28%  Similarity=0.484  Sum_probs=198.1

Q ss_pred             eEEeeeeeecCCeeEEEEEEc---CCCeEEEEEEeccch--------hhHHHHHHHHHHc-CCCCcccccceeecCCCCC
Q 014595           84 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  151 (422)
                      |++.+.||.|+||.||+|++.   .+|+.||+|++....        ....+|+.+++.+ +|+||+.+++++     ..
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~~   76 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----QT   76 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----ec
Confidence            889999999999999999874   478999999886421        2345799999999 599999998887     33


Q ss_pred             ceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      ...+++||||+++ ++.+.+..    ...+++..+..++.|++.||.|||+ .|++||||||+|||++.++ .+||+|||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg  150 (290)
T cd05613          77 DTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTDFG  150 (290)
T ss_pred             CCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCC-CEEEeeCc
Confidence            3457899999985 55444432    3568899999999999999999999 8999999999999999887 69999999


Q ss_pred             CccccccCC--CcccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          231 SAKVLVKGE--PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       231 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ++.......  ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+.+.....   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---  227 (290)
T cd05613         151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---  227 (290)
T ss_pred             cceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc---
Confidence            987653322  12245678899999998542 346789999999999999999999997543322222222211000   


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                                   .+     +    ++..+++.+.+|+++||..||.+|+     ++.++++||||+..++
T Consensus       228 -------------~~-----~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         228 -------------EP-----P----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             -------------CC-----C----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence                         00     0    1235788999999999999999997     8999999999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-39  Score=337.20  Aligned_cols=141  Identities=26%  Similarity=0.440  Sum_probs=121.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||.|+||+||+|++..+++.||||++....       ....+|+.+++.++|+||++++.++     ....+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            35999999999999999999999999999999986532       3456799999999999999998877     33345


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +|+||||+. ++|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            889999996 466666543    3568889999999999999999999 8999999999999999887 69999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-39  Score=296.92  Aligned_cols=246  Identities=35%  Similarity=0.597  Sum_probs=200.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||+|++|.||+|++..+++.||+|.+....      ....+|++++++++|+|++++++++..     ..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence            3889999999999999999999899999999886543      234579999999999999999988732     34578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++|||+++ ++.+.+..    ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            99999985 66555443    2678999999999999999999998 8999999999999999876 7999999999766


Q ss_pred             ccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+......++...              
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------  214 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------  214 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence            44332 13346788899999986544 889999999999999999999999876644443332210              


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                           ..+         .++..++..+.+++.+||..+|++|||+.++++||||
T Consensus       215 -----~~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         215 -----DHP---------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             -----CCC---------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                 000         1224578999999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.9e-39  Score=302.69  Aligned_cols=251  Identities=20%  Similarity=0.273  Sum_probs=190.0

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCe--EEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~--~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      |.+++.||+|+||.||+|.+..++.  .||+|.+...      .....+|+++++.++|+||++++++++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999999877765  6999987532      2234579999999999999999987643322 22234


Q ss_pred             EEEEeecch-hHHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          155 LNLVLEYVP-ETVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      .+++|||+. +++...+....  .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCC-CEEECCCCc
Confidence            678999998 46655443211  122457899999999999999999999 8999999999999999877 699999999


Q ss_pred             ccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          232 AKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       232 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ++.......   .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+....      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN------  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC------
Confidence            986543321   112234677999999855 458999999999999999999 899998766544333332210      


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                ...            .+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       232 ----------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         232 ----------RLK------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ----------CCC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                      000            113567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.1e-39  Score=298.64  Aligned_cols=242  Identities=22%  Similarity=0.322  Sum_probs=191.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|.+.+.||+|+||.||+|..+ .+..+|+|.+...   .....+|+.+++.++||||+++++++.     .....+++|
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv~   78 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIVT   78 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEEE
Confidence            4889999999999999999885 4568999987643   234567999999999999999999873     233478999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||++ +++.+.+...   ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||.++.....
T Consensus        79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~  153 (256)
T cd05114          79 EFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCC-eEEECCCCCccccCCC
Confidence            9997 4665554421   2458899999999999999999999 8999999999999999877 7999999998765332


Q ss_pred             CCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ...  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+.+..+.+...             
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-------------  219 (256)
T cd05114         154 EYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-------------  219 (256)
T ss_pred             ceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-------------
Confidence            221  122345679999998644 58999999999999999999 9999988776666655543100             


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                         ..            .+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       220 ---~~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         220 ---LY------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ---CC------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence               00            11235788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.7e-39  Score=329.68  Aligned_cols=280  Identities=22%  Similarity=0.283  Sum_probs=183.8

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCC----CeEEEEEEeccchhhHHHHHHHHHHc---CCCCcccccceeecCCC-CC
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRET----GEIVAIKKVLQDKRYKNRELQIMQML---DHPNIVALKHCFFSTTD-KE  151 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vAiK~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~-~~  151 (422)
                      ...+|.+.+.||+|+||.||+|++..+    +..||||++....   ..|+.+...+   .+.++..+...+..... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            456799999999999999999999988    8999999875432   1233333333   33444444433322211 33


Q ss_pred             ceEEEEEeecchh-HHHHHHHHhhh----------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          152 ELYLNLVLEYVPE-TVNRIARNYSR----------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                      ....++|+||+++ +|.+++.....                .........+..++.||+.||.|||+ +||+||||||+|
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N  285 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN  285 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence            4457799999984 56565543110                00112234567899999999999999 899999999999


Q ss_pred             eEEcCCCCcEEEeecCCccccccCC--CcccccccccccchhhhcCCC---------------------CCCCcchHHHH
Q 014595          215 LLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYICSRYYRAPELIFGAT---------------------EYTTAIDIWST  271 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diwsl  271 (422)
                      ||++.+...+||+|||+|+.+..+.  ......+|+.|+|||.+....                     .++.++|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9999654479999999997653322  224567899999999763221                     23456799999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc-CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhh
Q 014595          272 GCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ  350 (422)
Q Consensus       272 G~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  350 (422)
                      ||++|||+++..++  .+....+..++...+.... .+... .+..    .+.. . .....+ ......+.+||.+||+
T Consensus       366 GviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~----~~~~-~-~~~~~~-d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        366 GLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLV-AWRKLVEPRA----SPDL-R-RGFEVL-DLDGGAGWELLKSMMR  435 (566)
T ss_pred             HHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHH-HHHHhhcccc----chhh-h-hhhhhc-cccchHHHHHHHHHcc
Confidence            99999999976554  3444444444443333221 12111 1000    0000 0 000001 1234567799999999


Q ss_pred             cCCCCcCCHHHHhcCCcccccCC
Q 014595          351 YSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       351 ~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      .||++|||+.++|+||||+....
T Consensus       436 ~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        436 FKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             CCcccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999999987543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.2e-39  Score=299.32  Aligned_cols=244  Identities=24%  Similarity=0.327  Sum_probs=192.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|++.+.||+|+||.||+|.+. ++..||+|.+....   ....+|+.+++.++|+||+++++++.     .....+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEEE
Confidence            46999999999999999999975 56779999876432   34457999999999999999988773     23347799


Q ss_pred             eecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||++ +++.+.+...  ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05072          80 TEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESL-MCKIADFGLARVIED  155 (261)
T ss_pred             EecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCC-cEEECCCccceecCC
Confidence            99997 4776665432  23568888899999999999999999 8999999999999999877 799999999976543


Q ss_pred             CCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ....  ....++..|+|||.+.+ ..++.++|||||||++|+|+| |..||.+.........+....             
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-------------  221 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-------------  221 (261)
T ss_pred             CceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            2211  12334667999999855 448899999999999999998 999998776555444433210             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                           ..+          ....++.++.+++.+||..||++|||++++++
T Consensus       222 -----~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         222 -----RMP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -----CCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                 000          11346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.3e-39  Score=316.34  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=190.5

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCC-----CeEEEEEEeccch-----hhHHHHHHHHHHcC-CCCcccccceeecCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTD  149 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~-----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~  149 (422)
                      ..+|++++.||+|+||.||+|.+...     +..||||++....     ..+.+|+++++++. ||||+++++++.    
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~----  111 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT----  111 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc----
Confidence            34699999999999999999987433     3579999886432     23457999999996 999999999883    


Q ss_pred             CCceEEEEEeecch-hHHHHHHHHhhh-----------------------------------------------------
Q 014595          150 KEELYLNLVLEYVP-ETVNRIARNYSR-----------------------------------------------------  175 (422)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  175 (422)
                       ....+++|||||+ ++|.+++.....                                                     
T Consensus       112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence             2334789999997 466655543210                                                     


Q ss_pred             ---------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeE
Q 014595          176 ---------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (422)
Q Consensus       176 ---------------------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nil  216 (422)
                                                             ....+++..+..++.||+.||+|||+ .||+||||||+|||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil  269 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence                                                   11347888889999999999999999 89999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 014595          217 VNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  292 (422)
Q Consensus       217 l~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~  292 (422)
                      ++.++ .+||+|||+++.......   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.....
T Consensus       270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            99877 699999999876533221   1233456789999998654 48999999999999999997 999998754443


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .+...+...                 ...+          .+..++.++.+++.+||+.||++|||+.++.+
T Consensus       348 ~~~~~~~~~-----------------~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 TFYNKIKSG-----------------YRMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHhcC-----------------CCCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333322210                 0000          12357889999999999999999999988865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=297.88  Aligned_cols=244  Identities=23%  Similarity=0.327  Sum_probs=192.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|++.+.||+|+||.||+|.+. +++.||||.+....   ....+|+.+++.++|+||+++++++..     ....+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCeeee
Confidence            35999999999999999999975 45789999986532   345679999999999999999987732     2347899


Q ss_pred             eecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||++ +++.+.+....  ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||+++....
T Consensus        80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENN-ICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence            99995 67766665422  3468999999999999999999999 8999999999999999887 699999999987643


Q ss_pred             CCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ....  .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+....+..+....             
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  221 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-------------  221 (261)
T ss_pred             CcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            2211  11122357999998865 458999999999999999999 999998877655554443210             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                           ..+          .+...+..+.+++.+||..||.+||++.++++
T Consensus       222 -----~~~----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         222 -----RMP----------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             -----CCC----------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                 000          11346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4e-39  Score=298.06  Aligned_cols=243  Identities=21%  Similarity=0.295  Sum_probs=191.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|++.+.||+|+||+||+|.+.. +..||||.+....   ....+|+.+++.++||||+++++++..     ...++++|
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~   78 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYIVT   78 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEEEE
Confidence            59999999999999999998754 4569999886532   335679999999999999999998732     23467999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+.+ ++.+.+...   ...+++..+..++.||+.||.|||+ .|++|+||||+||+++.++ .+||+|||.++.....
T Consensus        79 e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~  153 (256)
T cd05113          79 EYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-CEEECCCccceecCCC
Confidence            99975 565555432   2368999999999999999999999 8999999999999999877 7999999998765433


Q ss_pred             CCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ...  ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+.+....            
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------  220 (256)
T cd05113         154 EYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL------------  220 (256)
T ss_pred             ceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC------------
Confidence            211  122345679999998654 48999999999999999998 99999877655544444331100            


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                      ..+...+..+++++.+||..||.+|||+.+++.+
T Consensus       221 ----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 ----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                            0112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3e-39  Score=297.91  Aligned_cols=238  Identities=23%  Similarity=0.320  Sum_probs=184.5

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      +.||+|+||.||+|++..+++.||+|.+...     .....+|+++++.++||||+++++++..     ....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence            3589999999999999999999999987542     2335679999999999999999998733     33478999999


Q ss_pred             hh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCc
Q 014595          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (422)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~  241 (422)
                      ++ ++.+.+..   ....+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++.........
T Consensus        76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence            75 56555432   23468899999999999999999999 8999999999999999877 6999999998754322111


Q ss_pred             c---cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          242 V---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       242 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      .   ....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+.......+....                
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~----------------  213 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV----------------  213 (252)
T ss_pred             ccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------------
Confidence            1   11124569999998654 48999999999999999997 899997665443332222110                


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ..            ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus       214 ~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         214 RL------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CC------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            00            012346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.8e-39  Score=303.54  Aligned_cols=247  Identities=20%  Similarity=0.321  Sum_probs=191.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEc----CCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      +|++.+.||+|+||+||+|.+.    .+++.||+|.+....     ..+.+|+++++.++||||+++++++..     ..
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~   80 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----EQ   80 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----CC
Confidence            5889999999999999999853    456789999886421     235579999999999999999998733     23


Q ss_pred             EEEEEeecchh-HHHHHHHHhh-------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC
Q 014595          154 YLNLVLEYVPE-TVNRIARNYS-------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~  219 (422)
                      ..+++|||+++ ++.+++....             .....+++..+..++.|++.||+|||+ +||+||||||+|||++.
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~~  159 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIGE  159 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEcC
Confidence            47899999984 6666553211             012347888899999999999999999 89999999999999998


Q ss_pred             CCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014595          220 HTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  295 (422)
Q Consensus       220 ~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~  295 (422)
                      ++ .+||+|||+++.......   .....++..|+|||++.+. .++.++|+|||||++|||++ |..||.+.+..+...
T Consensus       160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         160 QL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CC-cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            77 699999999976533221   1233446679999998654 48999999999999999998 999998876544433


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+.... .                 .          ..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       238 ~~~~~~-~-----------------~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MVRKRQ-L-----------------L----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHcCC-c-----------------C----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            332210 0                 0          0123578999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.1e-39  Score=301.47  Aligned_cols=249  Identities=27%  Similarity=0.452  Sum_probs=194.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||.|+||.||+|++..+++.||||.+...       .....+|+.+++.++|+||+++++++..     ..+.
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~   77 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNEL   77 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCeE
Confidence            488999999999999999999889999999987531       1234579999999999999999998843     3357


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++|||+++ ++..++.........+++..++.++.||+.||.|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~  155 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGRF  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEECcchhhhc
Confidence            799999985 7777666544445678999999999999999999999 8999999999999999877 699999999876


Q ss_pred             cccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          235 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       235 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.....  ....+.+.           
T Consensus       156 ~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~-----------  221 (267)
T cd08229         156 FSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIE-----------  221 (267)
T ss_pred             cccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhhh-----------
Confidence            543322 2234678899999998654 48899999999999999999999997654221  11111100           


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                          ....+..        .....++.+++||.+||..||.+|||+.++++
T Consensus       222 ----~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         222 ----QCDYPPL--------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ----cCCCCCC--------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                0000100        11346889999999999999999999997754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-39  Score=300.96  Aligned_cols=247  Identities=23%  Similarity=0.314  Sum_probs=193.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCC-----CeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      .+|++.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.++|+||+++++++..     
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   80 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-----   80 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-----
Confidence            4699999999999999999998643     4889999976432     234579999999999999999998733     


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhh------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcE
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSR------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  224 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~v  224 (422)
                      ....++||||++ ++|.+.+.....      ....+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~-~~  158 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDL-TV  158 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCC-CE
Confidence            244779999997 577766654321      12346788899999999999999999 8999999999999999887 69


Q ss_pred             EEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014595          225 KLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  300 (422)
Q Consensus       225 kl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~  300 (422)
                      ||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG  237 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence            9999999876543321   1233457789999998544 48999999999999999998 99999877655544333210


Q ss_pred             hCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                       .               ...            ++...+.++.+|+.+||+.+|++|||+.+++.
T Consensus       238 -~---------------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 -G---------------HLD------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             -C---------------CCC------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             0               001            11346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.7e-39  Score=301.07  Aligned_cols=249  Identities=21%  Similarity=0.298  Sum_probs=192.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC-----CCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ..|.+.+.||+|+||.||+|.+..     ++..||+|.+....     ..+.+|+.+++.++|+||+++++++...    
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   81 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER----   81 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC----
Confidence            459999999999999999999977     77899999875322     2345799999999999999999987432    


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEE
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLK  225 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vk  225 (422)
                       ...+++|||+. ++|..++.....   ....+++..+..++.||+.||+|||+ +|++||||||+||+++.++  ..+|
T Consensus        82 -~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          82 -LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             -CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcceE
Confidence             23579999996 477666654321   11358889999999999999999999 8999999999999998653  2599


Q ss_pred             EeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 014595          226 LCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVL  301 (422)
Q Consensus       226 l~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~  301 (422)
                      |+|||+++.......   ......+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+... 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-  237 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-  237 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence            999999976532211   1122234679999999654 48999999999999999997 99999877655443332211 


Q ss_pred             CCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      ..               ..            .+..++..+.+++.+||+.||++|||+.++++|
T Consensus       238 ~~---------------~~------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 GR---------------LD------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             Cc---------------CC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00               00            123578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.5e-39  Score=305.32  Aligned_cols=246  Identities=20%  Similarity=0.260  Sum_probs=191.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCC-----CeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      +|.+.+.||+|+||.||+|.+..+     ++.||||++....     ..+.+|+.++..++||||+++++++...     
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-----   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence            488899999999999999987543     5789999986432     2345789999999999999999987322     


Q ss_pred             eEEEEEeecchh-HHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~  219 (422)
                      ...++++||+.+ ++...+....            .....+++..+..++.|++.||.|||+ .||+||||||+|||++.
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEecC
Confidence            237789999874 5555543211            112357888899999999999999999 89999999999999998


Q ss_pred             CCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014595          220 HTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  295 (422)
Q Consensus       220 ~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~  295 (422)
                      ++ .+||+|||+++.......   .....+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+....+.+.
T Consensus       160 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05091         160 KL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE  237 (283)
T ss_pred             CC-ceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            76 699999999876533221   1223446789999998654 48999999999999999998 889998877665555


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .+......                            ..+..++.++.+|+.+||+.||.+||++.+++.
T Consensus       238 ~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         238 MIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            44331100                            012457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-39  Score=296.98  Aligned_cols=242  Identities=26%  Similarity=0.386  Sum_probs=195.0

Q ss_pred             eeeeecCCeeEEEEEEcCC---CeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||.||+|.+...   +..||+|.+....     ....+|+++++.++|+||+++++++..     ...++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4689999999999999865   8899999886532     344579999999999999999998743     34578999


Q ss_pred             ecch-hHHHHHHHHhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          160 EYVP-ETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      ||++ +++.+.+......     ...+++..+..++.|++.||+|||+ +||+|+||||+||+++.++ .+||+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~-~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDL-VVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCC-cEEEccccccc
Confidence            9995 6777766653211     3678999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          234 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       234 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ......   ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------  224 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--------  224 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence            765432   12344567889999998654 58999999999999999999 699998876655544443210        


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                              .            ...+..++.++.+++.+||+.||.+|||+.++++|
T Consensus       225 --------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 --------R------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------C------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                    0            01123568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-39  Score=294.19  Aligned_cols=238  Identities=35%  Similarity=0.598  Sum_probs=193.8

Q ss_pred             eeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      ||.|+||.||+|.+..+++.||+|.+....       .....|+.+++.++|+||+++++.+     ....+.+++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            689999999999998889999999876532       2456799999999999999999887     3445588999999


Q ss_pred             h-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC-CC
Q 014595          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  240 (422)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~-~~  240 (422)
                      + +++.+.+..    ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||++...... ..
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence            5 566555543    2468999999999999999999999 8999999999999999887 6999999998765443 22


Q ss_pred             cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCc
Q 014595          241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  320 (422)
Q Consensus       241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  320 (422)
                      .....++..|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+..                 ..+.
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----------------~~~~  211 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-----------------DPLR  211 (250)
T ss_pred             ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------CCCC
Confidence            3345678889999998654 478899999999999999999999977665433333322                 0111


Q ss_pred             CCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH---HHHhcCCcc
Q 014595          321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF  368 (422)
Q Consensus       321 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~---~e~l~hp~f  368 (422)
                                  ++..++..+.++|++||..||++|||+   +++++||||
T Consensus       212 ------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         212 ------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ------------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                        123468899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.1e-39  Score=302.50  Aligned_cols=247  Identities=23%  Similarity=0.343  Sum_probs=193.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+.||+|+||.||+|.+.     .++..+|+|.+....    ....+|+++++.++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            35999999999999999999854     345679999876432    34568999999999999999999873     23


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~  219 (422)
                      ...++||||++ +++.+.+.....            ....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence            34789999997 477666654221            12458899999999999999999999 89999999999999998


Q ss_pred             CCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014595          220 HTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  295 (422)
Q Consensus       220 ~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~  295 (422)
                      ++ .++|+|||++........   .....++..|+|||.+.+. .++.++|||||||++|+|+| |..||...+..+...
T Consensus       159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            87 699999999875533221   1234457789999998654 58999999999999999999 999998776655443


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .+....                   .+.         .+...+..+.+|+.+||+.||++|||+.++++
T Consensus       237 ~~~~~~-------------------~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         237 CITQGR-------------------VLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHhCCC-------------------CCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            332110                   000         11346889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.4e-39  Score=302.03  Aligned_cols=253  Identities=31%  Similarity=0.465  Sum_probs=204.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .|.+.+.||+|+||.||+|.+..+++.||+|++....   ....+|+++++.++|+||+++++++...     ...++++
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~   94 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWVVM   94 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEEEE
Confidence            4888999999999999999998889999999986543   3456799999999999999999988433     4578999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||++ ++|.+++....   ..+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCC-CEEECccchhhhhccc
Confidence            9999 57777666422   378999999999999999999999 8999999999999999877 6999999988654332


Q ss_pred             CC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 EP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      .. .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+... +.+             
T Consensus       170 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-------------  234 (286)
T cd06614         170 KSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIP-------------  234 (286)
T ss_pred             hhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCC-------------
Confidence            21 1234567889999998654 4899999999999999999999999876655444433221 000             


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                           .     ..  ....++..+++||.+||+.+|.+|||+.++++||||+...
T Consensus       235 -----~-----~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         235 -----P-----LK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             -----C-----Cc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence                 0     00  0123688999999999999999999999999999999844

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=300.96  Aligned_cols=253  Identities=20%  Similarity=0.206  Sum_probs=183.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCC---CeEEEEEEeccchhhHH---------------HHHHHHHHcCCCCccccccee
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN---------------RELQIMQMLDHPNIVALKHCF  144 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~---------------~E~~~l~~l~h~nIv~l~~~~  144 (422)
                      +|.+.+.||+|+||+||+|.+..+   +..+|+|+.........               .+...+..+.|+||++++++.
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            599999999999999999998877   67788886432221111               122334556899999998876


Q ss_pred             ecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcE
Q 014595          145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  224 (422)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~v  224 (422)
                      .... ....+.+++++++..++...+..    ....++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+
T Consensus        93 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~-~~  165 (294)
T PHA02882         93 SFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNN-RG  165 (294)
T ss_pred             eEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-cE
Confidence            4322 23345678899887666555443    2345788889999999999999999 8999999999999999877 69


Q ss_pred             EEeecCCccccccCC--------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014595          225 KLCDFGSAKVLVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE  296 (422)
Q Consensus       225 kl~DfG~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~  296 (422)
                      +|+|||+|+......        ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+......+..
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            999999997653221        11234689999999998654 489999999999999999999999987743322222


Q ss_pred             HHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       297 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ..+.      +.+..+..  ...             .....+..+.+++..|+..+|.+||+..++++
T Consensus       245 ~~~~------~~~~~~~~--~~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        245 AAKC------DFIKRLHE--GKI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HhHH------HHHHHhhh--hhh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1110      00000000  000             01346789999999999999999999999864

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.6e-39  Score=302.90  Aligned_cols=248  Identities=23%  Similarity=0.340  Sum_probs=192.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCC-----CeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|.+.+.||+|+||.||+|.+...     ...+|+|.+....     ....+|+.+++.+ +|+||+++++++..    
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----   87 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ----   87 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC----
Confidence            4699999999999999999998644     3789999886432     2245799999999 89999999998732    


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  217 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill  217 (422)
                       ...++++|||+++ ++...+....            .....+++..+..++.|++.||+|||+ .||+||||||+|||+
T Consensus        88 -~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil~  165 (293)
T cd05053          88 -EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVLV  165 (293)
T ss_pred             -CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEEE
Confidence             3347899999974 6666654321            234568899999999999999999999 899999999999999


Q ss_pred             cCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 014595          218 NPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  293 (422)
Q Consensus       218 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~  293 (422)
                      +.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus       166 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         166 TEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             cCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            9877 799999999976543221   112234567999998854 458999999999999999997 9999987765554


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      ...+....                ...            .+...+..+.+|+.+||..||++|||+.+++++
T Consensus       244 ~~~~~~~~----------------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         244 FKLLKEGY----------------RME------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHcCC----------------cCC------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            44332210                000            113467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-38  Score=296.23  Aligned_cols=243  Identities=25%  Similarity=0.373  Sum_probs=190.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|++.+.||+|+||.||+|++..+ ..||+|++....   ....+|+.+++.++|+||+++++.+.    .  .+.++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS----E--EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC----C--CCcEEE
Confidence            3599999999999999999998655 459999886532   34568999999999999999987652    1  225799


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ ++.+.+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~  154 (262)
T cd05071          79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIED  154 (262)
T ss_pred             EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence            999985 666665432  23457889999999999999999999 8999999999999999877 699999999976543


Q ss_pred             CCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ....  ....++..|+|||...+. .++.++|+|||||++|+|+| |..||.+....+....+....             
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-------------  220 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------  220 (262)
T ss_pred             cccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-------------
Confidence            3221  123346679999988544 48999999999999999999 889998776555444332210             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                           ..+          ....++..+.+|+.+||+.||++|||+.++++
T Consensus       221 -----~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         221 -----RMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----CCC----------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                 000          11346889999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-38  Score=295.49  Aligned_cols=249  Identities=30%  Similarity=0.506  Sum_probs=194.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|.+...       .....+|++++++++|+||+++++++..     ....
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~~   77 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNEL   77 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCeE
Confidence            599999999999999999999989999999987521       2344579999999999999999998843     2347


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++|||+++ +|..++.........+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++..
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~  155 (267)
T cd08224          78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATG-VVKLGDLGLGRF  155 (267)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCC-cEEEeccceeee
Confidence            899999984 7777666544444568999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          235 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       235 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ..... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||......  .....+.+.           
T Consensus       156 ~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-----------  221 (267)
T cd08224         156 FSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIE-----------  221 (267)
T ss_pred             ccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhh-----------
Confidence            54322 12335678889999998654 4899999999999999999999999654311  111111100           


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                          ...++.   .+     ....+..+.++|.+||..+|++|||+.++++
T Consensus       222 ----~~~~~~---~~-----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         222 ----KCDYPP---LP-----ADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ----cCCCCC---CC-----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                000000   00     1246789999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.3e-39  Score=299.15  Aligned_cols=245  Identities=22%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ..+|++.+.||.|+||.||+|.+.. ++.+|+|.+....    ....+|+.+++.++|+||+++++++.     .....+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence            3469999999999999999999977 8999999986543    34457999999999999999998873     233477


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ +|.+.+...  ....+++..+..++.||+.||.|||+ .||+|+||||+||+++.++ .+||+|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~  154 (261)
T cd05148          79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARLI  154 (261)
T ss_pred             EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCc-eEEEccccchhhc
Confidence            99999985 776666542  23568899999999999999999999 8999999999999999887 6999999999765


Q ss_pred             ccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+..+.+..+......          
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----------  223 (261)
T ss_pred             CCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------
Confidence            33221 112234667999999855 458999999999999999998 89999887766655554431100          


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                              +          .+...++.+.+++.+||+.||.+|||+.++++
T Consensus       224 --------~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 --------P----------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             --------C----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                    0          11357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-39  Score=296.42  Aligned_cols=243  Identities=22%  Similarity=0.331  Sum_probs=190.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|++.+.||+|+||.||+|.+. ++..+|+|.+....   ....+|+++++.++|+||+++++++.     ...+.++||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEEE
Confidence            4889999999999999999986 46789999876432   34457999999999999999988773     333578999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ ++.+.+...   ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||+++...+.
T Consensus        79 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~  153 (256)
T cd05059          79 EYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDD  153 (256)
T ss_pred             ecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCC-cEEECCcccceecccc
Confidence            99974 565555432   2468899999999999999999999 8999999999999999887 6999999998765432


Q ss_pred             CCcc--cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          239 EPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       239 ~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ....  ...++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+....              
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------  218 (256)
T cd05059         154 QYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY--------------  218 (256)
T ss_pred             cccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            2111  11234569999998654 58999999999999999999 899998776555444332210              


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                          ..          ..+...+.++.+++.+||..+|++|||+.++++.
T Consensus       219 ----~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         219 ----RL----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ----cC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                00          0113468999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-38  Score=301.33  Aligned_cols=254  Identities=19%  Similarity=0.259  Sum_probs=193.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCC----------------eEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETG----------------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL  140 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l  140 (422)
                      .+|++.+.||+|+||.||+|.+..++                ..||+|.+....     ....+|+++++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            35999999999999999999876543                568999886532     234579999999999999999


Q ss_pred             cceeecCCCCCceEEEEEeecchh-HHHHHHHHhhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 014595          141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (422)
Q Consensus       141 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp  212 (422)
                      ++++..     ..+.+++|||+.+ ++..++.....       ....+++..++.++.|++.||.|||+ .||+||||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp  158 (296)
T cd05051          85 LGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccch
Confidence            998732     2457899999974 67666654321       11268999999999999999999999 8999999999


Q ss_pred             CCeEEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh--CCCCCCC
Q 014595          213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG  287 (422)
Q Consensus       213 ~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--G~~pf~~  287 (422)
                      +||+++.++ .++|+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999886 799999999876533221   1233456789999998653 58999999999999999998  7788877


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .+..+.+..+.......               .....      ...+...+.++.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~---------------~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         237 LTDQQVIENAGHFFRDD---------------GRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cChHHHHHHHHhccccc---------------ccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            66555554443321000               00000      0011346789999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-38  Score=293.63  Aligned_cols=241  Identities=23%  Similarity=0.339  Sum_probs=190.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch--hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +|.+.+.||+|+||.||+|...  |..||+|.+..+.  ....+|+.+++.++|+|+++++++++..    ....+++||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~e   80 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVTE   80 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEEE
Confidence            5999999999999999999864  7889999886543  2355899999999999999999876432    223679999


Q ss_pred             cchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC
Q 014595          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (422)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~  239 (422)
                      |+++ ++.+.+....  ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCC-cEEecCCccceeccccC
Confidence            9984 6666554321  2357889999999999999999999 8999999999999999887 69999999987543322


Q ss_pred             CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          240 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       240 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                        ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.+..                 
T Consensus       157 --~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------------  216 (256)
T cd05082         157 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----------------  216 (256)
T ss_pred             --CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence              23344567999999855 458999999999999999997 999998765544443332210                 


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                       .          ......+++.+.+++.+||..||++|||+.++++
T Consensus       217 -~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 -K----------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -C----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             0          0012357899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1e-38  Score=300.41  Aligned_cols=254  Identities=29%  Similarity=0.458  Sum_probs=194.4

Q ss_pred             eEEeeeeeecCCeeEEEEEEc---CCCeEEEEEEeccch--------hhHHHHHHHHHHc-CCCCcccccceeecCCCCC
Q 014595           84 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  151 (422)
                      |.+.+.||+|+||.||+|++.   .+++.||||.+....        ....+|+.+++++ +||||+++++++     ..
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~~   76 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----QT   76 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----ec
Confidence            889999999999999999864   467899999885421        2345799999999 699999999887     33


Q ss_pred             ceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      ....++||||+++ ++...+..    ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~dfg  150 (288)
T cd05583          77 DTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEG-HVVLTDFG  150 (288)
T ss_pred             CCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEEECc
Confidence            3457899999985 55444332    3568899999999999999999999 8999999999999999887 69999999


Q ss_pred             CccccccCCC--cccccccccccchhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          231 SAKVLVKGEP--NVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       231 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ++........  .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+....    
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----  226 (288)
T cd05583         151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK----  226 (288)
T ss_pred             cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc----
Confidence            9876543322  12345788999999985432 3688999999999999999999999654322222222111000    


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC---HHHHhcCCcccccCC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRD  373 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~~  373 (422)
                               ....            .+..++..+.++|.+||+.||++|||   +.++|+||||+.+.+
T Consensus       227 ---------~~~~------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         227 ---------SKPP------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             ---------cCCC------------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence                     0000            11346889999999999999999998   568899999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.3e-38  Score=298.23  Aligned_cols=243  Identities=21%  Similarity=0.327  Sum_probs=187.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCe----EEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+.||.|+||+||+|++..+++    .||+|++...     .....+|+.+++.+.|+||+++++++...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----   81 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-----   81 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-----
Confidence            469999999999999999999877766    4899987542     22345789999999999999999877421     


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                       ..++++||++ +++.+.+..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~-~~kL~dfG~  155 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPN-HVKITDFGL  155 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCC-cEEECCCCc
Confidence             2558999997 466555443   13568999999999999999999999 8999999999999998777 699999999


Q ss_pred             ccccccCCCcc---cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          232 AKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       232 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ++.........   ...+++.|+|||.+.+. .++.++|||||||++|||++ |..||......... ..+.....+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~---  230 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERL---  230 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcC---
Confidence            98664332211   12335679999998654 48999999999999999998 99999766543332 222211000   


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                    +          .+...+.++.+++.+||..||++||++.+++.
T Consensus       231 --------------~----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         231 --------------P----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             --------------C----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          0          01346889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=296.32  Aligned_cols=244  Identities=25%  Similarity=0.344  Sum_probs=191.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCC---CeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +|.+.+.||+|+||+||+|.+..+   ...||||.+....     ..+.+|+.+++.++||||+++++.+.     ....
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   79 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSRP   79 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCCc
Confidence            599999999999999999998644   4589999875432     23456999999999999999999873     2334


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .+++|||+++ +|.+.+...   ...+++..+..++.|++.||.|||+ .||+|+||||+|||++.++ .++|+|||++.
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~-~~~l~dfg~~~  154 (266)
T cd05033          80 VMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR  154 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-CEEECccchhh
Confidence            7799999975 666655432   2478999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCCCc-c--cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          234 VLVKGEPN-V--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       234 ~~~~~~~~-~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ........ .  ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.+..        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------  225 (266)
T cd05033         155 RLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY--------  225 (266)
T ss_pred             cccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--------
Confidence            76422211 1  1233567999999865 458999999999999999998 999997766555444433210        


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                ..+          .+...+..+.+|+.+||+.||++||++.+++++
T Consensus       226 ----------~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         226 ----------RLP----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ----------CCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                      000          113468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-38  Score=303.13  Aligned_cols=248  Identities=22%  Similarity=0.321  Sum_probs=190.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC-------CCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  148 (422)
                      .+|.+.+.||+|+||.||+|++..       ++..||+|.+....     ....+|+++++.+ +|+||+++++++..  
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--
Confidence            469999999999999999998643       23579999886432     2344699999999 79999999998732  


Q ss_pred             CCCceEEEEEeecchh-HHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 014595          149 DKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Ni  215 (422)
                         ....++||||+++ +|.+++.....            ....+++..+..++.|++.||+|||+ .|++||||||+||
T Consensus        96 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Ni  171 (307)
T cd05098          96 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNV  171 (307)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHhe
Confidence               2347799999984 77666654321            12357888999999999999999999 8999999999999


Q ss_pred             EEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 014595          216 LVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  291 (422)
Q Consensus       216 ll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~  291 (422)
                      +++.++ .+||+|||+++.......   .....+++.|+|||++.+. .++.++|+|||||++|+|++ |..||.+.+..
T Consensus       172 ll~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         172 LVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             EEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            999887 699999999876533211   1112234679999998654 48999999999999999998 88999776544


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       292 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      +....+....                ..            ..+..++.++.+|+.+||..+|.+|||+.+++++
T Consensus       250 ~~~~~~~~~~----------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 ELFKLLKEGH----------------RM------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHcCC----------------CC------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            3333222100                00            0123568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-40  Score=313.22  Aligned_cols=255  Identities=27%  Similarity=0.464  Sum_probs=200.2

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-------hHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      +.-|+.++.||-|+||.|.+++...|...||+|.+.+...       ..+.|..||...+.+-||+|+..|.     +..
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ-----Dkd  702 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKD  702 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec-----cCC
Confidence            4458999999999999999999999999999998865432       2346999999999999999987773     333


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+|+||+|++| ++-.++-.    -+-|+|..++.|+.++..|+++.|. .|+|||||||+|||||.+|+ |||+|||++
T Consensus       703 nLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGH-IKLTDFGLC  776 (1034)
T KOG0608|consen  703 NLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGH-IKLTDFGLC  776 (1034)
T ss_pred             ceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCc-eeeeecccc
Confidence            47799999996 44333322    2679999999999999999999999 99999999999999999995 999999998


Q ss_pred             cccc---------cCCC----------------------------------cccccccccccchhhhcCCCCCCCcchHH
Q 014595          233 KVLV---------KGEP----------------------------------NVSYICSRYYRAPELIFGATEYTTAIDIW  269 (422)
Q Consensus       233 ~~~~---------~~~~----------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  269 (422)
                      +-+.         ++..                                  .-..+||+.|+|||++... .|+..+|+|
T Consensus       777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdww  855 (1034)
T KOG0608|consen  777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWW  855 (1034)
T ss_pred             ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-Cccccchhh
Confidence            5321         1100                                  0135789999999999655 499999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhh
Q 014595          270 STGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF  349 (422)
Q Consensus       270 slG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  349 (422)
                      |.|||||||+.|++||......+.-.+++..-         .      .+.++          ...++++++.+||.++ 
T Consensus       856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~---------~------~l~~~----------~~~~ls~e~~~li~kL-  909 (1034)
T KOG0608|consen  856 SVGVILYEMLVGQPPFLADTPGETQYKVINWR---------N------FLHIP----------YQGNLSKEALDLIQKL-  909 (1034)
T ss_pred             HhhHHHHHHhhCCCCccCCCCCcceeeeeehh---------h------ccccc----------cccccCHHHHHHHHHH-
Confidence            99999999999999998876655444443310         0      01111          1246899999999986 


Q ss_pred             hcCCCCcC---CHHHHhcCCcccccCC
Q 014595          350 QYSPNLRC---TALEACVHPFFDELRD  373 (422)
Q Consensus       350 ~~dP~~R~---t~~e~l~hp~f~~~~~  373 (422)
                      +.+++.|+   .++++..||||+.+.-
T Consensus       910 c~sad~RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  910 CCSADSRLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             hcChhhhhcccchhhhhcCccccccch
Confidence            45688888   4678999999998743

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.1e-39  Score=331.02  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=192.6

Q ss_pred             cceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecC------
Q 014595           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFST------  147 (422)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------  147 (422)
                      +...+|+...+||+||||.||+|+++-+|+.||||+|.-.     .....+|+..+.+|+|||||+++..+...      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            3455688899999999999999999999999999998543     23345899999999999999987554200      


Q ss_pred             ------------------------------------------------C-------------------------------
Q 014595          148 ------------------------------------------------T-------------------------------  148 (422)
Q Consensus       148 ------------------------------------------------~-------------------------------  148 (422)
                                                                      .                               
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0                               


Q ss_pred             ----------------------CCC-------ceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHH
Q 014595          149 ----------------------DKE-------ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI  199 (422)
Q Consensus       149 ----------------------~~~-------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L  199 (422)
                                            ..+       ..++||-||||+..+.+.+-.......  ....++.+++||+.||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                  000       157899999999765443332221111  4667899999999999999


Q ss_pred             HhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc-------------------cCCCcccccccccccchhhhcCCC
Q 014595          200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-------------------KGEPNVSYICSRYYRAPELIFGAT  260 (422)
Q Consensus       200 H~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~  260 (422)
                      |+ +|||||||||.||++++++ .|||+|||+|+...                   +....++.+||..|+|||++.+..
T Consensus       714 H~-~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  714 HD-QGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             Hh-CceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            99 8999999999999999887 69999999997621                   111345678999999999997666


Q ss_pred             --CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCC
Q 014595          261 --EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP  338 (422)
Q Consensus       261 --~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  338 (422)
                        .|+.|+||||||+|++||+.   ||..  .++-...+ ..+..+               ++|.    + .. |...--
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL-~~LR~g---------------~iP~----~-~~-f~~~~~  844 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASIL-TNLRKG---------------SIPE----P-AD-FFDPEH  844 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHH-HhcccC---------------CCCC----C-cc-cccccc
Confidence              69999999999999999984   5632  23322222 211111               1111    1 11 112233


Q ss_pred             hHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          339 PEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       339 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                      +.-..+|++||+.||++||||.|+|++-||-
T Consensus       845 ~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  845 PEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             hHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            5677899999999999999999999999997

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-38  Score=298.74  Aligned_cols=256  Identities=26%  Similarity=0.357  Sum_probs=187.4

Q ss_pred             eEEeeeeeecCCeeEEEEE----EcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           84 YIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~----~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      |.+.+.||+|+||+||++.    ...+++.||+|.+....     ....+|+++++.++||||+++++++..   ....+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence            4899999999999998865    33568899999886432     234579999999999999999987643   22345


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      ++++|||+++ ++.+.+..     ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~  155 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAK  155 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCC-cEEEeeccccc
Confidence            7799999985 55554432     468999999999999999999999 8999999999999999877 69999999997


Q ss_pred             ccccCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHH
Q 014595          234 VLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTPTREE  308 (422)
Q Consensus       234 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~-~~~~~~~~  308 (422)
                      ........    ....++..|+|||.+.+ ..++.++|||||||++|+|+||..||......  +...... .+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~  232 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVR  232 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhh
Confidence            65433221    12234667999999865 45899999999999999999999998654321  1111110 00000000


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +....            ........+..++.++.+++.+||+.||++|||+.+++.
T Consensus       233 ~~~~~------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         233 LIELL------------ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhh------------hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            00000            000000112457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-38  Score=300.62  Aligned_cols=245  Identities=21%  Similarity=0.373  Sum_probs=188.2

Q ss_pred             eEEeeeeeecCCeeEEEEEEcC-----CCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      |++.+.||+|+||.||+|.+..     ....+|+|.+....     ....+|+.+++.++||||+++++.+.     ...
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~   76 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QDG   76 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCC
Confidence            7888999999999999998753     23679999875432     23457999999999999999998873     233


Q ss_pred             EEEEEeecch-hHHHHHHHHhhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 014595          154 YLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (422)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp  212 (422)
                      ..++++||+. +++.+++.....                    ....+++..+..++.|++.||.|||+ .||+||||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dikp  155 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAA  155 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhhh
Confidence            4678999998 466666543211                    12357888999999999999999999 8999999999


Q ss_pred             CCeEEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014595          213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE  288 (422)
Q Consensus       213 ~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~  288 (422)
                      +|||++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.
T Consensus       156 ~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         156 RNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             heEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            999999876 799999999876533221   1122346679999998654 48999999999999999998 99999876


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ........+...                  +..+          .+..++.++.+|+.+||+.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~------------------~~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         234 APERLFNLLKTG------------------YRME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CHHHHHHHHhCC------------------CCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            644433222110                  0000          12357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.6e-38  Score=294.14  Aligned_cols=235  Identities=25%  Similarity=0.344  Sum_probs=183.3

Q ss_pred             eeeecCCeeEEEEEE--cCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           89 VVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~--~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      .||+|+||.||+|.+  ..++..||+|++....      ....+|+.+++.+.|+||+++++++.     . ...++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~-~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----A-ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----C-CCcEEEEe
Confidence            589999999999965  4568899999875432      23457899999999999999988752     1 12568999


Q ss_pred             cchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC
Q 014595          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (422)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~  239 (422)
                      |+++ ++...+..    ...+++..+..++.|++.||+|||+ +||+||||||.||+++.++ .+||+|||++.......
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            9985 56555432    3568999999999999999999999 8999999999999999877 69999999997654332


Q ss_pred             Cc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          240 PN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       240 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..    ....++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+.+..+....+.+.. .           
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~-----------  216 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-R-----------  216 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-C-----------
Confidence            21    12233578999998854 458899999999999999998 999998776655444432210 0           


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                          ..            .+..+++++.+||.+||+.||++||++.++..
T Consensus       217 ----~~------------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         217 ----ME------------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ----CC------------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                00            12357899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=320.92  Aligned_cols=203  Identities=28%  Similarity=0.418  Sum_probs=169.7

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----chhhHHHHHHHHHHcCCCCcccccceeecCC-CCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTT-DKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~~~~~~l  157 (422)
                      |...+.||+|+||.||+++++.||+.||||.+.+     .....-+|+++|++|+|+|||++.++-.... .--...-.+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            7778899999999999999999999999998865     2233347999999999999999977531111 000223458


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC---CcEEEeecCCcc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFGSAK  233 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~---~~vkl~DfG~a~  233 (422)
                      |||||.+ +|...+... ....++++.++..++..++.||.|||+ +|||||||||.||++-...   ...||+|||.|+
T Consensus        95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            9999985 666666543 346789999999999999999999999 8999999999999985322   368999999999


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE  288 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~  288 (422)
                      .+.++....+.+||+.|.+||++.....|+..+|.|||||++|+++||..||...
T Consensus       173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            9999888899999999999999965577999999999999999999999999653

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-38  Score=300.09  Aligned_cols=247  Identities=24%  Similarity=0.372  Sum_probs=191.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEE-----cCCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  149 (422)
                      ..+|.+.+.||+|+||.||+|.+     ..++..||+|.+....     ....+|+.+++++ +|+||+++++++..   
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---  110 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI---  110 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence            34699999999999999999975     3346689999876432     2345799999999 79999999998733   


Q ss_pred             CCceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                        ....+++|||++ ++|...+....  ...+++..+..++.|++.||+|||+ .||+|+||||+|||++.++ .++|+|
T Consensus       111 --~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~d  184 (302)
T cd05055         111 --GGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGK-IVKICD  184 (302)
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCC-eEEECC
Confidence              234789999998 46666554311  2348999999999999999999999 8999999999999999776 699999


Q ss_pred             cCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014595          229 FGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       229 fG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      ||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+.+.+.....   
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~---  260 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG---  260 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC---
Confidence            999876543321   1123346789999998654 48999999999999999998 999998776555444433210   


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                    +..          ..+...++++.+|+.+||..+|++|||+.++++
T Consensus       261 --------------~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 --------------YRM----------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             --------------CcC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                          000          011346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=300.97  Aligned_cols=255  Identities=21%  Similarity=0.288  Sum_probs=191.1

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCC--------------eEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETG--------------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALK  141 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~  141 (422)
                      +.+|.+.+.||+|+||.||+|++..++              ..||+|.+....     ..+.+|+++++.++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            346999999999999999999875432              359999886532     2345799999999999999999


Q ss_pred             ceeecCCCCCceEEEEEeecchh-HHHHHHHHhhh--------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 014595          142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR--------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (422)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp  212 (422)
                      +++..     ....++||||+.+ ++.+.+.....        ....+++..+..++.|++.||.|||+ .|++||||||
T Consensus        84 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp  157 (295)
T cd05097          84 GVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLAT  157 (295)
T ss_pred             EEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccCh
Confidence            98833     2347899999985 66666543211        01236788889999999999999999 8999999999


Q ss_pred             CCeEEcCCCCcEEEeecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh--CCCCCCC
Q 014595          213 QNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG  287 (422)
Q Consensus       213 ~Nill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--G~~pf~~  287 (422)
                      +||+++.++ .+||+|||++.........   ....++..|+|||++.+. .++.++|+|||||++|+|++  |..||..
T Consensus       158 ~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         158 RNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             hhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            999999877 6999999998765332211   122346689999998654 48999999999999999988  6788887


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .+..+.+..+.......            ....+.         ..+...++.+.+|+.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~------------~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         236 LSDEQVIENTGEFFRNQ------------GRQIYL---------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             cChHHHHHHHHHhhhhc------------cccccC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            76665555443311000            000000         011346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3e-38  Score=292.82  Aligned_cols=243  Identities=24%  Similarity=0.324  Sum_probs=190.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|.+...||+|+||.||+|.+..+ ..+|+|.+....   ....+|+.+++.++|+||+++++++.    .  ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~--~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS----E--EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc----C--CCcEEE
Confidence            3599999999999999999998654 469999876432   23457999999999999999988762    1  125699


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ ++.+.+...  ....+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05069          79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence            999985 676666532  23457889999999999999999999 8999999999999999887 699999999976533


Q ss_pred             CCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ....  ....++..|+|||...+ ..++.++|+|||||++|+|++ |..||.+....+....+....             
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  220 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-------------  220 (260)
T ss_pred             CcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            2211  12334667999998854 448999999999999999999 999998877655554433210             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                           ..          ..+...+..+.+++++||..||++||+++++++
T Consensus       221 -----~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         221 -----RM----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----CC----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                 00          011356889999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-38  Score=306.47  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=188.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEE-----cCCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|.+.+.||+|+||+||+|.+     ..+++.||||++....     ....+|+.++..+ +|+||+++++++..    
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----   82 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK----   82 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec----
Confidence            3699999999999999999984     3467899999986422     2345799999999 68999999987742    


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhh------------------------------------------------------
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSR------------------------------------------------------  175 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  175 (422)
                      ....++++|||+++ +|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            22346799999984 66665543110                                                      


Q ss_pred             ---------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCc---cc
Q 014595          176 ---------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VS  243 (422)
Q Consensus       176 ---------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~---~~  243 (422)
                               ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.........   ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence                     01346778888999999999999999 8999999999999999877 7999999998765322211   12


Q ss_pred             ccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCC
Q 014595          244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  322 (422)
Q Consensus       244 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  322 (422)
                      ..++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+......+........               ...  
T Consensus       241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------~~~--  302 (343)
T cd05103         241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---------------RMR--  302 (343)
T ss_pred             CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC---------------CCC--
Confidence            2345679999998654 58999999999999999997 9999977543333322221100               000  


Q ss_pred             CCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       323 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                .+...++++.+++.+||+.||.+|||+.++++|
T Consensus       303 ----------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         303 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      012357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-38  Score=293.68  Aligned_cols=242  Identities=24%  Similarity=0.343  Sum_probs=190.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|++.+.||+|+||.||+|.+. .+..||+|.+...   .....+|+.+++.++|+||+++++++.    .  ...+++|
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~lv~   79 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS----E--EPIYIVT   79 (260)
T ss_pred             HhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC----C--CCcEEEE
Confidence            5999999999999999999875 5677999988653   234568999999999999999988762    1  1256999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ ++.+.+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~  155 (260)
T cd05070          80 EYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDN  155 (260)
T ss_pred             EecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCc-eEEeCCceeeeeccCc
Confidence            99974 666655432  23458899999999999999999999 8999999999999999877 7999999999765332


Q ss_pred             CCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ...  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||.+.+..+....+....              
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------  220 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY--------------  220 (260)
T ss_pred             ccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            211  12234567999998854 448999999999999999999 899998877655554443210              


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                          ..+          .+...+..+.+|+.+||..||.+|||+.++++
T Consensus       221 ----~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         221 ----RMP----------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ----CCC----------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                000          11346889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.5e-38  Score=299.23  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=192.7

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEc-------CCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  147 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  147 (422)
                      ..+|.+.+.||+|+||.||+|++.       ..+..||+|.+....     ....+|+.+++.+ +||||+++++++.  
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence            446999999999999999999753       234579999875421     3345799999999 8999999999873  


Q ss_pred             CCCCceEEEEEeecchh-HHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                         ....++++|||+++ +|.+++.....            ....+++..+..++.||+.||.|||+ .||+||||||+|
T Consensus        92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  167 (304)
T cd05101          92 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAARN  167 (304)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccce
Confidence               23357899999974 77766654321            12357788899999999999999999 899999999999


Q ss_pred             eEEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 014595          215 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  290 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~  290 (422)
                      ||++.++ .+||+|||+++.......   .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus       168 ili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         168 VLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999877 799999999976543221   1123346779999998654 48999999999999999998 8899987765


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+....+....                ..            ..+..++.++.+||.+||..+|.+|||+.++++.
T Consensus       246 ~~~~~~~~~~~----------------~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EELFKLLKEGH----------------RM------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHcCC----------------cC------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            55444332210                00            0113578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-38  Score=291.31  Aligned_cols=240  Identities=25%  Similarity=0.382  Sum_probs=191.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh---hHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|.+.+.||.|+||.||+|...  |+.||+|.+.....   ...+|+.+++.++|+||+++++++..     ....++||
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~   79 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIVT   79 (256)
T ss_pred             hccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEEE
Confidence            5899999999999999999875  78999999876543   44579999999999999999998743     23377999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||++ +++.+.+....  ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~  155 (256)
T cd05039          80 EYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQG  155 (256)
T ss_pred             EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCC-CEEEcccccccccccc
Confidence            9998 47766655322  2368999999999999999999999 8999999999999999887 6999999999866322


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      .  .....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+...                 
T Consensus       156 ~--~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----------------  215 (256)
T cd05039         156 Q--DSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-----------------  215 (256)
T ss_pred             c--ccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            2  233345679999998644 58899999999999999997 99999876654433322210                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                       +..          ..+...++.+.++|.+||..+|.+|||+.++++
T Consensus       216 -~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         216 -YRM----------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -CCC----------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence             000          011346899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.4e-38  Score=296.79  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=190.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      +|++.+.||+|+||.||+|...     .++..+|+|.+....    ..+.+|+++++.++|+||+++++++..     ..
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   80 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----GR   80 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----CC
Confidence            5888999999999999999743     356789999876432    345679999999999999999887732     23


Q ss_pred             EEEEEeecchh-HHHHHHHHhhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  221 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~  221 (422)
                      ..+++|||+++ ++.+++.....           ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCCC
Confidence            46799999974 66666554221           01357889999999999999999999 8999999999999999877


Q ss_pred             CcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 014595          222 HQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  297 (422)
Q Consensus       222 ~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i  297 (422)
                       .+||+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||......+.+..+
T Consensus       160 -~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         160 -VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             -CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence             699999999875432221   1122346789999998654 48999999999999999998 99999877665555444


Q ss_pred             HHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ....                ..            ..+..+++.+.+||.+||+.||.+||++.+++.
T Consensus       238 ~~~~----------------~~------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGR----------------EL------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCc----------------cC------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3210                00            011357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.2e-38  Score=292.56  Aligned_cols=243  Identities=23%  Similarity=0.324  Sum_probs=191.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|++.++||+|+||.||+|... +++.||+|.+....   ....+|+.+++.++|+||+++++++.    .  ...+++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~--~~~~~v   78 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT----Q--EPIYII   78 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc----c--CCcEEE
Confidence            45999999999999999999875 57889999886533   34567999999999999999988652    1  136799


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+.+ ++.+.+...  ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETL-CCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCC-CEEEccCcceeecCC
Confidence            999974 666555432  23568889999999999999999998 8999999999999999887 699999999876542


Q ss_pred             CCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...  .....++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+.....            
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------  221 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR------------  221 (260)
T ss_pred             CCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC------------
Confidence            221  112334667999999854 448899999999999999999 9999988776554444322100            


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                            .+          .+...+.++.+++.+||..||++|||++++++
T Consensus       222 ------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         222 ------MP----------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ------CC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                  00          11346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.9e-38  Score=294.01  Aligned_cols=243  Identities=27%  Similarity=0.377  Sum_probs=190.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCC---eEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +|.+.+.||+|+||.||+|++..++   ..+|+|.+....     ....+|+.+++.++||||+++++++.     ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   79 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSKP   79 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCc
Confidence            5999999999999999999986544   379999875422     34457999999999999999998873     2335


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .+++|||+++ +|.+.+...   ...+++..+..++.|++.||.|||+ .|++||||||+|||++.++ .++|+|||++.
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~-~~~l~dfg~~~  154 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSR  154 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCC-eEEeCCCCccc
Confidence            7899999975 666555432   2468899999999999999999999 8999999999999999887 69999999997


Q ss_pred             ccccCCCcc----cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .........    ...++..|+|||.+.+. .++.++|+|||||++|++++ |..||.+.+..+....+.+..       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------  226 (267)
T cd05066         155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-------  226 (267)
T ss_pred             ccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-------
Confidence            664332211    11224579999999654 48999999999999999886 999998776555444433211       


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                 ..+          ....+++.+.+++.+||+.+|.+||++.++++
T Consensus       227 -----------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         227 -----------RLP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -----------cCC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                       000          01346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=295.57  Aligned_cols=240  Identities=24%  Similarity=0.343  Sum_probs=183.6

Q ss_pred             eeeecCCeeEEEEEEcCCCe--EEEEEEeccc-----hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEee
Q 014595           89 VVGTGSFGVVFQAKCRETGE--IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~--~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      .||+|+||.||+|++..++.  .+|+|.+...     .....+|+++++++ +||||+++++++..     ..+.+++||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~e   76 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAIE   76 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEEE
Confidence            58999999999999987775  4688877632     12345799999999 89999999998732     334789999


Q ss_pred             cch-hHHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEe
Q 014595          161 YVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (422)
Q Consensus       161 ~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~  227 (422)
                      |++ ++|.+++.....            ....+++..+..++.|++.||+|||+ .|++||||||+|||++.++ .+||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~-~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENY-VAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCC-eEEEC
Confidence            997 477776654321            12357889999999999999999999 8999999999999999887 69999


Q ss_pred             ecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       228 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      |||++..............+..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+...      
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------  227 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------  227 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC------
Confidence            9999853321111112223567999999854 458999999999999999997 99999876655444333210      


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                  +..+          .+..++.++.+|+.+||..||.+|||+.+++.
T Consensus       228 ------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 ------------YRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ------------CCCC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                        0000          11246789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.9e-39  Score=294.02  Aligned_cols=228  Identities=25%  Similarity=0.330  Sum_probs=180.2

Q ss_pred             cCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecchh-HHHHHHH
Q 014595           93 GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIAR  171 (422)
Q Consensus        93 G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~  171 (422)
                      |.||.||+|++..+++.||+|.+..... ..+|...+....||||+++++++.     .....+++|||+++ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence            8999999999999999999999876542 345666666678999999999873     23457899999985 6655554


Q ss_pred             HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCccccccccccc
Q 014595          172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR  251 (422)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~  251 (422)
                      .    ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .++|+|||.+......  .....++..|+
T Consensus        78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence            3    2458999999999999999999999 8999999999999999887 6999999987655332  22344567799


Q ss_pred             chhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCccc
Q 014595          252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK  331 (422)
Q Consensus       252 aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (422)
                      |||.+.+ ..++.++|+||+||++|+|++|+.||......     + .               ....+.           
T Consensus       150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~---------------~~~~~~-----------  196 (237)
T cd05576         150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-N---------------THTTLN-----------  196 (237)
T ss_pred             CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-c---------------cccccC-----------
Confidence            9998854 44789999999999999999999887532210     0 0               000001           


Q ss_pred             ccccCCChHHHHHHHhhhhcCCCCcCCH-----HHHhcCCcc
Q 014595          332 VFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFF  368 (422)
Q Consensus       332 ~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f  368 (422)
                       ++..+++.+++||.+||+.||++|+|+     +++++||||
T Consensus       197 -~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         197 -IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             -CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence             123578899999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.4e-38  Score=299.97  Aligned_cols=247  Identities=22%  Similarity=0.332  Sum_probs=190.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC-------CCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  148 (422)
                      .+|.+.+.||+|+||.||+|++..       ....||+|.+....     ....+|+.+++.+ +||||+++++++..  
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ--   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc--
Confidence            469999999999999999998632       34579999876432     2345799999999 69999999998732  


Q ss_pred             CCCceEEEEEeecchh-HHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 014595          149 DKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Ni  215 (422)
                         ..+++++|||+++ +|.+++.....            ....+++..+..++.||+.||.|||+ .||+||||||+||
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Ni  165 (314)
T cd05099          90 ---EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARNV  165 (314)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccceeE
Confidence               3347899999974 77666654321            12458888899999999999999999 8999999999999


Q ss_pred             EEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 014595          216 LVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  291 (422)
Q Consensus       216 ll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~  291 (422)
                      |++.++ .+||+|||+++.......   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus       166 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         166 LVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             EEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999877 699999999976532211   111223457999999865 458999999999999999999 89999877655


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       292 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +.+..+....                ...            .+..++.++++|+.+||..||++|||+.++++
T Consensus       244 ~~~~~~~~~~----------------~~~------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         244 ELFKLLREGH----------------RMD------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHcCC----------------CCC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            4444332210                000            11356889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-38  Score=303.40  Aligned_cols=248  Identities=22%  Similarity=0.320  Sum_probs=191.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCC-------CeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  148 (422)
                      .+|++++.||+|+||.||+|++...       +..||+|.+....     ....+|+++++++ +||||+++++++..  
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence            3599999999999999999986432       2379999876422     2345799999999 89999999998732  


Q ss_pred             CCCceEEEEEeecchh-HHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 014595          149 DKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Ni  215 (422)
                         ...++++|||+++ +|.+.+.....            ....++...+..++.|++.||.|||+ +||+||||||+||
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Ni  165 (334)
T cd05100          90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARNV  165 (334)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceE
Confidence               3347899999975 77666654211            12357788889999999999999999 8999999999999


Q ss_pred             EEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 014595          216 LVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  291 (422)
Q Consensus       216 ll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~  291 (422)
                      |++.++ .+||+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..
T Consensus       166 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         166 LVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             EEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999887 699999999876533221   1122234679999998654 48999999999999999998 88999887655


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       292 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      +....+....                ..            ..+...+.++.+|+.+||..+|.+|||+.+++++
T Consensus       244 ~~~~~~~~~~----------------~~------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         244 ELFKLLKEGH----------------RM------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHcCC----------------CC------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            5444332210                00            0113467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.4e-38  Score=294.85  Aligned_cols=248  Identities=19%  Similarity=0.255  Sum_probs=191.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC----CCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+.||+|+||.||+|.+..    ++..||+|++....     ....+|+.+++.++|+||+++++++...    .
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----~   81 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----G   81 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----C
Confidence            459999999999999999999875    35889999876432     2345799999999999999999876432    2


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEe
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRI----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~  227 (422)
                      ...+++++|++ +++...+......    ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .+||+
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kl~  159 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEEL-QVKIT  159 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCC-cEEEC
Confidence            23568999987 5666665543221    1468899999999999999999999 8999999999999999877 69999


Q ss_pred             ecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 014595          228 DFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  303 (422)
Q Consensus       228 DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~  303 (422)
                      |||+++.+......   ....++..|+|||.+.+. .++.++|||||||++|++++ |+.||...+..+....+...   
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---  235 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG---  235 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC---
Confidence            99999765333211   123346679999998654 48999999999999999998 99999876654433222210   


Q ss_pred             CCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                     +..+          ....+++++.+++.+||..||++|||+.++++
T Consensus       236 ---------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         236 ---------------YRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ---------------CCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                           0000          11246889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-38  Score=294.33  Aligned_cols=242  Identities=26%  Similarity=0.399  Sum_probs=186.4

Q ss_pred             EEeeeeeecCCeeEEEEEEc----CCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           85 IAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~----~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+.+.||.|.||.||+|...    ..+..|+||.+...     ...+.+|++++++++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            46788999999999999987    45678999998542     2345679999999999999999999863222     7


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++|+||++ ++|.+.+...  ....+++..+..++.||+.||.|||+ .+++|+||+++|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccc
Confidence            79999998 5777776653  13578999999999999999999999 8999999999999999887 799999999876


Q ss_pred             cccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          235 LVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       235 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ......   .........|+|||.+.+.. ++.++||||||+++|||++ |+.||.+.+..+....+.+..         
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~---------  222 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ---------  222 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE---------
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---------
Confidence            522211   12234567799999986544 8999999999999999999 789998887666555553310         


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                             ..            ..+..++..+.++|.+||..||.+|||+.++++
T Consensus       223 -------~~------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  223 -------RL------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             -------ET------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             -------cc------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                   00            012457899999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-38  Score=291.26  Aligned_cols=244  Identities=25%  Similarity=0.343  Sum_probs=193.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|++.+.||.|+||.||+|.+. .++.||||.+....   ....+|+.+++.++|+||+++++++.     .....+++
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v   79 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYIV   79 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEEE
Confidence            46999999999999999999975 45789999886532   34568999999999999999998773     22347899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ ++.+.+...  ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~  155 (261)
T cd05034          80 TEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENL-VCKIADFGLARLIED  155 (261)
T ss_pred             EeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCC-CEEECccccceeccc
Confidence            999974 666655432  23468999999999999999999999 8999999999999999887 699999999876543


Q ss_pred             CCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ....  .....+..|+|||.+.+. .++.++|+|||||++|+|++ |+.||.+.+....+..+......           
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  223 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-----------  223 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            2111  122235679999998654 48999999999999999998 99999887766655554331100           


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                             +          .+...+.++.+++.+||+.||.+||++++++.
T Consensus       224 -------~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 -------P----------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -------C----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                   0          11345789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.7e-38  Score=292.92  Aligned_cols=243  Identities=26%  Similarity=0.410  Sum_probs=190.1

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCe---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .|.+.+.||+|+||.||+|.+..+++   .||||.+...     ...+..|+.+++.++||||+++++++.     ....
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~   79 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSRP   79 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCCc
Confidence            48999999999999999999877665   6999987643     123457999999999999999998873     2334


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .++||||+++ ++...+...   ...+++..+..++.|++.||+|||+ +|++|+||||+||+++.++ .+||+|||++.
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~-~~kl~dfg~~~  154 (269)
T cd05065          80 VMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR  154 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCC-cEEECCCcccc
Confidence            6799999985 565555432   3568899999999999999999999 8999999999999999877 69999999987


Q ss_pred             ccccCCCcccc---c---ccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          234 VLVKGEPNVSY---I---CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       234 ~~~~~~~~~~~---~---~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      ...........   .   .+..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+...      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~------  227 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD------  227 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC------
Confidence            65433221111   1   1346999999864 458999999999999999886 99999877655544443221      


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                  +..+          .+..++..+.+++.+||..+|++||++.+++.
T Consensus       228 ------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         228 ------------YRLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ------------CcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        0111          11346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.4e-38  Score=296.85  Aligned_cols=247  Identities=24%  Similarity=0.317  Sum_probs=191.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      .+|.+.+.||+|+||.||+|.+.     .++..||+|.+....     ..+.+|+.+++.++||||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-----   79 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-----   79 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----
Confidence            45999999999999999999874     367899999876432     335579999999999999999987732     


Q ss_pred             ceEEEEEeecchh-HHHHHHHHhhh------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 014595          152 ELYLNLVLEYVPE-TVNRIARNYSR------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (422)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp  212 (422)
                      ....+++|||+++ ++.+.+.....                  ....+++..+..++.|++.||.|||+ .|++||||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p  158 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLAT  158 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccH
Confidence            2346799999984 77666653211                  11247788899999999999999999 8999999999


Q ss_pred             CCeEEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014595          213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE  288 (422)
Q Consensus       213 ~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~  288 (422)
                      +||+++.++ .++|+|||++........   ......+..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.
T Consensus       159 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         159 RNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             hheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999887 699999999875432211   1122345679999998654 58999999999999999997 88899877


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +..+....+....                   ..         ..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         237 AHEEVIYYVRDGN-------------------VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CHHHHHHHHhcCC-------------------CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            6655444332210                   00         011346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.8e-38  Score=292.04  Aligned_cols=243  Identities=24%  Similarity=0.340  Sum_probs=190.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCe---EEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .|+..+.||+|+||.||+|++..+++   .+|+|.+....     ....+|+++++.++|+||+++.+++..     ...
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   80 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-----FKP   80 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-----CCC
Confidence            48889999999999999999876654   79999876432     234579999999999999999988732     234


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .++||||+++ +|...+..   ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||++.
T Consensus        81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~  155 (268)
T cd05063          81 AMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNL-ECKVSDFGLSR  155 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCC-cEEECCCccce
Confidence            7799999985 55555432   23568899999999999999999999 8999999999999999877 69999999987


Q ss_pred             ccccCCCcc----cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .........    ....+..|+|||++.+. .++.++|+|||||++|+|++ |..||...+..+....+......     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~-----  229 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL-----  229 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC-----
Confidence            654332211    11224569999998654 58999999999999999997 99999877765555444321100     


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                   +          .....+.++.+|+.+||+.||++||++.++++
T Consensus       230 -------------~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         230 -------------P----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -------------C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                         0          01246789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6e-38  Score=290.38  Aligned_cols=236  Identities=24%  Similarity=0.304  Sum_probs=182.9

Q ss_pred             eeeecCCeeEEEEEEc--CCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeec
Q 014595           89 VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  161 (422)
                      .||+|+||.||+|.+.  ..+..||+|++....     ....+|+.++++++|+||+++++++.     . ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence            3899999999999765  446679999886432     23457999999999999999998762     1 136799999


Q ss_pred             chh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCC
Q 014595          162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  240 (422)
Q Consensus       162 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~  240 (422)
                      +++ +|.+.+..   ....+++..+..++.|++.||.|||+ +|++||||||+|||++.++ .+||+|||++........
T Consensus        76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence            974 56555432   23578999999999999999999999 8999999999999999877 799999999875533322


Q ss_pred             c----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          241 N----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       241 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .    ....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+.+..              
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------  215 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--------------  215 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------------
Confidence            1    111225679999998654 48999999999999999996 999998876655443332210              


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                        ..            ..+...++++.++|.+||..||++||++.++++
T Consensus       216 --~~------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         216 --RL------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             --CC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              00            012356899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.2e-38  Score=294.40  Aligned_cols=243  Identities=21%  Similarity=0.299  Sum_probs=186.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCe----EEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|++.+.||+|+||+||+|.+..+++    .||+|.+....     .....|+.+++.++||||+++++++.     . 
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~-   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----G-   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----C-
Confidence            358999999999999999999877776    47777764321     22345677888999999999998762     1 


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ...++++||++ +++.+.+...   ...+++..+..++.||+.||+|||+ +|++||||||+|||++.++ .+||+|||+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~-~~kl~Dfg~  155 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDS-IVQIADFGV  155 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEEcCCcc
Confidence            12567899987 5776665432   3568999999999999999999999 8999999999999999877 799999999


Q ss_pred             ccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          232 AKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       232 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ++........   ....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+...... .++.....     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~-----  228 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGE-----  228 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCC-----
Confidence            9765433221   223456789999998654 48999999999999999998 9999987654332 22222100     


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                ...            .+...+.++.+++.+||..||++|||+.|+++
T Consensus       229 ----------~~~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         229 ----------RLA------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ----------cCC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                      000            01235678999999999999999999999977

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.3e-38  Score=307.71  Aligned_cols=249  Identities=22%  Similarity=0.348  Sum_probs=192.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch-----hhHHHHHHHHHHcC-CCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  150 (422)
                      .+|.+.+.||+|+||.||+|++.     .+++.||||++....     ..+.+|++++.++. ||||+++++++...   
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~---  113 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG---  113 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC---
Confidence            45889999999999999999864     345789999986532     23457999999997 99999999988432   


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhh------------------------------------------------------
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSR------------------------------------------------------  175 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------------------------------------------------  175 (422)
                        ..+++||||++ ++|.+.+.....                                                      
T Consensus       114 --~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         114 --GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             --CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence              34789999998 477666643210                                                      


Q ss_pred             ----------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 014595          176 ----------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (422)
Q Consensus       176 ----------------------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Ni  215 (422)
                                                              ....+++..+..++.||+.||.|||+ .||+||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~Ni  270 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAARNV  270 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcceE
Confidence                                                    11235677788899999999999998 8999999999999


Q ss_pred             EEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 014595          216 LVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  291 (422)
Q Consensus       216 ll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~  291 (422)
                      |++.++ .+||+|||+++.......   .....+++.|+|||.+.+. .++.++|||||||++|||++ |..||......
T Consensus       271 Ll~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         271 LICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             EEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            999876 799999999976532221   1234567889999998654 48999999999999999998 89999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       292 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      +.+...+...                 ...          ..+..++.++.+|+.+||..||.+||++.++++.
T Consensus       349 ~~~~~~~~~~-----------------~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         349 EQFYNAIKRG-----------------YRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHHcC-----------------CCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5444433210                 000          0123468999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=304.54  Aligned_cols=260  Identities=26%  Similarity=0.368  Sum_probs=189.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..|.-...||+|+||.||+|.... |+.||||++...    ...+.+|++++.+++|||+|+|++||.+...    ..++
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~L  149 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRLL  149 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEEE
Confidence            357777899999999999999854 589999987653    3457899999999999999999999954332    4679


Q ss_pred             Eeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      |+||++ |+|.+.+......  .++|.....|+.+++.||+|||...  .|||||||++|||+|.+. ..||+|||+|+.
T Consensus       150 VYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa~~  226 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLAKL  226 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCccc
Confidence            999998 5877766542221  7899999999999999999999843  399999999999999888 699999999976


Q ss_pred             ccc-CCCcccc-cccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHH-HHhCCCCHHHH
Q 014595          235 LVK-GEPNVSY-ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEII-KVLGTPTREEI  309 (422)
Q Consensus       235 ~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~--~~~~~~~i~-~~~~~~~~~~~  309 (422)
                      ... ....... .||..|+|||++.. ...+.++|||||||+|.||+||+.+.....  ....+.... ..+.....  .
T Consensus       227 ~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~--~  303 (361)
T KOG1187|consen  227 GPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL--R  303 (361)
T ss_pred             CCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch--h
Confidence            544 3333333 78999999999854 568999999999999999999998876432  111122211 11111100  0


Q ss_pred             hhcCcCCccCcCCCCCCCCccccccc-CCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ..+++....            ..+.. ..-..+..+..+|++.+|.+||+..|+++
T Consensus       304 eiiD~~l~~------------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  304 EIVDPRLKE------------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             heeCCCccC------------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            011111100            00000 01123667888999999999999998743

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-38  Score=290.01  Aligned_cols=236  Identities=25%  Similarity=0.349  Sum_probs=184.0

Q ss_pred             eeeeecCCeeEEEEEEcCCC---eEEEEEEeccchh-----hHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~---~~vAiK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      ++||+|+||.||+|.+..++   ..||+|.+.....     ...+|+.+++.+.|+||+++++++.     . ...++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----G-EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----C-CceEEEE
Confidence            46999999999999876554   7899998865432     3457999999999999999988752     1 1257999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ ++.+.+..    ...+++..+..++.|++.||+|||. .|++|+||||+|||++.++ .+||+|||+++.....
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence            99874 66655543    2468999999999999999999998 8999999999999999887 6999999999766433


Q ss_pred             CCcc----cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          239 EPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       239 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ....    ...++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+....            
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~------------  215 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE------------  215 (257)
T ss_pred             CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC------------
Confidence            3221    11224579999998554 58999999999999999998 999998766544433332210            


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                            ..          ..+..++..++++|.+||..||++|||+.++++
T Consensus       216 ------~~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         216 ------RL----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ------cC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                  00          011356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.9e-38  Score=292.72  Aligned_cols=248  Identities=22%  Similarity=0.390  Sum_probs=194.3

Q ss_pred             eEEeeeeeecCCeeEEEEEEcC-CCeEEEEEEeccch--------------hhHHHHHHHHHH-cCCCCcccccceeecC
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK--------------RYKNRELQIMQM-LDHPNIVALKHCFFST  147 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~-~~~~vAiK~~~~~~--------------~~~~~E~~~l~~-l~h~nIv~l~~~~~~~  147 (422)
                      |++.+.||+|+||.||+|.+.. +++.+|+|.+....              ....+|+.++.. ++|+||+++++++.  
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--   79 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL--   79 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc--
Confidence            8888999999999999999987 68899999874211              112357777764 79999999999873  


Q ss_pred             CCCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEE
Q 014595          148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  226 (422)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl  226 (422)
                         ...+.+++|||+++ ++.+++.........+++..++.++.|++.||.|||+..|++|+||||+||+++.++ .+||
T Consensus        80 ---~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l  155 (269)
T cd08528          80 ---ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTI  155 (269)
T ss_pred             ---cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEE
Confidence               33457899999975 676666544444567899999999999999999999526899999999999999887 6999


Q ss_pred             eecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       227 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      +|||++.............++..|+|||.+.+ ..++.++|+||||+++|+|++|++||...+.......+......+  
T Consensus       156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  232 (269)
T cd08528         156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--  232 (269)
T ss_pred             ecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--
Confidence            99999976654433345567888999999965 448999999999999999999999997766544444333211000  


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                               ......++.+.++|.+||+.||++||++.|+..+
T Consensus       233 -------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 -------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             -------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                     0012467899999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.3e-38  Score=296.84  Aligned_cols=254  Identities=20%  Similarity=0.298  Sum_probs=189.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC----------------CCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL  140 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l  140 (422)
                      .+|++.+.||+|+||.||+|.+..                ++..||+|.+....     ..+.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            359999999999999999986532                34579999886432     234579999999999999999


Q ss_pred             cceeecCCCCCceEEEEEeecch-hHHHHHHHHhhhh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC
Q 014595          141 KHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRI-------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (422)
Q Consensus       141 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp  212 (422)
                      ++++..     ....+++|||++ +++..++......       ...+++..+..++.|++.||+|||+ .||+||||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp  158 (296)
T cd05095          85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence            998733     233789999997 4776666543211       1246778899999999999999999 8999999999


Q ss_pred             CCeEEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh--CCCCCCC
Q 014595          213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG  287 (422)
Q Consensus       213 ~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--G~~pf~~  287 (422)
                      +|||++.++ .++|+|||+++.......   .....+++.|+|||...+. .++.++|+|||||++|||++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999877 699999999876533321   1122335679999987654 48999999999999999998  7789977


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .+..+.+........           ........+          .+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~-----------~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         237 LSDEQVIENTGEFFR-----------DQGRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cChHHHHHHHHHHHh-----------hccccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            665554433221100           000000000          11346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7e-38  Score=294.08  Aligned_cols=259  Identities=26%  Similarity=0.398  Sum_probs=188.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEE----cCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +|++.+.||+|+||.||+|..    ..+++.||||.+....    ..+.+|+++++.++||||+++++++...   +...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~   81 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRN   81 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCCc
Confidence            589999999999999999974    4578899999986432    2446899999999999999998876432   2234


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||++ ++|.+.+...   ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~  156 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESEN-RVKIGDFGLTK  156 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCC-eEEECCCcccc
Confidence            779999997 4776665432   2458899999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCCCcc----cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCHHH
Q 014595          234 VLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-TPTREE  308 (422)
Q Consensus       234 ~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~  308 (422)
                      .........    ...++..|+|||++.+. .++.++|||||||++|||++|..++...... ....+..... ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHH
Confidence            664332211    11234569999998654 4899999999999999999998776443211 1110000000 000000


Q ss_pred             Hh-hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          309 IK-CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       309 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +. .+...   ...+          .+..++.++.+||.+||..||++|||+.++++
T Consensus       235 ~~~~~~~~---~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         235 LIELLKNN---GRLP----------APPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHhcC---CcCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            00 00000   0000          12457889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.2e-38  Score=291.25  Aligned_cols=245  Identities=21%  Similarity=0.299  Sum_probs=182.2

Q ss_pred             eeeecCCeeEEEEEEcC--CCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeec
Q 014595           89 VVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~--~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  161 (422)
                      .||+|+||+||+|....  ....+|+|.+....     ..+.+|+.+++.++|+||+++++.+..     ....++||||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e~   76 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLEF   76 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEEe
Confidence            58999999999996532  34678999765322     234579999999999999999998732     2347899999


Q ss_pred             chh-HHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC
Q 014595          162 VPE-TVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (422)
Q Consensus       162 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~  239 (422)
                      +++ +|.+.+..... .....++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCC-cEEEeccccccccccch
Confidence            984 77776654322 12345677888999999999999999 8999999999999999887 79999999986543221


Q ss_pred             C---cccccccccccchhhhcC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          240 P---NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       240 ~---~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      .   .....+++.|+|||++..      ...++.++|||||||++|||++ |..||......+.+..+......      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------  228 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI------  228 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc------
Confidence            1   122334677999998742      2346889999999999999999 88999877666555554432110      


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                ..+.       ......++..+.+++..|+ .||++|||++++++
T Consensus       229 ----------~~~~-------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         229 ----------KLPK-------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ----------cCCC-------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                      0110       0112357888999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.8e-38  Score=288.61  Aligned_cols=239  Identities=25%  Similarity=0.352  Sum_probs=188.2

Q ss_pred             eeeeecCCeeEEEEEEcC-CC--eEEEEEEeccchh-----hHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRE-TG--EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~-~~--~~vAiK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|++|.||+|.+.. .+  ..||||.+.....     .+.+|+.++++++|+||+++++.+..      ...+++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            368999999999999865 33  3699999865433     34579999999999999999988743      4477999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||++ +++.+.+.....  ..+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCC-EEEecccccccccccc
Confidence            9996 466666554221  468999999999999999999999 8999999999999999887 6999999999766442


Q ss_pred             CCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          239 EPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       239 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ...    ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+....            
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------  217 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG------------  217 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------------
Confidence            211    12345678999999854 458999999999999999998 999998777666555443210            


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                         ....            .+...+..+.+++.+||+.+|++|||+.++++
T Consensus       218 ---~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         218 ---ERLE------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ---CcCC------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence               0000            11346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.3e-37  Score=287.64  Aligned_cols=243  Identities=21%  Similarity=0.336  Sum_probs=190.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|++.+.||.|+||.||+|.+. .+..+|+|.+...   ...+.+|+++++.++||||+++++++.     ...+.+++|
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEEE
Confidence            5899999999999999999885 4678999988653   234568999999999999999998873     233478999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+.+ +|.+.+..   ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||++......
T Consensus        79 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~  153 (256)
T cd05112          79 EFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCC-eEEECCCcceeecccC
Confidence            99985 55444432   12457889999999999999999999 8999999999999999777 6999999998755332


Q ss_pred             CCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ...  ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||........+..+....              
T Consensus       154 ~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------  218 (256)
T cd05112         154 QYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--------------  218 (256)
T ss_pred             cccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC--------------
Confidence            211  122345679999998654 48899999999999999998 999998766555444432210              


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                          ..          ..+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus       219 ----~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         219 ----RL----------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ----CC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                00          0112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9.6e-38  Score=288.33  Aligned_cols=242  Identities=27%  Similarity=0.386  Sum_probs=192.2

Q ss_pred             EEeeeeeecCCeeEEEEEEcCCC----eEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           85 IAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~----~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ++.+.||.|+||.||+|++..++    ..||+|.+....     .....|+.+++.++|+||+++++++...     ...
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Cee
Confidence            46688999999999999998766    899999986533     2445799999999999999999987432     357


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++|||+++ ++.+.+....  ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~  152 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENL-VVKISDFGLSRD  152 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCC-eEEEcccCCcee
Confidence            899999975 6665554322  1228999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCCcc--cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          235 LVKGEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       235 ~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ........  ...+++.|+|||.+. ...++.++|+|||||++|+|++ |.+||.+.+.......+.....         
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------  222 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---------  222 (258)
T ss_pred             cccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence            64432211  123567899999984 4558999999999999999998 8899987666555554433100         


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                +         ..+...+.++.+++.+||..||++|||+.++++
T Consensus       223 ----------~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 ----------L---------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ----------C---------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                      0         011346889999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-38  Score=293.37  Aligned_cols=235  Identities=19%  Similarity=0.269  Sum_probs=179.8

Q ss_pred             eeeecCCeeEEEEEEcCCCe-------EEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           89 VVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~-------~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .||.|+||.||+|.+..++.       .||+|.+....    ....+|+.+++.+.||||+++++++...     ...++
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~l   76 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESIM   76 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcEE
Confidence            58999999999999865544       38888775432    2345788999999999999999988432     23679


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCc-------EEEeec
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-------LKLCDF  229 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~-------vkl~Df  229 (422)
                      ||||+++ +|..++...   ...+++..+..++.||+.||+|||+ +||+||||||+||+++.++..       ++++||
T Consensus        77 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          77 VQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            9999985 565554432   2368889999999999999999999 899999999999999876532       799999


Q ss_pred             CCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       230 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~-~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      |++.....   .....++..|+|||++.+...++.++|||||||++|+|++|. +||...+...... ....        
T Consensus       153 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--------  220 (258)
T cd05078         153 GISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--------  220 (258)
T ss_pred             ccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--------
Confidence            99865432   223467888999999976556899999999999999999984 6665544333221 1110        


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                               ...            ++...+.++.+||.+||+.||++|||++++++.
T Consensus       221 ---------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ---------RHQ------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ---------ccc------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                     001            112356789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-37  Score=288.11  Aligned_cols=243  Identities=24%  Similarity=0.364  Sum_probs=190.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|.+.+.||+|+||.||+|.+. .+..+|+|.+....   ....+|+.+++.++|+||+++++++..      ...+++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v   78 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYII   78 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEE
Confidence            45999999999999999999864 45679999886533   334579999999999999999887732      236789


Q ss_pred             eecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||++ +++.+.+...  ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  154 (260)
T cd05073          79 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARVIED  154 (260)
T ss_pred             EEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCCcceeeccC
Confidence            99997 4776666542  23457888899999999999999998 8999999999999999877 799999999876543


Q ss_pred             CCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ....  ....++..|+|||++.+ ..++.++|+|||||++|++++ |..||.+.+..+....+...              
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~--------------  219 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG--------------  219 (260)
T ss_pred             CCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC--------------
Confidence            2211  12234567999999854 458999999999999999999 99999887655544433221              


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                          +..+          .....+.++.+++.+||..||++||++.++++
T Consensus       220 ----~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         220 ----YRMP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ----CCCC----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                0000          11346889999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=301.06  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=202.1

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-----------hHHHHHHHHHHcCCCCcccccceeecCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----------YKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  149 (422)
                      ..+|.++++||+|||+.||+|.+....+.||||+-...+.           ..-+|.+|.+.|.||.||+++++|....+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            3479999999999999999999999999999997532211           11279999999999999999999854333


Q ss_pred             CCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCCeEEcCC--CCcEEE
Q 014595          150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVNPH--THQLKL  226 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~givHrDlkp~Nill~~~--~~~vkl  226 (422)
                          .+|-|+|||+|+-   +..|.+.+.-+++.+++.|+.||+.||.||.+- -.|||-||||.|||+-..  .+.+||
T Consensus       542 ----sFCTVLEYceGND---LDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  542 ----SFCTVLEYCEGND---LDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             ----cceeeeeecCCCc---hhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence                3789999999854   334445567899999999999999999999972 369999999999998532  236999


Q ss_pred             eecCCccccccCCCc--------ccccccccccchhhhc-C--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014595          227 CDFGSAKVLVKGEPN--------VSYICSRYYRAPELIF-G--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  295 (422)
Q Consensus       227 ~DfG~a~~~~~~~~~--------~~~~~t~~y~aPE~~~-~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~  295 (422)
                      +|||+++++..+...        ....||.+|++||.+. +  .+..+.++||||+|||+|.++.|+.||...-...   
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---  691 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---  691 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---
Confidence            999999988554322        2356899999999984 2  4568999999999999999999999995432221   


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      +|++.-.          --+..+..||..          +.++.++++||++||++--+.|....++..||||.-
T Consensus       692 dILqeNT----------IlkAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  692 DILQENT----------ILKATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HHHhhhc----------hhcceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            2211100          001123444432          358999999999999999999999999999999974

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-37  Score=290.60  Aligned_cols=246  Identities=20%  Similarity=0.256  Sum_probs=181.3

Q ss_pred             eeeeecCCeeEEEEEEc--CCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           88 HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +.||+|+||.||+|...  .++..+|+|.+....     ....+|+.+++.++||||+++++++..     ...+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence            35899999999999864  355789999875432     234579999999999999999988732     234779999


Q ss_pred             cch-hHHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          161 YVP-ETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       161 ~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      |++ +++.+.+...... ....++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence            998 5776666543221 2345667788899999999999999 8999999999999999877 6999999998654322


Q ss_pred             CC---cccccccccccchhhhcCC------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          239 EP---NVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       239 ~~---~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ..   .....+++.|+|||++.+.      ..++.++|+|||||++|||++ |+.||......+..........      
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------  227 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ------  227 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc------
Confidence            21   1223457789999998532      135789999999999999996 9999987665544332221100      


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                ..++.    +   ......+..+.+++.+|+ .+|++|||+++++.
T Consensus       228 ----------~~~~~----~---~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         228 ----------LKLPK----P---RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ----------CCCCC----C---ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                      00000    0   011245788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.8e-38  Score=291.62  Aligned_cols=249  Identities=23%  Similarity=0.314  Sum_probs=192.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC-----CCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      .+|.+.+.||.|+||.||+|+.+.     +.+.||+|.+....     ....+|++++++++|+||+++++++     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            359999999999999999999754     34679999875432     2356799999999999999999877     23


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEE
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  225 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vk  225 (422)
                      ..+.++||||++ ++|.+++......     ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQR-EVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCC-cEE
Confidence            345789999998 5776666543211     1268999999999999999999999 8999999999999999887 699


Q ss_pred             EeecCCccccccCC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014595          226 LCDFGSAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  302 (422)
Q Consensus       226 l~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~  302 (422)
                      |+|||++.......  ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+......+..+...  
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--  234 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--  234 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence            99999986543221  11233457779999988654 47899999999999999998 88999776554443332210  


Q ss_pred             CCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                     ...        |  .....++..+.+++.+||+.||.+|||+.+++.+
T Consensus       235 ---------------~~~--------~--~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 ---------------KLE--------L--PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ---------------CcC--------C--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                           000        0  0123578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=290.75  Aligned_cols=243  Identities=25%  Similarity=0.340  Sum_probs=190.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCe----EEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+.||+|+||+||+|.++.+|+    .||+|.+....     ....+|+.+++.++|+||+++++++..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            359999999999999999999876665    58999876542     234579999999999999999998743      


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ...+++|||++ +++.+.+...   ...+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||+
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kL~dfg~  155 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCC-eEEECCCcc
Confidence            23678999997 4665555432   3458999999999999999999999 8999999999999999877 699999999


Q ss_pred             ccccccCCCccc---ccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          232 AKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       232 a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ++..........   ..++..|+|||.+.. ..++.++|+|||||++||+++ |+.||.+....+....+....      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------  228 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE------  228 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC------
Confidence            976643322211   122567999998854 458999999999999999998 999998876555443332210      


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                ...            .+...+.++.+++.+||..||.+|||+.++++
T Consensus       229 ----------~~~------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         229 ----------RLP------------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ----------CCC------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                      000            11245788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.3e-38  Score=290.66  Aligned_cols=235  Identities=17%  Similarity=0.200  Sum_probs=176.3

Q ss_pred             eeeecCCeeEEEEEEcC------------CCeEEEEEEeccchh----hHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           89 VVGTGSFGVVFQAKCRE------------TGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~------------~~~~vAiK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .||+|+||.||+|+...            ....||+|.+.....    .+.+|+.+++.++||||+++++++...     
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-----   76 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-----   76 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            58999999999998532            223588998754322    334688999999999999999987432     


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC------cEE
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------QLK  225 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~------~vk  225 (422)
                      ...+++|||+++ .+..++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.      .++
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeE
Confidence            235799999985 44333322   23568999999999999999999999 89999999999999986542      289


Q ss_pred             EeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCC
Q 014595          226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       226 l~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tG~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      ++|||++......   ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||.+....+.. .....    
T Consensus       153 l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~----  224 (262)
T cd05077         153 LSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG----  224 (262)
T ss_pred             eCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc----
Confidence            9999998654322   23456788999998865566899999999999999998 588888765432211 11110    


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                   .+.            .....+.++.+|+.+||+.||.+||++.+++++
T Consensus       225 -------------~~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 -------------QCM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -------------Ccc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                         000            001245789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.7e-37  Score=289.23  Aligned_cols=243  Identities=28%  Similarity=0.368  Sum_probs=189.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCC---CeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|++.+.||+|+||.||+|.+...   ...||||......     ....+|+.+++.++||||+++++++..      .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            3599999999999999999987544   3569999875432     234579999999999999999987632      1


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ..++||||+++ ++.+.+...   ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~  154 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPD-CVKLGDFGLS  154 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCC-CeEEccCcee
Confidence            25689999974 666655432   2458999999999999999999999 8999999999999999877 6999999998


Q ss_pred             cccccCCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          233 KVLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       233 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      +........  ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--------  225 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE--------  225 (270)
T ss_pred             eecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------
Confidence            765433211  12223467999998854 458999999999999999996 999998877665554433210        


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                              ..            ..+..++..+.+++.+||..+|++|||+.+++.
T Consensus       226 --------~~------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         226 --------RL------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             --------cC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                    00            012457899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.7e-38  Score=292.45  Aligned_cols=235  Identities=17%  Similarity=0.239  Sum_probs=177.8

Q ss_pred             eeeecCCeeEEEEEEcCC------------------------CeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccc
Q 014595           89 VVGTGSFGVVFQAKCRET------------------------GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVAL  140 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~------------------------~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l  140 (422)
                      .||+|+||.||+|....+                        ...||+|++....    ..+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            599999999999985321                        2358899875432    234468889999999999999


Q ss_pred             cceeecCCCCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC
Q 014595          141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (422)
Q Consensus       141 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~  219 (422)
                      ++++..     ..+.++||||+++ ++..++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.
T Consensus        82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEe-----CCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence            998743     2347799999986 44444432   23568999999999999999999998 89999999999999975


Q ss_pred             CCC------cEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCChHH
Q 014595          220 HTH------QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD  292 (422)
Q Consensus       220 ~~~------~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tG~~pf~~~~~~~  292 (422)
                      .+.      .+|++|||++......   ....++..|+|||.+.+...++.++|||||||++|||+ +|..||.+....+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            431      3899999987644222   23356778999999866566899999999999999995 7999997765433


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .. .....                 ...            ++...++++.++|.+||+.+|++|||+.+++++
T Consensus       230 ~~-~~~~~-----------------~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 KE-RFYEK-----------------KHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HH-HHHHh-----------------ccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            22 11110                 000            112345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.1e-38  Score=293.40  Aligned_cols=256  Identities=23%  Similarity=0.372  Sum_probs=187.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEE----cCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      -|++.+.||+|+||.||+|+.    ..+++.||+|.+....     ....+|+.+++.+.||||+++++++...   +..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence            388999999999999999984    4578899999986331     3345799999999999999998877432   234


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      +.++||||+++ +|...+...   ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCC-CEEECCCccc
Confidence            47799999974 665555321   2458899999999999999999999 8999999999999999877 6999999999


Q ss_pred             cccccCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH--
Q 014595          233 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR--  306 (422)
Q Consensus       233 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~--  306 (422)
                      +........    ....++..|+|||.+.+. .++.++|||||||++|+|+|+..|+....  ....+   ..+....  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~--~~~~~---~~~~~~~~~  230 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPM--TLFLK---MIGPTHGQM  230 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCcccc--chhhh---hcccccccc
Confidence            765433221    133456679999998654 48899999999999999999887653321  11111   1110000  


Q ss_pred             --H-HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          307 --E-EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       307 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                        . ........   ...          ..+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~~~~---~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         231 TVTRLVRVLEEG---KRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cHHHHHHHHHcC---ccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence              0 00000000   000          0123578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.1e-37  Score=285.16  Aligned_cols=237  Identities=24%  Similarity=0.361  Sum_probs=183.7

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      ++||+|+||.||+|... +++.||+|.+....     ..+.+|+++++.++||||+++++++..     ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            36899999999999864 68899999876432     234579999999999999999998732     23477999999


Q ss_pred             hh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCc
Q 014595          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (422)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~  241 (422)
                      ++ ++...+..   ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||++.........
T Consensus        75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence            74 55544432   23457889999999999999999999 8999999999999999877 6999999998654322211


Q ss_pred             --ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          242 --VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       242 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                        ....++..|+|||++.+ ..++.++|||||||++|++++ |..||.+.........+....                .
T Consensus       150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------~  212 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----------------R  212 (250)
T ss_pred             cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----------------C
Confidence              11233567999999854 458999999999999999998 999998776554443332210                0


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .            ..+..++..+.+|+.+||..+|++||++.++++
T Consensus       213 ~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         213 M------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             C------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            0            012356899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-37  Score=286.74  Aligned_cols=240  Identities=23%  Similarity=0.373  Sum_probs=189.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .+|++.+.||+|+||.||++..  +++.||+|.+..+  .....+|+.+++.++||||+++++++..    +.  .+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~--~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH----NG--LYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC----CC--cEEEE
Confidence            3599999999999999999874  6889999988643  2345679999999999999999988732    11  57899


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ ++...+....  ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence            99984 7766665422  2457889999999999999999999 8999999999999999877 6999999998754322


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                        ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||.+.+..+....+.+.                 
T Consensus       154 --~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----------------  213 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-----------------  213 (254)
T ss_pred             --CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-----------------
Confidence              122334567999998854 458999999999999999997 99999877655443333221                 


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                       +...          ....++..+.+|+++||..+|++||++.+++.
T Consensus       214 -~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         214 -YRME----------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -CCCC----------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             0000          11356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=285.49  Aligned_cols=237  Identities=25%  Similarity=0.367  Sum_probs=184.4

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      ++||.|+||.||+|.+.. ++.||+|.+....     ..+.+|+++++.++|+||+++++++..     ..+.++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcC
Confidence            368999999999999977 9999999876432     234579999999999999999988733     23477999999


Q ss_pred             hh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCc
Q 014595          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (422)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~  241 (422)
                      ++ ++.+.+..   ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||++.........
T Consensus        75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence            74 56555433   23467888999999999999999998 8999999999999999887 6999999998755322111


Q ss_pred             ---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          242 ---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       242 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                         .....+..|+|||.+.+. .++.++|+|||||++|+|+| |..||.+.........+....                
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~----------------  212 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY----------------  212 (251)
T ss_pred             eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC----------------
Confidence               112235569999998654 58999999999999999999 889997766544333322110                


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                        ..          ..+..++.++.+++.+||+.+|.+|||+.|+++
T Consensus       213 --~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         213 --RM----------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             --CC----------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence              00          012356889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.1e-37  Score=293.82  Aligned_cols=244  Identities=23%  Similarity=0.337  Sum_probs=187.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCe----EEEEEEeccchh-----hHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vAiK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|+..+.||+|+||.||+|.+..+|+    .||+|.+.....     ...+|+.+++.++||||+++++++...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence            458899999999999999999877776    468887764321     345789999999999999999987421     


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                       ..++++||++ +++.+.+..   ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~-~~kL~Dfg~  155 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPN-HVKITDFGL  155 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCC-ceEEccccc
Confidence             1457899998 456555443   23468888999999999999999999 8999999999999998777 699999999


Q ss_pred             ccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          232 AKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       232 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ++........   ....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+..... +..+......    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~----  229 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGER----  229 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCC----
Confidence            9765433221   123346789999998654 48999999999999999997 999997765333 3333221100    


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                   .+          .+...+..+.+++.+||..||++||++.++++.
T Consensus       230 -------------~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         230 -------------LP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -------------CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         00          012357889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-38  Score=316.46  Aligned_cols=244  Identities=25%  Similarity=0.356  Sum_probs=199.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .-+..+.||+|+||+||+|+..     .....||||.++...     ..++||++++..|+|||||+|++++..     .
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----~  561 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-----G  561 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----C
Confidence            3556788999999999999864     234689999987533     456799999999999999999999943     3


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhh------cC----CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRI------HQ----RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  221 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~------~~----~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~  221 (422)
                      .-+|||+|||. |+|.++++.....      +.    .++..+...++.||+.|++||-+ +.+|||||-..|+||..+.
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccce
Confidence            33789999998 6888887754321      22    37888999999999999999998 8999999999999999887


Q ss_pred             CcEEEeecCCccccccCCCcc---cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 014595          222 HQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  297 (422)
Q Consensus       222 ~~vkl~DfG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i  297 (422)
                       .|||+|||+++.....+-..   ...-...|||||.+.- ..++.++||||+||+|||+++ |+.||.+.+..+.++-|
T Consensus       641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence             79999999998764433211   1223567999999964 459999999999999999997 99999999998888777


Q ss_pred             HHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHH
Q 014595          298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  362 (422)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~  362 (422)
                      .+..                .+.            -++++|.++.+|+.+||+.+|.+||++.||
T Consensus       719 ~~g~----------------lL~------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  719 RAGQ----------------LLS------------CPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HcCC----------------ccc------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            6531                011            125789999999999999999999999988

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.1e-37  Score=288.39  Aligned_cols=242  Identities=22%  Similarity=0.337  Sum_probs=185.3

Q ss_pred             eeeeecCCeeEEEEEEcCCC------eEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           88 HVVGTGSFGVVFQAKCRETG------EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~------~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +.||+|+||.||+|++....      +.||||.+...     .....+|+.+++.++||||+++++++..     ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence            35899999999999986543      78999987543     2234579999999999999999998743     22477


Q ss_pred             EEeecch-hHHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC----CcEEEee
Q 014595          157 LVLEYVP-ETVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCD  228 (422)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~----~~vkl~D  228 (422)
                      ++|||++ +++...+.....   ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++    ..++|+|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECC
Confidence            9999997 466666654322   12447888999999999999999998 8999999999999998754    2599999


Q ss_pred             cCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014595          229 FGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       229 fG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      ||++........   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...    
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----  229 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG----  229 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC----
Confidence            999876533221   112234678999999865 458999999999999999998 99999877655544333210    


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                  ..+.            .+..++..+.+||.+||..+|.+||++.++++
T Consensus       230 ------------~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         230 ------------GRLQ------------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ------------CccC------------CcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                        0000            11356889999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.1e-37  Score=285.41  Aligned_cols=245  Identities=19%  Similarity=0.256  Sum_probs=180.5

Q ss_pred             eeeecCCeeEEEEEEcCC--CeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeec
Q 014595           89 VVGTGSFGVVFQAKCRET--GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~--~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  161 (422)
                      .||+|+||+||+|.....  ...+++|.+....     ....+|+.+++.++||||+++++.+..     ....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEec
Confidence            599999999999975433  3456777665322     344578899999999999999998732     3347899999


Q ss_pred             chh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC-
Q 014595          162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-  239 (422)
Q Consensus       162 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~-  239 (422)
                      +++ +|...+..........++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++....... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence            984 7766665433233456777888999999999999999 8999999999999999887 69999999986432211 


Q ss_pred             --CcccccccccccchhhhcCC------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          240 --PNVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       240 --~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                        ......++..|+|||++...      ..++.++|||||||++|||++ |..||...+..+.+..+......       
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-------  227 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV-------  227 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc-------
Confidence              11234567889999987421      235789999999999999997 57888777666555554331100       


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                               ..       +...+...+++.+.+++..|| .+|++||++.++++
T Consensus       228 ---------~~-------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         228 ---------KL-------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ---------cc-------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                     00       001111346788999999999 68999999999865

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.3e-37  Score=285.87  Aligned_cols=239  Identities=22%  Similarity=0.341  Sum_probs=179.3

Q ss_pred             eeeeecCCeeEEEEEEcC---CCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~---~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||.||+|.+..   .+..||||.+....     ....+|+.+++.++||||+++++++...    +...+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            368999999999998653   34679999875321     2344789999999999999999866422    22356899


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+.+ ++.+++...   ....++..+..++.|++.||.|||+ .+++||||||+|||++.++ .+||+|||+++.....
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence            99884 666655432   2345677788899999999999999 8999999999999999887 6999999998754322


Q ss_pred             CC-----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          239 EP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       239 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ..     .....++..|+|||.+.+. .++.++|||||||++|||++ |.+||...+..+....+...  .         
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~---------  219 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--R---------  219 (262)
T ss_pred             cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--C---------
Confidence            11     1123346789999998654 58999999999999999999 56777766554433332210  0         


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                           ...            .+..++..+.+++.+||..||++||++.++++
T Consensus       220 -----~~~------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         220 -----RLL------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             -----CCC------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                 000            11246788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=308.53  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=213.8

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      |.+..+||.|.+|.||+++++.+|+.+|+|+...+.   ..++.|.++++.+ .|||++.++++|+.........++|||
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM  100 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM  100 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence            899999999999999999999999999999875432   4455688888888 699999999999776666677799999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      |||+ |+..++.++..  +.++.|..+..+++.++.||.+||. ..++|||||-.|||++.++ .|||+|||++..+...
T Consensus       101 EfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen  101 EFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDST  176 (953)
T ss_pred             eccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccC-cEEEeeeeeeeeeecc
Confidence            9998 47788888766  7899999999999999999999998 7999999999999999998 6999999998766433


Q ss_pred             -CCcccccccccccchhhhcCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          239 -EPNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                       ....+.+|||+|||||++...    ..|+..+|+||||++..||--|.+|+-+.-....+..|   ...|+.       
T Consensus       177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPP-------  246 (953)
T KOG0587|consen  177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPP-------  246 (953)
T ss_pred             cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCc-------
Confidence             234577899999999998542    34788999999999999999999999776554443322   112211       


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                    .+  ..++..+.++.+||..||..|-.+||+..++|+|||+.+.
T Consensus       247 --------------kL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  247 --------------KL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             --------------cc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence                          11  1124568899999999999999999999999999999854

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.7e-37  Score=287.30  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=187.9

Q ss_pred             eEEeeeeeecCCeeEEEEEEc---CCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCc-e
Q 014595           84 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE-L  153 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~-~  153 (422)
                      |.+.+.||+|+||.||+|.+.   .+++.||||++..+.      ....+|+.+++.++||||+++++++........ .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999864   357899999886432      234579999999999999999997754433222 2


Q ss_pred             EEEEEeecch-hHHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          154 YLNLVLEYVP-ETVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      ..+++++|+. +++...+....  .....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCC-CEEECccc
Confidence            3467889887 45554443211  112357888999999999999999999 8999999999999999877 69999999


Q ss_pred             CccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          231 SAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       231 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      +++.......   .....+++.|++||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+...      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~------  231 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG------  231 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC------
Confidence            9876533221   1122345679999998544 48899999999999999999 89999876654433333221      


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                ....            .+...+..+.+++.+||..+|++|||+.+++.
T Consensus       232 ----------~~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         232 ----------NRLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             ----------CcCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      0000            01246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.2e-38  Score=292.44  Aligned_cols=278  Identities=30%  Similarity=0.489  Sum_probs=213.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcC---CCeEEEEEEecc--chhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQ--DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vAiK~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .|.++++||+|.|++||+|.+..   .++.||+|.+..  .......|+++|..+ .+.||+++.+++     ..+..++
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd~v~  111 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNNDQVA  111 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCCeeE
Confidence            49999999999999999999877   788999998753  345567899999999 589999999988     4455588


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||++. ...++       ...++...++.|++.++.||.++|. .|||||||||.|+|.+.....-.|+|||+|...
T Consensus       112 ivlp~~~H~~f~~l-------~~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDL-------YRSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             EEecccCccCHHHH-------HhcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHHHH
Confidence            99999985 22222       2357788999999999999999998 899999999999999988878999999998621


Q ss_pred             c-----------------c--C--------------------------CCcccccccccccchhhhcCCCCCCCcchHHH
Q 014595          236 V-----------------K--G--------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWS  270 (422)
Q Consensus       236 ~-----------------~--~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  270 (422)
                      .                 .  +                          .......||++|+|||++.+.+..+.++||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            0                 0  0                          00123568999999999999888999999999


Q ss_pred             HHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhhcCcC------------------CccCcCCCCCC--C--
Q 014595          271 TGCVMAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMNPN------------------YTEFKFPQIKP--H--  327 (422)
Q Consensus       271 lG~il~elltG~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~--~--  327 (422)
                      .|||+..+++++.||. ..++.+.+.+|...+|.........+...                  |.......+..  .  
T Consensus       264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            9999999999998875 45667788888877766554443322211                  11110000000  0  


Q ss_pred             CcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       328 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      .+........+..+.||+.+||+.||.+|.||+++|+||||.+...
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence            1222222345678999999999999999999999999999997654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-38  Score=301.51  Aligned_cols=252  Identities=22%  Similarity=0.361  Sum_probs=196.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCe---E-EEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGE---I-VAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      +-.+.+.||+|+||.||+|+.+..+.   . ||||....+       ...+-+|+++|+.++|||||+++++.....-  
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P--  235 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP--  235 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc--
Confidence            34566899999999999998865422   3 899987642       1233479999999999999999998743332  


Q ss_pred             ceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                         +++|||+|.+ +|.+.++..   .+.++..+...++.+.+.||+|||+ +++|||||-..|+|++.++ .+||+|||
T Consensus       236 ---l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~-~vKISDFG  307 (474)
T KOG0194|consen  236 ---LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKG-VVKISDFG  307 (474)
T ss_pred             ---cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCC-eEEeCccc
Confidence               7799999986 766666553   2369999999999999999999999 8999999999999999876 58999999


Q ss_pred             CccccccCCCcc-cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          231 SAKVLVKGEPNV-SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       231 ~a~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      +++......... ..--...|+|||.+.. ..|+.++|||||||++||+++ |..||.+....+...+|...        
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~--------  378 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN--------  378 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc--------
Confidence            987543111111 1123567999999954 469999999999999999998 88999999988777777442        


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                               .+..          ..+...+.++..++.+|+..||++|||..++.+  +++.+...
T Consensus       379 ---------~~r~----------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~~~~  423 (474)
T KOG0194|consen  379 ---------GYRM----------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK--KLEALEKK  423 (474)
T ss_pred             ---------CccC----------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH--HHHHHHhc
Confidence                     1111          122356889999999999999999999998865  66655443

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.6e-37  Score=283.19  Aligned_cols=234  Identities=20%  Similarity=0.226  Sum_probs=179.0

Q ss_pred             eeeeecCCeeEEEEEEcCCC----------eEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           88 HVVGTGSFGVVFQAKCRETG----------EIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~----------~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +.||+|+||.||+|.+..++          ..|++|.+....   ..+.+|+.+++.++||||+++++++.. .     .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-----E   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C-----C
Confidence            36899999999999998776          358888765433   345679999999999999999998744 1     2


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC------cEEEe
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------QLKLC  227 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~------~vkl~  227 (422)
                      .++||||+++ ++..++...   ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.      .+||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeC
Confidence            5689999985 555554432   2368899999999999999999999 89999999999999987652      49999


Q ss_pred             ecCCccccccCCCcccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       228 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      |||++.....   .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+...........     
T Consensus       151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-----  222 (259)
T cd05037         151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-----  222 (259)
T ss_pred             CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-----
Confidence            9999976543   2234456779999998655 358999999999999999999 57888665422211111100     


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                 ..              .+......+.++|.+||..||.+|||+.++++
T Consensus       223 -----------~~--------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 -----------HR--------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -----------CC--------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                       00              00112378999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-37  Score=314.55  Aligned_cols=246  Identities=20%  Similarity=0.345  Sum_probs=197.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCC-----eEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .-++.+.||+|+||.||.|....-.     ..||||.+.+.     ...+.+|..+|+.++|||||+++++++....   
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~---  769 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP---  769 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC---
Confidence            4678899999999999999876432     34999988653     2344589999999999999999999976333   


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                        .++++|||.+ +|..++++...   ....++......++.||++|++||++ +++|||||...|+||+... .|||+|
T Consensus       770 --~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r-~VKIaD  845 (1025)
T KOG1095|consen  770 --PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERR-VVKIAD  845 (1025)
T ss_pred             --cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccC-cEEEcc
Confidence              5689999984 77777765311   13568889999999999999999999 8999999999999999886 799999


Q ss_pred             cCCccccccCCCcc---cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014595          229 FGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       229 fG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      ||+|+.+...+...   ...-...|||||.+.. ..++.|+|||||||+|||++| |..||.+.+..+.+.......   
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---  921 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---  921 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---
Confidence            99998543332111   1122356999999965 569999999999999999998 999999988887776555431   


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                     .++          .+..++..+.+++..||+.+|++||+...+++
T Consensus       922 ---------------RL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 ---------------RLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ---------------ccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                           111          12578999999999999999999999999987

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.6e-36  Score=297.67  Aligned_cols=274  Identities=21%  Similarity=0.280  Sum_probs=182.4

Q ss_pred             cceeeeEEeeeeeecCCeeEEEEEEc----------------CCCeEEEEEEeccchh------------------hHHH
Q 014595           79 KQKVSYIAEHVVGTGSFGVVFQAKCR----------------ETGEIVAIKKVLQDKR------------------YKNR  124 (422)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vAiK~~~~~~~------------------~~~~  124 (422)
                      ....+|.+.++||+|+||+||+|...                ..++.||||++.....                  ....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            34567999999999999999999752                2356799999754321                  1123


Q ss_pred             HHHHHHHcCCCCc-----ccccceeecCCC---CCceEEEEEeecchh-HHHHHHHHhh-----------h---------
Q 014595          125 ELQIMQMLDHPNI-----VALKHCFFSTTD---KEELYLNLVLEYVPE-TVNRIARNYS-----------R---------  175 (422)
Q Consensus       125 E~~~l~~l~h~nI-----v~l~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~~~~~~-----------~---------  175 (422)
                      |+.++.+++|.++     ++++++|.....   ......++||||+++ +|.+++....           .         
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6667777776654     566666543211   112346799999984 6666554211           0         


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCccc--ccccccccch
Q 014595          176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YICSRYYRAP  253 (422)
Q Consensus       176 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~--~~~t~~y~aP  253 (422)
                      ....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||++.....+.....  ..+|+.|+||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            11234667788999999999999999 8999999999999999887 699999999975543322222  2347899999


Q ss_pred             hhhcCCCC-------------------C--CCcchHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          254 ELIFGATE-------------------Y--TTAIDIWSTGCVMAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       254 E~~~~~~~-------------------~--~~~~DiwslG~il~elltG~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      |.+.....                   |  ..+.|+||+||++|+|++|.. ||.+........+...    .....|..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~----~~~~~~r~  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYD----NDLNRWRM  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhcc----chHHHHHh
Confidence            98853211                   1  234799999999999999985 7754322111100000    00001110


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCC---CCcCCHHHHhcCCcccc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP---NLRCTALEACVHPFFDE  370 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~R~t~~e~l~hp~f~~  370 (422)
                      ...  ..+.++          .....++.++||+++||..+|   .+|+|+.|+|+||||..
T Consensus       456 ~~~--~~~~~~----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        456 YKG--QKYDFS----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             hcc--cCCCcc----------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            000  001111          124578999999999999876   78999999999999953

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.4e-36  Score=282.26  Aligned_cols=259  Identities=25%  Similarity=0.371  Sum_probs=188.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEc----CCCeEEEEEEeccchh-----hHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~----~~~~~vAiK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .|.+.+.||+|+||.||+|+..    .+++.||||.+.....     .+.+|+++++.+.|+||+++++++..   ....
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~   81 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR   81 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence            4788899999999999999864    3488999998865432     45689999999999999999887632   2244


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      +.+++|||+++ ++...+...   ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~  156 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESED-LVKISDFGLA  156 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccccc
Confidence            57799999974 666655432   2358899999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCHH
Q 014595          233 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-VLGTPTRE  307 (422)
Q Consensus       233 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~-~~~~~~~~  307 (422)
                      .........    ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||........  .+.. ..+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~  233 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL--RMIGIAQGQMIVT  233 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhc--cccccccccccHH
Confidence            876432221    112345669999998654 589999999999999999999999865432110  0000 00000000


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .+.........  .+          .+..++.++.+|+.+||..||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~--~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         234 RLLELLKEGER--LP----------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHcCCc--CC----------CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            00000000000  00          11346788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=291.32  Aligned_cols=241  Identities=30%  Similarity=0.464  Sum_probs=189.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCC--C--eEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRET--G--EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~--~--~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..++.++||.|-||.||+|.....  |  --||||..+.+     ...+..|+.+|+.++|||||++++++....     
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-----  464 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-----  464 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-----
Confidence            345667899999999999987533  2  35889987653     344557999999999999999999983222     


Q ss_pred             EEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                       +++|||.++ |.|..++..   ....++......|++||+.||.|||+ ..+|||||...|||+.+.. .|||+|||++
T Consensus       465 -~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~-CVKLaDFGLS  538 (974)
T KOG4257|consen  465 -MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQ-CVKLADFGLS  538 (974)
T ss_pred             -eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcc-eeeecccchh
Confidence             679999998 555554443   34678999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCCcccccc--cccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          233 KVLVKGEPNVSYIC--SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       233 ~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      +.+.+..-.....|  ..-|||||.+ +-..++.++|||.|||++||++. |..||.|-...+.+..+.+.-..      
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl------  611 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL------  611 (974)
T ss_pred             hhccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC------
Confidence            98755443222223  4559999998 44569999999999999999985 99999987665544433332111      


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHh
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  363 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  363 (422)
                                        |    .++++|+.+..|..+||.+||.+||...++.
T Consensus       612 ------------------P----~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  612 ------------------P----CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ------------------C----CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                              1    2367999999999999999999999876654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=306.32  Aligned_cols=250  Identities=28%  Similarity=0.453  Sum_probs=190.6

Q ss_pred             eEEeeeeeecCCee-EEEEEEcCCCeEEEEEEeccchh-hHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEee
Q 014595           84 YIAEHVVGTGSFGV-VFQAKCRETGEIVAIKKVLQDKR-YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        84 y~~~~~lg~G~~g~-V~~~~~~~~~~~vAiK~~~~~~~-~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      |.-.+++|.|+-|+ ||+|...  |+.||||++..... ..++|+..|+.- +|||||+++..     +.+..+.|+..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEeh
Confidence            55567799999994 7999975  89999999876544 567999999988 69999998653     256677889999


Q ss_pred             cchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC---CC-CcEEEeecCCccccc
Q 014595          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HT-HQLKLCDFGSAKVLV  236 (422)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~---~~-~~vkl~DfG~a~~~~  236 (422)
                      .|..+|.+++...............+.++.|++.||++||+ .+||||||||.||||..   ++ -.++|+|||+++.+.
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            99999999887631111111214456778899999999999 89999999999999986   23 369999999999886


Q ss_pred             cCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          237 KGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       237 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      .+..    ..+..||-+|+|||++.... -+.++|||||||++|+.++| ..||.+.  .+.-.+|+..           
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~-----------  728 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTG-----------  728 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcC-----------
Confidence            6543    34557899999999997654 57799999999999999986 8999543  2222233321           


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                            .+..-.+.         +....++.|||.+||..||..||+|.++|.||||=.
T Consensus       729 ------~~~L~~L~---------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  729 ------NYTLVHLE---------PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             ------ccceeeec---------cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence                  11111110         111128999999999999999999999999999943

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=255.20  Aligned_cols=211  Identities=25%  Similarity=0.444  Sum_probs=175.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHH-cCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ....+..||+|+||.|-+.++..+|...|+|.+....     ....+|+.+..+ ..+|.+|.+++.++...+     ++
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-----vw  121 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-----VW  121 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----EE
Confidence            3455667999999999999999999999999985432     222356665444 479999999998865554     88


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +.||.|..++..+-+.....++.++|..+-.++..++.||.|||+...|||||+||.|||++.+| +||+||||.+..+.
T Consensus       122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLV  200 (282)
T ss_pred             EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeeh
Confidence            99999999998888887888899999999999999999999999978999999999999999998 79999999998887


Q ss_pred             cCCCcccccccccccchhhhcC---CCCCCCcchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 014595          237 KGEPNVSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLVEIIK  299 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~elltG~~pf~~-~~~~~~~~~i~~  299 (422)
                      +.-..+-..|...|||||.+..   ...|+-++||||||+++.||.+++.||.. .+..+++.+++.
T Consensus       201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            6665555677788999999832   33589999999999999999999999975 355566665544

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.6e-35  Score=266.07  Aligned_cols=238  Identities=38%  Similarity=0.642  Sum_probs=190.3

Q ss_pred             CCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecchh-HHH
Q 014595           94 SFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVN  167 (422)
Q Consensus        94 ~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~  167 (422)
                      +||.||+|.+..+|+.+|+|++...     .....+|++.+++++|+||+++++++..     ....++++||+++ ++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            5899999999988999999998643     3455689999999999999999998743     2347799999987 776


Q ss_pred             HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCccccccc
Q 014595          168 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS  247 (422)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t  247 (422)
                      ..+..    ...+++..+..++.+++.+|.|||+ .|++|+||+|.||+++.++ .++|+|||.+.............++
T Consensus        76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence            65543    2238889999999999999999999 8999999999999999887 6999999999876554444556678


Q ss_pred             ccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCC
Q 014595          248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH  327 (422)
Q Consensus       248 ~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (422)
                      ..|++||.+.+ ..++.++|+||||+++|+|++|..||..........+......                .....    
T Consensus       150 ~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~----------------~~~~~----  208 (244)
T smart00220      150 PEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPK----------------PPFPP----  208 (244)
T ss_pred             cCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC----------------CCCcc----
Confidence            88999999864 4478899999999999999999999977443333333222100                00000    


Q ss_pred             CcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       328 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                           ....++.++.+++.+||..||++||++.++++||||
T Consensus       209 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      209 -----PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             -----ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence                 001167899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=284.26  Aligned_cols=248  Identities=22%  Similarity=0.396  Sum_probs=199.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..+.+..++||.|.||.||.|.++.....||||.++.+.   ..+.+|+.+|+.++|||+|+|+++|..     +.-+||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYI  340 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYI  340 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEE
Confidence            335667789999999999999999999999999998754   455689999999999999999999843     233789


Q ss_pred             Eeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      |.|||. |+|.++++...+  ..++......++.||..|++||.. +++|||||-..|+|+..+. .||++|||+++.+.
T Consensus       341 iTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnh-iVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-IVKVADFGLSRLMT  416 (1157)
T ss_pred             EEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccc-eEEeeccchhhhhc
Confidence            999987 788888876554  567777888899999999999998 8999999999999999775 89999999999774


Q ss_pred             cCCCcccccc---cccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          237 KGEPNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       237 ~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .+. .+.-.|   ..-|.|||-+.- ..++.++|||+|||+|||+.| |-.||+|.+-.+.+..+.+             
T Consensus       417 gDT-YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-------------  481 (1157)
T KOG4278|consen  417 GDT-YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-------------  481 (1157)
T ss_pred             CCc-eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-------------
Confidence            432 222222   456999998843 448999999999999999997 8899999875444333222             


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                           .|.+.          -+.++++.+.+|++.||++.|..||+..|+  |.-|.
T Consensus       482 -----gyRM~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaei--HqafE  521 (1157)
T KOG4278|consen  482 -----GYRMD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEI--HQAFE  521 (1157)
T ss_pred             -----ccccc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHH--HHHHH
Confidence                 12221          135799999999999999999999999887  44443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=296.85  Aligned_cols=242  Identities=26%  Similarity=0.390  Sum_probs=203.9

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCC---eEEEEEEecc-----chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~---~~vAiK~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ..|.++||.|.||.|++|+.+..|   ..||||.++.     .++.+..|+.||-++.||||++|.++....     .-+
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-----~Pv  705 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-----KPV  705 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC-----cee
Confidence            568899999999999999998776   4799999864     334556799999999999999999988322     236


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .+|.|||+ |+|..+++...   +.+...++..+++.|+.|++||-+ .|+|||||...|||++.+- .+|++|||+++.
T Consensus       706 MIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnL-vCKVsDFGLSRv  780 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRV  780 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccce-EEEeccccceee
Confidence            78999998 57777777643   668888899999999999999999 9999999999999999987 799999999998


Q ss_pred             cccCCC-cccccc---cccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          235 LVKGEP-NVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       235 ~~~~~~-~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      +.++.+ ..+..|   ...|.|||.+. ..+++.++|+||+|++|||.++ |..||.+.+..+.+..|.+..+.|+    
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp----  855 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP----  855 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC----
Confidence            755542 222222   46799999994 5569999999999999999885 9999999999999988887544443    


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                              +..+|..+.+|+..||++|-.+||...+|+.
T Consensus       856 ------------------------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  856 ------------------------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ------------------------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                                    2468999999999999999999999999986

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-36  Score=289.42  Aligned_cols=244  Identities=24%  Similarity=0.337  Sum_probs=199.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCC-C--eEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRET-G--EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +..+.++||+|+||.|++|.+... |  -.||||.+..+.     ..+.+|+.+|.+|+|+|+++||+++.+..      
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp------  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP------  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch------
Confidence            366778999999999999998653 3  368999986543     44679999999999999999999985421      


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +.||||+++ |+|.+-+++  .....|.......|+.||+.|+.||.+ +++|||||-..|+|+-... .|||||||+.+
T Consensus       185 ~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllaspr-tVKI~DFGLmR  260 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPR-TVKICDFGLMR  260 (1039)
T ss_pred             hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccc-eeeeeccccee
Confidence            568999998 577766665  345678888999999999999999998 8999999999999998765 79999999999


Q ss_pred             ccccCCCcccccc----cccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGEPNVSYIC----SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .+..++..+...+    ...|+|||.+. ...++.++|+|++||+||||+| |.-||.|....+.+.+|-+.-       
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-------  332 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-------  332 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-------
Confidence            8876665543222    44599999995 5569999999999999999997 889999999887777664311       


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                               ...            -++.+++++.+++.+||.++|.+|||...|...
T Consensus       333 ---------rLp------------RPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  333 ---------RLP------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ---------cCC------------CCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                     011            124689999999999999999999999887543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=276.64  Aligned_cols=254  Identities=22%  Similarity=0.303  Sum_probs=197.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ...++++||+|-||.|.+|... .+..||+|.++.+.     ..+.+|+++|.+|+|||||+++++|...+-     +++
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----icm  612 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LCM  612 (807)
T ss_pred             heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hHH
Confidence            4678899999999999999874 36999999986532     445689999999999999999999854333     789


Q ss_pred             Eeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      |+||++ |.|.+++.....  ..+.-.....++.||+.|++||.+ .++|||||.+.|+|++.++ ++||+|||+++.+.
T Consensus       613 I~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcc-cEEecCcccccccc
Confidence            999998 577776665432  113334456689999999999999 8999999999999999998 69999999999776


Q ss_pred             cCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          237 KGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL--LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       237 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      .++..   ...+-...|||||.+... +++.++|+|+||+++||++  +...||....+.+...+....+..+....   
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~---  764 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV---  764 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce---
Confidence            55432   123446789999998754 5999999999999999986  57899988877766666544332221110   


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                               .         -..+.-++..+.+|+.+||..|-.+|||.+++  |-+|++
T Consensus       765 ---------~---------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq~  803 (807)
T KOG1094|consen  765 ---------V---------LSRPPACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQE  803 (807)
T ss_pred             ---------e---------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHHH
Confidence                     0         01124578899999999999999999999998  555554

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.7e-34  Score=312.97  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=181.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      .|...++||+|+||.||+|++..++..||||++........+|++++++++|||||++++++...     ...++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence            35667889999999999999988999999999876555556789999999999999999998432     2367999999


Q ss_pred             h-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH---NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      + +++.++++       .+++..+..++.|++.||+|||   + .+|+||||||+||+++.++ ..++. ||.+..... 
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT-  834 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence            8 46666553       3788889999999999999999   5 6999999999999999776 46664 665543321 


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                        .....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ...+.+..+..-...         ...
T Consensus       835 --~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~  902 (968)
T PLN00113        835 --DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC---------HLD  902 (968)
T ss_pred             --CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc---------chh
Confidence              123367899999999865 4589999999999999999999999954221 111111111100000         000


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+.-+......   ........++.+++.+||+.||++|||+.|+++.
T Consensus       903 ~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        903 MWIDPSIRGDV---SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             heeCccccCCC---CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00000000000   0001123467899999999999999999999874

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=273.91  Aligned_cols=199  Identities=29%  Similarity=0.449  Sum_probs=171.4

Q ss_pred             cceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhH------------HHHHHHHHHcC---CCCcccccce
Q 014595           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK------------NRELQIMQMLD---HPNIVALKHC  143 (422)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~------------~~E~~~l~~l~---h~nIv~l~~~  143 (422)
                      ++..+|+..+.+|.|+||.|++|.++.....|+||.+.+.+...            -.|+.||..|+   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            34557999999999999999999999999999999987754222            25999999997   9999999999


Q ss_pred             eecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCc
Q 014595          144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  223 (422)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~  223 (422)
                      |     ++..|+|++||--+.++ ++. .+......+.|.+++.++.|++.|+++||+ .||||||||-+||.++.+| -
T Consensus       638 F-----Eddd~yyl~te~hg~gI-DLF-d~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g-~  708 (772)
T KOG1152|consen  638 F-----EDDDYYYLETEVHGEGI-DLF-DFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNG-F  708 (772)
T ss_pred             e-----ecCCeeEEEecCCCCCc-chh-hhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCC-e
Confidence            9     55667889999876532 222 334456889999999999999999999999 8999999999999999998 5


Q ss_pred             EEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014595          224 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  287 (422)
Q Consensus       224 vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~  287 (422)
                      +||+|||.|... ...+...++||..|.|||++.|..+.+...|||+||++||.++....||..
T Consensus       709 ~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  709 VKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999999998754 455667889999999999998888889999999999999999999999863

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=260.05  Aligned_cols=252  Identities=24%  Similarity=0.309  Sum_probs=186.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc-chhhHHHHHHHHHH--cCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.++.+.||+|.||.||+|+++  |+.||||++.. +++...+|.+|.+.  |+|+||+.++..-...+ ..-..+++|.
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLvT  288 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLVT  288 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEee
Confidence            5889999999999999999997  89999999864 45666788888875  59999999887543222 3345688999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-------CCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-------IGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-------~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      +|-+ |+|.+++..     ..++......++..++.||++||..       -.|.|||||..|||+..++ .+.|+|+|+
T Consensus       289 dYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLGL  362 (513)
T KOG2052|consen  289 DYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL  362 (513)
T ss_pred             ecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeecee
Confidence            9998 688777764     5688888999999999999999952       2499999999999999988 799999999


Q ss_pred             ccccccCC-----CcccccccccccchhhhcCCCCC-----CCcchHHHHHHHHHHHHhC----------CCCCCCCC--
Q 014595          232 AKVLVKGE-----PNVSYICSRYYRAPELIFGATEY-----TTAIDIWSTGCVMAELLLG----------QPLFPGES--  289 (422)
Q Consensus       232 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-----~~~~DiwslG~il~elltG----------~~pf~~~~--  289 (422)
                      |.......     .....+||..|||||++......     -..+||||||.++||+...          .+||.+.-  
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            97654432     23467899999999999543221     2368999999999999852          37776531  


Q ss_pred             --hHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          290 --GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       290 --~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                        ..+.+.+++..                  -++....+..|..   ...-..+..+++.||..+|.-|.||..+.+
T Consensus       443 DPs~eeMrkVVCv------------------~~~RP~ipnrW~s---~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  443 DPSFEEMRKVVCV------------------QKLRPNIPNRWKS---DPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCHHHHhcceee------------------cccCCCCCccccc---CHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence              22222222211                  0111111223322   112234668899999999999999977754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=263.18  Aligned_cols=262  Identities=25%  Similarity=0.327  Sum_probs=187.9

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc-chhhHHHHHHHHHH--cCCCCcccccceeecCCCCCceEEEEEee
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      ..+..+||+|.||.||+|...  ++.||||++.. ++.....|.+|...  ++|+||++++..-.... ....-+++|++
T Consensus       212 l~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt~  288 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVTE  288 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEee
Confidence            567788999999999999975  69999999864 45667788888776  48999999877532222 22344679999


Q ss_pred             cch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          161 YVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--------IGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       161 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      |.+ |+|.+++..     ..+++....+++..+++||+|||+.        ..|+|||||..||||..|. +..|+|||+
T Consensus       289 fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGL  362 (534)
T KOG3653|consen  289 FHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGL  362 (534)
T ss_pred             eccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccce
Confidence            988 688888775     5689999999999999999999972        3599999999999999888 799999999


Q ss_pred             ccccccCCC---cccccccccccchhhhcCCCCCC-----CcchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhC
Q 014595          232 AKVLVKGEP---NVSYICSRYYRAPELIFGATEYT-----TAIDIWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKVLG  302 (422)
Q Consensus       232 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwslG~il~elltG~~pf~-~~~~~~~~~~i~~~~~  302 (422)
                      |..+..+..   ....+||..|||||++.+.....     .+.||||+|.+||||++...-+. +..+.-++.--..+..
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            988765543   33578999999999997765554     36899999999999998764443 2222111111112223


Q ss_pred             CCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHH
Q 014595          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  360 (422)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  360 (422)
                      .|..+.+...--.  .-..|. -+..|...   .-...+++.+..||..||+.|+||.
T Consensus       443 hPt~e~mq~~VV~--kK~RP~-~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  443 HPTLEEMQELVVR--KKQRPK-IPDAWRKH---AGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             CCCHHHHHHHHHh--hccCCC-ChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhH
Confidence            3444444321000  000111 11123221   1235688999999999999999984

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-34  Score=275.06  Aligned_cols=255  Identities=26%  Similarity=0.409  Sum_probs=201.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +.+|.+...+|.|.||.||+|+++.+++..|+|+++-.    ....++|+-+++..+|||||.+++-|.....     ++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----lw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----LW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----cE
Confidence            44699999999999999999999999999999998642    3445689999999999999999998854333     78


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +.||||++ ++.++    ....+.+++..+..+++..+.+|+|||+ .|-+|||||-.|||+++.+ .+|++|||.+..+
T Consensus        89 icMEycgggslQdi----y~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~g-DvklaDfgvsaqi  162 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDI----YHVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEG-DVKLADFGVSAQI  162 (829)
T ss_pred             EEEEecCCCcccce----eeecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccC-ceeecccCchhhh
Confidence            99999996 44332    2345789999999999999999999998 8999999999999999888 6999999987654


Q ss_pred             ccC-CCcccccccccccchhhhc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          236 VKG-EPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ... ....++.||++|||||+..  ....|...+|||++|+...|+---.+|-...-....+..+.+-            
T Consensus       163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS------------  230 (829)
T KOG0576|consen  163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS------------  230 (829)
T ss_pred             hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc------------
Confidence            322 2335789999999999862  2445999999999999999998777665554444433333221            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                           .|+-|..+..       ...++.+.+|++.+|..+|.+|||++.+|.|||...
T Consensus       231 -----~~qpp~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  231 -----GFQPPTLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             -----CCCCCcccCC-------ccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                 1222221111       234778899999999999999999999999999864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=7.5e-32  Score=265.70  Aligned_cols=241  Identities=25%  Similarity=0.362  Sum_probs=190.8

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCe----EEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~----~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+..++||+|+||+||+|.+...|+    +||||++...     ...+.+|+-+|..|+|||+++|++++..+.      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence            4556789999999999999866565    5788876432     344567999999999999999999885433      


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +-||++|++ |.|.+.++..   ...+-......|..||++|+.|||+ +++|||||-..||||.+-. .+||.|||+|+
T Consensus       772 ~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~-hvkitdfgla~  846 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPN-HVKITDFGLAK  846 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCC-eEEEEecchhh
Confidence            558999999 5777766653   4678888999999999999999999 8999999999999999876 59999999999


Q ss_pred             ccccCCCcccccc---cccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          234 VLVKGEPNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       234 ~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      .+..++......+   .+-|||-|.+.. ..|+.++|||||||++||++| |..|+.+....+.- +.++   .+     
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-dlle---~g-----  916 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-DLLE---KG-----  916 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-HHHh---cc-----
Confidence            8876655544333   456999999864 459999999999999999997 99999887644322 2221   11     


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                             .....            ++..+.++.-++.+||-.|+..||+++++..
T Consensus       917 -------eRLsq------------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  917 -------ERLSQ------------PPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             -------ccCCC------------CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                   11111            2467899999999999999999999987653

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=240.44  Aligned_cols=256  Identities=23%  Similarity=0.314  Sum_probs=187.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..|.+.+.||+|.||.+.+|+++.+++.+++|.+....   ..+.+|...--.| .|.||+.-+++-+...+    ++++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d----~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD----AYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc----eEEE
Confidence            46999999999999999999999999999999886543   3344666554445 58999998887654333    5668


Q ss_pred             Eeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE-cCCCCcEEEeecCCcccc
Q 014595          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill-~~~~~~vkl~DfG~a~~~  235 (422)
                      ++||++ |+|..-+.     ..++-|...+.++.|+++|+.|||+ +++||||||.+|||| +.+...|||||||+.+..
T Consensus       100 ~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999 45533222     2678899999999999999999999 899999999999998 445558999999998654


Q ss_pred             ccCCCcccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHh
Q 014595          236 VKGEPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  310 (422)
                      ..--.  ..-.+..|.+||.+..    .....+.+|+|.||+++|.++||.+||+..... ..+.+..+..+....    
T Consensus       174 g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~----  247 (378)
T KOG1345|consen  174 GTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP----  247 (378)
T ss_pred             Cceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc----
Confidence            22111  1122455999998732    223567899999999999999999999853322 223333333222111    


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCc---CCHHHHhcCCccccc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDEL  371 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---~t~~e~l~hp~f~~~  371 (422)
                               ..|        ..| ..+++.+..+.++-|..+|++|   .++....+.-|....
T Consensus       248 ---------~~P--------~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  248 ---------ALP--------KKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             ---------cCc--------hhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence                     111        111 3578999999999999999999   566666677787653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.7e-31  Score=268.27  Aligned_cols=245  Identities=25%  Similarity=0.386  Sum_probs=187.3

Q ss_pred             EEeeeeeecCCeeEEEEEEc---C----CCeEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCcccccceeecCCCCC
Q 014595           85 IAEHVVGTGSFGVVFQAKCR---E----TGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~---~----~~~~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  151 (422)
                      .+.+.||+|.||+|++|...   .    ....||||..+..     ...+..|+++|+.+ .|+||+.+++++..     
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-----  373 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-----  373 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-----
Confidence            56668999999999999743   1    1467999987643     34455799999998 69999999998843     


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhh---hh-------c--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEc
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYS---RI-------H--QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  218 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~---~~-------~--~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~  218 (422)
                      ...+++|+||+. |+|..+++...   ..       .  ..++......++.||+.|++||++ .++|||||-..|||+.
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLIT  452 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEec
Confidence            444779999998 57777776543   11       1  138889999999999999999999 8999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCCccc--cc--ccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 014595          219 PHTHQLKLCDFGSAKVLVKGEPNVS--YI--CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  293 (422)
Q Consensus       219 ~~~~~vkl~DfG~a~~~~~~~~~~~--~~--~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~  293 (422)
                      .+. .+||+|||+|+...+......  ..  -...|||||.+.. ..|+.++||||+|++|||++| |..||.+......
T Consensus       453 ~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  453 KNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             CCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence            876 799999999986544332211  11  1334999999966 569999999999999999997 8899988552222


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +.+.++..                 +...          .+..++.++.++++.||..+|++||+..++.+
T Consensus       531 l~~~l~~G-----------------~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  531 LLEFLKEG-----------------NRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHhcC-----------------CCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            23322210                 0111          12467999999999999999999999988765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.1e-29  Score=224.09  Aligned_cols=207  Identities=35%  Similarity=0.578  Sum_probs=173.2

Q ss_pred             eeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecch-
Q 014595           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-  163 (422)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-  163 (422)
                      ||+|++|.||++.+..+++.+++|++....     ....+|+..++.+.|++|+++++++...     ...++++|+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence            689999999999998889999999987654     3467899999999999999999887332     45779999999 


Q ss_pred             hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC-CCCcEEEeecCCccccccCC-Cc
Q 014595          164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGE-PN  241 (422)
Q Consensus       164 ~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~-~~~~vkl~DfG~a~~~~~~~-~~  241 (422)
                      +++..++....   ..++...+..++.+++.+|.+||+ .|++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus        76 ~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          76 GSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence            57766655321   468889999999999999999999 89999999999999998 55 79999999987654332 12


Q ss_pred             ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcC
Q 014595          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  321 (422)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  321 (422)
                      ....+...|++||.+.....++.+.|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            3345678899999985543688999999999999999                                           


Q ss_pred             CCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCC
Q 014595          322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (422)
Q Consensus       322 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  366 (422)
                                       ..+.+++.+||..||++||++.++++|+
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             1366899999999999999999999986

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=8.7e-31  Score=278.58  Aligned_cols=207  Identities=16%  Similarity=0.163  Sum_probs=146.6

Q ss_pred             HcCC-CCcccccceeecCCC--CCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcee
Q 014595          131 MLDH-PNIVALKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH  207 (422)
Q Consensus       131 ~l~h-~nIv~l~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givH  207 (422)
                      .++| .||+.+++.|-....  .....++++|||++.+|..++...   ...+++..++.++.||+.||+|||+ +||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHS-QGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence            4556 588888887522111  112346688999998888777532   3568999999999999999999998 89999


Q ss_pred             cCCCCCCeEEcCCC------------------CcEEEeecCCccccccCC-----------------Ccccccccccccc
Q 014595          208 RDIKPQNLLVNPHT------------------HQLKLCDFGSAKVLVKGE-----------------PNVSYICSRYYRA  252 (422)
Q Consensus       208 rDlkp~Nill~~~~------------------~~vkl~DfG~a~~~~~~~-----------------~~~~~~~t~~y~a  252 (422)
                      |||||+||||+..+                  ..+||+|||+++......                 ......+|++|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999996422                  246677777765321100                 0112457889999


Q ss_pred             hhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccc
Q 014595          253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV  332 (422)
Q Consensus       253 PE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (422)
                      ||++.+. .|+.++|||||||+||||++|.+||....  ..+..+.... .++.                     .    
T Consensus       184 PE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~---------------------~----  234 (793)
T PLN00181        184 PEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ---------------------I----  234 (793)
T ss_pred             hhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh---------------------h----
Confidence            9998765 48999999999999999999998875321  1122211110 0000                     0    


Q ss_pred             cccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          333 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       333 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                        ....+...+++.+||..||.+|||+.|+|+||||....
T Consensus       235 --~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        235 --LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             --hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence              01235577899999999999999999999999998753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=5.1e-29  Score=224.89  Aligned_cols=197  Identities=36%  Similarity=0.586  Sum_probs=163.3

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+...     .....+|++.++.++|+|++++++.+...     ...+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence            56778999999999999999888999999998653     34456799999999999999999877332     347789


Q ss_pred             eecchh-HHHHHHHHhhhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|++++ ++...+...    .. +++..+..++.+++.+|.+||+ .+++|+||+|.||+++.++ .++|+|||.+....
T Consensus        76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~  149 (225)
T smart00221       76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDG-LVKLADFGLARFIH  149 (225)
T ss_pred             EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence            999987 766655542    23 7889999999999999999999 8999999999999999876 79999999988765


Q ss_pred             cCC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CChH
Q 014595          237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGV  291 (422)
Q Consensus       237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~-~~~~  291 (422)
                      ...  ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.+ .+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            443  234456788899999884444577899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-28  Score=222.17  Aligned_cols=249  Identities=18%  Similarity=0.273  Sum_probs=187.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCC-----eEEEEEEeccchhhH-----HHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vAiK~~~~~~~~~-----~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      +.++++..++-+|.||.||.|.++...     +.|-+|.++.....+     ..|...+.-+.|||+..+.++.....+ 
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~-  361 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA-  361 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC-
Confidence            446888889999999999999765432     346667665543322     357777888899999999887754222 


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhh----hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEE
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYS----RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  225 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vk  225 (422)
                         ..+.++.+++ ++|..++....    ...+.++-.....++.|++.|++|||+ .||||.||...|.+||+.- +||
T Consensus       362 ---~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~L-qVk  436 (563)
T KOG1024|consen  362 ---TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQL-QVK  436 (563)
T ss_pred             ---cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhhe-eEE
Confidence               2345667766 57766665221    123446667788899999999999999 8999999999999999776 799


Q ss_pred             EeecCCccccccCCCcc---cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 014595          226 LCDFGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVL  301 (422)
Q Consensus       226 l~DfG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~  301 (422)
                      |+|=.+++.+.+.+-+.   .......||+||.+.+ ..|+.++|+|||||+||||+| |+.||..-++.++..-+.+. 
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-  514 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-  514 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-
Confidence            99999988765443221   1122556999999965 459999999999999999997 99999888877766554442 


Q ss_pred             CCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                       +.+.+          +-++|.++..++.-||..+|++||+.+|+..
T Consensus       515 -----------------yRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  515 -----------------YRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -----------------ceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                             11111          2378999999999999999999999998753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=5.1e-28  Score=210.69  Aligned_cols=166  Identities=22%  Similarity=0.180  Sum_probs=123.1

Q ss_pred             HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCcccc
Q 014595          165 TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY  244 (422)
Q Consensus       165 ~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~  244 (422)
                      +|.+++...   ...+++..++.++.||+.||.|||+ .+      ||+|||++.++ .+|+  ||++......    ..
T Consensus         2 sL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~~   64 (176)
T smart00750        2 SLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDG-LLKL--DGSVAFKTPE----QS   64 (176)
T ss_pred             cHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCcc-ceee--ccceEeeccc----cC
Confidence            455555432   3569999999999999999999998 67      99999999887 6888  9998765332    23


Q ss_pred             cccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhcCcCCccCcCCC
Q 014595          245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  323 (422)
Q Consensus       245 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (422)
                      .+|+.|||||++.+. .++.++|||||||++|||+||+.||....... .+..+........                +.
T Consensus        65 ~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~  127 (176)
T smart00750       65 RVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------PR  127 (176)
T ss_pred             CCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------cc
Confidence            678999999999654 58999999999999999999999997654332 2222222110000                00


Q ss_pred             CCCCCcccccccCCCh--HHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          324 IKPHPWHKVFQKRLPP--EAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       324 ~~~~~~~~~~~~~~s~--~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                       .. +    ....++.  ++++||.+||..||.+|||+.++++|+|+..
T Consensus       128 -~~-~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      128 -DR-S----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             -cc-c----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence             00 0    0012233  6999999999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.6e-27  Score=203.09  Aligned_cols=204  Identities=24%  Similarity=0.309  Sum_probs=166.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch--hhHHHHHHHHHHcCC-CCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .|.+++.||+|+||.+|+|....+|+.||||+-....  .....|..+.+.|.+ ..|..+.++.     .+..|-.+||
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvlVM   90 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVLVM   90 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccceeee
Confidence            5999999999999999999999999999999765433  344579999999965 5666666655     4556677999


Q ss_pred             ecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC--CCcEEEeecCCcccccc
Q 014595          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVK  237 (422)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~--~~~vkl~DfG~a~~~~~  237 (422)
                      +.++.+|.+++...   ...++..++..++-|++.-++|+|. +++|||||||+|+|..-+  .+.+.|+|||+|+.+.+
T Consensus        91 dLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             eccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            99999998877653   4689999999999999999999998 899999999999998643  34799999999987644


Q ss_pred             CCC--------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014595          238 GEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE  296 (422)
Q Consensus       238 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~  296 (422)
                      ...        .....||..|.+--...+.. .+...|+-|+|.+|.++..|..||+|.......++
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            322        23567899999887765543 68899999999999999999999999765544443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-26  Score=207.12  Aligned_cols=206  Identities=23%  Similarity=0.306  Sum_probs=171.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEec--cchhhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL--QDKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .|.++++||+|+||.+++|.+.-+++.||||.-.  .+.-.+..|.+..+.|. .++|..++.+.     .++.|-.||+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhhh
Confidence            3999999999999999999999999999999642  33445667999999985 67888775433     6677788999


Q ss_pred             ecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC----CCcEEEeecCCcccc
Q 014595          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKVL  235 (422)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~----~~~vkl~DfG~a~~~  235 (422)
                      |.++.+|.+++..   .+..|+...+..++.|++.-++|+|+ +.+|+|||||+|+||..-    -+.|.|+|||+|+.+
T Consensus       104 dLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  104 DLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            9999999888765   45789999999999999999999999 899999999999999643    346999999999887


Q ss_pred             ccCCC--------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHH
Q 014595          236 VKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEII  298 (422)
Q Consensus       236 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~  298 (422)
                      .+...        ..+..||..||+-...+|.. .+++.|+-|||-++++.|.|..||+|...   .+.+++|-
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG  252 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG  252 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence            55432        24567899999998888765 79999999999999999999999998643   34444443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.3e-28  Score=245.84  Aligned_cols=257  Identities=24%  Similarity=0.348  Sum_probs=188.4

Q ss_pred             EEeeeeeecCCeeEEEEEEcCCCeEEEEEEec----cchhh------HHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~----~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ....++|.|++|.|+.+......+.++.|.+.    .....      ...|+.+-..|.|+|++.....++....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            35678999999988888887767767666543    11111      2246666777899999887766643222     


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ..-+||||+.+|..++..    ...+....+..++.|++.|++|||. .||.|||+||+|+++..++ .+||+|||.+..
T Consensus       396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g-~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENG-ILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCC-ceEEeecCccee
Confidence            223499999855544443    2467788888999999999999999 8999999999999999887 799999999876


Q ss_pred             cccCCC-----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCHHH
Q 014595          235 LVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV-EIIKVLGTPTREE  308 (422)
Q Consensus       235 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~-~i~~~~~~~~~~~  308 (422)
                      ......     ....+|+..|+|||++.+........||||.|++++.|++|+.||.-....+... ....         
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~---------  540 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY---------  540 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---------
Confidence            543322     2467889999999999887777788999999999999999999997544332211 0000         


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                             ...++..   ..++ . +...++...+.+|.+||++||.+|.|+++|++.+||+.+.-
T Consensus       541 -------~~~~~~~---~~~~-~-~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  541 -------SDQRNIF---EGPN-R-LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             -------ccccccc---cChH-H-HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence                   0000000   0011 1 12457889999999999999999999999999999998753

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=8.9e-26  Score=215.48  Aligned_cols=251  Identities=20%  Similarity=0.199  Sum_probs=189.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCC-eEEEEEEeccch----hhHHHHHHHHHHcCC----CCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK----RYKNRELQIMQMLDH----PNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vAiK~~~~~~----~~~~~E~~~l~~l~h----~nIv~l~~~~~~~~~~~~~  153 (422)
                      +|.+.+.||+|+||.||+|.+..++ +.+|+|......    .....|..++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            5999999999999999999997764 689999765421    146789999999873    57777766552    2445


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC----CcEEEeec
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDF  229 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~----~~vkl~Df  229 (422)
                      +-++||+.++.+|.++.....  .+.++..++..++.|++.+|++||+ .|++||||||+|+++....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            677999999999988776554  5789999999999999999999999 8999999999999998653    46999999


Q ss_pred             CCcc--ccccCC--------C-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014595          230 GSAK--VLVKGE--------P-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  298 (422)
Q Consensus       230 G~a~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~  298 (422)
                      |+|+  ......        . .....||..|+++....+.. .+++.|+||++.++.+++.|..||.+........+..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  321111        1 22355999999999886654 8999999999999999999999998766443333332


Q ss_pred             HHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      +.....               ....         +....+.++.++...+-..+...+|....+...
T Consensus       251 ~~~~~~---------------~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKL---------------LTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhh---------------cccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            211000               0000         112345677777777777888888987766554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-27  Score=228.91  Aligned_cols=237  Identities=30%  Similarity=0.452  Sum_probs=187.7

Q ss_pred             eeeecCCeeEEEEEE---cCCCeEEEEEEeccc------hhhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEEEE
Q 014595           89 VVGTGSFGVVFQAKC---RETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~---~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      ++|.|+||.|++++.   ...|..+|+|+..+.      ......|..++...+ ||.+|+++..|....+     .+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k-----l~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK-----LYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc-----hhHh
Confidence            379999999998763   245778999976542      123346888888886 9999999988844333     7789


Q ss_pred             eecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      +++..++.   +-........+.+..++.+...++.|++++|+ .||+|||+|++||+++.+|+ +++.|||+++.....
T Consensus        76 ld~~rgg~---lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~Gh-i~~tdfglske~v~~  150 (612)
T KOG0603|consen   76 LDFLRGGD---LFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEGH-IKLTDFGLSKEAVKE  150 (612)
T ss_pred             hhhcccch---hhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccCc-cccCCchhhhHhHhh
Confidence            99987632   11222334667888899999999999999999 89999999999999999995 999999999877655


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                      +..   +||..|||||++.   ....++|.||+|+++++|+||..||.+    +....|.+.                 .
T Consensus       151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-----------------~  203 (612)
T KOG0603|consen  151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-----------------E  203 (612)
T ss_pred             hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh-----------------c
Confidence            433   8999999999995   367899999999999999999999987    444444441                 1


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccCCC
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDP  374 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  374 (422)
                      +.            ++..++..+++++..++..+|..|..     +.++++|+||+.+.+.
T Consensus       204 ~~------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  204 LE------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             cC------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            11            22457899999999999999999985     4799999999988653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.2e-25  Score=214.53  Aligned_cols=167  Identities=20%  Similarity=0.293  Sum_probs=122.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcC-CCeEEEEEEeccc---------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      +|.+.+.||+|+||+||+|++.. +++.||||++...         ...+.+|+++|+.++|+||+..+..+   .    
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~----   91 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G----   91 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C----
Confidence            59999999999999999999876 6788899986422         23457899999999999998532211   1    


Q ss_pred             eEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC-CCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDl-kp~Nill~~~~~~vkl~DfG~  231 (422)
                       ..++||||+++.......       ...   ...++.|++.||.|||+ .||+|||| ||+|||++.++ .+||+|||+
T Consensus        92 -~~~LVmE~~~G~~L~~~~-------~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~-~ikLiDFGl  158 (365)
T PRK09188         92 -KDGLVRGWTEGVPLHLAR-------PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDG-EAAVIDFQL  158 (365)
T ss_pred             -CcEEEEEccCCCCHHHhC-------ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCC-CEEEEECcc
Confidence             257999999863322111       111   14578899999999999 89999999 99999998776 699999999


Q ss_pred             ccccccCCCc---------ccccccccccchhhhcC-----CCCCCCcchHH
Q 014595          232 AKVLVKGEPN---------VSYICSRYYRAPELIFG-----ATEYTTAIDIW  269 (422)
Q Consensus       232 a~~~~~~~~~---------~~~~~t~~y~aPE~~~~-----~~~~~~~~Diw  269 (422)
                      |+........         ....+++.|+|||.+..     ....+..+|-|
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9866433211         23456777899998732     12234456776

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=9.4e-24  Score=200.44  Aligned_cols=261  Identities=34%  Similarity=0.500  Sum_probs=194.3

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCC-CcccccceeecCCCCCceEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~~~~~  155 (422)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+...       ...+.+|+.++..+.|+ +|+++.+.+.     .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence            788899999999999999986   78999987543       23345789999999988 7999998882     22226


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++++++.+ .+..+....... ..+....+..++.|++.++.|+|+ .|++|||+||+||+++..+..++++|||.+..
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            789999985 443233221100 268899999999999999999999 89999999999999998763599999999875


Q ss_pred             cccCC-------CcccccccccccchhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Q 014595          235 LVKGE-------PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG  302 (422)
Q Consensus       235 ~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~~~~~  302 (422)
                      .....       ......+|..|+|||.+.+.  ..+....|+||+|++++++++|..||.....   .......+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            54332       23567889999999999763  4689999999999999999999999877664   333443333222


Q ss_pred             CCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      .+             ....+.      ...........+.+++.+++..+|..|.+..+...++|......
T Consensus       232 ~~-------------~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         232 TP-------------SLASPL------SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             Cc-------------cccccc------CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence            11             000000      00000112367899999999999999999999999877765443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=1.4e-25  Score=227.85  Aligned_cols=226  Identities=28%  Similarity=0.490  Sum_probs=168.2

Q ss_pred             cceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      ....+|..++.|-.|+||.||+++|+.+.+.+|+| +.++....+            ||..+-+.         .+  .|
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR------------nilt~a~n---------pf--vv  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR------------NILTFAGN---------PF--VV  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh------------ccccccCC---------cc--ee
Confidence            34457999999999999999999999999999995 544332222            23332111         11  11


Q ss_pred             eecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                           ++...+++.    -+.++.        +++.|++|||+ .||+|||+||+|.+|..-| .+|++|||+++.....
T Consensus       136 -----gDc~tllk~----~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----GDCATLLKN----IGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----chhhhhccc----CCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeeecc-cccccchhhhhhhhhh
Confidence                 222222222    234443        44889999998 8999999999999999888 5999999998643211


Q ss_pred             C----------------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 014595          239 E----------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  302 (422)
Q Consensus       239 ~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~  302 (422)
                      .                .....+|||.|+|||++... .|+..+|+|++|+|+||.+.|..||.++..++.+...+....
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            0                01235889999999999754 499999999999999999999999999999888877765321


Q ss_pred             CCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC---CHHHHhcCCcccccCCC
Q 014595          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDP  374 (422)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~  374 (422)
                                       .++..         ...++++++++|.++|+.+|..|.   .+.++.+|+||+.+.+.
T Consensus       276 -----------------~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  276 -----------------EWPEE---------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             -----------------ccccc---------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence                             11111         135789999999999999999997   56789999999988654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=3.9e-24  Score=195.80  Aligned_cols=237  Identities=22%  Similarity=0.280  Sum_probs=144.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhH-------HHHHHHHHHcC----------CCCcccccceee
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLD----------HPNIVALKHCFF  145 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-------~~E~~~l~~l~----------h~nIv~l~~~~~  145 (422)
                      ....+..||.|+++.||.+.+..||+.+|+|++.......       ++|.-....+.          |-.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4788899999999999999999999999999875332221       22222222211          111221112111


Q ss_pred             --------cCC-CCCce---EEEEEeecchhHHHHHHHHhhhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCceecCC
Q 014595          146 --------STT-DKEEL---YLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRDI  210 (422)
Q Consensus       146 --------~~~-~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~givHrDl  210 (422)
                              ... +....   ..+++|+-+.++|..++.........   +.......+..|+++.+++||. .|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence                    111 11111   23678888888887776543332222   2233334455799999999999 89999999


Q ss_pred             CCCCeEEcCCCCcEEEeecCCccccccCCCcccccccccccchhhhcCC-------CCCCCcchHHHHHHHHHHHHhCCC
Q 014595          211 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQP  283 (422)
Q Consensus       211 kp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltG~~  283 (422)
                      ||+|++++.+| .++|+||+........  ......+..|.+||.....       ..++.+.|.|+||+++|.|.||+.
T Consensus       172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDG-GVFLGDFSSLVRAGTR--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCC-CEEEcChHHHeecCce--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999998 6999999877544221  1113445779999976321       247889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCc
Q 014595          284 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR  356 (422)
Q Consensus       284 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  356 (422)
                      ||.........                               ...|....  ++|+.+++||++||++||.+|
T Consensus       249 Pf~~~~~~~~~-------------------------------~~~f~~C~--~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADP-------------------------------EWDFSRCR--DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTS-------------------------------GGGGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccc-------------------------------cccchhcC--CcCHHHHHHHHHHccCCcccC
Confidence            99754321000                               00122222  689999999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-24  Score=220.74  Aligned_cols=241  Identities=29%  Similarity=0.433  Sum_probs=171.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHH---HHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKN---RELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~---~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .|...+.||++.|=+|.+|++.+ |. |+||++.+..     +.+.   +|++ ...++|||.+.+..+.     ....+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            47888999999999999999863 55 9999875533     1222   3444 5556999999876654     23334


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .|||-+|+..+|++-+..    ..-+.+.+.+.|+.|++.||.-+|. .||+|||||.+||||++-+. +.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWNW-~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWNW-LYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeech-hhhhcccccCC
Confidence            668889988888765554    3457788899999999999999999 89999999999999998664 99999986544


Q ss_pred             cccCCCc---cc-cc----ccccccchhhhcCCC----------CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014595          235 LVKGEPN---VS-YI----CSRYYRAPELIFGAT----------EYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  295 (422)
Q Consensus       235 ~~~~~~~---~~-~~----~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~  295 (422)
                      ..-.+..   .+ +.    .-.+|.|||.+....          ..+++.||||+||+++||++ |++||.    ..++.
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHH
Confidence            3222211   11 11    235699999985421          15678999999999999997 899994    22333


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      +....- ....+..                       +..--+..++.||..|++.||++|.+|++.|+-
T Consensus       246 aYr~~~-~~~~e~~-----------------------Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSGN-ADDPEQL-----------------------LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhccC-ccCHHHH-----------------------HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            222211 1111111                       001124578999999999999999999999974

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7.1e-24  Score=194.82  Aligned_cols=195  Identities=24%  Similarity=0.363  Sum_probs=139.1

Q ss_pred             CCCCcccccceeecCC----------------------CCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHH
Q 014595          133 DHPNIVALKHCFFSTT----------------------DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY  190 (422)
Q Consensus       133 ~h~nIv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  190 (422)
                      +|||||++...|.+..                      -.+...+|+||-....+|.+++..     ...+....+.++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            6999999988875321                      123445889999888888776654     4455666777888


Q ss_pred             HHHHHHHHHHhcCCceecCCCCCCeEEcCCC---CcEEEeecCCccccccC-------CCcccccccccccchhhhcCCC
Q 014595          191 QICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFGSAKVLVKG-------EPNVSYICSRYYRAPELIFGAT  260 (422)
Q Consensus       191 qi~~aL~~LH~~~givHrDlkp~Nill~~~~---~~vkl~DfG~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~  260 (422)
                      |+++|+.|||+ +||.|||+|.+|||+.-+.   ..+.|+|||++-.-...       ......-|.-.-||||+....+
T Consensus       349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999999 8999999999999984332   25899999987432111       1122334566789999985432


Q ss_pred             C-----CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCccccccc
Q 014595          261 E-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK  335 (422)
Q Consensus       261 ~-----~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (422)
                      .     .-.++|.|+.|.+.||+++...||.+..... +..                 ..|.+-.+|.         .++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~-----------------r~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDT-----------------RTYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ech-----------------hhhhhhhCCC---------Ccc
Confidence            2     1248999999999999999999998733211 000                 0122222222         236


Q ss_pred             CCChHHHHHHHhhhhcCCCCcCCHH
Q 014595          336 RLPPEAVDLVCRFFQYSPNLRCTAL  360 (422)
Q Consensus       336 ~~s~~~~~li~~~L~~dP~~R~t~~  360 (422)
                      .+++.+++|+..+|+.||++|+++.
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCcc
Confidence            7899999999999999999999864

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=5.7e-23  Score=180.45  Aligned_cols=135  Identities=18%  Similarity=0.217  Sum_probs=102.3

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh------------------------------hHHHHHHHHHHcCCCC
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------YKNRELQIMQMLDHPN  136 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------------------------------~~~~E~~~l~~l~h~n  136 (422)
                      ...||+|+||.||+|.+. +|+.||||++..+..                              ...+|++++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            457999999999999996 899999999864311                              1124899999998887


Q ss_pred             cccccceeecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCceecCCCCCCe
Q 014595          137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGICHRDIKPQNL  215 (422)
Q Consensus       137 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L-H~~~givHrDlkp~Ni  215 (422)
                      +.....+.  ..   .  .++||||++++......   .....+++..+..++.|++.+|.++ |+ .||+||||||+||
T Consensus        81 v~~p~~~~--~~---~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI  149 (190)
T cd05147          81 IPCPEPIL--LK---S--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL  149 (190)
T ss_pred             CCCCcEEE--ec---C--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence            74432221  11   1  25999999874211111   1135788999999999999999999 68 8999999999999


Q ss_pred             EEcCCCCcEEEeecCCcccc
Q 014595          216 LVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       216 ll~~~~~~vkl~DfG~a~~~  235 (422)
                      |++. + .++|+|||+|...
T Consensus       150 li~~-~-~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYHD-G-KLYIIDVSQSVEH  167 (190)
T ss_pred             EEEC-C-cEEEEEccccccC
Confidence            9984 4 6999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=2.3e-22  Score=178.91  Aligned_cols=169  Identities=12%  Similarity=0.154  Sum_probs=123.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhh---------HHHHHHHHHHcCCCCcccccceeecCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRY---------KNRELQIMQMLDHPNIVALKHCFFSTT  148 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~  148 (422)
                      .+|.+.++||.|+||.||++..  ++..+|||.+...    ...         ..+|+..+.++.|++|..+.+++....
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            4699999999999999999765  4678999988532    111         467888999999999999988765332


Q ss_pred             CC---CceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcE
Q 014595          149 DK---EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  224 (422)
Q Consensus       149 ~~---~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~v  224 (422)
                      ..   .....+++|||++| ++.++.        .+++    ....+++.+|..||+ .|++|||+||.||+++.++  +
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g--i  173 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG--L  173 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC--E
Confidence            11   12346789999997 443331        1222    235599999999999 8999999999999999765  9


Q ss_pred             EEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHH
Q 014595          225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL  279 (422)
Q Consensus       225 kl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  279 (422)
                      +|+|||........... .          ..+.. ..|+.++|+||||+++..+.
T Consensus       174 ~liDfg~~~~~~e~~a~-d----------~~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK-D----------RIDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH-H----------HHHHH-hHhcccccccceeEeehHHH
Confidence            99999988654221111 0          02222 33668999999999987654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.9e-21  Score=169.37  Aligned_cols=182  Identities=16%  Similarity=0.120  Sum_probs=131.8

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh--------hHHHHHHHHHHcC-CCCcccccceeecCCCCCceE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..+...|++|+||+||++..  .+..++.+.+.....        ...+|+++|++|. |++|++++++.    .     
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~-----   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----G-----   72 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----C-----
Confidence            34567899999999998875  577888776654332        3568999999995 47788887641    1     


Q ss_pred             EEEEeecchhH-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC-CCCCeEEcCCCCcEEEeecCCc
Q 014595          155 LNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       155 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDl-kp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++|+|+.|. |....          +.. ...++.|++.+|.++|+ .||+|||| ||+|||++.++ .++|+|||+|
T Consensus        73 ~~lvmeyI~G~~L~~~~----------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A  139 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRP----------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDG-SPAVIDFQLA  139 (218)
T ss_pred             EEEEEeeecCccHHhhh----------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCC-CEEEEECCCc
Confidence            56899999874 32111          111 13467899999999999 89999999 79999999877 6999999999


Q ss_pred             cccccCCCc--------------ccccccccccchhhhcCCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCC
Q 014595          233 KVLVKGEPN--------------VSYICSRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGES  289 (422)
Q Consensus       233 ~~~~~~~~~--------------~~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~elltG~~pf~~~~  289 (422)
                      .........              .-...++.|+.|+.-.-....+ ...++++.|+-+|.++|+..++.++.
T Consensus       140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            854332211              0112477788888653322233 45688899999999999998886543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.3e-21  Score=172.34  Aligned_cols=135  Identities=16%  Similarity=0.226  Sum_probs=104.4

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------------------------------hhHHHHHHHHHHcCCCC
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQIMQMLDHPN  136 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------------------------~~~~~E~~~l~~l~h~n  136 (422)
                      .+.||+|+||+||+|++. +|+.||||++....                              ....+|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 89999999876431                              01246889999999998


Q ss_pred             cccccceeecCCCCCceEEEEEeecchhH-HHH-HHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          137 IVALKHCFFSTTDKEELYLNLVLEYVPET-VNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       137 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~-l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                      |.....+..  .   .  .++||||+++. +.. .+.     ...+++..+..++.|++.+|.+||+..||+||||||+|
T Consensus        81 i~~p~~~~~--~---~--~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N  148 (190)
T cd05145          81 VPVPEPILL--K---K--NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN  148 (190)
T ss_pred             CCCceEEEe--c---C--CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence            754433321  1   1  35899999874 211 121     24577888999999999999999973699999999999


Q ss_pred             eEEcCCCCcEEEeecCCccccc
Q 014595          215 LLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||++ ++ .++|+|||++....
T Consensus       149 Ill~-~~-~~~liDFG~a~~~~  168 (190)
T cd05145         149 ILYH-DG-KPYIIDVSQAVELD  168 (190)
T ss_pred             EEEE-CC-CEEEEEcccceecC
Confidence            9999 55 69999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=6.3e-20  Score=162.75  Aligned_cols=135  Identities=20%  Similarity=0.239  Sum_probs=100.8

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHc-----CCCCcccccceeecCCCCCceEEEE
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-----DHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+.||+|+||.||.  +..++.. +||++...    .....+|+.+++.+     .||||+++++++.+..+ ....+.+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-~g~v~~~   82 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-TGYVYDV   82 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-CeEEEEE
Confidence            46799999999995  7666665 69987643    34567899999999     67999999998854321 2232447


Q ss_pred             Eeecch---hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHH-HHHHhcCCceecCCCCCCeEEcCCC---CcEEEeecC
Q 014595          158 VLEYVP---ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL-AYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFG  230 (422)
Q Consensus       158 v~e~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL-~~LH~~~givHrDlkp~Nill~~~~---~~vkl~DfG  230 (422)
                      |+||++   ++|.+++..     ..+++.  ..++.|++.++ +|||+ .+|+||||||+|||++..+   ..++|+||+
T Consensus        83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            899955   577777754     235555  35577888888 99999 8999999999999997432   269999955


Q ss_pred             Ccc
Q 014595          231 SAK  233 (422)
Q Consensus       231 ~a~  233 (422)
                      .+.
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=1.7e-20  Score=179.24  Aligned_cols=248  Identities=27%  Similarity=0.417  Sum_probs=160.7

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCC---CeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccc-------eeecCCC
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKH-------CFFSTTD  149 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~-------~~~~~~~  149 (422)
                      +.+.+-.+.++++.+....-...   .+.++-+....+.    ....+++-.+....|.+..-+.+       .+.....
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v  325 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV  325 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence            45556667777777766554332   2333333322222    12223444444444444333322       1111111


Q ss_pred             CCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                      ....|+|+.|++|.. +|.+++.. .+.....+....+.++.|++.|++|    +|.+|+|+||.||+...+. .+||.|
T Consensus       326 ~~~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~-q~kIgD  399 (516)
T KOG1033|consen  326 GKKVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDD-QLKIGD  399 (516)
T ss_pred             ccccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccch-hhhhhh
Confidence            224468899999984 66666653 3345567778889999999999999    4999999999999998776 799999


Q ss_pred             cCCccccccCC-------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHH
Q 014595          229 FGSAKVLVKGE-------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKV  300 (422)
Q Consensus       229 fG~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~  300 (422)
                      ||+.+......       ..+...||..||+||.+.+.. |+.++||||||++|+||++- ...|..   ...+..+.+ 
T Consensus       400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~-  474 (516)
T KOG1033|consen  400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRD-  474 (516)
T ss_pred             hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhc-
Confidence            99998776555       456678999999999997654 99999999999999999972 222211   111111111 


Q ss_pred             hCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                       |                 .+|   +..+     . -.+.-.+|+.+||...|.+||++.+.-.|+|.+
T Consensus       475 -g-----------------~ip---~~~~-----~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  475 -G-----------------IIP---PEFL-----Q-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             -C-----------------CCC---hHHh-----h-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence             0                 011   0000     0 134567999999999999999998888888753

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=7.7e-20  Score=189.69  Aligned_cols=190  Identities=26%  Similarity=0.414  Sum_probs=143.9

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhh-HHHHHHHHHHcC---CCCcccccceeecCCCCCceEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ...|.|.+.||+|+||+||+|.+.. |+.||+|+=+..... +---.+++.+|+   -+.|..+..++...+.     -+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-----S~  770 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-----SV  770 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc-----ce
Confidence            3469999999999999999999876 999999975443211 001123444444   2345555444432222     34


Q ss_pred             EEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC------CCCcEEEeec
Q 014595          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP------HTHQLKLCDF  229 (422)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~------~~~~vkl~Df  229 (422)
                      +|+||.+ |+|.+++.    ..+.+++..+..+.+|++.-++.||. .+|||+||||+|+||..      +...++|+||
T Consensus       771 lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEec
Confidence            8999998 67766665    46789999999999999999999999 89999999999999842      2225999999


Q ss_pred             CCcccc---ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCC
Q 014595          230 GSAKVL---VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ  282 (422)
Q Consensus       230 G~a~~~---~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~  282 (422)
                      |.+.-+   .++......++|-.+-.+|+..|.. ++..+|.|.|+.+++.||.|+
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence            998543   3343445567788899999997655 999999999999999999997

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.81  E-value=3.8e-20  Score=162.51  Aligned_cols=235  Identities=15%  Similarity=0.192  Sum_probs=171.0

Q ss_pred             EEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc------chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+.-+|.+...|..|+|++.  |..++.|++..      -.+.+..|.-.|+.+.||||+.+++.+-..     ..+.++
T Consensus       193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~i  265 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVII  265 (448)
T ss_pred             hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEe
Confidence            34557889999999999986  55566676532      234456788899999999999999988433     447789


Q ss_pred             eecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcee-cCCCCCCeEEcCCCCcEEEe--ecCCccc
Q 014595          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH-RDIKPQNLLVNPHTHQLKLC--DFGSAKV  234 (422)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givH-rDlkp~Nill~~~~~~vkl~--DfG~a~~  234 (422)
                      ..||+ ++|+.++.....  -...-.++..++.++++|++|||+-..++- --|....++||.+- +.+|+  |--++. 
T Consensus       266 sq~mp~gslynvlhe~t~--vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsf-  341 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSF-  341 (448)
T ss_pred             eeeccchHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeee-
Confidence            99998 688777765332  335556788899999999999998323443 36888889999775 45542  322221 


Q ss_pred             cccCCCcccccccccccchhhhcCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                           ........|.||+||.+...+.  .-+++|+|||++++|||.|...||.+.+..+--.+|.-.            
T Consensus       342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale------------  404 (448)
T KOG0195|consen  342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE------------  404 (448)
T ss_pred             -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc------------
Confidence                 1123345788999999965443  235799999999999999999999988776654443211            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHH
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  362 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~  362 (422)
                                     .++..++++++..+..|+.-|+..||.+||..+.+
T Consensus       405 ---------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  405 ---------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI  439 (448)
T ss_pred             ---------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence                           11223457889999999999999999999988765

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=8.5e-20  Score=165.79  Aligned_cols=139  Identities=17%  Similarity=0.131  Sum_probs=104.2

Q ss_pred             eeEEeeeeeecCCeeEEEEE-EcCCCeEEEEEEeccch----------------------------hhHHHHHHHHHHcC
Q 014595           83 SYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDK----------------------------RYKNRELQIMQMLD  133 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vAiK~~~~~~----------------------------~~~~~E~~~l~~l~  133 (422)
                      -|.+.+.||+|+||.||+|. +..+|+.||||++....                            ....+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999999 66789999999876321                            11347999999997


Q ss_pred             CCCcccccceeecCCCCCceEEEEEeecchhH-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-ceecCCC
Q 014595          134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIK  211 (422)
Q Consensus       134 h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g-ivHrDlk  211 (422)
                      +. ++.+..++.. .   .  .++||||+++. +....    .....+....+..++.||+.+|.+||+ .| |+|||||
T Consensus       109 ~~-~i~~p~~~~~-~---~--~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dik  176 (237)
T smart00090      109 EA-GVPVPKPIAW-R---R--NVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLS  176 (237)
T ss_pred             hc-CCCCCeeeEe-c---C--ceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCC
Confidence            63 3333333311 1   1  35999999973 22211    112345566678899999999999999 89 9999999


Q ss_pred             CCCeEEcCCCCcEEEeecCCcccc
Q 014595          212 PQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       212 p~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      |+||+++ ++ .++|+|||.+...
T Consensus       177 p~NIli~-~~-~i~LiDFg~a~~~  198 (237)
T smart00090      177 EYNILVH-DG-KVVIIDVSQSVEL  198 (237)
T ss_pred             hhhEEEE-CC-CEEEEEChhhhcc
Confidence            9999999 55 6999999998654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=2.6e-17  Score=147.54  Aligned_cols=129  Identities=19%  Similarity=0.332  Sum_probs=99.5

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch------------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +.||+|++|.||+|++  .|..|++|+.....            ....+|++++..+.|++|.....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5699999999999987  57789999754211            12347999999999999876655543222     25


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++|||++| ++.+++...       .. ....++.+++.+|.+||+ .|++|+|++|.|||++ ++ .++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            689999986 555544321       11 677889999999999999 8999999999999999 44 699999999865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=2.7e-19  Score=181.86  Aligned_cols=256  Identities=24%  Similarity=0.314  Sum_probs=188.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcC-CCeEEEEEEeccc---hhh---HHHHHHHHHHcC-CCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQD---KRY---KNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vAiK~~~~~---~~~---~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .|.+.+.||+|+|+.|-.+.... +...+|.|.+...   ...   ...|..+-+.+. |.|++.+++..     .+..+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCcc
Confidence            48888999999999999887743 3456677765432   122   234777777786 99999998876     44444


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH-~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++++|..++-  .......... ..+......++.|+..++.|+| . .++.|+|+||+|.+++..+..++++|||+|
T Consensus        96 ~~~~~~~s~g~~--~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   96 YLLSLSYSDGGS--LFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             cccccCcccccc--cccccccCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCchhh
Confidence            668999966421  1111101122 5667778889999999999999 8 899999999999999987635999999999


Q ss_pred             ccccc-CCC---cccccc-cccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          233 KVLVK-GEP---NVSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       233 ~~~~~-~~~---~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ..... ...   ....+| ++.|+|||...+........|+||+|+++..+++|..|+......+..             
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------------  239 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------------  239 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-------------
Confidence            87755 222   234577 999999999977666788999999999999999999999654432210             


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                              +..  +.... .......+..++....+++.++|..+|..|.+.+++..+||+..
T Consensus       240 --------~~~--~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  240 --------YSS--WKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             --------cee--ecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                    000  00000 01111122567899999999999999999999999999999998

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=1.8e-17  Score=147.14  Aligned_cols=130  Identities=18%  Similarity=0.192  Sum_probs=98.3

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch--------------------------hhHHHHHHHHHHcCCCCc
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------------RYKNRELQIMQMLDHPNI  137 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------------------------~~~~~E~~~l~~l~h~nI  137 (422)
                      |.+.+.||.|+||.||+|... +|+.||||++..+.                          ....+|..++..+.|+++
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888899999999999999875 79999999864321                          113468888888888753


Q ss_pred             --ccccceeecCCCCCceEEEEEeecchhH-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          138 --VALKHCFFSTTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       138 --v~l~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                        +..++.       .  ..+++|||+++. +..+..          ......++.+++.++.++|+ .||+||||||+|
T Consensus        96 ~v~~~~~~-------~--~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~N  155 (198)
T cd05144          96 PVPKPIDW-------N--RHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFN  155 (198)
T ss_pred             CCCceeec-------C--CceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCccc
Confidence              332221       1  146899999873 322110          02345678899999999999 899999999999


Q ss_pred             eEEcCCCCcEEEeecCCcccc
Q 014595          215 LLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~~~  235 (422)
                      |+++.++ .++|+|||.+...
T Consensus       156 ill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         156 ILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             EEEcCCC-cEEEEECCccccC
Confidence            9999876 7999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.73  E-value=1.6e-17  Score=161.81  Aligned_cols=204  Identities=27%  Similarity=0.369  Sum_probs=146.7

Q ss_pred             HHHcCCCCcccccceeecCCCCCceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcee
Q 014595          129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH  207 (422)
Q Consensus       129 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givH  207 (422)
                      |+.+.|.|+.++++.++..     ..++.|.+||+ |++.+.+..   ....++......++++|+.||.|||.+..-.|
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            4578999999999998655     33778999998 688777765   24567888888999999999999998433399


Q ss_pred             cCCCCCCeEEcCCCCcEEEeecCCccccccC---CCcccccccccccchhhhcCCCC------CCCcchHHHHHHHHHHH
Q 014595          208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNVSYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAEL  278 (422)
Q Consensus       208 rDlkp~Nill~~~~~~vkl~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~------~~~~~DiwslG~il~el  278 (422)
                      +.++..|.+++... .+||+|||+.......   .......-...|.|||.+.+...      .+.+.|+||+|++++|+
T Consensus        73 g~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   73 GALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            99999999999887 7999999998765321   11111223455999999965321      46679999999999999


Q ss_pred             HhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCC
Q 014595          279 LLGQPLFPGESGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN  354 (422)
Q Consensus       279 ltG~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  354 (422)
                      ++...||......    +.+..+.+....+.               .|.      .... ..+++++..++.+||..+|.
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~---------------rP~------i~~~-~e~~~~l~~l~~~cw~e~P~  209 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPF---------------RPS------IELL-NELPPELLLLVARCWEEIPE  209 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHhcCCCCc---------------Ccc------hhhh-hhcchHHHHHHHHhcccChh
Confidence            9999999763322    22222222011111               010      0000 13566899999999999999


Q ss_pred             CcCCHHHHh
Q 014595          355 LRCTALEAC  363 (422)
Q Consensus       355 ~R~t~~e~l  363 (422)
                      .||+++++-
T Consensus       210 ~rPs~~~i~  218 (484)
T KOG1023|consen  210 KRPSIEQIR  218 (484)
T ss_pred             hCccHHHHH
Confidence            999998774

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=7.3e-17  Score=143.25  Aligned_cols=125  Identities=18%  Similarity=0.317  Sum_probs=92.7

Q ss_pred             eeeecCCeeEEEEEEcCCCeEEEEEEeccch------------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .||+|+||.||+|..  +|..|++|+.....            ....+|+++++.+.|+++.....++....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            489999999999985  57889999754211            22347999999999887654433332211     246


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++|||+++ ++...+...    . .      .++.|++.+|.+||+ .|++|+|++|.||+++ ++ .++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~----~-~------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEG----N-D------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhc----H-H------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            89999986 444433221    0 0      678899999999999 8999999999999999 55 699999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=1.6e-16  Score=161.83  Aligned_cols=131  Identities=18%  Similarity=0.280  Sum_probs=97.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEec-cc-----------hhhHHHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QD-----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~-~~-----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      .|...+.||+|+||+||+|.+..  ..+++|+.. +.           .....+|+++++.++|++|+....+.....  
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--  409 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--  409 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--
Confidence            35678899999999999998753  334444321 10           123457999999999999887655443221  


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeec
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                         ..++||||+++ ++.+.+.            ....++.|++.+|.+||+ .||+||||||+|||++ ++ .++|+||
T Consensus       410 ---~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~-~~-~~~liDF  471 (535)
T PRK09605        410 ---EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR-DD-RLYLIDF  471 (535)
T ss_pred             ---CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE-CC-cEEEEeC
Confidence               24689999986 5544432            235678899999999999 8999999999999995 44 6999999


Q ss_pred             CCcccc
Q 014595          230 GSAKVL  235 (422)
Q Consensus       230 G~a~~~  235 (422)
                      |+++..
T Consensus       472 Gla~~~  477 (535)
T PRK09605        472 GLGKYS  477 (535)
T ss_pred             cccccC
Confidence            998753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=6.5e-16  Score=135.70  Aligned_cols=131  Identities=19%  Similarity=0.172  Sum_probs=90.0

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhH----------------------------HHHHHHHHHcCCCC--
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK----------------------------NRELQIMQMLDHPN--  136 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----------------------------~~E~~~l~~l~h~n--  136 (422)
                      .+.||+|+||+||+|.+. +|+.||||++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 79999999876432110                            13444455554332  


Q ss_pred             cccccceeecCCCCCceEEEEEeecchhHHH--HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          137 IVALKHCFFSTTDKEELYLNLVLEYVPETVN--RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       137 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                      +.+.+.+.         ..+++|||+++...  ..+....     .. ..++.++.+++.++.++|...||+|+||||+|
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N  145 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN  145 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence            22222211         14699999986210  1111111     01 45678899999999999963699999999999


Q ss_pred             eEEcCCCCcEEEeecCCcccc
Q 014595          215 LLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~~~  235 (422)
                      |+++ ++ .++|+|||.+...
T Consensus       146 ili~-~~-~~~liDfg~a~~~  164 (187)
T cd05119         146 ILVD-DG-KVYIIDVPQAVEI  164 (187)
T ss_pred             EEEE-CC-cEEEEECcccccc
Confidence            9999 55 6999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=2.2e-15  Score=137.11  Aligned_cols=133  Identities=15%  Similarity=0.246  Sum_probs=96.0

Q ss_pred             eeee-ecCCeeEEEEEEcCCCeEEEEEEeccc-----------------hhhHHHHHHHHHHcCCCCc--ccccceeecC
Q 014595           88 HVVG-TGSFGVVFQAKCRETGEIVAIKKVLQD-----------------KRYKNRELQIMQMLDHPNI--VALKHCFFST  147 (422)
Q Consensus        88 ~~lg-~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------------~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~  147 (422)
                      ..|| .||.|+||.+...  +..++||.+...                 .....+|++++..|.|++|  +..+.+....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 8899999998874  778999876421                 1223579999999998886  4454443221


Q ss_pred             CCCCceEEEEEeecchh--HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEE
Q 014595          148 TDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  225 (422)
Q Consensus       148 ~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vk  225 (422)
                       .......++|||++++  ++.+++..     ..+++..    +.||+.+|.+||+ .||+||||||+|||++.++ .++
T Consensus       115 -~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~-~v~  182 (239)
T PRK01723        115 -HGLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDPDG-KFW  182 (239)
T ss_pred             -cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCC-CEE
Confidence             1111223589999985  55555432     3445443    5689999999999 8999999999999999876 699


Q ss_pred             EeecCCccc
Q 014595          226 LCDFGSAKV  234 (422)
Q Consensus       226 l~DfG~a~~  234 (422)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998865

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1.4e-15  Score=148.46  Aligned_cols=253  Identities=25%  Similarity=0.256  Sum_probs=188.9

Q ss_pred             CCcceeeeEEeeeeee--cCCeeEEEEEE--cCCCeEEEEEEecc------chhhHHHHHHHHHHc-CCCCcccccceee
Q 014595           77 NSKQKVSYIAEHVVGT--GSFGVVFQAKC--RETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKHCFF  145 (422)
Q Consensus        77 ~~~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l-~h~nIv~l~~~~~  145 (422)
                      .......+.+.+.+|.  |.+|.||.+..  ..++..+|+|+-+.      ......+|+...+.+ .|+|.++.+..+ 
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-  187 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-  187 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-
Confidence            3344445778889999  99999999998  88899999997321      222334677777777 489999866665 


Q ss_pred             cCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHH----HHHHHHhcCCceecCCCCCCeEEcCCC
Q 014595          146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHT  221 (422)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~----aL~~LH~~~givHrDlkp~Nill~~~~  221 (422)
                          .+....++-+|+|+.++......   ...-++...++..+.+...    ||..+|+ .+++|-|+||+||++..+.
T Consensus       188 ----e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  188 ----EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDW  259 (524)
T ss_pred             ----ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheeccccc
Confidence                44555778999998766544433   2345888889999999999    9999998 8999999999999999884


Q ss_pred             CcEEEeecCCccccccCCCcc------cccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--ChHHH
Q 014595          222 HQLKLCDFGSAKVLVKGEPNV------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE--SGVDQ  293 (422)
Q Consensus       222 ~~vkl~DfG~a~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~--~~~~~  293 (422)
                      ...+++|||+...+.++....      ...+..-|++||...+  -++...|+|++|.++.+..+|..++...  +.+.+
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence            479999999988775554221      1145667999998844  4799999999999999999988666543  22222


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      +..+.                              ....+-...+.++...+..|+..||..|+++..+++|+++..
T Consensus       338 ~r~~~------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  338 LRQGY------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             ccccc------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            11110                              001111345667777999999999999999999999999874

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=2e-15  Score=127.21  Aligned_cols=131  Identities=20%  Similarity=0.251  Sum_probs=100.4

Q ss_pred             EeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch--hhHHHHHHHHHHcCC--CCcccccceeecCCCCCceEEEEEeec
Q 014595           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLNLVLEY  161 (422)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~~~~~~lv~e~  161 (422)
                      +.+.||.|.++.||++...  +..+++|.+....  ....+|+.+++.+.|  .++++++..+..     ....+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES-----DGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEEEEEe
Confidence            3577999999999999985  3789999886654  256789999999976  477777665521     2346789999


Q ss_pred             chhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +.+....          .++......++.+++.+|.+||..  .+++|+|++|+||+++..+ .++++|||.+..
T Consensus        75 ~~g~~~~----------~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecc----------cCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            9863211          014455567788999999999972  2699999999999999755 799999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=1.3e-15  Score=137.64  Aligned_cols=244  Identities=19%  Similarity=0.218  Sum_probs=164.8

Q ss_pred             eeEEEEEEcCCCeEEEEEEecc--------chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecch-hHH
Q 014595           96 GVVFQAKCRETGEIVAIKKVLQ--------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETV  166 (422)
Q Consensus        96 g~V~~~~~~~~~~~vAiK~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~l  166 (422)
                      -.||++.+...|..|.--.+..        .....+.-..-|-++.|.|||+++.++.+....+...+.++.||+. +++
T Consensus        80 d~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~  159 (458)
T KOG1266|consen   80 DDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL  159 (458)
T ss_pred             HHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence            4578888877776664432211        1111112234456678999999999886665545566778999998 688


Q ss_pred             HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCCeEEcCCCCcEEEeecCCcccc--cc---CCC
Q 014595          167 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL--VK---GEP  240 (422)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~--~~---~~~  240 (422)
                      ...++...+....+.....++|+.||+.||.|||++ --|+|+++..+-|++..++ -+|+.----...-  ..   ...
T Consensus       160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~E  238 (458)
T KOG1266|consen  160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAE  238 (458)
T ss_pred             HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhh
Confidence            888888888888999999999999999999999984 3599999999999999777 5776421111000  00   001


Q ss_pred             cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccC
Q 014595          241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  319 (422)
Q Consensus       241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  319 (422)
                      .....+-++|.|||.=. ....+.++|||++|....+|..|..- -.+.+....-..+.+.+                  
T Consensus       239 k~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------  299 (458)
T KOG1266|consen  239 KSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------  299 (458)
T ss_pred             hhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe------------------
Confidence            11223457799999642 34467899999999999999887632 22222211111111110                  


Q ss_pred             cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                   + ..-..--++++++||+-.|..||++.++|.||.+-++..
T Consensus       300 -------------~-~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs  339 (458)
T KOG1266|consen  300 -------------I-GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS  339 (458)
T ss_pred             -------------e-eccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence                         0 001223457999999999999999999999999877643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.55  E-value=2.6e-15  Score=153.90  Aligned_cols=259  Identities=24%  Similarity=0.288  Sum_probs=183.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..+.+.+-+-+|.++.++.+.-..+|-..++|+.....       +...++-.++-...+|-++....-+     ....-
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rsP  878 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRSP  878 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCCC
Confidence            34777788999999999999888888777777543321       1122233333333455555443222     12222


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .+++++|+++ ++...+.+    ....+....+.+...+..+++|||. ..++|+|++|.|+|+..++ ..+++|||...
T Consensus       879 ~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~  952 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDG-HRPLTDFGTLS  952 (1205)
T ss_pred             cchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccC-CcccCcccccc
Confidence            6689999864 44343333    2346666677788899999999998 6799999999999999888 49999998432


Q ss_pred             cccc---------------------C-----------CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhC
Q 014595          234 VLVK---------------------G-----------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG  281 (422)
Q Consensus       234 ~~~~---------------------~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG  281 (422)
                      ....                     .           .......+|+.|.+||...+.. ....+|+|++|++++|.++|
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcC
Confidence            1100                     0           0112346799999999997765 78899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHH-
Q 014595          282 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-  360 (422)
Q Consensus       282 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-  360 (422)
                      .+||........+..|....                         .+|.. -+...+.++++++.++|..+|.+|..+. 
T Consensus      1032 ~pp~na~tpq~~f~ni~~~~-------------------------~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRD-------------------------IPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred             CCCCCCcchhhhhhccccCC-------------------------CCCCC-CccccChhhhhhhhhhhccCchhccCccc
Confidence            99999887776665554421                         11211 1235689999999999999999999887 


Q ss_pred             --HHhcCCcccccCCCCCCC
Q 014595          361 --EACVHPFFDELRDPNTRL  378 (422)
Q Consensus       361 --e~l~hp~f~~~~~~~~~~  378 (422)
                        ++-.||||+.+.+....+
T Consensus      1086 ~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1086 AAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred             ccccccCCccCCCCcccccc
Confidence              899999999987655443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.45  E-value=1.2e-12  Score=129.30  Aligned_cols=179  Identities=22%  Similarity=0.285  Sum_probs=124.7

Q ss_pred             eEEeeeeeecCCeeEE-EEEEcCCCeEEEEEEeccchh----hHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           84 YIAEHVVGTGSFGVVF-QAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~-~~~~~~~~~~vAiK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      |.+ ...+-++.+ || .|..+.++.+|.|...+....    ..++-++-|+.++||||+++++.+     .....+|+|
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylv   87 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLV   87 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEE
Confidence            555 333333333 34 466677888888887754332    245678889999999999999987     333458899


Q ss_pred             eecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      +|-+...- ..+..       +....+...++||+.||.|||+..+++|++|.-+-|+++..| ..||++|-++......
T Consensus        88 TErV~Pl~-~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~  158 (690)
T KOG1243|consen   88 TERVRPLE-TVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGF  158 (690)
T ss_pred             eeccccHH-HHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccC
Confidence            99986421 12221       235667788899999999998547999999999999999988 6999999987543222


Q ss_pred             CC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhC
Q 014595          239 EP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG  281 (422)
Q Consensus       239 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG  281 (422)
                      .. ......--.|..|+.+..   -.-..|.|-|||++++++.|
T Consensus       159 ~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  159 NAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             CcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence            11 111111223667765521   12457999999999999999

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.40  E-value=2.3e-12  Score=127.45  Aligned_cols=137  Identities=22%  Similarity=0.268  Sum_probs=88.1

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-hh-------------------------------------------H
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RY-------------------------------------------K  122 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~-------------------------------------------~  122 (422)
                      .+.||.|++|+||+|+.+ +|+.||||+..... ..                                           +
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            467999999999999975 79999999874321 00                                           1


Q ss_pred             HHHHHHHHHc----CCCCcccccceeecCCCCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHH-HH
Q 014595          123 NRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR-AL  196 (422)
Q Consensus       123 ~~E~~~l~~l----~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~-aL  196 (422)
                      .+|+..+.++    +|.+-+.+..++....+    ..++||||++| .+.+......   ....   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHH
Confidence            1244444443    23333333333322111    14689999986 4433332211   1122   2334555555 46


Q ss_pred             HHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       197 ~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ..+|. .|++|+|+||.||+++.++ .++|+|||++..+.
T Consensus       271 ~ql~~-~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLR-DGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHh-CCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            78898 8999999999999998877 69999999987663

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=5.9e-13  Score=133.22  Aligned_cols=139  Identities=19%  Similarity=0.236  Sum_probs=86.4

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhh--------------------------------------H---
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--------------------------------------K---  122 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--------------------------------------~---  122 (422)
                      |.. +.||+|++|+||+|+.+.+|+.||||+.......                                      .   
T Consensus       122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E  200 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE  200 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence            555 7899999999999999888999999988643100                                      0   


Q ss_pred             ---HHHHHHHHHc----CCCCcccccceeecCCCCCceEEEEEeecchh-HHHHHHHHhhhhc---CCCCHHHHHHHHHH
Q 014595          123 ---NRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIH---QRMPLIYVKLYTYQ  191 (422)
Q Consensus       123 ---~~E~~~l~~l----~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~---~~~~~~~~~~~~~q  191 (422)
                         .+|+..+.++    .+.+.+.+..++.+..    ...++||||+.| .+.++... ...+   ..+.+..+..++.|
T Consensus       201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             hCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHH
Confidence               1233333332    2333333333332111    114599999987 33332111 1101   12444445555555


Q ss_pred             HHHHHHHHHhcCCceecCCCCCCeEEcCCC---CcEEEeecCCccccc
Q 014595          192 ICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFGSAKVLV  236 (422)
Q Consensus       192 i~~aL~~LH~~~givHrDlkp~Nill~~~~---~~vkl~DfG~a~~~~  236 (422)
                      ++       . .|++|+|+||.||+++.++   ..++++|||++..+.
T Consensus       276 if-------~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 VF-------R-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HH-------h-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            54       4 6999999999999999765   269999999987663

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.37  E-value=3.2e-12  Score=111.50  Aligned_cols=131  Identities=17%  Similarity=0.194  Sum_probs=91.4

Q ss_pred             eeeeecCCeeEEEEEEcC------CCeEEEEEEecc--------------chh------------hH----HHHHHHHHH
Q 014595           88 HVVGTGSFGVVFQAKCRE------TGEIVAIKKVLQ--------------DKR------------YK----NRELQIMQM  131 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~------~~~~vAiK~~~~--------------~~~------------~~----~~E~~~l~~  131 (422)
                      ..||.|--+.||.|....      .+..+|||+.+.              +.+            ..    ++|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998643      357899997631              100            11    268999998


Q ss_pred             cCC--CCcccccceeecCCCCCceEEEEEeecchhH-HH-HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCce
Q 014595          132 LDH--PNIVALKHCFFSTTDKEELYLNLVLEYVPET-VN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGIC  206 (422)
Q Consensus       132 l~h--~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L-H~~~giv  206 (422)
                      +..  -++..++.+.    .     -++||||+++. +. ..++.     ..+++.....+..|++.+|..| |+ .|||
T Consensus        83 l~~~Gv~vP~pi~~~----~-----~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~-~glV  147 (197)
T cd05146          83 MQKAGIPCPEVVVLK----K-----HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE-CNLV  147 (197)
T ss_pred             HHHcCCCCCeEEEec----C-----CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh-CCee
Confidence            854  3444444321    1     34899999853 11 11111     2344555667788999999998 88 7999


Q ss_pred             ecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       207 HrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      |+||++.|||++. + .+.|+|||.+...
T Consensus       148 HGDLs~~NIL~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146         148 HADLSEYNMLWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             cCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence            9999999999984 4 5999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=4e-12  Score=109.64  Aligned_cols=124  Identities=16%  Similarity=0.172  Sum_probs=89.3

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCccc-ccceeecCCCCCceEEEEEeecc
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVA-LKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      .+.|+.|.++.||++...  ++.|++|......   ....+|+.+++.+.+.+++. ++.+.     ...  .++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence            356899999999999874  7889999875543   34568999999997666543 33322     111  24899999


Q ss_pred             hhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCc-----eecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          163 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI-----CHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~gi-----vHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      ++....   ..     ..   ....++.+++.+|..||+ .++     +|+|++|.||+++ ++ .++++|||.+.
T Consensus        74 ~G~~l~---~~-----~~---~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          74 EGSELL---TE-----DF---SDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             CCCccc---cc-----cc---cCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            973211   00     01   113346799999999998 775     9999999999999 44 69999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=3.5e-13  Score=131.81  Aligned_cols=249  Identities=22%  Similarity=0.196  Sum_probs=173.2

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEc-CCCeEEEEEEeccchhhH------HHHHHHHHHc-CCCCcccccceeecCCCCC
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKRYK------NRELQIMQML-DHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vAiK~~~~~~~~~------~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  151 (422)
                      ...+|..+..||.|.|+.|+.+... .++..|++|.+.+.....      ..|+-+...+ -|.+++.+...+....   
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r---  339 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR---  339 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc---
Confidence            3446889999999999999998766 678899999876543222      2455555555 5888888766553222   


Q ss_pred             ceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                        ..|+-.|||.+....+..   .....+.+...+....|++.|+.++|+ ..++|+|+||+||++..++...++.|||+
T Consensus       340 --~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  340 --QGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             --cccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhcccccc
Confidence              245788999754333222   233557777788899999999999998 99999999999999987644689999999


Q ss_pred             ccccccCCCccccccccccc-chhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          232 AKVLVKGEPNVSYICSRYYR-APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ++.+.-.  .......-.++ ..|++.....+..+.|++|||..+.+.++|...-......   ..|...          
T Consensus       414 ~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~----------  478 (524)
T KOG0601|consen  414 WTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSG----------  478 (524)
T ss_pred             cccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecc----------
Confidence            8653111  11222233344 3666656667899999999999999999997443322211   111110          


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                               ..+.          .+....++..+.+.++..|+..|+.+.++..|.-|...
T Consensus       479 ---------~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  479 ---------DTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             ---------cccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                     0000          02334678889999999999999999999998877553

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.26  E-value=2.8e-10  Score=109.54  Aligned_cols=212  Identities=18%  Similarity=0.244  Sum_probs=149.5

Q ss_pred             eeEEEEEEcCCCeEEEEEEeccchh----hHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecchh--HHHHH
Q 014595           96 GVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNRI  169 (422)
Q Consensus        96 g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~  169 (422)
                      .+.|+|....+|..|++|++.-++.    ....-+++++++.|.|+|++.++|.... -.+..+++|++|.++  +|.++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHHH
Confidence            4789999999999999999843221    1225689999999999999999986333 445668899999984  55443


Q ss_pred             HHHh-----------hhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          170 ARNY-----------SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       170 ~~~~-----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ....           ...+...+|..+|.|+.|+..||.++|+ .|+.-+-|.|.+||++.+. +++|+..|....+..+
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQED  446 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcc-eEEEecccceeeecCC
Confidence            2211           1123457889999999999999999999 8999999999999999776 6999888877655433


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHH-HHHHHHHhCCCCHHHHhhcCcCC
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .           .  |.+.+    -.+-|.=.||.+++.|.||..- +........ +..|.                  
T Consensus       447 ~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~------------------  491 (655)
T KOG3741|consen  447 P-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT------------------  491 (655)
T ss_pred             C-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh------------------
Confidence            3           0  11211    2345889999999999999632 111111111 11111                  


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                        ...+.+++++|.-+...++++ -++.+++.
T Consensus       492 ------------------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  492 ------------------TTYSTDLRNVVEYLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             ------------------hhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence                              345778888888888887775 45666654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=3.6e-12  Score=126.48  Aligned_cols=155  Identities=21%  Similarity=0.334  Sum_probs=113.6

Q ss_pred             HHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCC--------cc--cccccccccchhhhcCCC
Q 014595          191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--------NV--SYICSRYYRAPELIFGAT  260 (422)
Q Consensus       191 qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~--------~~--~~~~t~~y~aPE~~~~~~  260 (422)
                      +++.||.|+|++.++||+.|.|++|.++..+ .+||+.|+++........        ..  .......|.|||++.+ .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            4458999999878999999999999999887 799999998754432111        01  1122456999999966 5


Q ss_pred             CCCCcchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCCh
Q 014595          261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP  339 (422)
Q Consensus       261 ~~~~~~DiwslG~il~ell-tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  339 (422)
                      ..+.++|+||+||++|.+. .|+..+.+.........-...             .+...+            .....+++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~-------------~~~~~~------------~~s~~~p~  239 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL-------------LNAGAF------------GYSNNLPS  239 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc-------------cccccc------------cccccCcH
Confidence            5899999999999999999 566666554332222111110             000111            11257899


Q ss_pred             HHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          340 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       340 ~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      ++++=|.++|..|+..||++.+++.-|||.+..
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            999999999999999999999999999999854

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.25  E-value=1.5e-10  Score=97.35  Aligned_cols=140  Identities=19%  Similarity=0.266  Sum_probs=97.8

Q ss_pred             EeeeeeecCCeeEEEEEEcCCCeEEEEEEec-c-----------chhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-Q-----------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~-~-----------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ...+|-+|+-+.|+++.+.  |+.+.||.-. +           .+....+|+++|.++.--.|..-.-+|.+...    
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~----   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG----   84 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence            4567899999999999874  8888888532 1           12334579999998864444332222322222    


Q ss_pred             EEEEEeecchh--HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcE--EEeec
Q 014595          154 YLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL--KLCDF  229 (422)
Q Consensus       154 ~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~v--kl~Df  229 (422)
                       -.++|||+++  ++.+.+.....  ..........++.+|-..+.-||. .+|||+||..+||++.++++.+  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence             3479999987  55555443322  223333336788899999999999 8999999999999998887655  89999


Q ss_pred             CCcccc
Q 014595          230 GSAKVL  235 (422)
Q Consensus       230 G~a~~~  235 (422)
                      |++...
T Consensus       161 gls~~s  166 (229)
T KOG3087|consen  161 GLSSVS  166 (229)
T ss_pred             cchhcc
Confidence            998643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=2.4e-09  Score=100.79  Aligned_cols=260  Identities=16%  Similarity=0.191  Sum_probs=154.2

Q ss_pred             EeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-hhHHHHHHHHHHc-CCCCccc-ccceee-cCCCCCceEEEEEeec
Q 014595           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML-DHPNIVA-LKHCFF-STTDKEELYLNLVLEY  161 (422)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~l-~h~nIv~-l~~~~~-~~~~~~~~~~~lv~e~  161 (422)
                      ..+.||+|+-+.+|-.-..  +. .+.|+..... ....+.++.|... .||-+-. +..--. -...++...+.++|+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             CCccccCCccceeeecchh--hc-hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            4567999999999865432  22 3345554322 1122233333333 4554322 110000 0111333347788988


Q ss_pred             chhH--HHHHHH--HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          162 VPET--VNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       162 ~~~~--l~~~~~--~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      +++-  ...+..  ..........+....++++.++.|..-||+ .|.+-+|++++|+|+.+++ .|.|.|=..-....+
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~n  169 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINAN  169 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCc-eEEEEcccceeeccC
Confidence            8752  111111  111223346778899999999999999999 8999999999999999877 699988654444455


Q ss_pred             CCCcccccccccccchhhhc----CCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCC--HHHHh
Q 014595          238 GEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPT--REEIK  310 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~  310 (422)
                      +......+|.+.|.+||.-.    ..-.-+...|.|.||+++++++.| +.||.|-..         ....|.  +..+.
T Consensus       170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~~ap~p~E~~Ia  240 (637)
T COG4248         170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------ISDAPNPLETDIA  240 (637)
T ss_pred             CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc---------cCCCCCcchhhhh
Confidence            55666778899999999752    111246789999999999999986 999987421         111111  11222


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhc--CCCCcCCHH
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY--SPNLRCTAL  360 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~R~t~~  360 (422)
                      .....|..-.-+..++.|..--+ .-+++++..|..+|++.  ++.-|||++
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             cceeeechhccCCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            11111111111122221111111 34789999999999974  467899974

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=5.7e-10  Score=94.35  Aligned_cols=124  Identities=15%  Similarity=0.315  Sum_probs=84.2

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEE-eccc-----------hhhHHHHHHHHHHcCCCCcc--cccceeecCCCCCce
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKK-VLQD-----------KRYKNRELQIMQMLDHPNIV--ALKHCFFSTTDKEEL  153 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~-~~~~-----------~~~~~~E~~~l~~l~h~nIv--~l~~~~~~~~~~~~~  153 (422)
                      ..+++|+-+.+|.+...  |..+.+|. +.+.           .....+|+.++.++.--.|.  .++++  +..   . 
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~---~-   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPD---N-   73 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCC---C-
Confidence            35789999999999663  55566764 2221           12234799999988644433  33332  222   2 


Q ss_pred             EEEEEeecchhHHH-HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPETVN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                       ..++|||++|.+. +.+..    .   .    ..++..+-.-+.-||. .||+|+||.++||++..+  .+.++|||++
T Consensus        74 -~~I~me~I~G~~lkd~l~~----~---~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~--~i~~IDfGLg  138 (204)
T COG3642          74 -GLIVMEYIEGELLKDALEE----A---R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGG--RIYFIDFGLG  138 (204)
T ss_pred             -CEEEEEEeCChhHHHHHHh----c---c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCC--cEEEEECCcc
Confidence             3489999998542 23322    1   1    3356677778888999 899999999999999965  4999999998


Q ss_pred             cc
Q 014595          233 KV  234 (422)
Q Consensus       233 ~~  234 (422)
                      ..
T Consensus       139 ~~  140 (204)
T COG3642         139 EF  140 (204)
T ss_pred             cc
Confidence            64

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=1.4e-09  Score=94.54  Aligned_cols=121  Identities=21%  Similarity=0.274  Sum_probs=74.8

Q ss_pred             eEEEEEEcCCCeEEEEEEeccch------------------------------hhHHHHHHHHHHcCCCC--ccccccee
Q 014595           97 VVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQIMQMLDHPN--IVALKHCF  144 (422)
Q Consensus        97 ~V~~~~~~~~~~~vAiK~~~~~~------------------------------~~~~~E~~~l~~l~h~n--Iv~l~~~~  144 (422)
                      .||.|.. ..|+.+|||+.....                              ...++|.+.|.++...+  +.+++.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3899987 458899999763210                              11236999999997664  44554332


Q ss_pred             ecCCCCCceEEEEEeecch--hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHH-HHhcCCceecCCCCCCeEEcCCC
Q 014595          145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY-IHNCIGICHRDIKPQNLLVNPHT  221 (422)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~-LH~~~givHrDlkp~Nill~~~~  221 (422)
                           .    -++||||++  |.....+...     .++......++.+++..+.. +|. .||+|+||.+.|||++.+ 
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-
T ss_pred             -----C----CEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-
Confidence                 1    248999998  5221112221     11123345667788886665 577 899999999999999965 


Q ss_pred             CcEEEeecCCcccc
Q 014595          222 HQLKLCDFGSAKVL  235 (422)
Q Consensus       222 ~~vkl~DfG~a~~~  235 (422)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             5999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.98  E-value=5.2e-09  Score=94.13  Aligned_cols=139  Identities=14%  Similarity=0.168  Sum_probs=89.2

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCC--cccccceeecCCCCCceEEEEEee
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +.|+.|..+.||++.... |+.+++|.....     .....+|+++++.+.+.+  +.+++.+..  ........++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~--~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCE--DPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECC--CCCccCCceEEEE
Confidence            568999999999998743 688999987643     235578999999997644  455544431  1111123468999


Q ss_pred             cchhH-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 014595          161 YVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--------------------------------------  201 (422)
Q Consensus       161 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--------------------------------------  201 (422)
                      |+++. +.....     ...+++.....++.+++.+|..||+                                      
T Consensus        81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            99863 111000     0123444444455555555555552                                      


Q ss_pred             -----------------cCCceecCCCCCCeEEcCC-CCcEEEeecCCccc
Q 014595          202 -----------------CIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKV  234 (422)
Q Consensus       202 -----------------~~givHrDlkp~Nill~~~-~~~vkl~DfG~a~~  234 (422)
                                       ...++|+|++|.||+++.+ +..+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                             1347999999999999973 23589999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.96  E-value=2.1e-08  Score=92.50  Aligned_cols=109  Identities=13%  Similarity=0.172  Sum_probs=76.9

Q ss_pred             HHHHHHHHHHcCCCCcccc--cceeecCCCCCceEEEEEeecchh--HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 014595          122 KNRELQIMQMLDHPNIVAL--KHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  197 (422)
Q Consensus       122 ~~~E~~~l~~l~h~nIv~l--~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~  197 (422)
                      ..+|...+.+|...+|...  +.+.....+.....-++|+|++++  ++.+++....  ....+......++.+++..+.
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~  152 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVR  152 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHH
Confidence            5689999888855444433  333322222222335689999987  5666654322  234556677789999999999


Q ss_pred             HHHhcCCceecCCCCCCeEEcCC------CCcEEEeecCCcc
Q 014595          198 YIHNCIGICHRDIKPQNLLVNPH------THQLKLCDFGSAK  233 (422)
Q Consensus       198 ~LH~~~givHrDlkp~Nill~~~------~~~vkl~DfG~a~  233 (422)
                      -||. .||+|+|+++.|||++.+      ...+.|+||+.+.
T Consensus       153 ~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        153 DMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999 899999999999999852      2379999999875

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.75  E-value=6.1e-08  Score=87.04  Aligned_cols=131  Identities=20%  Similarity=0.177  Sum_probs=89.8

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--------------------------hhhHHHHHHHHHHcCCC--
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------------------KRYKNRELQIMQMLDHP--  135 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------------------~~~~~~E~~~l~~l~h~--  135 (422)
                      +.++..||-|--+.||.|.+. .|..+|||.-...                          ....++|.++|++|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            567789999999999999985 6899999953211                          11224799999999654  


Q ss_pred             CcccccceeecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 014595          136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (422)
Q Consensus       136 nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Ni  215 (422)
                      .+.+.+++       +.  -++|||++.|....-+        ++.......++..|+.-+.-+-. .||||+|+.+=||
T Consensus       172 ~VP~P~~~-------nR--HaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIAW-------NR--HAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI  233 (304)
T ss_pred             CCCCcccc-------cc--ceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence            55554332       11  3489999987321111        11223334445555555555545 7999999999999


Q ss_pred             EEcCCCCcEEEeecCCccc
Q 014595          216 LVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       216 ll~~~~~~vkl~DfG~a~~  234 (422)
                      +++.+| .+.++||--+..
T Consensus       234 lV~~dg-~~~vIDwPQ~v~  251 (304)
T COG0478         234 LVTEDG-DIVVIDWPQAVP  251 (304)
T ss_pred             EEecCC-CEEEEeCccccc
Confidence            999987 599999976643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.65  E-value=4.2e-07  Score=80.92  Aligned_cols=107  Identities=21%  Similarity=0.313  Sum_probs=76.1

Q ss_pred             HHHHHHHHHHcCCCCcc--cccceeecCCCCCceEEEEEeecchh--HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 014595          122 KNRELQIMQMLDHPNIV--ALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  197 (422)
Q Consensus       122 ~~~E~~~l~~l~h~nIv--~l~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~  197 (422)
                      ..+|...+..|....|.  +.+.+........ ...++|+|++++  ++.+++....    ..+......++.+++..+.
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHHH
Confidence            45788888888544443  3333332222222 445789999986  4555554321    2556667888999999999


Q ss_pred             HHHhcCCceecCCCCCCeEEcCCC--CcEEEeecCCccc
Q 014595          198 YIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  234 (422)
Q Consensus       198 ~LH~~~givHrDlkp~Nill~~~~--~~vkl~DfG~a~~  234 (422)
                      -||. .||+|+|+++.|||++.++  ..+.|+||+-++.
T Consensus       133 ~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999 8999999999999999764  2599999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.64  E-value=4e-09  Score=104.10  Aligned_cols=246  Identities=18%  Similarity=0.175  Sum_probs=162.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCC-cccccceeecCCCCCceEEEEEeec
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN-IVALKHCFFSTTDKEELYLNLVLEY  161 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~~~~~~lv~e~  161 (422)
                      .|...+.+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++     ....+.|..+++++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccc-----cCCcccccchhhhh
Confidence            3566778999999999999987766555 7877665 34456899999999999 333322     22556678899999


Q ss_pred             chhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCc
Q 014595          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (422)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~  241 (422)
                      +.+.-.. ..........+.+-......+.-+++|+++|+ .-=+|+|    ||+....  ..|..||+....+......
T Consensus       316 ~s~~rs~-~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  316 CSTGRSS-ALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hcCCccc-cccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccccc--ccccccccCCcccCccccc
Confidence            9753000 00000011122223344455566788999998 4558888    8888864  5899999998777555555


Q ss_pred             ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcC
Q 014595          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  321 (422)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  321 (422)
                      .+..+++.++|||+..+. .+....|.|++|+--.+|.-|-+|-.....  ..    ..+|..              .+.
T Consensus       388 ~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~----~~~g~~--------------p~s  446 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VL----PMIGNG--------------PNS  446 (829)
T ss_pred             ccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCcc--cc----CCCCCC--------------CCc
Confidence            677889999999988654 489999999999877777777776544110  00    000000              011


Q ss_pred             CCCCC-CCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          322 PQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       322 ~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      +.... ..|...+       -.++...|+.-.|..|+.+..++.|.+|...
T Consensus       447 ~~L~~~~aw~~~~-------~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  447 PMLTDKSAWSPVF-------HRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cccchhhhcCccc-------ccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            11111 2222222       1267888999999999999999999999864

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=1.1e-06  Score=77.09  Aligned_cols=139  Identities=11%  Similarity=0.080  Sum_probs=96.0

Q ss_pred             eeecCCeeEEEEEEcCCCeEEEEEEec----------cchhhHHHHHHHHHHcCCCCcc--cccceeecCCCCCceEEEE
Q 014595           90 VGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQMLDHPNIV--ALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vAiK~~~----------~~~~~~~~E~~~l~~l~h~nIv--~l~~~~~~~~~~~~~~~~l  157 (422)
                      -|+||-+-|+.....  |+.+-+|.-.          -....+.+|+..+++|..-+|.  ++. ++..........-+|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            366888888887653  4567788643          1234456899999998654443  333 222222233455678


Q ss_pred             Eeecch--hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC-cEEEeecCCccc
Q 014595          158 VLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  234 (422)
Q Consensus       158 v~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~-~vkl~DfG~a~~  234 (422)
                      |+|-++  .+|.+++....  -.+.+......++.+++.++.-||+ .|+.|+|+-+.|||++.++. .++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            999888  46665554321  1345666677889999999999999 89999999999999986552 499999987653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.58  E-value=1.7e-07  Score=93.62  Aligned_cols=132  Identities=25%  Similarity=0.316  Sum_probs=80.6

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccchhh--------------------------------------------HH
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--------------------------------------------KN  123 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--------------------------------------------~~  123 (422)
                      ..|+.++-|+||+|+.+ +|+.||||+...+-+.                                            ..
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            56899999999999986 5999999986432100                                            01


Q ss_pred             HHHHHHHHc----CCCCcccccceeecCCCCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHH-----HHHHHHHHHH
Q 014595          124 RELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI-----YVKLYTYQIC  193 (422)
Q Consensus       124 ~E~~~l~~l----~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~-----~~~~~~~qi~  193 (422)
                      +|+.-+.++    +...-+.+-.+|.+...+    -.++|||+.| .+.+......   .+++..     .+..++.|++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f~~q~~  282 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAFLRQLL  282 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHHHHHHH
Confidence            355444444    222223333334221111    3489999987 3323221111   233322     2223333332


Q ss_pred             HHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       194 ~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      .        .|++|.|.+|.||+++.++ .+.+.|||+...+.
T Consensus       283 ~--------dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~  316 (517)
T COG0661         283 R--------DGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLD  316 (517)
T ss_pred             h--------cCccccCCCccceEEecCC-cEEEEcCcceecCC
Confidence            2        5999999999999999997 69999999986654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.53  E-value=1.1e-06  Score=78.28  Aligned_cols=132  Identities=16%  Similarity=0.165  Sum_probs=87.1

Q ss_pred             eeeecCCeeEEEEEEcCCCeEEEEEEeccchhh----------------------------HHHHHHHHHHcCCCC--cc
Q 014595           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY----------------------------KNRELQIMQMLDHPN--IV  138 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----------------------------~~~E~~~l~~l~h~n--Iv  138 (422)
                      .|..|--+.||+|.. .++..||+|++......                            ..+|+.-|+++....  +.
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            677888889999986 46899999987432111                            125777787774333  33


Q ss_pred             cccceeecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEc
Q 014595          139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  218 (422)
Q Consensus       139 ~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~  218 (422)
                      +-+.+.   .      -.+||||++...   ...-....-.+.......+..+++..+.-|-...|+||+||..=|||+.
T Consensus       134 ~Pi~~~---~------nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         134 EPIAFR---N------NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             Cceeec---C------CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence            333322   1      348999998531   0000001122233356677788888888776437999999999999999


Q ss_pred             CCCCcEEEeecCCcccc
Q 014595          219 PHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       219 ~~~~~vkl~DfG~a~~~  235 (422)
                       ++ .+.|+|||-|...
T Consensus       202 -~~-~p~iID~~QaV~~  216 (268)
T COG1718         202 -DG-EPYIIDVSQAVTI  216 (268)
T ss_pred             -CC-eEEEEECcccccc
Confidence             44 5999999988654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.52  E-value=2.5e-06  Score=75.15  Aligned_cols=134  Identities=17%  Similarity=0.249  Sum_probs=83.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhH-------------HHHHHHHHHcCCCCcccccceeec---
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQMLDHPNIVALKHCFFS---  146 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-------------~~E~~~l~~l~h~nIv~l~~~~~~---  146 (422)
                      .|.+.+++-......|.+...  .|+.+.+|.........             .+++..+..+....+..+.+.++.   
T Consensus        32 ~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek  109 (229)
T PF06176_consen   32 NYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK  109 (229)
T ss_pred             CceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence            588888888888887777764  47889999765432221             134444444433222222221111   


Q ss_pred             CCCCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEE
Q 014595          147 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  225 (422)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vk  225 (422)
                      ....-....+++|||++| .+.+..        .+++    .+...+..++.-||+ .|++|+|.+|.|+++..++  ++
T Consensus       110 k~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~~--i~  174 (229)
T PF06176_consen  110 KIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNNG--IR  174 (229)
T ss_pred             eeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECCc--EE
Confidence            111122334589999997 222211        1222    233567788999999 8999999999999999654  99


Q ss_pred             EeecCCcc
Q 014595          226 LCDFGSAK  233 (422)
Q Consensus       226 l~DfG~a~  233 (422)
                      ++||+..+
T Consensus       175 iID~~~k~  182 (229)
T PF06176_consen  175 IIDTQGKR  182 (229)
T ss_pred             EEECcccc
Confidence            99998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.44  E-value=2.4e-06  Score=90.22  Aligned_cols=203  Identities=19%  Similarity=0.281  Sum_probs=131.0

Q ss_pred             HHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 014595          124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC  202 (422)
Q Consensus       124 ~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~  202 (422)
                      -|.+.+..+.|+|++.++.+-+.....+ ..+.+..++|.. .+...+.    .-...+...++.+..+++.||.|+|+ 
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH-
Confidence            4677788889999999877654433322 222334455553 2222222    23678889999999999999999998 


Q ss_pred             CCceecCCCCC---CeEEcCCCCcEEEe--ecCCccccccCCCcccccccccccchhhhcCCC-CCCCcchHHHHHHHHH
Q 014595          203 IGICHRDIKPQ---NLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMA  276 (422)
Q Consensus       203 ~givHrDlkp~---Nill~~~~~~vkl~--DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~  276 (422)
                      ....|.-|...   +...+.++ .+.++  ||+......+.........+..+.++|...... ......|+|.+|....
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             hccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            54444433333   22333333 45666  888877665555444455566678888764322 1233479999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCc
Q 014595          277 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR  356 (422)
Q Consensus       277 elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  356 (422)
                      .+..|..+-.-.   ........                                   ........+++.+|+.-|+++|
T Consensus       384 ~~~~~~~i~~~~---~~~~~~l~-----------------------------------~~~~~~~~d~~~~~~~~~~~~R  425 (1351)
T KOG1035|consen  384 QLSQGEDISEKS---AVPVSLLD-----------------------------------VLSTSELLDALPKCLDEDSEER  425 (1351)
T ss_pred             hhhhcCcccccc---cchhhhhc-----------------------------------cccchhhhhhhhhhcchhhhhc
Confidence            999886432110   00000000                                   1112268899999999999999


Q ss_pred             CCHHHHhcCCccccc
Q 014595          357 CTALEACVHPFFDEL  371 (422)
Q Consensus       357 ~t~~e~l~hp~f~~~  371 (422)
                      +++.+++.|||..-.
T Consensus       426 l~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  426 LSALELLTHPFLRFP  440 (1351)
T ss_pred             cchhhhhhchhcccc
Confidence            999999999998754

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.31  E-value=2.5e-06  Score=85.11  Aligned_cols=139  Identities=20%  Similarity=0.273  Sum_probs=80.2

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhh-----------------------------------------HHHH
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-----------------------------------------KNRE  125 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-----------------------------------------~~~E  125 (422)
                      .+.||.-+.|+||+|+.+. |+.||||+-..+-+.                                         +.+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3679999999999999875 999999975332100                                         0123


Q ss_pred             HHH----HHHcCCCC---cccccceeecCCCCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 014595          126 LQI----MQMLDHPN---IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  197 (422)
Q Consensus       126 ~~~----l~~l~h~n---Iv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~  197 (422)
                      ++-    .+.+.|-+   -|.+-.+|.+...    .-.|+||||+| -+.++ ....  ...++...+...+.+...- .
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl-~~i~--~~gi~~~~i~~~l~~~~~~-q  316 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDL-DAID--KRGISPHDILNKLVEAYLE-Q  316 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCH-HHHH--HcCCCHHHHHHHHHHHHHH-H
Confidence            332    22334555   1222233321111    14589999996 22221 1111  1344544433322222211 1


Q ss_pred             HHHhcCCceecCCCCCCeEEcC---CCCcEEEeecCCccccc
Q 014595          198 YIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       198 ~LH~~~givHrDlkp~Nill~~---~~~~vkl~DfG~a~~~~  236 (422)
                      -++  .|++|+|-+|.||++++   .+..+.+-|||+...+.
T Consensus       317 If~--~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  317 IFK--TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHh--cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            122  58999999999999994   34579999999987653

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.29  E-value=7.5e-06  Score=74.01  Aligned_cols=74  Identities=18%  Similarity=0.205  Sum_probs=49.6

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHcCCCCc--ccccceeecCCCCCceEEEEEeecc
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....+  .+++...  ..+......+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            4679999999999999854  58999987654  3445689999998864443  3444322  1222233467899998


Q ss_pred             hh
Q 014595          163 PE  164 (422)
Q Consensus       163 ~~  164 (422)
                      ++
T Consensus        78 ~g   79 (239)
T PF01636_consen   78 PG   79 (239)
T ss_dssp             SS
T ss_pred             cc
Confidence            75

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.14  E-value=2.7e-05  Score=70.34  Aligned_cols=135  Identities=16%  Similarity=0.118  Sum_probs=74.5

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHcCCCCc--ccccceeecCCCCCceEEEEEeecch
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYVP  163 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~~~~~~~~~~lv~e~~~  163 (422)
                      ..||.|..+.||+.    .|..+++|.....  .....+|.++++.+..-.+  .+.+++.     .......+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            45899999999984    2456788876542  2345789999999864444  3333332     11112457999988


Q ss_pred             hH--HH---------------HHHHHhhhhcC----CCCHHH-HHHHHHH----------HHH-HHHHHHh---cCCcee
Q 014595          164 ET--VN---------------RIARNYSRIHQ----RMPLIY-VKLYTYQ----------ICR-ALAYIHN---CIGICH  207 (422)
Q Consensus       164 ~~--l~---------------~~~~~~~~~~~----~~~~~~-~~~~~~q----------i~~-aL~~LH~---~~givH  207 (422)
                      |.  +.               .+.....+.+.    ..+... ...+..+          +.. ...+|..   ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            73  10               00111111111    111111 0111000          111 1222221   135789


Q ss_pred             cCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          208 RDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       208 rDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +|+.|.||+++.++  +.|+||+.+.
T Consensus       158 gD~~~~Nii~~~~~--~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG--TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC--cEEEechhcC
Confidence            99999999999754  8999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.13  E-value=1.2e-05  Score=67.87  Aligned_cols=127  Identities=21%  Similarity=0.332  Sum_probs=83.9

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeec
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  161 (422)
                      -.+.+.||+|.+|.||+|.+.  |..+|+|+-..+  ...+..|+++|..+...++-.=+-.+   . .    .++.|||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y---g-~----~~i~me~   93 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY---G-E----DFIRMEY   93 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe---c-h----hhhhhhh
Confidence            345678999999999999985  678999976543  45567899999999877665322212   1 1    2256999


Q ss_pred             chh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCC--CCeEEcCCCCcEEEeecCCccc
Q 014595          162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP--QNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       162 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp--~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +.| .|......       ...    .-...++.+---|-. .||-|+.|.-  .||++.. + .+.|+||..|+.
T Consensus        94 i~G~~L~~~~~~-------~~r----k~l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~~-~-~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIG-------GDR----KHLLRVLEKAYKLDR-LGIEHGELSRPWKNVLVND-R-DVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhc-------ccH----HHHHHHHHHHHHHHH-hccchhhhcCCceeEEecC-C-cEEEEEccchhh
Confidence            987 44322211       111    223355565444555 8999998874  4566664 3 599999999874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.01  E-value=3.6e-05  Score=67.16  Aligned_cols=126  Identities=28%  Similarity=0.369  Sum_probs=86.3

Q ss_pred             eeeEEeeeeeecCC-eeEEEEEEcCCCeEEEEEEecc--------------c-h----------hhHHHHHHHHHHc---
Q 014595           82 VSYIAEHVVGTGSF-GVVFQAKCRETGEIVAIKKVLQ--------------D-K----------RYKNRELQIMQML---  132 (422)
Q Consensus        82 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vAiK~~~~--------------~-~----------~~~~~E~~~l~~l---  132 (422)
                      ..++..+.||.|.- |.||+++..  |+.||+|.+..              . .          ..+..|-+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            35888999999999 999999974  88999998321              0 0          0122466655555   


Q ss_pred             CCCCc--ccccceeecCCC-------------CCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 014595          133 DHPNI--VALKHCFFSTTD-------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  197 (422)
Q Consensus       133 ~h~nI--v~l~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~  197 (422)
                      .+.++  |+.++++.-..+             .......||.||++...            .+....    +.+|++-|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence            45566  788877643321             12223467888876422            112222    458889999


Q ss_pred             HHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       198 ~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+|. .||+-+|+++.|..   +   -||+|||.+
T Consensus       179 ~~~k-~gI~~~Dv~~~ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHK-LGIVPRDVKPRNYR---G---GKLVDFSSS  206 (207)
T ss_pred             HHHH-CCeeeccCcccccc---C---CEEEecccC
Confidence            9999 89999999999987   3   389999964

>PLN02876 acyl-CoA dehydrogenase

Probab=97.92  E-value=0.00014  Score=78.22  Aligned_cols=76  Identities=16%  Similarity=0.199  Sum_probs=48.6

Q ss_pred             eeeeeecCCeeEEEEEEcCCC--eEEEEEEecc-----chhhHHHHHHHHHHcC-CCCc--ccccceeecCCCCCceEEE
Q 014595           87 EHVVGTGSFGVVFQAKCRETG--EIVAIKKVLQ-----DKRYKNRELQIMQMLD-HPNI--VALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~--~~vAiK~~~~-----~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~~~~~~~~~~  156 (422)
                      .+.++.|.++.+|+......+  ..+++|+...     ......+|+++++.+. |.++  .+++.++.+.  ......+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence            456789999999998764332  4677776532     2234678999999995 6665  4444433211  1112356


Q ss_pred             EEeecchh
Q 014595          157 LVLEYVPE  164 (422)
Q Consensus       157 lv~e~~~~  164 (422)
                      +||||++|
T Consensus       121 lVME~v~G  128 (822)
T PLN02876        121 YIMEYLEG  128 (822)
T ss_pred             EEEEecCC
Confidence            89999876

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.73  E-value=0.00029  Score=64.04  Aligned_cols=30  Identities=33%  Similarity=0.407  Sum_probs=24.8

Q ss_pred             CCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .+++|+|+.+.||+++.+. ..-|+||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGR-LSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence            3589999999999998543 45799999875

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.65  E-value=0.00094  Score=58.70  Aligned_cols=123  Identities=21%  Similarity=0.312  Sum_probs=80.0

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccch--------------------hhHHHHHHHHHHcC------CCCccccc
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------RYKNRELQIMQMLD------HPNIVALK  141 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------------------~~~~~E~~~l~~l~------h~nIv~l~  141 (422)
                      ..||+|+.=.||.--   ......||+.....                    ....+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            468999999998643   34557888876544                    34456887777766      77888888


Q ss_pred             ceeecCCCCCceEEEEEeecch-------hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          142 HCFFSTTDKEELYLNLVLEYVP-------ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~-------~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                      +...+..+     ..+|+|.+.       .+|.+++.     .+.+++ ...   ..+-.-.+||-+ .+|+.+|++|.|
T Consensus        84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~---~~L~~f~~~l~~-~~Iv~~dl~~~N  148 (199)
T PF10707_consen   84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELR---QALDEFKRYLLD-HHIVIRDLNPHN  148 (199)
T ss_pred             EEEecCCc-----eEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHH---HHHHHHHHHHHH-cCCeecCCCccc
Confidence            87744333     456666553       24444442     244555 222   233444567777 799999999999


Q ss_pred             eEEcCCC--C-cEEEee
Q 014595          215 LLVNPHT--H-QLKLCD  228 (422)
Q Consensus       215 ill~~~~--~-~vkl~D  228 (422)
                      |++....  . .+.|+|
T Consensus       149 Iv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  149 IVVQRRDSGEFRLVLID  165 (199)
T ss_pred             EEEEecCCCceEEEEEe
Confidence            9996443  2 477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.62  E-value=0.00054  Score=62.61  Aligned_cols=68  Identities=16%  Similarity=0.094  Sum_probs=40.9

Q ss_pred             eeecCC-eeEEEEEEcCCCeEEEEEEeccc-hhhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEEEEeecchh
Q 014595           90 VGTGSF-GVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVPE  164 (422)
Q Consensus        90 lg~G~~-g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~  164 (422)
                      |-.|.. +.||++...  +..+.+|..... .....+|+++++.+. +--+.+++.+..   ..  ...++||++++|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~---~~--~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGS---DD--GRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEe---cC--CccEEEEEeeCC
Confidence            334444 789998753  467888876432 123568999999884 322334444331   11  224579999876

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.59  E-value=0.00035  Score=64.41  Aligned_cols=132  Identities=22%  Similarity=0.264  Sum_probs=72.8

Q ss_pred             eeecCCeeEEEEEEcCCCeEEEEEEeccchh----hHHHHHHHHHHcCCCCcc-cccceeecCCCCCceEEEEEeecchh
Q 014595           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYVPE  164 (422)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~lv~e~~~~  164 (422)
                      +..|-.+.+|+..  .+++.+++|.......    ...+|.++++.+....++ +++...     .    -++||||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            4567777888886  3467788887543321    346799999999654443 222211     1    1378999875


Q ss_pred             HH------------HHHHHHhhhhcC------CCCH-HHHHHHHHHH---------HHHHHHHHh-------cCCceecC
Q 014595          165 TV------------NRIARNYSRIHQ------RMPL-IYVKLYTYQI---------CRALAYIHN-------CIGICHRD  209 (422)
Q Consensus       165 ~l------------~~~~~~~~~~~~------~~~~-~~~~~~~~qi---------~~aL~~LH~-------~~givHrD  209 (422)
                      ..            ..+.....+.+.      .+.. ..+..+..++         ...+..+-.       ...++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            21            112221111111      1111 1112222111         111222211       02589999


Q ss_pred             CCCCCeEEcCCCCcEEEeecCCccc
Q 014595          210 IKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       210 lkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +.|.||+++.++  +.|+||..|..
T Consensus       153 l~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC--CEEEeccccCc
Confidence            999999999765  78999998854

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.56  E-value=0.00012  Score=79.84  Aligned_cols=215  Identities=14%  Similarity=-0.029  Sum_probs=135.6

Q ss_pred             HHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 014595          125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI  203 (422)
Q Consensus       125 E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~  203 (422)
                      |...++...|++++....-...   ....-.+..++|+. |.+..++-+.......+....+-....+.+.+..-+|+..
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            5555666789988765443321   22222446788876 4555555554444444544444444444477777777522


Q ss_pred             C----ceecCCCCCCeEEcCCCCcEEEeecCCccccccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHH
Q 014595          204 G----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  278 (422)
Q Consensus       204 g----ivHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  278 (422)
                      +    .+|+++|+-|.+|..+- .+|+.++|+.+...+. .......+++.|++|++.. .-.++.++|+|..|+.+|+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHH
Confidence            2    68999999999999876 6999999999843222 2223456788899999874 44578889999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC
Q 014595          279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  358 (422)
Q Consensus       279 ltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t  358 (422)
                      ..|..+|.     ..++.+.+.+           -.+-..++++.            ..|.++-.....+|-+.-..||.
T Consensus      1434 s~~n~~fi-----~flq~~Lkgi-----------idn~tf~sIe~------------l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKGI-----------IDNHTFFSIEK------------LKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred             hcccHHHH-----HHHHHHHcCc-----------ccccccccccc------------cCCCcccHHHHHHHHHHhhhcch
Confidence            98887773     2333333321           11112222222            12344445555556666678899


Q ss_pred             HHHHhcCCcccccC
Q 014595          359 ALEACVHPFFDELR  372 (422)
Q Consensus       359 ~~e~l~hp~f~~~~  372 (422)
                      -...+.-+.|....
T Consensus      1486 q~isls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1486 QYISLSRDHFAVGL 1499 (2724)
T ss_pred             hhhhcccccccccc
Confidence            98999888886543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.51  E-value=0.0014  Score=59.48  Aligned_cols=69  Identities=19%  Similarity=0.327  Sum_probs=43.4

Q ss_pred             eeeeeecCCeeEEEEEEcC-CCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcc-cccceeecCCCCCceEEEEEeec
Q 014595           87 EHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEY  161 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~-~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~lv~e~  161 (422)
                      .+.|..|-...+|++.... .++.|++|+.....   ....+|+.+++.+...+++ +++..+   .+      .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~---~~------~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF---QN------GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe---CC------cEEEEe
Confidence            3557788888999987543 35678899765422   1234799999998654443 332221   11      269999


Q ss_pred             chh
Q 014595          162 VPE  164 (422)
Q Consensus       162 ~~~  164 (422)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.49  E-value=0.00043  Score=65.31  Aligned_cols=137  Identities=18%  Similarity=0.197  Sum_probs=91.7

Q ss_pred             EEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------h------------------------hhHHHHHHHHHHcCC
Q 014595           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------K------------------------RYKNRELQIMQMLDH  134 (422)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~------------------------~~~~~E~~~l~~l~h  134 (422)
                      .+..+|..|--+.||.|.. .+|..+|||+++.+      +                        ....+|++-|++|+.
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            3556788888999999986 46888999976421      1                        111358888898877


Q ss_pred             CCcccccceeecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       135 ~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                      ..|..---+.+.       .-.|||+|++..-.-   ......-.++...+..+-.|++.-+.-|-+.+++||.||.-=|
T Consensus       226 aGIP~PePIlLk-------~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  226 AGIPCPEPILLK-------NHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             cCCCCCCceeee-------cceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            665432222210       134899999742110   0011123466666777777888888877554799999999999


Q ss_pred             eEEcCCCCcEEEeecCCccc
Q 014595          215 LLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~~  234 (422)
                      +|+.. | .+.|+|-+-+..
T Consensus       296 ~Lyhd-G-~lyiIDVSQSVE  313 (520)
T KOG2270|consen  296 LLYHD-G-KLYIIDVSQSVE  313 (520)
T ss_pred             heEEC-C-EEEEEEcccccc
Confidence            99994 4 599999987643

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.46  E-value=0.0025  Score=62.19  Aligned_cols=71  Identities=20%  Similarity=0.279  Sum_probs=46.5

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----------chhhHHHHHHHHHHcC---CCCcccccceeecCCCCCc
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~-----------~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+.||.|.+..||++.....++.|.||.-..           .......|.+.|+.+.   ..++.+++.+-     .+.
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~~  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EEL  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CCC
Confidence            3569999999999999864446899997421           1223456888888763   23455665532     211


Q ss_pred             eEEEEEeecchh
Q 014595          153 LYLNLVLEYVPE  164 (422)
Q Consensus       153 ~~~~lv~e~~~~  164 (422)
                        .++||||+++
T Consensus       106 --~~lVME~L~~  115 (401)
T PRK09550        106 --AVTVMEDLSD  115 (401)
T ss_pred             --CEEEEecCCC
Confidence              3489999864

>PRK10593 hypothetical protein; Provisional

Probab=97.36  E-value=0.0041  Score=58.65  Aligned_cols=75  Identities=9%  Similarity=0.018  Sum_probs=48.7

Q ss_pred             EeeeeeecCCeeEEEEEEcCCCeEEEEEEecc--chhhHHHHHHHHHHcCCC---CcccccceeecCCCCCceEEEEEee
Q 014595           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHP---NIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      -.+.||.|..+.||..... .+ .+.+|..+.  .......|.+.|+.|...   .+.++++++....  ....-++|||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEEEe
Confidence            3467999999999998653 23 467776543  234677999999998542   4555555442211  1222568999


Q ss_pred             cchh
Q 014595          161 YVPE  164 (422)
Q Consensus       161 ~~~~  164 (422)
                      ++++
T Consensus        94 ~i~G   97 (297)
T PRK10593         94 RLRG   97 (297)
T ss_pred             ccCC
Confidence            9875

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.34  E-value=0.0012  Score=62.16  Aligned_cols=141  Identities=13%  Similarity=0.096  Sum_probs=76.3

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEecc-chhhHHHHHHHHHHcCCCC--cccccceeecCCC----CCceEEEEEe
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQMLDHPN--IVALKHCFFSTTD----KEELYLNLVL  159 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~----~~~~~~~lv~  159 (422)
                      .+.|..|....+|+....  +..+++|+... .......|+++++.|.+.+  +.+++...   .+    ......++++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~---~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADR---DGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCC---CCcEeeeeCCceEEEE
Confidence            456777877899998653  45688898763 2344557899998885443  33332211   10    0112246799


Q ss_pred             ecchhHH---------HHHHHHhhhhc---CCC--------CHHHHHH------------HHHHHHHHHHHHHh------
Q 014595          160 EYVPETV---------NRIARNYSRIH---QRM--------PLIYVKL------------YTYQICRALAYIHN------  201 (422)
Q Consensus       160 e~~~~~l---------~~~~~~~~~~~---~~~--------~~~~~~~------------~~~qi~~aL~~LH~------  201 (422)
                      ++++|..         ..+.+...+.+   ..+        .......            ....+..++.++.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9886411         11111111100   000        0000000            01112233444432      


Q ss_pred             cCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       202 ~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      ..+++|+|+.|.|||++.++ .+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            14799999999999999754 46899999774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.28  E-value=0.0036  Score=59.35  Aligned_cols=144  Identities=13%  Similarity=0.099  Sum_probs=75.7

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHcCCCC--cccccceeecC-CCCCceEEEEEeec
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN--IVALKHCFFST-TDKEELYLNLVLEY  161 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~-~~~~~~~~~lv~e~  161 (422)
                      .+.++.|....+|++.. .+| .+++|+....  ......|++++..|....  +.+++...... ........+++++|
T Consensus        27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            45577777789998864 334 5778876542  334457888888885333  23332211000 00012235689999


Q ss_pred             chhHH---------HHHHHHhhhhc---CCC--------CHHH-----HH----------HHHHHHHHHHHHHHh-----
Q 014595          162 VPETV---------NRIARNYSRIH---QRM--------PLIY-----VK----------LYTYQICRALAYIHN-----  201 (422)
Q Consensus       162 ~~~~l---------~~~~~~~~~~~---~~~--------~~~~-----~~----------~~~~qi~~aL~~LH~-----  201 (422)
                      ++|..         ..+.+.....+   ..+        ....     ..          .....+...++++..     
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            76411         11111000000   000        0000     00          001122334555532     


Q ss_pred             -cCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          202 -CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       202 -~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                       ..+++|+|+++.||+++.++ .+.|+||+.+.
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence             25899999999999999765 46899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.25  E-value=0.0057  Score=58.31  Aligned_cols=30  Identities=27%  Similarity=0.286  Sum_probs=25.3

Q ss_pred             CCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .|+||+|++|.||+++.+. ..-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            4899999999999999543 45899999874

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.25  E-value=0.00045  Score=64.13  Aligned_cols=130  Identities=15%  Similarity=0.148  Sum_probs=82.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc----------ch----------------hhHHHHHHHHHHcC-CC
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----------DK----------------RYKNRELQIMQMLD-HP  135 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~----------~~----------------~~~~~E~~~l~~l~-h~  135 (422)
                      -|.++..||-|--+-||.+-+. .|++.++|.-.-          .+                -...+|+..|+.|. |-
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            3678889999999999999884 588999994311          11                11136888888884 32


Q ss_pred             C-cccccceeecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          136 N-IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       136 n-Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                      . +.+.+++.        . -++|||++.+--....+      .-..   ...+...+..-+--|-. .|+||+|+.-=|
T Consensus       172 fpVPkpiD~~--------R-H~Vvmelv~g~Pl~~v~------~v~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFN  232 (465)
T KOG2268|consen  172 FPVPKPIDHN--------R-HCVVMELVDGYPLRQVR------HVED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFN  232 (465)
T ss_pred             CCCCCccccc--------c-eeeHHHhhcccceeeee------ecCC---hHHHHHHHHHHHHHHHH-cCceecccchhe
Confidence            2 22332221        1 45799988752111111      1111   12223344444555666 799999999999


Q ss_pred             eEEcCCCCcEEEeecCCcc
Q 014595          215 LLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~  233 (422)
                      |+++.++ .++++||--..
T Consensus       233 imv~dd~-~i~vIDFPQmv  250 (465)
T KOG2268|consen  233 IMVKDDD-KIVVIDFPQMV  250 (465)
T ss_pred             eEEecCC-CEEEeechHhh
Confidence            9999776 59999997543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.23  E-value=0.00064  Score=66.72  Aligned_cols=171  Identities=19%  Similarity=0.244  Sum_probs=107.4

Q ss_pred             HHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 014595          123 NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC  202 (422)
Q Consensus       123 ~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~  202 (422)
                      .-...+++.+.|+|...++++-.  ...+.  ..+|||+++.++.+.+....     +..       .+++       . 
T Consensus        30 lgr~~~lktl~~~~l~~yl~~~r--~~~~r--~IVV~e~~~~Sled~~~~~~-----l~~-------~s~~-------~-   85 (725)
T KOG1093|consen   30 LGRFQYLKSLQHDNLCQYLDFSR--GKHER--VIVVMEHYTMSLEDILKTGN-----LKD-------ESLL-------A-   85 (725)
T ss_pred             hhhhHHHHhhcCccceeeEeeec--Cccce--EEEEehhhccchHHHHHhcc-----cch-------hhhc-------c-
Confidence            35677888999999998877542  21222  56899999988888766422     100       0111       1 


Q ss_pred             CCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCC
Q 014595          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ  282 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~  282 (422)
                      .|+.|-     |        .++.+| -++.    .           |  |-      ...+|+||||+|.++.++..|.
T Consensus        86 ~~~~~~-----~--------~~~~td-~~~t----~-----------~--~~------~~~pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   86 HGVLHL-----N--------IIYITD-HFLT----K-----------Y--PS------PIGPKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             ccccee-----h--------hhhccc-cccc----c-----------C--CC------CCCcchhhhhHHHHHHHHHHhh
Confidence            233332     1        244444 1110    0           0  11      1124999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHH
Q 014595          283 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  362 (422)
Q Consensus       283 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~  362 (422)
                      ..+......+.+..+.+....+..-....+.                 ..+.-.++....+++.+|+-..|..||...++
T Consensus       129 ~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e-----------------~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  129 SLEAELTESEYLEILLKYYTDDQELLSTAME-----------------HLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHHHHHHHHHHHHHHhccCchhHHHHHHH-----------------HHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            8887776666666655543333221111100                 01112457778899999999999999999999


Q ss_pred             hcCCccccc
Q 014595          363 CVHPFFDEL  371 (422)
Q Consensus       363 l~hp~f~~~  371 (422)
                      .+|+-|.++
T Consensus       192 ~k~~i~~ev  200 (725)
T KOG1093|consen  192 SKRCSFTEV  200 (725)
T ss_pred             hcCccHHHH
Confidence            999999876

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.01  E-value=0.002  Score=56.34  Aligned_cols=101  Identities=24%  Similarity=0.201  Sum_probs=73.2

Q ss_pred             HHHHHHHHHcCC-CCcccccceeecCCCCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 014595          123 NRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH  200 (422)
Q Consensus       123 ~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH  200 (422)
                      ..|.-+++.+.+ ++++++++.+     .    -.++.||.+. .+..... ....-...++.....++.+++..+.+++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHh
Confidence            358889999976 6899999887     1    2368999874 2221100 0001134678889999999999999998


Q ss_pred             hc--CCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          201 NC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       201 ~~--~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ..  ..+.-.|++++|+-++.++ .+|++|...+..
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~  111 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFV  111 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCC-cEEEEechhcch
Confidence            62  1366789999999999877 699999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.00  E-value=0.011  Score=55.77  Aligned_cols=31  Identities=35%  Similarity=0.590  Sum_probs=26.0

Q ss_pred             CCceecCCCCCCeEEcCC---CCcEEEeecCCcc
Q 014595          203 IGICHRDIKPQNLLVNPH---THQLKLCDFGSAK  233 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~---~~~vkl~DfG~a~  233 (422)
                      ..++|+|+.+.|||++.+   ...+.|+||..|.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            468999999999999974   2369999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.91  E-value=0.012  Score=56.32  Aligned_cols=68  Identities=21%  Similarity=0.257  Sum_probs=41.9

Q ss_pred             eeeecCCeeEEEEEEcCCCeEEEEEEecc-----------chhhHHHHHHHHHHcC--CC-CcccccceeecCCCCCceE
Q 014595           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD--HP-NIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vAiK~~~~-----------~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~~~~  154 (422)
                      .||.|....||++.+...++.|+||.-..           ......-|.+.|+...  -| .+.+++.+      .... 
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~------D~e~-   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF------DTEM-   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE------cccc-
Confidence            57999999999999864446899996321           1122235788887763  23 34444432      1122 


Q ss_pred             EEEEeecch
Q 014595          155 LNLVLEYVP  163 (422)
Q Consensus       155 ~~lv~e~~~  163 (422)
                      ..+|||+++
T Consensus        75 ~~~vMEdL~   83 (370)
T TIGR01767        75 AVTVMEDLS   83 (370)
T ss_pred             ceehHhhCc
Confidence            337999885

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.84  E-value=0.011  Score=55.09  Aligned_cols=31  Identities=29%  Similarity=0.528  Sum_probs=25.6

Q ss_pred             CceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       204 givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .++|+|++|.|||++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999996453457999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.80  E-value=0.027  Score=53.40  Aligned_cols=29  Identities=28%  Similarity=0.592  Sum_probs=25.0

Q ss_pred             CCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .+++|+|+++.||+++. + .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            57999999999999996 4 58999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02236 choline kinase

Probab=96.78  E-value=0.016  Score=55.92  Aligned_cols=31  Identities=26%  Similarity=0.655  Sum_probs=26.3

Q ss_pred             CceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       204 givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .++|+|+++.|||++.+...+.|+||..|..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5899999999999986444699999998753

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.68  E-value=0.016  Score=56.30  Aligned_cols=70  Identities=16%  Similarity=0.190  Sum_probs=44.3

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEecc----------chhhHHHHHHHHHHcC--CC-CcccccceeecCCCCCce
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----------DKRYKNRELQIMQMLD--HP-NIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~----------~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~~~  153 (422)
                      .+.||.|.-..||++.+...++.|+||.-..          +.....-|.++|+.+.  -| .+.+++.+      ....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~------D~e~  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF------DSVM  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE------CcHH
Confidence            5678999999999999854456799996321          1122345888888763  24 34445432      1122


Q ss_pred             EEEEEeecch
Q 014595          154 YLNLVLEYVP  163 (422)
Q Consensus       154 ~~~lv~e~~~  163 (422)
                       ..+|||+++
T Consensus       108 -~~~vMEdL~  116 (409)
T PRK12396        108 -NCCVMEDLS  116 (409)
T ss_pred             -hhHHHHhCc
Confidence             337899885

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.66  E-value=0.021  Score=54.79  Aligned_cols=30  Identities=27%  Similarity=0.445  Sum_probs=25.6

Q ss_pred             ceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       205 ivHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .+|.|+.+.|||++.+++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            699999999999975544699999998854

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.54  E-value=0.032  Score=52.69  Aligned_cols=30  Identities=27%  Similarity=0.524  Sum_probs=26.9

Q ss_pred             CceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       204 givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .++|+|+++.|++++.++ .+-|.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            489999999999999887 499999999875

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.52  E-value=0.037  Score=52.48  Aligned_cols=31  Identities=13%  Similarity=0.185  Sum_probs=26.8

Q ss_pred             CCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .+++|+|+.+.|||++.++ .+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETR-GGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence            4799999999999998776 689999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.38  E-value=0.047  Score=53.30  Aligned_cols=69  Identities=16%  Similarity=0.191  Sum_probs=43.7

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----------chhhHHHHHHHHHHcC---CCCcccccceeecCCCCCc
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~-----------~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+.||.|....||+..+.  +..|+||.-..           +......|.+.|+.+.   ..++.+++.+.     .+.
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~  109 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM  109 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence            567899999999999873  45688996431           2222335777777664   23566666544     211


Q ss_pred             eEEEEEeecchh
Q 014595          153 LYLNLVLEYVPE  164 (422)
Q Consensus       153 ~~~~lv~e~~~~  164 (422)
                        -+++||++++
T Consensus       110 --~vlvME~L~~  119 (418)
T PLN02756        110 --ALIGMRYLEP  119 (418)
T ss_pred             --CEEEEeecCC
Confidence              3478998854

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.00  E-value=0.023  Score=53.86  Aligned_cols=76  Identities=18%  Similarity=0.260  Sum_probs=57.9

Q ss_pred             CCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeec
Q 014595          150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      .+..|.|++|++-++.+...        ......++..++.+.+.-+.-+......-|||+...||||+ +| +|-|+||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            56778899999987654211        22344567778888888777777645788999999999999 67 6999999


Q ss_pred             CCcccc
Q 014595          230 GSAKVL  235 (422)
Q Consensus       230 G~a~~~  235 (422)
                      -+++..
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            999843

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.07  E-value=0.45  Score=45.49  Aligned_cols=28  Identities=25%  Similarity=0.367  Sum_probs=23.7

Q ss_pred             CCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .++||+|+.+.|||++ +  .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D--GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C--CcEEEeCCCCC
Confidence            4789999999999995 3  37899999774

>PTZ00384 choline kinase; Provisional

Probab=94.84  E-value=0.43  Score=46.61  Aligned_cols=29  Identities=28%  Similarity=0.389  Sum_probs=24.2

Q ss_pred             CCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      ...+|.|+-+.||+.+.+  .+.++||-.|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence            357999999999998754  49999998875

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=94.72  E-value=0.076  Score=52.37  Aligned_cols=30  Identities=17%  Similarity=0.313  Sum_probs=24.5

Q ss_pred             ceecCCCCCCeEEcCCCC----cEEEeecCCccc
Q 014595          205 ICHRDIKPQNLLVNPHTH----QLKLCDFGSAKV  234 (422)
Q Consensus       205 ivHrDlkp~Nill~~~~~----~vkl~DfG~a~~  234 (422)
                      ++|+||...|||.+.++.    ...|+||-.+..
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~  303 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR  303 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence            799999999999998653    467889887654

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.63  E-value=0.094  Score=50.66  Aligned_cols=60  Identities=25%  Similarity=0.267  Sum_probs=38.3

Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  221 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~  221 (422)
                      ++-+|..| ++...+.     ....++...+.++.-.+.||--+--..+.+|.|++|.||++..+.
T Consensus       322 l~E~~~~Gl~v~~~v~-----~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  322 LVETYERGLSVLRFVK-----WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             eeeeccccccHHhhhh-----cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            45556554 3333332     244566667777776777765544335899999999999996443

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.00  E-value=0.07  Score=50.02  Aligned_cols=38  Identities=32%  Similarity=0.480  Sum_probs=27.1

Q ss_pred             HHHHHHHHHHHHHHHHHHh---cCCceecCCCCCCeEEcCC
Q 014595          183 IYVKLYTYQICRALAYIHN---CIGICHRDIKPQNLLVNPH  220 (422)
Q Consensus       183 ~~~~~~~~qi~~aL~~LH~---~~givHrDlkp~Nill~~~  220 (422)
                      ..++.++.||+.-.-.+-+   +.+.+|-||||+|||+-+.
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            4577788888765433322   3579999999999998544

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=93.53  E-value=1.3  Score=41.41  Aligned_cols=72  Identities=13%  Similarity=0.116  Sum_probs=42.5

Q ss_pred             EEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-hhhHHHHHHHHHHcCC---CCcccccceeecCCCCCceEEEEEee
Q 014595           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH---PNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +-.+.|+.|....+|+..  .+++.+.||+-... ...+..|++-|+.|..   -.+.+++.+.....   .  -+++||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~---~--~fLlle   92 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD---D--AFLLLE   92 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS---C--CEEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC---C--ceEEEE
Confidence            345678999999999987  56788999976532 3456789999999842   23445555442211   1  268999


Q ss_pred             cch
Q 014595          161 YVP  163 (422)
Q Consensus       161 ~~~  163 (422)
                      |++
T Consensus        93 ~l~   95 (288)
T PF03881_consen   93 FLE   95 (288)
T ss_dssp             ---
T ss_pred             eec
Confidence            976

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.43  E-value=0.066  Score=46.42  Aligned_cols=29  Identities=28%  Similarity=0.340  Sum_probs=24.7

Q ss_pred             CceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       204 givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      -.+|+|+.|.||+++.++  ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            369999999999998654  89999998854

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.32  E-value=0.08  Score=49.90  Aligned_cols=78  Identities=21%  Similarity=0.367  Sum_probs=43.6

Q ss_pred             EEeecchhHHHHHHHH-hhhhcCCCCHHHHHHHHHHHHHHHHH---HHhcCCceecCCCCCCeEEcCCCC----------
Q 014595          157 LVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAY---IHNCIGICHRDIKPQNLLVNPHTH----------  222 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~~---LH~~~givHrDlkp~Nill~~~~~----------  222 (422)
                      +|++..-.+...+-.. ....+-..-...++.++.||+.-.--   |-.|.+.+|-||||+|||+-+...          
T Consensus       248 IIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~  327 (434)
T PF05445_consen  248 IIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRN  327 (434)
T ss_pred             EEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeE
Confidence            6777765433222111 11111112234567777787654311   222357999999999999854321          


Q ss_pred             -------cEEEeecCCccc
Q 014595          223 -------QLKLCDFGSAKV  234 (422)
Q Consensus       223 -------~vkl~DfG~a~~  234 (422)
                             .++|.||.+++.
T Consensus       328 ~vF~Epi~~~LnDFDfSqv  346 (434)
T PF05445_consen  328 YVFKEPIRCCLNDFDFSQV  346 (434)
T ss_pred             EEecccceeeecccCHHHh
Confidence                   356777777754

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.40  E-value=0.19  Score=47.88  Aligned_cols=29  Identities=34%  Similarity=0.562  Sum_probs=25.1

Q ss_pred             ceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       205 ivHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +||+|+.|.||+++.+...+.++||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            99999999999999775238899999774

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	422
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-131
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-131
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-131
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-131
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-131
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-131
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-131
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-130
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-130
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-130
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-130
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-130
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-130
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-129
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-129
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-129
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-129
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-129
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-128
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-128
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-127
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-124
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-86
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-79
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-43
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-42
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-42
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-42
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-42
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-42
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-42
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-42
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-42
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-42
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-42
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-42
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-42
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-42
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-42
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-42
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-42
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-42
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-42
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-42
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-42
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-42
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-42
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-42
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-42
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-42
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-42
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-42
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-42
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-42
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-41
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-41
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-41
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-41
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-41
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-41
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-41
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-41
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-41
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-41
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-41
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-41
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-41
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-41
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-41
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-40
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-40
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-40
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-40
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-40
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-40
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-40
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-40
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-40
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-40
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-40
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-40
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-40
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-40
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-40
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-40
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-40
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-40
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-40
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-40
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-39
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-39
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-39
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-39
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-39
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-39
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-39
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-38
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-38
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-38
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-38
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-38
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-38
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-38
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-38
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-37
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-37
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-37
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-37
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-37
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-37
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-37
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-37
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-37
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-37
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-37
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-37
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-37
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-37
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-37
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-37
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-37
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-37
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-37
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-37
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-37
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-37
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-37
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-37
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-37
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-37
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-37
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-37
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-37
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-37
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-37
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-37
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-37
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-37
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-37
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-37
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-37
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-37
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-37
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-37
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-37
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-37
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-37
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-37
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-37
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-37
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-37
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-37
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-37
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-37
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-37
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-37
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-36
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-36
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-36
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-36
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-36
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-36
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-36
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-36
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-36
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-35
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-34
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-32
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-32
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-31
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-31
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-31
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-30
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-30
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-30
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-30
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-30
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-30
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-30
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-30
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-30
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-29
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-29
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-29
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-29
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-29
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-29
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-29
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-29
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-29
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-29
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-29
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-29
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-29
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-29
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-29
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-29
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-29
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-29
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-29
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-29
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-29
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-29
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		5e-29
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-29
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-29
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-29
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-29
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-29
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-29
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-29
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-28
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-28
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-28
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-28
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-28
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-28
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-28
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-28
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-28
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-28
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-28
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-28
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-28
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-28
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-28
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-28
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-28
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		9e-28
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-28
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-27
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-27
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-27
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-26
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-26
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-26
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-26
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-26
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-26
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-26
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-26
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-26
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-26
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-24
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-24
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		6e-24
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-23
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-23
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		9e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-22
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-22
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-21
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		7e-20
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		7e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-19
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-19
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-19
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-19
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-19
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-18
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-18
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-18
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-18
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-17
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-17
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-17
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-17
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-17
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-16
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-16
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-16
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-16
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-15
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-15
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-15
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-15
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-15
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-15
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-15
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-15
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-15
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-15
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-15
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-14
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-14
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-14
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-14
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-14
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-14
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-14
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-13
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-13
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-12
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
3soa_A	444	Full-Length Human Camkii Length = 444		8e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		9e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-08
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-08
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-08
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		9e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-05
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-05
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-05
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-05
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-04
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-04
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-04
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-04

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  466 bits (1199), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 25  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 82
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 83  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 142
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 143 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 321
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 322 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 379

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  465 bits (1197), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 385

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  465 bits (1197), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 76  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 133
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 134 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 193
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 194 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 372
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 373 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 430

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  465 bits (1197), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 35  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 92
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 93  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 152
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 153 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 331
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 332 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 389

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  465 bits (1196), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 33  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 90
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 91  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 150
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 151 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 329
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 330 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 387

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  465 bits (1196), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 307 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 364

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  464 bits (1195), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 233/359 (64%), Positives = 275/359 (76%), Gaps = 7/359 (1%)
Query: 60  GAETGHVIRTTIG--GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ 117
           GA +   + T +   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ
Sbjct: 1   GAMSLSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 60
Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRI 176
           DKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR 
Sbjct: 61  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 120
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236
            Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV
Sbjct: 121 KQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 179
Query: 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
           +GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVE
Sbjct: 180 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 239
Query: 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
           IIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R
Sbjct: 240 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 299
Query: 357 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
            T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 300 LTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 356

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  462 bits (1189), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 363

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  462 bits (1189), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 385

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  461 bits (1187), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 363

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  461 bits (1187), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 313 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 370

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  461 bits (1186), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 302 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 359

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  461 bits (1185), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 229/342 (66%), Positives = 268/342 (78%), Gaps = 5/342 (1%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 412
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  459 bits (1181), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 231/357 (64%), Positives = 274/357 (76%), Gaps = 7/357 (1%)
Query: 58  GVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ 117
            +G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ
Sbjct: 2   AMGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 59
Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRI 176
           DKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR 
Sbjct: 60  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 119
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236
            Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV
Sbjct: 120 KQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 178
Query: 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
           +GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVE
Sbjct: 179 RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 238
Query: 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
           IIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R
Sbjct: 239 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 298
Query: 357 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 412
            T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 299 LTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 353

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  459 bits (1180), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 229/344 (66%), Positives = 268/344 (77%), Gaps = 5/344 (1%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 351

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  458 bits (1178), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 228/342 (66%), Positives = 267/342 (78%), Gaps = 5/342 (1%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 12  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 71
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 131
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 132 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 190
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 250
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 251 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 310
Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 412
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 311 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 350

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  457 bits (1177), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 228/342 (66%), Positives = 267/342 (78%), Gaps = 5/342 (1%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 412
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  457 bits (1177), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 228/342 (66%), Positives = 267/342 (78%), Gaps = 5/342 (1%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 412
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  455 bits (1171), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 227/342 (66%), Positives = 266/342 (77%), Gaps = 5/342 (1%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 412
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  455 bits (1170), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 227/344 (65%), Positives = 266/344 (77%), Gaps = 5/344 (1%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEF FPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 414
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 351

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  451 bits (1160), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 225/342 (65%), Positives = 264/342 (77%), Gaps = 5/342 (1%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEF FPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 412
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  442 bits (1136), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 216/352 (61%), Positives = 268/352 (76%), Gaps = 4/352 (1%)
Query: 66  VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE 125
           VI+          +++++Y    V+G GSFGVVFQAK  E+ E VAIKKVLQDKR+KNRE
Sbjct: 24  VIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 126 LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIY 184
           LQIM+++ HPN+V LK  F+S  DK               TV R +R+Y+++ Q MP++ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           +KLY YQ+ R+LAYIH+ IGICHRDIKPQNLL++P +  LKL DFGSAK+L+ GEPNVS 
Sbjct: 143 IKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           ICSRYYRAPELIFGAT YTT IDIWSTGCVMAEL+ GQPLFPGESG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           +RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+DL+ R  +Y+P+ R TA+EA  
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 365 HPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 416
           HPFFDELR    R+PNGR LPPLFN+   ELS + P+ I+RL+P+HA  + L
Sbjct: 322 HPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRLVPQHAEAELL 372

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  316 bits (810), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 162/369 (43%), Positives = 229/369 (62%), Gaps = 43/369 (11%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHC 143
           Y     +GTGSFG+V +    E+G+  A+KKVLQD RYKNREL IM++LDH NI+ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 144 FFSTTDK---------------------------------XXXXXXXXXXXXXXTVNRIA 170
           F++T D+                                               T++++ 
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
           +++ R  + +P+  + +Y YQ+ RA+ +IH+ +GICHRDIKPQNLLVN   + LKLCDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
           SAK L+  EP+V+ ICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+PLF GE+ 
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350
           +DQLV II+++GTPT+E++  MNP+YTE +FP +K   W K+  +  P  A+DL+ +  +
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 351 YSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKPPELSGIPPE 401
           Y P+LR    EA  HPFFD LR+        N+  P+G  + +P LFNF P ELS IP  
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGN 367
Query: 402 TINRLIPEH 410
            +NR++P++
Sbjct: 368 VLNRILPKN 376

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  290 bits (742), Expect = 9e-79,   Method: Compositional matrix adjust.
 Identities = 153/327 (46%), Positives = 203/327 (62%), Gaps = 10/327 (3%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ---MLDHP 135
           K+   +  E + G G+FG V   K + TG  VAIKKV+QD R++NRELQIMQ   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 136 NIVALKHCFFS--TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           NIV L+  F++    D+              T++R  RNY R     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           R++  +H   + +CHRDIKP N+LVN     LKLCDFGSAK L   EPNV+YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PELIFG   YTTA+DIWS GC+ AE++LG+P+F G++   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 313 NPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
           NP++T+      K  PW  VF     +   EA DL+    QY P  R    EA  HP+FD
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 370 ELRDPNTRLPNGRPLPP-LFNFKPPEL 395
           EL DP T+LPN + LP  LF F P E+
Sbjct: 320 ELHDPATKLPNNKDLPEDLFRFLPNEI 346

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 110/345 (31%), Positives = 179/345 (51%), Gaps = 28/345 (8%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIV 138
           Y     +G G++G+V  A        VAIKK+   + + Y  R   E+QI+    H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            ++    ++T +               + ++ ++     Q++   ++  + YQI R L Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS-----QQLSNDHICYFLYQILRGLKY 159
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPE 254
           IH+   + HRD+KP NLL+N  T  LK+CDFG A++      +  +    + +R+YRAPE
Sbjct: 160 IHSA-NVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 312
           ++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 313 --NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
               NY +   P      W K+F K    +A+DL+ R   ++PN R T  EA  HP+ ++
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 371 LRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
             DP        P    F F   EL  +P E +  LI  E AR Q
Sbjct: 336 YYDPTDEPVAEEP----FTFA-MELDDLPKERLKELIFQETARFQ 375

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 109/321 (33%), Positives = 166/321 (51%), Gaps = 56/321 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 75  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 116 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 171
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 228
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 229 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 285
Query: 363 CVHPFFDELRDPNTRLPNGRP 383
             HPFF ++  P   L   RP
Sbjct: 286 LAHPFFQDVTKPVPHLRLERP 306

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 78  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 119 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 174
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 231
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 232 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 288
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 289 LAHPFFQDVTKP 300

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/320 (31%), Positives = 170/320 (53%), Gaps = 29/320 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 143
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----------YICSRYYRA 252
            + HRD+KP NLL+N +   LK+CDFG A+++ +   + S           Y+ +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRA 190
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 311
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 369 DELRDPNTRLPNGRPLPPLF 388
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 103/320 (32%), Positives = 171/320 (53%), Gaps = 29/320 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 143
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPN------VSYICSRYYRA 252
            + HRD+KP NLL+N +   LK+CDFG A+++ +      EP       V ++ +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 311
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 369 DELRDPNTRLPNGRPLPPLF 388
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 168
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 75  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 116 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 171
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 228
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 229 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 285
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 286 LAHPFFQDVTKP 297

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 172/345 (49%), Gaps = 26/345 (7%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G G++GVV  A+ R TG+ VAIKK      V+ + +   REL+I++   H NI+A+K 
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 143 CFFSTTDKXXXXXXXXXXXXXXT-VNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYI 199
               T                 + +++I      IH   PL   +V+ + YQ+ R L Y+
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQI------IHSSQPLTLEHVRYFLYQLLRGLKYM 174
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----VSYICSRYYRAPE 254
           H+   + HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPE
Sbjct: 175 HSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           L+    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +  
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292
Query: 315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                     P  +P PW  V+      +A+ L+ R  ++ P+ R +A  A  HPF  + 
Sbjct: 293 ERVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351
Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 416
            DP+       P    F+ +      I    +  +   HAR++ +
Sbjct: 352 HDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGI 396

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 78  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 119 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 174
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 231
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 232 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 288
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 289 LAHPFFQDVTKP 300

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  167 bits (424), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 73  I-HTENKLYLVFEFLSMDLKDFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 235
Query: 321 FPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  167 bits (424), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEFLSMDLKDFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 321 FPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + L++ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLSFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEHVDQDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 321 FPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 172/345 (49%), Gaps = 26/345 (7%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G G++GVV  A+ R TG+ VAIKK      V+ + +   REL+I++   H NI+A+K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 143 CFFSTTDKXXXXXXXXXXXXXXT-VNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYI 199
               T                 + +++I      IH   PL   +V+ + YQ+ R L Y+
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQI------IHSSQPLTLEHVRYFLYQLLRGLKYM 175
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----VSYICSRYYRAPE 254
           H+   + HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPE
Sbjct: 176 HSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           L+    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +  
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 293
Query: 315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                     P  +P PW  V+      +A+ L+ R  ++ P+ R +A  A  HPF  + 
Sbjct: 294 ERVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 352
Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 416
            DP+       P    F+ +      I    +  +   HAR++ +
Sbjct: 353 HDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGI 397

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 105/308 (34%), Positives = 161/308 (52%), Gaps = 56/308 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDE 370
             HPFF +
Sbjct: 282 LAHPFFQD 289

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 72  I-HTENKLYLVFEFLSMDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 234
Query: 321 FPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEFLSMDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 321 FPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 162/312 (51%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+ K+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 162/312 (51%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+ K+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/320 (31%), Positives = 169/320 (52%), Gaps = 29/320 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 143
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----------YICSRYYRA 252
            + HRD+KP NLL+N +   LK+CDFG A+++ +   + S            + +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRA 190
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 311
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 369 DELRDPNTRLPNGRPLPPLF 388
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 105/294 (35%), Positives = 155/294 (52%), Gaps = 31/294 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
           +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              F   ++                +  I ++ S +   +   ++K Y     + L Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLH 129
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 257
               I HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLF 185
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPN 315
           GA  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT E+    C  P+
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 316 YTEFK-FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           Y  FK FP I   P H +F      + +DL+   F ++P  R TA +A    +F
Sbjct: 246 YVTFKSFPGI---PLHHIFSAA-GDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  165 bits (417), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 104/326 (31%), Positives = 158/326 (48%), Gaps = 49/326 (15%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN---RELQIMQMLDHPN 136
           +Y++   VG+G++G V  A  + +GE VAIKK+    Q + +     REL +++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--------- 187
           ++ L   F                    T     RN+   +  MP +   L         
Sbjct: 85  VIGLLDVF--------------------TPASSLRNFYDFYLVMPFMQTDLQKIMGLKFS 124
Query: 188 ------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
                   YQ+ + L YIH+  G+ HRD+KP NL VN    +LK+ DFG A+        
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEM 180
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
             Y+ +R+YRAPE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV 
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240
Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCT 358
           G P  E ++ +N    +  + Q  P    K F +  P   P+A DL+ +  +   + R T
Sbjct: 241 GVPGTEFVQKLNDKAAK-SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
Query: 359 ALEACVHPFFDELRDPNTRLPNGRPL 384
           A +A  HPFF+  RDP       +P 
Sbjct: 300 AAQALTHPFFEPFRDPEEETEAQQPF 325

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 104/326 (31%), Positives = 158/326 (48%), Gaps = 49/326 (15%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN---RELQIMQMLDHPN 136
           +Y++   VG+G++G V  A  + +GE VAIKK+    Q + +     REL +++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--------- 187
           ++ L   F                    T     RN+   +  MP +   L         
Sbjct: 103 VIGLLDVF--------------------TPASSLRNFYDFYLVMPFMQTDLQKIMGMEFS 142
Query: 188 ------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
                   YQ+ + L YIH+  G+ HRD+KP NL VN    +LK+ DFG A+        
Sbjct: 143 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEM 198
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
             Y+ +R+YRAPE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV 
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258
Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCT 358
           G P  E ++ +N    +  + Q  P    K F +  P   P+A DL+ +  +   + R T
Sbjct: 259 GVPGTEFVQKLNDKAAK-SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317
Query: 359 ALEACVHPFFDELRDPNTRLPNGRPL 384
           A +A  HPFF+  RDP       +P 
Sbjct: 318 AAQALTHPFFEPFRDPEEETEAQQPF 343

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 154/303 (50%), Gaps = 19/303 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 144 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F  +T+ +               +N I ++     Q +   +V+   YQ+ R L YIH+ 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKS-----QALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 151 -GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 323 QIKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 380
            + P P   +    +   P A+DL+ R      + R +A EA  H +F +  DP    P 
Sbjct: 267 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PE 325
Query: 381 GRP 383
             P
Sbjct: 326 AEP 328

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 339 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 375

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 152
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 153 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 269 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 326
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 363

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 339 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 375

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 320
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 321 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 317 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 353

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 266 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 324 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 360

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 150
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 151 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 267 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 324
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 325 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 361

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 141
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 142 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 258 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 315
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 316 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 352

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 105/341 (30%), Positives = 173/341 (50%), Gaps = 32/341 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC---MNP 314
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C   +  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
                  P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+  +  DP
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321
Query: 375 NTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           +       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 322 SDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 175/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+  +  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 321 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 153/303 (50%), Gaps = 19/303 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 144 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F  +T+ +               +N I +      Q +   +V+   YQ+ R L YIH+ 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKC-----QALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 151 -GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 323 QIKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 380
            + P P   +    +   P A+DL+ R      + R +A EA  H +F +  DP    P 
Sbjct: 267 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PE 325
Query: 381 GRP 383
             P
Sbjct: 326 AEP 328

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 175/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P +E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 317 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 353

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 106/342 (30%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAI+K+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  161 bits (407), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKC-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 103/297 (34%), Positives = 160/297 (53%), Gaps = 26/297 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG G++GVV++AK  + G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  ++               V  +  N + +        +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS--ERCLTLVFEFMEKDLKKV--LDENKTGLQDSQ----IKIYLYQLLRGVAHCHQH- 138
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 318
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
             F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 103/297 (34%), Positives = 160/297 (53%), Gaps = 26/297 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG G++GVV++AK  + G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  ++               V  +  N + +        +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS--ERCLTLVFEFMEKDLKKV--LDENKTGLQDSQ----IKIYLYQLLRGVAHCHQH- 138
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 318
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
             F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 174/342 (50%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/339 (30%), Positives = 174/339 (51%), Gaps = 28/339 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPELIFGAT 260
           + HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 316
            YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+ 
Sbjct: 268 L-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 377 RLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
                 P    F F   EL  +P E +  LI  E AR Q
Sbjct: 326 EPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/339 (30%), Positives = 174/339 (51%), Gaps = 28/339 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPELIFGAT 260
           + HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 316
            YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+ 
Sbjct: 269 L-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 326
Query: 377 RLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
                 P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 EPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 360

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/333 (30%), Positives = 168/333 (50%), Gaps = 57/333 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLD-HPNIVALKH 142
           +G G++G+V+++  R TGE+VA+KK+        D +   RE+ I+  L  H NIV L +
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +  D+               V R A     +H++    YV    YQ+ + + Y+H+ 
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIR-ANILEPVHKQ----YV---VYQLIKVIKYLHSG 128
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK---------------------GEPN 241
            G+ HRD+KP N+L+N   H +K+ DFG ++  V                       +P 
Sbjct: 129 -GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 242 VS-YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++ Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E+L G+P+FPG S ++QL  II V
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246
Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPH-------------PWHKVFQKRLPP-----EAV 342
           +  P+ E+++ +   + +     +K                W  +  K  P      EA+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306
Query: 343 DLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           DL+ +  Q++PN R +A +A  HPF     +PN
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 152/303 (50%), Gaps = 19/303 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 144 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F  +T+ +               +N I +      Q +   +V+   YQ+ R L YIH+ 
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKC-----QALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N+ VN    +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 143 -GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 198
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 199 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 258
Query: 323 QIKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 380
            + P P   +    +   P A+DL+ R      + R +A EA  H +F +  DP    P 
Sbjct: 259 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PE 317
Query: 381 GRP 383
             P
Sbjct: 318 AEP 320

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/297 (34%), Positives = 159/297 (53%), Gaps = 27/297 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
           +G GS+GVVF+ + R+TG+IVAIKK L+       K+   RE+++++ L HPN+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--N 201
           F                      + +     R  + +P   VK  T+Q  +A+ + H  N
Sbjct: 71  F--------RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 258
           CI   HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G
Sbjct: 123 CI---HRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVG 176
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNY 316
            T+Y   +D+W+ GCV AELL G PL+PG+S VDQL  I K LG   P  +++   N  +
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           +  K P  +     ++    +   A+ L+       P  R T  +   HP+F+ +R+
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 192
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 249
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLW 165
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 307
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 308 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 364 VHPFFDE 370
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 106/342 (30%), Positives = 173/342 (50%), Gaps = 34/342 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRY---KNRELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y     RE++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+ DFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 374 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 414
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 192
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 249
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLW 165
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 307
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 308 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 364 VHPFFDE 370
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 192
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 249
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLW 165
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 307
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 308 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 364 VHPFFDE 370
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 104/318 (32%), Positives = 160/318 (50%), Gaps = 25/318 (7%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  +   ++G  +A+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  +T+ +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 172
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 173 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   ++QL +I+++ GTP    I  M      NY 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377
               PQ+    +  VF     P AVDL+ +      + R TA EA  HP+F +  DP+  
Sbjct: 289 N-SLPQMPKRNFADVFIGA-NPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDE 346
Query: 378 LPNGRPLPPLFNFKPPEL 395
            P   P    F  +  E+
Sbjct: 347 -PESEPYDQSFESRQLEI 363

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++  A  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNAMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKX-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I ++     Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKS-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN  + +LK+ DFG  +     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKX-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 162
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 279 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 154
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 271 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 153
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 154 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 209
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 210 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 269
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 270 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 325

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 103/320 (32%), Positives = 159/320 (49%), Gaps = 29/320 (9%)
Query: 73  GRNGNSKQKVSYIAEHV---------VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKR 120
            R+G  +Q+V+  A  V         VG+G++G V  A    TG  VAIKK+    Q + 
Sbjct: 7   ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66
Query: 121 YKNR---ELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 177
           +  R   EL++++ + H N++ L   F  T D+                  + +     H
Sbjct: 67  FAKRAYRELRLLKHMRHENVIGLLDVF--TPDETLDDFTDFYLVMPFMGTDLGKLMK--H 122
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           +++    ++   YQ+ + L YIH   GI HRD+KP NL VN    +LK+ DFG A+    
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--A 178
Query: 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 297
                  + +R+YRAPE+I     YT  +DIWS GC+MAE++ G+ LF G   +DQL EI
Sbjct: 179 DSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
Query: 298 IKVLGTPTREEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
           +KV GTP  E ++ +      NY +   P+++   +  +      P AV+L+ +      
Sbjct: 239 MKVTGTPPAEFVQRLQSDEAKNYMK-GLPELEKKDFASILTN-ASPLAVNLLEKMLVLDA 296
Query: 354 NLRCTALEACVHPFFDELRD 373
             R TA EA  HP+F+ L D
Sbjct: 297 EQRVTAGEALAHPYFESLHD 316

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 154
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 271 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 166
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 167 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 222
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 283 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 206
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 142
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 198
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 199 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 258
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 259 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 314

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 95/290 (32%), Positives = 154/290 (53%), Gaps = 21/290 (7%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 142
           +VG GS+G+V + + ++TG IVAIKK L+       K+   RE+++++ L H N+V L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL-- 89
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
                  K               ++ +    + +  ++    V+ Y +QI   + + H+ 
Sbjct: 90  --LEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQV----VQKYLFQIINGIGFCHSH 143
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELIFGATE 261
             I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +
Sbjct: 144 -NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTEF 319
           Y  A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG   P  +E+   NP +   
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 320 KFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + P+IK   P  + + K L    +DL  +     P+ R    E   H FF
Sbjct: 262 RLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 162
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 279 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 103/301 (34%), Positives = 154/301 (51%), Gaps = 34/301 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  DK                  + + +   +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHS--DKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 320 KFPQIKPHPWHKVFQK------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           K P  KP+P +           +L     DL+    + +P  R +A EA  HP+F +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 374 P 374
           P
Sbjct: 292 P 292

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 96/308 (31%), Positives = 155/308 (50%), Gaps = 23/308 (7%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +YI    +G G++  V++ K + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L       T+K                     N   +H       VKL+ +Q+ R LA
Sbjct: 63  VTLHDIIH--TEKSLTLVFEYLDKDLKQYLDDCGNIINMHN------VKLFLFQLLRGLA 114
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 312
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           N  +  + +P+ +          RL  +  DL+ +  Q+    R +A +A  HPFF  L 
Sbjct: 231 NEEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 373 DPNTRLPN 380
           +   +LP+
Sbjct: 290 ERIHKLPD 297

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 166
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 167 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNWMH 222
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 283 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 140
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 257 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 141
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 142 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 197
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 198 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 257
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 258 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 313

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 140
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 257 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 103/301 (34%), Positives = 153/301 (50%), Gaps = 34/301 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  DK                  + + +   +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHS--DKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N    +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            Y+T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 320 KFPQIKPHPWHKVFQK------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           K P  KP+P +           +L     DL+    + +P  R +A EA  HP+F +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 374 P 374
           P
Sbjct: 292 P 292

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ D+G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +       ++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----AKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNWMH 219
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DF  A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+  FG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 95/297 (31%), Positives = 148/297 (49%), Gaps = 26/297 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G++  V++   + TG  VA+K+V  D          RE+ +M+ L H NIV L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            +                    +R   N  R    + L  VK + +Q+ + LA+ H    
Sbjct: 73  HTENKLTLVFEFMDNDLKKYMDSRTVGNTPR---GLELNLVKYFQWQLLQGLAFCHEN-K 128
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEYT 263
           I HRD+KPQNLL+N    QLKL DFG A+   +      S + + +YRAP+++ G+  Y+
Sbjct: 129 ILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYS 187
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNPNYT 317
           T+IDIWS GC++AE++ G+PLFPG +  +QL  I  ++GTP         ++   NPN  
Sbjct: 188 TSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN-- 245
Query: 318 EFKFPQIKPHPWHKVFQ----KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                Q  P    +V Q    + L    +D +    Q +P++R +A +A  HP+F E
Sbjct: 246 ---IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 154/297 (51%), Gaps = 24/297 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G G  G+VF A   +  + VAIKK++    Q  ++  RE++I++ LDH NIV +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 146 STTDKXXXXXXXXXXXXXXTVNR--IARNYSRIHQRMPLI--YVKLYTYQICRALAYIHN 201
            +  +               + +  +  + + + ++ PL+  + +L+ YQ+ R L YIH+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS 138
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-------ICSRYYRAPE 254
              + HRD+KP NL +N     LK+ DFG A+++   +P+ S+       + +++YR+P 
Sbjct: 139 A-NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHLSEGLVTKWYRSPR 194
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTREEIKC 311
           L+     YT AID+W+ GC+ AE+L G+ LF G   ++Q+   +E I V+    R+E+  
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS 254
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + P Y   +    +PH         +  EAVD + +   +SP  R TA EA  HP+ 
Sbjct: 255 VIPVY--IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 146/313 (46%), Gaps = 32/313 (10%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN------------RELQI 128
           Y  +  + +GS+G V  A     G  VAIK+V   + D R  N            RE+++
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI---YV 185
           +    HPNI+ L+  F    +                + ++      IH +  +I   ++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV------IHDQRIVISPQHI 136
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           + + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y+
Sbjct: 137 QYFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYV 194
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
             R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP 
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 306 REEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
            E++   +     +Y       +    W  V      P A+DL+ +  +++P  R +  +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQ 313
Query: 362 ACVHPFFDELRDP 374
           A  HP+F+ L DP
Sbjct: 314 ALRHPYFESLFDP 326

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 146/313 (46%), Gaps = 32/313 (10%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN------------RELQI 128
           Y  +  + +GS+G V  A     G  VAIK+V   + D R  N            RE+++
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI---YV 185
           +    HPNI+ L+  F    +                + ++      IH +  +I   ++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV------IHDQRIVISPQHI 136
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           + + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y+
Sbjct: 137 QYFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYV 194
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
             R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP 
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 306 REEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
            E++   +     +Y       +    W  V      P A+DL+ +  +++P  R +  +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQ 313
Query: 362 ACVHPFFDELRDP 374
           A  HP+F+ L DP
Sbjct: 314 ALRHPYFESLFDP 326

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 154/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 154/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS G +M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 110/398 (27%), Positives = 166/398 (41%), Gaps = 79/398 (19%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNI 137
           Y   H++GTGS+G V +A  +    +VAIKK+L+      D +   RE+ I+  L+H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V +         +                 ++ R    + +    +++K   Y +   + 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVGVK 170
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------------- 243
           Y+H+  GI HRD+KP N LVN     +K+CDFG A+ +   E   S              
Sbjct: 171 YVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 244 --------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--------- 280
                         ++ +R+YRAPELI     YT AID+WS GC+ AELL          
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 281 --GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
               PLFPG S                      DQL  I  +LGTP+ E+I+ +     +
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELR--- 372
            ++ +I P        +R P  + D   L+ R   ++PN R T  E   HPFF E+R   
Sbjct: 349 -RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407
Query: 373 -DPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPE 409
            + N       P     N   P+L     + I R  PE
Sbjct: 408 VETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS G +M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 137
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 138 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 369 DELRDP 374
           +   DP
Sbjct: 315 NVWYDP 320

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 142/291 (48%), Gaps = 23/291 (7%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALKHCFFST 147
           +G G +  VF+A      E V +K +   K+ K  RE++I++ L   PNI+ L       
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL------- 97
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
            D                VN    ++ +++Q +    ++ Y Y+I +AL Y H  +GI H
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNT--DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMH 154
Query: 208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAID 267
           RD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 268 IWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKF 321
           +WS GC++A ++   +P F G    DQLV I KVLGT    +        ++P + +   
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-L 273
Query: 322 PQIKPHPW----HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            +     W    H   Q  + PEA+D + +  +Y    R TA EA  HP+F
Sbjct: 274 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 369 DELRDP 374
           +   DP
Sbjct: 323 NVWYDP 328

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 144 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 200
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 260
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 261 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320
Query: 369 DELRDP 374
           +   DP
Sbjct: 321 NVWYDP 326

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 151/305 (49%), Gaps = 21/305 (6%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 130
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 131 MLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 186
            L+   HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
              +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 367 FFDEL 371
           +F +L
Sbjct: 299 YFQDL 303

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 369 DELRDP 374
           +   DP
Sbjct: 323 NVWYDP 328

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 148 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 206
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 207 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 266
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 267 ------DGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 320
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 321 RYDHQERLTALEAMTHPYFQQVR 343

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 138
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 369 DELRDP 374
           +   DP
Sbjct: 316 NVWYDP 321

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 138
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 369 DELRDP 374
           +   DP
Sbjct: 316 NVWYDP 321

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 149/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 182
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 183 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 369 DELRDP 374
           +   DP
Sbjct: 360 NVWYDP 365

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 137
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 138 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 369 DELRDP 374
           +   DP
Sbjct: 315 NVWYDP 320

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 182
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 183 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 369 DELRDP 374
           +   DP
Sbjct: 360 NVWYDP 365

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 151/305 (49%), Gaps = 21/305 (6%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 130
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 131 MLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 186
            L+   HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
              +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 367 FFDEL 371
           +F +L
Sbjct: 299 YFQDL 303

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 247 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 247 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 149/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 94  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 146
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+        V ++ +RYYRAPE+I G   
Sbjct: 147 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG- 203
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 204 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 263
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 264 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 322
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 323 INVWYDPS 330

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E
Sbjct: 202 YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                   KF ++ P    P      K    +A DL+ +     P+ R +  EA  HP+ 
Sbjct: 262 NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321
Query: 369 DELRDP 374
               DP
Sbjct: 322 TVWYDP 327

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 92/301 (30%), Positives = 144/301 (47%), Gaps = 31/301 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 D 369
           +
Sbjct: 322 N 322

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 129 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 187
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 188 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 247
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 248 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 301
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 302 RYDHQERLTALEAMTHPYFQQVR 324

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 93  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 263 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 322 INVWYDPS 329

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 149/302 (49%), Gaps = 21/302 (6%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 130
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 131 MLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 186
            L+   HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
              +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 367 FF 368
           +F
Sbjct: 299 YF 300

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 145/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD--HERMSYL-----LYQMLCGIKHLHS 142
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 143 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG- 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E
Sbjct: 200 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    F ++ P    P      K    +A DL+ +     P+ R +  EA  HP+ 
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319
Query: 369 DELRDP 374
               DP
Sbjct: 320 TVWYDP 325

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 90/305 (29%), Positives = 149/305 (48%), Gaps = 50/305 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK-- 141
           +G G++G V++A    T E VAIK++  +   +       RE+ +++ L H NI+ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 142 -------HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
                  H  F   +                     + Y   +  + +  +K + YQ+  
Sbjct: 102 IHHNHRLHLIFEYAENDL------------------KKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 195 ALAYIHN--CIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNVSY---I 245
            + + H+  C+   HRD+KPQNLL++      T  LK+ DFG A+    G P   +   I
Sbjct: 144 GVNFCHSRRCL---HRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEI 198
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
            + +YR PE++ G+  Y+T++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P 
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258
Query: 306 REEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                 +   P++ +  FP+ +     +V    L  E +DL+    +  P  R +A  A 
Sbjct: 259 DTTWPGVTALPDWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317
Query: 364 VHPFF 368
            HP+F
Sbjct: 318 EHPYF 322

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+L++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 102/354 (28%), Positives = 162/354 (45%), Gaps = 75/354 (21%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 136
           +YI +H++G GS+G V+ A  + T + VAIKKV      L D +   RE+ I+  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI----YVKLYTYQI 192
           I+ L                         V  IA +  +   + P+     ++K   Y +
Sbjct: 87  IIRLYDLIIPDD--------LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNV--------- 242
                +IH   GI HRD+KP N L+N     +K+CDFG A+ +  + + N+         
Sbjct: 139 LLGENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 243 -------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQ------ 282
                        S++ +R+YRAPELI     YT +IDIWSTGC+ AELL + Q      
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 283 ----PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
               PLFPG                 +S  DQL  I  ++GTPT +++K +N      K+
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV-IKY 315
Query: 322 PQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
            ++ PH      +++ P    + ++L+    +++PN R T  +A  HP+  ++R
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 125 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 183
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 184 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 243
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +      +   W    H   Q  + PEA
Sbjct: 244 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR-WERFVHSENQHLVSPEA 302
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 303 LDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 296
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 297 LDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 118 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 177 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 295
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 296 LDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 296
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 297 LDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 97  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 149
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 150 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 206
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 207 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 266
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 267 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 325
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 326 INVWYDPS 333

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 112/208 (53%), Gaps = 14/208 (6%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKPHPW----HKVFQKRLPPE 340
            DQLV I KVLGT        +  I+ ++P + +      +   W    H   Q  + PE
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDILGRHSRKR-WERFVHSENQHLVSPE 296
Query: 341 AVDLVCRFFQYSPNLRCTALEACVHPFF 368
           A+D + +  +Y    R TA EA  HP+F
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 86  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 138
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 196 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 255
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 256 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 314
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 315 INVWYDPS 322

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ ++ Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLRQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 93/308 (30%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 18/210 (8%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G 
Sbjct: 121 DFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGL 179
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+     +     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G+  
Sbjct: 180 AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN 239
Query: 291 VDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKPHPW----HKVFQKRLP 338
            DQLV I KVLGT   EE+          ++P++ +    Q     W    H   +  + 
Sbjct: 240 YDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVS 295
Query: 339 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           PEA+DL+ +  +Y    R TA EA  HP+F
Sbjct: 296 PEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 18/210 (8%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G 
Sbjct: 126 DFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGL 184
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+     +     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G+  
Sbjct: 185 AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN 244
Query: 291 VDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKPHPW----HKVFQKRLP 338
            DQLV I KVLGT   EE+          ++P++ +    Q     W    H   +  + 
Sbjct: 245 YDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVS 300
Query: 339 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           PEA+DL+ +  +Y    R TA EA  HP+F
Sbjct: 301 PEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP    +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVE 261
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 137 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 193
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 258
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 319 FKFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 137 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 193
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 258
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 319 FKFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 258
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 319 FKFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 143
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 258
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 144 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 202
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 203 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 261
Query: 319 FKFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 262 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 137 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 193
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 105/372 (28%), Positives = 158/372 (42%), Gaps = 80/372 (21%)
Query: 72  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRE 125
           G    N K   +Y  +H++G GS+G V+ A  +   + VAIKKV      L D +   RE
Sbjct: 18  GAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILRE 77
Query: 126 LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI-- 183
           + I+  L    I+ L H      D                V  IA +  +   + P+   
Sbjct: 78  ITILNRLKSDYIIRL-HDLIIPED-------LLKFDELYIVLEIADSDLKKLFKTPIFLT 129
Query: 184 --YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
             +VK   Y +     +IH   GI HRD+KP N L+N     +K+CDFG A+  +  + +
Sbjct: 130 EQHVKTILYNLLLGEKFIHES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKD 186
Query: 242 V---------------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCV 274
           +                           S++ +R+YRAPELI     YT +IDIWSTGC+
Sbjct: 187 IHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCI 246
Query: 275 MAELLLGQ-----------PLFPG-----------------ESGVDQLVEIIKVLGTPTR 306
            AELL              PLFPG                 +S  DQL  I  V+GTP  
Sbjct: 247 FAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPE 306
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKR---LPPEAVDLVCRFFQYSPNLRCTALEAC 363
           E++KC+       K+ ++ P        K+   +  E +DL+    +++   R T  +A 
Sbjct: 307 EDLKCITKQEV-IKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKAL 365
Query: 364 VHPFFDELRDPN 375
            HP+  ++R  N
Sbjct: 366 SHPYLKDVRKEN 377

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 140/299 (46%), Gaps = 35/299 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------------RELQIMQMLD--- 133
           +G G++G V++A+   +G  VA+K V    R  N             RE+ +++ L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 134 HPNIVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTY 190
           HPN+V L   C  S TD+               V++  R Y        +P   +K    
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 191 QICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
           Q  R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +
Sbjct: 128 QFLRGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           YRAPE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++ 
Sbjct: 185 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243
Query: 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 244 P-RDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 96/341 (28%), Positives = 146/341 (42%), Gaps = 60/341 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPN---- 136
           Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E++++++++  +    
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 96
Query: 137 --IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
             IV LK  F                      N   R  S       L   + +  Q+C 
Sbjct: 97  YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNLTRKFAQQMCT 149
Query: 195 ALAYIHN-CIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           AL ++    + I H D+KP+N LL NP    +K+ DFGS+  L  G+     I SR+YR+
Sbjct: 150 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRS 207
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG P    I   
Sbjct: 208 PEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQ 265
Query: 313 NPNYTEFKFPQIKPHPWH----KVFQKRLPPEAV-------------------------- 342
            P   +F F ++    W+    K  ++   P                             
Sbjct: 266 APKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 324
Query: 343 -------DLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                  DL+ R   Y P  R     A  H FF +  D  T
Sbjct: 325 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGT 365

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 119/232 (51%), Gaps = 21/232 (9%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPN---- 136
           Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E++++++++  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 137 --IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
             IV LK  F                      N   R  S       L   + +  Q+C 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNLTRKFAQQMCT 168
Query: 195 ALAYIHN-CIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           AL ++    + I H D+KP+N LL NP    +K+ DFGS+  L  G+     I SR+YR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRS 226
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG P
Sbjct: 227 PEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 119/232 (51%), Gaps = 21/232 (9%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPN---- 136
           Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E++++++++  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 137 --IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
             IV LK  F                      N   R  S       L   + +  Q+C 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNLTRKFAQQMCT 168
Query: 195 ALAYIHN-CIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           AL ++    + I H D+KP+N LL NP    +K+ DFGS+  L  G+     I SR+YR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIYQXIQSRFYRS 226
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG P
Sbjct: 227 PEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 133/282 (47%), Gaps = 38/282 (13%)
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQR---M 180
           RE+ +++ L HPN+++L+  F S  D+               + +  R  S+ +++   +
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRA-SKANKKPVQL 125
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL-- 235
           P   VK   YQI   + Y+H    + HRD+KP N+LV    P   ++K+ D G A++   
Sbjct: 126 PRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 236 -VKGEPNVS-YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-------- 285
            +K   ++   + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F        
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244
Query: 286 -PGESGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFK---------FPQIKPHPWHKV 332
                  DQL  I  V+G P     E+IK M  + T  K            IK    HKV
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304
Query: 333 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
              +   +A  L+ +     P  R T+ +A   P+F  L DP
Sbjct: 305 ---KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF--LEDP 341

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 148/320 (46%), Gaps = 51/320 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH------PNIVALKH 142
           V+G GSFG V +A   +  + VA+K V  +KR+  +  + +++L+H       N + + H
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              + T +              ++N          Q   L  V+ + + I + L  +H  
Sbjct: 164 MLENFTFRNHICMTFELL----SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 203 IGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             I H D+KP+N+L+       +K+ DFGS+    + +   + I SR+YRAPE+I GA  
Sbjct: 220 -RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGA-R 275
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P++   K ++ +     F
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDASKRAKNF 332
Query: 322 PQIKPHPWH------------------KVFQKRLPPEA---------------VDLVCRF 348
              K +P +                  +  + R PPE+               +D + + 
Sbjct: 333 VSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392
Query: 349 FQYSPNLRCTALEACVHPFF 368
            ++ P +R T  +A  HP+ 
Sbjct: 393 LEWDPAVRMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 148/320 (46%), Gaps = 51/320 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH------PNIVALKH 142
           V+G GSFG V +A   +  + VA+K V  +KR+  +  + +++L+H       N + + H
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              + T +              ++N          Q   L  V+ + + I + L  +H  
Sbjct: 164 MLENFTFRNHICMTFELL----SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 203 IGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             I H D+KP+N+L+       +K+ DFGS+    + +   + I SR+YRAPE+I GA  
Sbjct: 220 -RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGA-R 275
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P++   K ++ +     F
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDASKRAKNF 332
Query: 322 PQIKPHPWH------------------KVFQKRLPPEA---------------VDLVCRF 348
              K +P +                  +  + R PPE+               +D + + 
Sbjct: 333 VSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392
Query: 349 FQYSPNLRCTALEACVHPFF 368
            ++ P +R T  +A  HP+ 
Sbjct: 393 LEWDPAVRMTPGQALRHPWL 412

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 112 IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 163
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 164 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 223 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 266
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 267 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 111 IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 162
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 163 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 222 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 265
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 266 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K + +       DK    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 88  IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 139
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 140 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 199 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 242
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 243 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 145/320 (45%), Gaps = 51/320 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH------PNIVALKH 142
           V+G G FG V +A   +  + VA+K V  +KR+  +  + +++L+H       N + + H
Sbjct: 104 VIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              + T +              ++N          Q   L  V+ + + I + L  +H  
Sbjct: 164 MLENFTFRNHICMTFELL----SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 203 IGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             I H D+KP+N+L+       +K+ DFGS+    + +     I SR+YRAPE+I GA  
Sbjct: 220 -RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVILGA-R 275
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P +   K ++ +     F
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ---KLLDASKRAKNF 332
Query: 322 PQIKPHPWH------------------KVFQKRLPPEA---------------VDLVCRF 348
              K +P +                  +  + R PPE+               +D + + 
Sbjct: 333 VSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392
Query: 349 FQYSPNLRCTALEACVHPFF 368
            ++ P +R T  +A  HP+ 
Sbjct: 393 LEWDPAVRMTPGQALRHPWL 412

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K + +       DK    RE+Q+++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 94  IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGI 145
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 146 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 205 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 248
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 249 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 124/293 (42%), Gaps = 45/293 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I  L   F    DK                + I        +R   +       Q+   +
Sbjct: 88  IXKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 139
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 140 TYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPE 198
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 199 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 242
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            YT F+ PQ     W KV        A DL+ +   Y P+ R +A +A  H +
Sbjct: 243 KYT-FELPQ-----WKKV-----SESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 98/358 (27%), Positives = 150/358 (41%), Gaps = 51/358 (14%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQML 132
           G   +   YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 133 DHPN-----------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP 181
           +  +           I+ L   F     K                N +A      H+ +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 236
           LIYVK  + Q+   L Y+H   GI H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------ 290
             E   + I +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 291 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKPHPWHKV-FQKRL 337
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 338 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 388
             E  D +    Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 98/358 (27%), Positives = 150/358 (41%), Gaps = 51/358 (14%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQML 132
           G   +   YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 133 DHPN-----------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP 181
           +  +           I+ L   F     K                N +A      H+ +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 236
           LIYVK  + Q+   L Y+H   GI H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------ 290
             E   + I +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 291 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKPHPWHKV-FQKRL 337
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 338 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 388
             E  D +    Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 134/298 (44%), Gaps = 52/298 (17%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----RELQIMQMLDHPNIV 138
           ++I   V+G+G+F  VF  K R TG++ A+K + +   +++     E+ +++ + H NIV
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQICR 194
            L+  + STT                        + RI +R   +Y +    L   Q+  
Sbjct: 70  TLEDIYESTTHYYLVMQLVSG----------GELFDRILERG--VYTEKDASLVIQQVLS 117
Query: 195 ALAYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSR-YYR 251
           A+ Y+H   GI HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C    Y 
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYV 174
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE +     Y+ A+D WS G +   LL G P F  E+   +L E IK            
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK------------ 220
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
               Y EF+ P          F   +   A D +C   +  PN R T  +A  HP+ D
Sbjct: 221 --EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 137/308 (44%), Gaps = 52/308 (16%)
Query: 75  NGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQI 128
            G++K  ++  Y  E+ +G GS+G V  A  + T    A KK+    ++D     +E++I
Sbjct: 17  QGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEI 76
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV--NRIAR--NYSRIHQRMPLIY 184
           M+ LDHPNI+ L   F   TD                V   R+ R  + +RI +      
Sbjct: 77  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------ 130
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
                  +  A+AY H  + + HRD+KP+N   L +     LKL DFG A     G+   
Sbjct: 131 ------DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 183
Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
           + + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +  G
Sbjct: 184 TKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--G 239
Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
           T               F FP+     W  V      P+A  L+ R    SP  R T+L+A
Sbjct: 240 T---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 276
Query: 363 CVHPFFDE 370
             H +F++
Sbjct: 277 LEHEWFEK 284

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 137/307 (44%), Gaps = 52/307 (16%)
Query: 76  GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIM 129
           G++K  ++  Y  E+ +G GS+G V  A  + T    A KK+    ++D     +E++IM
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 130 QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV--NRIAR--NYSRIHQRMPLIYV 185
           + LDHPNI+ L   F   TD                V   R+ R  + +RI +       
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------- 113
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
                 +  A+AY H  + + HRD+KP+N   L +     LKL DFG A     G+   +
Sbjct: 114 -----DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
            + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +  GT
Sbjct: 168 KVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT 223
Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                          F FP+     W  V      P+A  L+ R    SP  R T+L+A 
Sbjct: 224 ---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260
Query: 364 VHPFFDE 370
            H +F++
Sbjct: 261 EHEWFEK 267

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 130/308 (42%), Gaps = 49/308 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                ++                 +  I R     H    +I       Q+   + Y+H 
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIK------QVFSGITYMHK 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+   ++  ++  P
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW---IQKYSSETP 288
Query: 380 NGRPLPPL 387
               LP L
Sbjct: 289 TISDLPSL 296

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 127
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 229
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 230 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 282
Query: 367 FFDE 370
           +  +
Sbjct: 283 WLQD 286

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSASKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 367 FFDE 370
           +  +
Sbjct: 277 WLQD 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 367 FFDE 370
           +  +
Sbjct: 277 WLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 367 FFDE 370
           +  +
Sbjct: 277 WLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 120
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 222
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 223 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 275
Query: 367 FFDE 370
           +  +
Sbjct: 276 WLQD 279

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 132/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 44  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 103
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            CF                      N     Y R          + YT +I  AL Y+H 
Sbjct: 104 FCF--------QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 155
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 156 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 214 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 254
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 255 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 301
Query: 371 LRDPN 375
           +   N
Sbjct: 302 VTWEN 306

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 98
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 99  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+  
Sbjct: 152 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 210 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 250
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 251 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 297
Query: 371 LRDPN 375
           +   N
Sbjct: 298 VTWEN 302

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 94
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 95  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+  
Sbjct: 148 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 206 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 246
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 247 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 293
Query: 371 LRDPN 375
           +   N
Sbjct: 294 VTWEN 298

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSAXKSS-DLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 133/304 (43%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAI+ ++  +++                E++I++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 246
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F        L           +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           ++I     N+         P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 355 DQITSGKYNFI--------PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 401
Query: 367 FFDE 370
           +  +
Sbjct: 402 WLQD 405

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 133/304 (43%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAI+ ++  +++                E++I++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 260
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F        L           +
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 368
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           ++I     N+         P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 369 DQITSGKYNFI--------PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 415
Query: 367 FFDE 370
           +  +
Sbjct: 416 WLQD 419

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 371 LRDPN 375
           +   N
Sbjct: 295 VTWEN 299

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVV + + R +G I+A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI + +    +   +  + R LAY+     
Sbjct: 84  YSDGE----ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLREKHQ 135
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y APE + G T Y+ 
Sbjct: 136 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERLQG-THYSV 192
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + EL +G+
Sbjct: 193 QSDIWSMGLSLVELAVGR 210

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 46/288 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    D                 + I +   R  +      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 46/288 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    D                 + I +   R  +      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 371 LRDPN 375
           +   N
Sbjct: 295 VTWEN 299

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 98
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 99  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 152 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 210 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 250
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 251 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 297
Query: 371 LRDPN 375
           +   N
Sbjct: 298 VTWEN 302

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 371 LRDPN 375
           +   N
Sbjct: 295 VTWEN 299

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 21  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 79
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 80  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 132
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 133 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 191 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 231
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 232 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 278
Query: 371 LRDPN 375
           +   N
Sbjct: 279 VTWEN 283

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 73
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 74  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 127 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 185 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 225
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 226 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272
Query: 371 LRDPN 375
           +   N
Sbjct: 273 VTWEN 277

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 14  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 72
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 73  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 125
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 126 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 184 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 224
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 225 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 271
Query: 371 LRDPN 375
           +   N
Sbjct: 272 VTWEN 276

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 46/323 (14%)
Query: 89  VVGTGSFGVVFQA-KCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
            +G G+FG V +    +  G  VA+K V    RY       +Q+L+H N       F   
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP--LIYVKLYTYQICRALAYIHNCIGI 205
                             +     ++ + +  +P  L +++   YQIC+++ ++H+   +
Sbjct: 81  QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KL 139
Query: 206 CHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
            H D+KP+N+L                     +NP    +K+ DFGSA      E + + 
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHHSTL 194
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-- 302
           + +R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++LG  
Sbjct: 195 VSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 303 -------TPTREEIKCMNPNYTE------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
                  T  R+       ++ E      +     KP     + Q        DL+ +  
Sbjct: 254 PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y P  R T  EA  HPFFD L+
Sbjct: 314 EYDPAKRITLREALKHPFFDLLK 336

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 17  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 75
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 76  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 128
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 129 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 187 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 227
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 228 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 274
Query: 371 LRDPN 375
           +   N
Sbjct: 275 VTWEN 279

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 94
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 95  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 148 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 206 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 246
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 247 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 293
Query: 371 LRDPN 375
           +   N
Sbjct: 294 VTWEN 298

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 16  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 75  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 127
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 128 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 186 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 226
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 227 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 273
Query: 371 LRDPN 375
           +   N
Sbjct: 274 VTWEN 278

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYK---NRELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+  +       +AIK++ + D RY    + E+ + + L H NIV     +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 84
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI----YVKLYTYQICRALAYIH 200
             +  +              +++ + R+     +  PL      +  YT QI   L Y+H
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRS-----KWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELI-FG 258
           +   I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G
Sbjct: 140 DN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              Y  A DIWS GC + E+  G+P F                        +   P    
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAM 235
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           FK    K HP      + +  EA   + + F+  P+ R  A +  V  F 
Sbjct: 236 FKVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYK---NRELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+  +       +AIK++ + D RY    + E+ + + L H NIV     +
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 70
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI----YVKLYTYQICRALAYIH 200
             +  +              +++ + R+     +  PL      +  YT QI   L Y+H
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRS-----KWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELI-FG 258
           +   I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G
Sbjct: 126 DN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 184
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              Y  A DIWS GC + E+  G+P F                        +   P    
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAM 221
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           FK    K HP      + +  EA   + + F+  P+ R  A +  V  F 
Sbjct: 222 FKVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 133/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF     A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 371 LRDPN 375
           +   N
Sbjct: 295 VTWEN 299

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 42/295 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIV 138
           +I +  +G+G+FG V   + R +G    IK + +D+          E+++++ LDHPNI+
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +   F    D                + RI    +R  + +   YV     Q+  ALAY
Sbjct: 84  KIFEVF---EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAY 139
Query: 199 IHNCIGICHRDIKPQNLL---VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
            H+   + H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y APE+
Sbjct: 140 FHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
                + T   DIWS G VM  LL G   F G S    L E+        +++     PN
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKEPN 243
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           Y      + +P          L P+AVDL+ +     P  R +A +   H +F +
Sbjct: 244 YA----VECRP----------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 134/323 (41%), Gaps = 46/323 (14%)
Query: 89  VVGTGSFGVVFQA-KCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
            +G G+FG V +    +  G  VA+K V    RY       +Q+L+H N       F   
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP--LIYVKLYTYQICRALAYIHNCIGI 205
                             +     ++ + +  +P  L +++   YQIC+++ ++H+   +
Sbjct: 81  QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KL 139
Query: 206 CHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
            H D+KP+N+L                     +NP    +K+ DFGSA      E + + 
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHHSTL 194
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-- 302
           +  R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++LG  
Sbjct: 195 VXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 303 -------TPTREEIKCMNPNYTE------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
                  T  R+       ++ E      +     KP     + Q        DL+ +  
Sbjct: 254 PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y P  R T  EA  HPFFD L+
Sbjct: 314 EYDPAKRITLREALKHPFFDLLK 336

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 132/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 42  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 100
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 101 --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 153
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 154 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 212 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 252
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP                P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 253 -EYDFPAA------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 299
Query: 371 LRDPN 375
           +   N
Sbjct: 300 VTWEN 304

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 20/200 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+ GVVF+   + +G ++A       IK  ++++    RELQ++   + P IV    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F+S  +               +++++ +   RI +++    +   +  + + L Y+   
Sbjct: 134 AFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREK 185
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y
Sbjct: 186 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 242
Query: 263 TTAIDIWSTGCVMAELLLGQ 282
           +   DIWS G  + E+ +G+
Sbjct: 243 SVQSDIWSMGLSLVEMAVGR 262

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ R++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  SR  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYCHSK 131
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 187
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFP 230
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++ + R T  E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+ GVVF+   + +G ++A       IK  ++++    RELQ++   + P IV    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F+S  +               +++++ +   RI +++    +   +  + + L Y+   
Sbjct: 72  AFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREK 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 180
Query: 263 TTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQ 293
           +   DIWS G  + E+ +G+ P+ P ++  D 
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 101 YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 152
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 153 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 209
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 210 QSDIWSMGLSLVEMAVGR 227

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 108/214 (50%), Gaps = 16/214 (7%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 93  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 145 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 201
Query: 265 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             DIWS G  + E+ +G+      SG   + E++
Sbjct: 202 QSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 115/251 (45%), Gaps = 17/251 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 144
           +GTG FG V +   ++TGE VAIK+  Q+   KNRE     +QIM+ L+HPN+V+ +   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 81
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALAYIHNC 202
                K                  + +  ++      L    ++     I  AL Y+H  
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 203 IGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
             I HRD+KP+N+++ P   +L  K+ D G AK L +GE    ++ +  Y APEL+    
Sbjct: 142 -RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQK 199
Query: 261 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
           +YT  +D WS G +  E + G +P  P      Q V+    +   + E I   +      
Sbjct: 200 KYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYDDLTGAV 255
Query: 320 KFPQIKPHPWH 330
           KF  + P P H
Sbjct: 256 KFSSVLPTPNH 266

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 48/284 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 141
            +G GSFG V   +  +T ++ A+K     K ++    +N  +ELQIMQ L+HP +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 197
           + F    D                V+ +     R H +  + +    VKL+  ++  AL 
Sbjct: 82  YSFQDEED------------MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           Y+ N   I HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+  
Sbjct: 130 YLQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187
Query: 258 G--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP--------TRE 307
                 Y+ A+D WS G    ELL G+  +   S      EI+    T         ++E
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQE 246
Query: 308 EI----KCMNPN----YTEFK----FPQIKPHPWHKVFQKRLPP 339
            +    K + PN    +++      FP +    W  VFQKRL P
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 115/251 (45%), Gaps = 17/251 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 144
           +GTG FG V +   ++TGE VAIK+  Q+   KNRE     +QIM+ L+HPN+V+ +   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 80
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALAYIHNC 202
                K                  + +  ++      L    ++     I  AL Y+H  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 203 IGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
             I HRD+KP+N+++ P   +L  K+ D G AK L +GE    ++ +  Y APEL+    
Sbjct: 141 -RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQK 198
Query: 261 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
           +YT  +D WS G +  E + G +P  P      Q V+    +   + E I   +      
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 320 KFPQIKPHPWH 330
           KF  + P P H
Sbjct: 255 KFSSVLPTPNH 265

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ R++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  SR  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYCHSK 131
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM-H 187
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFP 230
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++ + R T  E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ + +  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F  +T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDST----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -KVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  D    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 117/281 (41%), Gaps = 39/281 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFST 147
           +G GS+G V++A  +ETG+IVAIK+V  +   +   +E+ IMQ  D P++V     +F  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
           TD                +    RN +     +  I          + L Y+H    I H
Sbjct: 97  TDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATIL-----QSTLKGLEYLHFMRKI-H 148
Query: 208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEYTTAI 266
           RDIK  N+L+N   H  KL DFG A  L       +  I + ++ APE+I     Y    
Sbjct: 149 RDIKAGNILLNTEGHA-KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI-QEIGYNCVA 206
Query: 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
           DIWS G    E+  G+P +        +  +  +   PT       NP  T F+    KP
Sbjct: 207 DIWSLGITAIEMAEGKPPYA------DIHPMRAIFMIPT-------NPPPT-FR----KP 248
Query: 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
             W   F         D V +    SP  R TA +   HPF
Sbjct: 249 ELWSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 120/287 (41%), Gaps = 45/287 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALKH 142
           +G+G++G V   K + TG   AIK + +              E+ +++ LDHPNI+ L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    DK                + I      + Q+   +   +   Q+     Y+H  
Sbjct: 72  FF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 203 IGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
             I HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE++    
Sbjct: 124 -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RK 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y    D+WS G ++  LL G P F G++  DQ  EI+K                  +F 
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILK-------------RVEKGKFS 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           F    P  W +V       EA  LV     Y P+ R +A EA  HP+
Sbjct: 224 FD---PPDWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 89  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 91  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 256
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 141 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 304
                +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 199 -NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 60/323 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              D                  ++A  ++++ +   + Y++    Q+C+ L ++H     
Sbjct: 224 --EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN-NY 276
Query: 206 CHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYT 263
            H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    Y 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
           T  D+WS G +   LL G   F GE+  + L              +K  + N  +  F  
Sbjct: 337 T--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSG 382
Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NTRLPNG 381
           I               +  D + +     PN R T  +A  HP+      P  ++++P+ 
Sbjct: 383 IS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 429
Query: 382 R-----------------PLPPL 387
           R                 PLPPL
Sbjct: 430 RYTKIRDSIKTKYDAWPEPLPPL 452

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/310 (27%), Positives = 137/310 (44%), Gaps = 51/310 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G+G++G V   + + T    AIK + +     +       E+ ++++LDHPNI+ L + 
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL-YD 103
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHN 201
           FF   DK                + I      IH RM    +   +   Q+   + Y+H 
Sbjct: 104 FFE--DKRNYYLVMECYKGGELFDEI------IH-RMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 202 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
              I HRD+KP+NLL+        +K+ DFG + V    +     + + YY APE++   
Sbjct: 155 H-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL--R 211
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            +Y    D+WS G ++  LL G P F G++  DQ  EI++          K     YT F
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR----------KVEKGKYT-F 256
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
             P+     W     K +   A DL+ +  Q+    R +A +A  HP+  E+    ++  
Sbjct: 257 DSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM---CSKKE 303
Query: 380 NGRPLPPLFN 389
           +G  LP L N
Sbjct: 304 SGIELPSLAN 313

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 102 YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 153
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 154 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 209
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 252
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 253 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 60/323 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              D                  ++A  ++++ +   + Y++    Q+C+ L ++H     
Sbjct: 118 --EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN-NY 170
Query: 206 CHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYT 263
            H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    Y 
Sbjct: 171 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 230
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
           T  D+WS G +   LL G   F GE+  + L              +K  + N  +  F  
Sbjct: 231 T--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSG 276
Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NTRLPNG 381
           I               +  D + +     PN R T  +A  HP+      P  ++++P+ 
Sbjct: 277 IS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 323
Query: 382 R-----------------PLPPL 387
           R                 PLPPL
Sbjct: 324 RYTKIRDSIKTKYDAWPEPLPPL 346

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 89  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 91  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 256
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 141 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 304
                +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 199 -NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 93  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 144
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 145 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 200
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 243
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 244 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 89  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 91
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 92  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 256
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 142 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 199
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 304
                +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 200 -NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 75  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 126
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 127 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 182
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 225
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 226 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 121/287 (42%), Gaps = 45/287 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALKH 142
           +G+G++G V   K + TG   AIK + +              E+ +++ LDHPNI+ L  
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    DK                + I      + Q+   +   +   Q+     Y+H  
Sbjct: 89  FF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 203 IGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
             I HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE++    
Sbjct: 141 -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RK 197
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y    D+WS G ++  LL G P F G++  DQ  EI+K +                +F 
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILKRV-------------EKGKFS 240
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           F    P  W +V       EA  LV     Y P+ R +A EA  HP+
Sbjct: 241 FD---PPDWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 279

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 101/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 77  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 128
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y +PE + G T Y+ 
Sbjct: 129 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-THYSV 185
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 186 QSDIWSMGLSLVEMAVGR 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 188
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 88
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 89  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 139
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 140 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 197
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 198 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 241
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 242 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 290
Query: 375 NTRLP 379
            + +P
Sbjct: 291 ASIVP 295

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 74  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 131
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 182
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 183 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 240
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 241 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 284
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 285 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333
Query: 375 NTRLP 379
            + +P
Sbjct: 334 ASIVP 338

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 131
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 187
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 230
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 48/308 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 77
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 128
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 129 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 186
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 187 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 230
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 231 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279
Query: 375 NTRLPNGR 382
            + +P  R
Sbjct: 280 ASIVPLMR 287

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 188
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 81
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 82  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 132
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 133 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 190
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 191 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 234
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 235 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 283
Query: 375 NTRLP 379
            + +P
Sbjct: 284 ASIVP 288

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 129/305 (42%), Gaps = 48/305 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 208
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 259
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P     + + Y+ APE
Sbjct: 260 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 317
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 318 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 361
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 362 NLP----PRLK--NLHKVS-----PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410
Query: 375 NTRLP 379
            + +P
Sbjct: 411 ASIVP 415

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 86
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 87  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 137
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 138 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 195
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 196 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 239
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 240 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 288
Query: 375 NTRLP 379
            + +P
Sbjct: 289 ASIVP 293

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 184
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 227
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 228 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 200
           C+                         A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 122 CYLREHTAWLVMEYCLGS---------ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 171
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 172 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 226
Query: 261 E--YTTAIDIWSTGCVMAELLLGQP 283
           E  Y   +D+WS G    EL   +P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 102 YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 153
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 154 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM-H 209
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 252
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 253 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 111/261 (42%), Gaps = 30/261 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAI    KK L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
           GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMNPNY-- 316
           Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I     ++  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 317 --------TEFKFPQIKPHPW 329
                     F   Q   HPW
Sbjct: 255 HLMEKDPEKRFTCEQALQHPW 275

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 139
           E  +G G F  V++A C   G  VA+KKV    L D + +    +E+ +++ L+HPN++ 
Sbjct: 37  EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
               F    +                ++R+ +++ +  + +P   V  Y  Q+C AL ++
Sbjct: 97  YYASFIEDNE----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFG 258
           H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE I  
Sbjct: 153 HS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 209
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
              Y    DIWS GC++ E+   Q  F G+
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 78  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 129
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 130 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 185
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 228
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 42/288 (14%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYK-NRELQIMQMLDHPNIVALK 141
           +  +GTG+F  V  A+ + TG++ A+K    K L+ K      E+ +++ + H NIVAL+
Sbjct: 27  KETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALE 86
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             + S                   +  + + +        LI       Q+  A+ Y+H 
Sbjct: 87  DIYESPNHLYLVMQLVSGGELFDRI--VEKGFYTEKDASTLIR------QVLDAVYYLHR 138
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKL--CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
            +GI HRD+KP+NLL      + K+   DFG +K+  KG+   +   +  Y APE +   
Sbjct: 139 -MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPE-VLAQ 196
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y+ A+D WS G +   LL G P F  E+      +I+K                  E+
Sbjct: 197 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILK-----------------AEY 239
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           +F    P+ W  +        A D +    +  PN R T  +A  HP+
Sbjct: 240 EFDS--PY-WDDI-----SDSAKDFIRNLMEKDPNKRYTCEQAARHPW 279

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 137/339 (40%), Gaps = 76/339 (22%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 133
           Y  +  +G GS+GVV  A   +T  I AIK + ++K          R K  E+++M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 134 HPNIVALKHCFFS--------------------------TTDKXXXXXXXXXXXXXXTVN 167
           HPNI  L   +                            +T K                N
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 168 RIARNYSRIHQRMPLIYV---KLYT---YQICRALAYIHNCIGICHRDIKPQNLLVNPH- 220
             A N S    R  L +V   KL +    QI  AL Y+HN  GICHRDIKP+N L + + 
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLFSTNK 205
Query: 221 THQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELIFGATE-YTTAIDIWSTGCV 274
           + ++KL DFG +K   K      Y  +      Y+ APE++    E Y    D WS G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 275 MAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQ 334
           +  LL+G   FPG +  D + +++        +++   NPNY                  
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN----------------- 301
Query: 335 KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
             L P A DL+      + + R  A+ A  HP+  +  D
Sbjct: 302 -VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K +E++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM-H 184
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 227
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 228 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 200
           C+                         A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 83  CYLREHTAWLVMEYCLGS---------ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 132
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 187
Query: 261 E--YTTAIDIWSTGCVMAELLLGQP 283
           E  Y   +D+WS G    EL   +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRX-H 188
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 73  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 124
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 125 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 180
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 223
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 224 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 62/292 (21%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFG-------SAKVLVKGEPNVSYICSRYYRAPEL 255
             + HRDIKP+NLL+     +LK+ DFG       S +  + G  +        Y  PE+
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLPPEM 178
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           I G   +   +D+WS G +  E L+G+P F   +  +    I +V               
Sbjct: 179 IEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------------- 222
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
             EF FP              +   A DL+ R  +++P+ R    E   HP+
Sbjct: 223 --EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 41/288 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 143
           +G G++GVV + +   +G+I+A+K++      Q+++    +L I M+ +D P  V     
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 119 LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 260
            + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I       
Sbjct: 174 SVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+   DIWS G  M EL + +  FP +S            GTP ++             
Sbjct: 233 GYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------- 266
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 267 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALK 141
            +GTGSFG V   + R  G   A+K +       L+   + N E  ++ ++ HP I+ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    D                 + +     R  QR P    K Y  ++C AL Y+H+
Sbjct: 73  GTF---QDAQQIFMIMDYIEGGELFSLL-----RKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSR-YYRAPELIFGA 259
              I +RD+KP+N+L++ + H +K+ DFG AK +    P+V+Y +C    Y APE++   
Sbjct: 125 K-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV-ST 177
Query: 260 TEYTTAIDIWSTGCVMAELLLG 281
             Y  +ID WS G ++ E+L G
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAG 199

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 69  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 179
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 180 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 234
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 75  NGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQ 130
           +G+++  +S  +  E  +G G+  +V++ K + T +  A+K  K   DK+    E+ ++ 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L HPNI+ LK  F + T+                 +RI        +R     VK    
Sbjct: 104 RLSHPNIIKLKEIFETPTE---ISLVLELVTGGELFDRIVEK-GYYSERDAADAVK---- 155
Query: 191 QICRALAYIHNCIGICHRDIKPQNLL-VNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSR 248
           QI  A+AY+H   GI HRD+KP+NLL   P     LK+ DFG +K+ V+ +  +  +C  
Sbjct: 156 QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVCGT 213
Query: 249 -YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
             Y APE++ G   Y   +D+WS G +   LL G   F  E G DQ +          R 
Sbjct: 214 PGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------FRR 262
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + C      E+ F      PW       +   A DLV +     P  R T  +A  HP+
Sbjct: 263 ILNC------EYYFIS----PW----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 151
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 152 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 206
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 78  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 129
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G   +
Sbjct: 130 -RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 185
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 228
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 30/261 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
           GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMNPNYT- 317
           Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I     ++  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 318 ---------EFKFPQIKPHPW 329
                     F   Q   HPW
Sbjct: 255 HLMEKDPEKRFTCEQALQHPW 275

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 179
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            + + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  Y APE+I  +  
Sbjct: 180 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPEYLAPEIIL-SKG 235
Query: 262 YTTAIDIWSTGCVMAELLLGQPLF 285
           Y  A+D W+ G ++ E+  G P F
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 35  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 94
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 95  FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 146 SLDLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 200
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K +E++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 30/261 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
           GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMNPNY-- 316
           Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I     ++  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 317 --------TEFKFPQIKPHPW 329
                     F   Q   HPW
Sbjct: 255 HLMEKDPEKRFTCEQALQHPW 275

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            + + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SKG 214
Query: 262 YTTAIDIWSTGCVMAELLLGQPLF 285
           Y  A+D W+ G ++ E+  G P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 30/261 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
           GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMNPNY-- 316
           Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I     ++  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 317 --------TEFKFPQIKPHPW 329
                     F   Q   HPW
Sbjct: 255 HLMEKDPEKRFTCEQALQHPW 275

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            + + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SKG 214
Query: 262 YTTAIDIWSTGCVMAELLLGQPLF 285
           Y  A+D W+ G ++ E+  G P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 41/288 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 143
           +G G++GVV + +   +G+I+A+K++      Q+++    +L I M+ +D P  V     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 260
            + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I       
Sbjct: 130 SVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+   DIWS G  M EL + +  FP +S            GTP ++             
Sbjct: 189 GYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------- 222
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 223 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/335 (24%), Positives = 138/335 (41%), Gaps = 48/335 (14%)
Query: 89  VVGTGSFGVVFQ-AKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDH--PNIVALKH 142
            +G G+FG V Q    R  G  VA+K +   ++YK     E+ +++ ++   P+   L  
Sbjct: 40  TLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCV 99
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             F   D               T + +  N    +   P+  V+   +Q+C+A+ ++H+ 
Sbjct: 100 QMFDWFDYHGHMCISFELLGLSTFDFLKDNN---YLPYPIHQVRHMAFQLCQAVKFLHDN 156
Query: 203 IGICHRDIKPQNLLVNPHTHQL------------------KLCDFGSAKVLVKGEPNVSY 244
             + H D+KP+N+L     ++L                  ++ DFGSA      E + + 
Sbjct: 157 -KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF--DHEHHSTI 213
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-T 303
           + +R+YRAPE+I     ++   D+WS GC++ E  +G  LF      + L  + ++LG  
Sbjct: 214 VSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPI 272
Query: 304 PTREEIKCMNPNY--------------TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
           P+R   K     Y                +     KP   +   +     +  DL+    
Sbjct: 273 PSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESML 332
Query: 350 QYSPNLRCTALEACVHPFFDELRD--PNTRLPNGR 382
           +Y P  R T  EA  HPFF  LR   PN    + R
Sbjct: 333 EYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 89  VVGTGSFGVVFQAKCR---ETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  +     ++G + A+K +      ++D+     E  I+  ++HP +V 
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++   L 
Sbjct: 95  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALGLD 144
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 256
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 145 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV 202
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 304
                ++ + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 203 -NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRTWT--LCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 34  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 93
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H+
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 146 -LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRTWT--LCGTPEYLAPEIIL-SK 199
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                 + ++    S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL----SKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 188
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R ++  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FAEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 130/284 (45%), Gaps = 39/284 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQ----IMQMLDHPNIVALKHC 143
           +G G++G V +   + +G+I+A+K++    D++ + + L     +M+  D P IV     
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   D               + ++  +  YS +   +P   +   T    +AL ++   
Sbjct: 90  LFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 261
           + I HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +   
Sbjct: 145 LKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 262 --YTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTP---TREEIKCMNPN 315
             Y    D+WS G  + EL  G+  +P  + V DQL +++K  G P   +  E +  +P+
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQLSNSEEREFSPS 261
Query: 316 YTEF-------------KFPQIKPHPWHKVFQKRLPPEAVDLVC 346
           +  F             K+ ++  HP+  ++++R    AV++ C
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFILMYEER----AVEVAC 301

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 151
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 152 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 206
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIII-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 59/301 (19%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-RYKN------------- 123
           SY     +G+G++G V    C+E        I  IKK   DK RY +             
Sbjct: 37  SYFKVRKLGSGAYGEVLL--CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
            E+ +++ LDHPNI+ L   F    DK                 +I  N  +  +     
Sbjct: 95  NEISLLKSLDHPNIIKLFDVF---EDKKYFYLVTEFYEGGELFEQII-NRHKFDECDAAN 150
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPN 241
            +K    QI   + Y+H    I HRDIKP+N+L+      L  K+ DFG +    K    
Sbjct: 151 IMK----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
              + + YY APE++    +Y    D+WS G +M  LL G P F G++  D + ++ K  
Sbjct: 206 RDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-- 261
Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
                         Y +F       + W     K +  EA +L+     Y  N RCTA E
Sbjct: 262 -----------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 362 A 362
           A
Sbjct: 299 A 299

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 73  GRNGNSKQKVS-YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------- 123
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
           RE+Q +++  HP+I+ L     + TD                      +Y   H R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF--------DYICKHGRVEEM 111
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
             +    QI  A+ Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE   +
Sbjct: 112 EARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRT 169
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
              S  Y APE+I G       +DIWS G ++  LL G   F  E
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ ++  G P F
Sbjct: 214 GYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                 + ++    S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL----SKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRM-H 188
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 4/208 (1%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
            +I   ++G GSFG VF A+ ++T +  AIK + +D    + +++   +      +A +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F +                          + +   +  L     Y  +I   L ++H+ 
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATE 261
            GI +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G  +
Sbjct: 138 -GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QK 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGES 289
           Y  ++D WS G ++ E+L+GQ  F G+ 
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 179
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 180 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 234
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 73  GRNGNSKQKVS-YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------- 123
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
           RE+Q +++  HP+I+ L     + TD                      +Y   H R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF--------DYICKHGRVEEM 111
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
             +    QI  A+ Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE    
Sbjct: 112 EARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRD 169
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
              S  Y APE+I G       +DIWS G ++  LL G   F  E
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 43  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 102
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 103 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 153
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 154 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 208
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 209 GYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLHS 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 41/260 (15%)
Query: 60  GAETGHVIRTTIGGRNGNSK-QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 118
           G +TG++   TIGG+   ++   +  + E  +G+G+ G V++ + R+TG ++A+K++   
Sbjct: 7   GKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM--- 58
Query: 119 KRYKNRELQ---------IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRI 169
           +R  N+E           +++  D P IV     F + TD                +  +
Sbjct: 59  RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD------------VFIAMELM 106
Query: 170 ARNYSRIHQRM----PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 225
                ++ +RM    P   +   T  I +AL Y+    G+ HRD+KP N+L++    Q+K
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIK 165
Query: 226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLG 281
           LCDFG +  LV  +          Y APE I        +Y    D+WS G  + EL  G
Sbjct: 166 LCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 282 QPLFPGESGVDQLVEIIKVL 301
           Q  FP ++       + KVL
Sbjct: 226 Q--FPYKNCKTDFEVLTKVL 243

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP +I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPAIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 40/299 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G+G+FGVV +   + TG +   K +      DK     E+ IM  L HP ++ L   F 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF- 117
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              DK                +RIA    ++ +   + Y++    Q C  L ++H    I
Sbjct: 118 --EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHEH-SI 170
Query: 206 CHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
            H DIKP+N++        +K+ DFG A  L   E       +  + APE++        
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGF 229
Query: 265 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 324
             D+W+ G +   LL G   F GE  ++ L            + +K  +  + E  F  +
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDAFSSV 277
Query: 325 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD-ELRDPNTRLPNGR 382
            P             EA D +    Q  P  R T  +A  HP+   +  +  +R+P+ R
Sbjct: 278 SP-------------EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 323

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 84  YIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPN 136
           Y+A  + +G GS G+V  A  + TG+ VA+KK+  D R + R      E+ IM+   H N
Sbjct: 46  YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V +   +    +                V          H RM    +      + RAL
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIATVCLSVLRAL 154
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPEL 255
           +Y+HN  G+ HRDIK  ++L+     ++KL DFG    + K  P    +    Y+ APE+
Sbjct: 155 SYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEV 212
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
           I     Y T +DIWS G ++ E++ G+P +  E
Sbjct: 213 I-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 244

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDH 134
           +Y  +  +G G+F  V  A+   TG  VA+K +  DK   N        RE++IM++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 135 PNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           PNIV L    F   +                V     +Y   H RM     +    QI  
Sbjct: 74  PNIVKL----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVS 125
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           A+ Y H    I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APE
Sbjct: 126 AVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAAPE 183
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           L  G       +D+WS G ++  L+ G   F G++
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           YI    +G GSFG V  A   +T + VA+K + +    K+       RE+  +++L HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L     + TD                V +         +RM     + +  QI  A+
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEK---------KRMTEDEGRRFFQQIICAI 121
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            Y H    I HRD+KP+NLL++ + + +K+ DFG + ++  G    +   S  Y APE+I
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
            G       +D+WS G V+  +L+G+  F  E
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
           YI    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q +++  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           +I+ L     + +D                + +  R   +  +R+          QI   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL--------FQQILSG 128
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           + Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y APE+
Sbjct: 129 VDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCGSPNYAAPEV 186
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLG 281
           I G       +DIWS+G ++  LL G
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 21/219 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQML-DHPNIVAL 140
           V+G GSFG V  A+ +ETG++ A+K + +D   ++ +++       I+ +  +HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             C F T D+                 + +R +     R        Y  +I  AL ++H
Sbjct: 90  -FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR-------FYAAEIISALMFLH 141
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGA 259
           +  GI +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I   
Sbjct: 142 D-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQE 198
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             Y  A+D W+ G ++ E+L G   F  E+  D L E I
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 236

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 222
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 150 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 208
Query: 223 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 209 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 265
Query: 280 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKP 326
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 266 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 325
Query: 327 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF  L
Sbjct: 326 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 372

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK--------KVLQDKRYKNRELQIMQMLDHPNI 137
           V+G G +G VFQ +      TG+I A+K        +  +D  +   E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQIC 193
           V L + F +                   + R              I+++     Y  +I 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG------------IFMEDTACFYLAEIS 131
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRA 252
            AL ++H   GI +RD+KP+N+++N H   +KL DFG  K  +  G    ++  +  Y A
Sbjct: 132 MALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           PE++   + +  A+D WS G +M ++L G P F GE+    + +I+K
Sbjct: 190 PEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 222
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 127 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 185
Query: 223 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 186 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 242
Query: 280 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKP 326
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 243 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 302
Query: 327 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF  L
Sbjct: 303 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 349

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C      APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEALAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK--------KVLQDKRYKNRELQIMQMLDHPNI 137
           V+G G +G VFQ +      TG+I A+K        +  +D  +   E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQIC 193
           V L + F +                   + R              I+++     Y  +I 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG------------IFMEDTACFYLAEIS 131
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRA 252
            AL ++H   GI +RD+KP+N+++N H   +KL DFG  K  +         C    Y A
Sbjct: 132 MALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMA 189
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           PE++   + +  A+D WS G +M ++L G P F GE+    + +I+K
Sbjct: 190 PEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 222
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 223 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 177 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 233
Query: 280 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKP 326
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 327 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF  L
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 41/288 (14%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           ++G G FG V + +   TG  +A K +    ++DK     E+ +M  LDH N++ L   F
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            S  D                 +RI      + +   ++++K    QIC  + ++H    
Sbjct: 156 ESKND---IVLVMEYVDGGELFDRIIDESYNLTELDTILFMK----QICEGIRHMHQMY- 207
Query: 205 ICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI-FGATEY 262
           I H D+KP+N+L VN    Q+K+ DFG A+     E       +  + APE++ +    +
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSF 267
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
            T  D+WS G +   LL G   F G++  + L  I+        EE              
Sbjct: 268 PT--DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE-------------- 311
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                     FQ  +  EA + + +      + R +A EA  HP+  +
Sbjct: 312 ----------FQD-ISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 4/202 (1%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 148
           ++G GSFG VF A+ ++T +  AIK + +D    + +++   +      +A +H F +  
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 84
Query: 149 DKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208
                                   + +   +  L     Y  +I   L ++H+  GI +R
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-GIVYR 143
Query: 209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATEYTTAID 267
           D+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G  +Y  ++D
Sbjct: 144 DLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVD 201
Query: 268 IWSTGCVMAELLLGQPLFPGES 289
            WS G ++ E+L+GQ  F G+ 
Sbjct: 202 WWSFGVLLYEMLIGQSPFHGQD 223

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 47/297 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A+ + +G  VA+K  + D R + R      E+ IM+   H N+V +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +    +                V+++  N  +I               + +ALAY+H   
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI---------ATVCEAVLQALAYLH-AQ 160
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATEY 262
           G+ HRDIK  ++L+     ++KL DFG    + K  P    +    Y+ APE+I   + Y
Sbjct: 161 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLY 218
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
            T +DIWS G ++ E++ G+P +  +S V  +            + ++   P       P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------KRLRDSPP-------P 259
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
           ++K    HKV      P   D + R     P  R TA E   HPF  +   P   +P
Sbjct: 260 KLKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 123 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGES 289
              +D+WS G ++  +L  +  F  ES
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 133 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 190
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGES 289
              +D+WS G ++  +L  +  F  ES
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 131
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 132 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 189
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGES 289
              +D+WS G ++  +L  +  F  ES
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 126
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 127 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGES 289
              +D+WS G ++  +L  +  F  ES
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 126/320 (39%), Gaps = 60/320 (18%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 250
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE   +   +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTLCGTPNY 208
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           C+   Y   K  +           + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 371 LRDPNTRLPNG-RPLPPLFN 389
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA++ +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 116/254 (45%), Gaps = 28/254 (11%)
Query: 62  ETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 121
           E    + T   G+  +S     +    V+G GS+  V   + ++T  I A++ V ++   
Sbjct: 32  EEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN 91
Query: 122 KNRELQIMQM--------LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNY 173
            + ++  +Q          +HP +V L  CF + +                 + R     
Sbjct: 92  DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----- 146
Query: 174 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233
               +++P  + + Y+ +I  AL Y+H   GI +RD+K  N+L++   H +KL D+G  K
Sbjct: 147 ---QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCK 201
Query: 234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF------- 285
             ++ G+   ++  +  Y APE++ G  +Y  ++D W+ G +M E++ G+  F       
Sbjct: 202 EGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
Query: 286 -PGESGVDQLVEII 298
            P ++  D L ++I
Sbjct: 261 NPDQNTEDYLFQVI 274

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K V ++    + ++  +Q          +HP +V L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             CF + +                 + R         +++P  + + Y+ +I  AL Y+H
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLH 127
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGA 259
              GI +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G 
Sbjct: 128 ER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII 298
            +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I
Sbjct: 186 -DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 112/251 (44%), Gaps = 28/251 (11%)
Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
             + T   G+  +S     +    V+G GS+  V   + ++T  I A+K V ++    + 
Sbjct: 3   EAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE 62
Query: 125 ELQIMQM--------LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI 176
           ++  +Q          +HP +V L  CF + +                 + R        
Sbjct: 63  DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-------- 114
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236
            +++P  + + Y+ +I  AL Y+H   GI +RD+K  N+L++   H +KL D+G  K  +
Sbjct: 115 QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGL 172
Query: 237 KGEPNVSYICSR-YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF--------PG 287
           +     S  C    Y APE++ G  +Y  ++D W+ G +M E++ G+  F        P 
Sbjct: 173 RPGDTTSXFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 231
Query: 288 ESGVDQLVEII 298
           ++  D L ++I
Sbjct: 232 QNTEDYLFQVI 242

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HPNIV L
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNIVKL 76
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 77  ----FEVIETEKTLYLIMEYASGGEVF----DYLVAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G  
Sbjct: 129 QK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKK 186
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 187 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 82/320 (25%), Positives = 128/320 (40%), Gaps = 60/320 (18%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 87
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 88  VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 134
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 250
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 135 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTPNY 192
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 193 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 229
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           C+   Y      +IK + +     + + P A  L+ R     P LR +  E     FF  
Sbjct: 230 CLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 282
Query: 371 LRDPNTRLPNG-RPLPPLFN 389
              P  RLP     +PP F+
Sbjct: 283 GYAP-MRLPTSCLTVPPRFS 301

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA++ +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G     +  S  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 125/320 (39%), Gaps = 60/320 (18%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 250
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTPNY 208
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           C+   Y   K  +           + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 371 LRDPNTRLPNG-RPLPPLFN 389
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K V ++    + ++  +Q          +HP +V L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             CF + +                 + R         +++P  + + Y+ +I  AL Y+H
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLH 123
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGA 259
              GI +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G 
Sbjct: 124 ER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII 298
            +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I
Sbjct: 182 -DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 227

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 139
           V+G GSFG V  A+  +  E+    KVLQ K    K  E  IM       + + HP +V 
Sbjct: 45  VIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI-YVKLYTYQICRALAY 198
           L H  F T DK               +N     Y    +R  L    + Y  +I  AL Y
Sbjct: 104 L-HFSFQTADKLYFVLDY--------INGGELFYHLQRERCFLEPRARFYAAEIASALGY 154
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIF 257
           +H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE + 
Sbjct: 155 LHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VL 211
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLF 285
               Y   +D W  G V+ E+L G P F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 125/320 (39%), Gaps = 60/320 (18%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 250
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKXLCGTPNY 208
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           C+   Y   K  +           + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 371 LRDPNTRLPNG-RPLPPLFN 389
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQAHAERIDHIKLLQYTSQICKGMEY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 141
           +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 79
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 80  ---FEVIETEKTLYLIMEYASGGEVF----DYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G   
Sbjct: 133 K-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGES 289
               +D+WS G ++  L+ G   F G++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKN--RELQIMQMLDHPNIV 138
           E ++G G FG V++A     G+ VA+K    D      +  +N  +E ++  ML HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL+        K               +NR+        +R+P   +  +  QI R + Y
Sbjct: 70  ALRGVCL----KEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNY 120
Query: 199 IHN--CIGICHRDIKPQNLLV-------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
           +H+   + I HRD+K  N+L+       +     LK+ DFG A+   +    +S   +  
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYA 179
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
           + APE+I  A+ ++   D+WS G ++ ELL G+  F G  G+
Sbjct: 180 WMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 25  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 136
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 137 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 191
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 192 APESL-TESKFSVASDVWSFGVVLYELF 218

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 141/309 (45%), Gaps = 56/309 (18%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 91  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 199 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 246
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 149 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 247 -----SRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
                +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +   II+
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR 266
Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
             G  + +E+KC++                     + L  EA DL+ +   + P  R TA
Sbjct: 267 --GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTA 304
Query: 360 LEACVHPFF 368
           ++   HP F
Sbjct: 305 MKVLRHPLF 313

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 141/309 (45%), Gaps = 56/309 (18%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 91  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 199 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 246
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 149 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 247 -----SRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
                +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +   II+
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR 266
Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
             G  + +E+KC++                     + L  EA DL+ +   + P  R TA
Sbjct: 267 --GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTA 304
Query: 360 LEACVHPFF 368
           ++   HP F
Sbjct: 305 MKVLRHPLF 313

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 23  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 135 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 190 APESL-TESKFSVASDVWSFGVVLYELF 216

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI---FWY 184
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 22  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 133
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 134 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 188
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 189 APESL-TESKFSVASDVWSFGVVLYELF 215

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 127/295 (43%), Gaps = 46/295 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
           Y+    +G G FG+V   +C ET        + V +K    D+    +E+ I+ +  H N
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRN 62
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F S  +                  RI  +   +++R  + YV    +Q+C AL
Sbjct: 63  ILHLHESFESMEE---LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 197 AYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
            ++H+   I H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +      +TA D+WS G ++  LL G   F  E+   Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           YT   F +       + F K +  EA+D V R        R TA EA  HP+  +
Sbjct: 220 YT---FDE-------EAF-KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 24  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 135
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 136 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 190
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 191 APESL-TESKFSVASDVWSFGVVLYELF 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 184
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 49  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 161 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 215
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 216 APESL-TESKFSVASDVWSFGVVLYELF 242

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 17  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 128
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 129 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 183
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 184 APESL-TESKFSVASDVWSFGVVLYELF 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 16  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 127
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 128 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 182
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 183 APESL-TESKFSVASDVWSFGVVLYELF 209

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 126/320 (39%), Gaps = 60/320 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 84  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 132 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 188
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 226
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 227 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 278
Query: 377 RLP-NGRPLPPLFNFKPPEL 395
           RLP     +PP F+  P  L
Sbjct: 279 RLPITCLTIPPXFSIAPSSL 298

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 184
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 148 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 202
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 203 APESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 148 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 202
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 203 APESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  A  + T E+ AIK + +D   ++ +++       ++ +LD P  +   
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+               VN     Y  I Q  +        Y  +I   L ++
Sbjct: 86  HSCFQTVDRLYFVMEY--------VNGGDLMY-HIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFG 258
           H   GI +RD+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I  
Sbjct: 137 HKR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-A 193
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              Y  ++D W+ G ++ E+L GQP F GE   D+L + I
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGS------LREYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 126/320 (39%), Gaps = 60/320 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 84  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 132 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 188
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 226
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 227 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 278
Query: 377 RLP-NGRPLPPLFNFKPPEL 395
           RLP     +PP F+  P  L
Sbjct: 279 RLPITCLTIPPRFSIAPSSL 298

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 141
           +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
              F   +                V     +Y   H  M     +    QI  A+ Y H 
Sbjct: 72  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 125 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGES 289
               +D+WS G ++  L+ G   F G++
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 76
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 77  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 128
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 129 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 186
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 229
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 230 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 15  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 75  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 126
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 127 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 184
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 227
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 228 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 126/320 (39%), Gaps = 60/320 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 88  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 135
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 136 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 192
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 193 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 230
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 231 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 282
Query: 377 RLP-NGRPLPPLFNFKPPEL 395
           RLP     +PP F+  P  L
Sbjct: 283 RLPITCLTIPPRFSIAPSSL 302

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 16  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 75
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 76  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 127
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 128 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 185
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 228
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 229 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 116/285 (40%), Gaps = 40/285 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + + T E+VA+K + +         RE+   + L HPNIV  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H+ + IC
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGR-FSEDEAR-------FFFQQLLSGVSYCHS-MQIC 138
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++    EY   
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYDGK 197
Query: 266 I-DIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
           I D+WS G  +  +L+G  P    E   D    I ++L                ++  P 
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS--------------VKYSIPD 243
Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                       R+ PE   L+ R F   P  R +  E   H +F
Sbjct: 244 ----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 217
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 218 YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 269
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 270 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDN 327
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 370
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 371 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 215 YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 266
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 267 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDN 324
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 367
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 368 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 29/226 (12%)
Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 136
           V+GTG++G VF   +    +TG++ A+K      ++Q  +         Q+L+H    P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICR 194
           +V L + F + T                 +N     ++ + QR       V++Y  +I  
Sbjct: 121 LVTLHYAFQTET---------KLHLILDYING-GELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 252
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C    Y A
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 253 PELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 297
           P+++ G  + +  A+D WS G +M ELL G   F  +   +   EI
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 266 IDIWSTGCVMAELLLG 281
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 90/346 (26%), Positives = 132/346 (38%), Gaps = 65/346 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
           V+G G+F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 146
Query: 200 HNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 254
           H+   I HRD+KP+N+L+    ++  +KL DFG A  L  GE  +     + + ++ APE
Sbjct: 147 HDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPHFMAPE 203
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 247
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE---- 370
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E    
Sbjct: 248 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKERDRY 296
Query: 371 ------------LRDPNTRLP-NGRPLPPLFNFKPPELSGIPPETI 403
                       LR  N R    G  L  + + K     G PPE +
Sbjct: 297 AYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEEL 342

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  IVA+K + + +  K        RE++I   L HPNI+ L +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F+   D+                  + ++ +   QR   I  +L       AL Y H  
Sbjct: 91  YFY---DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL-----ADALMYCHGK 142
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 143 -KVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRM-H 198
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-----LGTPTREE---IKCMNP 314
              +D+W  G +  ELL+G P F   S  +    I+KV        PT  +    K +  
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRH 258
Query: 315 NYTE-FKFPQIKPHPWHKVFQKR-LPPEAVDLVC 346
           N +E     Q+  HPW +   +R LPP A+  V 
Sbjct: 259 NPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA 292

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 16/222 (7%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y+    +G GSFG     K  E G    IK++       +++    RE+ ++  + HPNI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V  +  F    +                  RI      + Q   ++    +  QIC AL 
Sbjct: 86  VQYRESF---EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD---WFVQICLALK 139
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELI 256
           ++H+   I HRDIK QN+ +      ++L DFG A+VL    E   + I + YY +PE I
Sbjct: 140 HVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPE-I 196
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
                Y    DIW+ GCV+ EL   +  F   S  + +++II
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 41/288 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 143
           +G G++GVV + +   +G+I A+K++      Q+++    +L I  + +D P  V     
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 102 LFREGD-----VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 260
            + HRD+KP N+L+N    Q+K CDFG +  LV           + Y APE I       
Sbjct: 157 SVIHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQK 215
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+   DIWS G    EL + +  FP +S            GTP ++             
Sbjct: 216 GYSVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ------------- 249
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 250 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 130 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 180
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
           L  IH+ +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 181 LDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 237
Query: 253 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 135 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 185
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
           L  IH+ +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 186 LDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 242
Query: 253 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 86  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 136
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++         
Sbjct: 137 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 196
Query: 266 IDIWSTGCVMAELLLG 281
            D+WS G  +  +L+G
Sbjct: 197 ADVWSCGVTLYVMLVG 212

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 125/320 (39%), Gaps = 60/320 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 106 GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 153
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 154 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 210
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 211 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 248
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 249 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 300
Query: 377 RLP-NGRPLPPLFNFKPPEL 395
           RLP     +PP F+  P  L
Sbjct: 301 RLPITCLTIPPRFSIAPSSL 320

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 135 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 185
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
           L  IH+ +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 186 LDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 242
Query: 253 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 125/320 (39%), Gaps = 60/320 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 108 GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 156 YLHRN-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 212
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 250
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 251 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 302
Query: 377 RLP-NGRPLPPLFNFKPPEL 395
           RLP     +PP F+  P  L
Sbjct: 303 RLPITCLTIPPRFSIAPSSL 322

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 23/228 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + + ++ A+K + +       D  +   E  IM   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F +  D                VN ++ NY      +P  + K YT ++  A
Sbjct: 136 WVVQL---FCAFQDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVLA 186
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS-AKVLVKGEPNV-SYICSRYYRAP 253
           L  IH+ +G+ HRD+KP N+L++ H H LKL DFG+  K+   G  +  + + +  Y +P
Sbjct: 187 LDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYISP 244
Query: 254 ELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           E++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 19  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 130
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HR++  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 131 LGTKRYI-HRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWY 185
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 186 APESL-TESKFSVASDVWSFGVVLYELF 212

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLD-HPNIVALKHC 143
           V+  G F  V++A+   +G   A+K++L ++  KNR    E+  M+ L  HPNIV     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL---IYVKLYTYQICRALAYIH 200
                ++                 ++     ++  R PL     +K++ YQ CRA+ ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF-YQTCRAVQHMH 153
Query: 201 NCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----------- 248
                I HRD+K +NLL++ +   +KLCDFGSA   +   P+ S+   R           
Sbjct: 154 RQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATT-ISHYPDYSWSAQRRALVEEEITRN 211
Query: 249 ---YYRAPELIFGATEYTTA--IDIWSTGCVMAELLLGQPLF 285
               YR PE+I   + +      DIW+ GC++  L   Q  F
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 121/289 (41%), Gaps = 46/289 (15%)
Query: 90  VGTGSFGVVFQ-----AKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     A      +I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                                 +  +AR Y         I       QI  A+ + H  +
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCI------QQILEAVLHCHQ-M 140
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
           G+ HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRK 198
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 199 DPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 241
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            FP  +   W  V      PEA DL+ +    +P+ R TA EA  HP+ 
Sbjct: 242 DFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 49/297 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALK 141
           ++G GSF  V++A+   TG  VAIK + +   YK         E++I   L HP+I+ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    +                +NR  +N  +          + + +QI   + Y+H+
Sbjct: 78  NYF----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE---ARHFMHQIITGMLYLHS 130
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGAT 260
             GI HRD+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE I   +
Sbjct: 131 H-GILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRS 187
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            +    D+WS GC+   LL+G+P F  ++  + L +++                   +++
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-----------------LADYE 230
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377
            P              L  EA DL+ +  + +P  R +      HPF    R+ +T+
Sbjct: 231 MPSF------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS--RNSSTK 273

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 124 RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 121
Query: 183 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 122 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 178
Query: 240 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
              S   +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 239 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 273
Query: 355 LRCTALEACVHPFFDE 370
            R TA EA  HPFF +
Sbjct: 274 KRYTAEEALAHPFFQQ 289

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 124 YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 167
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 168 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 227 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 279
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 280 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 324
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 325 IMQSTKVPQTPLHTSRVL 342

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 183 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 235
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 236 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 280
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 281 IMQSTKVPQTPLHTSRVL 298

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 129
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 130 YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 173
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 174 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 232
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 233 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 285
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 286 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 330
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 331 IMQSTKVPQTPLHTSRVL 348

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 140/313 (44%), Gaps = 60/313 (19%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 73  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 199 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 246
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+ +     
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 247 -----SRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
                +  +RAPEL+  +    T      +IDI+S GCV    +L +   P      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 248
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
            II+  G  + +E+KC++                     + L  EA DL+ +   + P  
Sbjct: 249 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 286
Query: 356 RCTALEACVHPFF 368
           R TA++   HP F
Sbjct: 287 RPTAMKVLRHPLF 299

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 124/317 (39%), Gaps = 60/317 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 82  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 130 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 186
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 224
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 225 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 276
Query: 377 RLP-NGRPLPPLFNFKP 392
           RLP     +PP F+  P
Sbjct: 277 RLPITCLTIPPRFSIAP 293

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 94  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 137
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 138 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 196
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 197 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 249
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 250 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 294
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 295 IMQSTKVPQTPLHTSRVL 312

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 68
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 69  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 121
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 219
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 220 KEKKTYLNPWKKI 232

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF--- 144
            ++G+G FG VF+AK R  G+   IK+V  +     RE++ +  LDH NIV    C+   
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 145 ---------FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
                     S+  K              T+ +      R  +   ++ ++L+  QI + 
Sbjct: 77  DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFE-QITKG 134
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y +PE 
Sbjct: 135 VDYIHSK-KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQ 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I  + +Y   +D+++ G ++AELL
Sbjct: 193 I-SSQDYGKEVDLYALGLILAELL 215

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 84
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 85  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 128
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 129 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 187
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 188 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 240
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 241 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 285
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 286 IMQSTKVPQTPLHTSRVL 303

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 85
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 86  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 129
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 130 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 188
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 189 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 241
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 242 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 286
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 287 IMQSTKVPQTPLHTSRVL 304

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 78  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 121
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 122 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 180
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 181 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 233
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 234 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 278
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 279 IMQSTKVPQTPLHTSRVL 296

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 83
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 84  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 127
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 128 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 186
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 187 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 239
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 240 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 284
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 285 IMQSTKVPQTPLHTSRVL 302

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 78
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 79  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 122
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 123 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 181
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 182 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 234
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 235 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 279
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 280 IMQSTKVPQTPLHTSRVL 297

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 123/296 (41%), Gaps = 43/296 (14%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALK 141
            Y+ +  +G GS+    +   + T    A+K + + KR  + E++I ++   HPNI+ LK
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +    D                +++I R      +    +      + I + + Y+H+
Sbjct: 88  DVY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHS 139
Query: 202 CIGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPEL 255
             G+ HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE 
Sbjct: 140 Q-GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE- 195
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +     Y    DIWS G ++  +L G  P   G S  D   EI+  +G+           
Sbjct: 196 VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG---------- 243
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                KF  +    W+ V +      A DLV +     P+ R TA +   HP+  +
Sbjct: 244 -----KF-TLSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 14  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-----YTYQICRALAYI 199
            +                          Y+ +H   PL Y        +  Q  + +AY+
Sbjct: 72  LNPV------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 200 HNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           H+     + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 176
Query: 258 GATEYTTAIDIWSTGCVMAELL 279
             + Y+   D++S G ++ E++
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVI 198

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 183 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 235
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 236 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 280
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 281 IMQSTKVPQTPLHTSRVL 298

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 144
           +G G+FG V++AK +ETG + A  KV++ K  +  E     ++I+   DHP IV L   +
Sbjct: 19  LGDGAFGKVYKAKNKETGALAA-AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +                    +  + R  +          +++   Q+  AL ++H+   
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQMLEALNFLHSK-R 129
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI----FGA 259
           I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 130 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 260 TEYTTAIDIWSTGCVMAELLLGQP 283
           T Y    DIWS G  + E+   +P
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEP 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 13  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-----YTYQICRALAYI 199
            +                          Y+ +H   PL Y        +  Q  + +AY+
Sbjct: 71  LNPV------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 200 HNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           H+     + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 175
Query: 258 GATEYTTAIDIWSTGCVMAELL 279
             + Y+   D++S G ++ E++
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVI 197

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 29/267 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ + +
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    D+                  + +     H R        +  ++  AL Y H  
Sbjct: 83  YFH---DRKRIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHER 134
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G T +
Sbjct: 135 -KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-H 190
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-------LGTPTREEIKCMNPN 315
              +D+W  G +  E L+G P F   S  +    I+ V       L   +++ I  +   
Sbjct: 191 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY 250
Query: 316 YTEFKFP--QIKPHPWHKVFQKR-LPP 339
           +   + P   +  HPW K   +R LPP
Sbjct: 251 HPPQRLPLKGVMEHPWVKANSRRVLPP 277

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++I ++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H R      +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVXEYASGGEV----FDYLVAHGRXKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 144
           +G G+FG V++AK +ETG + A  KV++ K  +  E     ++I+   DHP IV L   +
Sbjct: 27  LGDGAFGKVYKAKNKETGALAA-AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +                    +  + R  +          +++   Q+  AL ++H+   
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQMLEALNFLHSK-R 137
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI----FGA 259
           I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 138 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 260 TEYTTAIDIWSTGCVMAELLLGQP 283
           T Y    DIWS G  + E+   +P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEP 220

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 300
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 301 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 339
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 29/267 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ + +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    D+                  + +     H R        +  ++  AL Y H  
Sbjct: 82  YFH---DRKRIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHER 133
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G T +
Sbjct: 134 -KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-H 189
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-------LGTPTREEIKCMNPN 315
              +D+W  G +  E L+G P F   S  +    I+ V       L   +++ I  +   
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY 249
Query: 316 YTEFKFP--QIKPHPWHKVFQKR-LPP 339
           +   + P   +  HPW K   +R LPP
Sbjct: 250 HPPQRLPLKGVMEHPWVKANSRRVLPP 276

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 142
           Y+ +  +G GS+    +   + T    A+K + + KR  + E++I ++   HPNI+ LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    D                +++I R      +    +      + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHSQ 140
Query: 203 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
            G+ HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 257 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
                Y    DIWS G ++  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
               KF  +    W+ V +      A DLV +     P+ R TA +   HP+
Sbjct: 244 ----KFT-LSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF--F 145
            ++G+G FG VF+AK R  G+   I++V  +     RE++ +  LDH NIV    C+  F
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 77
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSR-----------------IHQRM-----PLI 183
               +                   +R+ ++                 I +R       ++
Sbjct: 78  DYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 137
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
            ++L+  QI + + YIH+   + HRD+KP N+ +   T Q+K+ DFG    L        
Sbjct: 138 ALELFE-QITKGVDYIHSK-KLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTR 194
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
              +  Y +PE I  + +Y   +D+++ G ++AELL
Sbjct: 195 SKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 253
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 254 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 305 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 361
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 300
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 421
Query: 301 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 339
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 422 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 467

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 127/318 (39%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 78  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 121
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK             +
Sbjct: 122 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYT 180
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 181 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 233
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 234 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 278
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 279 IMQSTKVPQTPLHTSRVL 296

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 139/313 (44%), Gaps = 60/313 (19%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 73  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 199 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 246
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 247 -----SRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
                +  +RAPEL+  +    T      +IDI+S GCV    +L +   P      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 248
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
            II+  G  + +E+KC++                     + L  EA DL+ +   + P  
Sbjct: 249 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 286
Query: 356 RCTALEACVHPFF 368
           R TA++   HP F
Sbjct: 287 RPTAMKVLRHPLF 299

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 261
           I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 262 --YTTAIDIWSTGCVMAELLLGQP 283
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 261
           I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 262 --YTTAIDIWSTGCVMAELLLGQP 283
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 300
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 301 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 339
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 300
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 301 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 339
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I  ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVAL 140
           I   V+G G FG   +   RETGE++ +K+++    + +R   +E+++M+ L+HPN++  
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK- 71
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              F     K              T+  I ++   +  + P      +   I   +AY+H
Sbjct: 72  ---FIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPN-------------VSYI 245
           + + I HRD+   N LV  + + + + DFG A+++V  K +P               + +
Sbjct: 126 S-MNIIHRDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
            + Y+ APE+I G + Y   +D++S G V+ E++
Sbjct: 184 GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 101/243 (41%), Gaps = 58/243 (23%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----------V 234
           V+ Y   + +AL  IH   GI HRD+KP N L N    +  L DFG A+           
Sbjct: 119 VREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 235 LVKGEP-------NVSYIC-SRY-----------YRAPELIFGATEYTTAIDIWSTGCVM 275
            V+ E        N   IC SR            +RAPE++      TTAID+WS G + 
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 276 AELLLGQ-PLFPGESGVDQLVEIIKVLGT--------------------PTR------EE 308
             LL G+ P +     +  L +I+ + G+                    P +      E 
Sbjct: 238 LSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCER 297
Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           ++ M+ +  +     I+ H  +      +P EA DL+ +    +P  R TA EA +HPFF
Sbjct: 298 LRGMDSSTPKLT-SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356
Query: 369 DEL 371
            ++
Sbjct: 357 KDM 359

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 47/256 (18%)
Query: 124 RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 108
Query: 183 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 109 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 165
Query: 240 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
                  +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 166 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 225
Query: 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 226 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 260
Query: 355 LRCTALEACVHPFFDE 370
            R TA EA  HPFF +
Sbjct: 261 KRYTAEEALAHPFFQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 47/256 (18%)
Query: 124 RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 121
Query: 183 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 122 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 178
Query: 240 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
                  +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 239 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 273
Query: 355 LRCTALEACVHPFFDE 370
            R TA EA  HPFF +
Sbjct: 274 KRYTAEEALAHPFFQQ 289

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 17  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 76
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 77  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 128
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 129 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 185
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 228
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 229 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 257
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 180
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 318 EFKFPQIKPHPWHKV 332
           ++K  +   +PW K+
Sbjct: 220 DWKEKKTYLNPWKKI 234

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+C FG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 266 IDIWSTGCVMAELLLG 281
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 257
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 318 EFKFPQIKPHPWHKV 332
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 90  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     TG+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I       QI  ++ + H   
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI------QQILESVNHCH-LN 122
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
           GI HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 223
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            FP  +   W  V      PEA DL+ +    +P  R TA EA  HP+ 
Sbjct: 224 DFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G+ G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 15  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 75  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 126
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 127 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 183
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 226
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 227 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 254
            H   GI HRD+KP N+L++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 90  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     TG+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I       QI  ++ + H   
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI------QQILESVNHCH-LN 122
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
           GI HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 223
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            FP  +   W  V      PEA DL+ +    +P  R TA EA  HP+ 
Sbjct: 224 DFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 257
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE-------------------YS 218
Query: 318 EFKFPQIKPHPWHKV 332
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 121/290 (41%), Gaps = 46/290 (15%)
Query: 90  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +      G+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                                 +  +AR Y         I       QI  A+ + H  +
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCI------QQILEAVLHCHQ-M 129
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
           G+ HR++KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRK 187
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 230
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
            FP  +   W  V      PEA DL+ +    +P+ R TA EA  HP+  
Sbjct: 231 DFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWIS 272

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 57/306 (18%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYKNRELQIM-Q 130
           Y  + V+G G   VV +   R TG   A+K            ++ + +    RE  I+ Q
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLY 188
           +  HP+I+ L   + S++                 + R    +  + +++ L     +  
Sbjct: 156 VAGHPHIITLIDSYESSS----------FMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
              +  A++++H    I HRD+KP+N+L++ +  Q++L DFG +  L  GE       + 
Sbjct: 206 MRSLLEAVSFLH-ANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTP 263
Query: 249 YYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
            Y APE++  + +     Y   +D+W+ G ++  LL G P F     +  L  I      
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI------ 317
Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                   M   Y +F  P+     W             DL+ R  Q  P  R TA +A 
Sbjct: 318 --------MEGQY-QFSSPE-----WDD-----RSSTVKDLISRLLQVDPEARLTAEQAL 358
Query: 364 VHPFFD 369
            HPFF+
Sbjct: 359 QHPFFE 364

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 261
           I HRD+K  N+L       +KL DFG SAK     +    +I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 262 --YTTAIDIWSTGCVMAELLLGQP 283
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 75  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQI 128
           N ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI 81
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 188
            + L HPNIV L       +                 +  +AR +         I     
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI----- 134
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYIC 246
             QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  
Sbjct: 135 -QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           +  Y +PE +     Y+  +DIW+ G ++  LL+G P F  E   DQ             
Sbjct: 193 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQ---------HRLY 239
Query: 307 EEIKCMNPNYTEFKFPQIKPHP-WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
            +IK    +Y         P P W  V      PEA  L+      +P  R TA +A   
Sbjct: 240 AQIKAGAYDY---------PSPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 366 PFF 368
           P+ 
Sbjct: 286 PWI 288

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 257
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 318 EFKFPQIKPHPWHKV 332
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 257
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 318 EFKFPQIKPHPWHKV 332
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+C FG +K  V        + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKV 197
Query: 266 IDIWSTGCVMAELLLG 281
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 118/293 (40%), Gaps = 41/293 (13%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALK 141
            Y  +  +G GS+ V  +   + T    A+K + + KR    E++I ++   HPNI+ LK
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLK 82
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +    D                +++I R      +    +      + I + + Y+H 
Sbjct: 83  DVY---DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-----FTITKTVEYLH- 133
Query: 202 CIGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPEL 255
             G+ HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + APE 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTANFVAPE- 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +     Y  A DIWS G ++  +L G   F      D   EI+  +G+            
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSG----------- 238
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
               KF  +    W+ V        A DLV +     P+ R TA     HP+ 
Sbjct: 239 ----KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRAPE 254
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V+     I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 254
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
              G +    + D++S GCV+ E+L G+P F G+S
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 124/318 (38%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K  LQD     RE++          I++++D 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-XLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 124 YENLYAGRKCLLIVXECLDG----------------GELFSRIQDRGDQAFTEREASEIX 167
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 168 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D WS G +   LL G P F    G      +    G  TR 
Sbjct: 227 PYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG------LAISPGXKTR- 278
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
               +     EF  P+     W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 279 ----IRXGQYEFPNPE-----WSEVSE-----EVKXLIRNLLKTEPTQRXTITEFXNHPW 324
Query: 368 FDE-LRDPNTRLPNGRPL 384
             +  + P T L   R L
Sbjct: 325 IXQSTKVPQTPLHTSRVL 342

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           Y+    +G G F  V   +    G   A+K++L    QD+    RE  + ++ +HPNI+ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 140 L-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIAR-----NYSRIHQRMPLIYVKLYTYQIC 193
           L  +C      K                N I R     N+    Q + L+        IC
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL------GIC 144
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS---AKVLVKGEPNVSYI----- 245
           R L  IH   G  HRD+KP N+L+     Q  L D GS   A + V+G      +     
Sbjct: 145 RGLEAIH-AKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 246 --CSRYYRAPELIFGATEYTTA---IDIWSTGCVMAELLLGQ 282
             C+  YRAPEL F    +       D+WS GCV+  ++ G+
Sbjct: 203 QRCTISYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRAPE 254
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V+     I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRAPE 254
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V+     I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 94
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 95  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 148
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRAPE 254
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V+     I +  Y +PE
Sbjct: 149 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 207 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 118/293 (40%), Gaps = 41/293 (13%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALK 141
            Y  +  +G GS+ V  +   + T    A+K + + KR    E++I ++   HPNI+ LK
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLK 82
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +    D                +++I R      +    +      + I + + Y+H 
Sbjct: 83  DVY---DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVL-----FTITKTVEYLH- 133
Query: 202 CIGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPEL 255
             G+ HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + APE 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFVAPE- 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +     Y  A DIWS G ++   L G   F      D   EI+  +G+            
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSG----------- 238
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
               KF  +    W+ V        A DLV +     P+ R TA     HP+ 
Sbjct: 239 ----KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 13/196 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G G+FGV    + ++  E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + + 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYAH-AMQVA 137
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+ DFG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKV 197
Query: 266 IDIWSTGCVMAELLLG 281
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 37/307 (12%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +++ V+G G  G V +   R TG+  A+K +    + +       Q    P+IV +   +
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIH 200
            +                   +      +SRI +R    + +    +I R    A+ ++H
Sbjct: 92  ENMHHGKRCLLIIMECMEGGEL------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 201 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +   I HRD+KP+NLL         LKL DFG AK   +         + YY APE + G
Sbjct: 146 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPE-VLG 202
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  + D+WS G +M  LL G P F   +G        + +    +  I+       +
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----GQ 249
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE-LRDPNTR 377
           + FP  +   W +V +     +A  L+    +  P  R T  +   HP+ ++ +  P T 
Sbjct: 250 YGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301
Query: 378 LPNGRPL 384
           L   R L
Sbjct: 302 LHTARVL 308

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/107 (39%), Positives = 64/107 (59%), Gaps = 7/107 (6%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YI 245
           +T QI   + + H+ + I HRDIKPQN+L++ +   LK+ DFG AK L +     +   +
Sbjct: 116 FTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETSLTQTNHVL 173
Query: 246 CSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
            +  Y +PE   G AT+  T  DI+S G V+ E+L+G+P F GE+ V
Sbjct: 174 GTVQYFSPEQAKGEATDECT--DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 37/307 (12%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +++ V+G G  G V +   R TG+  A+K +    + +       Q    P+IV +   +
Sbjct: 13  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 72
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIH 200
            +                   +      +SRI +R    + +    +I R    A+ ++H
Sbjct: 73  ENMHHGKRCLLIIMECMEGGEL------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 201 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +   I HRD+KP+NLL         LKL DFG AK   +         + YY APE + G
Sbjct: 127 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPE-VLG 183
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  + D+WS G +M  LL G P F   +G        + +    +  I+       +
Sbjct: 184 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----GQ 230
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE-LRDPNTR 377
           + FP  +   W +V +     +A  L+    +  P  R T  +   HP+ ++ +  P T 
Sbjct: 231 YGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 282
Query: 378 LPNGRPL 384
           L   R L
Sbjct: 283 LHTARVL 289

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQ 130
           ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L HPNIV L       +                 +  +AR +         I       
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------Q 112
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSR 248
           QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
            Y +PE +     Y+  +DIW+ G ++  LL+G P F  E
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQ 130
           ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L HPNIV L       +                 +  +AR +         I       
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------Q 112
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSR 248
           QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
            Y +PE +     Y+  +DIW+ G ++  LL+G P F  E
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 122/288 (42%), Gaps = 46/288 (15%)
Query: 90  VGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     TG     +I+  KK+  +D +   RE +I ++L H NIV L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I       QI  A+ + H  +
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAVLHCHQ-M 122
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
           G+ HRD+KP+NLL+        +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +DIW+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 EAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----------------GAY 223
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            FP  +   W  V      PEA +L+ +    +P  R TA EA  HP+
Sbjct: 224 DFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQMLDHPN 136
           +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I + L HPN
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 65
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L       +                 +  +AR +         I       QI  ++
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------QQILESI 117
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y +PE
Sbjct: 118 AYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 176
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
            +     Y+  +DIW+ G ++  LL+G P F  E
Sbjct: 177 -VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 209

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 53/230 (23%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQ-------------------- 223
           +KLY  +I +AL Y+   + + H D+KP+N+L++ P+  +                    
Sbjct: 139 IKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 224 ---LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 280
              +KL DFG A    K + + S I +R YRAPE+I     +  + D+WS GCV+AEL  
Sbjct: 198 STGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYT 254
Query: 281 GQPLFPGESGVDQLVEIIKVL----------GTPTREEIKCMNPNYTEFKFPQ------- 323
           G  LF     ++ L  +  ++           T T    K +N +  +  +P+       
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINS 313
Query: 324 ----IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
                K  P +K+ +  L     D +    Q  P LR +  E   H F +
Sbjct: 314 IKHVKKCLPLYKIIKHEL---FCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 136/324 (41%), Gaps = 51/324 (15%)
Query: 81  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLD 133
           K ++    V+G G FG V   + R TG++ A KK+ + +  K         E QI++ ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
              +V+L + + +                   +      Y       P      Y  +IC
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI------YHMGQAGFPEARAVFYAAEIC 296
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             L  +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y AP
Sbjct: 297 CGLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E++     YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ + 
Sbjct: 355 EVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL- 400
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                     +K  P  + + +R  P+A  L  +     P  R      +A E   HP F
Sbjct: 401 ----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 369 DELRDPNTRLPNGRPLPPLFNFKP 392
            +L     RL  G   PP   FKP
Sbjct: 449 KKLN--FKRLGAGMLEPP---FKP 467

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 122/288 (42%), Gaps = 46/288 (15%)
Query: 90  VGTGSFGVVFQAKCRE-----TGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +   +        +I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I+      QI  ++ +IH   
Sbjct: 99  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH------QILESVNHIHQH- 149
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
            I HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSPE-VLRK 207
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +DIW+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----------------GAY 250
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            FP  +   W  V      PEA +L+ +    +P  R TA +A  HP+
Sbjct: 251 DFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 114/296 (38%), Gaps = 48/296 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
           V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 93  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 148
Query: 200 HNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 254
           H+   I HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + ++ APE
Sbjct: 149 HDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPE 205
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 206 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 249
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E
Sbjct: 250 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 43/277 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLD-HPNIVALKHCFF 145
           +G GSF +  +   +++ +  A+K +   KR +    +E+  +++ + HPNIV L   F 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              D+                 RI +           I  KL +     A++++H+ +G+
Sbjct: 77  ---DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHMHD-VGV 127
Query: 206 CHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEY 262
            HRD+KP+NLL       L  K+ DFG A++       +   C + +Y APEL+     Y
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGY 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             + D+WS G ++  +L GQ  F            VEI+K +                +F
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-------------GDF 233
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
            F   +   W  V Q     EA DL+       PN R
Sbjct: 234 SF---EGEAWKNVSQ-----EAKDLIQGLLTVDPNKR 262

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 136/324 (41%), Gaps = 51/324 (15%)
Query: 81  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLD 133
           K ++    V+G G FG V   + R TG++ A KK+ + +  K         E QI++ ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
              +V+L + + +                   +      Y       P      Y  +IC
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI------YHMGQAGFPEARAVFYAAEIC 296
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             L  +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y AP
Sbjct: 297 CGLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E++     YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ + 
Sbjct: 355 EVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL- 400
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                     +K  P  + + +R  P+A  L  +     P  R      +A E   HP F
Sbjct: 401 ----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 369 DELRDPNTRLPNGRPLPPLFNFKP 392
            +L     RL  G   PP   FKP
Sbjct: 449 KKLN--FKRLGAGMLEPP---FKP 467

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 20/164 (12%)
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           Y++Q+ R + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 204 YSFQVARGMEFLSSRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKG 259
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 301
            +R    + APE IF    Y+T  D+WS G ++ E+  LG   +PG       V++ +  
Sbjct: 260 DTRLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDF 311
Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 345
            +  RE ++   P Y+  +  QI    WH+  ++R  P   +LV
Sbjct: 312 CSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELV 353

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 114/296 (38%), Gaps = 48/296 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
           V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 146
Query: 200 HNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 254
           H+   I HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + ++ APE
Sbjct: 147 HDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPE 203
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 247
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E
Sbjct: 248 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  ++ + T E+ A+K + +D   ++ +++       ++ +   P  +   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+               VN     Y  I Q  R    +   Y  +I   L ++
Sbjct: 87  HSCFQTMDRLYFVMEY--------VNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFG 258
            +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I  
Sbjct: 138 QSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 194
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 233

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
              T                 +     + ++I   +          +I + L Y+H+   
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---------REILKGLDYLHSEKK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYT 263
           I HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 126 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 182
Query: 264 TAIDIWSTGCVMAELLLGQP 283
           +  DIWS G    EL  G+P
Sbjct: 183 SKADIWSLGITAIELARGEP 202

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 87/177 (49%), Gaps = 8/177 (4%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
             I+ C+    ++   F +I+ HPW +     LP E  ++        P+ +  ALE
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEIHLHSLSPGPS-KAAALE 291

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
              T                 +     + ++I   +          +I + L Y+H+   
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---------REILKGLDYLHSEKK 145
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYT 263
           I HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 146 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 202
Query: 264 TAIDIWSTGCVMAELLLGQP 283
           +  DIWS G    EL  G+P
Sbjct: 203 SKADIWSLGITAIELARGEP 222

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  ++ + T E+ A+K + +D   ++ +++       ++ +   P  +   
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+               VN     Y  I Q  R    +   Y  +I   L ++
Sbjct: 408 HSCFQTMDRLYFVMEY--------VNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFG 258
            +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I  
Sbjct: 459 QS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 515
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
              T                 +           +  PL   ++ T   +I + L Y+H+ 
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQIATILREILKGLDYLHSE 138
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 261
             I HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 139 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 195
Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
           Y +  DIWS G    EL  G+P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 232
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 118 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 175
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 176 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 235
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 236 HLIRWCLALRPSDRPTFEEIQNHPW 260

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
              T                 +     + ++I   +          +I + L Y+H+   
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---------REILKGLDYLHSEKK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEYT 263
           I HRDIK  N+L++ H  ++KL DFG A  L   +   + ++ + ++ APE+I   + Y 
Sbjct: 126 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYD 182
Query: 264 TAIDIWSTGCVMAELLLGQP 283
           +  DIWS G    EL  G+P
Sbjct: 183 SKADIWSLGITAIELARGEP 202

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 50/302 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 138
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 72  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 123
Query: 199 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 124 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +          D+WS G +   LL G   F GE+  + L              I  +N +
Sbjct: 183 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNYD 229
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           + E  F                   A D + R     P  R T  ++  H +   +R  N
Sbjct: 230 FDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
Query: 376 TR 377
            R
Sbjct: 277 VR 278

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 119 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 176
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 177 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 119 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 176
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 177 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 13/209 (6%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           +    F    +                +  I          +    +     ++   L Y
Sbjct: 72  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNVSYICSRYYRA 252
           +H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ +  + A
Sbjct: 132 LHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 189
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLG 281
           PE++     Y    DIWS G    EL  G
Sbjct: 190 PEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 13/209 (6%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           +    F    +                +  I          +    +     ++   L Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNVSYICSRYYRA 252
           +H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ +  + A
Sbjct: 137 LHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLG 281
           PE++     Y    DIWS G    EL  G
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 232
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 264
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 142 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 199
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 200 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 154 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 211
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 113/253 (44%), Gaps = 28/253 (11%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 246
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 307 EEIKCMNPNYTEF 319
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 134 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 191
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 251
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 252 HLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 135 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 192
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 252
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 253 HLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 38/246 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 146 ---------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                    +   K              T+  +  + +   QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 242
           +YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 243 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+K L
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKL 241
Query: 302 GTPTRE 307
            + + E
Sbjct: 242 RSVSIE 247

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 135 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 192
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 135 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 192
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 134 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 191
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 38/246 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 146 ---------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                    +   K              T+  +  + +   QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 242
           +YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 243 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+K L
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKL 241
Query: 302 GTPTRE 307
            + + E
Sbjct: 242 RSVSIE 247

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 167 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 224
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 225 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 10  ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 65
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 119
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 238
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 120 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 175
Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 176 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 9   ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 64
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 118
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 238
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 119 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 174
Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 175 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 246
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVG 178
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 307 EEIKCMNPNYTEF 319
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 17/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG V + + ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPL----YGAVR 155
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H+   I H D
Sbjct: 156 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHS-RRILHGD 210
Query: 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 263
           +K  N+L++       LCDFG A  L       S +   Y      + APE++ G +   
Sbjct: 211 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CD 269
Query: 264 TAIDIWSTGCVMAELLLG 281
             +D+WS+ C+M  +L G
Sbjct: 270 AKVDVWSSCCMMLHMLNG 287

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 22  ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 131
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 238
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 132 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 187
Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 188 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 246
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 178
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 307 EEIKCMNPNYTEF 319
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 17  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 121
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 246
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 179
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 237
Query: 307 EEIKCMNPNYTEF 319
           +  + ++  + +F
Sbjct: 238 QNPEKLSAIFRDF 250

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 174 SRIHQRMPL--IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL---KLCD 228
           S IH+R     +   +    +  AL ++HN  GI HRD+KP+N+L   H +Q+   K+CD
Sbjct: 100 SHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCE-HPNQVSPVKICD 157
Query: 229 FG-SAKVLVKGE------PNVSYIC-SRYYRAPELIFGATE----YTTAIDIWSTGCVMA 276
           FG  + + + G+      P +   C S  Y APE++   +E    Y    D+WS G ++ 
Sbjct: 158 FGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 277 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
            LL G P F G  G D   +  +    P  + +   +    +++FP      W       
Sbjct: 218 ILLSGYPPFVGRCGSDCGWD--RGEACPACQNMLFESIQEGKYEFPD---KDW-----AH 267
Query: 337 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
           +   A DL+ +        R +A +   HP+       NT
Sbjct: 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           VG GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 120
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 175
Query: 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 263
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 234
Query: 264 TAIDIWSTGCVMAELLLG 281
             +DIWS+ C+M  +L G
Sbjct: 235 AKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           VG GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 136
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 191
Query: 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 263
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 192 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 250
Query: 264 TAIDIWSTGCVMAELLLG 281
             +DIWS+ C+M  +L G
Sbjct: 251 AKVDIWSSCCMMLHMLNG 268

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+      I  +K    DK+ ++   E  IM   DHPNI+
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 94  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + +   + HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 147 LSDMSAV-HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 203
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G VM E++
Sbjct: 204 EAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 180 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
           +P+  +K     +  + +YIHN   ICHRD+KP N+L++ +  ++KL DFG ++ +V  +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKK 206
Query: 240 PNVSYICSRYYRAPELIFGATEYTTA-IDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              S   +  +  PE     + Y  A +DIWS G  +  +      F  +     LVE+ 
Sbjct: 207 IKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVELF 262
Query: 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR-------LPPEAVDLVCRFFQY 351
             + T   E             +P  + H  + +  K+       L  E +D +  F + 
Sbjct: 263 NNIRTKNIE-------------YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309
Query: 352 SPNLRCTALEACVHPFF-----DELRDPNTRLPNGR 382
           +P  R T+ +A  H +      ++LR+ +  L   R
Sbjct: 310 NPAERITSEDALKHEWLADTNIEDLREFSKELYKKR 345

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNRELQIMQMLDHPNIVALKHCFFSTT 148
           +G GS+G VF+ + +E G + A+K+ +   R  K+R  ++ ++  H  +     C     
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV--RL 122
Query: 149 DKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208
           ++                  + ++       +P   V  Y      ALA++H+  G+ H 
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHL 181
Query: 209 DIKPQNLLVNPHTHQLKLCDFG--------SAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           D+KP N+ + P   + KL DFG         A  + +G+P         Y APEL+ G+ 
Sbjct: 182 DVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPELLQGS- 231
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
            Y TA D++S G  + E+     L  G  G  QL
Sbjct: 232 -YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 38/221 (17%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 6   ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 61
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +                     +   R++ + H+ R+    + L
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 115
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 238
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 116 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVR 171
Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 172 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 28/230 (12%)
Query: 70  TIGG-RNGNSKQKVSYIAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE 125
           ++GG + G +++ V  +   ++G G FG V++       GE   VA+K   +D    N+E
Sbjct: 1   SMGGPQYGIAREDV--VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE 58
Query: 126 -----LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM 180
                  IM+ LDHP+IV L        ++                + + RN       +
Sbjct: 59  KFMSEAVIMKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSL 110
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
            ++ + LY+ QIC+A+AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E 
Sbjct: 111 KVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDED 167
Query: 241 NVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLF 285
                 +R    + +PE I     +TTA D+W     M E+L    QP F
Sbjct: 168 YYKASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+      I  +K    DK+ ++   E  IM   DHPNI+
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 73  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 126 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 182
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G VM E++
Sbjct: 183 EAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 22/223 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   K +   ++ A+K + + +  K  E         ++   D   I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           H  F   +               T+       S+   R+P    + Y  ++  A+  +H 
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTL------LSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 256
            +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++   
Sbjct: 194 -LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 257 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             G   Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+    VAIK +     DK+ ++   E  IM   DHPNI+
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 79  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 132 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 188
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G VM E++
Sbjct: 189 EAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 134
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 189
Query: 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 263
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 248
Query: 264 TAIDIWSTGCVMAELLLG 281
             +DIWS+ C+M  +L G
Sbjct: 249 AKVDIWSSCCMMLHMLNG 266

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 113/253 (44%), Gaps = 28/253 (11%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 17  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 121
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 246
           +CR    AL ++H+   + HR+IK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 179
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 237
Query: 307 EEIKCMNPNYTEF 319
           +  + ++  + +F
Sbjct: 238 QNPEKLSAIFRDF 250

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 50/302 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 138
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 93  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 144
Query: 199 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 145 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 203
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +          D+WS G +   LL G   F GE+  + L              I  +N +
Sbjct: 204 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNYD 250
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           + E  F                   A D + R     P  R    ++  H +   +R  N
Sbjct: 251 FDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRN 297
Query: 376 TR 377
            R
Sbjct: 298 VR 299

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG V + + ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPL----YGAVR 136
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H+   I H D
Sbjct: 137 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHS-RRILHGD 191
Query: 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 263
           +K  N+L++       LCDFG A  L         +   Y      + APE++ G +   
Sbjct: 192 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CD 250
Query: 264 TAIDIWSTGCVMAELLLG 281
             +D+WS+ C+M  +L G
Sbjct: 251 AKVDVWSSCCMMLHMLNG 268

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 85  IAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE-----LQIMQMLDHPN 136
           +   ++G G FG V++       GE   VA+K   +D    N+E       IM+ LDHP+
Sbjct: 11  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L        ++                + + RN       + ++ + LY+ QIC+A+
Sbjct: 71  IVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAM 122
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
           AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +P
Sbjct: 123 AYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSP 179
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGES 289
           E I     +TTA D+W     M E+L    QP F  E+
Sbjct: 180 ESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 85  IAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE-----LQIMQMLDHPN 136
           +   ++G G FG V++       GE   VA+K   +D    N+E       IM+ LDHP+
Sbjct: 27  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 86
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L        ++                + + RN       + ++ + LY+ QIC+A+
Sbjct: 87  IVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAM 138
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
           AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +P
Sbjct: 139 AYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSP 195
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLF 285
           E I     +TTA D+W     M E+L    QP F
Sbjct: 196 ESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 22/202 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG V++     T E+VAIK +       +     +E+ ++   D P I      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHNC 202
             +T                 +           +  PL   Y+     +I + L Y+H+ 
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLL-----------KPGPLEETYIATILREILKGLDYLHSE 135
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATE 261
             I HRDIK  N+L++     +KL DFG A  L   +   + ++ + ++ APE+I   + 
Sbjct: 136 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 192
Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
           Y    DIWS G    EL  G+P
Sbjct: 193 YDFKADIWSLGITAIELAKGEP 214

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 15/218 (6%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 136
            Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV         T+                +  +    ++  Q +   +V     Q+  AL
Sbjct: 67  IVRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 197 AYIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 251
              H        + HRD+KP N+ ++     +KL DFG A++L   E     ++ + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 184 SPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 83/193 (43%), Gaps = 31/193 (16%)
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDF--GSAKVLVKG-----EPNV 242
           +  AL ++H   GI HRD+KP+N+L         +K+CDF  GS   L         P +
Sbjct: 120 VAAALDFLHT-KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL 178
Query: 243 SYIC-SRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QL 294
           +  C S  Y APE++      AT Y    D+WS G V+  +L G P F G  G D     
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDR 238
Query: 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354
            E+ +V      E I+       +++FP      W       +  EA DL+ +       
Sbjct: 239 GEVCRVCQNKLFESIQ-----EGKYEFPD---KDW-----AHISSEAKDLISKLLVRDAK 285
Query: 355 LRCTALEACVHPF 367
            R +A +   HP+
Sbjct: 286 QRLSAAQVLQHPW 298

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 25/221 (11%)
Query: 73  GRNGNSKQKVSYI-AEHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN-- 123
           GR+   + + S I  E ++G+G  G V   + R  G+      I A+K    +++ ++  
Sbjct: 39  GRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
            E  IM   DHPNI+ L+        +              +++   R +      M L+
Sbjct: 99  SEASIMGQFDHPNIIRLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
            +      +   + Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +
Sbjct: 155 GM---LRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAA 208
Query: 244 YICSR-----YYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           Y  +       + APE I   T +++A D+WS G VM E+L
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 25/225 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 138
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 79  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 130
Query: 199 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 189
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           +          D+WS G +   LL G   F GE+  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPN+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        +               ++   R +     +  +I +      I   + Y
Sbjct: 108 HLE----GVVTRGKPVMIVIEFMENGALDAFLRKHD---GQFTVIQLVGMLRGIAAGMRY 160
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + AP
Sbjct: 161 LAD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTAP 217
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G VM E++
Sbjct: 218 EAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   K + T  I A+K + + +  K  E         ++   D   I AL 
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 156
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    D+               +  +    S+   ++P    + Y  ++  A+  IH 
Sbjct: 157 YAF---QDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 256
            +   HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++   
Sbjct: 210 -LHYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 267
Query: 257 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 310

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPNI+
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   +   +   +  +I +      I   + Y
Sbjct: 87  HLE----GVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMKY 139
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 140 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 196
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G VM E++
Sbjct: 197 EAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   K + T  I A+K + + +  K  E         ++   D   I AL 
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 140
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    D+               +  +    S+   ++P    + Y  ++  A+  IH 
Sbjct: 141 YAF---QDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 256
            +   HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++   
Sbjct: 194 -LHYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 251
Query: 257 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 140
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           K     T D               ++   + +N ++I+ +  L Y      QIC+ + Y+
Sbjct: 89  KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGMDYL 142
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAPEL 255
                  HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ APE 
Sbjct: 143 -GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           +   +++  A D+WS G  + ELL
Sbjct: 201 LM-QSKFYIASDVWSFGVTLHELL 223

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 123/295 (41%), Gaps = 38/295 (12%)
Query: 75  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN------ 123
            G   QK S ++   +G+G+FG V+ A  +E  + V +K     KVL+D   ++      
Sbjct: 19  EGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 124 -RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
             E+ I+  ++H NI+ +   F     +               ++  A  +   H R+  
Sbjct: 77  TLEIAILSRVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFA--FIDRHPRLDE 129
Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
                   Q+  A+ Y+     I HRDIK +N+++      +KL DFGSA  L +G+   
Sbjct: 130 PLASYIFRQLVSAVGYLR-LKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKLFY 187
Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVD--------- 292
           ++  +  Y APE++ G       +++WS G  +  L+  + P    E  V+         
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247
Query: 293 --QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ---IKPHPWHKVFQKRLPPEAV 342
             +L+ ++  L  P  E    +    T+    Q   +  + W +VF+   P   V
Sbjct: 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGV 302

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 140
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           K     T D               ++   + +N ++I+ +  L Y      QIC+ + Y+
Sbjct: 77  KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGMDYL 130
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAPEL 255
                  HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ APE 
Sbjct: 131 -GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           +   +++  A D+WS G  + ELL
Sbjct: 189 LM-QSKFYIASDVWSFGVTLHELL 211

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 174 SRIHQRMPL--IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL---KLCD 228
           S IH+R     +   +    +  AL ++HN  GI HRD+KP+N+L   H +Q+   K+CD
Sbjct: 100 SHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCE-HPNQVSPVKICD 157
Query: 229 FG-SAKVLVKGE------PNVSYIC-SRYYRAPELIFGATE----YTTAIDIWSTGCVMA 276
           F   + + + G+      P +   C S  Y APE++   +E    Y    D+WS G ++ 
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 277 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
            LL G P F G  G D   +  +    P  + +   +    +++FP      W       
Sbjct: 218 ILLSGYPPFVGRCGSDCGWD--RGEACPACQNMLFESIQEGKYEFPD---KDW-----AH 267
Query: 337 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
           +   A DL+ +        R +A +   HP+       NT
Sbjct: 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HN  G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNX-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGKFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL---------QIMQMLDHPNIVAL 140
           +G G FGVVF+AK +      AIK++    R  NREL         + +  L+HP IV  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 141 KHCFF--STTDKXXXXXXXXXXXXXXTVNR------IARNYSRIHQRMPLIYVKLYTYQI 192
            + +   +TT+K               + R             I +R   + + ++  QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL-QI 127
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNVSY- 244
             A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +Y 
Sbjct: 128 AEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 245 -----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
                + ++ Y +PE I G + Y+  +DI+S G ++ ELL
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 18  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 75  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 127 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 186 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 30/261 (11%)
Query: 90  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIV 138
           +G G+FG V +A         T   VA+K + +     + R    EL+I+  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARN----YSRIHQR-MPLIYVKLYTYQIC 193
            L                        T  R  RN    Y  +++  + L ++  Y++Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 250
           + + ++ +   I HRD+  +N+L++   + +K+CDFG A+ + K    V    +R    +
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
            APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +E  
Sbjct: 213 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRLKEGT 264
Query: 310 KCMNPNYTEFKFPQIKPHPWH 330
           +   P+YT  +  Q     WH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWH 285

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 18  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 75  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 127 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 186 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 108 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 160
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 161 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 217
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 218 EAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILIGELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 101/260 (38%), Gaps = 72/260 (27%)
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN---------------------- 214
           +Q +P+  VK    Q+ + L Y+H+   I H DIKP+N                      
Sbjct: 134 YQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQK 193
Query: 215 ------------------LLVNP------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
                             LLVNP         ++K+ D G+A  + K       I +R Y
Sbjct: 194 AGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQY 251
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTP 304
           R+ E++ GA  Y+T  DIWST C+  EL  G  LF   SG       D +  II++LG+ 
Sbjct: 252 RSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSI 310
Query: 305 TREEIKCMNPNYTEFKF---------PQIKPHPWHKVFQKRL------PPEAVDLVCRFF 349
            R     ++  Y+   F          ++KP     V  ++         +  D +    
Sbjct: 311 PRH--FALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPML 368
Query: 350 QYSPNLRCTALEACVHPFFD 369
           +  P  R +A E   HP+ +
Sbjct: 369 EMVPEKRASAGECLRHPWLN 388

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 82  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 132
           VSY+  E V+G G FG V + + +  G+    VAIK +      + R     E  IM   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQ 191
           +HPNI+ L+    ++                   N    ++ R++  +  +I +      
Sbjct: 73  EHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG 124
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 248
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S    
Sbjct: 125 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 249 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               + APE I    ++T+A D WS G VM E++
Sbjct: 183 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 145
           +VG G++G V++ +  +TG++ AIK   V  D+  +  +E+ +++   H   +A  +  F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 146 STTDKXXXXXXXXXXXX---XXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +                  +V  + +N       +   ++     +I R L+++H  
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH 148
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 257
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 149 -KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 205
Query: 258 --GATEYTTAIDIWSTGCVMAELLLGQP 283
              AT Y    D+WS G    E+  G P
Sbjct: 206 NPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 81  RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 133
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 98  RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 150
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 151 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 207
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 208 EAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 81  RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 133
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 15/217 (6%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V         T+                +  +    ++  Q +   +V     Q+  AL 
Sbjct: 68  VRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 198 YIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRA 252
             H        + HRD+KP N+ ++     +KL DFG A++L        +++ + YY +
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 185 PEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGVFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 15/217 (6%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V         T+                +  +    ++  Q +   +V     Q+  AL 
Sbjct: 68  VRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 198 YIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRA 252
             H        + HRD+KP N+ ++     +KL DFG A++L        +++ + YY +
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 184
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 185 PEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H+ + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPNIV     
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----L 98
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           F     +              ++ R+     AR      +R+ +       Y + + + Y
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM------AYDVAKGMNY 152
Query: 199 IHN-CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 251
           +HN    I HRD+K  NLLV+   + +K+CDFG +++         ++ S+       + 
Sbjct: 153 LHNRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWM 206
Query: 252 APELIFGATEYTTAIDIWSTGCVMAEL-LLGQP 283
           APE++        + D++S G ++ EL  L QP
Sbjct: 207 APEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 252
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 253 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 305
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 306 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 341

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H+ + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 250
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 251 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 303
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 304 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 339

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 243
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 244 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 296
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 297 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 332

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 98/260 (37%), Gaps = 70/260 (26%)
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV------------------- 217
           +Q +PL  VK    Q+ + L Y+H    I H DIKP+N+L+                   
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199
Query: 218 -----------------------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
                                        N    ++K+ D G+A  + K       I +R
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTR 257
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLG 302
            YR+ E++ G+  Y T  DIWST C+  EL  G  LF   SG       D +  II++LG
Sbjct: 258 QYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
Query: 303 TPTREEIKCMNPNYTEFK-------FPQIKPHPWHKVFQKRLP---PEAV---DLVCRFF 349
              R+ I     +   F          ++KP    +V  ++      EA    D +    
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML 376
Query: 350 QYSPNLRCTALEACVHPFFD 369
           +  P  R TA E   HP+ +
Sbjct: 377 ELIPEKRATAAECLRHPWLN 396

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 180 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
           + L ++  Y++Q+ + + ++ +   I HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 240 PNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLV 295
             V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG VF+     T ++VAIK +  D      E++ +Q      I  L  C  S   
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQ----EITVLSQCDSSYVT 84
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNCIGICH 207
           K                     +   + +  P    ++ T   +I + L Y+H+   I H
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI-H 143
Query: 208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAI 266
           RDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + Y +  
Sbjct: 144 RDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKA 201
Query: 267 DIWSTGCVMAELLLGQP 283
           DIWS G    EL  G+P
Sbjct: 202 DIWSLGITAIELAKGEP 218

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 200
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 191
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 191
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 245
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 298
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 299 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 200
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARN---YSRIH------QRMPLIYVKLYTYQICRAL 196
              +                      N   Y  IH      QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 242
           +YIH+  GI HR++KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 243 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++ V I+K L
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER-VNILKKL 241
Query: 302 GTPTRE 307
            + + E
Sbjct: 242 RSVSIE 247

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 200
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPNIV     
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----L 98
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           F     +              ++ R+     AR      +R+ +       Y + + + Y
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM------AYDVAKGMNY 152
Query: 199 IHN-CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 251
           +HN    I HR++K  NLLV+   + +K+CDFG +++        +++ S+       + 
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSSKSAAGTPEWM 206
Query: 252 APELIFGATEYTTAIDIWSTGCVMAEL-LLGQP 283
           APE++        + D++S G ++ EL  L QP
Sbjct: 207 APEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 97/222 (43%), Gaps = 18/222 (8%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ----MLDHPNIVALKHCF 144
           V+G G+F  V   K ++TG++ A+K + +    K  E+   +    +L + +   +    
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F+  D+               +  +    S+  +R+P    + Y  +I  A+  +H  +G
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMAIDSVHR-LG 182
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEP-NVSYICSRYYRAPELIFGATEY 262
             HRDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +PE++      
Sbjct: 183 YVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 263 TTAI------DIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
                     D W+ G    E+  GQ  F  +S  +   +I+
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 97/262 (37%), Gaps = 74/262 (28%)
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV------------------- 217
           +Q +PL  VK    Q+ + L Y+H    I H DIKP+N+L+                   
Sbjct: 124 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 183
Query: 218 -----------------------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
                                        N    ++K+ D G+A  + K       I +R
Sbjct: 184 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTR 241
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLG 302
            YR+ E++ G+  Y T  DIWST C+  EL  G  LF   SG       D +  II++LG
Sbjct: 242 QYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 300
Query: 303 TPTREEIKCMNPNYTEFKFPQ-------IKPHPWHKV--------FQKRLPPEAVDLVCR 347
              R+ I  +   Y++  F +        K  PW           + +       D +  
Sbjct: 301 KVPRKLI--VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLP 358
Query: 348 FFQYSPNLRCTALEACVHPFFD 369
             +  P  R TA E   HP+ +
Sbjct: 359 MLELIPEKRATAAECLRHPWLN 380

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 112/264 (42%), Gaps = 37/264 (14%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIVALK 141
            V+   +FG+   A CR     VA+K + +     + R    EL+I+  +  H N+V L 
Sbjct: 44  QVIEADAFGIDKTATCR----TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 99
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP---------LIYVKLYTYQI 192
                                  T  R  RN    ++  P         L ++  Y++Q+
Sbjct: 100 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQV 159
Query: 193 CRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY- 249
            + + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K    V    +R  
Sbjct: 160 AKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 250 --YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTR 306
             + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +
Sbjct: 216 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRLK 267
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWH 330
           E  +   P+YT  +  Q     WH
Sbjct: 268 EGTRMRAPDYTTPEMYQTMLDCWH 291

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 237
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 238 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 290
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 291 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 326

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 200
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 191
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V     +  G+    VAIK +      K R     E  IM   DHPN++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R       +  +I +      I   + Y
Sbjct: 98  HLE----GVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKY 150
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 252
           + + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + A
Sbjct: 151 LAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 208
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
           PE I    ++T+A D+WS G VM E++
Sbjct: 209 PEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 25/221 (11%)
Query: 73  GRNGNSKQKVSYI-AEHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN-- 123
           GR+   + + S I  E ++G+G  G V   + R  G+      I A+K    +++ ++  
Sbjct: 39  GRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
            E  IM   DHPNI+ L+        +              +++   R +      M L+
Sbjct: 99  SEASIMGQFDHPNIIRLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
            +      +   + Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +
Sbjct: 155 GM---LRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAA 208
Query: 244 YICSR-----YYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
              +       + APE I   T +++A D+WS G VM E+L
Sbjct: 209 XTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 191
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 134
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 253
           +   I HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 135 SQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 189
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E +    ++  A D+WS G  + ELL
Sbjct: 190 ECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 87  EHVVGTGSFGVVFQAKCRETG---EI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
           + V+G G FG V++   + +    E+ VAIK +      K R     E  IM    H NI
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L+        K               +++  R        + L+ +      I   + 
Sbjct: 109 IRLE----GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM---LRGIAAGMK 161
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRA 252
           Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S       + A
Sbjct: 162 YLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTA 218
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
           PE I    ++T+A D+WS G VM E++
Sbjct: 219 PEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 255
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
           + G  EY  ++D ++ G  + E++  +  F
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 255
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
           + G  EY  ++D ++ G  + E++  +  F
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 255
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
           + G  EY  ++D ++ G  + E++  +  F
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 255
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
           + G  EY  ++D ++ G  + E++  +  F
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C                           R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 151
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYRAP 253
               I HRD+  +N+L++ +   +K+ DFG AK + +G       E   S +   ++ AP
Sbjct: 152 AQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---FWYAP 206
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E +    ++  A D+WS G  + ELL
Sbjct: 207 ECL-KEYKFYYASDVWSFGVTLYELL 231

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 134
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 253
               I HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 135 AQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 189
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E +    ++  A D+WS G  + ELL
Sbjct: 190 ECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/300 (23%), Positives = 128/300 (42%), Gaps = 47/300 (15%)
Query: 81  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIV 138
           K+S+  + V+G G+ G +      +  + VA+K++L +   + +RE+Q+++  D HPN++
Sbjct: 23  KISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVI 81
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                 +  T+K              T+          H  +  I +     Q    LA+
Sbjct: 82  R-----YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL---LQQTTSGLAH 133
Query: 199 IHNCIGICHRDIKPQNLLVN-PHTH---QLKLCDFGSAKVLVKGEPNVSYIC----SRYY 250
           +H+ + I HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  +
Sbjct: 134 LHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 251 RAPELIFGATEY--TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
            APE++    +   T  +DI+S GCV    ++ +   P    + +   I+  LG  +   
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LGACS--- 246
Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + C++P                   +K     A +L+ +     P  R +A     HPFF
Sbjct: 247 LDCLHP-------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/332 (20%), Positives = 118/332 (35%), Gaps = 77/332 (23%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------- 123
           G +G+  Q   Y  +  +G GS+GVV  A         A+K + + K  +          
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 124 ---------------------RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXX--- 159
                                +E+ I++ LDHPN+V L        +             
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 160 -XXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218
                 T+  ++ + +R            Y   + + + Y+H    I HRDIKP NLLV 
Sbjct: 124 PVMEVPTLKPLSEDQAR-----------FYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG 171
Query: 219 PHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEYTT--AIDIWSTGCVM 275
              H +K+ DFG +      +  +S  + +  + APE +    +  +  A+D+W+ G  +
Sbjct: 172 EDGH-IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 335
              + GQ  F                     E I C++         +IK        Q 
Sbjct: 231 YCFVFGQCPF-------------------MDERIMCLH--------SKIKSQALEFPDQP 263
Query: 336 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +  +  DL+ R    +P  R    E  +HP+
Sbjct: 264 DIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 30/261 (11%)
Query: 90  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIV 138
           +G G+FG V +A         T   VA+K + +     + R    EL+I+  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARN----YSRIHQR-MPLIYVKLYTYQIC 193
            L                        T  R  RN    Y  +++  + L ++  Y++Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 250
           + + ++ +   I HRD+  +N+L++   + +K+ DFG A+ + K    V    +R    +
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
            APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +E  
Sbjct: 213 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXRRLKEGT 264
Query: 310 KCMNPNYTEFKFPQIKPHPWH 330
           +   P+YT  +  Q     WH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWH 285

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/215 (21%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G FG V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 9   ERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 69  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 122
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 123 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 179
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 287
           E +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 180 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 82  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 132
           VSY+  E V+G G FG V + + +  G+    VAIK +      + R     E  IM   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQ 191
           +HPNI+ L+    ++                   N    ++ R++  +  +I +      
Sbjct: 75  EHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG 126
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 248
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +   S    
Sbjct: 127 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 249 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               + APE I    ++T+A D WS G VM E++
Sbjct: 185 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 121/318 (38%), Gaps = 79/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK    GE        
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE-------- 173
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
                        +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 174 -------------KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 214
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 215 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 259
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 260 IMQSTKVPQTPLHTSRVL 277

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 67/131 (51%), Gaps = 19/131 (14%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-- 235
           Q++P+     Y  +I  AL+Y+H+ IG+ + D+KP+N+++     QLKL D G+   +  
Sbjct: 177 QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINS 233
Query: 236 ---VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
              + G P         ++APE++   T  T A DI++ G  +A L L  P   G   VD
Sbjct: 234 FGYLYGTPG--------FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VD 282
Query: 293 QLVEIIKVLGT 303
            L E   VL T
Sbjct: 283 GLPEDDPVLKT 293

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + HPNI
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK--------NRELQIMQMLDHP 135
           Y+   ++G GS+G V +    ET    A+K + + K  +         +E+Q+++ L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N++ L    ++   +               +       S   +R P+     Y  Q+   
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD-----SVPEKRFPVCQAHGYFCQLIDG 121
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRA 252
           L Y+H+  GI H+DIKP NLL+      LK+   G A+ L      +   +   S  ++ 
Sbjct: 122 LEYLHS-QGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 253 PELIFGATEYTT-AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV--------LGT 303
           PE+  G   ++   +DIWS G  +  +  G   F G++ + +L E I           G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGP 238
Query: 304 PTREEIKCM--NPNYTEFKFPQIKPHPWHKVFQKRLPP 339
           P  + +K M        F   QI+ H W   F+K+ PP
Sbjct: 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSW---FRKKHPP 273

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +      Q +    RE++I++ L H +IV  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSL------RDYLPRHC-VGLAQLLLFAQQICEGMAYLH 129
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 253
               I HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 130 AQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 184
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E +    ++  A D+WS G  + ELL
Sbjct: 185 ECL-KECKFYYASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +      Q +    RE++I++ L H +IV  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSL------RDYLPRHC-VGLAQLLLFAQQICEGMAYLH 128
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 253
               I HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 129 AQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 183
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E +    ++  A D+WS G  + ELL
Sbjct: 184 ECL-KECKFYYASDVWSFGVTLYELL 208

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 22/223 (9%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 139 ALKHCFFSTTDKXXXXXXXXXX-XXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
            L      TT +               TV     N   + +   LI ++     +   + 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVGGMN 126
Query: 198 YIHNCIGICHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           ++    GI HR+IKP N++  +      + KL DFG+A+ L   E  VS   +  Y  P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 255 LIFGAT-------EYTTAIDIWSTGCVMAELLLGQ-PLFPGES 289
           +   A        +Y   +D+WS G        G  P  P E 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 97/223 (43%), Gaps = 17/223 (7%)
Query: 72  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQI 128
           G  +    ++     +H +G G +G V++   ++    VA+K + +D        +E  +
Sbjct: 1   GSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 60
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 188
           M+ + HPN+V L         +               +    R  +R  Q +  + +   
Sbjct: 61  MKEIKHPNLVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYM 114
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
             QI  A+ Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  ++
Sbjct: 115 ATQISSAMEYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAK 171
Query: 249 Y---YRAPELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 287
           +   + APE +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 172 FPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ------IMQMLDHPN 136
           ++  ++++G G FG V++ +  + G +VA+K+ L+++R +  ELQ      ++ M  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGRLAD-GTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQI--CR 194
           ++ L+    + T++               +        R   + PL + K     +   R
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 150
Query: 195 ALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYY 250
            LAY+H+     I HRD+K  N+L++     + + DFG AK++   + +V      +  +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
            APE +    + +   D++  G ++ EL+ GQ  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ------IMQMLDHPN 136
           ++  ++++G G FG V++ +  + G +VA+K+ L+++R +  ELQ      ++ M  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGRLAD-GXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQI--CR 194
           ++ L+    + T++               +        R   + PL + K     +   R
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 142
Query: 195 ALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY--Y 250
            LAY+H+     I HRD+K  N+L++     + + DFG AK++   + +V         +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
            APE +    + +   D++  G ++ EL+ GQ  F
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/215 (21%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 9   ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 69  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 122
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 123 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAP 179
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 287
           E +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 180 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 12  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 72  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 125
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 126 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 182
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 183 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 227

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 75  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 128
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 129 EYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 185
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 186 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 230

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 183
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 22/223 (9%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 139 ALKHCFFSTTDKXXXXXXXXXX-XXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
            L      TT +               TV     N   + +   LI ++     +   + 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVGGMN 126
Query: 198 YIHNCIGICHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           ++    GI HR+IKP N++  +      + KL DFG+A+ L   E  V    +  Y  P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 255 LIFGAT-------EYTTAIDIWSTGCVMAELLLGQ-PLFPGES 289
           +   A        +Y   +D+WS G        G  P  P E 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 183
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 24/207 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V     +  G+    VAIK +      K R     E  IM   DHPN++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R       +  +I +      I   + Y
Sbjct: 72  HLE----GVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKY 124
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 252
           + + +   HR +  +N+LVN +    K+ DFG ++ L     + +Y  +        + A
Sbjct: 125 LAD-MNYVHRALAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
           PE I    ++T+A D+WS G VM E++
Sbjct: 183 PEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 200
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 458 GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPEL 255
           +     HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE 
Sbjct: 509 S-KRFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPES 563
Query: 256 IFGATEYTTAIDIWSTGCVMAELLL 280
           I     +T+A D+W  G  M E+L+
Sbjct: 564 I-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 24  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 83
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 84  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 137
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 138 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 194
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 195 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 239

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 2/96 (2%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           + +  Q+  A+ + H+  G+ HRDIK +N+L++      KL DFGS   L+  EP   + 
Sbjct: 142 RCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD 199
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
            +R Y  PE I     +     +WS G ++ +++ G
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  + ++   +  +   +    Q  R + Y+H  
Sbjct: 72  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLH-A 126
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF-- 257
             I HRD+K  N+ ++   + +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 127 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R +S     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 184
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 89  VVGTGSFGVVFQAKC---RETGEIVAIK-KVLQDKRYKNR------ELQIM-QMLDHPNI 137
           V+G+G+FG V  A      +TG  + +  K+L++K   +       EL++M Q+  H NI
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 138 VALK---------HCFFSTTDKXXXXXXXXXXXXXXTVNRIA-RNYSRIHQRMPLIYVKL 187
           V L          +  F                   + + I   N  R+ +   L  +  
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 188 -----YTYQICRALAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
                + YQ+ + + ++   +C+   HRD+  +N+LV  H   +K+CDFG A+ ++    
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVT-HGKVVKICDFGLARDIMSDSN 227
Query: 241 NVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            V    +R    + APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 184
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 80  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 131
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 132 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 186
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 187 -NFRRFTSASDVWMFGVCMWEILM 209

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 81  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 132
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 133 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 187
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 188 -NFRRFTSASDVWMFGVCMWEILM 210

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 75  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 126
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 127 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 181
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 182 -NFRRFTSASDVWMFGVCMWEILM 204

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 106 GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 157
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 158 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 212
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 213 -NFRRFTSASDVWMFGVCMWEILM 235

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 83  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 134
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 135 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 189
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 190 -NFRRFTSASDVWMFGVCMWEILM 212

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 184
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/227 (20%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 278 LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 331
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HR++  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 332 EYLEKK-NFIHRNLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 388
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 389 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 433

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 200
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 458 GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPEL 255
           +     HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE 
Sbjct: 509 SK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPES 563
Query: 256 IFGATEYTTAIDIWSTGCVMAELLL 280
           I     +T+A D+W  G  M E+L+
Sbjct: 564 I-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/227 (20%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 257 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 316
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 317 LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 370
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HR++  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 371 EYLEKK-NFIHRNLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 427
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 428 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 472

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 85  IAEHVVGTGSFGVVFQA--KCRETGEIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   + R+    VAIK + Q     D     RE QIM  LD+P I
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L     +                   V +         + +P+  V    +Q+   + 
Sbjct: 73  VRLIGVCQAEALMLVMEMAGGGPLHKFLVGK--------REEIPVSNVAELLHQVSMGMK 124
Query: 198 YIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------- 249
           Y+       HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        
Sbjct: 125 YLEE-KNFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 178
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           + APE I    ++++  D+WS G  M E L
Sbjct: 179 WYAPECI-NFRKFSSRSDVWSYGVTMWEAL 207

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  + ++   +  +   +    Q  R + Y+H  
Sbjct: 84  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLH-A 138
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIF-- 257
             I HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 71  IGGRNGNSKQKVSYIAEHV----------VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           +G +N  S   + Y +  +          +GTG FGVV   K R   + VAIK + +   
Sbjct: 3   LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM 61
Query: 121 YKN---RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 177
            ++    E ++M  L H  +V L   +   T +               +N +     R  
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
            +  L   K     +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++ 
Sbjct: 119 TQQLLEMCK----DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD 172
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAEL 278
            E   S + S++   +  PE++   +++++  DIW+ G +M E+
Sbjct: 173 DEETSS-VGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEI 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/343 (21%), Positives = 131/343 (38%), Gaps = 52/343 (15%)
Query: 89  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +  F +  +                 + I  ++      + + Y+      + +AL YIH
Sbjct: 92  RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 201 NCIGICHRDIKPQNLLVNPHT--------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 146 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 305
             L      Y    DI+S G    EL  G   F        L+E +      +L T T  
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 306 REEIKCMNPNYT--------EFKFPQIKP-------HPWHKVFQKRLPPEAVDLVCRFFQ 350
            EE+  M+P+ +               +P       HP+H+ F     P     V +  Q
Sbjct: 265 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQCLQ 319
Query: 351 YSPNLRCTALEACVHPFFDEL-RDPNTRLPN-GRPLPPLFNFK 391
            +P+ R +A     H FF ++ R  +  LP   RP+ P+ NF+
Sbjct: 320 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 137
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----------L 187
           V L     + T                 +N + R  SR+ +  P   +            
Sbjct: 113 VNL---LGACTHGGPVLVITEYCCYGDLLNFLRRK-SRVLETDPAFAIANSTLSTRDLLH 168
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 169 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 225 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   +   +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAP 183
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 137
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----------L 187
           V L     + T                 +N + R  SR+ +  P   +            
Sbjct: 113 VNL---LGACTHGGPVLVITEYCCYGDLLNFLRRK-SRVLETDPAFAIANSTASTRDLLH 168
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 169 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 225 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 75/343 (21%), Positives = 131/343 (38%), Gaps = 52/343 (15%)
Query: 89  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +  F +  +                 + I  ++      + + Y+      + +AL YIH
Sbjct: 76  RATFIADNELWVVTSFMAYGSAK---DLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 201 NCIGICHRDIKPQNLLVNPHT--------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 130 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 305
             L      Y    DI+S G    EL  G   F        L+E +      +L T T  
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 248
Query: 306 REEIKCMNPNYT--------EFKFPQIKP-------HPWHKVFQKRLPPEAVDLVCRFFQ 350
            EE+  M+P+ +               +P       HP+H+ F     P     V +  Q
Sbjct: 249 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQCLQ 303
Query: 351 YSPNLRCTALEACVHPFFDEL-RDPNTRLPN-GRPLPPLFNFK 391
            +P+ R +A     H FF ++ R  +  LP   RP+ P+ NF+
Sbjct: 304 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 346

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 12  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 72  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 125
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   +   +++   + AP
Sbjct: 126 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAP 182
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 183 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 227

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 85  IAEHVVGTGSFGVVFQA--KCRETGEIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   + R+    VAIK + Q     D     RE QIM  LD+P I
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L     +                   V +         + +P+  V    +Q+   + 
Sbjct: 399 VRLIGVCQAEALMLVMEMAGGGPLHKFLVGK--------REEIPVSNVAELLHQVSMGMK 450
Query: 198 YIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------- 249
           Y+       HR++  +N LLVN   H  K+ DFG +K L   +   SY  +R        
Sbjct: 451 YLEE-KNFVHRNLAARNVLLVN--RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 504
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           + APE I    ++++  D+WS G  M E L
Sbjct: 505 WYAPECI-NFRKFSSRSDVWSYGVTMWEAL 533

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 71  IGGRNGNSKQKVSYIAEHV----------VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           +G +N  S   + Y +  +          +GTG FGVV   K R   + VAIK + +   
Sbjct: 3   LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM 61
Query: 121 YKN---RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 177
            ++    E ++M  L H  +V L   +   T +               +N +     R  
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
            +  L   K     +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++ 
Sbjct: 119 TQQLLEMCK----DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD 172
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAEL 278
            E   S + S++   +  PE++   +++++  DIW+ G +M E+
Sbjct: 173 DEYTSS-VGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEI 214

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 137
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 195
           V L                         + R A          PL    L  ++ Q+ + 
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 172
Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 250
           +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +    +R    +
Sbjct: 173 MAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 229 MAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 137
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 45  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 104
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 195
           V L                         + R A          PL    L  ++ Q+ + 
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 164
Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 250
           +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +    +R    +
Sbjct: 165 MAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 221 MAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 16  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 71
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 126
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 263
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 127 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 183
Query: 264 TAIDIWSTGCVMAEL 278
           +  DIW+ G +M E+
Sbjct: 184 SKSDIWAFGVLMWEI 198

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 72
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 127
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 263
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 128 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 184
Query: 264 TAIDIWSTGCVMAEL 278
           +  DIW+ G +M E+
Sbjct: 185 SKSDIWAFGVLMWEI 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 23  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 78
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 133
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 263
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 134 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 190
Query: 264 TAIDIWSTGCVMAEL 278
           +  DIW+ G +M E+
Sbjct: 191 SKSDIWAFGVLMWEI 205

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 67
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 122
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 263
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 123 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 179
Query: 264 TAIDIWSTGCVMAEL 278
           +  DIW+ G +M E+
Sbjct: 180 SKSDIWAFGVLMWEI 194

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 80  QKVSYIAEHVVGTGSFGVVF------QAKCRETGEIVAIKKVLQDKRYKN--RELQIMQM 131
           ++V   ++ V+G G FGVV+      QA+ R    I ++ ++ + ++ +   RE  +M+ 
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-YTY 190
           L+HPN++AL                          +     + R  QR P +   + +  
Sbjct: 79  LNHPNVLALIGIMLPPEG-------LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
           Q+ R + Y+       HRD+  +N +++  +  +K+ DFG A+ ++  E   S    R+ 
Sbjct: 132 QVARGMEYLAEQ-KFVHRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHRHA 188
Query: 251 RAPELIFGATE------YTTAIDIWSTGCVMAELL 279
           R P + + A E      +TT  D+WS G ++ ELL
Sbjct: 189 RLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   +                  + +  + ++   +  LI +     Q  R + Y+H  
Sbjct: 84  LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMK-KLIDI---ARQTARGMDYLH-A 138
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIF-- 257
             I HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 119/306 (38%), Gaps = 67/306 (21%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L     S T                 +  +  +   I  ++ L +      QI + + Y+
Sbjct: 105 LLGVCLSPT----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW----CVQIAKGMMYL 156
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 256
                + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E I
Sbjct: 157 EER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 257 FGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
               ++T   D+WS G  + EL+   G+P                  G PTRE      P
Sbjct: 215 H-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTRE-----IP 252
Query: 315 NYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           +  E   + PQ              PP     +C    Y   ++C  ++A   P F EL 
Sbjct: 253 DLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFKELA 293
Query: 373 DPNTRL 378
              +R+
Sbjct: 294 AEFSRM 299

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGXLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 83  LLGICLTSTVQLIMQLMPFGXLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 134 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 192 ILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 119/306 (38%), Gaps = 67/306 (21%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L     S T                 +  +  +   I  ++ L +      QI + + Y+
Sbjct: 82  LLGVCLSPT----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW----CVQIAKGMMYL 133
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 256
                + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E I
Sbjct: 134 EER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 257 FGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
               ++T   D+WS G  + EL+   G+P                  G PTRE      P
Sbjct: 192 H-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTRE-----IP 229
Query: 315 NYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           +  E   + PQ              PP     +C    Y   ++C  ++A   P F EL 
Sbjct: 230 DLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFKELA 270
Query: 373 DPNTRL 378
              +R+
Sbjct: 271 AEFSRM 276

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 86  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 137 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 195 ILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V+    ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 30  ERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 89
Query: 137 IVALKHC------FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--Y 188
           +V L         F+  T+                      +Y R   R  +  V L   
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLL--------------DYLRECNREEVTAVVLLYM 135
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
             QI  A+ Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  ++
Sbjct: 136 ATQISSAMEYLEK-KNFIHRDLAARNCLVGEN-HVVKVADFGLSR-LMTGDTYTAHAGAK 192
Query: 249 Y---YRAPELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 287
           +   + APE +   T ++   D+W+ G ++ E+   G   +PG
Sbjct: 193 FPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPG 234

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 72  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQI 128
           GG      + ++++ E  +GTG FGVV   K R   + VAIK + +    ++    E ++
Sbjct: 1   GGSWEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKV 57
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 188
           M  L H  +V L   +   T +               +N +     R   +  L   K  
Sbjct: 58  MMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK-- 112
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
              +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++  E    Y  SR
Sbjct: 113 --DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDE----YTSSR 164
Query: 249 YYR-----APELIFGATEYTTAIDIWSTGCVMAEL 278
             +     +P  +   +++++  DIW+ G +M E+
Sbjct: 165 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 86  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 137 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 195 ILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 107 LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 158 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 215
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 216 ILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 83  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 134 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 192 ILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 92  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 143 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 200
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 201 ILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 163 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 218
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 219 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICSR 248
           QI   + Y+H    I H D+KPQN+L++       +K+ DFG ++ +         + + 
Sbjct: 139 QILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
            Y APE I      TTA D+W+ G +   LL     F GE   +  + I +V    + E 
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256
Query: 309 IKCMNPNYTEF------KFPQIKP-------HPWHKV--FQKRLPPE 340
              ++   T+F      K P+ +P       H W +   F+    PE
Sbjct: 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPE 303

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 88  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 139 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 196
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 197 ILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R +S     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +     S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTXXKASKGKLPIKWMAPESI 184
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 171 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 227 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALKH 142
           +G GSF  V++    ET   VA  + LQD++    E Q        ++ L HPNIV    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            + ST                 T+    + Y +  +   +  ++ +  QI + L ++H  
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTL----KTYLKRFKVXKIKVLRSWCRQILKGLQFLHTR 148
Query: 203 IG-ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE      +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--EEK 205
Query: 262 YTTAIDIWSTG 272
           Y  ++D+++ G
Sbjct: 206 YDESVDVYAFG 216

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   + + R       N+E+     +M  +D+P++  
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 116 LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 166
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 167 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 224
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 225 ILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 76  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 127 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 185 ILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MSLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 248 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 248 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFG--SAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGE 288
              DI++  CV+ E L G P + G+
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI   + Y
Sbjct: 79  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 130 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 187
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 188 ILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSYVKRSQG 212
Query: 248 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 69/320 (21%), Positives = 129/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNRELQIMQML 132
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 68
Query: 133 DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +  +++    C           K               +    R+     +  P      
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 186
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 244
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++PN+R 
Sbjct: 245 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPNMRP 277
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 278 TFLEIVNLLKDDLHPSFPEV 297

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKN-RELQIMQMLDHPNIVALKHCF 144
           +G G+FG VF  + R    +VA+K   +    D + K  +E +I++   HPNIV L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--C 202
              T K               +  +    +R+  +  L  V          + Y+ +  C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG----DAAAGMEYLESKCC 234
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE-LIFG 258
           I   HRD+  +N LV    + LK+ DFG ++    G    S    +    + APE L +G
Sbjct: 235 I---HRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 259 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 289
              Y++  D+WS G ++ E   LG   +P  S
Sbjct: 291 --RYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNVS 243
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +
Sbjct: 172 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 244 Y------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           Y      + ++ Y +PE I G   Y+  +DI+S G ++ ELL
Sbjct: 230 YATHXGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL 270

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA--------- 139
           V+G+G+FG V++      GE V I   ++  R         ++LD   ++A         
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 140 -LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L  C  ST                  ++ +  N  R+  +  L +      QI + ++Y
Sbjct: 84  LLGICLTSTVQ-----LVTQLMPYGCLLDHVRENRGRLGSQDLLNW----CMQIAKGMSY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + + + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E 
Sbjct: 135 LED-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     +T   D+WS G  + EL+
Sbjct: 193 IL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 141
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 96  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 144
Query: 202 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 141
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 96  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 144
Query: 202 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 95  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 149
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 150 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKN-RELQIMQMLDHPNIVALKHCF 144
           +G G+FG VF  + R    +VA+K   +    D + K  +E +I++   HPNIV L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--C 202
              T K               +  +    +R+  +  L  V          + Y+ +  C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG----DAAAGMEYLESKCC 234
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 261
           I   HRD+  +N LV    + LK+ DFG    + + E +  Y  S   R   + + A E 
Sbjct: 235 I---HRDLAARNCLVT-EKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 262 -----YTTAIDIWSTGCVMAELL-LGQPLFPGES 289
                Y++  D+WS G ++ E   LG   +P  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 141
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 89
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 90  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 138
Query: 202 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 139 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 198 PEALRG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 70  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 124
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 125 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI  L  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             +ST  +                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 70  MGYSTAPQLAIVTQWCEG------SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 32/218 (14%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKK-VLQDKRYKN----------RELQIMQMLDHP 135
           E  +G G FG+V + +  +   +VAIK  +L D   +           RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           NIV L +       +               +++       +  R+ L         I   
Sbjct: 84  NIVKL-YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML--------DIALG 134
Query: 196 LAYIHN-CIGICHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNVSYICSRY- 249
           + Y+ N    I HRD++  N+ +        +C    DFG+++  V    +VS +   + 
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLLGNFQ 191
Query: 250 YRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLF 285
           + APE I GA E  YT   D +S   ++  +L G+  F
Sbjct: 192 WMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 52/239 (21%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDKRYK-----NRELQI 128
           +  + Y+ +  +G G+FG VFQA+       E   +VA+K + ++          RE  +
Sbjct: 46  RNNIEYVRD--IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 129 MQMLDHPNIVAL--------KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM 180
           M   D+PNIV L          C                     TV  ++ +      R+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 181 ------PLIYVK--LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232
                 PL   +      Q+   +AY+       HRD+  +N LV      +K+ DFG +
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVG-ENMVVKIADFGLS 221
Query: 233 KVLVKGEPNVSYICSRYYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
           + +   +         YY+A            PE IF    YTT  D+W+ G V+ E+ 
Sbjct: 222 RNIYSAD---------YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIF 270

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 68/320 (21%), Positives = 128/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNRELQIMQML 132
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 12  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 65
Query: 133 DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +  +++    C           K               +    R+     +  P      
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 126 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 183
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 184 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 241
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++P +R 
Sbjct: 242 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMRP 274
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 275 TFLEIVNLLKDDLHPSFPEV 294

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 70/320 (21%), Positives = 128/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 128 IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 73  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 186
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 244
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++P +R 
Sbjct: 245 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMRP 277
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 278 TFLEIVNLLKDDLHPSFPEV 297

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 88  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 142
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 143 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 70/320 (21%), Positives = 129/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 16  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 73
Query: 128 IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 74  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 129
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HR++  +N +V  H   +K+ DFG  + + + +  
Sbjct: 130 LQEMIQMAAEIADGMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 187
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 188 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 245
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++PN+R 
Sbjct: 246 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPNMRP 278
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 279 TFLEIVNLLKDDLHPSFPEV 298

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 73/329 (22%), Positives = 130/329 (39%), Gaps = 81/329 (24%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 128 IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 73  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
           L  +     +I   +AY+ N     HR++  +N +V  H   +K+ DFG  + + +    
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---- 182
Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
                + YYR            APE +     +TT+ D+WS G V+ E+  L +  + G 
Sbjct: 183 -----TDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGL 236
Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
           S  +Q+++ +             M+  Y +      +P           P    DL+   
Sbjct: 237 SN-EQVLKFV-------------MDGGYLD------QP--------DNCPERVTDLMRMC 268
Query: 349 FQYSPNLRCTALEAC------VHPFFDEL 371
           +Q++PN+R T LE        +HP F E+
Sbjct: 269 WQFNPNMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 48/222 (21%)
Query: 90  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQDKRYK----NRELQIMQMLDHPNIVAL 140
           +G G+FG VF A+C      +   +VA+K + +          RE +++ ML H +IV  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 107
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 190
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 108 ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 191 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 165 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 213
Query: 250 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 214 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 254

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 70/320 (21%), Positives = 128/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 14  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 128 IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 72  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 127
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 128 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 185
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 186 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 243
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++P +R 
Sbjct: 244 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMRP 276
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 277 TFLEIVNLLKDDLHPSFPEV 296

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR------ELQIMQMLDHPNIVA 139
           V+G+G FG V +      GE + I    KV++DK  +         +  +  LDH +IV 
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L                         ++ + ++   +  ++ L +      QI + + Y+
Sbjct: 98  L----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----GVQIAKGMYYL 149
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 256
               G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A E I
Sbjct: 150 EEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 207
Query: 257 -FGATEYTTAIDIWSTGCVMAELL 279
            FG  +YT   D+WS G  + EL+
Sbjct: 208 HFG--KYTHQSDVWSYGVTVWELM 229

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 70/320 (21%), Positives = 128/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 128 IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 73  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 186
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 244
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++P +R 
Sbjct: 245 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMRP 277
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 278 TFLEIVNLLKDDLHPSFPEV 297

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 48/222 (21%)
Query: 90  VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 140
           +G G+FG VF A+C     E  +++   K L++     ++   RE +++ ML H +IV  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 190
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 79  ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 191 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 136 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 184
Query: 250 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 185 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 225

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 142
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 133
Query: 203 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 237
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 73/329 (22%), Positives = 129/329 (39%), Gaps = 81/329 (24%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 128 IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 73  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + +    
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---- 182
Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
                + YYR            APE +     +TT+ D+WS G V+ E+  L +  + G 
Sbjct: 183 -----TAYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGL 236
Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
           S  +Q+++ +             M+  Y +      +P           P    DL+   
Sbjct: 237 SN-EQVLKFV-------------MDGGYLD------QP--------DNCPERVTDLMRMC 268
Query: 349 FQYSPNLRCTALEAC------VHPFFDEL 371
           +Q++P +R T LE        +HP F E+
Sbjct: 269 WQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKK-VLQDKRYKN----------RELQIMQMLDHP 135
           E  +G G FG+V + +  +   +VAIK  +L D   +           RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           NIV L +       +               +++       +  R+ L         I   
Sbjct: 84  NIVKL-YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML--------DIALG 134
Query: 196 LAYIHN-CIGICHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNVSYICSRY- 249
           + Y+ N    I HRD++  N+ +        +C    DFG ++  V    +VS +   + 
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQ 191
Query: 250 YRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLF 285
           + APE I GA E  YT   D +S   ++  +L G+  F
Sbjct: 192 WMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEI-VAIKKVL-----QDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G+GSFG V++ K    G++ V I KV+     Q + ++N E+ +++   H NI+     
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL----L 96
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F     K                  +    ++  Q   LI +     Q  + + Y+H   
Sbjct: 97  FMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKF-QMFQLIDI---ARQTAQGMDYLH-AK 151
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSY-ICSRYYRAPELIFGAT 260
            I HRD+K  N+ ++     +K+ DFG A V  +  G   V     S  + APE+I    
Sbjct: 152 NIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210
Query: 261 E--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              ++   D++S G V+ EL+ G+  +   +  DQ++ ++
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 142
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 73
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 131
Query: 203 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 237
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALKH 142
           G G FGVV++     T   VA+KK+         + K+  ++E+++     H N+V L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
               ++D                ++R+    S +    PL +     +  C+      N 
Sbjct: 87  -LGFSSDGDDLCLVYVYXPNGSLLDRL----SCLDGTPPLSW-----HXRCKIAQGAANG 136
Query: 203 IGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 253
           I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y AP
Sbjct: 137 INFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
           E + G  E T   DI+S G V+ E++ G P
Sbjct: 196 EALRG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR------ELQIMQMLDHPNIVA 139
           V+G+G FG V +      GE + I    KV++DK  +         +  +  LDH +IV 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L                         ++ + ++   +  ++ L +      QI + + Y+
Sbjct: 80  L----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----GVQIAKGMYYL 131
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 256
               G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A E I
Sbjct: 132 EEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 257 -FGATEYTTAIDIWSTGCVMAELL 279
            FG  +YT   D+WS G  + EL+
Sbjct: 190 HFG--KYTHQSDVWSYGVTVWELM 211

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 142
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 73
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 131
Query: 203 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 237
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 48/222 (21%)
Query: 90  VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 140
           +G G+FG VF A+C     E  +++   K L++     ++   RE +++ ML H +IV  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 84
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 190
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 85  ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 191 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 142 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 190
Query: 250 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 191 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 231

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 142
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 72  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 129
Query: 203 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 237
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 130 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 170

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 31/211 (14%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQM--LDHPNIVALKHCFF 145
           V   G FG V++A+     E VA+K   +QDK+    E ++  +  + H NI+       
Sbjct: 31  VKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-- 203
             T                +++   +  + +     L ++      + R LAY+H  I  
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHI---AETMARGLAYLHEDIPG 143
Query: 204 -------GICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEP---NVSYICSRYYR 251
                   I HRDIK +N+L+    + L  C  DFG A     G+        + +R Y 
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 252 APELIFGATEYT----TAIDIWSTGCVMAEL 278
           APE++ GA  +       ID+++ G V+ EL
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 186
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 280
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 167
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 221
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 222 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 261
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 262 PKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 228
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 229 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 264
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 265 PKQRISIPELLAHPYVQIQTHPVNQMAKG 293

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 166
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 224
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 225 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 260
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 261 PKQRISIPELLAHPYVQIQTHPVNQMAKG 289

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 80/209 (38%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +      V   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDXXXVVKD 186
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 280
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	422
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-101
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-99
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-98
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-95
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-95
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-94
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-93
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-92
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-92
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-92
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-91
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-90
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-90
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-90
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-90
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-89
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-89
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-87
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-87
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-86
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-85
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-84
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-84
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-81
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-62
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-60
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-60
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-59
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-58
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-58
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-58
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-58
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-58
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-57
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-56
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-56
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-55
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-55
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-55
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-54
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-53
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-53
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-53
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-53
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-52
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-52
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-52
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-52
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-52
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-52
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-52
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-51
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-51
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-51
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-51
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-51
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-50
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-50
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-50
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-50
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-50
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-50
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-50
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-49
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-49
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-49
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-49
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-49
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-49
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-49
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-48
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-48
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-48
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-48
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-48
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-48
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-48
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-48
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-48
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-47
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-47
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-47
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-47
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-47
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-46
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-46
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-46
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-46
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-44
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-44
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-44
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-43
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-43
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-43
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-43
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-43
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-42
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-42
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-42
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-42
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-42
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-41
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-41
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-40
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-40
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-40
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-40
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-40
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-40
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-40
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-39
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-39
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-39
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-39
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-39
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-38
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-38
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-38
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-38
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-38
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-37
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-37
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-37
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-37
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-37
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-37
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-36
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-36
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-36
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-36
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-36
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-36
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-35
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-35
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-34
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-32
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-32
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-30
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-30
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-29
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-29
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-28
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-23
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-20
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-13
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-09

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  622 bits (1606), Expect = 0.0
 Identities = 242/359 (67%), Positives = 287/359 (79%), Gaps = 5/359 (1%)

Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88

Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K +E+YLNLVL+YVPETV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327

Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 414
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS   P     LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS-SNPPLATILIPPHARIQ 385

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  620 bits (1602), Expect = 0.0
 Identities = 228/366 (62%), Positives = 286/366 (78%), Gaps = 5/366 (1%)

Query: 52  EPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVA 111
               ++ +      +      G+ G  ++ ++Y    V+G GSFGVVFQAK  E+ E VA
Sbjct: 11  NGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VA 68

Query: 112 IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-ELYLNLVLEYVPETVNRIA 170
           IKKVLQDKR+KNRELQIM+++ HPN+V LK  F+S  DK+ E++LNLVLEYVPETV R +
Sbjct: 69  IKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRAS 128

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
           R+Y+++ Q MP++ +KLY YQ+ R+LAYIH+ IGICHRDIKPQNLL++P +  LKL DFG
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFG 187

Query: 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
           SAK+L+ GEPNVSYICSRYYRAPELIFGAT YTT IDIWSTGCVMAEL+ GQPLFPGESG
Sbjct: 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247

Query: 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350
           +DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+DL+ R  +
Sbjct: 248 IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLE 307

Query: 351 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 410
           Y+P+ R TA+EA  HPFFDELR    R+PNGR LPPLFN+   ELS + P+ I+RL+P+H
Sbjct: 308 YTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRLVPQH 366

Query: 411 ARKQNL 416
           A  + L
Sbjct: 367 AEAELL 372

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  595 bits (1535), Expect = 0.0
 Identities = 163/358 (45%), Positives = 224/358 (62%), Gaps = 12/358 (3%)

Query: 64  GHVIRTTIGGRNG--NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 121
           G ++           + K+   +  E + G G+FG V   K + TG  VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 122 KNRELQIMQML---DHPNIVALKHCFFSTT--DKEELYLNLVLEYVPETVNRIARNYSRI 176
           +NRELQIMQ L    HPNIV L+  F++    D+ ++YLN+V+EYVP+T++R  RNY R 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 177 HQRMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
               P I +K++ +Q+ R++  +H   + +CHRDIKP N+LVN     LKLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
              EPNV+YICSRYYRAPELIFG   YTTA+DIWS GC+ AE++LG+P+F G++   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYS 352
           EI++VLG P+RE ++ +NP++T+      K  PW  VF     +   EA DL+    QY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP-LFNFKPPELSGIPPETINRLIPE 409
           P  R    EA  HP+FDEL DP T+LPN + LP  LF F P E+  +      +L+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  572 bits (1476), Expect = 0.0
 Identities = 171/382 (44%), Positives = 243/382 (63%), Gaps = 43/382 (11%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHP 135
           G       Y     +GTGSFG+V +    E+G+  A+KKVLQD RYKNREL IM++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 136 NIVALKHCFFSTTDK---------------------------------EELYLNLVLEYV 162
           NI+ L   F++T D+                                 +  YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 163 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH 222
           P+T++++ +++ R  + +P+  + +Y YQ+ RA+ +IH+ +GICHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDN 179

Query: 223 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 282
            LKLCDFGSAK L+  EP+V+YICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 283 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAV 342
           PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +K   W K+  +  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 343 DLVCRFFQYSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKPP 393
           DL+ +  +Y P+LR    EA  HPFFD LR+        N+  P+G  + +P LFNF P 
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359

Query: 394 ELSGIPPETINRLIPEHARKQN 415
           ELS IP   +NR++P++     
Sbjct: 360 ELSIIPGNVLNRILPKNFSPNY 381

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  303 bits (779), Expect = e-101
 Identities = 106/312 (33%), Positives = 160/312 (51%), Gaps = 22/312 (7%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G GS+GVVF+ + R+TG+IVAIKK L+ +          RE+++++ L HPN+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F     K  L+L  V EY   TV      Y    + +P   VK  T+Q  +A+ + H   
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEY 262
              HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 320
              +D+W+ GCV AELL G PL+PG+S VDQL  I K LG       +    N  ++  K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 321 FPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
            P  +   P    F   +   A+ L+       P  R T  +   HP+F+ +R+    L 
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI-EDLA 298

Query: 380 NGRPLPPLFNFK 391
                P    + 
Sbjct: 299 KEHDKPAENLYF 310

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  297 bits (764), Expect = 4e-99
 Identities = 99/295 (33%), Positives = 154/295 (52%), Gaps = 21/295 (7%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG GS+G+V + + ++TG IVAIKK L+    K       RE+++++ L H N+V L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                 K+  YL  V E+V  T+      +      +    V+ Y +QI   + + H+  
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEY 262
            I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 320
             A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG       E+   NP +   +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 321 FPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P+IK   P  + +  +L    +DL  +     P+ R    E   H FF      
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  294 bits (756), Expect = 5e-98
 Identities = 99/324 (30%), Positives = 167/324 (51%), Gaps = 33/324 (10%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLD 133
           +YI    +G G++  V++ K + T  +VA+K++    R ++         RE+ +++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           H NIV L         ++ L L  V EY+ + + +   +       + +  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLDKDLKQYLDDCG---NIINMHNVKLFLFQLL 110

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYY 250
           R LAY H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--- 307
           R P+++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E   
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            I      +  + +P+ +          RL  +  DL+ +  Q+    R +A +A  HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

Query: 368 FDELRDPNTRLPNGRPLPPLFNFK 391
           F  L +   +LP+   +  L   +
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQ 308

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  293 bits (753), Expect = 4e-97
 Identities = 107/312 (34%), Positives = 158/312 (50%), Gaps = 33/312 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
           +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F         ++LV +++   +  I ++ S     +   ++K Y     + L Y+H
Sbjct: 78  -LDAFGHKSN----ISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH 129

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 257
               I HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNP 314
           GA  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           +Y    F      P H +F      + +DL+   F ++P  R TA +A    +F     P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299

Query: 375 NTRLPNGRPLPP 386
                   P P 
Sbjct: 300 GPTPGCQLPRPN 311

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  289 bits (741), Expect = 1e-95
 Identities = 88/303 (29%), Positives = 146/303 (48%), Gaps = 23/303 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQIMQML-DHPNIVAL 140
           Y     +G G +  VF+A      E V +K +  ++ K+ K RE++I++ L   PNI+ L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                    +       V E+V  T      ++ +++Q +    ++ Y Y+I +AL Y H
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH 147

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           +  GI HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+    
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 261 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYT 317
            Y  ++D+WS GC++A ++   +P F G    DQLV I KVLGT    +   K       
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266

Query: 318 EFK--FPQIKPHPWHKVF----QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
            F     +     W +      Q  + PEA+D + +  +Y    R TA EA  HP+F  +
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

Query: 372 RDP 374
              
Sbjct: 327 VKD 329

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  286 bits (734), Expect = 8e-95
 Identities = 101/294 (34%), Positives = 163/294 (55%), Gaps = 27/294 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG G++GVV++AK    G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                 +  L L  V E++ + + ++          +    +K+Y YQ+ R +A+ H   
Sbjct: 88  I---HSERCLTL--VFEFMEKDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 317
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           +  F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  286 bits (735), Expect = 8e-95
 Identities = 89/315 (28%), Positives = 148/315 (46%), Gaps = 34/315 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD----KR-YKNRELQIMQMLDHPNI 137
           Y+    +G G  G+VF A   +  + VAIKK+ L D    K     RE++I++ LDH NI
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 138 VALKHCF-----------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK 186
           V +                S T+   +Y+  V EY+   +  +          +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--- 243
           L+ YQ+ R L YIH+   + HRD+KP NL +N     LK+ DFG A+++     +     
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 244 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
             + +++YR+P L+     YT AID+W+ GC+ AE+L G+ LF G   ++Q+  I++ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 303 TPTREEIKCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
               E+ + +      +          P  ++    +  EAVD + +   +SP  R TA 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301

Query: 361 EACVHPFFDELRDPN 375
           EA  HP+      P 
Sbjct: 302 EALSHPYMSIYSFPM 316

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  285 bits (732), Expect = 3e-94
 Identities = 90/313 (28%), Positives = 151/313 (48%), Gaps = 41/313 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G V++A    T E VAIK++  +   +       RE+ +++ L H NI+ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                    L+L  + EY    + +        +  + +  +K + YQ+   + + H+  
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR- 151

Query: 204 GICHRDIKPQNLLVNPHTH----QLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 256
              HRD+KPQNLL++         LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMN 313
            G+  Y+T++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           P++ +  FP+ +     +V    L  E +DL+    +  P  R +A  A  HP+F     
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325

Query: 374 PNTRLPNGRPLPP 386
                       P
Sbjct: 326 ---------DFDP 329

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  282 bits (723), Expect = 2e-93
 Identities = 101/294 (34%), Positives = 158/294 (53%), Gaps = 28/294 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                 K+ L L  V E++ + + ++          +  +  K +  Q+   +AY H+  
Sbjct: 69  I---HTKKRLVL--VFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 317
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           +  F   +P PW     K L    +DL+ +  +  PN R TA +A  H +F E 
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  281 bits (722), Expect = 2e-92
 Identities = 106/349 (30%), Positives = 180/349 (51%), Gaps = 39/349 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQD-KR-YKNRELQIMQMLDHPN 136
           +  + ++G G++GVV  A  + TGEIVAIKK+          R    RE++I++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 137 IVALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           I+ + +     + +   E+Y+  + E +   ++R+        Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLR 123

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----------- 243
           A+  +H    + HRD+KP NLL+N     LK+CDFG A+++ +   + S           
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
           ++ +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 304 PTREEI--KCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
           P  +       +P   E+    P     P  K+F + + P+ +DL+ R   + P  R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300

Query: 360 LEACVHPFFDELRDPNTRLPNGRPLPPL-FNFKPPELSGIPPETINRLI 407
            EA  HP+     DPN   P G P+PP  F F       +  + + +LI
Sbjct: 301 KEALEHPYLQTYHDPN-DEPEGEPIPPSFFEFD-HYKEALTTKDLKKLI 347

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  280 bits (718), Expect = 2e-92
 Identities = 97/318 (30%), Positives = 159/318 (50%), Gaps = 37/318 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
           +G G++  V++   + TG  VA+K+V    +  +         RE+ +M+ L H NIV L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                    + +L L  V E++   + +   +R      + + L  VK + +Q+ + LA+
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPEL 255
            H    I HRD+KPQNLL+N    QLKL DFG A+    G P  ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 312
           + G+  Y+T+IDIWS GC++AE++ G+PLFPG +  +QL  I  ++GTP       +  +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 313 NPNYTEFKFPQIKPHPWHKVFQK----RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            P Y      Q  P    +V Q      L    +D +    Q +P++R +A +A  HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 369 DELRDPNTRLPNGRPLPP 386
            E       +   R    
Sbjct: 298 AEYYHH-ASMGGSRSHHH 314

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  279 bits (715), Expect = 3e-92
 Identities = 101/298 (33%), Positives = 157/298 (52%), Gaps = 28/298 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                  ++L L  V E+  + + +   + +     +    VK + +Q+ + L + H+  
Sbjct: 70  L---HSDKKLTL--VFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 316
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
             +            V   +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 237 KPYPMYP-ATTSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  279 bits (716), Expect = 2e-91
 Identities = 92/336 (27%), Positives = 153/336 (45%), Gaps = 37/336 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------------RELQI 128
           Y  +  + +GS+G V        G  VAIK+V                       RE+++
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 129 MQMLDHPNIVALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IY 184
           +    HPNI+ L+  F  F      +LYL  V E +   + ++        QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           +  R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 305 TREEIKCM-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
             E++    +P   +Y       +    W  V      P A+DL+ +  +++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 396
           +A  HP+F+ L DP   L  G      F+F      
Sbjct: 313 QALRHPYFESLFDPL-DLTEGLSER--FHFDESVTD 345

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  275 bits (706), Expect = 4e-90
 Identities = 102/307 (33%), Positives = 164/307 (53%), Gaps = 31/307 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQD----KR-YKNRELQIMQMLDHP 135
           Y++   VG+G++G V  A  + +GE VAIKK+    Q     KR Y  REL +++ + H 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           N++ L   F   +      + YL  V+ ++   + +I      +  +     ++   YQ+
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKI------MGLKFSEEKIQYLVYQM 135

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYR 251
            + L YIH+  G+ HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YR
Sbjct: 136 LKGLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYR 190

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P  E ++ 
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250

Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +     +    PQ     + ++F  R  P+A DL+ +  +   + R TA +A  HPFF
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

Query: 369 DELRDPN 375
           +  RDP 
Sbjct: 310 EPFRDPE 316

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  274 bits (702), Expect = 5e-90
 Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 32/304 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQML---DHPNI 137
           +G G++G V++A+   +G  VA+K V                 RE+ +++ L   +HPN+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L     ++    E+ + LV E+V + +             +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLD 134

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           ++H    I HRD+KP+N+LV      +KL DFG A++       ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++     P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244

Query: 315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                    FP   P P   V    +      L+     ++P+ R +A  A  H +  + 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

Query: 372 RDPN 375
            + N
Sbjct: 304 -EGN 306

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  276 bits (707), Expect = 5e-90
 Identities = 94/308 (30%), Positives = 166/308 (53%), Gaps = 28/308 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQD----KR-YKNRELQIMQMLDHPN 136
           Y     +G G++G+V  A        VAIKK+   +     +R    RE++I+    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 137 IVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           I+ +       +    +++Y+  V + +   + ++ +      Q +   ++  + YQI R
Sbjct: 87  IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLKT-----QHLSNDHICYFLYQILR 139

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYY 250
            L YIH+   + HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+Y
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
           RAPE++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ 
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 311 CM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           C+ N     +    P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

Query: 368 FDELRDPN 375
            ++  DP+
Sbjct: 317 LEQYYDPS 324

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  274 bits (702), Expect = 7e-90
 Identities = 95/330 (28%), Positives = 158/330 (47%), Gaps = 33/330 (10%)

Query: 74  RNGNSKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN-------RE 125
           ++G  +    Y     +G G++G VF+A+  +  G  VA+K+V      +        RE
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIRE 61

Query: 126 LQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL 182
           + +++ L   +HPN+V L      +    E  L LV E+V + +             +P 
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
             +K   +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++       +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-M 174

Query: 243 SY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           +    + + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ 
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233

Query: 300 VLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
           V+G P  E+     P         F      P  K     +     DL+ +   ++P  R
Sbjct: 234 VIGLPGEEDW----PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKR 288

Query: 357 CTALEACVHPFFDELRDPNTRLPNGRPLPP 386
            +A  A  HP+F +L      L +   LPP
Sbjct: 289 ISAYSALSHPYFQDLERCKENLDS--HLPP 316

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  273 bits (700), Expect = 6e-89
 Identities = 97/305 (31%), Positives = 158/305 (51%), Gaps = 26/305 (8%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     VG+G++G V  A    TG  VAIKK+          +   REL++++ + H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 138 VALKHCFF---STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           + L   F    +  D  + YL  V+ ++   + ++ ++     +++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLK 139

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAP 253
            L YIH   GI HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 312
           E+I     YT  +DIWS GC+MAE++ G+ LF G   +DQL EI+KV GTP  E ++ + 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254

Query: 313 NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           +     +    P+++   +  +      P AV+L+ +        R TA EA  HP+F+ 
Sbjct: 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

Query: 371 LRDPN 375
           L D  
Sbjct: 314 LHDTE 318

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  273 bits (699), Expect = 9e-89
 Identities = 98/337 (29%), Positives = 157/337 (46%), Gaps = 38/337 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQD----KR-YKNRELQIMQMLDHP 135
           Y     +G+G+ G+V  A        VAIKK+    Q+    KR Y  REL +M+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           NI+ L + F      E   ++Y+  V+E +   + ++      I   +    +    YQ+
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQV------IQMELDHERMSYLLYQM 136

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
              + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE+I G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253

Query: 313 NPNYTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTA 359
            P    +    P+   + + K+F            K    +A DL+ +      + R + 
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313

Query: 360 LEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 396
            EA  HP+ +   DP+       P  P       E +
Sbjct: 314 DEALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREHT 349

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  269 bits (689), Expect = 2e-87
 Identities = 88/315 (27%), Positives = 139/315 (44%), Gaps = 26/315 (8%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 144 FFSTTDKEELYLN---LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +             LV ++    +  +  N   +  +  L  +K     +   L YIH
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV--LVKGEPNVSY---ICSRYYRAPEL 255
               I HRD+K  N+L+      LKL DFG A+   L K      Y   + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 312
           + G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    +   
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259

Query: 313 NPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
              Y + +  + +        +     P A+DL+ +     P  R  + +A  H FF   
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS- 317

Query: 372 RDPNTRLPNGRPLPP 386
            DP      G     
Sbjct: 318 -DPMPSDLKGMLSTH 331

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  268 bits (686), Expect = 6e-87
 Identities = 104/307 (33%), Positives = 161/307 (52%), Gaps = 30/307 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y     VG+G++G V  A   +TG  VA+KK+ +        KR Y  REL++++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           N++ L   F      E   ++YL  V   +   +N I +      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYR 251
            R L YIH+   I HRD+KP NL VN    +LK+ DFG A+        ++ Y+ +R+YR
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++     Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + + +   +     Q+    +  VF     P AVDL+ +      + R TA +A  H +F
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

Query: 369 DELRDPN 375
            +  DP+
Sbjct: 316 AQYHDPD 322

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  270 bits (693), Expect = 1e-86
 Identities = 96/331 (29%), Positives = 156/331 (47%), Gaps = 40/331 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y     +G+G+ G+V  A        VAIKK+ +        KR Y  REL +M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           NI++L + F      E   ++YL  V+E +   + ++      I   +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQV------IQMELDHERMSYLLYQM 173

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
              + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE+I G   Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 313 NPNYTEF--KFPQIKPHPWHKVF-----------QKRLPPEAVDLVCRFFQYSPNLRCTA 359
            P    +    P+     + K+F            K    +A DL+ +     P  R + 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 360 LEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
            +A  HP+ +   DP        P P +++ 
Sbjct: 351 DDALQHPYINVWYDPAEVEA---PPPQIYDK 378

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  263 bits (674), Expect = 8e-85
 Identities = 97/373 (26%), Positives = 176/373 (47%), Gaps = 65/373 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---QD----KR-YKNRELQIMQ-MLDH 134
           Y     +G G++G+V+++  R TGE+VA+KK+    Q+    +R +  RE+ I+  +  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
            NIV L +   +  D++ +YL  V +Y+   ++ + R        +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIK 120

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----------- 243
            + Y+H+  G+ HRD+KP N+L+N   H +K+ DFG ++  V      +           
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 244 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 293 QLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLP----------- 338
           QL  II V+  P+ E+++ + +P          +                          
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 339 ----PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPE 394
                EA+DL+ +  Q++PN R +A +A  HPF     +PN           +      +
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN----EEPNCDHIITIPIND 354

Query: 395 LSGIPPETINRLI 407
                 +    L+
Sbjct: 355 NVKHSIDDYRNLV 367

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  265 bits (678), Expect = 1e-84
 Identities = 107/366 (29%), Positives = 160/366 (43%), Gaps = 87/366 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y   H++GTGS+G V +A  +    +VAIKK+L+        KR    RE+ I+  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 136 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 191
           ++V +            +ELY+  VLE       ++          + L  +++K   Y 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYV--VLEIADSDFKKL------FRTPVYLTELHIKTLLYN 164

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------- 243
           +   + Y+H+  GI HRD+KP N LVN     +K+CDFG A+ +   E   S        
Sbjct: 165 LLVGVKYVHSA-GILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 244 --------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--- 280
                               ++ +R+YRAPELI     YT AID+WS GC+ AELL    
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282

Query: 281 --------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM 312
                     PLFPG S                      DQL  I  +LGTP+ E+I+ +
Sbjct: 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342

Query: 313 -NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
              +   +   FP+ +     + F      +A+ L+ R   ++PN R T  E   HPFF 
Sbjct: 343 EKEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401

Query: 370 ELRDPN 375
           E+R   
Sbjct: 402 EVRIAE 407

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  264 bits (676), Expect = 1e-84
 Identities = 104/358 (29%), Positives = 159/358 (44%), Gaps = 79/358 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQD-KR-YKNRELQIMQMLDHP 135
           YI +H++G GS+G V+ A  + T + VAIKKV      L D KR    RE+ I+  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 136 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 191
            I+ L            +ELY+  VLE     + ++          + L   ++K   Y 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKL------FKTPIFLTEEHIKTILYN 137

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------- 243
           +     +IH   GI HRD+KP N L+N     +K+CDFG A+ +   +            
Sbjct: 138 LLLGENFIHES-GIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 244 ---------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ------ 282
                          ++ +R+YRAPELI     YT +IDIWSTGC+ AELL         
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 283 -----PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF 319
                PLFPG S                   DQL  I  ++GTPT +++K +  P   ++
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315

Query: 320 --KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
              FP  KP    + +   +  + ++L+    +++PN R T  +A  HP+  ++R   
Sbjct: 316 IKLFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  254 bits (650), Expect = 4e-81
 Identities = 89/362 (24%), Positives = 159/362 (43%), Gaps = 44/362 (12%)

Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 145
           VG G++G V++AK ++    +  A+K++       +  RE+ +++ L HPN+++L+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 146 STTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           S  D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 201 NCIGICHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEPNVSY------ICSRYYR 251
               + HRD+KP N+LV    P   ++K+ D G A++     P          + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---------GVDQLVEIIKVLG 302
           APEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262

Query: 303 TPTRE---------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
            P  +         E   +  ++    +       + +  + +   +A  L+ +     P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322

Query: 354 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 413
             R T+ +A   P+F E  DP             +  +       P +  ++   +  + 
Sbjct: 323 IKRITSEQAMQDPYFLE--DPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQG 380

Query: 414 QN 415
            N
Sbjct: 381 NN 382

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  207 bits (528), Expect = 1e-62
 Identities = 92/338 (27%), Positives = 149/338 (44%), Gaps = 73/338 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 134
           Y    V+G GSFG V +A   +  + VA+K V  +KR+      E++I++ L      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 135 PNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLI 183
            N++ +   F         F     E L +NL  +++      N+         Q   L 
Sbjct: 159 MNVIHMLENFTFRNHICMTF-----ELLSMNLYELIKK-----NK--------FQGFSLP 200

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
            V+ + + I + L  +H    I H D+KP+N LL       +K+ DFGS+      +   
Sbjct: 201 LVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVY 257

Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
           +YI SR+YRAPE+I GA  Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG
Sbjct: 258 TYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316

Query: 303 TPTREEIK-----------CMNPNYTEFKF---------------PQIKPHPWHKVFQKR 336
            P+++ +               P Y                     +++  P  + +   
Sbjct: 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376

Query: 337 LPPEA----VDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           L        +D + +  ++ P +R T  +A  HP+   
Sbjct: 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  198 bits (505), Expect = 7e-60
 Identities = 86/340 (25%), Positives = 137/340 (40%), Gaps = 44/340 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 135
           YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 136 NIVALKHC-----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
           + +   H       F+      +++ +V E + E +  + + Y   H+ +PLIYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKVLVKGEPNVSYI 245
           Q+   L Y+H   GI H DIKP+N+L+           +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIK 299
            +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP--------------EAVDLV 345
           +LG      ++        F   +       K+    L                E  D +
Sbjct: 256 LLGELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 346 CRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP 385
               Q  P  R  A     HP+  +           R L 
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  198 bits (505), Expect = 8e-60
 Identities = 96/347 (27%), Positives = 143/347 (41%), Gaps = 78/347 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 134
           Y  + ++G GSFG V +A  R   E VAIK +   K + N    E+++++++        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 135 PNIVALKHCF---------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLI 183
             IV LK  F         F     E L  NL              +  R      + L 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVF-----EMLSYNL-------------YDLLRNTNFRGVSLN 157

Query: 184 YVKLYTYQICRALAYIHNC-IGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPN 241
             + +  Q+C AL ++    + I H D+KP+N LL NP    +K+ DFGS+     G+  
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRI 215

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
             YI SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VL
Sbjct: 216 YQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274

Query: 302 GTPTRE--------------------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 341
           G P                        +K       E+K P  +        +   P   
Sbjct: 275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGR 334

Query: 342 ---------------VDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
                           DL+ R   Y P  R     A  H FF +  D
Sbjct: 335 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  194 bits (496), Expect = 3e-59
 Identities = 72/344 (20%), Positives = 123/344 (35%), Gaps = 68/344 (19%)

Query: 59  VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--- 115
           +G E  +    ++ GR         Y     +G+G    VFQ    E  +I AIK V   
Sbjct: 13  LGTENLYFQSMSVKGRI--------YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLE 63

Query: 116 -LQDKRYKN--RELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIA 170
              ++   +   E+  +  L   +  I+ L          + +Y+  V+E     +N   
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWL 118

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
           +      + +     K Y   +  A+  IH   GI H D+KP N L+      LKL DFG
Sbjct: 119 KK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFG 171

Query: 231 SAKVLVKGEPNV---SYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAE 277
            A  +     +V   S + +  Y  PE I             ++ +   D+WS GC++  
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231

Query: 278 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL 337
           +  G+  F         +  I             ++PN+ E +FP I             
Sbjct: 232 MTYGKTPFQQIINQISKLHAI-------------IDPNH-EIEFPDI------------P 265

Query: 338 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG 381
             +  D++    +  P  R +  E   HP+      P  ++  G
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  194 bits (495), Expect = 2e-58
 Identities = 77/346 (22%), Positives = 131/346 (37%), Gaps = 82/346 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 135
           ++    +G G+FG V   +  +  +  A+K V   K+Y      E  I++ +     ++ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 136 NIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLIY 184
           NIV     F         F     E L  +L  ++            NY        +  
Sbjct: 97  NIVKYHGKFMYYDHMCLIF-----EPLGPSLYEIIT---------RNNY----NGFHIED 138

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------------PH 220
           +KLY  +I +AL Y+     + H D+KP+N+L++                          
Sbjct: 139 IKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 221 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 280
           +  +KL DFG A    K + + S I +R YRAPE+I     +  + D+WS GCV+AEL  
Sbjct: 198 STGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYT 254

Query: 281 GQPLFPGESGVDQLVEIIKVLGTPTREEI---------KCMNPNYTEFKFPQIKPHPWHK 331
           G  LF     ++ L  +  ++    +  +         K +N +  +  +P+        
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314

Query: 332 VFQKRLPPEA--------VDLVCRFFQYSPNLRCTALEACVHPFFD 369
              K+  P           D +    Q  P LR +  E   H F +
Sbjct: 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  193 bits (493), Expect = 3e-58
 Identities = 79/354 (22%), Positives = 129/354 (36%), Gaps = 76/354 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 133
           Y     +G G+FG V +      G   VA+K +    +Y+     E+ +++ +      +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 134 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 182
               V +   F         F     E L  N    L+           N+    Q  PL
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAF-----ELLGKNTFEFLK---------ENNF----QPYPL 122

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------PHTHQL 224
            +V+   YQ+C AL ++H    + H D+KP+N+L                         +
Sbjct: 123 PHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181

Query: 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 284
           ++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E   G  L
Sbjct: 182 RVADFGSA--TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTL 238

Query: 285 FPGESGVDQLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKPHPWHKVFQK 335
           F      + LV + K+LG      I               + E            K  + 
Sbjct: 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298

Query: 336 RLPPEA------VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 383
            +  ++       DL+ R  ++ P  R T  EA +HPFF  L          R 
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  192 bits (489), Expect = 4e-58
 Identities = 58/304 (19%), Positives = 110/304 (36%), Gaps = 27/304 (8%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            L      TT +    L  ++E+ P       +    +     +P     +    +   +
Sbjct: 71  KLFAIEEETTTRH-KVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 197 AYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            ++    GI HR+IKP N++           KL DFG+A+ L   E  VS   +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 254 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 304
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           +               +    P        + L      ++    +          +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 365 HPFF 368
               
Sbjct: 303 ETSD 306

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  192 bits (491), Expect = 4e-58
 Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 60/319 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN- 136
           Y     +G+G    VFQ    E  +I AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 137 -IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            I+ L          + +Y+  V+E     +N   +      + +     K Y   +  A
Sbjct: 70  KIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEA 120

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
           +  IH   GI H D+KP N L+      LKL DFG A  +     +V   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 253 PELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
           PE I             ++ +   D+WS GC++  +  G+  F         +  I    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
                    ++PN+ E +FP I               +  D++    +  P  R +  E 
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 271

Query: 363 CVHPFFDELRDPNTRLPNG 381
             HP+      P  ++  G
Sbjct: 272 LAHPYVQIQTHPVNQMAKG 290

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  193 bits (493), Expect = 6e-58
 Identities = 69/325 (21%), Positives = 116/325 (35%), Gaps = 60/325 (18%)

Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQM 131
           S +   Y     +G+G    VFQ    E  +I AIK V  ++           E+  +  
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 132 LDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 189
           L   +  I+ L          + +Y+  V+E     +N   +      + +     K Y 
Sbjct: 111 LQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYW 161

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYIC 246
             +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   S + 
Sbjct: 162 KNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 247 SRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
           +  Y  PE I             ++ +   D+WS GC++  +  G+  F         + 
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

Query: 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
            I             ++PN+ E +FP I               +  D++    +  P  R
Sbjct: 279 AI-------------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQR 312

Query: 357 CTALEACVHPFFDELRDPNTRLPNG 381
            +  E   HP+      P  ++  G
Sbjct: 313 ISIPELLAHPYVQIQTHPVNQMAKG 337

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  190 bits (485), Expect = 3e-57
 Identities = 79/345 (22%), Positives = 135/345 (39%), Gaps = 76/345 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 133
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q+++ L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 134 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 182
               V +   F         F     E L L+    ++            +        L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVF-----ELLGLSTYDFIK---------ENGF----LPFRL 117

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------PHTHQL 224
            +++   YQIC+++ ++H+   + H D+KP+N+L                         +
Sbjct: 118 DHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 284
           K+ DFGSA      E + + + +R+YRAPE+I     ++   D+WS GC++ E  LG  +
Sbjct: 177 KVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTV 233

Query: 285 FPGESGVDQLVEIIKVLGTPTREEI-KCMNPNY---TEFKFPQIKP-----HPWHKVFQK 335
           FP     + L  + ++LG   +  I K     Y       + +            K  ++
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293

Query: 336 RLPPE------AVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            +  +        DL+ +  +Y P  R T  EA  HPFFD L+  
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  186 bits (474), Expect = 5e-56
 Identities = 67/287 (23%), Positives = 106/287 (36%), Gaps = 49/287 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM-QMLDHPNIVALK 141
            +G GS+G VF+ + +E G + A+K+ +      +D+  K  E+    ++  HP  V L+
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +    +   LY  L  E    +   + ++       +P   V  Y      ALA++H+
Sbjct: 124 QAWE---EGGILY--LQTELCGPS---LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             G+ H D+KP N+ + P     KL DFG    L              Y APEL+     
Sbjct: 176 Q-GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGS 231

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y TA D++S G  + E+     L  G  G  QL +                         
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--------------------- 270

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           P+             L  E   ++    +  P LR TA      P  
Sbjct: 271 PEFTAG---------LSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  185 bits (472), Expect = 6e-56
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 42/299 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+  +       +AIK++  +D RY      E+ + + L H NIV      
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           +  +  E  ++ + +E VP  +++ + R+ +  +      I    YT QI   L Y+H+ 
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN 141

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGATE 261
             I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I     
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200

Query: 262 -YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y  A DIWS GC + E+  G+P F       +L E    +                 FK
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------FK 237

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
               K HP      + +  EA   + + F+  P+ R  A +  V  F           P
Sbjct: 238 VGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  188 bits (480), Expect = 1e-55
 Identities = 62/302 (20%), Positives = 118/302 (39%), Gaps = 51/302 (16%)

Query: 81  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIV 138
           K+S+  + V+G G+ G +   +       VA+K++L +   + +RE+Q+++  D HPN++
Sbjct: 23  KISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVI 81

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                      K+  +  + +E         + +         P+  ++    Q    LA
Sbjct: 82  RYFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLA 132

Query: 198 YIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKVLVKGEPNVSY---IC-SRY 249
           ++H+   I HRD+KP N+L++        +  + DFG  K L  G  + S    +  +  
Sbjct: 133 HLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 250 YRAPELIFGATE--YTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306
           + APE++    +   T  +DI+S GCV   ++  G   F                G   +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQ 235

Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            +   +            + H             A +L+ +     P  R +A     HP
Sbjct: 236 RQANILLGAC-SLDCLHPEKH---------EDVIARELIEKMIAMDPQKRPSAKHVLKHP 285

Query: 367 FF 368
           FF
Sbjct: 286 FF 287

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  185 bits (471), Expect = 5e-55
 Identities = 58/394 (14%), Positives = 105/394 (26%), Gaps = 57/394 (14%)

Query: 22  SSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQK 81
           S   + D   R++L+          E+   EP  +      T           +  S+ +
Sbjct: 2   SHMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGE 61

Query: 82  VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDH 134
                   +  G   VVF  +  E  E  A+K                +        L  
Sbjct: 62  RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121

Query: 135 PNIVALKHCF---------------------FSTTDKEELYLNLVLEYVP---ETVNRIA 170
            +    +                            D       L++       E +    
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
                      ++ + + T Q+ R  A + +  G+ H    P NL + P    L L D  
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGR-LMLGDVS 239

Query: 231 SAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           +   +  G    +      Y   E +      +T A++ W  G  +  +      F   +
Sbjct: 240 ALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 290 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
              +       L  P  +                             LP     L+ RF 
Sbjct: 298 PGIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFL 337

Query: 350 QYSPNLRCTALEACVHPFFDELRD-PNTRLPNGR 382
            +    R   LEA   P F +L++  ++ L  G+
Sbjct: 338 NFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  186 bits (473), Expect = 6e-55
 Identities = 63/313 (20%), Positives = 115/313 (36%), Gaps = 32/313 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            L      TT +      L++E+ P       +    +     +P     +    +   +
Sbjct: 71  KLFAIEEETTTR-HKV--LIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGM 125

Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            ++    GI HR+IKP N++           KL DFG+A+ L   E  VS   +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 254 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 304
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           +               +    P        + L      ++    +          +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQ--- 299

Query: 365 HPFFDELRDPNTR 377
             FF E  D   R
Sbjct: 300 --FFAETSDILHR 310

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  180 bits (459), Expect = 7e-54
 Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 61/320 (19%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD 133
           + +    +    V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60

Query: 134 HPNIVALKHCF--------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 183
           H  +V     +          T  K++  L + +EY       + I        +     
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
             +    QI  AL+YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK + +    + 
Sbjct: 121 LFR----QILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILK 174

Query: 244 YICSR---------------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
                                Y A E++ G   Y   ID++S G +  E++   P   G 
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGM 232

Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
                 V I+K L +                +FP     P    F          ++   
Sbjct: 233 E----RVNILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLL 267

Query: 349 FQYSPNLRCTALEACVHPFF 368
             + PN R  A       + 
Sbjct: 268 IDHDPNKRPGARTLLNSGWL 287

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  183 bits (467), Expect = 1e-53
 Identities = 75/323 (23%), Positives = 127/323 (39%), Gaps = 60/323 (18%)

Query: 75  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD 133
           N     K   ++E ++G GS G V   +    G  VA+K++L D       E++++   D
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66

Query: 134 -HPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARN--YSRIHQRMPLIYVKLYT 189
            HPN++   +C  +      LY+   LE       + +          +           
Sbjct: 67  DHPNVIRY-YCSET--TDRFLYI--ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVK 237
            QI   +A++H+   I HRD+KPQN+LV+  +             ++ + DFG  K L  
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 238 GEPNVSY----IC-SRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL-LGQPLF 285
           G+ +          +  +RAPEL+  +         T +IDI+S GCV   +L  G+  F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 345
             +    +   II+                   F   ++K      +       EA DL+
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276

Query: 346 CRFFQYSPNLRCTALEACVHPFF 368
            +   + P  R TA++   HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  178 bits (455), Expect = 1e-53
 Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 45/299 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           V          D+    L +V+EY     +  +    ++  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 197 AYIH----NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYR 251
              H        + HRD+KP N+ ++     +KL DFG A++L            + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           +PE +     Y    DIWS GC++ EL    P F   S   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                 E KF +I               E  +++ R        R +  E   +P   E
Sbjct: 230 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  187 bits (475), Expect = 4e-53
 Identities = 81/322 (25%), Positives = 132/322 (40%), Gaps = 29/322 (9%)

Query: 72  GGRNGNSKQKV--SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----R 124
           GGR+ +   +    +  +  +GTG FG V +   ++TGE VAIK+  Q+   KN      
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLN-LVLEYVP--ETVNRIARNYSRIHQRMP 181
           E+QIM+ L+HPN+V+ +             L  L +EY    +    + +        + 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLK 119

Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGE 239
              ++     I  AL Y+H    I HRD+KP+N+++ P   +   K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 240 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
               ++ +  Y APEL+    +YT  +D WS G +  E + G   F       Q    ++
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ----YSPNL 355
                + E I   +      KF  + P P        L       + R+ Q    +    
Sbjct: 238 ---EKSNEHIVVYDDLTGAVKFSSVLPTP------NHLSGILAGKLERWLQCMLMWHQRQ 288

Query: 356 RCTALEACVHPFFDELRDPNTR 377
           R T  +      F  L    + 
Sbjct: 289 RGTDPQNPNVGCFQALDSILSL 310

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  183 bits (466), Expect = 5e-53
 Identities = 73/318 (22%), Positives = 127/318 (39%), Gaps = 52/318 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
           Y     +G+G++G V   + + T    AIK +               E+ ++++LDHPNI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           + L   F     +++    LV+E     E  + I     ++        +   +   Q+ 
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNE-------VDAAVIIKQVL 146

Query: 194 RALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
             + Y+H    I HRD+KP+N LL +      +K+ DFG + V    +     + + YY 
Sbjct: 147 SGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++    +Y    D+WS G ++  LL G P F G++  DQ  EI+         +++ 
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEK 251

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
               +            W  V        A DL+ +  Q+    R +A +A  HP+  E+
Sbjct: 252 GKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

Query: 372 RDPNTRLPNGRPLPPLFN 389
                       L     
Sbjct: 299 CSKKESGIELPSLANAIE 316

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  182 bits (464), Expect = 1e-52
 Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 49/296 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K +    ++ K  K    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           I+ L   F     +++ Y  LV E     E  + I        +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLS 137

Query: 195 ALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
            + Y+H    I HRD+KP+N LL +      +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++ G   Y    D+WSTG ++  LL G P F G +  +   +I+        ++++  
Sbjct: 197 PEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEKG 242

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              +            W KV        A DL+ +   Y P++R +A +A  H + 
Sbjct: 243 KYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  182 bits (463), Expect = 1e-52
 Identities = 76/318 (23%), Positives = 129/318 (40%), Gaps = 52/318 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
           Y    ++G GSFG V + K R T +  A+K +       +D     RE+++++ LDHPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           + L        D    Y  +V E     E  + I +   +S                Q+ 
Sbjct: 84  MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131

Query: 194 RALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
             + Y+H    I HRD+KP+N LL +      +K+ DFG +    +       I + YY 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++ G   Y    D+WS G ++  LL G P F G++  +   +I+        + ++ 
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVET 236

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
               +            W  +       +A DL+ +   + P+LR TA +   HP+  + 
Sbjct: 237 GKYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

Query: 372 RDPNTRLPNGRPLPPLFN 389
                 + +   L     
Sbjct: 284 SSETPTISDLPSLESAMT 301

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  176 bits (448), Expect = 4e-52
 Identities = 66/328 (20%), Positives = 103/328 (31%), Gaps = 56/328 (17%)

Query: 70  TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRE 125
            I  ++        Y+    +G G F  V   +    G   A+K++L    QD+    RE
Sbjct: 25  IIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76

Query: 126 LQIMQMLDHPNIVALKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 183
             + ++ +HPNI+ L          K E +  L+L +    T+             +   
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTED 134

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG----- 238
            +      ICR L  IH   G  HRD+KP N+L+     Q  L D GS            
Sbjct: 135 QILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSR 192

Query: 239 -----EPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
                +   +  C+  YRAPEL             D+WS GCV+  ++ G+  +      
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252

Query: 292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY 351
              V +  V                 +   PQ            R       L+      
Sbjct: 253 GDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTV 286

Query: 352 SPNLRCTALEACVHPFFDELRDPNTRLP 379
            P+ R             +   P     
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPGQHTT 314

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  175 bits (446), Expect = 5e-52
 Identities = 77/327 (23%), Positives = 121/327 (37%), Gaps = 68/327 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 136
           Y+    +G G F   F+    +T E+ A K     +L     +     E+ I + L H +
Sbjct: 17  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V     F    D + ++  +VLE       +    R      + +     + Y  QI  
Sbjct: 77  VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 126

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYI 245
              Y+H    + HRD+K  NL +N    ++K+ DFG + KV   GE        PN    
Sbjct: 127 GCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN---- 180

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
               Y APE++     ++  +D+WS GC+M  LL+G+P F      +  + I K      
Sbjct: 181 ----YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 230

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                       E+  P              + P A  L+ +  Q  P  R T  E    
Sbjct: 231 ------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 266

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKP 392
            FF     P         +PP F+  P
Sbjct: 267 EFFTSGYIPARLPITCLTIPPRFSIAP 293

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  178 bits (454), Expect = 7e-52
 Identities = 84/305 (27%), Positives = 138/305 (45%), Gaps = 54/305 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------RELQIMQM 131
           YI    +G+G+ G V  A  R+T + VAI+ + + K                 E++I++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 189
           L+HP I+ +K+ F    D E+ Y  +VLE +   E  +++       ++R+     KLY 
Sbjct: 197 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 245

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICS 247
           YQ+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   +
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

Query: 248 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
             Y APE++       Y  A+D WS G ++   L G P F        L + I   G   
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 360

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                       ++ F    P  W +V       +A+DLV +     P  R T  EA  H
Sbjct: 361 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 400

Query: 366 PFFDE 370
           P+  +
Sbjct: 401 PWLQD 405

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  180 bits (459), Expect = 7e-52
 Identities = 81/306 (26%), Positives = 127/306 (41%), Gaps = 59/306 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------------REL 126
           Y     +G+G++G V   K +      AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 127 QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY 184
            +++ LDHPNI+ L   F    DK+  Y  LV E+    E   +I  N  +  +      
Sbjct: 98  SLLKSLDHPNIIKLFDVF---EDKKYFY--LVTEFYEGGELFEQII-NRHKFDEC----D 147

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNV 242
                 QI   + Y+H    I HRDIKP+N LL N ++   +K+ DFG +    K     
Sbjct: 148 AANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206

Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
             + + YY APE++    +Y    D+WS G +M  LL G P F G++  DQ  +II    
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII---- 256

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
               ++++     +          + W  +       EA +L+     Y  N RCTA EA
Sbjct: 257 ----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEEA 299

Query: 363 CVHPFF 368
               + 
Sbjct: 300 LNSRWI 305

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  174 bits (443), Expect = 9e-52
 Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 56/297 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 142
            +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPNIV    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            + ST   ++  + LV E +   T+    + Y +  + M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 202 C-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNVSYICSRYYRAP 253
               I HRD+K  N+ +   T  +K+ D G A +        V G P         + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E+     +Y  ++D+++ G  M E+   +  +       Q+   +               
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-------------- 243

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                     +KP      F K   PE  +++    + + + R +  +   H FF E
Sbjct: 244 --------SGVKP----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  175 bits (446), Expect = 2e-51
 Identities = 80/341 (23%), Positives = 125/341 (36%), Gaps = 71/341 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 136
           Y+    +G G F   F+    +T E+ A K     +L     +     E+ I + L H +
Sbjct: 43  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V     F    D + ++  +VLE       +    R      + +     + Y  QI  
Sbjct: 103 VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 152

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYI 245
              Y+H    + HRD+K  NL +N    ++K+ DFG + KV   GE        PN    
Sbjct: 153 GCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN---- 206

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
               Y APE++     ++  +D+WS GC+M  LL+G+P F      +  + I K      
Sbjct: 207 ----YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 256

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                       E+  P              + P A  L+ +  Q  P  R T  E    
Sbjct: 257 ------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 292

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRL 406
            FF     P         +PP F+  P   S + P     L
Sbjct: 293 EFFTSGYIPARLPITCLTIPPRFSIAP---SSLDPSNRKPL 330

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  174 bits (444), Expect = 2e-51
 Identities = 66/292 (22%), Positives = 108/292 (36%), Gaps = 47/292 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKH 142
              +  VG GSFG V + K ++TG   A+KKV L+   ++  EL     L  P IV L  
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYG 117

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                  +E  ++N+ +E +   ++ ++ +        +P      Y  Q    L Y+H 
Sbjct: 118 AV-----REGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHT 168

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPEL 255
              I H D+K  N+L++    +  LCDFG A  L       S +          + APE+
Sbjct: 169 R-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           + G       +DIWS+ C+M  +L G   +         ++I      P           
Sbjct: 228 VMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPI---------- 275

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                  +I P            P     +    +  P  R +A+E      
Sbjct: 276 ------REIPPS---------CAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  172 bits (439), Expect = 4e-51
 Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 46/317 (14%)

Query: 65  HVIRTTIGGRNGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQ 117
           H    + G  N   +  +   +I +  +G+G+FG V   + R +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSR 175
                  E+++++ LDHPNI+ +   F    D   +Y  +V+E     E + RI    +R
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF---EDYHNMY--IVMETCEGGELLERIVSAQAR 117

Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK 233
             + +   YV     Q+  ALAY H+   + H+D+KP+N+L    +    +K+ DFG A+
Sbjct: 118 -GKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

Query: 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 293
           +    E + +   +  Y APE+     + T   DIWS G VM  LL G   F G S  + 
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
             +                     E  +               L P+AVDL+ +     P
Sbjct: 234 QQKATYK-----------------EPNYA---VECRP------LTPQAVDLLKQMLTKDP 267

Query: 354 NLRCTALEACVHPFFDE 370
             R +A +   H +F +
Sbjct: 268 ERRPSAAQVLHHEWFKQ 284

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  175 bits (445), Expect = 6e-51
 Identities = 87/360 (24%), Positives = 135/360 (37%), Gaps = 48/360 (13%)

Query: 41  DQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQ 100
            +V    D     D            +   +  + G+      Y     +G+G+FGVV +
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY--YDILEELGSGAFGVVHR 69

Query: 101 AKCRETGEIVAIK----KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156
              + TG +   K        DK     E+ IM  L HP ++ L   F    DK E+   
Sbjct: 70  CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF---EDKYEMV-- 124

Query: 157 LVLEYVP--ETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ 213
           L+LE++   E  +RI A +Y      M    V  Y  Q C  L ++H    I H DIKP+
Sbjct: 125 LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPE 178

Query: 214 NLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTG 272
           N++        +K+ DFG A  L   E       +  + APE I          D+W+ G
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIG 237

Query: 273 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV 332
            +   LL G   F GE  ++ L  + +                  +++F       +  V
Sbjct: 238 VLGYVLLSGLSPFAGEDDLETLQNVKRC-----------------DWEFD---EDAFSSV 277

Query: 333 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPNGRPLPPLFNFK 391
                 PEA D +    Q  P  R T  +A  HP+   +  +  +R+P+ R        K
Sbjct: 278 -----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIK 332

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  171 bits (436), Expect = 9e-51
 Identities = 58/305 (19%), Positives = 110/305 (36%), Gaps = 52/305 (17%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
           + +  + +    ++G+G FG VF+AK R  G+   IK+V  +     RE++ +  LDH N
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVN 65

Query: 137 IVALKHCF-----------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 183
           IV    C+            +++  +   L + +E+         I +   R  +++  +
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK---RRGEKLDKV 122

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
                  QI + + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L        
Sbjct: 123 LALELFEQITKGVDYIHSK-KLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
              +  Y +PE I    +Y   +D+++ G ++AELL                ++      
Sbjct: 181 SKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD---- 233

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                                       +       +   L+ +     P  R    E  
Sbjct: 234 ---------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

Query: 364 VHPFF 368
                
Sbjct: 267 RTLTV 271

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  171 bits (435), Expect = 1e-50
 Identities = 76/306 (24%), Positives = 123/306 (40%), Gaps = 66/306 (21%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKHC 143
           G G FG V+ A+ +++  I+A+K     ++ +        RE++I   L HPNI+ L   
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    D   +Y  L+LEY P       + +       +        Y  ++  AL+Y H+
Sbjct: 78  FH---DATRVY--LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS 127

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRAPE 254
              + HRDIKP+NLL+      LK+ DFG +            G  +        Y  PE
Sbjct: 128 K-RVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YLPPE 177

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +I G   +   +D+WS G +  E L+G+P F   +  +    I +V              
Sbjct: 178 MIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------- 222

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
              EF FP      +       +   A DL+ R  +++P+ R    E   HP+       
Sbjct: 223 ---EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267

Query: 375 NTRLPN 380
            +   N
Sbjct: 268 PSNCQN 273

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  172 bits (437), Expect = 1e-50
 Identities = 72/294 (24%), Positives = 120/294 (40%), Gaps = 44/294 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 136
           +  E  +G G F  V++A C   G  VA+KKV        + +    +E+ +++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           ++     F      E+  LN+VLE      ++R+ +++ +  + +P   V  Y  Q+C A
Sbjct: 94  VIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRAPE 254
           L ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN 313
            I     Y    DIWS GC++ E+   Q  F G+   +  L + I+              
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-------------- 251

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
               +  +P +               E   LV       P  R           
Sbjct: 252 ----QCDYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  172 bits (438), Expect = 2e-50
 Identities = 84/303 (27%), Positives = 136/303 (44%), Gaps = 54/303 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN--------RELQIMQM 131
           YI    +G+G+ G V  A  R+T + VAIK    +       +          E++I++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 189
           L+HP I+ +K+ F    D E+ Y  +VLE +   E  +++       ++R+     KLY 
Sbjct: 72  LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 120

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICS 247
           YQ+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   +
Sbjct: 121 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179

Query: 248 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
             Y APE++       Y  A+D WS G ++   L G P F        L + I   G   
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 235

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                       ++ F    P  W +V       +A+DLV +     P  R T  EA  H
Sbjct: 236 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 275

Query: 366 PFF 368
           P+ 
Sbjct: 276 PWL 278

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  171 bits (436), Expect = 2e-50
 Identities = 79/306 (25%), Positives = 136/306 (44%), Gaps = 52/306 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----RELQIMQMLDHPNIVA 139
           +I   V+G+G+F  VF  K R TG++ A+K + +   +++     E+ +++ + H NIV 
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRA 195
           L+  +         Y  LV++ V   E  +RI     Y+   ++   + ++    Q+  A
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYT---EKDASLVIQ----QVLSA 118

Query: 196 LAYIHNCIGICHRDIKPQNLLV-NPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRA 252
           + Y+H   GI HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVA 175

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE +     Y+ A+D WS G +   LL G P F  E+      +I +             
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                 ++F       W  +        A D +C   +  PN R T  +A  HP+ D   
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269

Query: 373 DPNTRL 378
             +  +
Sbjct: 270 ALHRDI 275

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  172 bits (439), Expect = 2e-50
 Identities = 78/359 (21%), Positives = 127/359 (35%), Gaps = 68/359 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y+    +G GSFG     K  E G    IK++       +++    RE+ ++  + HPNI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V  +  F     +E   L +V++Y    +   RI     +         +  +  QIC A
Sbjct: 86  VQYRESF-----EENGSLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLA 137

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           L ++H+   I HRDIK QN+ +      ++L DFG A+VL            + YY +PE
Sbjct: 138 LKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +      Y    DIW+ GCV+ EL   +  F   S +  LV  I             ++ 
Sbjct: 196 ICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII------SGSFPPVSL 247

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL--- 371
           +Y                       +   LV + F+ +P  R +        F  +    
Sbjct: 248 HY---------------------SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286

Query: 372 -----------------RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 413
                            +  +  +P  RP     +        I        IP   +K
Sbjct: 287 FLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKK 345

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  170 bits (433), Expect = 3e-50
 Identities = 84/307 (27%), Positives = 132/307 (42%), Gaps = 52/307 (16%)

Query: 76  GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIM 129
           G++K  ++  Y  E+ +G GS+G V  A  + T    A K      ++D     +E++IM
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 185
           + LDHPNI+ L   F    D  ++Y  LV+E     E   R+     +            
Sbjct: 61  KSLDHPNIIRLYETF---EDNTDIY--LVMELCTGGELFERVVHKRVFRE-------SDA 108

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVS 243
                 +  A+AY H    + HRD+KP+N L    +    LKL DFG A     G+   +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167

Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
            + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +    
Sbjct: 168 KVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--- 222

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                          F FP      W  V      P+A  L+ R    SP  R T+L+A 
Sbjct: 223 --------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260

Query: 364 VHPFFDE 370
            H +F++
Sbjct: 261 EHEWFEK 267

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  172 bits (437), Expect = 3e-50
 Identities = 82/348 (23%), Positives = 133/348 (38%), Gaps = 84/348 (24%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---------QDKRYKNRELQIMQMLDH 134
           Y  +  +G GS+GVV  A   +T  I AIK +          +D      E+++M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKL----- 187
           PNI  L   +    D++ + L  V+E       ++++         +  +  VK      
Sbjct: 88  PNIARLYEVY---EDEQYICL--VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 188 ------------------------------YTYQICRALAYIHNCIGICHRDIKPQN-LL 216
                                            QI  AL Y+HN  GICHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201

Query: 217 VNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-----SRYYRAPELIFGATE-YTTAIDIWS 270
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 271 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            G ++  LL+G   FPG +  D + +++                   +  F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 331 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
            +      P A DL+      + + R  A+ A  HP+  +  D   ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  169 bits (430), Expect = 2e-49
 Identities = 74/295 (25%), Positives = 122/295 (41%), Gaps = 54/295 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVA---IKKVLQDKRYKNRELQIMQMLDHPNIVAL 140
           Y+    +G G FG+V +     + +      +K    D+    +E+ I+ +  H NI+ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VKLYTYQIC 193
              F      EEL   ++ E++   +   RI    +               +  Y +Q+C
Sbjct: 67  HESF---ESMEELV--MIFEFISGLDIFERINTSAFE---------LNEREIVSYVHQVC 112

Query: 194 RALAYIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYR 251
            AL ++H+   I H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y 
Sbjct: 113 EALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYY 170

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE +      +TA D+WS G ++  LL G   F  E+  +Q  +II        E I  
Sbjct: 171 APE-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMN 217

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
               + E  F +I               EA+D V R        R TA EA  HP
Sbjct: 218 AEYTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  167 bits (426), Expect = 4e-49
 Identities = 75/299 (25%), Positives = 123/299 (41%), Gaps = 52/299 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y    ++G GSFG V + K R T +  A+K + +            RE+++++ LDHPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           + L        D    Y  +V E     E  + I +   +S                Q+ 
Sbjct: 84  MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131

Query: 194 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
             + Y+H    I HRD+KP+N+L+        +K+ DFG +    +       I + YY 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++ G   Y    D+WS G ++  LL G P F G++  D L  +              
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                 ++ F       W  +       +A DL+ +   + P+LR TA +   HP+  +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  169 bits (430), Expect = 4e-49
 Identities = 62/325 (19%), Positives = 122/325 (37%), Gaps = 52/325 (16%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN----------------RELQIM 129
             G F  +      +  +  A+K      + + + +                   ELQI+
Sbjct: 40  NQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIY 184
             + +   +  +      T+ +E+Y+  + EY+      +               +P+  
Sbjct: 98  TDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           +K     +  + +YIHN   ICHRD+KP N+L++ +   +KL DFG ++ +V  +   S 
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKKIKGS- 210

Query: 245 IC-SRYYRAPELIFGATEY-TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
              +  +  PE     + Y    +DIWS G  +  +      F  +  + +L   I+   
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR--- 266

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
               + I+   P      F     +         L  E +D +  F + +P  R T+ +A
Sbjct: 267 ---TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

Query: 363 CVHPFF-----DELRDPNTRLPNGR 382
             H +      ++LR+ +  L   R
Sbjct: 321 LKHEWLADTNIEDLREFSKELYKKR 345

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  167 bits (425), Expect = 4e-49
 Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 67/305 (21%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 143
           G GSF  V++A+   TG  VAIK + +   YK         E++I   L HP+I+ L + 
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    D   +Y  LVLE     E    +        +       + + +QI   + Y+H+
Sbjct: 80  F---EDSNYVY--LVLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHS 130

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYICSRYYRA 252
             GI HRD+   NLL+  +   +K+ DFG + ++ +  E        PN        Y +
Sbjct: 131 H-GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPN--------YIS 180

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE+    + +    D+WS GC+   LL+G+P F  ++  + L +++              
Sbjct: 181 PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------------ 227

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                +++ P      +       L  EA DL+ +  + +P  R +      HPF     
Sbjct: 228 -----DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270

Query: 373 DPNTR 377
              ++
Sbjct: 271 STKSK 275

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  169 bits (430), Expect = 4e-49
 Identities = 85/325 (26%), Positives = 122/325 (37%), Gaps = 56/325 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 134
           Y    V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLY 188
           P+IV L   +   +    LY  +V E++   +    I +           +Y       Y
Sbjct: 86  PHIVELLETY---SSDGMLY--MVFEFMDGADLCFEIVK-----RADAGFVYSEAVASHY 135

Query: 189 TYQICRALAYIHNCIGICHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNVSYIC 246
             QI  AL Y H+   I HRD+KP   LL +   +  +KL  FG A  L +         
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 247 -SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
            + ++ APE +     Y   +D+W  G ++  LL G   F G    ++L E I       
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                       ++K     P  W  +        A DLV R     P  R T  EA  H
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNF 390
           P+  E      ++     +  L  F
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKF 312

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  173 bits (441), Expect = 8e-49
 Identities = 76/308 (24%), Positives = 130/308 (42%), Gaps = 45/308 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 139
           Y     +GTG+FGVV +   R TG   A K V      DK    +E+Q M +L HP +V 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L   F    D  E+   ++ E++   E   ++A  ++++ +   + Y++    Q+C+ L 
Sbjct: 219 LHDAF---EDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           ++H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+ 
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
            G        D+WS G +   LL G   F GE+  +            T   +K  + N 
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF--DELRDP 374
            +  F  I               +  D + +     PN R T  +A  HP+         
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

Query: 375 NTRLPNGR 382
           ++++P+ R
Sbjct: 423 DSQIPSSR 430

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  166 bits (423), Expect = 8e-49
 Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 66/296 (22%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 141
            +G G FG V+ A+ ++   I+A+K     ++ ++       RE++I   L HPNI+ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D++ +Y  L+LE+ P  E    + +     H R        +  ++  AL Y 
Sbjct: 81  NYFH---DRKRIY--LMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYC 130

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRA 252
           H    + HRDIKP+NLL+      LK+ DFG +            G  +        Y  
Sbjct: 131 HER-KVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YLP 180

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE+I G   +   +D+W  G +  E L+G P F   S  +    I+ V            
Sbjct: 181 PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------ 227

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                + KFP     P+       L   + DL+ +  +Y P  R        HP+ 
Sbjct: 228 -----DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  167 bits (426), Expect = 1e-48
 Identities = 79/319 (24%), Positives = 129/319 (40%), Gaps = 45/319 (14%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHC 143
           +++ V+G G  G V +   R TG+  A+K +L D     +E+         P+IV +   
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD- 89

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 197
            +      +  L +++E +   E        +SRI +R    +           I  A+ 
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGEL-------FSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           ++H+   I HRD+KP+NLL  +      LKL DFG AK   +    +   C + YY APE
Sbjct: 143 FLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE 199

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
            + G  +Y  + D+WS G +M  LL G P F   +G      + +         I+    
Sbjct: 200 -VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-- 248

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRD 373
              ++ FP      W +V       +A  L+    +  P  R T  +   HP+    +  
Sbjct: 249 ---QYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

Query: 374 PNTRLPNGRPLPPLFNFKP 392
           P T L   R L    +   
Sbjct: 298 PQTPLHTARVLQEDKDHWD 316

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  166 bits (423), Expect = 1e-48
 Identities = 67/318 (21%), Positives = 117/318 (36%), Gaps = 60/318 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIV 138
           +     +G G FGVVF+AK +      AIK++        +    RE++ +  L+HP IV
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 139 ALKHCFF-------STTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTY 190
              + +              ++YL + ++    E +         I +R           
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-- 248
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 249 -----------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 297
                       Y +PE I G   Y+  +DI+S G ++ ELL   P F  +    + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           ++                    KFP +              P    +V      SP  R 
Sbjct: 240 VR------------------NLKFPPLFTQ---------KYPCEYVMVQDMLSPSPMERP 272

Query: 358 TALEACVHPFFDELRDPN 375
            A+    +  F++L  P 
Sbjct: 273 EAINIIENAVFEDLDFPG 290

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  166 bits (422), Expect = 1e-48
 Identities = 58/339 (17%), Positives = 101/339 (29%), Gaps = 90/339 (26%)

Query: 72  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQ- 127
           G     S+    +     +G+G FG VF+   R  G I AIK+    L     +   L+ 
Sbjct: 1   GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60

Query: 128 ---IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 183
                 +  H ++V     +      E+ ++ +  EY    ++        RI       
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWA-----EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH------------------THQLK 225
            +K    Q+ R L YIH+   + H DIKP N+ ++                        K
Sbjct: 116 ELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 226 LCDFGSAKVL-----VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 280
           + D G    +      +G+          + A E++     +    DI++    +     
Sbjct: 175 IGDLGHVTRISSPQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAG 226

Query: 281 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP- 339
            +PL                                            WH++ Q RLP  
Sbjct: 227 AEPLPRNG--------------------------------------DQWHEIRQGRLPRI 248

Query: 340 ------EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                 E  +L+       P  R +A+    H       
Sbjct: 249 PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  167 bits (424), Expect = 1e-48
 Identities = 70/326 (21%), Positives = 119/326 (36%), Gaps = 59/326 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F +V + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYT 189
           H N++ L   +    ++ ++   L+LE V   E  + +A+  + S             + 
Sbjct: 74  HHNVITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKESLSE-------EEATSFI 121

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
            QI   + Y+H    I H D+KP+N+++   N     +KL DFG A  +  G      I 
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179

Query: 247 -SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
            +  + APE I          D+WS G +   LL G   F G++  + L  I  V     
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                        + F       +           A D + +        R T  EA  H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFK 391
           P+     D    +     +  L NF+
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFR 298

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  168 bits (428), Expect = 2e-48
 Identities = 73/304 (24%), Positives = 124/304 (40%), Gaps = 45/304 (14%)

Query: 71  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNREL 126
           +  + G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 127 QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLI 183
            +M  LDH N++ L   F     K ++   LV+EYV   E  +RI   +Y+     +  +
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYN-----LTEL 187

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNV 242
              L+  QIC  + ++H    I H D+KP+N+L VN    Q+K+ DFG A+     E   
Sbjct: 188 DTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246

Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
               +  + APE +      +   D+WS G +   LL G   F G++  + L  I+    
Sbjct: 247 VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-- 303

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
                           +         +  +       EA + + +      + R +A EA
Sbjct: 304 ---------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340

Query: 363 CVHP 366
             HP
Sbjct: 341 LKHP 344

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  165 bits (419), Expect = 3e-48
 Identities = 73/314 (23%), Positives = 118/314 (37%), Gaps = 62/314 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F +V + + + TG+  A K          +    +    RE+ I++ + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 187
           HPNI+ L   F    +K ++   L+LE V   E  + +A   S                 
Sbjct: 67  HPNIITLHDIF---ENKTDVV--LILELVSGGELFDFLAEKES---------LTEDEATQ 112

Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           +  QI   + Y+H+   I H D+KP+N+++   N    ++KL DFG A  +  G      
Sbjct: 113 FLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKN 170

Query: 245 IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
           I  +  + APE I          D+WS G +   LL G   F GE+  + L  I  V   
Sbjct: 171 IFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV--- 226

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                          + F       +           A D + R     P  R T  ++ 
Sbjct: 227 --------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSL 264

Query: 364 VHPFFDELRDPNTR 377
            H +   +R  N R
Sbjct: 265 EHSWIKAIRRRNVR 278

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  167 bits (424), Expect = 3e-48
 Identities = 87/291 (29%), Positives = 123/291 (42%), Gaps = 46/291 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 141
           +  E  +G G+  +V++ K + T +  A+K + +    K    E+ ++  L HPNI+ LK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 197
             F       E+   LVLE V   E  +RI     YS   +R     VK    QI  A+A
Sbjct: 115 EIF---ETPTEIS--LVLELVTGGELFDRIVEKGYYS---ERDAADAVK----QILEAVA 162

Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           Y+H   GI HRD+KP+NLL   P     LK+ DFG +K++       +   +  Y APE 
Sbjct: 163 YLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE- 220

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           I     Y   +D+WS G +   LL G   F  E G   +   I            C    
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----------NC---- 266

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
             E+ F       W +V        A DLV +     P  R T  +A  HP
Sbjct: 267 --EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQHP 307

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  166 bits (423), Expect = 5e-48
 Identities = 80/319 (25%), Positives = 120/319 (37%), Gaps = 51/319 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y  +  +G G+F VV +   + TG   A K +   K          RE +I + L HPNI
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           V L        ++   Y  LV + V   E    I     YS                QI 
Sbjct: 91  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 138

Query: 194 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
            ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y 
Sbjct: 139 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 197

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           +PE +     Y+  +DIW+ G ++  LL+G P F  E       +I              
Sbjct: 198 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 245

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                  + +P      W  V      PEA  L+      +P  R TA +A   P+    
Sbjct: 246 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291

Query: 372 RDPNTRLPNGRPLPPLFNF 390
               + +     +  L  F
Sbjct: 292 ERVASAIHRQDTVDCLKKF 310

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  165 bits (420), Expect = 7e-48
 Identities = 71/328 (21%), Positives = 121/328 (36%), Gaps = 63/328 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F VV + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 187
           HPN++ L   +    +K ++   L+LE V   E  + +A   S                 
Sbjct: 73  HPNVITLHEVY---ENKTDVI--LILELVAGGELFDFLAEKES---------LTEEEATE 118

Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           +  QI   + Y+H+   I H D+KP+N+++   N    ++K+ DFG A  +  G      
Sbjct: 119 FLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKN 176

Query: 245 IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
           I  +  + APE I          D+WS G +   LL G   F G++  + L  +  V   
Sbjct: 177 IFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV--- 232

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                          ++F       +           A D + R     P  R T  ++ 
Sbjct: 233 --------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSL 270

Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFK 391
            HP+    +D    L        +  FK
Sbjct: 271 QHPWIKP-KDTQQALSRKASAVNMEKFK 297

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  165 bits (420), Expect = 1e-47
 Identities = 71/329 (21%), Positives = 118/329 (35%), Gaps = 65/329 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F +V + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VK 186
           HPNI+ L   +    ++ ++   L+LE V   E  + +  +                   
Sbjct: 74  HPNIITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKES----------LSEEEAT 118

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVS 243
            +  QI   + Y+H    I H D+KP+N+++   N     +KL DFG A  +  G     
Sbjct: 119 SFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FK 176

Query: 244 YIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
            I  +  + APE I          D+WS G +   LL G   F G++  + L  I  V  
Sbjct: 177 NIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-- 233

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
                           + F       + +         A D + +        R T  EA
Sbjct: 234 ---------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEA 270

Query: 363 CVHPFFDELRDPNTRLPNGRPLPPLFNFK 391
             HP+     D    +     +  L NFK
Sbjct: 271 LRHPWITP-VDTQQAMVRRESVVNLENFK 298

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  166 bits (422), Expect = 1e-47
 Identities = 83/311 (26%), Positives = 124/311 (39%), Gaps = 42/311 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKH 142
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++       P+IV +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRAL 196
             +         L +V+E +   E        +SRI  R    +           I  A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 197 AYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y+H+   I HRD+KP+NLL  +   +  LKL DFG AK         +   + YY APE
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
            + G  +Y  + D+WS G +M  LL G P F    G+     +           I+    
Sbjct: 234 -VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR---- 280

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 373
              +++FP      W +V       E   L+    +  P  R T  E   HP+  +    
Sbjct: 281 -MGQYEFPN---PEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

Query: 374 PNTRLPNGRPL 384
           P T L   R L
Sbjct: 332 PQTPLHTSRVL 342

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  167 bits (425), Expect = 2e-47
 Identities = 77/320 (24%), Positives = 122/320 (38%), Gaps = 52/320 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G+F VV +      G+  A   +   K          RE +I ++L HPNI
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           V L       +++   Y  L+ + V   E    I     YS   +      ++    QI 
Sbjct: 73  VRLHDSI---SEEGHHY--LIFDLVTGGELFEDIVAREYYS---EADASHCIQ----QIL 120

Query: 194 RALAYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYY 250
            A+ + H   G+ HR++KP+NLL  +      +KL DFG A  +   +        +  Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            +PE +     Y   +D+W+ G ++  LL+G P F  E       +I             
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                   + FP      W  V      PEA DL+ +    +P+ R TA EA  HP+   
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273

Query: 371 LRDPNTRLPNGRPLPPLFNF 390
                + +     +  L  F
Sbjct: 274 RSTVASCMHRQETVDCLKKF 293

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  164 bits (418), Expect = 2e-47
 Identities = 74/319 (23%), Positives = 125/319 (39%), Gaps = 59/319 (18%)

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
           H I   +   +        Y  +  +G GS+ V  +   + T    A+K + + KR    
Sbjct: 7   HSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE 64

Query: 125 ELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS----- 174
           E++I+     HPNI+ LK  +    D + +Y  +V E +   E +++I R   +S     
Sbjct: 65  EIEILLRYGQHPNIITLKDVY---DDGKYVY--VVTELMKGGELLDKILRQKFFSEREAS 119

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGS 231
            +             + I + + Y+H   G+ HRD+KP N+L    + +   +++CDFG 
Sbjct: 120 AV------------LFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGF 166

Query: 232 AKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
           AK L      +   C +  + APE +     Y  A DIWS G ++  +L G   F     
Sbjct: 167 AKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225

Query: 291 VDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
                 + ++  G               +F         W+ V        A DLV +  
Sbjct: 226 DTPEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKML 262

Query: 350 QYSPNLRCTALEACVHPFF 368
              P+ R TA     HP+ 
Sbjct: 263 HVDPHQRLTAALVLRHPWI 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  161 bits (411), Expect = 5e-47
 Identities = 78/297 (26%), Positives = 115/297 (38%), Gaps = 51/297 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y  +  +G G+F VV +   + TG   A K +   K          RE +I + L HPNI
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           V L        ++   Y  LV + V   E    I     YS                QI 
Sbjct: 68  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115

Query: 194 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
            ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y 
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 174

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           +PE +     Y+  +DIW+ G ++  LL+G P F  E       +I              
Sbjct: 175 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                  + +P      W  V      PEA  L+      +P  R TA +A   P+ 
Sbjct: 223 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  161 bits (409), Expect = 3e-46
 Identities = 67/307 (21%), Positives = 115/307 (37%), Gaps = 48/307 (15%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDH-PNI 137
           +    +G G F VV Q   + TG+  A K + + +R ++       E+ ++++    P +
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           + L   +    +  E+   L+LEY    E  +        + + +    V     QI   
Sbjct: 92  INLHEVY---ENTSEII--LILEYAAGGEIFSLCL---PELAEMVSENDVIRLIKQILEG 143

Query: 196 LAYIHNCIGICHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRA 252
           + Y+H    I H D+KPQN LL + +    +K+ DFG ++ +      +  I  +  Y A
Sbjct: 144 VYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLA 201

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE I      TTA D+W+ G +   LL     F GE   +  + I +V            
Sbjct: 202 PE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------------ 248

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                   +       +  V        A D +      +P  R TA     H +  +  
Sbjct: 249 -----NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295

Query: 373 DPNTRLP 379
             N   P
Sbjct: 296 FENLFHP 302

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  160 bits (406), Expect = 3e-46
 Identities = 77/317 (24%), Positives = 121/317 (38%), Gaps = 62/317 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYK-NRELQIMQ 130
           Y  + ++G G   VV +   + T +  A+K            + +Q+ R    +E+ I++
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 131 MLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 185
            +  HPNI+ LK  +         +  LV + +   E  + +      S    R      
Sbjct: 79  KVSGHPNIIQLKDTY---ETNTFFF--LVFDLMKKGELFDYLTEKVTLSEKETR------ 127

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
                 +   +  +H    I HRD+KP+N+L++   + +KL DFG +  L  GE      
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVC 184

Query: 246 CSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
            +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L  I+  
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
                             ++F       W             DLV RF    P  R TA 
Sbjct: 245 -----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAE 279

Query: 361 EACVHPFFDELRDPNTR 377
           EA  HPFF +      R
Sbjct: 280 EALAHPFFQQYVVEEVR 296

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  160 bits (408), Expect = 3e-46
 Identities = 67/311 (21%), Positives = 132/311 (42%), Gaps = 42/311 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQMLD-HPNIVALK 141
            + +  +G GSF +  +   +++ +  A+K + +       +E+  +++ + HPNIV L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 197
             F    D+   +  LV+E +   E   RI +  ++S   +            ++  A++
Sbjct: 73  EVF---HDQLHTF--LVMELLNGGELFERIKKKKHFS---ETE----ASYIMRKLVSAVS 120

Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           ++H+  G+ HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y APE
Sbjct: 121 HMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
            +     Y  + D+WS G ++  +L GQ  F            ++++     ++IK    
Sbjct: 180 -LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG-- 231

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 373
              +F F       W  V       EA DL+       PN R        + +  +    
Sbjct: 232 ---DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

Query: 374 PNTRLPNGRPL 384
            +  L     L
Sbjct: 281 SSNPLMTPDIL 291

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  160 bits (407), Expect = 6e-46
 Identities = 73/340 (21%), Positives = 118/340 (34%), Gaps = 56/340 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQML-DHPNIV 138
                V+  G F  V++A+   +G   A+K++L    +  R   +E+  M+ L  HPNIV
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 139 ALKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                     +         L+L  + +               +    V    YQ CRA+
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 197 AYIHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------------EPNV 242
            ++H     I HRD+K +NLL++     +KLCDFGSA  +                E  +
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 243 SYICSRYYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           +   +  YR PE+I  +         DIW+ GC++  L   Q  F   +     + I+  
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRIVNG 264

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
                            ++  P   PH                L+    Q +P  R +  
Sbjct: 265 -----------------KYSIP---PHD-------TQYTVFHSLIRAMLQVNPEERLSIA 297

Query: 361 EACVHPF-FDELRDPNTRLPNGRPLPPLFNFKPPELSGIP 399
           E           R+ N + P    L     +    LS  P
Sbjct: 298 EVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  156 bits (397), Expect = 1e-44
 Identities = 79/307 (25%), Positives = 121/307 (39%), Gaps = 72/307 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++    Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D E+LY    L Y    E +  I +              + YT +I  AL Y+
Sbjct: 97  FTF---QDDEKLY--FGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYL 146

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS---------YICSRYY 250
           H   GI HRD+KP+N+L+N   H +++ DFG+AKVL                 Y+     
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV----- 199

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            +PEL+        + D+W+ GC++ +L+ G P F   +    + + I            
Sbjct: 200 -SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII----------- 245

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP------NLRCTALEACV 364
                  E+ FP            ++  P+A DLV +                       
Sbjct: 246 -----KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 288

Query: 365 HPFFDEL 371
           HPFF+ +
Sbjct: 289 HPFFESV 295

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  157 bits (399), Expect = 2e-44
 Identities = 52/338 (15%), Positives = 108/338 (31%), Gaps = 80/338 (23%)

Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 130
            ++  + +   V+G        +A  +ETGE   +      +R  +        E+  ++
Sbjct: 69  GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128

Query: 131 ML-------------------------DHPNIVALKHCFFSTTDKEELYLNLVLEYVPET 165
           +L                             ++ ++            +L   ++   +T
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188

Query: 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 225
              +  ++S  H+ +        T Q+ R LA +H+  G+ H  ++P +++++     + 
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGG-VF 246

Query: 226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELI----------FGATEYTTAIDIWSTGCVM 275
           L  F      V+    V    SR +  PEL              T  T + D W+ G V+
Sbjct: 247 LTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303

Query: 276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 335
             +         ++ +               E I         F+              K
Sbjct: 304 YWIWCADLPITKDAALG------------GSEWI---------FRSC------------K 330

Query: 336 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            +P     L+  F +Y    R   L+A   P +++LR 
Sbjct: 331 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  155 bits (394), Expect = 9e-44
 Identities = 73/309 (23%), Positives = 128/309 (41%), Gaps = 65/309 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----------KVLQDKRYK-NRELQIMQM 131
           Y  + V+G G   VV +   R TG   A+K           + L++ R    RE  I++ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 132 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS-RIHQRMPLIYV 185
           +  HP+I+ L   +        ++  LV + +   E  + +      S +          
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMF--LVFDLMRKGELFDYLTEKVALSEK--------ET 202

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           +     +  A++++H    I HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +
Sbjct: 203 RSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LREL 259

Query: 246 C-SRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           C +  Y APE++  + +     Y   +D+W+ G ++  LL G P F     +  L  I++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319

Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
                             +++F       W             DL+ R  Q  P  R TA
Sbjct: 320 G-----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTA 354

Query: 360 LEACVHPFF 368
            +A  HPFF
Sbjct: 355 EQALQHPFF 363

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  154 bits (392), Expect = 3e-43
 Identities = 79/320 (24%), Positives = 135/320 (42%), Gaps = 61/320 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
            +G GSFG V   +  +T ++ A+K     K ++    R   +ELQIMQ L+HP +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D+E+++  +V++ +   +    + +N            VKL+  ++  AL Y+
Sbjct: 82  YSF---QDEEDMF--MVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYL 131

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF-- 257
            N   I HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+    
Sbjct: 132 QNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNPN 315
               Y+ A+D WS G    ELL G+  +   S     ++V   +                
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---------------- 233

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDP 374
            T   +P                 E V L+ +  + +P+ R + L      P+     D 
Sbjct: 234 TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM---NDI 278

Query: 375 N-TRLPNGRPLPPLFNFKPP 393
           N   +   R +P    F P 
Sbjct: 279 NWDAVFQKRLIPG---FIPN 295

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  155 bits (393), Expect = 3e-43
 Identities = 61/438 (13%), Positives = 128/438 (29%), Gaps = 93/438 (21%)

Query: 13  SSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPD--IIDGVGAETGHV-IRT 69
            +    GF+ +      +      +   +     E   S  D  +   +        + +
Sbjct: 12  ENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVES 71

Query: 70  TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------ 123
            +G R        + +   V+G        +A  +ETGE   +      +R  +      
Sbjct: 72  ELGER------PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 125

Query: 124 -RELQIMQML-------------------------DHPNIVALKHCFFSTTDKEELYLNL 157
             E+  +++L                             ++ ++            +L  
Sbjct: 126 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 185

Query: 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV 217
            ++   +T   +  ++S  H+ +        T Q+ R LA +H+  G+ H  ++P ++++
Sbjct: 186 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVL 244

Query: 218 NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY----YRAPELIFGA----TEYTTAIDIW 269
           +     + L  F        G   VS I   +      A  ++       T  T A D W
Sbjct: 245 DQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301

Query: 270 STGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW 329
           + G  +  +         ++ +                                      
Sbjct: 302 TLGLAIYWIWCADLPNTDDAALGGS----------------------------------- 326

Query: 330 HKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD---PNTRLPNGRPL 384
             +F+  K +P     L+  F +Y    R   L+A   P +++LR        L      
Sbjct: 327 EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGE 386

Query: 385 PPLFNFKPPELSGIPPET 402
           P      PP  +  P E 
Sbjct: 387 PTREGGAPPSGTSQPDEA 404

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  153 bits (388), Expect = 5e-43
 Identities = 70/316 (22%), Positives = 129/316 (40%), Gaps = 33/316 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
           +     +G G+ GVVF+   + +G ++A K +   ++        RELQ++   + P IV
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                F+S  +     +++ +E++   +++++ +   RI    P   +   +  + + L 
Sbjct: 95  GFYGAFYSDGE-----ISICMEHMDGGSLDQVLKKAGRI----PEQILGKVSIAVIKGLT 145

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           Y+     I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + 
Sbjct: 146 YLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQ 203

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G   Y+   DIWS G  + E+ +G+   P     +  +     +     E          
Sbjct: 204 GTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262

Query: 318 EFKFPQIKPHPWHKVFQ----------KRLP-----PEAVDLVCRFFQYSPNLRCTALEA 362
                 +   P   +F+           +LP      E  D V +    +P  R    + 
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322

Query: 363 CVHPFFDELRDPNTRL 378
            VH F           
Sbjct: 323 MVHAFIKRSDAEEVDF 338

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  152 bits (385), Expect = 6e-43
 Identities = 77/332 (23%), Positives = 126/332 (37%), Gaps = 65/332 (19%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIMQML-DHPNIVA 139
           + E V+G G+   V       T +  A+K    +    +    RE++++     H N++ 
Sbjct: 16  LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT-------- 189
           L   F    +++  Y  LV E +             S IH+R      + +         
Sbjct: 76  LIEFF---EEEDRFY--LVFEKMRGGSI-------LSHIHKR------RHFNELEASVVV 117

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLL-VNP-HTHQLKLCDFGSAKVLVKGE-------P 240
             +  AL ++HN  GI HRD+KP+N+L  +P     +K+CDF     +           P
Sbjct: 118 QDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176

Query: 241 NVSYIC-SRYYRAPELI----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
            +   C S  Y APE++      A+ Y    D+WS G ++  LL G P F G  G D   
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236

Query: 296 EIIKVLGTPTR---EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           +  +          E I+       +++FP      W  +        A DL+ +     
Sbjct: 237 DRGEACPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRD 283

Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNGRPL 384
              R +A +   HP+      P   LP    L
Sbjct: 284 AKQRLSAAQVLQHPWVQG-CAPENTLPTPMVL 314

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  151 bits (383), Expect = 7e-43
 Identities = 77/318 (24%), Positives = 117/318 (36%), Gaps = 56/318 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKH 142
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++       P+IV +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +         L +V+E +   E  +RI     R  Q             I  A+ Y+H
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 201 NCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +   I HRD+KP+NLL  +   +  LKL DFG                     A E    
Sbjct: 135 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT-- 171

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  + D+WS G +M  LL G P F    G+     +           I+       +
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MGQ 218

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD-PNTR 377
           ++FP      W +V       E   L+    +  P  R T  E   HP+  +    P T 
Sbjct: 219 YEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

Query: 378 LPNGRPLPPLFNFKPPEL 395
           L   R L      +  ++
Sbjct: 271 LHTSRVL-KEDKERWEDV 287

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  154 bits (390), Expect = 1e-42
 Identities = 85/377 (22%), Positives = 130/377 (34%), Gaps = 100/377 (26%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKR--YKNRELQIMQMLDHPNIVALK 141
           V+G G+F  V   K ++TG++ A+K      +L+         E  ++   D   I  L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D+  LY  LV+EY    + +  +    S+  +R+P    + Y  +I  A+  +
Sbjct: 128 FAF---QDENYLY--LVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMAIDSV 178

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--------YICSRYYR 251
           H  +G  HRDIKP N+L++   H ++L DFGS   L       S        Y+      
Sbjct: 179 HR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL------ 230

Query: 252 APELI------FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
           +PE++       G   Y    D W+ G    E+  GQ  F  +S   +    I       
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------- 282

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEA 362
                 ++        P +            +P EA D + R     P  R     A + 
Sbjct: 283 ------VHYK-EHLSLPLVDEG---------VPEEARDFIQRLLC-PPETRLGRGGAGDF 325

Query: 363 CVHPFF-----DELRDPNTRLPNGRPLPPLF-----------NF------KPPELSGIPP 400
             HPFF     D LRD            P F           NF          +SG   
Sbjct: 326 RTHPFFFGLDWDGLRD----------SVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGE 375

Query: 401 ETINRLIPEHARKQNLF 417
              +            F
Sbjct: 376 TLSDIREGAPLGVHLPF 392

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  152 bits (385), Expect = 1e-42
 Identities = 87/351 (24%), Positives = 139/351 (39%), Gaps = 56/351 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           Y     +G+G+FGV    + + T E+VA+K       + +     RE+   + L HPNIV
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
             K    + T    L   +++EY    E   RI         R      + +  Q+   +
Sbjct: 80  RFKEVILTPTH---LA--IIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGV 129

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           +Y H+ + ICHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE+
Sbjct: 130 SYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 256 IFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +    EY     D+WS G  +  +L+G   F                   T + I  +  
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
              ++  P              + PE   L+ R F   P  R +  E   H +F  L++ 
Sbjct: 238 ---KYSIP---DDIR-------ISPECCHLISRIFVADPATRISIPEIKTHSWF--LKNL 282

Query: 375 NTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHA------RKQNLFMA 419
              L N         F+ PE      +TI ++I E        R  + FM 
Sbjct: 283 PADLMN--ESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMT 331

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  153 bits (388), Expect = 3e-42
 Identities = 76/307 (24%), Positives = 123/307 (40%), Gaps = 57/307 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   K +   ++ A+K     ++L+         E  ++   D   I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D   LY  LV++Y    + +  +    S+   R+P    + Y  ++  A+  +
Sbjct: 141 YAF---QDDNNLY--LVMDYYVGGDLLTLL----SKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRAPELI- 256
           H  +   HRDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++ 
Sbjct: 192 HQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249

Query: 257 ---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
               G   Y    D WS G  M E+L G+  F  ES + +    I             MN
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------MN 295

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN-LRCT-ALEACVHPFF--- 368
                F+FP              +   A DL+ R      + L      +   HPFF   
Sbjct: 296 HK-ERFQFPTQVTD---------VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345

Query: 369 --DELRD 373
             D +R+
Sbjct: 346 DWDNIRN 352

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  150 bits (380), Expect = 8e-42
 Identities = 44/297 (14%), Positives = 92/297 (30%), Gaps = 36/297 (12%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIK----KVLQDKRYKNRELQIMQMLD 133
                H++G G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
               +           +    L  V E       +N I    +   + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHL---FQNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----------LKLCDFGSAKVLVKGEPN 241
           +   +  +H+C  I H DIKP N ++     +          L L D G +  +      
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 242 V---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEI 297
               +   +  ++  E++     +   ID +     +  +L G  +    E G  +   +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 298 IKVL-GTPTREEIKCMNPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQ 350
            + L       E   +  N  +               KVFQ+    +   L  R   
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIV 355

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  148 bits (376), Expect = 9e-42
 Identities = 75/326 (23%), Positives = 130/326 (39%), Gaps = 59/326 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---RELQIMQMLDHP 135
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+Q+++ L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           N++ L    ++   K+++Y  +V+EY      E ++ +        +R P+     Y  Q
Sbjct: 67  NVIQLVDVLYNEE-KQKMY--MVMEYCVCGMQEMLDSVP------EKRFPVCQAHGYFCQ 117

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYIC-SR 248
           +   L Y+H+  GI H+DIKP NLL+      LK+   G A+ L     +        S 
Sbjct: 118 LIDGLEYLHSQ-GIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 249 YYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            ++ PE+  G   ++   +DIWS G  +  +  G   F G++        I  L     E
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FE 223

Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            I         +  P                P   DL+    +Y P  R +  +   H +
Sbjct: 224 NIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 368 FDELRDPNTRLPNGRPLPPLFNFKPP 393
           F +   P        P+PP  + K  
Sbjct: 267 FRKKHPPAEAPV---PIPPSPDTKDR 289

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  150 bits (381), Expect = 3e-41
 Identities = 87/374 (23%), Positives = 150/374 (40%), Gaps = 70/374 (18%)

Query: 41  DQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVS-----YIAEHVVGTGSF 95
             V +   + +  ++    G+ + +     +       K +V+     Y+   ++G G+F
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK--LLGKGTF 161

Query: 96  GVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFSTT 148
           G V   K + TG   A+K      ++      +   E +++Q   HP + ALK+ F  T 
Sbjct: 162 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-QTH 220

Query: 149 DKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
           D+  L    V+EY    E    ++R      +       + Y  +I  AL Y+H+   + 
Sbjct: 221 DR--LCF--VMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVV 271

Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTA 265
           +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE++    +Y  A
Sbjct: 272 YRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRA 329

Query: 266 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 325
           +D W  G VM E++ G+  F  +   ++L E+I                   E +FP   
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------MEEIRFP--- 369

Query: 326 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRDPN-TRLP 379
                    + L PEA  L+    +  P  R       A E   H FF          + 
Sbjct: 370 ---------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF---AGIVWQHVY 417

Query: 380 NGRPLPPLFNFKPP 393
             +  PP   FKP 
Sbjct: 418 EKKLSPP---FKPQ 428

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  147 bits (373), Expect = 5e-41
 Identities = 84/350 (24%), Positives = 141/350 (40%), Gaps = 60/350 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
           Y     +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           NIV L     +        L L++EY    E  + +       H RM     +    QI 
Sbjct: 75  NIVKLFEVIETEKT-----LYLIMEYASGGEVFDYLVA-----HGRMKEKEARSKFRQIV 124

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            A+ Y H    I HRD+K +NLL++     +K+ DFG +     G    ++  +  Y AP
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182

Query: 254 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           EL  G  +Y    +D+WS G ++  L+ G   F G++ + +L E +              
Sbjct: 183 ELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------- 227

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                +++ P      +       +  +  +L+ RF   +P  R T  +     + +   
Sbjct: 228 ---RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272

Query: 373 DPNTRLPNGRPLPPLFNFKPPELS---GIPPETINRLIPEHARKQNLFMA 419
           + +   P   P   + + K  ++    G   E I   +     K +   A
Sbjct: 273 EEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL--SKMKYDEITA 320

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  144 bits (366), Expect = 1e-40
 Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 50/296 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                          Y  L LEY    E  +RI          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYIC-SRYYRAP 253
            Y+H  IGI HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 254 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           EL+    E+    +D+WS G V+  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                          PW K     +    + L+ +    +P+ R T  +     ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  145 bits (369), Expect = 2e-40
 Identities = 83/320 (25%), Positives = 133/320 (41%), Gaps = 64/320 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K      ++      +   E +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           +  F T D+  L    V+EY    E    ++R      +       + Y  +I  AL Y+
Sbjct: 72  YA-FQTHDR--LC--FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYL 121

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIFG 258
           H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE++  
Sbjct: 122 HS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I                   E
Sbjct: 180 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------MEE 221

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 373
            +FP            + L PEA  L+    +  P  R       A E   H FF     
Sbjct: 222 IRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF---LS 266

Query: 374 PN-TRLPNGRPLPPLFNFKP 392
            N   +   + LPP   FKP
Sbjct: 267 INWQDVVQKKLLPP---FKP 283

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  145 bits (367), Expect = 3e-40
 Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 50/313 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                          Y  L LEY    E  +RI          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--SYIC-SRYYRAP 253
            Y+H  IGI HRDIKP+NLL++     LK+ DFG A V          + +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 254 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           EL+    E+    +D+WS G V+  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                          PW K     +    + L+ +    +P+ R T  +     ++++  
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269

Query: 373 DPNTRLPNGRPLP 385
               + P      
Sbjct: 270 KKGAKRPRVTSGG 282

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  144 bits (367), Expect = 3e-40
 Identities = 87/359 (24%), Positives = 148/359 (41%), Gaps = 86/359 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
            +GTGSFG V   + R  G   A+K      V++ K   + N E  ++ ++ HP I+ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D ++++  ++++Y+   E  + + ++     QR P    K Y  ++C AL Y+
Sbjct: 73  GTF---QDAQQIF--MIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYL 122

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAP 253
           H+   I +RD+KP+N+L++ + H +K+ DFG AK +        G P+        Y AP
Sbjct: 123 HSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIAP 172

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E++     Y  +ID WS G ++ E+L G   F   +   +  E I               
Sbjct: 173 EVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL-------------- 216

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFF 368
               E +FP                 +  DL+ R           NL+    +   HP+F
Sbjct: 217 --NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

Query: 369 DELRDPN-TRLPNGRPLPPLFNFKPPELSG---------IPPETINRLIPEHARKQNLF 417
            E+      +L +     P   ++PP   G          P E IN  +       +LF
Sbjct: 263 KEV---VWEKLLSRNIETP---YEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLF 315

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  149 bits (378), Expect = 4e-40
 Identities = 74/322 (22%), Positives = 121/322 (37%), Gaps = 58/322 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG VF  + + TG++ A  K L  KR K R        E +I+  +    IV+L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +  F T       L LV+  +   +    I       +          YT QI   L +
Sbjct: 251 AYA-FETKTD----LCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEH 304

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           +H    I +RD+KP+N+L++   + +++ D G A  L  G+        +  + APEL+ 
Sbjct: 305 LHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G  EY  ++D ++ G  + E++  +  F       +  E+         + +      Y 
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--------QRVLEQAVTYP 413

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 372
           +                    P + D      Q  P  R      +      HP F   R
Sbjct: 414 DK-----------------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF---R 453

Query: 373 DPN-TRLPNGRPLPPLFNFKPP 393
           D +  +L  G   PP   F P 
Sbjct: 454 DISWRQLEAGMLTPP---FVPD 472

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  143 bits (363), Expect = 5e-40
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 41/299 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
            +G G++GVV + +   +G+I+A+K++   +  +  K    +L I M+ +D P  V    
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             F   D     + + +E +  ++++  +      Q +P   +      I +AL ++H+ 
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG---A 259
           + + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I      
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y+   DIWS G  M EL + +  +       Q ++ + V                   
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
             PQ+    +          E VD   +  + +   R T  E   HPFF       T +
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  150 bits (381), Expect = 6e-40
 Identities = 73/324 (22%), Positives = 128/324 (39%), Gaps = 65/324 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V + + F      ++L    +L+ +   +    +++     H       ++ Y  +I   
Sbjct: 255 VCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILG 304

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ + + +  Y APE+
Sbjct: 305 LEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPEV 361

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +     Y ++ D +S GC++ +LL G   F      D             + EI      
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI------ 402

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CT---ALEACVHPFFDE 370
                                  PE   L+    Q   N R  C    A E    PFF  
Sbjct: 403 -----DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

Query: 371 LRDPN-TRLPNGRPLPPLFNFKPP 393
           L   +   +   +  PP     PP
Sbjct: 456 L---DWQMVFLQKYPPP---LIPP 473

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  143 bits (362), Expect = 2e-39
 Identities = 67/321 (20%), Positives = 118/321 (36%), Gaps = 67/321 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 133
           Y    ++G+G FG V+          VAIK     ++       N      E+ +++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 134 H--PNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 188
                ++ L   +F   D     L  +LE      +  + I          +     + +
Sbjct: 105 SGFSGVIRLLD-WFERPDS--FVL--ILERPEPVQDLFDFITE-----RGALQEELARSF 154

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 247
            +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS  +L            +
Sbjct: 155 FWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--DGT 211

Query: 248 RYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     Y   +  +WS G ++ +++ G   F  +       EII+       
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------- 257

Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
                      +  F             +R+  E   L+       P+ R T  E   HP
Sbjct: 258 ----------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

Query: 367 FFDELRDPNTRLP-NGRPLPP 386
           +  ++  P      +   L P
Sbjct: 296 WMQDVLLPQETAEIHLHSLSP 316

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  141 bits (358), Expect = 2e-39
 Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 40/289 (13%)

Query: 73  GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------R 124
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 182
           E+Q +++  HP+I+ L     + TD    +  +V+EYV   E  + I +     H R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTD---FF--MVMEYVSGGELFDYICK-----HGRVEE 110

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
           +  +    QI  A+ Y H    + HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167

Query: 243 SYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV- 300
              C S  Y APE+I G       +DIWS G ++  LL G   F  E  V  L + I+  
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRGG 226

Query: 301 -------LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 339
                  L       +  M   +P         I+ H W   F++ LP 
Sbjct: 227 VFYIPEYLNRSVATLLMHMLQVDPL-KRATIKDIREHEW---FKQDLPS 271

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  147 bits (373), Expect = 2e-39
 Identities = 85/321 (26%), Positives = 135/321 (42%), Gaps = 59/321 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A  K L+ KR K R        E QI++ ++   +V+L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +  + T D     L LVL  +   +    I   Y       P      Y  +IC  L  
Sbjct: 250 AYA-YETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++  
Sbjct: 302 LHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              YT + D W+ GC++ E++ GQ  F       +  E+ ++        +K +   Y+E
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------VKEVPEEYSE 410

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 373
                               P+A  L  +     P  R      +A E   HP F   + 
Sbjct: 411 R-----------------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF---KK 450

Query: 374 PN-TRLPNGRPLPPLFNFKPP 393
            N  RL  G   PP   FKP 
Sbjct: 451 LNFKRLGAGMLEPP---FKPD 468

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  144 bits (365), Expect = 3e-39
 Identities = 80/306 (26%), Positives = 125/306 (40%), Gaps = 68/306 (22%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   + + T ++ A+K     ++++     +   E  IM   + P +V L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D   LY  +V+EY+P  + VN ++         +P  + + YT ++  AL  I
Sbjct: 136 YAF---QDDRYLY--MVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAI 184

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--------YICSRYYR 251
           H+ +G  HRD+KP N+L++   H LKL DFG+   + K              YI      
Sbjct: 185 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI------ 236

Query: 252 APELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +PE++    G   Y    D WS G  + E+L+G   F  +S    LV             
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS--------- 283

Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVH 365
            K MN       FP              +  EA +L+C F      +R       E   H
Sbjct: 284 -KIMNHK-NSLTFP---DDND-------ISKEAKNLICAFLT-DREVRLGRNGVEEIKRH 330

Query: 366 PFFDEL 371
            FF   
Sbjct: 331 LFFKND 336

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  140 bits (355), Expect = 2e-38
 Identities = 89/324 (27%), Positives = 136/324 (41%), Gaps = 68/324 (20%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDHPNI 137
           V+G G +G VFQ +      TG+I A+K      ++++ +       E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V L + F  T  K  LYL  +LEY+   E   ++ R                Y  +I  A
Sbjct: 84  VDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMA 133

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPE 254
           L ++H   GI +RD+KP+N+++N   H +KL DFG  K  +         C    Y APE
Sbjct: 134 LGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++   + +  A+D WS G +M ++L G P F GE+   + ++ I                
Sbjct: 192 ILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL--------------- 234

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFD 369
              +   P              L  EA DL+ +  + +   R       A E   HPFF 
Sbjct: 235 -KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF- 280

Query: 370 ELRDPN-TRLPNGRPLPPLFNFKP 392
             R  N   L   +  PP   FKP
Sbjct: 281 --RHINWEELLARKVEPP---FKP 299

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  140 bits (355), Expect = 2e-38
 Identities = 86/322 (26%), Positives = 137/322 (42%), Gaps = 66/322 (20%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR-ELQIMQMLDHPNIVA 139
           V+G GSFG VF  K     +  ++ A+K      +    R + + E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L + F  T  K  LYL  +L+++   +   R+++             VK Y  ++  AL 
Sbjct: 91  LHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALD 140

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
           ++H+  GI +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE++
Sbjct: 141 HLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                +T + D WS G +M E+L G   F G+    + + +I                  
Sbjct: 199 NR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL----------------K 240

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDEL 371
            +   PQ             L PEA  L+   F+ +P  R         E   H FF   
Sbjct: 241 AKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF--- 285

Query: 372 RDPN-TRLPNGRPLPPLFNFKP 392
              +  +L      PP   FKP
Sbjct: 286 STIDWNKLYRREIHPP---FKP 304

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  140 bits (355), Expect = 2e-38
 Identities = 86/339 (25%), Positives = 140/339 (41%), Gaps = 63/339 (18%)

Query: 78  SKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIM 129
           SK+ +  YI    +G GSFG V  A   +T + VA+K      + +   +    RE+  +
Sbjct: 4   SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63

Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLY 188
           ++L HP+I+ L     + TD   +   +V+EY   E  + I        +RM     + +
Sbjct: 64  KLLRHPHIIKLYDVITTPTD---IV--MVIEYAGGELFDYIVE-----KKRMTEDEGRRF 113

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 247
             QI  A+ Y H    I HRD+KP+NLL++ +   +K+ DFG + ++  G   +   C S
Sbjct: 114 FQQIICAIEYCH-RHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGS 170

Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
             Y APE+I G       +D+WS G V+  +L+G+  F  E  +  L + +         
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN-------- 221

Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                      +  P      +       L P A  L+ R     P  R T  E    P+
Sbjct: 222 --------SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261

Query: 368 FDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRL 406
           F      N  LP       L   +  + S      +++L
Sbjct: 262 F------NVNLP-----DYLRPMEEVQGSYADSRIVSKL 289

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  138 bits (350), Expect = 5e-38
 Identities = 68/313 (21%), Positives = 114/313 (36%), Gaps = 73/313 (23%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---------------------- 123
           G GS+GVV  A         A+K     K+++   +                        
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 124 ---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQ 178
              +E+ I++ LDHPN+V L        +++ LY+  V E V     +           +
Sbjct: 82  QVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGPVMEVPT------LK 132

Query: 179 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
            +     + Y   + + + Y+H    I HRDIKP NLLV      +K+ DFG +      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGS 190

Query: 239 EPNVSYIC-SRYYRAPELIFGAT-EYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           +  +S    +  + APE +      ++  A+D+W+ G  +   + GQ  F  E  +  L 
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLH 249

Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
             IK                    +FP     P        +  +  DL+ R    +P  
Sbjct: 250 SKIK----------------SQALEFPD---QPD-------IAEDLKDLITRMLDKNPES 283

Query: 356 RCTALEACVHPFF 368
           R    E  +HP+ 
Sbjct: 284 RIVVPEIKLHPWV 296

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  138 bits (351), Expect = 1e-37
 Identities = 79/326 (24%), Positives = 130/326 (39%), Gaps = 77/326 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K     KV++ K   +   E +I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D   LY  +V+EYV   E  + +     R   R    + + Y  QI     Y+
Sbjct: 108 FSF---KDNSNLY--MVMEYVAGGEMFSHL-----RRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAP 253
           H+   + +RD+KP+NLL++   + +++ DFG AK +        G P           AP
Sbjct: 158 HSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALAP 207

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E+I     Y  A+D W+ G ++ E+  G P F  +    Q+ E I          +    
Sbjct: 208 EIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG-- 253

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFF 368
               + +FP                 +  DL+    Q        NL+    +   H +F
Sbjct: 254 ----KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

Query: 369 DELRDPN-TRLPNGRPLPPLFNFKPP 393
                 +   +   +   P   F P 
Sbjct: 298 ATT---DWIAIYQRKVEAP---FIPK 317

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  137 bits (348), Expect = 1e-37
 Identities = 68/323 (21%), Positives = 115/323 (35%), Gaps = 68/323 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 133
           Y    ++G G FG VF          VAIK     +VL      +      E+ ++  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 134 ----HPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVK 186
               HP ++ L   +F T +     L  VLE      +  + I          +     +
Sbjct: 93  AGGGHPGVIRL-LDWFETQEG--FML--VLERPLPAQDLFDYITE-----KGPLGEGPSR 142

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
            +  Q+  A+ + H+  G+ HRDIK +N+L++      KL DFGS  +L           
Sbjct: 143 CFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--D 199

Query: 247 -SRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
            +R Y  PE I    +Y      +WS G ++ +++ G   F  +       EI++     
Sbjct: 200 GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---- 248

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
                        E  FP              + P+   L+ R     P+ R +  E  +
Sbjct: 249 -------------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

Query: 365 HPFFDELRDPNTRLPNGRPLPPL 387
            P+     +     P+     PL
Sbjct: 284 DPWMQTPAEDVPLNPSKGGPAPL 306

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  136 bits (345), Expect = 3e-37
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 28/220 (12%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 13  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT-----YQICRALAY 198
               +     + LV+EY    ++      Y+ +H   PL Y           Q  + +AY
Sbjct: 70  --CLNP----VCLVMEYAEGGSL------YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 199 IHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           +H+     + HRD+KP NLL+      LK+CDFG+A          +   S  + APE+ 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVF 175

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
            G + Y+   D++S G ++ E++  +  F    G    + 
Sbjct: 176 EG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  137 bits (348), Expect = 4e-37
 Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 65/321 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLD-HPNIVAL 140
           V+G GSFG V  ++ + T E+ A+K      V+QD   +    E +++ +    P +  L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T D+  LY   V+EYV   + +  I +       R    +   Y  +I   L +
Sbjct: 87  HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 136

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
           + +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I 
Sbjct: 137 LQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y  ++D W+ G ++ E+L GQ  F GE   D+L + I                   
Sbjct: 195 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EH 236

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 372
              +P            K +  EAV +        P  R         +   H FF   R
Sbjct: 237 NVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---R 281

Query: 373 DPN-TRLPNGRPLPPLFNFKP 392
             +  +L      PP   +KP
Sbjct: 282 YIDWEKLERKEIQPP---YKP 299

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  136 bits (345), Expect = 4e-37
 Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 46/301 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
            +G+G+ G V++ + R+TG ++A+K++      +  K    +L + ++  D P IV    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F + TD     + + +E +     ++     R+   +P   +   T  I +AL Y+   
Sbjct: 92  TFITNTD-----VFIAMELMGTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI----FG 258
            G+ HRD+KP N+L++    Q+KLCDFG +  LV  +          Y APE I      
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT 317
             +Y    D+WS G  + EL  GQ  +       + L ++++    P             
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377
               P +  H            +    V          R    +   H F          
Sbjct: 248 ----PLLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

Query: 378 L 378
           +
Sbjct: 297 V 297

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  136 bits (345), Expect = 4e-37
 Identities = 63/358 (17%), Positives = 116/358 (32%), Gaps = 103/358 (28%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G FGVVF+AK +      AIK++    R        RE++ +  L+HP IV
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 139 ALKHCF----------------------------------------------------FS 146
              + +                                                      
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
                ++YL + ++   +   +   N     +            QI  A+ ++H+  G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLM 186

Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------------VKGEPNVSYICSRYYRAP 253
           HRD+KP N+        +K+ DFG    +                  +   + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E I G   Y+  +DI+S G ++ ELL     F  +    +++  ++              
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR-------------- 287

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                 KFP +    +         P+   +V      SP  R  A +   +  F+ L
Sbjct: 288 ----NLKFPLLFTQKY---------PQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  136 bits (345), Expect = 8e-37
 Identities = 82/318 (25%), Positives = 136/318 (42%), Gaps = 61/318 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 140
           ++G GSFG VF A+ ++T +  AIK      VL D   +    E +++ +  +HP +  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               F T +   L+   V+EY+   + +  I         +  L     Y  +I   L +
Sbjct: 84  FCT-FQTKEN--LF--FVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQF 133

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
           +H+  GI +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ 
Sbjct: 134 LHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 191

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G  +Y  ++D WS G ++ E+L+GQ  F G+   ++L   I+                  
Sbjct: 192 G-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR----------------MD 233

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDPN- 375
              +P            + L  EA DL+ + F   P  R         HP F   R+ N 
Sbjct: 234 NPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF---REINW 278

Query: 376 TRLPNGRPLPPLFNFKPP 393
             L      PP   F+P 
Sbjct: 279 EELERKEIDPP---FRPK 293

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  135 bits (343), Expect = 1e-36
 Identities = 69/300 (23%), Positives = 121/300 (40%), Gaps = 39/300 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
            +G G++G V +   + +G+I+A+K++   + +K  K    +L + M+  D P IV    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   D       + +E +  + ++  +  YS +   +P   +   T    +AL ++  
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            + I HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +  
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 262 ---YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              Y    D+WS G  + EL  G+  +P  + V   +  + V G P         P    
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP---------P---- 248

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
            +    +   +         P  ++ V        + R    E   HPF     +    +
Sbjct: 249 -QLSNSEEREF--------SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  136 bits (344), Expect = 1e-36
 Identities = 85/322 (26%), Positives = 139/322 (43%), Gaps = 66/322 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 140
           V+G GSFG V  A+ +ETG++ A+K      +LQD   +    E +I+ +  +HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T D+  L+   V+E+V   + +  I +      +R      + Y  +I  AL +
Sbjct: 90  FCC-FQTPDR--LF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMF 139

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
           +H+  GI +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE++ 
Sbjct: 140 LHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y  A+D W+ G ++ E+L G   F  E+  D L E I                   
Sbjct: 198 E-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------ND 239

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACVHPFFDEL 371
           E  +P              L  +A  ++  F   +P +R              HPFF   
Sbjct: 240 EVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF--- 284

Query: 372 RDPN-TRLPNGRPLPPLFNFKP 392
           ++ +  +L + +  PP   F+P
Sbjct: 285 KEIDWAQLNHRQIEPP---FRP 303

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  136 bits (345), Expect = 1e-36
 Identities = 79/320 (24%), Positives = 124/320 (38%), Gaps = 64/320 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIM-QMLDHPNIVAL 140
           V+G GSFG V  A+ +      A+K      +L+ K  ++   E  ++ + + HP +V L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               F T DK  LY   VL+Y+   E    + R      +       + Y  +I  AL Y
Sbjct: 105 HFS-FQTADK--LY--FVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGY 154

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
           +H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE++ 
Sbjct: 155 LHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y   +D W  G V+ E+L G P F   +   ++ + I                   
Sbjct: 213 K-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL----------------NK 254

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR----CTALEACVHPFFDELRD 373
             +                +   A  L+    Q     R       +E   H FF     
Sbjct: 255 PLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF---SL 299

Query: 374 PN-TRLPNGRPLPPLFNFKP 392
            N   L N +  PP   F P
Sbjct: 300 INWDDLINKKITPP---FNP 316

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  135 bits (342), Expect = 2e-36
 Identities = 88/328 (26%), Positives = 143/328 (43%), Gaps = 66/328 (20%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDH-PN 136
           V+GTG++G VF  +     +TG++ A+K      ++Q  +       E Q+++ +   P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V L + F  T  K  L+L  +L+Y+   E    +++      +R     V++Y  +I  
Sbjct: 121 LVTLHYAF-QTETK--LHL--ILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVL 170

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-IC-SRYYRA 252
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C +  Y A
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMA 228

Query: 253 PELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           P+++ G    +  A+D WS G +M ELL G   F  +   +   EI           I  
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL- 279

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHP 366
                +E  +PQ             +   A DL+ R     P  R       A E   H 
Sbjct: 280 ----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323

Query: 367 FFDELRDPN-TRLPNGRPLPPLFNFKPP 393
           FF   +  N   L   +   P   FKP 
Sbjct: 324 FF---QKINWDDLAAKKVPAP---FKPV 345

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  136 bits (345), Expect = 6e-36
 Identities = 78/289 (26%), Positives = 127/289 (43%), Gaps = 40/289 (13%)

Query: 73  GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--R 124
            +  + + K+  YI    +G G+FG V   K   TG  VA+K     K+          R
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 182
           E+Q +++  HP+I+ L     + +D   ++  +V+EYV   E  + I +     + R+  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSD---IF--MVMEYVSGGELFDYICK-----NGRLDE 115

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
              +    QI   + Y H    + HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 116 KESRRLFQQILSGVDYCH-RHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 172

Query: 243 SYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV- 300
              C S  Y APE+I G       +DIWS+G ++  LL G   F  +  V  L + I   
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICDG 231

Query: 301 -------LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 339
                  L       +K M   +P         I+ H W   F++ LP 
Sbjct: 232 IFYTPQYLNPSVISLLKHMLQVDPM-KRATIKDIREHEW---FKQDLPK 276

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  135 bits (340), Expect = 8e-36
 Identities = 79/364 (21%), Positives = 136/364 (37%), Gaps = 84/364 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQML-----DHP 135
           Y     +G G F  V+ +   +  + VA+K V   + Y      E+++++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 136 N---IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           N   +V L   F   +     ++ +V E +   + +     +  +Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 193 CRALAYIHNCIGICHRDIKPQNLLV----------------------------------- 217
            + L Y+H    I H DIKP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 218 -------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
                        N    ++K+ D G+A  +   +     I +R YR+ E++ G+  Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 265 AIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KC 311
             DIWST C+  EL  G  LF   SG       D +  II++LG   R+ I       + 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLP------PEAVDLVCRFFQYSPNLRCTALEACVH 365
                      ++KP    +V  ++            D +    +  P  R TA E   H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 366 PFFD 369
           P+ +
Sbjct: 393 PWLN 396

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  133 bits (337), Expect = 1e-35
 Identities = 79/322 (24%), Positives = 138/322 (42%), Gaps = 57/322 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K      V  D+   +   E  + +   +HP +V L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T  +  L+   V+EYV   + +  + R      +++P  + + Y+ +I  AL Y
Sbjct: 76  HSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 125

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           +H   GI +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ 
Sbjct: 126 LHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G  +Y  ++D W+ G +M E++ G+  F      D   +        T + +        
Sbjct: 184 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-------- 227

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACVHPFFDEL 371
              F  I          + L  +A  ++  F    P  R          +   HPFF   
Sbjct: 228 ---FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF--- 279

Query: 372 RDPN-TRLPNGRPLPPLFNFKP 392
           R+ +   +   + +PP   FKP
Sbjct: 280 RNVDWDMMEQKQVVPP---FKP 298

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  132 bits (335), Expect = 2e-35
 Identities = 72/328 (21%), Positives = 122/328 (37%), Gaps = 71/328 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-------RELQIMQM 131
           Y     +G+G+FG V+ A  +E  + V +K     KVL+D   ++        E+ I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 188
           ++H NI+ +   F    ++      LV+E      +    I R     H R+        
Sbjct: 86  VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLDLFAFIDR-----HPRLDEPLASYI 135

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 247
             Q+  A+ Y+     I HRDIK +N+++      +KL DFGSA  L +G+      C +
Sbjct: 136 FRQLVSAVGYLRL-KDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGT 192

Query: 248 RYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
             Y APE++ G   Y    +++WS G  +  L+  +  F       +L E ++       
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------- 238

Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
                          P              +  E + LV    Q  P  R T  +    P
Sbjct: 239 ----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDP 276

Query: 367 FFDELRDPNTRLPNGRPLPPLFNFKPPE 394
           +  +  +             +F    PE
Sbjct: 277 WVTQPVN-----LADYTWEEVFRVNKPE 299

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  133 bits (336), Expect = 3e-35
 Identities = 83/372 (22%), Positives = 148/372 (39%), Gaps = 64/372 (17%)

Query: 44  DNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEH-----VVGTGSFGVV 98
           D D            +G+             +G +   +    +      V+G GS+  V
Sbjct: 11  DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLG--LQDFDLLRVIGRGSYAKV 68

Query: 99  FQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVALKHCFFSTTDK 150
              + ++T  I A++      V  D+   +   E  + +   +HP +V L  C F T  +
Sbjct: 69  LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-FQTESR 127

Query: 151 EELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208
             L+   V+EYV   + +  + R      +++P  + + Y+ +I  AL Y+H   GI +R
Sbjct: 128 --LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE-RGIIYR 177

Query: 209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTAID 267
           D+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G  +Y  ++D
Sbjct: 178 DLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVD 235

Query: 268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
            W+ G +M E++ G+  F      D   +        T + +           F  I   
Sbjct: 236 WWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-----------FQVILEK 277

Query: 328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC----VHPFFDELRDPN-TRLPN 380
                  + L  +A  ++  F    P  R  C           HPFF   R+ +   +  
Sbjct: 278 QIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF---RNVDWDMMEQ 332

Query: 381 GRPLPPLFNFKP 392
            + +PP   FKP
Sbjct: 333 KQVVPP---FKP 341

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  127 bits (322), Expect = 4e-34
 Identities = 50/224 (22%), Positives = 85/224 (37%), Gaps = 30/224 (13%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHP 135
           E  +G G FG+V + +  +   +VAIK ++                  RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           NIV L        +       +V+E+VP   +     + +     +           I  
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIAL 133

Query: 195 ALAYIHNC-IGICHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNVSYICSRY 249
            + Y+ N    I HRD++  N+ +           K+ DFG ++           + +  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191

Query: 250 YRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           + APE I    E YT   D +S   ++  +L G+  F   S   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  127 bits (321), Expect = 4e-34
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 34/220 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIV 138
           E ++G G FG V++A     G+ VA+K    D             +E ++  ML HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 139 ALK-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           AL+  C      +  L   LV+E+     +NR+        +R+P   +  +  QI R +
Sbjct: 70  ALRGVC----LKEPNLC--LVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGM 118

Query: 197 AYIHNC--IGICHRDIKPQNLLVN-------PHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
            Y+H+   + I HRD+K  N+L+             LK+ DFG A+   +    +S   +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGA 177

Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
             + APE+I  +  ++   D+WS G ++ ELL G+  F G
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  131 bits (331), Expect = 2e-33
 Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 65/321 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQM-LDHPNIVAL 140
           V+G GSFG V  ++ + T E+ A+K      V+QD        E +++ +    P +  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T D+  LY   V+EYV   + +  I +       R    +   Y  +I   L +
Sbjct: 408 HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 457

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           + +  GI +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE+I 
Sbjct: 458 LQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y  ++D W+ G ++ E+L GQ  F GE   D+L + I                   
Sbjct: 516 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EH 557

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 372
              +P            K +  EAV +        P  R         +   H FF   R
Sbjct: 558 NVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---R 602

Query: 373 DPN-TRLPNGRPLPPLFNFKP 392
             +  +L      PP   +KP
Sbjct: 603 YIDWEKLERKEIQPP---YKP 620

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  124 bits (314), Expect = 7e-33
 Identities = 73/311 (23%), Positives = 120/311 (38%), Gaps = 46/311 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 139 ALKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           +    F     K+EL+  LV++      V + +  I          +    +     ++ 
Sbjct: 77  SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSR---- 248
             L Y+H   G  HRD+K  N+L+      +++ DFG SA +   G+   +    R    
Sbjct: 132 EGLEYLHK-NGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187

Query: 249 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
               + APE++     Y    DIWS G    EL  G   +     +  L+  ++      
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                  N        P ++     K   K+       ++    Q  P  R TA E   H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

Query: 366 PFFDELRDPNT 376
            FF + ++   
Sbjct: 289 KFFQKAKNKEF 299

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  126 bits (317), Expect = 1e-32
 Identities = 58/346 (16%), Positives = 119/346 (34%), Gaps = 44/346 (12%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           G      V  A+ + TGE V ++++      ++       EL + ++ +HPNIV  +  F
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            +  +     L +V  ++   +   +   +      M  + +      + +AL YIH+ +
Sbjct: 96  IADNE-----LWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-M 147

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSA--------KVLVKGEPNVSYICSRYYRAPEL 255
           G  HR +K  ++L++    ++ L    S         +  V  +     +    + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

Query: 256 IF-GATEYTTAIDIWSTGCVMAELLLGQP----------LF-------PGESGVDQLVEI 297
           +      Y    DI+S G    EL  G            L        P       +   
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266

Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
              +          ++ + T               + +   P     V +  Q +P+ R 
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326

Query: 358 TALEACVHPFFDELRDPNTRL--PNGRPLPPLFNFKPPELSGIPPE 401
           +A     H FF +++   +       RP+ P+ NF+  +       
Sbjct: 327 SASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGI 372

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  123 bits (312), Expect = 2e-32
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
           +  +G GSFG V +A+    G  VA+K +++   +        RE+ IM+ L HPNIV  
Sbjct: 42  KEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
                + T    L   +V EY+   ++ R+    S   +++         Y + + + Y+
Sbjct: 100 MG---AVTQPPNLS--IVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 200 HNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIF 257
           HN    I HR++K  NLLV+   + +K+CDFG +++      +  S   +  + APE++ 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
                    D++S G ++ EL   Q  +  
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (323), Expect = 3e-32
 Identities = 60/259 (23%), Positives = 103/259 (39%), Gaps = 44/259 (16%)

Query: 49  RDSEPDIIDGVGAETGH--------VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQ 100
                   +G     G              + G+         Y  +  +  G  G ++ 
Sbjct: 48  DSETKGASEGWCPYCGSPYSFLPQLNPGDIVAGQ---------YEVKGCIAHGGLGWIYL 98

Query: 101 AKCRE-TGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
           A  R   G  V +K  L               E Q +  + HP+IV +   F   TD+  
Sbjct: 99  ALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHPSIVQI-FNFVEHTDRHG 155

Query: 153 LYLN-LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI 210
             +  +V+EYV  +++ R         Q++P+     Y  +I  AL+Y+H+ IG+ + D+
Sbjct: 156 DPVGYIVMEYVGGQSLKRS------KGQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDL 208

Query: 211 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWS 270
           KP+N+++     QLKL D G+   +        Y  +  ++APE++      T A DI++
Sbjct: 209 KPENIMLTEE--QLKLIDLGAVSRI--NSFGYLYG-TPGFQAPEIVRTGP--TVATDIYT 261

Query: 271 TGCVMAELLLGQPLFPGES 289
            G  +A L L  P   G  
Sbjct: 262 VGRTLAALTLDLPTRNGRY 280

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  122 bits (308), Expect = 1e-31
 Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 51/303 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           +     +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            +  + C+            LV+EY   + + +   + +    +  + +   T+   + L
Sbjct: 116 TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++       S++ + Y+ APE+I
Sbjct: 168 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222

Query: 257 FGATE--YTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
               E  Y   +D+WS G +   EL   +P     + +  L  I +              
Sbjct: 223 LAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQ------------NE 269

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
                   P ++   W + F+        + V    Q  P  R T+     H F    R 
Sbjct: 270 S-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314

Query: 374 PNT 376
           P  
Sbjct: 315 PTV 317

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  120 bits (304), Expect = 2e-31
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKN--RELQIMQMLDHPNIVALKH 142
             V+G G FG   +   RETGE++ +K++++  ++  +   +E+++M+ L+HPN++    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                   + L    + EY+   T+  I ++      + P      +   I   +AY+H+
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS 126

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------------- 248
              I HRD+   N LV      + + DFG A+++V  +     + S              
Sbjct: 127 M-NIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 249 --YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
             Y+ APE+I G   Y   +D++S G V+ E++      P 
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  118 bits (299), Expect = 9e-31
 Identities = 70/241 (29%), Positives = 108/241 (44%), Gaps = 39/241 (16%)

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------ 118
           H+I   I  R         Y     +G G    V+ A+       VAIK  +        
Sbjct: 3   HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52

Query: 119 ---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYS 174
              KR++ RE+     L H NIV++        + +  YL  V+EY+   T+      Y 
Sbjct: 53  ETLKRFE-REVHNSSQLSHQNIVSM---IDVDEEDDCYYL--VMEYIEGPTL----SEYI 102

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
             H  + +     +T QI   + + H+ + I HRDIKPQN+L++     LK+ DFG AK 
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160

Query: 235 LVKGEPNVSY----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
           L   E +++     + +  Y +PE   G        DI+S G V+ E+L+G+P F GE+ 
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETA 217

Query: 291 V 291
           V
Sbjct: 218 V 218

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  119 bits (300), Expect = 1e-30
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 37/241 (15%)

Query: 67  IRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRY 121
             + +  R         Y    ++G G    V  A+       VA+K VL     +D  +
Sbjct: 6   TPSHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSF 55

Query: 122 KNR---ELQIMQMLDHPNIVALKHCFF---STTDKEELYLNLVLEYVP-ETVNRIARNYS 174
             R   E Q    L+HP IVA+    +              +V+EYV   T+    R+  
Sbjct: 56  YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIV 107

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
                M            C+AL + H   GI HRD+KP N++++  T+ +K+ DFG A+ 
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARA 165

Query: 235 LVKGEPNVSY----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
           +     +V+     I +  Y +PE   G +      D++S GCV+ E+L G+P F G+S 
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSP 224

Query: 291 V 291
           V
Sbjct: 225 V 225

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  118 bits (298), Expect = 1e-30
 Identities = 65/302 (21%), Positives = 116/302 (38%), Gaps = 48/302 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G GSFG VF+     T ++VAIK +  ++         +E+ ++   D P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                +   T      L +++EY+   +   +          +    +     +I + L 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLD 133

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI 256
           Y+H+     HRDIK  N+L++    ++KL DFG + ++        +++ + ++ APE+I
Sbjct: 134 YLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
             +  Y +  DIWS G    EL  G+P                    P  E    ++P  
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP--------------------PHSE----LHPMK 226

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
             F  P+  P P     +        + V       P+ R TA E   H F        +
Sbjct: 227 VLFLIPKNNP-P---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282

Query: 377 RL 378
            L
Sbjct: 283 YL 284

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  119 bits (300), Expect = 1e-30
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 34/216 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
              +G G +G V+  K R  GE VA+K     ++    RE +I Q   + H NI+  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 200
               T    +LYL  + +Y    ++    ++ +      + L Y           L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151

Query: 201 NCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----R 248
             I        I HRD+K +N+LV  +     + D G A   +     V    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 249 YYRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 279
            Y  PE++  +      +     D++S G ++ E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (297), Expect = 1e-30
 Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 47/292 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           Y     +G G+ G V+ A    TG+ VAI+++       K     E+ +M+   +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               +    +     L +V+EY+   ++  +          M    +     +  +AL +
Sbjct: 82  YLDSYLVGDE-----LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEF 131

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIF 257
           +H+   + HRDIK  N+L+      +KL DFG    +   +    + + + Y+ APE++ 
Sbjct: 132 LHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 258 GATEYTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
               Y   +DIWS G +MA E++ G+P +  E+ +  L  I    GTP  +         
Sbjct: 190 R-KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN-------- 238

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    P     +F+        D + R  +     R +A E   H F 
Sbjct: 239 ---------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  118 bits (297), Expect = 2e-30
 Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 34/216 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
              VG G +G V++   +  GE VA+K    +D++   RE ++     L H NI+  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 200
              S     +L+L  +  Y    ++    +  +      + ++        I   LA++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122

Query: 201 NCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----R 248
             I        I HRD+K +N+LV  +     + D G A +  +    +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 249 YYRAPELI-----FGATEYTTAIDIWSTGCVMAELL 279
            Y APE++         +    +DIW+ G V+ E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  117 bits (296), Expect = 2e-30
 Identities = 48/224 (21%), Positives = 95/224 (42%), Gaps = 26/224 (11%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
              +G+GSFG V++ K       VA+K +               E+ +++   H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
              F   +   +L +  V ++    ++            +  +  +     Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYL 136

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 256
           H    I HRD+K  N+ ++   + +K+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 HAK-SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 257 FGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
                  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  116 bits (294), Expect = 3e-30
 Identities = 24/211 (11%), Positives = 71/211 (33%), Gaps = 22/211 (10%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
              +     G +++ + +  G  + +K +          R  N E   +++  HPN++ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
                        +  L+  ++P  ++  +    +     +       +   + R +A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMARGMAFL 127

Query: 200 HNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           H     I    +  ++++++      ++                +      + APE +  
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182

Query: 259 --ATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
                   + D+WS   ++ EL+  +  F  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  117 bits (295), Expect = 4e-30
 Identities = 77/297 (25%), Positives = 123/297 (41%), Gaps = 41/297 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 141
           +     +G GS+G V++A  +ETG+IVAIK+V  +   +   +E+ IMQ  D P++V   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +F  TD     L +V+EY    +V+ I       ++ +    +        + L Y+H
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGA 259
             +   HRDIK  N+L+N      KL DFG + ++        + I + ++ APE+I   
Sbjct: 143 F-MRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y    DIWS G    E+  G+P +     +  +  I      PT  +           
Sbjct: 201 -GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK----------- 247

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 P  W   F         D V +    SP  R TA +   HPF    +  + 
Sbjct: 248 ------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  117 bits (294), Expect = 7e-30
 Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 47/286 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G GS G+V  A+ + +G  VA+K +     Q +     E+ IM+   H N+V +   + 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
                EEL++  ++E++    +  I         R+    +      + +ALAY+H   G
Sbjct: 113 V---GEELWV--LMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QG 161

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
           + HRDIK  ++L+     ++KL DFG  A++        S + + Y+ APE+I   + Y 
Sbjct: 162 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYA 219

Query: 264 TAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
           T +DIWS G +M  E++ G+P +  +S V  +  +      P  +               
Sbjct: 220 TEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN-------------- 263

Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
               H    V +        D + R     P  R TA E   HPF 
Sbjct: 264 ---SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  116 bits (292), Expect = 9e-30
 Identities = 73/307 (23%), Positives = 126/307 (41%), Gaps = 54/307 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           +     +G G+FG V++AK +ETG + A K +     ++      E++I+   DHP IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 140 LKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           L   ++         L +++E+     V   +  + R        +    +++   Q+  
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR-------GLTEPQIQVVCRQMLE 128

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAP 253
           AL ++H+   I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ AP
Sbjct: 129 ALNFLHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186

Query: 254 ELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           E++   T     Y    DIWS G  + E+   +P     + +  L++I K    PT    
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT- 244

Query: 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
                           P  W   F+        D +      +P  R +A +   HPF  
Sbjct: 245 ----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVS 280

Query: 370 ELRDPNT 376
            +     
Sbjct: 281 SITSNKA 287

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  115 bits (290), Expect = 2e-29
 Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 42/307 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQML-DHPNIVA 139
           +    +VG G++G V++ +  +TG++ AIK +     ++    +E+ +++    H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 140 LKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
               F        +  L LV+E+    +V  + +N       +   ++     +I R L+
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLS 143

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI 256
           ++H    + HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I
Sbjct: 144 HLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 257 ----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
                    Y    D+WS G    E+  G P       +  L  I +             
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------------- 248

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           NP       P++K   W K FQ          +      + + R    +   HPF  +  
Sbjct: 249 NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIRDQP 294

Query: 373 DPNTRLP 379
           +      
Sbjct: 295 NERQVRI 301

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  115 bits (289), Expect = 3e-29
 Identities = 56/259 (21%), Positives = 91/259 (35%), Gaps = 38/259 (14%)

Query: 44  DNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKC 103
            +             +         T  G           Y    +VG G  G V++A+ 
Sbjct: 6   HHHHHSSGLVPRGSHMDGTAESREGTQFGP----------YRLRRLVGRGGMGDVYEAED 55

Query: 104 RETGEIVAIKKVL-----QDKRYK---NRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155
                IVA+K ++      D  ++    RE +    L  P++V +           +LY+
Sbjct: 56  TVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI---HDFGEIDGQLYV 111

Query: 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214
              +  +             R    +          QI  AL   H   G  HRD+KP+N
Sbjct: 112 --DMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPEN 164

Query: 215 LLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWS 270
           +LV+       L DFG A      +  +    + + + YY APE    +   T   DI++
Sbjct: 165 ILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYA 220

Query: 271 TGCVMAELLLGQPLFPGES 289
             CV+ E L G P + G+ 
Sbjct: 221 LTCVLYECLTGSPPYQGDQ 239

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  113 bits (284), Expect = 2e-28
 Identities = 39/223 (17%), Positives = 83/223 (37%), Gaps = 37/223 (16%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
             ++G G FG V+  +       VAI+ +  ++  ++      RE+   +   H N+V  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 141 K-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C         L   ++       T+  + R+       + +   +    +I + + Y
Sbjct: 95  MGAC----MSPPHLA--IITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGY 145

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 252
           +H   GI H+D+K +N+  +     + + DFG   +    +        R       + A
Sbjct: 146 LHAK-GILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 253 PELIFGATE--------YTTAIDIWSTGCVMAELLLGQPLFPG 287
           PE+I   +         ++   D+++ G +  EL   +  F  
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  113 bits (285), Expect = 2e-28
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 32/215 (14%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
           +  +G G FG V++ K R  GE VA+K    +++R   RE +I Q   L H NI+  +  
Sbjct: 47  QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                    +L+L  V +Y    ++      Y+   + M    +KL        LA++H 
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGM----IKL-ALSTASGLAHLHM 157

Query: 202 CI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----RY 249
            I        I HRD+K +N+LV  +     + D G A         +    +     + 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 250 YRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 279
           Y APE++  +      E     DI++ G V  E+ 
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  112 bits (282), Expect = 3e-28
 Identities = 56/247 (22%), Positives = 98/247 (39%), Gaps = 35/247 (14%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
             V   G FG V++A+     E VA+K    QDK+    E ++  +  + H NI+  +  
Sbjct: 29  LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGA 86

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
               T+   +L+L  +  +          ++ + +         +    + R LAY+H  
Sbjct: 87  EKRGTSVDVDLWL--ITAFHE---KGSLSDFLKANVVSWNELCHIA-ETMARGLAYLHED 140

Query: 203 I---------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---- 249
           I          I HRDIK +N+L+  +     + DFG A      E   S   +      
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAGDTHGQVGT 196

Query: 250 --YRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
             Y APE++ GA     +    ID+++ G V+ EL        G      L    ++   
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256

Query: 304 PTREEIK 310
           P+ E+++
Sbjct: 257 PSLEDMQ 263

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  112 bits (282), Expect = 4e-28
 Identities = 56/254 (22%), Positives = 98/254 (38%), Gaps = 39/254 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQM--LDHPNIVALKHC 143
             ++G G +G V++         VA+K     +++    E  I ++  ++H NI      
Sbjct: 18  LELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 144 FFSTTDKEELYLNLVLEYVPET--VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
               T    +   LV+EY P       ++ + S       L +       + R LAY+H 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH------SVTRGLAYLHT 129

Query: 202 CI--------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---- 249
            +         I HRD+  +N+LV        + DFG +  L                  
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 250 -----YRAPELIFGA------TEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVD-QLVE 296
                Y APE++ GA            +D+++ G +  E+ +    LFPGES  + Q+  
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 297 IIKVLGTPTREEIK 310
             +V   PT E+++
Sbjct: 249 QTEVGNHPTFEDMQ 262

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  105 bits (265), Expect = 9e-26
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 52/238 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
             V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
             L   C         +   L+ + +P        +Y R H+  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                    A E ++     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  104 bits (261), Expect = 1e-25
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 46/218 (21%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V   +       TGE+VA+KK LQ    ++     RE++I++ L H NI
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 138 VALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           V  K      +     L   L++EY+P       R+Y + H+ R+  I +  YT QIC+ 
Sbjct: 74  VKYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         +++  
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDKE--------FFKVK 174

Query: 252 ----------APELIFGATEYTTAIDIWSTGCVMAELL 279
                     APE +   ++++ A D+WS G V+ EL 
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (260), Expect = 4e-25
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 44/217 (20%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIK--KVLQDKRYKN--RELQIMQMLDHPNIV 138
              +G G+FG V   +       TGE+VA+K  +   ++  ++  RE++I++ L H NIV
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 139 ALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
             K      +     L   L++EY+P       R+Y + H+ R+  I +  YT QIC+ +
Sbjct: 106 KYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         YY+   
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206

Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL 279
                    APE +   ++++ A D+WS G V+ EL 
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  101 bits (254), Expect = 2e-24
 Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 44/235 (18%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G FG V           TGE+VA+K +  D   ++     +E+ I++ L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           +  K C     D     L LV+EYVP       R+Y   H  + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148

Query: 198 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
           Y+H  + I   HRD+  +N+L++ +   +K+ DFG AK + +G          YYR    
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196

Query: 252 --------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                   APE +     +  A D+WS G  + ELL          +   +L+ I
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  101 bits (254), Expect = 2e-24
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 44/217 (20%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V   +       TG +VA+K  LQ           RE+QI++ L    I
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V  +        ++ L   LV+EY+P   +   R++ + H+ R+    + LY+ QIC+ +
Sbjct: 87  VKYRGV-SYGPGRQSLR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+    C+   HRD+  +N+LV      +K+ DFG AK+L   +         YY    
Sbjct: 141 EYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVRE 188

Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL 279
                    APE +     ++   D+WS G V+ EL 
Sbjct: 189 PGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  100 bits (251), Expect = 4e-24
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 43/217 (19%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G FG V   +       TGE VA+K +  +    +     +E++I++ L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRAL 196
           V  K      T+     + L++E++P   +   + Y   +  ++ L     Y  QIC+ +
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+     +   HRD+  +N+LV    HQ+K+ DFG  K +   +         YY    
Sbjct: 140 DYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKD 187

Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL 279
                    APE +  +  +  A D+WS G  + ELL
Sbjct: 188 DRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  100 bits (250), Expect = 4e-24
 Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 47/232 (20%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKV---LQDKRYKN---RELQIMQMLDHPN 136
           + +  +G+G+FG V +   +    +  VA+K +     D   K+    E  +MQ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV +        + E     LV+E            Y + ++ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+   N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+   
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178

Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                    APE + +   ++++  D+WS G +M E    GQ  + G  G +
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 33/216 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
               T +   Y  ++ E++         +Y R   R  +  V L     QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
            N I   HRD+  +N LV  + H +K+ DFG ++++        Y      +      AP
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 181

Query: 254 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           E L +   +++   D+W+ G ++ E+   G   +PG
Sbjct: 182 ESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 98.0 bits (245), Expect = 2e-23
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 37/220 (16%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
              +G G FG V     R  G  VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 200
               +K  LY  +V EY+         +Y R   R  L    L  ++  +C A+ Y+  +
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------APE 254
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 137 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 184

Query: 255 -LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
            L     +++T  D+WS G ++ E+   G+  +P     D
Sbjct: 185 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 98.1 bits (245), Expect = 3e-23
 Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 49/238 (20%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   R   +   VAIK + Q     +      E QIM  LD+P I
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L          E L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+   N +   HRD+  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171

Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                    APE + F   ++++  D+WS G  M E L  GQ  +    G +    +E
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 99.7 bits (249), Expect = 4e-23
 Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 37/215 (17%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
              +G G FG V     R  G  VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 200
               +K  LY  +V EY+         +Y R   R  L    L  ++  +C A+ Y+  +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------APE 254
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356

Query: 255 -LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            L     +++T  D+WS G ++ E+   G+  +P 
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  100 bits (250), Expect = 5e-23
 Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 33/226 (14%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
               T +   Y  ++ E++         +Y R   R  +  V L     QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
            N I   HR++  +N LV    H +K+ DFG ++++        Y      +      AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
           E +     ++   D+W+ G ++ E+   G   +PG       +L+E
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 98.2 bits (245), Expect = 5e-23
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 50/237 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
             V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
             L   C         +   L+ + +P        +Y R H+  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                    A E I     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 99.4 bits (248), Expect = 6e-23
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
            ++   +E +Y  +V EY+         ++ +      L   +L     QI   +AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 299 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 350

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
           E       +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 351 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 38/231 (16%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
             V+G+G FG V +      GE     V IK +      ++       +  +  LDH +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L            L   LV +Y+P        ++ R H+  +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+  H  +   HR++  +N+L+     Q+++ DFG A +L   +     +     +   
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPI 181

Query: 252 ---APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
              A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 182 KWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 44/235 (18%), Positives = 79/235 (33%), Gaps = 50/235 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI-------VAIKKVLQDKRYKN----RELQIMQMLDHP 135
              +G G+F  +F+   RE G+        V +K + +  R  +        +M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 136 NIVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQIC 193
           ++V     C       +E    LV E+V          Y + ++    I  KL    Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 194 RALAYI--HNCIGICHRDIKPQNLLVNPHTHQL-------KLCDFGSAKVLVKGEPNVSY 244
            A+ ++  +  I   H ++  +N+L+     +        KL D G +  ++  +     
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175

Query: 245 ICSRYYR------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                 +       PE I        A D WS G  + E+   G           
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 47/232 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
              +G G FG V+        + VA+K + Q     +    E  +M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
            ++   +E +Y  ++ EY+    N    ++ +    + L   KL     QI   +A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
            N I   HRD++  N+LV+      K+ DFG A+++   E         Y          
Sbjct: 128 RNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPI 174

Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
              APE + +G   +T   D+WS G ++ E++  G+  +PG +   V Q +E
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 98.4 bits (245), Expect = 2e-22
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
            ++   +E +Y  +V EY+         ++ +      L   +L     QI   +AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 382 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 433

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
           E       +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 434 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 94.2 bits (235), Expect = 3e-22
 Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
              +G+G FGVV   K +   + VA+K + +    ++   +E Q M  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
           C    + +  +Y  +V EY+    N    NY R H +       L   Y +C  +A++  
Sbjct: 72  C----SKEYPIY--IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
           H  I   HRD+  +N LV+     +K+ DFG  + ++  +         Y          
Sbjct: 123 HQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPV 169

Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
              APE   +   +Y++  D+W+ G +M E+  LG+  +   +   V   V 
Sbjct: 170 KWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 98.1 bits (244), Expect = 4e-22
 Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 47/232 (20%)

Query: 85  IAEHVVGTGSFGVVFQAKCR-ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   R    +I VAIK + Q     +      E QIM  LD+P I
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L          E L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+   N +   HR++  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497

Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                    APE + F   ++++  D+WS G  M E L  GQ  +    G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 93.8 bits (234), Expect = 6e-22
 Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 45/226 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
              +G+G FG+V         + VAIK + +    +     E ++M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
           C     ++  +   LV E++    +    +Y R  + +      L     +C  +AY+  
Sbjct: 72  C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
              I   HRD+  +N LV  +   +K+ DFG  + ++  +         Y          
Sbjct: 123 ACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPV 169

Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
              +PE   F    Y++  D+WS G +M E+   G+  +   S  +
Sbjct: 170 KWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 96.3 bits (240), Expect = 7e-22
 Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 47/232 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           E  +G G FG V+ A   +  + VA+K +            E  +M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
                 KE +Y  ++ E++         ++ +  +       KL  ++ QI   +A+I  
Sbjct: 252 VT----KEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
            N I   HRD++  N+LV+      K+ DFG A+V+   E         Y          
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349

Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
              APE + FG   +T   D+WS G ++ E++  G+  +PG S  +  + +E
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 48/230 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
             ++G G FG V++            VA+K   +D    N+     E  IM+ LDHP+IV
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L        ++E  +  +++E  P        +Y   ++  + ++ + LY+ QIC+A+A
Sbjct: 77  KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
           Y+   NC+   HRDI  +N+LV      +KL DFG ++ +   +         YY+    
Sbjct: 128 YLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVT 174

Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                  +PE + F    +TTA D+W     M E+L  G+  F      D
Sbjct: 175 RLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 58/230 (25%), Positives = 89/230 (38%), Gaps = 49/230 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 141
              +G G+FG VF  + R    +VA+K   +      +     E +I++   HPNIV L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 142 H--CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAY 198
              C    T K+ +Y  +V+E V          + R       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 199 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR----- 251
           +    CI   HRD+  +N LV    + LK+ DFG ++    G          Y       
Sbjct: 229 LESKCCI---HRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLR 275

Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                  APE L +G   Y++  D+WS G ++ E   LG   +P  S   
Sbjct: 276 QVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 51/239 (21%), Positives = 90/239 (37%), Gaps = 52/239 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
             ++G G FG V +A+ ++       VA+K +  D    +      RE   M+  DHP++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYT 189
             L      S          ++L ++           +RI  N   +  +  L+    + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT-LVR---FM 143

Query: 190 YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
             I   + Y+   N I   HRD+  +N ++      + + DFG ++ +  G+        
Sbjct: 144 VDIACGMEYLSSRNFI---HRDLAARNCMLAED-MTVCVADFGLSRKIYSGD-------- 191

Query: 248 RYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
            YYR            A E L      YT   D+W+ G  M E++  GQ  + G    +
Sbjct: 192 -YYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 55/239 (23%), Positives = 89/239 (37%), Gaps = 52/239 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
              +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           ++ L    +       +   +V E  P        +  R HQ    L  +  Y  Q+   
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+     I   HRD+  +NLL+      +K+ DFG  + L + +         +Y   
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181

Query: 252 ----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                     APE L      ++ A D W  G  + E+   GQ  + G +G      ++
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 47/238 (19%), Positives = 87/238 (36%), Gaps = 51/238 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
             ++G G FG V +   ++       VA+K +  D   +        E   M+   HPN+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 190
           + L       + +      ++L ++           +R+      I  +  L+    +  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT-LLK---FMV 154

Query: 191 QICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
            I   + Y+   N +   HRD+  +N ++      + + DFG +K +  G+         
Sbjct: 155 DIALGMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD--------- 201

Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
           YYR            A E L      YT+  D+W+ G  M E+   G   +PG    +
Sbjct: 202 YYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 91.1 bits (227), Expect = 7e-21
 Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 45/226 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
              +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
           C    T +  ++  ++ EY+    N    NY R  +        L     +C A+ Y+  
Sbjct: 88  C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
              +   HRD+  +N LVN     +K+ DFG ++ ++  E         Y          
Sbjct: 139 KQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPV 185

Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
               PE L++   ++++  DIW+ G +M E+  LG+  +   +  +
Sbjct: 186 RWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 90.8 bits (226), Expect = 9e-21
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 50/236 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
              +G G FG V Q            VAIK          R     E   M+  DHP+IV
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L         +  ++  +++E          R++ ++ +  + L  + LY YQ+  ALA
Sbjct: 80  KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
           Y+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+    
Sbjct: 131 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 177

Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                  APE + F    +T+A D+W  G  M E+L  G   F G    D    +E
Sbjct: 178 KLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 60/250 (24%), Positives = 94/250 (37%), Gaps = 60/250 (24%)

Query: 91  GTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHPNIVA 139
           G G+FG V +A        +    VA+K +     L ++     EL+++  L +H NIV 
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91

Query: 140 LKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLIYVK 186
           L       T        ++ EY                 +             + L    
Sbjct: 92  LLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 187 LYT--YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
           L +  YQ+ + +A++   NCI   HRD+  +N+L+       K+CDFG A+ +       
Sbjct: 147 LLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHG-RITKICDFGLARDIKNDS--- 199

Query: 243 SYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 289
                  Y             APE IF    YT   D+WS G  + EL  LG   +PG  
Sbjct: 200 ------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 290 GVDQLVEIIK 299
              +  ++IK
Sbjct: 253 VDSKFYKMIK 262

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 59/238 (24%), Positives = 93/238 (39%), Gaps = 51/238 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E ++G+G  G V   + R  G+    VAIK +      + R     E  IM   DHPNI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 139 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRAL 196
            L+       T        +V EY+    N     + R H     I   +     +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+     +   HRD+  +N+LV+ +    K+ DFG ++VL                   
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTT 212

Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                    APE + F    +++A D+WS G VM E+L  G+  +   +  D    VE
Sbjct: 213 GGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 92.6 bits (230), Expect = 2e-20
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 50/236 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
              +G G FG V Q            VAIK          R     E   M+  DHP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L         +  ++  +++E          R++ ++ +  + L  + LY YQ+  ALA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
           Y+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+    
Sbjct: 506 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 552

Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
                  APE + F    +T+A D+W  G  M E+L  G   F G     V   +E
Sbjct: 553 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 88.6 bits (220), Expect = 5e-20
 Identities = 31/263 (11%), Positives = 54/263 (20%), Gaps = 60/263 (22%)

Query: 50  DSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEI 109
                  D V    G  I     GR         Y      G       +QA        
Sbjct: 11  RESSAPPDDVQLVPGARI---ANGR---------YRLLIFHGGVPPLQFWQALDTALDRQ 58

Query: 110 VAIKKVL----QDKRYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162
           VA+  V                    +  +D P +  +         +    +  V E++
Sbjct: 59  VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGLV--VAEWI 113

Query: 163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT 221
              ++  +A            +        +  A    H   G+      P  + V+   
Sbjct: 114 RGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-D 165

Query: 222 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
             + L                                        DI   G  +  LL+ 
Sbjct: 166 GDVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYALLVN 198

Query: 282 QPLFPGESGVDQLVEIIKVLGTP 304
           +   P       L    +     
Sbjct: 199 RWPLPEAGVRSGLAPAERDTAGQ 221

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 47/231 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +   +    VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 139 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
            L+       T  + +   +V EY+    N    ++ R H  +  +I +      I   +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+     +   HRD+  +N+L+N +    K+ DFG  +VL              Y    
Sbjct: 161 KYLSDMGYV---HRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRG 209

Query: 252 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                   +PE + +   ++T+A D+WS G V+ E++  G+  +   S  D
Sbjct: 210 GKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 88.1 bits (219), Expect = 8e-20
 Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 55/236 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
           + V+G G FGVV+  +  +  +     AIK    + + +      RE  +M+ L+HPN++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
           AL          E L   ++L Y+    +     + R  QR P    LI    +  Q+ R
Sbjct: 86  ALIGI---MLPPEGLPH-VLLPYMC---HGDLLQFIRSPQRNPTVKDLIS---FGLQVAR 135

Query: 195 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
            + Y+     +   HRD+  +N +++  +  +K+ DFG A+ ++  E         YY  
Sbjct: 136 GMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE---------YYSV 182

Query: 252 -------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                        A E L      +TT  D+WS G ++ ELL  G P +      D
Sbjct: 183 QQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 46/231 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
           + V+G G FG V++   + +       VAIK +      K R     E  IM    H NI
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           + L+       +  + +   ++ EY+    N     + R       ++ +      I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+   N +   HRD+  +N+LVN +    K+ DFG ++VL             Y    
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEAT------YTTSG 209

Query: 252 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                   APE + +    +T+A D+WS G VM E++  G+  +   S  +
Sbjct: 210 GKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 88.1 bits (219), Expect = 9e-20
 Identities = 56/248 (22%), Positives = 100/248 (40%), Gaps = 61/248 (24%)

Query: 91  GTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALK 141
           G G+FG VF A+C          +VA+K +    L  ++   RE +++  L H +IV   
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83

Query: 142 HCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKLY-- 188
                  D + L   +V EY+                 I  +      +  L   ++   
Sbjct: 84  GV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 189 TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
             QI   + Y+   + +   HRD+  +N LV  +   +K+ DFG ++ +   +       
Sbjct: 139 ASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTD------- 187

Query: 247 SRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGESGV 291
             YYR             PE +++   ++TT  D+WS G ++ E+   G QP +   S  
Sbjct: 188 --YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP-WFQLS-N 241

Query: 292 DQLVEIIK 299
            +++E I 
Sbjct: 242 TEVIECIT 249

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 55/236 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
             V+G G FG V+     +        A+K    + D    +    E  IM+   HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
           +L         +      +VL Y+    +   RN+ R     P    LI    +  Q+ +
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 139

Query: 195 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
            + Y+     +   HRD+  +N +++     +K+ DFG A+ +   E         YY  
Sbjct: 140 GMKYLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSV 186

Query: 252 -------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                        A E L     ++TT  D+WS G ++ EL+  G P +P  +  D
Sbjct: 187 HNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 57/251 (22%)

Query: 88  HVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD-HPN 136
             +G G+FG V +A         T   VA+K +       + R    EL+I+  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLI 183
           +V L      T     L   +++E+               E V             + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 184 YVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
           ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    
Sbjct: 149 HLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEK-NVVKICDFGLARDIYKDP-- 202

Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
                   Y             APE IF    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 203 -------DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGV 254

Query: 289 SGVDQLVEIIK 299
              ++    +K
Sbjct: 255 KIDEEFCRRLK 265

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 50/245 (20%), Positives = 99/245 (40%), Gaps = 54/245 (22%)

Query: 88  HVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLDHPNI 137
             +G GSFG+V++   +   +      VAIK V     ++++     E  +M+  +  ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 190
           V L       +  +     +++E +            R A   + +     L  +     
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 191 QICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
           +I   +AY+  +  +   HRD+  +N +V      +K+ DFG  + + + +         
Sbjct: 146 EIADGMAYLNANKFV---HRDLAARNCMVAED-FTVKIGDFGMTRDIYETD--------- 192

Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 294
           YYR            +PE L  G   +TT  D+WS G V+ E+  L +  + G S  +Q+
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQV 249

Query: 295 VEIIK 299
           +  + 
Sbjct: 250 LRFVM 254

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 86.3 bits (214), Expect = 8e-19
 Identities = 51/233 (21%), Positives = 92/233 (39%), Gaps = 49/233 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
             V+G G FG V+     +        A+K    + D    +    E  IM+   HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
           +L         +      +VL Y+    +   RN+ R     P    LI    +  Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203

Query: 195 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
            + ++     +   HRD+  +N +++     +K+ DFG A+ +   E +        +  
Sbjct: 204 GMKFLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNK 253

Query: 252 ----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                     A E L     ++TT  D+WS G ++ EL+  G P +P  +  D
Sbjct: 254 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 52/260 (20%), Positives = 98/260 (37%), Gaps = 68/260 (26%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G FG V +A             VA+K +       + R    E  +++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 177
           ++ L       +    L   L++EY                      +      +     
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233
               L    L  + +QI + + Y+     +   HRD+  +N+LV     ++K+ DFG ++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEG-RKMKISDFGLSR 198

Query: 234 VLVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-L 280
            + + +          Y             A E +F    YTT  D+WS G ++ E++ L
Sbjct: 199 DVYEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTL 248

Query: 281 G-QPLFPGESGVDQLVEIIK 299
           G  P +PG    ++L  ++K
Sbjct: 249 GGNP-YPGIP-PERLFNLLK 266

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 60/251 (23%), Positives = 98/251 (39%), Gaps = 58/251 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLD-HP 135
              +G G+FG V +A     G+      VA+K +       +K     EL+IM  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP---------ETVNRIARNYSRIHQRMPLIYVK 186
           NIV L       T    +   ++ EY                +  + +            
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 187 L--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
           L  ++ Q+ + +A++   NCI   HRD+  +N+L+    H  K+ DFG A+ ++      
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS--- 218

Query: 243 SYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGE 288
                  Y             APE IF    YT   D+WS G ++ E+  LG  P +PG 
Sbjct: 219 ------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGI 270

Query: 289 SGVDQLVEIIK 299
               +  +++K
Sbjct: 271 LVNSKFYKLVK 281

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 60/251 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNI 137
           +  +G G+FG VF A+C          +VA+K +       ++   RE +++ ML H +I
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP----------ETVNRIARNYSRIHQRMPLIYVKL 187
           V         T+   L   +V EY+              +             PL   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 188 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
                Q+   + Y+   + +   HRD+  +N LV      +K+ DFG ++ +   +    
Sbjct: 161 LAVASQVAAGMVYLAGLHFV---HRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD---- 212

Query: 244 YICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGE 288
                YYR             PE +++   ++TT  D+WS G V+ E+   G QP +   
Sbjct: 213 -----YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQL 264

Query: 289 SGVDQLVEIIK 299
           S   + ++ I 
Sbjct: 265 S-NTEAIDCIT 274

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 50/245 (20%), Positives = 93/245 (37%), Gaps = 52/245 (21%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G+FG V++ +        +   VA+K +      QD+     E  I+   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           IV        +      +  +++E +      +  R  R        + ++ +      I
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 193 CRALAYI--HNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSR 248
                Y+  ++ I   HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 150 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197

Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 294
           YYR             PE  + G   +T+  D WS G ++ E+  LG   +P +S   ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254

Query: 295 VEIIK 299
           +E + 
Sbjct: 255 LEFVT 259

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 59/260 (22%), Positives = 97/260 (37%), Gaps = 67/260 (25%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHP 135
             V+G+G+FG V  A             VA+K +       ++     EL++M  L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP------------------ETVNRIARNYSRIH 177
           NIV L       T    +Y  L+ EY                    E      +      
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233
               L +  L  + YQ+ + + ++   +C+   HRD+  +N+LV      +K+CDFG A+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHG-KVVKICDFGLAR 220

Query: 234 VLVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--L 279
            ++             Y             APE +F    YT   D+WS G ++ E+  L
Sbjct: 221 DIMSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL 270

Query: 280 LGQPLFPGESGVDQLVEIIK 299
              P +PG        ++I+
Sbjct: 271 GVNP-YPGIPVDANFYKLIQ 289

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 51/245 (20%), Positives = 93/245 (37%), Gaps = 52/245 (21%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G+FG V++ +        +   VA+K +      QD+     E  I+   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           IV        +      +  ++LE +      +  R  R        + ++ +      I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 193 CRALAYI--HNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSR 248
                Y+  ++ I   HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 191 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238

Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 294
           YYR             PE  + G   +T+  D WS G ++ E+  LG   +P +S   ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295

Query: 295 VEIIK 299
           +E + 
Sbjct: 296 LEFVT 300

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 82.6 bits (205), Expect = 5e-18
 Identities = 53/253 (20%), Positives = 93/253 (36%), Gaps = 62/253 (24%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G   FG V++         E  + VAIK +        +     E  +   L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYV 185
           +V L       T  + L   ++  Y                + +         +  L   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 186 KL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
                  QI   + Y+  H+ +   H+D+  +N+LV      +K+ D G  + +   +  
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVV---HKDLATRNVLVYDK-LNVKISDLGLFREVYAAD-- 182

Query: 242 VSYICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFP 286
                  YY+            APE +++G  +++   DIWS G V+ E+   G QP + 
Sbjct: 183 -------YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YC 232

Query: 287 GESGVDQLVEIIK 299
           G S    +VE+I+
Sbjct: 233 GYS-NQDVVEMIR 244

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 56/261 (21%), Positives = 99/261 (37%), Gaps = 70/261 (26%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G+FG VFQA+       E   +VA+K +        +    RE  +M   D+PN
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 177
           IV L          + +   L+ EY+                       +   R      
Sbjct: 112 IVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233
              PL   +      Q+   +AY+     +   HRD+  +N LV  +   +K+ DFG ++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGEN-MVVKIADFGLSR 222

Query: 234 VLVKGEPNVSYICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL- 279
            +   +         YY+             PE + +    YTT  D+W+ G V+ E+  
Sbjct: 223 NIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 271

Query: 280 LG-QPLFPGESGVDQLVEIIK 299
            G QP + G +  ++++  ++
Sbjct: 272 YGLQP-YYGMA-HEEVIYYVR 290

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 61/254 (24%)

Query: 87  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
              +G G FG V  A+         +    VA+K +      +D      E+++M+M+  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 182
           H NI+ L       T    LY  +++EY  +                            +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
            +  L   TYQ+ R + Y+    CI   HRD+  +N+LV  + + +K+ DFG A+ +   
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 256

Query: 239 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 285
           +         YY+            APE +F    YT   D+WS G +M E+  LG   +
Sbjct: 257 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 306

Query: 286 PGESGVDQLVEIIK 299
           PG   V++L +++K
Sbjct: 307 PGIP-VEELFKLLK 319

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 61/254 (24%), Positives = 101/254 (39%), Gaps = 61/254 (24%)

Query: 87  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
              +G G+FG V  A+              VA+K +      +D      E+++M+M+  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPL 182
           H NI+ L       T    LY  +++EY                          +    L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
               L    YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG A+ +   
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTED-NVMKIADFGLARDIHHI 244

Query: 239 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 285
           +         YY+            APE +F    YT   D+WS G ++ E+  LG   +
Sbjct: 245 D---------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPY 294

Query: 286 PGESGVDQLVEIIK 299
           PG   V++L +++K
Sbjct: 295 PGVP-VEELFKLLK 307

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 61/254 (24%)

Query: 87  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
              +G G+FG V  A+         +    VA+K +      +D      E+++M+M+  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 182
           H NI+ L       T    LY  +++EY  +                            +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
            +  L   TYQ+ R + Y+    CI   HRD+  +N+LV  + + +K+ DFG A+ +   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 210

Query: 239 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 285
           +         YY+            APE +F    YT   D+WS G +M E+  LG   +
Sbjct: 211 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 260

Query: 286 PGESGVDQLVEIIK 299
           PG   V++L +++K
Sbjct: 261 PGIP-VEELFKLLK 273

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 80.7 bits (198), Expect = 5e-17
 Identities = 46/330 (13%), Positives = 91/330 (27%), Gaps = 74/330 (22%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----------RELQIMQML----- 132
           +G G FG VF  +       VAIK + ++     N            E+ I + L     
Sbjct: 28  IGEGVFGEVF--QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 133 ----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIY-- 184
                    + L            L L     Y     + N     +      + L +  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 185 -----------------VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 227
                             K   +Q+  +LA     +   HRD+   N+L+   + + KL 
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK-KLH 204

Query: 228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
              + K        +                  +YT +        V  ++ + + LF G
Sbjct: 205 YTLNGKSSTIPSCGL-------------QVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 288 ESGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKPHPW--HKVFQKRLP 338
           +   D   +I +++           +P       +Y   K  +        +    K++ 
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309

Query: 339 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            +  +       +S     +A +       
Sbjct: 310 RKIQEFHRTMLNFS-----SATDLLCQHSL 334

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 16/157 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 140
           Y     +G GSFGV+F+       + VAIK   +         E +  ++L     I  +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +       +E L+  LV++ +  ++  +     R   +  +  V +   Q+   +  IH
Sbjct: 72  YYF-----GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 123

Query: 201 NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSAK 233
               + +RDIKP N L+    + + + + + DFG  K
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 60/238 (25%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE--IVAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 138
           + V+G G+FG V +A+ ++ G     AIK++       D R    EL+++  L  HPNI+
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKL 187
            L         +  LY  L +EY P             +               L   +L
Sbjct: 90  NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 188 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
             +   + R + Y+     I   HRD+  +N+LV  + +  K+ DFG ++          
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191

Query: 244 YICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
                 Y             A E L +    YTT  D+WS G ++ E++ LG   + G
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 16/157 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQMLDH-PNIVAL 140
           +     +G G+FG +   K   T E VAIK   +       + E +  + L     I  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +           Y  +VLE +  ++  +     R      L  V +   Q+   + Y+H
Sbjct: 71  YYF-----GPCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVH 122

Query: 201 NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSAK 233
           +   + +RD+KP+N L+    N     + + DF  AK
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 14/155 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 140
           Y     +G+GSFG ++       GE VAIK      ++     E +I +M+     I  +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           + C       E  Y  +V+E +  ++  +    SR   +  L  V L   Q+   + YIH
Sbjct: 71  RWC-----GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH 122

Query: 201 NCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAK 233
           +     HRD+KP N L+      + + + DFG AK
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.0 bits (184), Expect = 8e-15
 Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 14/155 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQML-DHPNIVAL 140
           +     +G+GSFG ++     +T E VAIK      ++     E +I ++L     I  +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +         E  Y  LV++ +  ++  +   ++   +++ L  V +   Q+   + ++H
Sbjct: 69  RWF-----GVEGDYNVLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 201 NCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAK 233
           +     HRDIKP N L+      +Q+ + DFG AK
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 45/250 (18%), Positives = 81/250 (32%), Gaps = 49/250 (19%)

Query: 63  TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK 122
            G V+    G +         ++    +G+G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 123 N---RELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVPET 165
                EL+  Q +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQL 224
           + +I    +          V     ++   L YIH      H DIK  NLL+   +  Q+
Sbjct: 138 LQKI-SGQNG---TFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192

Query: 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------DIWSTG 272
            L D+G +        +  Y         +   G  E+ T++            D+   G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247

Query: 273 CVMAELLLGQ 282
             M   L G+
Sbjct: 248 YCMLRWLCGK 257

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 56/236 (23%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQ 127
            N  ++   +  + +G G FGVV+  K       VA+KK+                 E++
Sbjct: 25  NNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 82

Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS------RIHQRMP 181
           +M    H N+V L     S+   +     LV  Y+P        N S       +    P
Sbjct: 83  VMAKCQHENLVELLGF--SSDGDDLC---LVYVYMP--------NGSLLDRLSCLDGTPP 129

Query: 182 LIYVKLYTYQIC----RALAYIH-NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSA 232
           L +      +I       + ++H N   I HRDIK  N+L+           K+ DFG A
Sbjct: 130 LSWHM--RCKIAQGAANGINFLHENHH-I-HRDIKSANILLDEAFTA-----KISDFGLA 180

Query: 233 KVLVKGEPNVSYICSR----Y-YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
           +   K     + + SR      Y APE + G  E T   DI+S G V+ E++ G P
Sbjct: 181 RASEKFA--QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 51/219 (23%), Positives = 94/219 (42%), Gaps = 45/219 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVAL-K 141
           + ++G G FG V++   R+ G  VA+K+   +          E++ +    HP++V+L  
Sbjct: 44  KFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQIC----RA 195
            C       E   + L+ +Y+    N   +   Y      M + + +    +IC    R 
Sbjct: 103 FC------DERNEMILIYKYME---NGNLKRHLYGSDLPTMSMSWEQ--RLEICIGAARG 151

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----Y 250
           L Y+H    I HRD+K  N+L++ +    K+ DFG +K   + +   +++ +       Y
Sbjct: 152 LHYLHTR-AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLSTVVKGTLGY 207

Query: 251 RAPELIFGATEY------TTAIDIWSTGCVMAELLLGQP 283
             P       EY      T   D++S G V+ E+L  + 
Sbjct: 208 IDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 46/252 (18%), Positives = 76/252 (30%), Gaps = 52/252 (20%)

Query: 64  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
           G +I                +     +G G FG ++ A    + E V        K   +
Sbjct: 26  GEIITDMAAAA---------WKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPS 75

Query: 124 R------ELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVP 163
                  EL+  Q    P  +                           + Y  ++++   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135

Query: 164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTH 222
             + +I    ++   R     V   + +I   L YIH      H DIK  NLL+N  +  
Sbjct: 136 SDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191

Query: 223 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------DIWS 270
           Q+ L D+G A        + +Y             G  E+ T+I            D+  
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246

Query: 271 TGCVMAELLLGQ 282
            G  M + L G 
Sbjct: 247 LGYCMIQWLTGH 258

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 37/255 (14%), Positives = 78/255 (30%), Gaps = 56/255 (21%)

Query: 63  TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG--------EIVAIK- 113
           TG V+    G +         +  +      + G++++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 114 -----------KVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160
                         Q   K  +  + + +       I             ++ Y  LVL 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGV----HQDKYRFLVLP 138

Query: 161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP- 219
            +  ++        +    +    V     ++  AL ++H      H ++  +N+ V+P 
Sbjct: 139 SLGRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPE 195

Query: 220 HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------D 267
              Q+ L  +G A        +V+Y             G  E+  ++            D
Sbjct: 196 DQSQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSD 250

Query: 268 IWSTGCVMAELLLGQ 282
           + S G  M + L G 
Sbjct: 251 LQSLGYCMLKWLYGF 265

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 48/221 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 141
           ++++G G FG V++ +    G +VA+K++ +++          E++++ M  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-------RIHQRMPLIYVKLYTYQIC- 193
                 T  E L   LV  Y+         N S       R   + PL + K    +I  
Sbjct: 94  GF--CMTPTERL---LVYPYMA--------NGSVASCLRERPESQPPLDWPK--RQRIAL 138

Query: 194 ---RALAYIHN-C-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
              R LAY+H+ C   I HRD+K  N+L++    +  + DFG AK++   +   +++ + 
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTTA 194

Query: 249 Y-----YRAPE-LIFG-ATEYTTAIDIWSTGCVMAELLLGQ 282
                 + APE L  G ++E T   D++  G ++ EL+ GQ
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 29/127 (22%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K        
Sbjct: 198 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYKDP------ 247

Query: 246 CSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
               Y             APE IF    YT   D+WS G ++ E+  LG   +PG    +
Sbjct: 248 ---DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303

Query: 293 QLVEIIK 299
           +    +K
Sbjct: 304 EFCRRLK 310

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	422
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.02
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.59
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.51
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.22
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.2
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.19
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.12
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.05
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.89
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.55
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.51
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.5
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.46
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.23
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.08
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.06
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.04
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.02
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.96
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.86
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.79
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.49
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.93
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.99
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	80.56

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.6e-64  Score=468.85  Aligned_cols=252  Identities=31%  Similarity=0.517  Sum_probs=217.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++|+.|+|||||+++++|.     +..+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            3599999999999999999999999999999998642       234568999999999999999999983     3445


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +|+|||||++ +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus       107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g-~vKl~DFGla~  180 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTAK  180 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCC-CEEEEEcCCce
Confidence            8899999985 77776654    3679999999999999999999999 8999999999999999888 69999999998


Q ss_pred             ccccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          234 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       234 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      .+....   ...+.+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+.+|.+.          
T Consensus       181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~----------  249 (311)
T 4aw0_A          181 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL----------  249 (311)
T ss_dssp             ECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----------
T ss_pred             ecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence            764332   23467899999999999765 4899999999999999999999999999888888877662          


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHH------HhcCCcccccCCC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRDP  374 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e------~l~hp~f~~~~~~  374 (422)
                             .+.+            +..+++++++||++||+.||++|+|++|      +++||||+++.+.
T Consensus       250 -------~~~~------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~  300 (311)
T 4aw0_A          250 -------EYDF------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  300 (311)
T ss_dssp             -------CCCC------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             -------CCCC------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence                   1222            2468999999999999999999999987      5899999998643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-64  Score=488.40  Aligned_cols=287  Identities=37%  Similarity=0.651  Sum_probs=239.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-CCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~  155 (422)
                      +|.+++.||+|+||+||+|+++.+|+.||||++....      ....+|+++|+.|+|||||++++++..... .+...+
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            5999999999999999999999999999999986432      234579999999999999999998754321 234568


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      |+|||||+++|..++..    .+.+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+.+
T Consensus       135 ~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~  208 (398)
T 4b99_A          135 YVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENC-ELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCC-CEEEeecceeeec
Confidence            89999999887666543    4689999999999999999999999 8999999999999999888 6999999999865


Q ss_pred             ccC-----CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          236 VKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       236 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ...     ....+.+||+.|||||++.+...|+.++||||+||++|||++|++||.+.+..+++..|....+.|+...+.
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            332     233567899999999999887778999999999999999999999999999999999999999999876554


Q ss_pred             hcCcCCc---cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCC
Q 014595          311 CMNPNYT---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (422)
Q Consensus       311 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  376 (422)
                      .......   ...++...+.+|...+ +.++++++|||++||++||++|||+.|+|+||||++..++..
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~  356 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD  356 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence            3321111   1134455556666655 578999999999999999999999999999999999877654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.9e-64  Score=462.12  Aligned_cols=249  Identities=28%  Similarity=0.415  Sum_probs=202.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++++.++|||||++++++.     ....
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCE
Confidence            4699999999999999999999999999999998643       134568999999999999999999984     3345


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +|+|||||++++.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus        88 ~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~  161 (275)
T 3hyh_A           88 IIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHL-NVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTC-CEEECCSSCC--
T ss_pred             EEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCC-CEEEeecCCCee
Confidence            889999999888776654    4679999999999999999999999 8999999999999999887 699999999987


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ........+.+||+.|||||++.+...++.++|||||||++|+|+||++||.+.+..+.+..+...              
T Consensus       162 ~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--------------  227 (275)
T 3hyh_A          162 MTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--------------  227 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------
T ss_pred             cCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------------
Confidence            766666667899999999999987765678999999999999999999999998877776666542              


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                         .+.            ++..+|+++++||++||+.||++|||++|+|+||||+.
T Consensus       228 ---~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          228 ---VYT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ---CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ---CCC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence               111            12458999999999999999999999999999999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-62  Score=466.97  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=215.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..|.+.+.||+|+||+||+|+++.+|+.||||++...    ...+.+|+++|+.++|||||+++++|.+     ...+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            3599999999999999999999999999999998532    3445789999999999999999999843     335889


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      |||||++ +|.+++..     ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+.+.
T Consensus       149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence            9999985 77666643     579999999999999999999999 8999999999999999888 69999999998765


Q ss_pred             cC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .. ....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|......            
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~------------  288 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP------------  288 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC------------
T ss_pred             CCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC------------
Confidence            44 334567899999999999654 5899999999999999999999999998888877776552100            


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                          .++          .+..+|+++++||.+||+.||++|||+.|+|+||||++..
T Consensus       289 ----~~~----------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          289 ----RLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             ----CCS----------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ----CCC----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                000          1135799999999999999999999999999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-62  Score=467.35  Aligned_cols=251  Identities=27%  Similarity=0.419  Sum_probs=208.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|++++.||+|+||+||+|+++.+|+.||||++...      ...+.+|+++|+.|+|||||+++++|.+     ...+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEE
Confidence            4699999999999999999999999999999998643      2345689999999999999999999843     3458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      |+|||||++ +|.+++...  ....+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+.
T Consensus        99 yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~  174 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TVQLGDFGIARV  174 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTC-CEEECSTTEESC
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-CEEEccccccee
Confidence            899999984 887777542  23567999999999999999999999 8999999999999999888 699999999987


Q ss_pred             cccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          235 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       235 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ...... ..+.+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+.+.++....            
T Consensus       175 ~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~------------  241 (350)
T 4b9d_A          175 LNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS------------  241 (350)
T ss_dssp             CCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------------
T ss_pred             ecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------
Confidence            643322 2456899999999999764 58999999999999999999999999999888888776631            


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                             ++.         .+..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       242 -------~~~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 -------FPP---------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             -------CCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             -------CCC---------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                   110         12467999999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.1e-61  Score=469.07  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=215.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..|.+.+.||+|+||+||+|+++.+|+.||||++...    ...+.+|+.+|+.++|||||+++++|..     ...+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence            4599999999999999999999999999999998532    3456789999999999999999999854     334889


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      |||||++ +|.+++..     ..+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+.+.
T Consensus       226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence            9999985 77666643     579999999999999999999999 8999999999999999888 69999999998765


Q ss_pred             cC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .. ....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|......            
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~------------  365 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP------------  365 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC------------
T ss_pred             CCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC------------
Confidence            44 334567899999999999654 5899999999999999999999999999888877776552100            


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                          .++          ....+|+++++||.+||+.||++|||+.|+|+||||++..
T Consensus       366 ----~~~----------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          366 ----RLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             ----CCS----------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ----CCc----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                000          1146899999999999999999999999999999998753

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-60  Score=471.48  Aligned_cols=334  Identities=71%  Similarity=1.198  Sum_probs=292.6

Q ss_pred             CcceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceEEE
Q 014595           78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLN  156 (422)
Q Consensus        78 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~~  156 (422)
                      .....+|.+.+.||+|+||+||+|++..+|+.||||++..+.....+|+++++.++|||||+++++|+.... .+..+++
T Consensus        50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             CCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             CcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            345567999999999999999999999999999999998777777789999999999999999998865432 4567788


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++..++..+......+++..++.++.||+.||.|||+ +||+||||||+|||++.++..+||+|||+++...
T Consensus       130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            999999998888877766667889999999999999999999999 8999999999999999776578999999998776


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .........+|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.++++.++.|..+.+..+++.+
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            66666678899999999999776679999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS  396 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (422)
                      ..+.++.+...+|...+...+++++++||++||++||.+|||+.|+|+||||++++++...+++....+.+++|....+.
T Consensus       289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (420)
T 1j1b_A          289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS  368 (420)
T ss_dssp             CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHT
T ss_pred             hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHhc
Confidence            99999999999999999889999999999999999999999999999999999999887777777777777777644333


Q ss_pred             CCChhHHhhhCcHHHhh
Q 014595          397 GIPPETINRLIPEHARK  413 (422)
Q Consensus       397 ~~~~~~~~~~~~~~~~~  413 (422)
                      . .+.....++|.+.+.
T Consensus       369 ~-~~~~~~~~~~~~~~~  384 (420)
T 1j1b_A          369 S-NPPLATILIPPHARI  384 (420)
T ss_dssp             T-CGGGHHHHSCTTTTC
T ss_pred             c-ChhHHHhhCCHhhhh
Confidence            2 333444555555543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.8e-61  Score=446.89  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=207.2

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |.+.++||+|+||+||+|+++.+++.||||++....      ..+.+|+++|+.|+|||||+++++|.... ....++|+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            578889999999999999999999999999985432      33568999999999999999999885432 23456889


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeEEcC-CCCcEEEeecCCcc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNP-HTHQLKLCDFGSAK  233 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--ivHrDlkp~Nill~~-~~~~vkl~DfG~a~  233 (422)
                      |||||++ +|.+++..    ...+++..++.++.||+.||+|||+ +|  ||||||||+||||+. ++ .+||+|||+|+
T Consensus       107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~  180 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence            9999984 77776654    3679999999999999999999998 78  999999999999985 45 79999999997


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      .. ......+.+||+.|||||++.+  .|+.++|||||||++|||+||++||.+.+....+...+.....|         
T Consensus       181 ~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~---------  248 (290)
T 3fpq_A          181 LK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------  248 (290)
T ss_dssp             GC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------
T ss_pred             eC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC---------
Confidence            54 3334456789999999999854  49999999999999999999999998776655554433211000         


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                                       ..++...++++++||.+||+.||++|||+.|+|+||||++
T Consensus       249 -----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                             0123457899999999999999999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.9e-62  Score=455.85  Aligned_cols=250  Identities=29%  Similarity=0.449  Sum_probs=207.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc---CCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|++.+.||+|+||+||+|++.   .+++.||||++.+.      .....+|+++|+.++|||||+++++|.+     .
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence            46999999999999999999984   46889999998542      2345689999999999999999999843     3


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ..+|+|||||++ +|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGl  172 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGL  172 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence            458899999984 77666654    3679999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          232 AKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       232 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      |+..... ....+.+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+.+..|.+.          
T Consensus       173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----------  241 (304)
T 3ubd_A          173 SKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA----------  241 (304)
T ss_dssp             EEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred             ceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC----------
Confidence            9865433 334567899999999999765 4899999999999999999999999999888888777652          


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~  372 (422)
                             .+.            ++..+|+++++||++||+.||++|||     ++|+++||||+++.
T Consensus       242 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          242 -------KLG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             -------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -------CCC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence                   111            12468999999999999999999998     57999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-61  Score=458.68  Aligned_cols=256  Identities=26%  Similarity=0.371  Sum_probs=213.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeec
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  161 (422)
                      ..|.+.++||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+++.|+|||||+++++|.     +..++||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEec
Confidence            459999999999999999999999999999999976433 358999999999999999999984     33458899999


Q ss_pred             chh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCC
Q 014595          162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  240 (422)
Q Consensus       162 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~  240 (422)
                      |++ +|.+++..    .+.+++..++.|+.||+.||+|||+ +|||||||||+||||+.++..+||+|||+|+.......
T Consensus       132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            984 88777754    3679999999999999999999999 89999999999999998875699999999987644321


Q ss_pred             ------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          241 ------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       241 ------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                            ....+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+.+.+|...  .+          
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~----------  273 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PP----------  273 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CC----------
T ss_pred             ccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CC----------
Confidence                  1235799999999999765 5999999999999999999999999987776666666542  00          


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHH-------------hcCCcccccCCCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-------------CVHPFFDELRDPN  375 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~-------------l~hp~f~~~~~~~  375 (422)
                                   ++ ..+++.+|+++++||.+||+.||.+|||+.|+             |+|||+.+.++|.
T Consensus       274 -------------~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          274 -------------PI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             -------------GG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             -------------Cc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                         00 01235789999999999999999999999997             6799998876653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.7e-61  Score=467.89  Aligned_cols=331  Identities=51%  Similarity=0.981  Sum_probs=285.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCC------------
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD------------  149 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------------  149 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++..+.....+|+++++.++||||+++++++....+            
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~   86 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH   86 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence            35999999999999999999999999999999998877777799999999999999999999865433            


Q ss_pred             ---------------------CCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 014595          150 ---------------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR  208 (422)
Q Consensus       150 ---------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHr  208 (422)
                                           ....++++||||+++++.+.+..+......+++..++.++.||+.||.|||+ +||+||
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~H~  165 (383)
T 3eb0_A           87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHR  165 (383)
T ss_dssp             -----------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECS
T ss_pred             ccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCccC
Confidence                                 3456688999999999888888777777889999999999999999999999 899999


Q ss_pred             CCCCCCeEEcCCCCcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014595          209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE  288 (422)
Q Consensus       209 Dlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~  288 (422)
                      ||||+|||++.+.+.+||+|||+|+............+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.
T Consensus       166 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  245 (383)
T 3eb0_A          166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE  245 (383)
T ss_dssp             CCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Confidence            99999999985444799999999987766666677889999999999977667999999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                      +..+++..+++.++.|+.+.+..+++.+..+.++......|...++..+++++.+||.+||+.||.+|||+.|+|+||||
T Consensus       246 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  325 (383)
T 3eb0_A          246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF  325 (383)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHH
Confidence            99999999999999999999999999999999999999999999989999999999999999999999999999999999


Q ss_pred             cccCC-------CCCCCCCC--CCCCCCCCCCCCCCCCCChhHHhhhCcHHHhh
Q 014595          369 DELRD-------PNTRLPNG--RPLPPLFNFKPPELSGIPPETINRLIPEHARK  413 (422)
Q Consensus       369 ~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (422)
                      +++++       +...++++  ..+|++++|.+.+++.++++.+.+++|++...
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  379 (383)
T 3eb0_A          326 DHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSP  379 (383)
T ss_dssp             HHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC----
T ss_pred             HHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhcc
Confidence            98765       33344554  56788889888888878899999999988654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.2e-60  Score=463.51  Aligned_cols=332  Identities=68%  Similarity=1.176  Sum_probs=295.8

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceEEEEE
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNLV  158 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~~lv  158 (422)
                      ...+|.+.+.||+|+||+||+|++..+++ ||+|++........+|+++++.++||||+++++++..... ....++++|
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            45679999999999999999999987665 9999887777777789999999999999999999876554 566778899


Q ss_pred             eecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEc-CCCCcEEEeecCCcccccc
Q 014595          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~-~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++ .++ .+||+|||+|+....
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA  194 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccC
Confidence            9999998877777766667889999999999999999999999 8999999999999999 455 799999999988766


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      ........+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++.++.+.++.|..+.+..+++++.
T Consensus       195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66677788999999999997776799999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSG  397 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (422)
                      ...++.....+|...++..+++++.+||.+||+.||.+|||+.|+|+||||++++++...+++...++++++|....+. 
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  353 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-  353 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHH-
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhh-
Confidence            9999999999999989888999999999999999999999999999999999999888888888888888888754433 


Q ss_pred             CChhHHhhhCcHHHhhhh
Q 014595          398 IPPETINRLIPEHARKQN  415 (422)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~  415 (422)
                      +.++.+.+++|.+.++..
T Consensus       354 ~~~~~~~~~~~~~~~~~~  371 (394)
T 4e7w_A          354 VRPDLISRLVPQHAEAEL  371 (394)
T ss_dssp             TCGGGHHHHSCGGGCSSS
T ss_pred             cCHHHHHhhccHhhhhhh
Confidence            345788888988875543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.2e-59  Score=449.74  Aligned_cols=278  Identities=27%  Similarity=0.443  Sum_probs=214.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc---CCCeEEEEEEeccch--hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~--~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ++|++.+.||+|+||+||+|+++   .+++.||||++....  ....+|+++|+.+ +|||||+++++|.     ...++
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~~~~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KNDHV   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ETTEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----ECCEE
Confidence            35999999999999999999875   468899999886543  3456899999998 6999999999984     33458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      |+|||||++ +|.+++       +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||+|+.
T Consensus        96 ~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           96 VIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            899999984 665544       358999999999999999999999 89999999999999998745799999999975


Q ss_pred             cccCC-----------------------------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014595          235 LVKGE-----------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF  285 (422)
Q Consensus       235 ~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf  285 (422)
                      .....                             ...+.+||+.|||||++.+...|+.++||||+||++|||+||++||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            43221                             1234579999999999988777999999999999999999999998


Q ss_pred             C-CCChHHHHHHHHHHhCCCCHHHHhhcCcCC--c-------------------cCcCCCC----CCCCcccccccCCCh
Q 014595          286 P-GESGVDQLVEIIKVLGTPTREEIKCMNPNY--T-------------------EFKFPQI----KPHPWHKVFQKRLPP  339 (422)
Q Consensus       286 ~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~-------------------~~~~~~~----~~~~~~~~~~~~~s~  339 (422)
                      . +.+..+++..|...+|.+............  .                   ....|..    ............+|+
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            5 566788899999888865443322110000  0                   0000100    000001112246899


Q ss_pred             HHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          340 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       340 ~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      +++|||++||++||++|+||+|+|+||||++++
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.7e-58  Score=431.83  Aligned_cols=260  Identities=24%  Similarity=0.421  Sum_probs=192.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCC-------
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD-------  149 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-------  149 (422)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++....     ....+|+++|+.|+|||||+++++|.....       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35999999999999999999999999999999985422     334589999999999999999999865442       


Q ss_pred             CCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                      ....++|+|||||++ +|.+++..... ....++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~-~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCC-cEEEcc
Confidence            234568999999984 77776654221 1234556788999999999999999 8999999999999999888 699999


Q ss_pred             cCCccccccCCC-------------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014595          229 FGSAKVLVKGEP-------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  295 (422)
Q Consensus       229 fG~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~  295 (422)
                      ||+|+.......             ..+.+||+.|||||++.+. .|+.++|||||||++|||++   ||.+.  .+...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHH
Confidence            999987644321             2345799999999999764 59999999999999999996   77543  22222


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      .+.......                +|.         .....++.+.+||++||+.||.+|||+.|+|+||||+++..+.
T Consensus       236 ~~~~~~~~~----------------~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRNLK----------------FPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHTTC----------------CCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHhcCC----------------CCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            222221111                110         0023467889999999999999999999999999999876543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.1e-57  Score=460.14  Aligned_cols=252  Identities=24%  Similarity=0.381  Sum_probs=207.5

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHH---HHHHHHcCCCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRE---LQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E---~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      ..+|.+.++||+|+||+||+|+++.+|+.||||++.+..       ....+|   +.+++.++|||||+++++|.     
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~-----  262 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----  262 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE-----
Confidence            346999999999999999999999999999999986432       112233   55666779999999999983     


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeec
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      ...++|+|||||+| +|..++..    .+.+++..++.|+.||+.||+|||+ +|||||||||+||||+.+| .+||+||
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G-~vKL~DF  336 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDL  336 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTS-CEEECCC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCC-CEEeccc
Confidence            34458899999985 77666654    3679999999999999999999999 8999999999999999988 5999999


Q ss_pred             CCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCH
Q 014595          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPTR  306 (422)
Q Consensus       230 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~---~~~~~i~~~~~~~~~  306 (422)
                      |+|+..... ...+.+||+.|||||++.+...|+.++|||||||++|||++|++||.+.+..   +....+..       
T Consensus       337 GlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-------  408 (689)
T 3v5w_A          337 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------  408 (689)
T ss_dssp             TTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-------
T ss_pred             ceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-------
Confidence            999876443 3456799999999999965556999999999999999999999999864322   22222222       


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccCC
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  373 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  373 (422)
                                ....            ++..+|+++++||.+||+.||.+|++     ++|+++||||+++.+
T Consensus       409 ----------~~~~------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW  458 (689)
T 3v5w_A          409 ----------MAVE------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  458 (689)
T ss_dssp             ----------CCCC------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred             ----------CCCC------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence                      0111            23468999999999999999999998     799999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.8e-56  Score=453.83  Aligned_cols=259  Identities=26%  Similarity=0.416  Sum_probs=219.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.|+|||||+++++|.     ...++||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----CSSEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEE
Confidence            4699999999999999999999999999999998653    234568999999999999999999983     3445889


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC-CCcEEEeecCCcccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  235 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~-~~~vkl~DfG~a~~~  235 (422)
                      |||||++ +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+.+
T Consensus       232 v~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          232 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            9999985 66554432   24679999999999999999999999 899999999999999864 236999999999987


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .........+||+.|||||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..|....              
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~--------------  372 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD--------------  372 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC--------------
T ss_pred             cCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC--------------
Confidence            666666678899999999999765 48999999999999999999999999999888887776531              


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                         +.++.        .....+|+++++||++||+.||.+|||+.|+|+||||+....+.
T Consensus       373 ---~~~~~--------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          373 ---WNMDD--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             ---CCCCS--------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             ---CCCCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence               11111        11246899999999999999999999999999999999876543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.8e-56  Score=416.94  Aligned_cols=253  Identities=23%  Similarity=0.358  Sum_probs=206.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|++.+.||+|+||+||+|++.     .+++.||||++...    ...+.+|+++|++|+|||||++++++...     
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-----   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence            46999999999999999999875     35889999998643    23456899999999999999999998432     


Q ss_pred             eEEEEEeecch-hHHHHHHHHhh---------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYS---------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  222 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~  222 (422)
                      ..+++|||||+ |+|.+++....         .....+++..+..++.||+.||+|||+ ++||||||||+|||++.++ 
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~-  165 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL-  165 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCCC-
Confidence            33789999998 58888776532         123579999999999999999999999 8999999999999999887 


Q ss_pred             cEEEeecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014595          223 QLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII  298 (422)
Q Consensus       223 ~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~  298 (422)
                      .+||+|||+|+........   ....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..+.
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            6999999999865443222   234689999999999764 59999999999999999998 999999988877777665


Q ss_pred             HHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      +...                ..            .+..+|+++.+|+.+||+.||++|||+.++  |+|++++.
T Consensus       245 ~~~~----------------~~------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          245 QGRV----------------LQ------------RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HTCC----------------CC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             cCCC----------------CC------------CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            5210                00            124689999999999999999999999999  66888764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.5e-55  Score=409.05  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=194.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .++++.+.||+|+||+||+|++.   ..||||+++..      ...+.+|++++++++|||||++++++..    +  .+
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~--~~  106 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D--NL  106 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--SC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C--eE
Confidence            35889999999999999999864   35999988532      2345689999999999999999997621    1  26


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++|||||+ |+|.+.+..   ....+++..+..++.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+.
T Consensus       107 ~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~  181 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGL-TVKIGDFGLATV  181 (307)
T ss_dssp             EEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTE-EEEECCCSSCBC
T ss_pred             EEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCC-cEEEeeccCcee
Confidence            79999998 577776653   23579999999999999999999999 8999999999999999887 799999999986


Q ss_pred             cccCC---CcccccccccccchhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          235 LVKGE---PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       235 ~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      .....   .....+||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+....+..++...        
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~--------  253 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG--------  253 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT--------
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC--------
Confidence            54322   23456899999999999643  348999999999999999999999999887776666554421        


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                               +..|..      ...+..+|+++.+|+.+||+.||++|||+.|++++
T Consensus       254 ---------~~~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          254 ---------YASPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             ---------CCCCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ---------CCCCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                     111111      01224689999999999999999999999987653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-54  Score=413.22  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=199.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|++.++||+|+||+||+|+++     .+++.||||++....    ..+.+|+++|++|+|||||++++++..     .
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            35899999999999999999875     368899999986532    345689999999999999999999843     2


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  220 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~  220 (422)
                      ..+++|||||+ |+|.+++.....           ....+++..+..++.||+.||.|||+ ++||||||||+||||+.+
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECCC
Confidence            33789999998 588777765321           23468999999999999999999999 899999999999999988


Q ss_pred             CCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014595          221 THQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE  296 (422)
Q Consensus       221 ~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~  296 (422)
                      + .+||+|||+|+.......   .....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..
T Consensus       195 ~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          195 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             T-EEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             C-cEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            7 799999999986643322   2345789999999999654 59999999999999999999 9999999888777766


Q ss_pred             HHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       297 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      +.+...                ..            .+..+|+++.+|+.+||+.||++|||+.|++++  ++.+
T Consensus       273 i~~g~~----------------~~------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~l  317 (329)
T 4aoj_A          273 ITQGRE----------------LE------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQAL  317 (329)
T ss_dssp             HHHTCC----------------CC------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH--HHHH
T ss_pred             HHcCCC----------------CC------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHH
Confidence            655210                01            124689999999999999999999999999763  5544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1e-53  Score=427.17  Aligned_cols=319  Identities=32%  Similarity=0.534  Sum_probs=234.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++...      .....+|+.+|+.++|||||++++++..........+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            4599999999999999999999999999999998642      2334589999999999999999999865544445568


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      |+||||+++++..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|+..
T Consensus       133 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~  206 (458)
T 3rp9_A          133 YVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDC-SVKVCDFGLARTV  206 (458)
T ss_dssp             EEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCT
T ss_pred             EEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCC-CEeecccccchhc
Confidence            89999999988776653    4679999999999999999999999 8999999999999999887 6999999999865


Q ss_pred             ccCC----------------------------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-------
Q 014595          236 VKGE----------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-------  280 (422)
Q Consensus       236 ~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-------  280 (422)
                      ....                            .....+||+.|+|||++.....|+.++|||||||++|||++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            3221                            12346789999999987666679999999999999999999       


Q ss_pred             ----CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHhhcCcCCc---cCcCCCCCCCCccccc
Q 014595          281 ----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYT---EFKFPQIKPHPWHKVF  333 (422)
Q Consensus       281 ----G~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  333 (422)
                          |+++|.+.+                    ..+++..|...+|.|..+.+........   ...++......+...+
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                788887755                    3578889999999999888765432110   0122333333344433


Q ss_pred             ccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCCCChhHHhhhCcHHH
Q 014595          334 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHA  411 (422)
Q Consensus       334 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (422)
                       +.+++++++||++||++||.+|||++|+|+||||+++..+........+.  .+.+.  ....++.+.++..+.++.
T Consensus       367 -~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~e~  439 (458)
T 3rp9_A          367 -PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKV--RLPFN--DWMNMDEPQLRYAFVKEI  439 (458)
T ss_dssp             -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCC--CCSSC--TTSCCCHHHHHHHHHHHH
T ss_pred             -CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCC--CCCcc--ccccCCHHHHHHHHHHHH
Confidence             46799999999999999999999999999999999988765432221111  11121  234455666665554443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.9e-54  Score=428.21  Aligned_cols=284  Identities=31%  Similarity=0.540  Sum_probs=226.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|++.+.||+|+||+||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++..... .+...
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            4699999999999999999999999999999998643      2334589999999999999999999854332 23356


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +|+||||+++++...+.      ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|+.
T Consensus       142 ~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~  213 (464)
T 3ttj_A          142 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  213 (464)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCCC--
T ss_pred             EEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCC-CEEEEEEEeeee
Confidence            78999999987655442      458999999999999999999999 8999999999999999887 699999999987


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+++.++++.+|.|..+.+..+.+
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          214 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             ---CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             cCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            7665556678899999999999765 599999999999999999999999999999999999999999999887765432


Q ss_pred             CCccC--cCCCCCCCCcccccccC-----------CChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          315 NYTEF--KFPQIKPHPWHKVFQKR-----------LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       315 ~~~~~--~~~~~~~~~~~~~~~~~-----------~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      ....+  ..+......+...++..           .++++++||++||++||++|||++|+|+||||+...++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence            21111  11111122222222111           15779999999999999999999999999999987654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-54  Score=407.52  Aligned_cols=247  Identities=21%  Similarity=0.279  Sum_probs=202.1

Q ss_pred             eeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ++++.+.||+|+||+||+|+..     .+++.||||++...     ...+.+|+.++++|+|||||++++++...     
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-----  101 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-----  101 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-----
Confidence            4888999999999999999863     46789999998642     24567899999999999999999998432     


Q ss_pred             eEEEEEeecch-hHHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~  219 (422)
                      ..+++|||||+ |+|.+++....            .....+++..+..++.||+.||+|||+ ++||||||||+||||+.
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEECC
Confidence            23779999998 58888775432            123568999999999999999999999 89999999999999998


Q ss_pred             CCCcEEEeecCCccccccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014595          220 HTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  295 (422)
Q Consensus       220 ~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~  295 (422)
                      ++ .+||+|||+|+......   ......||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..+.+.
T Consensus       181 ~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          181 KL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            87 69999999998664332   22346789999999999754 59999999999999999998 899999988777666


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+......                  +          .+..+|+++.+|+.+||+.||++|||+.|++++
T Consensus       259 ~i~~~~~~------------------~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVL------------------P----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCC------------------C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCC------------------C----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55432100                  0          124689999999999999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.7e-54  Score=413.86  Aligned_cols=298  Identities=49%  Similarity=0.896  Sum_probs=244.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh---hHHHHHHHHHHcCCCCcccccceeecCCC--CCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTD--KEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~~~~~~  156 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++..+..   ...+|+..++.++||||+++++++.....  ....+++
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  102 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN  102 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence            469999999999999999999999999999998865433   23456777788899999999999865433  4566788


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--hcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +||||+++++...+..+......+++..++.++.|++.||.|||  + .||+||||||+|||++...+.+||+|||++..
T Consensus       103 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~  181 (360)
T 3e3p_A          103 VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK  181 (360)
T ss_dssp             EEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred             EEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence            99999999887777766666778999999999999999999999  8 89999999999999997333799999999987


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+.++.++.+.+..+.+
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3e3p_A          182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNP  261 (360)
T ss_dssp             CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT
T ss_pred             cCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhccc
Confidence            76666666778899999999997766789999999999999999999999999999999999999999999999988877


Q ss_pred             CCccCcCCCCCCCCccccccc---CCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN  380 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  380 (422)
                      ....+.+......+|...+..   ..++++.+||.+||+.||.+|||+.|+|+||||+++.++....++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~  330 (360)
T 3e3p_A          262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPN  330 (360)
T ss_dssp             TCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTT
T ss_pred             chhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCC
Confidence            766666665555666555432   357899999999999999999999999999999998877655444

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.7e-53  Score=418.02  Aligned_cols=320  Identities=31%  Similarity=0.524  Sum_probs=244.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++..........+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            3599999999999999999999999999999998642      2344589999999999999999998865433333558


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      |+||||++++|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|+..
T Consensus       106 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~-~~kL~DFGla~~~  179 (432)
T 3n9x_A          106 YIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDC-SVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCC-CEEEccCCCcccc
Confidence            89999999988776653    4569999999999999999999999 8999999999999999887 6999999999876


Q ss_pred             ccCC-----------------------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-----------C
Q 014595          236 VKGE-----------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-----------G  281 (422)
Q Consensus       236 ~~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-----------G  281 (422)
                      ....                       .....+||+.|+|||++.....++.++|||||||++|||++           |
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  259 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR  259 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence            4332                       12567889999999997666679999999999999999998           5


Q ss_pred             CCCCCCCC-----------------hHHHHHHHHHHhCCCCHHHHhhcCcCCc-c--CcCCCCCCCCcccccccCCChHH
Q 014595          282 QPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYT-E--FKFPQIKPHPWHKVFQKRLPPEA  341 (422)
Q Consensus       282 ~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~s~~~  341 (422)
                      .++|.+.+                 ..+++..++..+|.|+.+.+........ .  ..++.....++...+ +.+++++
T Consensus       260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~  338 (432)
T 3n9x_A          260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDDG  338 (432)
T ss_dssp             CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHHH
T ss_pred             cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHHH
Confidence            56666654                 4678899999999999988765432110 0  012222333333333 4689999


Q ss_pred             HHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCCCChhHHhhhCcHHHh
Q 014595          342 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHAR  412 (422)
Q Consensus       342 ~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  412 (422)
                      ++||++||++||.+|||++|+|+||||++++++..........  ...+.  ....+..+.++.++.++..
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~e~~  405 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKI--ILPFD--DWMVLSETQLRYIFLKEVQ  405 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCC--CCSSC--TTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCC--CCChh--hcccCCHHHHHHHHHHHHH
Confidence            9999999999999999999999999999998765432221111  11122  1234566667665555443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-53  Score=416.33  Aligned_cols=286  Identities=33%  Similarity=0.651  Sum_probs=223.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcC-CCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++...      .....+|+.+++.+. ||||+++++++...   +...
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~~   85 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDRD   85 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSSC
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCCE
Confidence            3599999999999999999999999999999988532      223457999999997 99999999988532   2335


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +|+|||||++++..++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|+.
T Consensus        86 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAEC-HVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCC-CEEecCCccccc
Confidence            789999999988777654     578999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccC----------------------CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 014595          235 LVKG----------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  292 (422)
Q Consensus       235 ~~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~  292 (422)
                      ....                      ......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5321                      112346789999999999876679999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCccCc------CCCCCCCCccccc------------ccCCChHHHHHHHhhhhcCCC
Q 014595          293 QLVEIIKVLGTPTREEIKCMNPNYTEFK------FPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPN  354 (422)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~------------~~~~s~~~~~li~~~L~~dP~  354 (422)
                      ++..++..++.|..+.+......+....      ........+...+            ...+++++++||++||++||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            9999999999999887765432211100      0000011111111            126789999999999999999


Q ss_pred             CcCCHHHHhcCCcccccCCCCCC
Q 014595          355 LRCTALEACVHPFFDELRDPNTR  377 (422)
Q Consensus       355 ~R~t~~e~l~hp~f~~~~~~~~~  377 (422)
                      +|||+.|+|+||||+...++...
T Consensus       319 ~R~t~~e~l~Hp~~~~~~~~~~~  341 (388)
T 3oz6_A          319 KRISANDALKHPFVSIFHNPNEE  341 (388)
T ss_dssp             GSCCHHHHTTSTTTTTTCCGGGC
T ss_pred             cCCCHHHHhCCHHHHHhcCCccC
Confidence            99999999999999998776543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.6e-53  Score=395.98  Aligned_cols=280  Identities=34%  Similarity=0.562  Sum_probs=225.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|++.+.||+|+||+||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++..     ...++
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   77 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT   77 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEEE
Confidence            5999999999999999999999999999999986432      334589999999999999999999843     34578


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++...+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus        78 lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           78 LVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAFG  152 (292)
T ss_dssp             EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccceecC
Confidence            9999999877655443   34679999999999999999999999 8999999999999999887 69999999998664


Q ss_pred             cC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      .. .......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+..+..
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence            33 2234567899999999997766689999999999999999987766 677777888899999888887765543321


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      .......+............+.+++++++||++||+.||++|||++|+|+||||++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            1111111111111111122356899999999999999999999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.1e-53  Score=407.60  Aligned_cols=250  Identities=23%  Similarity=0.349  Sum_probs=203.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCC-----CeEEEEEEeccc-----hhhHHHHHHHHHHcCC-CCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQD-----KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~  150 (422)
                      .+|++.+.||+|+||+||+|++..+     ++.||||++...     ...+.+|+++|.++.| ||||++++++...   
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~---  140 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---  140 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT---
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec---
Confidence            4699999999999999999998654     468999998643     2345689999999966 8999999987432   


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  217 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill  217 (422)
                       ...+++|||||+ |+|.++++....            ....+++..+..++.||+.||+|||+ ++||||||||+|||+
T Consensus       141 -~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NILl  218 (353)
T 4ase_A          141 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL  218 (353)
T ss_dssp             -TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             -CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccceee
Confidence             223679999998 588888775432            13458999999999999999999999 899999999999999


Q ss_pred             cCCCCcEEEeecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 014595          218 NPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  293 (422)
Q Consensus       218 ~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~  293 (422)
                      +.++ .+||+|||+|+........   ....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.
T Consensus       219 ~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          219 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             CGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             CCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9887 6999999999876544322   345789999999999764 59999999999999999998 9999998765555


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      +.+++.....+               .            .+..+++++.+|+.+||+.||++|||+.|+++|
T Consensus       297 ~~~~i~~g~~~---------------~------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKEGTRM---------------R------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHTCCC---------------C------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCC---------------C------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            55544321110               1            124579999999999999999999999999987

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.9e-53  Score=399.66  Aligned_cols=279  Identities=35%  Similarity=0.667  Sum_probs=226.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|++.+.||+|+||+||+|++. +|+.||||++....      ....+|+++++.++||||+++++++.     ...++
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   94 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERCL   94 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSCE
T ss_pred             hhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCEE
Confidence            46999999999999999999995 58999999986432      33458999999999999999999883     33457


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++||||+++++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++..
T Consensus        95 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~  169 (311)
T 3niz_A           95 TLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDG-ALKLADFGLARAF  169 (311)
T ss_dssp             EEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEET
T ss_pred             EEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCC-CEEEccCcCceec
Confidence            89999999887666553   23569999999999999999999999 8999999999999999887 6999999999866


Q ss_pred             ccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+.....
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred             CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence            433 2234457899999999997766789999999999999999999999999998899999999988887655443221


Q ss_pred             C--CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          315 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       315 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      .  +....+......+|... .+.+++++++||++||+.||.+|||+.|+|+||||+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSI-IPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHH-STTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             cchhhhcccccccCCcHHHh-CcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            0  11111222223333333 256889999999999999999999999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.4e-52  Score=404.00  Aligned_cols=317  Identities=32%  Similarity=0.611  Sum_probs=249.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|++.+.||+|+||+||+|++..+++.||||++....     ....+|+++++.++||||+++++++..........+++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            5999999999999999999999999999999986422     33458999999999999999999886544344456789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||+++++..++..     ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus       108 v~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          108 VQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADP  180 (364)
T ss_dssp             EEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECCG
T ss_pred             EEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCC-CEEEEeCcceEecCC
Confidence            999999988776653     569999999999999999999999 8999999999999999887 699999999976543


Q ss_pred             CCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          238 GEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       238 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ...    .....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+..+.+.+..
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            322    2345789999999998776678999999999999999999999999999999999999999999988776542


Q ss_pred             cCC---ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCC
Q 014595          314 PNY---TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  390 (422)
Q Consensus       314 ~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  390 (422)
                      ...   .....+.....+|...+ +.+++++.+||.+||+.||.+|||+.|+|+||||++...+......    ...+.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~----~~~~~~  335 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA----EAPFKF  335 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCC----SSCCCC
T ss_pred             hhhHHHHHHhcCCccCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCC----CCcCCc
Confidence            110   01123333334444433 5689999999999999999999999999999999997654432111    111222


Q ss_pred             CCCCCCCCChhHHhhhCcHHHh
Q 014595          391 KPPELSGIPPETINRLIPEHAR  412 (422)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~  412 (422)
                      . .....++.+.++.++.++..
T Consensus       336 ~-~~~~~~~~~~~~~~~~~e~~  356 (364)
T 3qyz_A          336 D-MELDDLPKEKLKELIFEETA  356 (364)
T ss_dssp             C------CCHHHHHHHHHHHTG
T ss_pred             c-cccccCCHHHHHHHHHHHHH
Confidence            2 34566777777766655443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-52  Score=396.52  Aligned_cols=285  Identities=28%  Similarity=0.523  Sum_probs=230.5

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---------hhHHHHHHHHHHcC---CCCcccccceeecCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLD---HPNIVALKHCFFSTT  148 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~  148 (422)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++....         ....+|+.+++.++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            346999999999999999999999999999999986321         24457888877764   999999999987766


Q ss_pred             CCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                      .....++++||||+++++...+....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-TVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTS-CEEECS
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEEee
Confidence            66666789999999998877766432  2349999999999999999999999 8999999999999999887 699999


Q ss_pred             cCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       229 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ||+++............+|+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+.++...++.++...
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            99998776555566778999999999997654 89999999999999999999999999999999999999888887654


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      +..... .....++.....++.. ..+.+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          243 WPRDVS-LPRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SCSSCS-SCGGGSCCCCCCCHHH-HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ccchhh-ccccccCCCCCCcHHH-hCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            432111 0111222222222222 2356899999999999999999999999999999998743

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.7e-53  Score=402.01  Aligned_cols=287  Identities=33%  Similarity=0.636  Sum_probs=228.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-----hHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|.+.+.||+|+||+||+|++..+++.||||++.....     ...+|+.+++.++||||+++++++..     ...+++
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   77 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLTL   77 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEEE
Confidence            59999999999999999999999999999999864322     22369999999999999999998843     334789


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||+++++.+.+...   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           78 VFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERG-ELKLADFGLARAKSI  152 (324)
T ss_dssp             EEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTC-CEEECSSSEEECC--
T ss_pred             EecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCC-CEEEccCcccccccC
Confidence            9999999887766542   3568999999999999999999999 8999999999999999887 699999999976543


Q ss_pred             CC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC-
Q 014595          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-  315 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  315 (422)
                      .. ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....+...... 
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence            22 2234577999999999977667899999999999999999999999999999999999999998877655432111 


Q ss_pred             -CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCC
Q 014595          316 -YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN  380 (422)
Q Consensus       316 -~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  380 (422)
                       +..+.++......+.. ....+++++.+||.+||+.||.+|||+.|+|+||||.++.......+.
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  297 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPD  297 (324)
T ss_dssp             HHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCT
T ss_pred             hhcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCC
Confidence             1122233222222222 224689999999999999999999999999999999998766544444

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-52  Score=404.71  Aligned_cols=285  Identities=33%  Similarity=0.614  Sum_probs=229.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            3599999999999999999999999999999998542      1234589999999999999999998854322 12234


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +|+||||++++|..++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  177 (367)
T 1cm8_A          105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  177 (367)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence            679999998888777654     578999999999999999999999 8999999999999999887 699999999986


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...  .....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+..+.|+.+.+..+..
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            532  344568899999999998766799999999999999999999999999999999999999999999887765432


Q ss_pred             CCcc---CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCC
Q 014595          315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (422)
Q Consensus       315 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  376 (422)
                      ....   ..++......+...+ ..+++++.+||.+||+.||.+|||+.|+|+||||+++.++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~  319 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  319 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             HHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence            1100   123333344454444 568999999999999999999999999999999999877653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8e-52  Score=395.35  Aligned_cols=254  Identities=28%  Similarity=0.401  Sum_probs=216.0

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++....      ....+|+++++.++||||+++++++.     ....
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEKT   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCE
Confidence            346999999999999999999999999999999986432      23458999999999999999999883     3344


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+++ ++.+.+..    .+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus        89 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  162 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADM-NIKIADFGFSN  162 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTCCG
T ss_pred             EEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCC-CEEEeeccCce
Confidence            7899999974 66665543    3679999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ...........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+...             
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------  229 (328)
T 3fe3_A          163 EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-------------  229 (328)
T ss_dssp             GGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred             ecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence            7766655667789999999999987665568999999999999999999999998877766666542             


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                          .+.+            +..+++++.+||++||+.||.+|||++|+++||||+.....
T Consensus       230 ----~~~~------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          230 ----KYRI------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             ----CCCC------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             ----CCCC------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence                1111            13578999999999999999999999999999999876543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.4e-52  Score=389.47  Aligned_cols=276  Identities=36%  Similarity=0.655  Sum_probs=221.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|++.+.||+|+||+||+|++ .+|+.||||++....      ....+|+.+++.++||||+++++++...     ..++
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLV   76 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEE
T ss_pred             cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEE
Confidence            599999999999999999999 679999999985432      3345899999999999999999988432     3478


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++..++...   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           77 LVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAFG  151 (288)
T ss_dssp             EEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHC
T ss_pred             EEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEeECccccccC
Confidence            99999999887766532   3678999999999999999999999 8999999999999999887 69999999997654


Q ss_pred             cC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 014595          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  313 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  313 (422)
                      .. .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+....+....  
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence            32 223345789999999999776678999999999999999999999999999999999999888877654443221  


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      +.+. -.++...+.+|... ...+++++.+||++||+.||++|||+.|+|+||||++.
T Consensus       232 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          232 PKYD-PNFTVYEPLPWESF-LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TTCC-TTCCCCCCCCGGGT-CCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccc-cccccccCccHHHH-hhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            1110 01222223334332 35689999999999999999999999999999999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.9e-52  Score=403.67  Aligned_cols=314  Identities=32%  Similarity=0.540  Sum_probs=232.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            3599999999999999999999999999999998542      2334589999999999999999998854321 12244


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++|+|+++++|..++..     ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus       109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~  181 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH  181 (367)
T ss_dssp             CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence            679999998887666543     579999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.|..+.+.....
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            532  234568899999999997766799999999999999999999999999999999999999999999887765432


Q ss_pred             CCcc---CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCC
Q 014595          315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  391 (422)
Q Consensus       315 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  391 (422)
                      ....   ..++.....++...+ ...++++.+||++||+.||.+|||+.|+|+||||+...++.....     .+.+.+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~-----~~~~~~~  333 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV-----ADPYDQS  333 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCC-----CCCCCGG
T ss_pred             HHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCC-----CCCCCcc
Confidence            2100   122333334444444 467999999999999999999999999999999999877654311     1112221


Q ss_pred             CCCCCCCChhHHhhhCcHHH
Q 014595          392 PPELSGIPPETINRLIPEHA  411 (422)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~  411 (422)
                       .....+..+.+++.+.+..
T Consensus       334 -~~~~~~~~~~~~~~~~~e~  352 (367)
T 2fst_X          334 -LESRDLLIDEWKSLTYDEV  352 (367)
T ss_dssp             -GSSCCCCHHHHHHHHHHHH
T ss_pred             -hhhccCCHHHHHHHHHHHH
Confidence             1223455666766655543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.8e-52  Score=394.26  Aligned_cols=286  Identities=33%  Similarity=0.577  Sum_probs=216.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++....     ....+|+.+++.++||||+++++++.     ....++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeEE
Confidence            35999999999999999999999999999999986432     34568999999999999999999883     334578


Q ss_pred             EEeecchhHHHHHHHHhhh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          157 LVLEYVPETVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +||||+++++.+.+.....  ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  157 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRG-QLKLGDFGLARA  157 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence            9999999988777765432  22458999999999999999999999 8999999999999999887 699999999986


Q ss_pred             cccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          235 LVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       235 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      .... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+....
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            5432 223456789999999999776668999999999999999999999999999999999999988887765443321


Q ss_pred             c--CCccCcCCCCCCCCcc----cccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          314 P--NYTEFKFPQIKPHPWH----KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       314 ~--~~~~~~~~~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      .  .+.. .++......+.    ......++.++++||.+||+.||++|||+.|+|+||||++...+.
T Consensus       238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          238 KLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             GCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred             hhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence            1  1100 11111111111    112246789999999999999999999999999999999976543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-51  Score=397.03  Aligned_cols=255  Identities=24%  Similarity=0.354  Sum_probs=215.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----------hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ..|.+.+.||+|+||+||+|+++.+|+.||||++....          ....+|+.+++.++||||+++++++.     .
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~   86 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE-----N   86 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----e
Confidence            45999999999999999999999999999999986432          34568999999999999999999883     3


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC---cEEEe
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLC  227 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~---~vkl~  227 (422)
                      ...+++||||++ ++|.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.   .+||+
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence            345789999996 577665532    4679999999999999999999999 89999999999999987653   59999


Q ss_pred             ecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       228 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      |||++............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+. 
T Consensus       162 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-  239 (361)
T 2yab_A          162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE-  239 (361)
T ss_dssp             CCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-
T ss_pred             ecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-
Confidence            9999987766655567789999999999965 45899999999999999999999999998888777776553211111 


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                              .+...+++++++||++||+.||.+|||+.|+|+||||+.+.
T Consensus       240 ------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          240 ------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             ------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             ------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence                                    12246799999999999999999999999999999998653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-51  Score=400.54  Aligned_cols=320  Identities=29%  Similarity=0.488  Sum_probs=231.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            45999999999999999999999999999999986421      234579999999999999999998854331 22346


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++||||+++++.+.+.      ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~  176 (371)
T 2xrw_A          105 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  176 (371)
T ss_dssp             EEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCCCC---
T ss_pred             eEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEEEeecccc
Confidence            78999999988766553      468999999999999999999999 8999999999999999887 699999999987


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.+..+.+..+.+
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             -------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             cccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            6554444567889999999999764 589999999999999999999999999999999999999999888776654432


Q ss_pred             CCccC--cCCCCCCCCcccccc-----------cCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCC
Q 014595          315 NYTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG  381 (422)
Q Consensus       315 ~~~~~--~~~~~~~~~~~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~  381 (422)
                      ....+  ..+......+...++           ...++++++||++||+.||.+|||++|+|+||||+...++.....  
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~--  333 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA--  333 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC--
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC--
Confidence            11110  011111111111111           112578999999999999999999999999999997655432111  


Q ss_pred             CCCCCCCCCCCCCCCCCChhHHhhhCcHHHhhh
Q 014595          382 RPLPPLFNFKPPELSGIPPETINRLIPEHARKQ  414 (422)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  414 (422)
                       +.|.+.... ........+.+++++++..+.-
T Consensus       334 -~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  364 (371)
T 2xrw_A          334 -PPPKIPDKQ-LDEREHTIEEWKELIYKEVMDL  364 (371)
T ss_dssp             -CCCCCCTTT-TCCCCCCHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCChh-hccccCcHHHHHHHHHHHHHHH
Confidence             111111111 1223345677777777666543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.7e-52  Score=399.65  Aligned_cols=252  Identities=29%  Similarity=0.476  Sum_probs=209.0

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|.+.+.||+|+||+||+|+++.+|+.||||++.+..       ....+|..+++.+ +||||+++++++.     ..
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-----TP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-----eC
Confidence            346999999999999999999999999999999986532       2345799999988 7999999999883     33


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ..+|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g-~ikL~DFG~  170 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGM  170 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCC-CEEEccccc
Confidence            458899999985 66655543    3679999999999999999999999 8999999999999999888 699999999


Q ss_pred             cccccc-CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          232 AKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       232 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      |+.... .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+...          
T Consensus       171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------  239 (353)
T 3txo_A          171 CKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----------  239 (353)
T ss_dssp             CBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred             eeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence            975432 3334567899999999999654 4899999999999999999999999999888888777652          


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH------HHHhcCCcccccCC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  373 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~------~e~l~hp~f~~~~~  373 (422)
                             ...+            +..+++++.+||++||+.||.+||++      .|+++||||+++.+
T Consensus       240 -------~~~~------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          240 -------EVVY------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             -------CCCC------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             -------CCCC------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence                   1111            23578999999999999999999998      89999999998753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.2e-51  Score=392.41  Aligned_cols=251  Identities=27%  Similarity=0.421  Sum_probs=212.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++||||+++++++.     ....
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~~   79 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCCE
Confidence            4699999999999999999999999999999998643       223457999999999999999999883     3345


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus        80 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~  153 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCK  153 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCC-CEEEeeccchh
Confidence            8899999985 66555543    3679999999999999999999999 8999999999999999888 69999999997


Q ss_pred             ccc-cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          234 VLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       234 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ... ........+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+...            
T Consensus       154 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------  220 (337)
T 1o6l_A          154 EGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------  220 (337)
T ss_dssp             CSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred             hcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence            643 23344567899999999999654 5899999999999999999999999988877666666541            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                           ...            ++..+++++++||.+||+.||.+||     ++.|+++||||+.+.+
T Consensus       221 -----~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          221 -----EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -----CCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence                 111            2246799999999999999999999     9999999999998753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-51  Score=393.74  Aligned_cols=281  Identities=31%  Similarity=0.580  Sum_probs=223.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..+|++.+.||+|+||+||+|++..+++.||||++....      ....+|+.+++.++||||+++++++..     ...
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  107 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----NHR  107 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----TTE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----CCE
Confidence            346999999999999999999999999999999986432      223479999999999999999999843     334


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC----CcEEEeecC
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDFG  230 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~----~~vkl~DfG  230 (422)
                      +++||||+++++.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++    ..+||+|||
T Consensus       108 ~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          108 LHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            789999999988776654    3569999999999999999999999 8999999999999995332    259999999


Q ss_pred             CccccccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          231 SAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       231 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+.++...++.+....+
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            99765432 22344577999999999977666899999999999999999999999999999999999998888876544


Q ss_pred             hhcC--cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          310 KCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       310 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      ....  +.+ ...++......+...+...+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus       263 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          263 PGVTALPDW-KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TTGGGSTTC-CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhh-hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            3221  111 1123333333444444455899999999999999999999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-51  Score=393.88  Aligned_cols=283  Identities=35%  Similarity=0.602  Sum_probs=226.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---------hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||++....         ....+|+.+++.++||||+++++++..     
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-----
Confidence            346999999999999999999999999999999986421         234589999999999999999998843     


Q ss_pred             ceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ....++||||+++++...+..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  158 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGL  158 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred             CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence            234779999999887665543   23568899999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          232 AKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       232 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ++...... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.+.
T Consensus       159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            98664332 33456789999999999766668999999999999999999999999999999999999988888776554


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      ..........+......++...+ ..++.++++||++||+.||++|||+.|+|+||||++...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hhccCcccccccccCCCChHHhh-ccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            43222111222222222333222 5678999999999999999999999999999999886544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=382.63  Aligned_cols=284  Identities=36%  Similarity=0.620  Sum_probs=220.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|++.+.||+|+||+||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++..     ....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence            35999999999999999999999999999999885432      234579999999999999999999843     3347


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++||||++++....+   ......+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 HLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHS-VIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEECCSEEHHHHH---HHTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEEeCCCchHHHH---HhhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence            899999997443222   2234679999999999999999999999 8999999999999999887 6999999999765


Q ss_pred             ccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--
Q 014595          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  312 (422)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  312 (422)
                      .... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++..........  
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            4322 2345578999999999987677899999999999999999999999999999999888888877766544322  


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      ...+.....+............+.+++++.+||++||+.||.+|||++|+|+||||+++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            111222222222111111112246899999999999999999999999999999999986543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.1e-51  Score=397.34  Aligned_cols=252  Identities=26%  Similarity=0.482  Sum_probs=206.7

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|.+.++||+|+||+||+|+++.+++.||||++.+..       ....+|..+++++ +||||++++++|.     ..
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----EC
Confidence            346999999999999999999999999999999986532       2345799999887 8999999999883     33


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ..+++||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DFGl  199 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGM  199 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCC-CEEEeecce
Confidence            458899999985 66555543    3679999999999999999999999 8999999999999999888 699999999


Q ss_pred             cccc-ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--------HH-HHHHHHHHh
Q 014595          232 AKVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VD-QLVEIIKVL  301 (422)
Q Consensus       232 a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~--------~~-~~~~i~~~~  301 (422)
                      |+.. .........+||+.|+|||++.+. .++.++|||||||++|||++|++||.+...        .+ ....+..  
T Consensus       200 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--  276 (396)
T 4dc2_A          200 CKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--  276 (396)
T ss_dssp             CBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--
T ss_pred             eeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--
Confidence            9863 333445667899999999999764 589999999999999999999999965321        11 2222222  


Q ss_pred             CCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH------HHHhcCCcccccCC
Q 014595          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  373 (422)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~------~e~l~hp~f~~~~~  373 (422)
                                     ....            ++..+++++++||++||+.||.+||++      +|+++||||+++.+
T Consensus       277 ---------------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          277 ---------------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             ---------------CCCC------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             ---------------cccC------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence                           0111            224689999999999999999999985      79999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.9e-51  Score=399.05  Aligned_cols=257  Identities=28%  Similarity=0.468  Sum_probs=215.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|+++.+++.||||++.+.       .....+|+.+++.++|||||++++++.     ...+
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~  143 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DDRY  143 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCE
Confidence            4699999999999999999999999999999998642       233568999999999999999999883     3445


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +|+|||||+ ++|..++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus       144 ~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DFG~a~  216 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTCM  216 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCC-CEEEeccceeE
Confidence            889999996 477766643     468999999999999999999999 8999999999999999888 69999999998


Q ss_pred             ccccCCC--cccccccccccchhhhcCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .......  ....+||+.|+|||++.+..   .++.++|||||||++|||++|++||.+.+..+.+.+|.....      
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------  290 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN------  290 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH------
T ss_pred             eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc------
Confidence            6644321  23568999999999996543   278999999999999999999999999988888887765310      


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCC--cCCHHHHhcCCcccccCCCC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~~  375 (422)
                               .+.+|.          ...+++++++||++||+.+|.+  |++++|+++||||+++.+.+
T Consensus       291 ---------~~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          291 ---------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW  340 (410)
T ss_dssp             ---------HCCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred             ---------cccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence                     111111          1357999999999999999988  99999999999999986554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.1e-50  Score=391.15  Aligned_cols=285  Identities=34%  Similarity=0.622  Sum_probs=228.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCC-CceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++...... ....
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            36999999999999999999999999999999986531      3345799999999999999999988543321 1223


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++||||+.+++...+      ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus       122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~  193 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH  193 (371)
T ss_dssp             CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred             EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence            4799999998775543      3569999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..+..
T Consensus       194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          194 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             ccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            532  334567899999999997756799999999999999999999999999999999999999999998876654432


Q ss_pred             CCcc---CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCC
Q 014595          315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (422)
Q Consensus       315 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  377 (422)
                      ....   ...+......+... ...+++++.+||++||+.||.+|||+.|+|+||||+.+..+...
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  336 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFTQL-FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE  336 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHHHH-STTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred             hhhhhhhhccCCCcchhHHHh-ccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccc
Confidence            1110   01112222222222 24679999999999999999999999999999999988766543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.7e-50  Score=400.23  Aligned_cols=279  Identities=30%  Similarity=0.536  Sum_probs=226.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHc------CCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML------DHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.+      +|+||+++++++..     .
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-----~  171 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-----R  171 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----T
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----C
Confidence            46999999999999999999999999999999997654   3345788888887      57799999998843     3


Q ss_pred             eEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC-cEEEeecCC
Q 014595          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~-~vkl~DfG~  231 (422)
                      ..+++||||+++++.+++....  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++. .+||+|||+
T Consensus       172 ~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          172 NHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             CeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            4588999999998877776532  2458999999999999999999999 89999999999999998762 299999999


Q ss_pred             ccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      +....  ......++|+.|+|||++.+.. ++.++|||||||++|||+||.+||.+.+..+.+..++..++.|+...+..
T Consensus       249 a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~  325 (429)
T 3kvw_A          249 SCYEH--QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA  325 (429)
T ss_dssp             CEETT--CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ceecC--CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence            97542  3345678899999999997654 89999999999999999999999999999999999999999999887654


Q ss_pred             cCcCCccC---cCC---------------------------CCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHH
Q 014595          312 MNPNYTEF---KFP---------------------------QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE  361 (422)
Q Consensus       312 ~~~~~~~~---~~~---------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e  361 (422)
                      .......+   .++                           ......|...+....++++.+||++||++||++|||+.|
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e  405 (429)
T 3kvw_A          326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ  405 (429)
T ss_dssp             BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence            32110000   000                           011123334444556889999999999999999999999


Q ss_pred             HhcCCccccc
Q 014595          362 ACVHPFFDEL  371 (422)
Q Consensus       362 ~l~hp~f~~~  371 (422)
                      +|+||||++.
T Consensus       406 ~L~Hpw~~~~  415 (429)
T 3kvw_A          406 ALRHPWLRRR  415 (429)
T ss_dssp             HHTSTTTC--
T ss_pred             HhCChhhccC
Confidence            9999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.6e-50  Score=388.53  Aligned_cols=287  Identities=29%  Similarity=0.582  Sum_probs=227.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---------------hhHHHHHHHHHHcCCCCcccccceeec
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------RYKNRELQIMQMLDHPNIVALKHCFFS  146 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------------~~~~~E~~~l~~l~h~nIv~l~~~~~~  146 (422)
                      .+|.+.+.||+|+||.||+|.+.. |+.||||++....               ....+|+++++.++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            359999999999999999999864 9999999885321               345689999999999999999999877


Q ss_pred             CCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEE
Q 014595          147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  226 (422)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl  226 (422)
                      .......++++||||+++++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||
T Consensus       101 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl  175 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNN-DITI  175 (362)
T ss_dssp             CCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEE
T ss_pred             ccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCC-CEEE
Confidence            66566667889999999988766653   23579999999999999999999999 8999999999999999887 6999


Q ss_pred             eecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       227 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      +|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999986655555566788999999999977567999999999999999999999999999999999999999999887


Q ss_pred             HHHhhcCcC----CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          307 EEIKCMNPN----YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       307 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      ..+......    +..-.........|.. ..+..++.+.+||.+||+.||.+|||+.|+|+||||+.+.++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  327 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL  327 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence            765432211    0001111222223332 2356789999999999999999999999999999999987654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.6e-51  Score=385.09  Aligned_cols=252  Identities=21%  Similarity=0.241  Sum_probs=186.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-hH--HHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YK--NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~--~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|++.+.||+|+||+||+|++  +|+.||||++..... ..  ++|+..+..++|||||++++++.... .....+++||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence            599999999999999999997  489999999865432 22  24555667889999999999885433 2334578999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------CceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--------givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      |||+ ++|.+++..     ..+++..+..++.|++.||+|||+ .        +||||||||+|||++.++ .+||+|||
T Consensus        81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG  153 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence            9998 588777754     568999999999999999999997 5        899999999999999888 69999999


Q ss_pred             CccccccCCCc-----ccccccccccchhhhcCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCh----------
Q 014595          231 SAKVLVKGEPN-----VSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESG----------  290 (422)
Q Consensus       231 ~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltG~~pf~~~~~----------  290 (422)
                      +|+........     ...+||+.|||||++.+..     .++.++|||||||++|||+||.+||.....          
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876544322     2457999999999996532     367799999999999999999877643221          


Q ss_pred             ----HHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          291 ----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       291 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                          .+.+.+....             ...    .|.++. .+   .....+..+.+|+.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~-------------~~~----rp~~p~-~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCE-------------QKL----RPNIPN-RW---QSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTT-------------SCC----CCCCCG-GG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhc-------------ccC----CCCCCc-cc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                1111111100             000    000000 00   001234578899999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-51  Score=394.97  Aligned_cols=250  Identities=29%  Similarity=0.423  Sum_probs=208.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .++|.+.+.||+|+||+||+|++..+|+.||||++...       .....+|+.+++.++||||+++++++..     ..
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----PT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence            34699999999999999999999999999999998542       2345689999999999999999999843     33


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .+++||||+++++.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus        83 ~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~DFG~s~  156 (336)
T 3h4j_B           83 DIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNL-NVKIADFGLSN  156 (336)
T ss_dssp             EEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTC-CEEECCSSCTB
T ss_pred             EEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCC-CEEEEEeccce
Confidence            4789999999887766554    3679999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ....+......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........                 
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-----------------  219 (336)
T 3h4j_B          157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-----------------  219 (336)
T ss_dssp             TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----------------
T ss_pred             eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----------------
Confidence            776665556778999999999997766557899999999999999999999976542111000                 


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                                +.  .....++..+++++.+||++||+.||.+|||+.|+++||||+.
T Consensus       220 ----------i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          220 ----------VN--SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             ----------CC--SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             ----------HH--cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                      00  0001123467999999999999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1e-49  Score=384.55  Aligned_cols=288  Identities=33%  Similarity=0.627  Sum_probs=227.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++....     ....+|+.+++.++||||+++++++...........+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            35999999999999999999999999999999986422     2335799999999999999999887543333345678


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+++++.+.+..     ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus        91 lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           91 IIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNC-DLKVCDFGLARIID  163 (353)
T ss_dssp             EEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCC-cEEEEecccccccc
Confidence            9999999988776654     579999999999999999999999 8999999999999999887 69999999997654


Q ss_pred             cCCC-----------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          237 KGEP-----------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       237 ~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      ....           .....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            3211           12346899999999987666789999999999999999999999999998888888888887765


Q ss_pred             HHHHh-hcCc-CCcc--CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCC
Q 014595          306 REEIK-CMNP-NYTE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (422)
Q Consensus       306 ~~~~~-~~~~-~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  377 (422)
                      ..... +... ....  -..+.....++... .+.+++++.+||.+||+.||++|||+.|+|+||||+....+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~  318 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKM-FPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDE  318 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHH-STTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSS
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhh-cccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccc
Confidence            32110 0000 0000  01111112222222 24689999999999999999999999999999999998776543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5e-50  Score=386.76  Aligned_cols=257  Identities=30%  Similarity=0.379  Sum_probs=210.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++...         .....+|+.+++.++||||+++++++..     .
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~   98 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----D   98 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence            4699999999999999999999999999999998532         2445689999999999999999998843     3


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC--cEEEeec
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDF  229 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~--~vkl~Df  229 (422)
                      ..+++|||||+ ++|...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  .+||+||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEecC
Confidence            45889999998 47766665544445568999999999999999999999 89999999999999986542  4999999


Q ss_pred             CCccccccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          230 GSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       230 G~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      |++........ ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .+.+..+.......... 
T Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~-  254 (351)
T 3c0i_A          178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR-  254 (351)
T ss_dssp             TTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH-
T ss_pred             cceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc-
Confidence            99987654332 3356789999999999654 48999999999999999999999998753 34444444321111111 


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                              ....+++++++||.+||+.||++|||+.|+|+||||++.
T Consensus       255 ------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          255 ------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             ------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             ------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                                    113578999999999999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6e-50  Score=382.36  Aligned_cols=255  Identities=23%  Similarity=0.366  Sum_probs=214.2

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----------hhhHHHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||++...          ...+.+|+.+++.++||||+++++++.     
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----   84 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----   84 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence            34699999999999999999999999999999998642          234568999999999999999999883     


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC---cEEE
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL  226 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~---~vkl  226 (422)
                      ....+++||||++ ++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.   .+||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           85 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence            3345789999996 477665542    4679999999999999999999999 89999999999999987652   5999


Q ss_pred             eecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       227 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      +|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus       160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (326)
T 2y0a_A          160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  238 (326)
T ss_dssp             CCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             EECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc
Confidence            99999987755555556789999999999854 45899999999999999999999999998877777666553211111


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                               .....+++.+++||++||+.||.+|||+.|+|+||||+..
T Consensus       239 -------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          239 -------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             -------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             -------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                                     1124578999999999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-50  Score=385.87  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=214.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||+|.+....   ....+|+.+++.++||||+++++++..     ...+++|
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv   79 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEEE
Confidence            35999999999999999999999999999999986432   334689999999999999999998843     3357899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC--CCCcEEEeecCCcccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVL  235 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~--~~~~vkl~DfG~a~~~  235 (422)
                      |||+++ +|.+.+..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.  ++ .+||+|||++...
T Consensus        80 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~  154 (321)
T 1tki_A           80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCC-CEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeEC
Confidence            999985 66555432   23469999999999999999999999 89999999999999986  44 7999999999877


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+...       
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------  226 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------  226 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred             CCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh-------
Confidence            655555567889999999999654 479999999999999999999999999888887777766432222211       


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                        ...+++++++||.+||..||.+|||+.|+|+||||++.
T Consensus       227 ------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                              13579999999999999999999999999999999874

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.6e-50  Score=397.33  Aligned_cols=260  Identities=26%  Similarity=0.415  Sum_probs=216.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.++||+|+||+||+|+++.+++.||||++.+.       .....+|+.++..++||||++++++|.     ....
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~~  148 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-----DDNN  148 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-----CSSE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCE
Confidence            4699999999999999999999999999999998642       223568999999999999999999883     3345


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++|||||+ ++|..++...   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g-~vkL~DFGla~  223 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSCL  223 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCC-CEEEcchhhhh
Confidence            889999996 5776666542   3679999999999999999999999 8999999999999999888 69999999997


Q ss_pred             ccccCCCc--ccccccccccchhhhc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          234 VLVKGEPN--VSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       234 ~~~~~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ........  ...+||+.|+|||++.    +...++.++|||||||++|||++|++||.+.+..+.+.+|+....     
T Consensus       224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----  298 (437)
T 4aw2_A          224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-----  298 (437)
T ss_dssp             ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-----
T ss_pred             hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc-----
Confidence            66443332  3467999999999986    244589999999999999999999999999988888887764210     


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCC--cCCHHHHhcCCcccccCCCC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~~  375 (422)
                                .+.+|..         ...+++++++||++||+.+|++  |++++|+++||||+++.+..
T Consensus       299 ----------~~~~p~~---------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~  349 (437)
T 4aw2_A          299 ----------RFQFPTQ---------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN  349 (437)
T ss_dssp             ----------HCCCCSS---------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred             ----------cccCCcc---------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence                      1112211         1357999999999999999988  99999999999999887543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.2e-50  Score=377.75  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=210.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|++.+.||+|+||+||+|++..+|+.||||++...    .....+|+.+++.++||||+++++++...     ..+++
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~l   94 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV   94 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEEE
Confidence            4599999999999999999999999999999998532    23456899999999999999999988432     34789


Q ss_pred             Eeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||++ ++|.+++..     ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus        95 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCC-CEEEeeCCCceecC
Confidence            999996 577666653     468999999999999999999999 8999999999999999887 69999999987664


Q ss_pred             cCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+......            
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------  234 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP------------  234 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC------------
T ss_pred             CcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence            433 23456789999999999765 4899999999999999999999999988877766655442110            


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                        .+.            .+..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       235 --~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          235 --ELQ------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             --CCS------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             --CCC------------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence              000            124578999999999999999999999999999999874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.4e-50  Score=389.01  Aligned_cols=251  Identities=27%  Similarity=0.481  Sum_probs=211.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++.+..       ....+|..+++.+ +||||+++++++.     ...
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-----~~~   91 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE   91 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----eCC
Confidence            35999999999999999999999999999999986532       2345788898877 9999999999883     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG~a  165 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFGMC  165 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCC-CEEEeEChhh
Confidence            58899999974 77666553    3679999999999999999999999 8999999999999999888 6999999999


Q ss_pred             ccccc-CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          233 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       233 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      +.... .......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+...           
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  233 (345)
T 1xjd_A          166 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-----------  233 (345)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             hhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------
Confidence            76433 2334567899999999999664 4899999999999999999999999998877777666541           


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHH-HHhcCCcccccCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD  373 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-e~l~hp~f~~~~~  373 (422)
                            ...            ++..+++++++||.+||+.||++||++. ++++||||+++.+
T Consensus       234 ------~~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          234 ------NPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             ------CCC------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence                  111            1245789999999999999999999998 9999999998753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-50  Score=380.84  Aligned_cols=249  Identities=27%  Similarity=0.483  Sum_probs=212.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++||||+++++++.     ....
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~~   80 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ   80 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCCE
Confidence            4699999999999999999999999999999998643       233457999999999999999999883     3345


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus        81 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~  154 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFAK  154 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred             EEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCC-CEEEeecCcce
Confidence            8899999985 77666653    3679999999999999999999999 8999999999999999888 69999999998


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ....  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+....+.++...             
T Consensus       155 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------  218 (318)
T 1fot_A          155 YVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------  218 (318)
T ss_dssp             ECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------
T ss_pred             ecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence            6532  33466899999999999654 5899999999999999999999999998887777777652             


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                          ...            ++..+++++++||++||+.||.+|+     +++++++||||+++.+
T Consensus       219 ----~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          219 ----ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             ----CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             ----CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence                111            1245789999999999999999999     8999999999998653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=392.48  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=209.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++.+..       ....+|+.+++.++|||||+++++|.     ....
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~   89 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEED   89 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCCE
Confidence            46999999999999999999999999999999986432       34458999999999999999999884     3335


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+.+ +|...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++
T Consensus        90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG~a~  163 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHG-HVHITDFNIAA  163 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCC-CEEEeccceee
Confidence            7899999975 66555543    4679999999999999999999999 8999999999999999888 69999999998


Q ss_pred             ccccCCCcccccccccccchhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~~---~~~~~i~~~~~~~~~~~  308 (422)
                      ...........+||+.|+|||++.+.  ..++.++|||||||++|+|++|..||.+.+..   .....+...        
T Consensus       164 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--------  235 (384)
T 4fr4_A          164 MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--------  235 (384)
T ss_dssp             ECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--------
T ss_pred             eccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--------
Confidence            77666666778899999999998642  34899999999999999999999999754322   222222110        


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-HHHHhcCCcccccCC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFDELRD  373 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-~~e~l~hp~f~~~~~  373 (422)
                               ...            ++..+++++.+||.+||+.||.+||+ ++++++||||+++.+
T Consensus       236 ---------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          236 ---------VVT------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             ---------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             ---------ccC------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence                     011            22457899999999999999999998 899999999998764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.7e-50  Score=385.22  Aligned_cols=250  Identities=26%  Similarity=0.486  Sum_probs=204.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||+||+|+++.+++.||||++.+..       ....+|+.+++.+ +||||+++++++.     ...
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~~   83 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TES   83 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eCC
Confidence            46999999999999999999999999999999986532       2345799999988 8999999999883     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFG~a  157 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGMC  157 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCGGGC
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEEecccc
Confidence            58899999975 77665543    3579999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccc-cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHHhC
Q 014595          233 KVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---------GVDQLVEIIKVLG  302 (422)
Q Consensus       233 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~---------~~~~~~~i~~~~~  302 (422)
                      +... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||....         .......+...  
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--  234 (345)
T 3a8x_A          158 KEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--  234 (345)
T ss_dssp             BCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--
T ss_pred             ccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--
Confidence            7643 23344567899999999999664 58999999999999999999999997531         11122222220  


Q ss_pred             CCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH------HHHhcCCcccccC
Q 014595          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELR  372 (422)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~------~e~l~hp~f~~~~  372 (422)
                                     ...            ++..+++++++||.+||+.||.+||++      .|+++||||+++.
T Consensus       235 ---------------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          235 ---------------QIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             ---------------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             ---------------CCC------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence                           111            224679999999999999999999995      8999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.8e-50  Score=386.25  Aligned_cols=288  Identities=29%  Similarity=0.480  Sum_probs=224.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC---CCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~~  152 (422)
                      .+|++.+.||+|+||+||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++.....   ...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            46999999999999999999999999999999885432      234589999999999999999998854321   124


Q ss_pred             eEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ..+++||||+++++...+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        97 ~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a  171 (351)
T 3mi9_A           97 GSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGLA  171 (351)
T ss_dssp             CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             ceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-CEEEccchhc
Confidence            457899999998776665542   3569999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccC-----CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          233 KVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       233 ~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      +.....     .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++..
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            765422     222445789999999999776678999999999999999999999999999999999998888877665


Q ss_pred             HHhhcCcC--CccCcCCCCCCCCccccc-ccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          308 EIKCMNPN--YTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       308 ~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      .+......  +..+.............+ ....++++++||.+||+.||.+|||+.|+|+||||+....+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            44332110  111111110000100000 01137889999999999999999999999999999875433

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.1e-50  Score=387.90  Aligned_cols=251  Identities=25%  Similarity=0.410  Sum_probs=211.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++.+..       ....+|..++..+ +||||+++++++.     ...
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~~   94 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMD   94 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----CSS
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----cCC
Confidence            35999999999999999999999999999999986532       2345788999887 8999999999883     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG~a  168 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFGMC  168 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCC-cEEEEeCCcc
Confidence            58899999975 77666553    3579999999999999999999999 8999999999999999888 6999999999


Q ss_pred             ccccc-CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          233 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       233 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      +.... .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+...           
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------  236 (353)
T 2i0e_A          169 KENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----------  236 (353)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             cccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence            86432 3344567899999999999654 5899999999999999999999999998887777777652           


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                            ...            ++..+++++++||++||+.||.+||     +++++++||||+.+.+
T Consensus       237 ------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w  285 (353)
T 2i0e_A          237 ------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  285 (353)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred             ------CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence                  111            2246799999999999999999999     4799999999998753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.5e-50  Score=383.38  Aligned_cols=285  Identities=33%  Similarity=0.584  Sum_probs=225.7

Q ss_pred             CCcceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        77 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      ......+|++.+.||+|+||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++.     
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   94 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----   94 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----
Confidence            3344567999999999999999999999999999999885432      22357999999999999999999884     


Q ss_pred             CceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      .....++||||+++++...+   ......+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg  169 (331)
T 4aaa_A           95 KKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFG  169 (331)
T ss_dssp             ETTEEEEEEECCSEEHHHHH---HHSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             cCCEEEEEEecCCcchHHHH---HhhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCC-cEEEEeCC
Confidence            33457899999997553332   2234679999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          231 SAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       231 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.......
T Consensus       170 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (331)
T 4aaa_A          170 FARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ  249 (331)
T ss_dssp             TC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             CceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence            99765432 22345578999999999977667899999999999999999999999999999999999988888776544


Q ss_pred             hhc--CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          310 KCM--NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       310 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      ..+  .+.+.....+............+.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            322  23333334444333222222335689999999999999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.6e-50  Score=388.47  Aligned_cols=254  Identities=29%  Similarity=0.413  Sum_probs=212.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++.     .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~  103 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESFH  103 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEE
Confidence            46999999999999999999999999999999986432      33458999999999999999999883     33457


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEEEeecCCc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSA  232 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vkl~DfG~a  232 (422)
                      ++||||+.+ +|.+.+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++  ..+||+|||++
T Consensus       104 ~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            899999985 6655443    24678999999999999999999999 8999999999999998653  25999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .............||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....           
T Consensus       179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~-----------  246 (362)
T 2bdw_A          179 IEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-----------  246 (362)
T ss_dssp             BCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------
T ss_pred             eEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            877655555567899999999999654 58999999999999999999999999988777766665521           


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                            +.++.   .     ....+++++++||.+||+.||.+|||+.++|+||||...
T Consensus       247 ------~~~~~---~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          247 ------YDYPS---P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ------CCCCT---T-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ------CCCCc---c-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                  11111   0     113578999999999999999999999999999999753

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=391.10  Aligned_cols=259  Identities=27%  Similarity=0.445  Sum_probs=213.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.++..++||||++++++|.     ...+
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~~  135 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ-----DENY  135 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-----CSSE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCE
Confidence            4699999999999999999999999999999998642       233568999999999999999999883     3445


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +|+||||++ ++|..++...   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g-~vkL~DFGla~  210 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCG-HIRLADFGSCL  210 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCC-CEEEeechhhe
Confidence            889999996 5777766542   3579999999999999999999999 8999999999999999888 69999999998


Q ss_pred             ccccCCC--cccccccccccchhhhcC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          234 VLVKGEP--NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       234 ~~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      .......  ....+||+.|+|||++.+      ...++.++|||||||++|||++|+.||.+.+..+.+.+|.....   
T Consensus       211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---  287 (412)
T 2vd5_A          211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE---  287 (412)
T ss_dssp             ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---
T ss_pred             eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---
Confidence            7644332  234589999999999862      34589999999999999999999999999888887777764210   


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCc---CCHHHHhcCCcccccCCCC
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDELRDPN  375 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---~t~~e~l~hp~f~~~~~~~  375 (422)
                                  .+.+|.         +...+|+++++||++||+ +|.+|   ++++|+++||||+++.+..
T Consensus       288 ------------~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~  338 (412)
T 2vd5_A          288 ------------HLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG  338 (412)
T ss_dssp             ------------HCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred             ------------CcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence                        011111         124689999999999999 99998   5999999999999986543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.1e-50  Score=384.76  Aligned_cols=248  Identities=26%  Similarity=0.429  Sum_probs=212.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++.+..       ....+|+.+++.++||||+++++++.     ....
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~  115 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCCE
Confidence            35999999999999999999999999999999985432       23457999999999999999999883     3345


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||++ ++|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus       116 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~  189 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGFAK  189 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCC-CEEEcccccce
Confidence            889999997 477666654    3579999999999999999999999 8999999999999999888 69999999998


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...             
T Consensus       190 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------------  253 (350)
T 1rdq_E          190 RVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------------  253 (350)
T ss_dssp             ECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred             eccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-------------
Confidence            6533  33466899999999999654 5899999999999999999999999998877777776652             


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~  372 (422)
                          ...            ++..+++++.+||.+||+.||.+||+     ++++++||||+.+.
T Consensus       254 ----~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          254 ----KVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             ----CCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             ----CCC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence                111            12467999999999999999999998     99999999999764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=395.15  Aligned_cols=255  Identities=27%  Similarity=0.399  Sum_probs=210.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..+|.+.+.||+|+||+||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.     ....
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~~   84 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEGH   84 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSSE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECCE
Confidence            346999999999999999999999999999999986432      33468999999999999999999883     3445


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC--CCcEEEeecCC
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGS  231 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~--~~~vkl~DfG~  231 (422)
                      .++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+  +..+||+|||+
T Consensus        85 ~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            7899999975 66555543    4679999999999999999999999 899999999999999842  23699999999


Q ss_pred             ccccccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          232 AKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       232 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      +........ .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....         
T Consensus       160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------  229 (444)
T 3soa_A          160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA---------  229 (444)
T ss_dssp             CBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC---------
T ss_pred             eEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---------
Confidence            976644332 2456899999999999654 58999999999999999999999999988877777766531         


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                              +.++.   ..     ...+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus       230 --------~~~~~---~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          230 --------YDFPS---PE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             --------CCCCT---TT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             --------CCCCc---cc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                    11111   01     13579999999999999999999999999999999764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.2e-49  Score=375.37  Aligned_cols=288  Identities=31%  Similarity=0.549  Sum_probs=230.7

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEc-CCCeEEEEEEeccch------hhHHHHHHHHHHc---CCCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vAiK~~~~~~------~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~  150 (422)
                      ..+|++.+.||+|+||+||+|++. .+|+.||||++....      ....+|+.+++.+   +||||+++++++......
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            456999999999999999999995 678999999885321      2455788888777   899999999988544444


Q ss_pred             CceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      ....+++||||+++++.+++....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        90 ~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~-~~kl~Dfg  165 (326)
T 1blx_A           90 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFG  165 (326)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred             CCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCC-CEEEecCc
Confidence            566788999999998877766432  2458999999999999999999999 8999999999999999887 69999999


Q ss_pred             CccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ++.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          166 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             ccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            99766544444456789999999999654 48999999999999999999999999999999999999988887765543


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                      ..... ....+......+. ..+...++..+++||.+||+.||.+|||+.|+++||||+++....
T Consensus       245 ~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          245 RDVAL-PRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             TTCSS-CGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccccc-chhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            21110 0001111111122 123356899999999999999999999999999999999876544

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.2e-50  Score=394.79  Aligned_cols=288  Identities=28%  Similarity=0.491  Sum_probs=210.2

Q ss_pred             eeEE-eeeeeecCCeeEEEEEEc--CCCeEEEEEEeccch--hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIA-EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .|.+ +++||+|+||+||+|+++  .+++.||||++....  ....+|+.+++.++||||+++++++....   ...+++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeEEE
Confidence            4776 568999999999999976  568999999986542  34568999999999999999999885422   345789


Q ss_pred             EeecchhHHHHHHHHhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE----cCCCCcEEEee
Q 014595          158 VLEYVPETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCD  228 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill----~~~~~~vkl~D  228 (422)
                      ||||+++++..++......     ...+++..++.++.||+.||.|||+ .||+||||||+|||+    +.++ .+||+|
T Consensus        98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kl~D  175 (405)
T 3rgf_A           98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIAD  175 (405)
T ss_dssp             EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTT-CEEECC
T ss_pred             EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCC-cEEEEE
Confidence            9999999887777643322     1248999999999999999999999 899999999999999    4445 799999


Q ss_pred             cCCccccccC----CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 014595          229 FGSAKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLV  295 (422)
Q Consensus       229 fG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---------~~~~~  295 (422)
                      ||+|+.....    ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+...         .+++.
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            9999866432    2223567899999999997766799999999999999999999999987654         47888


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCc------cCcCCCCCCCC---cccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCC
Q 014595          296 EIIKVLGTPTREEIKCMNPNYT------EFKFPQIKPHP---WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  366 (422)
                      .++..++.|....|..+.....      .+.........   +........++++.+||++||+.||.+|||++|+|+||
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp  335 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  335 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            9999999888665443211000      00000000000   00111123478899999999999999999999999999


Q ss_pred             cccccCCCC
Q 014595          367 FFDELRDPN  375 (422)
Q Consensus       367 ~f~~~~~~~  375 (422)
                      ||++...+.
T Consensus       336 ~f~~~~~~~  344 (405)
T 3rgf_A          336 YFLEDPLPT  344 (405)
T ss_dssp             GGTSSSCCC
T ss_pred             hhccCCCCc
Confidence            999865443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.6e-49  Score=382.05  Aligned_cols=314  Identities=32%  Similarity=0.581  Sum_probs=237.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCC-CceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~~~~  154 (422)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            35999999999999999999999999999999986432      2345799999999999999999988543221 1223


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++||||+++++...+      ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus       104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred             EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence            5799999998664432      2469999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.++.+.+..+..
T Consensus       176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            532  234567899999999997656789999999999999999999999999999999999999999988776654432


Q ss_pred             CCcc---CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCC
Q 014595          315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  391 (422)
Q Consensus       315 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  391 (422)
                      ....   ...+......+... ...+++++.+||.+||+.||++|||+.++|+||||+....+........   + +.. 
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~---~-~~~-  327 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQL-FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ---P-FDD-  327 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTTT-CTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS---C-CCC-
T ss_pred             HHHHHHHHhCcCCCCccHHHh-cCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC---C-Ccc-
Confidence            1100   01111112222222 2467999999999999999999999999999999998776543211111   1 111 


Q ss_pred             CCCCCCCChhHHhhhCcHHH
Q 014595          392 PPELSGIPPETINRLIPEHA  411 (422)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~  411 (422)
                      ......++.+.+++.+.++.
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~  347 (353)
T 3coi_A          328 SLEHEKLTVDEWKQHIYKEI  347 (353)
T ss_dssp             TTTTCCCCHHHHHHHHHHHH
T ss_pred             chhhccCCHHHHHHHHHHHH
Confidence            12223456666766665544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2e-49  Score=383.72  Aligned_cols=276  Identities=25%  Similarity=0.422  Sum_probs=219.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcC-----CCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----HPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~-----h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.+.     ||||+++++++..     ..
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-----~~  109 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-----YD  109 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-----TT
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-----CC
Confidence            35999999999999999999999999999999986433   33457999999996     9999999998843     23


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC--------------
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--------------  219 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~--------------  219 (422)
                      ++++||||++++|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.              
T Consensus       110 ~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          110 HMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             EEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             eeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhccc
Confidence            588999999888887776532  2468999999999999999999999 89999999999999974              


Q ss_pred             -----------CCCcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014595          220 -----------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE  288 (422)
Q Consensus       220 -----------~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~  288 (422)
                                 ++ .+||+|||+++....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus       187 ~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          187 DGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             TCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                       44 699999999976432  33466789999999999765 4899999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCc-c--------CcCCCCCCC--------CcccccccCCChHHHHHHHhhhhc
Q 014595          289 SGVDQLVEIIKVLGTPTREEIKCMNPNYT-E--------FKFPQIKPH--------PWHKVFQKRLPPEAVDLVCRFFQY  351 (422)
Q Consensus       289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~  351 (422)
                      +..+.+..+....+.++...+........ .        ..++.....        .....+....++.+.+||.+||+.
T Consensus       263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  342 (360)
T 3llt_A          263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI  342 (360)
T ss_dssp             SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred             cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence            99999999988888887766543221110 0        001100000        000011122357888999999999


Q ss_pred             CCCCcCCHHHHhcCCccc
Q 014595          352 SPNLRCTALEACVHPFFD  369 (422)
Q Consensus       352 dP~~R~t~~e~l~hp~f~  369 (422)
                      ||.+|||+.|+|+||||+
T Consensus       343 dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          343 DPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SGGGSCCHHHHTTSGGGC
T ss_pred             ChhhCCCHHHHhcCcccC
Confidence            999999999999999996

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.3e-50  Score=376.76  Aligned_cols=253  Identities=26%  Similarity=0.429  Sum_probs=203.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------------------------------hhHHHHHHHHH
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQIMQ  130 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------------------------~~~~~E~~~l~  130 (422)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||++....                              ....+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            446999999999999999999999999999999985432                              23568999999


Q ss_pred             HcCCCCcccccceeecCCCCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 014595          131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (422)
Q Consensus       131 ~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrD  209 (422)
                      .++||||+++++++..   .....+++||||+++ ++..+     .....+++..++.++.||+.||+|||+ .||+|||
T Consensus        92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~D  162 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHY-QKIIHRD  162 (298)
T ss_dssp             TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred             hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccC
Confidence            9999999999998843   224457899999985 43221     123579999999999999999999999 8999999


Q ss_pred             CCCCCeEEcCCCCcEEEeecCCccccccCCC-cccccccccccchhhhcCCCC--CCCcchHHHHHHHHHHHHhCCCCCC
Q 014595          210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFP  286 (422)
Q Consensus       210 lkp~Nill~~~~~~vkl~DfG~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltG~~pf~  286 (422)
                      |||+|||++.++ .+||+|||++........ .....||+.|+|||++.+...  ++.++|||||||++|+|++|+.||.
T Consensus       163 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          163 IKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999887 699999999986644322 234578999999999865432  4778999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCC
Q 014595          287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (422)
Q Consensus       287 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  366 (422)
                      +.+.......+...                 ...++.          ...+++++.+||.+||+.||++|||+.|+++||
T Consensus       242 ~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp  294 (298)
T 2zv2_A          242 DERIMCLHSKIKSQ-----------------ALEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP  294 (298)
T ss_dssp             CSSHHHHHHHHHHC-----------------CCCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred             CccHHHHHHHHhcc-----------------cCCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence            87765554444331                 111111          135789999999999999999999999999999


Q ss_pred             cccc
Q 014595          367 FFDE  370 (422)
Q Consensus       367 ~f~~  370 (422)
                      ||++
T Consensus       295 ~~~~  298 (298)
T 2zv2_A          295 WVTR  298 (298)
T ss_dssp             HHHC
T ss_pred             cccC
Confidence            9963

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.4e-49  Score=369.14  Aligned_cols=255  Identities=28%  Similarity=0.413  Sum_probs=205.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||+|++....     ....+|+++++.++||||+++++++.     .....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   96 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNMY   96 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeEE
Confidence            46999999999999999999999999999999986543     44568999999999999999999883     334478


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC--CCcEEEeecCCcc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAK  233 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~--~~~vkl~DfG~a~  233 (422)
                      +||||+++ ++.+.+.........+++..++.++.||+.||+|||+ .||+||||||+|||++.+  ...+||+|||++.
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            99999985 7777776655556789999999999999999999999 899999999999999532  2369999999998


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ............+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+.....           
T Consensus       176 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------  242 (285)
T 3is5_A          176 LFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP-----------  242 (285)
T ss_dssp             C----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred             ecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-----------
Confidence            7665555566788999999999843  489999999999999999999999998876655544433100           


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                            .++         .....+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       243 ------~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          243 ------NYA---------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             ------CCC---------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ------ccc---------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                  000         011346899999999999999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1e-49  Score=386.90  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=207.0

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-------hHHHHHHH-HHHcCCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|.+.+.||+|+||+||+|+++.+++.||||++.+...       ...+|..+ ++.++||||+++++++.     ..
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~~  111 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TA  111 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----CS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----eC
Confidence            3469999999999999999999999999999999865431       12345555 46689999999999883     33


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ..+|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~ikL~DFG~  185 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFGL  185 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEeeCcc
Confidence            458899999985 66665543    3678999999999999999999999 8999999999999999888 699999999


Q ss_pred             cccccc-CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          232 AKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       232 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ++.... .......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+...          
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------  254 (373)
T 2r5t_A          186 CKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----------  254 (373)
T ss_dssp             CGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS----------
T ss_pred             ccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------
Confidence            986433 3344567899999999999654 5899999999999999999999999998887777777652          


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH----HHHhcCCcccccCC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  373 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f~~~~~  373 (422)
                             ...            ++..++.++++||++||+.||.+|+++    .++++||||+.+.+
T Consensus       255 -------~~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w  302 (373)
T 2r5t_A          255 -------PLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW  302 (373)
T ss_dssp             -------CCC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred             -------ccC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence                   111            124679999999999999999999986    69999999998753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.3e-50  Score=386.61  Aligned_cols=258  Identities=27%  Similarity=0.438  Sum_probs=196.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.++||||+++++++..     ...+++|
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~lv   94 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLAII   94 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEEEE
Confidence            46999999999999999999999999999999986532   445689999999999999999999843     3347899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC-cEEEeecCCccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLV  236 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~-~vkl~DfG~a~~~~  236 (422)
                      |||+.+ +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||+++...
T Consensus        95 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           95 MEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            999964 77665543    3579999999999999999999999 89999999999999986652 49999999997654


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+......++...+..             
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~-------------  236 (361)
T 3uc3_A          170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS-------------  236 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT-------------
T ss_pred             ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc-------------
Confidence            4445556789999999999977654455599999999999999999999875543333333221100             


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      ..+.++.          ...+++++++||++||+.||.+|||+.|+++||||....
T Consensus       237 ~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          237 VKYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             TCCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             CCCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            0111111          125789999999999999999999999999999997643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.4e-49  Score=367.90  Aligned_cols=260  Identities=28%  Similarity=0.390  Sum_probs=214.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.     .....
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   80 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESFH   80 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCEE
Confidence            45999999999999999999999999999999986432      33457999999999999999999883     33457


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC--cEEEeecCCc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSA  232 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~--~vkl~DfG~a  232 (422)
                      ++||||+++ ++...+..    ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++.  .+||+|||++
T Consensus        81 ~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~  155 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLA  155 (284)
T ss_dssp             EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence            899999975 55454433    3679999999999999999999999 89999999999999986542  4999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+......         
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  225 (284)
T 3kk8_A          156 IEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD---------  225 (284)
T ss_dssp             EECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred             EEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc---------
Confidence            876655555567889999999999654 4899999999999999999999999988877766666542111         


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  377 (422)
                              ++..        ....+++++.+||.+||+.||++|||+.|+|+||||++.......
T Consensus       226 --------~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  274 (284)
T 3kk8_A          226 --------YPSP--------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA  274 (284)
T ss_dssp             --------CCTT--------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred             --------CCch--------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence                    1100        113578999999999999999999999999999999986654433

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-49  Score=378.90  Aligned_cols=281  Identities=31%  Similarity=0.533  Sum_probs=218.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-hhhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEEEEe
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .+|++.+.||+|+||+||+|++..+++.||||++... .....+|+.+++.++ ||||+++++++..   ....+.++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceEEEE
Confidence            4699999999999999999999999999999998643 345678999999997 9999999998843   2234577999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+.+ ++..++       ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++.....
T Consensus       113 e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          113 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             ECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99985 444332       348899999999999999999999 899999999999999977657999999999877666


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHh-hcCcCC
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEIK-CMNPNY  316 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~~  316 (422)
                      .......+|+.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+....+.+...... ......
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence            555667889999999999775679999999999999999999999984 456667777776666543322211 111000


Q ss_pred             cc-C--cCCCCCCCCccccc----ccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          317 TE-F--KFPQIKPHPWHKVF----QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       317 ~~-~--~~~~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      .. +  .........|...+    ...+++++++||++||+.||.+|||++|+|+||||+++.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            00 0  00000111122111    1337999999999999999999999999999999998754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.6e-49  Score=381.60  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=207.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      ..+|.+.+.||+|+||+||+|+++.+|+.||||++.+......+|++++.++ +||||+++++++.     +..++|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYD-----DGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCEEEEEE
Confidence            3469999999999999999999999999999999987776677899999888 7999999999883     344588999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC---cEEEeecCCcccc
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLCDFGSAKVL  235 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~---~vkl~DfG~a~~~  235 (422)
                      ||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||+..+.+   .+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99975 66555543    3579999999999999999999999 89999999999999854322   4999999999866


Q ss_pred             ccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHHhh
Q 014595          236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE---SGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ... ......++|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.   +..+.+..+...           
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-----------  238 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-----------  238 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC-----------
T ss_pred             cCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC-----------
Confidence            443 233456789999999999654 4889999999999999999999999863   233333333321           


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                            .+.++.        ..+..+++++++||++||+.||++|||+.++++||||.+.
T Consensus       239 ------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          239 ------KFSLSG--------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             ------CCCCCS--------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             ------CcccCc--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence                  111110        1124689999999999999999999999999999999764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.3e-49  Score=376.70  Aligned_cols=255  Identities=27%  Similarity=0.348  Sum_probs=205.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|++.+.||+|+||+||+|++..+++.||||++...     .....+|+.+++.++||||+++++++.     .....+
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~   81 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY   81 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeEE
Confidence            3599999999999999999999999999999998543     244568999999999999999999883     334578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ +|.+.+    .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~  155 (323)
T 3tki_A           82 LFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF  155 (323)
T ss_dssp             EEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCC-CEEEEEeecccee
Confidence            99999975 553333    334569999999999999999999999 8999999999999999887 6999999999765


Q ss_pred             ccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          236 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       236 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ....   ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..............         
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------  226 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------  226 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT---------
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc---------
Confidence            3322   2235678999999999977665688999999999999999999999876543222222111000         


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                  ...+     ...+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       227 ------------~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          227 ------------YLNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             ------------TSTT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             ------------cCCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                        0001     1357899999999999999999999999999999987543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-49  Score=395.00  Aligned_cols=251  Identities=28%  Similarity=0.419  Sum_probs=213.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     ..
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----PS   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CC
Confidence            346999999999999999999999999999999986432       345689999999999999999998843     33


Q ss_pred             EEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++||||++ ++|.+.+.    ..+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        90 ~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~-~vkL~DFG~a  163 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGLS  163 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTC-CEEECCCSSC
T ss_pred             EEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCC-CeEEEeccch
Confidence            4789999996 46655543    34679999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .....+......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+.++....           
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------  232 (476)
T 2y94_A          164 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-----------  232 (476)
T ss_dssp             EECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-----------
T ss_pred             hhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------
Confidence            877665555677899999999999776656789999999999999999999999888777666655421           


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                            +..            +..+++++.+||++||+.||.+|||+.|+++||||+..
T Consensus       233 ------~~~------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          233 ------FYT------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ------CCC------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ------cCC------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                  111            13578999999999999999999999999999999863

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-49  Score=396.46  Aligned_cols=253  Identities=27%  Similarity=0.412  Sum_probs=205.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     ..
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence            346999999999999999999999999999999986432       233468899999999999999998843     33


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++||||+++ +|...+..    ...+++..++.++.||+.||+|||+..||+||||||+|||++.++ .+||+|||+|
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a  296 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLC  296 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCC
T ss_pred             EEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCc
Confidence            47899999985 66555543    367999999999999999999999526999999999999999887 6999999999


Q ss_pred             ccccc-CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          233 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       233 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      +.... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+...           
T Consensus       297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  364 (446)
T 4ejn_A          297 KEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------  364 (446)
T ss_dssp             CTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             eeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----------
Confidence            76432 2334467899999999999654 5899999999999999999999999988877776666542           


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                            ...            ++..+++++.+||.+||+.||.+||     |+.|+++||||+++..
T Consensus       365 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          365 ------EIR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ------CCC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence                  111            2245789999999999999999999     9999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.6e-49  Score=384.24  Aligned_cols=285  Identities=20%  Similarity=0.332  Sum_probs=207.9

Q ss_pred             eeeeEEeeeeeec--CCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|++.+.||+|  +||+||+|++..+|+.||||++....      ....+|+.+++.++|||||++++++..     .
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   98 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----D   98 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----C
Confidence            4469999999999  99999999999999999999986432      334579999999999999999999843     3


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ..+++||||++ +++.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~dfg~  174 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRS  174 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCGGG
T ss_pred             CEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEccccc
Confidence            34789999998 47776665432  3569999999999999999999999 8999999999999999887 699999998


Q ss_pred             ccccccCC--------CcccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 014595          232 AKVLVKGE--------PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  302 (422)
Q Consensus       232 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~  302 (422)
                      +.......        ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....-
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            86543221        12234788999999999763 4589999999999999999999999988776665554432110


Q ss_pred             C--------CCHHHHhhcC-----cCCcc-C----cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          303 T--------PTREEIKCMN-----PNYTE-F----KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       303 ~--------~~~~~~~~~~-----~~~~~-~----~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .        +.........     ..... .    ..+.. .......++..+++++++||++||+.||++|||+.|+|+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSN-GDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CccccccccccccccccccccccccccccccccCcccccc-CCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0        0000000000     00000 0    00000 000111133567999999999999999999999999999


Q ss_pred             CCcccccCCCC
Q 014595          365 HPFFDELRDPN  375 (422)
Q Consensus       365 hp~f~~~~~~~  375 (422)
                      ||||+++....
T Consensus       334 hp~f~~~~~~~  344 (389)
T 3gni_B          334 HSFFKQIKRRA  344 (389)
T ss_dssp             SGGGGGC---C
T ss_pred             CHHHHHHhhcc
Confidence            99999987543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.7e-49  Score=383.56  Aligned_cols=253  Identities=26%  Similarity=0.382  Sum_probs=205.1

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      |...+.||+|+||.||+|++..+|+.||+|++...    ...+.+|+++++.++||||+++++++..     ...+++||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEEE
Confidence            44477899999999999999999999999998653    3445689999999999999999998843     33478999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEc--CCCCcEEEeecCCccccc
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN--PHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~--~~~~~vkl~DfG~a~~~~  236 (422)
                      ||+++ +|.+.+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||+.  .++ .+||+|||+++...
T Consensus       166 E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          166 EYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYK  240 (373)
T ss_dssp             ECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCC-cEEEEeCCCceecC
Confidence            99974 66555543   23468999999999999999999999 8999999999999994  344 79999999998776


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+.++......             
T Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-------------  306 (373)
T 2x4f_A          241 PREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-------------  306 (373)
T ss_dssp             TTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------------
T ss_pred             CccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------------
Confidence            5555556679999999999854 45899999999999999999999999999888888777663111             


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                          ++.        .....+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus       307 ----~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          307 ----LED--------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             ----SCS--------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             ----CCh--------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                110        01145799999999999999999999999999999998753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.6e-48  Score=371.55  Aligned_cols=256  Identities=23%  Similarity=0.343  Sum_probs=214.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----------hhhHHHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||++...          ...+.+|+.+++.++||||+++++++.     
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-----   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence            34699999999999999999999999999999998642          234568999999999999999999883     


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC---cEEE
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL  226 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~---~vkl  226 (422)
                      .....++||||++ ++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.   .+||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~kl  160 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL  160 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEEE
Confidence            3345789999996 477666643    4678999999999999999999999 89999999999999987763   5999


Q ss_pred             eecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       227 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      +|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (321)
T 2a2a_A          161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE  239 (321)
T ss_dssp             CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             ccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence            999999877665555567789999999999654 5899999999999999999999999988877776665542211111


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                               .+...+++.+.+||.+||+.||++|||+.|+++||||+.+.
T Consensus       240 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          240 -------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             -------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             -------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence                                     11246789999999999999999999999999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-49  Score=384.33  Aligned_cols=256  Identities=27%  Similarity=0.411  Sum_probs=212.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||+|++...    .....+|+.+++.++||||+++++++.     ....+++
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~l  125 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL  125 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEEE
Confidence            3599999999999999999999999999999998653    234568999999999999999999883     3345789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC-CCcEEEeecCCcccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  235 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~-~~~vkl~DfG~a~~~  235 (422)
                      ||||+.+ +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ ...+||+|||+++..
T Consensus       126 v~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          126 ILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccceec
Confidence            9999975 66554432   23468999999999999999999999 899999999999999753 236999999999877


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....              
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--------------  266 (387)
T 1kob_A          202 NPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--------------  266 (387)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--------------
T ss_pred             CCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------
Confidence            65555556689999999999965 458999999999999999999999999988777776665421              


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                         +.++.        .....+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus       267 ---~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          267 ---WEFDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             ---CCCCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ---CCCCc--------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence               11110        01135799999999999999999999999999999998743

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-48  Score=373.79  Aligned_cols=251  Identities=29%  Similarity=0.451  Sum_probs=204.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc---CCCeEEEEEEeccch--------hhHHHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|.+.+.||+|+||+||+|++.   .+|+.||||++.+..        ....+|+.+++.++||||+++++++..    
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----   92 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT----   92 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc----
Confidence            46999999999999999999985   689999999986432        234579999999999999999998843    


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeec
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                       ...+++||||++ ++|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus        93 -~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~Df  165 (327)
T 3a62_A           93 -GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQG-HVKLTDF  165 (327)
T ss_dssp             -SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTS-CEEECCC
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCC-cEEEEeC
Confidence             334789999997 466665543    3578999999999999999999999 8999999999999999887 6999999


Q ss_pred             CCccccccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          230 GSAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       230 G~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      |+++..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....       
T Consensus       166 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-------  237 (327)
T 3a62_A          166 GLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-------  237 (327)
T ss_dssp             SCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-------
T ss_pred             CcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-------
Confidence            998754332 223456789999999999654 48999999999999999999999999988877777766521       


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                                ..            ++..+++++++||.+||+.||.+||     ++.++++||||+++..
T Consensus       238 ----------~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          238 ----------LN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             ----------CC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             ----------CC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence                      11            1235789999999999999999999     8999999999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.8e-48  Score=363.12  Aligned_cols=253  Identities=30%  Similarity=0.444  Sum_probs=213.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|++.+.||+|+||+||+|++..++..||+|++...    .....+|+++++.++||||+++++++.     .....++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   83 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIYL   83 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEEE
Confidence            4699999999999999999999999999999998542    345668999999999999999999883     3344789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE---cCCCCcEEEeecCCcc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAK  233 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill---~~~~~~vkl~DfG~a~  233 (422)
                      ||||+++ ++.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||+   +.++ .+||+|||++.
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~  157 (277)
T 3f3z_A           84 VMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLAA  157 (277)
T ss_dssp             EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred             EEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCC-cEEEEecccce
Confidence            9999975 66555543    3668999999999999999999999 899999999999999   5555 69999999998


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ............+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.......+...+    
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  231 (277)
T 3f3z_A          158 RFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW----  231 (277)
T ss_dssp             ECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH----
T ss_pred             eccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh----
Confidence            7766655566789999999999854  3899999999999999999999999998887777776653222222111    


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                           ..+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus       232 ---------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          232 ---------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             ---------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             ---------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                                 25789999999999999999999999999999998754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.2e-49  Score=373.44  Aligned_cols=285  Identities=29%  Similarity=0.514  Sum_probs=218.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCC--------
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTD--------  149 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--------  149 (422)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++....    ....+|+.+++.++||||+++++++.....        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            35999999999999999999999999999999886432    334589999999999999999988743211        


Q ss_pred             -CCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          150 -KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       150 -~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                       ......++||||+++++.+.+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|
T Consensus        91 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           91 LTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence             23356789999999888766542     578999999999999999999999 89999999999999986555799999


Q ss_pred             cCCccccccC----CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014595          229 FGSAKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       229 fG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      ||++......    .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999865322    122345678999999998765678999999999999999999999999999888888888877766


Q ss_pred             CHHHHhhcCcCCccC---cCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          305 TREEIKCMNPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      ..+....+......+   .. .....++.. +.+.++.++++||.+||+.||++|||+.|+|+||||+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDM-TEPHKPLTQ-LLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHT-TSCCCCHHH-HSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             chhhhhhhhhcCcccccccc-cCCCCChhH-hcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            655443321111000   00 001111111 225689999999999999999999999999999999986544

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-48  Score=382.95  Aligned_cols=282  Identities=27%  Similarity=0.393  Sum_probs=220.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcC--------CCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD--------HPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~--------h~nIv~l~~~~~~~~~~  150 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.+.        |+||+++++++.... .
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-V  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-T
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-C
Confidence            46999999999999999999999999999999987543   33457999999985        788999999874322 2


Q ss_pred             CceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeEEcCCC--------
Q 014595          151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHT--------  221 (422)
Q Consensus       151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-givHrDlkp~Nill~~~~--------  221 (422)
                      ...++++||||+++++...+...  ....+++..++.++.||+.||+|||+ + ||+||||||+|||++.++        
T Consensus       116 ~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          116 NGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            45578899999998776655532  23569999999999999999999998 8 999999999999998664        


Q ss_pred             ----------------------------------------CcEEEeecCCccccccCCCcccccccccccchhhhcCCCC
Q 014595          222 ----------------------------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE  261 (422)
Q Consensus       222 ----------------------------------------~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  261 (422)
                                                              ..+||+|||++......  .....||+.|+|||++.+.. 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-  269 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-  269 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-
Confidence                                                    15999999999765432  34567899999999997654 


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhhcCcCCccC-------cCCCCCCCC
Q 014595          262 YTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKPHP  328 (422)
Q Consensus       262 ~~~~~DiwslG~il~elltG~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~  328 (422)
                      ++.++|||||||++|+|+||+.||.+.+      ..+.+..+.+.++.++...+.........+       .+....+..
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            8999999999999999999999998755      567788888888988877654322111111       000000000


Q ss_pred             cccc------cccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          329 WHKV------FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       329 ~~~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      ....      ++...++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            0000      11233567899999999999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.9e-48  Score=393.60  Aligned_cols=255  Identities=29%  Similarity=0.439  Sum_probs=213.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----------------hhHHHHHHHHHHcCCCCccccccee
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------------RYKNRELQIMQMLDHPNIVALKHCF  144 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----------------~~~~~E~~~l~~l~h~nIv~l~~~~  144 (422)
                      .+|.+.+.||+|+||+||+|+++.+++.||||++....                 ....+|+.+++.++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45999999999999999999999999999999986422                 2345799999999999999999998


Q ss_pred             ecCCCCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC-
Q 014595          145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-  222 (422)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~-  222 (422)
                      .     ...++++|||||++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++. 
T Consensus       116 ~-----~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          116 E-----DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             E-----CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTCC
T ss_pred             E-----cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCCC
Confidence            3     34458899999975 66555543    3679999999999999999999999 89999999999999987653 


Q ss_pred             -cEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014595          223 -QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  301 (422)
Q Consensus       223 -~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~  301 (422)
                       .+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus       186 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  263 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK  263 (504)
T ss_dssp             SSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             ccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence             599999999987766655667789999999999853  48999999999999999999999999988887777776532


Q ss_pred             CCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      ...+..                         ....+++++++||++||+.||.+|||+.|+|+||||++...
T Consensus       264 ~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          264 YYFDFN-------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CCCCHH-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCCCcc-------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            111111                         11467999999999999999999999999999999998643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.4e-49  Score=367.26  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=197.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh------hHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|++.+.||+|+||+||+|++..+|+.||||++.....      ...++...++.++||||+++++++...     ...
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~~   81 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GDV   81 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SSE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CCE
Confidence            469999999999999999999999999999999864321      122344557778999999999988532     237


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+++++.+.+.........+++..++.++.||+.||.|||+ + ||+||||||+|||++.++ .+||+|||++..
T Consensus        82 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  159 (290)
T 3fme_A           82 WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALG-QVKMCDFGISGY  159 (290)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTC-CEEBCCC-----
T ss_pred             EEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeecCCccc
Confidence            8999999998888777666667789999999999999999999998 7 999999999999999877 699999999987


Q ss_pred             cccCCCcccccccccccchhhh---cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHh
Q 014595          235 LVKGEPNVSYICSRYYRAPELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwslG~il~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ...........+|+.|+|||++   .....++.++|||||||++|+|++|+.||... .....+....... .       
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-------  231 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-S-------  231 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-C-------
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-C-------
Confidence            6555555556789999999997   24455889999999999999999999999864 3333343333310 0       


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                 +.        .....+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       232 -----------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          232 -----------PQ--------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             -----------CC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             -----------CC--------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence                       00        01135789999999999999999999999999999998743

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9e-49  Score=394.25  Aligned_cols=255  Identities=28%  Similarity=0.455  Sum_probs=211.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc------chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..+|.+.+.||+|+||+||+|++..+++.||||++..      ......+|+++++.++||||+++++++.     ....
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~   95 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence            3479999999999999999999999999999999853      2334568999999999999999999883     3345


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEEEeecCC
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS  231 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vkl~DfG~  231 (422)
                      +++|||||.+ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+  ..+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            7899999975 66555543    3679999999999999999999999 8999999999999996432  2699999999


Q ss_pred             ccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ++...........+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.......       
T Consensus       171 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-------  241 (486)
T 3mwu_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF-------  241 (486)
T ss_dssp             TTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-------
T ss_pred             CeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence            987765555566789999999999965  48999999999999999999999999988887777765521110       


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                              ..+          ....+++++++||++||+.||.+|||+.++|+||||+...
T Consensus       242 --------~~~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          242 --------DLP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             --------CSG----------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             --------CCc----------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                    011          1135799999999999999999999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1e-48  Score=395.34  Aligned_cols=256  Identities=23%  Similarity=0.384  Sum_probs=210.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.+.++||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+++.++||||+++++++.     ...
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TKT  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eCC
Confidence            356999999999999999999999999999999986432       23457999999999999999999883     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+|+||||+++ +|...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g-~vkL~DFGla  336 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDG-NVRISDLGLA  336 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCC-CEEEeeccee
Confidence            58899999984 7766665543334579999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCCCc-ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHH
Q 014595          233 KVLVKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       233 ~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~----~~~~~~i~~~~~~~~~~  307 (422)
                      +........ ...+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+.    .+....+...       
T Consensus       337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-------  408 (543)
T 3c4z_A          337 VELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-------  408 (543)
T ss_dssp             EECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-------
T ss_pred             eeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-------
Confidence            876544433 345899999999999764 589999999999999999999999987532    2333333321       


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccCC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  373 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  373 (422)
                                ...            ++..+++++++||++||+.||.+||+     ++++++||||+++.+
T Consensus       409 ----------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          409 ----------AVT------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             ----------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             ----------ccC------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                      111            22467999999999999999999995     589999999998753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.3e-49  Score=401.17  Aligned_cols=255  Identities=26%  Similarity=0.447  Sum_probs=210.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.+.+.||+|+||.||+|+++.+|+.||||++.+.       .....+|+.+++.++|||||++++++.     ...
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eCC
Confidence            34699999999999999999999999999999998543       223457999999999999999999883     334


Q ss_pred             EEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+|+||||++ ++|...+....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g-~vKL~DFGla  333 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHG-HIRISDLGLA  333 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCC-CeEEEecccc
Confidence            5889999997 47766554321  2459999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHH
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~~~~  309 (422)
                      +...........+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+.   ...+...+...        
T Consensus       334 ~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--------  404 (576)
T 2acx_A          334 VHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--------  404 (576)
T ss_dssp             EECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--------
T ss_pred             eecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--------
Confidence            877665555667899999999999654 489999999999999999999999987642   22222222210        


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                              ...            ++..+++++++||++||+.||.+||     ++.|+++||||+++.+
T Consensus       405 --------~~~------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          405 --------PEE------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             --------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             --------ccc------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence                    001            2246799999999999999999999     8999999999998753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=370.69  Aligned_cols=247  Identities=27%  Similarity=0.378  Sum_probs=196.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh------hHHHHHHHHHHc-CCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.++||+|+||+||+|++..+|+.||||++.....      ...+|+..+..+ +||||+++++++.     ....
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            469999999999999999999999999999998754221      122344444444 9999999999883     3445


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +++||||+++++...+...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus       132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRG-RCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence            8899999998887766543   4579999999999999999999999 8999999999999999887 699999999987


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...........||+.|+|||++.+  .++.++|||||||++|||++|..||.+.....   .+...  ..          
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~--~~----------  269 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQG--YL----------  269 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTT--CC----------
T ss_pred             cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhcc--CC----------
Confidence            655555556678999999999865  58999999999999999999987775533221   11110  00          


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                                     ...++..+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       270 ---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          270 ---------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ---------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ---------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                           01122467999999999999999999999999999999976

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=376.39  Aligned_cols=253  Identities=29%  Similarity=0.434  Sum_probs=192.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++...  .....+|+.+++.++||||+++++++..     ...+++||
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~  127 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTEISLVL  127 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEEC-----SSEEEEEE
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCeEEEEE
Confidence            3599999999999999999999999999999998653  2345689999999999999999998843     33478999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC---CCCcEEEeecCCcccc
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  235 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~---~~~~vkl~DfG~a~~~  235 (422)
                      ||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.   ++ .+||+|||+++..
T Consensus       128 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTC-CEEECCCC-----
T ss_pred             EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCC-CEEEccCcccccc
Confidence            99974 66555432    4568999999999999999999999 89999999999999975   45 7999999999876


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...... +..+....             
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~-------------  267 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE-------------  267 (349)
T ss_dssp             -----------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC-------------
T ss_pred             CcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC-------------
Confidence            554444566789999999999654 489999999999999999999999987765543 33332210             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                          +.++    .+    ....++.++++||++||+.||++|||+.|+|+||||+..
T Consensus       268 ----~~~~----~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          268 ----YYFI----SP----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             ----CCCC----TT----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             ----CccC----Cc----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                0000    01    124578999999999999999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.4e-49  Score=395.74  Aligned_cols=255  Identities=31%  Similarity=0.494  Sum_probs=214.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||++...       .....+|+.+++.++||||+++++++.     ...
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKG   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence            34699999999999999999999999999999998532       334568999999999999999999883     344


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEc---CCCCcEEEeec
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCDF  229 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~---~~~~~vkl~Df  229 (422)
                      ++++||||+.+ ++.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++   .++ .+||+||
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~-~~kl~Df  173 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDA-NIRIIDF  173 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCT
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCC-cEEEEee
Confidence            58899999974 66554433    4679999999999999999999999 8999999999999995   344 6999999


Q ss_pred             CCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       230 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      |+++...........+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.......     
T Consensus       174 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----  246 (484)
T 3nyv_A          174 GLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF-----  246 (484)
T ss_dssp             THHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----
T ss_pred             eeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence            99987766655566789999999999965  48999999999999999999999999988887777766521110     


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                ..+          ....+++++++||++||+.||.+|||+.|+|+||||+....
T Consensus       247 ----------~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          247 ----------ELP----------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             ----------CSG----------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             ----------CCc----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence                      011          11357999999999999999999999999999999998654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.9e-48  Score=374.21  Aligned_cols=253  Identities=26%  Similarity=0.417  Sum_probs=211.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------------hhHHHHHHHHHHc-CCCCcccccceeecCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  148 (422)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++....            ....+|+.+++.+ +||||+++++++.   
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  170 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE---  170 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence            46999999999999999999999899999999885432            2345799999999 8999999999883   


Q ss_pred             CCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEe
Q 014595          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~  227 (422)
                        .....++||||+++ ++.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+
T Consensus       171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEEC
T ss_pred             --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEE
Confidence              33458899999985 77666553    3579999999999999999999999 8999999999999999887 69999


Q ss_pred             ecCCccccccCCCcccccccccccchhhhcC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 014595          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  302 (422)
Q Consensus       228 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~  302 (422)
                      |||++.............||+.|+|||++.+     ...++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999987766555566789999999999853     23478999999999999999999999998877766666655321


Q ss_pred             CCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      ......                         ...++..+.+||.+||+.||++|||+.++|+||||+.
T Consensus       323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            111111                         1357899999999999999999999999999999973

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-48  Score=406.88  Aligned_cols=252  Identities=25%  Similarity=0.417  Sum_probs=213.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc-CCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|.+.+.||+|+||+||+|+++.+++.||||++.+..       .....|..++..+ +||||+.+++++     ...
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~~  414 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM  414 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BCS
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----EeC
Confidence            346999999999999999999999999999999986432       2345788888887 799999999988     334


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ..+|+||||+++ +|...+..    ...+++..++.|+.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g-~ikL~DFGl  488 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFGM  488 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSS-CEEECCCTT
T ss_pred             CEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCC-cEEEeecce
Confidence            458899999974 66665553    3679999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccc-cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          232 AKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       232 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      |+... ........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..|...          
T Consensus       489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------  557 (674)
T 3pfq_A          489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------  557 (674)
T ss_dssp             CEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS----------
T ss_pred             eeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC----------
Confidence            98643 33344567899999999999654 5899999999999999999999999998888777777541          


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCH-----HHHhcCCcccccCC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  373 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~  373 (422)
                             ...            ++..+++++++||++||+.||.+|+++     +|+++||||+.+.+
T Consensus       558 -------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w  606 (674)
T 3pfq_A          558 -------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  606 (674)
T ss_dssp             -------CCC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred             -------CCC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence                   111            224689999999999999999999997     99999999998753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.2e-48  Score=377.62  Aligned_cols=280  Identities=32%  Similarity=0.578  Sum_probs=216.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh---hHHHHHHHHHHcC-CCC-----cccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLD-HPN-----IVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~E~~~l~~l~-h~n-----Iv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++.....   ...+|+.+++.++ |++     |+++++++..     .
T Consensus        54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-----~  128 (382)
T 2vx3_A           54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-----R  128 (382)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-----T
T ss_pred             eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-----C
Confidence            469999999999999999999999999999999975432   3346888888885 554     8888887743     3


Q ss_pred             eEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCCeEEcC--CCCcEEEeec
Q 014595          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CIGICHRDIKPQNLLVNP--HTHQLKLCDF  229 (422)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~givHrDlkp~Nill~~--~~~~vkl~Df  229 (422)
                      ..+++||||++++|.+++....  ...+++..++.++.||+.||.|||. ..||+||||||+|||++.  ++ .+||+||
T Consensus       129 ~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~DF  205 (382)
T 2vx3_A          129 NHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVDF  205 (382)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECCC
T ss_pred             CceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEec
Confidence            3588999999998888776532  2568999999999999999999993 169999999999999953  44 6999999


Q ss_pred             CCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       230 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      |+++...  .......+|+.|+|||++.+. .++.++|||||||++|+|+||++||.+.+..+.+..+....+.++...+
T Consensus       206 G~a~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  282 (382)
T 2vx3_A          206 GSSCQLG--QRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL  282 (382)
T ss_dssp             TTCEETT--CCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cCceecc--cccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9998663  234467889999999999765 4899999999999999999999999999999999999999998887765


Q ss_pred             hhcCcC---C-----ccCcCC-------CCCC---CCccccccc-----------------CCChHHHHHHHhhhhcCCC
Q 014595          310 KCMNPN---Y-----TEFKFP-------QIKP---HPWHKVFQK-----------------RLPPEAVDLVCRFFQYSPN  354 (422)
Q Consensus       310 ~~~~~~---~-----~~~~~~-------~~~~---~~~~~~~~~-----------------~~s~~~~~li~~~L~~dP~  354 (422)
                      ......   +     ..+...       ...+   ..+...+..                 ..++++++||++||++||+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  362 (382)
T 2vx3_A          283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK  362 (382)
T ss_dssp             TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred             HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence            432110   0     000000       0000   000000000                 0014789999999999999


Q ss_pred             CcCCHHHHhcCCcccccC
Q 014595          355 LRCTALEACVHPFFDELR  372 (422)
Q Consensus       355 ~R~t~~e~l~hp~f~~~~  372 (422)
                      +|||+.|+|+||||++..
T Consensus       363 ~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          363 TRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TSCCHHHHTTSGGGCC--
T ss_pred             hCCCHHHHhcCcccccCC
Confidence            999999999999998754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.7e-48  Score=372.35  Aligned_cols=250  Identities=26%  Similarity=0.404  Sum_probs=209.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..|.+.+.||+|+||+||+|++..+|+.||||++....       ..+.+|+++++.++||||+++++++...     ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence            35999999999999999999999999999999985421       2345899999999999999999988432     34


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      .++||||+.+++.+.+...   ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus       129 ~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence            7899999998877666432   3679999999999999999999999 8999999999999999887 799999999976


Q ss_pred             cccCCCcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ...   .....||+.|+|||++.+  ...++.++|||||||++|||++|+.||.+.+....+..+.....          
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~----------  270 (348)
T 1u5q_A          204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------  270 (348)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC----------
T ss_pred             cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------
Confidence            532   235678999999999853  34589999999999999999999999998887776666554210          


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                               +.        .....+++.+.+||.+||+.||++|||+.++++||||...
T Consensus       271 ---------~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          271 ---------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             ---------CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ---------CC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                     00        0113578999999999999999999999999999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-48  Score=376.16  Aligned_cols=263  Identities=30%  Similarity=0.458  Sum_probs=208.5

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---------hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ..+|.+.+.||+|+||+||+|++..+++.||||++....         ....+|+.+++.++||||+++++++.     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-----D   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----c
Confidence            346999999999999999999999999999999985432         34567999999999999999999983     3


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhh------------------------------------cCCCCHHHHHHHHHHHHH
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRI------------------------------------HQRMPLIYVKLYTYQICR  194 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~qi~~  194 (422)
                      ....++||||++ ++|.+.+..+...                                    ...+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            345889999996 4666554311100                                    112467788899999999


Q ss_pred             HHHHHHhcCCceecCCCCCCeEEcCCCC-cEEEeecCCccccccCC-----CcccccccccccchhhhcCC-CCCCCcch
Q 014595          195 ALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGE-----PNVSYICSRYYRAPELIFGA-TEYTTAID  267 (422)
Q Consensus       195 aL~~LH~~~givHrDlkp~Nill~~~~~-~vkl~DfG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~D  267 (422)
                      ||+|||+ .||+||||||+|||++.++. .+||+|||++.......     ......||+.|+|||++.+. ..++.++|
T Consensus       180 ~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999999 89999999999999986542 69999999997653322     12356789999999998642 55899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHh
Q 014595          268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR  347 (422)
Q Consensus       268 iwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  347 (422)
                      ||||||++|+|++|+.||.+.+..+.+..+.......                 +.        .....+++++.+||.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------~~--------~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF-----------------EN--------PNYNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT-----------------TS--------GGGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc-----------------CC--------cccccCCHHHHHHHHH
Confidence            9999999999999999999988887777766521110                 00        0113478999999999


Q ss_pred             hhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          348 FFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       348 ~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      ||+.||.+|||+.++|+||||+++.+.
T Consensus       314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999999999999999987643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.1e-48  Score=392.36  Aligned_cols=254  Identities=27%  Similarity=0.434  Sum_probs=210.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||+|+||+||+|+++.+++.||||++...      .....+|+.+++.++||||+++++++.     ....+
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~  111 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRNY  111 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEE
Confidence            4699999999999999999999999999999998643      234568999999999999999999983     33457


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEEEeecCCc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSA  232 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vkl~DfG~a  232 (422)
                      ++|||||.+ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+  ..+||+|||++
T Consensus       112 ~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            899999975 66554443    3679999999999999999999999 8999999999999997643  25999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ............+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+......         
T Consensus       187 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------  255 (494)
T 3lij_A          187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT---------  255 (494)
T ss_dssp             EECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred             eECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            87766655567789999999999853  4899999999999999999999999998887777776653111         


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                              ++.        .....+++++++||++||+.||.+|||+.|+|+||||++..
T Consensus       256 --------~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          256 --------FDS--------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             --------CCS--------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             --------CCc--------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence                    110        01146799999999999999999999999999999998753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.7e-48  Score=361.44  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=210.2

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.+.+.||+|+||+||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++.     ...
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence            35699999999999999999999999999999998543       233457999999999999999999883     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ..++||||+++ ++.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~  162 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGLA  162 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCC-CEEEEeccCc
Confidence            57899999984 66555443    3678999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ...... .......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+....+....+...           
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------  230 (294)
T 2rku_A          163 TKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----------  230 (294)
T ss_dssp             EECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred             eecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-----------
Confidence            765432 233456789999999999654 4899999999999999999999999887766655444321           


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                            .+.            ++..+++.+.+||.+||+.||++|||+.|+++||||.+...+.
T Consensus       231 ------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          231 ------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             ------cCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence                  111            1235789999999999999999999999999999998755443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.2e-48  Score=360.53  Aligned_cols=258  Identities=25%  Similarity=0.378  Sum_probs=209.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----------hhhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||+|++...          ...+.+|+.+++.++||||+++++++..     
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-----   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence            4599999999999999999999999999999988643          2345689999999999999999998843     


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC---cEEEe
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLC  227 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~---~vkl~  227 (422)
                      ....++||||++ ++|.+++..    ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++.   .+||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEE
Confidence            334789999996 577666643    3578999999999999999999999 89999999999999987652   59999


Q ss_pred             ecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       228 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      |||++.............+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+.......+. 
T Consensus       155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  232 (283)
T 3bhy_A          155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE-  232 (283)
T ss_dssp             CCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred             ecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence            9999987655554556678999999999865 45899999999999999999999999988877666655432111111 


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  375 (422)
                                              .....+++.+.+||.+||+.||++|||+.++++||||+.++...
T Consensus       233 ------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          233 ------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             ------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             ------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence                                    11245789999999999999999999999999999999876443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6e-48  Score=360.08  Aligned_cols=251  Identities=29%  Similarity=0.473  Sum_probs=207.0

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.+.+.||+|+||+||+|++..+++.||||++...       .....+|+.+++.++||||+++++++.     ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCC
Confidence            34699999999999999999999999999999998542       233567999999999999999999883     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ..++||||+++ ++...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~  156 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGWS  156 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTS-CEEECSCCEE
T ss_pred             EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCC-CEEEEecccc
Confidence            47899999984 66665543    3568999999999999999999999 8999999999999999887 6999999998


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....           
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  223 (279)
T 3fdn_A          157 VHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----------  223 (279)
T ss_dssp             SCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-----------
T ss_pred             ccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-----------
Confidence            654332 33456789999999999654 58999999999999999999999999887776666654421           


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                            ..            ++..+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       224 ------~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          224 ------FT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             ------CC------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             ------CC------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence                  11            12357899999999999999999999999999999998653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.2e-48  Score=369.64  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=198.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCC------
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD------  149 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------  149 (422)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||++...     .....+|+.+++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            34699999999999999999999999999999998632     2345689999999999999999998754332      


Q ss_pred             ----------------------------------------------CCceEEEEEeecchh-HHHHHHHHhhhhcCCCCH
Q 014595          150 ----------------------------------------------KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPL  182 (422)
Q Consensus       150 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~  182 (422)
                                                                    ....++++|||||++ +|.+++..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                          123357899999985 77776654322 234566


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC-------------Cccccccccc
Q 014595          183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------------PNVSYICSRY  249 (422)
Q Consensus       183 ~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~-------------~~~~~~~t~~  249 (422)
                      ..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++......             ......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            6788999999999999999 8999999999999999887 79999999998765432             2234578999


Q ss_pred             ccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCc
Q 014595          250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW  329 (422)
Q Consensus       250 y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (422)
                      |+|||++.+. .++.++|||||||++|+|++|..|+..     ....+.......                ++.      
T Consensus       242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~----------------~~~------  293 (332)
T 3qd2_B          242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLK----------------FPL------  293 (332)
T ss_dssp             GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTC----------------CCH------
T ss_pred             ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccC----------------CCc------
Confidence            9999999764 589999999999999999998766521     111111111000                000      


Q ss_pred             ccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          330 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       330 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                         .....++++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence               012346788999999999999999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-47  Score=367.69  Aligned_cols=253  Identities=26%  Similarity=0.427  Sum_probs=211.1

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++.     ...
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence            34699999999999999999999999999999998643       233457999999999999999999883     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++||||+.+ ++.+++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~  188 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGLA  188 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             eEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCC-CEEEeeccCc
Confidence            57899999984 66655443    3678999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+...           
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----------  256 (335)
T 2owb_A          189 TKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----------  256 (335)
T ss_dssp             EECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-----------
T ss_pred             eecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-----------
Confidence            866432 233456789999999999654 4899999999999999999999999887766665554431           


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                            .+.            ++..+++++.+||.+||+.||++|||+.|+++||||.....+
T Consensus       257 ------~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          257 ------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             ------CCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence                  111            123578999999999999999999999999999999886544

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.2e-48  Score=370.17  Aligned_cols=253  Identities=25%  Similarity=0.433  Sum_probs=184.9

Q ss_pred             eeEEe---eeeeecCCeeEEEEEEcCCCeEEEEEEeccch-hhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAE---HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~---~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|.+.   +.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.+. ||||+++++++.     +....++
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~l   83 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFL   83 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEE
Confidence            46665   78999999999999999999999999987543 44568999999997 999999999983     3345789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC--cEEEeecCCccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKV  234 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~--~vkl~DfG~a~~  234 (422)
                      ||||+++ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  .+||+|||+++.
T Consensus        84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           84 VMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             EECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            9999975 77666543    4679999999999999999999999 89999999999999986542  699999999976


Q ss_pred             cccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhCCCCH
Q 014595          235 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-------DQLVEIIKVLGTPTR  306 (422)
Q Consensus       235 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-------~~~~~i~~~~~~~~~  306 (422)
                      ..... .....++|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..       +.+..+...      
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~------  231 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG------  231 (325)
T ss_dssp             CCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT------
T ss_pred             cCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC------
Confidence            54332 23456789999999998654 5899999999999999999999999875432       222222110      


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                 .+.+        .......+++++++||.+||+.||.+|||+.|+++||||++.
T Consensus       232 -----------~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          232 -----------DFSF--------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             -----------CCCC--------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             -----------CCCC--------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence                       0111        011123579999999999999999999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.6e-48  Score=383.48  Aligned_cols=256  Identities=30%  Similarity=0.446  Sum_probs=196.9

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------------hhHHHHHHHHHHcCCCCcccccceeecCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  148 (422)
                      ..+|.+.+.||+|+||+||+|.+..+++.||||++....            ....+|+.+++.++||||+++++++.   
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            347999999999999999999999999999999986432            13568999999999999999999862   


Q ss_pred             CCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEE
Q 014595          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLK  225 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vk  225 (422)
                        ... .++||||+++ +|.+.    ......+++..++.++.||+.||+|||+ +||+||||||+|||++.++  ..+|
T Consensus       211 --~~~-~~lv~e~~~~g~L~~~----l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 --AED-YYIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             --SSE-EEEEEECCTTCBGGGG----TSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             --cCc-eEEEEEcCCCCcHHHH----HhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence              112 5799999975 44332    2335679999999999999999999999 8999999999999997543  2599


Q ss_pred             EeecCCccccccCCCcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014595          226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  303 (422)
Q Consensus       226 l~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~  303 (422)
                      |+|||+++...........+||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+......+...+.....
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            999999987765555556789999999999853  345788999999999999999999999875543333332221100


Q ss_pred             CCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      .                        +.......+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       363 ~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          363 N------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             C------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             C------------------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            0                        0001124579999999999999999999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.1e-48  Score=380.49  Aligned_cols=259  Identities=27%  Similarity=0.379  Sum_probs=198.1

Q ss_pred             eeeEEe-eeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHH-HcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           82 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        82 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .+|.+. ++||+|+||+||+|++..+|+.||||++... ....+|+.++. ..+||||++++++|.... .+..++++||
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv~  138 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVM  138 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEEE
Confidence            347766 7999999999999999999999999998643 44568888874 558999999999874322 2355688999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC---CCCcEEEeecCCcccc
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  235 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~---~~~~vkl~DfG~a~~~  235 (422)
                      |||++ +|.+.+....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.   ++ .+||+|||+++..
T Consensus       139 E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~~~  214 (400)
T 1nxk_A          139 ECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKET  214 (400)
T ss_dssp             ECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTC-CEEECCCTTCEEC
T ss_pred             EeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCc-cEEEEeccccccc
Confidence            99974 7777665421  2469999999999999999999999 89999999999999997   44 6999999999876


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHhh
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~  311 (422)
                      .........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...    ....+..            
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~------------  281 (400)
T 1nxk_A          215 TSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM------------  281 (400)
T ss_dssp             C-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH------------
T ss_pred             CCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc------------
Confidence            55555566788999999999854 458999999999999999999999998754321    1222221            


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                           ..+.++.   .     ....+++++++||++||+.||++|||+.|+|+||||.+..
T Consensus       282 -----~~~~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          282 -----GQYEFPN---P-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             -----TCCCCCT---T-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             -----CcccCCC---c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence                 1111111   0     1135799999999999999999999999999999998643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.9e-47  Score=364.22  Aligned_cols=251  Identities=27%  Similarity=0.430  Sum_probs=207.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .|...+.||+|+||+||+|++..+|+.||||++....    ....+|+.+++.++||||+++++++...     ...++|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEE
Confidence            4888889999999999999999899999999985432    3356899999999999999999988432     347899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ ++.+++.     ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus       121 ~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~  193 (321)
T 2c30_A          121 MEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISK  193 (321)
T ss_dssp             ECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-cEEEeeeeeeeeccc
Confidence            999975 6655543     2569999999999999999999999 8999999999999999887 699999999876644


Q ss_pred             CC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....              
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--------------  258 (321)
T 2c30_A          194 DVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP--------------  258 (321)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC--------------
T ss_pred             CccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence            32 2345678999999999965 4589999999999999999999999998877666555543110              


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                           +..       .....+++++.+||.+||+.||++|||+.++++||||....
T Consensus       259 -----~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          259 -----PKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             -----CCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             -----CCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                 000       01134789999999999999999999999999999998743

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=371.74  Aligned_cols=246  Identities=24%  Similarity=0.383  Sum_probs=205.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------------hhHHHHHHHHHHcCCCCcccccceeecCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  148 (422)
                      ..+|.+.+.||+|+||+||+|++..+++.||||++....            ....+|+.+++.++||||+++++++.   
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~---   99 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE---   99 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE---
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            346999999999999999999999999999999986532            23357999999999999999999883   


Q ss_pred             CCCceEEEEEeecchh--HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEE
Q 014595          149 DKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  226 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl  226 (422)
                        ....+++||||+.+  ++...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||
T Consensus       100 --~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL  171 (335)
T 3dls_A          100 --NQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDF-TIKL  171 (335)
T ss_dssp             --CSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEE
T ss_pred             --eCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCC-cEEE
Confidence              34457899999864  55555443    4579999999999999999999999 8999999999999999887 6999


Q ss_pred             eecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       227 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      +|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||......      ..       
T Consensus       172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-------  238 (335)
T 3dls_A          172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-------  238 (335)
T ss_dssp             CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------
T ss_pred             eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------
Confidence            99999987766666667789999999999977665588999999999999999999999653210      00       


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                ....            .+..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       239 ----------~~~~------------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          239 ----------AAIH------------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             ----------TCCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             ----------hccC------------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence                      0000            1134789999999999999999999999999999998743

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.5e-48  Score=368.43  Aligned_cols=258  Identities=23%  Similarity=0.326  Sum_probs=206.7

Q ss_pred             eeeEEe-eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCce
Q 014595           82 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+. +.||+|+||+||+|++..+|+.||||++...      .....+|+.+++.+ .||||+++++++.     ...
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~-----~~~  102 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE-----NTS  102 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE-----eCC
Confidence            358887 8999999999999999999999999988642      23456899999999 5699999999883     334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC---CCCcEEEeec
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDF  229 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~---~~~~vkl~Df  229 (422)
                      .+++||||+.+ +|..++..  .....+++..++.++.||+.||+|||+ +||+||||||+|||++.   ++ .+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~-~~kL~Df  178 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLG-DIKIVDF  178 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBC-CEEECCG
T ss_pred             eEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCC-cEEEeeC
Confidence            47899999985 55443321  223678999999999999999999999 89999999999999987   45 6999999


Q ss_pred             CCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       230 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      |++.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.........   
T Consensus       179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---  254 (327)
T 3lm5_A          179 GMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE---  254 (327)
T ss_dssp             GGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---
T ss_pred             ccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc---
Confidence            999877655555567899999999999654 5899999999999999999999999998887777766553211110   


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                                            .....+++.+.+||.+||+.||.+|||++++|+||||+++...
T Consensus       255 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          255 ----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             ----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             ----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence                                  0113578999999999999999999999999999999987644

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.5e-48  Score=375.36  Aligned_cols=266  Identities=16%  Similarity=0.144  Sum_probs=189.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHc--CCCCcccccceee------
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML--DHPNIVALKHCFF------  145 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l--~h~nIv~l~~~~~------  145 (422)
                      ...|.+.+.||+|+||+||+|++..+|+.||||++....       ....+|+.+++.|  +||||++++..+.      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345999999999999999999999999999999987632       2234675555555  6999888653332      


Q ss_pred             -cCCC--------C----CceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHH------HHHHHHHHHHHHHHHhcCCce
Q 014595          146 -STTD--------K----EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV------KLYTYQICRALAYIHNCIGIC  206 (422)
Q Consensus       146 -~~~~--------~----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~------~~~~~qi~~aL~~LH~~~giv  206 (422)
                       ....        .    ....+++||||++++|.+++.....   .+++...      ..++.||+.||+|||+ +||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence             1111        0    1145789999999999888876432   3344444      5667999999999999 8999


Q ss_pred             ecCCCCCCeEEcCCCCcEEEeecCCccccccCCCcccccccccccchhhhcC-CCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014595          207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLF  285 (422)
Q Consensus       207 HrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltG~~pf  285 (422)
                      ||||||+|||++.++ .+||+|||+|+...  .......+|+.|+|||++.+ ...++.++|||||||++|+|+||+.||
T Consensus       217 HrDikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          217 HGHFTPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             ETTCSGGGEEECTTS-CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCcCCHHHEEECCCC-CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999887 69999999998653  22225567799999999964 145899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+.....                    ...+............+.......+++++.+||.+||+.||++|||+.++|+|
T Consensus       294 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          294 GLVTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TBCCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCcCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            8764210                    00011111111111111111124689999999999999999999999999999


Q ss_pred             CcccccCC
Q 014595          366 PFFDELRD  373 (422)
Q Consensus       366 p~f~~~~~  373 (422)
                      |||+++.+
T Consensus       354 p~f~~~~~  361 (371)
T 3q60_A          354 PEFLQLQN  361 (371)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.1e-47  Score=369.85  Aligned_cols=285  Identities=30%  Similarity=0.479  Sum_probs=219.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcC-----------CCCcccccceeecC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFFST  147 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~~  147 (422)
                      .+|++.+.||+|+||+||+|++..+++.||||++..+.   ....+|+.+++.+.           |+||+++++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            46999999999999999999999999999999987543   33457999998886           89999999988543


Q ss_pred             CCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeEEcCCC-----
Q 014595          148 TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHT-----  221 (422)
Q Consensus       148 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-givHrDlkp~Nill~~~~-----  221 (422)
                      . .+..++++||||+++++.+++....  ...+++..++.++.||+.||+|||+ + ||+||||||+|||++.++     
T Consensus        99 ~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A           99 G-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             E-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             C-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCCcCc
Confidence            2 3445788999999888888776533  3569999999999999999999998 8 999999999999995322     


Q ss_pred             CcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------hHHHHH
Q 014595          222 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLV  295 (422)
Q Consensus       222 ~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~------~~~~~~  295 (422)
                      ..+||+|||++.....  ......+|+.|+|||++.+. .++.++|||||||++|+|+||..||.+.+      ..+.+.
T Consensus       175 ~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  251 (373)
T 1q8y_A          175 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  251 (373)
T ss_dssp             EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             ceEEEcccccccccCC--CCCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence            2699999999976543  23455789999999999765 48999999999999999999999998654      556778


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCccC-------cCCCCCCCCccc------ccccCCChHHHHHHHhhhhcCCCCcCCHHHH
Q 014595          296 EIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWHK------VFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  362 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~  362 (422)
                      .+...++.++...+.........+       ........+...      .++...+.++.+||.+||+.||++|||+.|+
T Consensus       252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  331 (373)
T 1q8y_A          252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  331 (373)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence            888888888876554321100000       011111111110      0123346789999999999999999999999


Q ss_pred             hcCCcccccCC
Q 014595          363 CVHPFFDELRD  373 (422)
Q Consensus       363 l~hp~f~~~~~  373 (422)
                      |+||||++...
T Consensus       332 l~hp~f~~~~~  342 (373)
T 1q8y_A          332 VNHPWLKDTLG  342 (373)
T ss_dssp             HTCGGGTTCTT
T ss_pred             hhChhhhcccC
Confidence            99999998644

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-47  Score=364.39  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=196.6

Q ss_pred             eeeEEe-eeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ..|.+. +.||+|+||+||+|++..+++.||||++...    .....+|+++++++ +||||+++++++..     ...+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~~   86 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDRF   86 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCEE
Confidence            458885 7899999999999999999999999998643    23456899999885 79999999998843     3357


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC--cEEEeecCCc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSA  232 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~--~vkl~DfG~a  232 (422)
                      ++||||++ ++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  .+||+|||++
T Consensus        87 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             EEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            89999997 577666654    3578999999999999999999999 89999999999999987652  3999999998


Q ss_pred             cccccCC--------CcccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh----------
Q 014595          233 KVLVKGE--------PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----------  290 (422)
Q Consensus       233 ~~~~~~~--------~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~----------  290 (422)
                      .......        ......||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+...          
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            7553221        1223468999999999854    13478999999999999999999999987542          


Q ss_pred             -----HHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          291 -----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       291 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                           ......+...                 .+.++.        .....+++++++||++||+.||.+|||+.|+|+|
T Consensus       242 ~~~~~~~~~~~i~~~-----------------~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          242 CPACQNMLFESIQEG-----------------KYEFPD--------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             CHHHHHHHHHHHHHC-----------------CCCCCH--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             chhHHHHHHHHHhcc-----------------CcccCc--------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                 1122222221                 011110        0113578999999999999999999999999999


Q ss_pred             CcccccC
Q 014595          366 PFFDELR  372 (422)
Q Consensus       366 p~f~~~~  372 (422)
                      |||++..
T Consensus       297 p~~~~~~  303 (316)
T 2ac3_A          297 PWVQGCA  303 (316)
T ss_dssp             TTCC---
T ss_pred             hhhcCCC
Confidence            9999854

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.4e-47  Score=359.24  Aligned_cols=256  Identities=27%  Similarity=0.413  Sum_probs=212.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------------hhHHHHHHHHHHcC-CCCcccccceeecC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFST  147 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~  147 (422)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++....             ....+|+++++++. ||||+++++++.  
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--   94 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--   94 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred             hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec--
Confidence            45999999999999999999999999999999985421             23357999999995 999999999883  


Q ss_pred             CCCCceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEE
Q 014595          148 TDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  226 (422)
Q Consensus       148 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl  226 (422)
                         ...+.++||||++ ++|.+++..    ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||
T Consensus        95 ---~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl  165 (298)
T 1phk_A           95 ---TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIKL  165 (298)
T ss_dssp             ---CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEE
T ss_pred             ---cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCC-cEEE
Confidence               3445789999998 477666654    3578999999999999999999999 8999999999999999887 6999


Q ss_pred             eecCCccccccCCCcccccccccccchhhhc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014595          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIF-----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  301 (422)
Q Consensus       227 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~  301 (422)
                      +|||++.............+|+.|+|||++.     ....++.++|||||||++|+|++|..||.+.+.......+....
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  245 (298)
T 1phk_A          166 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  245 (298)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence            9999998776555556677899999999985     23457899999999999999999999999887776666555421


Q ss_pred             CCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                       +.++.   .     ....++.++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus       246 -----------------~~~~~---~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          246 -----------------YQFGS---P-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             -----------------CCCCT---T-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             -----------------cccCc---c-----cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence                             11110   0     01357899999999999999999999999999999998653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.8e-47  Score=364.83  Aligned_cols=281  Identities=26%  Similarity=0.480  Sum_probs=218.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEE-cCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCC------cccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKC-RETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPN------IVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~~  151 (422)
                      .+|++.+.||+|+||+||+|.+ ..+++.||||++....   ....+|+.+++.++|++      |+++++++.     .
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-----~   88 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-----H   88 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-----E
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-----c
Confidence            3599999999999999999998 5678999999986543   34457999999987654      888888873     2


Q ss_pred             ceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC-----------
Q 014595          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-----------  220 (422)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~-----------  220 (422)
                      ..++++||||+++++.+.+....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++..           
T Consensus        89 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           89 HGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCccc
Confidence            33588999999888877766432  2468899999999999999999999 899999999999999863           


Q ss_pred             -------CCcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 014595          221 -------THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ  293 (422)
Q Consensus       221 -------~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~  293 (422)
                             ...+||+|||++....  .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                   1269999999997643  233456789999999999654 489999999999999999999999999998888


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCc----cCcCCCCC---------CCCccc--ccccCCChHHHHHHHhhhhcCCCCcCC
Q 014595          294 LVEIIKVLGTPTREEIKCMNPNYT----EFKFPQIK---------PHPWHK--VFQKRLPPEAVDLVCRFFQYSPNLRCT  358 (422)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~t  358 (422)
                      +..+....+..+...+........    ........         ..++..  ......++++.+||.+||+.||.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            888888888877766554321100    00000000         000000  001223577999999999999999999


Q ss_pred             HHHHhcCCcccccCC
Q 014595          359 ALEACVHPFFDELRD  373 (422)
Q Consensus       359 ~~e~l~hp~f~~~~~  373 (422)
                      +.|+|+||||+.++.
T Consensus       323 ~~ell~hp~f~~~~~  337 (339)
T 1z57_A          323 LREALKHPFFDLLKK  337 (339)
T ss_dssp             HHHHTTSGGGGGGGC
T ss_pred             HHHHhcCHHHHHHhc
Confidence            999999999998753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-47  Score=357.74  Aligned_cols=252  Identities=21%  Similarity=0.276  Sum_probs=203.1

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCc
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ...+|.+.+.||+|+||+||+|++..+++.||||++...      .....+|+.++..+ +||||+++++++..     .
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----D   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----T
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----C
Confidence            345799999999999999999999999999999998642      23345788889888 99999999998843     3


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC----------
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----------  221 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~----------  221 (422)
                      ...++||||+++ +|.+++.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++          
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-------------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccccc
Confidence            357899999975 8888887766556789999999999999999999999 8999999999999998432          


Q ss_pred             --------CcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 014595          222 --------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ  293 (422)
Q Consensus       222 --------~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~  293 (422)
                              ..+||+|||++......   ....+|+.|+|||++.+...++.++|||||||++|+|++|.+++.....   
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             cccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                    26999999999765432   2346899999999997665677899999999999999999988755432   


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      ...+...                   ..+         .++..+++++.+||.+||+.||++|||+.|+++||||++.
T Consensus       237 ~~~~~~~-------------------~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 WHEIRQG-------------------RLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHTT-------------------CCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHHcC-------------------CCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            2222110                   001         1224679999999999999999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=361.43  Aligned_cols=257  Identities=25%  Similarity=0.408  Sum_probs=210.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|++...        .....+|+.+++.++||||+++++++..   .+..
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEKQ   81 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C---
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCCC
Confidence            4599999999999999999999999999999998643        2345689999999999999999998743   2233


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      ..++||||+++++.+++....  ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGG-TLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCC-cEEeecccccc
Confidence            478999999987766665432  3679999999999999999999999 8999999999999999887 69999999997


Q ss_pred             ccccCC---CcccccccccccchhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          234 VLVKGE---PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       234 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ......   ......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+...         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~---------  228 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG---------  228 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC---------
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC---------
Confidence            654221   123456899999999986532 2477999999999999999999999988766665555431         


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                              .+.            ++..+++.+.+||.+||..||.+|||+.|+++||||++...+
T Consensus       229 --------~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          229 --------SYA------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             --------CCC------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             --------CCC------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence                    111            123578999999999999999999999999999999986544

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.8e-47  Score=355.95  Aligned_cols=254  Identities=23%  Similarity=0.326  Sum_probs=206.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ..|.+.+.||+|+||+||+|.+..++..||+|++....      ....+|+.+++.++||||+++++++.... ....++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence            35999999999999999999999999999999886432      33457999999999999999999875433 345668


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--ivHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+ .|  |+||||||+|||++.+...+||+|||++
T Consensus       105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            899999975 77776654    3678999999999999999999998 78  9999999999999833337999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .... ........+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+................         
T Consensus       180 ~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  247 (290)
T 1t4h_A          180 TLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---------  247 (290)
T ss_dssp             GGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---------
T ss_pred             cccc-ccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC---------
Confidence            7543 233345678999999998853  4899999999999999999999999886655544433321100         


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                                       ...++...++++.+||.+||+.||.+|||+.|+++||||++
T Consensus       248 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 -----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -----------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                             01122456889999999999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.5e-49  Score=385.63  Aligned_cols=254  Identities=18%  Similarity=0.247  Sum_probs=193.7

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHH---HHHHcCCCCcccccceee-----
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQ---IMQMLDHPNIVALKHCFF-----  145 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~---~l~~l~h~nIv~l~~~~~-----  145 (422)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||++...       ...+.+|+.   +++.++|||||++++.+.     
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45799999999999999999999999999999998532       234568984   455558999999984432     


Q ss_pred             --cCC---------CCCce---EEEEEeecchhHHHHHHHHhhhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCceec
Q 014595          146 --STT---------DKEEL---YLNLVLEYVPETVNRIARNYSRIHQ---RMPLIYVKLYTYQICRALAYIHNCIGICHR  208 (422)
Q Consensus       146 --~~~---------~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~givHr  208 (422)
                        ...         +.+..   ..++||||++++|.+++........   .+++..+..++.||+.||+|||+ +||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence              111         11111   2679999999999888775432211   23347788899999999999999 899999


Q ss_pred             CCCCCCeEEcCCCCcEEEeecCCccccccCCCcccccccccccchhhhcCC----------CCCCCcchHHHHHHHHHHH
Q 014595          209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAEL  278 (422)
Q Consensus       209 Dlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~el  278 (422)
                      ||||+|||++.++ .+||+|||+++..  +.......| +.|+|||++.+.          ..++.++|||||||++|||
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999887 7999999999753  223345566 999999999754          2589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC
Q 014595          279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  358 (422)
Q Consensus       279 ltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t  358 (422)
                      ++|+.||.+.+.......+.                       .          ....+++++.+||.+||+.||++|||
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~-----------------------~----------~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIF-----------------------R----------SCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHSSCCC------CCSGGGG-----------------------S----------SCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHCCCCCcccccccchhhhh-----------------------h----------hccCCCHHHHHHHHHHcCCCchhCCC
Confidence            99999997654221111000                       0          01467999999999999999999999


Q ss_pred             HHHHhcCCcccccC
Q 014595          359 ALEACVHPFFDELR  372 (422)
Q Consensus       359 ~~e~l~hp~f~~~~  372 (422)
                      +.|+++||||+++.
T Consensus       354 ~~e~l~hp~f~~~~  367 (377)
T 3byv_A          354 PLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHTSHHHHHHH
T ss_pred             HHHHhhChHHHHHH
Confidence            99999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-47  Score=356.71  Aligned_cols=251  Identities=28%  Similarity=0.419  Sum_probs=201.2

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     ..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence            346999999999999999999999999999999985432       244689999999999999999998843     33


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ..++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~  158 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGLS  158 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTS-CEEECCCCGG
T ss_pred             eEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCC-CEEEeecccc
Confidence            47899999974 77666654    3568999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .............+|+.|+|||++.+....+.++||||||+++|+|++|..||.+.+.......+....           
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  227 (276)
T 2h6d_A          159 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-----------  227 (276)
T ss_dssp             GCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred             cccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------
Confidence            876555444556789999999999765545789999999999999999999998877665555543310           


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                            ..            ++..++..+.+||.+||+.||.+|||+.++++||||++.
T Consensus       228 ------~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          228 ------FY------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             ------CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ------cc------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                  01            123578999999999999999999999999999999863

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.3e-47  Score=353.68  Aligned_cols=250  Identities=27%  Similarity=0.469  Sum_probs=209.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++...       .....+|+++++.++||||+++++++..     ..
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----RK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----CC
Confidence            34699999999999999999999999999999998542       2345689999999999999999998842     34


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      ..++||||+++ ++.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~  161 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKG-ELKIADFGWS  161 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             EEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCC-CEEEeccccc
Confidence            57899999974 77666554    3568999999999999999999999 8999999999999999887 6999999998


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ..... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...            
T Consensus       162 ~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------  227 (284)
T 2vgo_A          162 VHAPS-LRRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------  227 (284)
T ss_dssp             EECSS-SCBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred             ccCcc-cccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc------------
Confidence            65533 233456789999999999654 4899999999999999999999999888766655554331            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                           ...            ++..++.++++||.+||+.||.+|||+.++++||||+...
T Consensus       228 -----~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          228 -----DLK------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             -----ccC------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                 111            1245789999999999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-48  Score=369.21  Aligned_cols=276  Identities=21%  Similarity=0.319  Sum_probs=207.2

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++....     ....+|+++++.++||||+++++++...   ...++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence            346999999999999999999999999999999986422     3445899999999999999999987432   23357


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE----cCCCCcEEEeecC
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCDFG  230 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill----~~~~~~vkl~DfG  230 (422)
                      ++||||++ ++|.+++..... ...+++..++.++.||+.||+|||+ .||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCE-EEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCc-eEEEccCC
Confidence            89999997 577777665322 2349999999999999999999999 899999999999998    6555 69999999


Q ss_pred             CccccccCCCcccccccccccchhhhcC-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHH
Q 014595          231 SAKVLVKGEPNVSYICSRYYRAPELIFG-------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIK  299 (422)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltG~~pf~~~~~----~~~~~~i~~  299 (422)
                      +++............+|+.|+|||++..       ...++.++|||||||++|+|++|+.||.....    .+.+.++..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            9987766666666789999999999852       34589999999999999999999999975432    334444433


Q ss_pred             HhCCCCHHHHhhcC-cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCc
Q 014595          300 VLGTPTREEIKCMN-PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (422)
Q Consensus       300 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  367 (422)
                      .  .|. ..+.... .....+.+..  ..+....+...++..+.+||++||+.||++|||++|+|+||-
T Consensus       242 ~--~p~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 G--KPS-GAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             H--CCT-TCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             C--CCc-ccchhhhcccCCccccCc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            2  111 1000000 0000000000  000011122345678999999999999999999999999984

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=356.74  Aligned_cols=251  Identities=28%  Similarity=0.466  Sum_probs=183.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++.     ....
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   85 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSNY   85 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSSE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCCe
Confidence            45999999999999999999999999999999986432       34568999999999999999999883     3345


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .++||||+++ ++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus        86 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~  160 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNM-NIKIADFGLAT  160 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEEeeccee
Confidence            7899999974 77665543   23578999999999999999999999 8999999999999999887 69999999997


Q ss_pred             ccccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          234 VLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       234 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ..... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+..             
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------  226 (278)
T 3cok_A          161 QLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-------------  226 (278)
T ss_dssp             ECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-------------
T ss_pred             eccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-------------
Confidence            65432 223356789999999998654 489999999999999999999999987654332221100             


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                          ..+.            .+..++.++.+||.+||+.||++|||+.++++||||.+..
T Consensus       227 ----~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          227 ----ADYE------------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             ----SCCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             ----cccC------------CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                0011            1235789999999999999999999999999999998743

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5e-47  Score=370.83  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=198.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcC--CCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||+||+|.+.. ++.||||++....      ....+|+.+++.+.  ||||+++++++..     ..
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence            359999999999999999999865 8999999985432      33468999999996  5999999998743     33


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      ++++|||+.+++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++ ++ .+||+|||+++
T Consensus       130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~  202 (390)
T 2zmd_A          130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIAN  202 (390)
T ss_dssp             EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES-SS-CEEECCCSSSC
T ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE-CC-eEEEEecCccc
Confidence            4889999887888777654    3578898999999999999999999 8999999999999996 44 69999999998


Q ss_pred             ccccCCC---cccccccccccchhhhcCC----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 014595          234 VLVKGEP---NVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIK  299 (422)
Q Consensus       234 ~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~  299 (422)
                      .......   ....+||+.|+|||++.+.          ..++.++|||||||++|+|++|+.||.+.... ..+..+..
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  282 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  282 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence            7643322   2356799999999998641          35889999999999999999999999875432 33333221


Q ss_pred             HhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      .              . ..+.            ++...+.++.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus       283 ~--------------~-~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          283 P--------------N-HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             T--------------T-SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             c--------------c-ccCC------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence            0              0 0011            123457899999999999999999999999999999865443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-47  Score=365.32  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=197.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCC--CCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||+||+|.+ .+++.||||++....      ....+|+.+++.+.|  +||+++++++.     ...
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~   82 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ   82 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eCC
Confidence            3599999999999999999998 468999999986432      334579999999987  99999999883     334


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      ++++|||+.+++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++ ++ .+||+|||+++
T Consensus        83 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~-~~kl~DFG~a~  155 (343)
T 3dbq_A           83 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIAN  155 (343)
T ss_dssp             EEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TT-EEEECCCSSSC
T ss_pred             EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CC-cEEEeeccccc
Confidence            5889999888888777654    4678999999999999999999999 8999999999999998 44 69999999998


Q ss_pred             ccccCCC---cccccccccccchhhhcC----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 014595          234 VLVKGEP---NVSYICSRYYRAPELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIK  299 (422)
Q Consensus       234 ~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~  299 (422)
                      .......   .....||+.|+|||++.+          ...++.++|||||||++|+|++|+.||.+.... ..+..+..
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  235 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  235 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence            6643322   235678999999999853          245888999999999999999999999875432 22222221


Q ss_pred             HhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      .   .            ...            .++...+.++.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus       236 ~---~------------~~~------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          236 P---N------------HEI------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             T---T------------SCC------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             C---C------------ccc------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence            0   0            001            1223467899999999999999999999999999999865443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.6e-47  Score=364.67  Aligned_cols=280  Identities=26%  Similarity=0.446  Sum_probs=217.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCC-eEEEEEEeccch---hhHHHHHHHHHHcCCCC------cccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK---RYKNRELQIMQMLDHPN------IVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vAiK~~~~~~---~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~~  151 (422)
                      .+|.+.+.||+|+||+||+|++..++ +.||||++....   ....+|+.+++.++|++      ++.+++++.     .
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-----~   93 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-----F   93 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-----E
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-----e
Confidence            35999999999999999999998777 799999987532   34457999999997766      777777763     2


Q ss_pred             ceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE--------------
Q 014595          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV--------------  217 (422)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill--------------  217 (422)
                      ...+++||||+++++.+.+....  ...+++..++.++.||+.||+|||+ +||+||||||+|||+              
T Consensus        94 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           94 HGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             CCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccccc
Confidence            33578999999987766655422  2468999999999999999999999 899999999999999              


Q ss_pred             -----cCCCCcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 014595          218 -----NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  292 (422)
Q Consensus       218 -----~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~  292 (422)
                           +.++ .+||+|||+++...  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+
T Consensus       171 ~~~~~~~~~-~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          171 CEEKSVKNT-SIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCEEEESCC-CEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccCCC-cEEEeecCcccccc--ccccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                 4445 79999999997643  233456789999999999654 58999999999999999999999999999888


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCccC----cCCCCC---------CCCccc--ccccCCChHHHHHHHhhhhcCCCCcC
Q 014595          293 QLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQIK---------PHPWHK--VFQKRLPPEAVDLVCRFFQYSPNLRC  357 (422)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~  357 (422)
                      .+..+.+..+..+...+.........+    ..+...         ..++..  ......+.++.+||.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            888888888888776654332110000    000000         000000  00112356899999999999999999


Q ss_pred             CHHHHhcCCcccccCC
Q 014595          358 TALEACVHPFFDELRD  373 (422)
Q Consensus       358 t~~e~l~hp~f~~~~~  373 (422)
                      |+.|+|+||||+++..
T Consensus       327 t~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTP  342 (355)
T ss_dssp             CHHHHTTSGGGGGCCH
T ss_pred             CHHHHhcChhhcCCCh
Confidence            9999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.1e-47  Score=362.86  Aligned_cols=255  Identities=31%  Similarity=0.466  Sum_probs=202.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------------hhHHHHHHHHHHcCCCCcccccceeecCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  149 (422)
                      .+|.+.+.||+|+||.||+|++..+++.||||++....            ....+|+++++.++||||+++++++..   
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   86 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA---   86 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence            46999999999999999999999999999999985432            235689999999999999999998732   


Q ss_pred             CCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC--cEEE
Q 014595          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKL  226 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~--~vkl  226 (422)
                       +.  .++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.  .+||
T Consensus        87 -~~--~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           87 -ED--YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             -SS--EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             -Cc--eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEEE
Confidence             11  6799999975 6655443    24679999999999999999999999 89999999999999986542  4999


Q ss_pred             eecCCccccccCCCcccccccccccchhhhc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014595          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       227 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      +|||++.............+|+.|+|||++.  +...++.++|||||||++|+|++|..||.+......+...+......
T Consensus       159 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (322)
T 2ycf_A          159 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN  238 (322)
T ss_dssp             CCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred             ccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence            9999998764433334557899999999974  34558999999999999999999999998755432232222211000


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                              +.......+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus       239 ------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          239 ------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             ------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             ------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence                                    0001124578999999999999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-47  Score=362.78  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=206.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++....       ..+.+|+.+++.++||||+++++++.... ....+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~~   90 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPL   90 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCcc
Confidence            45999999999999999999999999999999986532       23457999999999999999999875433 23345


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .++||||++ ++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTS-CEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCC-CEEEeeccCcc
Confidence            689999996 577776653    3579999999999999999999999 8999999999999999887 69999999997


Q ss_pred             ccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          234 VLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       234 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      .......    .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......++.   
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---  240 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS---  240 (311)
T ss_dssp             -----------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH---
T ss_pred             cccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc---
Confidence            6543321    2345689999999999765 5899999999999999999999999988877766665542211111   


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                            .....+++++.+||.+||+.||.+||++.+++.|+|++....
T Consensus       241 ----------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          241 ----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             ----------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             ----------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                                  112457999999999999999999999999999999987554

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.7e-47  Score=357.11  Aligned_cols=252  Identities=28%  Similarity=0.454  Sum_probs=208.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++....    ....+|+.+++.++||||+++++++.     .....++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   83 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYYL   83 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEEE
Confidence            46999999999999999999999999999999986532    33568999999999999999999883     3345789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE---cCCCCcEEEeecCCcc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAK  233 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill---~~~~~~vkl~DfG~a~  233 (422)
                      ||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||+   +.++ .+||+|||++.
T Consensus        84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~~  157 (304)
T 2jam_A           84 VMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENS-KIMITDFGLSK  157 (304)
T ss_dssp             EECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTTC
T ss_pred             EEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCC-CEEEccCCcce
Confidence            9999974 77665543    3578999999999999999999999 899999999999999   5555 69999999987


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      .... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....            
T Consensus       158 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------------  223 (304)
T 2jam_A          158 MEQN-GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY------------  223 (304)
T ss_dssp             CCCC-BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC------------
T ss_pred             ecCC-CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------
Confidence            5432 23345578999999999865 458999999999999999999999999888776666655421            


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                           +.++        ..+...+++++.+||.+||+.||++|||+.++|+||||++.
T Consensus       224 -----~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          224 -----YEFE--------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             -----CCCC--------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             -----CCCC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                 1111        01124678999999999999999999999999999999874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.9e-47  Score=352.02  Aligned_cols=253  Identities=26%  Similarity=0.358  Sum_probs=203.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|.+.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++||||+++++++..     ....+
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   81 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY   81 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEEE
Confidence            46999999999999999999999999999999985432     345689999999999999999998843     34578


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ +|.+.+    .....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~  155 (276)
T 2yex_A           82 LFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF  155 (276)
T ss_dssp             EEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCC-CEEEeeCCCcccc
Confidence            99999975 554433    234568999999999999999999999 8999999999999999887 6999999999765


Q ss_pred             ccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhh
Q 014595          236 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       236 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  311 (422)
                      ....   ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.... +..+....          
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  225 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------  225 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC----------
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc----------
Confidence            3322   233457899999999997655457899999999999999999999987654322 22211100          


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                             ...     .+     ...+++.+.+||.+||+.||.+|||+.|+++||||++..
T Consensus       226 -------~~~-----~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          226 -------TYL-----NP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             -------TTS-----TT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -------ccc-----Cc-----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence                   000     00     135789999999999999999999999999999998754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6.9e-47  Score=354.45  Aligned_cols=255  Identities=28%  Similarity=0.461  Sum_probs=210.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||+|+||.||+|++..+++.||||++...      .....+|+++++.++||||+++++++..     ....
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   96 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSSF   96 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCeE
Confidence            4699999999999999999999999999999998542      2345689999999999999999998843     3347


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEEEeecCCc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSA  232 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vkl~DfG~a  232 (422)
                      ++||||+.+ ++.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++  ..+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            899999974 66555443    3578999999999999999999999 8999999999999997643  26999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .............+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+......         
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  240 (287)
T 2wei_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA---------  240 (287)
T ss_dssp             GTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred             eeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            87655554555678999999999854  3899999999999999999999999988776666555442100         


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                            +..+          ....+++++.+||++||..||.+|||+.++|+||||++...
T Consensus       241 ------~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          241 ------FDLP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             ------CCSG----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             ------CCch----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                  0000          11357899999999999999999999999999999998653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=356.04  Aligned_cols=259  Identities=24%  Similarity=0.381  Sum_probs=204.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHc-CCCCcccccceeecCCCC-CceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK-EELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~-~~~~~~  156 (422)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...   .....+|+.+++.+ +||||+++++++...... ....++
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            3599999999999999999999999999999998543   34566899999999 899999999988653321 134678


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ +|.+++....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus       104 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL  179 (326)
T ss_dssp             EEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCTTTC--
T ss_pred             EEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCC-CEEEeeCcCceec
Confidence            99999985 8877776532  3578999999999999999999999 8999999999999999887 6999999998765


Q ss_pred             ccCC-CcccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          236 VKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      .... ......+|+.|+|||++.+    ...++.++|||||||++|+|++|..||.+.+....+..+....         
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------  250 (326)
T 2x7f_A          180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---------  250 (326)
T ss_dssp             -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---------
T ss_pred             CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---------
Confidence            4322 2334578999999999852    3458899999999999999999999998877666555443310         


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                .+        ......++..+.+||.+||..||.+|||+.++++||||++.
T Consensus       251 ----------~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          251 ----------AP--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             ----------CC--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ----------cc--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                      00        01124578999999999999999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.5e-46  Score=352.91  Aligned_cols=255  Identities=26%  Similarity=0.415  Sum_probs=204.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|.+.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++||||+++++++...     ...++
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   93 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLWI   93 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEEE
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEEE
Confidence            4599999999999999999999999999999988543    23456799999999999999999988532     34789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ ++..++..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        94 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNL  168 (302)
T ss_dssp             EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCC-CEEEEECCCCcccc
Confidence            9999975 66555443   24679999999999999999999999 8999999999999999887 69999999875432


Q ss_pred             cC-CCcccccccccccchhhhc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          237 KG-EPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      .. .......+|+.|+|||++.    ....++.++|||||||++|+|++|..||...+....+..+......        
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  240 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP--------  240 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--------
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc--------
Confidence            11 1223457899999999984    3445899999999999999999999999988876666555442100        


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                 .       ...+..++.++.+||.+||..||.+|||+.++++||||+.+.
T Consensus       241 -----------~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          241 -----------T-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             -----------C-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             -----------c-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence                       0       001235789999999999999999999999999999998864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4e-47  Score=367.67  Aligned_cols=281  Identities=24%  Similarity=0.417  Sum_probs=206.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ..+|.+.+.||+|+||+||+|++..+++.||+|++...     .....+|+.+++.++||||+++++++..     ...+
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence            34699999999999999999999999999999998643     2344689999999999999999998843     3347


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      ++||||+++ +|.+++..    ...+++..+..++.|++.||.|||+ . ||+||||||+|||++.++ .+||+|||++.
T Consensus       107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  180 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG  180 (360)
T ss_dssp             EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred             EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCC-CEEEEECCCCc
Confidence            899999975 87776654    3578999999999999999999998 5 999999999999999887 69999999997


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHHHHhh-
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKC-  311 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~-  311 (422)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... +......... 
T Consensus       181 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          181 QLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             ccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            65332 23456789999999999654 58999999999999999999999998876554432221111 0000000000 


Q ss_pred             -cCcCCccCcCCCCCC------------CCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          312 -MNPNYTEFKFPQIKP------------HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       312 -~~~~~~~~~~~~~~~------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                       .......+.......            ..........++.++.+||.+||+.||++|||+.|+|+||||+.....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence             000000000000000            000011123478899999999999999999999999999999986543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.2e-46  Score=349.23  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=210.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|++.+.||+|+||.||+|++..+|+.||+|++...      .....+|+.+++.++||||+++++++...   ....+
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~~   82 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL   82 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCceE
Confidence            4699999999999999999999999999999998642      23345799999999999999999977432   23457


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-----ceecCCCCCCeEEcCCCCcEEEeec
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g-----ivHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      ++||||+++ +|.+++.........+++..++.++.||+.||.|||+ .|     |+||||||+|||++.++ .+||+||
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~df  160 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF  160 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSS-CEEECCC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCC-CEEEecC
Confidence            899999975 8888887655555669999999999999999999999 78     99999999999999887 6999999


Q ss_pred             CCccccccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          230 GSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       230 G~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      |++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....       
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-------  232 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-------  232 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------
T ss_pred             chheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-------
Confidence            99976543321 1245689999999999654 48999999999999999999999999887666555554421       


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                  .+         .++..++.++.+||.+||+.||.+|||+.|+++|||+.+-.
T Consensus       233 ------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          233 ------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             ------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             ------------cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                        00         01235789999999999999999999999999999998743

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-47  Score=367.24  Aligned_cols=256  Identities=29%  Similarity=0.453  Sum_probs=202.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc---CCCeEEEEEEeccc--------hhhHHHHHHHHHHc-CCCCcccccceeecCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD--------KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~--------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  149 (422)
                      .+|.+.+.||+|+||+||+|++.   .+|+.||||++...        .....+|+.+++.+ .||||+++++++..   
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---  130 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---  130 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee---
Confidence            46999999999999999999984   58999999988542        13345799999999 69999999998843   


Q ss_pred             CCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                        ...+++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus       131 --~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~D  202 (355)
T 1vzo_A          131 --ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTD  202 (355)
T ss_dssp             --TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEESC
T ss_pred             --CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-cEEEee
Confidence              3347899999975 77666653    3579999999999999999999999 8999999999999999887 699999


Q ss_pred             cCCccccccCC--CcccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          229 FGSAKVLVKGE--PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       229 fG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      ||+++......  .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.+.+    
T Consensus       203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----  278 (355)
T 1vzo_A          203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI----  278 (355)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH----
T ss_pred             CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH----
Confidence            99997653322  22345789999999999653 347899999999999999999999997543222222222110    


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                          ..     ...            .++..++..+.+||.+||+.||.+||     |++|+++||||+++..
T Consensus       279 ----~~-----~~~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          279 ----LK-----SEP------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             ----HH-----CCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             ----hc-----cCC------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence                00     000            01245789999999999999999999     9999999999998753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.9e-46  Score=351.32  Aligned_cols=249  Identities=25%  Similarity=0.386  Sum_probs=207.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ..|.+.+.||+|+||.||+|++..+++.||||++...     .....+|+.+++.++||||+++++++..     ...++
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence            3599999999999999999999999999999998543     2445689999999999999999998843     23478


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+++ ++.+++.     ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        97 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQL  169 (303)
T ss_dssp             EEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCC-CEEEeecccceec
Confidence            99999985 6666553     2578999999999999999999999 8999999999999999887 6999999999765


Q ss_pred             ccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      .... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....             
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  235 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-------------  235 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------
T ss_pred             CccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-------------
Confidence            4432 23455789999999999654 58999999999999999999999998877665554443310             


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                            .+         .+...++..+.+||.+||+.||.+|||+.++++||||...
T Consensus       236 ------~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          236 ------PP---------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ------CC---------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ------CC---------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                  00         1224678999999999999999999999999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.7e-46  Score=351.32  Aligned_cols=254  Identities=30%  Similarity=0.441  Sum_probs=205.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch--hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .+|.+.+.||+|+||.||+|++..+|+.||||.+....  ....+|+.+++.++||||+++++++..     ...+++||
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~  103 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIVM  103 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEEe
Confidence            45999999999999999999999999999999986543  445689999999999999999998843     23478999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||+++ +|.+++..   ....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhh
Confidence            99985 77766653   24679999999999999999999999 8999999999999999887 6999999999765433


Q ss_pred             C-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      . ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....  +            .
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~------------~  243 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--P------------P  243 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C------------C
T ss_pred             ccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--C------------c
Confidence            2 23345789999999999654 58999999999999999999999998877655544333210  0            0


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      .+.            .+..++.++.+||.+||..||.+|||+.++++||||+...
T Consensus       244 ~~~------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          244 TFR------------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             CCS------------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             ccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            000            1234689999999999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.5e-46  Score=350.35  Aligned_cols=256  Identities=27%  Similarity=0.391  Sum_probs=202.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+|++.+.||+|+||.||+|++..+++.||||++...       ...+.+|+.+++.++||||+++++++     ....
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            34699999999999999999999999999999987432       13345899999999999999999987     3334


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  158 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIA  158 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCSSS
T ss_pred             eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEEeCCCc
Confidence            57899999975 77766654    3579999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          233 KVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       233 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      .......  ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+......+..... .+.     
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~-----  231 (294)
T 4eqm_A          159 KALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VPN-----  231 (294)
T ss_dssp             TTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CCC-----
T ss_pred             cccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CCC-----
Confidence            7654332  22345689999999999764 48999999999999999999999999887766554433210 000     


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                        ........+++.+.++|.+||+.||.+||+..+.+.+.|..-+.
T Consensus       232 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 ------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             ------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             ------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                              01112246899999999999999999999777777777765543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.7e-47  Score=356.34  Aligned_cols=266  Identities=25%  Similarity=0.372  Sum_probs=189.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++...     .....+|+.+++.++||||+++++++....     ..+
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   89 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----ELW   89 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----CEE
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----CcE
Confidence            4599999999999999999999889999999987543     233457899999999999999999885433     377


Q ss_pred             EEeecch-hHHHHHHHHhhh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          157 LVLEYVP-ETVNRIARNYSR----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      +||||++ ++|.+++.....    ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||+
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~  167 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDG-SVQIADFGV  167 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCC-CEEEEeccc
Confidence            9999996 477776654322    23558999999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccCC------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          232 AKVLVKGE------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       232 a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      +.......      ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+.......  +.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~  245 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND--PP  245 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--CC
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--CC
Confidence            87654322      12345689999999998654558999999999999999999999998876655443332210  00


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                    ....   ..........+++++.+||.+||+.||.+|||+.++++||||++...
T Consensus       246 --------------~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          246 --------------SLET---GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             --------------CTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             --------------cccc---ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence                          0000   00001122467899999999999999999999999999999998654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2e-46  Score=359.43  Aligned_cols=264  Identities=24%  Similarity=0.362  Sum_probs=183.7

Q ss_pred             eeeeEEee-eeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           81 KVSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        81 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      ..+|.+.+ +||+|+||+||+|++..+|+.||||++........+....++.+.||||+++++++.... ....++++||
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~  105 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLIIM  105 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEEE
Confidence            34699854 699999999999999999999999999776555545555677889999999999874422 3355678999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEEEeecCCccccc
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLV  236 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vkl~DfG~a~~~~  236 (422)
                      ||+++ +|.+.+....  ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++  ..+||+|||++....
T Consensus       106 e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~  182 (336)
T 3fhr_A          106 ECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT  182 (336)
T ss_dssp             ECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred             eccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence            99975 8777766422  2469999999999999999999999 8999999999999998542  259999999997654


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.............+..             
T Consensus       183 ~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  247 (336)
T 3fhr_A          183 QN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-------------  247 (336)
T ss_dssp             -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------
T ss_pred             cc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-------------
Confidence            32 3345678999999999854 45889999999999999999999999776543322111111000             


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      ..+.++.        .....+++++++||.+||+.||.+|||+.|+|+||||++.
T Consensus       248 ~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 GQYGFPN--------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ---CCCT--------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             cccccCc--------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            0001110        0113579999999999999999999999999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-45  Score=346.32  Aligned_cols=257  Identities=25%  Similarity=0.355  Sum_probs=197.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCC--------C
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTD--------K  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--------~  150 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++....   ....+|+.+++.++||||+++++++.....        .
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            46999999999999999999999999999999986543   334579999999999999999998754321        2


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeec
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      ....+++||||+++ +|.+++...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~-~~kl~df  160 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESR-NVKIGDF  160 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCC-CEEEeeC
Confidence            35668899999974 887776642   3457888999999999999999999 8999999999999999887 6999999


Q ss_pred             CCccccccC---------------CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HH
Q 014595          230 GSAKVLVKG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQ  293 (422)
Q Consensus       230 G~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~  293 (422)
                      |++......               .......+|+.|+|||++.+...++.++|||||||++|+|++   ||...... ..
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            998765321               122345689999999999766568999999999999999998   55432222 22


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                      ...+...                 ...++        ..+....++.+.+||++||+.||.+|||+.++++||||+..
T Consensus       238 ~~~~~~~-----------------~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          238 LKKLRSV-----------------SIEFP--------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHST-----------------TCCCC--------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHhcccc-----------------ccccC--------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            2222110                 00111        11234567889999999999999999999999999999763

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=350.71  Aligned_cols=257  Identities=23%  Similarity=0.368  Sum_probs=189.2

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||++....      ....++..+++.++||||+++++++..     ...
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NTD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CCc
Confidence            346999999999999999999999999999999986432      122234556788899999999998843     335


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+++.+..+...   ....+++..++.++.||+.||.|||+ . ||+||||||+|||++.++ .+||+|||++.
T Consensus        99 ~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~  173 (318)
T 2dyl_A           99 VFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERG-QIKLCDFGISG  173 (318)
T ss_dssp             EEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTS-CEEECCCTTC-
T ss_pred             EEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCC-CEEEEECCCch
Confidence            789999997665554432   24679999999999999999999998 5 999999999999999887 69999999997


Q ss_pred             ccccCCCcccccccccccchhhhc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~  308 (422)
                      ............+|+.|+|||++.    ....++.++|||||||++|+|++|+.||.... ..+.+..+....  +    
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~----  247 (318)
T 2dyl_A          174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--P----  247 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--C----
T ss_pred             hccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--C----
Confidence            765555555667899999999985    23458899999999999999999999998743 344444443310  0    


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                ..++          ....+++++.+||.+||+.||.+|||+.++++||||++...
T Consensus       248 ----------~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          248 ----------PLLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             ----------CCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             ----------CCCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence                      0000          01257899999999999999999999999999999987643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.1e-46  Score=354.11  Aligned_cols=261  Identities=25%  Similarity=0.385  Sum_probs=184.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHH-HHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++....     ....+|+. +++.++||||+++++++..     ....
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~~   96 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGDC   96 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCce
Confidence            46999999999999999999999999999999986532     12224444 6677899999999998843     2347


Q ss_pred             EEEeecchhHHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          156 NLVLEYVPETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~-givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      ++||||+++++..++..... ....+++..+..++.|++.||.|||+ . ||+||||||+|||++.++ .+||+|||++.
T Consensus        97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~  174 (327)
T 3aln_A           97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSG-NIKLCDFGISG  174 (327)
T ss_dssp             EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTT-EEEECCCSSSC
T ss_pred             EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCC-CEEEccCCCce
Confidence            89999999987776654322 35779999999999999999999998 7 999999999999999887 79999999998


Q ss_pred             ccccCCCcccccccccccchhhhc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHH
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  309 (422)
                      ............||+.|+|||++.   ....++.++|||||||++|+|++|..||.+.+.. +.+..+.           
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-----------  243 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-----------  243 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-----------
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-----------
Confidence            765554445557899999999983   2345899999999999999999999999765321 1110000           


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                   ......+.......+++++.+||.+||+.||.+|||+.++++||||.....
T Consensus       244 -------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          244 -------------KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             -------------CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             -------------cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence                         000001111112457899999999999999999999999999999987643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.5e-46  Score=356.48  Aligned_cols=273  Identities=20%  Similarity=0.329  Sum_probs=205.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---------------------hhHHHHHHHHHHcCCCCccc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------------RYKNRELQIMQMLDHPNIVA  139 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------------------~~~~~E~~~l~~l~h~nIv~  139 (422)
                      ..+|.+.+.||+|+||.||+|++  +|+.||||++....                     ....+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            34699999999999999999999  89999999985432                     45678999999999999999


Q ss_pred             ccceeecCCCCCceEEEEEeecchh-HHHHHHHHh--hh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNY--SR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       140 l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                      +++++..     ...+++||||+++ +|.+++...  ..  ....+++..++.++.||+.||.|||+..||+||||||+|
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9998843     3357899999986 554431100  11  146799999999999999999999962599999999999


Q ss_pred             eEEcCCCCcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCh-HH
Q 014595          215 LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT-AIDIWSTGCVMAELLLGQPLFPGESG-VD  292 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~elltG~~pf~~~~~-~~  292 (422)
                      ||++.++ .+||+|||++...... ......+|+.|+|||++.+...++. ++|||||||++|+|++|..||.+.+. .+
T Consensus       183 il~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          183 ILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             EEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            9999887 6999999999765433 3345678999999999976544555 99999999999999999999988766 44


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      ....+.......+        .....+..+ .... ........+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       261 ~~~~i~~~~~~~~--------~~~~~~~~~-~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          261 LFNNIRTKNIEYP--------LDRNHFLYP-LTNK-KSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHHTSCCCCCC--------CSSSSSTTT-TCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHhccCcCCc--------cchhhhhcc-cccc-ccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            4444322100000        000000000 0000 00112246899999999999999999999999999999998753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.1e-46  Score=356.93  Aligned_cols=246  Identities=25%  Similarity=0.388  Sum_probs=202.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----------hhHHHHHHHHHHcC--CCCcccccceeecCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFSTTD  149 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~  149 (422)
                      .+|++.+.||+|+||.||+|++..+++.||||++....          ....+|+.+++.+.  |+||+++++++..   
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~---  119 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER---  119 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC---
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec---
Confidence            35999999999999999999999999999999986432          23457999999996  5999999998842   


Q ss_pred             CCceEEEEEeecch--hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEe
Q 014595          150 KEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (422)
Q Consensus       150 ~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~  227 (422)
                        ....++|||++.  +++.+.+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.+...+||+
T Consensus       120 --~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          120 --PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             --SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             --CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence              334779999986  577666554    3678999999999999999999999 8999999999999999443479999


Q ss_pred             ecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       228 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      |||++..... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||...+      .+...       
T Consensus       193 Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~-------  258 (320)
T 3a99_A          193 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-------  258 (320)
T ss_dssp             CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred             eCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc-------
Confidence            9999986643 233456789999999999766656789999999999999999999996532      11110       


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                ..            .++..+++++.+||.+||+.||++|||+.++++||||++...
T Consensus       259 ----------~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          259 ----------QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             ----------CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             ----------cc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence                      00            022467999999999999999999999999999999998654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.3e-45  Score=351.13  Aligned_cols=246  Identities=19%  Similarity=0.204  Sum_probs=198.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|.+.+.||+|+||+||+|++..+|+.||||++...  .....+|+.+++.+ +||||+++++++..     ..+.++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv~   84 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMVL   84 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEEE
Confidence            599999999999999999999999999999988543  34567899999999 99999999998743     34578999


Q ss_pred             ecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCc-----EEEeecCCccc
Q 014595          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKV  234 (422)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~-----vkl~DfG~a~~  234 (422)
                      ||++++|.+++...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .     +||+|||+++.
T Consensus        85 e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           85 ELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEE
T ss_pred             EeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCC-CCCCceEEEEEccccee
Confidence            99988888877653   3679999999999999999999999 8999999999999999776 4     99999999986


Q ss_pred             cccCCC--------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Q 014595          235 LVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGT  303 (422)
Q Consensus       235 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~~~~~~  303 (422)
                      ......        .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.   .+.+..+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            644332        2456789999999999764 489999999999999999999999987533   3333333322111


Q ss_pred             CCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .+.+.                        .....+ ++.+||.+||..||.+||+++++++
T Consensus       239 ~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          239 TPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             SCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11110                        112344 9999999999999999999988876

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=344.61  Aligned_cols=254  Identities=27%  Similarity=0.432  Sum_probs=197.8

Q ss_pred             EeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEeec
Q 014595           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (422)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  161 (422)
                      ...+||+|+||.||+|++..+++.||||.+....    ....+|+.+++.++||||+++++++..     ....++||||
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~  100 (295)
T 2clq_A           26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFMEQ  100 (295)
T ss_dssp             SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEEC
T ss_pred             CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEEEe
Confidence            3448999999999999999999999999886432    345689999999999999999998843     3357899999


Q ss_pred             ch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC-
Q 014595          162 VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-  239 (422)
Q Consensus       162 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~-  239 (422)
                      ++ ++|.+++.... ....+++..++.++.||+.||.|||+ .||+||||||+|||++...+.+||+|||++....... 
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          101 VPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             CSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            96 57777665421 12356788899999999999999999 8999999999999999733379999999997654322 


Q ss_pred             CcccccccccccchhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          240 PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       240 ~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                      ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+................               
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------  243 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV---------------  243 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC---------------
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc---------------
Confidence            22345789999999998543 23789999999999999999999999765443322111111000               


Q ss_pred             CcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                 ...++..+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus       244 -----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          244 -----------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             -----------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence                       0012246789999999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.3e-45  Score=346.84  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=194.1

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..+|.+.+.||+|+||+||+|++  +|+.||||++....      ..+.+|++++++++||||+++++++..     ...
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~  108 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PPN  108 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TTC
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCc
Confidence            34699999999999999999987  48999999986432      234579999999999999999998843     223


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--ivHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      +++||||+++ +|.+++..... ...+++..++.++.||+.||+|||+ .|  |+||||||+|||++.++ .+||+|||+
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~  185 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKY-TVKVCDFGL  185 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTC-CEEECCCC-
T ss_pred             eEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCC-cEEECCCCC
Confidence            7799999975 77776654221 2348999999999999999999999 89  99999999999999887 699999999


Q ss_pred             ccccccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          232 AKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       232 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......       
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------  257 (309)
T 3p86_A          186 SRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-------  257 (309)
T ss_dssp             ----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-------
T ss_pred             CccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------
Confidence            97543332 23456789999999999654 4899999999999999999999999988776655554321100       


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc--CCcccc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  370 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~  370 (422)
                              .            .++..+++++.+||.+||+.||.+|||+.++++  +++++.
T Consensus       258 --------~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 --------L------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             --------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             --------C------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                    0            122468999999999999999999999999987  455544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=358.76  Aligned_cols=255  Identities=19%  Similarity=0.230  Sum_probs=203.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEE-----EcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      ..+|.+.+.||+|+||+||+|+     +..+++.||||++...     .....+|+.+++.++||||+++++++..    
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            3469999999999999999999     4557889999998542     2234579999999999999999998843    


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcE
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQL  224 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~v  224 (422)
                       ....++||||+. ++|.+++.....   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++  ..+
T Consensus       146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCceE
Confidence             233679999996 488877765432   12458999999999999999999999 8999999999999998543  259


Q ss_pred             EEeecCCccccccC---CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014595          225 KLCDFGSAKVLVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  300 (422)
Q Consensus       225 kl~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~  300 (422)
                      ||+|||+++.....   .......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999754322   223345678999999999654 48999999999999999998 99999988876666555432


Q ss_pred             hCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      ...                .            .+..++..+.+||.+||+.||.+|||+.++++|.++..
T Consensus       303 ~~~----------------~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 GRM----------------D------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCC----------------C------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC----------------C------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            100                0            12457899999999999999999999999999998764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.5e-45  Score=344.17  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=208.7

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCC-----------C
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT-----------D  149 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----------~  149 (422)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||++........+|+++++.++||||+++++++....           .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            34699999999999999999999999999999999877777889999999999999999999874311           1


Q ss_pred             CCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                      .....+++||||+++ +|.+++....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~D  165 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTK-QVKIGD  165 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCC-CEEECc
Confidence            234567899999986 8877776432  3678999999999999999999999 8999999999999999877 799999


Q ss_pred             cCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       229 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||....  .....+..         
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~---------  233 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD---------  233 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---------
T ss_pred             chhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---------
Confidence            9999877665555566789999999999654 48999999999999999999998874211  11111110         


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                                            ..++..++..+.+||.+||..||.+|||+.|+++|+|.-.
T Consensus       234 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 ----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                                  0012357899999999999999999999999999988754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.2e-45  Score=354.10  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=199.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEc-------CCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  147 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  147 (422)
                      ..+|.+.+.||+|+||+||+|++.       .++..||||++....     ....+|+.+++.+ +||||+++++++.. 
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence            456999999999999999999975       345689999986532     2345899999999 89999999998833 


Q ss_pred             CCCCceEEEEEeecchh-HHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                          ...+++||||+++ +|.+++.....            ....+++..+..++.||+.||+|||+ +||+||||||+|
T Consensus       159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~N  233 (370)
T 2psq_A          159 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN  233 (370)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGG
T ss_pred             ----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchhh
Confidence                2337799999985 88777765321            12458899999999999999999999 899999999999


Q ss_pred             eEEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 014595          215 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  290 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~  290 (422)
                      ||++.++ .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|||+| |..||.+.+.
T Consensus       234 Ill~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          234 VLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             EEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999887 699999999986543321   2334567889999999764 48999999999999999999 9999988776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+.+..+....                .   +         ..+..++.++.+||.+||+.||.+|||+.|++++
T Consensus       312 ~~~~~~~~~~~----------------~---~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          312 EELFKLLKEGH----------------R---M---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGHHHHHHTTC----------------C---C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCC----------------C---C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            55544433210                0   0         0124578999999999999999999999999874

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=348.28  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=200.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCe---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|.+.+.||+|+||+||+|++..+++   .||||++...     ...+.+|+.+++.++||||+++++++.     ..
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RG  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence            4569999999999999999999986554   5999998653     233557999999999999999999883     33


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ...++||||+++ +|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~  197 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGL  197 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred             CccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCC-CEEECCCCc
Confidence            447799999975 777766432   3579999999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          232 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       232 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      ++........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+  
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--  274 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--  274 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC--
Confidence            9876443221    123346789999999654 48999999999999999999 999999888776666554321100  


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                                .+..+++++.+||.+||..||.+|||+.++++  .++.+
T Consensus       275 --------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~--~L~~l  311 (325)
T 3kul_A          275 --------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS--VLDAL  311 (325)
T ss_dssp             --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             --------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence                                      12467899999999999999999999999986  44443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.8e-44  Score=339.52  Aligned_cols=248  Identities=19%  Similarity=0.191  Sum_probs=201.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|.+.+.||+|+||+||+|++..+|+.||||++...  .....+|+.+++.+ +|+||+++++++.     .....++||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~lv~   85 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLVI   85 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeEEEE
Confidence            599999999999999999999999999999988543  34567899999999 8999999998873     334578999


Q ss_pred             ecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC----cEEEeecCCcccc
Q 014595          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH----QLKLCDFGSAKVL  235 (422)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~----~vkl~DfG~a~~~  235 (422)
                      ||++++|.+++...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.    .+||+|||++...
T Consensus        86 e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           86 DLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99988888877643   3469999999999999999999999 89999999999999986652    3999999999866


Q ss_pred             ccCCC--------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCC
Q 014595          236 VKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTP  304 (422)
Q Consensus       236 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~---~~~~~~~i~~~~~~~  304 (422)
                      .....        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+   ....+..+......+
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            44322        2455789999999998654 48999999999999999999999998743   333444443321111


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +...                        ....+++++.+||.+||+.||++|||+.++++
T Consensus       241 ~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          241 PLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             CHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1111                        11357899999999999999999999999876

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=345.89  Aligned_cols=252  Identities=25%  Similarity=0.474  Sum_probs=199.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||+|++...    ...+.+|+++++.++||||+++++++..     ....++
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~l   84 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLNF   84 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeEE
Confidence            4699999999999999999999999999999987542    2345689999999999999999999843     334789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ +|.+++...   ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        85 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENK-NVVVADFGLARLMV  159 (310)
T ss_dssp             EEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCC-CEEEeecccceecc
Confidence            9999975 777766542   4679999999999999999999999 8999999999999999887 69999999997654


Q ss_pred             cCCCc---------------ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014595          237 KGEPN---------------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  301 (422)
Q Consensus       237 ~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~  301 (422)
                      .....               ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------  232 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------  232 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------
Confidence            33221               14578999999999965 458999999999999999999999986532110000      


Q ss_pred             CCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      .......                    .....+..+++.+.+||.+||+.||++|||+.++++  |++.+.
T Consensus       233 ~~~~~~~--------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          233 GLNVRGF--------------------LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             SBCHHHH--------------------HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             hhhhhcc--------------------ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence            0000000                    001123467899999999999999999999999987  777764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-44  Score=343.39  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=195.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcC--CCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||.||+|++. +++.||||++....      ....+|+.+++.+.  |+||+++++++..     ..
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~~  101 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ  101 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-----SS
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-----CC
Confidence            46999999999999999999985 58999999985422      33467999999997  5999999998742     33


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      ++++|||+.+++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++. + .+||+|||++.
T Consensus       102 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~~  174 (313)
T 3cek_A          102 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-G-MLKLIDFGIAN  174 (313)
T ss_dssp             EEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-T-EEEECCCSSSC
T ss_pred             EEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEEC-C-eEEEeeccccc
Confidence            5889999888888777664    3578999999999999999999999 89999999999999974 4 79999999997


Q ss_pred             ccccCCC---cccccccccccchhhhcCC----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 014595          234 VLVKGEP---NVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIK  299 (422)
Q Consensus       234 ~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~  299 (422)
                      .......   .....+|+.|+|||++.+.          ..++.++|||||||++|+|++|..||...... ..+..+..
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  254 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence            6543322   2345689999999998541          35788999999999999999999999775432 22222211


Q ss_pred             HhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      .              . ....            ++...+.++.+||.+||+.||.+|||+.|+++||||+....+
T Consensus       255 ~--------------~-~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          255 P--------------N-HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             T--------------T-SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             c--------------c-cccC------------CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            0              0 0001            123458899999999999999999999999999999875433

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.3e-45  Score=348.02  Aligned_cols=259  Identities=19%  Similarity=0.265  Sum_probs=188.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCe---EEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCC-
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~-  151 (422)
                      .+|.+.+.||+|+||+||+|++..+++   .||||++...      .....+|+++++.++||||+++++++....... 
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            359999999999999999999877765   8999988643      234568999999999999999999885443321 


Q ss_pred             ceEEEEEeecchh-HHHHHHHHhhh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          152 ELYLNLVLEYVPE-TVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                      ....++||||+.+ +|..++.....  ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~-~~kl~D  180 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDM-TVCVAD  180 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCC-CEEEee
Confidence            1234799999985 77776654332  12258999999999999999999999 8999999999999999887 699999


Q ss_pred             cCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014595          229 FGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       229 fG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      ||+++........   ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....  
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--  257 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR--  257 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--
T ss_pred             ccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC--
Confidence            9999765443221   234457789999999654 48999999999999999999 9999998877666555443110  


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-------HHHHhcCCccccc
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-------ALEACVHPFFDEL  371 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-------~~e~l~hp~f~~~  371 (422)
                                    .            ..+..+++++.+||.+||+.||.+|||       ++++++|||+...
T Consensus       258 --------------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          258 --------------L------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             --------------C------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             --------------C------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence                          0            012457899999999999999999999       7888999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-45  Score=351.70  Aligned_cols=267  Identities=21%  Similarity=0.248  Sum_probs=197.7

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh---hHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..+|++.+.||+|+||+||+|++.  ++.||||++.....   ...+|+.+++.++||||+++++++.... .....+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEEE
Confidence            346999999999999999999875  89999999865432   2346888899999999999999885433 22445789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC----------CceecCCCCCCeEEcCCCCcEEE
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------GICHRDIKPQNLLVNPHTHQLKL  226 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~----------givHrDlkp~Nill~~~~~~vkl  226 (422)
                      ||||+++ +|.+++..     ..+++..++.++.||+.||.|||+ .          ||+||||||+|||++.++ .+||
T Consensus       100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL  172 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACI  172 (322)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTC-CEEE
T ss_pred             EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCC-eEEE
Confidence            9999975 88777654     569999999999999999999998 8          999999999999999887 6999


Q ss_pred             eecCCccccccCCC---cccccccccccchhhhcCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014595          227 CDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  299 (422)
Q Consensus       227 ~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~  299 (422)
                      +|||+++.......   .....||+.|+|||++.+.    ..++.++|||||||++|||+||+.||.+............
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999976644322   2345789999999999653    2356688999999999999999999987543222211122


Q ss_pred             HhCCCCHHHHhhcCcCCccCcCCCCCCCCccccc-ccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ....+....+......  ....+     .+...+ ....++++.+||.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVH--KKKRP-----VLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HCSSCCHHHHHHHHTT--SCCCC-----CCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCchhhhhhhhhc--ccCCC-----CccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2222332222211000  00000     000001 0123456999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.9e-45  Score=336.47  Aligned_cols=244  Identities=19%  Similarity=0.324  Sum_probs=199.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|++.+.||+|+||+||+|++. +++.||+|++...   .....+|++++++++||||+++++++..     ....++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv   83 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLV   83 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceEEE
Confidence            46999999999999999999986 5788999998653   3445689999999999999999998843     3337899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ ++.+++..   ....+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBCC
T ss_pred             EEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCC-CEEeccccccccccc
Confidence            999975 67666643   23568999999999999999999999 8999999999999999877 699999999976532


Q ss_pred             CC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..  ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......           
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-----------  226 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-----------  226 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----------
T ss_pred             cccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC-----------
Confidence            21  12334567789999999654 48999999999999999999 99999988877666655432100           


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                       ..+...++++.+||.+||+.||.+|||+.++++|
T Consensus       227 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          227 -----------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                             0123568999999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.5e-45  Score=361.96  Aligned_cols=257  Identities=28%  Similarity=0.417  Sum_probs=189.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEee
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      .|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +|||||++++++     ....++++|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEEe
Confidence            48889999999999998764 4679999999986543 3446899999876 899999999887     33445889999


Q ss_pred             cchhHHHHHHHHhhhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC------------CcEE
Q 014595          161 YVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT------------HQLK  225 (422)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~------------~~vk  225 (422)
                      ||+++|.+++.........   .++..++.++.||+.||+|||+ +||+||||||+|||++.++            ..+|
T Consensus        90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            9999988887653322111   1233456789999999999999 8999999999999997532            2699


Q ss_pred             EeecCCccccccCCC-----cccccccccccchhhhcC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 014595          226 LCDFGSAKVLVKGEP-----NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  293 (422)
Q Consensus       226 l~DfG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~  293 (422)
                      |+|||+++.......     .....||+.|+|||++.+      ...++.++|||||||++|||+| |..||.+..... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            999999987644322     124578999999999965      2458999999999999999999 999997654432 


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                       ..+....                 +..+...     ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       248 -~~i~~~~-----------------~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 -SNIIRGI-----------------FSLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             -HHHHHTC-----------------CCCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             -HHHhcCC-----------------CCccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence             2232211                 1111110     0011235688999999999999999999999999999964

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.3e-45  Score=350.70  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=200.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEE-----EcCCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  149 (422)
                      ..+|.+.+.||+|+||.||+|+     +..+++.||||++....     ....+|+++++.+ +||||+++++++...  
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--   98 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   98 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC--
Confidence            3469999999999999999999     45667999999986532     2356899999999 789999999987432  


Q ss_pred             CCceEEEEEeecchh-HHHHHHHHhhhh----------------------------------------------------
Q 014595          150 KEELYLNLVLEYVPE-TVNRIARNYSRI----------------------------------------------------  176 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~----------------------------------------------------  176 (422)
                        ...+++||||+++ +|.+++......                                                    
T Consensus        99 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           99 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             --CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence              2336789999985 887777653221                                                    


Q ss_pred             ----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCC---ccc
Q 014595          177 ----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVS  243 (422)
Q Consensus       177 ----------~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~  243 (422)
                                ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.......   ...
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccc
Confidence                      1228999999999999999999999 8999999999999999887 699999999986543322   234


Q ss_pred             ccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCC
Q 014595          244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  322 (422)
Q Consensus       244 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  322 (422)
                      ..+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+....+.+.........+               .  
T Consensus       255 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------------~--  316 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------R--  316 (359)
T ss_dssp             CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC---------------C--
T ss_pred             cCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC---------------C--
Confidence            5678899999999654 58999999999999999998 999998877555554444321110               0  


Q ss_pred             CCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       323 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                .+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       317 ----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          317 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                      123578999999999999999999999999985

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.1e-44  Score=332.89  Aligned_cols=245  Identities=20%  Similarity=0.295  Sum_probs=199.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..+|++.+.||+|+||+||+|++. ++..||+|++...   .....+|+.+++.++||||+++++++.     .....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceEE
Confidence            346999999999999999999886 5778999998653   344568999999999999999999883     3334789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ ++.+++...   ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTC-CEEECCTTCEEECC
T ss_pred             EEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCC-CEEEccCccceecc
Confidence            9999974 677766543   3468999999999999999999999 8999999999999999887 69999999997654


Q ss_pred             cCCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          237 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       237 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      .....  ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......          
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  224 (268)
T 3sxs_A          156 DDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL----------  224 (268)
T ss_dssp             TTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----------
T ss_pred             hhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC----------
Confidence            33221  233456789999999654 48999999999999999999 99999888777666554431100          


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                        ..+...++.+.+||.+||+.||.+|||+.++++|
T Consensus       225 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          225 ------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              0113468899999999999999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-44  Score=348.81  Aligned_cols=257  Identities=17%  Similarity=0.135  Sum_probs=195.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCC-----CeEEEEEEeccchhhHHHHHH---------------HHHHcCCCCccccc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDKRYKNRELQ---------------IMQMLDHPNIVALK  141 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~E~~---------------~l~~l~h~nIv~l~  141 (422)
                      .+|.+.+.||+|+||+||+|.+..+     ++.||||++........+|++               .++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            3599999999999999999998764     588999998765544444444               44556799999999


Q ss_pred             ceeecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEc--C
Q 014595          142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN--P  219 (422)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~--~  219 (422)
                      +++.... ....+.++||||++++|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++  .
T Consensus       115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred             eeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence            9885433 33467889999998888877764   23679999999999999999999999 8999999999999998  6


Q ss_pred             CCCcEEEeecCCccccccCCC--------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH
Q 014595          220 HTHQLKLCDFGSAKVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV  291 (422)
Q Consensus       220 ~~~~vkl~DfG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~  291 (422)
                      ++ .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+....
T Consensus       190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            66 799999999976543221        1334589999999999655 4899999999999999999999999864333


Q ss_pred             HHHHHHHH-HhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          292 DQLVEIIK-VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       292 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ........ .........+...        +           ....+++++.+|+.+||..||.+||++.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~--------~-----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKC--------F-----------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHH--------S-----------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHh--------c-----------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            22222221 1111111111100        0           01357899999999999999999999999876

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=361.89  Aligned_cols=254  Identities=23%  Similarity=0.339  Sum_probs=189.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-hhHHHHHHHHHHc-CCCCcccccceeecCCCCCceEEEEEee
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +|.+.+.||+|+||+||.. ...+|+.||||++.... ....+|+.+++.+ +|||||++++++.     ...++++|||
T Consensus        25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~~lv~E   98 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQYIAIE   98 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEEEEEEE
T ss_pred             EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEEEEEEE
Confidence            5999999999999997643 34678999999986532 3456899999999 8999999998873     3445789999


Q ss_pred             cchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC----CcEEEeecCCccccc
Q 014595          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDFGSAKVLV  236 (422)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~----~~vkl~DfG~a~~~~  236 (422)
                      ||+++|.+.+....   ..+.+..++.++.||+.||.|||+ +||+||||||+|||++.++    ..+||+|||+|+...
T Consensus        99 ~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           99 LCAATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CCSEEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCCCCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            99998877766422   334455567899999999999999 8999999999999995322    258899999998764


Q ss_pred             cCC----CcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          237 KGE----PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       237 ~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ...    ......||+.|+|||++.+  ...++.++|||||||++|||+| |..||........ ..+..   ..     
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~---~~-----  245 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLG---AC-----  245 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTT---CC-----
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhc---cC-----
Confidence            432    2334678999999999864  3457889999999999999999 9999965443221 11111   00     


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                ......       .....+..+++||.+||+.||.+|||+.++++||||..+.
T Consensus       246 ----------~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          246 ----------SLDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             ----------CCTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             ----------CccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence                      000000       0012356789999999999999999999999999997643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=347.40  Aligned_cols=254  Identities=23%  Similarity=0.322  Sum_probs=203.1

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      ..+|.+.+.||+|+||.||+|++.     .+++.||||++....     ..+.+|+.+++.++||||+++++++..    
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----  121 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV----  121 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc----
Confidence            346999999999999999999987     355899999986532     335689999999999999999998843    


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhhh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSRI--------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~--------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrD  209 (422)
                       ...+++||||+++ +|.+++......                    ...+++..++.++.||+.||.|||+ +||+|||
T Consensus       122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~D  199 (343)
T 1luf_A          122 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD  199 (343)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             -CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence             3347799999985 887777653211                    2578999999999999999999999 8999999


Q ss_pred             CCCCCeEEcCCCCcEEEeecCCccccccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014595          210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLF  285 (422)
Q Consensus       210 lkp~Nill~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf  285 (422)
                      |||+|||++.++ .+||+|||++.......   ......+|+.|+|||++.+. .++.++|||||||++|+|+| |..||
T Consensus       200 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          200 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcC
Confidence            999999999887 69999999997653322   22345678899999998654 48999999999999999999 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+.+..+....+....                   .+         ..+..+++++.+||.+||+.||.+|||+.++++ 
T Consensus       278 ~~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~-  328 (343)
T 1luf_A          278 YGMAHEEVIYYVRDGN-------------------IL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR-  328 (343)
T ss_dssp             TTSCHHHHHHHHHTTC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-
T ss_pred             CCCChHHHHHHHhCCC-------------------cC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH-
Confidence            9887766555543310                   00         012467899999999999999999999999986 


Q ss_pred             CcccccC
Q 014595          366 PFFDELR  372 (422)
Q Consensus       366 p~f~~~~  372 (422)
                       +|+++.
T Consensus       329 -~L~~~~  334 (343)
T 1luf_A          329 -ILQRMC  334 (343)
T ss_dssp             -HHHHTT
T ss_pred             -HHHHHH
Confidence             455543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-44  Score=347.84  Aligned_cols=249  Identities=21%  Similarity=0.314  Sum_probs=201.2

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCC-------CeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  147 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  147 (422)
                      ..+|.+.+.||+|+||+||+|++..+       +..||||++....     ....+|+++++.+ +||||+++++++.. 
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  146 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-  146 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-
Confidence            45799999999999999999997543       3689999986532     3345899999999 99999999998843 


Q ss_pred             CCCCceEEEEEeecchh-HHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                          ...+++||||+++ +|.+++.....            ....+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus       147 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~N  221 (382)
T 3tt0_A          147 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  221 (382)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGG
T ss_pred             ----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCcce
Confidence                2337799999975 88777765331            12458999999999999999999999 899999999999


Q ss_pred             eEEcCCCCcEEEeecCCccccccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 014595          215 LLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  290 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~  290 (422)
                      ||++.++ .+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus       222 Ill~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          222 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             EEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999887 69999999998654332   22344568899999999764 58999999999999999999 9999988876


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+....+.....                .            ..+..+++++.+||.+||+.||++|||+.|++++
T Consensus       300 ~~~~~~~~~~~~----------------~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          300 EELFKLLKEGHR----------------M------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHTTCC----------------C------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCC----------------C------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            655544433110                0            0124578999999999999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.3e-46  Score=362.73  Aligned_cols=273  Identities=21%  Similarity=0.333  Sum_probs=201.1

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||++....     ....+|+++++.++||||+++++++...   ...+.
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence            346999999999999999999999999999999986422     3445899999999999999999987432   23356


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE----cCCCCcEEEeecC
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCDFG  230 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill----~~~~~~vkl~DfG  230 (422)
                      ++||||++ ++|.+++..... ...+++..++.++.||+.||+|||+ .||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCE-EEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCce-eEEEecCC
Confidence            79999997 477766654322 2349999999999999999999999 899999999999998    5554 69999999


Q ss_pred             CccccccCCCcccccccccccchhhhcCC-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH
Q 014595          231 SAKVLVKGEPNVSYICSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIK  299 (422)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltG~~pf~~~~----~~~~~~~i~~  299 (422)
                      +++............||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||.+..    ..+.+.++..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            99876555555567789999999998541       347889999999999999999999997532    3344444433


Q ss_pred             HhCCCCHHHHhhcC-cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          300 VLGTPTREEIKCMN-PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       300 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                        +.|. ..+.... .....+.+..  ..+....+...++..+.+||++||+.||++|||+.++++
T Consensus       242 --~~p~-~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 --GKPS-GAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             --SCCT-TCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             --CCCc-ccchhheeccCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence              2221 1110000 0000000000  000001112335678899999999999999999998854

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.9e-44  Score=341.78  Aligned_cols=249  Identities=20%  Similarity=0.344  Sum_probs=199.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      ..+|.+.+.||+|+||.||+|.+.     .+++.||||++....     ....+|+++++.++||||+++++++..    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----   97 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ----   97 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec----
Confidence            346999999999999999999983     456899999986532     334579999999999999999998833    


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrD  209 (422)
                       ....++||||++ ++|.+++.....                    ....+++..++.++.||+.||.|||+ +||+|||
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~d  175 (314)
T 2ivs_A           98 -DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHRD  175 (314)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred             -CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCcccc
Confidence             233779999998 588777765432                    12348899999999999999999999 8999999


Q ss_pred             CCCCCeEEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014595          210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLF  285 (422)
Q Consensus       210 lkp~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf  285 (422)
                      |||+|||++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||
T Consensus       176 ikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          176 LAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999877 799999999976543322   2234567889999999654 48999999999999999999 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+.+.......+....                ..            ..+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~----------------~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          254 PGIPPERLFNLLKTGH----------------RM------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TTCCGGGHHHHHHTTC----------------CC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHhhcCC----------------cC------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8877655444332210                00            0124678999999999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=347.58  Aligned_cols=245  Identities=25%  Similarity=0.412  Sum_probs=196.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----------hhHHHHHHHHHHc----CCCCcccccceeecC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQML----DHPNIVALKHCFFST  147 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l----~h~nIv~l~~~~~~~  147 (422)
                      .+|++.+.||+|+||.||+|++..+++.||||++....          ....+|+.+++++    +|+||+++++++.. 
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~-  109 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET-  109 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec-
Confidence            45999999999999999999999999999999985432          2234699999999    89999999998833 


Q ss_pred             CCCCceEEEEEeec-ch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEc-CCCCcE
Q 014595          148 TDKEELYLNLVLEY-VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQL  224 (422)
Q Consensus       148 ~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~-~~~~~v  224 (422)
                          ....++|||+ +. ++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+||+++ .++ .+
T Consensus       110 ----~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~~  179 (312)
T 2iwi_A          110 ----QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG-CA  179 (312)
T ss_dssp             -------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT-EE
T ss_pred             ----CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC-eE
Confidence                2346789998 44 577666654    3568999999999999999999999 8999999999999999 555 79


Q ss_pred             EEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014595          225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (422)
Q Consensus       225 kl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~  304 (422)
                      ||+|||++...... ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+..      .+...    
T Consensus       180 kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~----  248 (312)
T 2iwi_A          180 KLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA----  248 (312)
T ss_dssp             EECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT----
T ss_pred             EEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh----
Confidence            99999999866433 34456789999999998765545668999999999999999999996531      11110    


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                                   ...            ++..++.++.+||.+||+.||++|||+.|+++||||+....
T Consensus       249 -------------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          249 -------------ELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             -------------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             -------------ccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                         011            12457899999999999999999999999999999987543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=344.73  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=185.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcC-CCCcccccceeecCC---CCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLD-HPNIVALKHCFFSTT---DKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~---~~~~~  153 (422)
                      .+|++.+.||+|+||.||+|++..+|+.||||++....    ....+|+.+++.+. ||||+++++++....   .....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            36999999999999999999999999999999885432    33457999999996 999999999875322   24456


Q ss_pred             EEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--ivHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      .++++|||++++|.+.+.... ....+++..++.++.||+.||.|||+ .|  |+||||||+|||++.++ .+||+|||+
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQG-TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred             eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence            688999999998888776533 24569999999999999999999998 89  99999999999999887 699999999


Q ss_pred             ccccccCCCc-------------ccccccccccchhhhc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014595          232 AKVLVKGEPN-------------VSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE  296 (422)
Q Consensus       232 a~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~  296 (422)
                      +.........             ....+|+.|+|||++.  ....++.++|||||||++|+|++|..||.+.........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            9765433221             1456899999999983  234578899999999999999999999976443221110


Q ss_pred             HHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       297 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                           .+..+          .....+..+.+||++||+.||.+|||+.|+++|-+-
T Consensus       265 ---------------------~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  305 (337)
T 3ll6_A          265 ---------------------KYSIP----------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE  305 (337)
T ss_dssp             ----------------------CCCC----------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------------------cccCC----------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                                 00010          113467889999999999999999999999997543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.5e-44  Score=350.32  Aligned_cols=246  Identities=22%  Similarity=0.307  Sum_probs=198.4

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ...+|.+.+.||+|+||.||+|++..+++.||||++....     ..+.+|+++++.++||||+++++++..     ...
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCC
Confidence            3457999999999999999999999899999999986432     234579999999999999999998832     233


Q ss_pred             EEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||++ ++|.+.+...   ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~  261 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKN-VLKISDFGMSR  261 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             cEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCC-cEEECcCCCce
Confidence            779999997 5777766542   3468999999999999999999999 8999999999999999887 69999999997


Q ss_pred             ccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          234 VLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       234 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ........   ....+++.|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+....+....        
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------  332 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG--------  332 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC--------
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence            64322111   122356789999999654 48999999999999999998 999998877655444332210        


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                              ...            .+..+++++.+||.+||+.||++|||+.++++
T Consensus       333 --------~~~------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          333 --------RLP------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             --------CCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------CCC------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                    000            12457899999999999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.3e-44  Score=334.24  Aligned_cols=249  Identities=22%  Similarity=0.232  Sum_probs=198.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .+|++.+.||+|+||+||+|++..+|+.||||++...  .....+|+.+++.++|++++..+..+..    ...+.++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv~   84 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVM   84 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEEE
Confidence            3599999999999999999999999999999987543  3456789999999999998877665532    233578999


Q ss_pred             ecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEc---CCCCcEEEeecCCccccc
Q 014595          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~---~~~~~vkl~DfG~a~~~~  236 (422)
                      ||++++|.+++...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++   .++ .+||+|||++....
T Consensus        85 e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           85 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred             EecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccccc
Confidence            99988888777532   3579999999999999999999999 8999999999999994   555 79999999998765


Q ss_pred             cCCC--------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCC
Q 014595          237 KGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTPT  305 (422)
Q Consensus       237 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~~~~~~~~  305 (422)
                      ....        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.   ...+..+.......+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            4332        2455789999999999654 489999999999999999999999987432   223333332111111


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ..                        .+...+++++.+||.+||+.||.+|||+.++++
T Consensus       239 ~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 IE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            10                        112457899999999999999999999999886

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.2e-44  Score=334.04  Aligned_cols=245  Identities=21%  Similarity=0.297  Sum_probs=197.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..+|++.+.||+|+||+||+|.+. ++..||||++...   .....+|+++++.++||||+++++++.     ....+++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   96 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFI   96 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCeEE
Confidence            346999999999999999999886 6788999998753   344568999999999999999999883     2334779


Q ss_pred             Eeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||++ +++.+++...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus        97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           97 ITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVL  171 (283)
T ss_dssp             EECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTS-CEEECSTTGGGGBC
T ss_pred             EEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCC-CEEEcccccccccc
Confidence            999996 4776666542   3569999999999999999999999 8999999999999999887 69999999997653


Q ss_pred             cCC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ...  ......+|+.|+|||++.+. .++.++|||||||++|+|+| |+.||.+.+..+....+......          
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  240 (283)
T 3gen_A          172 DDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL----------  240 (283)
T ss_dssp             CHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----------
T ss_pred             ccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC----------
Confidence            221  12234457789999999654 48999999999999999998 99999988877666655442110          


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                        ..+...++.+.+||.+||+.||.+|||+.++++|
T Consensus       241 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          241 ------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                              0123568999999999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.2e-44  Score=331.27  Aligned_cols=242  Identities=28%  Similarity=0.451  Sum_probs=187.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||+||+|++.  |+.||||++...        .....+|+++++.++||||+++++++..     ..
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   79 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----EP   79 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C-
T ss_pred             hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----CC
Confidence            35999999999999999999985  899999987542        1345679999999999999999998832     33


Q ss_pred             EEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---ceecCCCCCCeEEcCC-------CC
Q 014595          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG---ICHRDIKPQNLLVNPH-------TH  222 (422)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---ivHrDlkp~Nill~~~-------~~  222 (422)
                      ..++||||++ +++..++.     ...+++..++.++.|++.||.|||+ .|   |+||||||+|||++.+       ..
T Consensus        80 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~  153 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNK  153 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred             ceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCc
Confidence            4789999997 46655543     3679999999999999999999999 88   9999999999999862       23


Q ss_pred             cEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 014595          223 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  302 (422)
Q Consensus       223 ~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~  302 (422)
                      .+||+|||++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.... 
T Consensus       154 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-  230 (271)
T 3dtc_A          154 ILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK-  230 (271)
T ss_dssp             CEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC-
T ss_pred             ceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC-
Confidence            69999999997654332 3356789999999998654 48999999999999999999999999887665554433210 


Q ss_pred             CCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                      ..          ...+..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus       231 ----------------~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 ----------------LA----------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ----------------CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CC----------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                            00          01124678999999999999999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.8e-44  Score=333.97  Aligned_cols=249  Identities=22%  Similarity=0.236  Sum_probs=197.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc--chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++..  ......+|+.+++.++|++++..+..+..    ...+.++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv~   84 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVM   84 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEEE
Confidence            459999999999999999999999999999998643  23456789999999999998887766643    233578999


Q ss_pred             ecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE---cCCCCcEEEeecCCccccc
Q 014595          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill---~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||++++|.+++...   ...+++..++.++.||+.||.|||+ +||+||||||+|||+   +.++ .+||+|||+++...
T Consensus        85 e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred             EccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCC-eEEEecCccceecc
Confidence            99988887776532   3579999999999999999999999 899999999999999   6655 79999999998764


Q ss_pred             cCCC--------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCC
Q 014595          237 KGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPT  305 (422)
Q Consensus       237 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~---~~~~~i~~~~~~~~  305 (422)
                      ....        .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..   ..+..+.......+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            4322        2345789999999999654 4899999999999999999999999875432   22222222110011


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ..                        .....+++++.+||.+||+.||++|||+.++++
T Consensus       239 ~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          239 IE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hh------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            00                        111457899999999999999999999999987

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.9e-44  Score=339.12  Aligned_cols=257  Identities=26%  Similarity=0.437  Sum_probs=192.7

Q ss_pred             eeeeEEeeeeeecCCeeEEEEE----EcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|++.+.||+|+||+||+|+    +..+++.||||++....    ..+.+|+++++.++||||+++++++...   +.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence            3469999999999999999998    56789999999986533    3456899999999999999999987432   22


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ..+++||||+++ +|.+++...   ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~  160 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFGL  160 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCCS
T ss_pred             CceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCC-eEEEccCcc
Confidence            346799999964 887776543   2458999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          232 AKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       232 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      +........    .....+++.|+|||++.+. .++.++|||||||++|+|+||..||.....  ...   ...+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~---~~~~~~~~~  234 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFM---RMIGNDKQG  234 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HHH---HHHCTTCCT
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChH--HHH---hhhcCcccc
Confidence            986643321    1234467789999999654 489999999999999999999999864321  111   111111100


Q ss_pred             H------HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          308 E------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       308 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .      ....... ..  .          ..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~-~~--~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          235 QMIVFHLIELLKNN-GR--L----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHHHHHTT-CC--C----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhHHHHHHHHhcc-Cc--C----------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0      0000000 00  0          012467899999999999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9e-44  Score=333.09  Aligned_cols=243  Identities=23%  Similarity=0.322  Sum_probs=194.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----------hhHHHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|.+.+.||+|+||+||+|++..+++.||||++....           ....+|+.+++.++||||+++++++.     
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----   93 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-----   93 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET-----
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec-----
Confidence            46999999999999999999999999999999985321           34568999999999999999999872     


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeEEcCCCC----c
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTH----Q  223 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--ivHrDlkp~Nill~~~~~----~  223 (422)
                      ...  ++||||++ +++.+.+..   ....+++..++.++.|++.||+|||+ .|  |+||||||+|||++.++.    .
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             CCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCcee
Confidence            222  48999998 566555443   24579999999999999999999999 89  999999999999987652    2


Q ss_pred             EEEeecCCccccccCCCcccccccccccchhhhcC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHH
Q 014595          224 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ--LVEIIKV  300 (422)
Q Consensus       224 vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~--~~~i~~~  300 (422)
                      +||+|||+++...  .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+....  ...+...
T Consensus       168 ~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  245 (287)
T 4f0f_A          168 AKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE  245 (287)
T ss_dssp             EEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred             EEeCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence            9999999997543  23445678999999999843 33478899999999999999999999987554332  2222210


Q ss_pred             hCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                       +.                          ...++..+++++.+||.+||+.||.+|||+.++++
T Consensus       246 -~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          246 -GL--------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             -CC--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CC--------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             00                          01123467899999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.9e-44  Score=337.85  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=200.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEE-----cCCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|.+.+.||+|+||+||+|++     ..+++.||||++....     ....+|+.+++.+ +||||+++++++..    
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----   98 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI----   98 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec----
Confidence            4699999999999999999985     4567899999986432     3456899999999 99999999998843    


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSR--------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Ni  215 (422)
                       ....++||||+++ +|.+++.....              ....+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus        99 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Ni  176 (313)
T 1t46_A           99 -GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNI  176 (313)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             -CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceE
Confidence             2236799999975 88777765321              12358999999999999999999999 8999999999999


Q ss_pred             EEcCCCCcEEEeecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 014595          216 LVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  291 (422)
Q Consensus       216 ll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~  291 (422)
                      |++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+....
T Consensus       177 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          177 LLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             EEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             EEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            999877 7999999999866444321   234567889999998654 48999999999999999999 99999887765


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       292 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      ..+..+......                           ...+..++.++.+||.+||+.||.+|||+.+++++
T Consensus       255 ~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          255 SKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            555554442100                           00124578999999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.5e-44  Score=334.62  Aligned_cols=247  Identities=21%  Similarity=0.343  Sum_probs=201.7

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ...+|.+.+.||+|+||+||+|.+..+++.||||++..+.   ....+|+.+++.++||||+++++++..     ...++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCEE
Confidence            3456999999999999999999999999999999987543   345589999999999999999998832     33378


Q ss_pred             EEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||++ ++|.+++....  ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        86 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLM  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGG-CEEECCCCGGGTS
T ss_pred             EEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCC-CEEEccCccceec
Confidence            9999998 58877765422  3568999999999999999999999 8999999999999999877 6999999999866


Q ss_pred             ccCCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          236 VKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       236 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ......  ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.......+.....          
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~----------  230 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------  230 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------
T ss_pred             cCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC----------
Confidence            433221  234567889999999654 48999999999999999999 9999988765554443332100          


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                        ...+..+++++.+||.+||..||.+|||+.++++
T Consensus       231 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 ------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                              0112467899999999999999999999999976

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.8e-44  Score=335.20  Aligned_cols=250  Identities=18%  Similarity=0.253  Sum_probs=195.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCC-------eEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  149 (422)
                      ..+|.+.+.||+|+||+||+|++..++       ..||+|++....    ....+|+.+++.++||||+++++++...  
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG--   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence            346999999999999999999998777       479999985432    3456899999999999999999988432  


Q ss_pred             CCceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCc-----
Q 014595          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----  223 (422)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~-----  223 (422)
                         ...++||||++ ++|.+++...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++..     
T Consensus        85 ---~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           85 ---DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             ---TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             ---CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCCccccccc
Confidence               23679999998 5887777642   2348999999999999999999999 899999999999999877621     


Q ss_pred             --EEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHH
Q 014595          224 --LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKV  300 (422)
Q Consensus       224 --vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~-~pf~~~~~~~~~~~i~~~  300 (422)
                        +||+|||++....   ......+|+.|+|||++.+...++.++|||||||++|+|++|. +||...+... ...+...
T Consensus       158 ~~~kl~Dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~  233 (289)
T 4fvq_A          158 PFIKLSDPGISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYED  233 (289)
T ss_dssp             CEEEECCCCSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT
T ss_pred             ceeeeccCccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhc
Confidence              9999999986542   2234567889999999976566899999999999999999955 5555444333 3222221


Q ss_pred             hCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      .                 ..            ++...++++.+||.+||+.||.+|||+.++++|  ++++..+
T Consensus       234 ~-----------------~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~p  276 (289)
T 4fvq_A          234 R-----------------HQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFTP  276 (289)
T ss_dssp             T-----------------CC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC--
T ss_pred             c-----------------CC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcCC
Confidence            0                 00            113457889999999999999999999999883  4555443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.6e-44  Score=337.89  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=192.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-hhHHHHHHHHHH--cCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|++.+.||+|+||+||+|++  +|+.||||++.... ....+|.+++..  ++||||+++++++.... .....+++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~lv   84 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWLI   84 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEEe
Confidence            4599999999999999999987  58999999986543 333467777777  79999999998865433 334567899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCceecCCCCCCeEEcCCCCcEEEeec
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--------~~~givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      |||+++ +|.+++.     ...+++..+..++.||+.||+|||        + .||+||||||+|||++.++ .+||+||
T Consensus        85 ~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~-~~kl~Df  157 (301)
T 3q4u_A           85 THYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNG-QCCIADL  157 (301)
T ss_dssp             ECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             hhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCC-CEEEeeC
Confidence            999985 7776663     257999999999999999999999        8 8999999999999999887 6999999


Q ss_pred             CCccccccCCCc-----ccccccccccchhhhcCCC-----CCCCcchHHHHHHHHHHHHhC----------CCCCCCCC
Q 014595          230 GSAKVLVKGEPN-----VSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLG----------QPLFPGES  289 (422)
Q Consensus       230 G~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltG----------~~pf~~~~  289 (422)
                      |+++........     ....||+.|+|||++.+..     .++.++|||||||++|||+||          ..||.+..
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            999765443322     2347899999999996543     244689999999999999999          88886532


Q ss_pred             ----hHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          290 ----GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       290 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                          ....+.......+                 ..+..    ....+....++++.+||.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQ-----------------QRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSCCHHHHHHHHTTSC-----------------CCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCcchhhhhHHHhccC-----------------CCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                2222222221100                 00000    011122335678999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=341.68  Aligned_cols=259  Identities=23%  Similarity=0.346  Sum_probs=199.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...    .....+|+++++.++||||+++++++.... ......++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence            4699999999999999999999999999999988542    234568999999999999999999885332 23456789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+.+ +|.+.+.........+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~  185 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence            9999986 8888777665556789999999999999999999999 8999999999999999887 69999999986542


Q ss_pred             cCCC----------cccccccccccchhhhcCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Q 014595          237 KGEP----------NVSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGT  303 (422)
Q Consensus       237 ~~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~~~~~  303 (422)
                      ....          .....||+.|+|||++.+..  .++.++|||||||++|+|++|+.||...... ..+......   
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---  262 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---  262 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence            2111          11335689999999985433  2689999999999999999999999531100 001111110   


Q ss_pred             CCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                    ....+          ....+++++.+||.+||+.||.+|||+.++++|  +..+.
T Consensus       263 --------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~  305 (317)
T 2buj_A          263 --------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEALQ  305 (317)
T ss_dssp             --------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTC
T ss_pred             --------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhcC
Confidence                          00111          013578999999999999999999999999985  44443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.7e-44  Score=343.28  Aligned_cols=249  Identities=23%  Similarity=0.315  Sum_probs=199.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEE--EEEEeccc-----hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--AiK~~~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|.+.+.||+|+||.||+|++..+|..+  |||.+...     .....+|+++++.+ +||||+++++++..     .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~   98 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R   98 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----C
Confidence            346999999999999999999999888865  99987542     23456899999999 99999999998833     3


Q ss_pred             eEEEEEeecchh-HHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~  219 (422)
                      .++++||||+++ +|.+++....            .....+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEcC
Confidence            457899999974 8877776532            123478999999999999999999999 89999999999999998


Q ss_pred             CCCcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014595          220 HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII  298 (422)
Q Consensus       220 ~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~  298 (422)
                      ++ .+||+|||+++............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       178 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          178 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CC-eEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence            87 6999999999754333333445668889999998654 48999999999999999998 999998887655544432


Q ss_pred             HHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      ...                ..            ..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       256 ~~~----------------~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          256 QGY----------------RL------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GTC----------------CC------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCC----------------CC------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            210                00            0123578999999999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-44  Score=342.14  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=200.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|.+.+.||+|+||+||+|++.     .+++.||||++...     .....+|+.+++.+ +||||+++++++..    
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----  120 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL----  120 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee----
Confidence            46999999999999999999973     45678999998643     23456899999999 99999999998843    


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhhh-------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSRI-------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI  210 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~-------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDl  210 (422)
                       ...+++||||+++ +|.+++......                   ...+++..++.++.||+.||.|||+ .||+||||
T Consensus       121 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Di  198 (344)
T 1rjb_A          121 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDL  198 (344)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTC
T ss_pred             -CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCC
Confidence             2337799999974 887777643210                   1347899999999999999999999 89999999


Q ss_pred             CCCCeEEcCCCCcEEEeecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 014595          211 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFP  286 (422)
Q Consensus       211 kp~Nill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~  286 (422)
                      ||+|||++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.
T Consensus       199 kp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          199 AARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             SGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999887 7999999999866544322   234567889999998654 48999999999999999998 999998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCC
Q 014595          287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (422)
Q Consensus       287 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  366 (422)
                      +.+....+..+......                 .          ..+..+++++.+||.+||+.||.+|||+.++++|.
T Consensus       277 ~~~~~~~~~~~~~~~~~-----------------~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFK-----------------M----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             TCCCSHHHHHHHHTTCC-----------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCcHHHHHHHHhcCCC-----------------C----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            87765555554442100                 0          01235789999999999999999999999999865


Q ss_pred             c
Q 014595          367 F  367 (422)
Q Consensus       367 ~  367 (422)
                      .
T Consensus       330 ~  330 (344)
T 1rjb_A          330 G  330 (344)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=342.51  Aligned_cols=256  Identities=16%  Similarity=0.137  Sum_probs=191.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC---CCeEEEEEEeccchhh---------------HHHHHHHHHHcCCCCcccccce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRY---------------KNRELQIMQMLDHPNIVALKHC  143 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~---------------~~~E~~~l~~l~h~nIv~l~~~  143 (422)
                      .+|.+.+.||+|+||+||+|++..   ++..||||++......               ..+|+.+++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            469999999999999999999987   7889999998654321               2356777888899999999998


Q ss_pred             eecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC-C
Q 014595          144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT-H  222 (422)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~-~  222 (422)
                      +.... .+..++++||||++++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .
T Consensus       117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSSTT
T ss_pred             ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCCC
Confidence            85533 33566889999997787666543    2378999999999999999999999 8999999999999998664 2


Q ss_pred             cEEEeecCCccccccCCC--------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHH
Q 014595          223 QLKLCDFGSAKVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQ  293 (422)
Q Consensus       223 ~vkl~DfG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~-~~~~~  293 (422)
                      .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+. .....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            699999999976533211        1345789999999999764 4899999999999999999999999653 22222


Q ss_pred             HHHHH-HHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          294 LVEII-KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       294 ~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ..... ......+.....+.                    -...+++++.+||.+||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            22222 21111111111110                    00257899999999999999999999999987

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.1e-44  Score=333.38  Aligned_cols=245  Identities=26%  Similarity=0.357  Sum_probs=187.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCC---CeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|.+.+.||+|+||+||+|++..+   +..||+|++...     ...+.+|+.+++.++||||+++++++..    + 
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~-   88 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----N-   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----S-
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc----C-
Confidence            34699999999999999999998654   567999987642     2334579999999999999999998721    1 


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                       ..++||||+++ +|.+++...   ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        89 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  162 (281)
T 1mp8_A           89 -PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFGL  162 (281)
T ss_dssp             -SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC---
T ss_pred             -ccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCC-CEEECcccc
Confidence             25689999985 777766532   3468999999999999999999999 8999999999999999877 799999999


Q ss_pred             ccccccCCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          232 AKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       232 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ++.......  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+.....      
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~------  235 (281)
T 1mp8_A          163 SRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------  235 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------
T ss_pred             ccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC------
Confidence            976643322  1233457789999998654 48999999999999999996 9999998776665555433100      


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                .            .++..+++++.+||.+||..||++|||+.+++++
T Consensus       236 ----------~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          236 ----------L------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ----------C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------C------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      0            0124679999999999999999999999999863

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1e-43  Score=336.98  Aligned_cols=253  Identities=19%  Similarity=0.270  Sum_probs=192.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC---CCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+.||+|+||+||+|++..   +++.||||++....      ....+|+.+++.++||||+++++++........
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            469999999999999999998765   56689999986431      234579999999999999999999865544444


Q ss_pred             eEEEEEeecchh-HHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeec
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      ...++||||+++ +|..++....  .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kl~Df  191 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDM-TVCVADF  191 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTS-CEEECSC
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEEeec
Confidence            456899999985 7776664322  234569999999999999999999999 8999999999999999887 6999999


Q ss_pred             CCccccccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          230 GSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       230 G~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      |++.......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+.......+.....   
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---  267 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR---  267 (313)
T ss_dssp             SCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---
T ss_pred             CcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC---
Confidence            9997654332   12234567889999999654 58999999999999999999 9999988776655554433110   


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                   .            ..+..+++++.+||.+||..||.+|||+.++++|
T Consensus       268 -------------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 -------------L------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             -------------C------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------C------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         0            0124678999999999999999999999999874

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.3e-45  Score=359.16  Aligned_cols=254  Identities=20%  Similarity=0.218  Sum_probs=192.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCC-CCcccccce----------
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDH-PNIVALKHC----------  143 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h-~nIv~l~~~----------  143 (422)
                      ..|...+.||+|+||+||+|++..+|+.||||++...       ...+.+|+.+++.+.| .|+..+..+          
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4599999999999999999999999999999988632       2345689999999987 333222111          


Q ss_pred             -----------eecCCCCCceEEEEEeecchhHHHHHHHHhh---hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 014595          144 -----------FFSTTDKEELYLNLVLEYVPETVNRIARNYS---RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (422)
Q Consensus       144 -----------~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrD  209 (422)
                                 +..........++++|+++.++|.+++....   .....+++..+..++.||+.||+|||+ +||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence                       1000011123356889988888887775432   223457778888999999999999999 8999999


Q ss_pred             CCCCCeEEcCCCCcEEEeecCCccccccCCCcccccccccccchhhhc---------CCCCCCCcchHHHHHHHHHHHHh
Q 014595          210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF---------GATEYTTAIDIWSTGCVMAELLL  280 (422)
Q Consensus       210 lkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwslG~il~ellt  280 (422)
                      |||+|||++.++ .+||+|||+++.....  ....+| +.|+|||++.         ....++.++|||||||++|+|+|
T Consensus       237 iKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          237 LRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999888 5999999998765332  344566 9999999983         33447889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHH
Q 014595          281 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  360 (422)
Q Consensus       281 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  360 (422)
                      |+.||.+.+.......+                       +.          ....+|+++.+||.+||+.||.+|||+.
T Consensus       313 g~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             SSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCHH
Confidence            99999765422111000                       00          0135789999999999999999999999


Q ss_pred             HHhcCCcccccCC
Q 014595          361 EACVHPFFDELRD  373 (422)
Q Consensus       361 e~l~hp~f~~~~~  373 (422)
                      ++++||||+.+..
T Consensus       360 ~~l~~~~~~~~~~  372 (413)
T 3dzo_A          360 QAMETPEYEQLRT  372 (413)
T ss_dssp             HHTTSHHHHHHHH
T ss_pred             HHHhCHHHHHHHH
Confidence            9999999987643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.7e-44  Score=341.34  Aligned_cols=245  Identities=22%  Similarity=0.303  Sum_probs=193.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeE----EEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ..+|++.+.||+|+||+||+|++..+++.    ||+|.+....     ....+|+.+++.++||||+++++++.     +
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~   86 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----G   86 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----B
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence            34699999999999999999999888876    6777664321     33458999999999999999999872     1


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                       ...++||||+. ++|.+.+...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        87 -~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg  160 (325)
T 3kex_A           87 -SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPS-QVQVADFG  160 (325)
T ss_dssp             -SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSS-CEEECSCS
T ss_pred             -CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCC-eEEECCCC
Confidence             12678999998 4666655432   3568899999999999999999999 8999999999999999887 69999999


Q ss_pred             CccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          231 SAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       231 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      +++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+....+....+....     
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----  234 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-----  234 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-----
T ss_pred             cccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-----
Confidence            9987644332   2344567789999999654 48999999999999999999 999998876555444433210     


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                 ...            .+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       235 -----------~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          235 -----------RLA------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             -----------BCC------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             -----------CCC------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                       000            113467889999999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-43  Score=338.12  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=205.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  150 (422)
                      ..+|++.+.||+|+||.||+|++.     .+++.||||.+....     ....+|+.+++.++||||+++++++..    
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   99 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----   99 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS----
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc----
Confidence            346999999999999999999886     357899999986432     234579999999999999999998833    


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCc
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  223 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~  223 (422)
                       ....++||||+++ +|.+++......      ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .
T Consensus       100 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~-~  176 (322)
T 1p4o_A          100 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T  176 (322)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC-C
T ss_pred             -CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCCC-e
Confidence             2346799999974 887777654321      2457899999999999999999999 8999999999999999887 6


Q ss_pred             EEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014595          224 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  299 (422)
Q Consensus       224 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~  299 (422)
                      +||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            99999999976543321   1234568889999998654 48999999999999999999 8999988876665554433


Q ss_pred             HhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC------CcccccCC
Q 014595          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH------PFFDELRD  373 (422)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h------p~f~~~~~  373 (422)
                      ..                   .+         ..+..++..+.+||.+||+.||.+|||+.|+++|      |+|+++..
T Consensus       256 ~~-------------------~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~  307 (322)
T 1p4o_A          256 GG-------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF  307 (322)
T ss_dssp             TC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred             CC-------------------cC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccc
Confidence            10                   00         0124678999999999999999999999999986      77766543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-43  Score=333.53  Aligned_cols=245  Identities=24%  Similarity=0.315  Sum_probs=188.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+.+.||+|+||.||+|++..+++.||||++....       ..+.+|+.+++.++||||+++++++..     ...
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~  108 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----DGQ  108 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----CCe
Confidence            46999999999999999999999999999999986432       334579999999999999999998843     335


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus       109 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~  182 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADD-FAYLVDFGIAS  182 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSCCC--
T ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCC-CEEEecCccCc
Confidence            7899999985 77776654    3578999999999999999999999 8999999999999999887 69999999987


Q ss_pred             ccccCC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          234 VLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       234 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ......  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. .+....... .        
T Consensus       183 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~--------  251 (309)
T 2h34_A          183 ATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA-I--------  251 (309)
T ss_dssp             --------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC-C--------
T ss_pred             cccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC-C--------
Confidence            654332  2234578999999999865 45899999999999999999999999876543 222222210 0        


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-CHHHHhc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACV  364 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-t~~e~l~  364 (422)
                                      +........+++++.+||.+||..||++|| |++++++
T Consensus       252 ----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 ----------------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ----------------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ----------------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                            000112356899999999999999999999 7777664

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.8e-43  Score=338.28  Aligned_cols=248  Identities=24%  Similarity=0.327  Sum_probs=200.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCe-----EEEEEEeccc-----hhhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|.+.+.||+|+||+||+|.+..+++     .||+|.+...     .....+|+.+++.+ +||||+++++++..    
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----  121 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH----  121 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec----
Confidence            469999999999999999999977664     7999998653     23456899999999 89999999998833    


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhhhh----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYSRI----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~  219 (422)
                       ...+++||||+++ +|.+++......          ...+++..+..++.||+.||.|||+ .||+||||||+|||++.
T Consensus       122 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          122 -GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEEEG
T ss_pred             -CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEECC
Confidence             2337799999975 888777654321          3468999999999999999999999 89999999999999998


Q ss_pred             CCCcEEEeecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014595          220 HTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  295 (422)
Q Consensus       220 ~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~  295 (422)
                      ++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+......+.
T Consensus       200 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          200 GH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             GG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            77 7999999999866443322   234567889999998654 48999999999999999998 999998876655555


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .+......                 .          ..+...++.+.+||.+||+.||.+|||+.++++
T Consensus       278 ~~~~~~~~-----------------~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          278 KLVKDGYQ-----------------M----------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHTCC-----------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCC-----------------C----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            54442100                 0          012346899999999999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.9e-44  Score=339.43  Aligned_cols=245  Identities=22%  Similarity=0.353  Sum_probs=190.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEE----EEEEecc-----chhhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----AiK~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ..+|.+.+.||+|+||+||+|++..+++.+    |+|.+..     ....+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence            346999999999999999999998887754    7776643     223456899999999999999999988531    


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      .  .+++++|+. +++.+.+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        90 ~--~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg  162 (327)
T 3poz_A           90 T--VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFG  162 (327)
T ss_dssp             S--EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred             C--eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCC-CEEEccCc
Confidence            1  457888887 4666655432   3578999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          231 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       231 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      +++........   ....+|+.|+|||++.+. .++.++|||||||++|+|+| |+.||.+.+..+....+.... .   
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~---  237 (327)
T 3poz_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-R---  237 (327)
T ss_dssp             HHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-C---
T ss_pred             ceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-C---
Confidence            99876443322   233457789999999754 48999999999999999999 999998876554433332210 0   


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                    .+          .+..++.++.+|+.+||+.||.+|||+.++++|
T Consensus       238 --------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 --------------LP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             --------------CC----------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             --------------CC----------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                          00          123578899999999999999999999999976

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.2e-44  Score=342.39  Aligned_cols=268  Identities=21%  Similarity=0.291  Sum_probs=200.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|.+.+.||+|+||+||+|++ .+|+.||||++....     ..+.+|+++++.++||||+++++++...     ...+
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~  103 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERL  103 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----SCCE
T ss_pred             hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC-----CceE
Confidence            3599999999999999999986 468999999986532     2457899999999999999999988432     2367


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---GICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      +||||+.+ +|.+++.........+++..+..++.|++.||+|||+ .   ||+||||||+|||++.++ .+||+|||++
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~  181 (326)
T 3uim_A          104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEF-EAVVGDFGLA  181 (326)
T ss_dssp             EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTC-CEEECCCSSC
T ss_pred             EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCC-CEEeccCccc
Confidence            99999975 8888777655555669999999999999999999999 8   999999999999999887 6999999999


Q ss_pred             cccccCCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCCCH
Q 014595          233 KVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE----SGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~----~~~~~~~~i~~~~~~~~~  306 (422)
                      ........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...    ............      
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------  254 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG------  254 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT------
T ss_pred             cccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH------
Confidence            86643322  2334589999999998654 4899999999999999999999999521    000001111110      


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                              ..................+....+..+.+|+.+||+.||.+|||+.|+++|-.-..+.
T Consensus       255 --------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  312 (326)
T 3uim_A          255 --------LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA  312 (326)
T ss_dssp             --------TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred             --------HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence                    0000011111111111111223457899999999999999999999999987655444

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.9e-43  Score=336.25  Aligned_cols=249  Identities=23%  Similarity=0.331  Sum_probs=198.1

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEc-------CCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  147 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  147 (422)
                      ..+|++.+.||+|+||+||+|++.       .+++.||||++....     ....+|+++++.+ +||||+++++++.. 
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  112 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  112 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence            346999999999999999999985       457789999986532     2345799999999 99999999998833 


Q ss_pred             CCCCceEEEEEeecchh-HHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCC
Q 014595          148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (422)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~N  214 (422)
                          ...+++||||+++ +|.+++.....            ....+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus       113 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~N  187 (334)
T 2pvf_A          113 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN  187 (334)
T ss_dssp             ----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGG
T ss_pred             ----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccce
Confidence                3347799999975 88777765321            12358999999999999999999999 899999999999


Q ss_pred             eEEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 014595          215 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  290 (422)
Q Consensus       215 ill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~  290 (422)
                      ||++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus       188 Ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          188 VLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             EEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            9999887 699999999976543321   2234567889999998654 48999999999999999999 9999998876


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+....+......                            ..+..++.++.+||.+||..||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          266 EELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6655544432100                            0124578999999999999999999999999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=344.31  Aligned_cols=259  Identities=14%  Similarity=0.109  Sum_probs=196.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCC--------CeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeec-------
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRET--------GEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS-------  146 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------  146 (422)
                      .+|.+.+.||+|+||+||+|++..+        ++.||||++... ....+|+++++.++||||+++++.+..       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            3599999999999999999999874        889999998765 456799999999999999985432211       


Q ss_pred             ----CCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC
Q 014595          147 ----TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  222 (422)
Q Consensus       147 ----~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~  222 (422)
                          .......+.++||||++++|.+++....  ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.
T Consensus       121 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~~~~~  197 (352)
T 2jii_A          121 TCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVDPEDQ  197 (352)
T ss_dssp             CCCEEEEETTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEETTEE
T ss_pred             chhhccccCCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEcCCCC
Confidence                0001234578999999889988877532  3679999999999999999999999 89999999999999997651


Q ss_pred             -cEEEeecCCccccccCCC--------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHH
Q 014595          223 -QLKLCDFGSAKVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVD  292 (422)
Q Consensus       223 -~vkl~DfG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~-~~~  292 (422)
                       .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ...
T Consensus       198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  276 (352)
T 2jii_A          198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE  276 (352)
T ss_dssp             EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH
Confidence             599999999976543221        1334789999999999654 58999999999999999999999998754 333


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .+..........        ...     +..      .......+++++.+||.+||+.||++|||+.++++
T Consensus       277 ~~~~~~~~~~~~--------~~~-----~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          277 DIMKQKQKFVDK--------PGP-----FVG------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHS--------CCC-----EEC------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhccCC--------hhh-----hhh------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            333332211000        000     000      00011357899999999999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-43  Score=325.56  Aligned_cols=244  Identities=19%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|.+.+.||+|+||.||+|++. +++.||+|++....   ....+|+++++.++||||+++++++..     ....++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv   81 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLV   81 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEEE
Confidence            46999999999999999999986 67899999986542   445689999999999999999998843     2337799


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ +|.+++...   ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD  156 (267)
T ss_dssp             ECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCC
T ss_pred             EeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCC-CEEEccccccccccc
Confidence            999974 777766542   3568999999999999999999999 8999999999999999877 699999999976532


Q ss_pred             CC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..  ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+.....            
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~------------  223 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------  223 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------------
T ss_pred             ccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc------------
Confidence            21  12234567789999999654 48999999999999999999 8999988877666555543110            


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                      ...+...++.+.+||.+||+.||++|||+.+++++
T Consensus       224 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 ----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                            00123568999999999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2e-43  Score=335.14  Aligned_cols=251  Identities=24%  Similarity=0.358  Sum_probs=199.2

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEE-----cCCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  149 (422)
                      ..+|.+.+.||+|+||+||+|++     ..+++.||||++....     ....+|+.+++.+ +||||+++++++...  
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence            34699999999999999999985     3567899999986532     2345899999999 799999999987432  


Q ss_pred             CCceEEEEEeecchh-HHHHHHHHhhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeE
Q 014595          150 KEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nil  216 (422)
                        ...+++||||+++ +|.+++......            ...+++..++.++.||+.||.|||+ .||+||||||+|||
T Consensus       104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil  180 (316)
T 2xir_A          104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  180 (316)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence              2346799999984 887777653221            1238899999999999999999999 89999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 014595          217 VNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  292 (422)
Q Consensus       217 l~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~  292 (422)
                      ++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+.....
T Consensus       181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99877 6999999999765443322   234568899999999654 48999999999999999998 999998876544


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .+.........               ..            .+..+++++.++|.+||+.||.+|||+.++++|
T Consensus       259 ~~~~~~~~~~~---------------~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTR---------------MR------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCC---------------CC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCcc---------------CC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            44443332100               00            123578999999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.4e-43  Score=331.56  Aligned_cols=254  Identities=27%  Similarity=0.451  Sum_probs=191.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...       .....+|+.+++.++||||+++++++..     ...
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~  106 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE  106 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCc
Confidence            4699999999999999999999999999999998641       2334579999999999999999998853     234


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .++||||+++ +|.+++.........+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~  184 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGR  184 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCC----
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCC-CEEEEecccee
Confidence            7899999986 8888887666666789999999999999999999999 8999999999999999887 69999999987


Q ss_pred             ccccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhh
Q 014595          234 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       234 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ....... .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+... ...+.......          
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  253 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC----------  253 (310)
T ss_dssp             --------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT----------
T ss_pred             eecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc----------
Confidence            6543322 2345689999999998654 589999999999999999999999976432 11222211110          


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                              .++.        .....+++++.+||.+||..||.+|||+.++++  .++++
T Consensus       254 --------~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~--~l~~l  295 (310)
T 2wqm_A          254 --------DYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD--VAKRM  295 (310)
T ss_dssp             --------CSCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             --------cCCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence                    0110        011357899999999999999999999999987  44444

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.1e-43  Score=337.06  Aligned_cols=263  Identities=24%  Similarity=0.330  Sum_probs=198.3

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEE----EcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ...+|++.+.||+|+||.||+|+    +..+++.||||++....    ....+|+++++.++||||+++++++..   .+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   97 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PG   97 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CC
Confidence            34579999999999999999999    46789999999986542    335689999999999999999998753   33


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      ...+++||||++ ++|.+++...   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg  172 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEA-HVKIADFG  172 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCGG
T ss_pred             CceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCC-CEEEcccc
Confidence            455789999996 5777776543   2468999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          231 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       231 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      ++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||......... ........+..
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~  250 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPAL  250 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHH
T ss_pred             cceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccH
Confidence            9986643332    2234578889999998654 4799999999999999999999999654322110 00000000000


Q ss_pred             HHH-hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          307 EEI-KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       307 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      ..+ ...... ..            ...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       251 ~~~~~~~~~~-~~------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          251 SRLLELLEEG-QR------------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHHTT-CC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhhcc-cC------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            000 000000 00            01124679999999999999999999999999753

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-43  Score=339.07  Aligned_cols=254  Identities=19%  Similarity=0.223  Sum_probs=197.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEE-----EcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      .+|.+.+.||+|+||.||+|+     +..+++.||||++...     .....+|+.+++.++||||+++++++..     
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----  104 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-----  104 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-----
Confidence            469999999999999999999     5567889999998532     2334579999999999999999998843     


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEE
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLK  225 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vk  225 (422)
                      ....++||||++ ++|.+++......   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++  ..+|
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcceEE
Confidence            233679999995 5887777653321   1458899999999999999999999 8999999999999998432  2699


Q ss_pred             EeecCCccccccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 014595          226 LCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVL  301 (422)
Q Consensus       226 l~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~  301 (422)
                      |+|||++.......   ......+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+.+..+....+....
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  262 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  262 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence            99999987553322   12345678899999998654 48999999999999999998 999998877665554443310


Q ss_pred             CCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      .                .            ..+..+++.+.+||.+||+.||.+|||+.++++|.|+..
T Consensus       263 ~----------------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          263 R----------------M------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             C----------------C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----------------C------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            0                0            012457899999999999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.9e-43  Score=327.81  Aligned_cols=245  Identities=27%  Similarity=0.376  Sum_probs=194.2

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcC---CCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|.+.+.||+|+||+||+|++..   ++..||+|.+...     ...+.+|+.+++.++||||+++++++..    +.
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----EP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS----SS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC----CC
Confidence            3469999999999999999998754   3456999998653     2345579999999999999999998731    11


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                        .++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        87 --~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  159 (281)
T 3cc6_A           87 --TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPE-CVKLGDFGL  159 (281)
T ss_dssp             --CEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETT-EEEECCCCG
T ss_pred             --CEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCC-cEEeCccCC
Confidence              468999998 4777666542   3568999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          232 AKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       232 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      +........  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+......     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-----  233 (281)
T 3cc6_A          160 SRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-----  233 (281)
T ss_dssp             GGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-----
T ss_pred             CcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-----
Confidence            976543321  2234567889999999654 48999999999999999998 99999877665555444331100     


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                 .            .+..+++.+.+||.+||..||.+|||+.+++++
T Consensus       234 -----------~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 -----------P------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             -----------C------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------C------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                       0            123578999999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-43  Score=356.37  Aligned_cols=247  Identities=20%  Similarity=0.350  Sum_probs=201.1

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ...+|.+.+.||+|+||.||+|++..++..||||++..+.   ..+.+|+.++++++||||+++++++..     ...++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEE
Confidence            3457999999999999999999999899999999987543   445689999999999999999998843     23377


Q ss_pred             EEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||++ ++|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       293 lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENH-LVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGG-CEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCC-cEEEeecccceec
Confidence            9999998 58877776432  3568999999999999999999999 8999999999999999877 6999999999865


Q ss_pred             ccCCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          236 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       236 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .....  .....+++.|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+....+....           
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----------  436 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-----------  436 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            43221  1233456789999999654 48999999999999999999 999998877655444332210           


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                             ..          ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       437 -------~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 -------RM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             -------CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------CC----------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                   00          012467899999999999999999999999976

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.2e-43  Score=348.16  Aligned_cols=243  Identities=23%  Similarity=0.336  Sum_probs=196.7

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch--hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      ..+|.+.+.||+|+||.||+|.+.  |+.||||++....  ..+.+|+.+++.++||||+++++++....    ..+++|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~iv  265 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIV  265 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEEE
Confidence            457999999999999999999985  7899999987543  34568999999999999999999875322    237799


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ +|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus       266 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS  341 (450)
T ss_dssp             EECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTS-CEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCC-CEEEeeCCCcccccc
Confidence            999975 8877776432  2347899999999999999999999 8999999999999999887 699999999975432


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .  .....+++.|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+....+.+..               
T Consensus       342 ~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------------  403 (450)
T 1k9a_A          342 T--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------  403 (450)
T ss_dssp             -------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC---------------
T ss_pred             c--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            2  2233568889999999654 58999999999999999998 999998876655554443311               


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                         ..          ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       404 ---~~----------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          404 ---KM----------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ---CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---CC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence               00          012467999999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.6e-44  Score=345.50  Aligned_cols=244  Identities=25%  Similarity=0.358  Sum_probs=186.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc---CCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+.||+|+||+||+|++.   .++..||||++...     ...+.+|+.++++++||||+++++++..     ..
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~  119 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----SK  119 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CC
Confidence            46999999999999999999986   46778999998643     2345689999999999999999998833     23


Q ss_pred             EEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++||||++ ++|.+++...   ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a  194 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLG  194 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred             ceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCC-CEEECcCccc
Confidence            4779999996 5887776542   3568999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          233 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       233 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      +........    ....+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.....     
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~-----  268 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-----  268 (373)
T ss_dssp             -------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE-----
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            866433211    122346789999999654 48999999999999999998 9999988876665554433110     


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                   .+          .+..++..+.+||.+||+.||.+|||+.++++
T Consensus       269 -------------~~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          269 -------------LP----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             -------------CC----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------CC----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                         00          11357899999999999999999999999876

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1e-44  Score=345.17  Aligned_cols=264  Identities=20%  Similarity=0.218  Sum_probs=195.1

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      +|.+.+.||+|+||+||+|++. +|+.||||++....    ....+|+.+++.++||||+++++++..     ....++|
T Consensus        40 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv  113 (321)
T 2qkw_B           40 NFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILI  113 (321)
T ss_dssp             CCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----TTCCEEE
T ss_pred             ccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeEEEE
Confidence            5999999999999999999974 68999999876432    345689999999999999999998732     2346799


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ +|.+.+.........+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENF-VPKITDFGISKKGTE  191 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTC-CEEECCCTTCEECSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence            999974 6655443322223458999999999999999999999 8999999999999999887 699999999976432


Q ss_pred             CC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+...     ....  ...
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~--~~~  263 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESH--NNG  263 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHH--TTT
T ss_pred             ccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhcc--ccc
Confidence            21   22345689999999998654 4899999999999999999999999765432111100000     0000  000


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  367 (422)
                           .+...........+....+..+.+|+.+||+.||++|||+.|+++|..
T Consensus       264 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          264 -----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             -----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                 011111111111122345678999999999999999999999998653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.4e-43  Score=330.72  Aligned_cols=257  Identities=23%  Similarity=0.374  Sum_probs=194.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEE----EcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ..+|++.+.||+|+||.||+|+    +..+++.||||++....     ....+|+.+++.++||||+++++++...   .
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence            3459999999999999999999    56789999999986432     4456899999999999999999988532   2


Q ss_pred             ceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      ...+++||||+++ +|.+++...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg  171 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFG  171 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCC-CEEECccc
Confidence            2347799999975 877776442   3569999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          231 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       231 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      ++........    .....+|..|+|||++.+. .++.++|||||||++|+|++|..|+....  ..   .....+....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~---~~~~~~~~~~  245 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPM--AL---FLKMIGPTHG  245 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HH---HHHHHCSCCG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchh--hH---HhhccCCccc
Confidence            9987654432    2344578889999999654 47899999999999999999998864321  11   1111111110


Q ss_pred             HH----H-hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          307 EE----I-KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       307 ~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ..    + ...... ..            ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~-~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          246 QMTVTRLVNTLKEG-KR------------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GGHHHHHHHHHHTT-CC------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHhcc-CC------------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            00    0 000000 00            0122467899999999999999999999999975

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.8e-43  Score=325.53  Aligned_cols=244  Identities=13%  Similarity=0.197  Sum_probs=197.0

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ..+|.+.+.||+|+||+||+|++.  ++.||||++....      ..+.+|+.+++.++||||+++++++...   ....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence            346999999999999999999985  8999999986432      3356799999999999999999988432   2234


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--ivHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      .++||||+++ +|.+++....  ...+++..++.++.||+.||.|||+ +|  |+||||||+|||++.++ .++|+|||+
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~  159 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDM-TARISMADV  159 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTS-CEEEEGGGS
T ss_pred             eEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCc-ceeEEeccc
Confidence            6799999985 8877776421  2358999999999999999999998 89  99999999999999887 699999988


Q ss_pred             ccccccCCCcccccccccccchhhhcCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          232 AKVLVKGEPNVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      +....    .....+|+.|+|||++.+...  ++.++|||||||++|+|++|+.||.+.+..+....+......+     
T Consensus       160 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----  230 (271)
T 3kmu_A          160 KFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-----  230 (271)
T ss_dssp             CCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC-----
T ss_pred             eeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC-----
Confidence            75432    234567999999999976432  2337999999999999999999999888776665554421110     


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                            .++..+++++.+||.+||+.||++|||+.++++
T Consensus       231 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 ----------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  122467999999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.4e-44  Score=369.82  Aligned_cols=284  Identities=25%  Similarity=0.335  Sum_probs=206.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~  155 (422)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++...     .....+|+++++.++||||+++++++..... ......
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            4599999999999999999999999999999987643     2334579999999999999999988643211 123446


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC--cEEEeecCCc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSA  232 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~--~vkl~DfG~a  232 (422)
                      ++||||++ ++|..++.... ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.  .+||+|||++
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            79999996 47777666432 12368899999999999999999999 89999999999999997653  3899999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..........   +...........
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~  247 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVVY  247 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCSC
T ss_pred             cccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhhh
Confidence            87766655566789999999999865 45899999999999999999999999876543221110   000000000000


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      ......+.+....  +....+...+++.+.+||.+||.+||++|||+.++++||||+.+.+
T Consensus       248 ~~l~g~~~~~~~l--p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          248 DDLTGAVKFSSVL--PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             CCCSSSCCCCSSS--CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             hhhcccccccccc--CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence            1111111111111  1112233446789999999999999999999999999999987643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-43  Score=333.46  Aligned_cols=245  Identities=23%  Similarity=0.329  Sum_probs=191.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCC----eEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+.||+|+||+||+|++..++    ..||||++....     ..+.+|+.+++.++||||+++++++.     ..
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  118 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY  118 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----cC
Confidence            35999999999999999999987553    469999986432     23457999999999999999999883     23


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ...++||||+++ +|.+++..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  193 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGL  193 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC
T ss_pred             CCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCC-cEEECCCCc
Confidence            347899999985 77776654   23579999999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          232 AKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       232 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      +........    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....    
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~----  268 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR----  268 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----
T ss_pred             chhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc----
Confidence            976543321    1123457789999999654 48999999999999999999 9999988876665555433110    


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                    .+          .+..+++++.+||.+||+.||.+||++.+++++
T Consensus       269 --------------~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          269 --------------LP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             --------------CC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             --------------CC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                          00          113578999999999999999999999999873

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=336.43  Aligned_cols=243  Identities=23%  Similarity=0.349  Sum_probs=188.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEE----EEEEecc-----chhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----AiK~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+.||+|+||+||+|++..+++.|    |+|.+..     ......+|+.+++.++||||+++++++...    .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----~   90 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----T   90 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----S
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----C
Confidence            35999999999999999999998888765    5665532     224456899999999999999999988432    1


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                        .+++++|+. +++.+.+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        91 --~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kL~DfG~  163 (327)
T 3lzb_A           91 --VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFGL  163 (327)
T ss_dssp             --EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTTC
T ss_pred             --ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCC-CEEEccCcc
Confidence              557888887 4666655542   3579999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          232 AKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       232 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      ++........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....     
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-----  237 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-----  237 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----
T ss_pred             eeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            9866433222   233457789999999754 48999999999999999999 9999988776554443332100     


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                   .+          .+..++.++.+||.+||..||.+|||+.|+++
T Consensus       238 -------------~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          238 -------------LP----------QPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             -------------CC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------CC----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                         00          12357899999999999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-43  Score=327.46  Aligned_cols=245  Identities=26%  Similarity=0.310  Sum_probs=196.3

Q ss_pred             eeEEee-eeeecCCeeEEEEEEc--CCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +|.+.+ .||+|+||.||+|.+.  .+++.||||++...     .....+|+++++.++||||+++++++. ..     .
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~-----~   83 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE-----A   83 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS-----S
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC-----C
Confidence            466665 9999999999999864  46889999998653     233458999999999999999999872 11     2


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .++||||+++ +|.+++..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus        84 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~  158 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGLSK  158 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred             cEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCC-CEEECccccee
Confidence            6799999985 77665542   23569999999999999999999999 8999999999999999877 79999999998


Q ss_pred             ccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .......    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+....       
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-------  230 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-------  230 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-------
T ss_pred             eeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-------
Confidence            6643322    1233457889999999654 48999999999999999998 999998887766555443310       


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  367 (422)
                                  .+         .++..+++++.+||.+||..||.+|||+.++++|.+
T Consensus       231 ------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          231 ------------RM---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             ------------CC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ------------cC---------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                        00         022467999999999999999999999999998754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.6e-43  Score=348.93  Aligned_cols=245  Identities=24%  Similarity=0.365  Sum_probs=199.4

Q ss_pred             ceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ...+|.+.+.||+|+||+||+|.+. .+..||||++...   ...+.+|+.+++.++||||+++++++.    .  ..++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~----~--~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT----K--EPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC----S--SSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe----C--CccE
Confidence            3457999999999999999999985 4788999998753   344568999999999999999998873    1  1267


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||+.+ +|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTC-CEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCC-cEEEeeCCCceEc
Confidence            99999974 8877776432  2467888999999999999999999 8999999999999999887 6999999999865


Q ss_pred             ccCC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          236 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       236 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ....  ......+|+.|+|||++... .++.++|||||||++|||+| |+.||.+.+..+.+..+......         
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------  404 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---------  404 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---------
T ss_pred             CCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            3221  11233457789999999654 48999999999999999999 99999998877766665542111         


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                               +          .+..+++++.+||.+||..||++|||+.++++
T Consensus       405 ---------~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          405 ---------P----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ---------C----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------C----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                     1          12457899999999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-42  Score=326.77  Aligned_cols=242  Identities=24%  Similarity=0.300  Sum_probs=193.8

Q ss_pred             eeeEEee-eeeecCCeeEEEEEE--cCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           82 VSYIAEH-VVGTGSFGVVFQAKC--RETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+ .||+|+||+||+|.+  ..+++.||||++...      ...+.+|+.+++.++||||+++++++ ...    
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~----   90 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE----   90 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS----
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC----
Confidence            4599988 999999999999954  567899999998643      23456899999999999999999987 211    


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                       ..++||||++ ++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        91 -~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~  163 (291)
T 1xbb_A           91 -SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGL  163 (291)
T ss_dssp             -SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred             -CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCC-cEEEccCCc
Confidence             2669999998 577666654    3568999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          232 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       232 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      +.........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....     
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----  237 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-----  237 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----
Confidence            9766443321    123456889999999654 47899999999999999999 999999877665544433210     


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                 .   +         .++..+++++.+||.+||+.||.+|||+.++++
T Consensus       238 -----------~---~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 -----------R---M---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -----------C---C---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------C---C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       0   0         012467899999999999999999999999876

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.5e-42  Score=327.05  Aligned_cols=241  Identities=26%  Similarity=0.361  Sum_probs=185.4

Q ss_pred             eeEEe-eeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHH-HHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           83 SYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        83 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +|.+. +.||+|+||.||+|.+..+++.||||++... ....+|+.++ +.++||||+++++++.... ....++++|||
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e   95 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVME   95 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEEC
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEEEEe
Confidence            47776 8899999999999999999999999998654 4456888887 6669999999999874322 23556889999


Q ss_pred             cchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC---CCCcEEEeecCCccccc
Q 014595          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~---~~~~vkl~DfG~a~~~~  236 (422)
                      |+++ +|.+.+....  ...+++..++.++.||+.||.|||+ +||+||||||+|||++.   ++ .+||+|||++....
T Consensus        96 ~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           96 CLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETT  171 (299)
T ss_dssp             CCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECT
T ss_pred             ecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCC-cEEEeccccccccc
Confidence            9975 8877766522  2469999999999999999999999 89999999999999997   44 69999999986432


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                                            ...++.++|||||||++|+|++|..||.+.+.......+..                 
T Consensus       172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-----------------  212 (299)
T 3m2w_A          172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-----------------  212 (299)
T ss_dssp             ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-----------------
T ss_pred             ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-----------------
Confidence                                  12367899999999999999999999977543321110000                 


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                       ....   ....+.......+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       213 -~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          213 -RIRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             -SSCT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             -HHhh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence             0000   000111111246799999999999999999999999999999998754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.4e-43  Score=325.42  Aligned_cols=243  Identities=22%  Similarity=0.332  Sum_probs=190.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch--hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      ..+|.+.+.||+|+||+||+|.+.  |+.||||++....  ....+|+.+++.++||||+++++++...    ...+++|
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv   93 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIV   93 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceEEE
Confidence            346999999999999999999874  8999999986543  3456899999999999999999986432    2246799


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||+++ +|.+.+....  ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS  169 (278)
T ss_dssp             ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC------
T ss_pred             EecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCC-cEEEeeccccccccc
Confidence            999985 8877776432  1347889999999999999999999 8999999999999999887 699999999875533


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .  .....+++.|+|||++.+. .++.++|||||||++|+|+| |..||...+..+....+....               
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---------------  231 (278)
T 1byg_A          170 T--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------  231 (278)
T ss_dssp             --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------------
T ss_pred             c--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------------
Confidence            2  2334568889999998654 48999999999999999998 999998776554443332210               


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                       .            ...+..+++.+.+||.+||..||.+|||+.++++
T Consensus       232 -~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 -K------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             -C------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -C------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence             0            0112467899999999999999999999999976

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.6e-42  Score=346.56  Aligned_cols=248  Identities=21%  Similarity=0.229  Sum_probs=196.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc--chhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +|.+.++||+|+||.||+|++..+++.||||++..  ......+|+++++.|.|++++..+..+..    ...+.++|||
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~lvme   83 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVLVMD   83 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEEEEE
Confidence            59999999999999999999999999999998753  23456789999999988666655554432    3345789999


Q ss_pred             cchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE---cCCCCcEEEeecCCcccccc
Q 014595          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill---~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |++++|.+++...   ...+++..++.++.||+.||.|||+ +||+||||||+||||   +.++ .+||+|||+++....
T Consensus        84 ~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           84 LLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEECBC
T ss_pred             CCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCC-eEEEEeCCcceeccC
Confidence            9988888877642   3679999999999999999999999 899999999999999   4555 799999999987654


Q ss_pred             CCCc--------ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCH
Q 014595          238 GEPN--------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTPTR  306 (422)
Q Consensus       238 ~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~  306 (422)
                      ....        ....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+...   ...+.++.........
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            3321        256789999999999664 489999999999999999999999987543   3333333322111111


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +                        .+...++.++.+||.+||+.||.+||++.++++
T Consensus       238 ~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 E------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             H------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             H------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1                        112457899999999999999999999987765

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9e-43  Score=326.86  Aligned_cols=246  Identities=20%  Similarity=0.285  Sum_probs=185.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|++.+.||+|+||+||+|++.   ..||||++....      ..+.+|+.+++.++||||++++++..    .  ...
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~--~~~   94 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST----A--PQL   94 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----S--SSC
T ss_pred             cceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc----C--Ccc
Confidence            35999999999999999999864   359999885422      33568999999999999999988541    1  126


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||+. +++.+.+..   ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~  169 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDN-TVKIGDFGLATE  169 (289)
T ss_dssp             EEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTT-EEEECCCC----
T ss_pred             EEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCC-CEEEccceeccc
Confidence            68999997 466555532   23568999999999999999999999 8999999999999999887 799999999975


Q ss_pred             cccC---CCcccccccccccchhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          235 LVKG---EPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       235 ~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ....   .......||+.|+|||++..  ...++.++|||||||++|+|++|+.||.+.+..+.+..+......++    
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----  245 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP----  245 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC----
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc----
Confidence            5321   22234568999999999852  34478899999999999999999999998777766666554311110    


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                        .+ ..+...+++++.+||.+||..||.+|||+.++++
T Consensus       246 ------------------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 ------------------DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ------------------CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                              00 0112467899999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-42  Score=323.11  Aligned_cols=243  Identities=23%  Similarity=0.311  Sum_probs=196.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|.+.+.||+|+||.||+|++. +++.||||++...   .....+|+++++.++||||+++++++..    +  ..++|
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~--~~~~v   85 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----E--PIYII   85 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCEEE
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC----C--CcEEE
Confidence            46999999999999999999985 5788999998653   3445689999999999999999988731    1  26689


Q ss_pred             eecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      |||++ ++|.+++....  ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus        86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLIED  161 (279)
T ss_dssp             EECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEECSS
T ss_pred             EecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCC-CEEECCCcccccccC
Confidence            99996 57766654321  2368999999999999999999999 8999999999999999877 699999999976643


Q ss_pred             CCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...  .....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.....            
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------------  228 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------------  228 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------
T ss_pred             cccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC------------
Confidence            321  1234457789999999644 48899999999999999999 9999998877665555433110            


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                      ...+..+++++.+||.+||..||++|||+.++++
T Consensus       229 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 ----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                            0112457899999999999999999999999886

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.7e-42  Score=326.18  Aligned_cols=246  Identities=21%  Similarity=0.313  Sum_probs=193.0

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCC---CeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|.+.+.||+|+||+||+|++..+   +..||+|.+....     ....+|+.+++.++||||+++++++...    .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence            34699999999999999999997543   3468999876422     3345899999999999999999986432    2


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ...++||||+++ +|.+++..   ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~  174 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGL  174 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred             CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCC-CEEECcccc
Confidence            346799999986 87776653   23568999999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccCC-----CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          232 AKVLVKGE-----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       232 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      ++......     ......+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....   
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~---  250 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---  250 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---
Confidence            97653322     12344567889999999654 48999999999999999999 6778877665554444433110   


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                               ...+..++..+.+||.+||+.||.+|||+.++++
T Consensus       251 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 -------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     0012457899999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-43  Score=333.62  Aligned_cols=252  Identities=21%  Similarity=0.289  Sum_probs=187.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-hhHHHHHHHHHHc--CCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML--DHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~l--~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|++.+.||+|+||.||+|++.  |+.||||++.... ....+|.+++..+  +||||+++++++.... .....+++|
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv  113 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYLI  113 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEEE
Confidence            46999999999999999999985  8999999986543 2234566666554  9999999999875433 223557899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------CceecCCCCCCeEEcCCCCcEEEeec
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--------givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      |||+++ +|.+++..     ..+++..++.++.|++.||.|||+ .        ||+||||||+|||++.++ .+||+||
T Consensus       114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df  186 (337)
T 3mdy_A          114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  186 (337)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence            999975 88777653     569999999999999999999998 7        999999999999999887 6999999


Q ss_pred             CCccccccCCCc-----ccccccccccchhhhcCCCCCCCc------chHHHHHHHHHHHHhC----------CCCCCCC
Q 014595          230 GSAKVLVKGEPN-----VSYICSRYYRAPELIFGATEYTTA------IDIWSTGCVMAELLLG----------QPLFPGE  288 (422)
Q Consensus       230 G~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~il~elltG----------~~pf~~~  288 (422)
                      |++.........     ....||+.|+|||++.+.. +...      +|||||||++|||+||          ..||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999765433221     2457899999999996544 4444      9999999999999999          6677543


Q ss_pred             C----hHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          289 S----GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       289 ~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .    ............                     ...+..........+++++.+||.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIK---------------------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             SCSSCCHHHHHHHHTTS---------------------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCchhhhHHHHhhh---------------------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            2    112222221100                     000000000111245678999999999999999999999987


Q ss_pred             C
Q 014595          365 H  365 (422)
Q Consensus       365 h  365 (422)
                      |
T Consensus       325 ~  325 (337)
T 3mdy_A          325 T  325 (337)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-42  Score=322.41  Aligned_cols=246  Identities=21%  Similarity=0.307  Sum_probs=192.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCe---EEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ...|.+.+.||+|+||+||+|++..+++   .||+|.+....     ....+|+.+++.++||||+++++++....    
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   95 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence            4468999999999999999999765544   79999886422     33458999999999999999999884322    


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ...+++|||+. +++.+.+..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~  170 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESF-TVKVADFGL  170 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECCTTS
T ss_pred             CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEeCcCCC
Confidence            22468999986 577666643   24678999999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccC-----CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCC
Q 014595          232 AKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       232 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      ++.....     .......+|+.|+|||.+.+. .++.++|||||||++|+|++| .+||.+.+..+....+......  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--  247 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL--  247 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC--
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC--
Confidence            9754322     222345678899999999654 589999999999999999995 5556555544443333321100  


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                                ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       248 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          248 --------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                      012357899999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.5e-42  Score=345.65  Aligned_cols=244  Identities=25%  Similarity=0.362  Sum_probs=194.6

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..+|++.+.||+|+||+||+|.+.. +..||||++....   ..+.+|+.+++.++||||+++++++..      ..+++
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~i  255 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI  255 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred             hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceEE
Confidence            4579999999999999999999964 5679999987532   445789999999999999999998732      12679


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+++ +|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus       256 v~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIE  331 (452)
T ss_dssp             EECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC---
T ss_pred             EehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCC-CEEECCCccceecC
Confidence            9999974 7877765322  3568999999999999999999999 8999999999999999877 69999999998654


Q ss_pred             cCCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          237 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       237 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ....  .....+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+.+..+.....           
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----------  399 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----------  399 (452)
T ss_dssp             -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             CCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            3321  1233457789999998654 58999999999999999999 9999998887666655443210           


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                             .+          .+..+++.+.+||.+||+.||++|||+.++++
T Consensus       400 -------~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          400 -------MP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             -------CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------CC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                   00          12457899999999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=336.80  Aligned_cols=274  Identities=22%  Similarity=0.298  Sum_probs=191.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh-hHHHHHHH--HHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YKNRELQI--MQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~E~~~--l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|.+.+.||+|+||+||+|++  +++.||||++..... ....|.++  +..++||||+++++.+..........+++|
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            4599999999999999999987  589999999865432 22334444  445899999999886654444556667899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---------CceecCCCCCCeEEcCCCCcEEEee
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------GICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---------givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                      |||+++ +|.+++..     ...++..+..++.||+.||.|||+ .         ||+||||||+|||++.++ .+||+|
T Consensus        91 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~D  163 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISD  163 (336)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTS-CEEECC
T ss_pred             EecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCC-cEEEee
Confidence            999964 88777654     456888999999999999999998 8         999999999999999887 699999


Q ss_pred             cCCccccccCC---------CcccccccccccchhhhcCC------CCCCCcchHHHHHHHHHHHHhCCCCCCC-CChHH
Q 014595          229 FGSAKVLVKGE---------PNVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVD  292 (422)
Q Consensus       229 fG~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~elltG~~pf~~-~~~~~  292 (422)
                      ||+++......         ......||+.|+|||++.+.      ..++.++|||||||++|||++|..||.. ....+
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            99997654321         12245689999999999652      2366789999999999999999766533 22111


Q ss_pred             HHHHHH-HHhCCCCHHHHhhcC-cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc------
Q 014595          293 QLVEII-KVLGTPTREEIKCMN-PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------  364 (422)
Q Consensus       293 ~~~~i~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~------  364 (422)
                      ....+. .....+....+.... .......++.    .|..  ....++++.+||.+||+.||++|||+.|+++      
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCc----cccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            000000 111222222221110 0000001110    0100  0124568999999999999999999999954      


Q ss_pred             CCcccc
Q 014595          365 HPFFDE  370 (422)
Q Consensus       365 hp~f~~  370 (422)
                      ++|-++
T Consensus       318 ~~~~~~  323 (336)
T 3g2f_A          318 MIWERN  323 (336)
T ss_dssp             HCCCC-
T ss_pred             HHHHhc
Confidence            566554

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=325.95  Aligned_cols=242  Identities=29%  Similarity=0.423  Sum_probs=185.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch--hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .+|.+.+.||+|+||+||+|++.  ++.||||++....  ..+.+|+.+++.++||||+++++++.     +.  .++||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv~   78 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLVM   78 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEEE
Confidence            35999999999999999999985  7899999986543  34568999999999999999998773     12  56899


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||+++ +|.+++.... ....+++..+..++.|++.||.|||+.  +||+||||||+|||++.++..+||+|||++....
T Consensus        79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             ECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            99975 7777665422 123478888999999999999999972  4899999999999999877558999999997553


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhcCc
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD--QLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......  ....+..  +.           
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~-----------  221 (307)
T 2eva_A          158 TH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GT-----------  221 (307)
T ss_dssp             ---------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TC-----------
T ss_pred             cc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CC-----------
Confidence            22  2345689999999999654 58999999999999999999999997643221  1111111  00           


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                            .+         .....+++.+.+||.+||+.||.+|||+.++++
T Consensus       222 ------~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          222 ------RP---------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ------CC---------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CC---------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                  00         012467899999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-43  Score=338.91  Aligned_cols=247  Identities=20%  Similarity=0.310  Sum_probs=186.5

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCC---CeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ...|.+.+.||+|+||+||+|++..+   +..||+|.+...     ...+.+|+.+++.++||||+++++++...    .
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~  163 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E  163 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----S
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----C
Confidence            34699999999999999999997543   246899988542     23445799999999999999999976432    2


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ...++||||+++ +|.+++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DFG~  238 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGL  238 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred             CCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCC-CEEEeeccc
Confidence            236799999985 77776653   23568899999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccCCC-----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          232 AKVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       232 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      ++.......     .....+|+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+....    
T Consensus       239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~----  313 (373)
T 3c1x_A          239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----  313 (373)
T ss_dssp             -------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC----
T ss_pred             cccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC----
Confidence            976533221     1234567889999999654 58999999999999999999 788888766554444333210    


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                  ..            ..+..++..+.+||.+||..||++|||+.+++++
T Consensus       314 ------------~~------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          314 ------------RL------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ------------CC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                        00            0124578999999999999999999999999873

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.2e-43  Score=329.74  Aligned_cols=256  Identities=21%  Similarity=0.273  Sum_probs=193.2

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      |...+.||+|+||+||+|++  +++.||||++...        ...+.+|+.+++.++||||+++++++..     ....
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCce
Confidence            66678999999999999986  5889999988542        2345689999999999999999998843     2337


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||++ +++.+.+.... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~  182 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAF-TAKISDFGLARA  182 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCC-cEEEeecccccc
Confidence            79999996 57777665432 24568999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          235 LVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       235 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      ......   .....||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......+..+...+..........
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             cccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence            543222   223568999999999854  378999999999999999999999987654433333322211110000000


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      ....     ++         ......+..+.+|+.+||..||.+|||+.+++++
T Consensus       261 ~~~~-----~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          261 IDKK-----MN---------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SCSS-----CS---------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccc-----cc---------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0000     00         0112345789999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=336.12  Aligned_cols=245  Identities=16%  Similarity=0.193  Sum_probs=190.1

Q ss_pred             eeeEEeeeeeecCCeeEEEE-----EEcCCCeEEEEEEeccch-hhHHHHHHHHHHcC---CCCcccccceeecCCCCCc
Q 014595           82 VSYIAEHVVGTGSFGVVFQA-----KCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~  152 (422)
                      .+|.+.+.||+|+||+||+|     .+..+++.||||++.... ....+|+++++.++   |+||+.+++++....    
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~----  140 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN----  140 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS----
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC----
Confidence            46999999999999999999     467789999999986543 34567888888887   899999999884433    


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC-----------
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-----------  219 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~-----------  219 (422)
                       ..++||||++ ++|.+++..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.           
T Consensus       141 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          141 -GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             -CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC------
T ss_pred             -CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCccccccc
Confidence             3679999997 588887765443 24679999999999999999999999 89999999999999987           


Q ss_pred             CCCcEEEeecCCcccccc---CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014595          220 HTHQLKLCDFGSAKVLVK---GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE  296 (422)
Q Consensus       220 ~~~~vkl~DfG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~  296 (422)
                      ++ .+||+|||+|+....   .......+||+.|+|||++.+.. ++.++|||||||++|||+||+.||......     
T Consensus       219 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~-----  291 (365)
T 3e7e_A          219 SA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG-----  291 (365)
T ss_dssp             CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred             cC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence            55 699999999965432   22234567899999999997654 899999999999999999999999643210     


Q ss_pred             HHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCc
Q 014595          297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (422)
Q Consensus       297 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  367 (422)
                                           .+.....    +..   ...++.+.+++.+||..+|.+|++..+.+.+.+
T Consensus       292 ---------------------~~~~~~~----~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          292 ---------------------ECKPEGL----FRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             ---------------------EEEECSC----CTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             ---------------------ceeechh----ccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence                                 0000000    000   123677899999999999999977655555443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.9e-42  Score=348.61  Aligned_cols=244  Identities=25%  Similarity=0.372  Sum_probs=198.4

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      ..+|++.+.||+|+||.||+|++.. +..||||++....   ..+.+|+++|+.++||||+++++++..      ..+++
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~l  338 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI  338 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccceE
Confidence            4579999999999999999999964 5679999986532   446789999999999999999998732      12679


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ||||+.+ +|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus       339 v~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIE  414 (535)
T ss_dssp             EECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCC
T ss_pred             eeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCC-cEEEcccccceecC
Confidence            9999975 7877765422  3568999999999999999999999 8999999999999999877 69999999997653


Q ss_pred             cCC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ...  ......++..|+|||++.+. .++.++|||||||++|||++ |+.||.+....+.+..+....            
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------  481 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------  481 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------
Confidence            221  11233457789999998654 58999999999999999999 999999887766665544311            


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                            ..+          .+..++.++.+||.+||..||++|||+.++++
T Consensus       482 ------~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          482 ------RMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             ------CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                  000          12457899999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.2e-42  Score=328.79  Aligned_cols=258  Identities=24%  Similarity=0.361  Sum_probs=192.9

Q ss_pred             eEEeeeeeecCCeeEEEEEE----cCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           84 YIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~----~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      |++.+.||+|+||+||+|..    ..+++.||||++....     ..+.+|+++++.++||||+++++++...   +...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence            59999999999999988764    4578999999987542     3356899999999999999999988542   2345


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+++ +|.+++..     ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCC-CEEECCccccc
Confidence            7899999975 77665542     458999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 014595          234 VLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--  307 (422)
Q Consensus       234 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~--  307 (422)
                      .......    .....+|+.|+|||++.+. .++.++|||||||++|+|+||..||.......  .   ...+.....  
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~---~~~~~~~~~~~  256 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKF--L---ELIGIAQGQMT  256 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--H---HHHCSCCHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhh--h---hhhcccccchh
Confidence            7654332    2234568889999999654 47899999999999999999999996532110  0   000110000  


Q ss_pred             --HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          308 --EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       308 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                        .+.........            ...+..+++++.+||++||+.||.+|||+.++++  +++.+
T Consensus       257 ~~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l  308 (318)
T 3lxp_A          257 VLRLTELLERGER------------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTV  308 (318)
T ss_dssp             HHHHHHHHHTTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             HHHHHHHHhcccC------------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHH
Confidence              00000000000            0112467899999999999999999999999985  45443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.8e-42  Score=321.74  Aligned_cols=250  Identities=24%  Similarity=0.362  Sum_probs=191.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC-CCe--EEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE-TGE--IVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      .+|++.+.||+|+||+||+|++.. +++  .||||++...       .....+|+.+++.++||||+++++++...    
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   93 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   93 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence            469999999999999999998643 333  6899987542       13345899999999999999999987431    


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      .  .++||||++ +++.+.+...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        94 ~--~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg  166 (291)
T 1u46_A           94 P--MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG  166 (291)
T ss_dssp             S--CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             C--ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCC-CEEEcccc
Confidence            1  568999998 4776666542   3568999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          231 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       231 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      ++.........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+.....   
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---  242 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---  242 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC---
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC---
Confidence            99776443321    234567789999999654 47899999999999999999 9999998887666555443110   


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                    ..+          .+..++.++.++|.+||..||.+|||+.++++  +++++.
T Consensus       243 --------------~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~~  283 (291)
T 1u46_A          243 --------------RLP----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ  283 (291)
T ss_dssp             --------------CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHC
T ss_pred             --------------CCC----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHhC
Confidence                          000          12457899999999999999999999999987  565543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.6e-42  Score=327.60  Aligned_cols=253  Identities=22%  Similarity=0.251  Sum_probs=192.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-hhHHHHHHHHHH--cCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++.... ....+|+++++.  ++||||+++++++.... .....+++|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence            3699999999999999999998  48999999986543 344578899888  79999999999875433 222357899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCceecCCCCCCeEEcCCCCcEEEeec
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--------~~~givHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      |||+++ +|.+++..     ..+++..++.++.||+.||.|||        + .||+||||||+|||++.++ .+||+||
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~-~~kL~Df  191 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNG-TCCIADL  191 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTS-CEEECCC
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCC-CEEEEEC
Confidence            999986 88777753     46899999999999999999999        7 8999999999999999887 6999999


Q ss_pred             CCccccccCCC-----cccccccccccchhhhcCCCC-----CCCcchHHHHHHHHHHHHhC----------CCCCCCCC
Q 014595          230 GSAKVLVKGEP-----NVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLG----------QPLFPGES  289 (422)
Q Consensus       230 G~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~elltG----------~~pf~~~~  289 (422)
                      |++........     .....+|+.|+|||++.+...     ++.++|||||||++|+|+||          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99976654432     234578999999999965432     23689999999999999999          78886642


Q ss_pred             h----HHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          290 G----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       290 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      .    .+.+........              ....++    ..+   .....+..+.+||.+||+.||++|||+.++++|
T Consensus       272 ~~~~~~~~~~~~~~~~~--------------~~~~~~----~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQK--------------LRPNIP----NRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSC--------------CCCCCC----GGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHH--------------hCCCCc----ccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            1    222222111000              000000    000   112345679999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.4e-41  Score=351.26  Aligned_cols=240  Identities=23%  Similarity=0.309  Sum_probs=190.8

Q ss_pred             eEE-eeeeeecCCeeEEEEEE--cCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           84 YIA-EHVVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        84 y~~-~~~lg~G~~g~V~~~~~--~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +.+ .+.||+|+||+||+|.+  ..+++.||||++....      ..+.+|+++++.++|||||++++++..    +  .
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~--~  443 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----E--S  443 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES----S--S
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec----C--C
Confidence            444 45899999999999955  4567899999986532      345689999999999999999998731    1  1


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+.+ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus       444 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~-~~kL~DFGla~  517 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSK  517 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred             EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence            5699999984 67666643    4678999999999999999999999 8999999999999999887 79999999998


Q ss_pred             ccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      .......    .....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.....      
T Consensus       518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------  590 (635)
T 4fl3_A          518 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------  590 (635)
T ss_dssp             HTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------
T ss_pred             ccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            6644322    1233457889999999654 48999999999999999998 9999998887766555543210      


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                ..            .+..+++++.+||.+||..||++|||+.++++
T Consensus       591 ----------~~------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          591 ----------MG------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ----------CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------CC------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                      00            12467899999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=323.96  Aligned_cols=257  Identities=26%  Similarity=0.440  Sum_probs=194.3

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEE----cCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|++.+.||+|+||.||+|++    ..+|+.||||++....    ..+.+|+.+++.++||||+++++++...   +.
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---CC
Confidence            44699999999999999999984    5689999999986532    3456899999999999999999987432   22


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ..+++||||+++ +|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kL~Dfg~  191 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFGL  191 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCTT
T ss_pred             CceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCC-cEEEecCcc
Confidence            346799999975 887776542   2468999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          232 AKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       232 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      +........    .....++..|+|||++.+. .++.++|||||||++|+|+||..||....  ..+   .+..+.....
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~--~~~---~~~~~~~~~~  265 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPP--AEF---MRMIGNDKQG  265 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHH---HHHHCTTCCT
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCH--HHH---HHhhccccch
Confidence            987644332    1233467789999998654 48899999999999999999999985421  111   1111111110


Q ss_pred             H------HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          308 E------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       308 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      .      ...+... ..  .          ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~-~~--~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          266 QMIVFHLIELLKNN-GR--L----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHHHHTT-CC--C----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHHHhhcC-CC--C----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0      0000000 00  0          012467899999999999999999999999975

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.1e-44  Score=341.67  Aligned_cols=247  Identities=18%  Similarity=0.167  Sum_probs=181.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------------hhHHHHHHHHHHcC----------------
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLD----------------  133 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l~----------------  133 (422)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++....            ....+|+.+++.++                
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            4699999999999999999998  68999999986542            44568999999886                


Q ss_pred             ----------CCCcccccceeecCCC--------CCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHH
Q 014595          134 ----------HPNIVALKHCFFSTTD--------KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR  194 (422)
Q Consensus       134 ----------h~nIv~l~~~~~~~~~--------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~  194 (422)
                                ||||++++++|.....        .....+++||||+.+ ++...+     ....+++..++.++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~-----~~~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGG-----TTTCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHH-----HhcCCCHHHHHHHHHHHHH
Confidence                      4555555555432100        013458899999864 232222     1256899999999999999


Q ss_pred             HHHHHH-hcCCceecCCCCCCeEEcCCC-------------------CcEEEeecCCccccccCCCcccccccccccchh
Q 014595          195 ALAYIH-NCIGICHRDIKPQNLLVNPHT-------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE  254 (422)
Q Consensus       195 aL~~LH-~~~givHrDlkp~Nill~~~~-------------------~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE  254 (422)
                      ||+||| + +||+||||||+|||++.++                   ..+||+|||+|+.....    ..+||+.|+|||
T Consensus       173 aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE  247 (336)
T 2vuw_A          173 SLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred             HHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence            999999 8 8999999999999999765                   16999999999876432    457899999999


Q ss_pred             hhcCCCCCCCcchHHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccc
Q 014595          255 LIFGATEYTTAIDIWSTGCV-MAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV  332 (422)
Q Consensus       255 ~~~~~~~~~~~~DiwslG~i-l~elltG~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (422)
                      ++.+..  +.++||||||++ .+++++|..||.+..... ....+.....                  ....   +. ..
T Consensus       248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~~---~~-~~  303 (336)
T 2vuw_A          248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT------------------FKTK---CN-TP  303 (336)
T ss_dssp             GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC------------------CSSC---CC-SH
T ss_pred             hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc------------------cCcc---cc-hh
Confidence            997643  889999998777 777889999995421111 1122221100                  0000   00 01


Q ss_pred             cccCCChHHHHHHHhhhhcCCCCcCCHHHHh-cCCccc
Q 014595          333 FQKRLPPEAVDLVCRFFQYSPNLRCTALEAC-VHPFFD  369 (422)
Q Consensus       333 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l-~hp~f~  369 (422)
                      ....+++++++||++||++|     |+.|+| +||||+
T Consensus       304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            12346889999999999987     999999 999995

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=348.48  Aligned_cols=247  Identities=26%  Similarity=0.326  Sum_probs=193.4

Q ss_pred             eeEEee-eeeecCCeeEEEEEEc--CCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+.+.+ .||+|+||+||+|.++  .++..||||++...     ...+.+|+++|+.++|||||++++++.. .     .
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~-----~  409 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----A  409 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-----S
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-----C
Confidence            355555 8999999999999875  35678999998653     2445689999999999999999998742 1     2


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+++ +|.+++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus       410 ~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~-~vkL~DFGla~  484 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRH-YAKISDFGLSK  484 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCSTTT
T ss_pred             eEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCC-cEEEeeccCcc
Confidence            6799999985 66665532   23569999999999999999999999 8999999999999999887 79999999998


Q ss_pred             ccccCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          234 VLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       234 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ........    ....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.....      
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------  557 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------  557 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC------
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            66433221    122346789999999654 58999999999999999998 9999999887776655543210      


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHh---cCCccc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC---VHPFFD  369 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l---~hp~f~  369 (422)
                                .            .++..+++++.+||.+||..||.+|||+.+++   ++.|+.
T Consensus       558 ----------~------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          558 ----------M------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             ----------C------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----------C------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                      0            01246899999999999999999999999874   455544

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=321.26  Aligned_cols=250  Identities=18%  Similarity=0.260  Sum_probs=192.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||+|+||.||+|++..   .||+|++...      ...+.+|+.+++.++||||+++++++...     ..+
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~  104 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----PHL  104 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----SCE
T ss_pred             HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----Cce
Confidence            359999999999999999999853   4999988542      13345799999999999999999988533     237


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++||||++ ++|.+++..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++ ++ .+||+|||++..
T Consensus       105 ~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~  178 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NG-KVVITDFGLFSI  178 (319)
T ss_dssp             EEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSCCC-
T ss_pred             EEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CC-CEEEeecCCccc
Confidence            89999997 577665543   23468999999999999999999999 8999999999999998 45 699999999865


Q ss_pred             ccc------CCCcccccccccccchhhhcC--------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014595          235 LVK------GEPNVSYICSRYYRAPELIFG--------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  300 (422)
Q Consensus       235 ~~~------~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~  300 (422)
                      ...      ........||+.|+|||++.+        ...++.++|||||||++|+|++|..||.+.+.......+...
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  258 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG  258 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence            421      112234468999999999864        234788999999999999999999999888766655544331


Q ss_pred             hCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      ..                   +.        .....++.++.+||.+||..||.+|||+.++++  .++.+...
T Consensus       259 ~~-------------------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~  303 (319)
T 2y4i_B          259 MK-------------------PN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKR  303 (319)
T ss_dssp             CC-------------------CC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC---
T ss_pred             CC-------------------CC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHh
Confidence            00                   00        011247889999999999999999999999987  56655443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.5e-40  Score=344.80  Aligned_cols=244  Identities=26%  Similarity=0.351  Sum_probs=196.0

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCC---CeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      ..+|.+.+.||+|+||+||+|++..+   +..||||++....     ..+.+|+.+++.++||||+++++++..    + 
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~-  463 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----N-  463 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----S-
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C-
Confidence            45799999999999999999998643   5679999876432     345579999999999999999998721    1 


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                       .+++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       464 -~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~-~vkL~DFG~  537 (656)
T 2j0j_A          464 -PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFGL  537 (656)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCCC
T ss_pred             -ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCC-CEEEEecCC
Confidence             2679999998 5777666532   3468999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          232 AKVLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       232 a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      ++........  ....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+......     
T Consensus       538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-----  611 (656)
T 2j0j_A          538 SRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-----  611 (656)
T ss_dssp             CCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC-----
T ss_pred             CeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            9866433221  233457889999999654 58999999999999999997 99999998877776666542100     


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                 .            ++..+++.+.+||.+||..||.+|||+.++++
T Consensus       612 -----------~------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          612 -----------P------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             -----------C------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------C------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                       0            12467899999999999999999999999976

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-41  Score=354.79  Aligned_cols=241  Identities=26%  Similarity=0.366  Sum_probs=194.5

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC-CCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|++.+.||+|+||+||+|++.. +|+.||||++....     ....+|+.+++.++||||+++++++.........+.
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            469999999999999999999976 78999999885432     234579999999999999999999876555455567


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      |+||||+++ +|.+.+      ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+  .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~------~~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~--~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS--CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC--cEEEEecccchh
Confidence            899999985 553332      2379999999999999999999999 899999999999999974  699999999986


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+....                       
T Consensus       231 ~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------------  282 (681)
T 2pzi_A          231 INSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------------  282 (681)
T ss_dssp             TTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------------
T ss_pred             cccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc-----------------------
Confidence            5432   456789999999998653  588999999999999999999988652100                       


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                           ..+.  ..+     ....++.+.+||.+||+.||.+||+..+++.|+|+.-+
T Consensus       283 -----~~~~--~~~-----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          283 -----GLPE--DDP-----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -----SCCT--TCH-----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----cccc--ccc-----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                 0000  000     01246789999999999999999999999999998654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.6e-39  Score=304.40  Aligned_cols=225  Identities=14%  Similarity=0.074  Sum_probs=174.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|++.+.||+|+||.||+|++..+|+.||||++....       ..+.+|+.+++.++||||+++++++..     ....
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~~  106 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAGG  106 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCcE
Confidence            5999999999999999999999999999999986532       345689999999999999999998843     3347


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      |+||||++ ++|.+++..      ......+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+++|    
T Consensus       107 ~lv~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g-~~kl~~~~----  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDG-DVVLAYPA----  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTS-CEEECSCC----
T ss_pred             EEEEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCC-CEEEEecc----
Confidence            89999997 477666532      24555688899999999999999 8999999999999999887 69998543    


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                                     |++        .++.++|||||||++|+|+||+.||.+.+..+.+..                  
T Consensus       175 ---------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------------  213 (286)
T 3uqc_A          175 ---------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------------  213 (286)
T ss_dssp             ---------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------------
T ss_pred             ---------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------------
Confidence                           332        268899999999999999999999987653211100                  


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                         ......... +....+...+++++.+||.+||+.||++| |+.|+++  .+..+.
T Consensus       214 ---~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~--~L~~~~  264 (286)
T 3uqc_A          214 ---AERDTAGQP-IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN--LMQQAT  264 (286)
T ss_dssp             ---CCBCTTSCB-CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH--HHHHHH
T ss_pred             ---HHHHhccCC-CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH--HHHHHh
Confidence               000000000 11112235689999999999999999999 9999988  455543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.8e-33  Score=285.28  Aligned_cols=180  Identities=17%  Similarity=0.072  Sum_probs=124.2

Q ss_pred             eeeecCCeeEEEEEEcCCCeEEEEEEeccc--------------hhhHHHHHHHHHHc-CCCCcccccceeecCCCCCce
Q 014595           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..+.|++|.+..++...+|+.||+|++.++              ...+.+|+++|+++ .|+||+++++++     .+..
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            467788888888888888999999998543              12345799999999 799999999988     4445


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+|||||||+| +|.+++..    .+.+++.   .|+.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg-~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQ-HARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCC-CEEEeecccC
Confidence            58899999996 77777654    3556654   478899999999999 8999999999999999888 6999999999


Q ss_pred             cccccC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014595          233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  284 (422)
Q Consensus       233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~p  284 (422)
                      +..... ....+.+||+.|||||++.+  .+..++|+||+|+++++|.+|..+
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence            876443 33456789999999999965  367889999999998887665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=6.9e-28  Score=244.18  Aligned_cols=180  Identities=16%  Similarity=0.234  Sum_probs=132.3

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------------hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      +...+.||+|+||+||+|.  ..++.+|+|+.....            ..+.+|++++++++||||+++..++.....  
T Consensus       338 ~~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--  413 (540)
T 3en9_A          338 KIPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--  413 (540)
T ss_dssp             ----------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT--
T ss_pred             CCCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc--
Confidence            3456789999999999994  457889999753211            224689999999999999955444432222  


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                         .++||||++ ++|.+++..            +..++.|++.||+|||+ +||+||||||+|||++.   .+||+|||
T Consensus       414 ---~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFG  474 (540)
T 3en9_A          414 ---KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFG  474 (540)
T ss_dssp             ---TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCT
T ss_pred             ---cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECc
Confidence               479999997 577665442            45788999999999999 89999999999999997   59999999


Q ss_pred             CccccccCCC--------cccccccccccchhhhcC-CCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014595          231 SAKVLVKGEP--------NVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFP  286 (422)
Q Consensus       231 ~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltG~~pf~  286 (422)
                      +|+.......        .....||+.|||||++.+ ...|+..+|+|+..+-..+.+.++.+|.
T Consensus       475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9987643322        125678999999999954 1237888999999999888888776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=3.1e-24  Score=199.78  Aligned_cols=138  Identities=18%  Similarity=0.159  Sum_probs=109.1

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----------------------hhhHHHHHHHHHHcCCCCccccc
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------------------KRYKNRELQIMQMLDHPNIVALK  141 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----------------------~~~~~~E~~~l~~l~h~nIv~l~  141 (422)
                      |.+.+.||+|+||.||+|++ .+|+.||||++...                      .....+|+++++.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            55669999999999999999 88999999998532                      123468999999999  5 6776


Q ss_pred             ceeecCCCCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC
Q 014595          142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  220 (422)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~  220 (422)
                      +++..      ...++||||+++ +|.+ +          .......++.|++.||.|||+ +||+||||||+|||++ +
T Consensus       168 ~~~~~------~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          168 KVYAW------EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             CEEEE------ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-T
T ss_pred             eEEec------cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-C
Confidence            65521      225799999975 5533 1          112345689999999999999 8999999999999999 6


Q ss_pred             CCcEEEeecCCccccccCCCcccccccccccchhhhc
Q 014595          221 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF  257 (422)
Q Consensus       221 ~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~  257 (422)
                      + .+||+|||+|+.            +..++|||.+.
T Consensus       229 ~-~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 E-GIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             T-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             C-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence            6 799999999863            33478999873

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1.2e-21  Score=179.89  Aligned_cols=135  Identities=17%  Similarity=0.238  Sum_probs=102.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeE--EEEEEeccch----------------------------hhHHHHHHHHHHc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDK----------------------------RYKNRELQIMQML  132 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vAiK~~~~~~----------------------------~~~~~E~~~l~~l  132 (422)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            388999999999999999999778999  9999864321                            1346799999999


Q ss_pred             CCCCcccccceeecCCCCCceEEEEEeecchh------HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH-hcCCc
Q 014595          133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-NCIGI  205 (422)
Q Consensus       133 ~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~gi  205 (422)
                      .|++|... ..+..      ...++||||+++      .+.+...       ..++..+..++.|++.||.||| + .||
T Consensus       128 ~~~~i~~p-~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~gi  192 (258)
T 1zth_A          128 KEAGVSVP-QPYTY------MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AEL  192 (258)
T ss_dssp             HHTTCCCC-CEEEE------ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred             HhCCCCCC-eEEEc------CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence            88865221 11111      124689999953      4433221       1234457788999999999999 8 899


Q ss_pred             eecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       206 vHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +||||||+|||++.   .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            99999999999996   5999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=2.3e-18  Score=164.87  Aligned_cols=141  Identities=12%  Similarity=0.092  Sum_probs=91.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh------------------hHHHHHHHHHHcCCCCccccccee
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------YKNRELQIMQMLDHPNIVALKHCF  144 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~~~~  144 (422)
                      -|.+.+.||.|+||.||+|.+. +|+.||||+++....                  ....++++.....|+|++++++..
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3899999999999999999984 699999998642110                  001122222223344444443322


Q ss_pred             ecCCCC-CceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC-
Q 014595          145 FSTTDK-EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-  222 (422)
Q Consensus       145 ~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~-  222 (422)
                      ...... .....++||||+++..   +..      .........++.||+.+|.+||+ .|||||||||.|||++.++. 
T Consensus       175 v~vp~p~~~~~~~LVME~i~G~~---L~~------l~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          175 FPVPEPIAQSRHTIVMSLVDALP---MRQ------VSSVPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             CSCCCEEEEETTEEEEECCSCEE---GGG------CCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEEEECS
T ss_pred             CCCCeeeeccCceEEEEecCCcc---Hhh------hcccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeCCCCc
Confidence            111100 0001258999998622   111      11122345678999999999999 89999999999999987652 


Q ss_pred             --------cEEEeecCCccc
Q 014595          223 --------QLKLCDFGSAKV  234 (422)
Q Consensus       223 --------~vkl~DfG~a~~  234 (422)
                              .+.|+||+-+..
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEE
T ss_pred             ccccccccceEEEEeCCccc
Confidence                    288999997754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=2.7e-11  Score=110.90  Aligned_cols=134  Identities=14%  Similarity=0.095  Sum_probs=98.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc----chhhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .|++...++.|+.+.||++...  ++.+++|+...    ......+|+++++.+. +.++.++++++.     .....++
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l   87 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL   87 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred             cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence            3888899999999999999753  68899998753    3345779999999995 566777777653     2234679


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC----------------------------------  202 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----------------------------------  202 (422)
                      ||||++| .+....         .+......++.+++.+|..||+.                                  
T Consensus        88 v~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999997 332210         01112345678999999999970                                  


Q ss_pred             ------------------------CCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          203 ------------------------IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       203 ------------------------~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                                              ..++|+|++|.|||++.+. .+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                                    2489999999999998543 46799999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.12  E-value=1.5e-10  Score=105.43  Aligned_cols=131  Identities=16%  Similarity=0.101  Sum_probs=87.8

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-hhhHHHHHHHHHHcCCCCc--ccccceeecCCCCCceEEEEEee
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      |.+..+.+.|..+.||++.. .+|+.+++|..... .....+|+.+++.+.+.++  .+++.+...     ....++|||
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~e   95 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLG   95 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEE
T ss_pred             CceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEEE
Confidence            55544445666799999964 46788999987543 2446789999999965454  446655421     123678999


Q ss_pred             cchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 014595          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG------------------------------------  204 (422)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g------------------------------------  204 (422)
                      |++|....    .    ....   ...++.+++..|..||+ ..                                    
T Consensus        96 ~i~G~~l~----~----~~~~---~~~~~~~l~~~l~~lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           96 EVPGQDLL----S----SHLA---PAEKVSIMADAMRRLHT-LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             CCSSEETT----T----SCCC---HHHHHHHHHHHHHHHTT-SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             ecCCcccC----c----CcCC---HhHHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            99873211    0    1111   12445677777777775 33                                    


Q ss_pred             ----------------------ceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          205 ----------------------ICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       205 ----------------------ivHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                                            ++|+|++|.|||++.++ .+.|+|||.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                                  99999999999998653 46799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.02  E-value=1e-09  Score=105.19  Aligned_cols=140  Identities=16%  Similarity=0.178  Sum_probs=97.4

Q ss_pred             EeeeeeecCCeeEEEEEEcCCCeEEEEEEec--cc-----hhhHHHHHHHHHHcCC--CCcccccceeecCCCCCceEEE
Q 014595           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVL--QD-----KRYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~--~~-----~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ..+.|+.|.++.||++...  +..+++|+..  ..     .....+|+.+++.|..  ..+.+++.++...  ......+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence            3566899999999998864  4678888765  22     3456789999999974  4456666654221  1112356


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC----------------------------------  202 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----------------------------------  202 (422)
                      +||||++|...   .  ......++......++.+++.+|..||+.                                  
T Consensus       118 ~vme~v~G~~l---~--~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          118 YIMEFVSGRVL---W--DQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEEECCCCBCC---C--CTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEEecCCeec---C--CCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            89999987321   0  01123466777788889999999999961                                  


Q ss_pred             -----------------------CCceecCCCCCCeEEcCCCC-cEEEeecCCccc
Q 014595          203 -----------------------IGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  234 (422)
Q Consensus       203 -----------------------~givHrDlkp~Nill~~~~~-~vkl~DfG~a~~  234 (422)
                                             ..++|+|++|.|||++.++. .+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                   36899999999999997652 368999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=4.1e-10  Score=105.35  Aligned_cols=183  Identities=13%  Similarity=0.173  Sum_probs=108.6

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHcC-CCCcccccceeecCC-CCCceEEEEEeecch
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLD-HPNIVALKHCFFSTT-DKEELYLNLVLEYVP  163 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~~~~~~lv~e~~~  163 (422)
                      +.++.|....||++.     ..+++|+....  .....+|+++++.+. +..+ .+..++.... .......|+||++++
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v-~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPL-PIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSS-CCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCC-CCCceEeecCCCCCCCcceEEEcccC
Confidence            458999999999863     45889976543  244568999999884 3332 2222221111 122223468999998


Q ss_pred             hH-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 014595          164 ET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC----------------------------------------  202 (422)
Q Consensus       164 ~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----------------------------------------  202 (422)
                      |. +.....      ..++......++.|++..|..||+.                                        
T Consensus       100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            62 211110      2345555566666666666666640                                        


Q ss_pred             -----------------CCceecCCCCCCeEEcCC-CCcEEEeecCCccccccCCCcccccccccc---cchhhhc---C
Q 014595          203 -----------------IGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYY---RAPELIF---G  258 (422)
Q Consensus       203 -----------------~givHrDlkp~Nill~~~-~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y---~aPE~~~---~  258 (422)
                                       ..++|+|++|.||+++.+ +..+.|+||+.+.....   .........+   ..|+...   .
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~---~~Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP---DNDFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT---THHHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh---HHHHHHHHhhccccCHHHHHHHHH
Confidence                             247999999999999974 43688999999864321   1111111111   2222210   0


Q ss_pred             -CC---------CCCCcchHHHHHHHHHHHHhCCCCC
Q 014595          259 -AT---------EYTTAIDIWSTGCVMAELLLGQPLF  285 (422)
Q Consensus       259 -~~---------~~~~~~DiwslG~il~elltG~~pf  285 (422)
                       ..         ......+.|++|.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             00         0112358999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.51  E-value=8.3e-07  Score=82.86  Aligned_cols=68  Identities=12%  Similarity=-0.046  Sum_probs=44.3

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHcCCCC---cccccceeecCCCCCceEEEEEeecc
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN---IVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~n---Iv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      +.++.|....||+.     |..+++|+....  .....+|+++|+.|.+..   +.+++.+..  .  .....++||+++
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~i   95 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEECC
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEecc
Confidence            45788888899988     566888975432  234568999999997632   233333221  1  122345899999


Q ss_pred             hh
Q 014595          163 PE  164 (422)
Q Consensus       163 ~~  164 (422)
                      +|
T Consensus        96 ~G   97 (306)
T 3tdw_A           96 QG   97 (306)
T ss_dssp             CS
T ss_pred             CC
Confidence            86

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.22  E-value=9.6e-06  Score=76.48  Aligned_cols=75  Identities=12%  Similarity=0.211  Sum_probs=40.0

Q ss_pred             eeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCC--CcccccceeecC-CCCCceEEEEEeecchh
Q 014595           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHP--NIVALKHCFFST-TDKEELYLNLVLEYVPE  164 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~-~~~~~~~~~lv~e~~~~  164 (422)
                      +.|+.|..+.||++...  +..+++|+..........|+.+++.|...  .+.+++...... ........+++|+|++|
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G  115 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG  115 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence            44666778899999763  34599998876544455677777776421  223332210000 00012235689999975

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.20  E-value=1.9e-05  Score=71.88  Aligned_cols=131  Identities=15%  Similarity=0.147  Sum_probs=78.5

Q ss_pred             eeecCCe-eEEEEEEcCCCeEEEEEEeccch-hhHHHHHHHHHHcCC-CCcccccceeecCCCCCceEEEEEeecchh-H
Q 014595           90 VGTGSFG-VVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-T  165 (422)
Q Consensus        90 lg~G~~g-~V~~~~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~  165 (422)
                      +..|.-| .||+......+..+.+|+-.... ....+|..+|+.|.. -.+.+++.+...   .  ...++|||+++| .
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~---~--~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT---P--DDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE---T--TEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE---C--CeEEEEEEeeCCcc
Confidence            3445444 69998877677889999765432 345689999998853 223444444421   1  235689999986 2


Q ss_pred             HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 014595          166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-------------------------------------------  202 (422)
Q Consensus       166 l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-------------------------------------------  202 (422)
                      +.......        ......++.++...|.-||..                                           
T Consensus       107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            22221110        001122333444444444420                                           


Q ss_pred             --------------CCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          203 --------------IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       203 --------------~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                                    ..++|+|+.+.|||++.++ .+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence                          0179999999999999654 567999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.12  E-value=8.8e-06  Score=78.70  Aligned_cols=71  Identities=18%  Similarity=0.206  Sum_probs=44.1

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----------hhhHHHHHHHHHHcCC--CCcc-cccceeecCCCCCc
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----------KRYKNRELQIMQMLDH--PNIV-ALKHCFFSTTDKEE  152 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~~E~~~l~~l~h--~nIv-~l~~~~~~~~~~~~  152 (422)
                      .+.||.|..+.||++....+++.|+||.....           ......|.++++.+..  +.++ +++.+  +   .+.
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~~  109 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM  109 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CCc
Confidence            45789999999999976556788999975321           1233579999988743  3333 33322  1   111


Q ss_pred             eEEEEEeecchh
Q 014595          153 LYLNLVLEYVPE  164 (422)
Q Consensus       153 ~~~~lv~e~~~~  164 (422)
                        .++|||++++
T Consensus       110 --~~lvmE~l~g  119 (397)
T 2olc_A          110 --AVTVMEDLSH  119 (397)
T ss_dssp             --TEEEECCCTT
T ss_pred             --cEEEEEeCCC
Confidence              3589999865

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.89  E-value=4e-05  Score=72.86  Aligned_cols=78  Identities=9%  Similarity=0.101  Sum_probs=48.5

Q ss_pred             EEeeee-eecCCeeEEEEEEc--C----CCeEEEEEEeccch-------hhHHHHHHHHHHcCC---CCcccccceeecC
Q 014595           85 IAEHVV-GTGSFGVVFQAKCR--E----TGEIVAIKKVLQDK-------RYKNRELQIMQMLDH---PNIVALKHCFFST  147 (422)
Q Consensus        85 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h---~nIv~l~~~~~~~  147 (422)
                      ...+.| +.|....+|++...  .    +++.+++|+.....       ....+|+.+++.|..   -.+.+++.+....
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345667 78888899988753  0    15678999765432       356789999998843   2345555543211


Q ss_pred             CCCCceEEEEEeecchh
Q 014595          148 TDKEELYLNLVLEYVPE  164 (422)
Q Consensus       148 ~~~~~~~~~lv~e~~~~  164 (422)
                        .-....++||||++|
T Consensus       103 --~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          103 --DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             --TTTSSCEEEEECCCC
T ss_pred             --CccCCceEEEEecCC
Confidence              111224579999875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.55  E-value=0.0014  Score=60.18  Aligned_cols=73  Identities=14%  Similarity=0.060  Sum_probs=48.6

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      ..-++.+|.|..+.||+++. .+|+.|.+|+....    ...+.+|++.|+.|.-..-|.+-.++....      -++||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~------~~lv~   89 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD------RTLAM   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET------TEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC------ceEEE
Confidence            55678899999999999987 46899999975432    234678999999985322222222221111      24788


Q ss_pred             ecch
Q 014595          160 EYVP  163 (422)
Q Consensus       160 e~~~  163 (422)
                      ||+.
T Consensus        90 e~l~   93 (288)
T 3f7w_A           90 EWVD   93 (288)
T ss_dssp             ECCC
T ss_pred             Eeec
Confidence            9875

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.51  E-value=0.00036  Score=64.50  Aligned_cols=63  Identities=13%  Similarity=0.073  Sum_probs=39.5

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcc-cccceeecCCCCCceEEEEEeecc
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      .+.|+.|....+|++      +.+++|+.....   ....+|+.+++.+....+. +++...     .+..  ++++||+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~~--~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PATG--VMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTTC--CEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCCC--EEEEeec
Confidence            567888999999998      458888765421   2235799888888543333 343322     1112  3689998

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.50  E-value=0.0014  Score=56.78  Aligned_cols=98  Identities=18%  Similarity=0.112  Sum_probs=62.2

Q ss_pred             HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCcccc
Q 014595          165 TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY  244 (422)
Q Consensus       165 ~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~  244 (422)
                      +|..++..+   +.++++.++|.++.|.+.+|.-+-..+.-..+=+-|..|++..+| .|.+.+ +.+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            567777765   489999999999999999987762101211233346888999888 466543 1110           


Q ss_pred             cccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh
Q 014595          245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL  280 (422)
Q Consensus       245 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt  280 (422)
                      .....+.|||...  ...+.+.=|||||+++|..+-
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence            1122367888762  346788899999999999885

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.46  E-value=0.00048  Score=66.99  Aligned_cols=77  Identities=13%  Similarity=-0.037  Sum_probs=46.7

Q ss_pred             CCceecCCCCCCeEEcCCCCcEEEeecCCccccccCCCcccccc--cccccchhhhcCCC--CCCCcchHHHHHHHHHHH
Q 014595          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFGAT--EYTTAIDIWSTGCVMAEL  278 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~--~~~~~~DiwslG~il~el  278 (422)
                      ..++|+|++|.|||++.++  ++|+||+.+..-...........  ...|++|+......  ......++.++...+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            6899999999999998654  99999998865321111111111  23467776552111  011124455777778877


Q ss_pred             HhC
Q 014595          279 LLG  281 (422)
Q Consensus       279 ltG  281 (422)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.23  E-value=0.0012  Score=61.44  Aligned_cols=142  Identities=13%  Similarity=0.070  Sum_probs=74.4

Q ss_pred             EeeeeeecCCeeEEEEEEcCCCeEEEEEEecc--chhhHHHHHHHHHHcCCCCc--ccccceeecCCCC----CceEEEE
Q 014595           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNI--VALKHCFFSTTDK----EELYLNL  157 (422)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~~~~----~~~~~~l  157 (422)
                      -.+.|+.|....+|++... .| .+++|....  .......|+.+++.|....+  .+++..   ..+.    .....++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEEE
Confidence            3456788888999999763 33 688998765  33455678998888843232  232211   1100    0122467


Q ss_pred             EeecchhH---------HHHH---HHH-hhh---hcCC----CCHHHHHHH---------------HHHHHHHHHHHHh-
Q 014595          158 VLEYVPET---------VNRI---ARN-YSR---IHQR----MPLIYVKLY---------------TYQICRALAYIHN-  201 (422)
Q Consensus       158 v~e~~~~~---------l~~~---~~~-~~~---~~~~----~~~~~~~~~---------------~~qi~~aL~~LH~-  201 (422)
                      +|+|++|.         ...+   +.. +..   ....    .........               ...+...++++.. 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            89998642         1111   110 000   0000    010000000               0113344555552 


Q ss_pred             -----cCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          202 -----CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       202 -----~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                           ..+++|+|+++.|||++.+. .+.|+||+.+.
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~  216 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  216 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence                 13699999999999998653 45799999875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.08  E-value=0.0044  Score=57.49  Aligned_cols=71  Identities=14%  Similarity=0.065  Sum_probs=49.1

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-hhhHHHHHHHHHHcCC---CCcccccceeecCCCCCceEEEEEeecc
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH---PNIVALKHCFFSTTDKEELYLNLVLEYV  162 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~~~~~~~~~~lv~e~~  162 (422)
                      .+.|+.|....+|+...  ++..+++|+.... ...+.+|++.|+.|..   ..+.+++.+...     ....++||||+
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEEec
Confidence            46689999999999875  4677889976543 3446789999998842   345555554321     12366899998


Q ss_pred             hh
Q 014595          163 PE  164 (422)
Q Consensus       163 ~~  164 (422)
                      ++
T Consensus       114 ~G  115 (312)
T 3jr1_A          114 NK  115 (312)
T ss_dssp             CC
T ss_pred             cC
Confidence            74

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.06  E-value=0.0049  Score=60.00  Aligned_cols=69  Identities=17%  Similarity=0.254  Sum_probs=45.9

Q ss_pred             eeeeeecCCeeEEEEEEcC-------CCeEEEEEEecc-ch-hhHHHHHHHHHHcCCCCc-ccccceeecCCCCCceEEE
Q 014595           87 EHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ-DK-RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~-------~~~~vAiK~~~~-~~-~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~~~~  156 (422)
                      .+.|+.|....||++....       .++.+.+|+... .. ....+|..+++.|...++ .++++.+     .+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence            4568888889999998643       257899998744 22 344579999998854444 3454443     11    1


Q ss_pred             EEeecchh
Q 014595          157 LVLEYVPE  164 (422)
Q Consensus       157 lv~e~~~~  164 (422)
                      +|++|++|
T Consensus       149 ~v~e~l~G  156 (429)
T 1nw1_A          149 RLEEYIPS  156 (429)
T ss_dssp             EEECCCCE
T ss_pred             EEEEEeCC
Confidence            68888763

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.04  E-value=0.0045  Score=57.65  Aligned_cols=72  Identities=14%  Similarity=0.009  Sum_probs=42.4

Q ss_pred             eeeecCCeeEEEEEEcCCCeEEEEEEecc---chhhHHHHHHHHHHcCCCC--cccccceeecCCC--CCceEEEEEeec
Q 014595           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPN--IVALKHCFFSTTD--KEELYLNLVLEY  161 (422)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~--~~~~~~~lv~e~  161 (422)
                      .|+ |....||++.. .+|+.+++|....   .......|..+++.|....  +++++..  ....  ......+++|++
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence            355 77788998764 3466799998753   2344567888888885323  3333321  0000  012234678999


Q ss_pred             chh
Q 014595          162 VPE  164 (422)
Q Consensus       162 ~~~  164 (422)
                      ++|
T Consensus       109 i~G  111 (328)
T 1zyl_A          109 VGG  111 (328)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.02  E-value=0.0056  Score=60.01  Aligned_cols=70  Identities=16%  Similarity=0.173  Sum_probs=45.2

Q ss_pred             EeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchh---hHHHHHHHHHHcCCCCcc-cccceeecCCCCCceEEEEEeec
Q 014595           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEY  161 (422)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~lv~e~  161 (422)
                      -.+.|+.|-...+|++.....+..+++|+......   ...+|..+++.|...++. ++++++     .+ .   +||||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~-G---~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN-G---RIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT-E---EEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC-e---EEEEe
Confidence            34568888899999998754457899998643221   225899999999765554 455443     11 1   48888


Q ss_pred             chh
Q 014595          162 VPE  164 (422)
Q Consensus       162 ~~~  164 (422)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            763

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.96  E-value=0.0021  Score=61.24  Aligned_cols=69  Identities=13%  Similarity=0.152  Sum_probs=40.2

Q ss_pred             eeeeeecCCeeEEEEEEcC--------CCeEEEEEEeccchh---hHHHHHHHHHHcCCCCc-ccccceeecCCCCCceE
Q 014595           87 EHVVGTGSFGVVFQAKCRE--------TGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELY  154 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~--------~~~~vAiK~~~~~~~---~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~~  154 (422)
                      .+.|+.|....+|++....        .++.+++|+......   ....|..+++.|...++ .+++..+     . .  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~-~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N-G--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T-T--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C-C--
Confidence            3457788888999998643        126788998654322   23679999998854444 3444332     1 1  


Q ss_pred             EEEEeecchh
Q 014595          155 LNLVLEYVPE  164 (422)
Q Consensus       155 ~~lv~e~~~~  164 (422)
                       ++||+|++|
T Consensus       110 -~~v~e~i~G  118 (369)
T 3c5i_A          110 -GRIEEWLYG  118 (369)
T ss_dssp             -EEEEECCCS
T ss_pred             -cEEEEEecC
Confidence             368888764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.86  E-value=0.0044  Score=57.96  Aligned_cols=32  Identities=38%  Similarity=0.561  Sum_probs=26.6

Q ss_pred             CCceecCCCCCCeEEcCC---CCcEEEeecCCccc
Q 014595          203 IGICHRDIKPQNLLVNPH---THQLKLCDFGSAKV  234 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~---~~~vkl~DfG~a~~  234 (422)
                      ..++|+|+.+.|||++.+   ...+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            479999999999999864   13689999998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.79  E-value=0.011  Score=56.31  Aligned_cols=138  Identities=20%  Similarity=0.264  Sum_probs=75.0

Q ss_pred             eeeeecCCeeEEEEEEcC-------CCeEEEEEEecc---chhhHHHHHHHHHHcCCCCc-ccccceeecCCCCCceEEE
Q 014595           88 HVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~-------~~~~vAiK~~~~---~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~~~~  156 (422)
                      +.|..|-...+|++....       .++.|.+|+.-.   ......+|..+++.|...++ .+++.++     .+.    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~g----  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PEG----  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TTE----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CCc----
Confidence            346667777888887632       346788987533   22344589999988853333 3444443     221    


Q ss_pred             EEeecchhH------------HHHHHHHhhhhcC-------CC--CHHHHHHHHHHHHH-------------------HH
Q 014595          157 LVLEYVPET------------VNRIARNYSRIHQ-------RM--PLIYVKLYTYQICR-------------------AL  196 (422)
Q Consensus       157 lv~e~~~~~------------l~~~~~~~~~~~~-------~~--~~~~~~~~~~qi~~-------------------aL  196 (422)
                      +||||++|.            ...+.....+.+.       ..  -...+..+..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            688998631            1122222222111       11  12344445444322                   23


Q ss_pred             HHHHh-------cCCceecCCCCCCeEEcCC---CCcEEEeecCCccc
Q 014595          197 AYIHN-------CIGICHRDIKPQNLLVNPH---THQLKLCDFGSAKV  234 (422)
Q Consensus       197 ~~LH~-------~~givHrDlkp~Nill~~~---~~~vkl~DfG~a~~  234 (422)
                      ..|.+       ...++|+|+.+.|||++.+   ...+.|+||..|..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33321       1258999999999999876   23699999998853

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.49  E-value=0.0097  Score=55.88  Aligned_cols=31  Identities=26%  Similarity=0.532  Sum_probs=26.5

Q ss_pred             CCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ..++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            4699999999999998665 599999988754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.99  E-value=0.064  Score=51.86  Aligned_cols=69  Identities=13%  Similarity=0.125  Sum_probs=43.5

Q ss_pred             eeeeeecCCeeEEEEEEcCC-------CeEEEEEEeccch---hhHHHHHHHHHHcCCCCcc-cccceeecCCCCCceEE
Q 014595           87 EHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYL  155 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~-------~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~  155 (422)
                      .+.|..|-...+|++.....       ++.|++|+.....   ....+|..+++.|...+++ ++++.+     .    -
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----~  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----E  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----T
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----C
Confidence            45577788889999987521       5779999864322   2235899999988543443 444322     1    1


Q ss_pred             EEEeecchh
Q 014595          156 NLVLEYVPE  164 (422)
Q Consensus       156 ~lv~e~~~~  164 (422)
                      ++||+|++|
T Consensus       146 ~~I~efI~G  154 (424)
T 3mes_A          146 GRIEEFIDG  154 (424)
T ss_dssp             EEEEECCCS
T ss_pred             CEEEEEeCC
Confidence            368888864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=80.56  E-value=0.77  Score=43.84  Aligned_cols=30  Identities=30%  Similarity=0.546  Sum_probs=24.3

Q ss_pred             ceecCCCCCCeEEcC-----CCCcEEEeecCCccc
Q 014595          205 ICHRDIKPQNLLVNP-----HTHQLKLCDFGSAKV  234 (422)
Q Consensus       205 ivHrDlkp~Nill~~-----~~~~vkl~DfG~a~~  234 (422)
                      ++|+|+.+.|||+..     +...+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            679999999999942     334699999998854

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	422
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-126
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-74
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-70
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-70
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-67
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-66
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-66
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-66
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-66
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-65
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-64
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-64
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-63
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-62
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-62
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-60
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-59
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-59
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-59
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-59
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-57
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-57
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-57
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-53
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-52
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-52
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-51
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-48
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-48
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-46
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-44
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-43
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-42
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-40
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-40
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-38
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-38
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-37
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-34
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-34
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  366 bits (939), Expect = e-126
 Identities = 238/341 (69%), Positives = 279/341 (81%), Gaps = 3/341 (0%)

Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70

Query: 133 DHPNIVALKHCFFST-TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+   K+E+YLNLVL+YVPETV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHAR 412
           RDPN +LPNGR  P LFNF   ELS  PP     LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLA-TILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (596), Expect = 2e-74
 Identities = 102/342 (29%), Positives = 175/342 (51%), Gaps = 25/342 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKN---RELQIMQMLDHPNIV 138
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++I+    H NI+
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +     + T ++   + LV   +   + ++ +      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKY 124

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 254
           IH+   + HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 312
           ++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 313 -NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 413
            DP+       P+         EL  +P E +  LI E   +
Sbjct: 302 YDPSD-----EPIAEAPFKFDMELDDLPKEKLKELIFEETAR 338

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 2e-70
 Identities = 99/303 (32%), Positives = 149/303 (49%), Gaps = 23/303 (7%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
            +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   F     K  + L  V +++      +          +   ++K Y     + L Y+
Sbjct: 65  LLDAF---GHKSNISL--VFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H    I HRD+KP NLL++ +   LKL DFG AK         ++   +R+YRAPEL+FG
Sbjct: 117 HQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
           A  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT E+   M      
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NT 376
             F      P H +F      + +DL+   F ++P  R TA +A    +F     P    
Sbjct: 235 VTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293

Query: 377 RLP 379
           +LP
Sbjct: 294 QLP 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 4e-70
 Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 31/305 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G+ GVVF+   + +G ++A K +  + +        RELQ++   + P IV
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                F       E+ +   +E++            +   R+P   +   +  + + L Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +     I HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT 317
            T Y+   DIWS G  + E+ +G+   P       +L+   +V G       +   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 318 EFKF--------------PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
              +                I   P  K+       E  D V +    +P  R    +  
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 364 VHPFF 368
           VH F 
Sbjct: 297 VHAFI 301

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 5e-67
 Identities = 102/307 (33%), Positives = 165/307 (53%), Gaps = 21/307 (6%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           +     +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L         + +LYL  V E++ + + +     +     +PL  +K Y +Q+ + LA
Sbjct: 64  VKLLDVI---HTENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLA 116

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 256
           + H+   + HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPN 315
            G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
             +  FP+     + KV    L  +   L+ +   Y PN R +A  A  HPFF ++  P 
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292

Query: 376 TRLPNGR 382
             +P+ R
Sbjct: 293 --VPHLR 297

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 2e-66
 Identities = 100/335 (29%), Positives = 159/335 (47%), Gaps = 24/335 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     VG+G++G V  A   +TG  VA+KK+      +   +   REL++++ + H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   F      EE     ++ ++         N     Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           YIH+   I HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIHSA-DIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 318 EF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
                   Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP
Sbjct: 252 RNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 375 NTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPE 409
           +       P+   ++    E   +  +    L  +
Sbjct: 311 DD-----EPVADPYDQ-SFESRDLLIDEWKSLTYD 339

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  213 bits (542), Expect = 2e-66
 Identities = 89/300 (29%), Positives = 147/300 (49%), Gaps = 21/300 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALK 141
           Y     +G G +  VF+A      E V +K +   K+ K  RE++I++ L   PNI+ L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                  D       LV E+V  T      ++ +++Q +    ++ Y Y+I +AL Y H+
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 262 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           Y  ++D+WS GC++A ++  + P F G    DQLV I KVLGT    +         + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 321 FPQIKPHPWHKVFQKRLP--------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           F  I      K +++ +         PEA+D + +  +Y    R TA EA  HP+F  + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (539), Expect = 4e-66
 Identities = 86/309 (27%), Positives = 144/309 (46%), Gaps = 22/309 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 138 VALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           V L     +     ++ +  + LV ++     + +A   S +  +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-----SYICSRY 249
            L YIH    I HRD+K  N+L+      LKL DFG A+     + +      + + + +
Sbjct: 129 GLYYIHRN-KILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           YR PEL+ G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 310 KCMNPNYTEFKFPQIKPHP---WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
             ++      K   +K        ++      P A+DL+ +     P  R  + +A  H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 367 FFDELRDPN 375
           FF     P+
Sbjct: 307 FFWSDPMPS 315

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 8e-66
 Identities = 97/316 (30%), Positives = 158/316 (50%), Gaps = 21/316 (6%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     VG+G++G V  A    TG  VAIKK+ +  + +       REL++++ + H N+
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 138 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           + L   F      ++     LV+ ++   + ++ +     H+++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGL 134

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            YIH   GI HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                YT  +DIWS GC+MAE++ G+ LF G   +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 317 TEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            +      P+++   +  +      P AV+L+ +        R TA EA  HP+F+ L D
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 374 PNTRLPNGRPLPPLFN 389
                P  +     F+
Sbjct: 310 TE-DEPQVQKYDDSFD 324

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  211 bits (538), Expect = 1e-65
 Identities = 73/309 (23%), Positives = 120/309 (38%), Gaps = 41/309 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           Y     +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V 
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   F    D  E+ +  + E++      +    +  H +M       Y  Q+C+ L ++
Sbjct: 88  LHDAF---EDDNEMVM--IYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 200 HNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G
Sbjct: 141 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
                   D+WS G +   LL G   F GE+  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NT 376
                             +  +  D + +     PN R T  +A  HP+      P  ++
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 377 RLPNGRPLP 385
           ++P+ R   
Sbjct: 294 QIPSSRYTK 302

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 3e-64
 Identities = 96/299 (32%), Positives = 150/299 (50%), Gaps = 18/299 (6%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L           +  L LV E+       + + +   +  +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 256
           + H+   + HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 257 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           FGA  Y+T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
                +P             +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 6e-64
 Identities = 90/299 (30%), Positives = 147/299 (49%), Gaps = 17/299 (5%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDKRYKN------RELQIMQML---D 133
           Y     +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++ L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPN+V L      +    E  L LV E+V +  +            +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ--DLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
           R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E++   + Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                  F      P  K     +     DL+ +   ++P  R +A  A  HP+F +L 
Sbjct: 243 VALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  202 bits (514), Expect = 7e-63
 Identities = 96/295 (32%), Positives = 151/295 (51%), Gaps = 20/295 (6%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NI
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L           +  L LV E++      + +        +  +  K +  Q+   +A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 256
           Y H+   + HRD+KPQNLL+N    +LK+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 315
            G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
             +  F   +P PW     K L    +DL+ +  +  PN R TA +A  H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 4e-62
 Identities = 79/309 (25%), Positives = 122/309 (39%), Gaps = 34/309 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKH 142
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++  +    P+IV +  
Sbjct: 14  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 72

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            + +     +  L +V+E +   E  +RI     R  Q             I  A+ Y+H
Sbjct: 73  VYENLYAGRK-CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 201 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +   I HRD+KP+NLL         LKL DFG AK         +   + YY APE++  
Sbjct: 129 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  + D+WS G +M  LL G P F    G+     +   +                +
Sbjct: 188 -EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------Q 233

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTR 377
           ++FP  +           +  E   L+    +  P  R T  E   HP+     + P T 
Sbjct: 234 YEFPNPEW--------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285

Query: 378 LPNGRPLPP 386
           L   R L  
Sbjct: 286 LHTSRVLKE 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  201 bits (512), Expect = 9e-62
 Identities = 80/335 (23%), Positives = 127/335 (37%), Gaps = 44/335 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
            +G+G+FGVV +   + TG +   K +      DK     E+ IM  L HP ++ L   F
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
               DK E+ L  +LE++   E  +RIA        +M    V  Y  Q C  L ++H  
Sbjct: 96  ---EDKYEMVL--ILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 203 IGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             I H DIKP+N++        +K+ DFG A  L   E       +  + APE++     
Sbjct: 147 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EP 204

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
                D+W+ G +   LL G   F GE  ++ L  + +       +              
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------ 252

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPN 380
                          + PEA D +    Q  P  R T  +A  HP+   +  +  +R+P+
Sbjct: 253 -------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299

Query: 381 GRPLPPLFNFKPPELSGIPPETINRLIPEHARKQN 415
            R        K        P+     I   +  + 
Sbjct: 300 SRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRK 334

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 2e-61
 Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 44/295 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                             L LEY          +       MP    + + +Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCS---GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPEL 255
           +H   GI HRDIKP+NLL++   + LK+ DFG A V               +  Y APEL
Sbjct: 119 LHGI-GITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +     +   +D+WS G V+  +L G+  +   S   Q                      
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----------------- 219

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
               K  +   +PW K+         + L+ +    +P+ R T  +     ++++
Sbjct: 220 ----KEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 5e-60
 Identities = 60/289 (20%), Positives = 117/289 (40%), Gaps = 40/289 (13%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
           +  +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPNIV  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +  + +T K +  + LV E +    +   + Y +  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 201 -NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
                I HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            +Y  ++D+++ G  M E+   +  +       Q+   +     P               
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                        F K   PE  +++    + + + R +  +   H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (496), Expect = 7e-60
 Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 49/305 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           +     +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            +  + C+     +   +  LV+EY        +       + +  + +   T+   + L
Sbjct: 77  TIQYRGCY---LREHTAW--LVMEYCL---GSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++    P  S++ + Y+ APE+I
Sbjct: 129 AYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 257 FGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
               E  Y   +D+WS G    EL   +P     + +  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
                + P ++   W             + V    Q  P  R T+     H F    R P
Sbjct: 229 ----NESPALQSGHW--------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Query: 375 NTRLP 379
              + 
Sbjct: 277 TVIMD 281

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 7e-60
 Identities = 99/344 (28%), Positives = 156/344 (45%), Gaps = 33/344 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G+G+ G+V  A        VAIKK+ +  + +       REL +M+ ++H NI
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 138 VALKHCFFSTTDKEEL-YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++L + F      EE   + LV+E +       A     I   +    +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMD------ANLCQVIQMELDHERMSYLLYQMLCGI 132

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++H+  GI HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 312
            G   Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K +    
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 313 ------NPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                  P Y    FP++ P    P      K    +A DL+ +     P  R +  +A 
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI 407
            HP+ +   DP        P P +++ +  E      E    LI
Sbjct: 310 QHPYINVWYDPAEVEA---PPPQIYDKQLDERE-HTIEEWKELI 349

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 3e-59
 Identities = 64/294 (21%), Positives = 117/294 (39%), Gaps = 44/294 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 139
           +     +G G+FG V++A+ +ET  + A K +     ++      E+ I+   DHPNIV 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   F     +  L++  ++E+       +      + + +    +++   Q   AL Y+
Sbjct: 74  LLDAF---YYENNLWI--LIEFCAG--GAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFG 258
           H+   I HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++  
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 259 AT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
            T     Y    D+WS G  + E+   +P     + +  L++I K               
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-------------- 230

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                  P             R      D + +  + + + R T  +   HPF 
Sbjct: 231 EPPTLAQP------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 4e-59
 Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 48/292 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           +     +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    D   +YL  +LEY P           +   +        Y  ++  AL
Sbjct: 68  ILRLYGYF---HDATRVYL--ILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 119

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           +Y H+   + HRDIKP+NLL+      LK+ DFG +          +   +  Y  PE+I
Sbjct: 120 SYCHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
            G   +   +D+WS G +  E L+G+P F   +  +    I +V                
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            EF FP              +   A DL+ R  +++P+ R    E   HP+ 
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 4e-59
 Identities = 67/296 (22%), Positives = 118/296 (39%), Gaps = 45/296 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           V         T+     L +V+EY     +  +    ++  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 197 AYIH----NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 251
              H        + HRD+KP N+ ++   + +KL DFG A++L        +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           +PE +     Y    DIWS GC++ EL    P F   S  +   +I              
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                 E KF +I               E  +++ R        R +  E   +P 
Sbjct: 228 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  194 bits (494), Expect = 5e-59
 Identities = 95/349 (27%), Positives = 150/349 (42%), Gaps = 49/349 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
           YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 141 KH----------CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
                         F+      +++ +V E + E +  + + Y   H+ +PLIYVK  + 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 132

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH-----QLKLCDFGSAKVLVKGEPNVSYI 245
           Q+   L Y+H   GI H DIKP+N+L+          Q+K+ D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIK 299
            +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 300 VLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWHKV------FQKRLPPEAVDLVC 346
           +LG      ++      T F          ++K  P   V      F K    E  D + 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 347 RFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 388
              Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 8e-59
 Identities = 72/293 (24%), Positives = 122/293 (41%), Gaps = 42/293 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVAL 140
           Y+    +G G FG+V +     + +    K V     D+    +E+ I+ +  H NI+ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              F      EEL +  + E++   +   RI  +   +++R     +  Y +Q+C AL +
Sbjct: 67  HESF---ESMEELVM--IFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117

Query: 199 IHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           +H+   I H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+  
Sbjct: 118 LHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
                +TA D+WS G ++  LL G   F  E+    +  I+    T   E          
Sbjct: 177 H-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                            K +  EA+D V R        R TA EA  HP+  +
Sbjct: 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 4e-57
 Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 45/309 (14%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++       K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +      +EL++  V+EY+                 M    +     +
Sbjct: 74  NKNPNIVNYLDSY---LVGDELWV--VMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYY 250
             +AL ++H+   + HRDIK  N+L+      +KL DFG    +   +   S +  + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP      
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------ 234

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                  E + P            ++L     D + R        R +A E   H F   
Sbjct: 235 -------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

Query: 371 LRDPNTRLP 379
            +  ++  P
Sbjct: 276 AKPLSSLTP 284

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (476), Expect = 7e-57
 Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 42/303 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y    V+GTG+F  V  A+ + T ++VAIK + +            E+ ++  + HPNIV
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL   +        LYL  +++ V         +                 +Q+  A+ Y
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 199 IHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           +H+   I HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                           +   +   A D +    +  P  R T  +A  HP+       + 
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 377 RLP 379
            + 
Sbjct: 276 NIH 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 7e-57
 Identities = 89/329 (27%), Positives = 132/329 (40%), Gaps = 67/329 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPN 136
           +    ++G GSF  V  A+   T    AIK + +    K        RE  +M  LDHP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            V L   F    D E+LY    L Y     N     Y R          + YT +I  AL
Sbjct: 70  FVKLYFTF---QDDEKLYF--GLSYAK---NGELLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAP 253
            Y+H    I HRD+KP+N+L+N   H +++ DFG+AKVL          S++ +  Y +P
Sbjct: 122 EYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           EL+        + D+W+ GC++ +L+ G P F   +      +IIK+             
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPF 367
               E+ FP+            +  P+A DLV +        R    E         HPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

Query: 368 FDELRDPNTRLPNGRPLPPLFNFKPPELS 396
           F+ +   N           L    PP+L+
Sbjct: 270 FESVTWEN-----------LHQQTPPKLT 287

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  186 bits (473), Expect = 8e-57
 Identities = 75/306 (24%), Positives = 121/306 (39%), Gaps = 54/306 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------------LQDKRYKNRELQIMQ 130
           Y  + ++G G   VV +   + T +  A+K +              + +    +E+ I++
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 131 ML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 189
            +  HPNI+ LK  +     +   +  LV + +         +Y      +     +   
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
             +   +  +H    I HRD+KP+N+L++   + +KL DFG +  L  GE       +  
Sbjct: 117 RALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174

Query: 250 YRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L  I       
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
                  M+ NY +F  P+                   DLV RF    P  R TA EA  
Sbjct: 228 -------MSGNY-QFGSPEW----------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

Query: 365 HPFFDE 370
           HPFF +
Sbjct: 270 HPFFQQ 275

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 4e-53
 Identities = 84/354 (23%), Positives = 142/354 (40%), Gaps = 62/354 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ--------IMQMLDHP 135
           +I   ++G GSFG VF A+ ++T +  AIK + +D    + +++        +    +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +  +   F     KE L+  +  EY+          + +   +  L     Y  +I   
Sbjct: 64  FLTHMFCTF---QTKENLFFVM--EYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           L ++H+  GI +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G  +Y  ++D WS G ++ E+L+GQ  F G+   +                I+  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFFDELRD 373
            Y  +                 L  EA DL+ + F   P  R         HP F E+  
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN- 262

Query: 374 PNTRLPNGRPLPP----------LFNFKPPELSGIPPETINRLIPEHARKQNLF 417
               L      PP            NF    L+  P  +       ++  QN+F
Sbjct: 263 -WEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMF 315

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-52
 Identities = 65/317 (20%), Positives = 120/317 (37%), Gaps = 49/317 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 133
           Y     +G+G F VV + + + TG   A K + + +   +          RE+ I++ + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPN++ L   +    +K ++ L  +LE V         ++    + +       +  QI 
Sbjct: 72  HPNVITLHEVY---ENKTDVIL--ILELVA---GGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 194 RALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
             + Y+H+   I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  +
Sbjct: 124 NGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE++          D+WS G +   LL G   F G++  + L  +  V      E   
Sbjct: 183 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE--- 238

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                                 +       A D + R     P  R T  ++  HP+   
Sbjct: 239 ----------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

Query: 371 LRDPNTRLPNGRPLPPL 387
            +D    L +    P  
Sbjct: 277 -KDTQQALSSAWSHPQF 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  174 bits (443), Expect = 6e-52
 Identities = 81/355 (22%), Positives = 143/355 (40%), Gaps = 68/355 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 136
           +     +GTGSFG V   + R  G   A+K +       L+   + N E  ++ ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ +   F     ++   + ++++Y+         +  R  QR P    K Y  ++C AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            Y+H+   I +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                Y  +ID WS G ++ E+L G   F   + +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDEL 371
            E +FP                 +  DL+ R      + R         +   HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

Query: 372 RDPNTRLPNGRPLPPLFNFKPPELSGI---------PPETINRLIPEHARKQNLF 417
                +L +     P   ++PP   G          P E IN  +       +LF
Sbjct: 264 --VWEKLLSRNIETP---YEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLF 313

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 1e-51
 Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 56/303 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 133
           Y    ++G+G FG V+          VAIK V +D+               E+ +++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 134 --HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
                ++ L   F            L+LE       +   ++      +     + + +Q
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           +  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
            PE I     +  +  +WS G ++ +++ G   F  +       EII+            
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                                F++R+  E   L+       P+ R T  E   HP+  ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

Query: 372 RDP 374
             P
Sbjct: 262 LLP 264

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  172 bits (438), Expect = 8e-51
 Identities = 69/325 (21%), Positives = 122/325 (37%), Gaps = 57/325 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 133
           +    ++G G FG V+  +  +TG++ A+K + + +            +   L ++   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
            P IV + + F      ++L    +L+ +          +   H       ++ Y  +I 
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMN---GGDLHYHLSQHGVFSEADMRFYAAEII 117

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S   +  Y AP
Sbjct: 118 LGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E++     Y ++ D +S GC++ +LL G   F      D+  EI +              
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR-------------- 219

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFF 368
                                    PE   L+    Q   N R       A E    PFF
Sbjct: 220 -----------MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

Query: 369 DELRDPNTRLPNGRPLPPLFNFKPP 393
             L      +   +  PP     PP
Sbjct: 269 RSL--DWQMVFLQKYPPP---LIPP 288

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  165 bits (418), Expect = 1e-48
 Identities = 65/295 (22%), Positives = 106/295 (35%), Gaps = 43/295 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           Y    ++G G    V  A+       VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IVA+ +              +V+EYV        R+       M            C+AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRA 252
            + H   GI HRD+KP N++++   + +K+ DFG A+ +     +V    + I +  Y +
Sbjct: 125 NFSHQN-GIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE   G        D++S GCV+ E+L G+P F G+S V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                                 + L  +   +V +    +P  R           
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-48
 Identities = 71/328 (21%), Positives = 120/328 (36%), Gaps = 59/328 (17%)

Query: 81  KVS---YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 130
           KV+   +    ++G G+FG V   + + TG   A+K + ++             E +++Q
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
              HP + ALK+ F      + L        +          +    +       + Y  
Sbjct: 61  NTRHPFLTALKYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGA 112

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
           +I  AL Y+H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C    
Sbjct: 113 EIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPE 170

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
                +    +Y  A+D W  G VM E++ G+  F  +        I+            
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----------- 219

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVH 365
                  E +FP            + L PEA  L+    +  P  R       A E   H
Sbjct: 220 ------EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKPP 393
            FF  +      +   + LPP   FKP 
Sbjct: 262 RFFLSIN--WQDVVQKKLLPP---FKPQ 284

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-46
 Identities = 52/294 (17%), Positives = 106/294 (36%), Gaps = 47/294 (15%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
                  +G+GSFG V++ K       VA+K +               E+ +++   H N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+                L +V ++   +   +  +   I  +  +I +     Q  + +
Sbjct: 66  ILLFMGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 117

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 253
            Y+H    I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + AP
Sbjct: 118 DYLH-AKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 254 ELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           E+I       Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++             
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----------- 224

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
               Y      +++ +          P     L+    +   + R    +    
Sbjct: 225 ---GYLSPDLSKVRSN---------CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (400), Expect = 7e-46
 Identities = 56/315 (17%), Positives = 103/315 (32%), Gaps = 54/315 (17%)

Query: 71  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 128
           +G R         Y     +G+GSFG ++       GE VAIK      ++     E +I
Sbjct: 5   VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
            +M+     +       +  D    Y  +V+E +  ++  +   ++   ++  L  V L 
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLL 108

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNV---- 242
             Q+   + YIH+     HRD+KP N L+        +   DFG AK       +     
Sbjct: 109 ADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167

Query: 243 ----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
               +   +  Y +     G  E +   D+ S G V+    LG   + G     +  +  
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY- 225

Query: 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358
                                +  + K     +V  K  P E    +        + +  
Sbjct: 226 --------------------ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265

Query: 359 A---LEACVHPFFDE 370
                +   + F  +
Sbjct: 266 YSYLRQLFRNLFHRQ 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  154 bits (390), Expect = 1e-44
 Identities = 48/280 (17%), Positives = 96/280 (34%), Gaps = 33/280 (11%)

Query: 71  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 128
           +G           Y     +G GSFGV+F+       + VAIK   +         E + 
Sbjct: 3   VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
            ++L     +   + F      E L+  LV++ +  ++  +     R   +  +  V + 
Sbjct: 54  YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMA 106

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNV-- 242
             Q+   +  IH    + +RDIKP N L+      + + + + DFG  K           
Sbjct: 107 AKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 243 ------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
                 +   +  Y +     G  E +   D+ + G V    L G   + G        +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
             ++        ++ +   + E +F +   +  +  F   
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 5e-44
 Identities = 54/281 (19%), Positives = 99/281 (35%), Gaps = 43/281 (15%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 145
             +G G FG V        G  VA+K +  D   +    E  +M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVM--LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
                    L +V EY+ +  + +    SR    +    +  ++  +C A+ Y+      
Sbjct: 71  EEKG----GLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NF 124

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
            HRD+  +N+LV+      K+ DFG  K         +      + APE +    +++T 
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFSTK 180

Query: 266 IDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 324
            D+WS G ++ E+   G+  +P     D +  + K                         
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------------- 215

Query: 325 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
               +        PP   +++   +     +R + L+    
Sbjct: 216 ---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  153 bits (386), Expect = 2e-43
 Identities = 64/312 (20%), Positives = 114/312 (36%), Gaps = 57/312 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K         E +I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++   +   +    +   + R          R    + + Y  QI     Y+H+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              + +RD+KP+NLL++   + +++ DFG AK         +   +    APE+I     
Sbjct: 160 L-DLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-KG 214

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y  A+D W+ G ++ E+  G P F  +  +    +I                        
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------------ 250

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFFDELRDPNT 376
                      F      +  DL+    Q        NL+    +   H +F      + 
Sbjct: 251 -----VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTDW 302

Query: 377 RLPNGRPLPPLF 388
                R +   F
Sbjct: 303 IAIYQRKVEAPF 314

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 7e-42
 Identities = 76/337 (22%), Positives = 132/337 (39%), Gaps = 61/337 (18%)

Query: 79  KQKVS---YIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKV--------LQDKRYKNR 124
            +KV    +    V+GTG++G VF  +     +TG++ A+K +         +   +   
Sbjct: 18  AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
           E Q+++ +     +   H  F    + +L+L L      E    +++      +R     
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAF--QTETKLHLILDYINGGELFTHLSQ-----RERFTEHE 130

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           V++Y  +I  AL ++H   GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y
Sbjct: 131 VQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAY 188

Query: 245 IC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
                  Y     +  G + +  A+D WS G +M ELL G   F  +   +   EI +  
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-- 246

Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR----- 356
                                  +       + + +   A DL+ R     P  R     
Sbjct: 247 -----------------------RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283

Query: 357 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 393
             A E   H FF ++   +  L   +   P   FKP 
Sbjct: 284 RDADEIKEHLFFQKINWDD--LAAKKVPAP---FKPV 315

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-41
 Identities = 58/299 (19%), Positives = 110/299 (36%), Gaps = 35/299 (11%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVA 139
           + + +  +G G FG V+  + +  GE VA+K     +    ++  E+    ML H NI+ 
Sbjct: 4   TIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
                 +  +     L LV +Y     +    +Y      + +  +          LA++
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHE---HGSLFDYLN-RYTVTVEGMIKLALSTASGLAHL 116

Query: 200 HNCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICS 247
           H  I        I HRD+K +N+LV        + D G A         +       + +
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 248 RYYRAPELIFGA-----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
           + Y APE++  +      E     DI++ G V  E+     +  G     QL     V  
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPS 234

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
            P+ EE++ +          +++P+  ++            ++   +  +   R TAL 
Sbjct: 235 DPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 3e-40
 Identities = 67/300 (22%), Positives = 110/300 (36%), Gaps = 47/300 (15%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVA 139
           S   E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L         +E +Y+  V EY+ +             + + L  +     QI   +AY+
Sbjct: 77  LYAVV----SEEPIYI--VTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYICSRYYRAPELIF 257
                  HRD++  N+LV  +    K+ DFG A+++   E            + APE   
Sbjct: 130 ERM-NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 258 GATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
               +T   D+WS G ++ EL   G+  +PG    + L ++ +    P   E        
Sbjct: 188 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------- 239

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFFDELRDP 374
                                P    DL+C+ ++  P  R T   L+A +  +F      
Sbjct: 240 ---------------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 4e-40
 Identities = 57/293 (19%), Positives = 107/293 (36%), Gaps = 47/293 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
                 +G G FG V+          VA+K + Q     +    E  +M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                    +E +Y+  + EY+    + +    +    ++ +  +     QI   +A+I 
Sbjct: 74  YAVV----TQEPIYI--ITEYMENG-SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFG 258
                 HRD++  N+LV+      K+ DFG A+++   E            + APE I  
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 259 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
              +T   D+WS G ++ E++  G+  +PG +  + +  + +                  
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE--ACVHPFF 368
                      +  V     P E   L+   ++  P  R T     + +  FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 3e-39
 Identities = 65/309 (21%), Positives = 117/309 (37%), Gaps = 54/309 (17%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVL-----QDKRYKNRELQIMQMLDH 134
               E V+G G FG V     +  G+    VAIK +      + +R    E  IM   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           PN++ L+      T    +   ++ E++      +     +   +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMEN--GSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------ 248
            + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +       
Sbjct: 140 GMKYLA-DMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            + APE I    ++T+A D+WS G VM E++  G+  +   +  D +  I +    P   
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           +                             P     L+   +Q   N R    +  V+  
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQ-IVNTL 287

Query: 368 FDELRDPNT 376
              +R+PN+
Sbjct: 288 DKMIRNPNS 296

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (352), Expect = 4e-39
 Identities = 53/293 (18%), Positives = 114/293 (38%), Gaps = 43/293 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
              +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 78

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                  T +   Y+    E++               Q +  + +     QI  A+ Y+ 
Sbjct: 79  LGVC---TREPPFYIIT--EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE 132

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--YYRAPELIFG 258
                 HRD+  +N LV  + H +K+ DFG ++++                + APE +  
Sbjct: 133 KK-NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +++   D+W+ G ++ E+            + Q+ E+++                   
Sbjct: 191 -NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------KDYR 234

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
            + P            +  P +  +L+   +Q++P+ R +  E  +H  F+ +
Sbjct: 235 MERP------------EGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETM 273

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 7e-39
 Identities = 57/298 (19%), Positives = 103/298 (34%), Gaps = 53/298 (17%)

Query: 89  VVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIV 138
            +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L              + +V E  P     +     +      L  +  Y  Q+   + Y
Sbjct: 75  RLYGVV------LTPPMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPEL 255
           + +     HRD+  +NLL+      +K+ DFG  + L + + +     +    +      
Sbjct: 127 LESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 256 IFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
                 ++ A D W  G  + E+   GQ  + G +G   L +I K      R E      
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE------ 238

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                                  P +  +++ + + + P  R T +   +  F  E +
Sbjct: 239 ---------------------DCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-38
 Identities = 47/282 (16%), Positives = 96/282 (34%), Gaps = 43/282 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
            +G+G FG+V         + VAIK + +    +     E ++M  L HP +V L     
Sbjct: 12  EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 69

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              ++  +   LV E++      ++              +      +C  +AY+     +
Sbjct: 70  --LEQAPIC--LVFEFMEH--GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CV 122

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFGATEYT 263
            HRD+  +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y+
Sbjct: 123 IHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYS 180

Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
           +  D+WS G +M E+     +        ++VE I                         
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------------------------ 216

Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                +     +        ++   ++  P  R         
Sbjct: 217 ---TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-38
 Identities = 58/301 (19%), Positives = 106/301 (35%), Gaps = 56/301 (18%)

Query: 85  IAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
           + +  +G+G+FG V +   +  +  + VA+K +  +            E  +MQ LD+P 
Sbjct: 10  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV +        + E   L  V+E            Y + ++ +    +    +Q+   +
Sbjct: 70  IVRMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NVSYICSRYYRA 252
            Y+       HRD+  +N+L+    H  K+ DFG +K L   E              + A
Sbjct: 121 KYLEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           PE I    ++++  D+WS G +M E    GQ  + G  G +    + K            
Sbjct: 179 PECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-- 235

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFF 368
                                     P E  DL+   + Y    R       +   + ++
Sbjct: 236 --------------------------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269

Query: 369 D 369
           D
Sbjct: 270 D 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 5e-38
 Identities = 68/300 (22%), Positives = 111/300 (37%), Gaps = 54/300 (18%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   R   +   VAIK + Q     +     RE QIM  LD+P I
Sbjct: 12  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 71

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L          +   L LV+E        + +      + +P+  V    +Q+   + 
Sbjct: 72  VRLIGVC------QAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMK 123

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAP 253
           Y+       HRD+  +N+L+    +  K+ DFG +K L   +   +   +      + AP
Sbjct: 124 YLE-EKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           E I    ++++  D+WS G  M E L  GQ  +    G + +  I +             
Sbjct: 182 ECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG------------ 228

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFFD 369
                  K  +  P           PPE   L+   + Y    R   L         ++ 
Sbjct: 229 -------KRMECPPE---------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 8e-38
 Identities = 62/317 (19%), Positives = 107/317 (33%), Gaps = 70/317 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQDKRYKN-----RELQIMQML- 132
                V+G+G+FG V  A      +      VA+K + +            EL++M  L 
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------------ETVNRIARN 172
            H NIV L       T    +Y  L+ EY                      E  N+    
Sbjct: 99  SHENIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 173 YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232
                  +    +  + YQ+ + + ++       HRD+  +N+LV      +K+CDFG A
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLA 211

Query: 233 KVLVKGEPNVSYICSR---YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
           + ++     V    +R    + APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
                  ++I+               N  +   P                 E   ++   
Sbjct: 271 PVDANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSC 303

Query: 349 FQYSPNLRCTALEACVH 365
           + +    R +       
Sbjct: 304 WAFDSRKRPSFPNLTSF 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-37
 Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 45/288 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
                 +GTG FGVV   K R     VAIK + +    ++    E ++M  L H  +V L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                  T +  ++  ++ EY+      +      +  R     +      +C A+ Y+ 
Sbjct: 65  YGVC---TKQRPIF--IITEYMAN--GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YICSRYYRAPELIFG 258
                 HRD+  +N LVN     +K+ DFG ++ ++  E   S        +  PE++  
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 259 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
            +++++  DIW+ G +M E+  LG+  +   +  +    I + L                
Sbjct: 176 -SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---------------- 218

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
               P +               +   ++   +    + R T      +
Sbjct: 219 RLYRPHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-37
 Identities = 64/329 (19%), Positives = 119/329 (36%), Gaps = 55/329 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
           V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L     ++T      + L+ + +P     +          +   Y+  +  QI + + Y+
Sbjct: 76  LLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR---YYRAPELI 256
            +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E I
Sbjct: 128 EDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 257 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
                YT   D+WS G  + EL+  G   + G     ++  I++      +  I      
Sbjct: 186 LH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPI------ 237

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
                                   +   ++ + +    + R    E  +  F    RDP 
Sbjct: 238 ---------------------CTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDPQ 275

Query: 376 TRLPNGRPLPPLFNFKPPELSGIPPETIN 404
             L          +   P  S      ++
Sbjct: 276 RYLV--IQGDERMHLPSPTDSNFYRALMD 302

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-35
 Identities = 62/308 (20%), Positives = 106/308 (34%), Gaps = 65/308 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQML- 132
                 +G G+FG V +A        +    VA+K +              EL+++  L 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP---------------ETVNRIARNYSRIH 177
           +H NIV L       T        ++ EY                               
Sbjct: 85  NHMNIVNLLGAC---TIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
             + L  +  ++YQ+ + +A++ +     HRD+  +N+L+       K+CDFG A+ +  
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRIT-KICDFGLARDIKN 197

Query: 238 GEPNVSYICSR---YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G  + EL  LG   +PG     +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
             ++IK                             +  +  +  P E  D++   +   P
Sbjct: 257 FYKMIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 354 NLRCTALE 361
             R T  +
Sbjct: 290 LKRPTFKQ 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (321), Expect = 2e-34
 Identities = 61/318 (19%), Positives = 108/318 (33%), Gaps = 73/318 (22%)

Query: 89  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
            +G G+FG VFQA+       E   +VA+K + ++          RE  +M   D+PNIV
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP---------------------ETVNRIARNYSRIH 177
                       + + L  + EY+                        ++  AR  S   
Sbjct: 80  ---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
             +          Q+   +AY+       HRD+  +N LV  +   +K+ DFG ++ +  
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMV-VKIADFGLSRNIYS 192

Query: 238 GEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
            +      +      +  PE IF    YTT  D+W+ G V+ E+   G   + G +  + 
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
           +  +                          I   P      +  P E  +L+   +   P
Sbjct: 252 IYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKLP 283

Query: 354 NLRCTALEACVHPFFDEL 371
             R +     +H     +
Sbjct: 284 ADRPSFCS--IHRILQRM 299

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-34
 Identities = 66/293 (22%), Positives = 100/293 (34%), Gaps = 50/293 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHP 135
                 +G G FG V Q            VAIK               +E   M+  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           +IV L           E  + +++E        +          + L  + LY YQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTL--GELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAP 253
           LAY+ +     HRDI  +N+LV+ +   +KL DFG ++ +       +        + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           E I     +T+A D+W  G  M E+L+ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                                    PP    L+ + + Y P+ R    E    
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-34
 Identities = 52/304 (17%), Positives = 106/304 (34%), Gaps = 57/304 (18%)

Query: 87  EHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
             V+G G FG V+     +        A+K + +            E  IM+   HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           +L      +    E    +VL Y+     R             +  +  +  Q+ + + +
Sbjct: 92  SLLGICLRS----EGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 145

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAP 253
           +       HRD+  +N +++     +K+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           E +    ++TT  D+WS G ++ EL+  G P +P  +  D  V +++       E     
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--- 259

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHP 366
                                    P    +++ + +     +R +       + A    
Sbjct: 260 -------------------------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

Query: 367 FFDE 370
           F  E
Sbjct: 295 FIGE 298

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 6e-34
 Identities = 55/292 (18%), Positives = 98/292 (33%), Gaps = 50/292 (17%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLD 133
               + V+G G FG V++   + +       VAIK +      K       E  IM    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           H NI+ L+         +   + ++ EY+        +          ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC----SRY 249
             + Y+ N     HRD+  +N+LVN +    K+ DFG ++VL                  
Sbjct: 121 AGMKYLANM-NYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           + APE I    ++T+A D+WS G VM E++        E    ++++ I           
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
                              +        P     L+ + +Q     R    +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 1e-33
 Identities = 58/300 (19%), Positives = 105/300 (35%), Gaps = 56/300 (18%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI--VAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 138
           + V+G G+FG V +A+ ++ G     AIK++       D R    EL+++  L  HPNI+
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQRMPLIYV 185
            L             YL L +EY P                +      +     +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
             +   + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
               + A E +   + YTT  D+WS G ++ E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                         + P                 E  DL+ + ++  P  R +  +  V 
Sbjct: 241 ---------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 6e-33
 Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 66/309 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDKRYKN-----RELQIMQM 131
            +    +G G+FG V  A+     +        VA+K +  D   K+      E+++M+M
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 132 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIH 177
           +  H NI+   +   + T    LY+  ++EY              P  +           
Sbjct: 75  IGKHKNII---NLLGACTQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           +++    +    YQ+ R + Y+ +     HRD+  +N+LV       K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 238 GEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
            +             + APE +F    YT   D+WS G ++ E+  LG   +PG   V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
           L +++K                  E        +            E   ++   +   P
Sbjct: 246 LFKLLK------------------EGHRMDKPSN---------CTNELYMMMRDCWHAVP 278

Query: 354 NLRCTALEA 362
           + R T  + 
Sbjct: 279 SQRPTFKQL 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-32
 Identities = 58/310 (18%), Positives = 107/310 (34%), Gaps = 62/310 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQML 132
                 +G G+FG V +A         T   VA+K + +       +   +    ++ + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQR 179
            H N+V L              L +++E+               E V             
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 180 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
           + L ++  Y++Q+ + + ++ +     HRD+  +N+L++     +K+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188

Query: 240 PNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLV 295
             V          + APE IF    YT   D+WS G ++ E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
             +K                 T  + P                PE    +   +   P+ 
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280

Query: 356 RCTALEACVH 365
           R T  E   H
Sbjct: 281 RPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-30
 Identities = 55/315 (17%), Positives = 114/315 (36%), Gaps = 63/315 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD 133
                 +G GSFG+V++   +     E    VAIK V     ++++     E  +M+  +
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVK 186
             ++V         +  +     +++E +            R A   + +     L  + 
Sbjct: 82  CHHVV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
               +I   +AY++      HRD+  +N +V      +K+ DFG  + + + +       
Sbjct: 137 QMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGK 194

Query: 247 ---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLG 302
                 + +PE +     +TT  D+WS G V+ E+  L +  + G S    L  +++   
Sbjct: 195 GLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--- 250

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--- 359
                                +   P         P    +L+   +QY+P +R +    
Sbjct: 251 -------------------GGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEI 285

Query: 360 ---LEACVHPFFDEL 371
              ++  + P F E+
Sbjct: 286 ISSIKEEMEPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.0 bits (212), Expect = 2e-20
 Identities = 31/204 (15%), Positives = 57/204 (27%), Gaps = 34/204 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV--------------LQDKRYKNRELQIMQMLDH 134
           ++G G    VF     E      +K                     + +         + 
Sbjct: 7   LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 135 PNIVALKHCFFSTT-DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
             +  L+          E   +  ++E             ++   R+ +         I 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAV--LMEL----------IDAKELYRVRVENPDEVLDMIL 113

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             +A  ++   I H D+   N+LV      + + DF  +  +  GE     I  R  R  
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168

Query: 254 ELIFGATEYTTAIDIWSTGCVMAE 277
              F    Y T  DI S    + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	422
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.14
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.81
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.72
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.93
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.37
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.93

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-65  Score=492.51  Aligned_cols=333  Identities=71%  Similarity=1.204  Sum_probs=290.6

Q ss_pred             CcceeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHHcCCCCcccccceeecCCC-CCceEEE
Q 014595           78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLN  156 (422)
Q Consensus        78 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~~  156 (422)
                      ..+..+|...++||+|+||+||+|+++.+|+.||||++..+.....+|+++|++++|||||+++++|..... .+..+++
T Consensus        16 ~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             CCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            344557999999999999999999999999999999998877777799999999999999999999865443 4567889


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +|||||++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++...
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            999999988777777666667789999999999999999999999 8999999999999999876679999999998877


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      ......+.+||+.|+|||.+.+...|+.++||||+||++|||++|++||.+.+..+++.++.+.+|.+..+.+....+.+
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  254 (350)
T d1q5ka_         175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  254 (350)
T ss_dssp             TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence            66667778899999999998877779999999999999999999999999999999999999999999999999999888


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS  396 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (422)
                      ....++.....+|.......+++++.+||.+||++||++|||+.|+|+||||+++.++...+++....+.++++...+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~  334 (350)
T d1q5ka_         255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS  334 (350)
T ss_dssp             -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHT
T ss_pred             hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhcc
Confidence            88889988888888888888999999999999999999999999999999999999888887777777776666544443


Q ss_pred             CCChhHHhhhCcHHHh
Q 014595          397 GIPPETINRLIPEHAR  412 (422)
Q Consensus       397 ~~~~~~~~~~~~~~~~  412 (422)
                      . .++....++|.|+|
T Consensus       335 ~-~~~~~~~~~p~~~r  349 (350)
T d1q5ka_         335 S-NPPLATILIPPHAR  349 (350)
T ss_dssp             T-CGGGHHHHSCTTTT
T ss_pred             C-CccccccCCCcccc
Confidence            3 34445567888776

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-60  Score=436.52  Aligned_cols=247  Identities=30%  Similarity=0.497  Sum_probs=211.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++++.++|||||++++++.     +...
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence            4699999999999999999999999999999998542       233468999999999999999999984     3345


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++|||||++ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        81 ~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~  154 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGWSV  154 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCSCS
T ss_pred             EEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCC-CEeecccceee
Confidence            8899999985 77666553    3679999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ..... ......||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.+.             
T Consensus       155 ~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------------  219 (263)
T d2j4za1         155 HAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------  219 (263)
T ss_dssp             CCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------
T ss_pred             ecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence            65433 34567899999999999764 4899999999999999999999999988877776665441             


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                          .+.            +++.+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       220 ----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         220 ----EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ----CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                111            22457999999999999999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-60  Score=444.91  Aligned_cols=276  Identities=35%  Similarity=0.599  Sum_probs=226.0

Q ss_pred             EeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+++.++|||||++++++..     ..++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence            3578999999999999999999999999985432         234589999999999999999999843     33478


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+.+++...+   ......+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        77 ivmE~~~~~~~~~~---~~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHH---TTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhh---hhcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCC-ccccccCccccccC
Confidence            99999997654333   2335679999999999999999999999 8999999999999999887 69999999997664


Q ss_pred             cCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ... .....+||+.|+|||++.+...|+.++|||||||++|||+||.+||.+.+..+++.+|.+.++.|..+.+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            433 3345678999999999977667899999999999999999999999999999999999999999887665443322


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      .....+......++...+ +.+++++++||++||+.||++||||.|+|+||||++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             chhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            222223333333444333 46799999999999999999999999999999998754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-60  Score=438.30  Aligned_cols=252  Identities=27%  Similarity=0.353  Sum_probs=206.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++...     .....+|+++++.++|||||++++++..     ...+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~~   79 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY   79 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----CceeE
Confidence            3599999999999999999999999999999998543     2345689999999999999999999843     34588


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +|||||++ +|.+.+    .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+..
T Consensus        80 ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~  153 (271)
T d1nvra_          80 LFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF  153 (271)
T ss_dssp             EEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCC-CEEEccchhheee
Confidence            99999985 654443    234679999999999999999999999 8999999999999999887 6999999999876


Q ss_pred             ccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          236 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       236 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ....   .....+||+.|||||++.+...++.++|||||||++|||+||++||.+.+..............         
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~---------  224 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------  224 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT---------
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------
Confidence            4332   2345689999999999977665678999999999999999999999876544333332221000         


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                                  ...+     ...+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       225 ------------~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         225 ------------YLNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             ------------TSTT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ------------CCCc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                        0001     1357999999999999999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-59  Score=438.70  Aligned_cols=249  Identities=25%  Similarity=0.394  Sum_probs=211.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      +|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+++++.++|||||+++++|..     ..++|+|
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~iv   95 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVV   95 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEEE
Confidence            599999999999999999999999999999998643    2345689999999999999999999843     3348899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||++ +|..+..     ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+....
T Consensus        96 mEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          96 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP  168 (293)
T ss_dssp             EECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCC-cEeeccchhheeecc
Confidence            999985 6655443     2579999999999999999999999 8999999999999999887 699999999987644


Q ss_pred             CC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .. .....+||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+..+..... +            
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~------------  234 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-P------------  234 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-C------------
T ss_pred             ccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-C------------
Confidence            33 34566799999999999764 589999999999999999999999999888777776655310 0            


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                         .+          ..+..+|+++++||.+||+.||++|||+.|+|+||||+.
T Consensus       235 ---~~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         235 ---EL----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             ---CC----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ---CC----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence               00          012457999999999999999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-59  Score=436.26  Aligned_cols=251  Identities=31%  Similarity=0.524  Sum_probs=210.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|++++++++|||||+++++|.     +...
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence            46999999999999999999999999999999986421       34568999999999999999999983     3345


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +|+|||||++ +|.+++..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~  156 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTAK  156 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCc-eEEecccccce
Confidence            7899999985 66665443    4679999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          234 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       234 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ......   .....+||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+.++.+.          
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~----------  225 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------  225 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT----------
T ss_pred             ecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC----------
Confidence            764332   23456799999999999765 4899999999999999999999999998887777766542          


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHH------HhcCCcccccCC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRD  373 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e------~l~hp~f~~~~~  373 (422)
                             .+.            ++..+++++++||++||+.||++|||++|      +++||||+++.+
T Consensus       226 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w  275 (288)
T d1uu3a_         226 -------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  275 (288)
T ss_dssp             -------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             -------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence                   111            22468999999999999999999999987      588999999853

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=435.60  Aligned_cols=286  Identities=32%  Similarity=0.554  Sum_probs=233.1

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCC-CeEEEEEEeccc------hhhHHHHHHHHHHc---CCCCcccccceeecCCCC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQD------KRYKNRELQIMQML---DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vAiK~~~~~------~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~  150 (422)
                      ..+|.+++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+++.|   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            35699999999999999999999765 678999998532      22345788888776   799999999998765556


Q ss_pred             CceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecC
Q 014595          151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (422)
Q Consensus       151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG  230 (422)
                      ...+++++|||+.++.......  .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~-~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCC-Ceeecchh
Confidence            6778899999999765443332  234679999999999999999999999 8999999999999999887 69999999


Q ss_pred             CccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      +++............||+.|+|||++.+. .|+.++|||||||++|||+||++||.+.+..+++..+....+.+....+.
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            99876555555678899999999999764 59999999999999999999999999999999999999999988876554


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      ...... ...+......++.. +...+++++++||++||++||++|||+.|+|+||||+++..
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         241 RDVALP-RQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             TTCSSC-GGGSCCCCCCCGGG-TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccch-hhhhccccccchhh-ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            321110 11111112222222 33578999999999999999999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-59  Score=432.58  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=204.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++....      ..+.+|++++++++|||||++++++.+   .....+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence            46999999999999999999999999999999985432      234579999999999999999998853   223347


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-----ceecCCCCCCeEEcCCCCcEEEeec
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVNPHTHQLKLCDF  229 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g-----ivHrDlkp~Nill~~~~~~vkl~Df  229 (422)
                      |+|||||+ ++|.+++.........+++..++.++.||+.||+|||+ +|     |+||||||+|||++.++ .+||+||
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DF  158 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF  158 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTS-CEEECCH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCC-cEEEeec
Confidence            89999998 48888887766667889999999999999999999998 56     99999999999999887 6999999


Q ss_pred             CCccccccCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          230 GSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       230 G~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      |+|+....... .....||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+...++....       
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-------  230 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-------  230 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-------
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------
Confidence            99987654432 3457889999999999654 58999999999999999999999999988777766665420       


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcc
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  368 (422)
                                  ++.         ++..+|+++++||++||+.||++|||+.|+|+|||+
T Consensus       231 ------------~~~---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 ------------FRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ------------CCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ------------CCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                        000         124679999999999999999999999999999995

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-59  Score=435.24  Aligned_cols=282  Identities=35%  Similarity=0.653  Sum_probs=229.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||+|+||+||+|++..+|+.||||++...      .....+|+++|++++|||||++++++..     ...+|
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~~   77 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY   77 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----cccee
Confidence            599999999999999999999999999999998542      2345689999999999999999999843     33488


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      +||||+.+++......  .....+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+...
T Consensus        78 iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  153 (298)
T ss_dssp             EEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHC
T ss_pred             EEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccC-cceeccCCcceecc
Confidence            9999999876555433  234679999999999999999999999 8999999999999999887 69999999997664


Q ss_pred             cC-CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .. .......||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+....+......
T Consensus       154 ~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence            33 33345688999999999877777899999999999999999999999999999999999998888776544322110


Q ss_pred             C-ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          316 Y-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       316 ~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      . ....++......+.... ..+++++++||++||+.||++|||+.|+|+||||+++.+|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccccccchhhhc-cCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            0 01112222222222222 4678999999999999999999999999999999998654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-58  Score=427.32  Aligned_cols=251  Identities=23%  Similarity=0.336  Sum_probs=205.7

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      |++.++||+|+||+||+|+++.+++.||+|++....      ..+.+|+++|++++|||||++++++.... .+...+++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            578889999999999999999999999999985432      23468999999999999999999885433 33456789


Q ss_pred             Eeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--ivHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      |||||++ +|.+++..    ...+++..++.++.||+.||+|||+ +|  |+||||||+|||++.+...+||+|||+|+.
T Consensus        90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999985 77666543    3679999999999999999999998 78  999999999999975333799999999975


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      .. .......+||+.|||||++.+  .++.++|||||||++|||++|+.||.+......+.+.+... ..+         
T Consensus       165 ~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~-~~~---------  231 (270)
T d1t4ha_         165 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKP---------  231 (270)
T ss_dssp             CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCC---------
T ss_pred             cc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC-CCC---------
Confidence            43 333456789999999999854  48999999999999999999999998766555544433210 000         


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                                      ..++...++++++||.+||+.||++|||++|+|+||||+
T Consensus       232 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                            012345789999999999999999999999999999996

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-58  Score=432.06  Aligned_cols=255  Identities=23%  Similarity=0.366  Sum_probs=216.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----------hhhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++.+.          ...+.+|+.+|++++|||||+++++|.     +
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            3599999999999999999999999999999998532          234568999999999999999999983     3


Q ss_pred             ceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC---cEEEe
Q 014595          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLC  227 (422)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~---~vkl~  227 (422)
                      ...+|+|||||++ +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.   .+||+
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEec
Confidence            3458899999984 77776654    3679999999999999999999999 89999999999999987653   49999


Q ss_pred             ecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       228 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      |||+|.............+|+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.+..+.+..+.......+  
T Consensus       160 DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~--  236 (293)
T d1jksa_         160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE--  236 (293)
T ss_dssp             CCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC--
T ss_pred             chhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--
Confidence            9999988766666667789999999999965 4589999999999999999999999999888887777655311111  


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                             ......+|+++++||++||+.||++|||++|+|+||||+...
T Consensus       237 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         237 -----------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             -----------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             -----------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                   112246899999999999999999999999999999998754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-59  Score=436.30  Aligned_cols=252  Identities=28%  Similarity=0.446  Sum_probs=198.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++....     ....+|+.+|+.++|||||++++++.     ...++|
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~~   83 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGHLY   83 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence            35999999999999999999999999999999986432     23457999999999999999999983     344588


Q ss_pred             EEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC---CCCcEEEeecCCc
Q 014595          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSA  232 (422)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~---~~~~vkl~DfG~a  232 (422)
                      +|||||+ ++|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||+..   ++ .+||+|||+|
T Consensus        84 lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a  157 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDS-KIMISDFGLS  157 (307)
T ss_dssp             EEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCC---
T ss_pred             EEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCc-eEEEecccee
Confidence            9999998 577666643    4679999999999999999999999 89999999999999953   44 6999999999


Q ss_pred             cccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      +.........+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+....+.+..           
T Consensus       158 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-----------  225 (307)
T d1a06a_         158 KMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE-----------  225 (307)
T ss_dssp             ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC-----------
T ss_pred             EEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC-----------
Confidence            877666656677899999999999664 58999999999999999999999999988777776665521           


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                            +.++.        ...+.+|+++++||.+||+.||++|||+.|+|+||||++
T Consensus       226 ------~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         226 ------YEFDS--------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             ------CCCCT--------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             ------CCCCC--------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                  11110        112468999999999999999999999999999999976

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=430.86  Aligned_cols=252  Identities=26%  Similarity=0.405  Sum_probs=210.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .|++.+.||+|+||+||+|+++.+|+.||||++...    ...+.+|+++|+.++|||||++++++..     ...+++|
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~lv   87 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL   87 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEEE
Confidence            499999999999999999999999999999998542    2445689999999999999999999843     3347899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||++ +|..++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+....
T Consensus        88 mEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          88 IEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR  162 (288)
T ss_dssp             EECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECHH
T ss_pred             EecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCC-CEEEEechhhhccCC
Confidence            999985 66555443   23679999999999999999999999 8999999999999999888 699999999976533


Q ss_pred             CC-CcccccccccccchhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          238 GE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .. ......||+.|+|||++..    ...|+.++|||||||++|||+||++||.+.+..+.+.++.+..  ++       
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~-------  233 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PP-------  233 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CC-------
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC-------
Confidence            21 2235678999999999842    3458899999999999999999999999988877777766521  00       


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                           .+            ..+..+|+++++||++||+.||++|||+.|+|+||||+.
T Consensus       234 -----~~------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 -----TL------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             -----CC------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             -----CC------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                 00            012457999999999999999999999999999999974

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-58  Score=436.15  Aligned_cols=250  Identities=27%  Similarity=0.428  Sum_probs=214.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|.+++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++|||||+++++|.     +..+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-----cccc
Confidence            3599999999999999999999999999999998643       233458999999999999999999983     4445


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +|+|||||++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        80 ~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~  153 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCK  153 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred             cccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCC-CEEEeeccccc
Confidence            8899999985 55554443    4689999999999999999999999 8999999999999999888 69999999998


Q ss_pred             cccc-CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       234 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      .... .......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+...            
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------------  220 (337)
T d1o6la_         154 EGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------  220 (337)
T ss_dssp             CSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred             ccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------------
Confidence            7544 3344567899999999999765 4899999999999999999999999999887777666552            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~  372 (422)
                           .+.            ++..+|+++++||++||+.||.+|++     +.|+++||||+++.
T Consensus       221 -----~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         221 -----EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----CCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence                 112            22468999999999999999999994     99999999998864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-58  Score=442.47  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=217.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      +|++.+.||+|+||+||+|+++.+|+.||||++....    ....+|+.+|+.++|||||++++++..     ...+|+|
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~iv  101 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVMI  101 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEE
Confidence            5999999999999999999999999999999986532    334589999999999999999999843     3458899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC-CCcEEEeecCCccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLV  236 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~-~~~vkl~DfG~a~~~~  236 (422)
                      ||||++ +|.+.+..   ..+.+++..++.++.||+.||+|||+ +|||||||||+|||++.+ .+.+||+|||+|+...
T Consensus       102 mE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         102 YEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             ECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            999984 76555532   24579999999999999999999999 899999999999999643 2379999999998876


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .........||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+.......            
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------------  244 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------------  244 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS------------
T ss_pred             cccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------
Confidence            66666678899999999999765 48999999999999999999999999998888888876632111            


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                           +.        .....+|+++++||++||+.||++|||++|+|+||||+....+
T Consensus       245 -----~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         245 -----DD--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             -----CC--------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             -----Cc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                 10        1124579999999999999999999999999999999987654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-58  Score=432.80  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=209.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .|++.+.||+|+||+||+|++..+|+.||||++....       ..+.+|+++|+.++|||||++++++..     ...+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCEE
Confidence            4999999999999999999999999999999986432       234579999999999999999999843     3348


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      |+|||||.++......   .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+..
T Consensus        91 ~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM  165 (309)
T ss_dssp             EEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBSS
T ss_pred             EEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCC-CEEEeeccccccc
Confidence            8999999875433322   234789999999999999999999999 8999999999999999887 7999999999865


Q ss_pred             ccCCCcccccccccccchhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ..   .....||+.|||||++.+.  ..|+.++|||||||++|||++|..||.+.+..+.+..+.....           
T Consensus       166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~-----------  231 (309)
T d1u5ra_         166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----------  231 (309)
T ss_dssp             SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----------
T ss_pred             CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence            33   3456899999999998642  3589999999999999999999999999888777777665210           


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                              +.        ..+..+|+++++||.+||+.||.+|||++|+|+||||..-
T Consensus       232 --------~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         232 --------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             --------CC--------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             --------CC--------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence                    00        0123578999999999999999999999999999999763

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=435.51  Aligned_cols=285  Identities=33%  Similarity=0.607  Sum_probs=230.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-CCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~  154 (422)
                      .+|++++.||+|+||+||+|+++.+|+.||||++....      ....+|+++|+.++|||||+++++|..... ....+
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            46999999999999999999999999999999986432      234579999999999999999999854432 23345


Q ss_pred             EEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      +|+|||||+.++..+...     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus        98 ~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~  170 (346)
T d1cm8a_          98 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  170 (346)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccccc-ccccccccceec
Confidence            789999998877665543     679999999999999999999999 8999999999999999888 699999999986


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..  .......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+.....
T Consensus       171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         171 AD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             CC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence            53  3345678999999999998777789999999999999999999999999999999999999999998877665432


Q ss_pred             CCc---cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCC
Q 014595          315 NYT---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (422)
Q Consensus       315 ~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  376 (422)
                      ...   ....+.....++...+ ..+++++++||++||+.||.+|||+.|+|+||||+.+.++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~  312 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  312 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             hhhhhhhccCCcccccchHHhc-cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence            111   1123333344444433 578999999999999999999999999999999999876543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2e-58  Score=441.19  Aligned_cols=255  Identities=26%  Similarity=0.398  Sum_probs=215.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .|++.+.||+|+||+||+|+++.+|+.||||++....    ....+|+.+|++++|||||+++++|.     +...+|+|
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~iv  104 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVLI  104 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEE
Confidence            5999999999999999999999999999999986532    34457999999999999999999983     33457899


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcC-CCCcEEEeecCCccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~-~~~~vkl~DfG~a~~~~  236 (422)
                      ||||++ +|.+.+.   .....+++..++.++.||+.||+|||+ +||+||||||+|||++. +.+.+||+|||+|+...
T Consensus       105 mE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         105 LEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccceecC
Confidence            999985 6544332   234579999999999999999999999 89999999999999973 22379999999999887


Q ss_pred             cCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 014595          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (422)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (422)
                      .........||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+..+......             
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-------------  246 (352)
T d1koba_         181 PDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-------------  246 (352)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-------------
T ss_pred             CCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence            66666678899999999999654 5899999999999999999999999999988888877663211             


Q ss_pred             ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                          ++.        .....+|+++++||++||+.||.+|||+.|+|+||||+...
T Consensus       247 ----~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         247 ----FDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             ----CCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ----CCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence                111        11246899999999999999999999999999999998743

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-57  Score=430.08  Aligned_cols=248  Identities=27%  Similarity=0.483  Sum_probs=212.4

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++|||||++++++.     ...++
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~   79 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQI   79 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSEE
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCee
Confidence            599999999999999999999999999999998642       234558999999999999999999984     34458


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      |+|||||.+ ++..++.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus        80 ~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~  153 (316)
T d1fota_          80 FMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFAKY  153 (316)
T ss_dssp             EEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSCEE
T ss_pred             eeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCC-CEEEecCccceE
Confidence            899999986 4444333    35678999999999999999999999 8999999999999999888 699999999987


Q ss_pred             cccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ...  ...+.+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+.++...              
T Consensus       154 ~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--------------  216 (316)
T d1fota_         154 VPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--------------  216 (316)
T ss_dssp             CSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred             ecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence            643  34567899999999999654 4899999999999999999999999999888887777652              


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                         ...            ++..+++++++||.+||+.||.+|+     |++++|+||||+++.+
T Consensus       217 ---~~~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         217 ---ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             ---CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             ---CCC------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence               111            1246799999999999999999996     8999999999998753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-58  Score=439.31  Aligned_cols=279  Identities=25%  Similarity=0.426  Sum_probs=205.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...     .....+|+.+|+.++|||||+++++|..     ...+|
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~   80 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS   80 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence            4699999999999999999999999999999998643     2345689999999999999999999843     33488


Q ss_pred             EEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      +|||||++ +|..++..    .+.+++..++.++.||+.||+|||+.+||+||||||+|||++.++ .+||+|||+|+..
T Consensus        81 iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~  155 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  155 (322)
T ss_dssp             EEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHH
T ss_pred             EEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCcccc
Confidence            99999985 77776654    367999999999999999999999613999999999999999888 6999999999876


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCc
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ... ...+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+..+. ...+....+.+..........
T Consensus       156 ~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         156 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             HHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             CCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            443 23467899999999999775 499999999999999999999999987654332 222222222211110000000


Q ss_pred             C--CccCcCCCCC------------CCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          315 N--YTEFKFPQIK------------PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       315 ~--~~~~~~~~~~------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                      .  ..........            ..+........+|.++++||.+||+.||.+|||++|+|+||||++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence            0  0000000000            00000111124689999999999999999999999999999998754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.3e-57  Score=421.59  Aligned_cols=276  Identities=35%  Similarity=0.634  Sum_probs=223.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|.+.+.||+|+||+||+|+++ +|+.||||++...      .....+|+.+|++++|||||++++++....     ..+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~~   76 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RLV   76 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CEE
T ss_pred             CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----cee
Confidence            6999999999999999999995 7899999998543      234568999999999999999999985433     377


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ++|||+.+++...+.   ...+.+++..++.++.||+.||+|||+ .|||||||||+|||++.++ .+||+|||.|....
T Consensus        77 i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          77 LVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAFG  151 (286)
T ss_dssp             EEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHC
T ss_pred             EEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCC-CEEecccccceecc
Confidence            999999986654443   335789999999999999999999999 8999999999999999887 69999999997764


Q ss_pred             cCCC-cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .... .....+++.|+|||.+.+...++.++|||||||++|||++|++||.+.+..+++.++....+.+....+......
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence            3322 345568999999999987777899999999999999999999999999999999999998888876654432111


Q ss_pred             C-ccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          316 Y-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       316 ~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      . ....+......++.. +...++++++|||++||+.||++|||+.|+|+||||++
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhcccccccccCcchhh-hcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            0 011122222333333 33678999999999999999999999999999999985

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.5e-57  Score=417.54  Aligned_cols=253  Identities=28%  Similarity=0.425  Sum_probs=215.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------------hhHHHHHHHHHHcC-CCCcccccceeecCC
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFSTT  148 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------------~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~  148 (422)
                      +|++.+.||+|+||+||+|+++.+|+.||||++.+..             ....+|+.++++++ |||||++++++.   
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~---   80 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE---   80 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc---
Confidence            5999999999999999999999999999999985431             12457999999997 999999999983   


Q ss_pred             CCCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEe
Q 014595          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~  227 (422)
                        +..++|+|||||++ +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+
T Consensus        81 --~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~~kl~  152 (277)
T d1phka_          81 --TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIKLT  152 (277)
T ss_dssp             --CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEEC
T ss_pred             --cCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCC-CeEEc
Confidence              34458899999974 87777654    4679999999999999999999999 8999999999999999887 69999


Q ss_pred             ecCCccccccCCCcccccccccccchhhhcC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 014595          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  302 (422)
Q Consensus       228 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~  302 (422)
                      |||+++............||+.|+|||++.+     ...++.++||||+||++|+|++|+.||.+.+..+....+...- 
T Consensus       153 DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~-  231 (277)
T d1phka_         153 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-  231 (277)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-
T ss_pred             cchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC-
Confidence            9999988766666667789999999999853     3447889999999999999999999999998887777776521 


Q ss_pred             CCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                                      +.++.        ....++|+++++||.+||+.||++|||++|+|+||||++.
T Consensus       232 ----------------~~~~~--------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         232 ----------------YQFGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             ----------------CCCCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ----------------CCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                            11110        0114689999999999999999999999999999999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-57  Score=432.09  Aligned_cols=249  Identities=26%  Similarity=0.416  Sum_probs=212.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+|+.++|||||++++++.     ....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----cccc
Confidence            35999999999999999999999999999999986422       23458999999999999999999883     3345


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +++||||+.+ ++...+..    .+.+++..++.++.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|+
T Consensus       116 ~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~  189 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGFAK  189 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             cccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCC-CEEeeeceeee
Confidence            7899999985 55444433    3679999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ....  ......||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+....+.++....            
T Consensus       190 ~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------  254 (350)
T d1rdqe_         190 RVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------------  254 (350)
T ss_dssp             ECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred             eccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC------------
Confidence            7643  34567899999999999764 48999999999999999999999999988887777776521            


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccCC
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  373 (422)
                           +.            ++..+++++.+||++||+.||.+|+     |++++++||||+++.+
T Consensus       255 -----~~------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         255 -----VR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             -----CC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             -----CC------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                 11            1246899999999999999999995     9999999999998653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-56  Score=426.51  Aligned_cols=314  Identities=32%  Similarity=0.613  Sum_probs=240.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      +|++++.||+|+||+||+|+++.+|+.||||++....     ....+|+++|+.++||||+++++++.........++++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            4999999999999999999999999999999986432     23457999999999999999999986555445556778


Q ss_pred             EeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ++++++++|.+++..     ..+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+....
T Consensus        89 ~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          89 VTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADP  161 (345)
T ss_dssp             EEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECCG
T ss_pred             EEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCC-CEEEcccCceeeccC
Confidence            888888888877753     579999999999999999999999 8999999999999999887 699999999976533


Q ss_pred             CC----CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          238 GE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       238 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ..    .....+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+....+...+..+.........
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            32    23456789999999998666678999999999999999999999999999989988888888888766543221


Q ss_pred             cC---CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCC
Q 014595          314 PN---YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  390 (422)
Q Consensus       314 ~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  390 (422)
                      ..   ......+.....+|...+ ..+++++++||.+||+.||.+|||+.|+|+||||+....+......    +..+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~----~~~~~~  316 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA----EAPFKF  316 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCC----SSCC--
T ss_pred             hhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccc----cCccCC
Confidence            10   011233444444555444 5789999999999999999999999999999999987665432111    112222


Q ss_pred             CCCCCCCCChhHHhhhCcH
Q 014595          391 KPPELSGIPPETINRLIPE  409 (422)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~  409 (422)
                      . .....++.+.+++++.+
T Consensus       317 ~-~~~~~~~~~~l~~l~~~  334 (345)
T d1pmea_         317 D-MELDDLPKEKLKELIFE  334 (345)
T ss_dssp             -------CCHHHHHHHHHH
T ss_pred             C-hhhhhCCHHHHHHHHHH
Confidence            2 34455667776665433

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-57  Score=427.14  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=215.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|++.+.||+|+||+||+|+++.+|+.||||++....   ....+|+++|+.++|||||+++++|.+     ...+|+||
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~lvm   80 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVMIF   80 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEEE
Confidence            5999999999999999999999999999999987543   335689999999999999999999843     34588999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC-CcEEEeecCCcccccc
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT-HQLKLCDFGSAKVLVK  237 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~-~~vkl~DfG~a~~~~~  237 (422)
                      |||++ +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||+++....
T Consensus        81 E~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          81 EFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99985 67655532   23469999999999999999999999 8999999999999998543 3699999999987765


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      ........+|+.|+|||.+.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..|.+.....+..          
T Consensus       157 ~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----------  225 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE----------  225 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH----------
T ss_pred             CCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh----------
Confidence            5555667889999999998654 58999999999999999999999999999888888887642222211          


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                                     ..+.+|+++++||.+||+.||.+|||++|+|+||||++
T Consensus       226 ---------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         226 ---------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ---------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ---------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                           12467999999999999999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.9e-57  Score=431.96  Aligned_cols=252  Identities=25%  Similarity=0.395  Sum_probs=205.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHH---HHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      +|.+.++||+|+||+||+|+++.+|+.||||++.+..       ....+   |+.+++.++|||||+++++|..     .
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-----~   79 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----P   79 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----S
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-----C
Confidence            5999999999999999999999999999999985422       11223   4566667789999999999843     3


Q ss_pred             eEEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ..+|+|||||+ ++|..++..    ...+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g-~iKl~DFGl  153 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGL  153 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSS-CEEECCCTT
T ss_pred             CEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCC-cEEEeeece
Confidence            44789999998 577666654    3678999999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014595          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (422)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (422)
                      |+..... .....+||+.|+|||++.+...|+.++|||||||++|||+||+.||.+.+..+... +......        
T Consensus       154 a~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~--------  223 (364)
T d1omwa3         154 ACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT--------  223 (364)
T ss_dssp             CEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSS--------
T ss_pred             eeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccc--------
Confidence            9876443 34466899999999999766668999999999999999999999998765433222 2221100        


Q ss_pred             cCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCC-----HHHHhcCCcccccC
Q 014595          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (422)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~  372 (422)
                           ...            .++..+|+++++||.+||+.||++|||     |+|+++||||+++.
T Consensus       224 -----~~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         224 -----MAV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             -----CCC------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             -----CCC------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence                 000            123468999999999999999999999     89999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.7e-56  Score=422.05  Aligned_cols=282  Identities=30%  Similarity=0.493  Sum_probs=223.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-hhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEEEEe
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.... ....+|+++|+.+. ||||++++++|..   ....++++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCceeEEE
Confidence            46999999999999999999999999999999987543 45568999999995 9999999998843   2334578999


Q ss_pred             ecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccCC
Q 014595          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (422)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~~  239 (422)
                      |||+++..      ....+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|+......
T Consensus       112 e~~~~~~L------~~~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDF------KQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBG------GGTTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcH------HHHhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            99986321      1223679999999999999999999999 8999999999999999777679999999998877666


Q ss_pred             CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhhcCcCCcc
Q 014595          240 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (422)
Q Consensus       240 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (422)
                      .....++|+.|+|||.+.+...++.++||||+||++|+|++|+.||... +..++...+...++.+....+.........
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            6677889999999999987777899999999999999999999999764 445666777777776554433221111000


Q ss_pred             Cc----CCCCCCCCcccc----cccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCC
Q 014595          319 FK----FPQIKPHPWHKV----FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (422)
Q Consensus       319 ~~----~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  373 (422)
                      ..    ........+...    ....++++++|||++||++||++|||++|+|+||||+++.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            00    001111111111    12347899999999999999999999999999999998764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-57  Score=418.80  Aligned_cols=245  Identities=25%  Similarity=0.387  Sum_probs=203.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----------hhHHHHHHHHHHcC--CCCcccccceeecCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFSTTD  149 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~  149 (422)
                      .+|++.+.||+|+||+||+|++..+|+.||||++.+..          ....+|+.++++++  |||||++++++..   
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~---   80 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER---   80 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC---
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee---
Confidence            35999999999999999999999999999999986432          22358999999997  8999999999843   


Q ss_pred             CCceEEEEEeecchh--HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEe
Q 014595          150 KEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~  227 (422)
                        ...+++||||+.+  ++..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+...+||+
T Consensus        81 --~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          81 --PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             --SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             --CCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEEC
Confidence              3347899999863  45444433    4679999999999999999999999 8999999999999999765579999


Q ss_pred             ecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       228 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      |||+|+... .....+..||+.|+|||++.+...++.++|||||||++|+|+||+.||.+.+      ++.+.       
T Consensus       154 DFG~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-------  219 (273)
T d1xwsa_         154 DFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-------  219 (273)
T ss_dssp             CCTTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred             ccccceecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-------
Confidence            999997653 3334567899999999999776666788999999999999999999997532      22221       


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccC
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  372 (422)
                                ...            ++..+|+++++||++||+.||++|||++|+|+||||+++.
T Consensus       220 ----------~~~------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 ----------QVF------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ----------CCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ----------ccC------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                      111            2346899999999999999999999999999999998754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-56  Score=418.94  Aligned_cols=249  Identities=28%  Similarity=0.503  Sum_probs=209.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHH-HcCCCCcccccceeecCCCCCceE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      +|++++.||+|+||+||+|+++.+|+.||||++.++.       ....+|..++. .++|||||++++++.     +..+
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~~   77 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKEN   77 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSSE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCCc
Confidence            5999999999999999999999999999999986432       12345666654 689999999999984     3345


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +|+|||||++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        78 ~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~  151 (320)
T d1xjda_          78 LFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFGMCK  151 (320)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred             eeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCC-ceeccccchhh
Confidence            8899999985 77666553    4679999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014595          234 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (422)
Q Consensus       234 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (422)
                      ...... ......||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+.++...            
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------------  218 (320)
T d1xjda_         152 ENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------------  218 (320)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred             hcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence            654333 33456899999999999765 4899999999999999999999999998887777766541            


Q ss_pred             CcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHH-HHhcCCcccccC
Q 014595          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELR  372 (422)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-e~l~hp~f~~~~  372 (422)
                           ...            +++.+|+++++||++||+.||.+|||+. ++++||||+++.
T Consensus       219 -----~~~------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         219 -----NPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             -----CCC------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence                 111            2246899999999999999999999996 899999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=410.06  Aligned_cols=282  Identities=34%  Similarity=0.564  Sum_probs=222.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  156 (422)
                      +|++++.||+|+||+||+|++..+|+.||||++....      ....+|+.+|+.++||||+++++++..     ..+.+
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-----~~~~~   77 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT   77 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-----cccee
Confidence            5999999999999999999999999999999985432      334589999999999999999998843     33477


Q ss_pred             EEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccc
Q 014595          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (422)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~  236 (422)
                      ++++++.+.....+   ....+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||.|+...
T Consensus        78 iv~~~~~~~~l~~~---~~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~  152 (292)
T d1unla_          78 LVFEFCDQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAFG  152 (292)
T ss_dssp             EEEECCSEEHHHHH---HHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeeeccccccccc---cccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCC-ceeeeecchhhccc
Confidence            89999987543322   2345789999999999999999999999 8999999999999999887 69999999998765


Q ss_pred             cCC-CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ... ......+++.|+|||++.+...++.++|||||||++|||++|+.| |.+.+..+.+.++....+.+....+.....
T Consensus       153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence            433 333456788899999997776689999999999999999999987 456677778888888877776654433221


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      .......+..............+++++++||++||+.||.+||||+|+|+||||+++.+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            111111111111111222335678999999999999999999999999999999987543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=415.89  Aligned_cols=285  Identities=29%  Similarity=0.469  Sum_probs=220.8

Q ss_pred             eeeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC---CC
Q 014595           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  151 (422)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~  151 (422)
                      ..+|.+++.||+|+||+||+|++..+|+.||||++....      ....+|+.+|+.++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            356999999999999999999999999999999985432      234589999999999999999998754321   22


Q ss_pred             ceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      ..++++||||+.+++....   ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~---~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~-~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHH---TCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CceEEEEEeccCCCccchh---hhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCC-cEEeeecce
Confidence            3457899999997664433   3345689999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccccC-----CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          232 AKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       232 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      ++.....     ......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+.+..+.+..+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9765322     22344678999999999987777999999999999999999999999999999999999998888776


Q ss_pred             HHHhhcCcCCcc--CcCCCCCCCCccccc-ccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          307 EEIKCMNPNYTE--FKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       307 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      +.+......-..  +........+....+ ....+++++|||.+||++||++|||++|+|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            544332211111  111111111111111 1124788999999999999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=425.22  Aligned_cols=261  Identities=26%  Similarity=0.366  Sum_probs=207.7

Q ss_pred             eeEEe-eeeeecCCeeEEEEEEcCCCeEEEEEEeccchhhHHHHHHHHHH-cCCCCcccccceeecCCCCCceEEEEEee
Q 014595           83 SYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        83 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +|.+. +.||+|+||+||+|++..+|+.||||++... ....+|++++.+ ++|||||+++++|.+.. ....++|+|||
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~ivmE   89 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVME   89 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEEEE
Confidence            58876 5699999999999999999999999998654 446689998765 58999999999884322 33566889999


Q ss_pred             cch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC--CcEEEeecCCcccccc
Q 014595          161 YVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLVK  237 (422)
Q Consensus       161 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~--~~vkl~DfG~a~~~~~  237 (422)
                      ||+ |+|.+++...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++  ..+||+|||+|+....
T Consensus        90 y~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          90 CLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             CCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeeccC
Confidence            998 5887777542  23579999999999999999999999 8999999999999998532  2699999999988776


Q ss_pred             CCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                      .......+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+.......+...+..             .
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~-------------~  232 (335)
T d2ozaa1         167 HNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-------------G  232 (335)
T ss_dssp             CCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS-------------C
T ss_pred             CCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc-------------C
Confidence            6666778899999999998654 5899999999999999999999999887655444433321100             1


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccc
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  370 (422)
                      .+.+|.        .....+|+++++||++||+.||++|||+.|+|+||||++
T Consensus       233 ~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         233 QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             SSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             CCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            111111        111357999999999999999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-55  Score=419.89  Aligned_cols=284  Identities=35%  Similarity=0.591  Sum_probs=228.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-CCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~  155 (422)
                      +|++.+.||+|+||+||+|++..+|+.||||++.+..      ....+|+++|+.++|||||++++++..... .+..++
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            5999999999999999999999999999999986432      234589999999999999999998854432 233345


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      ++++++++++|.+++.     .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||++...
T Consensus        99 ~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~~  171 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARHT  171 (348)
T ss_dssp             EEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCC----CC
T ss_pred             EEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccc-cccccccchhccc
Confidence            5666666678877653     3579999999999999999999999 8999999999999999887 6999999998754


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .  ....+..||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.+..+........
T Consensus       172 ~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         172 D--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             T--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             C--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence            2  33456778999999999877777899999999999999999999999999999999999999888887665433211


Q ss_pred             Cc---cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCCCC
Q 014595          316 YT---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (422)
Q Consensus       316 ~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  376 (422)
                      ..   ....+......+...+ ..++++++|||++||+.||.+|||+.|+|+||||+++.++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~  312 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  312 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred             hhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence            10   0112222333333333 468999999999999999999999999999999999876553

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=421.38  Aligned_cols=283  Identities=31%  Similarity=0.528  Sum_probs=218.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch------hhHHHHHHHHHHcCCCCcccccceeecCCC-CCceEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  155 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~  155 (422)
                      +|+++++||+|+||+||+|+++.+|+.||||++....      ....+|+.++++++|||||+++++|..... ....++
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence            5999999999999999999999999999999986431      234589999999999999999999854332 245678


Q ss_pred             EEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccc
Q 014595          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (422)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~  235 (422)
                      |+|||||.+++....      ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||+++..
T Consensus        98 ~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~  169 (355)
T d2b1pa1          98 YLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA  169 (355)
T ss_dssp             EEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC----
T ss_pred             EEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccccc-ceeeechhhhhcc
Confidence            999999998765433      3578999999999999999999999 8999999999999999887 6999999999877


Q ss_pred             ccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      .........++|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+......+++...+.+..+.+......
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         170 GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             -----------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             ccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            666666677899999999999765 5899999999999999999999999999999999999999999888877654322


Q ss_pred             CccC--cCCCCCCCCc-----------ccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCcccccCCC
Q 014595          316 YTEF--KFPQIKPHPW-----------HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (422)
Q Consensus       316 ~~~~--~~~~~~~~~~-----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  374 (422)
                      ...+  ..+......+           ........++++++||++||+.||++||||+|+|+||||+...++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~  320 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  320 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence            1111  0000011111           111112346789999999999999999999999999999986543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.5e-54  Score=397.19  Aligned_cols=255  Identities=26%  Similarity=0.363  Sum_probs=201.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch-------hhHHHHHHHHHHcCCCCcccccceeecCCCCCceE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  154 (422)
                      ++|++.+.||+|+||+||+|++..+|+.||||++....       ..+.+|+++++.++|||||++++++.... ....+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCce
Confidence            45999999999999999999999999999999985422       23468999999999999999999885433 34456


Q ss_pred             EEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      +|+|||||++ +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTS-CEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccc-cceeehhhhhh
Confidence            7899999985 55544432    4679999999999999999999999 8999999999999999887 69999999986


Q ss_pred             ccccCC----CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          234 VLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       234 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      ......    .....+||+.|+|||++.+. .++.++|||||||++|+|+||++||.+.+..+.+.++......++    
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~----  234 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP----  234 (277)
T ss_dssp             ECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG----
T ss_pred             hhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC----
Confidence            543322    23456799999999999654 589999999999999999999999999888877777665211110    


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccc
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  369 (422)
                                           ......+|+++.+||.+||+.||++||+..+.+.|+|.+
T Consensus       235 ---------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 ---------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ---------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ---------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                 112246899999999999999999999555555677764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-53  Score=394.10  Aligned_cols=251  Identities=20%  Similarity=0.324  Sum_probs=202.2

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++..+.   ..+.+|+++|++++|||||++++++...     ..+++|
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~iv   91 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYII   91 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC-----CeeEEE
Confidence            46999999999999999999999999999999986543   4456899999999999999999988432     336799


Q ss_pred             eecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||+ +++...+...  ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+....
T Consensus        92 ~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          92 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG  167 (287)
T ss_dssp             EECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCCS
T ss_pred             eecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCC-cEEEccccceeecCC
Confidence            99998 4666665432  23678999999999999999999999 8999999999999999887 699999999987644


Q ss_pred             CCCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ....  ....||+.|+|||++.+. .|+.++|||||||++|||++|..||........+.+++...              
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~--------------  232 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------------  232 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--------------
T ss_pred             CCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC--------------
Confidence            3322  234578899999998654 48999999999999999999766655544444444444311              


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCCccccc
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  371 (422)
                         +..          .++..+|+++++||.+||+.||++|||+.|+++  +|+.+
T Consensus       233 ---~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         233 ---YRM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             ---CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             ---CCC----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence               000          122468999999999999999999999999965  56554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-53  Score=389.73  Aligned_cols=249  Identities=22%  Similarity=0.313  Sum_probs=200.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|++.+.||+|+||+||+|+++ +++.||||++....   ..+.+|++++++++|||||++++++..    +  .+++|
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~--~~~iv   85 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----E--PIYII   85 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----C--CeEEE
Confidence            46999999999999999999985 67899999986533   345689999999999999999997631    1  15689


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||++ +|.+.+...  ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+|+....
T Consensus        86 ~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          86 TEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLIED  161 (272)
T ss_dssp             EECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeeccc-ceeeccccceEEccC
Confidence            999984 665544322  23468999999999999999999999 8999999999999999887 699999999987654


Q ss_pred             CC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..  ......+|+.|||||++.+. .++.++|||||||++|||+|| .+||...+..+.+..+.....            
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~------------  228 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------------  228 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------
T ss_pred             CccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            33  22345678999999999654 489999999999999999995 566666666555555433110            


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc--CCcccc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  370 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~  370 (422)
                                      ...+..+++++.+||.+||+.||++|||++++++  |+||..
T Consensus       229 ----------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         229 ----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                            0112468999999999999999999999999998  888864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=385.35  Aligned_cols=243  Identities=19%  Similarity=0.322  Sum_probs=190.7

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|++.+.||+|+||+||+|++. +++.||||++..+   ...+.+|++++++++|||||++++++....     .+++||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~lv~   79 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLVF   79 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEEEE
Confidence            5999999999999999999986 5788999998653   344568999999999999999999984332     367999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      |||++ +|.+++..   ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus        80 E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          80 EFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             ECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGG-CEEECSCC--------
T ss_pred             EecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCC-CeEecccchheeccCC
Confidence            99984 66665543   23568899999999999999999999 8999999999999999887 6999999999876443


Q ss_pred             CCc--ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ...  ....||+.|+|||++.+. .|+.++|||||||++|||+| |.+||.+.+..+.+..+......            
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~------------  221 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------------  221 (263)
T ss_dssp             ----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC------------
T ss_pred             CceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC------------
Confidence            322  345689999999999654 59999999999999999999 57777777766666655442110            


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                      ..+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       222 ----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 ----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            0124578999999999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-53  Score=390.23  Aligned_cols=247  Identities=21%  Similarity=0.279  Sum_probs=195.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      .+|.+.+.||+|+||+||+|+..   ..||||++...      ...+.+|+.++++++|||||++++++..    .  .+
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~--~~   78 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----P--QL   78 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--SC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----c--EE
Confidence            35999999999999999999853   35999998532      2345689999999999999999987521    1  26


Q ss_pred             EEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++|||||+ ++|.+.+..   ....+++..+..++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+.
T Consensus        79 ~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~  153 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATV  153 (276)
T ss_dssp             EEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTS-SEEECCCCCSCC
T ss_pred             EEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCC-CEEEccccceee
Confidence            79999998 577666643   23569999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCC---CcccccccccccchhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          235 LVKGE---PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       235 ~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      .....   ......||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+....+..+......++    
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p----  229 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----  229 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC----
T ss_pred             ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC----
Confidence            54322   22345789999999998643  3478999999999999999999999998877766665554211110    


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                   .      ....+..+|+++.+||.+||..||++|||+.|+++|
T Consensus       230 -------------~------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 -------------D------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             -------------C------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------c------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                         0      011234689999999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=397.05  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=201.4

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCe-----EEEEEEeccc-----hhhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|++.+.||+|+||+||+|++..+++     .||+|.+...     ...+.+|+.++.++ +|||||++++++...   
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~---  113 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS---  113 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC---
Confidence            469999999999999999999876543     6999987542     23355899999998 899999999998433   


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhh-------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSR-------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI  210 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDl  210 (422)
                        ..+++|||||+ ++|.+++.....                   ....+++..++.++.||+.||+|||+ +|||||||
T Consensus       114 --~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDl  190 (325)
T d1rjba_         114 --GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDL  190 (325)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTC
T ss_pred             --CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccC
Confidence              33789999998 488777754321                   12458999999999999999999999 89999999


Q ss_pred             CCCCeEEcCCCCcEEEeecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 014595          211 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFP  286 (422)
Q Consensus       211 kp~Nill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~  286 (422)
                      ||+|||++.++ .+||+|||+|+........   ....||+.|||||++.+. .++.++|||||||++|||+| |++||.
T Consensus       191 Kp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         191 AARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             SGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             chhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999887 7999999999876554432   245679999999998654 58999999999999999998 899999


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       287 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      +.+....+.+++....                 ..+          .+..+|+++++||.+||+.||++|||++|+++|
T Consensus       269 ~~~~~~~~~~~~~~~~-----------------~~~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         269 GIPVDANFYKLIQNGF-----------------KMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TCCCSHHHHHHHHTTC-----------------CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCC-----------------CCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8777666666655211                 110          124679999999999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-52  Score=391.29  Aligned_cols=245  Identities=24%  Similarity=0.366  Sum_probs=188.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCe---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      ..|.+.++||+|+||+||+|+++.+++   .||||.+...     ...+.+|+++|++++|||||++++++...     .
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence            359999999999999999999987664   6899987542     23456899999999999999999998432     2


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++|||||++ +|..++..   ....+++..+..++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla  175 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLS  175 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred             EEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCC-cEEECCcccc
Confidence            37799999985 66555443   23579999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCCc------ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          233 KVLVKGEPN------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       233 ~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      +........      ....+|+.|||||++.+. .++.++|||||||++|||+| |++||.+.+..+.+..+.+...   
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~---  251 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR---  251 (299)
T ss_dssp             --------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence            876443221      124568899999999654 58999999999999999998 8999998887766665543211   


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                     .+          .+..+++++.+||.+||+.||++|||+.|++++
T Consensus       252 ---------------~~----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         252 ---------------LP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ---------------CC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------CC----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                           00          124578999999999999999999999998874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=387.80  Aligned_cols=249  Identities=26%  Similarity=0.321  Sum_probs=200.9

Q ss_pred             eeeEEeee-eeecCCeeEEEEEEcC--CCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHV-VGTGSFGVVFQAKCRE--TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|.+.+. ||+|+||+||+|.++.  ++..||||++...     ...+.+|+++|++++|||||++++++.. .     
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~-----   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-----
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C-----
Confidence            45888885 9999999999998754  4558999998643     2345689999999999999999998732 1     


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++|||||++ +|.+++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla  156 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGLS  156 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTTC
T ss_pred             eEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCC-ceeeccchhh
Confidence            16799999985 77655432   23579999999999999999999999 8999999999999999887 7999999999


Q ss_pred             cccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          233 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       233 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      +.......    .....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+...     
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-----  230 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-----  230 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----
T ss_pred             hcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            87644322    2244678999999999654 58999999999999999998 9999998887766655543110     


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHH---hcCCcccc
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFDE  370 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~---l~hp~f~~  370 (422)
                                    +         .+++.+|+++.+||.+||+.||++|||+.++   |+|+|+.-
T Consensus       231 --------------~---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         231 --------------M---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             --------------C---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------------C---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                          0         0224689999999999999999999999877   67898854

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-52  Score=380.39  Aligned_cols=243  Identities=21%  Similarity=0.297  Sum_probs=201.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|++.+.||+|+||+||+|+++ +++.||||++..+   ...+.+|+.++++++|||||++++++...     ..+++||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv~   78 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEEE
T ss_pred             HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEEE
Confidence            5889999999999999999985 7889999998653   34567899999999999999999988432     2378999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||++ +++...+..   ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.....
T Consensus        79 Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          79 EYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             ECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSS
T ss_pred             EccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCC-cEEECcchhheeccCC
Confidence            9997 455554433   24578899999999999999999999 8999999999999999887 6999999999765443


Q ss_pred             CC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014595          239 EP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (422)
Q Consensus       239 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (422)
                      ..  .....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....            
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------------  220 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------------  220 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC------------
T ss_pred             CceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence            32  2345689999999999654 48999999999999999998 89999998877766665442110            


Q ss_pred             CccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                      ..+...++++.+||++||+.||++|||+.++++|
T Consensus       221 ----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 ----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            0124578999999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=385.72  Aligned_cols=242  Identities=24%  Similarity=0.317  Sum_probs=193.7

Q ss_pred             eeeeecCCeeEEEEEEc--CCCeEEEEEEeccc------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           88 HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        88 ~~lg~G~~g~V~~~~~~--~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +.||+|+||+||+|.+.  .+++.||||++...      ...+.+|+++|++++|||||++++++.. .   .  .++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~---~--~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E---S--WMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S---S--EEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C---C--EEEEE
Confidence            57999999999999864  45678999998542      1345689999999999999999998732 1   1  56899


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      |||++ +|.+++..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.....
T Consensus        87 E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          87 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRAD  160 (277)
T ss_dssp             ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTT
T ss_pred             EcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccC-cccccchhhhhhcccc
Confidence            99985 67665543    4679999999999999999999999 8999999999999999887 7999999999876443


Q ss_pred             CCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014595          239 EPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (422)
Q Consensus       239 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (422)
                      ...    ....||+.|||||++.+. .++.++|||||||++|||+| |++||.+.+..+....+.+..            
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~------------  227 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------------  227 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             ccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC------------
Confidence            322    234678999999999654 48999999999999999998 899999887766555443310            


Q ss_pred             cCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHH---hcCCcccc
Q 014595          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFDE  370 (422)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~---l~hp~f~~  370 (422)
                          ...            ++..+|+++.+||.+||+.||++|||+.++   |+|+|++-
T Consensus       228 ----~~~------------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         228 ----RMG------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             ----CCC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCC------------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                000            124689999999999999999999999988   56777654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-53  Score=397.67  Aligned_cols=255  Identities=29%  Similarity=0.463  Sum_probs=204.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEE---cCCCeEEEEEEeccc--------hhhHHHHHHHHHHcCC-CCcccccceeecCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKVLQD--------KRYKNRELQIMQMLDH-PNIVALKHCFFSTTD  149 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vAiK~~~~~--------~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~  149 (422)
                      .+|.+++.||+|+||+||+|++   +.+|+.||||++.+.        .....+|++++++++| |||+++++++..   
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~---  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence            4599999999999999999997   447899999988532        1234589999999977 899999998833   


Q ss_pred             CCceEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEee
Q 014595          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (422)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~D  228 (422)
                        ...++++|||+.+ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus       101 --~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~vkL~D  172 (322)
T d1vzoa_         101 --ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTD  172 (322)
T ss_dssp             --TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEESC
T ss_pred             --CCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCC-CEEEee
Confidence              3358899999984 66555443    4678899999999999999999999 8999999999999999887 699999


Q ss_pred             cCCccccccCC--CcccccccccccchhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014595          229 FGSAKVLVKGE--PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (422)
Q Consensus       229 fG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~  305 (422)
                      ||+|+......  ......|++.|+|||.+.+.. .++.++|||||||+||+|+||+.||.+.+..+....+.+..... 
T Consensus       173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-  251 (322)
T d1vzoa_         173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-  251 (322)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-
T ss_pred             ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-
Confidence            99997653322  234567899999999996543 47889999999999999999999998876555555444321000 


Q ss_pred             HHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcC-----CHHHHhcCCcccccC
Q 014595          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (422)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~  372 (422)
                                  ..            .++..+++++++||++||+.||.+||     |++|+|+||||+++.
T Consensus       252 ------------~~------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         252 ------------EP------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             ------------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             ------------CC------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence                        00            02246899999999999999999999     589999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-51  Score=379.10  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=195.7

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEE
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  158 (422)
                      .+|++.+.||+|+||+||+|+++.+ +.||||++....   ..+.+|+.++++++|||||++++++..    +.  +++|
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~----~~--~~lv   89 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----EP--IYIV   89 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec----CC--eEEE
Confidence            4699999999999999999999754 679999986533   456789999999999999999998731    11  5689


Q ss_pred             eecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCcccccc
Q 014595          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (422)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~  237 (422)
                      ||||++ ++..++...  ....+++..+..++.||+.||+|||+ .||+||||||+||||+.++ .+||+|||+|+....
T Consensus        90 ~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~~  165 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIED  165 (285)
T ss_dssp             ECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC----
T ss_pred             EEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCC-cEEEcccchhhhccC
Confidence            999985 454444332  23569999999999999999999999 8999999999999999887 699999999986643


Q ss_pred             CC--CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014595          238 GE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (422)
Q Consensus       238 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (422)
                      ..  ......+|+.|+|||++.+ ..++.++|||||||++|||+|| .+||.+....+.+..+.+....           
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-----------  233 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------  233 (285)
T ss_dssp             ----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----------
T ss_pred             CCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-----------
Confidence            32  2234568999999999965 4589999999999999999995 4555666655555554432100           


Q ss_pred             CCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc--CCccccc
Q 014595          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDEL  371 (422)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~  371 (422)
                             +          .+..+++++++||.+||+.||++|||++++++  |+||...
T Consensus       234 -------~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         234 -------P----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             -------C----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -------C----------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                   0          12467999999999999999999999999987  8888764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-51  Score=377.24  Aligned_cols=244  Identities=26%  Similarity=0.348  Sum_probs=189.1

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCC---CeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|++.+.||+|+||+||+|++..+   +..||||.+...     ...+.+|+.++++++|||||++++++..      .
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~   80 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------N   80 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------S
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------C
Confidence            4699999999999999999998654   356899987532     2334589999999999999999998731      1


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++||||+++ ++..++..   ....+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||+|
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a  155 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFGLS  155 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred             eEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCC-cEEEccchhh
Confidence            36799999984 55444332   24578999999999999999999999 8999999999999999887 7999999999


Q ss_pred             cccccCCC--cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014595          233 KVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (422)
Q Consensus       233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (422)
                      +.......  .....+|+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+.+..+.....       
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-------  227 (273)
T d1mp8a_         156 RYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------  227 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------
T ss_pred             eeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------
Confidence            86543322  2345678999999999654 58999999999999999998 8999998887776666544210       


Q ss_pred             hhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                               .            .+++.+|+++.+||.+||+.||++|||+.|+++|
T Consensus       228 ---------~------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         228 ---------L------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ---------C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------C------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                     0            0235689999999999999999999999999886

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-50  Score=373.49  Aligned_cols=243  Identities=23%  Similarity=0.316  Sum_probs=185.3

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCC----eEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~----~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .|.+.++||+|+||+||+|.++.++    ..||||++...     ...+.+|++++++++|||||++++++...     .
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----~   82 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----K   82 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----S
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----C
Confidence            4999999999999999999987654    47999998542     12345899999999999999999988433     2


Q ss_pred             EEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                      .+++|||||.+ ++......   ....+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+|
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla  157 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLS  157 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred             ceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCC-eEEEcccchh
Confidence            37799999986 44443332   34679999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCC----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHH
Q 014595          233 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE  307 (422)
Q Consensus       233 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~-~pf~~~~~~~~~~~i~~~~~~~~~~  307 (422)
                      +.......    .....||+.|||||++.+. .++.++|||||||++|||++|. +||.+.+..+.+..+....      
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------  230 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------  230 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC------
Confidence            87644322    1234578999999999654 5899999999999999999965 5555555544444333211      


Q ss_pred             HHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                  ..          ..+..++.++.+||.+||..||++|||+.|+++
T Consensus       231 ------------~~----------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         231 ------------RL----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ------------CC----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------CC----------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                        00          012457899999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=381.26  Aligned_cols=244  Identities=23%  Similarity=0.341  Sum_probs=192.5

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCe----EEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCce
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      +|++.++||+|+||+||+|++..+|+    .||+|++...     ...+.+|++++++++|||||++++++...    . 
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----~-   84 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----T-   84 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----S-
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----C-
Confidence            59999999999999999999988876    5788877532     23456899999999999999999988432    1 


Q ss_pred             EEEEEeecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCc
Q 014595          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (422)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a  232 (422)
                       .++++||+. +++...+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus        85 -~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~-~~kl~DFGla  158 (317)
T d1xkka_          85 -VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFGLA  158 (317)
T ss_dssp             -EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCCSHH
T ss_pred             -eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCC-CeEeeccccc
Confidence             346667665 566554433   35679999999999999999999999 8999999999999999887 7999999999


Q ss_pred             cccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014595          233 KVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (422)
Q Consensus       233 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (422)
                      +........   ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.+.. .+    
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~----  232 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RL----  232 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CC----
T ss_pred             eecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CC----
Confidence            876443322   234579999999999765 58999999999999999998 899998877665544443311 00    


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  366 (422)
                                   +          .++.+++++.+||.+||+.||.+|||+.|+++|.
T Consensus       233 -------------~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         233 -------------P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             -------------C----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -------------C----------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence                         0          1245789999999999999999999999999983

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=376.24  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=189.8

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC-----CCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|++.+.||+|+||+||+|++..     +++.||||++....     ....+|..++.++ +|+|||.+++++...   
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~---   89 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---   89 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST---
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC---
Confidence            469999999999999999999754     45789999986432     2334566777666 689999998876432   


Q ss_pred             CceEEEEEeecch-hHHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEE
Q 014595          151 EELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  217 (422)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill  217 (422)
                       ...+++|||||+ ++|.+++.....            ....+++..++.++.||+.||+|||+ +|||||||||+|||+
T Consensus        90 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl  167 (299)
T d1ywna1          90 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL  167 (299)
T ss_dssp             -TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             -CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccceeE
Confidence             233679999998 578777765332            13458999999999999999999999 899999999999999


Q ss_pred             cCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHH
Q 014595          218 NPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQ  293 (422)
Q Consensus       218 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~  293 (422)
                      +.++ .+||+|||+|+.......   .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||.+.+..+.
T Consensus       168 ~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         168 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             CGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             CCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9887 699999999986543322   2345789999999999764 589999999999999999986 578888766665


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      +..++.....+               .            .+..+++++++||.+||+.||++|||+.|+++|
T Consensus       246 ~~~~~~~~~~~---------------~------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEGTRM---------------R------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHTCCC---------------C------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCC---------------C------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55554421110               0            124578999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=368.82  Aligned_cols=243  Identities=22%  Similarity=0.324  Sum_probs=192.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch--hhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      .+|++.+.||+|+||.||+|+++  |+.||||++..+.  ..+.+|++++++++|||||++++++....    ..+++||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv~   80 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVT   80 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEEE
Confidence            35999999999999999999984  7899999996543  44668999999999999999999874322    2267999


Q ss_pred             ecch-hHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccccccC
Q 014595          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~~~~~  238 (422)
                      ||++ +++.+++....  ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus        81 ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          81 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC-------
T ss_pred             eccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCC-CEeecccccceecCCC
Confidence            9997 47777765432  2458999999999999999999999 8999999999999999988 6999999999865332


Q ss_pred             CCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 014595          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (422)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (422)
                        .....+|+.|+|||++.+. .++.++|||||||++|||+| |++||.+.+..+.+..+.+..                
T Consensus       157 --~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~----------------  217 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------  217 (262)
T ss_dssp             -------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------------
T ss_pred             --CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------
Confidence              3345678899999999764 58999999999999999998 789998877666555543210                


Q ss_pred             cCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                         .+         .++..+++++.+||++||..||.+|||+.+++++
T Consensus       218 ---~~---------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         218 ---KM---------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             ---CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CC---------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               00         1234678999999999999999999999999873

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-49  Score=371.68  Aligned_cols=252  Identities=23%  Similarity=0.315  Sum_probs=200.6

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      ++|++.+.||+|+||+||+|+++     .+++.||||++...     ...+.+|+++++.++||||+++++++....   
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~---   89 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK---   89 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS---
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC---
Confidence            46999999999999999999975     35689999998643     234568999999999999999999884332   


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhh--------------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYS--------------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI  210 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDl  210 (422)
                        .++++|||++ ++|.+++....                    .....+++..+..++.||+.||+|||+ +|||||||
T Consensus        90 --~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrDl  166 (301)
T d1lufa_          90 --PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDL  166 (301)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCC
T ss_pred             --ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeEE
Confidence              3778999997 47777664321                    112358899999999999999999999 89999999


Q ss_pred             CCCCeEEcCCCCcEEEeecCCccccccCC---CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCC-CCCC
Q 014595          211 KPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFP  286 (422)
Q Consensus       211 kp~Nill~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~-~pf~  286 (422)
                      ||+|||++.++ .+||+|||+|+......   ......+|+.|+|||.+.+. .|+.++|||||||++|||++|. +||.
T Consensus       167 Kp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         167 ATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             SGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             cccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCC
Confidence            99999999887 69999999997654332   22345678999999999754 4999999999999999999985 7888


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcCC
Q 014595          287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (422)
Q Consensus       287 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  366 (422)
                      +.+..+.+..+.+..                   .+.         .+..+++++.+||.+||+.||++|||+.|+++  
T Consensus       245 ~~~~~e~~~~v~~~~-------------------~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--  294 (301)
T d1lufa_         245 GMAHEEVIYYVRDGN-------------------ILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR--  294 (301)
T ss_dssp             TSCHHHHHHHHHTTC-------------------CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--
T ss_pred             CCCHHHHHHHHHcCC-------------------CCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHH--
Confidence            888777766654321                   010         12468999999999999999999999999954  


Q ss_pred             ccccc
Q 014595          367 FFDEL  371 (422)
Q Consensus       367 ~f~~~  371 (422)
                      +++++
T Consensus       295 ~L~~i  299 (301)
T d1lufa_         295 ILQRM  299 (301)
T ss_dssp             HHHHT
T ss_pred             HHHHh
Confidence            55543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=367.18  Aligned_cols=243  Identities=24%  Similarity=0.345  Sum_probs=188.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCC-C--eEEEEEEeccc-------hhhHHHHHHHHHHcCCCCcccccceeecCCCCCc
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRET-G--EIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  152 (422)
                      +|++.+.||+|+||+||+|++..+ +  ..||||++.++       ...+.+|+.+|++++|||||++++++...     
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-----   83 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-----   83 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-----
Confidence            599999999999999999986433 3  46899987542       13456899999999999999999988321     


Q ss_pred             eEEEEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                       .+++||||+++ ++.+.+..   ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        84 -~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~-~vkl~DfGl  157 (273)
T d1u46a_          84 -PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFGL  157 (273)
T ss_dssp             -SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCTT
T ss_pred             -chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccccc-ceeeccchh
Confidence             25689999984 55444433   23569999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCCc----ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014595          232 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (422)
Q Consensus       232 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~  306 (422)
                      ++........    ....++..|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+.++.+..     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~-----  231 (273)
T d1u46a_         158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-----  231 (273)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-----
T ss_pred             hhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC-----
Confidence            9876444322    233567889999999764 58999999999999999998 899999998888777665421     


Q ss_pred             HHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                                  ...+          .+..+|+++.+||.+||..||++|||+.++++
T Consensus       232 ------------~~~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         232 ------------ERLP----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             ------------CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCC----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                        0111          12468899999999999999999999999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=375.14  Aligned_cols=248  Identities=23%  Similarity=0.312  Sum_probs=199.9

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCCeE--EEEEEecc-----chhhHHHHHHHHHHc-CCCCcccccceeecCCCCCce
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQ-----DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vAiK~~~~-----~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~  153 (422)
                      .+|++.++||+|+||+||+|+++.+|..  ||||++..     ....+.+|+++|+++ +|||||++++++...     .
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence            4699999999999999999999888874  67787643     223457899999999 799999999998532     3


Q ss_pred             EEEEEeecch-hHHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC
Q 014595          154 YLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  220 (422)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~  220 (422)
                      .+++||||++ ++|.+++....            .....+++..+..++.||+.||.|||+ +||+||||||+|||++.+
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcCC
Confidence            4789999998 57777765431            234679999999999999999999999 899999999999999988


Q ss_pred             CCcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 014595          221 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIK  299 (422)
Q Consensus       221 ~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~-~pf~~~~~~~~~~~i~~  299 (422)
                      + .+||+|||+|+............+|+.|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+.+..+.+
T Consensus       164 ~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         164 Y-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             G-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             C-ceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            7 6999999999876555555566789999999999654 4899999999999999999965 67887776665554432


Q ss_pred             HhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                      ..                ..            ..+..+++++++||.+||+.||++|||+.|+++|
T Consensus       242 ~~----------------~~------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 GY----------------RL------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TC----------------CC------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cC----------------CC------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            10                00            0124678999999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-49  Score=369.48  Aligned_cols=258  Identities=21%  Similarity=0.252  Sum_probs=197.6

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEEEEEee
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  160 (422)
                      +|++.+.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++|+|++..+..+..    .....++|||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~ivme   83 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVME   83 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEEEEE
Confidence            499999999999999999999999999999987543  3456789999999998887766555432    2334678999


Q ss_pred             cchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC--CCcEEEeecCCccccccC
Q 014595          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKG  238 (422)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~--~~~vkl~DfG~a~~~~~~  238 (422)
                      |+++++......   ....+++..+..++.|++.||+|||+ +||+||||||+|||++..  ...+||+|||+|+.....
T Consensus        84 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            999877655443   34679999999999999999999999 899999999999998642  236999999999876543


Q ss_pred             CC--------cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014595          239 EP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (422)
Q Consensus       239 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (422)
                      ..        .....||+.|||||++.+. .++.++|||||||++|||+||+.||.+.........+.+....    .. 
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~----~~-  233 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KM-  233 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH----HH-
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc----cC-
Confidence            22        2345789999999999764 4899999999999999999999999886655444333221100    00 


Q ss_pred             hcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHH---HHhcCCcccc
Q 014595          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL---EACVHPFFDE  370 (422)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~---e~l~hp~f~~  370 (422)
                               ..      +. ......+|+++.+||.+||+.||++||++.   ++|+|+|.+.
T Consensus       234 ---------~~------~~-~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         234 ---------ST------PI-EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ---------HS------CH-HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---------CC------Ch-hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                     00      00 011246899999999999999999999986   5578887654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=368.73  Aligned_cols=247  Identities=21%  Similarity=0.316  Sum_probs=193.3

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcCCC-------eEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  148 (422)
                      .+|++.+.||+|+||.||+|++..++       ..||||++..+.     ....+|+..+.++ +|||||++++++..  
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~--   90 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--   90 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc--
Confidence            46999999999999999999986554       479999986533     2334688888887 89999999999843  


Q ss_pred             CCCceEEEEEeecch-hHHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 014595          149 DKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Ni  215 (422)
                         ...+++|||||. +++.+++.....            ....+++..++.++.||+.||+|||+ .|||||||||+||
T Consensus        91 ---~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~Ni  166 (299)
T d1fgka_          91 ---DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNV  166 (299)
T ss_dssp             ---SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             ---CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccce
Confidence               334789999998 477777654321            23568999999999999999999999 8999999999999


Q ss_pred             EEcCCCCcEEEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 014595          216 LVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  291 (422)
Q Consensus       216 ll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~  291 (422)
                      |++.++ .+||+|||+++.......   .....+|+.|+|||.+.+. .|+.++|||||||++|||++ |.+||.+.+..
T Consensus       167 Ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         167 LVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             EECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            999887 699999999987654432   2345788999999999654 59999999999999999998 78999887766


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       292 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +....+.... .               ..            ++..+++++.+||.+||+.||++|||+.|+++
T Consensus       245 ~~~~~i~~~~-~---------------~~------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         245 ELFKLLKEGH-R---------------MD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHTTC-C---------------CC------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCC-C---------------CC------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            5544433210 0               00            12467999999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-48  Score=375.16  Aligned_cols=285  Identities=30%  Similarity=0.456  Sum_probs=210.2

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch---hhHHHHHHHHHHcC-----------CCCcccccceeecCC
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFFSTT  148 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~~~  148 (422)
                      +|+++++||+|+||+||+|+++.+|+.||||++.++.   ....+|+.+++.++           |+||+++++++....
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            4999999999999999999999999999999997654   33457999988875           577888888764322


Q ss_pred             CCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCC-----c
Q 014595          149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-----Q  223 (422)
Q Consensus       149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~-----~  223 (422)
                       ....+.++.++++.++......  ......+++..++.++.||+.||+|||+..||+||||||+|||++.++.     .
T Consensus        94 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          94 -PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             -TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             -ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence             2233333444444443333222  3345788999999999999999999996479999999999999986542     4


Q ss_pred             EEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHH
Q 014595          224 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEI  297 (422)
Q Consensus       224 vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~------~~~~~~~i  297 (422)
                      ++|+|||.+....  ......+||+.|+|||++.+. .++.++||||+||++++|++|+.||...+      ..+.+..+
T Consensus       171 ~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~  247 (362)
T d1q8ya_         171 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  247 (362)
T ss_dssp             EEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eeEeecccccccc--cccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence            9999999997653  334567899999999999764 48999999999999999999999997543      34567777


Q ss_pred             HHHhCCCCHHHHhhcCcC-------CccCcCCCCCCCCcccc------cccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          298 IKVLGTPTREEIKCMNPN-------YTEFKFPQIKPHPWHKV------FQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +..+|.++.+.+......       ............++...      +....+++++|||.+||++||.+||||+|+|+
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            888888887765432211       01111122222222111      11234678999999999999999999999999


Q ss_pred             CCcccccCC
Q 014595          365 HPFFDELRD  373 (422)
Q Consensus       365 hp~f~~~~~  373 (422)
                      ||||++...
T Consensus       328 Hp~f~~~~~  336 (362)
T d1q8ya_         328 HPWLKDTLG  336 (362)
T ss_dssp             CGGGTTCTT
T ss_pred             CcccCCCCC
Confidence            999997543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-49  Score=368.57  Aligned_cols=254  Identities=21%  Similarity=0.281  Sum_probs=204.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEcC-----CCeEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccccceeecCCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  151 (422)
                      .+|.+.+.||+|+||+||+|.+..     +++.||||++....     ..+.+|++++++++|||||++++++...    
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----   95 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG----   95 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS----
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC----
Confidence            469999999999999999998752     35789999986432     2345899999999999999999988432    


Q ss_pred             ceEEEEEeecch-hHHHHHHHHhhh------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcE
Q 014595          152 ELYLNLVLEYVP-ETVNRIARNYSR------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  224 (422)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~v  224 (422)
                       ...++|||||. +++..++.....      ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+
T Consensus        96 -~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~~-~~  172 (308)
T d1p4oa_          96 -QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-TV  172 (308)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC-CE
T ss_pred             -CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCCc-eE
Confidence             23779999998 466666543321      12346888999999999999999999 8999999999999999887 69


Q ss_pred             EEeecCCccccccCCC---cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHH
Q 014595          225 KLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKV  300 (422)
Q Consensus       225 kl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG-~~pf~~~~~~~~~~~i~~~  300 (422)
                      ||+|||+|+.......   .....+|+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+.+.
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            9999999986644332   2334679999999999654 488999999999999999998 5888888877777665542


Q ss_pred             hCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc------CCccccc
Q 014595          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDEL  371 (422)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~~  371 (422)
                      ..                   +.         .+..+++.+.+||.+||+.||++|||+.++++      +|+|+++
T Consensus       252 ~~-------------------~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         252 GL-------------------LD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             CC-------------------CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             CC-------------------CC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence            10                   00         12467899999999999999999999999998      7777764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-48  Score=364.28  Aligned_cols=248  Identities=24%  Similarity=0.321  Sum_probs=200.0

Q ss_pred             eeeEEeeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccch-----hhHHHHHHHHHHc-CCCCcccccceeecCCCC
Q 014595           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (422)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  150 (422)
                      .+|++.+.||+|+||.||+|++.     .+++.||||++....     ..+.+|+.+++.+ +|||||++++++...   
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~---   99 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG---   99 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC---
Confidence            46999999999999999999863     467899999986432     2345799999999 699999999998432   


Q ss_pred             CceEEEEEeecchh-HHHHHHHHhh--------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCe
Q 014595          151 EELYLNLVLEYVPE-TVNRIARNYS--------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (422)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Ni  215 (422)
                        ..+++|||||++ ++..++....              .....+++..+..++.||+.||+|||+ +|||||||||+||
T Consensus       100 --~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~NI  176 (311)
T d1t46a_         100 --GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNI  176 (311)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             --CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccccccc
Confidence              337799999984 7766665432              123468999999999999999999999 8999999999999


Q ss_pred             EEcCCCCcEEEeecCCccccccCCCc---ccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 014595          216 LVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  291 (422)
Q Consensus       216 ll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-G~~pf~~~~~~  291 (422)
                      |++.++ .+||+|||+++........   ....+|+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..
T Consensus       177 l~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         177 LLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            999887 7999999999876544332   23577999999999965 458999999999999999998 77778777776


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       292 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +.+.++++....+                           ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 SKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6676665531111                           112457899999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=358.25  Aligned_cols=244  Identities=19%  Similarity=0.258  Sum_probs=187.6

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCC---eEEEEEEeccc-----hhhHHHHHHHHHHcCCCCcccccceeecCCCCCceEE
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~---~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  155 (422)
                      +...++||+|+||+||+|++..++   ..||||++...     ...+.+|+++|++++|||||++++++....    ...
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cce
Confidence            344688999999999999986543   36999998532     234568999999999999999999875322    247


Q ss_pred             EEEeecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCCCcEEEeecCCccc
Q 014595          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (422)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~~~vkl~DfG~a~~  234 (422)
                      ++|||||++ ++.+++..   ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~  179 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGLARD  179 (311)
T ss_dssp             EEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSSGGGCC
T ss_pred             EEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCC-CEEEecccchhh
Confidence            799999995 55555443   23567788899999999999999999 8999999999999999887 699999999986


Q ss_pred             cccCCC-----cccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHH
Q 014595          235 LVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREE  308 (422)
Q Consensus       235 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~  308 (422)
                      ......     .....||+.|+|||.+.+. .++.++|||||||++|||+||..||...... +....+...  .     
T Consensus       180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~-----  251 (311)
T d1r0pa_         180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R-----  251 (311)
T ss_dssp             TTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--C-----
T ss_pred             ccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--C-----
Confidence            643322     2235678999999998654 5899999999999999999977777654322 222222221  0     


Q ss_pred             HhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhcC
Q 014595          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (422)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  365 (422)
                                  .+         ..+..+++++.+||.+||..||++|||+.|+++|
T Consensus       252 ------------~~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 ------------RL---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CC---------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                        00         0124578999999999999999999999999997

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.8e-47  Score=352.33  Aligned_cols=248  Identities=19%  Similarity=0.205  Sum_probs=197.0

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEecc--chhhHHHHHHHHHHcCC-CCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|++.+.||+|+||+||+|++..+|+.||||++..  ......+|+++++.|.| +||+.+++++     ......++||
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~vm   80 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLVI   80 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEEEE
Confidence            49999999999999999999999999999998754  33456789999999976 8999988877     3344578999


Q ss_pred             ecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCC----CCcEEEeecCCcccc
Q 014595          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKVL  235 (422)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~----~~~vkl~DfG~a~~~  235 (422)
                      ||+++++..++..   ....+++..+..++.|++.||+|||+ +||+||||||+|||++..    .+.+||+|||+|+..
T Consensus        81 e~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            9999888776554   23579999999999999999999999 899999999999999742    236999999999876


Q ss_pred             ccCC--------CcccccccccccchhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC
Q 014595          236 VKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTP  304 (422)
Q Consensus       236 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltG~~pf~~~~~~---~~~~~i~~~~~~~  304 (422)
                      ....        .....+||+.|||||++.+. .++.++|||||||++|||+||+.||.+....   .....+......+
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            4322        22346799999999999764 5899999999999999999999999865432   3333332211111


Q ss_pred             CHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      +...                        +...+|+++.+++..|+..+|++||+.+.+.+
T Consensus       236 ~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 PLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             CHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ChHH------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            1111                        11467899999999999999999999876654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=358.69  Aligned_cols=266  Identities=21%  Similarity=0.193  Sum_probs=186.9

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccchhh-HHH--HHHHHHHcCCCCcccccceeecCCCCCceEEEEEe
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNR--ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~--E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  159 (422)
                      +|++.+.||+|+||+||+|++  +|+.||||++..+... ..+  |+..+..++|||||++++++.... .....+++||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence            599999999999999999987  5899999998654322 223  444556789999999999886544 3445678999


Q ss_pred             ecchh-HHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-------CCceecCCCCCCeEEcCCCCcEEEeecCC
Q 014595          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-------IGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (422)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-------~givHrDlkp~Nill~~~~~~vkl~DfG~  231 (422)
                      |||++ +|..++..     ..+++.....++.|++.||.|||+.       +|||||||||+||||+.++ .+||+|||+
T Consensus        81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl  154 (303)
T d1vjya_          81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL  154 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTT
T ss_pred             ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCc
Confidence            99975 88777754     4689999999999999999999951       5999999999999999887 799999999


Q ss_pred             ccccccCCC-----cccccccccccchhhhcCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014595          232 AKVLVKGEP-----NVSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  301 (422)
Q Consensus       232 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltG~~pf~~~~~~~~~~~i~~~~  301 (422)
                      ++.......     .....||+.|+|||++.+..     .++.++|||||||+||||+||..||............ ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~  233 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVP  233 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSC
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-ccc
Confidence            987654432     23467899999999985432     2567899999999999999999887432211000000 000


Q ss_pred             CCCCHHHHhhcCcCCccCcCCCCCCCCcccccccCCChHHHHHHHhhhhcCCCCcCCHHHHhc
Q 014595          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (422)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  364 (422)
                      ..+....+....      ......+..............+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~------~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         234 SDPSVEEMRKVV------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SSCCHHHHHHHH------TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHH------hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            001111110000      000000000001111123356899999999999999999999976

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=3.9e-26  Score=198.22  Aligned_cols=166  Identities=16%  Similarity=0.111  Sum_probs=117.1

Q ss_pred             eEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccch----------------------hhHHHHHHHHHHcCCCCccccc
Q 014595           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------------------RYKNRELQIMQMLDHPNIVALK  141 (422)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~  141 (422)
                      |.+++.||+|+||+||+|++. +|+.||||++....                      ....+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            578899999999999999985 68999999864211                      1113578889999999998876


Q ss_pred             ceeecCCCCCceEEEEEeecchhHHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCCeEEcCCC
Q 014595          142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  221 (422)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~givHrDlkp~Nill~~~~  221 (422)
                      ++.     .    .+++|||+++..          ...+++..+..++.|++.||.|||+ +||+||||||+|||++.+ 
T Consensus        81 ~~~-----~----~~lvme~~~~~~----------~~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKE----------LYRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEE----------GGGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETT-
T ss_pred             Eec-----C----CEEEEEeecccc----------ccchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCC-
Confidence            543     1    258999998632          1234555567889999999999999 899999999999999965 


Q ss_pred             CcEEEeecCCccccccCCCcccccccccccchhhhcCCCCCCCcchHHHHHHHH
Q 014595          222 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVM  275 (422)
Q Consensus       222 ~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  275 (422)
                       .++|+|||.|......... .+..--...-.+.+ . ..|+.++|+||+.--+
T Consensus       140 -~~~liDFG~a~~~~~~~~~-~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWR-EILERDVRNIITYF-S-RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHH-HHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcH-HHHHHHHHHHHHHH-c-CCCCCcccHHHHHHHH
Confidence             4999999999765322111 00000000001223 2 3488999999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.14  E-value=6.2e-06  Score=72.60  Aligned_cols=75  Identities=16%  Similarity=0.113  Sum_probs=47.8

Q ss_pred             eeEEeeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----hhhHHHHHHHHHHcC-CCCcccccceeecCCCCCceEEEE
Q 014595           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (422)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~l  157 (422)
                      .|++.+..+.++.+.||+..  ..++.+.+|+....    .....+|...++.+. +-.+.+++.+.     ......++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence            36677766656667899886  34667888877543    234568999988874 32234444443     12234668


Q ss_pred             Eeecchh
Q 014595          158 VLEYVPE  164 (422)
Q Consensus       158 v~e~~~~  164 (422)
                      ||++++|
T Consensus        88 v~~~l~G   94 (263)
T d1j7la_          88 LMSEADG   94 (263)
T ss_dssp             EEECCSS
T ss_pred             EEEeccc
Confidence            9999975

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.81  E-value=6.7e-05  Score=70.07  Aligned_cols=71  Identities=18%  Similarity=0.203  Sum_probs=42.3

Q ss_pred             eeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----------chhhHHHHHHHHHHcC-C-C-CcccccceeecCCCCCc
Q 014595           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD-H-P-NIVALKHCFFSTTDKEE  152 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vAiK~~~~-----------~~~~~~~E~~~l~~l~-h-~-nIv~l~~~~~~~~~~~~  152 (422)
                      .+.||.|....||++.+..+++.|+||.-..           .......|.+.|+.+. + | .+.+++.+  +   .+.
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d---~~~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c---CCC
Confidence            4568999999999999877788899996421           1122346888888773 2 2 23333322  1   112


Q ss_pred             eEEEEEeecchh
Q 014595          153 LYLNLVLEYVPE  164 (422)
Q Consensus       153 ~~~~lv~e~~~~  164 (422)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              2479999863

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.72  E-value=5.3e-05  Score=65.98  Aligned_cols=68  Identities=18%  Similarity=0.145  Sum_probs=42.3

Q ss_pred             eecC-CeeEEEEEEcCCCeEEEEEEeccch-hhHHHHHHHHHHcCCCCc--ccccceeecCCCCCceEEEEEeecchh
Q 014595           91 GTGS-FGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYVPE  164 (422)
Q Consensus        91 g~G~-~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~l~h~nI--v~l~~~~~~~~~~~~~~~~lv~e~~~~  164 (422)
                      ..|. -+.||+... .++..+.+|...... ....+|+..++.|....+  .+++.+...   .  ...++||++++|
T Consensus        19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~---~--~~~~~v~~~i~G   90 (255)
T d1nd4a_          19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE---A--GRDWLLLGEVPG   90 (255)
T ss_dssp             SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC---S--SCEEEEEECCSS
T ss_pred             CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc---c--cceEEEEEeeec
Confidence            4444 367898875 456778889765433 345789999988854333  344444321   1  235689999863

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.93  E-value=0.0016  Score=58.66  Aligned_cols=40  Identities=18%  Similarity=0.013  Sum_probs=29.4

Q ss_pred             CeeEEEEEEcCCCeEEEEEEeccc---hhhHHHHHHHHHHcCCC
Q 014595           95 FGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHP  135 (422)
Q Consensus        95 ~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~  135 (422)
                      --.||++.. .+|+.|++|+....   ...+..|...+..|...
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~   77 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVND   77 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHT
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhc
Confidence            358999987 46888999987653   34456788888888543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.37  E-value=0.0077  Score=55.54  Aligned_cols=68  Identities=18%  Similarity=0.238  Sum_probs=43.7

Q ss_pred             eeeeeecCCeeEEEEEEcC-------CCeEEEEEEeccc--hhhHHHHHHHHHHcCCCCcc-cccceeecCCCCCceEEE
Q 014595           87 EHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLN  156 (422)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~-------~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~~~~~~  156 (422)
                      ++.|+.|-.-.+|++....       ..+.|.+++.-..  .....+|..+++.+.-.++. ++++++     .+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence            4568888888999998753       2356777765422  22345799999988544544 555544     21    2


Q ss_pred             EEeecch
Q 014595          157 LVLEYVP  163 (422)
Q Consensus       157 lv~e~~~  163 (422)
                      +|+||++
T Consensus       118 ~I~efi~  124 (395)
T d1nw1a_         118 RLEEYIP  124 (395)
T ss_dssp             EEECCCC
T ss_pred             eEEEEec
Confidence            5788875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.93  E-value=0.014  Score=51.72  Aligned_cols=30  Identities=27%  Similarity=0.269  Sum_probs=25.8

Q ss_pred             CCceecCCCCCCeEEcCCCCcEEEeecCCcc
Q 014595          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (422)
Q Consensus       203 ~givHrDlkp~Nill~~~~~~vkl~DfG~a~  233 (422)
                      .|+||+|+.++||+++.+. ..-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCcchhhhhccccc-ceeEecccccc
Confidence            4799999999999999765 46899999874